Citrus Sinensis ID: 013064
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | 2.2.26 [Sep-21-2011] | |||||||
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.868 | 0.853 | 0.514 | 1e-117 | |
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.868 | 0.844 | 0.511 | 1e-116 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | yes | no | 0.906 | 0.879 | 0.495 | 1e-116 | |
| Q5R8M1 | 465 | Serine/threonine-protein | no | no | 0.891 | 0.862 | 0.492 | 1e-114 | |
| Q15208 | 465 | Serine/threonine-protein | no | no | 0.891 | 0.862 | 0.492 | 1e-114 | |
| A2VDV2 | 465 | Serine/threonine-protein | no | no | 0.891 | 0.862 | 0.492 | 1e-114 | |
| Q7TSE6 | 464 | Serine/threonine-protein | yes | no | 0.906 | 0.879 | 0.483 | 1e-114 | |
| Q91VJ4 | 465 | Serine/threonine-protein | no | no | 0.891 | 0.862 | 0.487 | 1e-113 | |
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.871 | 0.773 | 0.485 | 1e-113 | |
| Q5AP53 | 732 | Serine/threonine-protein | N/A | no | 0.882 | 0.542 | 0.465 | 1e-109 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 422 bits (1084), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/406 (51%), Positives = 290/406 (71%), Gaps = 15/406 (3%)
Query: 5 QAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE 64
++ ++ QE+ L++ ++ ETEY+RL+R ++G++DFE L +IG+GAFGEVRL + K TG
Sbjct: 58 ESLTESQRQEKRLQHAQK-ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGH 116
Query: 65 IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD 124
++AMK L+K++ML++ QV HVR+ER++L E D + +V+++YSFQD LYLIME+LPGGD
Sbjct: 117 VYAMKVLRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGD 176
Query: 125 IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184
+MTLLM++D LSE+ +FYI+E+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGL
Sbjct: 177 MMTLLMKKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGL 236
Query: 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP---KERLQQWKRNRRALAYSTVGTLD 241
C L+ + + D ++Q S+ G P K R + WKRNRRALAYSTVGT D
Sbjct: 237 CTGLKKSHRTDFYRD---LSQAKPSDFIGTCASPMDSKRRAESWKRNRRALAYSTVGTPD 293
Query: 242 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 301
Y+APEV L+ GYG CDWWSLG IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E
Sbjct: 294 YIAPEVFLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEI 353
Query: 302 KISDEARDLICHLLCDVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELD 360
IS+EA++ I C+ + RLG+ RG+E+LK P+FRG+ W+ + E AA V D
Sbjct: 354 PISEEAKETIIKFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDD 413
Query: 361 TQNFEKFPEV--DGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDV 404
T NF++FP+V + P + IP G +KD FI YT+K+ +V
Sbjct: 414 TSNFDEFPDVSLEIPSAPIPQGGE-----IAKDWVFINYTYKRFEV 454
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 208/407 (51%), Positives = 286/407 (70%), Gaps = 16/407 (3%)
Query: 7 AVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF 66
++S +++E ++ETEY+RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++
Sbjct: 60 SLSEAQRQEKRLQHAQKETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVY 119
Query: 67 AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIM 126
AMK L+K++ML++ QV HVR+ER++L E D + +V+++YSFQD LYLIME+LPGGD+M
Sbjct: 120 AMKVLRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMM 179
Query: 127 TLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186
TLLM++D LSE+ +FYI+E+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGLC
Sbjct: 180 TLLMKKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCT 239
Query: 187 PLEDKYSSILLED------EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 240
L+ + + D D I T + M K R + WKRNRRALAYSTVGT
Sbjct: 240 GLKKSHRTDFYRDLSQAKPSDFIG--TCASLSCSPMDSKRRAESWKRNRRALAYSTVGTP 297
Query: 241 DYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE 300
DY+APEV L+ GYG CDWWSLG IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E
Sbjct: 298 DYIAPEVFLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPE 357
Query: 301 PKISDEARDLICHLLCDVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGEL 359
IS+EA++ I + C+ + RLG+ RG+E+LK P+FRG+ W+ + E AA V
Sbjct: 358 IPISEEAKETIINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSID 417
Query: 360 DTQNFEKFPEV--DGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDV 404
DT NF++FP+V + P + IP G +KD FI YT+K+ +V
Sbjct: 418 DTSNFDEFPDVSLEIPSAPIPQGGE-----IAKDWVFINYTYKRFEV 459
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 417 bits (1072), Expect = e-116, Method: Compositional matrix adjust.
Identities = 205/414 (49%), Positives = 283/414 (68%), Gaps = 6/414 (1%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
++ +++EE++ R+ETE++RL+R ++G+DDFE L +IG+GAFGEVRL + K TG
Sbjct: 54 EEEGLADEEKKLRRSQHARKETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTG 113
Query: 64 EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
I+AMK L+KS+ML++ QV H+R+ER++L E D +V++FYSFQD LYLIME+LPGG
Sbjct: 114 HIYAMKILRKSDMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 173
Query: 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183
D+MTLLM++D L+E+ +FYI+E+VLAI +IHQ ++HRDIKPDNL+LD GH+KLSDFG
Sbjct: 174 DMMTLLMKKDTLTEEETQFYISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 233
Query: 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243
LC L+ + + + + S+ Q M K + + WK+NRR LAYSTVGT DY+
Sbjct: 234 LCTGLKKAHRTEFYRN---LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI 290
Query: 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 303
APEV ++ GY CDWWSLG IMYEMLIGYPPFCS+ P+ T RK++NWK L FP E I
Sbjct: 291 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPI 350
Query: 304 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
S++A+DLI D E R+G GVEE+K HP+F G+ W+ + E AA + DT N
Sbjct: 351 SEKAKDLILRFCIDSENRIGNSGVEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSN 410
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 417
F+ FPE D + P K SKD F+ YT+K+ + L + T M++
Sbjct: 411 FDDFPESDILQPVPNTTEPDYK---SKDWVFLNYTYKRFEGLTQRGSIPTYMKA 461
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 199/404 (49%), Positives = 279/404 (69%), Gaps = 3/404 (0%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
++ + +EE+ R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG
Sbjct: 53 EEEGLKDEEKRLRRSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTG 112
Query: 64 EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
++AMK L+K++ML++ QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGG
Sbjct: 113 HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 172
Query: 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183
D+MTLLM++D L+E+ +FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFG
Sbjct: 173 DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 232
Query: 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243
LC L+ + + + +N S+ Q M K + + WKRNRR LA+STVGT DY+
Sbjct: 233 LCTGLKKAHRTEFYRN---LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI 289
Query: 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 303
APEV ++ GY CDWWSLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E I
Sbjct: 290 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPI 349
Query: 304 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
S++A+DLI C+ E R+G GVEE+K + +F G+ W+ + E AA + DT N
Sbjct: 350 SEKAKDLILRFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSN 409
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407
F++FPE D + + +KD FI YT+K+ + L +
Sbjct: 410 FDEFPESDILKPTVATSNHPETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 199/404 (49%), Positives = 279/404 (69%), Gaps = 3/404 (0%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
++ + +EE+ R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG
Sbjct: 53 EEEGLKDEEKRLRRSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTG 112
Query: 64 EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
++AMK L+K++ML++ QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGG
Sbjct: 113 HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 172
Query: 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183
D+MTLLM++D L+E+ +FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFG
Sbjct: 173 DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 232
Query: 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243
LC L+ + + + +N S+ Q M K + + WKRNRR LA+STVGT DY+
Sbjct: 233 LCTGLKKAHRTEFYRN---LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI 289
Query: 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 303
APEV ++ GY CDWWSLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E I
Sbjct: 290 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPI 349
Query: 304 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
S++A+DLI C+ E R+G GVEE+K + +F G+ W+ + E AA + DT N
Sbjct: 350 SEKAKDLILRFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSN 409
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407
F++FPE D + + +KD FI YT+K+ + L +
Sbjct: 410 FDEFPESDILKPTVATSNHPETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1061), Expect = e-114, Method: Compositional matrix adjust.
Identities = 199/404 (49%), Positives = 279/404 (69%), Gaps = 3/404 (0%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
++ + +EE+ R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG
Sbjct: 53 EEEGLKDEEKRLRRSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTG 112
Query: 64 EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
++AMK L+K++ML++ QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGG
Sbjct: 113 HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 172
Query: 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183
D+MTLLM++D L+E+ +FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFG
Sbjct: 173 DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 232
Query: 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243
LC L+ + + + +N S+ Q M K + + WKRNRR LA+STVGT DY+
Sbjct: 233 LCTGLKKAHRTEFYRN---LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI 289
Query: 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 303
APEV ++ GY CDWWSLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E I
Sbjct: 290 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPI 349
Query: 304 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
S++A+DLI C+ E R+G GVEE+K + +F G+ W+ + E AA + DT N
Sbjct: 350 SEKAKDLILRFCCEWEHRIGAPGVEEIKNNSFFEGVDWEHIRERPAAISIEIKSIDDTSN 409
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407
F++FPE D + + +KD FI YT+K+ + L +
Sbjct: 410 FDEFPESDILKPTVATSNHPDTDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-114, Method: Compositional matrix adjust.
Identities = 200/414 (48%), Positives = 282/414 (68%), Gaps = 6/414 (1%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
++ +++EE++ R+ETE++RL+R ++G+DDFE L +IG+GAFGEVRL + K TG
Sbjct: 54 EEEGLADEEKKLRRSQHARKETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTG 113
Query: 64 EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
I+AMK L+K++ML++ QV H+R+ER++L E D +V++FYSFQD LYLIME+LPGG
Sbjct: 114 HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 173
Query: 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183
D+MTLLM++D L+E+ +FYI+E+VLAI +IHQ ++HRD+KPDNL+LD GH+KLSDFG
Sbjct: 174 DMMTLLMKKDTLTEEETQFYISETVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFG 233
Query: 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243
LC L+ + + + + S+ Q M K + + WK+NRR LAYSTVGT DY+
Sbjct: 234 LCTGLKKAHRTEFYRN---LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI 290
Query: 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 303
APEV ++ GY CDWWSLG IMYEMLIG+PPFCS+ P+ T RK+++WK L FP E +
Sbjct: 291 APEVFMQTGYNKLCDWWSLGVIMYEMLIGFPPFCSETPQETYRKVMSWKETLAFPPEVPV 350
Query: 304 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
S++A+DLI D E R+G GVEE+K HP+F G+ W + E AA + DT N
Sbjct: 351 SEKAKDLILRFCTDSENRIGNGGVEEIKGHPFFEGVDWGHIRERPAAIPIEIRSIDDTSN 410
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 417
F+ FPE D + P K SKD F+ YT+K+ + L + T M++
Sbjct: 411 FDDFPESDILQPVPNTTEPDYK---SKDWVFLNYTYKRFEGLTQRGSIPTYMKA 461
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1051), Expect = e-113, Method: Compositional matrix adjust.
Identities = 197/404 (48%), Positives = 278/404 (68%), Gaps = 3/404 (0%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
++ + +EE+ R+ETE++RL+R ++G++DFE L +IG+GAFGEVRL + K TG
Sbjct: 53 EEEGLKDEEKRLRRSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTG 112
Query: 64 EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
++AMK L+K++ML++ QV H+R+ER++L E DS +V++FYSFQD LYLIME+LPGG
Sbjct: 113 HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 172
Query: 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183
D+MTLLM++D L+E+ +FYIAE+VLAI SIHQ ++HRDIKPDNL+LD GH+KLSDFG
Sbjct: 173 DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 232
Query: 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243
LC L+ + + + +N S+ Q M K + + WKRNRR LA+STVGT DY+
Sbjct: 233 LCTGLKKAHRTEFYRN---LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI 289
Query: 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI 303
APEV ++ GY CDWWSLG IMYEMLIGYPPFCS+ P+ T +K++NWK L FP E +
Sbjct: 290 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPV 349
Query: 304 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
S++A+ LI C+ E R+G GVEE+K + +F G+ W+ + E AA + DT N
Sbjct: 350 SEKAKGLILRFCCEWEHRIGAPGVEEIKNNLFFEGVDWEHIRERPAAISIEIKSIDDTSN 409
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407
F++FPE D + + +KD FI YT+K+ + L +
Sbjct: 410 FDEFPESDILKPTVTTSSHPETDYKNKDWVFINYTYKRFEGLTA 453
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 408 bits (1049), Expect = e-113, Method: Compositional matrix adjust.
Identities = 200/412 (48%), Positives = 280/412 (67%), Gaps = 20/412 (4%)
Query: 9 SNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAM 68
S E ++ L +L ++E++++RL+R K+ ++DF + +IGKGAFGEVRL + TG+I+AM
Sbjct: 95 SEERKKRQLNSLGQKESQFLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAM 154
Query: 69 KKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL 128
K L KSEM K+ Q+ HV++ER++LAE DS +V L+YSFQDS +LYLIME+LPGGD+MT+
Sbjct: 155 KTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTM 214
Query: 129 LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC--- 185
L++ D SEDV RFYIAE +LAI ++H+ ++HRDIKPDN+++DK GH+KLSDFGL
Sbjct: 215 LIKYDTFSEDVTRFYIAECILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGF 274
Query: 186 -KPLEDKYSSILLEDEDIINQETVSEAEGQW-------MMPKERLQQWKRNRRALAYSTV 237
K ++ Y L E + IN T S M K+++ WK+NRR +AYSTV
Sbjct: 275 HKTHDNAYYQRLFESK--INTSTSSTQNSLMVDTISLTMSSKDKIATWKKNRRIMAYSTV 332
Query: 238 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 297
GT DY+APE+ + GYG ECDWWSLGAIM+E LIG+PPFCS++ T RKI+NW+ L F
Sbjct: 333 GTPDYIAPEIFTQHGYGQECDWWSLGAIMFECLIGWPPFCSENAHETYRKIINWRENLYF 392
Query: 298 PEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357
PE+ +S EA DLI LL + RLG G ++K HP+FRG+ WD + E+ A + P +
Sbjct: 393 PEDLHLSAEAEDLIRKLLTSADQRLGRYGANDIKLHPFFRGVNWDTIREINAPFIPQLKS 452
Query: 358 ELDTQNFEKFPEVDGPPSEIPSVGP--WRKMLTSKDTN--FIGYTFKKSDVL 405
DT FE E+D P+ + P K+ + D N F+GYT+K+ D++
Sbjct: 453 ITDTSYFE---EIDTIPNITMNSPPVLQNKIPSDVDQNLAFVGYTYKRFDMM 501
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5AP53|CBK1_CANAL Serine/threonine-protein kinase CBK1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 396 bits (1018), Expect = e-109, Method: Compositional matrix adjust.
Identities = 197/423 (46%), Positives = 281/423 (66%), Gaps = 26/423 (6%)
Query: 9 SNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAM 68
S E + L+NL ++E++++RL+R K+ ++DF + +IGKGAFGEVRL + K TG+I+AM
Sbjct: 304 SEERKNRQLQNLGKKESQFLRLKRTKLALEDFHTVKVIGKGAFGEVRLVQKKDTGKIYAM 363
Query: 69 KKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL 128
K L KSEM + Q+ HV++ER++LA DS IV L+YSFQDS +LYLIME+LPGGD+MT+
Sbjct: 364 KTLLKSEMFNKDQLAHVKAERDVLAGSDSPWIVALYYSFQDSQYLYLIMEFLPGGDLMTM 423
Query: 129 LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC--- 185
L+R ++ +ED+ RFYIAE VLAI +IH+ ++HRDIKPDN+++D GH+KLSDFGL
Sbjct: 424 LIRWEVFTEDITRFYIAECVLAIEAIHKLGFIHRDIKPDNILIDNRGHVKLSDFGLSTGF 483
Query: 186 -KPLEDKYSSILLEDEDI-----INQET------VSEAEGQWMMPKERLQQWKRNRRALA 233
K + Y + LLE E NQ T + +A M ++ +Q W+++RR +A
Sbjct: 484 HKTHDSNYYNKLLEKEPSNTHLQPNQLTSGRNSVMVDAIHLTMSNRQTMQTWRKSRRLMA 543
Query: 234 YSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT 293
YSTVGT DY+APE+ + +GYG ECDWWSLGAIM+E LIG+PPFCS++P T RKI+NW+
Sbjct: 544 YSTVGTPDYIAPEIFIHQGYGQECDWWSLGAIMFECLIGWPPFCSENPHDTYRKILNWQE 603
Query: 294 CLKFPEEPKISDEARDLICHLLCDVETRLGTR-GVEELKEHPWFRGIQWDKLYEMEAAYK 352
+ PE+ +S EA DLI L E R+G G EE+K+HP+FRG+ WD + ++A +
Sbjct: 604 SFQIPEDVHLSPEAEDLIKRFLTSAENRIGRYGGAEEIKQHPFFRGVDWDSIRGVQAPFV 663
Query: 353 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK----------DTNFIGYTFKKS 402
P ++ DT++F P + S ++ L +K D FIGYT+ +
Sbjct: 664 PRLSSMTDTRHFPTDDLASVPDNPAMSKAMEQRELDAKNGGGRKNPKEDLPFIGYTYSRF 723
Query: 403 DVL 405
D L
Sbjct: 724 DYL 726
|
Serine/threonine-protein kinase required for wild-type hyphal growth and transcriptional regulation of cell-wall-associated genes. Involved in the biofilm formation through phosphorylation of the master regulator of biofilm formation BCR1. Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| 224063515 | 523 | predicted protein [Populus trichocarpa] | 0.993 | 0.854 | 0.865 | 0.0 | |
| 356564186 | 525 | PREDICTED: serine/threonine-protein kina | 0.993 | 0.851 | 0.847 | 0.0 | |
| 255538292 | 522 | serine/threonine-protein kinase, putativ | 0.971 | 0.837 | 0.871 | 0.0 | |
| 356552208 | 523 | PREDICTED: serine/threonine-protein kina | 0.993 | 0.854 | 0.847 | 0.0 | |
| 449450225 | 523 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.852 | 0.841 | 0.0 | |
| 225458621 | 525 | PREDICTED: serine/threonine-protein kina | 0.986 | 0.845 | 0.847 | 0.0 | |
| 224137506 | 528 | predicted protein [Populus trichocarpa] | 0.984 | 0.839 | 0.854 | 0.0 | |
| 357437805 | 520 | Serine/threonine protein kinase 38-like | 0.982 | 0.85 | 0.834 | 0.0 | |
| 297811091 | 515 | hypothetical protein ARALYDRAFT_487812 [ | 0.988 | 0.864 | 0.796 | 0.0 | |
| 31088224 | 461 | protein kinase [Raphanus sativus] | 0.988 | 0.965 | 0.796 | 0.0 |
| >gi|224063515|ref|XP_002301182.1| predicted protein [Populus trichocarpa] gi|222842908|gb|EEE80455.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/455 (86%), Positives = 425/455 (93%), Gaps = 8/455 (1%)
Query: 1 MRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK 60
MRAQ+A VSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLT+IGKGAFGEVRLCRAK
Sbjct: 69 MRAQEAQVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTVIGKGAFGEVRLCRAK 128
Query: 61 TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 120
TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDFLYLIMEYL
Sbjct: 129 DTGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDFLYLIMEYL 188
Query: 121 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 180
PGGDIMTLLMREDILSEDVARFYIAES+LAI SIHQHNYVHRDIKPDNLILDKNGHLKLS
Sbjct: 189 PGGDIMTLLMREDILSEDVARFYIAESILAIQSIHQHNYVHRDIKPDNLILDKNGHLKLS 248
Query: 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ-------WMMPKERLQQWKRNRRALA 233
DFGLCKPL+DKYS+ LLE+E+ QE +E+EG W+MPKE+LQQWKRNRRALA
Sbjct: 249 DFGLCKPLDDKYSN-LLENENFSTQEGRNESEGHSTSDRPPWLMPKEKLQQWKRNRRALA 307
Query: 234 YSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT 293
YSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD+PRITCRKI+NWKT
Sbjct: 308 YSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDEPRITCRKIINWKT 367
Query: 294 CLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKP 353
CLKFPEEPKIS EA+DLICHLLCDVETRLGTRGVEELK HPWFR QWD LYE+EAAYKP
Sbjct: 368 CLKFPEEPKISSEAKDLICHLLCDVETRLGTRGVEELKVHPWFRSTQWDFLYELEAAYKP 427
Query: 354 TVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGT 413
TVNG+LDTQNFEKFP+++GPPS IPSVGPWRKMLTSKDTNFIG+T+KKSDVLKS+++SGT
Sbjct: 428 TVNGDLDTQNFEKFPDLEGPPSTIPSVGPWRKMLTSKDTNFIGFTYKKSDVLKSMQSSGT 487
Query: 414 DMRSNGSSKVPSLISLLGRIDVQETAISECDQQKQ 448
DM+ N SSK PSLISLLG+ID+QETA SE +Q+ +
Sbjct: 488 DMKLNDSSKAPSLISLLGQIDLQETATSEGEQKPE 522
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564186|ref|XP_003550337.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2108), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/451 (84%), Positives = 418/451 (92%), Gaps = 4/451 (0%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
+ Q++ VS EEQEEM+RNLERRETEYMRLQRRKIGIDDFEQLT+IGKGAFGEVRLCRAK
Sbjct: 74 KVQESQVSAEEQEEMMRNLERRETEYMRLQRRKIGIDDFEQLTVIGKGAFGEVRLCRAKD 133
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+L YSFQDSDFLYLIMEYLP
Sbjct: 134 TGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLHYSFQDSDFLYLIMEYLP 193
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD
Sbjct: 194 GGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 253
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEG----QWMMPKERLQQWKRNRRALAYSTV 237
FGLCKPL+DKYSSILLE++D+ +QE+ SE EG W+MPKE+LQQWKRNRRALAYSTV
Sbjct: 254 FGLCKPLDDKYSSILLENDDLTSQESTSETEGYSVSPWLMPKEQLQQWKRNRRALAYSTV 313
Query: 238 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 297
GTLDYMAPEVLLKKGYG+ECDWWSLGAIMYEMLIGYPPFCSDDPR+ CRKIVNWKTCLKF
Sbjct: 314 GTLDYMAPEVLLKKGYGIECDWWSLGAIMYEMLIGYPPFCSDDPRMACRKIVNWKTCLKF 373
Query: 298 PEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357
P+EPKIS EA+DLIC LLCDV++RLGTRG+EE+K HPWF+G+QWD LYE EAAYKPTV G
Sbjct: 374 PDEPKISAEAKDLICRLLCDVDSRLGTRGIEEIKAHPWFKGVQWDMLYESEAAYKPTVTG 433
Query: 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 417
+LDTQNFEKFPEVDGPPS +VGPWRKMLTSKD NFIGYTFKKSD+LKSLE+S D+R
Sbjct: 434 DLDTQNFEKFPEVDGPPSVTATVGPWRKMLTSKDNNFIGYTFKKSDILKSLESSDADIRV 493
Query: 418 NGSSKVPSLISLLGRIDVQETAISECDQQKQ 448
NGSSK PSLI+LLGRID+Q+T I E +Q+ +
Sbjct: 494 NGSSKTPSLITLLGRIDLQDTIIPESEQKPE 524
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538292|ref|XP_002510211.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223550912|gb|EEF52398.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2105), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/444 (87%), Positives = 416/444 (93%), Gaps = 7/444 (1%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
RAQ+A +SNEEQEEM+RNLERRETEYMRLQRRKIGIDDFEQLT+IGKGAFGEVRLCRAK+
Sbjct: 70 RAQEARISNEEQEEMMRNLERRETEYMRLQRRKIGIDDFEQLTVIGKGAFGEVRLCRAKS 129
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDFLYLIMEYLP
Sbjct: 130 TGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDFLYLIMEYLP 189
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSEDVARFYIAES+LAI SIHQH+YVHRDIKPDNLILDKNGHLKLSD
Sbjct: 190 GGDIMTLLMREDILSEDVARFYIAESILAIQSIHQHSYVHRDIKPDNLILDKNGHLKLSD 249
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ------WMMPKERLQQWKRNRRALAYS 235
FGLCKPL+DKYSSILLE+EDI +QE +EA G W MPKE LQQWKRNRRALAYS
Sbjct: 250 FGLCKPLDDKYSSILLENEDI-SQEGTNEAGGHSGSEAPWSMPKEVLQQWKRNRRALAYS 308
Query: 236 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL 295
TVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCRKI+NWKTCL
Sbjct: 309 TVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLLGYPPFCSDDPRITCRKIINWKTCL 368
Query: 296 KFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTV 355
KFP+EPKIS+EA+DLICHLLCDVETRLGTRGV+ELK HPWFR QWD LYEMEAAYKP V
Sbjct: 369 KFPDEPKISNEAKDLICHLLCDVETRLGTRGVDELKAHPWFRCTQWDMLYEMEAAYKPVV 428
Query: 356 NGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDM 415
NG+LDTQNFEKFP+++GPPS IP VGPWRKMLTSKDTNFIG+TFKKSDV+ S+E+SGT
Sbjct: 429 NGDLDTQNFEKFPDLEGPPSAIPRVGPWRKMLTSKDTNFIGFTFKKSDVINSMESSGTYA 488
Query: 416 RSNGSSKVPSLISLLGRIDVQETA 439
+SN SSK PSLISLLGRID+QETA
Sbjct: 489 KSNASSKAPSLISLLGRIDLQETA 512
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552208|ref|XP_003544461.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 812 bits (2097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/451 (84%), Positives = 415/451 (92%), Gaps = 4/451 (0%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
+ Q++ +S EEQEEM+RNLERRETEYMRLQRRKIG+DDFEQLT+IGKGAFGEVRLCRAK
Sbjct: 72 KVQESQISAEEQEEMMRNLERRETEYMRLQRRKIGMDDFEQLTVIGKGAFGEVRLCRAKG 131
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+L YSFQDSDFLYLIMEYLP
Sbjct: 132 TGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLHYSFQDSDFLYLIMEYLP 191
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD
Sbjct: 192 GGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 251
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEG----QWMMPKERLQQWKRNRRALAYSTV 237
FGLCKPL+DKYSSILLE+ED+ QE+ SE E W+MPKERLQQWKRNRRALAYSTV
Sbjct: 252 FGLCKPLDDKYSSILLENEDLTGQESTSETEAYSVSPWLMPKERLQQWKRNRRALAYSTV 311
Query: 238 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 297
GTLDYMAPEVLLKKGYG+ECDWWSLGAIMYEMLIGYPPFCSDDPR+ CRKIVNWKTCLKF
Sbjct: 312 GTLDYMAPEVLLKKGYGIECDWWSLGAIMYEMLIGYPPFCSDDPRMACRKIVNWKTCLKF 371
Query: 298 PEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357
P+EPKIS EA+DLIC LLCDV++RLGTRGVEE+K HPWF+GIQWD LYE EAAYKPTV G
Sbjct: 372 PDEPKISAEAKDLICRLLCDVDSRLGTRGVEEIKAHPWFKGIQWDMLYESEAAYKPTVTG 431
Query: 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 417
+LDTQNFEKFPEVDGPPS SVGPWRKMLTSKD NFIGYTFKKSD+LKSLE+S D+R
Sbjct: 432 DLDTQNFEKFPEVDGPPSVTASVGPWRKMLTSKDNNFIGYTFKKSDILKSLESSDADIRV 491
Query: 418 NGSSKVPSLISLLGRIDVQETAISECDQQKQ 448
NGS K PSLI+LLG+ID+Q+T I E +Q+ +
Sbjct: 492 NGSLKTPSLITLLGQIDLQDTVIPESEQKPE 522
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450225|ref|XP_004142864.1| PREDICTED: serine/threonine-protein kinase tricorner-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2090), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/454 (84%), Positives = 420/454 (92%), Gaps = 8/454 (1%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
RAQ+A +S EEQEEMLRNLERRETE+MRLQRRK+GIDDFEQLT+IGKGAFGEVRLCRAK
Sbjct: 70 RAQEAQMSVEEQEEMLRNLERRETEFMRLQRRKVGIDDFEQLTVIGKGAFGEVRLCRAKG 129
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDS+FLYLIMEYLP
Sbjct: 130 TGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSEFLYLIMEYLP 189
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNY+HRDIKPDNLILDKNGHLKLSD
Sbjct: 190 GGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYIHRDIKPDNLILDKNGHLKLSD 249
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ-------WMMPKERLQQWKRNRRALAY 234
FGLCKPL+DKYS+ILL DED+ Q+ +E + Q WMMPKE++QQWKRNRRALA+
Sbjct: 250 FGLCKPLDDKYSNILLNDEDLTAQQCKNEGQSQSDSNGSHWMMPKEQIQQWKRNRRALAF 309
Query: 235 STVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTC 294
STVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML GYPPFCSDDPR+T RKI+NW+TC
Sbjct: 310 STVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLAGYPPFCSDDPRMTFRKIINWRTC 369
Query: 295 LKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPT 354
LKFPE+PKIS+EA+DLI HLLCDVETRLGTRGVEE+K HPWF+GIQWDKLYEMEAAYKPT
Sbjct: 370 LKFPEDPKISEEAKDLISHLLCDVETRLGTRGVEEIKSHPWFKGIQWDKLYEMEAAYKPT 429
Query: 355 VNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTD 414
V GELDTQNFEKFPEV PPSE+P+VGPWRKMLTSKDTNFIG+TFKKS+V KSLE +GTD
Sbjct: 430 VTGELDTQNFEKFPEVQDPPSEMPTVGPWRKMLTSKDTNFIGFTFKKSNV-KSLETTGTD 488
Query: 415 MRSNGSSKVPSLISLLGRIDVQETAISECDQQKQ 448
+ SN SSK PSL+SLL RID+QET I E +Q+++
Sbjct: 489 IHSNTSSKSPSLVSLLDRIDLQETVIPEVEQKQE 522
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458621|ref|XP_002284758.1| PREDICTED: serine/threonine-protein kinase CBK1 [Vitis vinifera] gi|302142312|emb|CBI19515.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/453 (84%), Positives = 415/453 (91%), Gaps = 9/453 (1%)
Query: 5 QAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE 64
+A VSNEEQE+MLR+LER+ETEYMRLQR KI IDDFEQLT+IGKGAFGEVRLCR K+TGE
Sbjct: 72 EAQVSNEEQEQMLRSLERKETEYMRLQRHKIRIDDFEQLTIIGKGAFGEVRLCRGKSTGE 131
Query: 65 IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD 124
IFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDFLYLIMEYLPGGD
Sbjct: 132 IFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDFLYLIMEYLPGGD 191
Query: 125 IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184
IMTLLMRED+LSEDVARFYIAES+LAIHSIHQH+YVHRDIKPDNLILDKNGHLKLSDFGL
Sbjct: 192 IMTLLMREDVLSEDVARFYIAESILAIHSIHQHSYVHRDIKPDNLILDKNGHLKLSDFGL 251
Query: 185 CKPLEDKYSSILLEDEDIINQETVSEAEG-------QWMMPKERLQQWKRNRRALAYSTV 237
CKPL+DKYS+ILLE++ QE+ SE EG W MPKERLQQWKRNRRALAYSTV
Sbjct: 252 CKPLDDKYSTILLENDVFNTQESTSETEGYSGYDRAPWSMPKERLQQWKRNRRALAYSTV 311
Query: 238 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 297
GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKI+NWKTCLK
Sbjct: 312 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIINWKTCLKL 371
Query: 298 PEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357
PEEPKISDEA+DLICHLLCDVETRLGT GVEE+K HPWFR IQWDKLYEMEAA+KPTV G
Sbjct: 372 PEEPKISDEAKDLICHLLCDVETRLGTGGVEEIKAHPWFRCIQWDKLYEMEAAHKPTVTG 431
Query: 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 417
ELDTQNFEKF EV+GPPS IP VGPWRKMLTSKD NFIGYTFKKSD++KS+ SGTD+RS
Sbjct: 432 ELDTQNFEKFDEVEGPPSTIPRVGPWRKMLTSKDANFIGYTFKKSDIMKSIGTSGTDVRS 491
Query: 418 NGSSKVPSLISLLGRIDVQETAISECDQQKQET 450
NGSSK PSL+SL G+ID+QETA D++K++
Sbjct: 492 NGSSKAPSLVSLFGQIDLQETATE--DEEKEDA 522
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137506|ref|XP_002327143.1| predicted protein [Populus trichocarpa] gi|222835458|gb|EEE73893.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/459 (85%), Positives = 419/459 (91%), Gaps = 16/459 (3%)
Query: 5 QAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE 64
+A VSNEEQEEMLRNLERRETE+MRLQRRKIGIDDFEQLT+IGKGAFGEVRLCRAK TGE
Sbjct: 73 EAQVSNEEQEEMLRNLERRETEFMRLQRRKIGIDDFEQLTVIGKGAFGEVRLCRAKDTGE 132
Query: 65 IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD 124
IFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+LFYSFQDSDFLYLIMEYLPGGD
Sbjct: 133 IFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLFYSFQDSDFLYLIMEYLPGGD 192
Query: 125 IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR------DIKPDNLILDKNGHLK 178
IMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHR DIKPDNLILDKNGHLK
Sbjct: 193 IMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRERSPCRDIKPDNLILDKNGHLK 252
Query: 179 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ-------WMMPKERLQQWKRNRRA 231
LSDFGLCKPL DKYS+ LLE+EDI QE +E+ G W+MPKE+LQQWKRNRRA
Sbjct: 253 LSDFGLCKPL-DKYSN-LLENEDISTQEVANESGGHSASDRPPWLMPKEKLQQWKRNRRA 310
Query: 232 LAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNW 291
LAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKI+NW
Sbjct: 311 LAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIINW 370
Query: 292 KTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAY 351
KTCLKFPE+PKIS EA DLICHLLCDVETRLGTRGVEELK HPWFR QWD LYE+EAAY
Sbjct: 371 KTCLKFPEDPKISSEAEDLICHLLCDVETRLGTRGVEELKAHPWFRCTQWDLLYELEAAY 430
Query: 352 KPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENS 411
KPTV G+LDTQNFEKFP+++GPPS IPSVGPWRKMLTSKDTNFIG+T+KKSDVLKSLE+S
Sbjct: 431 KPTVIGDLDTQNFEKFPDLEGPPSTIPSVGPWRKMLTSKDTNFIGFTYKKSDVLKSLESS 490
Query: 412 GTDMRSNGSSKVPSLISLLGRIDVQETAISECDQQKQET 450
GTDM+ N SSK SLISLLG+I+++ET ISE +QK ET
Sbjct: 491 GTDMKLNESSKAASLISLLGQIELEETVISE-GEQKPET 528
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357437805|ref|XP_003589178.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] gi|355478226|gb|AES59429.1| Serine/threonine protein kinase 38-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/447 (83%), Positives = 411/447 (91%), Gaps = 5/447 (1%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
+ Q++ + EEQE M+RNLER+ETEYMRLQRRKIGIDDFEQLT+IGKGAFGEVRLCRAK+
Sbjct: 70 KVQESQLPAEEQEVMMRNLERKETEYMRLQRRKIGIDDFEQLTVIGKGAFGEVRLCRAKS 129
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TGEIFAMKKLKKSEML RGQVEHVRSERNLLAEVDSRCIV+L YSFQDSDFLYLIMEYLP
Sbjct: 130 TGEIFAMKKLKKSEMLSRGQVEHVRSERNLLAEVDSRCIVKLHYSFQDSDFLYLIMEYLP 189
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSE VARFYIAES+LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD
Sbjct: 190 GGDIMTLLMREDILSEHVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 249
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAE----GQWMMPKERLQQWKRNRRALAYSTV 237
FGLCK L+DKYS+ILLE++D QE+ SE E W+MPKE+LQ WKRNRRALAYSTV
Sbjct: 250 FGLCKTLDDKYSTILLENDDFNGQESTSETEYNFVSPWLMPKEQLQAWKRNRRALAYSTV 309
Query: 238 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 297
GTLDYMAPEVLLKKGYG+ECDWWSLGAI+YEML+GYPPFCSDDPR+TCRKIVNWKTCLKF
Sbjct: 310 GTLDYMAPEVLLKKGYGIECDWWSLGAILYEMLVGYPPFCSDDPRMTCRKIVNWKTCLKF 369
Query: 298 PEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357
PEEPKIS EA+DLIC LLCDV+TRLGTRGV+E+K HPWFRG+QWD LYE+EAAYKPTV G
Sbjct: 370 PEEPKISAEAKDLICRLLCDVDTRLGTRGVDEIKAHPWFRGVQWDMLYELEAAYKPTVIG 429
Query: 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRS 417
+LDTQNFEKFP+V GPPS +VGPWRKMLTSKDTNFIGYTFKKSD+LKS+E++ D+R
Sbjct: 430 DLDTQNFEKFPDV-GPPSVTETVGPWRKMLTSKDTNFIGYTFKKSDILKSIESTDEDIRV 488
Query: 418 NGSSKVPSLISLLGRIDVQETAISECD 444
NGSSK PSLISLLGRID+Q+TAI E +
Sbjct: 489 NGSSKSPSLISLLGRIDLQDTAIPESE 515
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811091|ref|XP_002873429.1| hypothetical protein ARALYDRAFT_487812 [Arabidopsis lyrata subsp. lyrata] gi|297319266|gb|EFH49688.1| hypothetical protein ARALYDRAFT_487812 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/451 (79%), Positives = 410/451 (90%), Gaps = 6/451 (1%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
+ Q+A + EEQ+EM+RNL RRETEYMRLQRRKIGIDDFE LT+IGKGAFGEVRLCR ++
Sbjct: 64 KVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRS 123
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
T E++AMKKLKK+EML RGQVEHVRSERNLLAEVDSR IV+LFYSFQDS+ LYLIMEYLP
Sbjct: 124 TSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLP 183
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLILDK+GHLKLSD
Sbjct: 184 GGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHLKLSD 243
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAE------GQWMMPKERLQQWKRNRRALAYS 235
FGLCKPL+DKYSS+LLED+++++Q++ +++E W MPKE+L QWKRNRRALAYS
Sbjct: 244 FGLCKPLDDKYSSLLLEDDEMLSQDSENQSEKSDADKAPWQMPKEQLLQWKRNRRALAYS 303
Query: 236 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL 295
TVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCRKI+NWK CL
Sbjct: 304 TVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINWKVCL 363
Query: 296 KFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTV 355
KFPEEPKISDEARDLIC LLCDV++RLGTRGVEE+K HPWF+G WDKLY+MEAAY+P V
Sbjct: 364 KFPEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYDMEAAYRPIV 423
Query: 356 NGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDM 415
+GELDTQNFEKFPEV+G PSE P VGPWRKMLTSKDTNFIG+TFKKSD+ +S+E+SG DM
Sbjct: 424 DGELDTQNFEKFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITRSMESSGADM 483
Query: 416 RSNGSSKVPSLISLLGRIDVQETAISECDQQ 446
+SNGS + PSLISLLGRI+++E E + +
Sbjct: 484 KSNGSGEAPSLISLLGRINMEEGEGGELNHK 514
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|31088224|dbj|BAC76894.1| protein kinase [Raphanus sativus] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/451 (79%), Positives = 408/451 (90%), Gaps = 6/451 (1%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
+ Q+A + EEQ+EM+R+L RRETEYMRLQRRKIGIDDFE LT+IGKGAFGEVRLCR ++
Sbjct: 10 KVQEAQLPVEEQDEMMRSLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRS 69
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TGE++AMKKLKK++ML RGQVEHVRSERNLLAEVDSR IV+LFYSFQDS+ LYLIMEYLP
Sbjct: 70 TGEVYAMKKLKKTDMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLP 129
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQH+YVHRDIKPDNLILDK+GHLKLSD
Sbjct: 130 GGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHSYVHRDIKPDNLILDKSGHLKLSD 189
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEA------EGQWMMPKERLQQWKRNRRALAYS 235
FGLCKPL+DKYSS+LLEDE++++QE S++ + W MPKE+L QWKRNRRALAYS
Sbjct: 190 FGLCKPLDDKYSSLLLEDEEMLSQEAESQSGKADSDKAPWQMPKEQLLQWKRNRRALAYS 249
Query: 236 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL 295
TVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCRKI+NW+ CL
Sbjct: 250 TVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINWRVCL 309
Query: 296 KFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTV 355
KFPEEPKIS+EARDLIC LLCDVE+RLGTRG EE+K HPWF G QWDKLYEMEAAY+PTV
Sbjct: 310 KFPEEPKISEEARDLICRLLCDVESRLGTRGAEEIKTHPWFNGTQWDKLYEMEAAYRPTV 369
Query: 356 NGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDM 415
+GELDTQNFEKFPEV+G SE P VGPWRKMLTSKD NFIG+TFKKSD+ +S+EN+GTDM
Sbjct: 370 DGELDTQNFEKFPEVEGSASEAPQVGPWRKMLTSKDNNFIGFTFKKSDITRSMENTGTDM 429
Query: 416 RSNGSSKVPSLISLLGRIDVQETAISECDQQ 446
+ NGS PSLISLLGRI+++E E +Q+
Sbjct: 430 KPNGSGDAPSLISLLGRINMEEAEGGELNQK 460
|
Source: Raphanus sativus Species: Raphanus sativus Genus: Raphanus Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.968 | 0.844 | 0.803 | 2e-200 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.935 | 0.741 | 0.645 | 3.5e-155 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.933 | 0.762 | 0.644 | 2.9e-151 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.935 | 0.739 | 0.649 | 9.5e-150 | |
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.931 | 0.807 | 0.631 | 2.2e-146 | |
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.935 | 0.739 | 0.624 | 7.3e-146 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.913 | 0.779 | 0.623 | 4.2e-143 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.935 | 0.749 | 0.600 | 2.1e-141 | |
| UNIPROTKB|Q2LZZ7 | 458 | trc "Serine/threonine-protein | 0.882 | 0.866 | 0.515 | 5.5e-109 | |
| FB|FBgn0003744 | 463 | trc "tricornered" [Drosophila | 0.871 | 0.846 | 0.519 | 8.1e-108 |
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1940 (688.0 bits), Expect = 2.0e-200, P = 2.0e-200
Identities = 356/443 (80%), Positives = 408/443 (92%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
+ Q+A + EEQ+EM+RNL RRETEYMRLQRRKIGIDDFE LT+IGKGAFGEVRLCR ++
Sbjct: 64 KVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRS 123
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
T E++AMKKLKK+EML RGQVEHVRSERNLLAEVDSR IV+LFYSFQDS+ LYLIMEYLP
Sbjct: 124 TSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLP 183
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGDIMTLLMREDILSEDVARFYIAES+LAIHSIHQHNYVHRDIKPDNLILDK+GHLKLSD
Sbjct: 184 GGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHLKLSD 243
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEA------EGQWMMPKERLQQWKRNRRALAYS 235
FGLCKPL+DKYSS+LLED+++++Q++ +++ + W MPKE+L QWKRNRRALAYS
Sbjct: 244 FGLCKPLDDKYSSLLLEDDEMLSQDSENQSGKSDADKAPWQMPKEQLLQWKRNRRALAYS 303
Query: 236 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL 295
TVGTLDYMAPEVLLKKGYGMECDWWSLGAI+YEML+GYPPFCSDDPRITCRKI+NW+ CL
Sbjct: 304 TVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINWRVCL 363
Query: 296 KFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTV 355
KFPEEPKISDEARDLIC LLCDV++RLGTRGVEE+K HPWF+G WDKLY+MEAAY+P V
Sbjct: 364 KFPEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYDMEAAYRPIV 423
Query: 356 NGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGT-D 414
+GELDTQNFEKFPEV+G PSE P VGPWRKMLTSKDTNFIG+TFKKSD+ +S+E+SG+ D
Sbjct: 424 DGELDTQNFEKFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITRSMESSGSAD 483
Query: 415 MRSNGSSKVPSLISLLGRIDVQE 437
M+SNGS + PSLISLLGRI+++E
Sbjct: 484 MKSNGSGEAPSLISLLGRINMEE 506
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1513 (537.7 bits), Expect = 3.5e-155, P = 3.5e-155
Identities = 280/434 (64%), Positives = 352/434 (81%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI 65
A VS EEQ+ +L++LE++ETEYMR QR K+G DDFE LT+IGKGAFGEVR+CR KTTG +
Sbjct: 86 AEVSEEEQKNLLKDLEKKETEYMRRQRHKMGTDDFEPLTMIGKGAFGEVRICREKTTGNV 145
Query: 66 FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125
+AMKKLKKSEML+RGQVEHV++ERNLLAEVDS CIV+L+ SFQD ++LYLIMEYLPGGD+
Sbjct: 146 YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDM 205
Query: 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185
MTLLMR+D L+ED ARFY+ E+VLAI SIH+HNY+HRDIKPDNL+LD++GH+KLSDFGLC
Sbjct: 206 MTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRSGHMKLSDFGLC 265
Query: 186 KPLEDKYSSILLEDEDII--NQETVSEAEGQWMMPK------ERLQQWKRNRRALAYSTV 237
KPL+ SIL E + ++ N +++G+ + P+ E+LQ W+RNRR LAYSTV
Sbjct: 266 KPLD---CSILQEKDFVVAHNLSGALQSDGRPVAPRRTRSQMEQLQNWQRNRRMLAYSTV 322
Query: 238 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 297
GT DY+APEVLLKKGYGMECDWWSLGAIMYEML+G+PPF SD+P TCRKIVNWK LKF
Sbjct: 323 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFYSDEPMTTCRKIVNWKNYLKF 382
Query: 298 PEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357
P+E ++S EA+DLIC LLC+VE R+GT+G E+KEHPWF G++W+KLY+M+AA+ P VN
Sbjct: 383 PDEVRLSPEAKDLICRLLCNVEQRIGTKGANEIKEHPWFSGVEWEKLYQMKAAFIPQVND 442
Query: 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDMR 416
ELDTQNFEKF E D + P GPWRKML+SKD NF+GYT+K +++ + G +++
Sbjct: 443 ELDTQNFEKFEETDKQVPKTPKSGPWRKMLSSKDINFVGYTYKNVEIVNHDQLPGIAELK 502
Query: 417 SNGSS-KVPSLISL 429
+ K PS+ SL
Sbjct: 503 KKSTKPKRPSIKSL 516
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1476 (524.6 bits), Expect = 2.9e-151, P = 2.9e-151
Identities = 279/433 (64%), Positives = 346/433 (79%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI 65
A VS EEQ +L++LE +ETEYMR QR K+G DDFE LT+IGKGAFGEVR+CR K TG +
Sbjct: 85 AEVSEEEQNNLLKDLEMKETEYMRRQRHKMGADDFEPLTMIGKGAFGEVRICREKGTGNV 144
Query: 66 FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125
+AMKKLKKSEML+RGQVEHV++ERNLLAEVDS CIV+L+ SFQD ++LYLIMEYLPGGD+
Sbjct: 145 YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDEEYLYLIMEYLPGGDM 204
Query: 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185
MTLLMR+D L+ED ARFYI E+VLAI SIH+HNY+HRDIKPDNL+LDK+GH+KLSDFGLC
Sbjct: 205 MTLLMRKDTLTEDEARFYIGETVLAIESIHKHNYIHRDIKPDNLLLDKDGHMKLSDFGLC 264
Query: 186 KPLEDKYSSILLEDEDIINQETVS---EAEGQWMMPK----ERLQQWKRNRRALAYSTVG 238
KPL+ S+ L+++D VS +++G+ + + E+L W+RNRR LAYSTVG
Sbjct: 265 KPLD--CSN--LQEKDFTVARNVSGALQSDGRPVATRRTQQEQLLNWQRNRRMLAYSTVG 320
Query: 239 TLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP 298
T DY+APEVLLKKGYGMECDWWSLGAIMYEML+G+PPF SDDP TCRKIVNW+ LKFP
Sbjct: 321 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFYSDDPMTTCRKIVNWRNYLKFP 380
Query: 299 EEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGE 358
+E ++S EA+DLIC LLC+VE RLGT+G +E+K HPWFRG +W KLY+M+AA+ P VN E
Sbjct: 381 DEVRLSPEAKDLICRLLCNVEQRLGTKGADEIKGHPWFRGTEWGKLYQMKAAFIPQVNDE 440
Query: 359 LDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDMRS 417
LDTQNFEKF E D + GPWRKML+SKD NF+GYT+K +++ + G +++
Sbjct: 441 LDTQNFEKFEETDKQVPKSAKSGPWRKMLSSKDINFVGYTYKNVEIVNDDQIPGIAELKK 500
Query: 418 NGSS-KVPSLISL 429
+ K PS+ SL
Sbjct: 501 KSNKPKRPSIKSL 513
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1445 (513.7 bits), Expect = 9.5e-150, Sum P(2) = 9.5e-150
Identities = 280/431 (64%), Positives = 339/431 (78%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI 65
A V E+Q +++ LE++ETEYMRLQR K+G DDFE LT+IGKGAFGEVR+ R TG +
Sbjct: 103 ADVCEEDQTNLMKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVREINTGHV 162
Query: 66 FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125
FAMKKLKKSEML+RGQVEHVR+ERNLLAEVDS CIV+L+ SFQD+++LYLIMEYLPGGD+
Sbjct: 163 FAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEYLPGGDM 222
Query: 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185
MTLLMR+D LSED A+FYIAESVLAI SIH NY+HRDIKPDNL+LD+ GHL+LSDFGLC
Sbjct: 223 MTLLMRKDTLSEDEAKFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRLSDFGLC 282
Query: 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK----ERLQQWKRNRRALAYSTVGTLD 241
KPL+ S I ED + N + +E PK E+L+ W++NRR LAYSTVGT D
Sbjct: 283 KPLD--CSVIDGEDFTVGNAGSGGGSESVSTTPKRSQQEQLEHWQKNRRMLAYSTVGTPD 340
Query: 242 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 301
Y+APEVLLKKGYGMECDWWSLGAIMYEML+GYPPF +DDP TCRKIVNWKT LKFPEE
Sbjct: 341 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPMSTCRKIVNWKTHLKFPEES 400
Query: 302 KISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDT 361
++S ARDLI LLC V RLG+ G ++K HPWF G+QW+K+Y+MEAA+ P VN +LDT
Sbjct: 401 RLSRGARDLIGKLLCSVNQRLGSTGASQIKAHPWFEGVQWEKIYQMEAAFIPEVNDDLDT 460
Query: 362 QNFEKFPEVDGPPSEIPS-VGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDMRSNG 419
QNFEKF E D ++ PS GPWRKML+SKD NF+GYT+K +++ + G +++
Sbjct: 461 QNFEKFDEEDNQ-TQAPSRTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGIAELKKKE 519
Query: 420 S-SKVPSLISL 429
S SK PS+ SL
Sbjct: 520 SKSKRPSVKSL 530
|
|
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1430 (508.4 bits), Expect = 2.2e-146, P = 2.2e-146
Identities = 274/434 (63%), Positives = 339/434 (78%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI 65
+ V EEQ M+++LER+ETE+MRL+R KI +DDFE LT+IG+GAFGEVRLCR + +G I
Sbjct: 60 SGVPKEEQINMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNI 119
Query: 66 FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125
+AMKKLKKSEM+ RGQVEHVR+ERNLLAEV+S IV+L+YSFQD ++LYLIMEYLPGGD+
Sbjct: 120 YAMKKLKKSEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDM 179
Query: 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185
MTLLMRED L EDVARFYIA+SVLAI SIH++NY+HRDIKPDNL+LDK+GH+KLSDFGLC
Sbjct: 180 MTLLMREDTLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLC 239
Query: 186 KPLEDKYSSILLEDEDIINQETVSEA------------EGQWMMPKERLQQWKRNRRALA 233
KPL+ + + E+ + ET+SE + W P+E+LQ W+ NRR LA
Sbjct: 240 KPLDCRNLPSIQENR-ATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLA 298
Query: 234 YSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT 293
+STVGT DY+APEVLLKKGYGMECDWWSLGAIMYEML+GYPPF +DDP TCRKIV+W+
Sbjct: 299 FSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKIVHWRN 358
Query: 294 CLKFPEEPKISDEARDLICHLLCDVETRLGTRG-VEELKEHPWFRGIQWDKLYEMEAAYK 352
LKFPE+ K S EA+DLIC LLC+V+ RLGT G +++K+HPWF+ + W+KLYEMEAAYK
Sbjct: 359 HLKFPEDAKFSSEAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEKLYEMEAAYK 418
Query: 353 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTS-KDTNFIGYTFKKSDVLKSLENS 411
P VN ELDTQNF KF EV+ P E G RKML + KD +F+GYT+K D +K L +S
Sbjct: 419 PEVNDELDTQNFMKFDEVNSPAPERTRSGLSRKMLLAPKDLSFVGYTYKNFDAVKGLRHS 478
Query: 412 GTDMRSNGSSKVPS 425
R+ + P+
Sbjct: 479 LEMARTMSLDRSPA 492
|
|
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1425 (506.7 bits), Expect = 7.3e-146, P = 7.3e-146
Identities = 268/429 (62%), Positives = 334/429 (77%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI 65
A VS E+Q +L+ LE++ETEYMRLQR K+G+ DF+ LT+IGKGAFGEVR+CR KTTG++
Sbjct: 90 ADVSEEDQNNLLKFLEKKETEYMRLQRHKLGVADFDLLTMIGKGAFGEVRVCREKTTGQV 149
Query: 66 FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125
+AMKKLKK+EML+RGQVEHVR+ERNLLAEVDS IV+L+ SFQD D LYL+MEYLPGGD+
Sbjct: 150 YAMKKLKKAEMLRRGQVEHVRAERNLLAEVDSNYIVKLYCSFQDDDHLYLVMEYLPGGDM 209
Query: 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185
MTLLMR+D L+E+ A+FY+AE+VLAI SIH+HNY+HRDIKPDNL+LD+ GHL+LSDFGLC
Sbjct: 210 MTLLMRKDTLTEEEAKFYVAETVLAIESIHRHNYIHRDIKPDNLLLDRYGHLRLSDFGLC 269
Query: 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK----ERLQQWKRNRRALAYSTVGTLD 241
KPL+ S + E++ N +E E PK E+L+ W+RNRR LAYSTVGT D
Sbjct: 270 KPLD---CSAIGENDFSNNSNGSTEQEAGSTAPKRTQQEQLEHWQRNRRTLAYSTVGTPD 326
Query: 242 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 301
Y+APEVLLKKGYGMECDWWSLGAIMYEML+GYPPF SDDP TCRKIVNWK+ LKFPEE
Sbjct: 327 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWKSHLKFPEEA 386
Query: 302 KISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDT 361
+S EA+DLI LLC V RLG++G +ELK H WF + WD +++M+AA+ P VN +LDT
Sbjct: 387 ILSREAKDLINSLLCSVRRRLGSKGADELKAHTWFETVDWDTIFDMDAAFVPEVNDDLDT 446
Query: 362 QNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TDMRSNGS 420
QNFEKF E + GPWRKML+SKD NF+GYT+K +++ + G +++
Sbjct: 447 QNFEKFDESESETQTSSKSGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGMAELKKKKK 506
Query: 421 SKVPSLISL 429
S P + SL
Sbjct: 507 STRPMVKSL 515
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1399 (497.5 bits), Expect = 4.2e-143, P = 4.2e-143
Identities = 267/428 (62%), Positives = 335/428 (78%)
Query: 8 VSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFA 67
VS +EQ E+L +L+R+ETEY RL R ++ +DDF+ L++IG+GAFGEVRLCR K TG I+A
Sbjct: 73 VSEKEQLELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYA 132
Query: 68 MKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMT 127
MKKLKKSEML RGQVEHVR+ERNLLAEV S CIV+L+YSFQD ++LYLIMEYL GGD+MT
Sbjct: 133 MKKLKKSEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMT 192
Query: 128 LLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187
LLMRE+ L+E VARFYIA+SVLAI SIH+HNYVHRDIKPDNL+LDK GH+KLSDFGLCKP
Sbjct: 193 LLMREETLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKP 252
Query: 188 LEDKYSSILLEDEDIINQETVSEA-EG-----------QWMMPKERLQQWKRNRRALAYS 235
L+ + S + +E + N E ++E+ +G +W P E+LQ W+ NRR LAYS
Sbjct: 253 LDCRNISAMNVNEPL-NDENINESIDGDENCSIGRRGRRWKSPLEQLQHWQINRRKLAYS 311
Query: 236 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL 295
TVGT DY+APEVLLKKGYG+ECDWWSLGAIMYEML+GYPPF SDDP TCRKIV+W+T L
Sbjct: 312 TVGTPDYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVSWRTHL 371
Query: 296 KFPEEPKISDEARDLICHLLCDVETRLGTRGV--EELKEHPWFRGIQWDKLYEMEAAYKP 353
FPE +++ EARDLIC LLCD E RLG+ G E++K H WF+ ++W+KLYEM+AA+KP
Sbjct: 372 VFPEGARLTPEARDLICRLLCDSEHRLGSHGAGAEQIKAHTWFKDVEWEKLYEMDAAFKP 431
Query: 354 TVNGELDTQNFEKFPEVDGPPSEIPSVGP-WRKMLTSKDTNFIGYTFKKSDVLKSLENSG 412
VNGELDTQNF KF EV+ P GP W+ +T ++ NF+GYT++ D ++ +S
Sbjct: 432 VVNGELDTQNFMKFDEVECPKPARTGSGPSWKVSITPQNINFVGYTYRNFDAVRGSRHS- 490
Query: 413 TDMRSNGS 420
D++ + S
Sbjct: 491 LDIKGSVS 498
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1383 (491.9 bits), Expect = 2.1e-141, P = 2.1e-141
Identities = 262/436 (60%), Positives = 337/436 (77%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI 65
A V+ E++ ++L+N E++E EYMRLQR+K+G+DDFE L++IG+GAFGEVR+C+ K+TG +
Sbjct: 86 ADVTVEDKMDILKNFEKKEMEYMRLQRQKMGVDDFELLSIIGRGAFGEVRICKEKSTGSV 145
Query: 66 FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125
+AMKKLKKSEML+RGQVEHV++ERN+LAEVDS IV+L YSFQD + LYLIMEYLPGGD+
Sbjct: 146 YAMKKLKKSEMLRRGQVEHVKAERNVLAEVDSPFIVKLCYSFQDDEHLYLIMEYLPGGDM 205
Query: 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185
MTLLMR+D L ED RFY+A+++LAI SIH+HNYVHRDIKPDNL++ +NGH+KLSDFGL
Sbjct: 206 MTLLMRKDTLREDETRFYVAQTILAIESIHKHNYVHRDIKPDNLLITRNGHIKLSDFGLS 265
Query: 186 KPLEDK-YSSILLEDEDIINQETVSEAEGQWMM-----PK----ERLQQWKRNRRALAYS 235
K LE K + E ++++ T AE + P+ E+L W++NRR LA+S
Sbjct: 266 KSLESKNFPDFKAE---LVDRSTKPAAEHDRLSKPPSAPRRTQQEQLLHWQQNRRTLAFS 322
Query: 236 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL 295
TVGT DY+APEVLLKKGYGMECDWWSLGAIM+EML+G+PPF S++P TCRKIVNWKTCL
Sbjct: 323 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMFEMLVGFPPFYSEEPLATCRKIVNWKTCL 382
Query: 296 KFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTV 355
KFP+E K+S E +DLI LLC+VE RLGT+GV E+K HPWFRG++W++LYE A Y P V
Sbjct: 383 KFPDEAKLSIEVKDLIRRLLCNVEQRLGTKGVHEIKAHPWFRGVEWERLYESNAPYIPQV 442
Query: 356 NGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSG-TD 414
ELDTQNFEKF EV PWRKM++SKD NF+GYTFK +++ G +
Sbjct: 443 KHELDTQNFEKFDEVPSTCQTSSKSSPWRKMISSKDANFLGYTFKNLEIVDEHHIPGMAE 502
Query: 415 M-RSNGSSKVPSLISL 429
+ R + ++ PSL +L
Sbjct: 503 LKRKSKTANKPSLKTL 518
|
|
| UNIPROTKB|Q2LZZ7 trc "Serine/threonine-protein kinase tricorner" [Drosophila pseudoobscura pseudoobscura (taxid:46245)] | Back alignment and assigned GO terms |
|---|
Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
Identities = 211/409 (51%), Positives = 293/409 (71%)
Query: 5 QAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE 64
++ ++ QE+ L++ ++ ETEY+RL+R ++G++DFE L +IG+GAFGEVRL + K TG
Sbjct: 58 ESLTESQRQEKRLQHAQK-ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGH 116
Query: 65 IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD 124
++AMK L+K++ML++ QV HVR+ER++L E D + +V+++YSFQD LYLIME+LPGGD
Sbjct: 117 VYAMKVLRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGD 176
Query: 125 IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184
+MTLLM++D LSE+ +FYI+E+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGL
Sbjct: 177 MMTLLMKKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGL 236
Query: 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP---KERLQQWKRNRRALAYSTVGTLD 241
C L+ + + D ++Q S+ G P K R + WKRNRRALAYSTVGT D
Sbjct: 237 CTGLKKSHRTDFYRD---LSQAKPSDFIGTCASPMDSKRRAESWKRNRRALAYSTVGTPD 293
Query: 242 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 301
Y+APEV L+ GYG CDWWSLG IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E
Sbjct: 294 YIAPEVFLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEI 353
Query: 302 KISDEARDLICHLLCDVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELD 360
IS+EA++ I C+ + RLG+ RG+E+LK P+FRG+ W+ + E AA V D
Sbjct: 354 PISEEAKETIIKFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDD 413
Query: 361 TQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLE 409
T NF++FP+V EIPS + +KD FI YT+K+ +V ++LE
Sbjct: 414 TSNFDEFPDVS---LEIPSAPIPQGGEIAKDWVFINYTYKRFEV-RNLE 458
|
|
| FB|FBgn0003744 trc "tricornered" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 211/406 (51%), Positives = 289/406 (71%)
Query: 11 EEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK 70
+ QE+ L++ ++ ETEY+RL+R ++G++DFE L +IG+GAFGEVRL + K TG ++AMK
Sbjct: 65 QRQEKRLQHAQK-ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKV 123
Query: 71 LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM 130
L+K++ML++ QV HVR+ER++L E D + +V+++YSFQD LYLIME+LPGGD+MTLLM
Sbjct: 124 LRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLM 183
Query: 131 REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190
++D LSE+ +FYI+E+ LAI SIH+ ++HRDIKPDNL+LD GHLKLSDFGLC L+
Sbjct: 184 KKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKK 243
Query: 191 KYSSILLED------EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 244
+ + D D I T + M K R + WKRNRRALAYSTVGT DY+A
Sbjct: 244 SHRTDFYRDLSQAKPSDFIG--TCASLSCSPMDSKRRAESWKRNRRALAYSTVGTPDYIA 301
Query: 245 PEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKIS 304
PEV L+ GYG CDWWSLG IMYEML+GYPPFCSD+P+ T RK++NW+ L FP E IS
Sbjct: 302 PEVFLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPIS 361
Query: 305 DEARDLICHLLCDVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
+EA++ I + C+ + RLG+ RG+E+LK P+FRG+ W+ + E AA V DT N
Sbjct: 362 EEAKETIINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSN 421
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLE 409
F++FP+V EIPS + +KD FI YT+K+ +V ++LE
Sbjct: 422 FDEFPDVS---LEIPSAPIPQGGEIAKDWVFINYTYKRFEV-RNLE 463
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9Y2H1 | ST38L_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.4951 | 0.9066 | 0.8793 | yes | no |
| Q7TSE6 | ST38L_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4830 | 0.9066 | 0.8793 | yes | no |
| Q2L6W9 | SAX1_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.4691 | 0.8644 | 0.8172 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.5147 | 0.8688 | 0.8537 | yes | no |
| O13310 | ORB6_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.4778 | 0.8733 | 0.8379 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.5110 | 0.8688 | 0.8444 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_II1138 | hypothetical protein (523 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 450 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-173 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-152 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-137 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-136 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-128 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-115 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-115 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-114 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-111 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-110 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-109 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-109 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-108 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-107 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-100 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-98 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-92 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-91 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-89 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-87 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-87 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-86 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-82 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-82 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-80 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-77 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-77 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-75 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-72 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-72 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-70 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-70 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-69 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-69 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-68 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-68 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-66 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-64 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-62 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-61 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-60 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-58 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-58 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-58 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-56 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-55 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-55 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-55 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-55 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-54 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-54 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-53 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-51 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-50 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-49 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-49 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-49 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-48 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-46 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-46 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-45 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-45 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-45 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-44 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-44 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-44 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-41 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-39 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-36 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-34 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-33 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-31 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-30 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-29 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-29 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-26 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-25 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-25 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-24 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-22 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 6e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-07 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.003 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 593 bits (1532), Expect = 0.0
Identities = 204/366 (55%), Positives = 263/366 (71%), Gaps = 2/366 (0%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE + +IG+GAFGEVRL + K TG I+AMKKL+KSEML++ QV HVR+ER++LAE D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+V+L+YSFQD ++LYLIMEYLPGGD+MTLLM++D +E+ RFYIAE++LAI SIH+
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
Y+HRDIKPDNL+LD GH+KLSDFGLC L+ + + + + M
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
K + + WKRNRRALAYSTVGT DY+APEV L+ GY ECDWWSLG IMYEML+GYPPFC
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 337
SD+P+ T RKI+NWK L+FP+E +S EA+DLI L C+ E RLG GV E+K HP+F+
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
Query: 338 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 397
G+ W+ + E A P + DT NF+ F E+D P GP R + SKD FIGY
Sbjct: 301 GVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAFIGY 358
Query: 398 TFKKSD 403
T+K+ +
Sbjct: 359 TYKRFE 364
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 487 bits (1257), Expect = e-173
Identities = 179/363 (49%), Positives = 246/363 (67%), Gaps = 13/363 (3%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE + +IG+GAFGEV L R K TG+++AMK L+KS+M+KR Q+ HVR+ER++LA+ DS
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV+L+YSFQD + LYL+MEY+PGGD+M LL+R+D+ E+ ARFYIAE VLA+ S+H+
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
++HRDIKPDN+++D +GH+KL+DFGLCK + ++ + +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR-- 178
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
+ RR A STVGT DY+APEVL YG+ECDWWSLG I+YEML G+PPF
Sbjct: 179 -------DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 337
SD + T KI+NWK L+FP +P +S EA DLIC LLCD E RLG+ EE+K HP+F+
Sbjct: 232 SDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHPFFK 289
Query: 338 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 397
GI W+ L E + + P ++ LDT NF+ F + D S+ S +K+ K F+G+
Sbjct: 290 GIDWENLRETKPPFVPELSSPLDTSNFDDFED-DKDLSDYLS-QNSKKLNKGKQLAFVGF 347
Query: 398 TFK 400
T+K
Sbjct: 348 TYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 435 bits (1121), Expect = e-152
Identities = 182/379 (48%), Positives = 253/379 (66%), Gaps = 15/379 (3%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+DF + +IGKGAFGEVRL + K TG+I+AMK L KSEM K+ Q+ HV++ER++LAE DS
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+V L+YSFQD+ +LYLIME+LPGGD+MT+L++ D SEDV RFY+AE VLAI ++H+
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLC----KPLEDKYSSILLEDEDIINQETVSEAEG 213
++HRDIKPDN+++D+ GH+KLSDFGL K + Y LL+ + N+ +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK--SNKNRIDNRNS 178
Query: 214 QW-------MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
M K+++ WK+NRR +AYSTVGT DY+APE+ L++GYG ECDWWSLGAIM
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 267 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRG 326
+E LIG+PPFCS++ T RKI+NW+ L FP++ +S EA DLI L+ + E RLG G
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGG 298
Query: 327 VEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 386
E+K HP+FRG+ WD + ++ A + P + DT F P + +
Sbjct: 299 AHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQ 358
Query: 387 LTSKDTN--FIGYTFKKSD 403
S + + FIGYT+K+ D
Sbjct: 359 EESVELDLAFIGYTYKRFD 377
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 399 bits (1026), Expect = e-137
Identities = 193/364 (53%), Positives = 254/364 (69%), Gaps = 6/364 (1%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE L +IG+GAFGEVRL + K TG I+AMK L+K++ML++ QV H+R+ER++L E D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+V++FYSFQD LYLIME+LPGGD+MTLLM++D LSE+ +FYIAE+VLAI +IHQ
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
++HRDIKPDNL+LD GH+KLSDFGLC L+ + + + + S+ Q M
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN---LTHNPPSDFSFQNMN 177
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
K + + WK+NRR LAYSTVGT DY+APEV ++ GY CDWWSLG IMYEMLIGYPPFC
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 337
S+ P+ T RK++NWK L FP E IS++A+DLI D E R+G+ GVEE+K HP+F
Sbjct: 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297
Query: 338 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 397
G+ W + E AA + DT NF++FPE D ++ P K SKD F+ Y
Sbjct: 298 GVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYK---SKDWVFLNY 354
Query: 398 TFKK 401
T+K+
Sbjct: 355 TYKR 358
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 395 bits (1015), Expect = e-136
Identities = 188/364 (51%), Positives = 255/364 (70%), Gaps = 3/364 (0%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+DFE L +IG+GAFGEVRL + K TG ++AMK L+K++ML++ QV H+R+ER++L E DS
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+V++FYSFQD LYLIME+LPGGD+MTLLM++D L+E+ +FYIAE+VLAI SIHQ
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
++HRDIKPDNL+LD GH+KLSDFGLC L+ + + + +N S+ Q M
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN---LNHSLPSDFTFQNMN 177
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
K + + WKRNRR LA+STVGT DY+APEV ++ GY CDWWSLG IMYEMLIGYPPFC
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 337
S+ P+ T +K++NWK L FP E IS++A+DLI C+ E R+G GVEE+K +P+F
Sbjct: 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297
Query: 338 GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGY 397
G+ W+ + E AA + DT NF++FP+ D + + +KD FI Y
Sbjct: 298 GVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINY 357
Query: 398 TFKK 401
T+K+
Sbjct: 358 TYKR 361
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 375 bits (964), Expect = e-128
Identities = 162/372 (43%), Positives = 231/372 (62%), Gaps = 10/372 (2%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F ++ IG GAFGEV L R T ++AMK L+K+++L R Q HV++ER++LAE D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
+V+L+YSFQD D LY +M+Y+PGGD+M+LL+R I ED+ARFYIAE AI S+H+ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIKPDN+++D++GH+KL+DFGLC + S + D Q+++ +E + +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 220 ERLQQWKRNR-----RALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
RL+ +R R R LA+S VGT +Y+APEVLL+ GY CDWWS+G I+YEML+G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHP 334
PF +D P T K++NW+T L P + K+S EA DLI L C E RLG G +E+K HP
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHP 302
Query: 335 WFRGIQWDKLY-EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWRKMLTS 389
+F+GI + L +A Y P + DT NF+ D P
Sbjct: 303 FFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKR 362
Query: 390 KDTNFIGYTFKK 401
+ F +TF++
Sbjct: 363 TEHAFYEFTFRR 374
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 339 bits (872), Expect = e-115
Identities = 131/335 (39%), Positives = 192/335 (57%), Gaps = 50/335 (14%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE + +G G+FG V L R K +G+ +A+K L K++++K QVEHV +E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+V L+ SFQD LYL+MEY+PGG++ + L + E VARFY A+ VLA+ +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+ V+RD+KP+NL+LD +G++K++DFG K ++ +
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------------------------- 154
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
Y+ GT +Y+APE++L KGYG DWW+LG ++YEML GYPPF
Sbjct: 155 ---------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGT--RGVEELKEHP 334
D+P KI+ K ++FP S +A+DLI +LL D+ RLG GV ++K HP
Sbjct: 200 DDNPIQIYEKILEGK--VRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255
Query: 335 WFRGIQWDKLYEM--EAAYKPTVNGELDTQNFEKF 367
WF GI W L + EA + P V G DT NF+ +
Sbjct: 256 WFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDDY 290
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 340 bits (873), Expect = e-115
Identities = 162/375 (43%), Positives = 213/375 (56%), Gaps = 58/375 (15%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE L +IG+GAFGEV + + K TG+++AMK L K EMLKR + R ER++L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 156
R I L Y+FQD + LYL+M+Y GGD++TLL + ED L ED+ARFY+AE VLAI S+HQ
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
YVHRDIKPDN++LDKNGH++L+DFG C L D Q V+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSC----------LRLLADGTVQSNVA------- 163
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 271
VGT DY++PE+L K YG ECDWWSLG MYEML
Sbjct: 164 --------------------VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLCDVETRLGTRGVEEL 330
G PF ++ T KI+N K +FP + +S+EA+DLI L+C ETRLG G+++
Sbjct: 204 GETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDF 263
Query: 331 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFE------KFPEVDGPPSEIPSVGPWR 384
K+HP+F GI WD + A Y P V+ DT NF+ + E P S
Sbjct: 264 KDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTESLPPSSH-------- 315
Query: 385 KMLTSKDTNFIGYTF 399
+ F+G+T+
Sbjct: 316 GAFSGNHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 336 bits (864), Expect = e-114
Identities = 126/292 (43%), Positives = 177/292 (60%), Gaps = 43/292 (14%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+GKG+FG+V L R K TG+++AMK LKK +++KR +VEH +ERN+L+ ++ IV+L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
+FQ + LYL++EY PGG++ + L +E SE+ ARFY AE VLA+ +H ++RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 225
P+N++LD +GH+KL+DFGL K L + S
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSR------------------------------- 149
Query: 226 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 285
+ GT +Y+APEVLL KGYG DWWSLG ++YEML G PPF ++D +
Sbjct: 150 -------TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
Query: 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
KI+ L+FPE +S EARDLI LL D RLG+ G EE+K HP+F
Sbjct: 203 EKILKDP--LRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 332 bits (852), Expect = e-111
Identities = 153/388 (39%), Positives = 224/388 (57%), Gaps = 48/388 (12%)
Query: 20 LERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 79
L R E ++ + ++ +DF+ + +IG+GAFGEV+L R K++ +++AMK L K EM+KR
Sbjct: 25 LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR 84
Query: 80 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
ER+++A +S IVQL Y+FQD +LY++MEY+PGGD++ L+ DI E
Sbjct: 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKW 143
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
ARFY AE VLA+ +IH ++HRD+KPDN++LDK+GHLKL+DFG C + ++
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---------MKMDA 194
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGM 255
++ +T VGT DY++PEVL +G YG
Sbjct: 195 NGMVRCDT----------------------------AVGTPDYISPEVLKSQGGDGYYGR 226
Query: 256 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
ECDWWS+G +YEML+G PF +D T KI++ K L FP++ +IS +A+DLIC L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL 286
Query: 316 CDVETRLGTRGVEELKEHPWFRGIQW--DKLYEMEAAYKPTVNGELDTQNFEKFPEVDGP 373
D E RLG GV+E+K HP+F+ QW D + E A P ++ ++DT NF+ + D
Sbjct: 287 TDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKN 346
Query: 374 PSEIPSVGPWRKMLTSKDTNFIGYTFKK 401
P K FIG+T+ K
Sbjct: 347 EETFPL----PKAFAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 327 bits (839), Expect = e-110
Identities = 150/369 (40%), Positives = 208/369 (56%), Gaps = 47/369 (12%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DF+ +L+G+G FGEV++ R K TG+I+AMK +KKS +L + V ER++L+ +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 156
I QL Y+FQD D LYL+MEY PGGD+++LL R ED ED+A+FY+AE VLAIHS+HQ
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
YVHRDIKP+N+++D+ GH+KL+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGAIMYEML 270
N+ + VGT DY+APEVL K YG+ECDWWSLG I YEM+
Sbjct: 154 ----------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEEL 330
G PF T I+N++ LKFPE+PK+S + DLI LLC + RLG G L
Sbjct: 204 YGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEG---L 260
Query: 331 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 390
HP+F I W+ + + PT+ + DT NF++ + S+ + + K
Sbjct: 261 CCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGK 320
Query: 391 DTNFIGYTF 399
D F+G++F
Sbjct: 321 DLPFVGFSF 329
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 323 bits (830), Expect = e-109
Identities = 134/297 (45%), Positives = 190/297 (63%), Gaps = 33/297 (11%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
I KGA+G V L + K+TG+I+A+K +KK++M+++ QV+ V +ER++L++ S +V+L+Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
SFQ LYL+MEYLPGGD+ +LL L EDVAR YIAE VLA+ +H + +HRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 225
PDN+++D NGHLKL+DFGL S + L IN
Sbjct: 121 PDNILIDSNGHLKLTDFGL--------SKVGLVRR-QINLNDDE---------------- 155
Query: 226 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 285
K ++R VGT DY+APEV+L +G+ DWWSLG I+YE L+G PPF + P
Sbjct: 156 KEDKR-----IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210
Query: 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341
+ I+N K +++PE+ ++SDEA DLI LL D E RLG + +EE+K HP+F+GI W
Sbjct: 211 QNILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 325 bits (835), Expect = e-109
Identities = 141/376 (37%), Positives = 208/376 (55%), Gaps = 57/376 (15%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
DF+ LT +G+G +G+V L + K TGEI A+K++KKS + K +V HV +ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 158
+V+L Y+FQD ++LYL MEY+PGGD TLL +LSED ARFY+AE A+ ++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
Y+HRD+KP+N ++D +GH+KL+DFGL K V+
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-------------------GIVT--------- 153
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
A S VG+ DYMAPEVL KGY D+WSLG ++YE L G+PPF
Sbjct: 154 -------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
Query: 279 DDPRITCRKIVNWKTCLKFP--EEPK--ISDEARDLICHLLCDVETRLGTRGVEELKEHP 334
P T + WK L+ P ++P+ +SDEA DLI L+ D R G +E++K HP
Sbjct: 201 STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG--SLEDIKNHP 258
Query: 335 WFRGIQWDKLYEMEAAYKPTVNGELDTQNFE---------KFPEVDGPPSEIPSVGPWRK 385
+F+ + W++L E++ + P + E+DT F+ K+ +V G +
Sbjct: 259 FFKEVDWNELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGANGR 318
Query: 386 MLTSKDTNFIGYTFKK 401
F+G+TF+
Sbjct: 319 D-PGNRRKFVGFTFRH 333
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 325 bits (833), Expect = e-108
Identities = 154/379 (40%), Positives = 236/379 (62%), Gaps = 19/379 (5%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F ++ +G GAFGEV L T ++AMK L+K ++L R QV HV++ER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
+V+L+YSFQD D LY +M+Y+PGGD+M+LL+R ++ E +ARFYIAE LAI S+H+ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE------- 212
+HRDIKPDN+++D +GH+KL+DFGLC ++S + I Q+++ ++
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 213 ---GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
G + E+ K+++R LA+S VGT +Y+APEVLL+KGY CDWWS+G I++EM
Sbjct: 183 CRCGDRLKTLEQRAT-KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEE 329
L+G PPF + P T K++NW+ L P + K+S EA DLI L C E RLG G ++
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301
Query: 330 LKEHPWFRGIQWDK-LYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIP--SVGPWRKM 386
+K HP+F + + + A Y P ++ +DT NF+ E + P ++ S W +
Sbjct: 302 IKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEE-ESPWNDASGDSTRTWDTL 360
Query: 387 LTSKDTN----FIGYTFKK 401
+ + F +TF++
Sbjct: 361 CSPNGKHPEHAFYEFTFRR 379
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 321 bits (825), Expect = e-107
Identities = 153/337 (45%), Positives = 222/337 (65%), Gaps = 12/337 (3%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F ++ +G GAFGEV L R T ++AMK L+K ++L R QV HV++ER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
+V+L+YSFQD D LY +M+Y+PGGD+M+LL+R I ED+ARFYIAE A+ S+H+ +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIKPDN+++D++GH+KL+DFGLC + S + D + Q+++ + +W P
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM-DFSNEWGDPA 181
Query: 220 -----ERLQQWKR-----NRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+RL+ +R ++R LA+S VGT +Y+APEVLL+ GY CDWWS+G I+YEM
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEE 329
L+G PPF + P T K++NW+T L P + K+S EA DLI L E RLG G +E
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADE 301
Query: 330 LKEHPWFRGIQWDK-LYEMEAAYKPTVNGELDTQNFE 365
+K HP+F+ I + L + A Y P + DT NF+
Sbjct: 302 IKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFD 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = e-100
Identities = 118/299 (39%), Positives = 162/299 (54%), Gaps = 47/299 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+E L +G+G+FG+V L R K TG++ A+K +KK ++ K E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
IV+L+ F+D D LYL+MEY GGD+ LL + LSED ARFY+ + + A+ +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
VHRD+KP+N++LD++GH+KL+DFGL + L+
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE--------------------------- 151
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
+ VGT +YMAPEVLL KGYG D WSLG I+YE+L G PPF D
Sbjct: 152 ------------KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD 199
Query: 280 D-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
D +KI K P E IS EA+DLI LL D E RL EE +HP+F
Sbjct: 200 DQLLELFKKIGKPKPPF-PPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 298 bits (763), Expect = 2e-98
Identities = 161/369 (43%), Positives = 217/369 (58%), Gaps = 46/369 (12%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE + +IG+GAFGEV + + K T I+AMK L K EMLKR + R ERN+L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 156
+ I L Y+FQD ++LYL+M+Y GGD++TLL + ED L ED+ARFYIAE VLAIHSIHQ
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+YVHRDIKPDN++LD NGH++L+DFG C L ++D Q +V+
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSC----------LKMNQDGTVQSSVA------- 163
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKG---YGMECDWWSLGAIMYEMLI 271
VGT DY++PE+L ++ G YG ECDWWSLG MYEML
Sbjct: 164 --------------------VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEEL 330
G PF ++ T KI+N + +FP +S+EA+DLI L+C E RLG G+E+
Sbjct: 204 GETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDF 263
Query: 331 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 390
K+H +F GI W+ + +EA Y P V+ DT NF+ +V P P +
Sbjct: 264 KKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPPSS--HTGFSGL 321
Query: 391 DTNFIGYTF 399
F+G+T+
Sbjct: 322 HLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 284 bits (728), Expect = 1e-92
Identities = 152/386 (39%), Positives = 222/386 (57%), Gaps = 48/386 (12%)
Query: 20 LERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 79
L R + +++ ++ +D+E + +IG+GAFGEV+L R K+T +++AMK L K EM+KR
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 80 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
ER+++A +S +VQLFY+FQD +LY++MEY+PGGD++ L+ D+ E
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKW 143
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
ARFY AE VLA+ +IH ++HRD+KPDN++LDK+GHLKL+DFG C +
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM----------- 192
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGM 255
N+E + + + VGT DY++PEVL +G YG
Sbjct: 193 ----NKEGMVRCD----------------------TAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 256 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
ECDWWS+G +YEML+G PF +D T KI+N K L FP++ IS EA++LIC L
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 286
Query: 316 CDVETRLGTRGVEELKEHPWFRGIQ--WDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGP 373
D E RLG GVEE+K H +F+ Q W+ L + A P ++ ++DT NF+ E G
Sbjct: 287 TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGE 346
Query: 374 PSEIPSVGPWRKMLTSKDTNFIGYTF 399
P K F+G+T+
Sbjct: 347 EETFPI----PKAFVGNQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 3e-91
Identities = 156/369 (42%), Positives = 216/369 (58%), Gaps = 46/369 (12%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+DFE L +IG+GAFGEV + + K ++FAMK L K EMLKR + R ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 156
+ I L Y+FQD + LYL+M+Y GGD++TLL + ED L ED+ARFY+AE V+AI S+HQ
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+YVHRDIKPDN+++D NGH++L+DFG C L+ED + Q +V+
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLK--------LMEDGTV--QSSVA------- 163
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 271
VGT DY++PE+L K YG ECDWWSLG MYEML
Sbjct: 164 --------------------VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEEL 330
G PF ++ T KI+N K +FP + +S++A+DLI L+C E RLG G+E+
Sbjct: 204 GETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF 263
Query: 331 KEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 390
K+HP+F GI WD + EA Y P V+ DT NF+ + +P P +
Sbjct: 264 KQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPP--PSHTAFSGH 321
Query: 391 DTNFIGYTF 399
F+G+T+
Sbjct: 322 HLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 9e-89
Identities = 147/388 (37%), Positives = 225/388 (57%), Gaps = 48/388 (12%)
Query: 20 LERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 79
L R E ++++ ++ +D++ + +IG+GAFGEV+L R K++ +++AMK L K EM+KR
Sbjct: 25 LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 80 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
ER+++A +S +VQLF +FQD +LY++MEY+PGGD++ L+ D+ E
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKW 143
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
A+FY AE VLA+ +IH +HRD+KPDN++LDK+GHLKL+DFG C + +++
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---------MKMDE 194
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGM 255
++ +T VGT DY++PEVL +G YG
Sbjct: 195 TGMVRCDT----------------------------AVGTPDYISPEVLKSQGGDGYYGR 226
Query: 256 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
ECDWWS+G ++EML+G PF +D T KI++ K L FPE+ +IS A++LIC L
Sbjct: 227 ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL 286
Query: 316 CDVETRLGTRGVEELKEHPWFRGIQ--WDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGP 373
D E RLG GVEE+K+HP+F+ Q WD + E A P ++ ++D+ NF+ + G
Sbjct: 287 TDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGD 346
Query: 374 PSEIPSVGPWRKMLTSKDTNFIGYTFKK 401
P K FIG+T+ +
Sbjct: 347 VETFPI----PKAFVGNQLPFIGFTYYR 370
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 266 bits (683), Expect = 2e-87
Identities = 108/303 (35%), Positives = 160/303 (52%), Gaps = 46/303 (15%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G FG V L + K+ FA+K +KK +++ GQ EH+ SE+ +L E + IV+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
+F+D ++Y++MEY GG++ T+L + E ARFYIA VLA +H ++RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 225
P+NL+LD NG++KL DFG K L+
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLK------------------------------------ 144
Query: 226 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD--DPRI 283
++ GT +Y+APE++L KGY D+WSLG ++YE+L G PPF D DP
Sbjct: 145 ---SGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201
Query: 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLCD-VETRLGTR--GVEELKEHPWFRGIQ 340
I+ L+FP I A+DLI LL E RLG G++++K+H WF G
Sbjct: 202 IYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259
Query: 341 WDK 343
W+
Sbjct: 260 WEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 6e-87
Identities = 129/306 (42%), Positives = 174/306 (56%), Gaps = 58/306 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER-NLLAEVDSRCIVQLF 104
I KGAFG V L + ++TG+ FA+K LKKS+M+ + QV +V++ER ++ + +S + +L+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
YSFQ D+LYL+MEYL GGD +L+ L ED A+ YIAE VL + +HQ +HRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 224
KP+NL++D+ GHLKL+DFGL S LE++
Sbjct: 124 KPENLLIDQTGHLKLTDFGL--------SRNGLENKKF---------------------- 153
Query: 225 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP--- 281
VGT DY+APE +L G DWWSLG +++E L GYPPF ++ P
Sbjct: 154 ------------VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201
Query: 282 --RITCRKIVNWKTCLKFPEEPK--ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
I R+I NW PEE K S EA DLI LLC D RLG G +E+K HP+F
Sbjct: 202 FDNILSRRI-NW------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
Query: 337 RGIQWD 342
+ I WD
Sbjct: 255 KSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (678), Expect = 8e-86
Identities = 128/332 (38%), Positives = 184/332 (55%), Gaps = 31/332 (9%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
F+++ L+GKG G V L R K TG++FA+K L K EM+KR +V+ V +E+ +LA +D
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIH 155
+ L+ SFQ +L L+M+Y PGG++ LL R LSE+VARFY AE +LA+ +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK-----YSSILLEDEDIINQ---ET 207
V+RD+KP+N++L ++GH+ LSDF L K + + + +N ET
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
SE P R + S VGT +Y+APEV+ G+G DWW+LG ++Y
Sbjct: 181 FSEE------PSFR-----------SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-R 325
EML G PF + T I+ K + FP P +S ARDLI LL D RLG+ R
Sbjct: 224 EMLYGTTPFKGSNRDETFSNIL--KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281
Query: 326 GVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357
G E+K+HP+FRG+ W + P +
Sbjct: 282 GAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 257 bits (657), Expect = 1e-82
Identities = 138/369 (37%), Positives = 202/369 (54%), Gaps = 61/369 (16%)
Query: 43 LTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVE--HVRSERNLLAEVDS 97
L ++GKG +G+V R T TG+IFAMK LKK+ + R Q + H ++ERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-TIVRNQKDTAHTKAERNILEAVKH 59
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV L Y+FQ LYLI+EYL GG++ L RE I ED A FY++E LA+ +HQ
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
++RD+KP+N++LD GH+KL+DFGLCK E++ E
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK-------------------ESIHEGT----- 155
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
+ ++ GT++YMAPE+L++ G+G DWWSLGA+MY+ML G PPF
Sbjct: 156 --------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHP 334
+++ + T KI+ K L P P ++ EARDL+ LL + +RLG E++ HP
Sbjct: 202 AENRKKTIDKILKGK--LNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257
Query: 335 WFRGIQWDKLY--EMEAAYKPTVNGELDTQNFE-KFPEVDGPPSEIPSVGPWRKMLTSKD 391
+FR + WD L ++E +KP + E D F+ KF + P P L+
Sbjct: 258 FFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTR------QTPVDSPDDSTLSESA 311
Query: 392 TN-FIGYTF 399
F+G+T+
Sbjct: 312 NQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 7e-82
Identities = 130/356 (36%), Positives = 187/356 (52%), Gaps = 57/356 (16%)
Query: 19 NLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 78
+ +T +L DFE +G G+FG VR+ + K TGE +A+K LKK E+LK
Sbjct: 6 MFTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK 58
Query: 79 RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED 138
QV+HV E+++L E+ IV + SFQD + +Y ++E++ GG++ T L + D
Sbjct: 59 MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND 118
Query: 139 VARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198
VA+FY AE VLA +H + ++RD+KP+NL+LD GH+K++DFG K + D+
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------- 171
Query: 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 258
++ GT +Y+APEV+ KG+G D
Sbjct: 172 ----------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVD 197
Query: 259 WWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CD 317
WW++G ++YE + GYPPF D P KI+ + LKFP ARDL+ LL D
Sbjct: 198 WWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNW--FDGRARDLVKGLLQTD 253
Query: 318 VETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGELDTQNFEKFPE 369
RLGT GV ++K HP+F G WDKLY A V DT NFEK+P+
Sbjct: 254 HTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPD 309
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 4e-80
Identities = 115/336 (34%), Positives = 178/336 (52%), Gaps = 50/336 (14%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DD E++ +G G FG V L R + + +A+K + E+++ Q +HV +E+ +L EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
I++LF++ D FLY++MEY+PGG++ + L S FY +E V A+ +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
V+RD+KP+N++LDK GH+KL+DFG K L D+
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-------------------------- 154
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
++ GT +Y+APEV+ KG+ DWW+LG ++YEML+GYPPF
Sbjct: 155 ---------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGT--RGVEELKEHP 334
D+P KI+ K L+FP + A+DLI LL D RLG G +++K H
Sbjct: 200 DDNPFGIYEKILAGK--LEFPRHLDLY--AKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255
Query: 335 WFRGIQWDKLYEM--EAAYKPTVNGELDTQNFEKFP 368
WF+ + WD + + + P V+ + DT NF+ +P
Sbjct: 256 WFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDYP 291
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 1e-79
Identities = 108/302 (35%), Positives = 174/302 (57%), Gaps = 25/302 (8%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD- 96
DDF+ +IG+G+F V L + K T + +A+K L K +++K +V++V+ E+ +L ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
I++L+Y+FQD + LY ++EY P G+++ + + L E RFY AE +LA+ +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+KP+N++LDK+ H+K++DFG ++ +L+
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFG---------TAKVLDPNSSPESNKGDA------ 165
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
Q ++NRR A S VGT +Y++PE+L +K G D W+LG I+Y+ML G PPF
Sbjct: 166 --TNIDSQIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR-GVEELKEHP 334
+ +T +KI+ K FP P +A+DLI LL D + RLG G +ELK HP
Sbjct: 223 RGSNEYLTFQKIL--KLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278
Query: 335 WF 336
+F
Sbjct: 279 FF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 3e-77
Identities = 106/302 (35%), Positives = 148/302 (49%), Gaps = 47/302 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+E L +G G+FG V + K TG+I A+K LKK K + + R E +L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
IV+L +F+D D LYL+MEY GGD+ L R LSED A+ + + + +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+KP+N++LD+NG +K++DFGL K L SS
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS------------------------- 154
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCS 278
+ VGT YMAPEVLL GYG + D WSLG I+YE+L G PPF
Sbjct: 155 -------------LTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG 201
Query: 279 DDPRITCRKIVNWKTC---LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334
++ + I P+ S+EA+DLI L D R EE+ +HP
Sbjct: 202 ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHP 258
Query: 335 WF 336
WF
Sbjct: 259 WF 260
|
Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 7e-77
Identities = 131/364 (35%), Positives = 189/364 (51%), Gaps = 50/364 (13%)
Query: 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQ 102
+IGKG+FG+V L + K G+ +A+K L+K +LK+ + +H+ +ERN LL V +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
L YSFQ +D LY +++Y+ GG++ L RE E ARFY AE A+ +H N ++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
D+KP+N++LD GH+ L+DFGLCK E I + +T S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-------------EGIEHSKTTS------------- 154
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282
+ GT +Y+APEVL K+ Y DWW LGA++YEML G PPF S D
Sbjct: 155 ------------TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202
Query: 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG-VEELKEHPWFRGIQ 340
I+N LK P IS AR L+ LL D RLG + E+K H +F I
Sbjct: 203 EMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258
Query: 341 WDKLY--EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGP--WRKMLTSKDTNFI 395
WD L ++ + P V+G +D ++F+ F E P S S + D F+
Sbjct: 259 WDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFL 318
Query: 396 GYTF 399
G+++
Sbjct: 319 GFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 1e-75
Identities = 122/330 (36%), Positives = 187/330 (56%), Gaps = 27/330 (8%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+DFE + LI GA+G V L R K T + FAMKK+ K ++ R Q++ V ER++L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+V +F SF+ L ++MEY+ GGD TLL L D+AR Y AE+VLA+ +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
VHRD+KPDNL++ GH+KL+DFGL K ++ L E E + + +
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI--------EKDTREFL 172
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
K+ GT +Y+APEV+L++GYG DWW++G I+YE L+G PF
Sbjct: 173 DKQ---------------VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217
Query: 278 SDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPW 335
D P ++++ +++PE + + +A+DLI LL + RLGT G E+K+H +
Sbjct: 218 GDTPEELFGQVISDD--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
Query: 336 FRGIQWDKLYEMEAAYKPTVNGELDTQNFE 365
F G+ W+ L +A + P + E DT F+
Sbjct: 276 FLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 3e-72
Identities = 135/373 (36%), Positives = 192/373 (51%), Gaps = 62/373 (16%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL---AEVDSRCIVQ 102
IGKG FG+V R K T I+AMK L K E++ + +V H ERN+L +S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
L +SFQ LYL+ +Y+ GG++ L +E SED A+FYIAE VLA+ +H+++ V+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
D+KP+N++LD GH+ L DFGL K L D N
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA--------NLTDNKTTN------------------ 154
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281
+ GT +Y+APEVLL +KGY D+WSLG +++EM G+ PF ++D
Sbjct: 155 ------------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202
Query: 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG-TRGVEELKEHPWFRGI 339
+ R I K ++FP+ +SDE R + LL + + RLG R ELKEHP+F I
Sbjct: 203 QQMYRNIAFGK--VRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259
Query: 340 QWDKLYE--MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKML---------- 387
WD L + + +KP V+ + D NF+ PE + PW +
Sbjct: 260 DWDLLSKKQITPPFKPIVDSDEDVSNFD--PEFTNSSLLNAGIVPWEDVPGLPGANSTPL 317
Query: 388 -TSKDTNFIGYTF 399
+S NF G+TF
Sbjct: 318 SSSVQENFRGFTF 330
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 5e-72
Identities = 123/326 (37%), Positives = 176/326 (53%), Gaps = 49/326 (15%)
Query: 39 DFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEML-KRGQVEHVRSERNLLAE 94
+FE L ++G GA+G+V L R G+++AMK LKK+ ++ K EH R+ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 95 VDSRC--IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
V RC +V L Y+FQ L+LI++Y+ GG++ T L + + +E R YIAE VLA+
Sbjct: 61 V-RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+HQ ++RDIK +N++LD GH+ L+DFGL S L +E
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGL--------SKEFLAEE------------ 159
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLGAIMYEML 270
+ER AYS GT++YMAPEV+ G+ DWWSLG + +E+L
Sbjct: 160 ------EER-----------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329
G PF D + + +I K P +S EARD I LL D + RLG G +E
Sbjct: 203 TGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADE 262
Query: 330 LKEHPWFRGIQWDKLYE--MEAAYKP 353
+K HP+F+GI WD L + A +KP
Sbjct: 263 IKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 1e-70
Identities = 116/330 (35%), Positives = 171/330 (51%), Gaps = 50/330 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 103
++GKG+FG+V L K T E++A+K LKK +L+ VE +E+ +LA + QL
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
FQ D L+ +MEY+ GGD+M + R E ARFY AE VL + +H+ ++RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K DN++LD GH+K++DFG+CK E I+ T S
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCK-------------EGILGGVTTS-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT DY+APE+L + YG DWW+LG ++YEML G PF DD
Sbjct: 155 -----------TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
Query: 284 TCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGI 339
+ I+ P+ +S EA+ ++ L + E RLG G +++K HP+FR I
Sbjct: 204 LFQSILE-----DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258
Query: 340 QWDKL--YEMEAAYKPTVNGELDTQNFEKF 367
WDKL E++ +KP + G D NF+
Sbjct: 259 DWDKLERKEIKPPFKPKIKGRFDVSNFDDE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 3e-70
Identities = 117/324 (36%), Positives = 183/324 (56%), Gaps = 45/324 (13%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IGKG+FG+V R + T I+A+K ++K+ ++ R +V H +ER +LA+V+ IV L +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
SFQ + LYL++ ++ GG++ L RE ARFY AE + A+ ++H+ N ++RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 225
P+N++LD GH+ L DFGLCK + ++D+D N
Sbjct: 121 PENILLDYQGHIALCDFGLCK--------LNMKDDDKTN--------------------- 151
Query: 226 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 285
+ GT +Y+APE+LL GY DWW+LG ++YEML G PPF ++
Sbjct: 152 ---------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202
Query: 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 344
RKI+ + L+FP+ +A+DL+ LL D RLG G +E+K HP+F + W KL
Sbjct: 203 RKIL--QEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKL 258
Query: 345 Y--EMEAAYKPTVNGELDTQNFEK 366
++ +KP V+ +DT NF++
Sbjct: 259 LMKGIQPPFKPAVSSAIDTSNFDE 282
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 2e-69
Identities = 104/302 (34%), Positives = 160/302 (52%), Gaps = 50/302 (16%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
FE L +IGKGAFG+V + + + T ++FAMK + K + +++G V +V +ER +L E++
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
+V L+YSFQD + +YL+++ L GGD+ L ++ SE+ +F+I E VLA+ +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIKPDN++LD+ GH+ ++DF + + + + +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNI---------ATKVTPDTLTT--------------- 157
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
ST GT YMAPEVL ++GY + DWWSLG YE L G P+
Sbjct: 158 ---------------STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY--- 199
Query: 280 DPRITCRKIVNWKTCLKFPEEPKI----SDEARDLICHLL-CDVETRLGTRGVEELKEHP 334
R R I + + + S EA D I LL D + RLG +++LK HP
Sbjct: 200 --RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHP 256
Query: 335 WF 336
+F
Sbjct: 257 YF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 4e-69
Identities = 122/338 (36%), Positives = 174/338 (51%), Gaps = 49/338 (14%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
L+GKG FG+V L R K TG+ +AMK LKK ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
YSFQ D L +MEY GG++ L RE + SED ARFY AE V A+ +H + V+RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 224
K +NL+LDK+GH+K++DFGLCK E I + T+
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------EGISDGATMK--------------- 153
Query: 225 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 284
+ GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 154 ----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
Query: 285 CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL--GTRGVEELKEHPWFRGIQW 341
I+ + ++FP +S EA+ L+ LL D + RL G +E+ EH +F I W
Sbjct: 204 FELILMEE--IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259
Query: 342 DKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEI 377
+ ++E +KP V E DT+ F++ E I
Sbjct: 260 QDVVQKKLEPPFKPQVTSETDTRYFDE--EFTAQSITI 295
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 1e-68
Identities = 135/376 (35%), Positives = 202/376 (53%), Gaps = 62/376 (16%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 94
+FE L ++G GA+G+V L R T TG+++AMK L+K+ ++++ + VEH R+ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 95 V-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
V S +V L Y+FQ L+LI++Y+ GG++ T L + D SED RFY E +LA+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H+ V+RDIK +N++LD GH+ L+DFGL K L +E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF--------LSEE------------- 159
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIG 272
KER YS GT++YMAPE++ K G+G DWWSLG +++E+L G
Sbjct: 160 -----KER-----------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEE 329
PF + R T ++ P I EA+DL+ LL D + RLG +G E
Sbjct: 204 ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263
Query: 330 LKEHPWFRGIQWDKLYE--MEAAYKPTVNGELDTQNF-EKFPEVD---GPPSEIPSVGPW 383
+KEHP+F+G+ W+ L + ++P++ ELD NF E+F ++ P PS
Sbjct: 264 IKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGARV 323
Query: 384 RKMLTSKDTNFIGYTF 399
F GY+F
Sbjct: 324 ----------FQGYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 9e-68
Identities = 117/340 (34%), Positives = 176/340 (51%), Gaps = 61/340 (17%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR- 98
F L ++G+G FG+V L K TGE++A+K LKK +++ R +VE + E+ + +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 99 --CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
+V LF FQ D + +MEY GGD+M + + D+ SE A FY A VL + +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+ V+RD+K DNL+LD G +K++DFGLCK EG
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-------------------------EGMG- 153
Query: 217 MPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
+R ST GT +++APEVL + Y DWW LG ++YEML+G P
Sbjct: 154 -FGDRT------------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
Query: 276 FCSDDPRITCRKIVNWKTCLKFPEEPK----ISDEARDLICHLLC-DVETRLGT--RGVE 328
F DD IVN +E + +S EA ++ LL + E RLG+ + E
Sbjct: 201 FPGDDEEEVFDSIVN--------DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAE 252
Query: 329 ELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 366
++K+ P+FR I WD L +++ + PT+ G D NF++
Sbjct: 253 DVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDE 292
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 2e-66
Identities = 130/349 (37%), Positives = 194/349 (55%), Gaps = 54/349 (15%)
Query: 43 LTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
L ++G+G+FG+V L R T G+++AMK LKK+ + R +V + ER++LAEV+
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
IV+L Y+FQ LYLI+++L GGD+ T L +E + +E+ +FY+AE LA+ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
++RD+KP+N++LD+ GH+KL+DFGL K
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLS---------------------------------K 146
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
E + K+ AYS GT++YMAPEV+ ++G+ DWWS G +M+EML G PF
Sbjct: 147 ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201
Query: 280 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWF 336
D + T I+ K L P+ +S EA+ L+ L + RLG GVEE+K HP+F
Sbjct: 202 DRKETMTMILKAK--LGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257
Query: 337 RGIQWDKLY--EMEAAYKPTVNGELDTQNFEKFPEVDG-PPSEIPSVGP 382
I W+KLY E++ +KP V DT F+ PE P + P + P
Sbjct: 258 STIDWNKLYRREIKPPFKPAVGRPDDTFYFD--PEFTSRTPKDSPGIPP 304
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 7e-64
Identities = 124/364 (34%), Positives = 184/364 (50%), Gaps = 61/364 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQ 102
++GKG+FG+V L K T E FA+K LKK +L+ VE ER +LA + +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLA-LAWEHPFLTH 60
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
LF +FQ + L+ +MEYL GGD+M + E ARFY AE + + +H+ ++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
D+K DN++LDK+GH+K++DFG+CK E++
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK-------------ENM-------------------- 147
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282
N A + GT DY+APE+L + Y DWWS G ++YEMLIG PF +D
Sbjct: 148 -----NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-- 200
Query: 283 ITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340
+ P P+ IS EA+D + L D RLG G ++++HP+FRGI
Sbjct: 201 ---EDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGID 255
Query: 341 WDKL--YEMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPW-RKMLTSKDTN-FI 395
W++L E+ +KP V D NF++ F +E + P +K+L S D F
Sbjct: 256 WERLEKREIPPPFKPKVKSPSDASNFDREF------TNEKVRLSPVDKKLLASMDQEQFR 309
Query: 396 GYTF 399
G++F
Sbjct: 310 GFSF 313
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-62
Identities = 124/360 (34%), Positives = 183/360 (50%), Gaps = 47/360 (13%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQL 103
+IGKG+FG+V L + K+ G +A+K L+K +LK+ + H+ +ERN LL + +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
YSFQ ++ LY +++Y+ GG++ L RE E ARFY AE AI +H N ++RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+KP+N++LD GH+ L+DFGLCK E + +ET S
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK-------------EGVEPEETTS-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT +Y+APEVL K+ Y DWW LGA++YEML G PPF S D
Sbjct: 155 -----------TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203
Query: 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG-VEELKEHPWFRGIQW 341
I++ L+ P + A DL+ LL D RLG + E+K H +F I W
Sbjct: 204 MYDNILHKP--LQLP--GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259
Query: 342 DKLYEMEAA--YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 399
D LY Y P V G D ++F+ + S + +S + F+G+++
Sbjct: 260 DDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 3e-61
Identities = 114/345 (33%), Positives = 182/345 (52%), Gaps = 51/345 (14%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSER 89
++ K+ +DF + +G G+FG V L K A+K+ +KS+++K+ QV+HV SER
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 90 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 149
+L ++ V L+ SF+D +LYL++E++ GG+ T L R DV FY A+ VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ N V+RD+KP+NL+LDK+G +K++DFG K ++ +
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------------------ 184
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
Y+ GT +Y+APE+LL G+G DWW+LG +YE+
Sbjct: 185 -----------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RG 326
L+G PPF +++P + +KI+ + + FP+ + + + L+ LL D+ R G +G
Sbjct: 222 LVGCPPFYANEPLLIYQKIL--EGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKG 277
Query: 327 VEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGELDTQNFEKFPE 369
+ +KEHPWF I W L +E YKP D+ NFE+ E
Sbjct: 278 AQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-60
Identities = 132/367 (35%), Positives = 193/367 (52%), Gaps = 58/367 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQL 103
+IGKG+FG+V L R K + +A+K L+K +LK+ + +H+ SERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
+SFQ +D LY +++Y+ GG++ L RE E ARFY AE A+ +H N V+RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+KP+N++LD GH+ L+DFGLCK E+I + T S
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK-------------ENIEHNGTTS-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT +Y+APEVL K+ Y DWW LGA++YEML G PPF S +
Sbjct: 155 -----------TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
Query: 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG-TRGVEELKEHPWFRGIQW 341
I+N LK P I++ AR L+ LL D RLG E+K H +F I W
Sbjct: 204 MYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
Query: 342 DKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIP-SVG--PWRKMLTSKDTN--- 393
D L ++ + P V+G D ++F+ PE P +P S+G P ++T+
Sbjct: 260 DDLINKKITPPFNPNVSGPNDLRHFD--PEFTEEP--VPNSIGQSPDSILVTASVKEAAE 315
Query: 394 -FIGYTF 399
F+G+++
Sbjct: 316 AFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 1e-58
Identities = 119/368 (32%), Positives = 176/368 (47%), Gaps = 53/368 (14%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS- 97
DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+ QL FQ D LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
++RD+K DN++LD GH+K++DFG+CK E+I +T
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK-------------ENIFGGKTTR-------- 159
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
+ GT DY+APE++ + YG DWW+ G ++YEML G PPF
Sbjct: 160 -----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLCDVET-RLGT--RGVEELKEH 333
+D + I+ PK +S EA + LL RLG G +++EH
Sbjct: 203 GEDEDELFQSIME-----HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257
Query: 334 PWFRGIQWDKLYEME--AAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKD 391
+FR I W+KL E +KP V G +NF+KF PP P +
Sbjct: 258 AFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKF-FTREPPVLTPP--DKLVIANIDQ 314
Query: 392 TNFIGYTF 399
+ F G++F
Sbjct: 315 SEFQGFSF 322
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-58
Identities = 122/363 (33%), Positives = 183/363 (50%), Gaps = 50/363 (13%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQL 103
+IGKG+FG+V L + K G+ +A+K L+K +L R + +H+ +ERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
YSFQ ++ LY +++++ GG++ L RE E ARFY AE A+ +H N V+RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+KP+N++LD GH+ L+DFGLCK E I +T +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK-------------EGIAQSDTTT-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT +Y+APEV+ K+ Y DWW LGA++YEML G PPF D
Sbjct: 155 -----------TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
Query: 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGTR-GVEELKEHPWFRGIQW 341
I++ L+ P S A ++ LL D + RLG + E++EHP+F + W
Sbjct: 204 MYDNILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259
Query: 342 DKLYE--MEAAYKPTVNGELDTQNFE-KFPEVDGPPSEIPSVGPW--RKMLTSKDTNFIG 396
L + + + P V G D NF+ F E P S S + D F+G
Sbjct: 260 TDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVG 319
Query: 397 YTF 399
+++
Sbjct: 320 FSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 3e-58
Identities = 116/326 (35%), Positives = 170/326 (52%), Gaps = 47/326 (14%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
L+GKG FG+V L R K TG +AMK L+K ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
Y+FQ D L +MEY GG++ L RE + +E+ ARFY AE V A+ +H + V+RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 224
K +NL+LDK+GH+K++DFGLCK E I + T+
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------EGISDGATMK--------------- 153
Query: 225 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 284
+ GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 154 ----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 203
Query: 285 CRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRL--GTRGVEELKEHPWFRGIQW 341
I+ + ++FP +S EA+ L+ LL D + RL G +E+ EH +F I W
Sbjct: 204 FELILMEE--IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259
Query: 342 DKLYE--MEAAYKPTVNGELDTQNFE 365
+ + + +KP V E+DT+ F+
Sbjct: 260 QDVVQKKLLPPFKPQVTSEVDTRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-56
Identities = 87/296 (29%), Positives = 139/296 (46%), Gaps = 46/296 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
L+G+G+FG V L K TGE+ A+K ++ S + ++E + E +L+ + IV+ +
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 105 YSFQDS--DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
S +D + L + +EY+ GG + +LL + L E V R Y + + + +H + VHR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
DIK N+++D +G +KL+DFG K L D +
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC-SDDP 281
S GT +MAPEV+ + YG D WSLG + EM G PP+ +P
Sbjct: 161 -----------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP 209
Query: 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
KI + + PE +S+EA+D + L D + R +EL +HP+
Sbjct: 210 MAALYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 2e-55
Identities = 103/307 (33%), Positives = 158/307 (51%), Gaps = 50/307 (16%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+GKG FGEV C+ K TG+++A KKL K + KR + +E+ +L +V SR IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
+F+ D L L+M + GGD+ + + E E A FY A+ + + +HQ V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+KP+N++LD +G++++SD GL L+ K R
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK------------------------IKGR-- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
GT YMAPEVL + Y DW++LG +YEM+ G PF ++
Sbjct: 155 -------------AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV 201
Query: 284 TCRKIVNWKTC---LKFPEEPKISDEARDLICHLLC-DVETRLGTRG--VEELKEHPWFR 337
++ + +T +++P+ K S EA+DL LL D E RLG RG +E++EHP F+
Sbjct: 202 E-KEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
Query: 338 GIQWDKL 344
+ W +L
Sbjct: 259 DLNWRRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 109/337 (32%), Positives = 172/337 (51%), Gaps = 64/337 (18%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQL 103
++GKG+FG+V L K T E++A+K LKK +L+ V+ +E+ +LA + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
FQ D L+ +MEY+ GGD+M + R E +RFY AE LA+ +H+H ++RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K DN++LD GH KL+DFG+CK E I+N T +
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCK-------------EGILNGVTTT-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT DY+APE+L + YG DWW+LG +MYEM+ G PPF +D+
Sbjct: 155 -----------TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
Query: 284 TCRKIVN-------WKTCLKFPEEPKISDEARDLICHLLC-DVETRLG---TRGVEE-LK 331
I++ W +S EA ++ + + RLG ++G E+ +K
Sbjct: 204 LFESILHDDVLYPVW-----------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252
Query: 332 EHPWFRGIQWDKL--YEMEAAYKPTVNGELDTQNFEK 366
+HP+F+ I W L +++ +KP + + D NF++
Sbjct: 253 QHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 5e-55
Identities = 121/328 (36%), Positives = 173/328 (52%), Gaps = 48/328 (14%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
L+GKG FG+V L + K TG +AMK LKK ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH-QHNYVHRD 163
YSFQ D L +MEY GG++ L RE + SED ARFY AE V A+ +H + N V+RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K +NL+LDK+GH+K++DFGLCK E I + T+
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK-------------EGIKDGATMK-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 155 -----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203
Query: 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRL--GTRGVEELKEHPWFRGIQ 340
I+ + ++FP +S EA+ L+ LL D + RL G +E+ +H +F GI
Sbjct: 204 LFELILMEE--IRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259
Query: 341 WDKLYE--MEAAYKPTVNGELDTQNFEK 366
W +YE + +KP V E DT+ F++
Sbjct: 260 WQDVYEKKLVPPFKPQVTSETDTRYFDE 287
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 6e-55
Identities = 117/327 (35%), Positives = 170/327 (51%), Gaps = 47/327 (14%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
L+GKG FG+V L R K +G+ +AMK LKK ++ + +V H +E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
YSFQ D L +MEY+ GG++ L RE + SED RFY AE V A+ +H V+RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 224
K +NL+LDK+GH+K++DFGLCK E +++A
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK-------------------EGITDA------------- 149
Query: 225 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 284
A + GT +Y+APEVL YG DWW LG +MYEM+ G PF + D
Sbjct: 150 ------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
Query: 285 CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL--GTRGVEELKEHPWFRGIQW 341
I+ +KFP +S +A+ L+ LL D RL G +E+ H +F G+ W
Sbjct: 204 FELIL--MEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259
Query: 342 DKLYE--MEAAYKPTVNGELDTQNFEK 366
+Y+ + +KP V E DT+ F++
Sbjct: 260 QDVYDKKLVPPFKPQVTSETDTRYFDE 286
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-54
Identities = 107/327 (32%), Positives = 165/327 (50%), Gaps = 50/327 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 103
++GKG+FG+V L K T + FA+K LKK +L VE E+ +L+ + + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
+ +FQ + L+ +MEYL GGD+M + A FY AE + + +H V+RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K DN++LD +GH+K++DFG+CK E+++
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK-------------ENMLGDAKTC-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT DY+APE+LL + Y DWWS G ++YEMLIG PF D
Sbjct: 155 -----------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
Query: 284 TCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341
+ I + P P+ ++ EA+D++ L + E RLG +G ++++HP+FR I W
Sbjct: 204 LFQSIR-----MDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDW 256
Query: 342 DKL--YEMEAAYKPTVNGELDTQNFEK 366
L E+E +KP V D NF+K
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDK 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 9e-54
Identities = 84/257 (32%), Positives = 123/257 (47%), Gaps = 56/257 (21%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G+G FG V L R K TG+ A+K +KK + +E + E +L +++ IV+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
F+D + LYL+MEY GG + LL E LSED + + + + +H + +HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 165 KPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
KP+N++LD NG +KL+DFGL K L S
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS------------------------------ 148
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPF------ 276
L + VGT YMAPEVLL K Y + D WSLG I+YE+ P
Sbjct: 149 --------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----PELKDLIRK 196
Query: 277 -CSDDP--RITCRKIVN 290
DP R + ++I+
Sbjct: 197 MLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 9e-54
Identities = 114/329 (34%), Positives = 180/329 (54%), Gaps = 53/329 (16%)
Query: 39 DFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRGQV-EHVRSERNLLAE 94
+FE L ++G GA+G+V L R +G+++AMK LKK+ ++++ + EH R+ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 95 V-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
+ S +V L Y+FQ L+LI++Y+ GG++ T L + + E + Y E VLA+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H+ ++RDIK +N++LD NGH+ L+DFGL K EDE
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE--------FHEDEV------------ 160
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECDWWSLGAIMYEMLI 271
ER AYS GT++YMAP+++ G+ DWWS+G +MYE+L
Sbjct: 161 ------ER-----------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
Query: 272 GYPPFCSDDPRITCRKIVN--WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RG 326
G PF D + + +I K+ +P+E +S A+D+I LL D + RLG
Sbjct: 204 GASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCGPSD 261
Query: 327 VEELKEHPWFRGIQWDKLY--EMEAAYKP 353
+E+K+HP+F+ I WD L ++ A +KP
Sbjct: 262 ADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 105/328 (32%), Positives = 172/328 (52%), Gaps = 49/328 (14%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 103
++GKG+FG+V L R K +G ++A+K LKK +L+ VE +E+ +L+ + + QL
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
+ FQ D L+ +ME++ GGD+M + + E ARFY AE A+ +H ++RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K DN++LD GH KL+DFG+CK E I N +T S
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCK-------------EGIFNGKTTS-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+ GT DY+APE+L + YG DWW++G ++YEML G+ PF +++
Sbjct: 155 -----------TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
Query: 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGI 339
I+N + +P +S +A D++ + + RLG+ G E + HP+F+ +
Sbjct: 204 LFEAILNDEVV--YPTW--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259
Query: 340 QWDKLY--EMEAAYKPTVNGELDTQNFE 365
W+KL ++E ++P + D NF+
Sbjct: 260 DWEKLNRRQIEPPFRPRIKSREDVSNFD 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 5e-51
Identities = 110/335 (32%), Positives = 173/335 (51%), Gaps = 49/335 (14%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+ +LA D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 99 -CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+ QL FQ D LY +MEY+ GGD+M + + E A FY AE + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
++RD+K DN++LD GH+K++DFG+CK E +++ T
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-------------EHMVDGVTTR-------- 159
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
+ GT DY+APE++ + YG DWW+ G ++YEML G PPF
Sbjct: 160 -----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETR---LGTRGVEELKEHP 334
+D + I+ + +P+ +S EA + L+ ++ G G +++EH
Sbjct: 203 GEDEDELFQSIMEHN--VSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258
Query: 335 WFRGIQWDKL--YEMEAAYKPTVNGELDTQNFEKF 367
+FR I WDKL E++ +KP V G+ +NF+KF
Sbjct: 259 FFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 78/282 (27%), Positives = 128/282 (45%), Gaps = 48/282 (17%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
+E + IGKG+FG+V L R K+ G+++ +K++ S M + E +E +L +++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL----MREDILSEDVARFYIAESVLAIHSI 154
I++ + SF++ L ++MEY GGD+ + E+ + + LA+ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H +HRDIKP N+ L NG +KL DFG+ K L
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---------------------- 157
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
LA + VGT Y++PE+ K Y + D WSLG ++YE+
Sbjct: 158 ----------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKI-SDEARDLICHLL 315
PF ++ KI+ ++P P S E R+L+ LL
Sbjct: 202 PFEGENLLELALKILK----GQYPPIPSQYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-50
Identities = 85/301 (28%), Positives = 130/301 (43%), Gaps = 52/301 (17%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
FE L IGKG FGEV R K TG+ A+K +K K+ E + +E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSIH 155
IV+ + S+ D L+++ME+ GG D++ + L+E + E + + +H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--LTESQIAYVCKELLKGLEYLH 115
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
+ +HRDIK N++L +G +KL DFGL L D +
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN-------------------- 155
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
+ VGT +MAPEV+ K Y + D WSLG E+ G PP
Sbjct: 156 -------------------TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
Query: 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334
+ S+ P + + K SDE +D + L + E R E+L +HP
Sbjct: 197 Y-SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHP 252
Query: 335 W 335
+
Sbjct: 253 F 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 117/349 (33%), Positives = 174/349 (49%), Gaps = 55/349 (15%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDS 97
DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+ QL FQ D LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
++RD+K DN++LD GH+K++DFG+CK E++ + T
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-------------ENMWDGVTTK-------- 159
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
+ GT DY+APE++ + YG DWW+ G ++YEML G PF
Sbjct: 160 -----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVE--TRLGT--RGVEELKEH 333
+D + I+ + +P+ +S EA IC L RLG G ++KEH
Sbjct: 203 GEDEDELFQSIMEHN--VAYPKS--MSKEAV-AICKGLMTKHPGKRLGCGPEGERDIKEH 257
Query: 334 PWFRGIQWDKL--YEMEAAYKPTVNGELDTQNFEKF----PEVDGPPSE 376
+FR I W+KL E++ YKP G D +NF+KF P V PP +
Sbjct: 258 AFFRYIDWEKLERKEVQPPYKPKACGR-DAENFDKFFTRHPPVLTPPDQ 305
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-49
Identities = 108/327 (33%), Positives = 164/327 (50%), Gaps = 50/327 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQL 103
++GKG+FG+V L K GE FA+K LKK +L VE E+ +LA ++ + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
+ +FQ + L+ +ME+L GGD+M + + A FY AE V + +H ++RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K DN++LD++GH+K++DFG+CK E++
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK-------------ENVFGD------------------ 150
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
NR A + GT DY+APE+L Y DWWS G ++YEMLIG PF DD
Sbjct: 151 ----NR---ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
Query: 284 TCRKIVNWKTCLKFPEEPK-ISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRGIQW 341
I + P P+ I+ E++D++ L D RLG G ++ HP+F+ I W
Sbjct: 204 LFESIR-----VDTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINW 256
Query: 342 DKL--YEMEAAYKPTVNGELDTQNFEK 366
L E++ +KP V D NF++
Sbjct: 257 TALEKRELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 5e-49
Identities = 104/312 (33%), Positives = 158/312 (50%), Gaps = 48/312 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F ++GKG FGEV C+ + TG+++A KKL+K + KR +E+ +L +V+SR
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 157
+V L Y+++ D L L++ + GGD+ + M E+ A FY AE + +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
V+RD+KP+N++LD GH+++SD GL V EG+ +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGL----------------------AVEIPEGETI- 158
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
R R VGT+ YMAPEV+ + Y DWW LG ++YEM+ G PF
Sbjct: 159 ---------RGR-------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
Query: 278 SDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTR--GVEELKE 332
++ R+ V + + EE K S+ AR + LL D RLG R G EE+K
Sbjct: 203 QRKEKVK-REEVE-RRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260
Query: 333 HPWFRGIQWDKL 344
HP+FR + +L
Sbjct: 261 HPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 109/323 (33%), Positives = 166/323 (51%), Gaps = 50/323 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F Q ++GKG FGEV C+ + TG+++A KKL+K + KR +E+ +L +V+SR
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 157
+V L Y+++ D L L++ + GGD+ + M E E A FY AE + +HQ
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
V+RD+KP+N++LD +GH+++SD GL V EGQ +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGL----------------------AVHVPEGQTIK 159
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
+ VGT+ YMAPEV+ + Y DWW+LG ++YEM+ G PF
Sbjct: 160 GR-----------------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
Query: 278 SDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRG--VEELKE 332
+I ++ + + EE K S +AR L LLC D + RLG +G E+KE
Sbjct: 203 QRKKKIKREEVE--RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260
Query: 333 HPWFRGIQWDKLYE--MEAAYKP 353
HP F+ I + +L +E +KP
Sbjct: 261 HPLFKQINFKRLEAGMLEPPFKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 6e-48
Identities = 104/338 (30%), Positives = 172/338 (50%), Gaps = 56/338 (16%)
Query: 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQ 102
+IG+G++ +V L K T I+AMK +KK + ++ V++E+++ + +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
L FQ L+ ++E++ GGD+M + R+ L E+ ARFY AE LA++ +H+ ++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
D+K DN++LD GH+KL+D+G+CK E I +T S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK-------------EGIRPGDTTS------------- 154
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF----CS 278
+ GT +Y+APE+L + YG DWW+LG +M+EM+ G PF S
Sbjct: 155 ------------TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202
Query: 279 DDPRITCR----KIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEEL 330
D+P +++ K ++ P +S +A ++ L D + RLG G ++
Sbjct: 203 DNPDQNTEDYLFQVILEKQ-IRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDI 259
Query: 331 KEHPWFRGIQWDKLYEMEAA--YKPTVNGELDTQNFEK 366
K HP+FR I WD L + + YKP + + D NF+
Sbjct: 260 KSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 163 bits (412), Expect = 7e-46
Identities = 119/425 (28%), Positives = 171/425 (40%), Gaps = 61/425 (14%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS- 97
+ L +G+G+FGEV L R + ++ A+K L K K +VE E +LA ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSI 154
IV+L+ FQD LYL+MEY+ GG + LL R+ LSE A F +A+ + A+ +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 155 HQHNYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
H +HRDIKP+N++LD++G +KL DFGL K L D S+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST------------------- 158
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEML 270
+ AL ++VGT YMAPEVLL D WSLG +YE+L
Sbjct: 159 -------------SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL 205
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPE---------EPKISDEARDLICHLL-CDVET 320
G PPF + + + L P IS A DL+ LL D +
Sbjct: 206 TGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKN 265
Query: 321 RLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSV 380
RL + H L E+ + + P +
Sbjct: 266 RLSSS---SDLSHDLLA-----HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNS 317
Query: 381 GPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRSNGSSKVPSLISLLGRIDVQETAI 440
D + + V S NS + + S SSK SL + R +
Sbjct: 318 LAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISARSSPSSLSS 377
Query: 441 SECDQ 445
S Q
Sbjct: 378 SSRQQ 382
|
Length = 384 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 7e-46
Identities = 101/313 (32%), Positives = 167/313 (53%), Gaps = 50/313 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F Q ++GKG FGEV C+ + TG+++A K+L+K + KR +E+ +L +V+S+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 157
+V L Y+++ D L L++ + GGD+ + M E+ A FY AE + + +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
N V+RD+KP+N++LD GH+++SD GL ++ + + + I
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGL---------AVKIPEGESI-------------- 158
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
R R VGT+ YMAPEVL + Y + D+W LG ++YEM+ G PF
Sbjct: 159 ---------RGR-------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
Query: 278 SDDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC--DVETRLGTR--GVEELK 331
++ R+ V+ + L+ E K S+EA+ IC +L D + RLG + G E+K
Sbjct: 203 GRKEKVK-REEVD-RRVLETEEVYSAKFSEEAKS-ICKMLLTKDPKQRLGCQEEGAGEVK 259
Query: 332 EHPWFRGIQWDKL 344
HP+FR + + +L
Sbjct: 260 RHPFFRNMNFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 102/332 (30%), Positives = 179/332 (53%), Gaps = 50/332 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 103
+IG+G++ +V L R K +I+AMK +KK + ++ V++E+++ + S +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
FQ + L+L++EY+ GGD+M + R+ L E+ ARFY AE +A++ +H+ ++RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K DN++LD +GH+KL+D+G+CK E + +T S
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK-------------EGLGPGDTTS-------------- 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF--CSDDP 281
+ GT +Y+APE+L + YG DWW+LG +M+EM+ G PF +D+P
Sbjct: 155 -----------TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP 203
Query: 282 RITCRKIVNWKTCLKFP-EEPK-ISDEARDLICHLLC-DVETRLGTR---GVEELKEHPW 335
+ + ++ L+ P P+ +S +A ++ L D + RLG + G ++K H +
Sbjct: 204 DMNTEDYL-FQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262
Query: 336 FRGIQWDKLYEMEAA--YKPTVNGELDTQNFE 365
FR I WD L + + +KP + + +NF+
Sbjct: 263 FRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-45
Identities = 94/308 (30%), Positives = 150/308 (48%), Gaps = 49/308 (15%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+GKG FGEV C+ + TG+++A KKL K + KR E E+ +LA+V SR IV L Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDI----LSEDVARFYIAESVLAIHSIHQHNYVH 161
+FQ L L+M + GGD+ + D E A FY A+ + + +HQ ++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 162 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
RD+KP+N++LD +G++++SD GL L+D S
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQS---------------------------- 152
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281
+ Y+ GT +MAPE+L + Y D+++LG +YEM+ PF +
Sbjct: 153 --------KTKGYA--GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
Query: 282 RITCRKIVN--WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWF 336
++ +++ + +P+ K S ++ LL D E RLG R + L+ HP F
Sbjct: 203 KVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
Query: 337 RGIQWDKL 344
R + W +L
Sbjct: 261 RDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 102/334 (30%), Positives = 170/334 (50%), Gaps = 52/334 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQL 103
+IG+G++ +V L R K T I+AMK +KK + ++ V++E+++ + + +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
FQ L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA++ +H+ ++RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K DN++LD GH+KL+D+G+CK EG + P +
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK-------------------------EG--LRPGDTTS 154
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF----CSD 279
+ GT +Y+APE+L + YG DWW+LG +M+EM+ G PF SD
Sbjct: 155 TF-----------CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
Query: 280 DPRITCRKI---VNWKTCLKFPEEPKISDEARDLICHLLCDVETRLG---TRGVEELKEH 333
+P V + ++ P + A L L D + RLG G +++ H
Sbjct: 204 NPDQNTEDYLFQVILEKQIRIPRSLSVK-AASVLKSFLNKDPKERLGCHPQTGFADIQGH 262
Query: 334 PWFRGIQWDKLYEMEAA--YKPTVNGELDTQNFE 365
P+FR + WD + + + +KP ++GE NF+
Sbjct: 263 PFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFD 296
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-44
Identities = 65/150 (43%), Positives = 102/150 (68%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
I++F + I +GAFG+V L R K +++A+K +KK++M+ + V V++ER+ LA
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
S IV L+YS Q ++ +YL+MEYL GGD+ +LL E++A YI+E LA+ +H+
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186
H +HRD+KPDN+++ GH+KL+DFGL K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 99/311 (31%), Positives = 156/311 (50%), Gaps = 46/311 (14%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F ++GKG FGEV C+ + TG+++A KKL+K + KR +E+ +L +V+SR
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 157
+V L Y+++ D L L++ + GGD+ + M E A FY AE + + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
V+RD+KP+N++LD GH+++SD GL V EG+ +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGL----------------------AVQIPEGETV- 158
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
R R VGT+ YMAPEV+ + Y DWW LG ++YEM+ G PF
Sbjct: 159 ---------RGR-------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
Query: 278 SDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTR--GVEELKEH 333
R+ R+ V+ + E K S++A+ + LL + + RLG R G +K+H
Sbjct: 203 KRKERVK-REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261
Query: 334 PWFRGIQWDKL 344
P F+ I + +L
Sbjct: 262 PIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 101/311 (32%), Positives = 151/311 (48%), Gaps = 54/311 (17%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIV 101
+IG+G FGEV CR TG+++AMK L K + + +ER +L+ V D IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 161
+ Y+F D L I++ + GGD+ L + + SE RFY AE +L + +H V+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 162 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
RD+KP N++LD++GH+++SD GL K
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP---------------------------- 152
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF--CS 278
+++VGT YMAPEVL K Y DW+SLG +++++L G+ PF
Sbjct: 153 ------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
Query: 279 DDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLG--TRGVEELKEHP 334
+ ++ T E P S E R L+ LL DV RLG RG +E+KEHP
Sbjct: 201 TKDKHEIDRM----TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256
Query: 335 WFRGIQWDKLY 345
+FR + W ++
Sbjct: 257 FFRSLDWQMVF 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 81/310 (26%), Positives = 132/310 (42%), Gaps = 54/310 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVD 96
D E++ ++G+G+ G V R K TG+I+A+KK+ + R Q+ E L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCE 57
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIH 155
S +V+ + +F + +++EY+ GG + LL + + E V YIA +L + +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLH 116
Query: 156 Q-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
+ +HRDIKP NL+++ G +K++DFG+ K LE
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE------------------------- 151
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
N + VGT+ YM+PE + + Y D WSLG + E +G
Sbjct: 152 -------------NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198
Query: 275 PFCSD---DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330
PF + I + + S E RD I L D + R EL
Sbjct: 199 PFLPPGQPSFFELMQAICD--GPPPSLPAEEFSPEFRDFISACLQKDPKKR---PSAAEL 253
Query: 331 KEHPWFRGIQ 340
+HP+ +
Sbjct: 254 LQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 79/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
LIG+GAFG V TG+ A+K++ + +K ++ + E +LL + IV+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
S + SD LY+I+EY G + ++ + E + Y+ + + + +H+ +HRDI
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125
Query: 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 224
K N++ K+G +KL+DFG+ ++ L +
Sbjct: 126 KAANILTTKDGVVKLADFGV--------ATKLNDVSKDDA-------------------- 157
Query: 225 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 284
S VGT +MAPEV+ G D WSLG + E+L G PP+ +P
Sbjct: 158 ----------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA 207
Query: 285 CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+IV PE IS E +D + D R + +L +HPW
Sbjct: 208 LFRIVQ-DDHPPLPEG--ISPELKDFLMQCFQKDPNLRPTAK---QLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 102/310 (32%), Positives = 157/310 (50%), Gaps = 52/310 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LKRGQVEHVRSERNLLAEV---DSRCI 100
+IG+G FGEV CR TG+++AMK L K + +K+G+ + +ER +L+ V D I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-NERIMLSLVSTGDCPFI 59
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 160
V + Y+F D L I++ + GGD+ L + + SE RFY E +L + +H V
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 161 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 220
+RD+KP N++LD++GH+++SD GL K
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKP--------------------------- 152
Query: 221 RLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
+++VGT YMAPEVL K Y DW+SLG +++++L G+ PF
Sbjct: 153 -------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF--R 197
Query: 280 DPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGT--RGVEELKEHPW 335
+ + ++ T E P S E + L+ LL DV RLG RG +E+KEH +
Sbjct: 198 QHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257
Query: 336 FRGIQWDKLY 345
F+GI W ++Y
Sbjct: 258 FKGIDWQQVY 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 7e-39
Identities = 92/297 (30%), Positives = 138/297 (46%), Gaps = 54/297 (18%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS---ERNLLAEVDSRCIV 101
L+G G+FG V G+ FA+K++ ++ + GQ E V+ E LL+++ IV
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQ-EAVKQLEQEIALLSKLQHPNIV 65
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 161
Q + ++ D LY+ +E +PGG + LL + E V R Y + +L + +H N VH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 162 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
RDIK N+++D NG +KL+DFG+ K + +
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEF------------------------------ 155
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPPFCSDD 280
+ A S G+ +MAPEV+ ++G YG+ D WSLG + EM G PP+ +
Sbjct: 156 ---------SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206
Query: 281 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC---DVETRLGTRGVEELKEHP 334
KI K P+ +SDEA+D I L C D R EL EHP
Sbjct: 207 GVAAVFKIGRSKELPPIPDH--LSDEAKDFI--LKCLQRDPSLRP---TAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 84/300 (28%), Positives = 127/300 (42%), Gaps = 44/300 (14%)
Query: 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
++ IG G FG+V TGE+ A+K+++ + ++ + E +L + +
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNL 61
Query: 101 VQLFYSFQ-DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
V+ +Y + + +Y+ MEY GG + LL IL E V R Y + + + +H H
Sbjct: 62 VK-YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
VHRDIKP N+ LD NG +KL DFG + T + E
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAV---------------KLKNNTTTMGEEV----- 160
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLIGYPPF 276
S GT YMAPEV+ KG+G D WSLG ++ EM G P+
Sbjct: 161 --------------QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
Query: 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICH-LLCDVETRLGTRGVEELKEHPW 335
D V P+ ++S E +D + L D + R EL +HP+
Sbjct: 207 SELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTA---SELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 93/307 (30%), Positives = 141/307 (45%), Gaps = 63/307 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ E+ IG+GA GEV + TG+ A+KK++ L++ E + +E ++ +
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKH 74
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMT---LLMREDILSEDVARFYIAESVL-A 150
IV + S+ D L+++MEY+ GG DI+T + M E ++ Y+ VL
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA------YVCREVLQG 128
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H N +HRDIK DN++L K+G +KL+DFG + +E
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA---------------QLTKE---- 169
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ KRN S VGT +MAPEV+ +K YG + D WSLG + EM
Sbjct: 170 -------------KSKRN------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329
G PP+ + P I K K S E +D + L D E R EE
Sbjct: 211 EGEPPYLREPPLRALFLITT-KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSA---EE 266
Query: 330 LKEHPWF 336
L +HP+
Sbjct: 267 LLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 75/249 (30%), Positives = 114/249 (45%), Gaps = 50/249 (20%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
D+E L IGKG+FG VR R K+ G+I K++ M + + + SE N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHP 59
Query: 99 CIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIH 152
IV+ + D + LY++MEY GGD+ L+ + + E+ + + +LA++
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 153 SIH-----QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
H + +HRD+KP N+ LD N ++KL DFGL K L
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH----------------- 162
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
+ A + VGT YM+PE L Y + D WSLG ++Y
Sbjct: 163 ---------------------DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201
Query: 268 EMLIGYPPF 276
E+ PPF
Sbjct: 202 ELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-36
Identities = 85/294 (28%), Positives = 126/294 (42%), Gaps = 41/294 (13%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLK--KSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
L+G+GAFG V LC TG A+K++ + +V + E LL + IVQ
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
+ +D + L + MEY+PGG + L L+E V R Y + + + +H + VHR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
DIK N++ D G++KL DFG K L+ SS
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSG--------------------------- 161
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282
S GT +M+PEV+ +GYG + D WS+G + EML PP+ +
Sbjct: 162 --------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213
Query: 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 336
KI T + P +S +AR+ + VE EEL H +
Sbjct: 214 AAIFKIATQPTNPQLPSH--VSPDARNFLR--RTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 76/246 (30%), Positives = 114/246 (46%), Gaps = 45/246 (18%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK--LKKSEMLKRGQVEHVRSERNLLAEV 95
+ F L IGKG+FGEV K T ++ A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 155
S I + + SF L++IMEY GG + LL + L E F + E +L + +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
+ +HRDIK N++L + G +KL+DFG+ L S
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---------------------- 153
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
KRN + VGT +MAPEV+ + GY + D WSLG E+ G PP
Sbjct: 154 ----------KRN------TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
Query: 276 FCSDDP 281
P
Sbjct: 198 LSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 80/254 (31%), Positives = 123/254 (48%), Gaps = 43/254 (16%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
DFE L IGKG+FG V K ++AMK++ S+M +R + E + R +LA++DS
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSED-VARFYIAESVLAIHSIH 155
I++ + SF D L ++MEY GD+ LL R L ED V RF+I + +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
+HRDIK NL LD ++K+ D G+ K +++ T
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK---------------LLSDNTN------- 156
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
A + VGT Y++PE+ K Y + D W+LG ++YE G P
Sbjct: 157 ----------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
Query: 276 FCSDDPRITCRKIV 289
F +++ KI+
Sbjct: 201 FDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 90/307 (29%), Positives = 151/307 (49%), Gaps = 50/307 (16%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+GKG FGEV + K TG+++A KKL K + K+ + E+ +L +V+S IV L Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR--FYIAESVLAIHSIHQHNYVHRD 163
+F+ L L+M + GGD+ + ++ R Y A+ I +H + V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+KP+N++LD G+ +LSD GL ++ L+D I Q
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL---------AVELKDGKTITQRA---------------- 155
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
GT YMAPE+L ++ Y DW+++G +YEM+ G PF ++
Sbjct: 156 --------------GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201
Query: 284 TCRKIVNWKTC---LKFPEEPKISDEARDLICHLLC--DVETRLGTRGV-EELKEHPWFR 337
++ + +T +KF E ++E++D IC L E RLG+R ++ ++H +F+
Sbjct: 202 A-KEELKRRTLEDEVKF-EHQNFTEESKD-ICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258
Query: 338 GIQWDKL 344
I + +L
Sbjct: 259 TINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 81/301 (26%), Positives = 141/301 (46%), Gaps = 49/301 (16%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
+ IG+G+ G V + K+TG A+KK+ ++ K+ + E + +E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHP 76
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQH 157
IV+++ S+ D L+++ME+L GG + ++ + E +A + +VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHAQ 134
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRDIK D+++L +G +KLSDFG C + + +
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------------------------V 169
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
P+ + S VGT +MAPEV+ + YG E D WSLG ++ EM+ G PP+
Sbjct: 170 PRRK-------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
++ P ++I + K K+S R + +L D R EL HP+
Sbjct: 217 NEPPLQAMKRIRDNLP-PKLKNLHKVSPRLRSFLDRMLVRDPAQRATA---AELLNHPFL 272
Query: 337 R 337
Sbjct: 273 A 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 84/304 (27%), Positives = 143/304 (47%), Gaps = 53/304 (17%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLK-------KSEMLKRGQVEHVRSERNLLAEVDS 97
LIGKG +G V L TTGE+ A+K+++ + + ++ V+ +RSE L ++D
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IVQ ++L + +EY+PGG I + L E + RF+ + + + +H
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRD+K DNL++D +G K+SDFG+ K +D Y + D+++
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN----DQNM--------------- 168
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEV--LLKKGYGMECDWWSLGAIMYEMLIGYPP 275
S G++ +MAPEV +GY + D WSLG ++ EM G P
Sbjct: 169 -----------------SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
Query: 276 FCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLI--CHLLCDVETRLGTRGVEELK 331
+ ++ K+ N ++ P + +S A D + C + + + R R EL
Sbjct: 212 WSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTI-NPDNRPTAR---ELL 267
Query: 332 EHPW 335
+HP+
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-33
Identities = 101/331 (30%), Positives = 141/331 (42%), Gaps = 79/331 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEVD 96
+E L ++G+GA+G V CR K TGEI A+KK K+S E +K+ + V+ R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
IV L +F+ LYL+ EY+ + L L D R YI + + AI H
Sbjct: 61 --NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
HN +HRDIKP+N+++ ++G LKL DFG + L
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARAL---------------------------- 150
Query: 217 MPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYP 274
R R A + V T Y APE+L+ YG D W++G IM E+L G P
Sbjct: 151 ----------RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200
Query: 275 PFCSD----------------DPRITCRKIVNWK-TCLKFPE-----------EPKISDE 306
F D P N + + FPE K+S
Sbjct: 201 LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP 260
Query: 307 ARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
A D + L D + RL +EL +HP+F
Sbjct: 261 ALDFLKACLRMDPKERLTC---DELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 90/328 (27%), Positives = 141/328 (42%), Gaps = 77/328 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-QVEHVRSERNLLAEVDSR 98
+E+L +G+G +G V R K TGEI A+KK++ + + G +R E +LL E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKELKHP 58
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQH 157
IV+L LYL+ EY D+ L R LS ++ + + + + + H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRD+KP N++++++G LKL+DFGL + +
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAF---------------------------GI 150
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 276
P V TL Y APE+LL K Y D WS+G I EM+ G P F
Sbjct: 151 PLRTYTHE-----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199
Query: 277 CSDD--------------------PRITCRKIVNWKTCL-KFPEE------PKISDEARD 309
D P +T K+ ++K KFP + P++ E D
Sbjct: 200 PGDSEIDQLFKIFQILGTPTEESWPGVT--KLPDYKPTFPKFPPKDLEKVLPRLDPEGID 257
Query: 310 LICHLLC-DVETRLGTRGVEELKEHPWF 336
L+ +L + R+ +E +HP+F
Sbjct: 258 LLSKMLQYNPAKRI---SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 83/331 (25%), Positives = 139/331 (41%), Gaps = 78/331 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+E++ IG+G +G+V R K TGE+ A+KK++ + + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 100 IVQL---FYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIH 155
IV+L S Y++ EY+ D+ LL ++ +E + Y+ + + + +H
Sbjct: 60 IVRLKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
+ +HRDIK N++++ +G LKL+DFGL +P
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-------------------------- 151
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYP 274
KRN + TL Y PE+LL YG E D WS+G I+ E+ +G P
Sbjct: 152 ----------KRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP 200
Query: 275 PFCSDDP-----RIT-------------CRKIVNWKTCLKFPEEPK----------ISDE 306
F +I K+ ++ LK + K I
Sbjct: 201 IFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN-LKPKKPYKRRLREFFKHLIDPS 259
Query: 307 ARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
A DL+ LL D + R+ ++ +H +F
Sbjct: 260 ALDLLDKLLTLDPKKRI---SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 70/241 (29%), Positives = 107/241 (44%), Gaps = 46/241 (19%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN--LLAEVDS 97
+++L IG+G +G V R K TGEI A+KK+K + + R LL E++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQ 156
I++L F+ LYL+ E++ D+ L+ R+ L E + + Y+ + + + H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
H +HRD+KP+NL+++ G LKL+DFGL +
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSP----------------------VRP 154
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 275
V T Y APE+LL KGY D WS+G I E+L P
Sbjct: 155 YTHY----------------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
Query: 276 F 276
F
Sbjct: 199 F 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 73/241 (30%), Positives = 108/241 (44%), Gaps = 56/241 (23%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKK-----SEMLKRGQVEHVRSERNLLAEVDSRCI 100
+G G FG V L R K TGE+ A+KK+KK E + + V+S R L I
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM---NLREVKSLRKLNEH---PNI 60
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHN 158
V+L F+++D LY + EY+ G ++ L+ SE V R I + + + IH+H
Sbjct: 61 VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
+ HRD+KP+NL++ +K++DFGL + +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREI------------------------------ 149
Query: 219 KERLQQWKRNRRAL-AYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPPF 276
R+R Y V T Y APE+LL+ Y D W+LG IM E+ P F
Sbjct: 150 --------RSRPPYTDY--VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199
Query: 277 C 277
Sbjct: 200 P 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 65/242 (26%), Positives = 114/242 (47%), Gaps = 48/242 (19%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ F+ L +G+G++G V K TG++ A+K + + ++ + E ++L + DS
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 154
IV+ + S+ + L+++MEY G DIM + L+E+ + +++ + +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H + +HRDIK N++L++ G KL+DFG+ L D + + TV
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK----------RNTV------ 159
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+GT +MAPEV+ + GY + D WSLG EM G P
Sbjct: 160 ----------------------IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197
Query: 275 PF 276
P+
Sbjct: 198 PY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 87/323 (26%), Positives = 125/323 (38%), Gaps = 77/323 (23%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--GQVEH-VRSERNLLAEVDSRCIVQ 102
IG+GA G V + + TGE A+KK+ L+R G + + E L +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
L F L+MEY+P L E L E + Y+ + + +H + +HR
Sbjct: 64 LLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR 123
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
D+KP NL++ +G LK++DFGL + + + RL
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSE---------------------------EEPRL 156
Query: 223 QQWKRNRRALAYS-TVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSD- 279
YS V T Y APE+L + Y D W++G I E+L G P F +
Sbjct: 157 -----------YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205
Query: 280 DPRITCRKI-----VNWKTC-----------LKFPEE---------PKISDEARDLICHL 314
D N +T + FPE P S EA DL+ L
Sbjct: 206 DIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGL 265
Query: 315 L-CDVETRLGTRGVEELKEHPWF 336
L D RL E HP+F
Sbjct: 266 LVYDPSKRLSA---AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 83/274 (30%), Positives = 132/274 (48%), Gaps = 43/274 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLK------KSEMLKRGQVEHVRSERNLLAEVDSR 98
LIG G+FG V L ++GE+ A+K+++ S+ KR ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 158
IVQ S D+D L + +EY+PGG + LL E + R ++ + + ++ +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
+HRDIK N+++D G +K+SDFG+ K LE + ++ +T
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLE----------ANSLSTKT----------- 165
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
R +L G++ +MAPEV+ + Y + D WSLG ++ EML G PF
Sbjct: 166 -------NGARPSLQ----GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-- 212
Query: 279 DDPRITCRKIVNWKTCLKFPEEPK-ISDEARDLI 311
P T + + PE P IS EA D +
Sbjct: 213 --PDCTQLQAIFKIGENASPEIPSNISSEAIDFL 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 83/279 (29%), Positives = 130/279 (46%), Gaps = 45/279 (16%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+E + IG+G+FG++ L +AK+ E +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQH 157
IV F SFQ++ L+++MEY GGD+M + R+ + SED + + L + IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 158 NYVHRDIKPDNLILDKNGHL-KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRDIK N+ L KNG + KL DFG+ + L D
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME----------------------- 157
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
LAY+ VGT Y++PE+ + Y + D WSLG ++YE+ PF
Sbjct: 158 ---------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF 202
Query: 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
++ KI P P S + R LI L
Sbjct: 203 EGNNLHQLVLKICQGYFA---PISPNFSRDLRSLISQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 87/334 (26%), Positives = 136/334 (40%), Gaps = 93/334 (27%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLLAE 94
DD E L +G G G V + TG+I A+K ++ + K+ + E ++L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-----ILRELDILHK 55
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYIAESV 148
+S IV + +F ++ + + MEY+ GG + +L E IL + IA +V
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK------IAVAV 109
Query: 149 LA--IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206
L + +H +HRD+KP N++++ G +KL DFG+ L +
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---------------- 153
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
+LA + VGT YMAPE + Y ++ D WSLG +
Sbjct: 154 ------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSL 189
Query: 267 YEMLIG---YPPFCSDDPRIT----CRKIVNWKTCLKFPEEP------KISDEARDLICH 313
E+ G YPP +DP + IVN E P K S + +D +
Sbjct: 190 IELATGRFPYPP--ENDPPDGIFELLQYIVN--------EPPPRLPSGKFSPDFQDFVNL 239
Query: 314 LLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEM 347
L +EL EHP+ K YE
Sbjct: 240 CLIKDPRE--RPSYKELLEHPFI------KKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 40/243 (16%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DD+E + +IG GA V E A+K++ + + V+ +R E +++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 154
+V+ + SF D L+L+M YL GG DIM L E + + E + + +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H + +HRDIK N++L ++G +K++DFG+ S+ L + D
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGV--------SASLADGGD------------- 157
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-LKKGYGMECDWWSLGAIMYEMLIGY 273
R R+ + VGT +MAPEV+ GY + D WS G E+ G
Sbjct: 158 ------------RTRKVR-KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
Query: 274 PPF 276
P+
Sbjct: 205 APY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 41/298 (13%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAEVDSRCIV 101
+G GAF R TG + A+K++ Q VE +R E L+A ++ I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 161
++ + + L +E++ GG + LL + E V Y + + + +H++ +H
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 162 RDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 220
RD+K NL++D G L+++DFG L K + E +GQ
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-------------AGEFQGQL----- 168
Query: 221 RLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 280
+GT+ +MAPEVL + YG CD WS+G ++ EM PP+ ++
Sbjct: 169 ----------------LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
Query: 281 PRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 337
I + P P+ +S RD+ L C EL +HP FR
Sbjct: 213 HSNHLALIFKIASATTAPSIPEHLSPGLRDVT--LRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 63/234 (26%), Positives = 113/234 (48%), Gaps = 43/234 (18%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+E++ ++G+GAFG V LCR K ++ +K++ +M K + ++E +L +
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIHSIHQH 157
I++ + +F + L ++MEY PGG + + +L ED + + +LA+H +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 158 NYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+K N++LDK+ +K+ DFG+ K L K
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK------------------------- 155
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ AY+ VGT Y++PE+ K Y + D W+LG ++YE+
Sbjct: 156 --------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 64/243 (26%), Positives = 116/243 (47%), Gaps = 47/243 (19%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
DF+ L +GKG++G V + + + +A+K++ M ++ + + V +E +LA V+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-----MREDILSEDVARFYIAESVLAIHS 153
I+ +F D + L ++MEY P GD+ + R+ I +++ R +I + + + +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQA 118
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H+ +HRD+K N++L N +K+ D G+ K L
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL------------------------- 153
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
++ +A + +GT YMAPEV + Y + D WSLG ++YEM
Sbjct: 154 ---------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
Query: 274 PPF 276
PPF
Sbjct: 199 PPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 89/295 (30%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLK----KSEMLKRGQVEHVRSERNLLAEVDSRCI 100
L+G+GAFG V LC TG A+K+++ E K +V + E LL + I
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK--EVNALECEIQLLKNLLHERI 66
Query: 101 VQLFYSFQDS--DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 158
VQ + +D L + ME++PGG I L L+E+V R Y + + + +H +
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
VHRDIK N++ D G++KL DFG K L+ +I L G M
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQ----TICL--------------SGTGMK- 167
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
S GT +M+PEV+ +GYG + D WS+G + EML PP+
Sbjct: 168 ----------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
Query: 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEH 333
+ KI T P P +SD RD + + + + R +EL H
Sbjct: 212 FEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLR---PSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-29
Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 49/244 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+D+E + IG G +G+V R TGE+ A+K +K E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 154
IV F S+ D L+++MEY GG DI + LSE + E++ + +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYL 117
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H+ +HRDIK N++L ++G +KL+DFG+ L T++
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----------------ATIA----- 156
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWSLGAIMYEMLI 271
KR S +GT +MAPEV K GY +CD W+LG E+
Sbjct: 157 -----------KRK------SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE 199
Query: 272 GYPP 275
PP
Sbjct: 200 LQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 78/316 (24%)
Query: 38 DDFEQLTLIGK-----GAFGEVRLCRAKTTGEIFAMKKLKKS-----EMLKRGQVEHVRS 87
+ ++ K G FG+V + + K T ++F K +K E + V +
Sbjct: 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPM----VHQLMK 66
Query: 88 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
D+ ++L+YS LIM+Y+ GD+ LL +E LSE + I +
Sbjct: 67 --------DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQL 118
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206
V A++ +H+HN +H DIK +N++ D + L D+GLCK II
Sbjct: 119 VEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------------IIGTP 163
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
+ + GTLDY +PE + Y + DWW++G +
Sbjct: 164 SCYD---------------------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLT 196
Query: 267 YEMLIGYPPFCSD-----DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 320
YE+L G PF D D ++ K P +S A D + +L ++
Sbjct: 197 YELLTGKHPFKEDEDEELDLESLLKRQQK-----KLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 321 RLGTRGVEELKEHPWF 336
RL E+ +HP+
Sbjct: 252 RLTN--YNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 44/278 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+ + ++GKGAFGE L R + K++ + + ++ + +E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQH 157
I+ + F D + L + MEY GG + ++R+ + E++ +Y+ + V A+ IH+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRDIK N+ L K G +KL DFG+ K L +YS
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS------------------------ 156
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
+A + VGT YM+PE+ Y + D W+LG ++YE+L F
Sbjct: 157 --------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
+ +P KIV P S E L+ LL
Sbjct: 203 ATNPLNLVVKIV---QGNYTPVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 88/316 (27%), Positives = 134/316 (42%), Gaps = 65/316 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
FE + +IG+G +G+V R K TG++ A+K + E + E ++ E N+L + +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61
Query: 98 RCIVQLFY-------SFQDSDFLYLIMEYLPGGDIM----TLLMREDILSEDVARFYIAE 146
+ FY + D L+L+ME GG + L + L E+ + + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 147 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206
++ + +H++ +HRDIK N++L KN +KL DFG+ L
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----------------DS 165
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGMECDWWS 261
T+ +RN + +GT +MAPEV+ Y D WS
Sbjct: 166 TLG----------------RRN------TFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203
Query: 262 LGAIMYEMLIGYPPFCSDDPRITCRKIV-NWKTCLKFPEEPKISDEARDLICHLLC-DVE 319
LG E+ G PP C P KI N LK PE S + D I L + E
Sbjct: 204 LGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE--NWSKKFNDFISECLIKNYE 261
Query: 320 TRLGTRGVEELKEHPW 335
R +EEL EHP+
Sbjct: 262 QR---PFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-27
Identities = 90/297 (30%), Positives = 130/297 (43%), Gaps = 48/297 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLK----KSEMLKRGQVEHVRSERNLLAEVDSRCI 100
L+G+GAFG V LC TG A K+++ E K +V + E LL + I
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK--EVSALECEIQLLKNLQHERI 66
Query: 101 VQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 158
VQ + +D L + MEY+PGG + L L+E V R Y + + + +H +
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
VHRDIK N++ D G++KL DFG K L+ +I + I
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQ----TICMSGTGI---------------- 166
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
S GT +M+PEV+ +GYG + D WSLG + EML PP+
Sbjct: 167 ---------------RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
Query: 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPW 335
+ KI T + P IS+ ARD + + + R EEL HP+
Sbjct: 212 YEAMAAIFKIATQPTNPQLPSH--ISEHARDFLGCIFVEARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 89/294 (30%), Positives = 139/294 (47%), Gaps = 49/294 (16%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IG+GA G V TG+ A+K++ + K+ E + +E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
S+ D L+++MEYL GG +T ++ E + E E + A+ +H + +HRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGS-LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 225
DN++L +G +KL+DFG C + +Q
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITP--------------------------------EQS 170
Query: 226 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP-RIT 284
KR+ + VGT +MAPEV+ +K YG + D WSLG + EM+ G PP+ +++P R
Sbjct: 171 KRS------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224
Query: 285 CRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 337
N L+ PE K+S RD + L DVE R + EL +HP+ +
Sbjct: 225 YLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 36/240 (15%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKK--LKKSEMLK-RGQVEHVRSERNLLAEVDSRCIV 101
++GKGA+G V C G++ A+K+ L S +L + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 161
Q + D + + + ME++PGG I ++L R L E V Y + + + +H + VH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 162 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
RDIK +N++L NG +KL DFG + L + + +++
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRL--AWVGLHGTHSNMLK----------------- 166
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281
S GT +MAPEV+ + GYG + D WS+G ++EM G PP S D
Sbjct: 167 -------------SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 41/233 (17%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+ ++ IG+G+FG+ L ++K G+ + +K++ S+M + + E R E +L+ +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPN 60
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHSIHQH 157
IVQ SF+++ LY++M+Y GGD+ + R + ED + + LA+ +H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRDIK N+ L K+G +KL DFG+ + L TV
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----------------TVE-------- 156
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
LA + +GT Y++PE+ + Y + D W+LG ++YEM
Sbjct: 157 --------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 71/246 (28%), Positives = 111/246 (45%), Gaps = 45/246 (18%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---D 96
+++L LIG+GA+G V + TG + A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
I + + S+ L++IMEY GG + TL M+ ++E I E ++A+ IH+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRDIK N+++ G++KL DFG+
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAA------------------------------ 149
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 275
L Q R VGT +MAPEV+ + K Y + D WSLG +YEM G PP
Sbjct: 150 ----LLNQNSSKRSTF----VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
Query: 276 FCSDDP 281
+ D
Sbjct: 202 YSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-26
Identities = 85/298 (28%), Positives = 143/298 (47%), Gaps = 47/298 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
E IG+G+ G V + R K +G A+K + ++ K+ + E + +E ++ + +
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHN 158
+V+++ S+ + L+++ME+L GG + ++ + + E +A + ESVL A+ +H
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT--VCESVLQALCYLHSQG 137
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
+HRDIK D+++L +G +KLSDFG C + +P
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-------------------------VP 172
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
K + S VGT +MAPEV+ + YG E D WSLG ++ EM+ G PP+ S
Sbjct: 173 KRK-------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219
Query: 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 336
D P + K + K KIS RD + +L T +EL +HP+
Sbjct: 220 DSP-VQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT--AQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 50/283 (17%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ +F+ IGKG F V G + A+KK++ EM+ + E +LL ++D
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIH 152
+++ SF +++ L +++E GD+ ++ ++ ++ E Y + A+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+H +HRDIKP N+ + G +KL D GL + K ++
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA------------------ 162
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
A+S VGT YM+PE + + GY + D WSLG ++YEM
Sbjct: 163 --------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 273 YPPFCSDDPRI--TCRKIVNWKTCLKFPEEPK--ISDEARDLI 311
PF D + C+KI C +P P S+E RDL+
Sbjct: 203 QSPFYGDKMNLYSLCKKIEK---C-DYPPLPADHYSEELRDLV 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 95/320 (29%), Positives = 151/320 (47%), Gaps = 53/320 (16%)
Query: 24 ETEYMRLQRRKIGIDD----FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 79
+ E M R + I D + + IG+GA G V TG+ A+K++ + K+
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQ 57
Query: 80 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
+ E + +E ++ E+ + IV SF D L+++MEYL GG +T ++ E + E
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS-LTDVVTETCMDEAQ 116
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
E + A+ +H + +HRDIK DN++L +G +KL+DFG C +
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--------- 167
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
+Q KR+ + VGT +MAPEV+ +K YG + D
Sbjct: 168 -----------------------EQSKRS------TMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 260 WSLGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CD 317
WSLG + EM+ G PP+ +++P R N L+ PE K+S RD + L D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMD 256
Query: 318 VETRLGTRGVEELKEHPWFR 337
VE R + EL +HP+ +
Sbjct: 257 VEKRGSAK---ELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 90/337 (26%), Positives = 146/337 (43%), Gaps = 84/337 (24%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+D++E+L I +G +G V R K TGEI A+KKLK + + + +R E N+L ++
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQ 62
Query: 97 SRCIVQL----FYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 150
IV + S + D +Y++MEY+ D+ +L+ M++ L +V + + + +
Sbjct: 63 HPNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV-KCLMLQLLSG 118
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H + +HRD+K NL+L+ G LK+ DFGL + +Y S
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR----EYGS---------------- 158
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 269
P + Q V TL Y APE+LL K Y D WS+G I E+
Sbjct: 159 -------PLKPYTQ-----------LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200
Query: 270 LIGYPPFC--SDDPRITC----------------RKIVNWKTCLKFPEEP---------- 301
L P F S+ ++ ++ K F + P
Sbjct: 201 LTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK-TFTKYPYNQLRKKFPA 259
Query: 302 -KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+SD DL+ LL D R+ E+ +HP+F
Sbjct: 260 LSLSDNGFDLLNRLLTYDPAKRISA---EDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 73/242 (30%), Positives = 106/242 (43%), Gaps = 46/242 (19%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ L ++G+G+FG L + + + +AMK +L KS VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL--LMREDILSEDVARFYIAESVLAIHSI 154
IV SF+ LY++MEY GGD+M L R + ED + + L + I
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H+ +HRDIK N+ L +NG +KL DFG + L
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT------------------------- 151
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+ A A + VGT Y+ PE+ Y + D WSLG I+YE+
Sbjct: 152 -------------SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKH 198
Query: 275 PF 276
PF
Sbjct: 199 PF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 87/333 (26%), Positives = 133/333 (39%), Gaps = 83/333 (24%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS---ERNLLAEVD 96
+E+ +G+G + V R K TG I A+KK+K E K + + E LL E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGER-KEAKDGINFTALREIKLLQELK 60
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPG------GDIMTLLMREDILSEDVARFYIAESVLA 150
I+ L F + L+ E++ D +L DI S Y+ ++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKS------YMLMTLRG 114
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H + +HRD+KP+NL++ +G LKL+DFGL + + S
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR----SFGS---------------- 154
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 269
P ++ V T Y APE+L + YG+ D WS+G I E+
Sbjct: 155 -------PNRKMT-----------HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196
Query: 270 LIGYPPFCSDDPRITCRKIV---------NWK--TCL----KFPEEPKI---------SD 305
L+ P D KI NW T L +F P SD
Sbjct: 197 LLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASD 256
Query: 306 EARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
+A DL+ LL + R+ R + EHP+F
Sbjct: 257 DALDLLQRLLTLNPNKRITAR---QALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 88/302 (29%), Positives = 133/302 (44%), Gaps = 48/302 (15%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLAE 94
++ L+G+GAFGEV LC TG A+K++ E K +V + E LL
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK--EVNALECEIQLLKN 60
Query: 95 VDSRCIVQLFYSFQDSD--FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
+ IVQ + +D + L + +EY+PGG I L L+E+V R Y + + +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+H + VHRDIK N++ D G++KL DFG K ++ +I + I
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ----TICMSGTGI---------- 166
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
S GT +M+PEV+ +GYG + D WS+ + EML
Sbjct: 167 ---------------------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTE 205
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKE 332
PP+ + KI T P+ +SD RD + + + E R T E L
Sbjct: 206 KPPWAEYEAMAAIFKIATQPTKPMLPD--GVSDACRDFLKQIFVE-EKRRPT--AEFLLR 260
Query: 333 HP 334
HP
Sbjct: 261 HP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 83/303 (27%), Positives = 148/303 (48%), Gaps = 50/303 (16%)
Query: 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+D F + IG+G+ G V + K TG+ A+KK+ ++ K+ + E + +E ++ +
Sbjct: 23 YLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDY 76
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSI 154
+V ++ S+ D L+++ME+L GG + ++ + E +A + SVL A+ +
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT--VCLSVLRALSYL 134
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H +HRDIK D+++L +G +KLSDFG C + +
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----------------------- 171
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+PK + S VGT +MAPEV+ + YG E D WSLG ++ EM+ G P
Sbjct: 172 --VPKRK-------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHP 334
P+ ++ P R+I + + + K+S R + +L ++ T +EL +HP
Sbjct: 217 PYFNEPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT--AQELLQHP 273
Query: 335 WFR 337
+ +
Sbjct: 274 FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 89/317 (28%), Positives = 139/317 (43%), Gaps = 68/317 (21%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEV 95
+ +L+ +G+GA G V CR K TG IFA+K + L++ + E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK----QILRELEINKSC 56
Query: 96 DSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAESVL 149
S IV+ + +F D S + + MEY GG + ++ R + E V IAESVL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVL 115
Query: 150 -AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ +H +HRDIKP N++L + G +KL DFG ++ E V
Sbjct: 116 KGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG-------------------VSGELV 156
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+ +LA + GT YMAPE + K Y + D WSLG + E
Sbjct: 157 N---------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195
Query: 269 MLIGYPPFCSD-DPRITCRKIVNWKTCLKFPE---EPKI----SDEARDLICHLLCDVET 320
+ PF + +P + +++++ + PE EP S+E +D I L
Sbjct: 196 VAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCL----E 251
Query: 321 RLGTR--GVEELKEHPW 335
+ TR ++ EHPW
Sbjct: 252 KDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 5e-25
Identities = 87/300 (29%), Positives = 142/300 (47%), Gaps = 49/300 (16%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+ + IG+GA G V TG+ A+K++ + K+ E + +E ++ E +
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPN 77
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
IV S+ D L+++MEYL GG +T ++ E + E E + A+ +H +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGS-LTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIK DN++L +G +KL+DFG C +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP----------------------------- 167
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
+Q KR+ + VGT +MAPEV+ +K YG + D WSLG + EM+ G PP+ ++
Sbjct: 168 ---EQSKRS------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
Query: 280 DP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRG-VEELKEHPWFR 337
+P R N L+ PE ++S RD + L E + RG +EL +HP+ +
Sbjct: 219 NPLRALYLIATNGTPELQNPE--RLSAVFRDFLNRCL---EMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 56/277 (20%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
++GKG +G V R +T A+K++ + + V+ + E L + + R IVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLL------MREDILSEDVARFYIAESVLAIHSIHQHN 158
S ++ F + ME +PGG + LL ++++ E FY + + + +H +
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLKYLHDNQ 128
Query: 159 YVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
VHRDIK DN++++ +G +K+SDFG K L IN T
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG------------INPCT---------- 166
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPP 275
+ GTL YMAPEV+ K +GYG D WSLG + EM G PP
Sbjct: 167 ----------------ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 276 FCS-DDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 311
F +P+ K+ +K + PE +S EA++ I
Sbjct: 211 FIELGEPQAAMFKVGMFKIHPEIPES--LSAEAKNFI 245
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-25
Identities = 76/239 (31%), Positives = 113/239 (47%), Gaps = 38/239 (15%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ FE L ++G+GA+G V CR K T EI A+KK K SE + + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV+L +F+ LYL+ EY+ + L + + + R YI + + AIH H++
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+ VHRDIKP+NL++ N LKL DFG + L + ++ E
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE------------------- 160
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
V T Y +PE+LL YG D WS+G I+ E+ G P F
Sbjct: 161 ------------------YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 66/294 (22%)
Query: 49 GAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI---VQLFY 105
G +V L T + F +K L+KS R ++ + C+ V L
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTII-----------PHCVPNMVCLHK 52
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
D ++L++++ GG + + + + + E+ + + AE V+A+ ++H+ V RD+
Sbjct: 53 YIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112
Query: 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQW 225
P+N++LD GH++L+ F +ED D + + E +
Sbjct: 113 PNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAV----------------ENM--- 147
Query: 226 KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 285
Y APEV CDWWSLGAI++E+L G I
Sbjct: 148 ----------------YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-- 189
Query: 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETR---LGTRGVEELKEHPWF 336
N T L PE +S+EAR L+ LL T G GVE++K HP+F
Sbjct: 190 ----NTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 78/292 (26%), Positives = 145/292 (49%), Gaps = 47/292 (16%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IG+G+ G V + K++G++ A+KK+ ++ K+ + E + +E ++ + +V+++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVHRDI 164
S+ D L+++ME+L GG + ++ + E +A + +VL A+ +H +HRDI
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLAVLKALSVLHAQGVIHRDI 142
Query: 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 224
K D+++L +G +KLSDFG C +++E +P+ +
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQ---------------VSKE----------VPRRK--- 174
Query: 225 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRIT 284
S VGT +MAPE++ + YG E D WSLG ++ EM+ G PP+ ++P +
Sbjct: 175 ----------SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-FNEPPLK 223
Query: 285 CRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 336
K++ K K+S + + LL + T EL +HP+
Sbjct: 224 AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT--AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 83/339 (24%), Positives = 131/339 (38%), Gaps = 84/339 (24%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLAEV 95
+E L IG GA+G V K TG A+KK+ KR + E LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-----ILREIKLLRHL 56
Query: 96 DSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
I+ L DF +Y++ E + D+ ++ L++D ++++ + +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H N +HRD+KP N++++ N LK+ DFGL + D D + ++E
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR----------GVDPDEDEKGFLTE 165
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269
Y V T Y APE+LL Y D WS+G I E+
Sbjct: 166 -----------------------Y--VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 270 L---------------------IGYPPFCSDDPRITCRKIVNWKTCLKFPEE-------P 301
L +G P D IT K N+ L + P
Sbjct: 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSE-EDLKFITSEKARNYLKSLPKKPKKPLSKLFP 259
Query: 302 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339
S EA DL+ +L D + R+ +E HP+ +
Sbjct: 260 GASPEAIDLLEKMLVFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 87/300 (29%), Positives = 140/300 (46%), Gaps = 49/300 (16%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+ + IG+GA G V TG+ A++++ + K+ E + +E ++ E +
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPN 78
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
IV S+ D L+++MEYL GG +T ++ E + E E + A+ +H +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS-LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIK DN++L +G +KL+DFG C +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP----------------------------- 168
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
+Q KR+ VGT +MAPEV+ +K YG + D WSLG + EM+ G PP+ ++
Sbjct: 169 ---EQSKRST------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
Query: 280 DP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 337
+P R N L+ PE K+S RD + L DVE R + EL +H + +
Sbjct: 220 NPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRGSAK---ELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 74/242 (30%), Positives = 110/242 (45%), Gaps = 41/242 (16%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F +L IGKG+FGEV T E+ A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
I + + S+ L++IMEYL GG + LL + L E + E + + +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIK N++L + G +KL+DFG+ L D
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---------------------------- 154
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
Q KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 155 ----QIKRN------TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
Query: 280 DP 281
P
Sbjct: 205 HP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 83/311 (26%), Positives = 130/311 (41%), Gaps = 60/311 (19%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D+ E L +GKG +G V + TG AMK+++ L + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSI 154
IV + +F +Y+ MEY+ G + L + + + EDV R V + +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 155 -HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+HN +HRD+KP N++++ NG +KL DFG+ L
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------------------------ 154
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YGMECDWWSLGAIMY 267
+LA + +G YMAPE + G Y ++ D WSLG +
Sbjct: 155 ----------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198
Query: 268 EMLIG---YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGT 324
EM +G YPP + IV+ P SD+A+D + L + R T
Sbjct: 199 EMALGRYPYPPETYANIFAQLSAIVD-GDPPTLP--SGYSDDAQDFVAKCLNKIPNRRPT 255
Query: 325 RGVEELKEHPW 335
+L EHPW
Sbjct: 256 --YAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 73/251 (29%), Positives = 110/251 (43%), Gaps = 59/251 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLAEV 95
++++ IG+G +G V R K TGEI A+KK++ + E V S E +LL E+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE-----TEDEGVPSTAIREISLLKEL 55
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLAIHS 153
+ IV+L + LYL+ E+L D+ + L + + Y+ + + I
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK----PLEDKYSSILLEDEDIINQETVS 209
H H +HRD+KP NL++D+ G LKL+DFGL + P+
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--------------------- 153
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYE 268
R + V TL Y APE+LL + Y D WS+G I E
Sbjct: 154 --------------------RTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAE 192
Query: 269 MLIGYPPFCSD 279
M+ P F D
Sbjct: 193 MVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 73/245 (29%), Positives = 115/245 (46%), Gaps = 48/245 (19%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE---MLKRGQVEHVRSERNLLAEVD 96
+E L L+G+G++G V C+ K TG+I A+KK +SE M+K+ + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
+V L F+ LYL+ E++ + L + L E R Y+ + + I H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
HN +HRDIKP+N+++ ++G +KL DFG + L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-------------------------- 152
Query: 217 MPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYP 274
P E Y+ V T Y APE+L+ YG D W++G ++ EML G P
Sbjct: 153 -PGE------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
Query: 275 PFCSD 279
F D
Sbjct: 200 LFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 68/259 (26%), Positives = 105/259 (40%), Gaps = 67/259 (25%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--------MLKRGQVEHVRSERNL 91
+E+L IG+GA+G V R TG A+KK++ L+ E L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---------EIAL 51
Query: 92 LAEVDSRC---IVQLFYSFQDSDF-----LYLIMEYLPGGDIMTLLMR--EDILSEDVAR 141
L +++S IV+L L L+ E++ D+ T L + + L + +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK 110
Query: 142 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
+ + + + +H H VHRD+KP N+++ +G +K++DFGL + YS
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR----IYS-------- 158
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
AL S V TL Y APEVLL+ Y D WS
Sbjct: 159 --------------------------FEMALT-SVVVTLWYRAPEVLLQSSYATPVDMWS 191
Query: 262 LGAIMYEMLIGYPPFCSDD 280
+G I E+ P F
Sbjct: 192 VGCIFAELFRRRPLFRGTS 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 7e-23
Identities = 62/255 (24%), Positives = 115/255 (45%), Gaps = 55/255 (21%)
Query: 46 IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+G+GAFGEV + K A+K LK+ + Q+E E ++ ++D +V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNVV 64
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFY--IAESVLAIHSIHQH 157
+L + + LY++MEY+ GGD+++ L R + D+ F IA + +
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR---GMEYLESK 121
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
N++HRD+ N ++ +N +K+SDFGL + L D+D
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSR---------DLYDDDYYR------------- 159
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
KR + + +MAPE L + + + D WS G +++E+ +G P+
Sbjct: 160 --------KRGGKL-------PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY 204
Query: 277 CSDDPRITCRKIVNW 291
P ++ +++ +
Sbjct: 205 ----PGMSNEEVLEY 215
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 41/236 (17%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F +L IGKG+FGEV T ++ A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
+ + + S+ L++IMEYL GG + LL R E + E + + +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIK N++L + G +KL+DFG+ L D
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTD----------------------------- 153
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
Q KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 154 ---TQIKRN------TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 84/329 (25%), Positives = 137/329 (41%), Gaps = 91/329 (27%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKK---SEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
IG+G F EV +++ TG+ +A+K +KK S QV ++R + L I++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILR 62
Query: 103 LFYSFQD--SDFLYLIMEYLPGGDIMTL--LM--REDILSEDVARFYIAESVLAIHSIHQ 156
L D + L L+ E + M L L+ R+ L E + Y+ + + ++ +H+
Sbjct: 63 LIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK--YSSILLEDEDIINQETVSEAEGQ 214
+ HRDIKP+N IL K+ LKL+DFG C+ + K Y+ E +S
Sbjct: 119 NGIFHRDIKPEN-ILIKDDILKLADFGSCRGIYSKPPYT------------EYIS----- 160
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGY 273
+W Y APE LL G YG + D W++G + +E+L +
Sbjct: 161 --------TRW----------------YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
Query: 274 PPF----------------CSDDPRITCRKIVNWKTCLKFPEE---------PKISDEAR 308
P F + D + + + FP + P S E
Sbjct: 197 PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGL 256
Query: 309 DLICHLLC-DVETRLGTRGVEELKEHPWF 336
DL+ LL D + R+ + + HP+F
Sbjct: 257 DLLKKLLAYDPDERITAK---QALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-22
Identities = 52/131 (39%), Positives = 75/131 (57%), Gaps = 7/131 (5%)
Query: 237 VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLK 296
+GT DY+APE+LL K +G DWW+LG ++E L G PPF + P+ + I+N +
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRD--IP 598
Query: 297 FPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPT 354
+PE E K+S A++ I LL D R G++ELK+HP F G+ W+ L + P
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKR---AGLKELKQHPLFHGVDWENLQNQTMPFIPQ 655
Query: 355 VNGELDTQNFE 365
+ E DT FE
Sbjct: 656 PDDETDTSYFE 666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 9e-22
Identities = 70/288 (24%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ +F+ IG+G F EV + A+KK++ EM+ + E +LL +++
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIH 152
+++ SF + + L +++E GD+ ++ ++ ++ E Y + A+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+H +HRDIKP N+ + G +KL D GL + K ++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA------------------ 162
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
A+S VGT YM+PE + + GY + D WSLG ++YEM
Sbjct: 163 --------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
Query: 273 YPPFCSDDPRI--TCRKIVNWKTCLKFPEEPK--ISDEARDLICHLLC 316
PF D + C+KI + C +P P S++ R+L+ +
Sbjct: 203 QSPFYGDKMNLFSLCQKI---EQC-DYPPLPTEHYSEKLRELVSMCIY 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 61/239 (25%)
Query: 46 IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+G+GAFGEV K A+K LK+ + Q+E E ++ ++D IV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNIV 64
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSE--------DVARFYIAESVLAI 151
+L + + L ++MEY+PGGD++ L R LS +AR +
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR--------GM 116
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ N++HRD+ N ++ +N +K+SDFGL + L D+D
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR---------DLYDDDYYK------- 160
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ + + +MAPE L + + + D WS G +++E+
Sbjct: 161 --------------VKGGKL-------PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 71/242 (29%), Positives = 111/242 (45%), Gaps = 41/242 (16%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F +L IGKG+FGEV T ++ A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
+ + + S+ L++IMEYL GG + LL + +A + E + + +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI-LREILKGLDYLHSEKK 122
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIK N++L ++G +KL+DFG+ L D
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD----------------------------- 153
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
Q KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 154 ---TQIKRN------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
Query: 280 DP 281
P
Sbjct: 205 HP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 70/230 (30%), Positives = 102/230 (44%), Gaps = 45/230 (19%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQL 103
+GKG+FG V L + K +K LK+ + L + E LL+++D IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 104 FYSFQDSDFLYLIMEYLPGGD----IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
SF + D +I EY G D + L LSE+ + + +L +H +HQ
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+K N+ L KN LK+ DFG+ S +L+ D
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGV--------SRLLMGSCD------------------ 160
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
LA + GT YM+PE L +GY + D WSLG I+YEM
Sbjct: 161 ------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 47/278 (16%)
Query: 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
+ ++GKG++GEV L R +T G+ + +KKL +R + + E LL+++ IV
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIVA 63
Query: 103 LFYSFQDSD-FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNY 159
S++ D LY++M + GGD+ L + +L E+ + + +A+ +H+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+K N+ L + +K+ D G+ + LE++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-------------------------- 157
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
+A + +GT YM+PE+ K Y + D W+LG +YEM F +
Sbjct: 158 ------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205
Query: 280 DPRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC 316
D +I+ K P PK S E +LI +L
Sbjct: 206 DMNSLVYRIIEG----KLPPMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 87/327 (26%), Positives = 129/327 (39%), Gaps = 74/327 (22%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVDSR 98
F+QL +G+G + V R +TTGEI A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDI---MTLLMREDILSEDVARFYIAESVLAIHSIH 155
IV+L + L L+ EY+ D+ M L + + + + + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
++ +HRD+KP NL+++K G LKL+DFGL + I T S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG-------------IPVNTFS------ 158
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYP 274
+ V TL Y AP+VLL + Y D WS+G IM EM+ G P
Sbjct: 159 -------------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199
Query: 275 PFCSDDPRITCRKIVN---------WKTCLKFPE----------------EPKISDEARD 309
F + KI W + PE P D
Sbjct: 200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGID 259
Query: 310 LICHLLCDVETRLGTRGVEELKEHPWF 336
L+ LL + L + L+ HPWF
Sbjct: 260 LLHRLL-QLNPELRISAHDALQ-HPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 71/247 (28%), Positives = 106/247 (42%), Gaps = 69/247 (27%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLAEV 95
F+++ IG+G +G V R K TGE+ A+KK++ + E V S E +LL E+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-----ETEGVPSTAIREISLLKEL 56
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYL-----------PGGDIMTLLMREDILSEDVARFYI 144
+ IV+L + LYL+ E+L P I L++ Y+
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YL 106
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + + H H +HRD+KP NL+++ G +KL+DFGL +
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR------------------ 148
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 263
A G + R + V TL Y APE+LL K Y D WSLG
Sbjct: 149 ------AFGVPV-------------RTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLG 188
Query: 264 AIMYEML 270
I EM+
Sbjct: 189 CIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 78/249 (31%), Positives = 107/249 (42%), Gaps = 52/249 (20%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVDS 97
D+ ++ IG+G +G V R K TG+I AMKK++ +SE + G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED------VARFYIAESVLAI 151
IV L LYLI E+L M L D L + + + Y+ + + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
H +HRD+KP NL++D G +KL+DFGL + A
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR------------------------A 150
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEML 270
G +P R + V TL Y APEVLL Y D WS+G I EM
Sbjct: 151 FG---IPV----------RVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196
Query: 271 IGYPPFCSD 279
P F D
Sbjct: 197 TKKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 72/242 (29%), Positives = 109/242 (45%), Gaps = 46/242 (19%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEVD 96
+DFE + IG G +G+V R TGE+ A+K +K L+ G+ V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
IV F S+ D L++ ME+ GG + + LSE + E++ ++ +H
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRDIK N++L NGH+KL+DFG+ Q T + A
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSA------------------QITATIA----- 161
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 273
KR S +GT +MAPEV K GY CD W++G E+
Sbjct: 162 ---------KRK------SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ 206
Query: 274 PP 275
PP
Sbjct: 207 PP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 66/248 (26%), Positives = 116/248 (46%), Gaps = 39/248 (15%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--------GQVE-HVRSERNL--LAE 94
+G+G +G+V TG+I A+KK+K E+ G H + R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
+ I+ L + + DF+ L+M+ + D+ ++ R+ L+E + + + + ++ +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLC-KPLEDKYSSILLEDEDIINQETVSEAEG 213
H+ ++HRD+ P N+ ++ G K++DFGL + YS L +DE
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE------------- 182
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIG 272
M +E + S V TL Y APE+L+ + Y D WS+G I E+L G
Sbjct: 183 -TMQRREEMT-----------SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 273 YPPFCSDD 280
P F ++
Sbjct: 231 KPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-20
Identities = 73/250 (29%), Positives = 109/250 (43%), Gaps = 66/250 (26%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK--RGQVEHVRSERNLLAEV 95
DDFE+L +G G G V + +G I A +KL E+ R Q+ +R E +L E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQI--IR-ELKVLHEC 56
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI- 154
+S IV + +F + + ME++ GG + D + + R I E++L SI
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKKAGR--IPENILGKISIA 107
Query: 155 ---------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+H +HRD+KP N++++ G +KL DFG+ L D
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--------------- 152
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
++A S VGT YM+PE L Y ++ D WSLG
Sbjct: 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 266 MYEMLIG-YP 274
+ EM IG YP
Sbjct: 188 LVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 1e-19
Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 60/251 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
E +G+GAFGEV K GE A+K LK+ + + E E +++ ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-------EDIL--SEDVARFYIAE 146
IV+L + LY++ EY+PGGD++ L + +D+L + +A+
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAK----- 113
Query: 147 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206
+ + N+VHRD+ N ++ +N +K+SDFGL + DI +
Sbjct: 114 ---GMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR--------------DIYEDD 156
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
+ G + K W MAPE L + + D WS G ++
Sbjct: 157 YYRKRGGGKLPIK-----W-----------------MAPESLKDGKFTSKSDVWSFGVLL 194
Query: 267 YEML-IGYPPF 276
+E+ +G P+
Sbjct: 195 WEIFTLGEQPY 205
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 50/238 (21%), Positives = 99/238 (41%), Gaps = 54/238 (22%)
Query: 46 IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
+G+GAFGEV + K A+K LK+ + + + E ++ ++ +V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60
Query: 103 LF-YSFQDSDFLYLIMEYLPGGDIMTLL----------MREDILSEDVARFYIAESVLAI 151
L ++ LYL++EY+ GGD++ L + + +D+ F + +
Sbjct: 61 LLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAKGM 118
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ +VHRD+ N ++ ++ +K+SDFGL + + D + +
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD-------------DDYYRKKT 165
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
G +P + +MAPE L + + D WS G +++E+
Sbjct: 166 GG--KLP---------------------IRWMAPESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 50/274 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IG+G F EV G A+KK++ +++ E +LL +++ +++ +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIHSIHQHNYVH 161
SF + + L +++E GD+ ++ ++ ++ E Y + A+ +H +H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 162 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
RDIKP N+ + G +KL D GL + K ++
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--------------------------- 162
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281
A+S VGT YM+PE + + GY + D WSLG ++YEM PF D
Sbjct: 163 -----------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
Query: 282 RI--TCRKIVNWKTCLKFPEEPK--ISDEARDLI 311
+ C+KI + C +P P S+E R L+
Sbjct: 212 NLYSLCKKI---EQC-DYPPLPSDHYSEELRQLV 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 64/265 (24%), Positives = 119/265 (44%), Gaps = 53/265 (20%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGE-IFAMKKLK-KSEMLKRGQVEHVRSERNLLAEVD- 96
+ L +G GAFG V R K G+ + A+K++ + + + E +S ++++EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 97 ------SRCIVQLFYSFQDSDFLYLIMEYLPGGDI----MTLLMREDILSEDVARFYIAE 146
IV+ + +F ++D LY++M+ + G + +L ++ +E+ +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 147 SVLAIHSIHQHNY-VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
VLA+ +H+ VHRD+ P+N++L ++ + ++DFGL K
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------- 162
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
++ + S VGT+ Y PE++ + YG + D W+ G I
Sbjct: 163 --------------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCI 202
Query: 266 MYEMLIGYPPFCSDDPRITCRKIVN 290
+Y+M PPF S + KIV
Sbjct: 203 LYQMCTLQPPFYSTNMLSLATKIVE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 79/248 (31%), Positives = 119/248 (47%), Gaps = 54/248 (21%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN--LLAEV-D 96
+E L +GKGA+G V + T E+ A+KK+ + R + R+ R L E+ D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQELGD 65
Query: 97 SRCIVQL---FYSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVL- 149
IV+L + D D +YL+ EY+ T L +R +IL EDV + YI +L
Sbjct: 66 HPNIVKLLNVIKAENDKD-IYLVFEYME-----TDLHAVIRANIL-EDVHKRYIMYQLLK 118
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
A+ IH N +HRD+KP N++L+ + +KL+DFGL + L S + E+ + + V+
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL----SELEENPENPVLTDYVA 174
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 268
+W Y APE+LL Y D WS+G I+ E
Sbjct: 175 -------------TRW----------------YRAPEILLGSTRYTKGVDMWSVGCILGE 205
Query: 269 MLIGYPPF 276
ML+G P F
Sbjct: 206 MLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 65/244 (26%), Positives = 113/244 (46%), Gaps = 52/244 (21%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE---MLKRGQVEHVRSERNLLAE 94
+ +E+L+ IG+G++G V CR + TG+I A+KK +SE ++K+ + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
+ +V L F+ L+L+ EY + L + E + + I +++ A++
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK---PLEDKYSSILLEDEDIINQETVSEA 211
H+HN +HRD+KP+N+++ K G +KL DFG + D Y+
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY---------------- 160
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEML 270
V T Y APE+L+ YG D W++G + E+L
Sbjct: 161 -------------------------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195
Query: 271 IGYP 274
G P
Sbjct: 196 TGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 71/256 (27%), Positives = 114/256 (44%), Gaps = 67/256 (26%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK-------------LKKSEMLKRGQVEH 84
++ L+ IG+GA+G V K TG A+KK L++ ++L+R + E+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 85 VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 144
+ +++ S SF D +Y++ E + D+ L+ + LS D ++++
Sbjct: 65 IIGILDII-RPPSFE------SFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYFL 112
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK---PLEDKYSSILLEDED 201
+ + + IH N +HRD+KP NL+L+ N LK+ DFGL + P D ++ L E
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-HTGFLTE--- 168
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWW 260
Y V T Y APE++L KGY D W
Sbjct: 169 --------------------------------Y--VATRWYRAPEIMLNSKGYTKAIDIW 194
Query: 261 SLGAIMYEMLIGYPPF 276
S+G I+ EML P F
Sbjct: 195 SVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 70/221 (31%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 61 TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119
T G K + K ML Q + RSE + LA D IV+ F F+ D L LIMEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 120 LPGGDIMTLL---MREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 175
GGD+ + ++E + E + VLA+ +H +HRD+K N+ L G
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG 206
Query: 176 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYS 235
+KL DFG K D S+ L+ +A S
Sbjct: 207 IIKLGDFGFSKQYSD---SVSLD---------------------------------VASS 230
Query: 236 TVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
GT Y+APE+ +K Y + D WSLG I+YE+L + PF
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 69/247 (27%), Positives = 111/247 (44%), Gaps = 50/247 (20%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-QVEHVRSERNLLAEV 95
+ +FE+L IG+G +G V R T+GEI A+KK++ + + G + +R E LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLR-EITLLLNL 63
Query: 96 DSRCIVQLFYSFQDS--DFLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLA 150
IV+L D ++L+MEY D+ +LL +++ SE + + + +
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL--DNMPTPFSESQVKCLMLQLLRG 120
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H++ +HRD+K NL+L G LK++DFGL +
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP---------------- 164
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 269
M PK V TL Y APE+LL Y D W++G I+ E+
Sbjct: 165 -----MTPK-----------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
Query: 270 LIGYPPF 276
L P
Sbjct: 203 LAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 86/313 (27%), Positives = 128/313 (40%), Gaps = 64/313 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D +E + IGKG +G+V K G A+K L + E + +E N+L +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 98 RCIVQLFYSF------QDSDFLYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAES 147
V FY ++ D L+L++E GG + L L R + + E + + + E+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
++ + +H + +HRD+K +N++L G +KL DFG+ L
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS----------------- 176
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGMECDWWSL 262
R RR ++VGT +MAPEV+ L Y CD WSL
Sbjct: 177 ------------------TRLRRN---TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215
Query: 263 GAIMYEMLIGYPPFCSDDPRITCRKIV-NWKTCLKFPEEPKISDEARDLICHLLC-DVET 320
G E+ G PP P KI N L PE S+E D I L D E
Sbjct: 216 GITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE--LWSNEFNDFIRKCLTKDYEK 273
Query: 321 RLGTRGVEELKEH 333
R V +L +H
Sbjct: 274 R---PTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 74/261 (28%), Positives = 110/261 (42%), Gaps = 70/261 (26%)
Query: 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+ +E+L IG+G FGEV R K T +I A+KK+ E K G E +L +
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM-ENEKEGFPITALREIKILQLL 68
Query: 96 DSRCIVQLF---------YSFQDSDFLYLIMEY----LPGGDIMTLLMREDILSEDVARF 142
+V L Y+ F YL+ E+ L G +LS +F
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSF-YLVFEFCEHDLAG-----------LLSNKNVKF 116
Query: 143 YIAE--SVL-----AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195
++E V+ ++ IH++ +HRD+K N+++ K+G LKL+DFGL +
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF------- 169
Query: 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL-KKGY 253
S ++ K NR Y+ V TL Y PE+LL ++ Y
Sbjct: 170 -------------SLSKNS-----------KPNR----YTNRVVTLWYRPPELLLGERDY 201
Query: 254 GMECDWWSLGAIMYEMLIGYP 274
G D W G IM EM P
Sbjct: 202 GPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 56/256 (21%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-R 98
FE + ++G G +G+V R TG++ A+K + +E + E ++ E N+L + R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 99 CIVQLFYSF------QDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 150
I + +F D L+L+ME+ G + L+ + + L ED + E +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H H +HRDIK N++L +N +KL DFG+ L+ TV
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------------RTVG- 176
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAI 265
+RN + +GT +MAPEV+ Y D WSLG
Sbjct: 177 ---------------RRN------TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT 215
Query: 266 MYEMLIGYPPFCSDDP 281
EM G PP C P
Sbjct: 216 AIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 60/244 (24%), Positives = 107/244 (43%), Gaps = 51/244 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL---KKSEMLKRGQVEHVRSERNLLAE 94
+D E ++ +G G G V + TG + A K + KS + K+ + E ++ E
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA--IH 152
S IV + +F + + + + ME++ G + + + + ++ IA +V+ +
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLTY 118
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+ H +HRDIKP N++++ G +KL DFG+ L IN
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--------------IN-------- 156
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
++A + VGT YM+PE + Y ++ D WSLG + E+ +G
Sbjct: 157 ------------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
Query: 273 YPPF 276
PF
Sbjct: 199 KFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 3e-18
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 56/256 (21%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-R 98
FE + L+G G +G+V R TG++ A+K + + + E ++ E N+L + R
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 99 CIVQLFYSFQDS------DFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 150
I + +F D L+L+ME+ G + L+ + + L E+ + E +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +HQH +HRDIK N++L +N +KL DFG+ L+ TV
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------------RTVG- 166
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAI 265
+RN + +GT +MAPEV+ Y + D WSLG
Sbjct: 167 ---------------RRN------TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 205
Query: 266 MYEMLIGYPPFCSDDP 281
EM G PP C P
Sbjct: 206 AIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 66/254 (25%), Positives = 109/254 (42%), Gaps = 51/254 (20%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK-LKKSEMLKRG-QVEHVRSERNLLAE 94
+ D+E L +G+G FGEV R TG + A+KK L +E K G + +R E +L +
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALR-EIKILKK 63
Query: 95 VDSRCIVQL---FYSFQDSDF-----LYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIA 145
+ +V L D +Y++ Y+ D+ LL + L+E + Y+
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYML 122
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ + I+ +H+++ +HRDIK N+++D G LK++DFGL +P +
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGP-------------- 168
Query: 206 ETVSEAEGQWMMPKERLQQWKR----NRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWW 260
K R + V T Y PE+LL ++ Y D W
Sbjct: 169 ----------------PPNPKGGGGGGTRKYT-NLVVTRWYRPPELLLGERRYTTAVDIW 211
Query: 261 SLGAIMYEMLIGYP 274
+G + EM P
Sbjct: 212 GIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 66/257 (25%), Positives = 108/257 (42%), Gaps = 63/257 (24%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK---SEMLKRGQVEHVRSERNLLAE 94
D ++ L+ +G GA+G+V TG A+KKL + S + + +R LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR----LLKH 70
Query: 95 VDSRCIVQL---------FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA 145
+D ++ L FQD +YL+ L G D+ + ++ LS+D +F +
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQD---VYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVY 125
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ + + IH +HRD+KP N+ ++++ LK+ DFGL + +D+ +
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT------------ 173
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGA 264
Y V T Y APE++L Y D WS+G
Sbjct: 174 ---------------------------GY--VATRWYRAPEIMLNWMHYNQTVDIWSVGC 204
Query: 265 IMYEMLIGYPPFCSDDP 281
IM E+L G F D
Sbjct: 205 IMAELLTGKTLFPGSDH 221
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 76/264 (28%), Positives = 119/264 (45%), Gaps = 82/264 (31%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD- 96
+D + L IG+GAFG V K +G I A+K++ R V+ + ++ LL ++D
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-------RSTVDE-KEQKRLLMDLDV 55
Query: 97 ----SRC--IVQLFYS--FQDSDFLYLIMEYLPGGDIMTLLMREDILSE---DVARFYIA 145
S C IV+ FY F++ D ++ ME +M + + D + +V + I
Sbjct: 56 VMRSSDCPYIVK-FYGALFREGD-CWICME------LMDISL--DKFYKYVYEVLKSVIP 105
Query: 146 ESVL---AIHSIHQHNY-------VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195
E +L A+ ++ NY +HRD+KP N++LD+NG++KL DFG+ L D SI
Sbjct: 106 EEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SI 162
Query: 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKG 252
+ R A G YMAPE + + G
Sbjct: 163 ------------------------------AKTRDA------GCRPYMAPERIDPSARDG 186
Query: 253 YGMECDWWSLGAIMYEMLIGYPPF 276
Y + D WSLG +YE+ G P+
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 55/249 (22%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAE 94
D +E + +G GAFG+V + K TG A K +++ E ++E E ++L+E
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSE 58
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAI 151
IV L+ ++ + L++++E+ GG IM L E L+E R+ + + A+
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEAL 116
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ +H H +HRD+K N++L +G +KL+DFG+ S +
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV---------SAKNKSTL---------- 157
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIM 266
KR+ + +GT +MAPEV+ Y + D WSLG +
Sbjct: 158 -------------QKRD------TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITL 198
Query: 267 YEMLIGYPP 275
E+ PP
Sbjct: 199 IELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 88/317 (27%), Positives = 129/317 (40%), Gaps = 64/317 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D +E + IGKG +G+V K G + A+K L E + +E N+L + +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLPN 77
Query: 98 RCIVQLFYS-FQDSDF-----LYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAES 147
V FY F +D L+L++E GG + L L+ L E + + + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+L + +H + +HRD+K +N++L G +KL DFG+ L
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST---------------- 181
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGMECDWWSL 262
RL +RN ++VGT +MAPEV+ Y CD WSL
Sbjct: 182 -------------RL---RRN------TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219
Query: 263 GAIMYEMLIGYPPFCSDDPRITCRKIV-NWKTCLKFPEEPKISDEARDLICH-LLCDVET 320
G E+ G PP P T KI N L PE K I L+ D E
Sbjct: 220 GITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE--KWCRSFNHFISQCLIKDFEA 277
Query: 321 RLGTRGVEELKEHPWFR 337
R V L EHP+ +
Sbjct: 278 R---PSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 88/340 (25%), Positives = 136/340 (40%), Gaps = 100/340 (29%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLAEV 95
+E+L IG+G +G V + + T EI A+K+++ + E V S E LL E+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----DDEGVPSSALREICLLKEL 56
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLP----------GGDIMTLLMREDILSEDVARFYIA 145
+ IV+L+ L L+ EY GDI ++ + ++
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI----------DPEIVKSFMF 106
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ + + H HN +HRD+KP NL+++KNG LKL+DFGL +
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA------------------ 148
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL-KKGYGMECDWWSLG 263
+ +P YS V TL Y P+VL K Y D WS G
Sbjct: 149 ---------FGIPVR------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 187
Query: 264 AIMYEML-IGYPPFCSDDPRITCRKIV---------NWKTCLKFPEE------------- 300
I E+ G P F +D ++I +W K P+
Sbjct: 188 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLV 247
Query: 301 ---PKISDEARDLI-CHLLCDVETRLGTRGVEELKEHPWF 336
PK++ RDL+ L+C+ R+ EE +HP+F
Sbjct: 248 NVVPKLNSTGRDLLQNLLVCNPVQRISA---EEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 72/252 (28%), Positives = 115/252 (45%), Gaps = 51/252 (20%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+D F+ + IG+G +G+V R K TGE+ A+KK++ + + +R E +L +++
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64
Query: 97 SRCIVQLFYSFQDS----DFL------YLIMEYLPGGDIMTLLMREDI-LSEDVARFYIA 145
R IV L D DF YL+ EY+ D+M LL + SED + ++
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ + ++ H+ N++HRDIK N++L+ G +KL+DFGL
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA-------------------- 163
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGA 264
RL + + V TL Y PE+LL ++ YG D WS G
Sbjct: 164 ---------------RL--YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206
Query: 265 IMYEMLIGYPPF 276
I+ E+ P F
Sbjct: 207 ILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 69/311 (22%)
Query: 24 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 83
+ + Q +K I ++G GA G V + + GE FA+K + E +
Sbjct: 23 DEATAKEQAKKYWIS-----RVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKN 76
Query: 84 HVRSERNLLAEVDSRCIVQLFYSFQDSD--------FLYLIMEYLPGGDIMTLLMREDIL 135
++E L D IV+ F D + L+++Y GD +R++I
Sbjct: 77 RAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD-----LRQEIK 131
Query: 136 S---------EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186
S E A + +LA+H +H + +HRDIK N++L NG +KL DFG K
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 246
Y++ TVS+ G+ + GT Y+APE
Sbjct: 192 ----MYAA------------TVSDDVGR--------------------TFCGTPYYVAPE 215
Query: 247 VLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF-PEEPKISD 305
+ +K Y + D +SLG ++YE+L PF ++ ++++ ++ P P IS
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHKTLAGRYDPLPPSISP 271
Query: 306 EARDLICHLLC 316
E ++++ LL
Sbjct: 272 EMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 86/334 (25%), Positives = 131/334 (39%), Gaps = 73/334 (21%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+D +E++ IG+G +G V R + T E A+KK++ E G E +LL E+
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQ 59
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED--VARFYIAESVLAIHSI 154
IV+L LYL+ EYL D+ + +++ + + Y+ + + I
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 155 HQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
H H +HRD+KP NL++D+ LKL+DFGL + A G
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR------------------------AFG 154
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIG 272
+P R + V TL Y APE+LL + Y D WS+G I EM+
Sbjct: 155 ---IPV----------RTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200
Query: 273 YPPFCSDDPRITCRKIVN---------WKTCLKFPE----------------EPKISDEA 307
P F D KI W P+ P +
Sbjct: 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAG 260
Query: 308 RDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340
DL+ +L D R+ R EH +F+ +
Sbjct: 261 VDLLSKMLRLDPSKRITARAA---LEHEYFKDLG 291
|
Length = 294 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 67/246 (27%), Positives = 107/246 (43%), Gaps = 43/246 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE+++ +G G G V K +G I A +KL E +K + E +L E +S
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV-ARFYIAESVLAIHSIHQ 156
IV + +F + + ME++ GG + +L + + E + + IA + +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
H +HRD+KP N++++ G +KL DFG+ L D
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------------------------- 156
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
++A S VGT YM+PE L Y ++ D WS+G + EM IG P
Sbjct: 157 --------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
Query: 277 CSDDPR 282
D +
Sbjct: 203 PPPDAK 208
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 66/246 (26%), Positives = 108/246 (43%), Gaps = 43/246 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE+++ +G G G V + K +G I A +KL E +K + E +L E +S
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLE-IKPAIRNQIIRELQVLHECNS 62
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV-ARFYIAESVLAIHSIHQ 156
IV + +F + + ME++ GG + +L + E++ + IA + +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
H +HRD+KP N++++ G +KL DFG+ L D
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------------------------- 156
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
++A S VGT YM+PE L Y ++ D WS+G + E+ IG P
Sbjct: 157 --------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
Query: 277 CSDDPR 282
D +
Sbjct: 203 PPPDAK 208
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 88/327 (26%), Positives = 138/327 (42%), Gaps = 91/327 (27%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD- 96
DD E + +G+GA+G V R TG I A+K++ R V + ++ LL ++D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 97 ---SRCIVQL--FYS--FQDSDFLYLIME-------------YLPGGDIMTLLMREDILS 136
S FY F++ D +++ ME Y G L + EDIL
Sbjct: 53 SMRSVDCPYTVTFYGALFREGD-VWICMEVMDTSLDKFYKKVYDKG-----LTIPEDILG 106
Query: 137 EDVARFYIAESVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194
+ IA S++ A+ +H + + +HRD+KP N+++++NG +KL DFG+ L D
Sbjct: 107 K------IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--- 157
Query: 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE----VLLK 250
+ + D G YMAPE L +
Sbjct: 158 -VAKTIDA-----------------------------------GCKPYMAPERINPELNQ 181
Query: 251 KGYGMECDWWSLGAIMYEMLIGYPPFCS-DDPRITCRKIVNWKTCLKFPEEPKISDEARD 309
KGY ++ D WSLG M E+ G P+ S P +++V + + P E K S E +D
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAE-KFSPEFQD 239
Query: 310 LICHLLCDVETRLGTRGVEELKEHPWF 336
+ L EL +HP+F
Sbjct: 240 FVNKCLKKNYKERPN--YPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 74/259 (28%), Positives = 109/259 (42%), Gaps = 61/259 (23%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-D 96
D +E+L IG+G +G+V R K TG++ A+KK + EM + G E +LL + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 97 SRCIVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAE 146
S IV+L LYL+ EYL D+ + L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 147 SVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCK----PLEDKYSSILLEDED 201
+ + H+H +HRD+KP NL++DK G LK++D GL + P++ Y+
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYT-------- 169
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWW 260
E V TL Y APEVLL Y D W
Sbjct: 170 ---HEIV------------------------------TLWYRAPEVLLGSTHYSTPVDIW 196
Query: 261 SLGAIMYEMLIGYPPFCSD 279
S+G I EM P F D
Sbjct: 197 SVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 104/395 (26%), Positives = 158/395 (40%), Gaps = 111/395 (28%)
Query: 40 FEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKLKK---SEML-KRGQVE-----HVRSE 88
+ L +G GA+G V C A K TGE A+KKL + SE+ KR E H++ E
Sbjct: 17 YTSLKQVGSGAYGSV--CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
N++ +D FQD YL+M Y+ D+ ++ LSED ++ + + +
Sbjct: 75 -NVIGLLDVFTSAVSGDEFQD---FYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQML 127
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ IH +HRD+KP NL ++++ LK+ DFGL +
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH--------------------- 166
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 267
++AE M + +W Y APEV+L Y D WS+G IM
Sbjct: 167 ADAE----MTGYVVTRW----------------YRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 268 EMLIGYPPFCSDDPRITCRKIVN---------------------WKTCLKFPEE------ 300
EML G F D +I+ K+ K+P +
Sbjct: 207 EMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF 266
Query: 301 PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGEL 359
PK S +A DL+ +L DV+ RL E EHP+F D + + +
Sbjct: 267 PKASPQAVDLLEKMLELDVDKRLTA---TEALEHPYF-----DSFRDADEETEQQ----- 313
Query: 360 DTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNF 394
P D +E SV W+K + + +F
Sbjct: 314 --------PYDDSLENEKLSVDEWKKHIYKEVKSF 340
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 74/262 (28%), Positives = 116/262 (44%), Gaps = 67/262 (25%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRS 87
Q+ ++D E L IG G G+V R K TG + A+K+++++ E KR +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR----ILMD 63
Query: 88 ERNLLAEVDSRCIVQLFYSF-QDSDFLYLIMEYLPGGDIMTLLMR------EDILSEDVA 140
+L D IV+ + F DSD +++ ME L + LL R EDIL +
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSD-VFICME-LMSTCLDKLLKRIQGPIPEDILGK--- 118
Query: 141 RFYIAESVL-AIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198
+ +++ A+H + + H +HRD+KP N++LD +G++KL DFG+ L D
Sbjct: 119 ---MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-------- 167
Query: 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYG 254
S+A + R A G YMAPE + Y
Sbjct: 168 ----------SKA---------------KTRSA------GCAAYMAPERIDPPDPNPKYD 196
Query: 255 MECDWWSLGAIMYEMLIGYPPF 276
+ D WSLG + E+ G P+
Sbjct: 197 IRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 67/241 (27%), Positives = 105/241 (43%), Gaps = 46/241 (19%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEVDS 97
D+E + +G G +G+V R TGE+ A+K +K L+ G ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV F S+ + L++ MEY GG + + LSE + E++ + +H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRDIK N++L NG +KL+DFG+ + T + A
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKI------------------TATIA------ 161
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAIMYEMLIGYP 274
KR S +GT +MAPEV + GY CD W++G E+ P
Sbjct: 162 --------KRK------SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207
Query: 275 P 275
P
Sbjct: 208 P 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 91/339 (26%), Positives = 150/339 (44%), Gaps = 57/339 (16%)
Query: 27 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHV 85
Y ++R + +E + +G GAFG+V + K TG + A K ++ KSE ++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDY 56
Query: 86 RSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYI 144
E +LA + IV+L +F L++++E+ PGG + +++ D L+E +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + A+ +H +HRD+K N++L +G +KL+DFG+ N
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK----------------N 160
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDW 259
+T+ +R+ S +GT +MAPEV++ Y + D
Sbjct: 161 VKTLQ----------------RRD------SFIGTPYWMAPEVVMCETMKDTPYDYKADI 198
Query: 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWK-TCLKFPEEPKISDEARDLICHLL-CD 317
WSLG + EM PP +P KI + L P K S E RD + L
Sbjct: 199 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS--KWSMEFRDFLKTALDKH 256
Query: 318 VETRLGTRGVEELKEHPWFRGIQWDK-LYEMEAAYKPTV 355
ETR +L EHP+ + ++ L E+ A K V
Sbjct: 257 PETR---PSAAQLLEHPFVSSVTSNRPLRELVAEAKAEV 292
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 76/253 (30%), Positives = 110/253 (43%), Gaps = 57/253 (22%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK---SEML-KRGQVE-----HVRSE 88
D + L +G GA+G V + TG A+KKL + SE+ KR E H++ E
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
N++ +D F D YL+M ++ G + LM+ + LSED +F + + +
Sbjct: 75 -NVIGLLDVFTPDLSLDRFHD---FYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ IH +HRD+KP NL ++++ LK+ DFGL + +T
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QTD 169
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 267
SE G V T Y APEV+L Y D WS+G IM
Sbjct: 170 SEMTGY----------------------VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207
Query: 268 EMLIGYPPFCSDD 280
EML G P F D
Sbjct: 208 EMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 67/250 (26%), Positives = 115/250 (46%), Gaps = 49/250 (19%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKL-KKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
+G GAFG+V + K TG + A K + KSE ++E E ++LA D IV+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCDHPNIVKLL 68
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
+F + L++++E+ GG + +++ E L+E R +++ A++ +H++ +HRD
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+K N++ +G +KL+DFG+ N T+ +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAK----------------NTRTIQRRD----------- 161
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
S +GT +MAPEV++ + Y + D WSLG + EM PP
Sbjct: 162 -----------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210
Query: 279 DDPRITCRKI 288
+P KI
Sbjct: 211 LNPMRVLLKI 220
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 57/247 (23%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL--KKSEMLKRGQVEHVRSERNLLAEVD 96
+ E++ IG GA G V + TG ++A+K + + ++R + E +L +V+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIM-TLLMREDILSEDVARFYIAESVLA-IHSI 154
+V+ F + + +++E++ GG + T + E L+ DVAR +L+ I +
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-DVAR-----QILSGIAYL 184
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H+ + VHRDIKP NL+++ ++K++DFG+ S IL + D N
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGV--------SRILAQTMDPCN---------- 226
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGY--GMECDWWSLGAIMYEM 269
S+VGT+ YM+PE + L G G D WSLG + E
Sbjct: 227 --------------------SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266
Query: 270 LIGYPPF 276
+G PF
Sbjct: 267 YLGRFPF 273
|
Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 64/286 (22%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVEHVRSERNLLAEV 95
++ + LIGKG GEV L A+KK+++ + +LK+ E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK----RFLREAKIAADL 59
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYIAESVLAIH 152
IV ++ D D +Y M Y+ G + +LL +++ LS+++A SV A
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFL 116
Query: 153 SI-----------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
SI H +HRD+KPDN++L G + + D+G LE+ED
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI-------FKKLEEED 169
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-------VGTLDYMAPEVLLKKGYG 254
+++ + R + YS+ VGT DYMAPE LL
Sbjct: 170 LLDI--------------------DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209
Query: 255 MECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE 300
D ++LG I+Y+ML P+ R RKI ++ + P E
Sbjct: 210 ESTDIYALGVILYQMLTLSFPY----RRKKGRKIS-YRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 62/243 (25%), Positives = 93/243 (38%), Gaps = 51/243 (20%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F L IG G+FG V R T E+ A+KK+ S + + + E L ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
++ + +L+MEY G L + + L E ++ + +H H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 160 VHRDIKPDNLILDKNGHLKLSDFG---LCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRDIK N++L + G +KL+DFG L P
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSP----------------------------- 167
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 273
A S VGT +MAPEV+L + Y + D WSLG E+
Sbjct: 168 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 274 PPF 276
PP
Sbjct: 212 PPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 72/256 (28%), Positives = 99/256 (38%), Gaps = 61/256 (23%)
Query: 40 FEQLTLI---GKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRS----E 88
L I G+G FG+V LCR TGE A+K L E RS E
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFERE 56
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDF--LYLIMEYLPGGDIMTLL--MREDILSEDVARF-- 142
+L +D IV+ + L LIMEYLP G + L R+ I + + F
Sbjct: 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS 116
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202
I + + + S Y+HRD+ N++++ +K+SDFGL K +L ED+D
Sbjct: 117 QICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK--------VLPEDKDY 165
Query: 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262
V E P E W APE L + D WS
Sbjct: 166 Y---YVKE-------PGESPIFW-----------------YAPECLRTSKFSSASDVWSF 198
Query: 263 GAIMYEMLIGYPPFCS 278
G +YE+ P S
Sbjct: 199 GVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 80/342 (23%), Positives = 136/342 (39%), Gaps = 88/342 (25%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL-KKSEMLKRGQVEHVRSERNL--LAE 94
++ + IG GA+G V +G+ A+KK+ ++ + R+ R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK----RTLRELKILRH 60
Query: 95 VDSRCIVQLFYSFQ--DSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
I+ + + +DF +Y++M+ L D+ ++ + L+E+ R+++ + +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ IH N +HRD+KP NL+++++ L++ DFG+ + L S
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS------------------SP 161
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269
E ++ M V T Y APE+LL Y D WS+G I EM
Sbjct: 162 TEHKYFMT----------------EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 270 LIGYPPFCSDDP--------------------RITC---RKIVNWKTCLKFPEE------ 300
L F + RI RK + P +
Sbjct: 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ-----NLPRKQPVPWS 260
Query: 301 ---PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRG 338
PK S EA DL+ +L D E R+ VE+ +HP+
Sbjct: 261 KIFPKASPEALDLLSQMLQFDPEERI---TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 64/247 (25%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVE-----HVRSERNLLAEVD 96
+G GAFG V R + TG+ A+KK+ K + KR E H+R E N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE-NII---- 72
Query: 97 SRCIVQLFYS-FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 155
+ +F S +D +Y + E L G D+ LL L + ++++ + + + +H
Sbjct: 73 --SLSDIFISPLED---IYFVTELL-GTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVH 125
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
VHRD+KP N+++++N LK+ DFGL + + + +
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY-------------------- 165
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274
V T Y APE++L + Y +E D WS G I EML G P
Sbjct: 166 ---------------------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204
Query: 275 PFCSDDP 281
F D
Sbjct: 205 LFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 88/339 (25%), Positives = 135/339 (39%), Gaps = 89/339 (26%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTT----GEIFAMKKL----KKSEMLKRGQVE-----HVR 86
+E + +G+GA+G V C A+ E A+KK+ K + KR E H R
Sbjct: 2 YELIKELGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 87 SERNLLAEVDSRCIVQLFYSFQDSDFLYL-IMEYLPGGDIMTLLMREDILSEDVARFYIA 145
+N+ D IV F + +LY +ME D+ ++ L++ + +I
Sbjct: 60 GHKNITCLYDMD-IV--FPGNFNELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIY 112
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ + + IH N +HRD+KP NL+++ + LK+ DFGL + +S E N
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR----GFSENPGE-----NA 163
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 264
++E Y V T Y APE++L + Y D WS+G
Sbjct: 164 GFMTE-----------------------Y--VATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 265 IMYEMLIGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE---- 300
I+ E+L P F D RI K N+ L +
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258
Query: 301 ---PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335
P + A DL+ LL D R+ VEE EHP+
Sbjct: 259 SIFPNANPLALDLLEKLLAFDPTKRI---SVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 68/248 (27%)
Query: 46 IGKGAFGEVRLCRAKT--TGEIFAMKK--------------LKKSEMLKRGQVEHVRSER 89
IG+GA+G V C AK T E A+KK L++ ++L+ E+V + +
Sbjct: 13 IGRGAYGIV--CSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 90 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 149
+++ +F D +Y++ E L D+ ++ LS+D ++++ + +
Sbjct: 71 DIMPPPHRE-------AFND---VYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ IH N +HRD+KP NL+L+ N LK+ DFGL + +
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------------------TT 158
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 268
+G +M V T Y APE+LL Y D WS+G I E
Sbjct: 159 SEKGDFMT-----------------EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 269 MLIGYPPF 276
+L P F
Sbjct: 202 LLGRKPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 63/252 (25%), Positives = 110/252 (43%), Gaps = 59/252 (23%)
Query: 45 LIGKGAFGEVRLCRAKT-----TGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
+G GAFGEV A +G I A+K L+K + + E ++ E +L++ +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNHP 59
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI------- 151
IV+L ++ Y+IME + GGD+++ L + + E +L I
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE-LLDICLDVAKG 118
Query: 152 -HSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ Q +++HRD+ N ++ + G+ +K+ DFGL + D Y S
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKS----------- 164
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
EG+ ++P + +MAPE LL + + D WS G +
Sbjct: 165 -DYYRKEGEGLLP---------------------VRWMAPESLLDGKFTTQSDVWSFGVL 202
Query: 266 MYEML-IGYPPF 276
M+E+L +G P+
Sbjct: 203 MWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 40/225 (17%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
IGKG FG+V K E+ A+K + L E +L + D IV+L
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
+Y++ME +PGG ++T L ++ + L+ ++ + + N +HRD
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+ N ++ +N LK+SDFG+ + E+E I TVS+ Q +P
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR-----------EEEGGI--YTVSDGLKQ--IP----- 158
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+ + APE L Y E D WS G +++E
Sbjct: 159 ----------------IKWTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 8e-13
Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 43/241 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D +E+L +G+G++ V ++K G++ A+K ++ E + G E +LL +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV L + L L+ EY+ + L + + ++ + + + IHQ
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRD+KP NL++ G LKL+DFGL +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR------------------------------- 151
Query: 218 PKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGYGMEC-DWWSLGAIMYEMLIGYPP 275
++ + YS V TL Y P+VLL C D W +G I EM+ G
Sbjct: 152 --------AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
Query: 276 F 276
F
Sbjct: 204 F 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 59/241 (24%)
Query: 43 LTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
+ +GKG FG V LCR TGE+ A+KKL+ S + E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 99 CIVQ---LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF-------YIAESV 148
IV+ + YS + L L+MEYLP G + D L + R Y ++
Sbjct: 66 NIVKYKGVCYSAGRRN-LRLVMEYLPYGSL------RDYLQKHRERLDHRKLLLYASQIC 118
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ + YVHRD+ N++++ +K+ DFGL K +L +D++ V
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK--------VLPQDKEYY---KV 167
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
E P E W APE L + + + D WS G ++YE
Sbjct: 168 RE-------PGESPIFW-----------------YAPESLTESKFSVASDVWSFGVVLYE 203
Query: 269 M 269
+
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 9e-13
Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 50/240 (20%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAEVD 96
D + ++G G G V T I A+K L + L++ + SE +L + D
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
S I+ + +F + + + E++ GG +L + I + R +A V + +
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+KP N++++ G +KL DFG+ L +N
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--------------VN------------ 147
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
++A + VGT YMAPE + + YG+ D WSLG E+ +G P+
Sbjct: 148 --------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 57/253 (22%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM----LKRGQVE-----HVRSE 88
+ ++ L+ +G GA+G V TG A+KKL + KR E H++ E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
N++ +D + F D +YL+ +L G D+ ++ + L++D +F I + +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIVKCQK-LTDDHVQFLIYQIL 130
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ IH + +HRD+KP NL ++++ LK+ DFGL + +D+ +
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY------------- 177
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 267
V T Y APE++L Y D WS+G IM
Sbjct: 178 ----------------------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 209
Query: 268 EMLIGYPPFCSDD 280
E+L G F D
Sbjct: 210 ELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 67/248 (27%), Positives = 107/248 (43%), Gaps = 52/248 (20%)
Query: 40 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLLAEV 95
+E + IG+GA+G+V R K G A+K+++ E + + V R+L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL-ETF 61
Query: 96 DSRCIVQLF----YSFQDSDF-LYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESV 148
+ +V+LF S D + L L+ E++ D+ T L + E + + + + + +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ +H H VHRD+KP N+++ +G +KL+DFGL + YS
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR----IYSF-------------- 162
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+ S V TL Y APEVLL+ Y D WS+G I E
Sbjct: 163 ---------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 201
Query: 269 MLIGYPPF 276
M P F
Sbjct: 202 MFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 92/282 (32%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++++E + IG G FGEV L + K T E F K + + +R + + V E N++ E+
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK 70
Query: 97 SRCIVQLFYSF--QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
+ IV+ F + + LY++ME+ GD LS ++ + Y + H+I
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGD----------LSRNIQKCYKMFGKIEEHAI 120
Query: 155 ------------HQHNY---------VHRDIKPDNLILDK---------------NGH-- 176
+ HN +HRD+KP N+ L NG
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 177 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 236
K+ DFGL K +I +E ++A+S
Sbjct: 181 AKIGDFGLSK-------NIGIE--------------------------------SMAHSC 201
Query: 237 VGTLDYMAPEVLL--KKGYGMECDWWSLGAIMYEMLIGYPPF 276
VGT Y +PE+LL K Y + D W+LG I+YE+ G PF
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 62/240 (25%), Positives = 93/240 (38%), Gaps = 45/240 (18%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F L IG G+FG V R T E+ A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
++ + +L+MEY G L + + L E ++ + +H HN
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIK N++L + G +KL+DFG + S A
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG--------------------SASIASPAN------- 179
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPPF 276
S VGT +MAPEV+L + Y + D WSLG E+ PP
Sbjct: 180 ---------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 41/241 (17%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++ + +L +G+G + V R+K T + A+K+++ + G E +LL +
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK 61
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
IV L L L+ EYL L +++S + ++ + + + H+
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+KP NL++++ G LKL+DFGL + + +T S
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKS-------------VPTKTYS------- 161
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPP 275
+ V TL Y P+VLL Y D W +G I+YEM G P
Sbjct: 162 ------------------NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM 203
Query: 276 F 276
F
Sbjct: 204 F 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 61/259 (23%), Positives = 98/259 (37%), Gaps = 69/259 (26%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK--------------KSEMLKR-GQVEH 84
+E + IG GA+G V R +G A+K ++ + +LKR +H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 85 VRSERNL----LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA 140
R + + D V L + D D + + P G L +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-----------LPAETI 110
Query: 141 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200
+ + + + + +H + VHRD+KP+N+++ G +KL+DFGL + YS +
Sbjct: 111 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTP 166
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260
++ TL Y APEVLL+ Y D W
Sbjct: 167 VVV-----------------------------------TLWYRAPEVLLQSTYATPVDMW 191
Query: 261 SLGAIMYEMLIGYPPFCSD 279
S+G I EM P FC +
Sbjct: 192 SVGCIFAEMFRRKPLFCGN 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 41/241 (17%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++ + +L +G+G + V R+K T + A+K+++ + G E +LL ++
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
IV L L L+ EYL L + ++ + ++ + + ++ H+
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+KP NL++++ G LKL+DFGL + I +T S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKS-------------IPTKTYS------- 162
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPP 275
+ V TL Y P++LL Y + D W +G I YEM G P
Sbjct: 163 ------------------NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL 204
Query: 276 F 276
F
Sbjct: 205 F 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 70/243 (28%), Positives = 104/243 (42%), Gaps = 55/243 (22%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKL------KKSEMLKRGQVEHVRSERNLLAEVDSR 98
+IG G+FG V T E A+KK+ K E+L + H+ N++ D
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NIIFLKDYY 128
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGG--DIMTLLMRED-ILSEDVARFYIAESVLAIHSIH 155
+ F + + FL ++ME++P M R + L + + Y + A+ IH
Sbjct: 129 -YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 156 QHNYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
HRD+KP NL++D N H LKL DFG K L GQ
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL----------------------LAGQ 225
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGY 273
R+++Y + + Y APE++L Y D WSLG I+ EM++GY
Sbjct: 226 ---------------RSVSY--ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268
Query: 274 PPF 276
P F
Sbjct: 269 PIF 271
|
Length = 440 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 48/237 (20%)
Query: 45 LIGKGAFGEVR--LCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
L+GKG FGEV + KT + K+ E+ + SE +L + D IV+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYV 160
L +Y++ME +PGGD ++ L + +++ ++ + +F + ++ + + N +
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCI 115
Query: 161 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 220
HRD+ N ++ +N LK+SDFG+ + ED+ I + + + +W
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQ----------EDDGIYSSSGLKQIPIKW----- 160
Query: 221 RLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
APE L Y E D WS G +++E +G P+
Sbjct: 161 ----------------------TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 46 IGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+G+G FG+V LCR TGE A+K LK + ++ E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 102 QL--FYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHN 158
+ + + + LIME+LP G + L R ++ ++ Y + + +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
YVHRD+ N++++ +K+ DFGL K +E ++D+
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD------------------ 171
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ Y APE L++ + + D WS G +YE+L
Sbjct: 172 --------LDSPVFWY---------APECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 41/241 (17%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++ + +L +G+G + V R+K T + A+K+++ + G E +LL ++
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
IV L L L+ EYL + +I+S + ++ + + + H+
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+KP NL++++ G LKL+DFGL + + +T S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKS-------------VPTKTYS------- 162
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 275
+ V TL Y P+VLL Y + D W +G I +EM G P
Sbjct: 163 ------------------NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL 204
Query: 276 F 276
F
Sbjct: 205 F 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 68/260 (26%), Positives = 107/260 (41%), Gaps = 76/260 (29%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-- 95
++ +IGKG++G V C A TGE A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVV--CSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKL 52
Query: 96 -------DSRCIVQLFY--------SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA 140
D IV++ + F+D +Y++ E L D+ ++ D L+ +
Sbjct: 53 LRLLRHPD---IVEIKHIMLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHH 105
Query: 141 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP-LEDKYSSILLED 199
+F++ + + A+ IH N HRD+KP N++ + + LK+ DFGL + D ++I D
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV---LLKKGYGME 256
V T Y APE+ K Y
Sbjct: 166 ------------------------------------YVATRWYRAPELCGSFFSK-YTPA 188
Query: 257 CDWWSLGAIMYEMLIGYPPF 276
D WS+G I E+L G P F
Sbjct: 189 IDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 45/240 (18%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F L IG G+FG V T E+ A+KK+ S + + + E L ++
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
++ + +L+MEY G L + + L E ++ + +H HN
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRDIK N++L + G +KL+DFG
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFG------------------------------------ 166
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPPF 276
++ + A S VGT +MAPEV+L + Y + D WSLG E+ PP
Sbjct: 167 ------SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/240 (25%), Positives = 94/240 (39%), Gaps = 45/240 (18%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
F L IG G+FG V R E+ A+KK+ S + + + E L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
+Q + +L+MEY G L + + L E ++ + +H HN
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+K N++L + G +KL DFG +SI+
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG--------SASIM----------------------- 165
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPPF 276
A A VGT +MAPEV+L + Y + D WSLG E+ PP
Sbjct: 166 -----------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 55/238 (23%), Positives = 99/238 (41%), Gaps = 48/238 (20%)
Query: 46 IGKGAFGEVR--LCRAKTTGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
+G G FG V + K+ E+ A+K LK+ + G+ E +R E +++A++D CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-AAGKKEFLR-EASVMAQLDHPCIVR 60
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
L + + L L+ME P G ++ L + + + + + + + ++VHR
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 163 DIKPDNLILDKNGHLKLSDFGLCKPL---EDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
D+ N++L K+SDFG+ + L D Y + G+W
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR---------------ATTAGRW---- 160
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
L + APE + + + D WS G ++E G P+
Sbjct: 161 -------------------PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 70/254 (27%), Positives = 103/254 (40%), Gaps = 63/254 (24%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVEHVRSERNLLAEV 95
++ L IG GA G V TG+ A+KKL + KR E V L+ V
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-----LMKLV 72
Query: 96 DSRCIVQLFYSF--QDS--DF--LYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAE 146
+ + I+ L F Q S +F +YL+ME +M + + I L + + + +
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQ 126
Query: 147 SVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206
+ I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-------------------- 166
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
A +MM V T Y APEV+L GY D WS+G IM
Sbjct: 167 ---TAGTSFMMTPY----------------VVTRYYRAPEVILGMGYKENVDIWSVGCIM 207
Query: 267 YEMLIGYPPFCSDD 280
EM+ G F D
Sbjct: 208 GEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 17/151 (11%)
Query: 46 IGKGAFGEVRLCRAKT----TGEIFAMKKLKK--SEMLKRGQVEHVRSERNLLAEVDSRC 99
+G+G FG+V L TGE+ A+K LK+ + G + E N+L +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK----EINILKTLYHEN 67
Query: 100 IVQL--FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIH 155
IV+ S Q L LIMEY+P G + L + + + F I E + +HS H
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186
Y+HRD+ N++LD + +K+ DFGL K
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 68/252 (26%), Positives = 100/252 (39%), Gaps = 59/252 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTT--GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
++QL IG GA G V C A T G A+KKL + + + E LL V+
Sbjct: 23 YQQLKPIGSGAQGIV--CAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNH 79
Query: 98 RCIVQL---------FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
+ I+ L FQD +YL+ME + + M L + + + + +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQD---VYLVMELMDANLCQVIHME---LDHERMSYLLYQML 133
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------------- 171
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
A +MM V T Y APEV+L GY D WS+G IM E
Sbjct: 172 -TACTNFMMT----------------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 269 MLIGYPPFCSDD 280
++ G F D
Sbjct: 215 LVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 49/251 (19%)
Query: 43 LTLIGKGAFGE--VRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLAEVD 96
LTLIGK V L + K T + A+KK+ E LK Q E + S + +
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQ-----LQ 57
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHS 153
I+ SF LY++ + G L++ + L E F + + + A+
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDY 116
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
IH ++HR +K +++L +G + LS +I
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVS--------------MIKHG------- 155
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLI 271
+ +R S+V L +++PEVL + +GY + D +S+G E+
Sbjct: 156 ----------KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205
Query: 272 GYPPFCSDDPR 282
G+ PF D P
Sbjct: 206 GHVPF-KDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 56/243 (23%), Positives = 107/243 (44%), Gaps = 52/243 (21%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G FGEV + + ++ A+K LK M V+ E NL+ + +V+L+
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHNYVH 161
+ +Y+I EY+ G ++ L ++ +L + + + A+ + I + NY+H
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--FSAQIAEGMAYIERKNYIH 126
Query: 162 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
RD++ N+++ ++ K++DFGL + +ED N+ T E P
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIED-------------NEYTAREGA---KFP--- 167
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML----IGYPPFC 277
+ + APE + + ++ D WS G ++YE++ I YP
Sbjct: 168 ------------------IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
Query: 278 SDD 280
+ D
Sbjct: 210 NSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 66/246 (26%), Positives = 99/246 (40%), Gaps = 60/246 (24%)
Query: 45 LIGKGAFGEVRLCRAKTTG--EI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+IG G FGEV R K G EI A+K LK K Q SE +++ + D I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI------- 154
L S + ++ EY+ G + L + D +F + + V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
YVHRD+ N++++ N K+SDFGL + LED EA
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----------------PEA--- 162
Query: 215 WMMPKERLQQWKRNRRALAYSTVG---TLDYMAPEVLLKKGYGMECDWWSLGAIMYE-ML 270
AY+T G + + APE + + + D WS G +M+E M
Sbjct: 163 ------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 271 IGYPPF 276
G P+
Sbjct: 205 YGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 60/251 (23%), Positives = 104/251 (41%), Gaps = 57/251 (22%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS---ERNLLAEVD 96
++ LT +G GA+G V + A+KKL + + H R E LL +
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ----SLIHARRTYRELRLLKHMK 72
Query: 97 SRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
++ L S ++ + +YL+ L G D+ ++ + LS++ +F I + +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQK-LSDEHVQFLIYQLLRG 130
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ IH +HRD+KP N+ ++++ L++ DFGL + +D+ +
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY--------------- 175
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269
V T Y APE++L Y D WS+G IM E+
Sbjct: 176 --------------------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 270 LIGYPPFCSDD 280
L G F +D
Sbjct: 210 LKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEVDSRCIVQL 103
I K F + G FA K E ++K GQ +E ++L ++ I+QL
Sbjct: 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQL 148
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVHR 162
+F + F LI+ L + +I D+ I SVL AI +H++ +HR
Sbjct: 149 KGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDI--LAIERSVLRAIQYLHENRIIHR 206
Query: 163 DIKPDNLILDKNGHLKLSDFG-LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
DIK +N+ ++ G + L DFG C P++ IN
Sbjct: 207 DIKAENIFINHPGDVCLGDFGAACFPVD-------------INA---------------- 237
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
N+ Y GT+ APE+L + YG D WS G +++EM +
Sbjct: 238 ------NKY---YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 69/253 (27%), Positives = 108/253 (42%), Gaps = 65/253 (25%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--------VRSE 88
++ +++L +G+G++ V R+K TG++ A+K+++ +EH +R E
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR-E 53
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAES 147
+LL ++ IV L L L+ EYL D+ + LS R ++ +
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQL 112
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL--CKPLEDK-YSSILLEDEDIIN 204
+ + HQ +HRD+KP NL++ + G LKL+DFGL K + K YS+
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN---------- 162
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLG 263
E V TL Y P+VLL Y D W +G
Sbjct: 163 -EVV------------------------------TLWYRPPDVLLGSTEYSTSLDMWGVG 191
Query: 264 AIMYEMLIGYPPF 276
I YEM G P F
Sbjct: 192 CIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 83/291 (28%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC----- 99
+IG+G FG+V R K G ++ + +K + R+ E++ C
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHH 55
Query: 100 --IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED--VARFYIAESVLA----- 150
I+ L + + +LYL +EY P G+++ L + +L D A S L+
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 151 ---------IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
+ + Q ++HRD+ N+++ +N K++DFGL + ++
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQE 163
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
+ ++T+ +WM + +L+Y Y D WS
Sbjct: 164 VYVKKTMGRLPVRWM-------------------AIESLNYSV--------YTTNSDVWS 196
Query: 262 LGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFP-----EEPKISDE 306
G +++E++ +G P+C +TC ++ K P E+P D+
Sbjct: 197 YGVLLWEIVSLGGTPYCG----MTCAELYE-----KLPQGYRLEKPLNCDD 238
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 62/291 (21%), Positives = 121/291 (41%), Gaps = 83/291 (28%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC----- 99
+IG+G FG+V K G +K +MLK E+ R+ E++ C
Sbjct: 9 VIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHH 62
Query: 100 --IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED--VARFYIAESVLA----- 150
I+ L + ++ +LY+ +EY P G+++ L + +L D A+ + S L
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 151 ---------IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
+ + + ++HRD+ N+++ +N K++DFGL + E+
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------------GEE 170
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
+ ++T+ +WM + +L+Y Y + D WS
Sbjct: 171 VYVKKTMGRLPVRWM-------------------AIESLNYSV--------YTTKSDVWS 203
Query: 262 LGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFP-----EEPKISDE 306
G +++E++ +G P+C +TC ++ K P E+P+ D+
Sbjct: 204 FGVLLWEIVSLGGTPYCG----MTCAELYE-----KLPQGYRMEKPRNCDD 245
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 51/244 (20%), Positives = 92/244 (37%), Gaps = 59/244 (24%)
Query: 46 IGKGAFGEV---RLCRAKTTGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
+G+GAFG+V + + + A+K LK E + E LL I
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELLTNFQHENI 70
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-----ILSEDVARFYIAESVLAIHSIH 155
V+ + + D ++ EY+ GD+ L + S D + S L ++
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 156 ----------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
QH +VHRD+ N ++ + +K+ DFG+ + D Y++
Sbjct: 131 IASGMVYLASQH-FVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTT----------- 175
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
G M+P + +M PE ++ + + E D WS G +
Sbjct: 176 -DYYRVGGHTMLP---------------------IRWMPPESIMYRKFTTESDVWSFGVV 213
Query: 266 MYEM 269
++E+
Sbjct: 214 LWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 62/278 (22%), Positives = 118/278 (42%), Gaps = 79/278 (28%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+D + +IG+G FG+V R K G A+K++K+ + +H R+ E+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDH----RDFAGEL 58
Query: 96 DSRC-------IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
+ C I+ L + + +LYL +EY P G+++ L + +L D A F IA S
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANST 117
Query: 149 LAIHS-----------------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191
+ S + Q ++HRD+ N+++ +N K++DFGL +
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----- 172
Query: 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 251
+++ ++T+ +WM + +L+Y
Sbjct: 173 -------GQEVYVKKTMGRLPVRWM-------------------AIESLNYSV------- 199
Query: 252 GYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKI 288
Y D WS G +++E++ +G P+C +TC ++
Sbjct: 200 -YTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAEL 232
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 57/260 (21%), Positives = 100/260 (38%), Gaps = 64/260 (24%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--------S 97
+G+G FGEV LC A+ E + V+ +R++ A D S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 98 RC----IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSE--------DVAR---F 142
R I++L D L +I EY+ GD+ L + +I S V+
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 143 YIAESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
Y+A + + + + N+VHRD+ N ++ + +K++DFG+ + L YS
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL---YSG------- 182
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
+G+ ++P + +MA E +L + D W+
Sbjct: 183 -----DYYRIQGRAVLP---------------------IRWMAWESILLGKFTTASDVWA 216
Query: 262 LGAIMYEMLIGYPPFCSDDP 281
G ++EM C + P
Sbjct: 217 FGVTLWEMFT----LCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 53/222 (23%)
Query: 71 LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--------------DFLYLI 116
+KK + V+H E ++ +D IV+++ S + +Y++
Sbjct: 35 VKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94
Query: 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 176
EY+ + ++ + LSE+ AR ++ + + + IH N +HRD+KP N+ ++
Sbjct: 95 QEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152
Query: 177 -LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYS 235
LK+ DFGL + ++ YS + +++ V+ +W
Sbjct: 153 VLKIGDFGLARIVDPHYSH-----KGYLSEGLVT----KW-------------------- 183
Query: 236 TVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 276
Y +P +LL Y D W+ G I EML G P F
Sbjct: 184 ------YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 49/239 (20%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
++ L IG GA G V A+KKL + + + E L+ V+ +
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKN 84
Query: 100 IVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
I+ L S ++ +Y++ME + + M L + + + + + I
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKH 141
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H +HRD+KP N+++ + LK+ DFGL + A
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------------------TAGT 178
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
+MM + ++ Y APEV+L GY D WS+G IM EM+ G
Sbjct: 179 SFMMTPYVVTRY----------------YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 60/237 (25%), Positives = 94/237 (39%), Gaps = 45/237 (18%)
Query: 43 LTLIGKGAFGEVRLCRAKTTGEIFAMK--KLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
L +G+G++ V ++ G++ A+K +K E + + E +LL + I
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANI 65
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 160
V L + L + EY+ ++ L R ++ + + + IH + +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 161 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 220
HRD+KP NL++ G LKL+DFGL + + I +Q SE
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARA------------KSIPSQTYSSE---------- 163
Query: 221 RLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPF 276
V TL Y P+VLL Y D W G I EML G P F
Sbjct: 164 ----------------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 53/247 (21%), Positives = 107/247 (43%), Gaps = 61/247 (24%)
Query: 41 EQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHV----RSERNL 91
+++T +G+G FGEV L +AK E + +K L+K++ E++ R E ++
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------DENLQSEFRRELDM 61
Query: 92 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM----REDILSED----VARFY 143
++ + +V+L ++++ Y+I+EY GD+ L +++ L +
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 144 IAESV-LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202
+ + L + + +VHRD+ N ++ +K+S L K D Y+S
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNS-------- 170
Query: 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262
++ + R AL L ++APE + + + + D WS
Sbjct: 171 ---------------------EYYKLRNALI-----PLRWLAPEAVQEDDFSTKSDVWSF 204
Query: 263 GAIMYEM 269
G +M+E+
Sbjct: 205 GVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 57/237 (24%), Positives = 91/237 (38%), Gaps = 49/237 (20%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
++ L IG GA G V A+KKL + + + E L+ V+ +
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKN 77
Query: 100 IVQLFYSFQDSDFL------YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
I+ L F L YL+ME + + M L + + + + + I
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKH 134
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H +HRD+KP N+++ + LK+ DFGL + A
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------------------TAGT 171
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+MM + ++ Y APEV+L GY D WS+G IM EM+
Sbjct: 172 SFMMTPYVVTRY----------------YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 63/247 (25%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL--------------KKSEMLKRGQVEH 84
D E IG GAFG V G+ A+KK+ ++ +ML + ++
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 85 VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 144
V S ++L F++ +Y++ E L D+ +++ LS D + ++
Sbjct: 61 VLSALDILQPPHIDP-------FEE---IYVVTE-LMQSDLHKIIVSPQPLSSDHVKVFL 109
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + + +H +HRDIKP NL+++ N LK+ DFGL + E ++ +
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE-------PDESKHMT 162
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLG 263
QE V++ Y Y APE+L+ + Y D WS+G
Sbjct: 163 QEVVTQ-----------------------Y-------YRAPEILMGSRHYTSAVDIWSVG 192
Query: 264 AIMYEML 270
I E+L
Sbjct: 193 CIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 50/234 (21%), Positives = 100/234 (42%), Gaps = 46/234 (19%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G FG V L + + ++ A+K + + M + +E E ++ ++ +VQL+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
LY++ E++ G ++ L R+ LS+D+ + + + +++++HRD+
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 165 KPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
N ++ G +K+SDFG+ + L+D+Y+S
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTS----------------------------- 157
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPF 276
+ + + PEV Y + D WS G +M+E+ G PF
Sbjct: 158 ---------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 60/266 (22%), Positives = 106/266 (39%), Gaps = 68/266 (25%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
I + + IGKG FG+V L + G+ A+K LK + + + LAE
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAE 50
Query: 95 VDSRC------IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYIA 145
+VQL + LY++ EY+ G ++ L R I F +
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL- 109
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ + + + N+VHRD+ N+++ ++ K+SDFGL K +
Sbjct: 110 DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK------------------E 151
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
+ + G+ +P + + APE L +K + + D WS G +
Sbjct: 152 ASQGQDSGK--LP---------------------VKWTAPEALREKKFSTKSDVWSFGIL 188
Query: 266 MYEML-IGYPPFCSDDPRITCRKIVN 290
++E+ G P+ PRI + +V
Sbjct: 189 LWEIYSFGRVPY----PRIPLKDVVP 210
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G +GEV K A+K LK+ M +VE E ++ E+ +VQL
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSED-VARFYIAESV-LAIHSIHQHNYVHRD 163
Y+I E++ G+++ L + + V Y+A + A+ + + N++HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPL-EDKYSS 194
+ N ++ +N +K++DFGL + + D Y++
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 53/238 (22%), Positives = 98/238 (41%), Gaps = 61/238 (25%)
Query: 46 IGKGAFGEVR--LCRAKTTGEIFAMKKLK-------KSEMLKRGQVEHVRSERNLLAEVD 96
+G G FG V+ + + + A+K LK + EM++ ++ H ++D
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIHSI 154
+ IV++ +++ L L+ME GG + L +++I +V + + + + +
Sbjct: 54 NPYIVRMI-GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYL 111
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL--EDKYSSILLEDEDIINQETVSEAE 212
N+VHRD+ N++L + K+SDFGL K L +D Y + +
Sbjct: 112 EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--------------ARSA 157
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
G+W L + APE + + + D WS G M+E
Sbjct: 158 GKW-----------------------PLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 55/233 (23%)
Query: 46 IGKGAFGEVR--LCRAKTTGEIFAMKKLK--------KSEMLKRGQVEHVRSERNLLAEV 95
+G G FG V+ + + K + + A+K LK K E+L+ E N++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---------EANVMQQL 53
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 155
D+ IV++ +++ L+ME G + L + ++E + + + + +
Sbjct: 54 DNPYIVRMI-GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
+ N+VHRD+ N++L + K+SDFGL K L DE+ +T G+W
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALG--------ADENYYKAKT----HGKW 160
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+ +W APE + + + D WS G +M+E
Sbjct: 161 PV------KW-----------------YAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 41/150 (27%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G FGEV + ++ A+K LK+ M E +E NL+ ++ +V+L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRL-Y 67
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY-----IAESVLAIHSIHQHNYV 160
+ + +Y+I EY+ G ++ L + + + + IAE + I + NY+
Sbjct: 68 AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE---GMAFIERKNYI 124
Query: 161 HRDIKPDNLILDKNGHLKLSDFGLCKPLED 190
HRD++ N+++ + K++DFGL + +ED
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 45/249 (18%), Positives = 94/249 (37%), Gaps = 55/249 (22%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKT--TGEIF---AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ + +G+G+FG V AK GE A+K + ++ + + +E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVM 63
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
E + +V+L ++ME + GD+ + L R + ++
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFI 122
Query: 153 S-----------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
+ +VHRD+ N ++ ++ +K+ DFG+ + D
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------------D 168
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
I + + G+ ++P + +MAPE L + + D WS
Sbjct: 169 IYETDYYRK-GGKGLLP---------------------VRWMAPESLKDGVFTTKSDVWS 206
Query: 262 LGAIMYEML 270
G +++EM
Sbjct: 207 FGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 41/187 (21%)
Query: 87 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 146
E ++L + R I+ L ++++ + ++M D+ T + R L + A I
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQR 192
Query: 147 SVL-AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG-LCKPLEDKYSSILLEDEDIIN 204
+L A+ +H +HRD+K +N+ LD+ + L DFG CK +
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT----------- 241
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264
P+ Y GTL+ +PE+L Y + D WS G
Sbjct: 242 -------------PQ-------------CYGWSGTLETNSPELLALDPYCAKTDIWSAGL 275
Query: 265 IMYEMLI 271
+++EM +
Sbjct: 276 VLFEMSV 282
|
Length = 392 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 55/247 (22%)
Query: 39 DFEQLTLI---GKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
D + LT + G G FG V+ + + ++ A+K +K+ M + +E + L E
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK 60
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSI 154
+VQL+ +Y++ EY+ G ++ L + + + V + +
Sbjct: 61 ----LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEG 213
++HRD+ N ++D G +K+SDFGL + L+D+Y+
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-------------------- 156
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
S+VG+ + + PEVLL + + D W+ G +M+E+
Sbjct: 157 ---------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195
Query: 271 -IGYPPF 276
+G P+
Sbjct: 196 SLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 46/234 (19%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
+F +G G FGEV K + A+K LK ++LK+ + E L + +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQ---KEVQALKRLRHK 62
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF-YIAESVL-AIHSIHQ 156
++ LF + +Y+I E + G ++ L + VA +A V + + +
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSSILLEDEDIINQETVSEAEGQW 215
N +HRD+ N+++ ++ K++DFGL + + ED Y S D+ I + T
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS---SDKKIPYKWT-------- 171
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
APE + + D WS G ++YEM
Sbjct: 172 ----------------------------APEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 24/162 (14%)
Query: 45 LIGKGAFGEVRLCRAKTTG--EIFAMKKLKKSEMLKRGQVEHVR----SERNLLAEVDSR 98
+IG G FGEV R K G EIF K LK G E R SE +++ + D
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIK-----TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI---- 154
I+ L S + +I E++ G + + L + D +F + + V + I
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGM 119
Query: 155 ---HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193
+ NYVHRD+ N++++ N K+SDFGL + LED S
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 37/147 (25%), Positives = 77/147 (52%), Gaps = 8/147 (5%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G FGEV + ++ A+K +K M VE +E N++ + +V+L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL-H 67
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIHQHNYVHRD 163
+ + +Y+I E++ G ++ L ++ + + + + A+ + I Q NY+HRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLED 190
++ N+++ + K++DFGL + +ED
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 69/281 (24%)
Query: 46 IGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
+G+GAFG+V L + + A+K LK + R + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQHEHI 69
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIM---------TLLMREDILSEDVAR---FYIAESV 148
V+ + + D L ++ EY+ GD+ +LM E ++ + +IA+ +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 149 LA--IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206
A ++ QH +VHRD+ N ++ +N +K+ DFG+ + D YS+
Sbjct: 130 AAGMVYLASQH-FVHRDLATRNCLVGENLLVKIGDFGMSR---DVYST------------ 173
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
G M+P + +M PE ++ + + E D WSLG ++
Sbjct: 174 DYYRVGGHTMLP---------------------IRWMPPESIMYRKFTTESDVWSLGVVL 212
Query: 267 YEMLI-GYPPF--CSDDPRITC----RKIVNWKTCLKFPEE 300
+E+ G P+ S++ I C R + +TC P+E
Sbjct: 213 WEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC---PKE 250
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 62/264 (23%), Positives = 102/264 (38%), Gaps = 71/264 (26%)
Query: 46 IGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD----- 96
+G+G FGEV LC A K + F++ +L V+ +R + N A D
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLV--AVKMLREDANKNARNDFLKEI 70
Query: 97 ---SRC----IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----EDILSEDVA----- 140
SR I++L SD L +I EY+ GD+ L R E DV
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 141 --RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSSILL 197
F + + + N+VHRD+ N ++ KN +K++DFG+ + L Y I
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI-- 188
Query: 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 257
+G+ ++P + +M+ E +L +
Sbjct: 189 --------------QGRAVLP---------------------IRWMSWESILLGKFTTAS 213
Query: 258 DWWSLGAIMYEMLIGYPPFCSDDP 281
D W+ G ++E+L C + P
Sbjct: 214 DVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 62/247 (25%)
Query: 46 IGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
+G+GAFG+V L + A+K LK + R + + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNLQHEHI 69
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----ILSEDVAR-----------FYIA 145
V+ + D D L ++ EY+ GD+ L IL + R +IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 146 ESVLA--IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+ + ++ QH +VHRD+ N ++ N +K+ DFG+ + D YS+
Sbjct: 130 SQIASGMVYLASQH-FVHRDLATRNCLVGANLLVKIGDFGMSR---DVYST--------- 176
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263
G M+P + +M PE ++ + + E D WS G
Sbjct: 177 ---DYYRVGGHTMLP---------------------IRWMPPESIMYRKFTTESDVWSFG 212
Query: 264 AIMYEML 270
I++E+
Sbjct: 213 VILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 57/259 (22%), Positives = 107/259 (41%), Gaps = 56/259 (21%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+ + + + L IGKG FG+V L G A+K +K + +E +++ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML--GDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 95 VDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAI 151
+ +VQL ++ LY++ EY+ G ++ L +L D + + A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ +N+VHRD+ N+++ ++ K+SDFGL K S
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------------------EASST 155
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML- 270
+ +P + + APE L +K + + D WS G +++E+
Sbjct: 156 QDTGKLP---------------------VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
Query: 271 IGYPPFCSDDPRITCRKIV 289
G P+ PRI + +V
Sbjct: 195 FGRVPY----PRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 40/233 (17%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IG+G FGEV R + A+K + E L E +L + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA-IHSIHQHNYVHRDI 164
+Y++ME + GGD +T L E + + E+ A + + + +HRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQ 224
N ++ + LK+SDFG+ + E+ED + T G +P
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-----------EEEDGVYAST----GGMKQIP------ 159
Query: 225 WKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
+ + APE L Y E D WS G +++E +G P+
Sbjct: 160 ---------------VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 61/272 (22%), Positives = 117/272 (43%), Gaps = 51/272 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G+G FGEV + T + A+K LK M E E ++ ++ +VQL Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIHQHNYVHRD 163
+ + +Y++ EY+ G ++ L E + + A+ + + + NYVHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
++ N+++ +N K++DFGL + +ED N+ T
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIED-------------NEYTA--------------- 159
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPR 282
R+ + + + APE L + ++ D WS G ++ E+ G P+ P
Sbjct: 160 -----RQGAKFP----IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PG 206
Query: 283 ITCRKIVNW-KTCLKFPEEPKISDEARDLICH 313
+ R++++ + + P P+ + DL+C
Sbjct: 207 MVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 53/218 (24%), Positives = 82/218 (37%), Gaps = 37/218 (16%)
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSDFLYLIMEYL 120
TG A+K L+ + Q R E L A + IV L S + L+ + EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 121 PGGDIMTLLMREDILS-EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---H 176
PG + +L + L + R + + + A+ H VHRD+KP N+++ + G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 177 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 236
K+ DFG+ ++L D E
Sbjct: 121 AKVLDFGI--------GTLLPGVRDADVATLTRTTE-----------------------V 149
Query: 237 VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+GT Y APE L + D ++ G I E L G
Sbjct: 150 LGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 54/243 (22%)
Query: 45 LIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+IG G FGEV K G A+K LK K Q + SE +++ + I+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNII 69
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS----IHQH 157
+L +I EY+ G + L D + + + + + I + +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
NYVHRD+ N++++ N K+SDFGL + LED + EG
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLED-------------------DPEG---- 163
Query: 218 PKERLQQWKRNRRALAYSTVG---TLDYMAPEVLLKKGYGMECDWWSLGAIMYE-MLIGY 273
Y+T G + + APE + + + D WS G +M+E M G
Sbjct: 164 ---------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
Query: 274 PPF 276
P+
Sbjct: 209 RPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 37/147 (25%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G+G FGEV + T ++ A+K LK M+ ++ E ++ ++ +V L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPL-Y 67
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA--IHSIHQHNYVHRD 163
+ + +Y++ E++ G ++ L D + + + +A + I + NY+HRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLED 190
++ N+++ N K++DFGL + +ED
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 53/257 (20%), Positives = 91/257 (35%), Gaps = 59/257 (22%)
Query: 63 GEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 120
G +F K + + +LK GQ E LL V+ ++++ + +++ +
Sbjct: 80 GRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139
Query: 121 PGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179
D+ T L + L D A + + + +H +HRD+K +N+ ++ + +
Sbjct: 140 -SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCI 198
Query: 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 239
D G Q V GT
Sbjct: 199 GDLGAA-------------------QFPVVAPA--------------------FLGLAGT 219
Query: 240 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE 299
++ APEVL + Y + D WS G +++EML YP +DP T PE
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPST-------------PE 265
Query: 300 EPKISDEA--RDLICHL 314
E S + +I L
Sbjct: 266 EYVKSCHSHLLKIISTL 282
|
Length = 357 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 35/121 (28%), Positives = 48/121 (39%), Gaps = 37/121 (30%)
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
A+ IH +HRDIK +N+ L+ +G + L DFG P E +
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE------------------ 320
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
R A Y VGT+ +PE+L GY D WS G I+ +M
Sbjct: 321 -------------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 270 L 270
L
Sbjct: 362 L 362
|
Length = 501 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 6e-07
Identities = 10/50 (20%), Positives = 17/50 (34%), Gaps = 3/50 (6%)
Query: 354 TVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 403
V DT NF+ PP S + + F G+++ +
Sbjct: 1 KVKSPTDTSNFDPE-FTSEPPKL--SPPDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 38/159 (23%), Positives = 77/159 (48%), Gaps = 8/159 (5%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
+I + + + +G G FGEV + ++ A+K LK M +E E ++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMK 56
Query: 94 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAI 151
++ +VQL Y+ + +Y++ EY+ G ++ L + + + A+ +
Sbjct: 57 KLRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190
I + NY+HRD++ N+++ K++DFGL + +ED
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 61/260 (23%), Positives = 103/260 (39%), Gaps = 72/260 (27%)
Query: 46 IGKGAFGEVRLCRAKTTGEIF-----------AMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+G+GAFG+V GE+ A+K LK++ K + R E L+++
Sbjct: 13 LGEGAFGKV------YKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSD 64
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----EDILSEDVAR--------- 141
+ IV L ++ EYL GD+ L+R D+ +E
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 142 --FYIAESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198
+IA + A + + H++VHRD+ N ++ + +K+SDFGL + D YS+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSA---- 177
Query: 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 258
D ++ S +W M PE +L + E D
Sbjct: 178 --DYYRVQSKSLLPVRW---------------------------MPPEAILYGKFTTESD 208
Query: 259 WWSLGAIMYEML-IGYPPFC 277
WS G +++E+ G P+
Sbjct: 209 IWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-06
Identities = 22/70 (31%), Positives = 31/70 (44%), Gaps = 13/70 (18%)
Query: 337 RGIQWDKLY--EMEAAYKPTVNGELDTQNF-EKFPE---VDGPPSEIPSVGPWRKMLTSK 390
RGI WDKL E+E + P + DT NF +F E V P S G ++
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEP---- 56
Query: 391 DTNFIGYTFK 400
F G+++
Sbjct: 57 ---FRGFSYV 63
|
Length = 64 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 68/242 (28%)
Query: 46 IGKGAFGEVRLCRAKTTG--EIF-AMKKLKKSEMLKRGQVEHVR----SERNLLAEVDSR 98
IG G FGEV R K G EI A+K LK G + R +E +++ + D
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIK------TLKAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI---- 154
I++L S + +I EY+ G + L D +F + + V + I
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGM 119
Query: 155 ---HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ NYVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA------------------ 161
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVG---TLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
Y+T G + + APE + + + D WS G +M+E
Sbjct: 162 ---------------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200
Query: 269 ML 270
++
Sbjct: 201 VM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 65/248 (26%)
Query: 46 IGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
+G+GAFG+V L + + A+K LK++ R + + E LL + + I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE----DIL--SEDVA------------RF 142
V+ + + L ++ EY+ GD+ L IL EDVA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202
IA ++ + S+H +VHRD+ N ++ + +K+ DFG+ + D YS+
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYST-------- 175
Query: 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262
G+ M+P + +M PE +L + + E D WS
Sbjct: 176 ----DYYRVGGRTMLP---------------------IRWMPPESILYRKFTTESDIWSF 210
Query: 263 GAIMYEML 270
G +++E+
Sbjct: 211 GVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 46/229 (20%), Positives = 95/229 (41%), Gaps = 51/229 (22%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G FG V L + + ++ A+K +++ M + +E + L +VQL+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKLSHPN----LVQLYG 66
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
++++ EY+ G ++ L R+ L + ++ A+ + + ++HRD+
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 165 KPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
N ++ ++ +K+SDFGL + L+D+Y+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYT------------------------------ 156
Query: 224 QWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
S+ GT + + PEV + + D WS G +M+E+
Sbjct: 157 -----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 23/130 (17%), Positives = 49/130 (37%), Gaps = 11/130 (8%)
Query: 58 RAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV--QLFYSFQDSDFLYL 115
T E + +K E + E +L + + + ++ S + + YL
Sbjct: 16 LLGTKDEDYVLKINPSRE-----KGADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70
Query: 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 175
+ME++ G L ++ +AE + +H + H D+ P N+++D
Sbjct: 71 LMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126
Query: 176 HLKLSDFGLC 185
L + D+
Sbjct: 127 ILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 59/261 (22%), Positives = 96/261 (36%), Gaps = 69/261 (26%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRG-----QVEHVRSERN 90
++ E + IG+GAFG V RA E F M +K MLK Q + R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQR-EAA 60
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYI 144
L+AE D IV+L + L+ EY+ GD+ L + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 145 AESVLAIHSIHQ----------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188
+ L + Q +VHRD+ N ++ +N +K++DFGL +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-- 178
Query: 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248
+ YS+ +A +P + +M PE +
Sbjct: 179 -NIYSA------------DYYKASENDAIP---------------------IRWMPPESI 204
Query: 249 LKKGYGMECDWWSLGAIMYEM 269
Y E D W+ G +++E+
Sbjct: 205 FYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 32/176 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEI----------------FAMKKLKKSEMLKRGQVEHVRSER 89
+G+G FGEV LC A + A+K L+ E E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEV 70
Query: 90 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR-------- 141
+L+ + I +L L +IMEY+ GD+ L + + +A
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 142 --FYIAESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194
Y+A + + + + N+VHRD+ N ++ KN +K++DFG+ + L YSS
Sbjct: 131 TLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---YSS 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 62/244 (25%), Positives = 106/244 (43%), Gaps = 55/244 (22%)
Query: 46 IGKGAFGEVRLCRA----KTTGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC- 99
+G GAFG+V A K+ + A+K LK + + E + SE +++ + +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHEN 100
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILS-EDVARF--YIAESVLAIHSI 154
IV L + + +I EY GD++ L R E L+ ED+ F +A+ + + S
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS- 159
Query: 155 HQHNYVHRDIKPDNLILDKNGHL-KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
N +HRD+ N++L +G + K+ DFGL + DI+N +G
Sbjct: 160 --KNCIHRDLAARNVLL-THGKIVKICDFGLAR--------------DIMNDSNYV-VKG 201
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IG 272
+P + +MAPE + Y E D WS G +++E+ +G
Sbjct: 202 NARLP---------------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240
Query: 273 YPPF 276
P+
Sbjct: 241 SNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 59/271 (21%), Positives = 105/271 (38%), Gaps = 77/271 (28%)
Query: 46 IGKGAFGEVRLCRAKTTGEI------FAMKK----LKKSEMLKRGQVEHVRS----ERNL 91
+G+G FGEV LC ++ F ++K L ++L+ ++ R+ E +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 92 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARFYIAESV 148
L+ + I++L D D L +I EY+ GD+ L +D A +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 149 LAI------HSIHQ----------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE--D 190
AI H Q N+VHRD+ N ++ +N +K++DFG+ + L D
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD 192
Query: 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250
Y +G+ ++P + +MA E +L
Sbjct: 193 YY-----------------RIQGRAVLP---------------------IRWMAWECILM 214
Query: 251 KGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281
+ D W+ G ++E+L+ C + P
Sbjct: 215 GKFTTASDVWAFGVTLWEILM----LCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 50/253 (19%)
Query: 29 RLQRRKIGIDDFEQLTLIGKGAFGEVR--LCRAKTTGEI-FAMKKLKKSEMLKRGQVEHV 85
+QR I + IG+G FG+V + + +I A+K K E
Sbjct: 2 EIQREDITLGR-----CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKF 54
Query: 86 RSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI-MTLLMREDILSEDVARFYI 144
E ++ + D IV+L ++ ++++ME P G++ L + + L Y
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ A+ + +VHRDI N+++ +KL DFGL S LEDE
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGL---------SRYLEDESY-- 162
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264
+K ++ L + +MAPE + + + D W G
Sbjct: 163 --------------------YKASKGKLP------IKWMAPESINFRRFTSASDVWMFGV 196
Query: 265 IMYEMLI-GYPPF 276
M+E+L+ G PF
Sbjct: 197 CMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 61/270 (22%), Positives = 102/270 (37%), Gaps = 88/270 (32%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSE---------------MLKRGQV 82
+E IG+G +G V + K G+ +A+KK K + +L+ +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 83 EHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI-------MEYLPGGDIMTLLMREDIL 135
E+V S + E + + LF + + D +I +P + +LL + IL
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLF-DYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--IL 118
Query: 136 SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC----KP 187
+ +H +H + +HRD+KP N+++ + G +K+ D GL P
Sbjct: 119 N-------------GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 247
L+ L D D V T+ Y APE+
Sbjct: 166 LK------PLADLD---------------------------------PVVVTIWYRAPEL 186
Query: 248 LL-KKGYGMECDWWSLGAIMYEMLIGYPPF 276
LL + Y D W++G I E+L P F
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 33/119 (27%), Positives = 44/119 (36%), Gaps = 36/119 (30%)
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
AI IH +HRDIK +N++++ + L DFG
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-----------------------AAC 308
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
A G W P Y GT+D APEVL Y D WS G +++E
Sbjct: 309 FARGSWSTP-------------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
E L L +G G FGEV + T ++ A+K LK M E E ++ ++
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRH 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS---- 153
+VQL+ + + +Y++ EY+ G +LL D L + ++ + +
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKG---SLL---DFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 154 ----IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190
+ NY+HRD+ N+++ +N K++DFGL + +ED
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G G FGEV T + A+K LK M + +E ++ ++ ++QL+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDI----LSE--DVARFYIAESVLAIHSIHQHNY 159
+ +Y++ E + G ++ L L + D+A A+ + + NY
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQVASGMAYLEAQNY 124
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSS 194
+HRD+ N+++ +N K++DFGL + + ED Y +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 50/239 (20%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
E++ ++G GAFG V GE A+K L++ + + E ++A V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV 66
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARF--YIAESVLAI 151
D +V+L S + LI + +P G ++ + +++I S+ + + IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ + VHRD+ N+++ H+K++DFGL K L+ DE + A
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--------VDEKEYH------A 168
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
EG +P + +MA E +L + Y + D WS G ++E++
Sbjct: 169 EGG-KVP---------------------IKWMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 62/287 (21%), Positives = 112/287 (39%), Gaps = 62/287 (21%)
Query: 45 LIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
++GKG FG VR + K+ + + A+K LK +++ +E E + E D ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 102 QLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDI------LSEDVARFYIAESVL 149
+L + +I+ ++ GD+ T L+ I L ++ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ + N++HRD+ N +L++N + ++DFGL K + YS D Q S
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI---YSG------DYYRQGCAS 175
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE- 268
+ +W +A E L Y D W+ G M+E
Sbjct: 176 KLPVKW---------------------------LALESLADNVYTTHSDVWAFGVTMWEI 208
Query: 269 MLIGYPPFCSDDPRITCRKIVNWKTC---LKFPEEPKISDEARDLIC 312
M G P+ + +I N+ LK P P ++ +L+C
Sbjct: 209 MTRGQTPY----AGVENSEIYNYLIKGNRLKQP--PDCLEDVYELMC 249
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 50/248 (20%)
Query: 41 EQLTLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
E LT+IG+G V L R K TGE ++++ E V ++ E ++ +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVL-AIHSIH 155
IV +F + L+++ ++ G L+ D +SE +A YI + VL A+ IH
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE-LAIAYILQGVLKALDYIH 118
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
YVHR +K ++++ +G + LS GL S L +IN GQ
Sbjct: 119 HMGYVHRSVKASHILISVDGKVYLS--GL--------RSNL----SMINH-------GQR 157
Query: 216 M-----MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYE 268
+ PK YS V L +++PEVL + +GY + D +S+G E
Sbjct: 158 LRVVHDFPK--------------YS-VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202
Query: 269 MLIGYPPF 276
+ G+ PF
Sbjct: 203 LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 47/174 (27%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFA--------MKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
IG G FG+V L GE+ + +K+L+ S V+ + L E
Sbjct: 3 IGNGWFGKVIL------GEVNSGYTPAQVVVKELRVSA--------SVQEQMKFLEEA-- 46
Query: 98 RCIVQLFYSFQDSDFL------------YLIMEYLPGGDIMTLLM---REDILSED--VA 140
Q + S Q S+ L L+ME+ P GD+ L + ++++ D
Sbjct: 47 ----QPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL 102
Query: 141 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL--CKPLEDKY 192
+ E L + +H++N++H D+ N +L + +K+ D+GL K ED Y
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 84/271 (30%)
Query: 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLK-----KSEMLKRG--QVEH--VRSERNLLAE 94
+G+G FG+V F +K +MLK E + SE NLL +
Sbjct: 6 KTLGEGEFGKV------VKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
V+ +++L+ + L LI+EY G + + L S V Y+ S
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLR----ESRKVGPSYLGSDGNRNSSY 115
Query: 155 HQH----------------------------NYVHRDIKPDNLILDKNGHLKLSDFGLCK 186
+ VHRD+ N+++ + +K+SDFGL +
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 246
D Y E++ + KR++ + + +MA E
Sbjct: 176 ---DVY-----EEDSYV----------------------KRSKGRIP------VKWMAIE 199
Query: 247 VLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
L Y + D WS G +++E++ +G P+
Sbjct: 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 39/129 (30%)
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK--YSSILLEDEDIINQETVSEAEG 213
+VHRD+ N +LD++ +K++DFGL + + DK YS ++ T ++
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS---------VHNHTGAKLPV 166
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272
+W M E LQ K + + D WS G +++E++ G
Sbjct: 167 KW-MALESLQTQK--------------------------FTTKSDVWSFGVLLWELMTRG 199
Query: 273 YPPFCSDDP 281
PP+ D
Sbjct: 200 APPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 46/226 (20%), Positives = 91/226 (40%), Gaps = 45/226 (19%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IG G FG V L ++ A+K +++ M + E E ++ ++ +VQL+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
+ + L+ E++ G + L + S++ + + + N +HRD+
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 165 KPDNLILDKNGHLKLSDFGLCK-PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
N ++ +N +K+SDFG+ + L+D+Y+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTS----------------------------- 157
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+ T + + +PEV Y + D WS G +M+E+
Sbjct: 158 ---------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 30/118 (25%), Positives = 53/118 (44%), Gaps = 37/118 (31%)
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+ N++L +N +K+ DFGL + D Y +D D + + G +P
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLAR---DIY-----KDPDYVRK-------GDARLP- 244
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
L +MAPE + + Y ++ D WS G +++E+ +G P+
Sbjct: 245 --------------------LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 49/242 (20%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 45 LIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
++G+G FG V +L + + A+K +K ++ ++E SE + + D ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 102 QLF-YSFQDSDFLYL-----IMEYLPGGDIMTLLMR-------EDILSEDVARFYIAESV 148
+L F+ S + I+ ++ GD+ + L+ E + + + +F + +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDIA 123
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
L + + N++HRD+ N +L ++ + ++DFGL K + YS D Q +
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI---YS------GDYYRQGRI 174
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
++ MP + ++A E L + Y + D W+ G M+E
Sbjct: 175 AK------MP---------------------VKWIAIESLADRVYTSKSDVWAFGVTMWE 207
Query: 269 ML 270
+
Sbjct: 208 IA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 72/264 (27%)
Query: 38 DDFEQLTLIGKGAFGEV-----RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92
D L +G GAFGEV R A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 93 AEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLL--------------MREDI-LS 136
++ + + IV+L SF+ ++++E + GGD+ + L M++ + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 137 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYS 193
DVA + +++++HRDI N +L G K++DFG+ +
Sbjct: 123 RDVA--------KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR------- 167
Query: 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253
DI + G+ M+P + +M PE L +
Sbjct: 168 -------DIYRASYYRKG-GRAMLP---------------------IKWMPPEAFLDGIF 198
Query: 254 GMECDWWSLGAIMYEML-IGYPPF 276
+ D WS G +++E+ +GY P+
Sbjct: 199 TSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 37/118 (31%)
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+ N++L +N +K+ DFGL + D Y +D D + + G +P
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLAR---DIY-----KDPDYVRK-------GSARLP- 239
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
L +MAPE + K Y + D WS G +++E+ +G P+
Sbjct: 240 --------------------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 55/259 (21%), Positives = 113/259 (43%), Gaps = 65/259 (25%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+ ++LTL IG+G FG V + + TG+ A+K +K ++ + +E E ++ ++
Sbjct: 4 NLQKLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIK-CDVTAQAFLE----ETAVMTKL 56
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARF--YIAESVLA 150
+ +V+L + LY++ME + G+++ L R + + +F +AE +
Sbjct: 57 HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ S VHRD+ N+++ ++G K+SDFGL +
Sbjct: 116 LES---KKLVHRDLAARNILVSEDGVAKVSDFGLARV----------------------- 149
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ S + + + APE L K + + D WS G +++E+
Sbjct: 150 -----------------GSMGVDNSKL-PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191
Query: 271 -IGYPPFCSDDPRITCRKI 288
G P+ P+++ +++
Sbjct: 192 SYGRAPY----PKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 57/253 (22%), Positives = 106/253 (41%), Gaps = 60/253 (23%)
Query: 46 IGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+G+ AFG++ G ++ A+K LK ++ Q + E +L+AE+ IV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMT-LLMR-----------EDIL---SEDVARF-YIA 145
L + ++ EYL GD+ L+MR ED S D F +IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 146 ESVLA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ A + + H +VH+D+ N+++ + H+K+SD GL + + YS+
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI---YSA---------- 177
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264
+ + ++P + +M PE ++ + + D WS G
Sbjct: 178 --DYYRVQPKSLLP---------------------IRWMPPEAIMYGKFSSDSDIWSFGV 214
Query: 265 IMYEML-IGYPPF 276
+++E+ G P+
Sbjct: 215 VLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 56/245 (22%), Positives = 107/245 (43%), Gaps = 47/245 (19%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+F+++ ++G GAFG V GE A+K+L+++ K + + E ++A
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMAS 65
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIH 152
VD+ + +L S + LI + +P G ++ + +++I S+ + + + + ++
Sbjct: 66 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV-QIAKGMN 123
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+ + VHRD+ N+++ H+K++DFGL K L E AE
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--------------ADEKEYHAE 169
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE-MLI 271
G + K +MA E +L + Y + D WS G ++E M
Sbjct: 170 GGKVPIK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTF 207
Query: 272 GYPPF 276
G P+
Sbjct: 208 GSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 74/268 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRA-------KTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
++LTL +G+G FG+V + A A+K LK K + + SE
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 72
Query: 91 LLAEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL----SEDVARFYIA 145
++ + + I+ L + LY+I+EY G++ L S D+AR +
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR--VP 130
Query: 146 ESVLAIHSIHQHNY--------------VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191
+ + + Y +HRD+ N+++ +N +K++DFGL +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----- 185
Query: 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL--DYMAPEVLL 249
D+ N + +K+ +T G L +MAPE L
Sbjct: 186 ---------DVNN-----------------IDYYKK-------TTNGRLPVKWMAPEALF 212
Query: 250 KKGYGMECDWWSLGAIMYEML-IGYPPF 276
+ Y + D WS G +M+E+ +G P+
Sbjct: 213 DRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 20/66 (30%), Positives = 38/66 (57%)
Query: 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 177
E++ G + M +D +V + + + + + +H+ VHRDIKP+NL++ +G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 178 KLSDFG 183
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 40/189 (21%), Positives = 80/189 (42%), Gaps = 40/189 (21%)
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQH 157
I+ + F +L++I ++ G +LL + +SE + + ++ ++ +HQ+
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
Y+HR+IK ++++ +G + LS L YS + GQ
Sbjct: 121 GYIHRNIKASHILISGDGLVSLSG------LSHLYSLV---------------RNGQ--- 156
Query: 218 PKERLQQWKRNRRALAYSTVGT--LDYMAPEVLLKK--GYGMECDWWSLGAIMYEMLIGY 273
+ + + T L +++PE+L + GY ++ D +S+G E+ G
Sbjct: 157 ---------KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
Query: 274 PPFCSDDPR 282
PF D R
Sbjct: 208 VPF-QDMLR 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 43/230 (18%), Positives = 91/230 (39%), Gaps = 43/230 (18%)
Query: 45 LIGKGAFGEVRLCRAKT-TGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+G G+FG VR T G++ A+K LK ++ ++ E ++ +D ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLI 59
Query: 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVLAIHSIHQHNY 159
+L Y + L ++ E P G ++ L ++ + ++ Y + + + +
Sbjct: 60 RL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+ N++L + +K+ DFGL + L ++ + +E
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRAL-------PQNEDHYVMEE------------- 158
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+ + + APE L + + D W G ++EM
Sbjct: 159 --------HLKV-------PFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 46/190 (24%)
Query: 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKR----GQV 82
L R DDF +G+GAFG V K + K+ KK +LK+ G V
Sbjct: 123 GLFRPSFKKDDFVLGKKLGEGAFGVVY----KASL---VNKQSKKEGKYVLKKATEYGAV 175
Query: 83 EHVRSER--------------NLLAEVDSR-----CIV-------QLFYSFQDSDFLYLI 116
E +ER L V S+ +V L Q +F Y +
Sbjct: 176 EIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV 235
Query: 117 MEYLPG--GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-K 173
YL G D+ L RE+ + + + R + + A+ +H VHRD+KP N+I
Sbjct: 236 EPYLLGKVQDLPKGLERENKIIQTIMR----QILFALDGLHSTGIVHRDVKPQNIIFSEG 291
Query: 174 NGHLKLSDFG 183
+G K+ D G
Sbjct: 292 SGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 30/134 (22%), Positives = 53/134 (39%), Gaps = 39/134 (29%)
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL-EDKYSSILLEDEDIINQETV 208
+ +H+ +H+DI N ++D+ +K++D L + L Y L D +
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC--LGDNE------- 179
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
NR + +MA E L+ K Y D WS G +++E
Sbjct: 180 -------------------NR---------PVKWMALESLVNKEYSSASDVWSFGVLLWE 211
Query: 269 ML-IGYPPFCSDDP 281
++ +G P+ DP
Sbjct: 212 LMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 45/239 (18%), Positives = 94/239 (39%), Gaps = 53/239 (22%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMK---KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
+G+G FG V + + +K K K + R ++E SE + E D +++
Sbjct: 7 LGEGEFGSVM--EGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 103 LF-YSFQDSD-----FLYLIMEYLPGGDIMTLLMREDI------LSEDVARFYIAESVLA 150
L Q + +I+ ++ GD+ + L+ + L + ++ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ + +++HRD+ N +L++N ++ ++DFGL K + + D Q +++
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG---------DYYRQGRIAK 175
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+W +A E L + Y + D WS G M+E+
Sbjct: 176 MPVKW---------------------------IAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 31/118 (26%), Positives = 52/118 (44%), Gaps = 37/118 (31%)
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+ N++L +N +K+ DFGL + D Y +D D + + G +P
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR---DIY-----KDPDYVRK-------GDARLP- 238
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPF 276
L +MAPE + K Y + D WS G +++E+ +G P+
Sbjct: 239 --------------------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.87 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.76 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.4 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.19 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.78 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.77 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.6 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.57 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 97.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.51 | |
| PLN02236 | 344 | choline kinase | 97.36 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.09 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.02 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.95 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.85 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.76 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.57 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.39 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.39 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.25 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.19 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.83 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.57 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 95.41 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.31 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.47 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-104 Score=780.76 Aligned_cols=409 Identities=62% Similarity=1.035 Sum_probs=370.2
Q ss_pred hhhhcCCCHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhh
Q 013064 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ 81 (450)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~ 81 (450)
+++....+++.+...++.+..+|++|+|++|.+++++||+++++||+|+||.||+|+.+.||++||||+++|+.+.+.++
T Consensus 105 ~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q 184 (550)
T KOG0605|consen 105 KLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ 184 (550)
T ss_pred HHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh
Confidence 46677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEE
Q 013064 82 VEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 161 (450)
Q Consensus 82 ~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givH 161 (450)
++|++.|++||...++||||+||++|||.+++||||||+||||++++|.+.+.|+|++++||++++++||+.||++||||
T Consensus 185 v~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIH 264 (550)
T KOG0605|consen 185 VEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIH 264 (550)
T ss_pred HHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCcEEEccCCceEEeeccccccCccccccccccccccccccc--------ccc--ccccCCChHHHHHHHHhhccc
Q 013064 162 RDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET--------VSE--AEGQWMMPKERLQQWKRNRRA 231 (450)
Q Consensus 162 rDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (450)
|||||+|+|||..|||||+|||||+.+....-..... .+...+.. ... .....+.+...+.+|+++|+.
T Consensus 265 RDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~ 343 (550)
T KOG0605|consen 265 RDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR-LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQ 343 (550)
T ss_pred ccCChhheeecCCCCEeeccccccchhhhhhhhhhhc-chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhh
Confidence 9999999999999999999999997765432211100 00000111 111 112334477888999999999
Q ss_pred cccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHH
Q 013064 232 LAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 311 (450)
Q Consensus 232 ~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli 311 (450)
++++++|||+||||||+.+++|+..|||||||||+||||+|+|||.++++.+++++|++|+..+.+|....+|++|+|||
T Consensus 344 ~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI 423 (550)
T KOG0605|consen 344 LAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLI 423 (550)
T ss_pred hhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCC---
Q 013064 312 CHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLT--- 388 (450)
Q Consensus 312 ~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~--- 388 (450)
.+|||||.+|+|++|++||++||||++|+|+.|++..|||+|.+++++|++|||+|++.....+.....++++++..
T Consensus 424 ~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~ 503 (550)
T KOG0605|consen 424 TRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVD 503 (550)
T ss_pred HHHhcCHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccccCcccccCcccccccccchhhhhccc
Confidence 99999999999999999999999999999999999999999999999999999999988777666666666666544
Q ss_pred ----CcCCCcCCceeeCCccccccccC
Q 013064 389 ----SKDTNFIGYTFKKSDVLKSLENS 411 (450)
Q Consensus 389 ----~~~~~f~~~~~~~~~~~~~~~~~ 411 (450)
+++.+|+||||++++.++....+
T Consensus 504 ~~~~~~~~~FvgfTyk~~~~~~~~~~~ 530 (550)
T KOG0605|consen 504 TNNSSKDINFVGFTYKNFDGLNKANSL 530 (550)
T ss_pred ccCCcccccccceeeeccccccccccc
Confidence 66788999999999988766555
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-84 Score=616.96 Aligned_cols=328 Identities=45% Similarity=0.808 Sum_probs=287.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.++++||+++++||+|+||+|++|+.+.|++.||||+++|..+...+.++++++|++||..++|||||+|+++||+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|||+||++||+|+.+|++++.|+|+.|++|+++|++||.|||++|||||||||||||||.+|||+|+|||||+......
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~- 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG- 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999654321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
..+.++|||++|||||++.+.+|+.+||||||||++||||+|.
T Consensus 180 -------------------------------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~ 222 (357)
T KOG0598|consen 180 -------------------------------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK 222 (357)
T ss_pred -------------------------------------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence 1234689999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CCHHHHHcCCCcCCCCcccccc--ccC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEA 349 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~--~~~ 349 (450)
+||.+.+...++.+|.+.+ +..+. ..+|.+++|||++||. ||.+|+|. .++++|++||||++|||+.+.. +.|
T Consensus 223 pPF~~~~~~~~~~~I~~~k--~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~P 299 (357)
T KOG0598|consen 223 PPFYAEDVKKMYDKILKGK--LPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSP 299 (357)
T ss_pred CCCcCccHHHHHHHHhcCc--CCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCC
Confidence 9999999999999999854 22222 3599999999999998 99999984 4799999999999999999984 889
Q ss_pred CccccCCCcccCCCCCC-CCCCCCCCCCC---CCCCcccccCCCcCCCcCCceeeCC
Q 013064 350 AYKPTVNGELDTQNFEK-FPEVDGPPSEI---PSVGPWRKMLTSKDTNFIGYTFKKS 402 (450)
Q Consensus 350 p~~p~~~~~~d~~~f~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~~f~~~~~~~~ 402 (450)
||+|.+.+..|+++||. |+......... +...............|.||||..+
T Consensus 300 pF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~~ 356 (357)
T KOG0598|consen 300 PFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVAS 356 (357)
T ss_pred CeecCCCCccccccccHHHHhccccCCccccCcccccccccccccccccCCccccCC
Confidence 99999999999999996 33322211111 1101111122334456999999764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-82 Score=583.54 Aligned_cols=293 Identities=43% Similarity=0.884 Sum_probs=279.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
+.+++||+++++||.|+||+|.+|+++.+|..||||+++|..+.+..+++|+.+|+.+|+.+.||++++|+++|+|.+++
T Consensus 40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred CcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 38899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
||||||++||+|+++|++.++|+|..|+||++||++||+|||+++|+||||||||||||.+||+||+|||+|+.....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999976432
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
+.+.||||+|+|||++..++|+.++|||||||++|||+.|+
T Consensus 198 ---------------------------------------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 198 ---------------------------------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred ---------------------------------------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 56899999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--cc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--ME 348 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~ 348 (450)
+||.+.++..++.+|+. ..+.+|. .+|++++|||++||+ |-.+|.|. +|.++|++||||++++|+.+.+ ++
T Consensus 239 pPF~~~~~~~iY~KI~~--~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie 314 (355)
T KOG0616|consen 239 PPFYDDNPIQIYEKILE--GKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIE 314 (355)
T ss_pred CCCcCCChHHHHHHHHh--CcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhcccc
Confidence 99999999999999998 4578885 899999999999998 99999985 5899999999999999999984 88
Q ss_pred CCccc-cCCCcccCCCCCCCCCCC
Q 013064 349 AAYKP-TVNGELDTQNFEKFPEVD 371 (450)
Q Consensus 349 ~p~~p-~~~~~~d~~~f~~~~~~~ 371 (450)
+||.| .+..+.|++||+.+++..
T Consensus 315 ~P~~pp~~~~~gdtsnfd~y~e~~ 338 (355)
T KOG0616|consen 315 PPFEPPNIHGPGDTSNFDDYEEED 338 (355)
T ss_pred CCCCCccccCCccccccccccccc
Confidence 99988 889999999999987764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-81 Score=626.37 Aligned_cols=399 Identities=41% Similarity=0.751 Sum_probs=342.8
Q ss_pred hhhcCCCHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhH
Q 013064 3 AQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQV 82 (450)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~ 82 (450)
|..+++++.++++|+++|..+|+.|.|++|.|+..+-|..++.||-|+||+|.||+..+|...||||.+.|..++.++++
T Consensus 594 M~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQv 673 (1034)
T KOG0608|consen 594 MVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQV 673 (1034)
T ss_pred HHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhh
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEe
Q 013064 83 EHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162 (450)
Q Consensus 83 ~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHr 162 (450)
.|++.|++||...+++|||+||+.|||++++|+||||++|||++++|.+.+.|.|+.|+||++++.+|++++|+.|+|||
T Consensus 674 aHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHR 753 (1034)
T KOG0608|consen 674 AHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHR 753 (1034)
T ss_pred hhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccc-cccCCChHHHHHHH---Hhhcccccccccc
Q 013064 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA-EGQWMMPKERLQQW---KRNRRALAYSTVG 238 (450)
Q Consensus 163 DLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~s~~G 238 (450)
||||+|||||.+|||||+|||||+-+...+.+.....++-..+....-. +-....+....-.. +..+|.++.+.+|
T Consensus 754 DiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvg 833 (1034)
T KOG0608|consen 754 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVG 833 (1034)
T ss_pred ccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcC
Confidence 9999999999999999999999998776554443332222222221110 10111111111111 2345778889999
Q ss_pred CCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCc
Q 013064 239 TLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDV 318 (450)
Q Consensus 239 t~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp 318 (450)
|+.|+|||++...+|+..|||||.|||||||+.|++||...++.++..+|++|+..+.+|....+|.++.+||.+|.|++
T Consensus 834 t~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sa 913 (1034)
T KOG0608|consen 834 TPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSA 913 (1034)
T ss_pred CCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcCh
Confidence 99999999999999999999999999999999999999999999999999999999999998899999999999999999
Q ss_pred cccCCCCCHHHHHcCCCcCCCCccccccccCCccccCCCcccCCCCCCCCCCCCCCCC-CCCCCcccccCCCcCCCcCCc
Q 013064 319 ETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSE-IPSVGPWRKMLTSKDTNFIGY 397 (450)
Q Consensus 319 ~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~f~~~ 397 (450)
+.|+|..++++|+.||||++|||..|+...+||+|.++.+.|++|||.+.... .-.. ....+.+.....-.+.+|..|
T Consensus 914 d~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdpek-lwnddses~~~~~~~nkhpehaFyEF 992 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDPEK-LWNDDSESPNVRDTLNKHPEHAFYEF 992 (1034)
T ss_pred hhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCccccCCcCCccc-cccccccCCCcccccccCCccceeEe
Confidence 99999999999999999999999999999999999999999999999765321 1110 011111111112234579999
Q ss_pred eeeCC
Q 013064 398 TFKKS 402 (450)
Q Consensus 398 ~~~~~ 402 (450)
||+++
T Consensus 993 TfRrF 997 (1034)
T KOG0608|consen 993 TFRRF 997 (1034)
T ss_pred eeehh
Confidence 99987
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-80 Score=651.24 Aligned_cols=339 Identities=47% Similarity=0.827 Sum_probs=303.2
Q ss_pred HHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEE
Q 013064 26 EYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105 (450)
Q Consensus 26 ~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 105 (450)
-....+.-++..+||+++++||+|+||.|.+|+++.|+++||||+++|..++++.....++.|++||...+++|||.|++
T Consensus 63 ~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy 142 (1317)
T KOG0612|consen 63 IVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY 142 (1317)
T ss_pred HHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence 33456667889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+|||+.++||||||++||||.+++.+.++++|+.|+||+++|+.||..||+.|+|||||||+|||||..|||||+|||.|
T Consensus 143 AFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 143 AFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred HhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCcccccc
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWW 260 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~DiW 260 (450)
-.+..... ..+.+.||||+|+|||++.. ..||..||||
T Consensus 223 lkm~~dG~-------------------------------------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW 265 (1317)
T KOG0612|consen 223 LKMDADGT-------------------------------------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW 265 (1317)
T ss_pred HhcCCCCc-------------------------------------EEeccccCCCCccCHHHHHhhcCCccccCCccchh
Confidence 88764310 11235799999999999973 4589999999
Q ss_pred chhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCC
Q 013064 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
||||++||||+|.+||+.++..++|.+|++.+..+.||....+|++++|||++|||+|+.|+|.+|+++|+.||||.+++
T Consensus 266 SlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 266 SLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred hhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCC
Confidence 99999999999999999999999999999999999999878899999999999999999999999999999999999999
Q ss_pred ccccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCc
Q 013064 341 WDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 403 (450)
Q Consensus 341 w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 403 (450)
|+.+++..|||+|.++++.||+|||-...........+. ...+.....+.+|+||||....
T Consensus 346 W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~--~~~~~f~Gn~LPFIGfTy~~~~ 406 (1317)
T KOG0612|consen 346 WDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPP--RIPKAFSGNHLPFIGFTYTHES 406 (1317)
T ss_pred hhhhhhcCCCCCCcCCCCCccccccccccccchhhccCC--CCCCCCcCCcCCeeeeeeccch
Confidence 999999999999999999999999643222111111111 0112334578899999999743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-77 Score=609.30 Aligned_cols=325 Identities=37% Similarity=0.708 Sum_probs=290.1
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD 111 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~ 111 (450)
.++++++|.++++||+|+||+|+++..+.++++||||+++|..++.++.++.++.|+.|+...+ |||+++|+.+||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 5899999999999999999999999999999999999999999999999999999999999884 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
++|+||||+.||| +.+++..+.|+|..|+||+|+|++||.|||++||||||||.+|||||.+||+||+|||+|+.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999 555566789999999999999999999999999999999999999999999999999999975422
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
...+.|+||||+|||||++.+..|+.++|||||||+|||||+
T Consensus 522 --------------------------------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~ 563 (694)
T KOG0694|consen 522 --------------------------------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV 563 (694)
T ss_pred --------------------------------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc
Confidence 123568999999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE-- 346 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~-- 346 (450)
|.+||.|++.++.+..|++ ....+|. ++|.++.+++++||. +|++|+|+ +++++|+.||||+.|||+.|..
T Consensus 564 Gq~PF~gddEee~FdsI~~--d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~ 639 (694)
T KOG0694|consen 564 GESPFPGDDEEEVFDSIVN--DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRR 639 (694)
T ss_pred CCCCCCCCCHHHHHHHHhc--CCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhcc
Confidence 9999999999999999998 4566674 899999999999998 99999997 5799999999999999999984
Q ss_pred ccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCc
Q 013064 347 MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 403 (450)
Q Consensus 347 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 403 (450)
++|||+|.++++.|.+|||+-.+...+..+.+.. +.+....+..|.||+|.+.+
T Consensus 640 i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~---~~l~~~~q~~F~~Fs~~~~~ 693 (694)
T KOG0694|consen 640 IKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDP---RPLTEEEQEAFRDFSFVAEW 693 (694)
T ss_pred CCCCCCcccCChhhhcccchhhhcCCCccCCCCc---cccchhhHHHhcCccccCCC
Confidence 8999999999999999999733333322221111 11223355789999998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-73 Score=545.71 Aligned_cols=325 Identities=35% Similarity=0.614 Sum_probs=274.1
Q ss_pred HhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 30 ~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
.+...+.+++|++++.||.|.-|+||||+.+.++..+|||++.|..+..++.+.++..|++||+.++||+++.||..|++
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 35577999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+++.|+|||||+||||..+++++ ++|+|+.|+||+++++.||+|||.+||||||||||||||.++|||.|+||.|+..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999999999876 5899999999999999999999999999999999999999999999999999987
Q ss_pred Cccccccccccccc-cc-c-c-------ccccc-c--cccCC-C--hH---HHHHHH-HhhccccccccccCCCccchhh
Q 013064 188 LEDKYSSILLEDED-II-N-Q-------ETVSE-A--EGQWM-M--PK---ERLQQW-KRNRRALAYSTVGTLDYMAPEV 247 (450)
Q Consensus 188 ~~~~~~~~~~~~~~-~~-~-~-------~~~~~-~--~~~~~-~--~~---~~~~~~-~~~~~~~~~s~~Gt~~Y~APEv 247 (450)
.... +.+..... .. . + ....+ . ..... . .. .-.... ...-..+..++|||-+|+|||+
T Consensus 229 ~~~~--Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 229 CPVS--PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred CCCC--CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 6321 11110000 00 0 0 00000 0 00000 0 00 000000 0111234568999999999999
Q ss_pred hccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-C
Q 013064 248 LLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-R 325 (450)
Q Consensus 248 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~-~ 325 (450)
+.+.+++.+||||+|||+|||||+|.+||.|.+..+++.+|+. ..+.||..+.+|..|+|||++||. ||.+|+|. +
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r 384 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR 384 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--CCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc
Confidence 9999999999999999999999999999999999999999997 678999988999999999999998 99999996 6
Q ss_pred CHHHHHcCCCcCCCCccccccccCCccccCCCc
Q 013064 326 GVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGE 358 (450)
Q Consensus 326 ~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~ 358 (450)
|+.||+.||||++|+|.-++-..||++|...+.
T Consensus 385 GA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 385 GAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred chHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 899999999999999998888999999976543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-74 Score=535.95 Aligned_cols=330 Identities=38% Similarity=0.679 Sum_probs=291.1
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
.+.++.++||+.+++||+|.||+|.+|+.+.||+.||||+++|..++.++.+.|...|-++|+..+||++..|.++||+.
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 34578999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+.+|+||||+.||+|+.+|.+.+.|+|+.++||-++|++||.|||+++|||||||.||+|+|.+|||||+|||||+.-..
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999996433
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ..+.++||||+|+|||++....|+.++|||.+||++|||+
T Consensus 321 ~g--------------------------------------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm 362 (516)
T KOG0690|consen 321 YG--------------------------------------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM 362 (516)
T ss_pred cc--------------------------------------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence 21 1245799999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY-- 345 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~-- 345 (450)
+|+.||+..+...++..|+- ..+.||. .+|++|+.|+..||. ||.+|+|. .++.||..|+||++|+|..++
T Consensus 363 CGRLPFyn~dh~kLFeLIl~--ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~K 438 (516)
T KOG0690|consen 363 CGRLPFYNKDHEKLFELILM--EDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRK 438 (516)
T ss_pred hccCcccccchhHHHHHHHh--hhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHh
Confidence 99999999999999999987 5688885 899999999999998 99999986 358999999999999999887
Q ss_pred cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCC
Q 013064 346 EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 402 (450)
Q Consensus 346 ~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 402 (450)
++.|||+|.+.++.|+.+||. |+.......+....++..-........|.-|+|...
T Consensus 439 ki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~ 496 (516)
T KOG0690|consen 439 KIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSAS 496 (516)
T ss_pred ccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchhhhhccCCcceeeecc
Confidence 489999999999999999997 443221111111111111122233457888888764
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-72 Score=535.42 Aligned_cols=330 Identities=36% Similarity=0.667 Sum_probs=297.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 112 (450)
.+...||.++.+||+|+||+|.++..+.|.+.||||+++|..+++.+.++..+.|.++|... +.|++++|+..||+-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 46778999999999999999999999999999999999999999999999999999999987 57999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||||+.||||+.+++.-++|.|..|.||+++|+.||-|||++||||||||.+|||+|.+|||||+|||+|+.-...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~- 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD- 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999964322
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
...+.++||||.|+|||++..++|+.++||||+||+|||||.|
T Consensus 504 -------------------------------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaG 546 (683)
T KOG0696|consen 504 -------------------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 546 (683)
T ss_pred -------------------------------------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcC
Confidence 1235689999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--cc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EM 347 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~ 347 (450)
++||.|++..+++..|.. ....+|. .+|.+|.++++.+|. .|.+|+|. .+-.+|..||||+.|||+++. ++
T Consensus 547 QpPFdGeDE~elF~aI~e--hnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~ei 622 (683)
T KOG0696|consen 547 QPPFDGEDEDELFQAIME--HNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREI 622 (683)
T ss_pred CCCCCCCCHHHHHHHHHH--ccCcCcc--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccC
Confidence 999999999999999997 4577785 899999999999998 99999996 357899999999999999998 58
Q ss_pred cCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCcccccc
Q 013064 348 EAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSL 408 (450)
Q Consensus 348 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~ 408 (450)
+|||+|.++-..+.+|||++.+...+..+.+. ...|..-++..|.||+|.|++++...
T Consensus 623 qPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD---~~v~~nldq~eF~gFsfvNpefv~~~ 680 (683)
T KOG0696|consen 623 QPPFKPKIKCGRDAENFDKFFTREPTDLTPPD---KLVMMNLDQSEFEGFSFVNPEFVKPI 680 (683)
T ss_pred CCCCCCccccCCchhhhhHHHhcCCCCCCCch---HHHHhcCchhhcCceeeeChhhcCCC
Confidence 99999999999999999997665544333222 12344557789999999999887654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-69 Score=535.81 Aligned_cols=285 Identities=36% Similarity=0.687 Sum_probs=258.5
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 112 (450)
+.+.+||.+.+.||.|+|++|++|+.+.|++.||||++.|..+++...++.+.+|+++|..| .||.|++||.+|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 77889999999999999999999999999999999999999999999999999999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+|+||+++|||.++|.+.+.|+|..+++|++||+.||+|||++|||||||||||||||.+||+||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999887542
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
... +...... + ......++|||..|++||+|.+...+..+|+|+||||||.|+.|
T Consensus 229 ~~~----------~~~~~~~------------~---a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 229 KSQ----------ENPVDPN------------Q---ASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred ccc----------cCccCcc------------c---ccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 210 0000000 0 01113479999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 350 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p 350 (450)
.+||.+.+...++++|+. ....|| +.+++.++|||++||. ||.+|+ ++++|++||||++|||+.|.+..||
T Consensus 284 ~PPFra~NeyliFqkI~~--l~y~fp--~~fp~~a~dLv~KLLv~dp~~Rl---t~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 284 QPPFRAANEYLIFQKIQA--LDYEFP--EGFPEDARDLIKKLLVRDPSDRL---TSQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred CCCCccccHHHHHHHHHH--hcccCC--CCCCHHHHHHHHHHHccCccccc---cHHHHhhCcccccCChhhhhhcCCC
Confidence 999999999999999997 345666 4899999999999998 999999 5799999999999999999986654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-66 Score=495.99 Aligned_cols=264 Identities=32% Similarity=0.553 Sum_probs=238.1
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR----GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~----~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
..+.|.+.+.||+|+||.|.+|..+.||+.||||+++|...... .....+.+|++||++|+||+||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34678888999999999999999999999999999998876542 23455789999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC---CceEEeeccccccC
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLKLSDFGLCKPL 188 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~---g~ikL~DFGla~~~ 188 (450)
+.||||||+.||+|++.+..++.+.|+..+.|+.||+.||.|||++||+||||||||||+..+ .++||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999765 78999999999987
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC---CccccccchhHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY---GMECDWWSLGAI 265 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y---~~~~DiWSlGvi 265 (450)
... ....|+||||.|.|||++.++++ ..++|+|||||+
T Consensus 330 g~~---------------------------------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcv 370 (475)
T KOG0615|consen 330 GEG---------------------------------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCV 370 (475)
T ss_pred ccc---------------------------------------eehhhhcCCccccChhheecCCeecccchheeeeccce
Confidence 542 12457999999999999998764 568899999999
Q ss_pred HHHHhhCCCCCCCCChhh-hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 266 MYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
||-+|+|++||.+..... +..+|.+++..+.-+.|..+|+++.|||.+||. ||++|+ +++|+|+||||+.++-
T Consensus 371 LfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~---s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 371 LFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP---SADEALNHPWFKDAPC 445 (475)
T ss_pred EEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc---CHHHHhcChhhhcccc
Confidence 999999999999876666 788999888777777788999999999999998 999999 7899999999998663
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-67 Score=512.64 Aligned_cols=302 Identities=36% Similarity=0.697 Sum_probs=285.6
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
.-..+.+++++++..||-||||.|=+|+.+.....+|+|+++|..+....+.+|+..|++||..+.+||||+||-+|.|+
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS 492 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence 44668899999999999999999999998877777999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+++||+||-|-||+|++.|++++.|++..++||++.++.|++|||++|||||||||||+|+|.+|.+||.|||+|+.+..
T Consensus 493 kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
. ..+.++||||+|+|||++.+++++.++|+||||+++||||
T Consensus 573 g---------------------------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL 613 (732)
T KOG0614|consen 573 G---------------------------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELL 613 (732)
T ss_pred C---------------------------------------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHH
Confidence 4 2355899999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCC--CCCHHHHHcCCCcCCCCccccc--
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGIQWDKLY-- 345 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~--~~~~~eil~Hpff~~i~w~~l~-- 345 (450)
+|.|||.+.++..+|..|+++...+.+|. .++..+.+||++|.. +|.+|+| .+++.+|++|.||.++||+.|+
T Consensus 614 ~G~pPFs~~dpmktYn~ILkGid~i~~Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~ 691 (732)
T KOG0614|consen 614 TGSPPFSGVDPMKTYNLILKGIDKIEFPR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSR 691 (732)
T ss_pred cCCCCCCCCchHHHHHHHHhhhhhhhccc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhc
Confidence 99999999999999999999988899994 899999999999987 9999999 5789999999999999999988
Q ss_pred cccCCccccCCCcccCCCCCCCCCCCCC
Q 013064 346 EMEAAYKPTVNGELDTQNFEKFPEVDGP 373 (450)
Q Consensus 346 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~ 373 (450)
.+.||++|.+.++.|++|||.||.....
T Consensus 692 ~L~pPi~~~va~ptD~s~Fd~~p~dnd~ 719 (732)
T KOG0614|consen 692 TLPPPIIPSVANPTDVSNFDNFPPDNDE 719 (732)
T ss_pred cCCCCccccCCCcccchhccCCCcccCC
Confidence 4899999999999999999999865543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-65 Score=480.83 Aligned_cols=329 Identities=31% Similarity=0.624 Sum_probs=282.1
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
...++++||.++++||+|+|++|.+|+++.|.+.||||+++|.-+...+.++-+..|+.+..+. +||++|.|+.+||++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3568999999999999999999999999999999999999999888888899999999999876 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..+++|.||++||||+.++++++.++|+.|+||.++|++||.|||++|||+||||.+|+|||..|||||+|+|+|+....
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997432
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
. ...+.++||||.|+|||++++..|+.++|||+|||++|||+
T Consensus 404 ~--------------------------------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 404 P--------------------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred C--------------------------------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 2 12245799999999999999999999999999999999999
Q ss_pred hCCCCCCC---C----Chhh-hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CCHHHHHcCCCcCC
Q 013064 271 IGYPPFCS---D----DPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~---~----~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~---~~~~eil~Hpff~~ 338 (450)
.|+.||.- . +..+ ++.-|+. ..+.+|. .+|-.|..+++..|. ||.+|+|. .++.+++.||||+.
T Consensus 446 agrspfdivgm~n~d~ntedylfqvile--kqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 446 AGRSPFDIVGMDNPDMNTEDYLFQVILE--KQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred cCCCCcceecCCCcccchhHHHHHHHhh--hcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99999952 1 2222 3344444 3466664 789999999999998 99999996 37999999999999
Q ss_pred CCcccccc--ccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCccc
Q 013064 339 IQWDKLYE--MEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 405 (450)
Q Consensus 339 i~w~~l~~--~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 405 (450)
|||+.+.+ +.|||.|.+.++.+..|||...+.+.+..+.......+ .-++..|.||.|.|+-.+
T Consensus 522 idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~---ridqsefegfeyinpl~m 587 (593)
T KOG0695|consen 522 IDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIK---RIDQSEFEGFEYINPLLM 587 (593)
T ss_pred CCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCHHHHH---hcchhhcCcceecchhhc
Confidence 99999985 77999999999999999997433333222221111122 235568999999997443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-62 Score=496.22 Aligned_cols=364 Identities=56% Similarity=1.004 Sum_probs=299.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|..++||||++++++|+++.++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 58999999999999999999999999999999999876666667788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999865432111000
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
...........................|...++....+.+||+.|+|||++.+.+|+.++|+|||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 00000000000000001111223334455555556667899999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCCccccCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~ 357 (450)
+.+..+.+.++.++...+.+|....+|+++++||.+||++|.+|++..++++++.||||++++|+.+....+|+.|.+.+
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~ 320 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPELKS 320 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCCCC
Confidence 99988888899888777888876678999999999999999999976679999999999999999998888999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCc
Q 013064 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSD 403 (450)
Q Consensus 358 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~ 403 (450)
..|.++|+.+++........+ +.......+++..|+||+|++++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 321 ITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred chhhhhccccccccccccCCC--ccccccccccCCCCCCCeeeCCC
Confidence 999999998776543322221 11122345678899999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-64 Score=489.83 Aligned_cols=298 Identities=36% Similarity=0.671 Sum_probs=265.5
Q ss_pred HHHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEE
Q 013064 25 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104 (450)
Q Consensus 25 ~~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 104 (450)
-+|--++.++++.+.|...++||+||||.||-|+.+.||+.||+|.+.|..+.++.......+|+.||++++.+|||.|-
T Consensus 172 lQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsla 251 (591)
T KOG0986|consen 172 LQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLA 251 (591)
T ss_pred HHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEe
Confidence 34455667899999999999999999999999999999999999999999988888888999999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 105 YSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 105 ~~f~~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
++|++.+.+||||..|.||||..+|.+.+ .|+|..++||++||++||++||+.+||||||||+|||+|+.|||+|+|+
T Consensus 252 YAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 252 YAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred eeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeecc
Confidence 99999999999999999999999998766 8999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|||..+..... ....+||..|||||++.++.|+.++|||||
T Consensus 332 GLAvei~~g~~---------------------------------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l 372 (591)
T KOG0986|consen 332 GLAVEIPEGKP---------------------------------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSL 372 (591)
T ss_pred ceEEecCCCCc---------------------------------------cccccCcccccCHHHHcCCcccCCccHHHH
Confidence 99998765421 124599999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChh----hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCC
Q 013064 263 GAIMYEMLIGYPPFCSDDPR----ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPW 335 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpf 335 (450)
||+||||+.|+.||...... +.-+++.+ ...++|+ .+|+++++|++.||+ ||++|+|.+ +++++++|||
T Consensus 373 GCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf 448 (591)
T KOG0986|consen 373 GCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF 448 (591)
T ss_pred HhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence 99999999999999764332 33444554 4466664 899999999999998 999999974 6999999999
Q ss_pred cCCCCccccc--cccCCccccCC-----CcccCCCCC
Q 013064 336 FRGIQWDKLY--EMEAAYKPTVN-----GELDTQNFE 365 (450)
Q Consensus 336 f~~i~w~~l~--~~~~p~~p~~~-----~~~d~~~f~ 365 (450)
|+++||..+. .++|||+|... +.+|..+|+
T Consensus 449 Fk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs 485 (591)
T KOG0986|consen 449 FKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFS 485 (591)
T ss_pred cccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcc
Confidence 9999999998 48999999753 455666665
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-62 Score=493.73 Aligned_cols=362 Identities=51% Similarity=0.916 Sum_probs=288.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.++..++||||+++++.|++...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999999877666667788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+++.+.+.+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999999899999999999999999999999999999999999999999999999999999865432111000
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
............. ...........|+.++.....+.+||+.|+|||++.+.+|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 161 RNLNHSLPSDFTF---QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccc---cccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0000000000000 0000001111233333334456799999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCCccccCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~ 357 (450)
+.+..+.+.+|..+...+.+|....+|+++++||.+|+++|.+|+++.++++|++||||++++|+.+....++..+.+.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (363)
T cd05628 238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKS 317 (363)
T ss_pred CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 99999999999987777778876678999999999998888999887789999999999999999998766666677788
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCC
Q 013064 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 402 (450)
Q Consensus 358 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 402 (450)
..|+++|+.++..............-.......+..|.||||+.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (363)
T cd05628 318 IDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKRF 362 (363)
T ss_pred cchhhccCCCCccccccccccccCCcccccCcCCcccCCceeecC
Confidence 889999998875543322211110001112334456999999843
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-62 Score=495.00 Aligned_cols=255 Identities=35% Similarity=0.590 Sum_probs=242.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
.+|...+.||+|||++||.+++..+|+.||+|++.|..+.+..+.+.+.+|++|.+.|+|||||++|.+|+|.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|+|+.|+|+.++++.+.++|.+|++|+.||+.||.|||+++|||||||..|++|+++-+|||+|||||..+.....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E---- 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE---- 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
+..|.||||.|+||||+.+.+++..+||||+||+||-||+|+|||.
T Consensus 174 ----------------------------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe 219 (592)
T KOG0575|consen 174 ----------------------------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE 219 (592)
T ss_pred ----------------------------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence 1347999999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
..+..+++.+|.. ....+|. .+|.+|+|||.+||. ||.+|| ++++|+.|+||+
T Consensus 220 tk~vkety~~Ik~--~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rp---sl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 220 TKTVKETYNKIKL--NEYSMPS--HLSAEAKDLIRKLLRPNPSERP---SLDEVLDHPFFK 273 (592)
T ss_pred cchHHHHHHHHHh--cCccccc--ccCHHHHHHHHHHhcCCcccCC---CHHHHhcCHhhh
Confidence 9999999999987 4566775 899999999999998 999999 799999999993
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-61 Score=486.72 Aligned_cols=364 Identities=43% Similarity=0.783 Sum_probs=286.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+++.||+|++.+..........++.+|+.+++.++|||||+++++|++++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999999877666777889999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+++.+.+.+++..++++++||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998754321111000
Q ss_pred cccccccccc--cccc--------cccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 198 EDEDIINQET--VSEA--------EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 198 ~~~~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
...+...... .... ......+..+. ..+........+.+||+.|+|||++.+.+|+.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR-AARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhh-hccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 0000000000 0000 00000000000 00011122234678999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCcccc-cc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKL-YE 346 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l-~~ 346 (450)
||++|.+||.+.++.+...++.++...+.+|....+++++++||.+|+.+|.+|++..++++++.||||++++|... .+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 319 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQ 319 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHHHHhc
Confidence 99999999999998888888888877788887778999999999998779999998777999999999999999874 46
Q ss_pred ccCCccccCCCcccCCCCCCCCCCCCC---CC--C-CCCCCcccccCCCcCCCcCCceeeCC
Q 013064 347 MEAAYKPTVNGELDTQNFEKFPEVDGP---PS--E-IPSVGPWRKMLTSKDTNFIGYTFKKS 402 (450)
Q Consensus 347 ~~~p~~p~~~~~~d~~~f~~~~~~~~~---~~--~-~~~~~~~~~~~~~~~~~f~~~~~~~~ 402 (450)
..+|+.|.+..+.|+++|+.+...... .. . ......|.+....++..|.||||+.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (382)
T cd05625 320 QSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTFRRF 381 (382)
T ss_pred CCCCccCcCCCcchhhhcCCCCccccccccccccccccccccccccccccCcccccceeccc
Confidence 788999999999999999875432110 00 0 01111223334456678999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=484.07 Aligned_cols=366 Identities=50% Similarity=0.919 Sum_probs=289.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|.+++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.++..++|||||+++++|+++.++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 58999999999999999999999999999999998876656667788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc--
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI-- 195 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~-- 195 (450)
||++||+|..++.+.+.+++..++.|+.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999997543211000
Q ss_pred --cccccccccc----ccc-ccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 196 --LLEDEDIINQ----ETV-SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 196 --~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
.......... ... ................|..++.....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0000000000 000 000000000111122333333334446789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCcccccccc
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEME 348 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~ 348 (450)
|++|.+||.+.+..+.+.+|..+...+.+|....++.++++||.+||++|.+|+++.++.+++.||||++++|+.+....
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~ 320 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIR 320 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHHHccCC
Confidence 99999999998888888889887777888876679999999999999999999887789999999999999999999999
Q ss_pred CCccccCCCcccCCCCCCCCCCCCCCCCCCCCC--cccccCCCcCCCcCCceeeCCc
Q 013064 349 AAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVG--PWRKMLTSKDTNFIGYTFKKSD 403 (450)
Q Consensus 349 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~f~~~~~~~~~ 403 (450)
+|+.|.+....+..+|........+..+..... .........+.+|+||||++++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (377)
T cd05629 321 APFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRFD 377 (377)
T ss_pred CCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCCC
Confidence 999999988888887764332221111111100 0112234456789999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-61 Score=481.64 Aligned_cols=359 Identities=53% Similarity=0.939 Sum_probs=288.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+.++..++||||++++++|++++++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998877666677888999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+++.+.+.+++..++.|++|++.||+|||++||+||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999865432111000
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.... .... ................|..++.....+.+||+.|+|||++.+.+|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 161 RNLT--HNPP-SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccc--cCCc-ccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0000 0000 000000000001111233333444567899999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCCccccCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~ 357 (450)
+.+....+.++..+...+.+|....+|+++++||.+|+.||.+|+++.++++++.||||++++|..+....++..+.+.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (360)
T cd05627 238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKS 317 (360)
T ss_pred CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCC
Confidence 99998899999887777777766678999999999976799999998789999999999999999998766665567788
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCC
Q 013064 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 402 (450)
Q Consensus 358 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 402 (450)
..|.++|+.+++............ .-..+++-.|.+|+|...
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 359 (360)
T cd05627 318 IDDTSNFDEFPESDILQPAENTIE---PDYKSKDWVFLNYTYKRF 359 (360)
T ss_pred cchhhhcCCCCcccccCCCccccc---cccCcCCcccCCceeecC
Confidence 889999998776543322211111 122456667999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-59 Score=474.57 Aligned_cols=365 Identities=41% Similarity=0.766 Sum_probs=278.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||+|+||+||+|+++.+++.||+|++.+..........++.+|+.+|..++||||++++++|.+.+++|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999999877767777889999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+||||+.+|++||+|||+++.+.........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999998755322111000
Q ss_pred cccccccccccc-----cccc--c--CCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 198 EDEDIINQETVS-----EAEG--Q--WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 198 ~~~~~~~~~~~~-----~~~~--~--~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
..+......... .... . ..................+.+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000000000000 0000 0 000000000000111223456799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccc-cc
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY-EM 347 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~-~~ 347 (450)
|++|.+||.+.+..+...+++.+...+.+|....+++++++||.+||+.+.+|.++.+++++++||||.+++|.... ..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~~~~~ 320 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQ 320 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHHhhcC
Confidence 99999999998888888888877666777776679999999999998744444444479999999999999998754 46
Q ss_pred cCCccccCCCcccCCCCCCCCCCCCCCCCCCC-CCccccc----CCCcCCCcCCceeeCC
Q 013064 348 EAAYKPTVNGELDTQNFEKFPEVDGPPSEIPS-VGPWRKM----LTSKDTNFIGYTFKKS 402 (450)
Q Consensus 348 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~f~~~~~~~~ 402 (450)
.+|+.|.+..+.++++|+...+.......... ...+... .......|.||||+.+
T Consensus 321 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (381)
T cd05626 321 PAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRRF 380 (381)
T ss_pred CCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeecc
Confidence 78999999999999999875433211111110 0111111 1122468999999854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-58 Score=465.08 Aligned_cols=330 Identities=47% Similarity=0.870 Sum_probs=268.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+|..++||||+++++.|++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999998754321111000
Q ss_pred cccccccccccccc-----cc-cCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 198 EDEDIINQETVSEA-----EG-QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 198 ~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
.............. .. ....+..+ ............+.+||+.|+|||++.+.+++.++|||||||++|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLER-RRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhh-hhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 00000000000000 00 00000000 0000011122335789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccc-cccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY-EMEAA 350 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~-~~~~p 350 (450)
|..||.+.+..+...++..+...+.+|....+++++.+||.+|+.+|.+|++..+++++++||||++++|..+. ...+|
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~~ 319 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAP 319 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCCC
Confidence 99999999888888888877777777766689999999999987799999987789999999999999999884 57789
Q ss_pred ccccCCCcccCCCCCCCC
Q 013064 351 YKPTVNGELDTQNFEKFP 368 (450)
Q Consensus 351 ~~p~~~~~~d~~~f~~~~ 368 (450)
+.|.+..+.+.++|+...
T Consensus 320 ~~~~~~~~~~~~~~~~~~ 337 (376)
T cd05598 320 YIPKITHPTDTSNFDPVD 337 (376)
T ss_pred CCCcCCCcchhhhcCCCC
Confidence 999999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-58 Score=456.57 Aligned_cols=295 Identities=43% Similarity=0.807 Sum_probs=265.0
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
......+++|++.+.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|..+|+.++||||++++++|.++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 34567789999999999999999999999999999999999887666666678899999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+.+|+||||++||+|.+++.+.+.++++.++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
. ..+.+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 171 ~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 171 R-----------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred C-----------------------------------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 2 12468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc-
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE- 346 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~- 346 (450)
+|..||.+.+....+.++... .+.+|. .++..+++||.+||. ||.+|+++ .++++++.||||++++|+.+..
T Consensus 210 tg~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~ 285 (329)
T PTZ00263 210 AGYPPFFDDTPFRIYEKILAG--RLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR 285 (329)
T ss_pred cCCCCCCCCCHHHHHHHHhcC--CcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence 999999998888888888764 345553 689999999999998 99999974 4589999999999999998874
Q ss_pred -ccCCccccCCCcccCCCCCCCCCC
Q 013064 347 -MEAAYKPTVNGELDTQNFEKFPEV 370 (450)
Q Consensus 347 -~~~p~~p~~~~~~d~~~f~~~~~~ 370 (450)
..+|+.+.+....+..+|+.+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~s 310 (329)
T PTZ00263 286 YYPAPIPVRVKSPGDTSNFEKYPDS 310 (329)
T ss_pred CCCCCcCCCCCCcccchhccCCccc
Confidence 567888888888889999887643
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=460.06 Aligned_cols=331 Identities=43% Similarity=0.841 Sum_probs=277.5
Q ss_pred HHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 28 MRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 28 ~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
..+++..+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|
T Consensus 33 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (370)
T cd05621 33 RKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF 112 (370)
T ss_pred HHHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 44566677889999999999999999999999999999999999887665555667788999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
.+++.+|+|||||+||+|.+++... .+++..+++++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 113 QDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999999999998654 689999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC----CCccccccchh
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWWSLG 263 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~----y~~~~DiWSlG 263 (450)
...... ....+.+||+.|+|||++.+.+ ++.++||||||
T Consensus 192 ~~~~~~-------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05621 192 MDETGM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred cccCCc-------------------------------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeeh
Confidence 542210 0122568999999999997643 78999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCc--
Q 013064 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQW-- 341 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w-- 341 (450)
|++|+|++|.+||.+.+....+.+|......+.+|....+++.+++||.+||+++.+|+++.+++++++||||++..|
T Consensus 235 ~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~~ 314 (370)
T cd05621 235 VFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNW 314 (370)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcCh
Confidence 999999999999999998888888887666677787667899999999999997777776668999999999998655
Q ss_pred cccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 342 DKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 342 ~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
..+....+|+.|.+....|.++|+............+. + +....+ +..|.||+|.
T Consensus 315 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~-~~~~~~~~~~ 369 (370)
T cd05621 315 DNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPI--P-KAFVGN-QLPFIGFTYY 369 (370)
T ss_pred HhcCCCCCCcCCCCCCcchhhhcCCccccccccccCCC--C-cccccc-ccccCCCEec
Confidence 45556778999999999999999865443221111111 1 112223 5789999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-58 Score=460.21 Aligned_cols=350 Identities=51% Similarity=0.935 Sum_probs=285.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+|+.||+|++++...........+..|+.++..++||||++++++|++++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 58999999999999999999999999999999999887666677888999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++............
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876543210000
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.... ........... .......+.......+||+.|+|||++.+..++.++|+|||||++|||++|..||.
T Consensus 161 ~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 161 LNDS-HNLLFRDNVLV--------RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccc-ccccccccccc--------cccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 0000 00000000000 00000111122345689999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCCccccCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNG 357 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~ 357 (450)
+.+....+.++..+...+.+|....+++++++||.+||+||.+|++ +++++++||||++++|+......+|+.|.+.+
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~ 309 (350)
T cd05573 232 SDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLG--SFEEIKSHPFFKGIDWENLRETKPPFVPELSS 309 (350)
T ss_pred CCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCC
Confidence 9998888889998877888887777899999999999999999994 29999999999999999999888999999999
Q ss_pred cccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 358 ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 358 ~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
..+..+|+........... ......+.......+|.||+|+
T Consensus 310 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 350 (350)
T cd05573 310 PLDTSNFDDFEDDKDLSDY--LSQNSKKLNKGKQLAFVGFTYK 350 (350)
T ss_pred chhhhhcCCCCcccccccc--cccccccccccccCccCCCccC
Confidence 9999999886644322111 1111222334456789999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-58 Score=441.62 Aligned_cols=259 Identities=33% Similarity=0.597 Sum_probs=237.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+.+|++.+.||+|+||.||+++++.++..+|||.+.+..+ .+...+.+..|+.||+.++|||||.|+++..+++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 46899999999999999999999999999999999998875 56678889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC------CceEEeeccccccCc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN------GHLKLSDFGLCKPLE 189 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~------g~ikL~DFGla~~~~ 189 (450)
|||||.||||..||++.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999764 468999999999886
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
.. .++.+.||+|.||||||+..+.|+.++|+||+|+|||+|
T Consensus 167 ~~---------------------------------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~ 207 (429)
T KOG0595|consen 167 PG---------------------------------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC 207 (429)
T ss_pred ch---------------------------------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence 53 235579999999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|++||...+..+.+..|.+.......+. ..+++...+|+..+|+ +|..|. +.++...|||...
T Consensus 208 l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~---~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 208 LTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRI---SFEDFFDHPFLAA 273 (429)
T ss_pred HhCCCCccccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccC---chHHhhhhhhccc
Confidence 999999999999999998887766665554 4678888899999998 999999 5788889998765
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-57 Score=457.24 Aligned_cols=331 Identities=44% Similarity=0.839 Sum_probs=279.6
Q ss_pred HHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 29 ~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
..+...+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|+
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35566788899999999999999999999999999999999998876655566677889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
++.++|+||||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|...
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999999999988654 5899999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC----CCccccccchhH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWWSLGA 264 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~----y~~~~DiWSlGv 264 (450)
..... ....+.+||+.|+|||++.+.+ |+.++|||||||
T Consensus 193 ~~~~~-------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGv 235 (371)
T cd05622 193 NKEGM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 235 (371)
T ss_pred CcCCc-------------------------------------ccccCcccCccccCHHHHhccCCCccCCCccceeehhH
Confidence 42210 0112468999999999997643 789999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCC--cc
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQ--WD 342 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~--w~ 342 (450)
++|||++|.+||.+.+....+.+|......+.+|....+|..+++||.+||.+|..|+++.++++|++||||++.+ |.
T Consensus 236 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~~~ 315 (371)
T cd05622 236 FLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 315 (371)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChhHH
Confidence 9999999999999999888888988766667788777899999999999999888888777899999999999855 55
Q ss_pred ccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeC
Q 013064 343 KLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 343 ~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
.+....+|+.|.+.+..+.++|+............+. .......+..|.||+|.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 370 (371)
T cd05622 316 TLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPI----PKAFVGNQLPFVGFTYYS 370 (371)
T ss_pred hcCCCCCCCCCCCCCcchhhhcCCCcccccccccCCC----CccccccccccCCCeecC
Confidence 6667889999999999999999875543322121111 111222357899999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=451.48 Aligned_cols=316 Identities=38% Similarity=0.643 Sum_probs=264.0
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
+.||+|+||.||+|+++.+|+.||+|++++..........++.+|..+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999999876656666778889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccc
Q 013064 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203 (450)
Q Consensus 124 ~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~ 203 (450)
+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----------- 149 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----------- 149 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----------
Confidence 999999998999999999999999999999999999999999999999999999999999987532210
Q ss_pred cccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhh
Q 013064 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283 (450)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 283 (450)
......+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.+...
T Consensus 150 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 202 (323)
T cd05571 150 ---------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (323)
T ss_pred ---------------------------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH
Confidence 01124689999999999999999999999999999999999999999888877
Q ss_pred hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCccccc--cccCCccccCCCc
Q 013064 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGE 358 (450)
Q Consensus 284 ~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~ 358 (450)
....+... ...+|. .+++++++||.+||. ||.+|++.. ++.++++||||.+++|..+. ...||+.|.+...
T Consensus 203 ~~~~~~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05571 203 LFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSE 278 (323)
T ss_pred HHHHHHcC--CCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCc
Confidence 77777653 345553 799999999999998 999999642 59999999999999999887 4678999999999
Q ss_pred ccCCCCCCCCCCCCCCCCCCCCCcccc-cCCCcCCCcCCceeeC
Q 013064 359 LDTQNFEKFPEVDGPPSEIPSVGPWRK-MLTSKDTNFIGYTFKK 401 (450)
Q Consensus 359 ~d~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~f~~~~~~~ 401 (450)
.++.+|+...+........+....... ...+....|.+|+|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05571 279 TDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSYSA 322 (323)
T ss_pred chhhhcCcccccCCcccCCCCcccccccccccccccCCCCeeeC
Confidence 999988752222111111111000000 1123456799998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=453.33 Aligned_cols=323 Identities=46% Similarity=0.802 Sum_probs=276.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+..|+.+++.++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 57999999999999999999999999999999999876655566778899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999876 68999999999999999999999999999999999999999999999999999865432100
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc------cCCCCccccccchhHHHHHHh
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~------~~~y~~~~DiWSlGvilyeml 270 (450)
.....+||+.|+|||++. ...++.++|+|||||++|||+
T Consensus 159 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~ 203 (330)
T cd05601 159 -----------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203 (330)
T ss_pred -----------------------------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec
Confidence 012357999999999997 456789999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 350 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p 350 (450)
+|..||.+.+....+.+|.+....+.+|....+++++++||.+||++|.+|+ ++++++.||||..++|..+....||
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~---t~~~l~~h~~~~~~~~~~~~~~~~~ 280 (330)
T cd05601 204 YGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERL---GYEGLCCHPFFSKIDWNNIRNSLPP 280 (330)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCC---CHHHHhCCCCcCCCCHHHHhhCCCC
Confidence 9999999988888888888766667778777899999999999999999999 6899999999999999999988899
Q ss_pred ccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 351 YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 351 ~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
+.|.+....|.++|+...................+..+.++..|+||+|.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (330)
T cd05601 281 FVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSFI 330 (330)
T ss_pred ccCcCCCcchhhhcCCCccccccccccccccCCCcCCCCCCCCccCceeC
Confidence 99999999999999764433222111111111122335677899999883
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-57 Score=454.29 Aligned_cols=295 Identities=39% Similarity=0.791 Sum_probs=263.4
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCC-CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~-~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+...+..++|++++.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.++||||++++++|.+
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 445678899999999999999999999977665 6899999988776666677889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
.. ..+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 183 ~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 221 (340)
T PTZ00426 183 TR-----------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221 (340)
T ss_pred CC-----------------------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHH
Confidence 21 1246899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc-
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY- 345 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~- 345 (450)
++|.+||.+.+....+.++... ...+|. .+++.+++||++||. ||.+|++. .+++++++||||++++|..+.
T Consensus 222 l~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~ 297 (340)
T PTZ00426 222 LVGCPPFYANEPLLIYQKILEG--IIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLH 297 (340)
T ss_pred hcCCCCCCCCCHHHHHHHHhcC--CCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 9999999998888888888763 344553 689999999999998 99999864 379999999999999999877
Q ss_pred -cccCCccccCCCcccCCCCCCCCCC
Q 013064 346 -EMEAAYKPTVNGELDTQNFEKFPEV 370 (450)
Q Consensus 346 -~~~~p~~p~~~~~~d~~~f~~~~~~ 370 (450)
...+|+.|......+.++|+...+.
T Consensus 298 ~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (340)
T PTZ00426 298 KNVEVPYKPKYKNVFDSSNFERVQED 323 (340)
T ss_pred CCCCCCcCCCCCCCcchhhcCCCccc
Confidence 4679999999998888888765443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-56 Score=452.12 Aligned_cols=328 Identities=43% Similarity=0.834 Sum_probs=273.3
Q ss_pred HhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 30 ~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||++++++|.+
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred hccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 44566888999999999999999999999999999999999988766555666778899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+.++|+||||++||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999999998865 468999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC----CCCccccccchhHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK----GYGMECDWWSLGAI 265 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~----~y~~~~DiWSlGvi 265 (450)
.... ....+.+||+.|+|||++.+. .++.++|+|||||+
T Consensus 194 ~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvi 236 (370)
T cd05596 194 ANGM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred CCCc-------------------------------------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHH
Confidence 2200 011246899999999999753 37899999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc-
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK- 343 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~- 343 (450)
+|||++|.+||.+.+....+.+|......+.+|....+|.++++||++||. +| +|+++.+++++++||||++.+|..
T Consensus 237 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p-~r~~R~s~~ell~h~~~~~~~~~~~ 315 (370)
T cd05596 237 LYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDRE-VRLGRNGVDEIKSHPFFKNDQWTFD 315 (370)
T ss_pred HHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChh-hccCCCCHHHHhcCcccCCCChhhH
Confidence 999999999999999888888888766677788767899999999999998 66 444444899999999999988864
Q ss_pred -cccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 344 -LYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 344 -l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
+....+|+.|.+.+..++.+|+............. .+ +.. ......|.||+|.
T Consensus 316 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~-~~~~~~~~~~~~~ 369 (370)
T cd05596 316 NIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETFP--LP-KAF-AGNQLPFIGFTYS 369 (370)
T ss_pred HhcCCCcCccCcCCCcchhhhcCCccccccccccCC--Cc-ccc-ccccCccCCCeec
Confidence 44567899999999999999987554332111100 01 111 2234569999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-57 Score=453.49 Aligned_cols=261 Identities=37% Similarity=0.638 Sum_probs=236.4
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch--hhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--GQVEHVRSERNLLAEVD-SRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~--~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~ 110 (450)
......|.+.+.||+|+||+|+++++..+|..+|+|++++...... ...+.+.+|+.+++.+. ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3567899999999999999999999999999999998887643322 34567889999999998 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-CceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~-g~ikL~DFGla~~~~ 189 (450)
..+|+|||||.||+|++++.+.+++.|++++.|+.||+.||+|||++||+||||||||||+|.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999998763
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC-C-CccccccchhHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-Y-GMECDWWSLGAIMY 267 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~-y-~~~~DiWSlGvily 267 (450)
.. .....+.||||.|+|||++.+.+ | +.++|+||+||+||
T Consensus 173 ~~--------------------------------------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy 214 (370)
T KOG0583|consen 173 GE--------------------------------------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILY 214 (370)
T ss_pred CC--------------------------------------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHH
Confidence 11 01234789999999999999988 8 69999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCC-CHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI-SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~-s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
.|++|+.||...+...++.+|.. ..+.+|. .+ |+++++||.+||. ||.+|+ ++.+|+.||||+.-
T Consensus 215 ~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~---t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 215 VLLCGRLPFDDSNVPNLYRKIRK--GEFKIPS--YLLSPEARSLIEKMLVPDPSTRI---TLLEILEHPWFQKE 281 (370)
T ss_pred HHHhCCCCCCCccHHHHHHHHhc--CCccCCC--CcCCHHHHHHHHHHcCCCcccCC---CHHHHhhChhhccC
Confidence 99999999999999999999887 4577776 56 9999999999998 999999 79999999999863
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=445.82 Aligned_cols=288 Identities=45% Similarity=0.851 Sum_probs=259.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|++..+|+.||+|++++...........+..|+.++..++||||+++++++++.+++|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876555566778899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999999999998889999999999999999999999999999999999999999999999999999864321
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus 155 -----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 199 (333)
T cd05600 155 -----------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199 (333)
T ss_pred -----------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence 124689999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCC----CCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCCcc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEP----KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYK 352 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~----~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~ 352 (450)
+.+..+.+..+..+...+..|... .+|+++++||.+||. +|.+|+ +++++++||||++++|..+....||+.
T Consensus 200 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~---s~~~ll~h~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd05600 200 GSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG---SLEDIKNHPFFKEVDWNELRELKPPFV 276 (333)
T ss_pred CCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC---CHHHHHhCcccCCCCHHHHhhCCCCCC
Confidence 998888888887765555555432 579999999999998 777787 699999999999999999998899999
Q ss_pred ccCCCcccCCCCCCCCC
Q 013064 353 PTVNGELDTQNFEKFPE 369 (450)
Q Consensus 353 p~~~~~~d~~~f~~~~~ 369 (450)
|.+....+..+|+.+..
T Consensus 277 ~~~~~~~~~~~~~~~~~ 293 (333)
T cd05600 277 PELESEIDTGYFDDFEN 293 (333)
T ss_pred CCCCCcchhhhccCCCC
Confidence 99988888888876544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-56 Score=441.34 Aligned_cols=318 Identities=36% Similarity=0.658 Sum_probs=268.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~lylVm 117 (450)
+|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|..++..+.| ++|++++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 69999999999999999999999999999999998766556667788899999999976 56899999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----
Confidence 999999999999988899999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 156 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 156 ---------------------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred ---------------------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 00124689999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--ccCCcc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYK 352 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~ 352 (450)
+.+..+.+..+... ...+| ..+++++++||.+||. ||.+|++. ...+++++||||+.++|..+.. ..+|+.
T Consensus 203 ~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~ 278 (324)
T cd05587 203 GEDEDELFQSIMEH--NVSYP--KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFK 278 (324)
T ss_pred CCCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcc
Confidence 98888888888763 34445 3789999999999998 99999975 2468999999999999998863 678999
Q ss_pred ccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeC
Q 013064 353 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 353 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
|.+....+.++|+.+......... +. ....+.......|.+|+|.|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 279 PKVKGRRSAENFDKFFTREPPVLT-PP--DKLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred CcCCCcchhhhcCcccccCccccC-CC--CccccccccccccCCCcccC
Confidence 999888899999886544322221 11 01122334456788888864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=441.45 Aligned_cols=317 Identities=35% Similarity=0.647 Sum_probs=267.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVm 117 (450)
||++++.||+|+||.||+|+++.+++.||||++++..............|..++..+ .||+|++++++|++.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 699999999999999999999999999999999987655555667788898988877 5899999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~----- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----- 155 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987532210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 156 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 156 ---------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred ---------------------------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence 01224689999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--cccCCcc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYK 352 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~~p~~ 352 (450)
+.+....+..|... ...+|. .+++++++||.+||. ||.+|++. .+..+++.||||+.++|+.+. ...+|+.
T Consensus 203 ~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05616 203 GEDEDELFQSIMEH--NVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYK 278 (323)
T ss_pred CCCHHHHHHHHHhC--CCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcC
Confidence 99888888888763 345553 689999999999998 99999975 247899999999999999987 4778999
Q ss_pred ccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeC
Q 013064 353 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 353 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
|... ..|..+|+.|.....+... + ..-..+.+..+..|.||+|.+
T Consensus 279 ~~~~-~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 279 PKAC-GRDAENFDKFFTRHPPVLT-P--PDQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred CcCC-CchhhhcCchhccCCccCC-C--CCccccccccccccCCCcccC
Confidence 8765 4777888887653322111 1 111123344456888998864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-56 Score=441.36 Aligned_cols=324 Identities=47% Similarity=0.858 Sum_probs=269.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+++.+.+++.||+|++.+...........+..|+.++..++|+||+++++++++...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999998876656666677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--- 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc---
Confidence 99999999999977 46799999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHHHHHhh
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvilyeml~ 271 (450)
......+||+.|+|||++. ...|+.++|||||||++|||++
T Consensus 158 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~ 203 (332)
T cd05623 158 ----------------------------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY 203 (332)
T ss_pred ----------------------------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc
Confidence 0012358999999999996 3468999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 350 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p 350 (450)
|..||.+.+..+.+.+|........+|.. ..+++++++||++||+.+.+|+++.+++++++||||.+++|+.+....+|
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~ 283 (332)
T cd05623 204 GETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAP 283 (332)
T ss_pred CCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhCCCC
Confidence 99999999988888888875555555542 36899999999999996677877778999999999999999999988899
Q ss_pred ccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 351 YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 351 ~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
+.|...++.++++++............+... ..........|.||||.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 331 (332)
T cd05623 284 YIPEVSSPTDTSNFDVDDDCLKNSETMPPPS--HTAFSGHHLPFVGFTYT 331 (332)
T ss_pred ccCCCCCCcccccCCCCcccccccCCCCCCC--ccccccCCCCcCCeeec
Confidence 9999988888888764322211111111111 11122346689999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-57 Score=459.41 Aligned_cols=263 Identities=31% Similarity=0.568 Sum_probs=242.6
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..-.+.-|.+.+.||+|+-|.|.+|++..||+..|||++.|..-....+...+.+|+-||+.+.||||++||+++.++.+
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 44566789999999999999999999999999999999999866667777889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+|.||++||+|+++|.++++++|.+++.|+.||+.|+.|||..+|+||||||||+|||..++|||+|||+|..-...
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999864332
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~ 271 (450)
.+..+.||+|.|.|||++.+.+| |.++||||+|||||.||+
T Consensus 166 --------------------------------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt 207 (786)
T KOG0588|consen 166 --------------------------------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT 207 (786)
T ss_pred --------------------------------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence 23457899999999999999999 899999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
|..||.+++...++.++..+ .+..| ..+|++|+|||++||. ||.+|+ +.+||++|||+.+..-
T Consensus 208 G~LPFdDdNir~LLlKV~~G--~f~MP--s~Is~eaQdLLr~ml~VDp~~Ri---T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 208 GKLPFDDDNIRVLLLKVQRG--VFEMP--SNISSEAQDLLRRMLDVDPSTRI---TTEEILKHPFLSGYTS 271 (786)
T ss_pred CCCCCCCccHHHHHHHHHcC--cccCC--CcCCHHHHHHHHHHhccCccccc---cHHHHhhCchhhcCCC
Confidence 99999999999999999874 45666 4899999999999998 999999 6899999999987653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-57 Score=439.63 Aligned_cols=286 Identities=40% Similarity=0.816 Sum_probs=257.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 58999999999999999999999999999999998766555556778899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999999889999999999999999999999999999999999999999999999999998865321
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
..+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 155 -----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~ 199 (291)
T cd05612 155 -----------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199 (291)
T ss_pred -----------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 124689999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--ccCCcc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYK 352 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~ 352 (450)
+.+..+.+..+... ...+|. .+++.+++||++||. ||.+|++. .++++++.||||..++|..+.. ..||..
T Consensus 200 ~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~ 275 (291)
T cd05612 200 DDNPFGIYEKILAG--KLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIV 275 (291)
T ss_pred CCCHHHHHHHHHhC--CcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEe
Confidence 98888888888764 344553 679999999999998 99999963 2599999999999999998763 678899
Q ss_pred ccCCCcccCCCCCCCC
Q 013064 353 PTVNGELDTQNFEKFP 368 (450)
Q Consensus 353 p~~~~~~d~~~f~~~~ 368 (450)
|.+....++.||+..|
T Consensus 276 p~~~~~~~~~~~~~~~ 291 (291)
T cd05612 276 PKVSHDGDTSNFDDYP 291 (291)
T ss_pred CCCCCccccccccCCC
Confidence 9999999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-56 Score=441.52 Aligned_cols=294 Identities=51% Similarity=0.908 Sum_probs=258.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+++++.+++.||+|++.+...........+..|+.++..++|++|++++++|++++++|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998866555666777889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++||+|..++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--- 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---
Confidence 99999999999987 46899999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCccccccchhHHHHHHhh
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~DiWSlGvilyeml~ 271 (450)
......+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 158 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 203 (331)
T cd05624 158 ----------------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred ----------------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh
Confidence 00113579999999999975 467899999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 350 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p 350 (450)
|+.||.+.+..+.+.+|......+.+|.. ..+++++++||.+||+.+.+|++..+++++++||||++++|+.+....+|
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~ 283 (331)
T cd05624 204 GETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAP 283 (331)
T ss_pred CCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCC
Confidence 99999998888888888765544555542 35799999999999996667877778999999999999999999999999
Q ss_pred ccccCCCcccCCCCCCCC
Q 013064 351 YKPTVNGELDTQNFEKFP 368 (450)
Q Consensus 351 ~~p~~~~~~d~~~f~~~~ 368 (450)
+.|....+.+.++|+.-.
T Consensus 284 ~~p~~~~~~~~~~~~~~~ 301 (331)
T cd05624 284 YIPDVSSPSDTSNFDVDD 301 (331)
T ss_pred ccCCCCCcchhhhcCCcc
Confidence 999988888888887533
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=432.71 Aligned_cols=260 Identities=30% Similarity=0.500 Sum_probs=234.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe-
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF- 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~- 112 (450)
.+++++.+.++.||+|+.|+||+|+|+.|++.||+|++.-. ......+++.+|++|++.++|||||++|++|.++..
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 36667999999999999999999999999999999999322 345567889999999999999999999999999995
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
++++||||.||+|..++...++++|.....++.+++.||.|||+ ++||||||||.|||++..|.|||||||.++.+...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999999999999999999999999999999999995 99999999999999999999999999999876542
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
++.|++||..|||||.+.+..|+.++||||||+.+.||++
T Consensus 233 ----------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~ 272 (364)
T KOG0581|consen 233 ----------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI 272 (364)
T ss_pred ----------------------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence 3568999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 272 GYPPFCSD-----DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 272 G~~PF~~~-----~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
|+.||... +..+++..|+.. ....+|.. .+|+++++||..||. ||.+|+ ++.++++|||++...
T Consensus 273 GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~---s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 273 GRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG-EFSPEFRSFVSCCLRKDPSERP---SAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc-cCCHHHHHHHHHHhcCCcccCC---CHHHHhcCHHHhhcc
Confidence 99999875 566777888874 34556652 599999999999998 999999 789999999998644
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-59 Score=421.90 Aligned_cols=258 Identities=33% Similarity=0.573 Sum_probs=239.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++..+||+|.|+.|+.|.+..||+.||+|+++...+... ..+.+.+|..|.+.|+|||||+|..+++...+.|||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 678899999999999999999999999999999987776544 6788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFGla~~~~~~~~~ 194 (450)
|++.||+|..-|..+-.++|..+-.|+.||+.||.|+|.+||||||+||+|+|+.+ ..-+||+|||+|..+...
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g--- 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG--- 166 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc---
Confidence 99999999998888888999999999999999999999999999999999999953 446999999999987632
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
..+..++|||.|||||+++..+|+..+|+|+.|||||-||.|++
T Consensus 167 ------------------------------------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~ 210 (355)
T KOG0033|consen 167 ------------------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 210 (355)
T ss_pred ------------------------------------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCC
Confidence 22456899999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||++++...++++|+.+...+.-|.++.+|++|++||++||. ||.+|+ ++.|+|+|||+.+
T Consensus 211 PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI---ta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 211 PFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI---TADEALKHPWICN 272 (355)
T ss_pred CCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc---cHHHHhCCchhcc
Confidence 999999999999999988777778889999999999999998 999999 6899999999976
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-56 Score=438.43 Aligned_cols=279 Identities=41% Similarity=0.798 Sum_probs=251.3
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||+|+||.||+|+++.+++.||+|++++...........+.+|+.+|..++||||++++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999887665666778889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccc
Q 013064 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205 (450)
Q Consensus 126 ~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~ 205 (450)
..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------------- 147 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------------- 147 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------------
Confidence 9999988899999999999999999999999999999999999999999999999999988542210
Q ss_pred cccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhh
Q 013064 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 285 (450)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 285 (450)
......+||+.|+|||++.+..|+.++|+|||||++|+|++|.+||.+.+..+.+
T Consensus 148 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 202 (312)
T cd05585 148 -------------------------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202 (312)
T ss_pred -------------------------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH
Confidence 0112468999999999999999999999999999999999999999998888888
Q ss_pred hhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc--cccCCccccCCCcccCC
Q 013064 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQ 362 (450)
Q Consensus 286 ~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~ 362 (450)
..+... ...+|. .+++++++||.+||. ||.+|++..++.+++.||||+.++|..+. ...+++.|.+.+..+++
T Consensus 203 ~~~~~~--~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (312)
T cd05585 203 RKILQE--PLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTS 278 (312)
T ss_pred HHHHcC--CCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchh
Confidence 887763 445553 789999999999998 99999987789999999999999998775 46789999999889999
Q ss_pred CCCC
Q 013064 363 NFEK 366 (450)
Q Consensus 363 ~f~~ 366 (450)
+|+.
T Consensus 279 ~~~~ 282 (312)
T cd05585 279 NFDE 282 (312)
T ss_pred hcCc
Confidence 9975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-55 Score=439.13 Aligned_cols=324 Identities=48% Similarity=0.862 Sum_probs=268.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+++++.+++.||+|++.+.........+.+.+|+.++..++||||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999998876666667778899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-- 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998765432100
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCccccccchhHHHHHHhh
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~DiWSlGvilyeml~ 271 (450)
.....+||+.|+|||++.. ..++.++|||||||++|+|++
T Consensus 159 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (331)
T cd05597 159 -----------------------------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY 203 (331)
T ss_pred -----------------------------------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh
Confidence 0112479999999999973 457889999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCccccccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 350 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p 350 (450)
|..||.+.+..+.+.+|......+.+|.. ..+|+.+++||++||+.|.+|+++.++++++.||||.+++|..+....+|
T Consensus 204 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~ 283 (331)
T cd05597 204 GETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAP 283 (331)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhCCCC
Confidence 99999998888888888765544555432 35899999999999997778877778999999999999999999888899
Q ss_pred ccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 351 YKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 351 ~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
+.|...+..++++|+............+. +......+....+.||+|.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 331 (331)
T cd05597 284 YVPEVSSPTDTSNFDVDDDDLRNTESLPP--SSHGAFSGNHLPFVGFTYT 331 (331)
T ss_pred ccCcCCCcchhhhcCCcccccccccccCC--CCcCcCCcCCCCCCceeeC
Confidence 99999888888888753221111111110 0011223345678888884
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=437.34 Aligned_cols=281 Identities=36% Similarity=0.685 Sum_probs=249.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||.||+|+++.+++.||+|++++.........+....|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999887655566677888899998876 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---------- 150 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---------- 150 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (320)
T cd05590 151 ----------------------------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202 (320)
T ss_pred ----------------------------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 0112468999999999999999999999999999999999999999999888
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC---CHHHHHcCCCcCCCCccccc--cccCCccccCC
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVN 356 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~---~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~ 356 (450)
+.+..|... ...+| ..+++++++||++||. ||.+|+++. +.++++.||||.+++|+.+. ...|||.|.+.
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 278 (320)
T cd05590 203 DLFEAILND--EVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIK 278 (320)
T ss_pred HHHHHHhcC--CCCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 888888763 33444 3689999999999998 999999752 35999999999999999876 46899999999
Q ss_pred CcccCCCCCC
Q 013064 357 GELDTQNFEK 366 (450)
Q Consensus 357 ~~~d~~~f~~ 366 (450)
+..|.++|+.
T Consensus 279 ~~~~~~~~~~ 288 (320)
T cd05590 279 SREDVSNFDP 288 (320)
T ss_pred CcchhhhcCc
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=436.19 Aligned_cols=281 Identities=41% Similarity=0.744 Sum_probs=249.9
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+|+.++||||++++++|++++.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998876666667788899999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccc
Q 013064 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203 (450)
Q Consensus 124 ~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~ 203 (450)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----------- 149 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----------- 149 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-----------
Confidence 999999888899999999999999999999999999999999999999999999999999987542210
Q ss_pred cccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhh
Q 013064 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283 (450)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 283 (450)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+
T Consensus 150 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~ 202 (328)
T cd05593 150 ---------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (328)
T ss_pred ---------------------------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH
Confidence 00124689999999999999999999999999999999999999999888777
Q ss_pred hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--ccCCccccCCCc
Q 013064 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 358 (450)
Q Consensus 284 ~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~~ 358 (450)
....+.. ....+|. .+++++.+||++||. ||.+|++. .++.++++||||.+++|..+.. ..+|+.|.+.++
T Consensus 203 ~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (328)
T cd05593 203 LFELILM--EDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSE 278 (328)
T ss_pred HHHHhcc--CCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCc
Confidence 7776654 3345553 789999999999998 99999864 3699999999999999998764 678999999988
Q ss_pred ccCCCCCC
Q 013064 359 LDTQNFEK 366 (450)
Q Consensus 359 ~d~~~f~~ 366 (450)
.+...|+.
T Consensus 279 ~~~~~~~~ 286 (328)
T cd05593 279 TDTRYFDE 286 (328)
T ss_pred chhhhcCc
Confidence 88888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-55 Score=434.37 Aligned_cols=317 Identities=36% Similarity=0.661 Sum_probs=264.8
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVm 117 (450)
+|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+..|..++..+. |++|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5899999999999999999999999999999998876555566778888999998885 578889999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~----- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----- 155 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-----
Confidence 999999999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.
T Consensus 156 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (323)
T cd05615 156 ---------------------------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202 (323)
T ss_pred ---------------------------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCC
Confidence 00124679999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCcccccc--ccCCcc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEAAYK 352 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~p~~ 352 (450)
+.+.......|... ...+|. .++.++++||.+||. +|.+|++.. ..++++.||||+.++|..+.. ..+|+.
T Consensus 203 ~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05615 203 GEDEDELFQSIMEH--NVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFK 278 (323)
T ss_pred CCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCcc
Confidence 98888888888763 344553 689999999999998 999999753 478999999999999998874 678999
Q ss_pred ccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeC
Q 013064 353 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 353 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
|.... ....+|+.+.+...+....+... .+......-|.||+|.+
T Consensus 279 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 279 PKVCG-KGAENFDKFFTRGQPVLTPPDQL---VIANIDQADFEGFSYVN 323 (323)
T ss_pred CccCC-CchhhcCccccccCCCCCCCccc---ccccccccccCCCcccC
Confidence 87655 35788888765443322211111 12222334788888864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=434.63 Aligned_cols=281 Identities=37% Similarity=0.689 Sum_probs=248.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
++||+|+||.||+|+++.+++.||+|++++.........+....|..++..+ +||||++++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999887665666677788899999866 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---------- 150 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---------- 150 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 202 (321)
T cd05591 151 ----------------------------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202 (321)
T ss_pred ----------------------------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH
Confidence 0112468999999999999999999999999999999999999999999988
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC----CHHHHHcCCCcCCCCcccccc--ccCCccccC
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR----GVEELKEHPWFRGIQWDKLYE--MEAAYKPTV 355 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~----~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~ 355 (450)
..+..+... ...+| ..++.++.+||.+||. ||.+|++.. +++++++||||.+++|..+.. ..+|+.|..
T Consensus 203 ~~~~~i~~~--~~~~p--~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T cd05591 203 DLFESILHD--DVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKI 278 (321)
T ss_pred HHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCC
Confidence 888888763 33444 3689999999999998 999999652 689999999999999998864 678899988
Q ss_pred CCcccCCCCCC
Q 013064 356 NGELDTQNFEK 366 (450)
Q Consensus 356 ~~~~d~~~f~~ 366 (450)
....+..+|+.
T Consensus 279 ~~~~~~~~~~~ 289 (321)
T cd05591 279 KTKRDVNNFDQ 289 (321)
T ss_pred CCcchhhhcCC
Confidence 88778888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-55 Score=434.48 Aligned_cols=316 Identities=37% Similarity=0.676 Sum_probs=264.0
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH---hcCCCCeeeEEEEEEcCCeEEEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA---EVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~---~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
|++++.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|+.++. .++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999999876555566778888887764 56799999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---- 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----
Confidence 999999999988754 579999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
....+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 156 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf 201 (324)
T cd05589 156 ----------------------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201 (324)
T ss_pred ----------------------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 0112468999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--cccCCc
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAY 351 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~~p~ 351 (450)
.+.+..+....+... ...+| ..+++.+.+||.+||. ||.+|++. .++.++++||||++++|..+. ...+|+
T Consensus 202 ~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~ 277 (324)
T cd05589 202 PGDDEEEVFDSIVND--EVRYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPF 277 (324)
T ss_pred CCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCc
Confidence 998888888777763 23445 3689999999999998 99999975 369999999999999999875 467899
Q ss_pred cccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 352 KPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 352 ~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
.|.+....|.++|+.-.....+....+ .+.+.+..+.+..|.+|+|.
T Consensus 278 ~~~~~~~~d~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05589 278 VPTIKGPEDVSNFDEEFTSEAPVLTPP--REPRLLTEEEQELFRGFDYV 324 (324)
T ss_pred cCCCCCcchhhhcCccccccccccCCC--ccccccchhhhcccCCcccC
Confidence 999999899998875322222222111 12223445566789999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=432.73 Aligned_cols=311 Identities=38% Similarity=0.695 Sum_probs=259.4
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
++||+|+||.||+|++..+++.||+|++++.........+....|+.++..+ +||||++++++|.++..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999887655555666677788888754 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------- 150 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999997543211
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 151 ----------------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred ----------------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 0122468999999999999999999999999999999999999999998888
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc--cccCCccccCCCcc
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGEL 359 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~ 359 (450)
+.+..+... ...+| ..++.++.+||.+||. ||.+|++. ..+++.||||+.++|..+. ...||+.|......
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05592 203 ELFDSILND--RPHFP--RWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPS 276 (316)
T ss_pred HHHHHHHcC--CCCCC--CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 877777653 23344 3689999999999998 99999953 4689999999999999876 36789999999999
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcccccC-CCcCCCcCCceeeCC
Q 013064 360 DTQNFEKFPEVDGPPSEIPSVGPWRKML-TSKDTNFIGYTFKKS 402 (450)
Q Consensus 360 d~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~~~~~~~~ 402 (450)
+..+|+.............. .+.. +-....|.||.|.++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 277 DASNFDREFTNEKVRLSPVD----KKLLASMDQEQFRGFSFTNP 316 (316)
T ss_pred hhhhcCcccccccccCCCcc----ccccccccccccCCCcccCc
Confidence 99999863322221111111 1122 224568999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-55 Score=434.61 Aligned_cols=281 Identities=40% Similarity=0.716 Sum_probs=249.9
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
+.||+|+||.||+|+++.+|+.||+|++++...........+.+|..+++.++||||++++++|.+++.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998876655666778889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccc
Q 013064 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203 (450)
Q Consensus 124 ~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~ 203 (450)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------- 150 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875322100
Q ss_pred cccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhh
Q 013064 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283 (450)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 283 (450)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+...
T Consensus 151 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 202 (323)
T cd05595 151 ----------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202 (323)
T ss_pred ----------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 0124689999999999999999999999999999999999999999888877
Q ss_pred hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--ccCCccccCCCc
Q 013064 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 358 (450)
Q Consensus 284 ~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~~ 358 (450)
....+... ...+|. .+++++++||.+||. ||.+|++. .++.++++||||.+++|..+.. ..||+.|.+.++
T Consensus 203 ~~~~~~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05595 203 LFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSE 278 (323)
T ss_pred HHHHHhcC--CCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCh
Confidence 77777652 345553 789999999999998 99999964 3699999999999999998764 568999999999
Q ss_pred ccCCCCCC
Q 013064 359 LDTQNFEK 366 (450)
Q Consensus 359 ~d~~~f~~ 366 (450)
.+...|+.
T Consensus 279 ~~~~~~~~ 286 (323)
T cd05595 279 VDTRYFDD 286 (323)
T ss_pred hhhhhcCc
Confidence 99988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-55 Score=433.05 Aligned_cols=315 Identities=40% Similarity=0.723 Sum_probs=260.7
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|+.+ ++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999988765555555666677664 5779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---------- 150 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|+|||||++|+|++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 202 (323)
T cd05575 151 ----------------------------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202 (323)
T ss_pred ----------------------------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence 0112468999999999999999999999999999999999999999998888
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC-CHHHHHcCCCcCCCCcccccc--ccCCccccCCCc
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR-GVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 358 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~-~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~~ 358 (450)
+.+.++.... ...+ +.+++.+.+||++||. ||.+|++.. .+.+++.||||..++|..+.. +.+|+.|.+...
T Consensus 203 ~~~~~i~~~~--~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05575 203 EMYDNILNKP--LRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGP 278 (323)
T ss_pred HHHHHHHcCC--CCCC--CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCc
Confidence 8888887632 3333 3689999999999998 999999863 578999999999999998873 678999999888
Q ss_pred ccCCCCCC-CCCCCCCCCCC--CCCCcccccCCCcCCCcCCceee
Q 013064 359 LDTQNFEK-FPEVDGPPSEI--PSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 359 ~d~~~f~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
.+.+.|+. +.+...+++.. +............+..|.||+|.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05575 279 MDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSYA 323 (323)
T ss_pred chhhhcCccccccccccccCCCcccccccccccccccccCCCccC
Confidence 88888875 33222222211 11111222344556789999873
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-55 Score=433.52 Aligned_cols=281 Identities=35% Similarity=0.675 Sum_probs=241.9
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
++||+|+||.||+|+++.+++.||+|++++...........+.+|+.++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987655556677889999999988 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------- 150 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCCh-
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP- 281 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~- 281 (450)
....+.+||+.|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 202 (329)
T cd05588 151 ----------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202 (329)
T ss_pred ----------------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccc
Confidence 012246899999999999999999999999999999999999999963211
Q ss_pred --------hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CCHHHHHcCCCcCCCCcccccc--c
Q 013064 282 --------RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLYE--M 347 (450)
Q Consensus 282 --------~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l~~--~ 347 (450)
......+.. ....+|. .++..+++||++||. ||.+|++. .+++++++||||..++|+.+.. .
T Consensus 203 ~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~ 278 (329)
T cd05588 203 DNPDQNTEDYLFQVILE--KQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQV 278 (329)
T ss_pred ccccccchHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCC
Confidence 112333443 2344553 689999999999998 99999974 2589999999999999998763 5
Q ss_pred cCCccccCCCcccCCCCCC
Q 013064 348 EAAYKPTVNGELDTQNFEK 366 (450)
Q Consensus 348 ~~p~~p~~~~~~d~~~f~~ 366 (450)
.||+.|.+....+..+|+.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~ 297 (329)
T cd05588 279 LPPYKPNIESDRDLDNFDP 297 (329)
T ss_pred CCCccccCCCcchhhhcCC
Confidence 6888999888888888875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=432.32 Aligned_cols=282 Identities=34% Similarity=0.668 Sum_probs=243.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||+||+|+++.+++.||+|++++.........+.+..|..++..+ +||+|++++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987665566678889999999888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------- 150 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------- 150 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCCh-
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP- 281 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~- 281 (450)
....+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.....
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~ 202 (327)
T cd05617 151 ----------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202 (327)
T ss_pred ----------------------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC
Confidence 011246899999999999999999999999999999999999999964221
Q ss_pred ------hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CCHHHHHcCCCcCCCCccccc--cccC
Q 013064 282 ------RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLY--EMEA 349 (450)
Q Consensus 282 ------~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l~--~~~~ 349 (450)
......+.. ....+|. .++..++++|++||. ||.+|++. .++++++.||||++++|+.+. ...+
T Consensus 203 ~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~ 278 (327)
T cd05617 203 PDMNTEDYLFQVILE--KPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTP 278 (327)
T ss_pred cccccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCC
Confidence 122333333 2344553 689999999999998 99999975 368999999999999999887 4678
Q ss_pred CccccCCCcccCCCCCCC
Q 013064 350 AYKPTVNGELDTQNFEKF 367 (450)
Q Consensus 350 p~~p~~~~~~d~~~f~~~ 367 (450)
||+|.+.+..+..+|+..
T Consensus 279 ~~~~~~~~~~~~~~~~~~ 296 (327)
T cd05617 279 PFKPQITDDYGLENFDTQ 296 (327)
T ss_pred CccCCCCCCcchhhcCCc
Confidence 999999888888888753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-55 Score=432.73 Aligned_cols=316 Identities=37% Similarity=0.672 Sum_probs=261.4
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|+.+ ++.++||||++++++|.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 479999999999999999999999999987765555555666667664 6778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------- 150 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---------- 150 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (325)
T cd05604 151 ----------------------------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202 (325)
T ss_pred ----------------------------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH
Confidence 0012468999999999999999999999999999999999999999998888
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC-CHHHHHcCCCcCCCCcccccc--ccCCccccCCCc
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR-GVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 358 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~-~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~~ 358 (450)
+.+.++... .+.++ +.++..+.++|++||. +|.+|++.. ++.+++.||||++++|..+.. ..+|+.|.+...
T Consensus 203 ~~~~~~~~~--~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05604 203 EMYDNILHK--PLVLR--PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGP 278 (325)
T ss_pred HHHHHHHcC--CccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCc
Confidence 888887763 23333 3689999999999998 999999863 588999999999999988764 678899999888
Q ss_pred ccCCCCCC-CCCCCCCCCCC--CCCCcccccCCCcCCCcCCceeeC
Q 013064 359 LDTQNFEK-FPEVDGPPSEI--PSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 359 ~d~~~f~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
.+.++|+. +.+...+.+.. +............+.+|.||+|..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (325)
T cd05604 279 DDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAP 324 (325)
T ss_pred chhhhcCCccccCCcccCcccccccccccccccccccccCCCEecC
Confidence 89999985 33322222211 111111222334577899999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-57 Score=406.94 Aligned_cols=259 Identities=38% Similarity=0.622 Sum_probs=241.7
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
...+++||++.+.||+|-||.||+++.+.++-.+|+|++-|+++....-...+.+|++|.+.|+||||+++|++|.|+..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 56889999999999999999999999999999999999999998877777889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 113 LYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~--~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+||++||.++|+|+..|. +...|+|..+.-|+.|++.||.|+|..+||||||||||+|++..|.+||+|||.+....+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999999 667899999999999999999999999999999999999999999999999999876442
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
+ + -.+.|||.+|.+||++.+.+++..+|+|++|++.||+|
T Consensus 177 ~-------------------------------------k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 177 N-------------------------------------K---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred C-------------------------------------C---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 1 1 23789999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+|.+||.+.+..+++.+|.+ ..+.+| ..+|.+|+|||.+||. +|.+|+ ...|++.|||...
T Consensus 217 vg~ppFes~~~~etYkrI~k--~~~~~p--~~is~~a~dlI~~ll~~~p~~r~---~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 217 VGLPPFESQSHSETYKRIRK--VDLKFP--STISGGAADLISRLLVKNPIERL---ALTEVMDHPWIVA 278 (281)
T ss_pred hcCCchhhhhhHHHHHHHHH--ccccCC--cccChhHHHHHHHHhccCccccc---cHHHHhhhHHHHh
Confidence 99999999999999999987 456777 4899999999999998 999999 6899999999854
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-55 Score=431.01 Aligned_cols=311 Identities=38% Similarity=0.698 Sum_probs=260.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||.||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999987666666677888999999887 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------- 150 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---------- 150 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~ 202 (318)
T cd05570 151 ----------------------------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202 (318)
T ss_pred ----------------------------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH
Confidence 0122468999999999999999999999999999999999999999988887
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--cccCCccccCCC
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNG 357 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~ 357 (450)
.....+... ...+| ..++..+++||++||. ||.+|++. ....+++.||||+.++|.... ...+|++|.+..
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (318)
T cd05570 203 ELFQSILED--EVRYP--RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKG 278 (318)
T ss_pred HHHHHHHcC--CCCCC--CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 777777653 33445 3689999999999998 99999953 123999999999999998766 467899999999
Q ss_pred cccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 358 ELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 358 ~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
..+.++|+. |... .+....+... .+..-++..|.||+|.
T Consensus 279 ~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~ 318 (318)
T cd05570 279 RFDVSNFDDEFTKE-KPVLTPPDEA---IIRNIDQEEFRGFSYI 318 (318)
T ss_pred cchhhhcCchhccC-cccCCCCccc---ccccccccccCCCCCC
Confidence 999999975 3222 1211111111 1223355689999983
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=429.32 Aligned_cols=311 Identities=35% Similarity=0.632 Sum_probs=255.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
++||+|+||.||+|+++.+|+.||+|++++..............|..++..+ +||+|++++++|++++++|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999887654445667778888888764 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 151 ----------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred ----------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 0122468999999999999999999999999999999999999999988887
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc--cccCCccccCCCcc
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGEL 359 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~ 359 (450)
+....+... ...+|. .++.++++||++||. ||.+|++. .++++.||||++++|..+. ...+|+.|....+.
T Consensus 203 ~~~~~~~~~--~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05620 203 ELFESIRVD--TPHYPR--WITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPS 276 (316)
T ss_pred HHHHHHHhC--CCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 777776542 234443 689999999999998 99999953 4689999999999999876 46789999998888
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeC
Q 013064 360 DTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 360 d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
+.++|+.-.....+.. +...........+..|.||.|.+
T Consensus 277 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05620 277 DYSNFDREFLSEKPRL---SYSDKNLIDSMDQSAFAGFSFIN 315 (316)
T ss_pred hhhhcCccccccCccc---CCCcccccccccccCcCCCcccC
Confidence 8888875211111110 00111111223446888888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=429.20 Aligned_cols=313 Identities=32% Similarity=0.630 Sum_probs=252.5
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||.||+|+++.+++.||+|++++...........+.+|..++..+ +||||++++++|.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987655556677888999998876 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---------- 150 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCC--
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD-- 280 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-- 280 (450)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (329)
T cd05618 151 ----------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 202 (329)
T ss_pred ----------------------------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCc
Confidence 00124689999999999999999999999999999999999999995311
Q ss_pred -------hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CCHHHHHcCCCcCCCCcccccc--c
Q 013064 281 -------PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLYE--M 347 (450)
Q Consensus 281 -------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l~~--~ 347 (450)
.......+.. ....+|. .++..+++||++||. ||.+|++. .+++++++||||++++|+.+.. .
T Consensus 203 ~~~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~ 278 (329)
T cd05618 203 DNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQV 278 (329)
T ss_pred CCcccccHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCC
Confidence 1112333333 2344553 789999999999998 99999975 2578999999999999997763 6
Q ss_pred cCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeC
Q 013064 348 EAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 348 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
.+|++|.+.+..+..+|+........... +... ..........|.||.|.|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~ 329 (329)
T cd05618 279 VPPFKPNISGEFGLDNFDAQFTNEPVQLT-PDDD--DIVRKIDQSEFEGFEYIN 329 (329)
T ss_pred CcCccCCCCCcccchhcCcccccCCccCC-CCcc--cccccccccccCCCcccC
Confidence 78999998888777777652222111111 1111 011123346788998864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-54 Score=427.41 Aligned_cols=314 Identities=41% Similarity=0.761 Sum_probs=254.5
Q ss_pred CeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 113 (450)
+|++++.||+|+||.||+|++. .+|+.||+|++.+..... ....+++..|+.+|..+ +||+|++++++|.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 6999999999999999999874 578999999998765433 23456788999999999 589999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||++||+|..++.+.+.++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999886532210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G 272 (450)
....+.+||+.|+|||++.+. .++.++|+|||||++|||++|
T Consensus 161 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 161 -------------------------------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred -------------------------------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence 112346899999999999875 488999999999999999999
Q ss_pred CCCCCCCChh----hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCccccc
Q 013064 273 YPPFCSDDPR----ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 273 ~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~ 345 (450)
..||...... .....+... ...+| ..+++.+++||.+||. ||.+|+++. +++++++||||++++|..+.
T Consensus 204 ~~pf~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 204 ASPFTLEGERNTQSEVSRRILKC--DPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred CCCCCCCCCCCCHHHHHHHHhcC--CCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 9999754332 233334432 22333 4689999999999998 999999875 79999999999999998876
Q ss_pred --cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceee
Q 013064 346 --EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFK 400 (450)
Q Consensus 346 --~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 400 (450)
...+|+.|......+..+|.. +....... .+.. ...+....|.||+|.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~ 330 (332)
T cd05614 280 LRKVNPPFRPSIRNELDVGNFAEEFTNLEPVY--SPAG-----TPPSGARVFQGYSFV 330 (332)
T ss_pred hCCCCCCcCCCCCCcchhhhcCcccccCCccc--CCCC-----CCcccccccCCceec
Confidence 467899999988888888764 22221111 1110 112234578899886
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-54 Score=425.76 Aligned_cols=310 Identities=36% Similarity=0.646 Sum_probs=256.1
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||.||+|+++.+++.||||++++..............|..++.. ++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999988755444556677788888876 4999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
....+.+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 151 ----------------------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred ----------------------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 0012468999999999999999999999999999999999999999988887
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc--cccCCccccCCCcc
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGEL 359 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~ 359 (450)
+....+.... ..+| ..++.++++||.+||+ ||.+|++. .++++.||||+.++|..+. ...+|+.|.+.+..
T Consensus 203 ~~~~~i~~~~--~~~~--~~~~~~~~~li~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T cd05619 203 ELFQSIRMDN--PCYP--RWLTREAKDILVKLFVREPERRLGV--KGDIRQHPFFREIDWSALEEREIEPPFKPKVKSAN 276 (316)
T ss_pred HHHHHHHhCC--CCCC--ccCCHHHHHHHHHHhccCHhhcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 7777765432 3344 3689999999999998 99999953 2589999999999999876 46899999999999
Q ss_pred cCCCCCCCCCCCCCCCCCCCCCcccccCCCcCC-CcCCceeeC
Q 013064 360 DTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDT-NFIGYTFKK 401 (450)
Q Consensus 360 d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~f~~~~~~~ 401 (450)
+.++|+.......+..... .+.+..+.+. .|.+|+|-+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05619 277 DCSNFDKEFLNEKPRLSVT----DRMLINSMDQNMFENFSFIN 315 (316)
T ss_pred chhhcChhhhcCCcccCCC----cccccccccccccCCCcccC
Confidence 9999986332221111111 1122334443 487877754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=429.65 Aligned_cols=268 Identities=35% Similarity=0.626 Sum_probs=232.1
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch-----------hhHHHHHHHHHHHHhcCCCCee
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----------GQVEHVRSERNLLAEVDSRCIV 101 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv 101 (450)
.+..+++|++++.||+|.||+|.+|++..+++.||||++.|....+. ..++.+++|+.||+++.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 45678999999999999999999999999999999999988765432 2357899999999999999999
Q ss_pred eEEEEEEcC--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEE
Q 013064 102 QLFYSFQDS--DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 102 ~l~~~f~~~--~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL 179 (450)
+|+++..|. +++|||+|||..|.+...=....-+++.+|+.|+..++.||+|||.+|||||||||.|+||+.+|+|||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999999875 579999999999988654322223999999999999999999999999999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCC-Cc
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGY-GM 255 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y-~~ 255 (450)
+|||.+-.......... ++ . ....+|||.|+|||.+.+ ..| +.
T Consensus 252 sDFGVs~~~~~~~~~~~---d~-----------------------------~-L~~tvGTPAF~APE~c~~~~~~~~~g~ 298 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGS---DD-----------------------------Q-LSRTVGTPAFFAPELCSGGNSFSYSGF 298 (576)
T ss_pred eccceeeecccCCcccc---HH-----------------------------H-HhhcCCCccccchHhhcCCCCccccch
Confidence 99999886643311000 00 0 112689999999999986 233 78
Q ss_pred cccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCC
Q 013064 256 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334 (450)
Q Consensus 256 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hp 334 (450)
+.|||||||+||.|+.|..||.++...+++.+|++ ..+.||..+.+.++++|||.+||+ ||++|+ ++.+|+.||
T Consensus 299 a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri---~l~~ik~Hp 373 (576)
T KOG0585|consen 299 ALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRI---TLPDIKLHP 373 (576)
T ss_pred hhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhhee---ehhhheecc
Confidence 99999999999999999999999999999999998 679999988899999999999999 999999 689999999
Q ss_pred CcCC
Q 013064 335 WFRG 338 (450)
Q Consensus 335 ff~~ 338 (450)
|...
T Consensus 374 wvt~ 377 (576)
T KOG0585|consen 374 WVTR 377 (576)
T ss_pred eecc
Confidence 9753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-54 Score=419.31 Aligned_cols=275 Identities=33% Similarity=0.653 Sum_probs=235.3
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|+.++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|..++|++|++++++|.+++.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987765544455667899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++||+|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 99999999887643 469999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
.....+||+.|+|||++.+..|+.++|+|||||++|+|++|..||
T Consensus 157 -----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 201 (285)
T cd05631 157 -----------------------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201 (285)
T ss_pred -----------------------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCC
Confidence 012357999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhhhcc--cccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--ccC
Q 013064 277 CSDDPRITCRKIVNW--KTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEA 349 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~ 349 (450)
.+.+.......+... .....++ ..+|+++.+||++||. ||.+|++. .+++++++||||.+++|..+.+ .+|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~ 279 (285)
T cd05631 202 RKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEP 279 (285)
T ss_pred CCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCc
Confidence 876543322222211 1122333 3689999999999998 99999974 3589999999999999999985 689
Q ss_pred Ccccc
Q 013064 350 AYKPT 354 (450)
Q Consensus 350 p~~p~ 354 (450)
||+|.
T Consensus 280 ~~~~~ 284 (285)
T cd05631 280 PFCPD 284 (285)
T ss_pred CCCCC
Confidence 99985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=423.70 Aligned_cols=281 Identities=41% Similarity=0.746 Sum_probs=244.3
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
++||+|+||.||+|+++.+|+.||+|++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998876544445556666665 57889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---------- 150 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (321)
T cd05603 151 ----------------------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS 202 (321)
T ss_pred ----------------------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH
Confidence 0112468999999999999999999999999999999999999999998887
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CCHHHHHcCCCcCCCCcccccc--ccCCccccCCCc
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 358 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~~ 358 (450)
..+..+... ...+| ...+..+.++|.+||. ||.+|++. .++.++++||||..++|..+.. ..+|+.|.....
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T cd05603 203 QMYDNILHK--PLQLP--GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGP 278 (321)
T ss_pred HHHHHHhcC--CCCCC--CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCc
Confidence 777777763 34445 3689999999999998 99999976 3678999999999999998763 678888888887
Q ss_pred ccCCCCCC
Q 013064 359 LDTQNFEK 366 (450)
Q Consensus 359 ~d~~~f~~ 366 (450)
.+...|+.
T Consensus 279 ~~~~~~~~ 286 (321)
T cd05603 279 ADLRHFDP 286 (321)
T ss_pred chhhhcCC
Confidence 77777774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-54 Score=424.99 Aligned_cols=281 Identities=42% Similarity=0.753 Sum_probs=243.7
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998766544444455555554 46788999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---------- 150 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---------- 150 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----------
Confidence 9999999988899999999999999999999999999999999999999999999999999987542210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (325)
T cd05602 151 ----------------------------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202 (325)
T ss_pred ----------------------------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH
Confidence 0122468999999999999999999999999999999999999999998888
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC-CHHHHHcCCCcCCCCcccccc--ccCCccccCCCc
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR-GVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNGE 358 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~-~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~~ 358 (450)
+.+..+... ...++ +.+++.+++||.+||. ||.+|++.. .+.++++|+||..++|+.+.. ..+|+.|.+..+
T Consensus 203 ~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05602 203 EMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGP 278 (325)
T ss_pred HHHHHHHhC--CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCc
Confidence 888887753 23333 4789999999999998 999999863 477999999999999998873 678888988888
Q ss_pred ccCCCCCC
Q 013064 359 LDTQNFEK 366 (450)
Q Consensus 359 ~d~~~f~~ 366 (450)
.+...|+.
T Consensus 279 ~~~~~~~~ 286 (325)
T cd05602 279 NDLRHFDP 286 (325)
T ss_pred chhhhcCC
Confidence 88888864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-57 Score=414.73 Aligned_cols=251 Identities=33% Similarity=0.545 Sum_probs=222.6
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEE-EEEcCC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY-SFQDSD 111 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~f~~~~ 111 (450)
...++.+|+++++||+|+||.||+|++..+|+.+|.|.+.-. .......+.+..|+.+|++|+|||||+.|+ .|..+.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 356778999999999999999999999999999999999844 345556678889999999999999999998 666555
Q ss_pred e-EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhh--CC--eEEeecCCCcEEEccCCceEEeec
Q 013064 112 F-LYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQ--HN--YVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 112 ~-lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~--~g--ivHrDLKpeNILld~~g~ikL~DF 182 (450)
. +++|||||.+|||..+++. ++.++|..++.|+.|++.||.++|+ .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 9999999999999998854 4679999999999999999999999 45 999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
||++.+.... .-+.+.+|||.||+||++...+|+.++|+|||
T Consensus 173 GL~r~l~s~~--------------------------------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 173 GLGRFLSSKT--------------------------------------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred hhHhHhcchh--------------------------------------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 9999876531 22457999999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
||++|||+.-.+||.|.+-.+++.+|.++.. ...|. ...|.++..||..|++ ||..||++
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-~~~p~-~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-PPLPD-EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCC-CCCcH-HHhhhHHHHHHHHHccCCcccCCCc
Confidence 9999999999999999999999999998622 22442 4789999999999999 99999964
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=424.14 Aligned_cols=281 Identities=42% Similarity=0.740 Sum_probs=247.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
+.||+|+||.||+|+++.+|+.||+|++++...........+..|..++..++||||++++++|.+++.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998876555566777889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 124 ~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---------- 150 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---------- 150 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----------
Confidence 999999888899999999999999999999997 799999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+.+..
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~ 202 (325)
T cd05594 151 ----------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202 (325)
T ss_pred ----------------------------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH
Confidence 0012467999999999999999999999999999999999999999988877
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--ccCCccccCCC
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNG 357 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~ 357 (450)
.....+.. ....+|. .+++++.+||.+||. ||.+|++. .++.++++||||.++.|..+.. ..+|+.|....
T Consensus 203 ~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (325)
T cd05594 203 KLFELILM--EEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTS 278 (325)
T ss_pred HHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC
Confidence 77777665 3345553 689999999999998 99999864 3689999999999999998764 56889998888
Q ss_pred cccCCCCCC
Q 013064 358 ELDTQNFEK 366 (450)
Q Consensus 358 ~~d~~~f~~ 366 (450)
..++..|+.
T Consensus 279 ~~~~~~~~~ 287 (325)
T cd05594 279 ETDTRYFDE 287 (325)
T ss_pred cchhhhcCc
Confidence 888888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-54 Score=431.04 Aligned_cols=260 Identities=36% Similarity=0.576 Sum_probs=240.5
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lyl 115 (450)
...|++.+.||+|.||.||+|+++.||+.||+|++.|..+......+.+.+|+.||+.+. |||||.++++|.+...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 357999999999999999999999999999999999988766667789999999999998 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc----CCceEEeeccccccCccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK----NGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~----~g~ikL~DFGla~~~~~~ 191 (450)
|||+|.||+|++.+.+. .++|..+..++.|++.|+.|||+.||+||||||||+|+.. ++.+|++|||+++.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999887 4999999999999999999999999999999999999953 357999999999986542
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
......||||.|+|||++...+|+..+|+||+||++|.||+
T Consensus 193 ---------------------------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~ 233 (382)
T KOG0032|consen 193 ---------------------------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS 233 (382)
T ss_pred ---------------------------------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh
Confidence 12346899999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
|.+||.+.+....+.+|......+..+.++.+|..|+|||++||. ||.+|+ ++.++++|||+++.
T Consensus 234 G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~---ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 234 GVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL---TAAQALQHPWIKSI 299 (382)
T ss_pred CCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC---CHHHHhcCccccCC
Confidence 999999999999999999988777778888999999999999998 999999 68999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=436.85 Aligned_cols=255 Identities=33% Similarity=0.589 Sum_probs=234.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|-+...||+|+||.||+++.+.|.++||||.+.|... ....++.+.+|++|++.++|||||.++++|++..++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 4789999999999999999999999999999999998753 445688899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
+|||.| +|+++|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++..|++||||||+|+.+..+.
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t---- 154 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT---- 154 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc----
Confidence 999987 999999999999999999999999999999999999999999999999999999999999999876531
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
....+.-|||.|||||++.+.+|+..+|.||||||+|||++|+|||
T Consensus 155 ----------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF 200 (808)
T KOG0597|consen 155 ----------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF 200 (808)
T ss_pred ----------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence 1233578999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
...+.....+.|.. .+...| ..+|..+++|++.||. ||.+|+ ++.+++.|||.++
T Consensus 201 ~a~si~~Lv~~I~~--d~v~~p--~~~S~~f~nfl~gLL~kdP~~Rl---tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 201 YARSITQLVKSILK--DPVKPP--STASSSFVNFLQGLLIKDPAQRL---TWTDLLGHPFWKG 256 (808)
T ss_pred hHHHHHHHHHHHhc--CCCCCc--ccccHHHHHHHHHHhhcChhhcc---cHHHHhcChHHhh
Confidence 99999999999987 344455 3899999999999998 999999 6899999999886
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=421.40 Aligned_cols=282 Identities=44% Similarity=0.835 Sum_probs=245.3
Q ss_pred EeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 43 LTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
++.||+|+||.||+|+.. .+++.||+|++++..... .....++.+|+.+|+.++||||++++++|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999874 578999999998765432 2345677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|++||+|..++.+.+.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 154 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------ 154 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC------
Confidence 99999999999999999999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
......+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+
T Consensus 155 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 155 --------------------------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred --------------------------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 012246899999999999999999999999999999999999999999
Q ss_pred CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--ccCCccc
Q 013064 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--MEAAYKP 353 (450)
Q Consensus 279 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~p 353 (450)
.+......++... ...+| ..+++++++||++||. ||.+|++. .++++++.||||...+|+.+.. ..+|+.|
T Consensus 203 ~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~ 278 (323)
T cd05584 203 ENRKKTIDKILKG--KLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKP 278 (323)
T ss_pred CCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCC
Confidence 8888878877763 34445 4789999999999998 99999953 3589999999999999998863 6688888
Q ss_pred cCCCcccCCCCCC
Q 013064 354 TVNGELDTQNFEK 366 (450)
Q Consensus 354 ~~~~~~d~~~f~~ 366 (450)
...+..+.+.|+.
T Consensus 279 ~~~~~~~~~~~~~ 291 (323)
T cd05584 279 LLQSEEDVSQFDS 291 (323)
T ss_pred CCCCcchhhhcCc
Confidence 8888888777764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-54 Score=426.52 Aligned_cols=280 Identities=43% Similarity=0.763 Sum_probs=244.2
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
||+|+||+||+|+++.+|+.||+|++.+..............|..++... +||+|++++++|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999887665555666677788888765 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------- 150 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---------- 150 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----------
Confidence 9999999998999999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCCCCCCCh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 281 (450)
......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.
T Consensus 151 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 151 ----------------------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred ----------------------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 01224689999999999975 4589999999999999999999999999888
Q ss_pred hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CCHHHHHcCCCcCCCCcccccc--ccCCccccCCC
Q 013064 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYE--MEAAYKPTVNG 357 (450)
Q Consensus 282 ~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~~~ 357 (450)
.+.+.++... ...+|. ..+++++++||++||+ ||.+|+++ .++++++.||||.+++|+.+.. +.+|+.|.+..
T Consensus 203 ~~~~~~i~~~--~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (330)
T cd05586 203 QQMYRNIAFG--KVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDS 279 (330)
T ss_pred HHHHHHHHcC--CCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCC
Confidence 8877777653 244443 3589999999999998 99999975 3699999999999999998763 67899999988
Q ss_pred cccCCCCCC
Q 013064 358 ELDTQNFEK 366 (450)
Q Consensus 358 ~~d~~~f~~ 366 (450)
..+.++|+.
T Consensus 280 ~~~~~~~~~ 288 (330)
T cd05586 280 DEDVSNFDP 288 (330)
T ss_pred CcchhhcCc
Confidence 888888864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=404.67 Aligned_cols=263 Identities=33% Similarity=0.546 Sum_probs=238.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
.+.|+-.+.||+|..+.|..|.++.||+.+|+|++.-.... .....+....|+.||+++ .||+|+++.++|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35677788999999999999999999999999998643221 123356678899999987 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.++++|+|.|+.|+|+++|...-.++|..++.++.|++.|++|||.++||||||||||||+|++-+|||+|||+|+.+..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc------CCCCccccccchhH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK------KGYGMECDWWSLGA 264 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~------~~y~~~~DiWSlGv 264 (450)
.. .....||||.|+|||.+.. .+|+..+|.||+||
T Consensus 176 Ge---------------------------------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GV 216 (411)
T KOG0599|consen 176 GE---------------------------------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGV 216 (411)
T ss_pred ch---------------------------------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHH
Confidence 41 1235899999999999963 67999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
|||-||.|.+||+.....-+++.|+.++..+.-|+|.++|..++|||++||+ ||.+|+ +++|+|.||||..+--
T Consensus 217 ImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ri---take~LaHpff~q~~~ 291 (411)
T KOG0599|consen 217 IMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRI---TAKEALAHPFFIQIAQ 291 (411)
T ss_pred HHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcc---cHHHHhcChHHHHHHH
Confidence 9999999999999999999999999999899999999999999999999998 999999 6899999999976443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-55 Score=417.51 Aligned_cols=259 Identities=30% Similarity=0.587 Sum_probs=237.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.-...+|++.+.||+|.||+|.+|.....|+.||||.|+|..+.....+-++++|++||+.|+||||+.+|++|++.+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 34446999999999999999999999999999999999999988888899999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
.+||||..||+|++|+.+.+.++|.+++.+++||+.|+.|||+++++|||||.||||+|.++++||+||||+..+...
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-- 206 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-- 206 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G 272 (450)
....++||+|-|.+||++.+.+| +..+|.|||||+||.|++|
T Consensus 207 -------------------------------------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 207 -------------------------------------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred -------------------------------------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 12347999999999999999999 8999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
..||.|.+...+.++|.++. ..-| .-+.+|.-||+.||. ||++|. ++++|-.|-|. ||.
T Consensus 250 tMPFDG~Dhk~lvrQIs~Ga--YrEP---~~PSdA~gLIRwmLmVNP~RRA---TieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 250 TMPFDGRDHKRLVRQISRGA--YREP---ETPSDASGLIRWMLMVNPERRA---TIEDIASHWWV---NWG 309 (668)
T ss_pred ccccCCchHHHHHHHhhccc--ccCC---CCCchHHHHHHHHHhcCcccch---hHHHHhhhhee---ecc
Confidence 99999999999999998742 3333 456789999999998 999998 69999999885 564
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=418.03 Aligned_cols=281 Identities=42% Similarity=0.757 Sum_probs=243.2
Q ss_pred EeEEeecCceEEEEEEE---cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 43 LTLIGKGAFGEVRLCRA---KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~---~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
++.||+|+||.||+|++ +.+|+.||+|++.+.... .........|+.+|+.++||||++++++|.++..+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 46899999999999986 468899999999876532 23445677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccc
Q 013064 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 120 ~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
++||+|.+++.+...++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------- 152 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------- 152 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence 9999999999888889999999999999999999999999999999999999999999999999987643220
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 279 (450)
....+.+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.
T Consensus 153 -------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 153 -------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred -------------------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 0123568999999999999999999999999999999999999999998
Q ss_pred ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC--HHHHHcCCCcCCCCcccccc--ccCCcccc
Q 013064 280 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG--VEELKEHPWFRGIQWDKLYE--MEAAYKPT 354 (450)
Q Consensus 280 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~--~~eil~Hpff~~i~w~~l~~--~~~p~~p~ 354 (450)
+.......+... ...+|. .+++.+++||++||. ||.+|+++.. +++++.||||..++|..+.. ..+|+.|.
T Consensus 202 ~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (318)
T cd05582 202 DRKETMTMILKA--KLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPA 277 (318)
T ss_pred CHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCC
Confidence 888777777653 344553 689999999999998 9999997644 89999999999999998774 66788887
Q ss_pred CCCcccCCCCCC
Q 013064 355 VNGELDTQNFEK 366 (450)
Q Consensus 355 ~~~~~d~~~f~~ 366 (450)
.....+..+++.
T Consensus 278 ~~~~~~~~~~~~ 289 (318)
T cd05582 278 VGRPDDTFYFDP 289 (318)
T ss_pred CCCcchhhhcCc
Confidence 776666666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=401.05 Aligned_cols=259 Identities=32% Similarity=0.525 Sum_probs=220.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
++.|+.+.++|+|+||.|++|+++.||+.||||++..++ .....-+-.++|+.+|++++|||+|.|.++|.....+|||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 367999999999999999999999999999999997554 1223345678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
+|||... +.+-|.+ ...++++.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+.....
T Consensus 80 FE~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-- 156 (396)
T KOG0593|consen 80 FEYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-- 156 (396)
T ss_pred eeecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--
Confidence 9999764 4444444 45799999999999999999999999999999999999999999999999999998763210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.-+.++.|.+|.|||.+.+ ..||.++||||+||++.||++|.+
T Consensus 157 ------------------------------------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~p 200 (396)
T KOG0593|consen 157 ------------------------------------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEP 200 (396)
T ss_pred ------------------------------------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCc
Confidence 1124799999999999987 889999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccc-----------------cccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 275 PFCSDDPRITCRKIVNWKT-----------------CLKFPE----------EPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
.|.|.+..+++..|...-. -+.+|. .+.+|..+.||+++||. ||.+|+ +
T Consensus 201 L~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~---s 277 (396)
T KOG0593|consen 201 LWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL---S 277 (396)
T ss_pred CCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc---c
Confidence 9999988777766652100 012222 25788999999999999 999999 6
Q ss_pred HHHHHcCCCcCC
Q 013064 327 VEELKEHPWFRG 338 (450)
Q Consensus 327 ~~eil~Hpff~~ 338 (450)
.++++.||||.+
T Consensus 278 c~qll~H~yFd~ 289 (396)
T KOG0593|consen 278 CEQLLHHPYFDG 289 (396)
T ss_pred HHHHhcChHHHH
Confidence 899999999954
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=413.10 Aligned_cols=262 Identities=31% Similarity=0.482 Sum_probs=229.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--C
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--D 111 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~ 111 (450)
+...+.|+.+..||+|.||.||+|++..||+.||+|.+.... .+.+......+|+.||++|+||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 455689999999999999999999999999999999998764 4566778889999999999999999999988776 7
Q ss_pred eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|||+|||+. ||..++...+ .|++.+++.|+.||+.||+|||++||+|||||..|||||.+|.+||+|||||+.+..
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999965 8998887744 799999999999999999999999999999999999999999999999999997765
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 269 (450)
... ...++.|-|.+|.|||++.+ ..|+.++|+||+||||.||
T Consensus 271 ~~~-------------------------------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El 313 (560)
T KOG0600|consen 271 SGS-------------------------------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAEL 313 (560)
T ss_pred CCC-------------------------------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHH
Confidence 321 11235789999999999997 6799999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhc---------ccccccCCC-----------------CCCCCHHHHHHHHHhhc-CccccC
Q 013064 270 LIGYPPFCSDDPRITCRKIVN---------WKTCLKFPE-----------------EPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~---------~~~~~~~p~-----------------~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+.|++.|.|.+..+++.+|.+ |. ...+|. ...++..+.+|+..||+ ||.+|.
T Consensus 314 ~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~ 392 (560)
T KOG0600|consen 314 FLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG 392 (560)
T ss_pred HcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc
Confidence 999999999999999988863 22 222331 14678999999999999 999999
Q ss_pred CCCCHHHHHcCCCcCC
Q 013064 323 GTRGVEELKEHPWFRG 338 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~ 338 (450)
++.+++.|+||..
T Consensus 393 ---tA~~aL~seyF~t 405 (560)
T KOG0600|consen 393 ---TASSALQSEYFTT 405 (560)
T ss_pred ---cHHHHhcCccccc
Confidence 6899999999943
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=399.09 Aligned_cols=275 Identities=35% Similarity=0.668 Sum_probs=234.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|++++.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 99999999888654 469999999999999999999999999999999999999999999999999987653210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
.....+||+.|+|||++.+..++.++|+||+||++|||++|..||
T Consensus 157 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf 201 (285)
T cd05605 157 -----------------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201 (285)
T ss_pred -----------------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCC
Confidence 012357999999999999889999999999999999999999999
Q ss_pred CCCChhhhhhhhhccc--ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCcccccc--ccC
Q 013064 277 CSDDPRITCRKIVNWK--TCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEA 349 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~ 349 (450)
.+.+.......+.... ....++ ..+++.+++||.+||. ||.+|++.. ++++++.||||...+|.++.. ..|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 279 (285)
T cd05605 202 RQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEP 279 (285)
T ss_pred CCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCC
Confidence 8866544333322111 122233 3689999999999998 999999865 799999999999999998874 668
Q ss_pred Ccccc
Q 013064 350 AYKPT 354 (450)
Q Consensus 350 p~~p~ 354 (450)
||.|.
T Consensus 280 ~~~~~ 284 (285)
T cd05605 280 PFCPD 284 (285)
T ss_pred CCCCC
Confidence 88884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=398.18 Aligned_cols=266 Identities=36% Similarity=0.663 Sum_probs=226.2
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+|+.++||||++++++|.++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999877655555567788899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 126 MTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 126 ~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-------- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--------
Confidence 888743 35699999999999999999999999999999999999999999999999999876543210
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCCh
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 281 (450)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 153 ------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 153 ------------------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred ------------------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 01235799999999999999999999999999999999999999986543
Q ss_pred hh----hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCcccccc--ccCCcc
Q 013064 282 RI----TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEAAYK 352 (450)
Q Consensus 282 ~~----~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~p~~ 352 (450)
.. ....+.. ....+| ..+++.+.+||.+||. ||.+|++.. +++++++||||++++|..+.. ..+||.
T Consensus 203 ~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~ 278 (280)
T cd05608 203 KVENKELKQRILN--DSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFV 278 (280)
T ss_pred chhHHHHHHhhcc--cCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCC
Confidence 22 2223332 223333 3689999999999998 999999752 689999999999999998764 556666
Q ss_pred c
Q 013064 353 P 353 (450)
Q Consensus 353 p 353 (450)
|
T Consensus 279 ~ 279 (280)
T cd05608 279 P 279 (280)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=415.92 Aligned_cols=254 Identities=32% Similarity=0.554 Sum_probs=226.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
..|.....||+|+-|.||.++...+++.||+|.+.+.... ..+-+.+|+.+|+..+|+|||++++.|--.+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 5788899999999999999999999999999999876533 3467899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+.+.. ..++|.+++.++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.....
T Consensus 350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---- 424 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---- 424 (550)
T ss_pred eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----
Confidence 99999998888754 4599999999999999999999999999999999999999999999999999998765411
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.-.+.+|||+|||||++..+.|+.++||||||+++.||+-|.|||.
T Consensus 425 ----------------------------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 425 ----------------------------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred ----------------------------------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 1136899999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhh-cccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 278 SDDPRITCRKIV-NWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 278 ~~~~~~~~~~i~-~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+++-..+..|. ++...++.| ..+|+.++||+.+||+ |+.+|. ++.|+|.||||+-
T Consensus 471 nE~PlrAlyLIa~ng~P~lk~~--~klS~~~kdFL~~cL~~dv~~Ra---sA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 471 NENPLRALYLIATNGTPKLKNP--EKLSPELKDFLDRCLVVDVEQRA---SAKELLEHPFLKM 528 (550)
T ss_pred CCChHHHHHHHhhcCCCCcCCc--cccCHHHHHHHHHHhhcchhcCC---CHHHHhcChhhhh
Confidence 877766555554 444444444 5899999999999999 999999 7899999999953
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=394.68 Aligned_cols=285 Identities=46% Similarity=0.883 Sum_probs=256.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57999999999999999999999999999999998877666667788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||+|.|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999998899999999999999999999999999999999999999999999999999998865432
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus 155 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 199 (290)
T cd05580 155 -----------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF 199 (290)
T ss_pred -----------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 123579999999999988889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCcccccc--ccCCcc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--MEAAYK 352 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~p~~ 352 (450)
..+......++... ...+|. .+++.++++|.+||. ||.+|++.. +++++++||||+.++|..+.. +.+|+.
T Consensus 200 ~~~~~~~~~~~~~~--~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 275 (290)
T cd05580 200 DDNPIQIYEKILEG--KVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFI 275 (290)
T ss_pred CCCHHHHHHHHhcC--CccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCcc
Confidence 88877777777653 344453 679999999999998 999999753 799999999999999998874 778999
Q ss_pred ccCCCcccCCCCCCC
Q 013064 353 PTVNGELDTQNFEKF 367 (450)
Q Consensus 353 p~~~~~~d~~~f~~~ 367 (450)
|....+.+.+.|+.+
T Consensus 276 ~~~~~~~~~~~~~~~ 290 (290)
T cd05580 276 PKVKGPGDTSNFDDY 290 (290)
T ss_pred CCCCCccccccccCC
Confidence 998888888888753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=400.59 Aligned_cols=258 Identities=36% Similarity=0.577 Sum_probs=219.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--eEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--FLY 114 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--~ly 114 (450)
..++...+.||+|+||.||++.++.+|..+|+|.+.... ....+.+.+|+.+|.+++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 467888999999999999999999999999999987652 122677899999999999999999999755554 699
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DFGla~~~~~~~ 192 (450)
+.|||++||+|.+++.+.+ .++|+.++.|++||+.||+|||++|||||||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 7999999999999999999999999999999999999999 7999999999998765310
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC--CccccccchhHHHHHHh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY--GMECDWWSLGAIMYEML 270 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y--~~~~DiWSlGvilyeml 270 (450)
.. .....+..|||.|||||++.. ++ +.++|+|||||++.||+
T Consensus 173 ~~-----------------------------------~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~ 216 (313)
T KOG0198|consen 173 TK-----------------------------------SDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEML 216 (313)
T ss_pred cc-----------------------------------ccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEecc
Confidence 00 011235789999999999986 43 35999999999999999
Q ss_pred hCCCCCCC-CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 271 IGYPPFCS-DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||.+||.. ......+.+|........+|. .+|+++++||.+|+. ||.+|+ +++++|.|||...
T Consensus 217 Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rp---ta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 217 TGKPPWSEFFEEAEALLLIGREDSLPEIPD--SLSDEAKDFLRKCFKRDPEKRP---TAEELLEHPFLKQ 281 (313)
T ss_pred CCCCcchhhcchHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHhhcCcccCc---CHHHHhhChhhhc
Confidence 99999987 455555555554433345564 799999999999998 999999 7999999999876
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-52 Score=406.17 Aligned_cols=258 Identities=34% Similarity=0.571 Sum_probs=235.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
.-|++-+.||+|.|+.|.+|++--||+.||+|++.|..+ ..-...++..|.+.|+.+.|||||+||++..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 568899999999999999999999999999999999874 3445678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-cCCceEEeeccccccCccccccc
Q 013064 118 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|+=.||||++||+++ ..++|+.++.|++||+.|+.|+|+..+|||||||||+++- .-|-|||+|||++-.+...
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---- 172 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---- 172 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc----
Confidence 999999999999886 4799999999999999999999999999999999999875 6799999999998876543
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCC-ccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG-MECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~-~~~DiWSlGvilyeml~G~~ 274 (450)
....+.||+..|-|||++.+..|+ +++||||||||||-|++|++
T Consensus 173 -----------------------------------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~ 217 (864)
T KOG4717|consen 173 -----------------------------------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP 217 (864)
T ss_pred -----------------------------------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence 123478999999999999999994 78999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
||...+..+++..|+.++ ...|. .+|.+++|||.+||. ||.+|. ++++|..|+|++.+|-.
T Consensus 218 PFqeANDSETLTmImDCK--YtvPs--hvS~eCrdLI~sMLvRdPkkRA---slEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 218 PFQEANDSETLTMIMDCK--YTVPS--HVSKECRDLIQSMLVRDPKKRA---SLEEIVSTSWLQAGDRG 279 (864)
T ss_pred ccccccchhhhhhhhccc--ccCch--hhhHHHHHHHHHHHhcCchhhc---cHHHHhccccccCCCCC
Confidence 999999999999999865 45564 899999999999998 999998 79999999999998854
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=385.26 Aligned_cols=263 Identities=30% Similarity=0.474 Sum_probs=227.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCe
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDF 112 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~ 112 (450)
-++++|+.+..|++|+||.||.|+++.|++.||+|.++... .+.+..-...+|+++|.+++|||||.+..+... -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 35689999999999999999999999999999999998665 344555667899999999999999999998764 457
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|||||||+. ||.+++..-+ +|++.+++.++.|++.||+|||.+.|+||||||.|+|++..|.+||+|||+|+.+.+.
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999965 9999998765 8999999999999999999999999999999999999999999999999999988765
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
..+ .+..+-|.+|.|||++.+ ..|+.++|+||+|||+.||+
T Consensus 231 ~k~--------------------------------------~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l 272 (419)
T KOG0663|consen 231 LKP--------------------------------------YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL 272 (419)
T ss_pred ccc--------------------------------------CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHH
Confidence 211 235789999999999997 67999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhc---------ccc--------cccCCCC-----------CCCCHHHHHHHHHhhc-Ccccc
Q 013064 271 IGYPPFCSDDPRITCRKIVN---------WKT--------CLKFPEE-----------PKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~---------~~~--------~~~~p~~-----------~~~s~~~~dli~~lL~-dp~~R 321 (450)
++.|.|.|.+..+.+.+|.+ |.. ...++.. ..+|+...||+..||+ ||.+|
T Consensus 273 ~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR 352 (419)
T KOG0663|consen 273 TQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKR 352 (419)
T ss_pred hcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccc
Confidence 99999999999888888863 111 1122211 1267999999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCCC
Q 013064 322 LGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i~ 340 (450)
+ ++++.|+|+||.+..
T Consensus 353 ~---tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 353 I---TAEDGLKHEYFRETP 368 (419)
T ss_pred c---cHHHhhcccccccCC
Confidence 9 689999999998744
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=373.54 Aligned_cols=258 Identities=31% Similarity=0.537 Sum_probs=224.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
.+|..++.||+|.||.||+|++..||+.||||.++... .+.+.-....+|+..|+.++||||+.|.++|.+.+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~-~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN-AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc-cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57888999999999999999999999999999998764 33444556889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++. ||...++.. ..++...++.|+.+++.||+|||++.|+||||||.|+||+++|.+||+|||+|+.+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 99965 898888664 47999999999999999999999999999999999999999999999999999987654211
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
....+-|.+|.|||++.+ +.|+..+|+||.|||+.||+-|.|-
T Consensus 158 ------------------------------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~ 201 (318)
T KOG0659|consen 158 ------------------------------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF 201 (318)
T ss_pred ------------------------------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC
Confidence 112388999999999986 7799999999999999999999999
Q ss_pred CCCCChhhhhhhhhc---------ccccccCCC---------------CCCCCHHHHHHHHHhhc-CccccCCCCCHHHH
Q 013064 276 FCSDDPRITCRKIVN---------WKTCLKFPE---------------EPKISDEARDLICHLLC-DVETRLGTRGVEEL 330 (450)
Q Consensus 276 F~~~~~~~~~~~i~~---------~~~~~~~p~---------------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei 330 (450)
|.|.+..+++..|.. |..--.+|+ .+..|+++.||+.+||. ||.+|+ ++.|+
T Consensus 202 fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri---ta~qa 278 (318)
T KOG0659|consen 202 FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI---TASQA 278 (318)
T ss_pred CCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc---cHHHH
Confidence 999999888888763 222112221 14568899999999999 999999 68999
Q ss_pred HcCCCcCC
Q 013064 331 KEHPWFRG 338 (450)
Q Consensus 331 l~Hpff~~ 338 (450)
++||||+.
T Consensus 279 L~~~yf~~ 286 (318)
T KOG0659|consen 279 LKHPYFKS 286 (318)
T ss_pred hcchhhhc
Confidence 99999986
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=389.10 Aligned_cols=274 Identities=37% Similarity=0.706 Sum_probs=231.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+..|+.+++.++|++|+.+++.+.+++.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 99999999988653 369999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.+||
T Consensus 157 -----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf 201 (285)
T cd05630 157 -----------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201 (285)
T ss_pred -----------------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 012357999999999999999999999999999999999999999
Q ss_pred CCCChhh---hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCcccccc--cc
Q 013064 277 CSDDPRI---TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYE--ME 348 (450)
Q Consensus 277 ~~~~~~~---~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~ 348 (450)
.+..... ....+... ....++ ..+++++++||.+||+ ||.+|++.. +++++++||||+.++|..+.. ..
T Consensus 202 ~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~ 278 (285)
T cd05630 202 QQRKKKIKREEVERLVKE-VQEEYS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLE 278 (285)
T ss_pred CCCCccchHHHHHhhhhh-hhhhcC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCC
Confidence 8654321 22222211 111223 3689999999999999 999999642 389999999999999998874 66
Q ss_pred CCcccc
Q 013064 349 AAYKPT 354 (450)
Q Consensus 349 ~p~~p~ 354 (450)
|||+|.
T Consensus 279 ~~~~~~ 284 (285)
T cd05630 279 PPFKPD 284 (285)
T ss_pred CCCCCC
Confidence 888885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=405.17 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=222.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCC-e
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD-F 112 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~-~ 112 (450)
.-.++|.+++.||.|+||.||+|+.+.+|+.||||.++++-. ..++. .-.+|+.-|++++ |||||+|++++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 345789999999999999999999999999999999987642 32222 2357888999998 999999999999988 9
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|+||||| ..+|+.+++.+ +.|+|+.++.|+.||+.||+|+|++|+.||||||||||+.....|||+|||||+.+.+.
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 99999999 45899888654 57999999999999999999999999999999999999998999999999999987654
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
.. -+.+|.|.+|.|||++.. .-|+.++|+||+|||++|+.
T Consensus 164 pP---------------------------------------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~ 204 (538)
T KOG0661|consen 164 PP---------------------------------------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY 204 (538)
T ss_pred CC---------------------------------------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHH
Confidence 21 124799999999999986 45799999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcc-----------------cccccCCCC---------CCCCHHHHHHHHHhhc-CccccCC
Q 013064 271 IGYPPFCSDDPRITCRKIVNW-----------------KTCLKFPEE---------PKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~-----------------~~~~~~p~~---------~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
+-++.|.|.+..+++.+|+.- ...+.+|.. +..++++.+||.+||. ||.+||
T Consensus 205 sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp- 283 (538)
T KOG0661|consen 205 SLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP- 283 (538)
T ss_pred HhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc-
Confidence 999999999998888887631 112333321 4579999999999999 999999
Q ss_pred CCCHHHHHcCCCcCC
Q 013064 324 TRGVEELKEHPWFRG 338 (450)
Q Consensus 324 ~~~~~eil~Hpff~~ 338 (450)
+|.++++||||..
T Consensus 284 --TA~~al~~pffq~ 296 (538)
T KOG0661|consen 284 --TASQALQHPFFQV 296 (538)
T ss_pred --cHHHHhcCccccc
Confidence 6899999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=389.96 Aligned_cols=270 Identities=29% Similarity=0.463 Sum_probs=233.6
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+-.+..++|++..+||.|..+.||+|++..++++||||++.-+.. ...++.+.+|...|+.++||||++++.+|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 346788999999999999999999999999999999999987764 344889999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+|+||.||.+|++.+++... ..|+|..++.++++++.||.|||++|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999763 469999999999999999999999999999999999999999999999999987665
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMY 267 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvily 267 (450)
..... .+.+ ..+++|||.|||||++.. .+|+.++||||||+...
T Consensus 178 ~~G~R---------------------------------~~~r-f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 178 DSGDR---------------------------------QVTR-FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred ccCce---------------------------------eeEe-eccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 43111 1111 157899999999999764 78999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhccccc------ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTC------LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~------~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
||.+|..||..-.+.+.+..-+++..+ +.......++..++.+|..||. ||.+|| +++++++|+||+...
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp---tAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP---TASKLLKHAFFKKAK 300 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC---CHHHHhccHHHhhcc
Confidence 999999999988888776655554332 1222234677889999999998 999999 689999999998754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=386.87 Aligned_cols=266 Identities=32% Similarity=0.589 Sum_probs=223.2
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||+|+||.||+|+.+.+|+.||+|.+.+..+........+..|+++++.++||||++++++|.++.++|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999876654444455667799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccc
Q 013064 126 MTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203 (450)
Q Consensus 126 ~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~ 203 (450)
.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---------- 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---------- 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----------
Confidence 98886543 588999999999999999999999999999999999999999999999999886543210
Q ss_pred cccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChh-
Q 013064 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR- 282 (450)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~- 282 (450)
.....||+.|+|||++.+..++.++|+|||||++|||++|..||.+....
T Consensus 151 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~ 201 (277)
T cd05607 151 -----------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV 201 (277)
T ss_pred -----------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh
Confidence 11357999999999999888999999999999999999999999765332
Q ss_pred ---hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC-HHHHHcCCCcCCCCcccccc--ccCCccc
Q 013064 283 ---ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG-VEELKEHPWFRGIQWDKLYE--MEAAYKP 353 (450)
Q Consensus 283 ---~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~-~~eil~Hpff~~i~w~~l~~--~~~p~~p 353 (450)
+....+... ...++ ...+++++++||++||. ||.+|+++.. .++++.||||++++|..+.. ..+||.|
T Consensus 202 ~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 202 AKEELKRRTLED--EVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred hHHHHHHHhhcc--ccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 222333321 22222 13689999999999998 9999997532 47899999999999998873 5677766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=386.97 Aligned_cols=257 Identities=28% Similarity=0.490 Sum_probs=215.8
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+++|++++.||.|+||.||+|+++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 46899999999999999999999999999999999975431 2234567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||||++| +|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 9999975 8999887654 589999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.
T Consensus 159 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 201 (288)
T cd07871 159 -------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201 (288)
T ss_pred -------------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence 0123578999999999875 56899999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
+||.+.+..+....+..... ...+|. .+.++++++|||++||+ ||.+|+ +
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~---t 278 (288)
T cd07871 202 PMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI---S 278 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC---C
Confidence 99998877665554432100 001111 13578999999999999 999999 6
Q ss_pred HHHHHcCCCc
Q 013064 327 VEELKEHPWF 336 (450)
Q Consensus 327 ~~eil~Hpff 336 (450)
++|+++||||
T Consensus 279 ~~~~l~hp~f 288 (288)
T cd07871 279 AEAALRHSYF 288 (288)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=388.47 Aligned_cols=261 Identities=27% Similarity=0.417 Sum_probs=212.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+... ......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999976432 22334577899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||++ ++|.+++.+. +.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--- 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence 99995 6788877654 579999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
....+.+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus 158 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 158 -----------------------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred -----------------------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 00124579999999999875 458999999999999999999999
Q ss_pred CCCCCChh-hhhhhhhcc---------ccccc------------CCC-------CCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 275 PFCSDDPR-ITCRKIVNW---------KTCLK------------FPE-------EPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 275 PF~~~~~~-~~~~~i~~~---------~~~~~------------~p~-------~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
||.+.... .....+... ..... .|. ....+++++|||.+||+ ||.+|+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~-- 280 (303)
T cd07869 203 AFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL-- 280 (303)
T ss_pred CCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc--
Confidence 99875432 222222110 00000 000 01346789999999998 999999
Q ss_pred CCHHHHHcCCCcCCCCc
Q 013064 325 RGVEELKEHPWFRGIQW 341 (450)
Q Consensus 325 ~~~~eil~Hpff~~i~w 341 (450)
+++++++||||+++++
T Consensus 281 -s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 281 -SAQAALSHEYFSDLPP 296 (303)
T ss_pred -CHHHHhcCcccccCCh
Confidence 6899999999998774
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=384.40 Aligned_cols=258 Identities=34% Similarity=0.486 Sum_probs=216.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+++.||+|++++... .....+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 579999999999999999999999999999999976542 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++++.+..+......++++.++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+|.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--- 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc---
Confidence 99999877666555668999999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.....+||+.|+|||++.+..++.++|+|||||++|||++|.+||.
T Consensus 157 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 157 ----------------------------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred ----------------------------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 0123579999999999999899999999999999999999999998
Q ss_pred CCChhhhhhhhhcccc-----------------cccCCC-----------CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 278 SDDPRITCRKIVNWKT-----------------CLKFPE-----------EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~-----------------~~~~p~-----------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
+.+..+....+..... ...+|. ...+|++++|||++||. ||.+|+ +++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~---s~~ 279 (287)
T cd07848 203 GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY---LTE 279 (287)
T ss_pred CCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC---CHH
Confidence 8765444333321100 011111 01378899999999999 999999 689
Q ss_pred HHHcCCCc
Q 013064 329 ELKEHPWF 336 (450)
Q Consensus 329 eil~Hpff 336 (450)
++++||||
T Consensus 280 ~~l~hp~f 287 (287)
T cd07848 280 QCLNHPAF 287 (287)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=383.14 Aligned_cols=303 Identities=40% Similarity=0.724 Sum_probs=252.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|+++++.++||||+++++.+.+++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999998776544556678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++...........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998743211110000
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
... ... ...........|++.|+|||.+.+..++.++|+|||||++|||++|..||.
T Consensus 161 ~~~------------~~~-----------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 161 EGH------------IEK-----------DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred ccc------------ccc-----------chhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 000 000 000001123578999999999998899999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCC-CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCCccccC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTV 355 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~ 355 (450)
+.+..+....+.... ...|.. ..+++++++||.+||. ||.+|++..++.+++.||||...+|..+.....++.|.+
T Consensus 218 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 295 (305)
T cd05609 218 GDTPEELFGQVISDD--IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQL 295 (305)
T ss_pred CCCHHHHHHHHHhcc--cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCC
Confidence 888777777665532 222321 2578999999999998 999999887899999999999999999887777888888
Q ss_pred CCcccCCCCC
Q 013064 356 NGELDTQNFE 365 (450)
Q Consensus 356 ~~~~d~~~f~ 365 (450)
....+.++||
T Consensus 296 ~~~~~~~~~~ 305 (305)
T cd05609 296 ESEDDTSYFD 305 (305)
T ss_pred CCccccccCC
Confidence 7777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-51 Score=376.66 Aligned_cols=255 Identities=34% Similarity=0.538 Sum_probs=220.8
Q ss_pred CCCCCCeEEE-eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEc--
Q 013064 34 KIGIDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQD-- 109 (450)
Q Consensus 34 ~~~~~~f~~~-~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~-- 109 (450)
.-..+||.+- ++||-|-.|+|..|.++.||+.||+|++.-. ...++|.++--. ..|||||.++++|.+
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3445788876 5899999999999999999999999998643 346677776543 479999999998764
Q ss_pred --CCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeec
Q 013064 110 --SDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDF 182 (450)
Q Consensus 110 --~~~lylVmEy~~gg~L~~~l~~~~~--~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DF 182 (450)
...+.+|||.|+||+|+..++.++. |+|.+|..++.||..|+.|||+.+|.||||||||+|... +..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 5679999999999999999998765 999999999999999999999999999999999999964 457999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|+|+.-... ....+.|-||.|.|||++..+.|+..+|+|||
T Consensus 209 GFAK~t~~~---------------------------------------~~L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 209 GFAKETQEP---------------------------------------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred ccccccCCC---------------------------------------ccccCCcccccccCHHHhCchhcCCCCCccch
Confidence 999975532 12347899999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCC----hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 263 GAIMYEMLIGYPPFCSDD----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
||++|-||+|++||++.. +..+-.+|..+...+.-|+|..+|++++|+|++||. +|.+|+ ++++++.|||++
T Consensus 250 gVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl---TI~~~m~hpwi~ 326 (400)
T KOG0604|consen 250 GVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL---TIEEVMDHPWIN 326 (400)
T ss_pred hHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe---eHHHhhcCchhc
Confidence 999999999999998754 334667888876666667788999999999999998 999999 699999999997
Q ss_pred C
Q 013064 338 G 338 (450)
Q Consensus 338 ~ 338 (450)
.
T Consensus 327 ~ 327 (400)
T KOG0604|consen 327 Q 327 (400)
T ss_pred c
Confidence 6
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=380.45 Aligned_cols=261 Identities=30% Similarity=0.480 Sum_probs=221.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-----CCe
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-----SDF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-----~~~ 112 (450)
..|..++.||+|+||.|+.+.++.||+.||||++... .......++..+|+.+|+.++|+||+.+++.+.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4556689999999999999999999999999998643 2345567889999999999999999999999976 346
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+|+|+| +.||...++.+..++++.+++++.||+.||.|+|+.||+||||||.|+|++.++.+||+|||+|+.....
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 99999999 7799999988888999999999999999999999999999999999999999999999999999987542
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~ 271 (450)
.. ..-.+..+-|.+|.|||++.. ..|+.++|+||+|||+.|||+
T Consensus 179 ~~-----------------------------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~ 223 (359)
T KOG0660|consen 179 FE-----------------------------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT 223 (359)
T ss_pred Cc-----------------------------------ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc
Confidence 00 011235799999999999874 789999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccc---------------------cccCCC------CCCCCHHHHHHHHHhhc-CccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKT---------------------CLKFPE------EPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p~------~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
|++.|.|.+....+..|+..-+ ....|. .+.+++.|.||+.+||. ||.+|+
T Consensus 224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi- 302 (359)
T KOG0660|consen 224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI- 302 (359)
T ss_pred CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC-
Confidence 9999999887666655542100 011111 25789999999999999 999999
Q ss_pred CCCHHHHHcCCCcCCC
Q 013064 324 TRGVEELKEHPWFRGI 339 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i 339 (450)
+++|+++||||+..
T Consensus 303 --ta~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 303 --TAEEALAHPYLAPY 316 (359)
T ss_pred --CHHHHhcChhhhhh
Confidence 79999999999763
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=379.91 Aligned_cols=275 Identities=34% Similarity=0.657 Sum_probs=233.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|+..+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.+|+.++|++|+.++++|.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987665444455667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 99999999888653 469999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
...+..|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 -----------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~ 201 (285)
T cd05632 157 -----------------------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201 (285)
T ss_pred -----------------------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 012357999999999999889999999999999999999999999
Q ss_pred CCCChhhhhhhhhccc--ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCccccc--cccC
Q 013064 277 CSDDPRITCRKIVNWK--TCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEA 349 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~--~~~~ 349 (450)
.+.........+.... ....++ ..+++++.+||.+||. ||.+|++.. .+.+++.||||+.++|..+. +..|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 279 (285)
T cd05632 202 RGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDP 279 (285)
T ss_pred CCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCC
Confidence 8766544333332211 112222 4688999999999998 999999742 38999999999999999876 3678
Q ss_pred Ccccc
Q 013064 350 AYKPT 354 (450)
Q Consensus 350 p~~p~ 354 (450)
||.|.
T Consensus 280 ~~~~~ 284 (285)
T cd05632 280 PFVPD 284 (285)
T ss_pred CCCCC
Confidence 88875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=375.05 Aligned_cols=260 Identities=31% Similarity=0.558 Sum_probs=220.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
..||+|+|+.|-.|....||+.||+|++.|.. .....++.+|.+++..+ .|+||++|+++|+++...|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 47999999999999999999999999998863 34567899999999998 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc---eEEeeccccccCccccccccccc
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~---ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
|.|..+|.++..|+|.+|..++..|+.||.|||.+||.||||||||||-....+ ||||||.|...+.....-
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~----- 235 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC----- 235 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC-----
Confidence 999999999999999999999999999999999999999999999999876554 799999987654322111
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHHHHHhhCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
+ +-.+| -..+.||+.+|||||++. ..-|+..+|.||||||||-||.|++
T Consensus 236 ---------s----pastP-------------~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 236 ---------S----PASTP-------------ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred ---------C----CCCCc-------------cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 0 00111 123689999999999985 2458999999999999999999999
Q ss_pred CCCCCC---------------hhhhhhhhhcccccccCC--CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 275 PFCSDD---------------PRITCRKIVNWKTCLKFP--EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 275 PF~~~~---------------~~~~~~~i~~~~~~~~~p--~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
||.|.- ...++..|..+. ++|| +|..+|.+++|||+.||. |+.+|+ ++..+++|||+
T Consensus 290 PFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rl---sa~~vlnhPw~ 364 (463)
T KOG0607|consen 290 PFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRL---SAAQVLNHPWV 364 (463)
T ss_pred CccCccCCcCCccCCCccHHHHHHHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhh---hhhhccCCccc
Confidence 997642 234566777754 5566 467899999999999998 999999 68899999999
Q ss_pred CCCCcc
Q 013064 337 RGIQWD 342 (450)
Q Consensus 337 ~~i~w~ 342 (450)
+.+.-+
T Consensus 365 ~~~~~e 370 (463)
T KOG0607|consen 365 QRCAPE 370 (463)
T ss_pred cccchh
Confidence 987654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=381.27 Aligned_cols=308 Identities=39% Similarity=0.695 Sum_probs=247.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|..+++.++||+|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998876554456778999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 118 EYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||+.|++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998764 579999999999999999999999999999999999999999999999999998654321110
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
...... ...... .. ..-...............+||..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 161 ~~~~~~----~~~~~~---~~--~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 161 SKALRK----GSRRSS---VN--SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccc----cccccc---cc--ccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 000000 000000 00 000000000011122346899999999999998899999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CCHHHHHcCCCcCCCCccccccccCCccc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLYEMEAAYKP 353 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~~~~p~~p 353 (450)
|.+.+....+.++.. ....++....+++.+++||.+||+ ||.+|++. .++++++.||||++++|..+....+|-.|
T Consensus 232 f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~ 309 (316)
T cd05574 232 FKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIP 309 (316)
T ss_pred CCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCC
Confidence 998888777777765 234455544589999999999998 99999953 23899999999999999999887777766
Q ss_pred cCC
Q 013064 354 TVN 356 (450)
Q Consensus 354 ~~~ 356 (450)
.+.
T Consensus 310 ~~~ 312 (316)
T cd05574 310 RPD 312 (316)
T ss_pred Ccc
Confidence 554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=385.29 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=213.9
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----CeE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DFL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~~l 113 (450)
+|++.+.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 2233445688999999999999999999988543 358
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||| +++|..++.+.+.++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 579999998888999999999999999999999999999999999999999999999999999986432210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHHHhh
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~ 271 (450)
.. ......+||+.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 159 ~~-----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 159 TA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred cc-----------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence 00 01124689999999999976 678999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcc--------------------------cccccCC-CCCCCCHHHHHHHHHhhc-CccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNW--------------------------KTCLKFP-EEPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~--------------------------~~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
|++||.+.+.......+... .....+. ..+.+++.+.+||.+||. ||.+|+
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp- 282 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP- 282 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC-
Confidence 99999876643322211100 0000000 113578899999999998 999999
Q ss_pred CCCHHHHHcCCCcCCCCc
Q 013064 324 TRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i~w 341 (450)
+++++++||||+++..
T Consensus 283 --t~~e~l~hp~f~~~~~ 298 (338)
T cd07859 283 --TAEEALADPYFKGLAK 298 (338)
T ss_pred --CHHHHhcCchhhhcCc
Confidence 6899999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=392.83 Aligned_cols=257 Identities=32% Similarity=0.498 Sum_probs=234.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe-EEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF-LYL 115 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~-lyl 115 (450)
+++|+.++++|+|+||.+++++++..++.|++|.+.-.....+ .......|..+++++.|||||..++.|..++. +|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 5789999999999999999999999999999999987765444 33478899999999999999999999998887 999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 116 IMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
||+||+||+|...|.+. ..|+|+.+..|+.|++.||.|||+++|+|||||+.||++..++.|||.|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999999999999765 479999999999999999999999999999999999999999999999999999887642
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
..+.+.+|||.||.||++.+.+|+.++|+|||||++|||++-+
T Consensus 161 -------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 161 -------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred -------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcc
Confidence 1355789999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|.+.+...+..+|.+.. -.|.....|.+++.||+.||. +|..|| ++.+++.+|....
T Consensus 204 ~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RP---sa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 204 PAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRP---SALELLRRPHLLR 263 (426)
T ss_pred cccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCC---CHHHHhhChhhhh
Confidence 9999999999999998743 345556899999999999998 999999 6899999998763
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=382.80 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=221.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||+|+++.+|..||+|++.... .......+.+|.++|+.++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999987542 2334567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999999999888899999999999999999999986 69999999999999999999999999987653220
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....+||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 159 ---------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 199 (331)
T cd06649 159 ---------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199 (331)
T ss_pred ---------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 12457999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhc------------------------------------------c---cccccCCCCCCCCHHHH
Q 013064 274 PPFCSDDPRITCRKIVN------------------------------------------W---KTCLKFPEEPKISDEAR 308 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~------------------------------------------~---~~~~~~p~~~~~s~~~~ 308 (450)
.||...+..+....+.. + ......+ ...++++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~ 278 (331)
T cd06649 200 YPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFTPDFQ 278 (331)
T ss_pred CCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-CccccHHHH
Confidence 99976654332211100 0 0000111 124789999
Q ss_pred HHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 309 DLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 309 dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
+||.+||. ||++|+ ++++|++||||+....
T Consensus 279 ~li~~~L~~~P~~Rp---t~~ell~h~~~~~~~~ 309 (331)
T cd06649 279 EFVNKCLIKNPAERA---DLKMLMNHTFIKRSEV 309 (331)
T ss_pred HHHHHHccCCcccCC---CHHHHhcChHHhhccc
Confidence 99999999 999999 7899999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=372.33 Aligned_cols=261 Identities=31% Similarity=0.520 Sum_probs=221.7
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCC----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSD---- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~---- 111 (450)
+..|+.+..||+|+||+||.|+.+.+|+.||+|++.-..- .++......+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 5678888999999999999999999999999999976532 1334567899999999999999 999999999888
Q ss_pred --eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 112 --FLYLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 112 --~lylVmEy~~gg~L~~~l~~~~----~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
.+|+|+||+ .-||..++.... .++...++.++.||+.||+|||++||+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 459999997755 5788899999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGA 264 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGv 264 (450)
+...-.. ....+-++|.+|.|||++.+. .|+..+|+||+||
T Consensus 168 ra~~ip~--------------------------------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~Gc 209 (323)
T KOG0594|consen 168 RAFSIPM--------------------------------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGC 209 (323)
T ss_pred HHhcCCc--------------------------------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHH
Confidence 8543220 002346899999999999985 7999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhc---------ccccc-------cCCCC----------CCCCHHHHHHHHHhhc-C
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVN---------WKTCL-------KFPEE----------PKISDEARDLICHLLC-D 317 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~---------~~~~~-------~~p~~----------~~~s~~~~dli~~lL~-d 317 (450)
|++||+++.+.|.|.+..++..+|.. |.... .++.+ +..++++.||+.+||+ +
T Consensus 210 IfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~ 289 (323)
T KOG0594|consen 210 IFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYD 289 (323)
T ss_pred HHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccC
Confidence 99999999999999998888877752 22222 22211 2344689999999999 9
Q ss_pred ccccCCCCCHHHHHcCCCcCCCC
Q 013064 318 VETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 318 p~~R~~~~~~~eil~Hpff~~i~ 340 (450)
|.+|+ ++..++.||||..+.
T Consensus 290 p~~R~---Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 290 PAKRI---SAKGALTHPYFSELP 309 (323)
T ss_pred cccCc---CHHHHhcChhhcccc
Confidence 99999 789999999998864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=388.86 Aligned_cols=257 Identities=30% Similarity=0.473 Sum_probs=230.5
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
-..|..+..||+|+||.||++.+..|++.||+|++.-.. ....++.+..|+.+|..++++||.++|++|-.+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 357888899999999999999999999999999998764 355788899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||||.||++.++|.....++|.++..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--- 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--- 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh---
Confidence 99999999999998888889999999999999999999999999999999999999999999999999987654311
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
+..+++|||.||||||+.+.+|+.++||||||+++|||++|.||+
T Consensus 167 -----------------------------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~ 211 (467)
T KOG0201|consen 167 -----------------------------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH 211 (467)
T ss_pred -----------------------------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC
Confidence 124799999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
....+...+..|-+.. +..+. ..+|+.+++||..||. ||+.|+ +|.++++|+|++..
T Consensus 212 s~~hPmrvlflIpk~~-PP~L~--~~~S~~~kEFV~~CL~k~P~~Rp---sA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 212 SKLHPMRVLFLIPKSA-PPRLD--GDFSPPFKEFVEACLDKNPEFRP---SAKELLKHKFIKRA 269 (467)
T ss_pred cccCcceEEEeccCCC-CCccc--cccCHHHHHHHHHHhhcCcccCc---CHHHHhhhHHHHhc
Confidence 9988866666665422 22222 3789999999999998 999999 68999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=398.92 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=211.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC---
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--- 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--- 110 (450)
.....+|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 344578999999999999999999999999999999886432 2345799999999999999999887542
Q ss_pred -----CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEe
Q 013064 111 -----DFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLS 180 (450)
Q Consensus 111 -----~~lylVmEy~~gg~L~~~l~----~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~ 180 (450)
.++|+||||+++ +|..++. ....+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 358899999975 6666554 356799999999999999999999999999999999999999765 69999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDW 259 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~Di 259 (450)
|||+|+.+.... ...+.+||+.|+|||++.+ ..|+.++||
T Consensus 214 DFGla~~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 254 (440)
T PTZ00036 214 DFGSAKNLLAGQ---------------------------------------RSVSYICSRFYRAPELMLGATNYTTHIDL 254 (440)
T ss_pred ccccchhccCCC---------------------------------------CcccCCCCcCccCHHHhcCCCCCCcHHHH
Confidence 999998654321 0124689999999999876 469999999
Q ss_pred cchhHHHHHHhhCCCCCCCCChhhhhhhhhcccc---------------cccCCC----------CCCCCHHHHHHHHHh
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT---------------CLKFPE----------EPKISDEARDLICHL 314 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~~l 314 (450)
|||||++|||++|++||.+.+..+.+.+++.... .+.+|. ....++++++||.+|
T Consensus 255 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~ 334 (440)
T PTZ00036 255 WSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQF 334 (440)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHH
Confidence 9999999999999999999877666665543110 111121 124688999999999
Q ss_pred hc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 315 LC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 315 L~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
|+ ||.+|+ ++.|+++||||..+..
T Consensus 335 L~~dP~~R~---ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 335 LKYEPLKRL---NPIEALADPFFDDLRD 359 (440)
T ss_pred CCCChhHCc---CHHHHhCChhHHhhhc
Confidence 99 999999 6899999999987654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=391.34 Aligned_cols=260 Identities=28% Similarity=0.510 Sum_probs=237.1
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
........|.+++.||+|.|++|.++++..|+..||||++.|..+. .....++.+|+++|..++|||||+|+.+..+..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 3445678999999999999999999999999999999999998754 344456899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||+.||+++++|.++++..|..++.++.|++.|++|||+++|||||||++||||+.+-++||+|||++..+...
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987643
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml 270 (450)
.+..+.||+|.|.|||+..+..| +..+|+||||++||-|+
T Consensus 209 ---------------------------------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV 249 (596)
T KOG0586|consen 209 ---------------------------------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV 249 (596)
T ss_pred ---------------------------------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee
Confidence 12347899999999999999888 89999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.|..||.+.+..+...+.+.++ +.+|. .+|.++++||++||. +|.+|. +.++|++|.|...
T Consensus 250 ~GsLPFDG~~lk~Lr~rvl~gk--~rIp~--~ms~dce~lLrk~lvl~Pskr~---~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 250 EGSLPFDGQNLKELRPRVLRGK--YRIPF--YMSCDCEDLLRKFLVLNPSKRG---PCDQIMKDRWRND 311 (596)
T ss_pred ecccccCCcccccccchheeee--ecccc--eeechhHHHHHHhhccCccccC---CHHHhhhhcccch
Confidence 9999999999999888888754 44443 689999999999998 999999 6899999999874
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=371.93 Aligned_cols=251 Identities=31% Similarity=0.531 Sum_probs=213.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--C---eE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--D---FL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~---~l 113 (450)
.|.-.+++|.|+||.||.+....+++.+|||..-...- .-.+|..||+.++|||||+|.++|... + ++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 58889999999999999999999999999998754432 234699999999999999999999742 2 56
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-CceEEeeccccccC
Q 013064 114 YLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPL 188 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~-g~ikL~DFGla~~~ 188 (450)
.+||||+|. +|...++. +..++.-.++.|+.||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 789999975 88888764 5789999999999999999999999999999999999999976 89999999999987
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 267 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvily 267 (450)
..... ..+...|..|.|||.+.+ ..|+.++|+||.||++.
T Consensus 177 ~~~ep---------------------------------------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~a 217 (364)
T KOG0658|consen 177 VKGEP---------------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMA 217 (364)
T ss_pred ccCCC---------------------------------------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHH
Confidence 65421 125788999999999987 78999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhccc---------------ccccCCC----------CCCCCHHHHHHHHHhhc-Ccccc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWK---------------TCLKFPE----------EPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dli~~lL~-dp~~R 321 (450)
||+-|++.|.|++...++..|++.- ....+|. ...+++++.||+.++|. +|.+|
T Consensus 218 ELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 218 ELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred HHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhc
Confidence 9999999999999888777776310 0122221 14678999999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCC
Q 013064 322 LGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i 339 (450)
+ ++.|++.||||...
T Consensus 298 ~---~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 298 L---SALEALAHPFFDEL 312 (364)
T ss_pred C---CHHHHhcchhhHHh
Confidence 9 68999999999764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=388.57 Aligned_cols=258 Identities=25% Similarity=0.348 Sum_probs=211.8
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+..+...+|++++.||+|+||.||+|++..+++.||+|.... ..+.+|+.+|+.++|||||+++++|..+.
T Consensus 86 ~~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred hcccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 344666889999999999999999999999999999997532 34678999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
..|+|||++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 157 ~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 157 FTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred eeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 999999999 4789999988888999999999999999999999999999999999999999999999999999753221
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
.. ......+||+.|+|||++.+..|+.++|+|||||++|||++
T Consensus 236 ~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 278 (391)
T PHA03212 236 NA-------------------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278 (391)
T ss_pred cc-------------------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 00 01124689999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-------hhhhhhhhccc------------------------ccc----cCCCC---CCCCHHHHHHHHH
Q 013064 272 GYPPFCSDDP-------RITCRKIVNWK------------------------TCL----KFPEE---PKISDEARDLICH 313 (450)
Q Consensus 272 G~~PF~~~~~-------~~~~~~i~~~~------------------------~~~----~~p~~---~~~s~~~~dli~~ 313 (450)
|..||.+.+. ......++... ... ..|.+ ..++.++.+||.+
T Consensus 279 g~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~ 358 (391)
T PHA03212 279 CHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICK 358 (391)
T ss_pred CCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHH
Confidence 9988754321 11111111100 000 00100 1356789999999
Q ss_pred hhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 314 LLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 314 lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||+ ||.+|+ +++|++.||||..+
T Consensus 359 mL~~dP~~Rp---ta~elL~hp~f~~~ 382 (391)
T PHA03212 359 MLAFDAHHRP---SAEALLDFAAFQDI 382 (391)
T ss_pred HhcCChhhCC---CHHHHhcChhhccC
Confidence 999 999999 78999999999874
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=370.63 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=209.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcC-CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEE-----
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQ----- 108 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~-t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~----- 108 (450)
++|++++.||+|+||.||+|++.. +|+.+|+|+++.... .........+|..+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 568899999875432 223344566788877766 6999999999985
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
....+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 6899998763 458999999999999999999999999999999999999999999999999987
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvil 266 (450)
...... .....+||+.|+|||++.+..++.++|+|||||++
T Consensus 159 ~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 199 (290)
T cd07862 159 IYSFQM---------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIF 199 (290)
T ss_pred eccCCc---------------------------------------ccccccccccccChHHHhCCCCCCccchHHHHHHH
Confidence 643210 11246799999999999989999999999999999
Q ss_pred HHHhhCCCCCCCCChhhhhhhhhcccc---------cccCCC--------------CCCCCHHHHHHHHHhhc-CccccC
Q 013064 267 YEMLIGYPPFCSDDPRITCRKIVNWKT---------CLKFPE--------------EPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~~~~~i~~~~~---------~~~~p~--------------~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
|||++|.+||.+.+..+.+.+|..... ...++. .+.+++.+++||.+||+ ||++|+
T Consensus 200 ~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 279 (290)
T cd07862 200 AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279 (290)
T ss_pred HHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC
Confidence 999999999998887777766653211 000000 13578899999999999 999999
Q ss_pred CCCCHHHHHcCCCc
Q 013064 323 GTRGVEELKEHPWF 336 (450)
Q Consensus 323 ~~~~~~eil~Hpff 336 (450)
++.++++||||
T Consensus 280 ---s~~~~l~hp~f 290 (290)
T cd07862 280 ---SAYSALSHPYF 290 (290)
T ss_pred ---CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=368.43 Aligned_cols=267 Identities=37% Similarity=0.678 Sum_probs=225.1
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||+|+||+||+|.++.+|+.||+|++.+...........+..|..+|+.++||+|++++++|...+.+|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554445566678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccc
Q 013064 126 MTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203 (450)
Q Consensus 126 ~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~ 203 (450)
.+++.+.. .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------- 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----------- 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----------
Confidence 99997765 79999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhh
Q 013064 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283 (450)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 283 (450)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.....
T Consensus 150 ----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 201 (277)
T cd05577 150 ----------------------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV 201 (277)
T ss_pred ----------------------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc
Confidence 0113468899999999988889999999999999999999999998765422
Q ss_pred hhhhhhccc--ccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-C-CHHHHHcCCCcCCCCcccccc--ccCCccc
Q 013064 284 TCRKIVNWK--TCLKFPEEPKISDEARDLICHLLC-DVETRLGT-R-GVEELKEHPWFRGIQWDKLYE--MEAAYKP 353 (450)
Q Consensus 284 ~~~~i~~~~--~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~-~-~~~eil~Hpff~~i~w~~l~~--~~~p~~p 353 (450)
....+.... ....+| ..+++.+++||.+||. ||.+|++. . ++.+++.||||+.++|..+.. ..|||.|
T Consensus 202 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 202 EKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cHHHHHhccccccccCC--ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 222222211 122233 3689999999999998 99999974 2 588999999999999998874 5677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=363.53 Aligned_cols=258 Identities=46% Similarity=0.834 Sum_probs=221.7
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH-hcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
++.||.|+||.||+|.+..+|+.||+|++.+..............|..++. ..+||||+++++++..++.+|+||||++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 367999999999999999999999999998765444444445566666554 4589999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 122 gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
||+|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---------- 150 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---------- 150 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc----------
Confidence 9999999988888999999999999999999999999999999999999999999999999998753221
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCCh
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 281 (450)
....|++.|+|||.+.+..++.++|+||||+++|+|++|.+||...+.
T Consensus 151 --------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 151 --------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred --------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 135789999999999988899999999999999999999999998887
Q ss_pred hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 282 ~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
......+..............+++++.++|.+||. +|.+|+++.+++|++.||||++++|+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 199 DAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 77766665432222212223689999999999998 99999998889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=384.49 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=217.8
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----eE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-----FL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-----~l 113 (450)
+|++++.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+|+.++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 6899999999999999999999999999999986532 22234567889999999999999999999999877 89
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 68999888888999999999999999999999999999999999999999999999999999986432210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G 272 (450)
......+||+.|+|||++.+. .|+.++|+|||||++|||++|
T Consensus 159 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 201 (372)
T cd07853 159 -------------------------------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201 (372)
T ss_pred -------------------------------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC
Confidence 001235789999999999874 579999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccc---------------------cccC-------CCCCCCCHHHHHHHHHhhc-CccccCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKT---------------------CLKF-------PEEPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~---------------------~~~~-------p~~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
++||.+.+.......|..... .... ......++++.+||.+||+ ||.+|+
T Consensus 202 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~- 280 (372)
T cd07853 202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI- 280 (372)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc-
Confidence 999998877665555432100 0000 1113468899999999999 999999
Q ss_pred CCCHHHHHcCCCcCCCCc
Q 013064 324 TRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i~w 341 (450)
++.+++.||||.+..+
T Consensus 281 --t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 281 --SAADALAHPYLDEGRL 296 (372)
T ss_pred --CHHHHhcCHhhCCCcc
Confidence 6899999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=367.89 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=208.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEc-----C
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQD-----S 110 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~-----~ 110 (450)
+|++++.||+|+||.||+|+++.+|+.||+|.+++... .......+.+|..+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999876432 222233456677777655 79999999999875 3
Q ss_pred CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
..+++||||+++ +|.+++.+. ..++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999974 898888764 35899999999999999999999999999999999999999999999999998865
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
.... .....+||+.|+|||++.+..++.++|+|||||++|+
T Consensus 159 ~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 159 SCQM---------------------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 199 (288)
T ss_pred cCcc---------------------------------------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHH
Confidence 4321 0123578999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhccc---------ccccCCC--------------CCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWK---------TCLKFPE--------------EPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~---------~~~~~p~--------------~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
|++|.+||.+.+......++.... .....+. .+.++..+++||.+||+ ||.+|+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-- 277 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI-- 277 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC--
Confidence 999999998877766655554311 0011000 13578889999999999 999999
Q ss_pred CCHHHHHcCCCc
Q 013064 325 RGVEELKEHPWF 336 (450)
Q Consensus 325 ~~~~eil~Hpff 336 (450)
++.+++.||||
T Consensus 278 -t~~~~l~hp~f 288 (288)
T cd07863 278 -SAFRALQHPFF 288 (288)
T ss_pred -CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=381.74 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=210.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
...+++|+.++.||+|+||.||+|++..+|+.||||++.+.. .......+.+|+.+|+.++|+||++++++|.+++.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 445689999999999999999999999999999999986542 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||+.||+|... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999999999998643 3467888899999999999999999999999999999999999999999999986543210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCccccccchhHHHHH
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~DiWSlGvilye 268 (450)
.....+||+.|+|||++.. ..++.++|||||||++||
T Consensus 224 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~e 265 (353)
T PLN00034 224 --------------------------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265 (353)
T ss_pred --------------------------------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHH
Confidence 0124589999999999853 234678999999999999
Q ss_pred HhhCCCCCCCCChhhh---hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 269 MLIGYPPFCSDDPRIT---CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~---~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|++|..||........ ...+.. ......+ ..++.++++||.+||. ||.+|+ ++.||++||||.+
T Consensus 266 l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rp---t~~ell~hp~~~~ 333 (353)
T PLN00034 266 FYLGRFPFGVGRQGDWASLMCAICM-SQPPEAP--ATASREFRHFISCCLQREPAKRW---SAMQLLQHPFILR 333 (353)
T ss_pred HHhCCCCCCCCCCccHHHHHHHHhc-cCCCCCC--CccCHHHHHHHHHHccCChhhCc---CHHHHhcCccccc
Confidence 9999999974332221 112211 1112222 4689999999999998 999999 6899999999987
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=380.37 Aligned_cols=257 Identities=27% Similarity=0.457 Sum_probs=212.7
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS----- 110 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~----- 110 (450)
..++|.+++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3589999999999999999999999999999999997643 2334456788899999999999999999988654
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 -DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 -~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 358999999965 67776643 48899999999999999999999999999999999999999999999999998653
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... .....+||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 178 ~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 178 TSF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred CCC---------------------------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence 321 11246899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhccccc----------------------------------ccCCC----CCCCCHHHHHHH
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTC----------------------------------LKFPE----EPKISDEARDLI 311 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~----~~~~s~~~~dli 311 (450)
++|..||.+.+..+.+.+++..... ..++. ....+..+++||
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 9999999988776665555421000 00000 012356899999
Q ss_pred HHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 312 CHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 312 ~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+||+ ||.+|+ ++++++.||||..
T Consensus 299 ~~mL~~dP~~R~---t~~e~L~hp~~~~ 323 (364)
T cd07875 299 SKMLVIDASKRI---SVDEALQHPYINV 323 (364)
T ss_pred HHhcCcCcccCC---CHHHHhcCccccc
Confidence 99999 999999 6899999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=374.96 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=218.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||++.+..++..+|+|++.... .......+.+|.++|+.++||||++++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45689999999999999999999999999999999987542 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|.+++.+.+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999999999888899999999999999999999975 79999999999999999999999999987543210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 159 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 199 (333)
T cd06650 159 ---------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199 (333)
T ss_pred ---------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 12357999999999999888999999999999999999999
Q ss_pred CCCCCCChhhhhhh--------------------------------------------hhcccccccCCCCCCCCHHHHH
Q 013064 274 PPFCSDDPRITCRK--------------------------------------------IVNWKTCLKFPEEPKISDEARD 309 (450)
Q Consensus 274 ~PF~~~~~~~~~~~--------------------------------------------i~~~~~~~~~p~~~~~s~~~~d 309 (450)
.||........... +.+. ....++. ..++.++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~ 277 (333)
T cd06650 200 YPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPS-GVFGAEFQD 277 (333)
T ss_pred CCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC-CCccCCC-CCcCHHHHH
Confidence 99976544322111 0000 0011111 236789999
Q ss_pred HHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 310 LICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 310 li~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||.+||. ||.+|+ ++++++.||||+..
T Consensus 278 li~~~L~~~P~~Rp---t~~ell~h~~~~~~ 305 (333)
T cd06650 278 FVNKCLIKNPAERA---DLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHhccCCcccCc---CHHHHhhCHHHhcC
Confidence 9999999 999999 69999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=393.32 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=206.4
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC------CCeeeEEEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS------RCIVQLFYSFQ 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~f~ 108 (450)
+..++|++++.||+|+||+||+|.+..+++.||||++++.. ........|+.+++.+.| ++|++++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999996532 123345667777777644 56899999998
Q ss_pred cC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCC-----------
Q 013064 109 DS-DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNG----------- 175 (450)
Q Consensus 109 ~~-~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g----------- 175 (450)
.+ .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 5799999998 88999999888899999999999999999999998 6999999999999998766
Q ss_pred -----ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc
Q 013064 176 -----HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250 (450)
Q Consensus 176 -----~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~ 250 (450)
.+||+|||++...... ....+||+.|+|||++.+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~-----------------------------------------~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS-----------------------------------------RTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred CCCCceEEECCCCccccCccc-----------------------------------------cccccCCccccCcHHhhc
Confidence 4999999987642211 124689999999999999
Q ss_pred CCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccc-----------------------c---CCC-----
Q 013064 251 KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL-----------------------K---FPE----- 299 (450)
Q Consensus 251 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------------------~---~p~----- 299 (450)
..|+.++|||||||++|||++|++||.+.+..+....|......+ . .|.
T Consensus 320 ~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARI 399 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhh
Confidence 999999999999999999999999998877655444332210000 0 000
Q ss_pred -------CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 300 -------EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 300 -------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
...-++.+.|||.+||+ ||.+|+ +++|+++||||..
T Consensus 400 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 400 ARARPVREVIRDDLLCDLIYGLLHYDRQKRL---NARQMTTHPYVLK 443 (467)
T ss_pred hcccchhhhhchHHHHHHHHHhCCcChhhCC---CHHHHhcCccccc
Confidence 00124567899999999 999999 7999999999975
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=364.13 Aligned_cols=258 Identities=37% Similarity=0.689 Sum_probs=212.0
Q ss_pred EEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh---cCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE---VDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~---l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
.||+|+||.||++.+..+|+.||+|++.+.............+|..+++. .+||+|+.++++|.+++.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999987654333333334455544443 479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 122 gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
||+|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--------- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence 99999999888899999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-cCCCCccccccchhHHHHHHhhCCCCCCCCC
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 280 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 280 (450)
.....||+.|+|||++. +..++.++|+||+||++|+|++|..||....
T Consensus 152 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 -------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 11347999999999986 4668999999999999999999999997643
Q ss_pred hhh--hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc
Q 013064 281 PRI--TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 281 ~~~--~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~ 345 (450)
... ....... .....+| ..+++++++||++||. ||.+|++. .++.++++||||++++|....
T Consensus 201 ~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 201 TKDKHEIDRMTL-TVNVELP--DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred CcCHHHHHHHhh-cCCcCCc--cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 221 1111111 1122333 3689999999999998 99999963 369999999999999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=404.23 Aligned_cols=153 Identities=42% Similarity=0.763 Sum_probs=144.4
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+++|.+++.||+|+||.||+|++..+++.||||++++...........+..|+.++..++||||+++++++.+..++|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999999988766666667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
||||++||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++..
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=377.18 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=210.1
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD---- 111 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~---- 111 (450)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|..+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4589999999999999999999999999999999997653 23344567789999999999999999999997553
Q ss_pred --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 112 --FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 112 --~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+|+||||+.+ +|...+. ..++++.+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999975 5666553 358999999999999999999999999999999999999999999999999997543
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... .....+||+.|+|||++.+..|+.++|+|||||++|+|
T Consensus 175 ~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 175 TNF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred cCc---------------------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence 210 01245799999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhccc--------------------cccc--------------CCC----CCCCCHHHHHHH
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWK--------------------TCLK--------------FPE----EPKISDEARDLI 311 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~--------------------~~~~--------------~p~----~~~~s~~~~dli 311 (450)
++|..||.+.+....+..+.... .... +|. ....++++++||
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 99999998876544332221100 0000 010 112467899999
Q ss_pred HHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 312 CHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 312 ~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+||+ ||.+|+ ++.|++.||||..
T Consensus 296 ~~mL~~dP~~R~---t~~e~l~hp~~~~ 320 (359)
T cd07876 296 SKMLVIDPDKRI---SVDEALRHPYITV 320 (359)
T ss_pred HHHhccCcccCC---CHHHHhcCchhhh
Confidence 99999 999999 6899999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=370.07 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=215.6
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+++|.+++.||+|+||.||+++++.+++.+|+|.++.... ......+.+|..+++.++||||+++++++.+++.+|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 46889999999999999999999999999999999975432 2233456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 9999975 888887664 4589999999999999999999999999999999999999999999999999875432210
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.
T Consensus 160 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~ 202 (309)
T cd07872 160 -------------------------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202 (309)
T ss_pred -------------------------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 0113578999999999875 56899999999999999999999
Q ss_pred CCCCCCChhhhhhhhhccc-----------------ccccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 274 PPFCSDDPRITCRKIVNWK-----------------TCLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~-----------------~~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
+||.+.+..+....+.... ....+|. .+.+++++++||.+||. ||.+|+ +
T Consensus 203 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t 279 (309)
T cd07872 203 PLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI---S 279 (309)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC---C
Confidence 9998877655444433210 0011111 13578999999999999 999999 6
Q ss_pred HHHHHcCCCcCCC
Q 013064 327 VEELKEHPWFRGI 339 (450)
Q Consensus 327 ~~eil~Hpff~~i 339 (450)
++|++.||||+.+
T Consensus 280 ~~e~l~h~~~~~~ 292 (309)
T cd07872 280 AEEAMKHAYFRSL 292 (309)
T ss_pred HHHHhcChhhhhc
Confidence 8999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=390.56 Aligned_cols=257 Identities=30% Similarity=0.425 Sum_probs=221.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCC-CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTT-GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t-~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
..|.+.+.||+|+||.||+|....+ +..+|+|.+... .......+.+|+.+|+.++|||||+++++|.+++++|+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998887 788999976433 234456778899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 117 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 117 mEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|||++||+|.++|.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988753 3569999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
.. ....+.+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 224 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg 267 (478)
T PTZ00267 224 SL------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267 (478)
T ss_pred cc------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 10 012356899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
..||.+.+..+.+..+..... ..+| ..+++++++||.+||. ||.+|+ ++++++.|||++.+
T Consensus 268 ~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 268 HRPFKGPSQREIMQQVLYGKY-DPFP--CPVSSGMKALLDPLLSKNPALRP---TTQQLLHTEFLKYV 329 (478)
T ss_pred CCCCCCCCHHHHHHHHHhCCC-CCCC--ccCCHHHHHHHHHHhccChhhCc---CHHHHHhCHHHHHH
Confidence 999998888777777765322 1223 4689999999999998 999999 68999999999754
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=358.50 Aligned_cols=256 Identities=42% Similarity=0.825 Sum_probs=226.8
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999877655555667899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccc
Q 013064 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205 (450)
Q Consensus 126 ~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~ 205 (450)
.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.+|.++|+|||++.......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCC--hhh
Q 013064 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD--PRI 283 (450)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~ 283 (450)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+ ...
T Consensus 148 --------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 201 (262)
T cd05572 148 --------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201 (262)
T ss_pred --------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH
Confidence 0123578999999999988889999999999999999999999998776 556
Q ss_pred hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcc
Q 013064 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 284 ~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~ 342 (450)
.+.++........+|. ..+++++++|.+||+ +|.+|++. .+++|+++||||++.+|+
T Consensus 202 ~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 202 IYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 6666664444556664 558999999999998 99999962 248999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=359.10 Aligned_cols=255 Identities=38% Similarity=0.600 Sum_probs=215.2
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|++++.||+|+||.||+|+++.+++.||+|++........ ......+|..+++.++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999999988754332 233345599999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccc
Q 013064 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 120 ~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
+++++|.+++.+.+.+++..+..++.||+.||.+||++||+||||||+||+++.+|.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~------- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN------- 152 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999988899999999999999999999999999999999999999999999999999987541110
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-cCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
......+||+.|+|||++. +..++.++|+||||+++|+|++|..||..
T Consensus 153 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 153 -------------------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp -------------------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred -------------------------------ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0122468999999999998 78899999999999999999999999998
Q ss_pred CC---hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 279 DD---PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 279 ~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
.. ......+................+..+.+||.+||. ||.+|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~l~~~~~~ 260 (260)
T PF00069_consen 202 SNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP---SAEELLKHPWF 260 (260)
T ss_dssp SSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST---THHHHHTSGGG
T ss_pred ccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc---CHHHHhcCCCC
Confidence 73 333333333322222222112235899999999998 999999 69999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=390.74 Aligned_cols=263 Identities=28% Similarity=0.450 Sum_probs=225.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-- 111 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-- 111 (450)
+...++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|..++|++|++++..|....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445899999999999999999999999999999999976643 3445667889999999999999999998876432
Q ss_pred ------eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEee
Q 013064 112 ------FLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181 (450)
Q Consensus 112 ------~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~D 181 (450)
.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 47899999999999999865 34699999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccc
Q 013064 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261 (450)
Q Consensus 182 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWS 261 (450)
||+++.+...... ....+.+||+.|+|||++.+..|+.++|+||
T Consensus 187 FGls~~~~~~~~~------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwS 230 (496)
T PTZ00283 187 FGFSKMYAATVSD------------------------------------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFS 230 (496)
T ss_pred cccCeeccccccc------------------------------------cccccccCCcceeCHHHhCCCCCCcHHHHHH
Confidence 9999865432110 0122468999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 262 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 262 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
|||++|||++|..||.+.+..+.+.++...... .+| ..+++++.+||.+||. ||.+|| ++.+++.|||++..
T Consensus 231 lGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~--~~~~~~l~~li~~~L~~dP~~RP---s~~ell~~p~~~~~ 303 (496)
T PTZ00283 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLP--PSISPEMQEIVTALLSSDPKRRP---SSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCC--CCCCHHHHHHHHHHcccChhhCc---CHHHHHhCHHHHHh
Confidence 999999999999999998887777777653221 233 4789999999999998 999999 68999999998753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=360.38 Aligned_cols=259 Identities=38% Similarity=0.679 Sum_probs=214.2
Q ss_pred EEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH---HHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN---LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~---il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
+||+|+||.||+|++..+++.||+|++.+..............|.. +++...||+|+.++++|.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999998765432222223344444 3444589999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 122 gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
||+|..++.+.+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence 99999999888899999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCCCCCCC
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCSDD 280 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 280 (450)
....+||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+..
T Consensus 152 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 152 -------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred -------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 123579999999999974 468999999999999999999999998763
Q ss_pred h---hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCccccccc
Q 013064 281 P---RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLYEM 347 (450)
Q Consensus 281 ~---~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~~ 347 (450)
. ......+.. ....+| ..+|+++.++|.+||. +|.+|+... ++.++++||||++++|..+...
T Consensus 201 ~~~~~~~~~~~~~--~~~~~~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 201 TKDKHEIDRMTLT--MAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred ccchHHHHHHhhc--cCCCCC--CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 2 222222222 223344 3579999999999998 999999765 7999999999999999988653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=355.98 Aligned_cols=259 Identities=32% Similarity=0.522 Sum_probs=224.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
++|++.+.||+|++|.||.|.+..+++.||+|.+.+.... .......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 12345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987653211000
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.......|++.|+|||++.+..++.++|+|||||++|+|++|.+|
T Consensus 162 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 206 (263)
T cd06625 162 -----------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206 (263)
T ss_pred -----------------------------------ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 000135789999999999998899999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|.+.+......++........+| ..++..+.+||++||. +|.+|| ++.++++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 263 (263)
T cd06625 207 WAEFEAMAAIFKIATQPTNPQLP--SHVSPDARNFLRRTFVENAKKRP---SAEELLRHFFV 263 (263)
T ss_pred ccccchHHHHHHHhccCCCCCCC--ccCCHHHHHHHHHHhhcCcccCC---CHHHHhhCCCC
Confidence 98877766666665544444445 3689999999999998 999999 68999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=371.21 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=217.6
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCE-EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~-~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
..+..+++.+...||+|+||+||.+..+ |.. +|+|++......... .+.+.+|..+|.+++|||||++++++.+..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4456677788888999999999998885 444 999999876644333 778999999999999999999999999888
Q ss_pred -eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCC-eEEeecCCCcEEEccCC-ceEEeeccccc
Q 013064 112 -FLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHN-YVHRDIKPDNLILDKNG-HLKLSDFGLCK 186 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~g-ivHrDLKpeNILld~~g-~ikL~DFGla~ 186 (450)
.+++||||+++|+|..++.+ .+.++...+..++-+|+.||+|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999988 688999999999999999999999999 99999999999999998 99999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc--cCCCCccccccchhH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECDWWSLGA 264 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~--~~~y~~~~DiWSlGv 264 (450)
....... ......||+.|||||++. ...|+.++|+||+|+
T Consensus 193 ~~~~~~~--------------------------------------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgI 234 (362)
T KOG0192|consen 193 EKVISKT--------------------------------------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGI 234 (362)
T ss_pred eeccccc--------------------------------------cccCCCCCccccChhhhcCCCCcCCccchhhhHHH
Confidence 6543210 011368999999999999 669999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+||||+||..||.+.........+........+|. ..++.+..|+.+|+. ||..||+ +.+|.
T Consensus 235 vlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP~---f~ei~ 297 (362)
T KOG0192|consen 235 VLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRPS---FLEIV 297 (362)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCCC---HHHHH
Confidence 99999999999999888666666665445555554 489999999999998 9999995 44544
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=373.04 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=210.4
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD---- 111 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~---- 111 (450)
..++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4589999999999999999999999999999999987643 23334567788999999999999999999987543
Q ss_pred --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 112 --FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 112 --~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+|+||||+++ +|...+.. .+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 57999999965 56666643 58999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... .....+||+.|+|||++.+..|+.++|+|||||++|+|
T Consensus 171 ~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el 211 (355)
T cd07874 171 TSF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211 (355)
T ss_pred Ccc---------------------------------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 321 01246899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhccc----------------------cc---cc---------CC----CCCCCCHHHHHHH
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWK----------------------TC---LK---------FP----EEPKISDEARDLI 311 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~----------------------~~---~~---------~p----~~~~~s~~~~dli 311 (450)
++|..||.+.+..+.+..++..- .. +. +| .....+.++++||
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (355)
T cd07874 212 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291 (355)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHH
Confidence 99999998876544433322100 00 00 00 0123467889999
Q ss_pred HHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 312 CHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 312 ~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+||. ||.+|+ +++|+++||||..
T Consensus 292 ~~mL~~dP~~Rp---s~~ell~hp~~~~ 316 (355)
T cd07874 292 SKMLVIDPAKRI---SVDEALQHPYINV 316 (355)
T ss_pred HHHhcCCchhcC---CHHHHhcCcchhc
Confidence 99998 999999 7899999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=379.45 Aligned_cols=262 Identities=22% Similarity=0.348 Sum_probs=215.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~--~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
..+|++++.||+|+||.||+|... .+++.+|+|.+.+.. ...+|+.+|+.++|||||+++++|.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999999864 356789999886532 2457999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+......
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 9999995 689999987889999999999999999999999999999999999999999999999999999865432110
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
......+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 242 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 242 ------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred ------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 01224689999999999999999999999999999999999999
Q ss_pred CCCCCChh---hhhhhhhccc--cc-------------------------ccCCC---CCCCCHHHHHHHHHhhc-Cccc
Q 013064 275 PFCSDDPR---ITCRKIVNWK--TC-------------------------LKFPE---EPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 275 PF~~~~~~---~~~~~i~~~~--~~-------------------------~~~p~---~~~~s~~~~dli~~lL~-dp~~ 320 (450)
||.+.... ..+..|+... .. ...|. ...++.++++||++||+ ||.+
T Consensus 286 pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 286 TLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 99875432 1122221100 00 01110 12457789999999999 9999
Q ss_pred cCCCCCHHHHHcCCCcCCCCcccccc
Q 013064 321 RLGTRGVEELKEHPWFRGIQWDKLYE 346 (450)
Q Consensus 321 R~~~~~~~eil~Hpff~~i~w~~l~~ 346 (450)
|+ ++.+++.||||...+|+.+..
T Consensus 366 Rp---sa~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 366 RP---SAQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred CC---CHHHHhhCchhhccchhhhcC
Confidence 99 689999999999999987754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=374.03 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=211.7
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 110 (450)
.++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3789999999999999999999999999999999976432 223455677899999999999999999988654
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..+|++||++ |++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3579999998 889987764 45799999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 269 (450)
. ....+||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 171 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 171 E-----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred C-----------------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence 1 124689999999999977 5689999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhccccc---------------------ccCCC------CCCCCHHHHHHHHHhhc-Ccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTC---------------------LKFPE------EPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dli~~lL~-dp~~R 321 (450)
++|+.||.+.+.......+...... ...|. ....++.+.+||.+||. ||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 9999999877655544443321000 00110 12457789999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCC
Q 013064 322 LGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i 339 (450)
+ ++.+++.||||...
T Consensus 290 ~---s~~ell~hp~~~~~ 304 (343)
T cd07878 290 I---SASEALAHPYFSQY 304 (343)
T ss_pred C---CHHHHhcCcchhcc
Confidence 9 68999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=378.24 Aligned_cols=253 Identities=27% Similarity=0.437 Sum_probs=216.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-C-----CCeeeEEEEEEcCCe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-S-----RCIVQLFYSFQDSDF 112 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-h-----p~Iv~l~~~f~~~~~ 112 (450)
+|+++++||+|+||+|-+|.+..|++.||||+++.. .....+...|+.||..|+ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 789999999999999999999999999999999864 345677888999999996 4 489999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC--CceEEeeccccccC
Q 013064 113 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--GHLKLSDFGLCKPL 188 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~--g~ikL~DFGla~~~ 188 (450)
+|||+|.+ +-+|.++|+.+ ..|+...++.++.||+.||.+||++||||.|||||||||..- ..|||+|||.|...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 66999999876 469999999999999999999999999999999999999643 37999999999875
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
... .++.+-+..|.||||+.+.+|+.+.|+||||||++|
T Consensus 342 ~q~-----------------------------------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAE 380 (586)
T KOG0667|consen 342 SQR-----------------------------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAE 380 (586)
T ss_pred CCc-----------------------------------------ceeeeeccccccchhhccCCCCCccceeehhhhHHh
Confidence 442 236788999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhccc--------------------------------------------------ccccCC
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWK--------------------------------------------------TCLKFP 298 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~--------------------------------------------------~~~~~p 298 (450)
|++|.|.|.|++..+++..|+.-- .....|
T Consensus 381 L~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P 460 (586)
T KOG0667|consen 381 LFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGP 460 (586)
T ss_pred HhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCC
Confidence 999999999999888887776210 000111
Q ss_pred -CC-------C-CCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 299 -EE-------P-KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 299 -~~-------~-~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
.. . .-...+.|||++||. ||.+|+ ++.++++||||.+..
T Consensus 461 ~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~---tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 461 PGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI---TPAQALNHPFLTGTS 509 (586)
T ss_pred CCCcccchhcccccHHHHHHHHHHHhccCchhcC---CHHHHhcCccccccc
Confidence 00 0 112456899999999 999999 688999999998644
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=369.85 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=207.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~-----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|++.+.||+|+||.||+|.+ ..+++.||+|++++.. .......+.+|..+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45567999999999999999999985 3456789999987542 233456788999999999 899999999988
Q ss_pred EcC-CeEEEEEeccCCCChHHHHHhc------------------------------------------------------
Q 013064 108 QDS-DFLYLIMEYLPGGDIMTLLMRE------------------------------------------------------ 132 (450)
Q Consensus 108 ~~~-~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------ 132 (450)
... ..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4689999999999999998753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccccc
Q 013064 133 --------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204 (450)
Q Consensus 133 --------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~ 204 (450)
..++++.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---------- 230 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 230 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch----------
Confidence 24788899999999999999999999999999999999999999999999999865322100
Q ss_pred ccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCChhh
Q 013064 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRI 283 (450)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~ 283 (450)
....+..+++.|+|||++.+..|+.++|||||||++|||++ |.+||.+....+
T Consensus 231 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~ 284 (338)
T cd05102 231 --------------------------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284 (338)
T ss_pred --------------------------hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence 00113457789999999999999999999999999999997 999998866554
Q ss_pred hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 284 TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 284 ~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.+...+........| ..+++.+++||.+||. ||.+|| ++.+|++
T Consensus 285 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~el~~ 329 (338)
T cd05102 285 EFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERP---TFSALVE 329 (338)
T ss_pred HHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 444444332333333 4689999999999998 999999 5667653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=373.71 Aligned_cols=257 Identities=34% Similarity=0.602 Sum_probs=223.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
++||+|-||+||-++++.||+.||+|+|.|..... .+...+++|..||+.+.||.||.|-..|++.+.+++|||-+. |
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 68999999999999999999999999999987654 455889999999999999999999999999999999999995 5
Q ss_pred ChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEEeeccccccCcccccccccc
Q 013064 124 DIMTLLM--REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 124 ~L~~~l~--~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|+..+|. ..++++|...+|++.||+.||.|||-+||+|.||||||||+.+.. .+||||||+|+.+.+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 6666653 467999999999999999999999999999999999999996543 79999999999887641
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
| .++.+|||.|+|||++++++|+.+.|+||+|||+|--|.|..||..
T Consensus 722 --------------------------F-------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 722 --------------------------F-------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred --------------------------h-------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 1 1268999999999999999999999999999999999999999964
Q ss_pred CChhhhhhhhhcccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC-Ccccccccc
Q 013064 279 DDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI-QWDKLYEME 348 (450)
Q Consensus 279 ~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i-~w~~l~~~~ 348 (450)
+. ++-.+|.+. .+-+|. |..+|++|.|||..||+ .-.+|. +++..+.|||+++. -|..|++++
T Consensus 769 dE--dIndQIQNA--aFMyPp~PW~eis~~AidlIn~LLqVkm~kRy---svdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 769 DE--DINDQIQNA--AFMYPPNPWSEISPEAIDLINNLLQVKMRKRY---SVDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred cc--chhHHhhcc--ccccCCCchhhcCHHHHHHHHHHHHHHHHHhc---chHhhccchhhhcchHHHHHHHHH
Confidence 43 344556553 344443 56799999999999998 999999 79999999999986 488888643
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=362.12 Aligned_cols=262 Identities=26% Similarity=0.482 Sum_probs=216.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
..+++|++++.||.|+||.||+|+++.+++.||+|.++... .......+.+|+.+++.++||||+++++++.++..+|
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 35789999999999999999999999999999999987543 2223456778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++ ++|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 9999997 5888888664 5789999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G 272 (450)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 160 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg 201 (301)
T cd07873 160 --------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201 (301)
T ss_pred --------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhC
Confidence 0113467999999999875 4578999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhccc-----------------ccccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWK-----------------TCLKFPE---------EPKISDEARDLICHLLC-DVETRLGTR 325 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~-----------------~~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~ 325 (450)
++||.+.+..+....+.... ....+|. ...+++++++||.+||+ ||.+|+
T Consensus 202 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~--- 278 (301)
T cd07873 202 RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI--- 278 (301)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc---
Confidence 99998877655443332110 0011111 13578999999999999 999999
Q ss_pred CHHHHHcCCCcCCCC
Q 013064 326 GVEELKEHPWFRGIQ 340 (450)
Q Consensus 326 ~~~eil~Hpff~~i~ 340 (450)
++++++.||||..+-
T Consensus 279 t~~eil~h~~f~~~~ 293 (301)
T cd07873 279 SAEEAMKHPYFHCLG 293 (301)
T ss_pred CHHHHhcCccccccc
Confidence 689999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.49 Aligned_cols=264 Identities=28% Similarity=0.454 Sum_probs=224.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||.|+||.||++++..+++.+|+|++.+. .......+.+|+.+++.++||||+++++.|..+..+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 5699999999999999999999999999999998754 2345677888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.......
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---- 164 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL---- 164 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc----
Confidence 99999999888755 4578999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHHHHHhh
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvilyeml~ 271 (450)
.......|++.|+|||++. ...++.++|+|||||++|+|++
T Consensus 165 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~ 210 (292)
T cd06644 165 ----------------------------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ 210 (292)
T ss_pred ----------------------------------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc
Confidence 0012357899999999985 3457889999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccccc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 346 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 346 (450)
|.+||...+......++..... ...+....++.++.+||.+||. ||.+|| +++++++||||..++|.+..+
T Consensus 211 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~~~~~ 282 (292)
T cd06644 211 IEPPHHELNPMRVLLKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLEHPFVSSVTSNRPLR 282 (292)
T ss_pred CCCCCccccHHHHHHHHhcCCC-ccCCCCcccCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccccccchhHH
Confidence 9999988776666655544221 1222234688999999999998 999999 689999999999999988654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=353.45 Aligned_cols=264 Identities=49% Similarity=0.884 Sum_probs=227.9
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||.|+||.||+|++..+|+.||+|++.+.........+.+.+|.++++.++||||+++++.+.++..+|+||||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999877655556778899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccc
Q 013064 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205 (450)
Q Consensus 126 ~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~ 205 (450)
.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++............
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-------- 152 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN-------- 152 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc--------
Confidence 999988889999999999999999999999999999999999999999999999999998764332110000
Q ss_pred cccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhh
Q 013064 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 285 (450)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 285 (450)
.........++++.|+|||++....++.++|+|||||++|+|++|..||......+..
T Consensus 153 ----------------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (265)
T cd05579 153 ----------------------DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210 (265)
T ss_pred ----------------------cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0000012357899999999999888999999999999999999999999988887777
Q ss_pred hhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 286 ~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
..+... ...+|....++..+.+||.+||+ +|.+||+..++.++++||||++++|
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 211 QNILNG--KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHhcC--CcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 776652 34445433459999999999998 9999998777899999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=361.07 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=216.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||++.+..+|..||+|.+.... .......+.+|++++..++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 57999999999999999999999999999999986532 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .+|+||||||+|||++.+|.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999999988899999999999999999999997 699999999999999999999999999987543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
..+.+|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 155 ------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 198 (308)
T cd06615 155 ------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198 (308)
T ss_pred ------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 12468999999999998888999999999999999999999999
Q ss_pred CCCChhhhhhhhhccc-----------------------------------ccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 013064 277 CSDDPRITCRKIVNWK-----------------------------------TCLKFPEEPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~-----------------------------------~~~~~p~~~~~s~~~~dli~~lL~-dp~~ 320 (450)
...+.......+.... .....|. ..++.++++||.+||. ||++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~ 277 (308)
T cd06615 199 PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKE 277 (308)
T ss_pred CCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhh
Confidence 7655433222111100 0011111 1368899999999998 9999
Q ss_pred cCCCCCHHHHHcCCCcCC
Q 013064 321 RLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 321 R~~~~~~~eil~Hpff~~ 338 (450)
|| ++.+++.||||.+
T Consensus 278 Rp---t~~~ll~~~~~~~ 292 (308)
T cd06615 278 RA---DLKELTKHPFIKR 292 (308)
T ss_pred Cc---CHHHHhcChhhhh
Confidence 99 6899999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=357.44 Aligned_cols=274 Identities=42% Similarity=0.759 Sum_probs=227.6
Q ss_pred CeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 113 (450)
+|++.+.||+|+||.||+|+.. .+++.||+|++++..... ....+++.+|..++..+ +||+|+++++.|.++..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 467899999998755432 23456788999999999 699999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||++||+|..++.+...+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876533210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC--CCccccccchhHHHHHHhh
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~--y~~~~DiWSlGvilyeml~ 271 (450)
......+|++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus 161 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 161 -------------------------------------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred -------------------------------------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence 0112357999999999987654 7889999999999999999
Q ss_pred CCCCCCCCChh----hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccccc
Q 013064 272 GYPPFCSDDPR----ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 346 (450)
Q Consensus 272 G~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 346 (450)
|..||...+.. +....+.. ...+....++..++++|.+||. ||++|++..++.++++||||+.++|+.+..
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~ 279 (288)
T cd05583 204 GASPFTVDGEQNSQSEISRRILK----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAA 279 (288)
T ss_pred CCCCcccCcccchHHHHHHHHHc----cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhh
Confidence 99999654332 22223332 1122234688999999999998 999999888899999999999999998864
Q ss_pred --ccCCccc
Q 013064 347 --MEAAYKP 353 (450)
Q Consensus 347 --~~~p~~p 353 (450)
..+||.|
T Consensus 280 ~~~~~~~~~ 288 (288)
T cd05583 280 KRIPAPFKP 288 (288)
T ss_pred hccCCCCCC
Confidence 4556653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=355.50 Aligned_cols=270 Identities=39% Similarity=0.710 Sum_probs=222.6
Q ss_pred CeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 113 (450)
+|++.+.||.|+||.||+|+.. .+|+.||+|++++..... ....+++.+|+.+|..+ +||+|++++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 478999999998654332 23456788999999999 689999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||++||+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999876533210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHHHhh
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~ 271 (450)
......+|++.|+|||.+.+ ..++.++|+|||||++|+|++
T Consensus 161 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~ 203 (290)
T cd05613 161 -------------------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203 (290)
T ss_pred -------------------------------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence 00124679999999999875 457889999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~ 345 (450)
|..||...........+.........|....+++.+.+|+.+||. ||.+|++. .++++++.||||..++|+.+.
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 204 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred CCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 999997543332222222111111112224689999999999998 99999864 479999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=353.70 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=212.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+++++.++||||++++++|.+.+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.++|+|||++.......
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----- 149 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----- 149 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence 99999998654 357899999999999999999999999999999999999999999999999987653220
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 150 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 194 (279)
T cd06619 150 -----------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194 (279)
T ss_pred -----------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence 123689999999999999999999999999999999999999996
Q ss_pred CCChh-------hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 278 SDDPR-------ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 278 ~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
..... .....+... .....+ ....++++++||.+||+ +|.+|| ++++++.||||...+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp---~~~eil~~~~~~~~~ 260 (279)
T cd06619 195 QIQKNQGSLMPLQLLQCIVDE-DPPVLP-VGQFSEKFVHFITQCMRKQPKERP---APENLMDHPFIVQYN 260 (279)
T ss_pred hhcccccccchHHHHHHHhcc-CCCCCC-CCcCCHHHHHHHHHHhhCChhhCC---CHHHHhcCccccccc
Confidence 53321 111222211 111222 23578999999999998 999999 689999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=353.73 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=215.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
...++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|..+++.++||||+++++++.+.+.+|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999987542 233456788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.........
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998765322100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhh
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~ 271 (450)
....+||+.|+|||++. ...++.++|+|||||++|+|++
T Consensus 163 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~ 204 (267)
T cd06645 163 --------------------------------------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred --------------------------------------cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc
Confidence 11357999999999985 4568899999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhccccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
|.+||....+......+...... ........++..+.+||.+||. +|++|+ ++++|+.|||
T Consensus 205 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~ll~~~~ 267 (267)
T cd06645 205 LQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP---TAEKLLQHPF 267 (267)
T ss_pred CCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCc---CHHHHhcCCC
Confidence 99999766554433333221111 1111123578899999999998 999999 6899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.18 Aligned_cols=253 Identities=28% Similarity=0.532 Sum_probs=217.0
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SDFLYLIM 117 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~~~lylVm 117 (450)
+|++++.||+|++|.||++.++.+++.||+|.+..... .....+.+.+|..+++.++||+|+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999976542 33445678889999999999999999999874 45789999
Q ss_pred eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 118 EYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 118 Ey~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||++|++|.+++.. ...+++.++..++.|++.||++||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 99999999999876 34689999999999999999999999999999999999999999999999999886532210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 158 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 201 (257)
T cd08223 158 ------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201 (257)
T ss_pred ------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 11245799999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|.+.+.......+..... ...+ ..+++++.+||.+||. ||.+|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 257 (257)
T cd08223 202 FNAKDMNSLVYRIIEGKL-PPMP--KDYSPELGELIATMLSKRPEKRP---SVKSILRQPYI 257 (257)
T ss_pred CCCCCHHHHHHHHHhcCC-CCCc--cccCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 988776665555554221 1222 3689999999999998 999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=397.45 Aligned_cols=264 Identities=28% Similarity=0.422 Sum_probs=219.8
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-- 109 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-- 109 (450)
.....+++|++++.||+|+||.||+|+++.+++.+|+|++..... .......+..|+.+|+.++|||||+++++|.+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 345667899999999999999999999999999999999976543 33456778899999999999999999999865
Q ss_pred CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhC-------CeEEeecCCCcEEEcc-----
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQH-------NYVHRDIKPDNLILDK----- 173 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~-------givHrDLKpeNILld~----- 173 (450)
...+||||||+++|+|..+|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4579999999999999999865 35799999999999999999999985 4999999999999964
Q ss_pred ------------CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCC
Q 013064 174 ------------NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 241 (450)
Q Consensus 174 ------------~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~ 241 (450)
.+.+||+|||++..+.... .....+||+.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------------------------------------~~~s~vGTp~ 206 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES---------------------------------------MAHSCVGTPY 206 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc---------------------------------------cccccCCCcc
Confidence 2358999999998653220 1124689999
Q ss_pred ccchhhhcc--CCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-Cc
Q 013064 242 YMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 318 (450)
Q Consensus 242 Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp 318 (450)
|+|||++.+ ..|+.++||||||||||||++|..||...+....+..++.... .+|. ...+.++.+||..||. +|
T Consensus 207 YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p--~lpi-~~~S~eL~dLI~~~L~~dP 283 (1021)
T PTZ00266 207 YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP--DLPI-KGKSKELNILIKNLLNLSA 283 (1021)
T ss_pred ccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC--CCCc-CCCCHHHHHHHHHHhcCCh
Confidence 999999964 4589999999999999999999999987665544444443222 2222 3578999999999998 99
Q ss_pred cccCCCCCHHHHHcCCCcCCCCc
Q 013064 319 ETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 319 ~~R~~~~~~~eil~Hpff~~i~w 341 (450)
.+|| ++.+++.|||++.+..
T Consensus 284 eeRP---Sa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 284 KERP---SALQCLGYQIIKNVGP 303 (1021)
T ss_pred hHCc---CHHHHhccHHHhhcCC
Confidence 9999 6899999999987653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=348.45 Aligned_cols=261 Identities=32% Similarity=0.504 Sum_probs=219.7
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--Ce
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DF 112 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~ 112 (450)
.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ......+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 3689999999999999999999999999999999864321 1233567888999999999999999999999874 57
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+|+||||+||+++.+|.++|+|||++.......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 89999999999999999888889999999999999999999999999999999999999999999999999988653210
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
... .......||..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 161 ~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 205 (265)
T cd06652 161 LSG-----------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTE 205 (265)
T ss_pred ccc-----------------------------------cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhC
Confidence 000 001235799999999999988899999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~ 337 (450)
..||..........++.........| ..++..+.++|++|+.+|.+|| ++++|+.|||++
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~p~~Rp---~~~~il~~~~~~ 265 (265)
T cd06652 206 KPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLRP---SADELLRHTFVH 265 (265)
T ss_pred CCCCCccchHHHHHHHhcCCCCCCCc--hhhCHHHHHHHHHHhcChhhCC---CHHHHhcCcccC
Confidence 99998776555555544322222333 3678899999999999999999 689999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.85 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=194.7
Q ss_pred EeEEeecCceEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEEEEe
Q 013064 43 LTLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFLYLIME 118 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~--~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~lylVmE 118 (450)
.+.||+|+||.||+|+++ .+++.||+|.+.... ....+.+|+.+|+.++||||++++++|.+ +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 467899999986543 22456789999999999999999999854 567999999
Q ss_pred ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE----ccCCceEEeecccc
Q 013064 119 YLPGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC 185 (450)
Q Consensus 119 y~~gg~L~~~l~~~---------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl----d~~g~ikL~DFGla 185 (450)
|+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+|.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5888877532 258999999999999999999999999999999999999 46689999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 264 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGv 264 (450)
+........ .......+||+.|+|||++.+ ..|+.++|+|||||
T Consensus 160 ~~~~~~~~~-----------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 204 (317)
T cd07868 160 RLFNSPLKP-----------------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred eccCCCCcc-----------------------------------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHH
Confidence 865432110 001124689999999999987 45899999999999
Q ss_pred HHHHHhhCCCCCCCCChh---------hhhhhhhcc---------cccccCC-------------------------CCC
Q 013064 265 IMYEMLIGYPPFCSDDPR---------ITCRKIVNW---------KTCLKFP-------------------------EEP 301 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~---------~~~~~i~~~---------~~~~~~p-------------------------~~~ 301 (450)
++|+|++|.+||.+.... ..+.++.+. ......| ...
T Consensus 205 il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (317)
T cd07868 205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 284 (317)
T ss_pred HHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCC
Confidence 999999999999754321 111111110 0000000 001
Q ss_pred CCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 302 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 302 ~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
..+.++.|||++||+ ||.+|+ +++|+++||||
T Consensus 285 ~~~~~~~dli~~mL~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07868 285 KPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYF 317 (317)
T ss_pred CCChHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 245679999999999 999999 79999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=349.40 Aligned_cols=255 Identities=41% Similarity=0.740 Sum_probs=221.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++.+.||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999988765555667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|+.|++|..++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------ 154 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------
Confidence 99999999999888889999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 155 ---------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 155 ---------------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred ---------------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 01135689999999999988899999999999999999999999987
Q ss_pred CCh--hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 279 DDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 279 ~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
.+. ...+.+.... ....+| ..++..+.++|.+||. ||.+|++.. +.|+++||||
T Consensus 202 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 202 HSRTIRDQIRAKQET-ADVLYP--ATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred CCccHHHHHHHHhcc-ccccCc--ccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 764 2222222221 223333 4688999999999998 999999643 5999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=379.26 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=229.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.++|+..||.|+||+||+|..+.|+-..|-|+|... ..+.++.++-|++||..++||+||+|+++|.-++.++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4678999999999999999999999999999998643 4567889999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||.||-....+.. ...++|.+++.++.|++.||.|||+++|||||||..|||+.-+|.|+|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----- 183 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence 99999998887655 567999999999999999999999999999999999999999999999999997653221
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHHHHHhh
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvilyeml~ 271 (450)
+...-+++|||+|||||++. ..+|++++||||||+.|.||..
T Consensus 184 ---------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq 230 (1187)
T KOG0579|consen 184 ---------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ 230 (1187)
T ss_pred ---------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc
Confidence 01123789999999999986 4789999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
+.||-...++...+.+|.+..+ ..+-.+..+|..++||+++||. ||..|+ .+.++++||||.+++-.+
T Consensus 231 iEPPHhelnpMRVllKiaKSeP-PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp---~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 231 IEPPHHELNPMRVLLKIAKSEP-PTLLQPSHWSRSFSDFLKRCLVKNPRNRP---PAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred cCCCccccchHHHHHHHhhcCC-CcccCcchhhhHHHHHHHHHHhcCCccCC---CHHHHhhCcccccCCcch
Confidence 9999999999999888876422 2222345899999999999998 999999 578999999999887554
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=347.97 Aligned_cols=260 Identities=33% Similarity=0.529 Sum_probs=218.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFL 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~l 113 (450)
.+|+..+.||+|+||.||+|.+..++..||+|++.+... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 579999999999999999999999999999999875432 122345678899999999999999999999876 3678
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||+++++|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999886543110
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.. .......|+..|+|||.+.+..++.++|+|||||++|||++|.
T Consensus 162 ~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~ 206 (266)
T cd06651 162 SG-----------------------------------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206 (266)
T ss_pred cC-----------------------------------CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCC
Confidence 00 0011356899999999999888999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~ 337 (450)
.||...+......++........+| ..+++.+++||+.|+.+|.+|| ++++|+.||||+
T Consensus 207 ~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~~~~p~~Rp---~~~eil~hp~~~ 265 (266)
T cd06651 207 PPWAEYEAMAAIFKIATQPTNPQLP--SHISEHARDFLGCIFVEARHRP---SAEELLRHPFAQ 265 (266)
T ss_pred CCccccchHHHHHHHhcCCCCCCCc--hhcCHHHHHHHHHhcCChhhCc---CHHHHhcCcccc
Confidence 9998776655555554433333444 3678999999954444999999 699999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=352.21 Aligned_cols=255 Identities=32% Similarity=0.496 Sum_probs=209.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++++.||+|++|.||+|.++.+++.||+|+++... ........+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 6899999999999999999999999999999987543 223345678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 119 YLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 119 y~~gg~L~~~l~~~---~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 997 5888887643 5699999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus 157 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 157 ------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred ------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence 0113468999999999875 457899999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccc----------------cccCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 275 PFCSDDPRITCRKIVNWKT----------------CLKFP---------EEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~----------------~~~~p---------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
||.+.+.......+..... ...++ ....+++++++||++||+ ||.+|| ++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---t~~ 277 (285)
T cd07861 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI---SAK 277 (285)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC---CHH
Confidence 9987654333222211000 00000 113578999999999999 999999 689
Q ss_pred HHHcCCCc
Q 013064 329 ELKEHPWF 336 (450)
Q Consensus 329 eil~Hpff 336 (450)
+|+.||||
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=355.03 Aligned_cols=251 Identities=21% Similarity=0.264 Sum_probs=215.6
Q ss_pred CCCCCCeEEE--eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--
Q 013064 34 KIGIDDFEQL--TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-- 109 (450)
Q Consensus 34 ~~~~~~f~~~--~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-- 109 (450)
.+..++++.. ..||+|++|.||++.. +|+.||+|++++.........+.+.+|+.+|.+++|||||++++++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 3455566555 7899999999999987 788999999987654444446788899999999999999999999977
Q ss_pred --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 110 --SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 110 --~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
...+|+||||++||+|.+++.+.+.+++..+..++.+++.||.|||+ .+++||||||+|||++.+|.+||+|||+++
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 45799999999999999999988889999999999999999999998 599999999999999999999999999988
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGA 264 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGv 264 (450)
.+... ....+||+.|+|||++.+ ..|+.++|+|||||
T Consensus 172 ~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv 210 (283)
T PHA02988 172 ILSSP-----------------------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210 (283)
T ss_pred hhccc-----------------------------------------cccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence 64321 013578999999999976 68999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|||++|..||.+.+..+.+..+......+.+| ...++.+++||.+||. ||.+|| ++.+++.
T Consensus 211 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~ 274 (283)
T PHA02988 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRP---NIKEILY 274 (283)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCc---CHHHHHH
Confidence 9999999999999888888887776654444444 3689999999999998 999999 5777763
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=349.36 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=215.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
...++|++++.||+|+||.||+++++.+++.||+|++.... ......+.+|+.+++.++||||+++++++.+++.+|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 34578999999999999999999999999999999986542 234456888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.........
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999865322100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhh
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~ 271 (450)
....+|++.|+|||++. ...++.++|+|||||++|||++
T Consensus 163 --------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~ 204 (267)
T cd06646 163 --------------------------------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred --------------------------------------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh
Confidence 11357999999999985 3557889999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhccccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
|..||...++......+...... ...+....++..+.+||++||+ +|.+|| ++++|++|+|
T Consensus 205 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~l~ 267 (267)
T cd06646 205 LQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP---TAERLLTHLF 267 (267)
T ss_pred CCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCc---CHHHHhcCCC
Confidence 99999766554443333221111 1111223578999999999998 999999 6899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=353.06 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=221.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||.|+||.||++.+..+++.+|+|++... .....+.+.+|..+++.++||||+++++++.++..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 36799999999999999999999999999999998643 334567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||++||+|..++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999998764 5799999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHHHHHh
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvilyeml 270 (450)
......||+.|+|||++. ..+++.++|+|||||++|+|+
T Consensus 159 ------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 159 ------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred ------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 012357999999999985 345788999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
+|.+||.+.+......++..... ..+.....++.++.+||.+||. +|.+|+ +++++++||||.....
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~~~ 270 (280)
T cd06611 203 QMEPPHHELNPMRVLLKILKSEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVSDQSD 270 (280)
T ss_pred hCCCCcccCCHHHHHHHHhcCCC-CCcCCcccCCHHHHHHHHHHhccChhhCc---CHHHHhcChhhcccch
Confidence 99999988877666666654321 1222224689999999999998 999999 6899999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.82 Aligned_cols=249 Identities=30% Similarity=0.535 Sum_probs=204.2
Q ss_pred CCeEEEeEE--eecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEE
Q 013064 38 DDFEQLTLI--GKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 38 ~~f~~~~~L--G~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 114 (450)
++|++.+.+ |+|+||.||+++.+.++..||+|++.+..... .|..+...+ +||||+++++.|..++.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 466666665 99999999999999999999999997653211 122222222 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|..++.....++++.++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999999999998888999999999999999999999999999999999999999998 9999999998754321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 164 ----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 203 (267)
T PHA03390 164 ----------------------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203 (267)
T ss_pred ----------------------------------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence 1246899999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.||.....................+....+|+.+++||.+||+ +|.+|++ +++++++||||.+
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 204 HPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred CCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 9998654433211111111111122224689999999999999 9999995 3799999999964
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=342.36 Aligned_cols=253 Identities=33% Similarity=0.510 Sum_probs=220.8
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|.+.+.||+|++|.||+|.++.+|+.||+|.+..... .......+..|..+++.++||||+++++++.+++..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 68999999999999999999999999999999976543 34456678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--- 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--- 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence 99999999999774 5789999999999999999999999999999999999999999999999999886543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 201 (256)
T cd08529 157 -----------------------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201 (256)
T ss_pred -----------------------------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 012357899999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
...+......++.... ...++ ..++..+.++|.+||+ +|++|| ++.+++.|||+
T Consensus 202 ~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 256 (256)
T cd08529 202 DANNQGALILKIIRGV-FPPVS--QMYSQQLAQLIDQCLTKDYRQRP---DTFQLLRNPSL 256 (256)
T ss_pred CCCCHHHHHHHHHcCC-CCCCc--cccCHHHHHHHHHHccCCcccCc---CHHHHhhCCCC
Confidence 9888766666665422 12222 2678999999999998 999999 68999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=353.89 Aligned_cols=254 Identities=31% Similarity=0.514 Sum_probs=214.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|++..+|+.||+|.+... ........+.+|..+++.++||||++++++|..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 5799999999999999999999999999999998653 23334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 118 EYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~---~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
||++|++|..++... ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999888763 379999999999999999999996 599999999999999999999999999987653220
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC------CCCccccccchhHHHH
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK------GYGMECDWWSLGAIMY 267 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~------~y~~~~DiWSlGvily 267 (450)
....+|++.|+|||++.+. .++.++|+|||||++|
T Consensus 158 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 158 ---------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred ---------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 1235789999999998543 3588999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhh---hhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 268 EMLIGYPPFCSDDPRITCRK---IVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~---i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+|++|..||...+....... +... ....+| ..+++++.+||.+||. +|.+|| ++++++.||||...
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~~~~~~~ 268 (286)
T cd06622 199 EMALGRYPYPPETYANIFAQLSAIVDG-DPPTLP--SGYSDDAQDFVAKCLNKIPNRRP---TYAQLLEHPWLVKY 268 (286)
T ss_pred HHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCC--cccCHHHHHHHHHHcccCcccCC---CHHHHhcChhhhhc
Confidence 99999999977655444333 2222 122333 3589999999999998 999999 68999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=349.93 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=217.1
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|++++.||+|+||.||++++..++..+|+|.+.... ....+.+.+|+.+++.++||||++++++|..++..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 578899999999999999999999999999986542 34566788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 120 LPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 120 ~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
+++|+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence 999999988765 46799999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHHHHHhhCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
......||+.|+|||++. +..++.++|+|||||++|+|++|.
T Consensus 159 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 205 (282)
T cd06643 159 ---------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE 205 (282)
T ss_pred ---------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence 012357999999999984 355788999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+||...+.......+..... ...+....++.++++||.+||. ||.+|+ +++++++||||...
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 268 (282)
T cd06643 206 PPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPFVTVN 268 (282)
T ss_pred CCccccCHHHHHHHHhhcCC-CCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCCCEecc
Confidence 99988877666666554321 1222234688999999999998 999999 68999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=343.81 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=221.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||.|+||.||+|....++..+|+|++.+..... ....+.+|..+|+.++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 58999999999999999999999999999999997654322 5678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~---~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 46999999999999999999999999999999999999999999999999999866543110
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~ 273 (450)
. .......+|++.|+|||++... .++.++|+|||||++|+|++|.
T Consensus 159 ~----------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 159 T----------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred c----------------------------------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence 0 0011245799999999999876 7899999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCC---CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEE---PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~---~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
.||...+....+.++..... ..++.. ..+++.+++||.+||. ||.+|| ++++|+.||||
T Consensus 205 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~ll~~p~~ 267 (267)
T cd06610 205 APYSKYPPMKVLMLTLQNDP-PSLETGADYKKYSKSFRKMISLCLQKDPSKRP---TAEELLKHKFF 267 (267)
T ss_pred CCccccChhhhHHHHhcCCC-CCcCCccccccccHHHHHHHHHHcCCChhhCc---CHHHHhhCCCC
Confidence 99988777666665554321 122221 3678999999999998 999999 69999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=359.61 Aligned_cols=265 Identities=22% Similarity=0.352 Sum_probs=209.9
Q ss_pred EEEeEEeec--CceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 41 EQLTLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 41 ~~~~~LG~G--~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+++++||+| +||+||+++.+.+|+.||+|.++.... .....+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 357889999 789999999999999999999976542 33456678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+...........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999998653 4699999999999999999999999999999999999999999999999987654322100000
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHHHhhCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.........+++..|+|||++.+ .+|+.++|+|||||++|||++|..
T Consensus 160 -------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 208 (327)
T cd08227 160 -------------------------------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 208 (327)
T ss_pred -------------------------------ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 00000112467888999999976 568999999999999999999999
Q ss_pred CCCCCChhhhhhhhhccccc------------------------------------------ccCCCCCCCCHHHHHHHH
Q 013064 275 PFCSDDPRITCRKIVNWKTC------------------------------------------LKFPEEPKISDEARDLIC 312 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~------------------------------------------~~~p~~~~~s~~~~dli~ 312 (450)
||.................. ...+....+++.+++||.
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 288 (327)
T cd08227 209 PFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVE 288 (327)
T ss_pred CCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHH
Confidence 99765433322222111000 000111245789999999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 313 HLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
+||+ ||.+|+ +++++++||||+.+.
T Consensus 289 ~~l~~dP~~Rp---t~~ell~~p~f~~~~ 314 (327)
T cd08227 289 QCLQRNPDARP---SASTLLNHSFFKQIK 314 (327)
T ss_pred HHHhhCchhcC---CHHHHhcChhhhhcc
Confidence 9998 999999 689999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=353.76 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=208.2
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++++.||+|+||.||+|+++.+|+.||+|.++.... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48999999999999999999999999999999976432 23344567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 119 YLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 119 y~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|++ ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---- 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---- 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC----
Confidence 996 578887765 56799999999999999999999999999999999999999999999999999986533210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......+++.|+|||++.+. .++.++|+|||||++|+|++|..||
T Consensus 155 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 155 ----------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred ----------------------------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 01134689999999998764 4799999999999999999988885
Q ss_pred -CCCChhhhhhhhhccc---------------ccccCC----------CCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 277 -CSDDPRITCRKIVNWK---------------TCLKFP----------EEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 277 -~~~~~~~~~~~i~~~~---------------~~~~~p----------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
.+.+..+.+..+...- ....++ ..+.+++++++||.+||. ||.+|+ ++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~~ 277 (284)
T cd07839 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI---SAEE 277 (284)
T ss_pred cCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC---CHHH
Confidence 4444433333332100 000011 013578999999999998 999999 6899
Q ss_pred HHcCCCc
Q 013064 330 LKEHPWF 336 (450)
Q Consensus 330 il~Hpff 336 (450)
++.||||
T Consensus 278 il~h~~f 284 (284)
T cd07839 278 ALQHPYF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=345.30 Aligned_cols=260 Identities=32% Similarity=0.520 Sum_probs=219.7
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK------RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~------~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
.|.+.+.||+|+||.||+|.+..+++.||+|.+.+..... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999999999999999887543221 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
.|+||||++|++|.+++...+.+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
.... .........|++.|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 161 ~~~~--------------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 161 LSTK--------------------------------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred ccCC--------------------------------ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhC
Confidence 1000 00001235799999999999988899999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
..||.+.+......++... ....+| ..++..+.++|++||. ||.+|| ++.+|++||||
T Consensus 209 ~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 267 (267)
T cd06628 209 KHPFPDCTQLQAIFKIGEN-ASPEIP--SNISSEAIDFLEKTFEIDHNKRP---TAAELLKHPFL 267 (267)
T ss_pred CCCCCCccHHHHHHHHhcc-CCCcCC--cccCHHHHHHHHHHccCCchhCc---CHHHHhhCCCC
Confidence 9999877665555554432 122333 3689999999999998 999999 68999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=348.55 Aligned_cols=257 Identities=32% Similarity=0.484 Sum_probs=214.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+++++.+|+.||+|++.+... .....+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999999999999999875532 2223456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.+|.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 9999998888877777899999999999999999999999999999999999999999999999999987643210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|.+||
T Consensus 156 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~ 201 (286)
T cd07847 156 ----------------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW 201 (286)
T ss_pred ----------------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 0113468899999999876 55789999999999999999999999
Q ss_pred CCCChhhhhhhhhccc-----------------ccccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 277 CSDDPRITCRKIVNWK-----------------TCLKFPE----------EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~-----------------~~~~~p~----------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
.+.+..+....+.... .....|. ...++..+.+||.+||. +|++|| ++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ 278 (286)
T cd07847 202 PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL---SCE 278 (286)
T ss_pred CCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC---CHH
Confidence 8776544333322100 0011111 13578899999999998 999999 689
Q ss_pred HHHcCCCc
Q 013064 329 ELKEHPWF 336 (450)
Q Consensus 329 eil~Hpff 336 (450)
+++.||||
T Consensus 279 eil~~~~f 286 (286)
T cd07847 279 ELLEHPYF 286 (286)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=348.18 Aligned_cols=257 Identities=32% Similarity=0.507 Sum_probs=222.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||.|+||.||++++..+++.||+|++.... .......+.+|+.+++.++||||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47899999999999999999999999999999987653 2344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||+++++|.+++... .+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||+++.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 999999999998765 799999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|.+||.
T Consensus 154 ----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~ 199 (274)
T cd06609 154 ----------------------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199 (274)
T ss_pred ----------------------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 0123578999999999998889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
+.+.......+... .....+. ..+++++.++|.+||. +|.+|+ +++++++||||.+..
T Consensus 200 ~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rp---t~~~il~~~~~~~~~ 258 (274)
T cd06609 200 DLHPMRVLFLIPKN-NPPSLEG-NKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKAK 258 (274)
T ss_pred cCchHHHHHHhhhc-CCCCCcc-cccCHHHHHHHHHHhhCChhhCc---CHHHHhhChhhcCCC
Confidence 87766655555442 1222222 2378999999999998 999999 689999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.33 Aligned_cols=253 Identities=20% Similarity=0.311 Sum_probs=203.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+...+|++++.||+|+||.||+|++..+++.||+|+..+.. ...|..+|+.++||||+++++++.+....|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 44468999999999999999999999999999999865432 346899999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||+. |+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 9999995 588888765 4679999999999999999999999999999999999999999999999999987532210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
......||+.|+|||++.+..|+.++|+|||||++|||+++.
T Consensus 212 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 212 --------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred --------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcC
Confidence 012467999999999999999999999999999999999854
Q ss_pred C-CCCCCChh---------hhhhhhhcc--cccccCC----------------------------CCCCCCHHHHHHHHH
Q 013064 274 P-PFCSDDPR---------ITCRKIVNW--KTCLKFP----------------------------EEPKISDEARDLICH 313 (450)
Q Consensus 274 ~-PF~~~~~~---------~~~~~i~~~--~~~~~~p----------------------------~~~~~s~~~~dli~~ 313 (450)
. +|...... ..+.+++.. .....+| ....++.++.+||.+
T Consensus 254 ~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 333 (357)
T PHA03209 254 STIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHK 333 (357)
T ss_pred CccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHH
Confidence 4 44432211 111111110 0000111 012567788999999
Q ss_pred hhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 314 LLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 314 lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||+ ||.+|| +++|+++||||+.+
T Consensus 334 mL~~dP~~Rp---ta~e~l~hp~f~~~ 357 (357)
T PHA03209 334 MLTFDAAMRP---SAEEILNYPMFAQL 357 (357)
T ss_pred HHcCCcccCc---CHHHHhcCchhccC
Confidence 999 999999 68999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=346.89 Aligned_cols=252 Identities=30% Similarity=0.501 Sum_probs=210.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC------
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS------ 110 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~------ 110 (450)
+.|++.+.||+|+||.||++..+.+++.||+|++.... .....+..|+.++..+ +||||++++++|.+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 56888999999999999999999999999999987542 2345678899999988 799999999998753
Q ss_pred CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
..+|+||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999999999998763 46899999999999999999999999999999999999999999999999998865
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchh
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLG 263 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlG 263 (450)
..... ......|++.|+|||++. +..|+.++|+||||
T Consensus 162 ~~~~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 203 (272)
T cd06637 162 DRTVG--------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203 (272)
T ss_pred ccccc--------------------------------------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence 32210 012467999999999986 34688999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|++|||++|..||...........+... .........++.++.+||.+||. ||.+|| ++.+++.||||
T Consensus 204 v~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~~ 272 (272)
T cd06637 204 ITAIEMAEGAPPLCDMHPMRALFLIPRN--PAPRLKSKKWSKKFQSFIESCLVKNHSQRP---TTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHhCCCCccccCHHHHHHHHhcC--CCCCCCCCCcCHHHHHHHHHHcCCChhhCC---CHHHHhhCCCC
Confidence 9999999999999776554444433321 11111224678999999999998 999999 68999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=374.26 Aligned_cols=243 Identities=36% Similarity=0.623 Sum_probs=213.0
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 114 (450)
..++|++...+|.|+|+.|..|.+..+++.+++|++.+.. ....+|..++... +||||+++++++.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4678999999999999999999999999999999998762 2234566666554 8999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE-ccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL-DKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl-d~~g~ikL~DFGla~~~~~~~~ 193 (450)
+|||++.||.|.+.+.....+. .++..|++||+.|+.|||++|||||||||+|||+ +..|+|+|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999999998887777 8888999999999999999999999999999999 69999999999999876532
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
..+.|-|..|.|||++...+|+.+|||||||++||+||+|+
T Consensus 470 ---------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~ 510 (612)
T KOG0603|consen 470 ---------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGR 510 (612)
T ss_pred ---------------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCC
Confidence 22468899999999999999999999999999999999999
Q ss_pred CCCCCCChh-hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 274 PPFCSDDPR-ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 274 ~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
+||...... ++..+|.. .++. ..+|+.|+|||++||+ ||.+|+ ++.+++.||||
T Consensus 511 tp~~~~P~~~ei~~~i~~----~~~s--~~vS~~AKdLl~~LL~~dP~~Rl---~~~~i~~h~w~ 566 (612)
T KOG0603|consen 511 TLFAAHPAGIEIHTRIQM----PKFS--ECVSDEAKDLLQQLLQVDPALRL---GADEIGAHPWF 566 (612)
T ss_pred CccccCCchHHHHHhhcC----Cccc--cccCHHHHHHHHHhccCChhhCc---ChhhhccCcch
Confidence 999876555 44444443 2222 4799999999999999 999999 68999999999
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=344.13 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=216.7
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh---cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM---LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~---~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
+|.+.+.||+|+||.||++.. .+|+.+|+|.+..... ........+.+|+.+|+.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578899999999999999976 4888999999865321 123345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||||++||+|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.+|.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999988653210000
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
. .........|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 160 ~--------------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 207 (265)
T cd06631 160 T--------------------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207 (265)
T ss_pred c--------------------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCc
Confidence 0 00011245799999999999998999999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccc-cccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~-~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|...+.......+..... ....+ ..++.++.+||++||. +|.+|| ++.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~ 265 (265)
T cd06631 208 LASMDRLAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHERP---SALQLLRHDFL 265 (265)
T ss_pred cccCChHHHHHHhhhccCCCCCCC--CCCCHHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 987665554444433211 11233 3689999999999998 999999 68999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=343.84 Aligned_cols=259 Identities=31% Similarity=0.546 Sum_probs=216.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-------chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-------KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
.|.+.+.||.|+||.||++....+|+.+|+|.++..... .....+.+..|..+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999999999999988643211 1123467888999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865322
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC--CCccccccchhHHHHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMYEM 269 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~--y~~~~DiWSlGvilyem 269 (450)
... .......|+..|+|||++.... ++.++|+|||||++|+|
T Consensus 162 ~~~------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l 205 (272)
T cd06629 162 YDN------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205 (272)
T ss_pred ccc------------------------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHH
Confidence 100 0012357899999999998654 89999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCC--CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
++|..||...+.......+........++.. ..++..+++||.+||. +|.+|| +++++++||||
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~ 272 (272)
T cd06629 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP---TARELLQHPFI 272 (272)
T ss_pred HhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC---CHHHHhhCCCC
Confidence 9999999766555444444332222333321 3578999999999998 999999 69999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=349.06 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=218.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
..+|++++.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|..+++.++||||+++++.|.++..+|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 3699999999999999999999999999999999876442 2346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||++||+|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 171 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc---
Confidence 999999999998854 4689999999999999999999999999999999999999999999999999876432210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus 172 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf 216 (296)
T cd06654 172 -----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216 (296)
T ss_pred -----------------------------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 011357999999999999888999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
...+.......+... .....+....+++.+.+||.+||. ||.+|| ++++|+.||||..
T Consensus 217 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~eil~~~~~~~ 275 (296)
T cd06654 217 LNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (296)
T ss_pred CCCCHHHhHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCCcccCc---CHHHHhhChhhhc
Confidence 887764443333221 111222224688999999999998 999999 6899999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=364.48 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=209.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCC-----CEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTG-----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~ 108 (450)
+..++|++.+.||+|+||.||+|++..+| +.||+|+++... .......+.+|+.+++.+ +|||||++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 44568999999999999999999865443 579999997643 233456788999999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE-------------------------------------------------------- 132 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~-------------------------------------------------------- 132 (450)
+...+|+|||||++|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 133 --------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 133 --------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
..++++.++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~---- 268 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY---- 268 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce----
Confidence 24788999999999999999999999999999999999999999999999999865432100
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFC 277 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~ 277 (450)
....+..+++.|+|||++.+..|+.++|||||||++|||++ |..||.
T Consensus 269 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~ 316 (374)
T cd05106 269 --------------------------------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP 316 (374)
T ss_pred --------------------------------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 00112346678999999998899999999999999999997 999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.........++.........| ..++++++++|.+||. ||.+|| ++++|.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~~l~~ 367 (374)
T cd05106 317 GILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERP---TFSQISQ 367 (374)
T ss_pred cccccHHHHHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 766555555554433233333 3578999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=349.06 Aligned_cols=256 Identities=32% Similarity=0.521 Sum_probs=219.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
.+|++++.||.|+||.||++.+..+|+.||+|.+.... ....+.+.+|..+++.++||||++++++|.+.+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 56999999999999999999999999999999987543 234567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|..++.+ ..+++.++..++.|++.||+|||++|++||||||+||+++.+|.+||+|||++........
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---- 170 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---- 170 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc----
Confidence 99999999998865 4689999999999999999999999999999999999999999999999999886543210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|..||.
T Consensus 171 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~ 216 (296)
T cd06655 171 ----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (296)
T ss_pred ----------------------------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0113579999999999998889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+.+.......+.... .........+++.+++||.+||. ||.+|+ ++.+|+.||||+..
T Consensus 217 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~il~~~~~~~~ 275 (296)
T cd06655 217 NENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKLA 275 (296)
T ss_pred CCCHHHHHHHHHhcC-CcccCCcccCCHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhhc
Confidence 877655544443211 11122224689999999999998 999999 68999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=343.58 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=217.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc---hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK---RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
+|+..+.||+|+||.||++.+..+++.||+|++.+..... ....+.+.+|..+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999997543221 2245778999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~~~~~ 194 (450)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888999999999999999999999999999999999999998877 5999999999876432100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
. .......+||..|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 161 ~----------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 206 (268)
T cd06630 161 A----------------------------------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206 (268)
T ss_pred C----------------------------------CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCC
Confidence 0 000113578999999999998889999999999999999999999
Q ss_pred CCCCCChhhhhhhhhc---ccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 275 PFCSDDPRITCRKIVN---WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
||...+.......+.. ......+| ..+++++.++|.+||. +|.+|+ ++.++++||||+
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~ll~~~~~~ 268 (268)
T cd06630 207 PWNAEKHSNHLALIFKIASATTAPSIP--EHLSPGLRDVTLRCLELQPEDRP---PSRELLKHPVFR 268 (268)
T ss_pred CCCCCCCcchHHHHHHHhccCCCCCCc--hhhCHHHHHHHHHHcCCCcccCc---CHHHHhcCcccC
Confidence 9976554333333322 11122233 3688999999999998 999999 689999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=338.32 Aligned_cols=253 Identities=31% Similarity=0.527 Sum_probs=221.7
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|+.++.||.|+||.|++++...+++.+++|.+..... .......+.+|+.+++.++|+||++++++|.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999876543 33456678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999765 5689999999999999999999999999999999999999999999999999886543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 -----------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08221 157 -----------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF 201 (256)
T ss_pred -----------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCC
Confidence 012457999999999998888999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
...+..+....+...... +....++.++.++|.+||+ +|.+|+ +++++++|||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~---s~~~ll~~~~l 256 (256)
T cd08221 202 DATNPLNLVVKIVQGNYT---PVVSVYSSELISLVHSLLQQDPEKRP---TADEVLDQPLL 256 (256)
T ss_pred CCCCHHHHHHHHHcCCCC---CCccccCHHHHHHHHHHcccCcccCC---CHHHHhhCcCC
Confidence 988888877777653221 1124689999999999998 999999 68999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=340.44 Aligned_cols=254 Identities=31% Similarity=0.484 Sum_probs=217.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+.+|..+++.++||||+++++++.+...+|+||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 78999999999999999999999999999999997543 235678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++|++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--- 156 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--- 156 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh---
Confidence 999999999998776 7899999999999999999999999999999999999999999999999999876543200
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC---CCCccccccchhHHHHHHhhCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~---~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+|+..|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 157 -----------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~ 201 (262)
T cd06613 157 -----------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201 (262)
T ss_pred -----------------------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC
Confidence 01235789999999999876 7899999999999999999999
Q ss_pred CCCCCCChhhhhhhhhccccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
+||.+.+.......+...... ........++.++++||.+||. +|..|+ ++.+|+.|||
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~ 262 (262)
T cd06613 202 PPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP---TATKLLQHPF 262 (262)
T ss_pred CCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC---CHHHHhcCCC
Confidence 999887765554444332100 1111123567899999999998 999999 6899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=350.69 Aligned_cols=261 Identities=30% Similarity=0.454 Sum_probs=215.7
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFL 113 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~l 113 (450)
.+++|++++.||+|+||.||+|.++.+|+.||+|+++.... .......+.+|+.+++.++|+||+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 57899999999999999999999999999999999875432 222334566799999999999999999999765 579
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.+|.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999964 78888765 3679999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~ 271 (450)
.. .....+++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 163 ~~--------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~ 204 (309)
T cd07845 163 KP--------------------------------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204 (309)
T ss_pred CC--------------------------------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh
Confidence 00 112356889999999875 568999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
|.+||.+.+..+.+..+.+... ....+. ...+++.+.+||++||+ ||.+|+
T Consensus 205 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-- 282 (309)
T cd07845 205 HKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA-- 282 (309)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc--
Confidence 9999998887777666553210 011111 02368999999999999 999999
Q ss_pred CCHHHHHcCCCcCCC
Q 013064 325 RGVEELKEHPWFRGI 339 (450)
Q Consensus 325 ~~~~eil~Hpff~~i 339 (450)
++++++.||||.+.
T Consensus 283 -t~~~il~h~~f~~~ 296 (309)
T cd07845 283 -TAEEALESSYFKEK 296 (309)
T ss_pred -CHHHHhcChhhccC
Confidence 68999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=351.10 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=225.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+-|+++..||+|+||.||+|.++.+|.++|||.+.-. ..+..+..|+.||+++++|+||++|++|-....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 4688999999999999999999999999999988643 35678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||..|++.+.++- +.+++|+++..++...+.||+|||...-||||||..|||++.+|+.||+|||.|..+.....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--- 184 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--- 184 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH---
Confidence 99999999999864 56899999999999999999999999999999999999999999999999999987654311
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
...+.+|||.|||||++..-+|+..+||||||+...||..|++||
T Consensus 185 -----------------------------------KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPY 229 (502)
T KOG0574|consen 185 -----------------------------------KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPY 229 (502)
T ss_pred -----------------------------------hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCc
Confidence 013689999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
.+-.+......|-. +.+..|..+..+|.++.|||++||. +|++|- ++-++++|||.++-.-..
T Consensus 230 sDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~---TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 230 SDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK---TALRLCEHTFIKNAPGCD 293 (502)
T ss_pred ccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---HHHHHhhhhhhcCCCccc
Confidence 88777654444432 2333443344789999999999998 999998 688999999999755443
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=357.44 Aligned_cols=256 Identities=29% Similarity=0.485 Sum_probs=211.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 110 (450)
.++|++++.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999987543 2333456677899999999999999999998754
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..+|+||||+. |+|...+... +++..+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5888877654 89999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 171 ~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~ 211 (353)
T cd07850 171 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211 (353)
T ss_pred CC---------------------------------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence 21 012357899999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccc----------------------------------cccCCC-----CCCCCHHHHHHH
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKT----------------------------------CLKFPE-----EPKISDEARDLI 311 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~----------------------------------~~~~p~-----~~~~s~~~~dli 311 (450)
+|..||.+.+....+.+++..-. ...++. ....++.+++||
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 291 (353)
T cd07850 212 RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291 (353)
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHH
Confidence 99999987765544444321000 000010 113466789999
Q ss_pred HHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 312 CHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 312 ~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+||+ ||.+|+ ++.+++.||||+.
T Consensus 292 ~~~L~~dP~~R~---t~~eiL~~~~~~~ 316 (353)
T cd07850 292 SKMLVIDPEKRI---SVDDALQHPYINV 316 (353)
T ss_pred HHHcCCChhhCc---CHHHHhcChhHhh
Confidence 99999 999999 6899999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=349.09 Aligned_cols=255 Identities=31% Similarity=0.523 Sum_probs=217.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
..+|++++.||+|+||.||++.+..+|+.||+|.+..... ...+.+.+|..+++.++||||++++++|..++.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3799999999999999999999999999999999875432 2346688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||++||+|..++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 170 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---
Confidence 999999999999865 4689999999999999999999999999999999999999999999999999876432210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|++.|+|||.+.+..++.++|+|||||++|+|++|.+||
T Consensus 171 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf 215 (297)
T cd06656 171 -----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (297)
T ss_pred -----------------------------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 011357899999999999988999999999999999999999999
Q ss_pred CCCChhhhhhhhhcc-cccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 277 CSDDPRITCRKIVNW-KTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+.+.......+... ......| ..+++.+++||.+||. +|.+|+ ++++++.||||..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~ 274 (297)
T cd06656 216 LNENPLRALYLIATNGTPELQNP--ERLSAVFRDFLNRCLEMDVDRRG---SAKELLQHPFLKL 274 (297)
T ss_pred CCCCcchheeeeccCCCCCCCCc--cccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhcc
Confidence 877654433333221 1112222 4688999999999998 999999 6899999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=339.36 Aligned_cols=253 Identities=30% Similarity=0.494 Sum_probs=217.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
-++|++.+.||+|+||.||+++...+++.||+|.+..... .+.+.+|..+++.++||||+++++.+.++..+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999999999999999875432 57788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999875 45789999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|.+|
T Consensus 155 ------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 155 ------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred ------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01134689999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|...+.......+.... ...+.....++.++.+||.+||. ||.+|+ ++.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERP---SAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCc---CHHHHhcCCCC
Confidence 98766554443333211 11222223678899999999998 999999 68999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=337.31 Aligned_cols=253 Identities=28% Similarity=0.524 Sum_probs=220.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++++.||+|+||.||+++...+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.++.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999976543 23345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++|++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 999999999987643 589999999999999999999999999999999999999999999999999876543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus 157 -----------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~ 201 (256)
T cd08218 157 -----------------------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201 (256)
T ss_pred -----------------------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCc
Confidence 011346899999999999888999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
...+..+....++.... ...| ..++.++.++|.+||. +|.+|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~vl~~~~~ 256 (256)
T cd08218 202 EAGNMKNLVLKIIRGSY-PPVS--SHYSYDLRNLVSQLFKRNPRDRP---SVNSILEKNFI 256 (256)
T ss_pred cCCCHHHHHHHHhcCCC-CCCc--ccCCHHHHHHHHHHhhCChhhCc---CHHHHhhCcCC
Confidence 88877777777665321 2223 3689999999999998 999999 78999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=378.92 Aligned_cols=269 Identities=24% Similarity=0.367 Sum_probs=203.4
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCC-CEEEEE--------------EeechhhcchhhHHHHHHHHHHHHhcCCCCe
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMK--------------KLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~-~~~AiK--------------~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I 100 (450)
..++|++++.||+|+||+||+|..+... ...+.| ++.+...........+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999999865432 222222 1212111222345568899999999999999
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 175 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~-----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g 175 (450)
|++++++.+.+..|+|||++ +++|..++... .......++.++.||+.||+|||++|||||||||+|||++.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 45777776542 2345677889999999999999999999999999999999999
Q ss_pred ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCc
Q 013064 176 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255 (450)
Q Consensus 176 ~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~ 255 (450)
.+||+|||+++.+..... ....+.+||+.|+|||++.+..|+.
T Consensus 305 ~vkL~DFGla~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 347 (501)
T PHA03210 305 KIVLGDFGTAMPFEKERE-------------------------------------AFDYGWVGTVATNSPEILAGDGYCE 347 (501)
T ss_pred CEEEEeCCCceecCcccc-------------------------------------cccccccCCcCCCCchhhcCCCCCc
Confidence 999999999987643210 0112468999999999999999999
Q ss_pred cccccchhHHHHHHhhCCCCCCC-C--Chhhhhhhhhcccc--cccCCC--------------------------CCCCC
Q 013064 256 ECDWWSLGAIMYEMLIGYPPFCS-D--DPRITCRKIVNWKT--CLKFPE--------------------------EPKIS 304 (450)
Q Consensus 256 ~~DiWSlGvilyeml~G~~PF~~-~--~~~~~~~~i~~~~~--~~~~p~--------------------------~~~~s 304 (450)
++|||||||++|||++|..++.+ . +....+.+++.... ...+|. ...++
T Consensus 348 ~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 427 (501)
T PHA03210 348 ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLP 427 (501)
T ss_pred HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCC
Confidence 99999999999999998754432 2 22222222221000 001110 12456
Q ss_pred HHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 305 DEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 305 ~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
.++.++|.+||+ ||.+|+ ++.|++.||||...+...+.
T Consensus 428 ~~~~~li~kmL~~DP~~Rp---sa~elL~hp~f~~~~~~~~~ 466 (501)
T PHA03210 428 ADFEYPLVKMLTFDWHLRP---GAAELLALPLFSAEEEEEIL 466 (501)
T ss_pred hHHHHHHHHHhccCcccCc---CHHHHhhChhhhcCCchHHH
Confidence 788899999999 999999 78999999999988776554
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.38 Aligned_cols=263 Identities=19% Similarity=0.294 Sum_probs=215.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+..++|++++.||+|+||.||+|..+. .+..||+|.++... .......+.+|..+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 556899999999999999999997653 34579999886543 22234457889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEE
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~----------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL 179 (450)
....|+||||++||+|.+++.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999997532 3456788999999999999999999999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccc
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~Di 259 (450)
+|||+++........ ......+++..|+|||.+.+..++.++|+
T Consensus 161 ~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv 204 (288)
T cd05061 161 GDFGMTRDIYETDYY------------------------------------RKGGKGLLPVRWMAPESLKDGVFTTSSDM 204 (288)
T ss_pred CcCCccccccccccc------------------------------------cccCCCcccccccCHHHhccCCCChHhHH
Confidence 999998865332100 00012356788999999998889999999
Q ss_pred cchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc-----
Q 013064 260 WSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE----- 332 (450)
Q Consensus 260 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~----- 332 (450)
|||||++|||++ |.+||.+.+..+....+... .....+ ...++.++++|.+||. ||.+||+ +.++++
T Consensus 205 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~l~~~ 278 (288)
T cd05061 205 WSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQP--DNCPERVTDLMRMCWQFNPKMRPT---FLEIVNLLKDD 278 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhHCcC---HHHHHHHHHhh
Confidence 999999999998 89999887776666665542 222333 3578999999999998 9999994 555554
Q ss_pred -CCCcCCCCc
Q 013064 333 -HPWFRGIQW 341 (450)
Q Consensus 333 -Hpff~~i~w 341 (450)
||||++++|
T Consensus 279 ~~~~~~~~~~ 288 (288)
T cd05061 279 LHPSFPEVSF 288 (288)
T ss_pred cCCCCCCCCC
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=368.82 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=205.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
...|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|.++|+.++|||||++++++..++..|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996422 2356799999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||++. |+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 99994 6888888664 57999999999999999999999999999999999999999999999999999865332100
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
......+||+.|+|||++.+..++.++|||||||+||||++|..|
T Consensus 317 -----------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~ 361 (461)
T PHA03211 317 -----------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS 361 (461)
T ss_pred -----------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCC
Confidence 001246799999999999999999999999999999999998876
Q ss_pred CCCCCh-------hhhhhhhhcc-ccc-ccCC-----------------------------CCCCCCHHHHHHHHHhhc-
Q 013064 276 FCSDDP-------RITCRKIVNW-KTC-LKFP-----------------------------EEPKISDEARDLICHLLC- 316 (450)
Q Consensus 276 F~~~~~-------~~~~~~i~~~-~~~-~~~p-----------------------------~~~~~s~~~~dli~~lL~- 316 (450)
+.+... .....+++.. ... ..++ ....++.++.+||++||.
T Consensus 362 lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 441 (461)
T PHA03211 362 LFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF 441 (461)
T ss_pred cccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHccc
Confidence 543221 1112222211 000 0010 012456789999999999
Q ss_pred CccccCCCCCHHHHHcCCCcCC
Q 013064 317 DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 317 dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||.+|+ ++.|+|+||||+.
T Consensus 442 DP~~RP---sa~elL~hp~f~~ 460 (461)
T PHA03211 442 DGARRP---SAAELLRLPLFQS 460 (461)
T ss_pred ChhhCc---CHHHHhhCcccCC
Confidence 999999 7999999999964
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.27 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=209.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
++|++++.||+|+||.||+|+++.+|+.||+|.+++... .... ..+..|..+ ++.++||||+++++++..+..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 589999999999999999999999999999999976532 2222 344455554 6677999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 117 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 117 mEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|||++ |+|..++.. ...+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 677777654 34699999999999999999999997 9999999999999999999999999998765321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc----CCCCccccccchhHHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK----KGYGMECDWWSLGAIMY 267 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~----~~y~~~~DiWSlGvily 267 (450)
.. .....|+..|+|||++.+ .+++.++|+|||||++|
T Consensus 158 ~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~ 198 (283)
T cd06617 158 VA---------------------------------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198 (283)
T ss_pred cc---------------------------------------cccccCCccccChhhcCCcccccccCccccchhhHHHHH
Confidence 00 112468999999999864 56789999999999999
Q ss_pred HHhhCCCCCCCC-ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 268 EMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 268 eml~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
+|++|..||... ...+....+... ....+|. ..+|.++++||.+||. +|.+|| ++++++.||||....+.
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 199 ELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPA-EKFSPEFQDFVNKCLKKNYKERP---NYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHhCCCCCCccccCHHHHHHHHhc-CCCCCCc-cccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhhhcccc
Confidence 999999999653 222333333331 2223332 3588999999999998 999999 68999999999886654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=344.95 Aligned_cols=274 Identities=38% Similarity=0.709 Sum_probs=227.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylV 116 (450)
++|.+.+.||+|+||.||+|....+|+.||+|++.+..+........+.+|..+++.+. ||||++++++|.+++.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 58999999999999999999999999999999998876655556678889999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|+++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999987654321100
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
...... ...... ...........|++.|+|||++....++.++|+|||||++|+|++|..||
T Consensus 161 ~~~~~~------~~~~~~------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 161 NKGDAT------NIDSQI------------EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred CCCCCc------cccccc------------cccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 000000 000000 00001123467899999999998888999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH----HHHHcCCCc
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV----EELKEHPWF 336 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~----~eil~Hpff 336 (450)
...+....+..+.. ....+| ..+++.+.+||.+||. +|.+|| ++ +++++||||
T Consensus 223 ~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~R~---~~~~~~~~ll~~~~~ 280 (280)
T cd05581 223 RGSNEYLTFQKILK--LEYSFP--PNFPPDAKDLIEKLLVLDPQDRL---GVNEGYDELKAHPFF 280 (280)
T ss_pred CCccHHHHHHHHHh--cCCCCC--CccCHHHHHHHHHHhcCCHhhCC---CcccCHHHHhcCCCC
Confidence 98877666666653 223444 3679999999999998 999999 56 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=344.69 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=207.7
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+++|++++.||+|++|.||++.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.++++.|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 46899999999999999999999999999999999875431 2223456789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||||+++ +|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 9999975 999988764 4689999999999999999999999999999999999999999999999999875322100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~ 273 (450)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 159 -------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 159 -------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred -------------------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence 0112357899999999875 56899999999999999999999
Q ss_pred CCCCCCC-hhhhhhhhhccc-----------------ccccCC---------CCCCCC--HHHHHHHHHhhc-CccccCC
Q 013064 274 PPFCSDD-PRITCRKIVNWK-----------------TCLKFP---------EEPKIS--DEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 274 ~PF~~~~-~~~~~~~i~~~~-----------------~~~~~p---------~~~~~s--~~~~dli~~lL~-dp~~R~~ 323 (450)
+||.+.. ..+....+.... ....++ ....++ .++.++|.+||+ +|.+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp- 280 (291)
T cd07844 202 PLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI- 280 (291)
T ss_pred CCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc-
Confidence 9997655 222222211000 000000 001344 889999999998 999999
Q ss_pred CCCHHHHHcCCCc
Q 013064 324 TRGVEELKEHPWF 336 (450)
Q Consensus 324 ~~~~~eil~Hpff 336 (450)
++.+++.||||
T Consensus 281 --s~~e~l~~~~f 291 (291)
T cd07844 281 --SAAEAMKHPYF 291 (291)
T ss_pred --CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=347.89 Aligned_cols=257 Identities=32% Similarity=0.507 Sum_probs=214.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|.++.+++.||+|.+.+.... ....+.+.+|+.+++.++||||++++++|.+++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 5799999999999999999999999999999998765432 234567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++++.|..+......+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc----
Confidence 9999999988877777799999999999999999999999999999999999999999999999999886533210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|++.|+|||++.+ ..++.++|+|||||++|||++|.+||
T Consensus 156 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~ 201 (286)
T cd07846 156 ----------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201 (286)
T ss_pred ----------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC
Confidence 0123568999999999875 45788999999999999999999999
Q ss_pred CCCChhhhhhhhhccccc-----------------ccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 277 CSDDPRITCRKIVNWKTC-----------------LKFPE----------EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~-----------------~~~p~----------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
.+.+..+....+...... ...|. .+.++..+++||.+||. +|.+|| ++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~ 278 (286)
T cd07846 202 PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP---SSS 278 (286)
T ss_pred CCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch---hHH
Confidence 876654433333211100 00110 13678999999999998 999999 689
Q ss_pred HHHcCCCc
Q 013064 329 ELKEHPWF 336 (450)
Q Consensus 329 eil~Hpff 336 (450)
+++.||||
T Consensus 279 ~il~~~~~ 286 (286)
T cd07846 279 QLLHHEFF 286 (286)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=337.16 Aligned_cols=248 Identities=30% Similarity=0.514 Sum_probs=214.3
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++.+.||.|+||.||+|+++.+++.||+|.++... .....+.+.+|..+++.++||||++++++|.++..+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 6899999999999999999999999999999987543 23456778889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|++||+|..++.. ...++++.+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 9999999998865 34689999999999999999999999999999999999999999999999999876533210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 156 -----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~ 200 (255)
T cd08219 156 -----------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF 200 (255)
T ss_pred -----------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCC
Confidence 012357999999999999888999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
...+.......+.... ....| ..++..+++||.+||. ||.+|| ++.+|+.
T Consensus 201 ~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~ 251 (255)
T cd08219 201 QANSWKNLILKVCQGS-YKPLP--SHYSYELRSLIKQMFKRNPRSRP---SATTILS 251 (255)
T ss_pred CCCCHHHHHHHHhcCC-CCCCC--cccCHHHHHHHHHHHhCCcccCC---CHHHHhh
Confidence 9887766666665432 12223 3688999999999998 999999 6788875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=346.71 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=218.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||++.+..+|+.||+|++.... .......+.+|..+++.++||||+++++++.+...+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 45689999999999999999999999999999999987542 2334577889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||+++|+|..++.+.+.+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999999999888889999999999999999999997 699999999999999999999999999986542210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....+||..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 159 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~ 199 (284)
T cd06620 159 ---------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199 (284)
T ss_pred ---------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence 11357999999999998888999999999999999999999
Q ss_pred CCCCCCChh-----------hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPR-----------ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~-----------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.||...+.. +....+... ....++. ..++.++.+||.+||. ||.+|| +++|+++||||..
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp---t~~e~~~~~~~~~ 271 (284)
T cd06620 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPS-SDFPEDLRDFVDACLLKDPTERP---TPQQLCAMPPFIQ 271 (284)
T ss_pred CCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCc-hhcCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccc
Confidence 999865542 222233221 1122222 2378899999999998 999999 6899999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=347.79 Aligned_cols=259 Identities=30% Similarity=0.469 Sum_probs=215.7
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+|++++.||+|+||.||+|.++.+|+.||+|.++..... .......+..|+.+++.++||||+++++++.++..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999876533 122345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||+ +|+|..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 999999998776 899999999999999999999999999999999999999999999999999986543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus 158 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~ 201 (298)
T cd07841 158 ------------------------------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201 (298)
T ss_pred ------------------------------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence 0112457889999999865 567899999999999999999999
Q ss_pred CCCCCChhhhhhhhhccccc------------------c---cCC---CCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 275 PFCSDDPRITCRKIVNWKTC------------------L---KFP---EEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~------------------~---~~p---~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
||.+.+..+.+.++...... . ..+ ....++..+.+||.+||. ||.+|+ ++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s~~e 278 (298)
T cd07841 202 FLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI---TARQ 278 (298)
T ss_pred cccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc---CHHH
Confidence 99887765555444321000 0 000 013457899999999998 999999 6899
Q ss_pred HHcCCCcCCC
Q 013064 330 LKEHPWFRGI 339 (450)
Q Consensus 330 il~Hpff~~i 339 (450)
++.||||++.
T Consensus 279 ~l~~~~~~~~ 288 (298)
T cd07841 279 ALEHPYFSND 288 (298)
T ss_pred HhhCccccCC
Confidence 9999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.33 Aligned_cols=258 Identities=30% Similarity=0.485 Sum_probs=213.4
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEc-
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD- 109 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~- 109 (450)
......+.|++.+.||.|+||.||+|+++.+++.+|+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 33445589999999999999999999999999999999986542 2345678899999988 79999999999853
Q ss_pred -----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 110 -----SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 110 -----~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 56899999999999999998753 45889999999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccc
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMEC 257 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~ 257 (450)
|++........ .....+|++.|+|||++. +..++.++
T Consensus 166 g~~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~ 207 (282)
T cd06636 166 GVSAQLDRTVG--------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDYRS 207 (282)
T ss_pred cchhhhhcccc--------------------------------------CCCcccccccccCHhhcCcccCcCcCCCccc
Confidence 99876532110 012467999999999986 35688899
Q ss_pred cccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|+|||||++|||++|.+||....+......+.... .... ....++.++.+||.+||. ||.+|| ++.+|++||||
T Consensus 208 DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---~~~ell~~~~~ 282 (282)
T cd06636 208 DIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKL-KSKKWSKKFIDFIEGCLVKNYLSRP---STEQLLKHPFI 282 (282)
T ss_pred chhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC-CCCC-cccccCHHHHHHHHHHhCCChhhCc---CHHHHhcCCCC
Confidence 99999999999999999998766554444433211 1111 123578999999999998 999999 68999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.80 Aligned_cols=257 Identities=29% Similarity=0.470 Sum_probs=211.5
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE-----
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF----- 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f----- 107 (450)
....++|++++.||+|+||.||+|.++.+++.||+|++.+.. .....+.+|..+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345689999999999999999999999999999999986532 1235577899999998 799999999987
Q ss_pred EcCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecc
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFG 183 (450)
+++..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++.+|.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 355689999999999999988753 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCcccc
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECD 258 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~D 258 (450)
++........ .....+|++.|+|||++.. ..|+.++|
T Consensus 170 ~~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 211 (286)
T cd06638 170 VSAQLTSTRL--------------------------------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211 (286)
T ss_pred ceeecccCCC--------------------------------------ccccccCCCcccChhhhchhhhccccccchhh
Confidence 9886543210 0123579999999999853 45889999
Q ss_pred ccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 259 WWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 259 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
+|||||++|||++|..||...+......++.... ..........+..+.+||.+||. ||.+|| ++.||++||||
T Consensus 212 v~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~~~~ 286 (286)
T cd06638 212 VWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRP---TVSDLLQHVFI 286 (286)
T ss_pred hhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCC---CHHHHhhcccC
Confidence 9999999999999999998776544444433221 11111223568899999999998 999999 69999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=342.00 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=213.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC---
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS--- 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~--- 110 (450)
-..++|++.+.||+|+||.||+|..+.+++.||+|++.+.. .....+.+|..++..+ +||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34688999999999999999999999999999999986532 2345677899999988 899999999998754
Q ss_pred --CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 111 --DFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 111 --~~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 368999999999999998753 45799999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-----CCCccccc
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-----GYGMECDW 259 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-----~y~~~~Di 259 (450)
+........ .....+|++.|+|||++... .++.++|+
T Consensus 175 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 216 (291)
T cd06639 175 SAQLTSTRL--------------------------------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDV 216 (291)
T ss_pred chhcccccc--------------------------------------cccCccCCccccChhhhcCCCCcccccCCccch
Confidence 886543210 01135789999999998643 36899999
Q ss_pred cchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
|||||++|+|++|++||...+.......+..... ........++..+++||.+||. +|.+|| ++.+|+.||||+
T Consensus 217 ~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~ 291 (291)
T cd06639 217 WSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP-PTLLHPEKWCRSFNHFISQCLIKDFEARP---SVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC-CCCCcccccCHHHHHHHHHHhhcChhhCc---CHHHHhcCcccC
Confidence 9999999999999999988776555555543221 1121223577899999999998 999999 689999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=336.59 Aligned_cols=260 Identities=31% Similarity=0.494 Sum_probs=221.2
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|.+.+.||+|+||.||++....+++.||+|+++.... .......+..|..+++.++|++|+++++.+.+.+.+|+|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999999999999999986643 24577889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|+++++|.+++.+...+++..++.++.|++.||.|||++||+||||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~-- 157 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-- 157 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc--
Confidence 999999999998888899999999999999999999999999999999999999999999999999987644311100
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC---CCccccccchhHHHHHHhhCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~---y~~~~DiWSlGvilyeml~G~~P 275 (450)
.......|++.|+|||++.+.. ++.++|+|||||++|+|++|..|
T Consensus 158 --------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p 205 (264)
T cd06626 158 --------------------------------EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205 (264)
T ss_pred --------------------------------ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 0011357899999999998766 89999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|.+.+........+.......+|....+++.+.+||.+||. +|.+|+ ++++++.|||+
T Consensus 206 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~i~~~~~~ 264 (264)
T cd06626 206 WSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPFV 264 (264)
T ss_pred ccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 97654333322222223445566655679999999999998 999999 68999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=337.17 Aligned_cols=259 Identities=32% Similarity=0.504 Sum_probs=219.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechh--hcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE--MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFL 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~l 113 (450)
.+|++.+.||+|+||.||++.++.+|+.||+|.+.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 68999999999999999999999999999999875432 11234566888999999999999999999999764 468
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
++||||++|++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 162 ~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 206 (264)
T cd06653 162 SG-----------------------------------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206 (264)
T ss_pred cC-----------------------------------ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 00 0012357899999999999888999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff 336 (450)
+||..........++........+| ..+++.+.++|.+||.+|..|+ ++.+++.|||.
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~~i~~~l~~~~~r~---~~~~~~~~~~~ 264 (264)
T cd06653 207 PPWAEYEAMAAIFKIATQPTKPMLP--DGVSDACRDFLKQIFVEEKRRP---TAEFLLRHPFV 264 (264)
T ss_pred CCCCccCHHHHHHHHHcCCCCCCCC--cccCHHHHHHHHHHhcCcccCc---cHHHHhcCCCC
Confidence 9998776666555555433333344 4789999999999999889999 68899999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.97 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=215.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999976542 23445678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 119 YLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 119 y~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|+ |++|.+++.. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999865 45799999999999999999999999999999999999999999999999999886543210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......+|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||
T Consensus 155 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~ 201 (286)
T cd07832 155 ---------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF 201 (286)
T ss_pred ---------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc
Confidence 00123579999999999875 44689999999999999999999999
Q ss_pred CCCChhhhhhhhhccc-----------------ccccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 277 CSDDPRITCRKIVNWK-----------------TCLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~-----------------~~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
.+.+....+..+...- ....++. .+..+..+.+||++||. ||.+|+ ++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~ 278 (286)
T cd07832 202 PGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL---SAAE 278 (286)
T ss_pred CCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC---CHHH
Confidence 8877655554443210 0011111 12467899999999998 999999 6899
Q ss_pred HHcCCCcC
Q 013064 330 LKEHPWFR 337 (450)
Q Consensus 330 il~Hpff~ 337 (450)
++.||||.
T Consensus 279 ~l~h~~~~ 286 (286)
T cd07832 279 ALRHPYFT 286 (286)
T ss_pred HhhCcCcC
Confidence 99999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=335.87 Aligned_cols=254 Identities=35% Similarity=0.570 Sum_probs=217.7
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+|+..+.||+|+||+||+|..+.+++.||+|.+..... ......+.+.+|..+++.++||+|+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 46778999999999999999998999999999876432 1233567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999988653321
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC-CCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~-y~~~~DiWSlGvilyeml~G~~P 275 (450)
......|++.|+|||.+.... ++.++|+|||||++|+|++|..|
T Consensus 157 -----------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p 201 (258)
T cd06632 157 -----------------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201 (258)
T ss_pred -----------------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 012357899999999998766 89999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|..........++........+| ..+++.+++||.+||. +|.+|+ ++.+++.|||+
T Consensus 202 f~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 258 (258)
T cd06632 202 WSQLEGVAAVFKIGRSKELPPIP--DHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPFV 258 (258)
T ss_pred cccCcHHHHHHHHHhcccCCCcC--CCcCHHHHHHHHHHhhcCcccCc---CHHHHhcCCCC
Confidence 98766544444444322222333 3688999999999998 999999 68999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=334.39 Aligned_cols=252 Identities=29% Similarity=0.553 Sum_probs=219.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++++.||+|+||.||+|....+++.+|+|.+.+... .......+.+|..+|+.++||||+++++.+..++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999986543 33456788899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccCccccccc
Q 013064 119 YLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 119 y~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~~~~~~ 195 (450)
|++|++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999764 3589999999999999999999999999999999999998655 579999999987543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
....+|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 158 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 200 (256)
T cd08220 158 -------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA 200 (256)
T ss_pred -------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 1135789999999999988899999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|.+.+......++.... ...++ ..++++++++|.+||. +|.+|| ++.++++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~ll~~p~~ 256 (256)
T cd08220 201 FEAANLPALVLKIMSGT-FAPIS--DRYSPDLRQLILSMLNLDPSKRP---QLSQIMAQPIC 256 (256)
T ss_pred cccCchHHHHHHHHhcC-CCCCC--CCcCHHHHHHHHHHccCChhhCC---CHHHHhhCCCC
Confidence 98887777666665422 12233 3689999999999998 999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=337.23 Aligned_cols=257 Identities=29% Similarity=0.515 Sum_probs=221.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ......+.+|..++..++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 579999999999999999999999999999999876532 144677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.+|.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 999999999999888899999999999999999999999 9999999999999999999999999999886543211
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|+..|+|||.+....++.++|+||||+++|+|++|..||
T Consensus 156 -----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~ 200 (264)
T cd06623 156 -----------------------------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF 200 (264)
T ss_pred -----------------------------------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 011357899999999999888999999999999999999999999
Q ss_pred CCCC---hhhhhhhhhcccccccCCCCCC-CCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 277 CSDD---PRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 277 ~~~~---~~~~~~~i~~~~~~~~~p~~~~-~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
...+ ..+....+... .....+ .. ++..+.++|++||. +|.+|+ ++++++.||||+.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~---~~~~ll~~~~~~~~~ 263 (264)
T cd06623 201 LPPGQPSFFELMQAICDG-PPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKKAD 263 (264)
T ss_pred ccccccCHHHHHHHHhcC-CCCCCC--cccCCHHHHHHHHHHccCChhhCC---CHHHHHhCHHHHhcc
Confidence 8774 33344444421 112222 24 78999999999998 999999 689999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=343.75 Aligned_cols=257 Identities=32% Similarity=0.496 Sum_probs=210.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCe----
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDF---- 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~---- 112 (450)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 57999999999999999999999999999999986543 22334466788999999995 6999999999987766
Q ss_pred -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeecccc
Q 013064 113 -LYLIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLC 185 (450)
Q Consensus 113 -lylVmEy~~gg~L~~~l~~~-----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DFGla 185 (450)
+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 788887653 35899999999999999999999999999999999999998 899999999998
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 264 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGv 264 (450)
..+..... ......+++.|+|||++.+ ..++.++|+|||||
T Consensus 159 ~~~~~~~~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 159 RAFSIPVK--------------------------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred eecCCCcc--------------------------------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 86532100 0112467899999999865 56799999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccc---c------------ccCCC---------CCCCCHHHHHHHHHhhc-Ccc
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKT---C------------LKFPE---------EPKISDEARDLICHLLC-DVE 319 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~---~------------~~~p~---------~~~~s~~~~dli~~lL~-dp~ 319 (450)
++|+|++|.+||.+.+......++..... . ..++. .+.+++++.+||.+||. ||.
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 99999999999988776655544432100 0 00110 13588999999999998 999
Q ss_pred ccCCCCCHHHHHcCCCcC
Q 013064 320 TRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 320 ~R~~~~~~~eil~Hpff~ 337 (450)
+|+ ++++++.||||+
T Consensus 281 ~R~---~~~eil~~~~~~ 295 (295)
T cd07837 281 KRI---SAKAALTHPYFD 295 (295)
T ss_pred hcC---CHHHHhcCCCcC
Confidence 999 689999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=344.39 Aligned_cols=261 Identities=31% Similarity=0.479 Sum_probs=213.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++.+.||+|++|.||++.++.+|+.||+|.+..... .....+.+.+|..+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999876532 223456778899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DFGla~~~~~~~~ 193 (450)
|||++ ++|..++.... .+++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++........
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99995 58888876544 3588899999999999999999999999999999999985 55799999999976432200
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G 272 (450)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 159 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg 200 (294)
T PLN00009 159 --------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200 (294)
T ss_pred --------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0113468999999999876 4578999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccc----------------cCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCL----------------KFP---------EEPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~----------------~~p---------~~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
.+||.+.+..+...++....... .++ ..+.++++++++|.+||. +|.+|+ +
T Consensus 201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s 277 (294)
T PLN00009 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI---T 277 (294)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc---C
Confidence 99998877655555443210000 000 013578999999999998 999999 6
Q ss_pred HHHHHcCCCcCCCC
Q 013064 327 VEELKEHPWFRGIQ 340 (450)
Q Consensus 327 ~~eil~Hpff~~i~ 340 (450)
+++++.||||.+++
T Consensus 278 ~~~~l~~~~~~~~~ 291 (294)
T PLN00009 278 ARAALEHEYFKDLG 291 (294)
T ss_pred HHHHhcCchHhHHh
Confidence 89999999998754
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.91 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=213.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD---- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~---- 111 (450)
.++|++++.||+|+||.||+|.++.+++.||+|++.... ...+.+.+|..+++.+ +||||++++++|.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 489999999999999999999999999999999987543 2346788999999998 7999999999997644
Q ss_pred --eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 112 --FLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 112 --~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 59999999999999998865 357999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCcccccc
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWW 260 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~DiW 260 (450)
........ ......|++.|+|||++.. ..++.++|+|
T Consensus 161 ~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 202 (275)
T cd06608 161 AQLDSTLG--------------------------------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVW 202 (275)
T ss_pred eecccchh--------------------------------------hhcCccccccccCHhHhcccccccCCccccccHH
Confidence 76533210 0123579999999999863 3478899999
Q ss_pred chhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
||||++|+|++|.+||...+......++.... .........++.++++||.+||. ||.+|| +++++++|||+
T Consensus 203 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~ll~~~~~ 275 (275)
T cd06608 203 SLGITAIELADGKPPLCDMHPMRALFKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRP---FMEELLEHPFI 275 (275)
T ss_pred HhHHHHHHHHhCCCCccccchHHHHHHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCc---CHHHHhcCCCC
Confidence 99999999999999998766655555555422 11222223478899999999998 999999 68999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=359.65 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=208.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~-----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|++.+.||+|+||.||+|.. ..++..||+|+++... .....+.+.+|+.+|..+ +|||||++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34456899999999999999999974 3567789999997543 223456788999999999 899999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcC------------------------------------------------------
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRED------------------------------------------------------ 133 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~------------------------------------------------------ 133 (450)
.+....|+|||||+||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986532
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 134 ---------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 134 ---------------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
.++++.+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47888899999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ....+..+++.|+|||++.+..++.++|+|||||++|||++
T Consensus 269 ~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~ 312 (375)
T cd05104 269 NY------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 312 (375)
T ss_pred cc------------------------------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhc
Confidence 00 00112346778999999999999999999999999999997
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||.+........+++........| ...+.++++||.+||. ||.+|| ++.+|++
T Consensus 313 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RP---s~~eil~ 369 (375)
T cd05104 313 GSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLKRP---TFKQIVQ 369 (375)
T ss_pred CCCCCCCCCchHHHHHHHHhCccCCCC--CCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 999998765544444444322222223 3578899999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=357.58 Aligned_cols=261 Identities=32% Similarity=0.531 Sum_probs=213.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 112 (450)
++.-..|++++.||+||.++||+|+....+ .||+|.+.-.. .....+.-+.+|+.+|.+| .|.+||+||++-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 455678999999999999999999876554 46666553322 2344577899999999999 58999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCH-HHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSE-DVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e-~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+||||||= ..||..+|.+.....+ -.+++|..||++|+.++|+.||||-||||.|+|+ -.|.+||+|||+|..+...
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence 99999975 6699999988765443 5899999999999999999999999999999998 5799999999999987765
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC-----------CCcccccc
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-----------YGMECDWW 260 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~-----------y~~~~DiW 260 (450)
..+.+ ..+.|||+.|||||.+.... .+.++|||
T Consensus 513 TTsI~------------------------------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW 556 (677)
T KOG0596|consen 513 TTSIV------------------------------------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW 556 (677)
T ss_pred cccee------------------------------------eccccCcccccCHHHHhhccccccCCCcceeecCccchh
Confidence 32211 23679999999999997432 46889999
Q ss_pred chhHHHHHHhhCCCCCCCC-ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 261 SLGAIMYEMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|||||||+|++|++||..- +...-+..|......++||..+. ..++.++++.||. ||.+|+ ++.++|+|||...
T Consensus 557 SLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~---si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 557 SLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRW---SIPELLQHPFLQI 632 (677)
T ss_pred hhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCC---CcHHHhcCccccc
Confidence 9999999999999999753 34455666776556677875322 2239999999998 999999 6899999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=345.18 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=205.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC----------------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT----------------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~----------------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp 98 (450)
+..++|.+.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|..+|..++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 456799999999999999999998542 34579999987542 234456788999999999999
Q ss_pred CeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHhhhCCe
Q 013064 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-------------------ILSEDVARFYIAESVLAIHSIHQHNY 159 (450)
Q Consensus 99 ~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~-------------------~~~e~~~~~~~~qil~aL~~LH~~gi 159 (450)
||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999986532 36778899999999999999999999
Q ss_pred EEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccC
Q 013064 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 239 (450)
Q Consensus 160 vHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt 239 (450)
+||||||+|||++.++.+||+|||+++.+...... .......++
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------------------------------------~~~~~~~~~ 203 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY------------------------------------RIQGRAVLP 203 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCcee------------------------------------EecCcCCCC
Confidence 99999999999999999999999999865332110 001134678
Q ss_pred CCccchhhhccCCCCccccccchhHHHHHHhh--CCCCCCCCChhhhhhhhhcc----cccccCCCCCCCCHHHHHHHHH
Q 013064 240 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNW----KTCLKFPEEPKISDEARDLICH 313 (450)
Q Consensus 240 ~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dli~~ 313 (450)
+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+... .........+.++..+.+||.+
T Consensus 204 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 283 (304)
T cd05096 204 IRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQ 283 (304)
T ss_pred ccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHH
Confidence 89999999998889999999999999999986 66888876655544433211 0011111123678999999999
Q ss_pred hhc-CccccCCCCCHHHHH
Q 013064 314 LLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 314 lL~-dp~~R~~~~~~~eil 331 (450)
||. ||.+|| ++++|.
T Consensus 284 cl~~~p~~RP---s~~~i~ 299 (304)
T cd05096 284 CWSRDCRERP---SFSDIH 299 (304)
T ss_pred HccCCchhCc---CHHHHH
Confidence 998 999999 567773
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.65 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=211.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++++.||.|++|.||+|+++.+|+.||+|.+.... ........+.+|+++++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999987543 223344678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|+. ++|..++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 996 689888865 35789999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC-CCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~-y~~~~DiWSlGvilyeml~G~~P 275 (450)
......+++.|+|||++.+.. ++.++|+|||||++|+|++|..|
T Consensus 156 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p 200 (284)
T cd07860 156 -----------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 200 (284)
T ss_pred -----------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 011346789999999987644 68899999999999999999999
Q ss_pred CCCCChhhhhhhhhccccc----------------ccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 276 FCSDDPRITCRKIVNWKTC----------------LKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~----------------~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
|.+.+......++...... ..++. .+.+++++++||.+||. ||.+|| ++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~ 277 (284)
T cd07860 201 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI---SAKA 277 (284)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC---CHHH
Confidence 9887665544443321100 00110 13578999999999998 999999 6899
Q ss_pred HHcCCCc
Q 013064 330 LKEHPWF 336 (450)
Q Consensus 330 il~Hpff 336 (450)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07860 278 ALAHPFF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.27 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=215.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCC-----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTG-----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+.+++|++++.||+|+||.||+|.....+ +.+|+|.++... .......+.+|+.++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45689999999999999999999987655 679999986542 23345668899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 173 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~ 173 (450)
....|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45888999999999999999999999999999999999999
Q ss_pred CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC
Q 013064 174 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253 (450)
Q Consensus 174 ~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y 253 (450)
++.++|+|||++......... .......+++.|+|||.+.+..+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY------------------------------------RVQSKSLLPVRWMPPEAILYGKF 203 (283)
T ss_pred CCcEEECCCcceeeccccccc------------------------------------cccCCCcccccccCHHHhccCcC
Confidence 999999999998865322100 00123467899999999998889
Q ss_pred CccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 254 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 254 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+.++|+|||||++|||++ |..||.+.+..+....|.... ....| ..+++++.+|+.+||. ||.+|| ++.+|+
T Consensus 204 ~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~l~~~c~~~~p~~Rp---~~~~i~ 277 (283)
T cd05048 204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LLPCP--EDCPARVYALMIECWNEIPARRP---RFKDIH 277 (283)
T ss_pred chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCc--ccCCHHHHHHHHHHccCChhhCc---CHHHHH
Confidence 999999999999999997 999999988877777666432 22233 4789999999999998 999999 677877
Q ss_pred cC
Q 013064 332 EH 333 (450)
Q Consensus 332 ~H 333 (450)
+|
T Consensus 278 ~~ 279 (283)
T cd05048 278 TR 279 (283)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=341.25 Aligned_cols=254 Identities=29% Similarity=0.488 Sum_probs=217.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||+|+||.||+|.++.+++.+|+|.+.+... ......+.+|+++++.++||||+++++.+.++..+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478999999999999999999999999999999876532 244567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 118 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||++|++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.+|.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999987543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 156 -------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 198 (265)
T cd06605 156 -------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198 (265)
T ss_pred -------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 0125789999999999999999999999999999999999999
Q ss_pred CCCCC-----hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 276 FCSDD-----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 276 F~~~~-----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|...+ .......+... .....+. ..++.++++||.+||. ||.+|| ++.+++.||||+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~~~ 262 (265)
T cd06605 199 YPPENDPPDGIFELLQYIVNE-PPPRLPS-GKFSPDFQDFVNLCLIKDPRERP---SYKELLEHPFIKK 262 (265)
T ss_pred CCccccccccHHHHHHHHhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCchhCc---CHHHHhhCchhhc
Confidence 97542 22333333332 1222332 1278999999999998 999999 6899999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=348.71 Aligned_cols=249 Identities=24% Similarity=0.443 Sum_probs=192.7
Q ss_pred eEEeecCceEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeEEEEEec
Q 013064 44 TLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDFLYLIMEY 119 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~--t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~~~lylVmEy 119 (450)
+.||+|+||.||+|+.+. ++..||+|.+.+.. ....+.+|..+|+.++||||++++++|. ++..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 589999999999999764 66889999987543 2345678999999999999999999985 45689999999
Q ss_pred cCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE----ccCCceEEeeccccc
Q 013064 120 LPGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCK 186 (450)
Q Consensus 120 ~~gg~L~~~l~~~---------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl----d~~g~ikL~DFGla~ 186 (450)
+. ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 86 4777776421 258899999999999999999999999999999999999 567899999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAI 265 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvi 265 (450)
......... ......+||+.|+|||++.+ ..++.++|+|||||+
T Consensus 161 ~~~~~~~~~-----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 205 (317)
T cd07867 161 LFNSPLKPL-----------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCI 205 (317)
T ss_pred ccCCCcccc-----------------------------------cccCcceecccccCcHHhcCCCccCcHHHHHhHHHH
Confidence 654321100 01124679999999999976 458999999999999
Q ss_pred HHHHhhCCCCCCCCChhh---------hhhhhhc---------ccc---cccC----------------------CCCCC
Q 013064 266 MYEMLIGYPPFCSDDPRI---------TCRKIVN---------WKT---CLKF----------------------PEEPK 302 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~---------~~~~i~~---------~~~---~~~~----------------------p~~~~ 302 (450)
+|||++|.+||.+..... ...++.. |.. ...+ .....
T Consensus 206 l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (317)
T cd07867 206 FAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVK 285 (317)
T ss_pred HHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCC
Confidence 999999999997543211 0111100 000 0000 00123
Q ss_pred CCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 303 ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 303 ~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
.+..+.+||.+||+ ||.+|+ +++|+++||||
T Consensus 286 ~~~~~~~ll~~~l~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07867 286 PDSKVFLLLQKLLTMDPTKRI---TSEQALQDPYF 317 (317)
T ss_pred CChHHHHHHHHHhccCccccc---CHHHHhcCCCC
Confidence 46678999999999 999999 68999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=334.99 Aligned_cols=253 Identities=36% Similarity=0.587 Sum_probs=217.9
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFLYLI 116 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~lylV 116 (450)
+|++++.||.|+||.||+|.+..+|+.||+|++..... .....+.+..|+.+++.++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 68999999999999999999999999999999976543 34456778899999999999999999998764 4578999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhh-----hCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 117 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIH-----QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 117 mEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH-----~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
|||+++|+|.+++.. ...++++.++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999876 467999999999999999999999 89999999999999999999999999999987
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
...... ......|++.|+|||++.+..++.++|+|||||++|
T Consensus 160 ~~~~~~--------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~ 201 (265)
T cd08217 160 LGHDSS--------------------------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201 (265)
T ss_pred ccCCcc--------------------------------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHH
Confidence 643210 012357999999999999888999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
+|++|..||...+.......+.... ...+| ..++..+.+|+.+||. +|.+|| ++++|++|||+
T Consensus 202 ~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~il~~~~~ 265 (265)
T cd08217 202 ELCALSPPFTARNQLQLASKIKEGK-FRRIP--YRYSSELNEVIKSMLNVDPDKRP---STEELLQLPLI 265 (265)
T ss_pred HHHHCCCcccCcCHHHHHHHHhcCC-CCCCc--cccCHHHHHHHHHHccCCcccCC---CHHHHhhCCCC
Confidence 9999999999887666555555422 22233 3688999999999998 999999 78999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=345.62 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=210.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCE--EEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI--FAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~--~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
.+.+++|++.+.||+|+||.||+|+++.++.. +|+|.++.. ........+.+|+.++..+ +||||+++++++.++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 46789999999999999999999999888765 466665432 2334556788899999999 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 174 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~ 174 (450)
+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 57899999999999999999999999999999999999999
Q ss_pred CceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCC
Q 013064 175 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 254 (450)
Q Consensus 175 g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~ 254 (450)
+.+||+|||++........ .....+++.|+|||++.+..++
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~ 201 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYT 201 (303)
T ss_pred CcEEeCccccCcccchhhh---------------------------------------cccCCCcccccCHHHHhccCCc
Confidence 9999999999864221100 0112356789999999888899
Q ss_pred ccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 255 MECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 255 ~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.++|+|||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. +|.+|| ++++++.
T Consensus 202 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~ 275 (303)
T cd05088 202 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 275 (303)
T ss_pred ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999999999998 99999887776666655432 122223 3578999999999998 999999 5778876
Q ss_pred C
Q 013064 333 H 333 (450)
Q Consensus 333 H 333 (450)
+
T Consensus 276 ~ 276 (303)
T cd05088 276 S 276 (303)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=337.34 Aligned_cols=253 Identities=16% Similarity=0.260 Sum_probs=211.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+..++|++.+.||+|+||.||++..+ ..+..+|+|.++... .......+.+|..++..++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 45678999999999999999999865 346689999987642 2334567889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999774 5799999999999999999999999999999999999999999999999998765322
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
... .......+++.|+|||++.+..++.++|+|||||++|||+
T Consensus 160 ~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 202 (266)
T cd05064 160 EAI-------------------------------------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202 (266)
T ss_pred cch-------------------------------------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHh
Confidence 100 0011234678899999999999999999999999999977
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+ |..||.+.+..+....+... ...|....++..+.+++.+||. +|.+|| ++++|++
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~RP---~~~~i~~ 260 (266)
T cd05064 203 SYGERPYWDMSGQDVIKAVEDG---FRLPAPRNCPNLLHQLMLDCWQKERGERP---RFSQIHS 260 (266)
T ss_pred cCCCCCcCcCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHHHcCCCchhCC---CHHHHHH
Confidence 5 99999988877766666543 2223335789999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.27 Aligned_cols=256 Identities=29% Similarity=0.524 Sum_probs=216.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|.....||+|+||.||++.+..+++.||||.+.... ....+.+.+|..+++.++||||+++++.|...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45566778999999999999999999999999986532 234566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++|++|.+++.. +.++++.+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---- 173 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---- 173 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc----
Confidence 99999999998754 5699999999999999999999999999999999999999999999999999875432210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.....+|++.|+|||++.+..++.++|+|||||++|||++|..||.
T Consensus 174 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 174 ----------------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred ----------------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0123579999999999998889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+.+.......+... .....+....++..+++||.+||. ||.+|+ +++++++||||+..
T Consensus 220 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~~~~ 278 (292)
T cd06658 220 NEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLKLA 278 (292)
T ss_pred CCCHHHHHHHHHhc-CCCccccccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhhcc
Confidence 87766555544332 112223334678999999999998 999999 68999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=341.45 Aligned_cols=258 Identities=36% Similarity=0.550 Sum_probs=215.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||+|+||.||+|.++.+++.||+|+++... ......+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999987653 23345577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++++.+..++.+...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999988877777777899999999999999999999999999999999999999999999999999887644311
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......+|++.|+|||++.+. .++.++|+|||||++|+|++|.+||
T Consensus 156 ---------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~ 202 (288)
T cd07833 156 ---------------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202 (288)
T ss_pred ---------------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 011246789999999999887 8899999999999999999999999
Q ss_pred CCCChhhhhhhhhcccc-----------------cccCCC-----------CCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 277 CSDDPRITCRKIVNWKT-----------------CLKFPE-----------EPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~-----------------~~~~p~-----------~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
.+.+..+....+..... ...++. ...++.++++||++||. +|.+|| ++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~ 279 (288)
T cd07833 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL---TC 279 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc---cH
Confidence 87655433322211000 000100 12358999999999998 999999 68
Q ss_pred HHHHcCCCc
Q 013064 328 EELKEHPWF 336 (450)
Q Consensus 328 ~eil~Hpff 336 (450)
+++++||||
T Consensus 280 ~~il~~~~f 288 (288)
T cd07833 280 DELLQHPYF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.31 Aligned_cols=265 Identities=26% Similarity=0.436 Sum_probs=213.0
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~ly 114 (450)
..++|+.++.||+|+||.||++.+..+|+.||+|.+.+... ......+.+|..++.++. ||||+++++++.++...|
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 34678888999999999999999999999999999876532 234567788999999985 999999999999999999
Q ss_pred EEEeccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 115 LIMEYLPGGDIMTLL---M--REDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 115 lVmEy~~gg~L~~~l---~--~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
++|||+.+ +|.++. . ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99999864 444432 2 24679999999999999999999997 49999999999999999999999999998754
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC---CCCccccccchhHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAI 265 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~---~y~~~~DiWSlGvi 265 (450)
..... .....||+.|+|||++.+. .++.++|+|||||+
T Consensus 159 ~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 159 VDSIA---------------------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred ccCCc---------------------------------------cccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 32210 1134689999999999865 68999999999999
Q ss_pred HHHHhhCCCCCCCCCh-hhhhhhhhccc-ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 266 MYEMLIGYPPFCSDDP-RITCRKIVNWK-TCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 266 lyeml~G~~PF~~~~~-~~~~~~i~~~~-~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
+|+|++|.+||...+. .+...++.... ..+.......++.++.+||.+||. ||.+|| ++++|++||||+...|.
T Consensus 200 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 200 LYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP---KYKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCc---CHHHHhcChhhhchhhc
Confidence 9999999999976542 12222222211 111111123589999999999998 999999 68999999999987776
Q ss_pred ccc
Q 013064 343 KLY 345 (450)
Q Consensus 343 ~l~ 345 (450)
+..
T Consensus 277 ~~~ 279 (288)
T cd06616 277 NVD 279 (288)
T ss_pred chh
Confidence 554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=373.53 Aligned_cols=304 Identities=37% Similarity=0.655 Sum_probs=261.5
Q ss_pred EEeecCceEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEecc
Q 013064 45 LIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
++|.|+||+|++|+.. ..|..||||+++|.....+... +...|+.++..++ ||++|++++.|+++..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999998853 5678899999998876655555 8889999999997 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccc
Q 013064 121 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200 (450)
Q Consensus 121 ~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~ 200 (450)
.||+|+..+.+...+++..+++|.++++.|++++|+.||+|||+|++||+++.+||+++.|||+++.....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--------- 150 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCC
Q 013064 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 280 (450)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 280 (450)
...|||..|||||++. ++..++||||+|+++|||++|..||.+
T Consensus 151 ---------------------------------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-- 193 (612)
T KOG0603|consen 151 ---------------------------------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-- 193 (612)
T ss_pred ---------------------------------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--
Confidence 0139999999999998 889999999999999999999999988
Q ss_pred hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--cccCCccccC
Q 013064 281 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTV 355 (450)
Q Consensus 281 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~ 355 (450)
++..+|.. ..+..| ..++..+++++..|+. +|.+|++. .++.+|++|+||..++|..+. +..|||+|.+
T Consensus 194 --~~~~~Il~--~~~~~p--~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~ 267 (612)
T KOG0603|consen 194 --DTMKRILK--AELEMP--RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGS 267 (612)
T ss_pred --HHHHHHhh--hccCCc--hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcc
Confidence 67777776 234444 5899999999999998 99999997 479999999999999999887 4789999999
Q ss_pred CCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCccccc
Q 013064 356 NGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407 (450)
Q Consensus 356 ~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 407 (450)
..+.|+.+|+. |+...+ ...+... ...+...-|.||+|..+..+.+
T Consensus 268 ~~e~~~~~fd~eft~~~P--~dsp~~~----~~~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 268 ITERDVAQFDPEFTSQVP--ADSPLLS----ASGSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred cchhhhhhcCchhccCCc--ccCCCCC----CCccccchhcCCCccChHHhhc
Confidence 99999999998 443322 1112111 1223446899999998876654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=342.72 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=208.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD---- 111 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~---- 111 (450)
.+++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|..+++.++||+|+++++++.+..
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 35789999999999999999999999999999999865432 2233445678999999999999999999987654
Q ss_pred ----eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 112 ----FLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 112 ----~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
..|+||||+. ++|..++.... .+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999996 58888876653 78999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAI 265 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvi 265 (450)
.+....... .......++++.|+|||++.+. .++.++|+|||||+
T Consensus 168 ~~~~~~~~~----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 213 (310)
T cd07865 168 AFSLSKNSK----------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCI 213 (310)
T ss_pred cccCCcccC----------------------------------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHH
Confidence 654321100 0001235689999999998764 47899999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccc-----------------cccCCCC-----------CCCCHHHHHHHHHhhc-
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKT-----------------CLKFPEE-----------PKISDEARDLICHLLC- 316 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~-----------~~~s~~~~dli~~lL~- 316 (450)
+|+|++|.+||.+.+.......+..... ...+|.. ...++.+++||.+||+
T Consensus 214 l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~ 293 (310)
T cd07865 214 MAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293 (310)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcC
Confidence 9999999999988765544333221100 0011110 1236788999999999
Q ss_pred CccccCCCCCHHHHHcCCCc
Q 013064 317 DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 317 dp~~R~~~~~~~eil~Hpff 336 (450)
||.+|+ ++++++.||||
T Consensus 294 ~P~~R~---t~~e~l~h~~f 310 (310)
T cd07865 294 DPAKRI---DADTALNHDFF 310 (310)
T ss_pred Chhhcc---CHHHHhcCCCC
Confidence 999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=335.61 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=212.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++.+.||+|+||.||+|+.+.+++.||+|.++............+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999998765555555667788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 117 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 117 mEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988753 3458999999999999999999999999999999999999999999999999988654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
. ......|++.|+|||.+.+..++.++|+|||||++|||++|
T Consensus 161 ~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g 202 (267)
T cd08228 161 T--------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred H--------------------------------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcC
Confidence 0 01235789999999999988899999999999999999999
Q ss_pred CCCCCCCCh--hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 273 YPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 273 ~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
..||..... ......+... .....+ ....+..+++||.+||. +|.+|| ++.++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp---~~~~vl~ 260 (267)
T cd08228 203 QSPFYGDKMNLFSLCQKIEQC-DYPPLP-TEHYSEKLRELVSMCIYPDPDQRP---DIGYVHQ 260 (267)
T ss_pred CCCCccccccHHHHHHHHhcC-CCCCCC-hhhcCHHHHHHHHHHCCCCcccCc---CHHHHHH
Confidence 999976532 2333333221 111111 12578899999999998 999999 6778775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=339.29 Aligned_cols=254 Identities=32% Similarity=0.523 Sum_probs=211.9
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++++.||.|++|.||+|+++.+|+.||+|+++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 68999999999999999999999999999999976532 2334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 119 YLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 119 y~~gg~L~~~l~~~---~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|++| +|.+++... ..++++.+..++.||+.||.|||+.||+||||||+||+++.+|.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9985 888887654 3689999999999999999999999999999999999999999999999999975432210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....++|+.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus 156 ------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 156 ------------------------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred ------------------------------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0113468999999999876 457899999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccc----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 275 PFCSDDPRITCRKIVNWKT----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~----------------~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
||.+.+..+...++.+... ...+|. .+.+++.++++|.+||. ||.+|+ ++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~ 276 (284)
T cd07836 200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI---SAH 276 (284)
T ss_pred CCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC---CHH
Confidence 9998876665555432100 000110 12468899999999998 999999 689
Q ss_pred HHHcCCCc
Q 013064 329 ELKEHPWF 336 (450)
Q Consensus 329 eil~Hpff 336 (450)
++++||||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07836 277 DALQHPWF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=339.81 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=211.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+..++|.+.+.||+|+||+||+|... .++..+|+|.+.+.. ......+.+|+.+++.++||+|+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45679999999999999999999863 355679999987542 3345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED-------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 176 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~-------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ 176 (450)
.+.+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997543 4899999999999999999999999999999999999999999
Q ss_pred eEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcc
Q 013064 177 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256 (450)
Q Consensus 177 ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~ 256 (450)
+||+|||++......... .......+++.|+|||++.+..++.+
T Consensus 159 ~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 202 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYY------------------------------------RVGGHTMLPIRWMPPESIMYRKFTTE 202 (288)
T ss_pred EEeccCCccccccCCcee------------------------------------ecCCCCCccccccCHHHhccCCCCch
Confidence 999999998865322100 00112456889999999998999999
Q ss_pred ccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 257 CDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 257 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+|+|||||++|+|++ |.+||.+.+.......+.+... ...+ ..++.++.+||.+||. ||.+|| ++.+++
T Consensus 203 sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~v~ 273 (288)
T cd05093 203 SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRP--RTCPKEVYDLMLGCWQREPHMRL---NIKEIH 273 (288)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-CCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 999999999999998 9999998887777777765321 2222 3688999999999998 999999 456653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=350.97 Aligned_cols=263 Identities=26% Similarity=0.428 Sum_probs=214.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----SDFL 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~~~l 113 (450)
++|++.+.||.|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.+|+.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 78999999999999999999999999999999997643 223345677889999999999999999998863 4579
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||+. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998888899999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G 272 (450)
. ........+|+..|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 163 ~----------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g 208 (334)
T cd07855 163 E----------------------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR 208 (334)
T ss_pred C----------------------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence 0 0011124589999999999876 5689999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcc------------------------cccccCC---CCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 273 YPPFCSDDPRITCRKIVNW------------------------KTCLKFP---EEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~------------------------~~~~~~p---~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
++||.+.+.......+... ......+ ..+..++++++||++||+ +|.+||
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-- 286 (334)
T cd07855 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI-- 286 (334)
T ss_pred CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc--
Confidence 9999877654333222210 0000010 013578999999999998 999999
Q ss_pred CCHHHHHcCCCcCCC
Q 013064 325 RGVEELKEHPWFRGI 339 (450)
Q Consensus 325 ~~~~eil~Hpff~~i 339 (450)
++++++.||||.+.
T Consensus 287 -t~~~~l~~~~~~~~ 300 (334)
T cd07855 287 -TVEQALQHPFLAQY 300 (334)
T ss_pred -CHHHHHhChhhhhc
Confidence 68999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=349.83 Aligned_cols=256 Identities=31% Similarity=0.485 Sum_probs=212.5
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
.++|++++.||+|+||.||++.+..+|+.||+|++.+.. ........+.+|..+|+.++||||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 468999999999999999999999999999999986542 22334456889999999999999999999998764
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+||||+ |++|..++. ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 459999999 789988775 45799999999999999999999999999999999999999999999999999886532
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 269 (450)
. .....|++.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 171 ~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 171 E-----------------------------------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred C-----------------------------------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 2 113568999999999976 4588999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccc------------------cCC---------CCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCL------------------KFP---------EEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~------------------~~p---------~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
++|.+||.+.+....+..++...... ..| ....+++.+.++|.+||+ ||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 99999998876554444443211000 000 013578899999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCC
Q 013064 322 LGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i 339 (450)
+ ++.+++.||||+..
T Consensus 290 ~---t~~~~l~~~~~~~~ 304 (343)
T cd07880 290 I---TAAEALAHPYFEEF 304 (343)
T ss_pred C---CHHHHhcCccHhhh
Confidence 9 68999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=338.45 Aligned_cols=254 Identities=30% Similarity=0.520 Sum_probs=217.7
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|...+.||+|++|.||++.++.+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 5666789999999999999999999999999886432 2345668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|++|++|.+++.. +.++++.+..++.|++.||+|||++||+||||+|+||+++.+|.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~----- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence 9999999999877 6799999999999999999999999999999999999999999999999998875432110
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 171 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 171 ---------------------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ---------------------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 01135799999999999988899999999999999999999999988
Q ss_pred CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 279 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+......++.... ....+....++..+.+||.+||. +|.+|+ ++.+++.||||+.
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 274 (285)
T cd06648 218 EPPLQAMKRIRDNL-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLAK 274 (285)
T ss_pred CCHHHHHHHHHhcC-CCCCcccccCCHHHHHHHHHHcccChhhCc---CHHHHccCccccc
Confidence 87766666665431 11222223478999999999998 999999 6899999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=339.57 Aligned_cols=254 Identities=21% Similarity=0.371 Sum_probs=213.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+..++|.+++.||+|+||.||+|.+.. +++.||+|++++.. .....+.+.+|+++|+.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 346789999999999999999998753 46789999987542 23345788999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED--------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 175 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~--------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g 175 (450)
...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 999999999999999999997643 478999999999999999999999999999999999999999
Q ss_pred ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCc
Q 013064 176 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255 (450)
Q Consensus 176 ~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~ 255 (450)
.+||+|||++......... .......+++.|+|||++.+..++.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY------------------------------------RVGGHTMLPIRWMPPESIMYRKFTT 203 (280)
T ss_pred eEEECCcccceecccCcce------------------------------------ecCCCCcccceecChhhhccCCcch
Confidence 9999999998754322100 0011245788999999999999999
Q ss_pred cccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 256 ECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 256 ~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|+|||||++|||++ |..||.+.+..+....+..... ...+ ..++..+++||.+||. ||.+|| +++|++.
T Consensus 204 ~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~eil~ 276 (280)
T cd05049 204 ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL-LQRP--RTCPSEVYDIMLGCWKRDPQQRI---NIKDIHE 276 (280)
T ss_pred hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc-CCCC--CCCCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 9999999999999998 9999988887777766664321 1222 3689999999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=331.64 Aligned_cols=249 Identities=50% Similarity=0.897 Sum_probs=220.4
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||.|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.++||||+++++.+.++..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999999999999999887766666778899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccc
Q 013064 126 MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205 (450)
Q Consensus 126 ~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~ 205 (450)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------------ 148 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------------ 148 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------------
Confidence 99998888899999999999999999999999999999999999999999999999999876543210
Q ss_pred cccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhh
Q 013064 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC 285 (450)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 285 (450)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 149 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 202 (250)
T cd05123 149 --------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202 (250)
T ss_pred --------------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 012357899999999999888899999999999999999999999887776666
Q ss_pred hhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 286 ~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
..+.. ..+.+| ..++..+.++|++||+ ||.+|++...++++++||||
T Consensus 203 ~~~~~--~~~~~~--~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 203 EKILK--DPLRFP--EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHhc--CCCCCC--CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 66665 334444 3679999999999998 99999965445999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=377.34 Aligned_cols=272 Identities=26% Similarity=0.339 Sum_probs=209.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47899999999999999999999999999999999765433334456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 117 MEYLPGGDIMTLLMRE-----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-----------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23455677889999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
+.......... . ......... .+........+||+.|+|||++.+..++.++|+|||||+
T Consensus 161 k~i~~~~~~~~-------~-l~~~~~~s~------------~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVI 220 (932)
T PRK13184 161 IFKKLEEEDLL-------D-IDVDERNIC------------YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220 (932)
T ss_pred eeccccccccc-------c-ccccccccc------------ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHH
Confidence 87632110000 0 000000000 000001123689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+|||++|..||.+.+.......... ...........+++.+.+++.+||. ||.+|+++ +++++
T Consensus 221 LyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss--~eeLl 284 (932)
T PRK13184 221 LYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS--VQELK 284 (932)
T ss_pred HHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCH--HHHHH
Confidence 9999999999987654433222111 0111222224688999999999998 99999963 44444
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=337.45 Aligned_cols=256 Identities=31% Similarity=0.522 Sum_probs=216.2
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~lyl 115 (450)
.|++++.||+|+||.||+|.+..+++.||+|.+++.. .......+.+|+.+++.+. ||||+++++++.++...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987542 2345667888999999986 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||++.........
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999999999865 47999999999999999999999999999999999999999999999999999876432100
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
....+|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+
T Consensus 158 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 200 (277)
T cd06917 158 -------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200 (277)
T ss_pred -------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence 123579999999999865 557899999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
||.+.+.......+... ....++. ..++.++.++|.+||. ||.+|+ ++.+++.||||+...
T Consensus 201 p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~---~~~~il~~~~~~~~~ 262 (277)
T cd06917 201 PYSDVDAFRAMMLIPKS-KPPRLED-NGYSKLLREFVAACLDEEPKERL---SAEELLKSKWIKAHS 262 (277)
T ss_pred CCCCCChhhhhhccccC-CCCCCCc-ccCCHHHHHHHHHHcCCCcccCc---CHHHHhhChHhhccc
Confidence 99877665444433321 1122222 2378899999999998 999999 689999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=339.32 Aligned_cols=257 Identities=30% Similarity=0.437 Sum_probs=219.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
..|+.++.||.|+||.||+|.+..+++.+|+|++.+... ......+.+|..+++.++||||+++++++.++..+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999999999999999876432 344678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.. +.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence 99999999998864 5789999999999999999999999999999999999999999999999999876533210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......|+..|+|||++.+..++.++|+|||||++|||++|.+||.
T Consensus 157 ----------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 157 ----------------------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred ----------------------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 0113468999999999998889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
..++......+.... ....+ ..++..+.+||.+||. +|.+|| ++++++.||||.....
T Consensus 203 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06640 203 DMHPMRVLFLIPKNN-PPTLT--GEFSKPFKEFIDACLNKDPSFRP---TAKELLKHKFIVKNAK 261 (277)
T ss_pred CcChHhHhhhhhcCC-CCCCc--hhhhHHHHHHHHHHcccCcccCc---CHHHHHhChHhhhcch
Confidence 877665555443321 11222 2578899999999998 999999 6899999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.89 Aligned_cols=253 Identities=27% Similarity=0.381 Sum_probs=214.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
..|.+++.||+|+||.||++.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999999999999997654444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++ |+|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence 9997 566666653 567999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhhCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....|++.|+|||++. ...++.++|+|||||++|||++|.
T Consensus 169 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~ 211 (307)
T cd06607 169 -------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (307)
T ss_pred -------------------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCC
Confidence 1356899999999985 356889999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+||.+.+.......+... .....+. ..++..+++||.+||. ||.+|| ++.+|+.||||..
T Consensus 212 ~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 272 (307)
T cd06607 212 PPLFNMNAMSALYHIAQN-DSPTLSS-NDWSDYFRNFVDSCLQKIPQDRP---SSEELLKHRFVLR 272 (307)
T ss_pred CCCCCccHHHHHHHHhcC-CCCCCCc-hhhCHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcc
Confidence 999887766555444432 1122221 2478899999999998 999999 6899999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=342.76 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=207.7
Q ss_pred CeEEEeEEeecCceEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLY 114 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~--t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~ly 114 (450)
.|++++.||+|+||.||+|..+. +++.||+|.+.+...........+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999875433344456778899999999999999999999998 8899
Q ss_pred EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc----CCceEEeecccc
Q 013064 115 LIMEYLPGGDIMTLLMRE-----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK----NGHLKLSDFGLC 185 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~-----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~----~g~ikL~DFGla 185 (450)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 677766432 36899999999999999999999999999999999999999 999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 264 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGv 264 (450)
.......... ......+||+.|+|||++.+ ..++.++|+|||||
T Consensus 160 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 204 (316)
T cd07842 160 RLFNAPLKPL-----------------------------------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC 204 (316)
T ss_pred cccCCCcccc-----------------------------------cccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence 8754321100 01123578999999998876 46899999999999
Q ss_pred HHHHHhhCCCCCCCCChhh---------hhhhhhc------------------------ccccccCC---------CCCC
Q 013064 265 IMYEMLIGYPPFCSDDPRI---------TCRKIVN------------------------WKTCLKFP---------EEPK 302 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~---------~~~~i~~------------------------~~~~~~~p---------~~~~ 302 (450)
++|+|++|.+||.+..... .+..++. ......++ ....
T Consensus 205 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd07842 205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284 (316)
T ss_pred HHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccC
Confidence 9999999999998655432 0111100 00001111 0015
Q ss_pred CCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 303 ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 303 ~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
.+..+.++|.+||. ||++|| ++.+++.||||
T Consensus 285 ~~~~~~~~i~~~l~~~P~~Rp---s~~eil~~~~f 316 (316)
T cd07842 285 PDSQGFDLLRKLLEYDPTKRI---TAEEALEHPYF 316 (316)
T ss_pred CCHHHHHHHHHHhcCCcccCc---CHHHHhcCCCC
Confidence 67889999999999 999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=349.15 Aligned_cols=260 Identities=30% Similarity=0.495 Sum_probs=208.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----Ce
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~~ 112 (450)
++|++.+.||+|+||.||+|++..+|+.||+|++.... .......+..|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 78999999999999999999999999999999986432 233456678899999999999999999887654 35
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||||+. ++|..++. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999996 58887774 4579999999999999999999999999999999999999999999999999988653321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~ 271 (450)
.. .......+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 161 ~~-----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~ 205 (336)
T cd07849 161 DH-----------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205 (336)
T ss_pred cc-----------------------------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 00 001123579999999998764 568999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhc---------------cc-----ccc----cCC---CCCCCCHHHHHHHHHhhc-CccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVN---------------WK-----TCL----KFP---EEPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~---------------~~-----~~~----~~p---~~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
|++||.+.+.......+.. .. ... ..+ ..+.+++++.+||.+||. ||.+|+
T Consensus 206 G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp- 284 (336)
T cd07849 206 NRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI- 284 (336)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc-
Confidence 9999987654332222211 00 000 000 013568899999999998 999999
Q ss_pred CCCHHHHHcCCCcCCC
Q 013064 324 TRGVEELKEHPWFRGI 339 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i 339 (450)
++.+++.||||+.+
T Consensus 285 --t~~e~l~hp~~~~~ 298 (336)
T cd07849 285 --TVEEALAHPYLEQY 298 (336)
T ss_pred --CHHHHhcCcccccc
Confidence 68999999999853
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=369.71 Aligned_cols=267 Identities=24% Similarity=0.379 Sum_probs=215.9
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE-c-
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQ-D- 109 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~-~- 109 (450)
-.++-...++.++|.+|||+.||+|+....|..||+|.+--. .......+++|+++|+.|. |+|||.++++.. .
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 346667889999999999999999999988899999987543 4567888999999999995 999999999432 1
Q ss_pred -----CCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEccCCceEEe
Q 013064 110 -----SDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 110 -----~~~lylVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld~~g~ikL~ 180 (450)
.-.++|+||||.||.|-+++.+ +..|+|.++..|+++++.|+.+||.+. |||||||-|||||+.+|++|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 1258899999999999999974 456999999999999999999999998 9999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMEC 257 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~ 257 (450)
|||.|.......... . ...-.++ .-....||.|+|||++. +.+.+.++
T Consensus 189 DFGSatt~~~~~~~~----~-----------------e~~~ve~--------eI~k~TTp~YRsPEMIDlysg~pI~eKs 239 (738)
T KOG1989|consen 189 DFGSATTKILSPTSA----Q-----------------EVNYVEE--------EIEKYTTPQYRSPEMIDLYSGLPIGEKS 239 (738)
T ss_pred cccccccccCCCccH----H-----------------HHHHHHH--------HHHhhCCccccChHHHhhhcCCCCcchh
Confidence 999987532211000 0 0000000 00135799999999985 67889999
Q ss_pred cccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc----
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE---- 332 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~---- 332 (450)
|||||||+||-|++...||.+... ..|++ ..+.||..+..|..+++||+.||. ||.+|| ++.+++.
T Consensus 240 DIWALGclLYkLCy~t~PFe~sg~----laIln--g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP---nI~Qv~~~~~~ 310 (738)
T KOG1989|consen 240 DIWALGCLLYKLCYFTTPFEESGK----LAILN--GNYSFPPFPNYSDRLKDLIRTMLQPNPDERP---NIYQVLEEIFE 310 (738)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCcc----eeEEe--ccccCCCCccHHHHHHHHHHHHhccCcccCC---CHHHHHHHHHH
Confidence 999999999999999999976533 45776 457888888999999999999999 999999 5666653
Q ss_pred ----CCCcCCCC
Q 013064 333 ----HPWFRGIQ 340 (450)
Q Consensus 333 ----Hpff~~i~ 340 (450)
++++.++.
T Consensus 311 l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 311 LANKPCPIPDIY 322 (738)
T ss_pred HhcCCCCccccc
Confidence 45555554
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=349.73 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=213.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----Ce
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~~ 112 (450)
+.|.+++.||+|+||.||+|++..+|+.||||.+.+.. ........+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 57999999999999999999999999999999987643 2333456677899999999999999999988754 35
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||||+. ++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 899999995 7899999888899999999999999999999999999999999999999999999999999998653320
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~ 271 (450)
. .....+||..|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 163 ~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 204 (337)
T cd07858 163 D--------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204 (337)
T ss_pred c--------------------------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc
Confidence 0 0123578999999999875 568999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccc--------------------------cccC-CCCCCCCHHHHHHHHHhhc-CccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKT--------------------------CLKF-PEEPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~--------------------------~~~~-p~~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
|++||.+.+.......+..... ...+ ...+.+++++++||++||+ +|.+|+
T Consensus 205 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp- 283 (337)
T cd07858 205 RKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI- 283 (337)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc-
Confidence 9999987654333322221000 0000 0123689999999999999 999999
Q ss_pred CCCHHHHHcCCCcCCC
Q 013064 324 TRGVEELKEHPWFRGI 339 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i 339 (450)
+++++++||||+.+
T Consensus 284 --s~~ell~h~~~~~~ 297 (337)
T cd07858 284 --TVEEALAHPYLASL 297 (337)
T ss_pred --CHHHHHcCcchhhh
Confidence 68999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=342.72 Aligned_cols=257 Identities=32% Similarity=0.493 Sum_probs=213.1
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFL 113 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~l 113 (450)
.+++|++.+.||.|+||.||+|.++.+++.+|+|.++..... ......+.+|+.++..++||||+++++++.+. ..+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 357899999999999999999999999999999999765432 33445667899999999999999999999887 899
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|+||||+++ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999999974 8999887644 59999999999999999999999999999999999999999999999999988654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~ 271 (450)
. ......+++.|+|||++.+. .++.++|+|||||++|+|++
T Consensus 161 ~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 202 (293)
T cd07843 161 K--------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202 (293)
T ss_pred c--------------------------------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh
Confidence 0 01134688999999998764 46899999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccc-----------------------------cccCCCCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKT-----------------------------CLKFPEEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~-----------------------------~~~~p~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
|.+||.+.+....+.++...-. .-.++. ..+++.+++||++||. ||++|
T Consensus 203 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R 281 (293)
T cd07843 203 KKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKR 281 (293)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCcccc
Confidence 9999988776655554432100 001111 1158899999999999 99999
Q ss_pred CCCCCHHHHHcCCCc
Q 013064 322 LGTRGVEELKEHPWF 336 (450)
Q Consensus 322 ~~~~~~~eil~Hpff 336 (450)
+ ++.|++.||||
T Consensus 282 ~---t~~ell~~~~f 293 (293)
T cd07843 282 I---SAEDALKHPYF 293 (293)
T ss_pred C---CHHHHhcCCCC
Confidence 9 68999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=343.95 Aligned_cols=255 Identities=30% Similarity=0.529 Sum_probs=216.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
.-|+....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++..++||||+++++.|..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 455566689999999999999999999999999865432 23456888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++|++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~---- 172 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---- 172 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc----
Confidence 99999999987754 5689999999999999999999999999999999999999999999999999875432210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.....+|++.|+|||++.+..++.++|+|||||++|||++|+.||.
T Consensus 173 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 173 ----------------------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred ----------------------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0123679999999999998889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
..+..+....+.... .........+++.+.++|.+||+ +|.+|+ ++++++.||||..
T Consensus 219 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp---s~~~ll~~~~~~~ 276 (297)
T cd06659 219 SDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERA---TAQELLDHPFLLQ 276 (297)
T ss_pred CCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCc---CHHHHhhChhhcc
Confidence 877666555544321 11122234678999999999998 999999 6899999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.37 Aligned_cols=255 Identities=18% Similarity=0.340 Sum_probs=211.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEc----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+.+++|++.+.||+|+||.||+|... .+++.+|+|.+.... .......+.+|..+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 46789999999999999999999853 456789999987532 233456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE-----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 173 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~-----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~ 173 (450)
...|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 24788999999999999999999999999999999999999
Q ss_pred CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC
Q 013064 174 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253 (450)
Q Consensus 174 ~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y 253 (450)
++.+||+|||+++........ ....+..++..|+|||++.+..+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY------------------------------------RVQPKSLLPIRWMPPEAIMYGKF 203 (283)
T ss_pred CCcEEeccccccccccCCcce------------------------------------ecccCCCccceecChHHhccCCC
Confidence 999999999999875432110 00123456788999999988889
Q ss_pred CccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 254 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 254 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+.++|+|||||++|||++ |.+||.+.+.......+... ..+..+ ..+++.++++|.+||+ ||.+|| ++.+|+
T Consensus 204 ~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~i~ 277 (283)
T cd05090 204 SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCS--EDCPPRMYSLMTECWQEGPSRRP---RFKDIH 277 (283)
T ss_pred CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCc---CHHHHH
Confidence 999999999999999998 99999887766655555442 223333 4689999999999998 999999 567776
Q ss_pred cC
Q 013064 332 EH 333 (450)
Q Consensus 332 ~H 333 (450)
++
T Consensus 278 ~~ 279 (283)
T cd05090 278 TR 279 (283)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=362.62 Aligned_cols=250 Identities=32% Similarity=0.555 Sum_probs=217.4
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
-+||+|.||+||-+++..|...+|||.+.... .....-+..|+.+-+.++|.|||+.++++..++++-+.||-+|||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 37999999999999999999999999986543 335567889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-cCCceEEeeccccccCccccccccccc
Q 013064 124 DIMTLLMR-EDIL--SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 124 ~L~~~l~~-~~~~--~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-~~g~ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
+|.++|+. .+++ .|....||..||+.||.|||++.|||||||-+|+||+ -.|.+||+|||-++.+..-.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------- 730 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------- 730 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-------
Confidence 99999976 4777 8999999999999999999999999999999999997 48999999999999875321
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHHHhhCCCCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
..+.++.||..|||||++.. .+|+.++|||||||.+.||.||+|||.
T Consensus 731 -------------------------------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 731 -------------------------------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred -------------------------------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 22457899999999999975 679999999999999999999999997
Q ss_pred CC-ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 278 SD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 278 ~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
.. ++...+-++--.+.+..+|+ .+|.+|+.||.+|.. ||..|+ ++.+++..||+..-
T Consensus 780 ElgspqAAMFkVGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~---sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 780 ELGSPQAAMFKVGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRP---SAKDLLQDPFLQHN 838 (1226)
T ss_pred ecCChhHhhhhhcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCc---cHHHhccCcccccC
Confidence 53 33344444444445666775 799999999999998 999999 68999999999753
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.40 Aligned_cols=253 Identities=34% Similarity=0.591 Sum_probs=217.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|.+.+.||+|+||.||++..+.+|..+|+|.+..... .....+.+.+|+.+++.++||||+++++.+.+...+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999976543 22345677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc-eEEeeccccccCccccccc
Q 013064 119 YLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-LKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 119 y~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~-ikL~DFGla~~~~~~~~~~ 195 (450)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+++|+||||||+||+++.++. +||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999999987643 5899999999999999999999999999999999999998865 69999999876543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 158 ------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p 201 (257)
T cd08225 158 ------------------------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201 (257)
T ss_pred ------------------------------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01134689999999999888899999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|.+.+.......+..... .+..+.++.+++++|.+||. +|++|| ++.++++||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~~~~~ 257 (257)
T cd08225 202 FEGNNLHQLVLKICQGYF---APISPNFSRDLRSLISQLFKVSPRDRP---SITSILKRPFL 257 (257)
T ss_pred CCCccHHHHHHHHhcccC---CCCCCCCCHHHHHHHHHHhccChhhCc---CHHHHhhCCCC
Confidence 988777666666554221 12224678999999999998 999999 69999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=337.21 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=205.2
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC--CeEEEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS--DFLYLI 116 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~--~~lylV 116 (450)
|.+++.||+|+||.||+|.++.+++.||+|++++... .. .......|..++..+ +||||+++++++.++ +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999876431 11 222345688888888 499999999999988 899999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||++ |+|.+.+.. ...+++..++.++.|++.||+|||+.||+||||||+||+++. |.+||+|||++........
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 99997 578888765 457899999999999999999999999999999999999999 9999999999986543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+++.|+|||++.. ..++.++|+|||||++|||++|.+
T Consensus 155 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 155 -------------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred -------------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 112468999999998754 556899999999999999999999
Q ss_pred CCCCCChhhhhhhhhccc----------------ccccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 275 PFCSDDPRITCRKIVNWK----------------TCLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~----------------~~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
||.+.+..+....+.... ....+|. ...++.++++||.+||. +|.+|+ +++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~ 274 (282)
T cd07831 198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI---TAK 274 (282)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc---CHH
Confidence 998877655444443210 1111221 12568999999999998 999999 689
Q ss_pred HHHcCCCc
Q 013064 329 ELKEHPWF 336 (450)
Q Consensus 329 eil~Hpff 336 (450)
+++.||||
T Consensus 275 ~~l~~~~~ 282 (282)
T cd07831 275 QALRHPYF 282 (282)
T ss_pred HHhhCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.15 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=205.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|.+++.||+|+||.||+|.++.+|+.||+|++..... ......+.+|..+++.++|+||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875432 22334567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||+. ++|..++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 99995 677766654 45688999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....++++.|+|||++.+ ..++.++|+|||||++|+|++|..
T Consensus 159 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 159 ------------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred ------------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0113468999999999875 458899999999999999999999
Q ss_pred CCCCCChh-hhhhhhhcc------------------ccc---ccCC-------CCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 275 PFCSDDPR-ITCRKIVNW------------------KTC---LKFP-------EEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 275 PF~~~~~~-~~~~~i~~~------------------~~~---~~~p-------~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
||.+.+.. +...++... ... ...+ .....++++.+||.+||. ||.+|+
T Consensus 203 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~-- 280 (291)
T cd07870 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI-- 280 (291)
T ss_pred CCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc--
Confidence 99765432 222221100 000 0000 001236789999999998 999999
Q ss_pred CCHHHHHcCCCc
Q 013064 325 RGVEELKEHPWF 336 (450)
Q Consensus 325 ~~~~eil~Hpff 336 (450)
++.+++.||||
T Consensus 281 -t~~~~l~h~~~ 291 (291)
T cd07870 281 -SAQDALLHPYF 291 (291)
T ss_pred -CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=327.79 Aligned_cols=263 Identities=28% Similarity=0.457 Sum_probs=223.7
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD 109 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~ 109 (450)
++....+++.+.+..||.|+.|.|+.++.+.+|...|+|.+.+.. ..+..+++....+++... ++|+||+.+++|..
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 466788899999999999999999999999999999999998764 455677788888877666 59999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+..+++.||.|.. -+..+|++ .++++|..+-.+...++.||.||-. +||+|||+||.|||+|+.|+|||||||++.+
T Consensus 163 n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 163 NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR 241 (391)
T ss_pred CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence 9999999999843 34444433 5789999999999999999999986 5999999999999999999999999999988
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGA 264 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGv 264 (450)
+.....+ ....|-+.|||||.+. ...|+..+|+||||+
T Consensus 242 lvdSkAh---------------------------------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGI 282 (391)
T KOG0983|consen 242 LVDSKAH---------------------------------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGI 282 (391)
T ss_pred eeccccc---------------------------------------ccccCCccccCccccCCCCCCccchhhhhhhhcc
Confidence 7654211 1246999999999996 356999999999999
Q ss_pred HHHHHhhCCCCCCCCC-hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 265 IMYEMLIGYPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 265 ilyeml~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
.|+||.||..||.+.+ .-+++.+|++. .+..+|....+|+++.+|+..||+ |+.+|| ...++++|||+...
T Consensus 283 TlveLaTg~yPy~~c~tdFe~ltkvln~-ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP---~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 283 TLVELATGQYPYKGCKTDFEVLTKVLNE-EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP---KYNKLLEHPFIKRY 355 (391)
T ss_pred chhhhhcccCCCCCCCccHHHHHHHHhc-CCCCCCcccCcCHHHHHHHHHHhhcCcccCc---chHHHhcCcceeec
Confidence 9999999999998854 45677788873 445666666799999999999998 999999 57899999999753
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.07 Aligned_cols=257 Identities=31% Similarity=0.511 Sum_probs=218.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|.+++.||+|+||.||++....+++.||+|.+.... ....+.+.+|..+++.++||||++++++|...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 479999999999999999999999999999999986432 23356788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
+||++||+|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--- 170 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence 999999999999865 4589999999999999999999999999999999999999999999999999875433210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......|++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus 171 -----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf 215 (293)
T cd06647 171 -----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215 (293)
T ss_pred -----------------------------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 011357999999999998888999999999999999999999999
Q ss_pred CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
...+.......+... ....++....++..+++||.+||. +|.+|+ ++++++.||||+..
T Consensus 216 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~h~~~~~~ 275 (293)
T cd06647 216 LNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKIA 275 (293)
T ss_pred CCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcC
Confidence 877655443333322 122233334678899999999998 999999 68999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=335.34 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=212.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLYL 115 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~lyl 115 (450)
++|+.++.||.|++|.||+|.+..+++.||+|.+.+.. .......+.+|.++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 57999999999999999999999999999999987643 223456788999999999999999999998654 47999
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 116 IMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
||||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887653 356899999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
. .....++..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 159 ~----------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 159 L----------------------------------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred c----------------------------------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 0 112468889999999998999999999999999999999
Q ss_pred CCCCCCCCC-----hhhhhhhhhcccccccCCC----CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 272 GYPPFCSDD-----PRITCRKIVNWKTCLKFPE----EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 272 G~~PF~~~~-----~~~~~~~i~~~~~~~~~p~----~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
|..||.... ..+....+.... ....+. ...+++.+.+||.+||. +|.+|| ++.|++.||||....
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~eil~~~~~~~~~ 273 (287)
T cd06621 199 NRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP---TPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCCCcccCCCCChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCC---CHHHHHhCccccccc
Confidence 999998652 222333333211 111111 12357889999999998 999999 689999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=330.72 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=210.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+.+++|++++.||+|+||.||+++.+. +..+|+|.+.+... ..+.+..|..+|+.++||||+++++++.+...+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 356889999999999999999998764 55799998875432 2356788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|.+++.. .+.++++.+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999999999999875 35689999999999999999999999999999999999999999999999999886532210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
. ......++..|+|||++.+..++.++|+|||||++|+|++ |
T Consensus 156 ~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g 198 (256)
T cd05114 156 T-------------------------------------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198 (256)
T ss_pred e-------------------------------------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCC
Confidence 0 0012345678999999998899999999999999999999 9
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.+||...+..+....+.... ....| ...+..+.+||.+||. +|.+|| ++++++.
T Consensus 199 ~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~~l~~ 253 (256)
T cd05114 199 KMPFEKKSNYEVVEMISRGF-RLYRP--KLASMTVYEVMYSCWHEKPEGRP---TFAELLR 253 (256)
T ss_pred CCCCCCCCHHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99999888877777776532 22223 3578899999999998 999999 5777763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=331.28 Aligned_cols=255 Identities=32% Similarity=0.523 Sum_probs=209.4
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
..+.+.....||+|+||.||++++..++..||+|.+.+.. ....+.+.+|..+++.++||||+++++++.+++..|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455666678999999999999999999999999887543 2345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeeccccccCccc
Q 013064 116 IMEYLPGGDIMTLLMRE-DIL--SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~-~~~--~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DFGla~~~~~~ 191 (450)
||||++|++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999999764 456 88999999999999999999999999999999999986 679999999998765321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC--CCCccccccchhHHHHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~--~y~~~~DiWSlGvilyem 269 (450)
.. ......|++.|+|||++.+. .++.++|+|||||++|+|
T Consensus 163 ~~--------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l 204 (268)
T cd06624 163 NP--------------------------------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204 (268)
T ss_pred CC--------------------------------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHH
Confidence 10 01124689999999998653 488999999999999999
Q ss_pred hhCCCCCCCCChhh-hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 270 LIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 270 l~G~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
++|.+||....... ....+........+| ..+++++++||++||. +|.+|| ++.+++.||||
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 268 (268)
T cd06624 205 ATGKPPFIELGEPQAAMFKVGMFKIHPEIP--ESLSAEAKNFILRCFEPDPDKRA---SAHDLLQDPFL 268 (268)
T ss_pred HhCCCCCccccChhhhHhhhhhhccCCCCC--cccCHHHHHHHHHHcCCCchhCC---CHHHHHhCCCC
Confidence 99999997543221 111221111222334 3688999999999998 999999 68999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=334.81 Aligned_cols=253 Identities=30% Similarity=0.452 Sum_probs=216.5
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
-|++++.||+|+||.||++.+..+++.||+|++..... ......+.+|+.++..++||||++++++|.++..+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|++||+|..++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++..+.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence 9999999998864 5689999999999999999999999999999999999999999999999999876533200
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
......|+..|+|||.+.+..++.++|+|||||++|+|++|.+||..
T Consensus 157 ---------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 ---------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred ---------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 01135789999999999888889999999999999999999999987
Q ss_pred CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 279 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+.......+... ....++ ..++.++.++|.+||. +|.+|| ++.++++||||..
T Consensus 204 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~~~ 258 (277)
T cd06641 204 LHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIVR 258 (277)
T ss_pred cchHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhh
Confidence 7665555554332 111222 3578999999999998 999999 6899999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.06 Aligned_cols=252 Identities=28% Similarity=0.491 Sum_probs=211.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|.+.+.||+|+||.||+++.+.+|+.||+|.+.+...........+.+|..+++.++||||++++++|.+++.+|+|
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999999999999998876555555667888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 117 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 117 mEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|||++|++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998864 3568999999999999999999999999999999999999999999999999987654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
. .....+|++.|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 161 ~--------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 161 T--------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred c--------------------------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhC
Confidence 0 01235799999999999988999999999999999999999
Q ss_pred CCCCCCCCh--hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 273 YPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 273 ~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
..||.+... ......+.... ....+ ...+++.+++||.+||. ||.+|| ++.+|+
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i~ 259 (267)
T cd08229 203 QSPFYGDKMNLYSLCKKIEQCD-YPPLP-SDHYSEELRQLVNMCINPDPEKRP---DITYVY 259 (267)
T ss_pred CCCcccccchHHHHhhhhhcCC-CCCCC-cccccHHHHHHHHHhcCCCcccCC---CHHHHH
Confidence 999976543 23333333211 11111 13578999999999998 999999 566554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=330.58 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=213.6
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+...+|.+.+.||+|+||.||+|..+.+++.+|+|++.+.. .....+.+|+.+++.++||||+++++++..+..+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 356678999999999999999999999999999999987542 2346688899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999998764 36899999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
.... .....+++.|+|||++.+..++.++|+|||||++|||++
T Consensus 158 ~~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 200 (263)
T cd05052 158 TYTA-------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200 (263)
T ss_pred eeec-------------------------------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 1100 011235678999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||.+.+..+....+... .....| ..++.++.+||.+||. ||.+||+ +.++++
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~l~~ 257 (263)
T cd05052 201 YGMSPYPGIDLSQVYELLEKG-YRMERP--EGCPPKVYELMRACWQWNPSDRPS---FAEIHQ 257 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHccCCcccCCC---HHHHHH
Confidence 99999988877776666542 122333 4789999999999998 9999994 566543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=347.98 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=207.8
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~ 108 (450)
+..++|++.+.||+|+||.||+|... .+++.||+|+++... .......+..|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 44568999999999999999999754 345789999987532 233456778899999999 8999999999886
Q ss_pred c-CCeEEEEEeccCCCChHHHHHhc-------------------------------------------------------
Q 013064 109 D-SDFLYLIMEYLPGGDIMTLLMRE------------------------------------------------------- 132 (450)
Q Consensus 109 ~-~~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------- 132 (450)
. +..+|+||||++||+|.+++...
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 5 45799999999999999998642
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccccccc
Q 013064 133 ------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206 (450)
Q Consensus 133 ------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~ 206 (450)
..++++.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------------ 229 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------ 229 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch------------
Confidence 25789999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhh
Q 013064 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITC 285 (450)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~ 285 (450)
....+..+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+
T Consensus 230 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~ 285 (337)
T cd05054 230 ------------------------VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285 (337)
T ss_pred ------------------------hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH
Confidence 00113456788999999999999999999999999999997 99999876555544
Q ss_pred hhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 286 RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 286 ~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
...+........| ...++++.+++.+||+ +|.+|| ++++|++|
T Consensus 286 ~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~~RP---s~~ell~~ 329 (337)
T cd05054 286 CRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRP---TFSELVEI 329 (337)
T ss_pred HHHHhccCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 4444322223333 3678999999999998 999999 67888765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=335.63 Aligned_cols=261 Identities=32% Similarity=0.505 Sum_probs=224.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ..+.+.+|..+++.++|+||+++++.+......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 44679999999999999999999998999999999976432 45678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999999998876 899999999999999999999999999999999999999999999999999875432210
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
......|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 172 -------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 172 -------------------------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred -------------------------------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 0113468899999999998889999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
||...+.......+... .....+....++..+++||.+||. +|.+|+ ++.+++.||||....|.
T Consensus 215 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 215 PYLREPPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLKKACPK 279 (286)
T ss_pred CCCCCCHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCc---CHHHHhhChHhhccCch
Confidence 99887766555555432 122233333488999999999998 999999 78999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=341.37 Aligned_cols=257 Identities=30% Similarity=0.453 Sum_probs=217.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|..++.||+|+||.||++.+..+++.+|+|.+.+.. .....+.+.+|+.+++.++||||++++++|.++..+|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 34667788999999999999999999999999987543 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch----
Confidence 99999999998854 5789999999999999999999999999999999999999999999999999876543210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......|+..|+|||++.+..++.++|+|||||++|||++|.+||.
T Consensus 157 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 157 ----------------------------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred ----------------------------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 0113568999999999999889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
..........+.... ....+ ..++..+.+||.+||. +|.+|| ++.++++||||....+
T Consensus 203 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06642 203 DLHPMRVLFLIPKNS-PPTLE--GQYSKPFKEFVEACLNKDPRFRP---TAKELLKHKFITRYTK 261 (277)
T ss_pred ccchhhHHhhhhcCC-CCCCC--cccCHHHHHHHHHHccCCcccCc---CHHHHHHhHHHHHHhh
Confidence 766555444433221 11222 3578899999999998 999999 6899999999976554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.63 Aligned_cols=254 Identities=32% Similarity=0.520 Sum_probs=211.3
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|++++.||.|++|.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||+|+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6789999999999999999999999999999976532 233446678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 120 LPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 120 ~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
++ ++|..++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 95 68999987765 799999999999999999999999999999999999999999999999999876532200
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||
T Consensus 155 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 200 (283)
T cd07835 155 ----------------------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200 (283)
T ss_pred ----------------------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC
Confidence 01124678999999988764 5789999999999999999999999
Q ss_pred CCCChhhhhhhhhcccc----------------cccCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHH
Q 013064 277 CSDDPRITCRKIVNWKT----------------CLKFP---------EEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~----------------~~~~p---------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei 330 (450)
.+.+......++..... ...++ ..+.++..+.+||.+||+ ||.+|| +++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~i 277 (283)
T cd07835 201 PGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI---SAKAA 277 (283)
T ss_pred CCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc---CHHHH
Confidence 88766544444332100 00011 124678999999999999 999999 68999
Q ss_pred HcCCCc
Q 013064 331 KEHPWF 336 (450)
Q Consensus 331 l~Hpff 336 (450)
+.||||
T Consensus 278 l~~~~~ 283 (283)
T cd07835 278 LQHPYF 283 (283)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=324.94 Aligned_cols=253 Identities=31% Similarity=0.543 Sum_probs=221.5
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++.+.||+|++|.||++.+..+++.||+|.+.+... .....+.+.+|.+++..++||+|+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999987653 23466789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988889999999999999999999999999999999999999999999999999999876442110
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 156 ----------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 156 ----------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ----------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1135789999999999888899999999999999999999999987
Q ss_pred CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 279 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
.+......++... ....+| ..+++.++++|.+||. +|++|+ ++++++.||||
T Consensus 202 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~~ 254 (254)
T cd06627 202 LNPMAALFRIVQD-DHPPLP--EGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254 (254)
T ss_pred ccHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHHhCChhhCc---CHHHHhcCCCC
Confidence 7655555444432 222333 4689999999999998 999999 68999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=345.88 Aligned_cols=256 Identities=32% Similarity=0.503 Sum_probs=210.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------ 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~------ 111 (450)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 68999999999999999999999999999999987643 22333456789999999999999999999987653
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||+. ++|..++ ...++++.+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 4699999996 4776654 346999999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
....+||+.|+|||++.+ ..++.++|+|||||++|||+
T Consensus 171 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 171 -----------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred -----------------------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 113578999999999876 46899999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccc---------------------cccCCC------CCCCCHHHHHHHHHhhc-CccccC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKT---------------------CLKFPE------EPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p~------~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+|+.||.+.+....+..+..... ....+. .+..++.+.+||.+||. ||.+|+
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 99999998775554444332100 000010 13578899999999998 999999
Q ss_pred CCCCHHHHHcCCCcCCCCc
Q 013064 323 GTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~i~w 341 (450)
++++++.||||..+.+
T Consensus 290 ---~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 290 ---TATEALEHPYFDSFRD 305 (342)
T ss_pred ---CHHHHhcCcchhhccc
Confidence 6899999999988654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.36 Aligned_cols=256 Identities=22% Similarity=0.360 Sum_probs=212.3
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCC----------------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTG----------------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~----------------~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp 98 (450)
+..++|++++.||+|+||.||+|.+..++ ..+|+|.+.+.. .....+.+.+|+++++.++||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCC
Confidence 34579999999999999999999877644 468999987653 234567889999999999999
Q ss_pred CeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCC
Q 013064 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-----------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 167 (450)
Q Consensus 99 ~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpe 167 (450)
||+++++++.++..+++||||+++++|..++.+.. .+++..+..++.|++.||.|||++||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999999999998765 6899999999999999999999999999999999
Q ss_pred cEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhh
Q 013064 168 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 247 (450)
Q Consensus 168 NILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEv 247 (450)
||+++.++.++|+|||++......... ....+..+++.|+|||+
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~ 203 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYY------------------------------------RVQGRAPLPIRWMAWES 203 (296)
T ss_pred ceeecCCCceEEccccceeecccCcce------------------------------------eecCcCCCCceecCHHH
Confidence 999999999999999998765332100 00123567889999999
Q ss_pred hccCCCCccccccchhHHHHHHhh--CCCCCCCCChhhhhhhhhcc----cccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 013064 248 LLKKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNW----KTCLKFPEEPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 248 l~~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dli~~lL~-dp~~ 320 (450)
+.+..++.++|+|||||++|||++ |..||...+.......+... ......+.....+.++.+||.+||. ||.+
T Consensus 204 ~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 283 (296)
T cd05051 204 VLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEED 283 (296)
T ss_pred hhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhc
Confidence 988889999999999999999998 78899877666665555432 1112223334678999999999998 9999
Q ss_pred cCCCCCHHHHH
Q 013064 321 RLGTRGVEELK 331 (450)
Q Consensus 321 R~~~~~~~eil 331 (450)
|| ++.+|+
T Consensus 284 Rp---t~~el~ 291 (296)
T cd05051 284 RP---TFREIH 291 (296)
T ss_pred CC---CHHHHH
Confidence 99 567774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=329.28 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=211.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++++.||+|+||.||++... ++..||+|.+.... ...+.+.+|..+++.++||||+++++++.+.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 356789999999999999999999865 55679999886543 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||++||+|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999998653 56889999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... ......++..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 157 ~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t 199 (261)
T cd05072 157 EYT-------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199 (261)
T ss_pred cee-------------------------------------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHc
Confidence 100 0012346778999999988889999999999999999998
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|..||.+.+.......+... ...|....++.++.+||.+||. +|++||+ ++++.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~ 255 (261)
T cd05072 200 YGKIPYPGMSNSDVMSALQRG---YRMPRMENCPDELYDIMKTCWKEKAEERPT---FDYLQ 255 (261)
T ss_pred cCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCCcccCcC---HHHHH
Confidence 99999888777666666542 2334345789999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=389.11 Aligned_cols=257 Identities=32% Similarity=0.499 Sum_probs=222.0
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEecc
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
.-...||.|.||.||.|.+..||+..|||-++-.... ......+.+|..+|..++|||+|+.|++=.+.+.+|+.||||
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 3455799999999999999999999999988655433 556678899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccc
Q 013064 121 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200 (450)
Q Consensus 121 ~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~ 200 (450)
.||+|.+++...+..+|...+.|..|++.|+.|||+.|||||||||+||+|+.+|.||++|||.|+.+..+.....
T Consensus 1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~---- 1392 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP---- 1392 (1509)
T ss_pred ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999998765421110
Q ss_pred ccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHHHHHhhCCCCCC
Q 013064 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.-..+.+|||.|||||++.+ +|.+.+.|||||||++.||.||+.||.
T Consensus 1393 ------------------------------~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1393 ------------------------------GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred ------------------------------HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 00125799999999999975 778999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
.-+..-....-+......++|+ .+|++.+|||.+||. ||++|. .+.||+.|.|-+
T Consensus 1443 ~~dne~aIMy~V~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw---~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1443 ELDNEWAIMYHVAAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRW---TASQLLEHAFGK 1498 (1509)
T ss_pred hccchhHHHhHHhccCCCCCch--hhhHhHHHHHHHHHhcCchhhh---HHHHHHHhhccc
Confidence 7655444333333445667776 599999999999998 999998 577999998854
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.11 Aligned_cols=231 Identities=32% Similarity=0.525 Sum_probs=196.1
Q ss_pred cCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHH
Q 013064 49 GAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL 128 (450)
Q Consensus 49 G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~ 128 (450)
|.||+||+|+++.+|+.||+|.+.+.. ....|...+....||||+++++++++.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997653 123455555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccccccccc
Q 013064 129 LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208 (450)
Q Consensus 129 l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 208 (450)
+.+...+++..+..++.|++.||+|||++||+||||||+||+++.+|.++|+|||++......
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988888999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhh
Q 013064 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKI 288 (450)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 288 (450)
.....+++.|+|||.+.+..++.++|+||+||++|||++|..||...... +
T Consensus 139 ------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~ 189 (237)
T cd05576 139 ------------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I 189 (237)
T ss_pred ------------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c
Confidence 11245678899999998888999999999999999999999998643221 1
Q ss_pred hcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCc
Q 013064 289 VNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWF 336 (450)
Q Consensus 289 ~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff 336 (450)
.....+.+| ..+++.+++||.+||. ||.+|+++ .+++++++||||
T Consensus 190 -~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 190 -NTHTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -ccccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 111223344 3689999999999998 99999975 357999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=327.64 Aligned_cols=252 Identities=30% Similarity=0.507 Sum_probs=211.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++.+.||+|+||.||+|....+|+.||+|.++..........+.+.+|+.+++.++|++|++++++|.+++..|+|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999999999999999866555555677899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 117 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 117 mEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|||++||+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999999864 3458999999999999999999999999999999999999999999999999988654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 161 ~--------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g 202 (267)
T cd08224 161 T--------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred c--------------------------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHC
Confidence 0 01235789999999999998999999999999999999999
Q ss_pred CCCCCCCCh--hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 273 YPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 273 ~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
..||..... ......+... .....|. ..++..+.++|.+||. +|.+|| ++.+|+
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp---~~~~il 259 (267)
T cd08224 203 QSPFYGDKMNLYSLCKKIEKC-DYPPLPA-DHYSEELRDLVSRCINPDPEKRP---DISYVL 259 (267)
T ss_pred CCCcccCCccHHHHHhhhhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCcccCC---CHHHHH
Confidence 999965432 2233333321 1112221 2678899999999998 999999 456655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=337.68 Aligned_cols=253 Identities=28% Similarity=0.389 Sum_probs=214.4
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|..++.||+|+||.||+|++..+|+.||+|++.............+.+|..+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 67778899999999999999999999999999866544445567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 120 LPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 120 ~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 96 577777755 45789999999999999999999999999999999999999999999999999864321
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhhCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
....+|++.|+|||++. ...++.++|+|||||++|+|++|.+|
T Consensus 174 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p 219 (313)
T cd06633 174 ----------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219 (313)
T ss_pred ----------------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 11357899999999984 35688999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
|.+.+......++...... ..+ ...++..+++||.+||. +|.+|| ++.+++.||||+..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~li~~~l~~~P~~Rp---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 220 LFNMNAMSALYHIAQNDSP-TLQ-SNEWTDSFRGFVDYCLQKIPQERP---ASAELLRHDFVRRDR 280 (313)
T ss_pred CCCCChHHHHHHHHhcCCC-CCC-ccccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCc
Confidence 9887766655555432211 111 23578889999999998 999999 689999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=324.39 Aligned_cols=253 Identities=32% Similarity=0.581 Sum_probs=221.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+..|.++++.++|||++++++.+.+....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999976542 23456678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 119 YLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 119 y~~gg~L~~~l~~~----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|++|++|..++.+. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999764 779999999999999999999999999999999999999999999999999988654321
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
......+|++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 158 ------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 201 (258)
T cd08215 158 ------------------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201 (258)
T ss_pred ------------------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCC
Confidence 01124579999999999998889999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
||...+.......+.... ....| ..++..+.++|.+||. +|.+|+ ++.+++.||||
T Consensus 202 p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 258 (258)
T cd08215 202 PFEGENLLELALKILKGQ-YPPIP--SQYSSELRNLVSSLLQKDPEERP---SIAQILQSPFI 258 (258)
T ss_pred CCCCCcHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCCCC
Confidence 998877666666655422 22333 3688999999999998 999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.74 Aligned_cols=251 Identities=34% Similarity=0.527 Sum_probs=217.2
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|+..+.||+|++|.||++.+..+++.+++|++..... .....+.+|..+++.++||+|+++++.+..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 68999999999999999999999999999999976542 356778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 119 YLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 119 y~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|++|++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999998776 6899999999999999999999999999999999999999999999999999886543210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus 154 -----------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 198 (253)
T cd05122 154 -----------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198 (253)
T ss_pred -----------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 113578999999999998889999999999999999999999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
..+.......+.. ......+....++..+.++|.+||. ||.+|+ ++.+++.|||
T Consensus 199 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~~~~l~~~~ 253 (253)
T cd05122 199 ELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253 (253)
T ss_pred CCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCC---CHHHHhcCCC
Confidence 7755444443332 1222333333458999999999998 999999 6899999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=317.90 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=217.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-----
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----- 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----- 109 (450)
++-++|.+.+.||.|||+-|++|+...+++.||+|.+.... .++.+.+++|++..++++||||++++++.-.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 45579999999999999999999999999999999987543 4678899999999999999999999876543
Q ss_pred CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEccCCceEEeecc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDFG 183 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld~~g~ikL~DFG 183 (450)
....|++++|...|+|.+.+.. +..++|.++..|+.+|+.||++||+.. ++||||||.|||+.+++.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 3459999999999999998864 347999999999999999999999998 9999999999999999999999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC---CCcccccc
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWW 260 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~---y~~~~DiW 260 (450)
.+....-. ...++...++++|... ..|..|.|||.+.-+. .+.++|||
T Consensus 175 S~~~a~i~---------------------i~~~~~a~~lQe~a~e--------~Ct~pyRAPELf~vk~~~ti~ertDIW 225 (302)
T KOG2345|consen 175 SATQAPIQ---------------------IEGSRQALRLQEWAEE--------RCTIPYRAPELFNVKSHCTITERTDIW 225 (302)
T ss_pred CccccceE---------------------eechHHHHHHHHHHHH--------hCCCcccCchheecccCcccccccchh
Confidence 99865422 1123445667777543 3678899999997544 48999999
Q ss_pred chhHHHHHHhhCCCCCCCCC--hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 261 SLGAIMYEMLIGYPPFCSDD--PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
||||+||.|++|..||.-.- .......+.+ ..+.+|....+|+.+..||+.||+ ||.+|| ++.+++.+
T Consensus 226 SLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP---~i~~ll~~ 296 (302)
T KOG2345|consen 226 SLGCTLYAMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRP---TIPELLSK 296 (302)
T ss_pred hhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCC---CHHHHHHH
Confidence 99999999999999995321 1122333444 457788878899999999999999 999999 56777653
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.12 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=206.3
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFY 105 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t-----~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~ 105 (450)
+..+..++|++++.||+|+||.||+|.+... +..||+|++++.. .....+.+.+|+.+|..+. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3446678999999999999999999987433 3479999996542 2344567899999999996 999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhc-----------------------------------------------------
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMRE----------------------------------------------------- 132 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~----------------------------------------------------- 132 (450)
++.+...+|+|||||+||+|.++|.+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988652
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 133 -------------------------------------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 133 -------------------------------------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2477888899999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.++.+||+|||+++........ ....+..|++.|+|||++.
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~ 312 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY------------------------------------VSKGSTFLPVKWMAPESIF 312 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc------------------------------------cccCCcCCCcceEChhhhc
Confidence 9999999999999999865332100 0012346788999999999
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
+..++.++|||||||++|||++ |..||.+..........+........+ ..++.++.++|.+||. ||.+||+.
T Consensus 313 ~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHCccCHhHCcCH
Confidence 9899999999999999999997 999998765544443333322223333 4789999999999998 99999954
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=339.32 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=209.6
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCE----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~----~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
.+...+|++++.||+|+||.||+|++..+++. ||+|+++... .......+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 35668999999999999999999998776664 8999986432 23345678899999999999999999999886
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
. ..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5 578999999999999999874 46899999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
...... .......+++.|+|||++.+..++.++|+|||||++||
T Consensus 160 ~~~~~~------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~e 203 (316)
T cd05108 160 GADEKE------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 203 (316)
T ss_pred cCCCcc------------------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHH
Confidence 432110 00112345778999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|++ |..||.+....+.. .++.... ..|.....+.++.++|.+||. +|.+|| ++.+++.+
T Consensus 204 l~t~g~~p~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~l~~~ 264 (316)
T cd05108 204 LMTFGSKPYDGIPASEIS-SILEKGE--RLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 264 (316)
T ss_pred HHcCCCCCCCCCCHHHHH-HHHhCCC--CCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 997 99999877655443 3433222 233335678999999999998 999999 57787765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=330.59 Aligned_cols=255 Identities=19% Similarity=0.291 Sum_probs=213.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t-----~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
.+..++|++.+.||+|+||.||++..+.. +..||+|.+.... .......+.+|+.+|+.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35678999999999999999999998654 4789999986543 2234567888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceE
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 178 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~----------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ik 178 (450)
+....|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 999999999999999999998653 2367889999999999999999999999999999999999999999
Q ss_pred EeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcccc
Q 013064 179 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 258 (450)
Q Consensus 179 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~D 258 (450)
|+|||+++.+...... .......+|..|+|||.+.+..++.++|
T Consensus 160 l~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 203 (277)
T cd05032 160 IGDFGMTRDIYETDYY------------------------------------RKGGKGLLPVRWMAPESLKDGVFTTKSD 203 (277)
T ss_pred ECCcccchhhccCccc------------------------------------ccCCCCCccccccCHHHHhcCCCCcccc
Confidence 9999998865432100 0011346788999999998888999999
Q ss_pred ccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 259 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 259 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|||||++|||++ |.+||.+.+..+....+.. .....+|. ..+..+.+||.+||+ +|.+|+ ++.+++.
T Consensus 204 i~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 273 (277)
T cd05032 204 VWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGHLDLPE--NCPDKLLELMRMCWQYNPKMRP---TFLEIVS 273 (277)
T ss_pred hHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9999999999998 9999988887776666653 23344453 579999999999999 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=354.11 Aligned_cols=251 Identities=28% Similarity=0.393 Sum_probs=220.1
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|.-++.||.|+||.||.|++..+.++||||.+.-+.....+....+..|+..|..++|||+|.+.++|-.+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55578899999999999999999999999999876655666778899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 120 LPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 120 ~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|-| +-.+++.- ..++-|.++..+..+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|.....
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 955 55555533 35789999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHHHHHhhCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
+.+++|||+|||||||.. +.|+-++||||||++..||.-.+||
T Consensus 179 ----------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPP 224 (948)
T KOG0577|consen 179 ----------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 224 (948)
T ss_pred ----------------------------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCC
Confidence 457999999999999974 5699999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+...+....+..|.+.. ...++. ..+|..++.||..||. -|.+|| +.+++++|+|...
T Consensus 225 lFnMNAMSALYHIAQNe-sPtLqs-~eWS~~F~~Fvd~CLqKipqeRp---tse~ll~H~fv~R 283 (948)
T KOG0577|consen 225 LFNMNAMSALYHIAQNE-SPTLQS-NEWSDYFRNFVDSCLQKIPQERP---TSEELLKHRFVLR 283 (948)
T ss_pred ccCchHHHHHHHHHhcC-CCCCCC-chhHHHHHHHHHHHHhhCcccCC---cHHHHhhcchhcc
Confidence 99999888777776532 233333 3689999999999998 899999 6799999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=331.73 Aligned_cols=255 Identities=20% Similarity=0.323 Sum_probs=212.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|..+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345789999999999999999999987 77899999886432 23334568889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEE
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED-------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKL 179 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~-------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL 179 (450)
....|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.+| .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999997653 589999999999999999999999999999999999998765 5999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccc
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~Di 259 (450)
+|||+++.+...... .......+++.|+|||++.+..++.++|+
T Consensus 161 ~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (277)
T cd05036 161 ADFGMARDIYRASYY------------------------------------RKGGRAMLPIKWMPPEAFLDGIFTSKTDV 204 (277)
T ss_pred ccCccccccCCccce------------------------------------ecCCCCCccHhhCCHHHHhcCCcCchhHH
Confidence 999999876322100 00012234678999999998889999999
Q ss_pred cchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 260 WSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 260 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|||||++|||++ |..||.+.+..+....+... .....| ..++..+.+++.+||. +|.+|| ++.++++|
T Consensus 205 wslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~p~~Rp---s~~~vl~~ 274 (277)
T cd05036 205 WSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPP--KGCPGPVYRIMTDCWQHTPEDRP---NFATILER 274 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 999999999996 99999988777666555442 223333 4689999999999998 999999 68888876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=331.41 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=209.7
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEcCCe----
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDF---- 112 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~~~~---- 112 (450)
|++++.||+|+||.||+|+++.+++.||+|.++.... .......+.+|..++..+ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999999999999999975432 223344566788877666 69999999999998877
Q ss_pred -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 113 -LYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 113 -lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+|+||||+++ +|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8988887643 59999999999999999999999999999999999999999999999999987654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
.... .....+++.|+|||++.+..++.++|+|||||++|+|
T Consensus 159 ~~~~---------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l 199 (287)
T cd07838 159 FEMA---------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199 (287)
T ss_pred CCcc---------------------------------------cccccccccccChHHhccCCCCCcchhhhHHHHHHHH
Confidence 3210 1134688999999999998999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccc---cccCC-----------C---------CCCCCHHHHHHHHHhhc-CccccCCCC
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKT---CLKFP-----------E---------EPKISDEARDLICHLLC-DVETRLGTR 325 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~---~~~~p-----------~---------~~~~s~~~~dli~~lL~-dp~~R~~~~ 325 (450)
++|.+||.+.+..+.+.++..... ...++ . .+.+++.+.+||.+||+ ||.+||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp--- 276 (287)
T cd07838 200 FRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI--- 276 (287)
T ss_pred HhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC---
Confidence 999999998887776666643110 00000 0 02457889999999998 999999
Q ss_pred CHHHHHcCCCc
Q 013064 326 GVEELKEHPWF 336 (450)
Q Consensus 326 ~~~eil~Hpff 336 (450)
++++++.||||
T Consensus 277 ~~~~il~~~~~ 287 (287)
T cd07838 277 SAFEALQHPYF 287 (287)
T ss_pred CHHHHhcCcCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.41 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=214.3
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe---
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF--- 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~--- 112 (450)
..++|++++.||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3578999999999999999999999999999999987542 223345667889999999999999999998876654
Q ss_pred ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 113 ---LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 113 ---lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+|+|+||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 99999999 7799888865 579999999999999999999999999999999999999999999999999988653
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilye 268 (450)
.. .....+|+.|+|||++.+ ..++.++|+|||||++|+
T Consensus 170 ~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 170 DE-----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred cc-----------------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHH
Confidence 21 113578999999999865 467899999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhcccccc--------------------c------CC-CCCCCCHHHHHHHHHhhc-Cccc
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWKTCL--------------------K------FP-EEPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~~~~--------------------~------~p-~~~~~s~~~~dli~~lL~-dp~~ 320 (450)
|++|+.||.+.+....+..+.+..... . ++ ....+++.+.+||.+||+ ||.+
T Consensus 209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 999999998877766555554321100 0 00 012468999999999998 9999
Q ss_pred cCCCCCHHHHHcCCCcCC
Q 013064 321 RLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 321 R~~~~~~~eil~Hpff~~ 338 (450)
|| ++.+|+.||||..
T Consensus 289 Rp---t~~ell~h~~~~~ 303 (343)
T cd07851 289 RI---TAAEALAHPYLAE 303 (343)
T ss_pred CC---CHHHHhcCCCccc
Confidence 99 6899999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=328.25 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=213.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..++|++.+.||+|+||.||+|+.+.+ ...+|+|++++.. .......+.+|..+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 467899999999999999999998754 4579999987543 23345678889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998764 47999999999999999999999999999999999999999999999999999876421
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... .......+++.|+|||.+.+..++.++|+|||||++|+|++
T Consensus 160 ~~~------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (266)
T cd05033 160 EAT------------------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203 (266)
T ss_pred ccc------------------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHc
Confidence 100 00112345788999999998899999999999999999997
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|..||...........+... ...|.....++.+.+|+.+||. +|.+|| ++++|+++
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~ei~~~ 261 (266)
T cd05033 204 YGERPYWDMSNQDVIKAVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERP---TFSQIVST 261 (266)
T ss_pred cCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 99999887776666666542 1223334689999999999998 999999 57777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=331.51 Aligned_cols=255 Identities=18% Similarity=0.256 Sum_probs=209.8
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+..++|++.+.||+|+||.||+++++. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 455789999999999999999998652 45679999986532 22334567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEE
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~----------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL 179 (450)
....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999987532 3567888999999999999999999999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccc
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~Di 259 (450)
+|||+++......... ......+++.|+|||++.+..++.++|+
T Consensus 161 ~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (277)
T cd05062 161 GDFGMTRDIYETDYYR------------------------------------KGGKGLLPVRWMSPESLKDGVFTTYSDV 204 (277)
T ss_pred CCCCCccccCCcceee------------------------------------cCCCCccCHhhcChhHhhcCCcCchhHH
Confidence 9999988654321100 0012356889999999998889999999
Q ss_pred cchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 260 WSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 260 WSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|||||++|||++ |..||.+.+.......+.... ....+ ..+++.+++||.+||. ||.+|| ++.+++.+
T Consensus 205 ~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 274 (277)
T cd05062 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEIISS 274 (277)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999998 799998887776666655422 22233 3678899999999998 999999 57777753
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.34 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=219.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----eE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-----FL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-----~l 113 (450)
+|++.+.||.|+||.||+|++..+|+.||+|++.+.. ......+.+.+|..+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987643 22345577889999999999999999999998875 89
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||++ ++|..++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 58999998888999999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G 272 (450)
. ........||+.|+|||++.+. .++.++|+|||||++|+|++|
T Consensus 159 ~-----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g 203 (330)
T cd07834 159 E-----------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203 (330)
T ss_pred c-----------------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence 0 0011235789999999999887 889999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhccccccc------------------------CC---CCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLK------------------------FP---EEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~------------------------~p---~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
.+||.+.+..+.+..+........ .+ ..+.+++++.+||.+||+ +|.+||
T Consensus 204 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-- 281 (330)
T cd07834 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI-- 281 (330)
T ss_pred CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC--
Confidence 999998887666655543211000 00 012478899999999998 999999
Q ss_pred CCHHHHHcCCCcCCCC
Q 013064 325 RGVEELKEHPWFRGIQ 340 (450)
Q Consensus 325 ~~~~eil~Hpff~~i~ 340 (450)
++++++.||||+++.
T Consensus 282 -t~~~ll~~~~~~~~~ 296 (330)
T cd07834 282 -TADEALAHPYLAQLH 296 (330)
T ss_pred -CHHHHHhCccHHhhc
Confidence 689999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=337.92 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=215.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
..|..++.||+|+||.||++++..+|..+|+|++.+...........+..|..+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45888999999999999999999999999999997654444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++| +|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 99975 77777654 567999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhhCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....|++.|+|||++. ...++.++|+|||||++|+|++|.
T Consensus 179 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~ 221 (317)
T cd06635 179 -------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221 (317)
T ss_pred -------------------------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC
Confidence 1357899999999984 356889999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+||.+.+.......+...... ......+++.+++||.+||. +|.+|+ ++.++++|||+..
T Consensus 222 ~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 282 (317)
T cd06635 222 PPLFNMNAMSALYHIAQNESP--TLQSNEWSDYFRNFVDSCLQKIPQDRP---TSEELLKHMFVLR 282 (317)
T ss_pred CCCCCccHHHHHHHHHhccCC--CCCCccccHHHHHHHHHHccCCcccCc---CHHHHHhChhhhc
Confidence 999887766666666543221 11223678899999999998 999999 6899999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=336.12 Aligned_cols=257 Identities=21% Similarity=0.322 Sum_probs=212.2
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 106 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~-----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 106 (450)
.++..++|.+.+.||+|+||.||++.. ..++..+|+|++++.. .....+.+.+|..+++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 456778999999999999999999975 3356689999987543 233456788999999999 79999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
+...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 389999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
++........ .......+++.|+|||++.+..++.++|+|||||
T Consensus 188 ~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGv 231 (302)
T cd05055 188 ARDIMNDSNY------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231 (302)
T ss_pred cccccCCCce------------------------------------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHH
Confidence 9865432100 0011235688999999999888999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 265 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 265 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|+|++ |.+||.+......+.+........ +.....++++.+||.+||. +|++|| ++.+++.
T Consensus 232 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ell~ 296 (302)
T cd05055 232 LLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQPEHAPAEIYDIMKTCWDADPLKRP---TFKQIVQ 296 (302)
T ss_pred HHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 9999998 999998877665555544322222 2224678999999999998 999999 5677763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=327.00 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=202.7
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
+.||+|+||.||+|+++.+++.||+|.+.+.. .......+.+|..+++.++||||+++++++.+...+|+||||++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999886432 3344567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 124 DIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 124 ~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
+|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 9999997644 68999999999999999999999999999999999999999999999999987643211000
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCCh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDP 281 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~ 281 (450)
......++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+.
T Consensus 152 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 152 -----------------------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred -----------------------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 0001123567999999998889999999999999999997 9999987766
Q ss_pred hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 282 ~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
......+... .....| ...+..+.+||.+||. +|.+|| ++.+++
T Consensus 203 ~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~ 247 (252)
T cd05084 203 QQTREAIEQG-VRLPCP--ELCPDAVYRLMERCWEYDPGQRP---SFSTVH 247 (252)
T ss_pred HHHHHHHHcC-CCCCCc--ccCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 5555555432 222333 3678999999999998 999999 566665
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.25 Aligned_cols=256 Identities=34% Similarity=0.538 Sum_probs=220.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLYLI 116 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~lylV 116 (450)
+|.+.+.||+|++|.||++.+..+++.+++|++..... .....+.+.+|..+++.++||||+++++.+.+. ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 58889999999999999999999999999999976543 245678889999999999999999999999998 899999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988889999999999999999999999999999999999999999999999999998876543110
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
.......++..|+|||.+....++.++|+||||+++|+|++|..||
T Consensus 158 ----------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 203 (260)
T cd06606 158 ----------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203 (260)
T ss_pred ----------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 0012357899999999998888999999999999999999999999
Q ss_pred CCCC-hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 277 CSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 277 ~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
...+ .......+........+| ..++..+++||.+||. ||.+|+ ++.+++.||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 260 (260)
T cd06606 204 SELGNPMAALYKIGSSGEPPEIP--EHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260 (260)
T ss_pred CCCCchHHHHHhccccCCCcCCC--cccCHHHHHHHHHhCcCChhhCC---CHHHHhhCCCC
Confidence 8765 223333333222333344 3679999999999998 999999 68999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=342.78 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=209.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------D 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------~ 111 (450)
++|++++.||+|+||.||++.+..+|+.||+|++.+.. ......+.+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 88999999999999999999999999999999997643 1223456678899999999999999999998653 3
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
..|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 578899887 8899887754 46999999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
.....||+.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 174 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 174 -----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred -----------------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence 113578999999999876 56899999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhccccc---------------------ccCCC------CCCCCHHHHHHHHHhhc-CccccC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTC---------------------LKFPE------EPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+|.+||.+.+.......+...... ...|. ....++++++||.+||. ||.+|+
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 292 (345)
T cd07877 213 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 292 (345)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC
Confidence 999999876655444433221100 00110 11368899999999998 999999
Q ss_pred CCCCHHHHHcCCCcCC
Q 013064 323 GTRGVEELKEHPWFRG 338 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~ 338 (450)
++.+++.||||..
T Consensus 293 ---t~~e~l~h~~f~~ 305 (345)
T cd07877 293 ---TAAQALAHAYFAQ 305 (345)
T ss_pred ---CHHHHhcChhhhh
Confidence 6899999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=344.48 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=205.7
Q ss_pred eEEeec--CceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G--~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
..||+| +||+||+|++..+|+.||+|++..... .....+.+.+|..+++.++||||++++++|++++.+|+||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456766 999999999999999999999876532 23456788999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccc
Q 013064 122 GGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 122 gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
+|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~--- 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK--- 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence 99999998764 3589999999999999999999999999999999999999999999999987643321100000
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHHHhhCCCCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
..........++..|+|||++.+ .+++.++|+|||||++|+|++|.+||.
T Consensus 160 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 160 ----------------------------VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred ----------------------------ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 00000001245678999999976 457899999999999999999999998
Q ss_pred CCChhhhhhhhhcccc-------------------------------------------cccCCCCCCCCHHHHHHHHHh
Q 013064 278 SDDPRITCRKIVNWKT-------------------------------------------CLKFPEEPKISDEARDLICHL 314 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~-------------------------------------------~~~~p~~~~~s~~~~dli~~l 314 (450)
+.........+..... .+..+.....++.+++||++|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 291 (328)
T cd08226 212 DMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELC 291 (328)
T ss_pred CcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 7655444433322110 001111224678899999999
Q ss_pred hc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 315 LC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 315 L~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
|+ ||.+|+ +++++++||||+.+
T Consensus 292 l~~dP~~Rp---ta~e~l~~~~~~~~ 314 (328)
T cd08226 292 LQQDPEKRP---SASSLLSHAFFKQV 314 (328)
T ss_pred ccCCcccCC---CHHHHhhCHHHHHH
Confidence 98 999999 68999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=332.19 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=211.3
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+...+|.+.++||+|+||.||+|... .++..+|+|.+.+.. ......+.+|.++++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 55678999999999999999999753 356789999887542 3445678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED---------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 174 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~---------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~ 174 (450)
....|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997653 48899999999999999999999999999999999999999
Q ss_pred CceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCC
Q 013064 175 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 254 (450)
Q Consensus 175 g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~ 254 (450)
+.+||+|||++......... .......+++.|+|||++.+..++
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY------------------------------------RVGGRTMLPIRWMPPESILYRKFT 202 (280)
T ss_pred CCEEECCCCceeEcCCCcee------------------------------------ecCCCccccccccCHHHhccCCcC
Confidence 99999999998754322100 001124567899999999999999
Q ss_pred ccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 255 MECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 255 ~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
.++|+|||||++|||++ |.+||...........+..+. ....| ..+++.+.+||.+||+ ||.+|+ ++++|+
T Consensus 203 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~Rp---~~~~l~ 275 (280)
T cd05092 203 TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQRM---VIKDIH 275 (280)
T ss_pred chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 99999999999999998 999998877776666665532 22333 4689999999999998 999999 466665
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=347.78 Aligned_cols=242 Identities=23% Similarity=0.402 Sum_probs=208.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.+.+++.||+|-||.||++..+.+. .+|+|.++...+ ..+.+.+|++||.+|+|++||+|++++..++.+||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCC-cccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 45566889999999999999987543 589999976543 3356779999999999999999999999988999999
Q ss_pred eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 118 EYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 118 Ey~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||+.|+|.++|+. .+.+...+...+++||+.|++||+++++|||||-..|||+++++.+||+|||||+......+..
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999999987 5679999999999999999999999999999999999999999999999999999655443221
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~ 274 (450)
. ...--..-|.|||.+....++.++|||||||+||||+| |+.
T Consensus 361 ~-------------------------------------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~ 403 (468)
T KOG0197|consen 361 S-------------------------------------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRV 403 (468)
T ss_pred c-------------------------------------CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCC
Confidence 0 00112456999999999999999999999999999997 999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
||.+.+..+....+.++ ..+ |.+...++++.+++..|+. +|++||+.
T Consensus 404 py~~msn~ev~~~le~G-yRl--p~P~~CP~~vY~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 404 PYPGMSNEEVLELLERG-YRL--PRPEGCPDEVYELMKSCWHEDPEDRPTF 451 (468)
T ss_pred CCCCCCHHHHHHHHhcc-CcC--CCCCCCCHHHHHHHHHHhhCCcccCCCH
Confidence 99999999999988875 334 4445899999999999998 99999954
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.39 Aligned_cols=257 Identities=20% Similarity=0.336 Sum_probs=213.6
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCC-----CEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 106 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 106 (450)
..+..++|++.+.||+|+||.||++..+..+ ..+|+|.+.... .......+.+|+.++..+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3566789999999999999999999986543 689999987542 233456788999999999 89999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEE
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 170 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNIL 170 (450)
+..++.+|+||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999998642 46889999999999999999999999999999999999
Q ss_pred EccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc
Q 013064 171 LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250 (450)
Q Consensus 171 ld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~ 250 (450)
++.++.+||+|||+++.+...... .......+++.|+|||++.+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~ 208 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYY------------------------------------RKTTNGRLPVKWMAPEALFD 208 (293)
T ss_pred EcCCCeEEeCccccccccccccce------------------------------------eccCCCCCCccccCHHHhcc
Confidence 999999999999999875432110 00112345678999999998
Q ss_pred CCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 251 KGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 251 ~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
..++.++|+|||||++|||++ |..||.+....+.+..+... .....| ...+..+.+||.+||. ||.+|| ++.
T Consensus 209 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~ 282 (293)
T cd05053 209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKP--QNCTQELYHLMRDCWHEVPSQRP---TFK 282 (293)
T ss_pred CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCc---CHH
Confidence 999999999999999999997 99999888776666665542 222333 4678999999999998 999999 577
Q ss_pred HHHcC
Q 013064 329 ELKEH 333 (450)
Q Consensus 329 eil~H 333 (450)
+++++
T Consensus 283 eil~~ 287 (293)
T cd05053 283 QLVED 287 (293)
T ss_pred HHHHH
Confidence 88754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=329.79 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=209.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
-+..++|++++.||+|+||.||+|++..+|+ .||+|+++... .......+.+|..++..++||||+++++++.+
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 3567899999999999999999999887776 48999986542 23345678889999999999999999999876
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
. ..+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus 81 ~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred C-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4 578999999999999999764 57999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
....... ......+++.|+|||.+.+..++.++|||||||++||
T Consensus 160 ~~~~~~~------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05109 160 DIDETEY------------------------------------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWE 203 (279)
T ss_pred cccccee------------------------------------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHH
Confidence 4321100 0012245778999999998999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|++ |.+||...........+... .. .+.....+.++.++|.+||. ||.+|| ++.+++.
T Consensus 204 l~t~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~l~~ 263 (279)
T cd05109 204 LMTFGAKPYDGIPAREIPDLLEKG-ER--LPQPPICTIDVYMIMVKCWMIDSECRP---RFRELVD 263 (279)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHCC-Cc--CCCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 998 99999877665555444432 22 22234689999999999998 999999 5777773
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.88 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=212.5
Q ss_pred eEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEecc
Q 013064 44 TLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
+.||+|+||.||+|..... +..||+|++...... ...+.+.+|..++..++|++|+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 889999999765432 25678899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 121 PGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 121 ~gg~L~~~l~~~---------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999876542
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... .......+++.|+|||.+....++.++|+|||||++|+|++
T Consensus 159 ~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (262)
T cd00192 159 DYY------------------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202 (262)
T ss_pred ccc------------------------------------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHh
Confidence 100 00123568999999999998899999999999999999999
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|..||.+.+.......+... .....| ..+++++.++|.+||+ +|.+|| +++++++|
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 260 (262)
T cd00192 203 LGATPYPGLSNEEVLEYLRKG-YRLPKP--EYCPDELYELMLSCWQLDPEDRP---TFSELVER 260 (262)
T ss_pred cCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCChHHHHHHHHHccCCcccCc---CHHHHHHh
Confidence 69999988877777777652 233334 4679999999999998 999999 68888765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=327.19 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=203.5
Q ss_pred eEEeecCceEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKGAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~--~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
+.||+|+||.||+|.. +.+++.+|+|+++... ......+.+.+|..+++.++||||+++++++.. +..++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence 3689999999999864 4678899999986543 233456778999999999999999999998864 56799999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 122 gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
+|+|.+++.+...+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++..+.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~------ 152 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY------ 152 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee------
Confidence 99999999888889999999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCC
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDD 280 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~ 280 (450)
.......+++.|+|||++....++.++|+|||||++|||++ |.+||.+.+
T Consensus 153 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 153 -----------------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred -----------------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00112345789999999988889999999999999999997 999998887
Q ss_pred hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 281 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 281 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
..+....+.+. .....| ..+++++++||.+||. ||.+||+ +++|.
T Consensus 204 ~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~~~~~p~~Rp~---~~~i~ 249 (257)
T cd05116 204 GNEVTQMIESG-ERMECP--QRCPPEMYDLMKLCWTYGVDERPG---FAVVE 249 (257)
T ss_pred HHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHhccCchhCcC---HHHHH
Confidence 77776666543 223444 3689999999999998 9999995 45543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=341.34 Aligned_cols=274 Identities=28% Similarity=0.446 Sum_probs=215.7
Q ss_pred CCeEE-EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchh-----------hHHHHHHHHHHHHhcCCCCeeeEEE
Q 013064 38 DDFEQ-LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-----------QVEHVRSERNLLAEVDSRCIVQLFY 105 (450)
Q Consensus 38 ~~f~~-~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~-----------~~~~~~~E~~il~~l~hp~Iv~l~~ 105 (450)
++|.. .+.||.|+||.||+|+++.+++.||+|++++....... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 47799999999999999999999999998765432211 1124678999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+|..++.+|+||||+. |+|.+++.....++++.+..++.|++.||+|||+.||+||||||+||+++.+|.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGA 264 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGv 264 (450)
................ .. ..+.......+++.|+|||++.+. .++.++|+|||||
T Consensus 167 ~~~~~~~~~~~~~~~~-----------~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 222 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDE-----------TM-------------QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222 (335)
T ss_pred eecccccccccccccc-----------cc-------------cccccccccccccCCCCChhcccCCCCCcHHHHHHHHH
Confidence 8765321110000000 00 000111234689999999999764 4799999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccc---------cccCC---------------CCCCCCHHHHHHHHHhhc-Ccc
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKT---------CLKFP---------------EEPKISDEARDLICHLLC-DVE 319 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~---------~~~~p---------------~~~~~s~~~~dli~~lL~-dp~ 319 (450)
++|+|++|.+||.+.+..+.+..+..... ....| .....+.++.+||.+||. +|.
T Consensus 223 ~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 223 IFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 99999999999998887666655543110 00000 012458889999999998 999
Q ss_pred ccCCCCCHHHHHcCCCcCCC
Q 013064 320 TRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 320 ~R~~~~~~~eil~Hpff~~i 339 (450)
+|+ ++++++.||||++.
T Consensus 303 ~R~---s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 303 ERI---SAKEALKHEYFKSD 319 (335)
T ss_pred hcc---CHHHHhcCcccCCC
Confidence 999 68999999999863
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=336.78 Aligned_cols=268 Identities=28% Similarity=0.449 Sum_probs=210.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------- 109 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------- 109 (450)
+++|++++.||+|+||.||+|.++.+++.+|+|++..... .......+.+|..+++.++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 6899999999999999999999999999999999876532 22233456789999999999999999998754
Q ss_pred -CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
...+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 3457999999965 67777654 45799999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvil 266 (450)
.......... .. ........+..|++.|+|||++.+ ..++.++|+|||||++
T Consensus 165 ~~~~~~~~~~--------------~~-------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 217 (311)
T cd07866 165 YDGPPPNPKG--------------GG-------------GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217 (311)
T ss_pred ccCCCccccc--------------CC-------------cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHH
Confidence 5432111000 00 000011234578999999999865 4589999999999999
Q ss_pred HHHhhCCCCCCCCChhhhhhhhhcccccc---------------------cCC-----CCCCCCHHHHHHHHHhhc-Ccc
Q 013064 267 YEMLIGYPPFCSDDPRITCRKIVNWKTCL---------------------KFP-----EEPKISDEARDLICHLLC-DVE 319 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p-----~~~~~s~~~~dli~~lL~-dp~ 319 (450)
|+|++|.+||.+.+.......+....... ..+ ....+++.+.+||.+||. ||.
T Consensus 218 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 297 (311)
T cd07866 218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297 (311)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence 99999999998877765555443211000 000 012456789999999998 999
Q ss_pred ccCCCCCHHHHHcCCCc
Q 013064 320 TRLGTRGVEELKEHPWF 336 (450)
Q Consensus 320 ~R~~~~~~~eil~Hpff 336 (450)
+|+ ++.+++.||||
T Consensus 298 ~R~---t~~ell~~~~f 311 (311)
T cd07866 298 KRL---TASDALEHPYF 311 (311)
T ss_pred cCc---CHHHHhcCCCC
Confidence 999 68999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=327.06 Aligned_cols=249 Identities=20% Similarity=0.330 Sum_probs=208.6
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
...+|++.+.||+|+||.||+++++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 4578999999999999999999886 466799999875432 23457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999998763 57899999999999999999999999999999999999999999999999998765322100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~ 273 (450)
......++..|+|||++.+..++.++|+|||||++|+|++ |.
T Consensus 157 -------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~ 199 (256)
T cd05059 157 -------------------------------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred -------------------------------------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence 0001234567999999998999999999999999999998 89
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+||.+.+..+....+... .....| ...+..+.+++.+||+ +|.+|| ++.++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---t~~~~l~ 253 (256)
T cd05059 200 MPYERFSNSEVVESVSAG-YRLYRP--KLAPTEVYTIMYSCWHEKPEDRP---AFKKLLS 253 (256)
T ss_pred CCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 999887777666666542 122233 4689999999999998 999999 6788875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.63 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=207.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~--~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 113 (450)
.++|++.+.||+|+||.||+|..+.++. .+|+|.++.. ......+.+.+|..++.++ +||||+++++++.+...+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 3789999999999999999999887775 4688877632 2333456788899999999 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCce
Q 013064 114 YLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 177 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~i 177 (450)
|+||||+++|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999997642 48889999999999999999999999999999999999999999
Q ss_pred EEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccc
Q 013064 178 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 257 (450)
Q Consensus 178 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~ 257 (450)
||+|||++........ .....++..|+|||++.+..++.++
T Consensus 159 kl~dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (297)
T cd05089 159 KIADFGLSRGEEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYTTKS 199 (297)
T ss_pred EECCcCCCccccceec---------------------------------------cCCCCcCccccCchhhccCCCCchh
Confidence 9999999864321100 0012335679999999988999999
Q ss_pred cccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 258 DWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 258 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|+|||||++|||++ |.+||.+.+......++... .....| ..++..+++||.+||. +|.+|| ++++|+..
T Consensus 200 DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~~ 271 (297)
T cd05089 200 DVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKP--RNCDDEVYELMRQCWRDRPYERP---PFAQISVQ 271 (297)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 99999999999997 99999988887777766542 122233 4689999999999998 999999 57777643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=323.94 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=218.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+|++.+.||.|+||.||+|+++.+++.||+|.+.+... .......+..|..+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999987653 23445677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 119 YLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 119 y~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|++|++|..++.+ ...++++.+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999999866 3578999999999999999999999999999999999999999999999999987654320
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 158 --------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~ 199 (256)
T cd08530 158 --------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199 (256)
T ss_pred --------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 113468999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
||...+..+....+.... ....+ ..++.+++++|.+||. +|.+|| ++.+++.||+.
T Consensus 200 p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~p~~ 256 (256)
T cd08530 200 PFEARSMQDLRYKVQRGK-YPPIP--PIYSQDLQNFIRSMLQVKPKLRP---NCDKILASPAV 256 (256)
T ss_pred CCCCCCHHHHHHHHhcCC-CCCCc--hhhCHHHHHHHHHHcCCCcccCC---CHHHHhcCCCC
Confidence 999887766655554421 12222 3688999999999998 999999 68999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=330.69 Aligned_cols=255 Identities=31% Similarity=0.526 Sum_probs=212.3
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--CeEEEEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--DFLYLIM 117 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~~lylVm 117 (450)
|++++.||.|+||.||+|....+|+.+|+|++.+.. ........+.+|..+++.++||||+++++++.+. +.+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998764 3344556788899999999999999999999988 8999999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||+++ +|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+||+++.+|.+||+|||++.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 99975 898888765 57999999999999999999999999999999999999999999999999999865432100
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
......+++.|+|||.+.+ ..++.++|+|||||++|||++|..|
T Consensus 157 -----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p 201 (287)
T cd07840 157 -----------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPI 201 (287)
T ss_pred -----------------------------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCC
Confidence 0112467889999998765 4679999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccc---cCCC-----------------------CCC-CCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 276 FCSDDPRITCRKIVNWKTCL---KFPE-----------------------EPK-ISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~---~~p~-----------------------~~~-~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
|.+.+.......+....... .++. ... .++.+.++|++||+ +|.+|| ++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~ 278 (287)
T cd07840 202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI---SA 278 (287)
T ss_pred CCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc---CH
Confidence 98887766555544311000 0000 012 38899999999998 999999 68
Q ss_pred HHHHcCCCc
Q 013064 328 EELKEHPWF 336 (450)
Q Consensus 328 ~eil~Hpff 336 (450)
++++.||||
T Consensus 279 ~~~l~~~~~ 287 (287)
T cd07840 279 DQALQHEYF 287 (287)
T ss_pred HHHhhCcCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.79 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=211.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..++|++.+.||+|+||.||+|.++.++. .+|+|.+++.. .....+.+.+|..+++.++||||+++++++.+++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 45789999999999999999999875544 79999987543 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|+||||++||+|.+++.+. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999765 46899999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
.... .......+++.|+|||.+.+..++.++|+|||||++|+|++
T Consensus 160 ~~~~-----------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 160 PEAA-----------------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204 (267)
T ss_pred ccee-----------------------------------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence 1100 00011234678999999998889999999999999999886
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|..||.+.+..+....+.+. ...|....+++.+.+++.+||+ +|.+|| ++.+++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~ 260 (267)
T cd05066 205 YGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERP---KFEQIV 260 (267)
T ss_pred CCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCC---CHHHHH
Confidence 99999887776666666543 2334445688999999999998 999999 456665
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.03 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=209.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+...+|.+.+.||+|+||.||+|+.. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 45678999999999999999999864 345679999886443 2334568889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 173 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~ 173 (450)
....++||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999997543 3889999999999999999999999999999999999999
Q ss_pred CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC
Q 013064 174 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253 (450)
Q Consensus 174 ~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y 253 (450)
++.++|+|||++......... .......|++.|+|||++.+..+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 202 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYY------------------------------------RVGGHTMLPIRWMPPESIMYRKF 202 (291)
T ss_pred CCcEEECCCCcccccCCCcee------------------------------------ecCCCCCcceeecChHHhccCCC
Confidence 999999999999765432100 00123567899999999999999
Q ss_pred CccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 254 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 254 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+.++|+|||||++|||++ |.+||...+..+....+.... ....+ ...+..+.+||.+||. ||.+||+ +.+++
T Consensus 203 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt---~~~v~ 276 (291)
T cd05094 203 TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLERP--RVCPKEVYDIMLGCWQREPQQRLN---IKEIY 276 (291)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCCC--ccCCHHHHHHHHHHcccChhhCcC---HHHHH
Confidence 999999999999999998 999998887776666655422 12222 3578999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=341.23 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=208.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-------
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------- 110 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------- 110 (450)
.+|++.+.||.|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 68999999999999999999999999999999986553 24567788999999999999999999876654
Q ss_pred -------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeec
Q 013064 111 -------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDF 182 (450)
Q Consensus 111 -------~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DF 182 (450)
..+|+||||++ ++|..++. .+.+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 46899999997 58888775 457999999999999999999999999999999999999984 567899999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccc
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWS 261 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWS 261 (450)
|++..+...... .......+|++.|+|||++.+ ..++.++|+||
T Consensus 160 g~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS 204 (342)
T cd07854 160 GLARIVDPHYSH-----------------------------------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204 (342)
T ss_pred ccceecCCcccc-----------------------------------ccccccccccccccCHHHHhCccccCchhhHHH
Confidence 998765332100 000112468999999998764 56889999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhhhhhhhccc-----------------------ccccCC---CCCCCCHHHHHHHHHhh
Q 013064 262 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWK-----------------------TCLKFP---EEPKISDEARDLICHLL 315 (450)
Q Consensus 262 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----------------------~~~~~p---~~~~~s~~~~dli~~lL 315 (450)
|||++|+|++|..||.+.+..+....+.... .....| ..+.++.++++||.+||
T Consensus 205 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 284 (342)
T cd07854 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL 284 (342)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHh
Confidence 9999999999999998776555444433210 000000 01257899999999999
Q ss_pred c-CccccCCCCCHHHHHcCCCcCCC
Q 013064 316 C-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 316 ~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+ ||.+|+ ++++++.||||+.+
T Consensus 285 ~~dP~~R~---t~~ell~h~~~~~~ 306 (342)
T cd07854 285 TFNPMDRL---TAEEALMHPYMSCY 306 (342)
T ss_pred CCCchhcc---CHHHHhCCCccccc
Confidence 9 999999 68999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=302.43 Aligned_cols=258 Identities=31% Similarity=0.558 Sum_probs=218.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
..|...+.||+|.||+|++++++.|++.+|+|.++-.. ...+......+|+-+|+.++|.|||+|+++...++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35667789999999999999999999999999987654 23445677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||. -+|..+... ++.++.+.++.++.|++.+|.|+|+.++.||||||.|+||+.+|.+||+|||+++-+.-..
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv---- 155 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---- 155 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce----
Confidence 9994 477777755 5789999999999999999999999999999999999999999999999999998765331
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhcccccc-ccccCCCccchhhhcc-CCCCccccccchhHHHHHHh-hCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAY-STVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML-IGY 273 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml-~G~ 273 (450)
+++ .-+-|.+|.+|.++.+ +-|+.+.|+||.|||+.|+. .|+
T Consensus 156 -----------------------------------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagr 200 (292)
T KOG0662|consen 156 -----------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_pred -----------------------------------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCC
Confidence 011 2477999999999987 56899999999999999998 599
Q ss_pred CCCCCCChhhhhhhhhc---------ccccccCCCC----------------CCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 274 PPFCSDDPRITCRKIVN---------WKTCLKFPEE----------------PKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~---------~~~~~~~p~~----------------~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+.|.|.+..+...+|.. |..--..|+. +.++..-+||+++||. +|.+|+ ++
T Consensus 201 plfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri---sa 277 (292)
T KOG0662|consen 201 PLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI---SA 277 (292)
T ss_pred CCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc---CH
Confidence 99999999988888863 3222222221 3456678999999995 999999 78
Q ss_pred HHHHcCCCcCCC
Q 013064 328 EELKEHPWFRGI 339 (450)
Q Consensus 328 ~eil~Hpff~~i 339 (450)
++.++||||.+.
T Consensus 278 eaalqhpyf~d~ 289 (292)
T KOG0662|consen 278 EAALQHPYFSDF 289 (292)
T ss_pred HHHhcCcccccc
Confidence 999999999864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.95 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=207.0
Q ss_pred eEEEeEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe----
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF---- 112 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~---- 112 (450)
|.+.+.||+|+||.||.|....+ +..||+|.++... ........+.+|..+++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987653 4789999987543 234456788999999999999999999998765443
Q ss_pred --EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 113 --LYLIMEYLPGGDIMTLLMRE------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 113 --lylVmEy~~gg~L~~~l~~~------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999988542 3689999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
++........ .......+++.|+|||++.+..++.++|||||||
T Consensus 160 ~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~ 203 (273)
T cd05035 160 SKKIYSGDYY------------------------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 203 (273)
T ss_pred eeeccccccc------------------------------------cccccccCCccccCHhhcccCCCCcccchHHHHH
Confidence 9865432100 0011134577899999998889999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 265 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 265 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++|||++ |.+||.+....+.+..+... .....| ..+++.+.++|.+||. ||.+|| ++.+++++
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~e~~~~ 268 (273)
T cd05035 204 TMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQP--EDCLDELYDLMYSCWRADPKDRP---TFTKLREV 268 (273)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999 99999888777777666543 223334 4789999999999998 999999 57777653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=332.89 Aligned_cols=254 Identities=19% Similarity=0.317 Sum_probs=213.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t-----~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+.+++|.+++.||+|+||.||++....+ ++.+|+|+++... .....+.+.+|..++..++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 5667899999999999999999987643 5789999997542 23345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 173 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~ 173 (450)
...+++++||+++++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998532 35888899999999999999999999999999999999999
Q ss_pred CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC
Q 013064 174 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253 (450)
Q Consensus 174 ~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y 253 (450)
++.+||+|||+++........ .......+++.|+|||++.+..+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY------------------------------------KLMGNSLLPIRWMSPEAIMYGKF 203 (283)
T ss_pred CCceEecccccccccccchhe------------------------------------eeccCccCCccccCHHHHhcCCC
Confidence 999999999998865432100 01123457889999999988889
Q ss_pred CccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 254 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 254 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+.++|||||||++|||++ |..||.+.+..+....+.... ....| ..++..+.+|+.+||. +|.+|| ++.+|+
T Consensus 204 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~RP---~~~~i~ 277 (283)
T cd05091 204 SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCP--DDCPAWVYTLMLECWNEFPSRRP---RFKDIH 277 (283)
T ss_pred CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhCCCcccCC---CHHHHH
Confidence 999999999999999998 999999888877777776532 22233 4689999999999998 999999 577877
Q ss_pred c
Q 013064 332 E 332 (450)
Q Consensus 332 ~ 332 (450)
.
T Consensus 278 ~ 278 (283)
T cd05091 278 S 278 (283)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=328.03 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=212.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
...+|++++.||.|+||.||+|..+. ++.+|+|++.+... .....+..|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34689999999999999999999987 88999999876542 234568889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 116 IMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999763 4689999999999999999999999999999999999999999999999999986533210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
. ..+..+++.|+|||++.+..++.++|+|||||++|+|++ |
T Consensus 160 ~--------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g 201 (261)
T cd05148 160 L--------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201 (261)
T ss_pred c--------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 0 112346778999999998899999999999999999998 8
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
..||.+.+..+.+..+... ...+.....++.+.++|.+||. ||.+||+ +.+|+
T Consensus 202 ~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~l~ 255 (261)
T cd05148 202 QVPYPGMNNHEVYDQITAG---YRMPCPAKCPQEIYKIMLECWAAEPEDRPS---FKALR 255 (261)
T ss_pred CCCCCcCCHHHHHHHHHhC---CcCCCCCCCCHHHHHHHHHHcCCCchhCcC---HHHHH
Confidence 9999988877777777642 2233335789999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=324.16 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=210.3
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||+++... +..+|+|.+..... ..+.+.+|..+++.++||||+++++++.+...+|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 356789999999999999999998754 44599999875432 2356788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999999999764 4789999999999999999999999999999999999999999999999999876533210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
. ......++..|+|||++.+..++.++|+|||||++|+|++ |
T Consensus 156 ~-------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g 198 (256)
T cd05113 156 T-------------------------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198 (256)
T ss_pred e-------------------------------------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCC
Confidence 0 0011245678999999998889999999999999999998 9
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
..||...+.......+.+... ...+ ...+..+++++.+||. ||.+|| ++.+|+.+
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~ll~~ 254 (256)
T cd05113 199 KMPYERFNNSETVEKVSQGLR-LYRP--HLASEKVYAIMYSCWHEKAEERP---TFQQLLSS 254 (256)
T ss_pred CCCcCcCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcCCCcccCC---CHHHHHHh
Confidence 999988777777777765322 1222 3578999999999998 999999 67888754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=333.75 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=209.9
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLF 104 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~-------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 104 (450)
..+..++|.+.+.||+|+||.||+|++.. ++..+|+|.+++.. .......+..|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 34556899999999999999999998743 33569999997542 233456788899999999 799999999
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCc
Q 013064 105 YSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 168 (450)
Q Consensus 105 ~~f~~~~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeN 168 (450)
+++.+...+|+||||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997642 47889999999999999999999999999999999
Q ss_pred EEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 169 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 169 ILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
||++.++.+||+|||+++........ .......+++.|+|||++
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~ 214 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY------------------------------------KKTTNGRLPVKWMAPEAL 214 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh------------------------------------hccccCCCccceeChHHh
Confidence 99999999999999998765321000 000112356789999999
Q ss_pred ccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 249 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 249 ~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
.+..++.++|+|||||++|+|++ |..||.+.+..+....+... .....| ..++.++++||.+||. +|.+|| +
T Consensus 215 ~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s 288 (307)
T cd05098 215 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCWHAVPSQRP---T 288 (307)
T ss_pred ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcccChhhCc---C
Confidence 98889999999999999999998 89999887766666555432 223333 4689999999999998 999999 5
Q ss_pred HHHHHc
Q 013064 327 VEELKE 332 (450)
Q Consensus 327 ~~eil~ 332 (450)
+.++++
T Consensus 289 ~~evl~ 294 (307)
T cd05098 289 FKQLVE 294 (307)
T ss_pred HHHHHH
Confidence 677764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=323.42 Aligned_cols=249 Identities=21% Similarity=0.353 Sum_probs=209.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++.+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|..+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 55678999999999999999999875 456799999876432 2456788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997654 78999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
... .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 158 ~~~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~ 200 (261)
T cd05068 158 YEA-------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred ccc-------------------------------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhc
Confidence 000 001233468999999998899999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|..||.+.+.......+... ...+.....+..+.++|.+||. +|.+||. +.++.
T Consensus 201 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~l~ 255 (261)
T cd05068 201 GRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPKELYDIMLDCWKEDPDDRPT---FETLQ 255 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHhhcCcccCCC---HHHHH
Confidence 99999988877777666542 1223334688999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.10 Aligned_cols=253 Identities=29% Similarity=0.528 Sum_probs=212.6
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|+....||+|+||.||++..+.+|+.+|+|.+... .......+.+|..+++.++||||+++++.|.+.+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 33456899999999999999999999999987532 223456688899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccc
Q 013064 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 120 ~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
+++++|.+++. .+.+++..++.++.|++.||+|||+.|++||||+|+||+++.+|+++|+|||++........
T Consensus 99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------ 171 (292)
T cd06657 99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------ 171 (292)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc------
Confidence 99999998764 45689999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 279 (450)
.....+||+.|+|||.+.+..++.++|+||+||++|+|++|.+||.+.
T Consensus 172 --------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 172 --------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred --------------------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 011357899999999998888899999999999999999999999887
Q ss_pred ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 280 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 280 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+.......+... ....++....+++.+.++|.+||. ||.+|+ ++.+++.||||..
T Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---~~~~ll~~~~~~~ 275 (292)
T cd06657 220 PPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAK 275 (292)
T ss_pred CHHHHHHHHHhh-CCcccCCcccCCHHHHHHHHHHHhCCcccCc---CHHHHhcChHHhc
Confidence 665554444321 112222224678999999999998 999999 6899999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.86 Aligned_cols=261 Identities=28% Similarity=0.458 Sum_probs=211.6
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
...+..++|++.+.||+|+||.||+|.+..+++.||+|.+++... ......+..|..++... .||||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 346788999999999999999999999999999999999976532 22334556677666666 599999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
..+|+||||++ +.|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++..+
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999999985 577777655 4579999999999999999999997 69999999999999999999999999998765
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC----CCccccccchhH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWWSLGA 264 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~----y~~~~DiWSlGv 264 (450)
..... .....|++.|+|||.+.+.. ++.++|+|||||
T Consensus 166 ~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 206 (296)
T cd06618 166 VDSKA---------------------------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI 206 (296)
T ss_pred cCCCc---------------------------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHH
Confidence 32210 01236889999999997553 789999999999
Q ss_pred HHHHHhhCCCCCCCCCh-hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 265 IMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|+|++|+.||..... .+.+.++.... ....+....++.++.+||.+||. ||.+|| ++++++.||||..
T Consensus 207 il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 278 (296)
T cd06618 207 SLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRP---KYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhc
Confidence 99999999999976332 33444444322 12233333578999999999998 999999 6899999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=336.71 Aligned_cols=261 Identities=29% Similarity=0.404 Sum_probs=209.2
Q ss_pred CeEEEeEEeecCceEEEEEEEcCC--CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEc----CC
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTT--GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD----SD 111 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t--~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~----~~ 111 (450)
+|++.+.||+|+||.||+|+...+ ++.||+|.+.... ........+.+|..+++.+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999988 9999999986532 2223456678899999998 69999999987532 35
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|++|||+. ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999985 689999988889999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
.... .......+||+.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 159 ~~~~----------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~ 204 (332)
T cd07857 159 PGEN----------------------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204 (332)
T ss_pred cccc----------------------------------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 1100 001123579999999998865 57899999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhccc--------------------------ccccCC-CCCCCCHHHHHHHHHhhc-CccccC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWK--------------------------TCLKFP-EEPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~--------------------------~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+|.+||.+.+.......++..- ....++ ..+..+..+.+||.+||. ||.+|+
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 284 (332)
T cd07857 205 GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284 (332)
T ss_pred hCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC
Confidence 9999998766443333222110 000111 113468899999999998 999999
Q ss_pred CCCCHHHHHcCCCcCC
Q 013064 323 GTRGVEELKEHPWFRG 338 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~ 338 (450)
++.+++.||||+.
T Consensus 285 ---t~~~ll~~~~~~~ 297 (332)
T cd07857 285 ---SVEEALEHPYLAI 297 (332)
T ss_pred ---CHHHHhcChhhhh
Confidence 6899999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=322.63 Aligned_cols=244 Identities=24% Similarity=0.420 Sum_probs=205.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE-EcCCeE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF-QDSDFL 113 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f-~~~~~l 113 (450)
+..++|++.+.||+|+||.||++.. .|..+|+|.++... ..+.+.+|..+++.++|++|+++++++ .+++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4567999999999999999999976 47789999986432 345688999999999999999999875 566789
Q ss_pred EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999997654 4889999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
..+..++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 156 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 156 -----------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred -----------------------------------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh
Confidence 012345678999999998899999999999999999997
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|.+||...+.......+... .....+ ..+++.++++|.+||. +|.+|| ++.++++
T Consensus 195 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 251 (256)
T cd05082 195 FGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPVVYDVMKQCWHLDAATRP---SFLQLRE 251 (256)
T ss_pred CCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999887776666665442 122222 4689999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=332.45 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=210.3
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 105 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~-------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 105 (450)
.+..++|.+.+.||+|+||.||+|++.. .+..+|+|.+++.. .......+..|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3556799999999999999999998642 34579999987542 234566788999999999 6999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
++.+...+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999763 3488899999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.++.+||+|||+++........ .......+++.|+|||++.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~ 209 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY------------------------------------KKTSNGRLPVKWMAPEALF 209 (314)
T ss_pred EEcCCCcEEEccccccccccccccc------------------------------------cccccCCCCccccCHHHHc
Confidence 9999999999999999865432100 0001123557899999999
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+..++.++|||||||++|+|++ |..||.+.+..+.+..+.... ....| ..++.++++||.+||. +|.+|| ++
T Consensus 210 ~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~Rp---s~ 283 (314)
T cd05099 210 DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-RMDKP--SNCTHELYMLMRECWHAVPTQRP---TF 283 (314)
T ss_pred cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCc---CH
Confidence 8899999999999999999998 999998887777777665532 23333 3678899999999998 999999 46
Q ss_pred HHHHc
Q 013064 328 EELKE 332 (450)
Q Consensus 328 ~eil~ 332 (450)
.++++
T Consensus 284 ~~ll~ 288 (314)
T cd05099 284 KQLVE 288 (314)
T ss_pred HHHHH
Confidence 66653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=333.33 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=213.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
..|..++.||+|+||.||+++++.+++.+|+|.+.............+.+|..+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34778899999999999999999999999999987544334445567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||+. |+|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.+|.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 9996 577776644 456899999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhhCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....|++.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 169 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 211 (308)
T cd06634 169 -------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211 (308)
T ss_pred -------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence 1357899999999985 345788999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
.||...+.......+..... ...+ ...++..+++||.+||. +|.+|| +++++++|||+...
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~li~~cl~~~P~~Rp---~~~~ll~~~~~~~~ 273 (308)
T cd06634 212 PPLFNMNAMSALYHIAQNES-PALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRE 273 (308)
T ss_pred CCCccccHHHHHHHHhhcCC-CCcC-cccccHHHHHHHHHHhhCCcccCC---CHHHHhhCcccccc
Confidence 99987665555444443211 1111 23688999999999998 999999 68999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=323.43 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=212.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+..++|+..+.||+|+||.||+|+.+.+++ .+|+|.++... .....+.+..|..++..++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456799999999999999999999887665 79999986542 2334567888999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..|+||||+++|+|..++... +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999998764 5789999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
..... ........++.|+|||++.+..++.++|+|||||++|||+
T Consensus 160 ~~~~~-----------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell 204 (268)
T cd05063 160 DPEGT-----------------------------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204 (268)
T ss_pred ccccc-----------------------------------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence 21100 0001123456799999999888999999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+ |..||...+..+....|... ...|.....+..+.+|+.+||. +|.+|| ++.+|++
T Consensus 205 ~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~i~~ 262 (268)
T cd05063 205 SFGERPYWDMSNHEVMKAINDG---FRLPAPMDCPSAVYQLMLQCWQQDRARRP---RFVDIVN 262 (268)
T ss_pred hCCCCCCCcCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 7 99999888777777766542 2334334678999999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.78 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=205.6
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------D 111 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~--~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------~ 111 (450)
|.+.+.||+|+||.||+++...++. .+|+|.++... ......+.+..|..+++.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999987776 59999987643 3445577889999999999999999999876421 2
Q ss_pred eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~------~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
..++||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57999999999999988742 234899999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
+.+....... ......+++.|+|||++.+..++.++|+|||||+
T Consensus 160 ~~~~~~~~~~------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~i 203 (272)
T cd05075 160 KKIYNGDYYR------------------------------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVT 203 (272)
T ss_pred cccCccccee------------------------------------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHH
Confidence 8754321000 0012356788999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 266 MYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 266 lyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+|||++ |.+||.+.........+.+.. ....+ ..++..++++|.+||+ ||.+|| ++.+|+++
T Consensus 204 l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 267 (272)
T cd05075 204 MWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQP--PDCLDGLYSLMSSCWLLNPKDRP---SFETLRCE 267 (272)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 999999 899998877777666666532 22223 4688999999999998 999999 57777653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=336.64 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=205.7
Q ss_pred eEEeec--CceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G--~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
.+||+| ++|.||+++...+++.||+|++++.. ......+.+..|+.+++.++||||++++++|.+++..|++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 445554 56778888888899999999998653 234567889999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccc
Q 013064 122 GGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 122 gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
+|+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~--- 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR--- 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc---
Confidence 99999999763 4689999999999999999999999999999999999999999999999999876543211000
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHHHhhCCCCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
..........++..|+|||++.+ .+|+.++|+||+||++|||++|.+||.
T Consensus 160 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~ 211 (314)
T cd08216 160 ----------------------------VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211 (314)
T ss_pred ----------------------------ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 00001123568889999999976 468999999999999999999999998
Q ss_pred CCChhhhhhhhhccc------------------------------ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 278 SDDPRITCRKIVNWK------------------------------TCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~------------------------------~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
............... .....+....++.++.+||.+||+ ||.+|+ +
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t 288 (314)
T cd08216 212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP---S 288 (314)
T ss_pred CCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc---C
Confidence 755433221111100 000001112346789999999999 999999 6
Q ss_pred HHHHHcCCCcCCC
Q 013064 327 VEELKEHPWFRGI 339 (450)
Q Consensus 327 ~~eil~Hpff~~i 339 (450)
++++++||||+.+
T Consensus 289 ~~~ll~~p~~~~~ 301 (314)
T cd08216 289 ASQLLNHSFFKQC 301 (314)
T ss_pred HHHHhcCchHhhh
Confidence 8999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.15 Aligned_cols=260 Identities=32% Similarity=0.496 Sum_probs=211.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC---
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--- 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--- 111 (450)
...++|++.+.||+|+||.||+|.++.+|+.||+|+++.... .......+.+|..+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456899999999999999999999999999999999976432 2334456778999999999999999999987755
Q ss_pred -------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecc
Q 013064 112 -------FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183 (450)
Q Consensus 112 -------~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFG 183 (450)
.+|+||||+++ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999976 677776653 479999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccch
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSL 262 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSl 262 (450)
++......... ......+++.|+|||++.+ ..++.++|+|||
T Consensus 162 ~~~~~~~~~~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 162 LARLYNSEESR-------------------------------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred ccccccCCccc-------------------------------------ccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 99865432100 0012356889999998865 457899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhccc---ccccC-----------------------CCCCCCCHHHHHHHHHhhc
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWK---TCLKF-----------------------PEEPKISDEARDLICHLLC 316 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~---~~~~~-----------------------p~~~~~s~~~~dli~~lL~ 316 (450)
||++|+|++|++||...+..+.+..+.... ....+ .....++..+.+||.+||.
T Consensus 205 G~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 284 (302)
T cd07864 205 GCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLT 284 (302)
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHcc
Confidence 999999999999998776655554443210 00000 0112478999999999998
Q ss_pred -CccccCCCCCHHHHHcCCCc
Q 013064 317 -DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 317 -dp~~R~~~~~~~eil~Hpff 336 (450)
||.+|| ++++++.||||
T Consensus 285 ~~P~~Rp---~~~~il~~~~~ 302 (302)
T cd07864 285 LDPSKRC---TAEEALNSPWL 302 (302)
T ss_pred CChhhCC---CHHHHhcCCCC
Confidence 999999 68999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=336.01 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=210.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SDFLY 114 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~~~ly 114 (450)
..++|++++.||.|+||.||+|.++.+|+.||+|++.+.. ......+.+..|..+++.++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3478999999999999999999999999999999987643 233445678899999999999999999999976 56899
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+||||+ +++|..++. ...+++..+..++.||+.||.|||++||+||||+|.|||++.+|.++|+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999998 668888775 456899999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~ 273 (450)
..+.++++.|+|||++.+ ..++.++|+|||||++|+|++|.
T Consensus 162 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 203 (328)
T cd07856 162 --------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203 (328)
T ss_pred --------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence 113578899999999865 67899999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcc------------------------cccccCCC---CCCCCHHHHHHHHHhhc-CccccCCCC
Q 013064 274 PPFCSDDPRITCRKIVNW------------------------KTCLKFPE---EPKISDEARDLICHLLC-DVETRLGTR 325 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~------------------------~~~~~~p~---~~~~s~~~~dli~~lL~-dp~~R~~~~ 325 (450)
+||.+.+.......+.+. ......|. .+.+++.+.++|++||+ +|.+|+
T Consensus 204 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~--- 280 (328)
T cd07856 204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI--- 280 (328)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC---
Confidence 999876653322211110 00001110 13578999999999998 999999
Q ss_pred CHHHHHcCCCcCC
Q 013064 326 GVEELKEHPWFRG 338 (450)
Q Consensus 326 ~~~eil~Hpff~~ 338 (450)
++++++.||||..
T Consensus 281 t~~ell~~~~~~~ 293 (328)
T cd07856 281 SAAEALAHPYLAP 293 (328)
T ss_pred CHHHHhcCCcccc
Confidence 6899999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=326.01 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=212.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCC-----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t-----~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+..++|++++.||+|+||.||+|+.+.+ .+.+|+|.+.... .....+.+.+|..+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 3457999999999999999999997643 4679999886532 22345678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEe
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~---------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~ 180 (450)
....|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+++++|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 999999999999999999998765 69999999999999999999999999999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcccccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiW 260 (450)
|||++......... ......+++.|+|||.+.+..++.++|+|
T Consensus 160 ~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~ 202 (275)
T cd05046 160 LLSLSKDVYNSEYY-------------------------------------KLRNALIPLRWLAPEAVQEDDFSTKSDVW 202 (275)
T ss_pred ccccccccCccccc-------------------------------------ccCCceeEEeecChhhhccCCCCchhhHH
Confidence 99998754321000 01134678889999999888899999999
Q ss_pred chhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 261 SLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 261 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
||||++|+|++ |..||.+.........+.... ...+....++..+.++|.+||. +|.+|+ ++.+++.+
T Consensus 203 slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~~~l~~ 272 (275)
T cd05046 203 SFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--LELPVPEGCPSRLYKLMTRCWAVNPKDRP---SFSELVSA 272 (275)
T ss_pred HHHHHHHHHHhCCCCCccccchHHHHHHHHcCC--cCCCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHH
Confidence 99999999998 889998776666666655432 2233334688999999999998 999999 67887753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=332.23 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=213.9
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEc-------CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK-------TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 103 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~-------~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 103 (450)
+..+..++|.+.+.||+|+||.||+|+.. .++..+|+|.+.+.. .......+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34577889999999999999999999853 234579999987542 234457788999999999 89999999
Q ss_pred EEEEEcCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCC
Q 013064 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 167 (450)
Q Consensus 104 ~~~f~~~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpe 167 (450)
++++.+...+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999764 24777889999999999999999999999999999
Q ss_pred cEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhh
Q 013064 168 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 247 (450)
Q Consensus 168 NILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEv 247 (450)
|||++.++.+||+|||+++........ .......+++.|+|||+
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~ 210 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY------------------------------------KKTTNGRLPVKWMAPEA 210 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc------------------------------------ccccCCCCCceeeCchh
Confidence 999999999999999999866432100 00112456788999999
Q ss_pred hccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 013064 248 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 325 (450)
Q Consensus 248 l~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~ 325 (450)
+.+..|+.++|+|||||++|+|++ |..||.+.+..+....+.... ....| ...+..+++||.+||. +|.+||
T Consensus 211 ~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rp--- 284 (304)
T cd05101 211 LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAIPSHRP--- 284 (304)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcccChhhCC---
Confidence 998889999999999999999998 899998888777776665432 22333 4688999999999998 999999
Q ss_pred CHHHHHcC
Q 013064 326 GVEELKEH 333 (450)
Q Consensus 326 ~~~eil~H 333 (450)
++.++++.
T Consensus 285 s~~e~l~~ 292 (304)
T cd05101 285 TFKQLVED 292 (304)
T ss_pred CHHHHHHH
Confidence 57777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.01 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=211.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+-++....+..||+|+.|.||+++. .++.||||+++.- -..++.-|++|+||||+.+.+++...-.+
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 45566666788999999999999987 4678999987532 23467779999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+|||||+.|-|...|+....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++.+....
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S- 266 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS- 266 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988764431
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
...+++||..|||||+|++++.+.++|||||||+|||||||.
T Consensus 267 --------------------------------------TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~E 308 (904)
T KOG4721|consen 267 --------------------------------------TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGE 308 (904)
T ss_pred --------------------------------------hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcC
Confidence 123689999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hp 334 (450)
.||.+-+...++--+-. ..+.+|-+...++.++=||+.||. .|.+|| ++.+|+.|-
T Consensus 309 iPYkdVdssAIIwGVGs--NsL~LpvPstcP~GfklL~Kqcw~sKpRNRP---SFrqil~Hl 365 (904)
T KOG4721|consen 309 IPYKDVDSSAIIWGVGS--NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP---SFRQILLHL 365 (904)
T ss_pred CCccccchheeEEeccC--CcccccCcccCchHHHHHHHHHHhcCCCCCc---cHHHHHHHH
Confidence 99987665443322222 234455556889999999999998 999999 678888873
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=323.12 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=206.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++.+.||+|+||.||+|++..++ .+|+|++++... ..+.+.+|+.+++.++||||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 44578999999999999999999887664 599999976432 23567889999999999999999998854 5689
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||+++|+|.+++.+. ..++++.+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999763 458999999999999999999999999999999999999999999999999997654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ......++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~ 199 (262)
T cd05071 157 YT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199 (262)
T ss_pred cc-------------------------------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcC
Confidence 00 0112356788999999988889999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|.+||.+....+....+.... ..+....++..+.+||.+||. ||.+||+ +.+++
T Consensus 200 g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~~~ 254 (262)
T cd05071 200 GRVPYPGMVNREVLDQVERGY---RMPCPPECPESLHDLMCQCWRKEPEERPT---FEYLQ 254 (262)
T ss_pred CCCCCCCCChHHHHHHHhcCC---CCCCccccCHHHHHHHHHHccCCcccCCC---HHHHH
Confidence 899998887777766665421 223234688999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=321.72 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=211.9
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
.+++|.+.+.||+|+||.||+|..+.+++ .||+|++++.. .......+..|..+++.++||||+++++++.++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 46789999999999999999999987765 59999987542 34456778999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|+||||+++|+|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999999876 456899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
..... ........++..|+|||.+.+..++.++|+|||||++|||++
T Consensus 160 ~~~~~---------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~ 206 (269)
T cd05065 160 TSDPT---------------------------------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206 (269)
T ss_pred ccccc---------------------------------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhc
Confidence 10000 000001122467999999998999999999999999999886
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||.+.+.......+... ...|....++..+.+++.+||. +|.+|| ++++|+.
T Consensus 207 ~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 263 (269)
T cd05065 207 YGERPYWDMSNQDVINAIEQD---YRLPPPMDCPTALHQLMLDCWQKDRNARP---KFGQIVS 263 (269)
T ss_pred CCCCCCCCCCHHHHHHHHHcC---CcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999888777666666432 2334334688999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=319.84 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=210.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++.+.||+|+||.||+|... .++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356789999999999999999999876 457799999876432 345688899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||+++++|.+++... ..++++.+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999764 36899999999999999999999999999999999999999999999999998865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
.... .....++..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 157 ~~~~-------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t 199 (261)
T cd05034 157 EYTA-------------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199 (261)
T ss_pred hhhh-------------------------------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHh
Confidence 1000 001235678999999998889999999999999999998
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|+.||.+.+......++... ...+.....+.++.+++.+||+ +|.+|| +++++.
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~ 255 (261)
T cd05034 200 YGRVPYPGMTNREVLEQVERG---YRMPRPPNCPEELYDLMLQCWDKDPEERP---TFEYLQ 255 (261)
T ss_pred CCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHH
Confidence 99999888777777766542 2223334678999999999998 999999 456654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.62 Aligned_cols=265 Identities=32% Similarity=0.477 Sum_probs=213.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC--Ce
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS--DF 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~--~~ 112 (450)
-.++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+.. ........+.+|..+++.+ +||||++++++|... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3578999999999999999999999999999999986532 2233445677899999999 999999999998754 47
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||||++ ++|..++... .+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999997 5999888765 78999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~ 271 (450)
... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 162 ~~~---------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t 208 (337)
T cd07852 162 ENP---------------------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208 (337)
T ss_pred ccc---------------------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh
Confidence 100 0001123579999999998865 567899999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhccccc-----------------------ccC---C-CCCCCCHHHHHHHHHhhc-CccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTC-----------------------LKF---P-EEPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~-----------------------~~~---p-~~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
|++||.+........++...... ... . ..+.++.++.+||.+||. ||.+|+
T Consensus 209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp- 287 (337)
T cd07852 209 GKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL- 287 (337)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc-
Confidence 99999877655544443221100 000 0 012478999999999998 999999
Q ss_pred CCCHHHHHcCCCcCCC
Q 013064 324 TRGVEELKEHPWFRGI 339 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i 339 (450)
++.+++.||||+.+
T Consensus 288 --s~~~il~~~~~~~~ 301 (337)
T cd07852 288 --TAEEALEHPYVAQF 301 (337)
T ss_pred --CHHHHhhChhhhhh
Confidence 68999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=326.80 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=209.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+..++|++++.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 456899999999999999999999753 67889999987543 22344668889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED----------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPD 167 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~----------------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpe 167 (450)
+..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 999999999999999999997532 4788889999999999999999999999999999
Q ss_pred cEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhh
Q 013064 168 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 247 (450)
Q Consensus 168 NILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEv 247 (450)
||+++.++.++|+|||++.......... ......+++.|+|||+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~ 203 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYK------------------------------------ASENDAIPIRWMPPES 203 (288)
T ss_pred heEecCCCceEECccccceecccCcccc------------------------------------ccCCCccChhhcCHHH
Confidence 9999999999999999987543221000 0012345678999999
Q ss_pred hccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 013064 248 LLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 325 (450)
Q Consensus 248 l~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~ 325 (450)
+.+..++.++|+|||||++|||++ |..||.+.+..+....+.... ....| ..++.++.+||.+||+ ||.+||+
T Consensus 204 ~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt-- 278 (288)
T cd05050 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCP--DNCPLELYNLMRLCWSKLPSDRPS-- 278 (288)
T ss_pred HhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcccCcccCCC--
Confidence 998999999999999999999997 889998888777776665432 12223 3678999999999998 9999994
Q ss_pred CHHHHH
Q 013064 326 GVEELK 331 (450)
Q Consensus 326 ~~~eil 331 (450)
++|++
T Consensus 279 -~~el~ 283 (288)
T cd05050 279 -FASIN 283 (288)
T ss_pred -HHHHH
Confidence 56654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=319.77 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=201.8
Q ss_pred eEEeecCceEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEecc
Q 013064 44 TLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++.. +..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876555 78999999866532 345678899999999999999999998764 4689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccc
Q 013064 121 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200 (450)
Q Consensus 121 ~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~ 200 (450)
++|+|.+++.+...+++..+..++.|++.||.|||..|++||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~----- 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY----- 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-----
Confidence 999999999888889999999999999999999999999999999999999999999999999988654321100
Q ss_pred ccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCC
Q 013064 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSD 279 (450)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~ 279 (450)
.......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...
T Consensus 153 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 153 ------------------------------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred ------------------------------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 00001234578999999998899999999999999999997 99999887
Q ss_pred ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 280 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 280 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+..+....+.... ....| ..++..++++|.+||. +|.+|| ++.+++
T Consensus 203 ~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~Rp---~~~~l~ 249 (257)
T cd05060 203 KGAEVIAMLESGE-RLPRP--EECPQEIYSIMLSCWKYRPEDRP---TFSELE 249 (257)
T ss_pred CHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHH
Confidence 7766665555432 22333 4688999999999998 999999 455554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=343.86 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=209.8
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYS 106 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~ 106 (450)
..+..++|.+.+.||+|+||.||+|++. .+++.||+|+++... .......+..|..+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3456678999999999999999999964 355689999997542 2334557889999999997 9999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcC-----------------------------------------------------
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRED----------------------------------------------------- 133 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~----------------------------------------------------- 133 (450)
+++.+.+|+|||||+||+|.+++.+.+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCc
Q 013064 134 ---------------------------------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 168 (450)
Q Consensus 134 ---------------------------------------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeN 168 (450)
.+++..+..|+.||+.||+|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35677788899999999999999999999999999
Q ss_pred EEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 169 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 169 ILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
||++.++.+||+|||+++........ ....+.+|++.|+|||++
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY------------------------------------ISKGSTFLPLKWMAPESI 313 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc------------------------------------ccCCCcCCCCceeChHHh
Confidence 99999999999999999865322100 001134688999999999
Q ss_pred ccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 249 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 249 ~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
.+..++.++|+|||||++|||++ |..||......+.....+.....+..| ..++.++.+||.+||. +|.+|| +
T Consensus 314 ~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~RP---s 388 (401)
T cd05107 314 FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQKCWEEKFEIRP---D 388 (401)
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCChhHCc---C
Confidence 98889999999999999999998 899998765555444444322223333 4689999999999998 999999 5
Q ss_pred HHHHHc
Q 013064 327 VEELKE 332 (450)
Q Consensus 327 ~~eil~ 332 (450)
+.+|+.
T Consensus 389 ~~ell~ 394 (401)
T cd05107 389 FSQLVH 394 (401)
T ss_pred HHHHHH
Confidence 777764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=328.73 Aligned_cols=255 Identities=20% Similarity=0.344 Sum_probs=205.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCC--------------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCee
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTG--------------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~--------------~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 101 (450)
..++|++.+.||+|+||.||+|++..++ ..||+|.++... .......+.+|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999876432 358999987542 234456788999999999999999
Q ss_pred eEEEEEEcCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 102 QLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 102 ~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
++++++.....+|+||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 368889999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
+++.++.+||+|||++..+...... .......+++.|+|||++.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~ 204 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYY------------------------------------RIQGRAVLPIRWMAWESIL 204 (295)
T ss_pred EEcCCCcEEecccccccccccCcce------------------------------------eccCcCcCceeecChhhhc
Confidence 9999999999999998765322100 0011235678999999999
Q ss_pred cCCCCccccccchhHHHHHHhh--CCCCCCCCChhhhhhhhhccc----ccccCCCCCCCCHHHHHHHHHhhc-CccccC
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNWK----TCLKFPEEPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~~----~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+..++.++|+|||||++|+|++ |..||...+.......+.... ........+.+++.+++||.+||. ||.+||
T Consensus 205 ~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 284 (295)
T cd05097 205 LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP 284 (295)
T ss_pred cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 8889999999999999999987 778998776655544432200 111112234578999999999998 999999
Q ss_pred CCCCHHHHH
Q 013064 323 GTRGVEELK 331 (450)
Q Consensus 323 ~~~~~~eil 331 (450)
++++|+
T Consensus 285 ---s~~~i~ 290 (295)
T cd05097 285 ---TFNKIH 290 (295)
T ss_pred ---CHHHHH
Confidence 566664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.89 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=209.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++.+.||+|+||.||+|... |+.+|+|.++.... ..+++.+|..+++.++|+||+++++++.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 46789999999999999999999864 78899999975532 4677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999998765 79999999999999999999999999999999999999999999999999998653210
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
....++..|+|||.+....++.++|+|||||++|+|++
T Consensus 157 -----------------------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 157 -----------------------------------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred -----------------------------------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhc
Confidence 01235667999999988889999999999999999997
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||...+.......+... .....| ..+++.+.+||.+||. +|.+|| +++++++
T Consensus 196 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 251 (256)
T cd05039 196 GRVPYPRIPLKDVVPHVEKG-YRMEAP--EGCPPEVYKVMKDCWELDPAKRP---TFKQLRE 251 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcC-CCCCCc--cCCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 99999887766655554432 122333 3678999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=321.30 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=206.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||+|... .+..+|+|.+..... ..+.+.+|+.+++.++||+|+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999876 556699999876432 2356889999999999999999999885 45689
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998763 458999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ......++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 157 YT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cc-------------------------------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 00 0012345678999999988889999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|.+||.+.+..+....+... ...+.....+..+++||.+||. +|.+||+ +.++.
T Consensus 200 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~l~ 254 (260)
T cd05070 200 GRVPYPGMNNREVLEQVERG---YRMPCPQDCPISLHELMLQCWKKDPEERPT---FEYLQ 254 (260)
T ss_pred CCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHcccCcccCcC---HHHHH
Confidence 99999888777777666542 2223334688999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=337.38 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=205.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~-----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~ 108 (450)
+..++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|..+|..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4557999999999999999999984 3567899999997542 233456788999999999 6899999999876
Q ss_pred c-CCeEEEEEeccCCCChHHHHHhc-------------------------------------------------------
Q 013064 109 D-SDFLYLIMEYLPGGDIMTLLMRE------------------------------------------------------- 132 (450)
Q Consensus 109 ~-~~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------- 132 (450)
. +..+|+|||||++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 45689999999999999998653
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccc
Q 013064 133 ------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200 (450)
Q Consensus 133 ------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~ 200 (450)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 23677888999999999999999999999999999999999999999999998865322100
Q ss_pred ccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCC
Q 013064 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSD 279 (450)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~ 279 (450)
....+..+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+.
T Consensus 236 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 236 ------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred ------------------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 00112346778999999999999999999999999999996 99999876
Q ss_pred ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 280 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 280 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
.........+........| ..+++++.+++.+||. ||.+|| ++.+|++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~Rp---s~~eil~~ 335 (343)
T cd05103 286 KIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 335 (343)
T ss_pred cccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 5443333333222223333 3578899999999998 999999 68888876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=326.96 Aligned_cols=254 Identities=33% Similarity=0.535 Sum_probs=212.9
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|++.+.||+|+||.||+|+...+++.||+|++.+.. ......+.+..|..+++.++||+|+++++++.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998764 2334456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 120 LPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 120 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.+|.++|+|||++.........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence 97 5899999876 58999999999999999999999999999999999999999999999999999865432100
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.....+++.|+|||++.+. .++.++|+|||||++|||++|.+||.
T Consensus 155 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 155 ----------------------------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred ----------------------------------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1124568889999999776 78999999999999999999999998
Q ss_pred CCChhhhhhhhhccc----------------ccccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 278 SDDPRITCRKIVNWK----------------TCLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~----------------~~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+.+..+.+.++...- ....++. .+.++..+.++|.+||. ||.+|+ ++++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~~l 277 (282)
T cd07829 201 GDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---SAKEAL 277 (282)
T ss_pred CccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC---CHHHHh
Confidence 877655544443210 0001111 12457899999999998 999999 689999
Q ss_pred cCCCc
Q 013064 332 EHPWF 336 (450)
Q Consensus 332 ~Hpff 336 (450)
.||||
T Consensus 278 ~~p~~ 282 (282)
T cd07829 278 KHPYF 282 (282)
T ss_pred hCcCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.52 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=207.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||+|..+ +++.||+|.+.+... ..+.+.+|+.+++.++||||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45689999999999999999999865 567899999875442 3456888999999999999999999875 45799
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998753 468999999999999999999999999999999999999999999999999987654211
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ......++..|+|||++....++.++|+|||||++|||++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~ 199 (260)
T cd05067 157 YT-------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTY 199 (260)
T ss_pred cc-------------------------------------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhC
Confidence 00 0112356788999999998889999999999999999998
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|.+||.+.+..+....+... ...+.....+.++.+||.+||. +|.+|| ++++++.
T Consensus 200 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05067 200 GRIPYPGMTNPEVIQNLERG---YRMPRPDNCPEELYELMRLCWKEKPEERP---TFEYLRS 255 (260)
T ss_pred CCCCCCCCChHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 99999888776666655432 2223334678999999999998 999999 4666653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.72 Aligned_cols=253 Identities=30% Similarity=0.459 Sum_probs=212.3
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+|.+.+.||+|+||.||+|.+..++..+++|+++..... .......+..|..+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999999888888888887653321 223345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 117 MEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 117 mEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988864 357999999999999999999999999999999999999974 679999999987653321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
. ......|++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 160 ~--------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 160 D--------------------------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201 (260)
T ss_pred c--------------------------------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 0 01135689999999999888899999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
..||.+.+......++.... ....| ..++.++.++|.+||. +|.+|| ++++++.||||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 260 (260)
T cd08222 202 AHAFEGQNFLSVVLRIVEGP-TPSLP--ETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPFI 260 (260)
T ss_pred CCCCCCccHHHHHHHHHcCC-CCCCc--chhcHHHHHHHHHHhcCChhhCc---CHHHHhhCCCC
Confidence 99998777666666655421 12222 3678999999999998 999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=346.64 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=223.5
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe--EEEEE
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF--LYLIM 117 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~--lylVm 117 (450)
..-.+||+|+|-+||+|.+..+|..||.-.++-..+.+ ....+++..|+.+|+.|+|||||++|+++.+..+ +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34468999999999999999999999988776666554 3457899999999999999999999999998765 88999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEc-cCCceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld-~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|.+.+|+|..|+.+.+.++...++.|++||+.||.|||++. |||||||.+||+|+ ..|.|||+|+|||+.....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 99999999999999999999999999999999999999985 99999999999996 5699999999999976543
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.+.+.+|||+|||||++. ..|+..+||||||..+.||+|+..
T Consensus 200 -------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eY 241 (632)
T KOG0584|consen 200 -------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEY 241 (632)
T ss_pred -------------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccC
Confidence 234679999999999996 889999999999999999999999
Q ss_pred CCC-CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCC
Q 013064 275 PFC-SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 275 PF~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||. +.++..+|+++..+..+-.+-. --.+++++||.+||.-.+.|+ ++.|+|+||||..-
T Consensus 242 PYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~~~~R~---sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 242 PYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLATKSERL---SAKELLKDPFFDED 302 (632)
T ss_pred ChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcCchhcc---CHHHHhhChhhccc
Confidence 996 6788899999998765544432 337899999999998789999 68999999999864
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.90 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=204.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcC----------------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKT----------------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~----------------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I 100 (450)
.++|++.+.||+|+||.||+|++.. ++..+|+|++.... .......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3689999999999999999986543 34579999987542 23345678899999999999999
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-----------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
+++++++.+++.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987643 367788999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.++.++|+|||+++.+...... .......+++.|+|||++.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY------------------------------------RIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce------------------------------------eccCcCcCccccCCHHHHh
Confidence 9999999999999998865332100 0011235578899999998
Q ss_pred cCCCCccccccchhHHHHHHhh--CCCCCCCCChhhhhhhhhcc----cccccCCCCCCCCHHHHHHHHHhhc-CccccC
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI--GYPPFCSDDPRITCRKIVNW----KTCLKFPEEPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+..++.++|+|||||++|||++ |..||...+..+........ ......|....+++.+.+|+.+||. ||.+||
T Consensus 206 ~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 285 (296)
T cd05095 206 LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285 (296)
T ss_pred cCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 8889999999999999999998 78999876655544332110 0112233345678999999999998 999999
Q ss_pred CCCCHHHHH
Q 013064 323 GTRGVEELK 331 (450)
Q Consensus 323 ~~~~~~eil 331 (450)
+ +.+|.
T Consensus 286 ~---~~~i~ 291 (296)
T cd05095 286 S---FQEIH 291 (296)
T ss_pred C---HHHHH
Confidence 4 55554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=325.31 Aligned_cols=254 Identities=33% Similarity=0.534 Sum_probs=211.9
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|++++.||.|++|.||+|.+..+|+.+|+|.++.... .......+..|..+|+.++||+|+++++++.++..+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999876542 234456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 120 LPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 120 ~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
+++ +|..++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 975 88888766 46899999999999999999999999999999999999999999999999999876643210
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......++..|+|||++.+. .++.++|+|||||++|+|++|++||.
T Consensus 154 ---------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 154 ---------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred ---------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 01124688999999999876 78999999999999999999999998
Q ss_pred CCChhhhhhhhhcccc-----------------cccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHHHH
Q 013064 278 SDDPRITCRKIVNWKT-----------------CLKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVEEL 330 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei 330 (450)
+.+..+...++...-. ...++. .+.++.++++||.+||. ||.+|| ++.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~l 277 (283)
T cd05118 201 GKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI---TAEQA 277 (283)
T ss_pred CCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc---CHHHH
Confidence 8776555444432100 001110 12468899999999998 999999 68999
Q ss_pred HcCCCc
Q 013064 331 KEHPWF 336 (450)
Q Consensus 331 l~Hpff 336 (450)
+.||||
T Consensus 278 l~~~~~ 283 (283)
T cd05118 278 LAHPYF 283 (283)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.98 Aligned_cols=257 Identities=19% Similarity=0.311 Sum_probs=211.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCC-------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTT-------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLF 104 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t-------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 104 (450)
..+...+|++.+.||+|+||.||+|++... +..||+|+++.. ........+.+|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 445567899999999999999999986432 236899988753 2334567788999999999 899999999
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCc
Q 013064 105 YSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 168 (450)
Q Consensus 105 ~~f~~~~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeN 168 (450)
+++..++.+|+||||+++|+|.+++.+.. .++...+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999997532 36778889999999999999999999999999999
Q ss_pred EEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 169 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 169 ILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
||++.++.+||+|||+++........ .......++..|+|||++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYY------------------------------------KKTTNGRLPVKWMAPEAL 208 (334)
T ss_pred EEEcCCCcEEECCcccceeccccccc------------------------------------ccccCCCcCceEcCHHHh
Confidence 99999999999999999865432100 001123456789999999
Q ss_pred ccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 249 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 249 ~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
.+..++.++|+|||||++|||++ |..||.+.+..+....+... .....| ...+.++.+||.+||. +|.+|| +
T Consensus 209 ~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp---s 282 (334)
T cd05100 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTHELYMIMRECWHAVPSQRP---T 282 (334)
T ss_pred ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccChhhCc---C
Confidence 99999999999999999999998 89999988877776666542 122233 3678999999999998 999999 6
Q ss_pred HHHHHcC
Q 013064 327 VEELKEH 333 (450)
Q Consensus 327 ~~eil~H 333 (450)
+.+++.+
T Consensus 283 ~~ell~~ 289 (334)
T cd05100 283 FKQLVED 289 (334)
T ss_pred HHHHHHH
Confidence 7888765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.72 Aligned_cols=242 Identities=25% Similarity=0.403 Sum_probs=199.7
Q ss_pred eEEeecCceEEEEEEEcCCCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEecc
Q 013064 44 TLIGKGAFGEVRLCRAKTTGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~--~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
+.||+|+||.||+|+.+.++. .+|+|.++.. ........+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988876 4688887642 2234456788999999999 8999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 121 PGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 121 ~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997643 478999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
+....... ......+++.|+|||++....++.++|+|||||
T Consensus 159 ~~~~~~~~---------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 199 (270)
T cd05047 159 SRGQEVYV---------------------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 199 (270)
T ss_pred ccccchhh---------------------------------------hccCCCCccccCChHHHccCCCCchhhHHHHHH
Confidence 86322110 001123467899999999889999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 265 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 265 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|||++ |..||.+.+..+....+... .....+ ..++.++.+||.+||. ||.+|| ++++++.
T Consensus 200 il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 263 (270)
T ss_pred HHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCC--CcCCHHHHHHHHHHcccChhhCC---CHHHHHH
Confidence 9999996 99999887776666665432 122233 3578999999999998 999999 5667653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=321.40 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=197.6
Q ss_pred CCe-EEEeEEeecCceEEEEEEE----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--C
Q 013064 38 DDF-EQLTLIGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--S 110 (450)
Q Consensus 38 ~~f-~~~~~LG~G~fg~V~l~~~----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~ 110 (450)
++| .+++.||+|+||+||++.. ..++..+|+|+++... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 344 8999999999999988753 3578899999987542 22345677889999999999999999998865 3
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..+|+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4689999999999999998664 599999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
..... .......++..|+|||++.+..++.++|||||||++|||+
T Consensus 160 ~~~~~-----------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 160 GHEYY-----------------------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204 (283)
T ss_pred cchhh-----------------------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence 21100 0011234677899999998888999999999999999999
Q ss_pred hCCCCCCCCChhh--h------------hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 271 IGYPPFCSDDPRI--T------------CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 271 ~G~~PF~~~~~~~--~------------~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+|..||....... . ....+... ...|....++..+.+++.+||. +|++|| ++++++
T Consensus 205 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~i~ 275 (283)
T cd05080 205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG--MRLPCPKNCPQEVYILMKNCWETEAKFRP---TFRSLI 275 (283)
T ss_pred hCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC--CCCCCCCCCCHHHHHHHHHHhccChhhCC---CHHHHH
Confidence 9999986533210 0 00111111 1122224678999999999998 999999 466665
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.83 Aligned_cols=264 Identities=27% Similarity=0.452 Sum_probs=211.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCC----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CC
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SD 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~~ 111 (450)
+..|++++.||+|.||.||+|..+.++ +.||||.++-+.. ..+......+|+.+++.++||||+.|..+|-. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 468999999999999999999665553 3699999975532 23344567899999999999999999999987 88
Q ss_pred eEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC----CceEEeec
Q 013064 112 FLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN----GHLKLSDF 182 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~-----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~----g~ikL~DF 182 (450)
.++|++||.+. ||...|.- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999965 88888753 2468999999999999999999999999999999999999877 89999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccc
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWS 261 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWS 261 (450)
|+++.+...-.+.. + ....+-|.+|.|||.+.+ ..|+.++|+||
T Consensus 181 GlaR~~~~plkpl~-s----------------------------------~d~VVVTiWYRAPELLLGa~hYT~AiDvWA 225 (438)
T KOG0666|consen 181 GLARLFNNPLKPLA-S----------------------------------LDPVVVTIWYRAPELLLGARHYTKAIDVWA 225 (438)
T ss_pred cHHHHhhccccccc-c----------------------------------CCceEEEEEecChHHhcccccccchhhhHH
Confidence 99998765421100 0 113578999999999997 67899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChh---------hhhhhhhc---------ccccccCCCC-----------------------
Q 013064 262 LGAIMYEMLIGYPPFCSDDPR---------ITCRKIVN---------WKTCLKFPEE----------------------- 300 (450)
Q Consensus 262 lGvilyeml~G~~PF~~~~~~---------~~~~~i~~---------~~~~~~~p~~----------------------- 300 (450)
+|||+.|||+-.|.|.+...+ ..+.+|.+ |..--+.|++
T Consensus 226 iGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~ 305 (438)
T KOG0666|consen 226 IGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHK 305 (438)
T ss_pred HHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHH
Confidence 999999999999999775321 23334432 2222222322
Q ss_pred -CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 301 -PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 301 -~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
..-++.+.+|+.+||+ ||.+|+ +++++++|+||..-+
T Consensus 306 ~k~k~~~a~~LL~klL~yDP~kRI---ta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 306 HKVKDPSALDLLQKLLTYDPIKRI---TAEQALEHPYFTEDP 344 (438)
T ss_pred hcCCCchHHHHHHHHhccCchhhc---cHHHHhcccccccCC
Confidence 1135669999999999 999999 689999999998643
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=318.00 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=199.1
Q ss_pred EEeecCceEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 45 LIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~--~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
.||+|+||.||++... .++..+|+|++.... .....+.+.+|..+++.++||||++++++++. ..+|+||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999998765 455679999986542 23445678899999999999999999998864 578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 123 GDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 123 g~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~------ 152 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY------ 152 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce------
Confidence 999999875 4579999999999999999999999999999999999999999999999999998654321100
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCC
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDD 280 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~ 280 (450)
.......+++.|+|||++....++.++|+|||||++|+|++ |..||.+..
T Consensus 153 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 153 -----------------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred -----------------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 00011234678999999998889999999999999999996 999998887
Q ss_pred hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 281 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 281 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
..+....+..+. ....| ...++++.++|.+||. +|.+||+...+.+.+
T Consensus 204 ~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 204 GPEVMSFIEQGK-RLDCP--AECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred HHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 766666555432 23333 4679999999999998 999999543333333
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=315.93 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=211.3
Q ss_pred eEEEeEEeecCceEEEEEEEcCCC----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
|++++.||.|+||.||++.+..++ ..+|+|++.... .....+.+..|+.+++.++||||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998776 899999996543 22256788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 116 IMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~--~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
||||++|++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
.. .....+++.|+|||.+.+..++.++|+|||||++|+|++ |
T Consensus 159 ~~-------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g 201 (258)
T smart00219 159 YK-------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201 (258)
T ss_pred cc-------------------------------------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCC
Confidence 00 001237889999999988889999999999999999998 8
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.+||.+.+.......+.... ....+ ...+.++.+++.+||. ||.+|| ++.++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~ 256 (258)
T smart00219 202 ESPYPGMSNEEVLEYLKKGY-RLPKP--ENCPPEIYKLMLQCWAEDPEDRP---TFSELVE 256 (258)
T ss_pred CCCCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHCcCChhhCc---CHHHHHh
Confidence 99998877777777666533 22333 3589999999999999 999999 6788764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=317.14 Aligned_cols=246 Identities=20% Similarity=0.362 Sum_probs=206.0
Q ss_pred eEEeecCceEEEEEEEcC-CCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEecc
Q 013064 44 TLIGKGAFGEVRLCRAKT-TGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~-t~~--~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
+.||+|++|.||+|.+.. .++ .+|+|.+.+.... ...+.+.+|..+++.++||||+++++.+.+ ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876532 566788999999999999999999999998 8999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 121 PGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 121 ~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 9999999997764 68999999999999999999999999999999999999999999999999998764321100
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFC 277 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~ 277 (450)
.......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.
T Consensus 155 --------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 155 --------------------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred --------------------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 00112467889999999998899999999999999999998 999998
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
..+..+....+.........| ...+..+.++|.+||+ +|.+|| ++.+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 253 (257)
T cd05040 203 GLSGSQILKKIDKEGERLERP--EACPQDIYNVMLQCWAHNPADRP---TFAALRE 253 (257)
T ss_pred CCCHHHHHHHHHhcCCcCCCC--ccCCHHHHHHHHHHCCCCcccCC---CHHHHHH
Confidence 877777666665432333333 3678999999999998 999999 5667653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.86 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=205.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
+|++.+.||+|+||.||+|.... ....+|+|.+.+.. .......+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 33578999886543 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 114 YLIMEYLPGGDIMTLLMRE------------------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~------------------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478899999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.++.+||+|||+++........ .......++..|+|||++.
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY------------------------------------VKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred EEcCCCcEEeccccccccccCccch------------------------------------hcccCCCCCccccCHHHHc
Confidence 9999999999999998765322100 0001235678899999998
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+..++.++|+|||||++|||++ |.+||.+..+......+... ...+....++.++.+||.+||. +|.+|| ++
T Consensus 203 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp---~~ 276 (290)
T cd05045 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG---YRMERPENCSEEMYNLMLTCWKQEPDKRP---TF 276 (290)
T ss_pred cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---CCCCCCCCCCHHHHHHHHHHccCCcccCC---CH
Confidence 8889999999999999999998 99999887776665554432 2222234689999999999998 999999 56
Q ss_pred HHHHc
Q 013064 328 EELKE 332 (450)
Q Consensus 328 ~eil~ 332 (450)
.++++
T Consensus 277 ~~i~~ 281 (290)
T cd05045 277 ADISK 281 (290)
T ss_pred HHHHH
Confidence 66653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.64 Aligned_cols=252 Identities=33% Similarity=0.537 Sum_probs=207.6
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEe
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmE 118 (450)
|.+.+.||+|++|.||+|....+++.+|||.+.+... . .......+|...+..+. ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6789999999999999999999999999999876432 1 12223456888999998 9999999999999999999999
Q ss_pred ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 119 YLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 119 y~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|+ +|+|..++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 889999987765 789999999999999999999999999999999999999999999999999886543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|++|
T Consensus 155 ------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~ 198 (283)
T cd07830 155 ------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL 198 (283)
T ss_pred ------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence 113568999999998854 5578999999999999999999999
Q ss_pred CCCCChhhhhhhhhccccc-----------------ccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 276 FCSDDPRITCRKIVNWKTC-----------------LKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
|.+.+..+.+.++...... ..++. .+..+.++++||++||. ||.+|+ +++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ 275 (283)
T cd07830 199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP---TAS 275 (283)
T ss_pred cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC---CHH
Confidence 9887765555443321000 00000 11346889999999998 999999 689
Q ss_pred HHHcCCCc
Q 013064 329 ELKEHPWF 336 (450)
Q Consensus 329 eil~Hpff 336 (450)
|++.||||
T Consensus 276 ei~~~~~~ 283 (283)
T cd07830 276 QALQHPYF 283 (283)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=318.84 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=208.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+...+|++++.||+|+||.||+|..+.+|+ .+|+|.+.+... ......+.+|..+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 456799999999999999999999887765 589998876532 3455678899999999999999999999987
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
...++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999999774 579999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
...... ......+++.|+|||.+....++.++|+|||||++|||
T Consensus 161 ~~~~~~------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05057 161 VDEKEY------------------------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWEL 204 (279)
T ss_pred Ccccce------------------------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHH
Confidence 321100 00112346789999999888899999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
++ |..||.+....+....+... .....| ...+.++.+++.+||. ||..||+.
T Consensus 205 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~~ 258 (279)
T cd05057 205 MTFGAKPYEGIPAVEIPDLLEKG-ERLPQP--PICTIDVYMVLVKCWMIDAESRPTF 258 (279)
T ss_pred hcCCCCCCCCCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCCCH
Confidence 98 99999988777766666543 223333 4678999999999998 99999953
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=320.45 Aligned_cols=253 Identities=20% Similarity=0.327 Sum_probs=203.8
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCE----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~----~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+..++|++++.||+|+||.||+|....+|.. +|+|.+... ........+..|..++..++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4568999999999999999999999888774 566665422 12233456777888899999999999999876 4
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
...++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 568899999999999999976 4578999999999999999999999999999999999999999999999999998653
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... .......|+..|+|||.+.+..|+.++|+|||||++|||
T Consensus 161 ~~~~~------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el 204 (279)
T cd05111 161 PDDKK------------------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204 (279)
T ss_pred CCCcc------------------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 22100 001124577889999999988899999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++ |..||.+.........+.+ ......| ...+.++.+++.+|+. ||.+|| ++.++++
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~el~~ 263 (279)
T cd05111 205 MSYGAEPYAGMRPHEVPDLLEK-GERLAQP--QICTIDVYMVMVKCWMIDENVRP---TFKELAN 263 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHC-CCcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 98 9999988776554444432 2222223 3567889999999998 999999 5777754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=313.95 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=204.5
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
+.||.|+||.||+|.+.. ++.||+|.+..... ......+.+|.++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999887 99999999876542 235567899999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 124 DIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 124 ~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
+|.+++.+ ...+++..+..++.+++.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV------- 150 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-------
Confidence 99999966 3568999999999999999999999999999999999999999999999999988654221000
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCCh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDP 281 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~ 281 (450)
......++..|+|||++.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 151 -----------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 151 -----------------------------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred -----------------------------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 0011234677999999988889999999999999999998 8999988776
Q ss_pred hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 282 ~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
......+... .....| ..++.++.+||.+||+ +|.+|| ++++++.
T Consensus 202 ~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~ell~ 247 (251)
T cd05041 202 QQTRERIESG-YRMPAP--QLCPEEIYRLMLQCWAYDPENRP---SFSEIYN 247 (251)
T ss_pred HHHHHHHhcC-CCCCCC--ccCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 6666555432 122223 4688999999999998 999999 6788774
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=316.13 Aligned_cols=248 Identities=22% Similarity=0.360 Sum_probs=204.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++...||+|+||.||+|....++ .+|+|.+..... ..+.+.+|+.+++.++||+|+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 34578999999999999999999887654 589998865432 2356788999999999999999999885 45689
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999999764 348899999999999999999999999999999999999999999999999997653321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~ 199 (260)
T cd05069 157 YT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cc-------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhC
Confidence 00 0012346778999999988889999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|.+||.+....+....+... ...+....++..+++||++||. ||.+|| ++++|+
T Consensus 200 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~ 254 (260)
T cd05069 200 GRVPYPGMVNREVLEQVERG---YRMPCPQGCPESLHELMKLCWKKDPDERP---TFEYIQ 254 (260)
T ss_pred CCCCCCCCCHHHHHHHHHcC---CCCCCCcccCHHHHHHHHHHccCCcccCc---CHHHHH
Confidence 99999988777766666542 1222234688999999999998 999999 456654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=321.62 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=202.7
Q ss_pred CCeEEEeEEeecCceEEEEEEE----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC--C
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS--D 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~--~ 111 (450)
.-|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3578899999999999999984 4578899999986542 234456789999999999999999999999875 6
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.+|.++|+|||++..+..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 799999999999999998765 4689999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
..... .......|+..|+|||++.+..++.++|+|||||++|||+
T Consensus 162 ~~~~~-----------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ell 206 (284)
T cd05079 162 DKEYY-----------------------------------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206 (284)
T ss_pred Cccce-----------------------------------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhh
Confidence 21100 0011356788899999998888999999999999999999
Q ss_pred hCCCCCCCCCh--------------hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 271 IGYPPFCSDDP--------------RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 271 ~G~~PF~~~~~--------------~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++..|+..... .......+... ...+....+++.+.+||.+||. ||.+|| ++.+++.+
T Consensus 207 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~ 279 (284)
T cd05079 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG--KRLPRPPNCPEEVYQLMRKCWEFQPSKRT---TFQNLIEG 279 (284)
T ss_pred cCCCCCccccchhhhhcccccccccHHHHHHHHHcC--ccCCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 98876543211 00111111111 1223334689999999999998 999999 57787753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=314.30 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=208.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
..++|++.+.||+|+||.||++... .+..+|+|.+.+... ....+.+|+++++.++||+|+++++++.+....|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 4579999999999999999999875 467899999875432 23467889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||||++||+|.+++... +.++++.++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999998764 56899999999999999999999999999999999999999999999999998754322100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~ 273 (450)
......++..|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 157 -------------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 157 -------------------------------------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred -------------------------------------ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 0012345678999999998889999999999999999998 99
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+||...........+.... ....| ...+..+.+|+.+||. +|.+|| ++.++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~~l~ 253 (256)
T cd05112 200 TPYENRSNSEVVETINAGF-RLYKP--RLASQSVYELMQHCWKERPEDRP---SFSLLLH 253 (256)
T ss_pred CCCCcCCHHHHHHHHhCCC-CCCCC--CCCCHHHHHHHHHHcccChhhCC---CHHHHHH
Confidence 9998877766666654321 11222 3578999999999998 999999 5778775
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=327.56 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=210.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--C----CeeeEEEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--R----CIVQLFYSFQ 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p----~Iv~l~~~f~ 108 (450)
.-.++|++++.+|+|.||+|..|.+..++..+|+|+++.- ....+..+.|+++|+++.+ | .+|.+.++|.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3357999999999999999999999999999999998643 2345667889999999932 2 4789999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-------------
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK------------- 173 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~------------- 173 (450)
-.++.|+|+|.+ |-+++++|..++ +|+-+.++.+.+|++.+++|||+++++|-||||||||+-+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999998 779999998764 7999999999999999999999999999999999999831
Q ss_pred -------CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchh
Q 013064 174 -------NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 246 (450)
Q Consensus 174 -------~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APE 246 (450)
+-+|+|+|||.|+...+.. .+.+.|..|.|||
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----------------------------------------s~iVsTRHYRAPE 279 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----------------------------------------STIVSTRHYRAPE 279 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----------------------------------------ceeeeccccCCch
Confidence 2368999999998765542 2578999999999
Q ss_pred hhccCCCCccccccchhHHHHHHhhCCCCCCCCChhh---hhhhhhcc----------------cccccCCCC-------
Q 013064 247 VLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI---TCRKIVNW----------------KTCLKFPEE------- 300 (450)
Q Consensus 247 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~----------------~~~~~~p~~------- 300 (450)
|+.+-|++..||+||+||||+|+.+|...|...+..+ ++++|+.- ...+..|+.
T Consensus 280 ViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k 359 (415)
T KOG0671|consen 280 VILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSK 359 (415)
T ss_pred heeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccch
Confidence 9999999999999999999999999999999877655 44444310 001111110
Q ss_pred ----------------CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 301 ----------------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 301 ----------------~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
..--.++-|||++||. ||.+|+ ++.|++.||||+..
T Consensus 360 ~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri---Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 360 YVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI---TLREALSHPFFARL 412 (415)
T ss_pred hhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc---cHHHHhcCHHhhcC
Confidence 0112347799999999 999999 68999999999863
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=317.98 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=192.8
Q ss_pred eEEeecCceEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~--t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
+.||+|+||.||++.... ....+|+|.+.... .......+.+|..+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 468999999999997543 34568888775432 23334567889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 122 GGDIMTLLMRED-----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 122 gg~L~~~l~~~~-----~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 999999997643 3567888999999999999999999999999999999999999999999998753221000
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-------CCCCccccccchhHHHHHH
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-------KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-------~~y~~~~DiWSlGvilyem 269 (450)
.......+++.|+|||++.. ..++.++|+|||||++|||
T Consensus 157 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 202 (269)
T cd05042 157 ----------------------------------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202 (269)
T ss_pred ----------------------------------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHH
Confidence 00112456788999999853 3568899999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCC---CCCCCHHHHHHHHHhhcCccccCCCCCHHHHH
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLCDVETRLGTRGVEELK 331 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~---~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil 331 (450)
++ |.+||......+....+.... ....|. ...+++...+++..|+.||.+||+...+.+++
T Consensus 203 ~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 203 FTAADQPYPDLSDEQVLKQVVREQ-DIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELL 267 (269)
T ss_pred HhCCCCCCCcCCHHHHHHHHhhcc-CccCCCCcccccCCHHHHHHHHHHhcCcccccCHHHHHHHh
Confidence 99 889998776665555544321 122221 23678889999998888999999543333333
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=317.87 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=210.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcC----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
.+..++|++.+.||+|+||.||.|.+.. ++..+|+|.+... ........+.+|..+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3567899999999999999999999876 3578999988643 244557788999999999999999999998655
Q ss_pred -CCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEe
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMRE--------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~~--------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~ 180 (450)
+...++++||+++|+|..++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 57899999999999999998663 458999999999999999999999999999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcccccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiW 260 (450)
|||+++.+........ .....++..|+|||++.+..++.++|+|
T Consensus 160 d~g~~~~~~~~~~~~~------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Di~ 203 (280)
T cd05043 160 DNALSRDLFPMDYHCL------------------------------------GDNENRPVKWMALESLVNKEYSSASDVW 203 (280)
T ss_pred CCCCcccccCCceEEe------------------------------------CCCCCcchhccCHHHHhcCCCCchhhHH
Confidence 9999986543211100 0123467789999999988999999999
Q ss_pred chhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 261 SLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 261 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
||||++|||++ |.+||...+..+....+... ...+....+++++.+++.+||. ||++|| ++.+++
T Consensus 204 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~ 270 (280)
T cd05043 204 SFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---YRLAQPINCPDELFAVMACCWALDPEERP---SFSQLV 270 (280)
T ss_pred HhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHcCCChhhCC---CHHHHH
Confidence 99999999998 99999888776665555432 2223334678999999999998 999999 566665
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=316.22 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=208.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
++.++|.+.+.||+|+||.||+|.+..+ ...+|+|...... .....+.+.+|..+++.++||||+++++++.++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 4567899999999999999999987654 3468999886542 234556788999999999999999999998864
Q ss_pred eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 5789999999999999997644 689999999999999999999999999999999999999999999999999886543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.... ......+++.|+|||.+....++.++|+|||||++|||+
T Consensus 160 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 202 (270)
T cd05056 160 ESYY-------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202 (270)
T ss_pred ccce-------------------------------------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 2100 001234567899999998889999999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+ |..||.+.+..+....+.+.. ....| ..++..+.++|.+|+. +|.+|| ++.+++.
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---t~~~~~~ 260 (270)
T cd05056 203 MLGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSKRP---RFTELKA 260 (270)
T ss_pred HcCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 6 999998887766666665432 22333 4789999999999998 999999 5666664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=311.22 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=201.5
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg 123 (450)
++||+|+||.||++... ++..+|+|.+.... .......+.+|..+++.++||||+++++++.+....|+||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999865 68889999987542 2333456888999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccc
Q 013064 124 DIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202 (450)
Q Consensus 124 ~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~ 202 (450)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-------- 149 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-------- 149 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc--------
Confidence 999998754 46899999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCCh
Q 013064 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDP 281 (450)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~ 281 (450)
......+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 150 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 150 -----------------------------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred -----------------------------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 0011245678999999988889999999999999999998 9999988777
Q ss_pred hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 282 ~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
......+... .....+ ..++..+.+|+.+||. +|.+|| ++.++++
T Consensus 201 ~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 246 (250)
T cd05085 201 QQAREQVEKG-YRMSCP--QKCPDDVYKVMQRCWDYKPENRP---KFSELQK 246 (250)
T ss_pred HHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 6666655432 222333 3688999999999998 999999 5677654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.67 Aligned_cols=248 Identities=21% Similarity=0.364 Sum_probs=205.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|.+.+.||+|+||.||++... .+..+|+|.+.+.. ...+.+.+|+.+++.++|+||+++++.+.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45689999999999999999999865 45569999887542 234678889999999999999999999988 7889
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 467888999999999999999999999999999999999999999999999997654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ......++..|+|||++....++.++|+|||||++|+|++
T Consensus 157 ~~-------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 157 YT-------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred cc-------------------------------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 00 0012346678999999998889999999999999999998
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|.+||.+.+.......+... ...+.....+.++.+++.+||. +|.+||+ +.+++
T Consensus 200 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~l~ 254 (260)
T cd05073 200 GRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPT---FEYIQ 254 (260)
T ss_pred CCCCCCCCCHHHHHHHHhCC---CCCCCcccCCHHHHHHHHHHcccCcccCcC---HHHHH
Confidence 99999887766666655442 2223334788999999999998 9999994 55554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=316.03 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=193.4
Q ss_pred eEEeecCceEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~--~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
+.||+|+||.||++... .++..+|+|.++.... ......+.+|..+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3567799998865431 2234568889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 122 GGDIMTLLMRED-----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 122 gg~L~~~l~~~~-----~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
+|+|.+++.... ..++..++.++.|++.||+|||++|++||||||+||+++.++++||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999999987532 4567788899999999999999999999999999999999999999999998753321100
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-------CCCccccccchhHHHHHH
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-------GYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-------~y~~~~DiWSlGvilyem 269 (450)
......+|++.|+|||++.+. .++.++|+|||||++|||
T Consensus 157 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el 202 (269)
T cd05087 157 ----------------------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202 (269)
T ss_pred ----------------------------------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHH
Confidence 001134688999999998642 357899999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcc-cccccCCC-CCCCCHHHHHHHHHhhcCccccCCCCCHHHHH
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNW-KTCLKFPE-EPKISDEARDLICHLLCDVETRLGTRGVEELK 331 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~-~~~~~~p~-~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil 331 (450)
++ |.+||......+........ ......|. ....++.+++++..|+.+|.+|| ++++|.
T Consensus 203 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---t~~~l~ 264 (269)
T cd05087 203 FELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRP---SAEEVH 264 (269)
T ss_pred HhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHhcCcccCC---CHHHHH
Confidence 96 99999876655544333221 11122221 12467889999999988999999 566665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=313.65 Aligned_cols=242 Identities=20% Similarity=0.343 Sum_probs=202.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+.+++|++.+.||+|+||.||++. .+++.||+|.++... ....+.+|+.+++.++||||+++++++..+ ..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 356789999999999999999885 478889999986432 345788899999999999999999998765 479
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||++||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 9999999999999997653 58999999999999999999999999999999999999999999999999987532210
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.....+..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 155 -----------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~ 193 (254)
T cd05083 155 -----------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193 (254)
T ss_pred -----------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhC
Confidence 01234578999999988889999999999999999997
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|.+||.+.+..+....+... ..... ...+++.+++||++||. +|.+|| ++++++
T Consensus 194 g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~ 248 (254)
T cd05083 194 GRAPYPKMSLKEVKECVEKG-YRMEP--PEGCPADVYVLMTSCWETEPKKRP---SFHKLR 248 (254)
T ss_pred CCCCCccCCHHHHHHHHhCC-CCCCC--CCcCCHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 99999888776666555442 12222 24688999999999998 999999 456665
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=327.64 Aligned_cols=269 Identities=29% Similarity=0.465 Sum_probs=223.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh----cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM----LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ- 108 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~- 108 (450)
+..-++|-++..||+|||+.||+|.+...++++|+|+-.-... .+.+..++..+|.+|-+.|+||-||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3445688899999999999999999999999999998532211 23345788999999999999999999999997
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC--CeEEeecCCCcEEEc---cCCceEEeecc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--NYVHRDIKPDNLILD---KNGHLKLSDFG 183 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~--givHrDLKpeNILld---~~g~ikL~DFG 183 (450)
|.+.+|-|+|||+|.||..||..+..++|.+|+.++.||+.||.||... -|||-||||.|||+- .-|.|||+|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 5567899999999999999999999999999999999999999999986 599999999999994 45789999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc----CCCCccccc
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK----KGYGMECDW 259 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~----~~y~~~~Di 259 (450)
|++.+....+... ++ -.++.-..||-+|++||.+.- ...+.++|+
T Consensus 619 LSKIMdddSy~~v---dG----------------------------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV 667 (775)
T KOG1151|consen 619 LSKIMDDDSYNSV---DG----------------------------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV 667 (775)
T ss_pred hhhhccCCccCcc---cc----------------------------eeeecccCceeeecCcceeecCCCCCccccceee
Confidence 9999876533211 00 022345689999999998753 235899999
Q ss_pred cchhHHHHHHhhCCCCCCCCChhh-h--hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDPRI-T--CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~~~-~--~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
||+|||+|..++|+.||....... + ..-|++. ....||.-+.+|.+|++||++||. .-+.|. ++.++.+|||
T Consensus 668 WSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~---DV~qLA~dpy 743 (775)
T KOG1151|consen 668 WSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI---DVQQLACDPY 743 (775)
T ss_pred EeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhh---hHHHHccCcc
Confidence 999999999999999997654322 1 2234443 467899888999999999999998 888898 7899999999
Q ss_pred cC
Q 013064 336 FR 337 (450)
Q Consensus 336 f~ 337 (450)
|.
T Consensus 744 ll 745 (775)
T KOG1151|consen 744 LL 745 (775)
T ss_pred cc
Confidence 84
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.93 Aligned_cols=244 Identities=30% Similarity=0.450 Sum_probs=196.3
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------e
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------F 112 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~------~ 112 (450)
-+..-+.||+||||.||+++++.||+.+|+|.+++.. .....+...+|+++|++++|||||+++++=.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4556678999999999999999999999999998764 3345677889999999999999999999866544 4
Q ss_pred EEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc--cCC--ceEEeecccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNG--HLKLSDFGLC 185 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~---~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld--~~g--~ikL~DFGla 185 (450)
-.+|||||+||||+..|++. ..++|.+...++..++.||.|||++|||||||||+||++- .+| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999999763 4699999999999999999999999999999999999984 444 3599999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 264 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGv 264 (450)
+.+.+.. ...+.+||+.|++||++.. +.|+..||.||+||
T Consensus 172 rel~d~s---------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 172 RELDDNS---------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred ccCCCCC---------------------------------------eeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 9887641 2457999999999999984 88999999999999
Q ss_pred HHHHHhhCCCCCCCCC----hhhhhhhhhccc-----------------ccccCCCCCCCCHHHH----HHHHHhhc-Cc
Q 013064 265 IMYEMLIGYPPFCSDD----PRITCRKIVNWK-----------------TCLKFPEEPKISDEAR----DLICHLLC-DV 318 (450)
Q Consensus 265 ilyeml~G~~PF~~~~----~~~~~~~i~~~~-----------------~~~~~p~~~~~s~~~~----dli~~lL~-dp 318 (450)
++|+..||..||.... ..+....++..+ ....+|....+|+... ..+..+|. +|
T Consensus 213 tlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~ 292 (732)
T KOG4250|consen 213 TLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNP 292 (732)
T ss_pred HHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhH
Confidence 9999999999995432 222333332111 1122333345665544 45666776 99
Q ss_pred cccCC
Q 013064 319 ETRLG 323 (450)
Q Consensus 319 ~~R~~ 323 (450)
.+|-+
T Consensus 293 ~~~~~ 297 (732)
T KOG4250|consen 293 RKRGH 297 (732)
T ss_pred HHhCC
Confidence 99983
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=322.29 Aligned_cols=254 Identities=20% Similarity=0.339 Sum_probs=206.3
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+..++|+.++.||+|+||.||++.+..+|. .+|+|.+.... .......+.+|..+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456899999999999999999999988876 46888876542 223344678899999999999999999998764
Q ss_pred CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
..++|+||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 4789999999999999987654 68999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... .......+++.|+|||++.+..++.++|+|||||++|||
T Consensus 161 ~~~~~------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el 204 (303)
T cd05110 161 GDEKE------------------------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204 (303)
T ss_pred Ccccc------------------------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 32100 001123567899999999989999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++ |..||.+.........+.. .. ..+.....+..+.+++.+|+. +|.+|| ++++++..
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGIPTREIPDLLEK-GE--RLPQPPICTIDVYMVMVKCWMIDADSRP---KFKELAAE 264 (303)
T ss_pred HhCCCCCCCCCCHHHHHHHHHC-CC--CCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 97 9999987765444433332 22 223334678899999999998 999999 56777653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.06 Aligned_cols=236 Identities=18% Similarity=0.309 Sum_probs=193.6
Q ss_pred eEEeecCceEEEEEEEcCCCCE-------EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEI-------FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~-------~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+.||+|+||.||+|.++.++.. +|+|.+.+.. ....+.+..|..+++.++||||+++++++.++...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 3689999999999998765543 8888876542 33456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc--------eEEeecccccc
Q 013064 117 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--------LKLSDFGLCKP 187 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~--------ikL~DFGla~~ 187 (450)
|||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 68999998765
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvil 266 (450)
.... ....|++.|+|||++.+ ..++.++|+|||||++
T Consensus 158 ~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 158 VLPK------------------------------------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred cCCc------------------------------------------hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 4221 13568899999999986 4589999999999999
Q ss_pred HHHhhC-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 267 YEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 267 yeml~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|+|++| .+||...+...... +.. ....+|. ..+.++.+||.+||. ||.+|| ++++|++
T Consensus 196 ~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 255 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPA--PKWTELANLINQCMDYEPDFRP---SFRAIIR 255 (258)
T ss_pred HHHHcCCCCChhhccHHHHHH-HHH--ccccCCC--CCcHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 999998 57776655544332 222 2234443 567899999999998 999999 6788875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.57 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=200.1
Q ss_pred CCeEEEeEEeecCceEEEEEEE----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CC
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SD 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~ 111 (450)
.+|++++.||+|+||.||++.. ..+++.||+|.+.... ....+.+.+|..+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5899999999999999999984 4578899999986542 3456678899999999999999999998643 45
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.++++||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 799999999999999999764 4689999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
..... .......++..|+|||++.+..++.++|+|||||++|||+
T Consensus 161 ~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 205 (284)
T cd05081 161 DKEYY-----------------------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 205 (284)
T ss_pred CCcce-----------------------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHh
Confidence 21100 0001123455699999999888999999999999999999
Q ss_pred hCCCCCCCCChhhh---------------hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 271 IGYPPFCSDDPRIT---------------CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 271 ~G~~PF~~~~~~~~---------------~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|..|+........ ...++.. ...+|....++.++.+||.+||. +|++|| ++.+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05081 206 TYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--NGRLPAPPGCPAEIYAIMKECWNNDPSQRP---SFSELAL 278 (284)
T ss_pred hcCCcCCCcchhhhhhcccccccccchHHHHHHHhc--CCcCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 98877644321100 0111111 12223335788999999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=314.83 Aligned_cols=248 Identities=31% Similarity=0.475 Sum_probs=203.7
Q ss_pred EEEeEEeecCceEEEEEEEc----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 41 EQLTLIGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.+.+.||.|+||.||.|... ..+..|++|+++.. ......+.+.+|.++++.++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 44567999999542 2334578899999999999999999999999988889999
Q ss_pred EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 117 MEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 78999999999999999999999999999999999999999999999999999876321100
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~ 273 (450)
.......+...|+|||.+.+..++.++||||||+++|||++ |.
T Consensus 160 ------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~ 203 (259)
T PF07714_consen 160 ------------------------------------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGK 203 (259)
T ss_dssp ------------------------------------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSS
T ss_pred ------------------------------------cccccccccccccccccccccccccccccccccccccccccccc
Confidence 00113457788999999998889999999999999999999 78
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.||...+..+...++.+. .....| ..++..+.++|..||. ||.+|| ++.+|++
T Consensus 204 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~C~~~~p~~RP---s~~~i~~ 257 (259)
T PF07714_consen 204 FPFSDYDNEEIIEKLKQG-QRLPIP--DNCPKDIYSLIQQCWSHDPEKRP---SFQEILQ 257 (259)
T ss_dssp GTTTTSCHHHHHHHHHTT-EETTSB--TTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred cccccccccccccccccc-ccceec--cchhHHHHHHHHHHcCCChhhCc---CHHHHHh
Confidence 999888887777777543 333333 4689999999999998 999999 6777753
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=314.78 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=201.3
Q ss_pred eEEeecCceEEEEEEEcCCC------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 44 TLIGKGAFGEVRLCRAKTTG------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~------~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.||+|+||.||+++.+... +.+|+|.+.+.. .......+.+|..+++.++||||+++++++.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 689999886542 2234567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-----ceEEeecccc
Q 013064 118 EYLPGGDIMTLLMRE-------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-----HLKLSDFGLC 185 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-----~ikL~DFGla 185 (450)
||++||+|.+++.+. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 3478899999999999999999999999999999999999887 8999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
+........ .......+++.|+|||++.+..++.++|+|||||+
T Consensus 159 ~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 202 (269)
T cd05044 159 RDIYKSDYY------------------------------------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVL 202 (269)
T ss_pred ccccccccc------------------------------------ccCcccCCCccccCHHHHccCCcccchhHHHHHHH
Confidence 865322100 00012356788999999998889999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 266 MYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 266 lyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|+|++ |..||...+..+....+... ..+..+ ..++..+.+||.+||. +|.+|| ++++|++
T Consensus 203 l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 265 (269)
T cd05044 203 MWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKP--ENCPDKIYQLMTNCWAQDPSERP---TFDRIQE 265 (269)
T ss_pred HHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCc--ccchHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 999998 99999887776666655432 222333 4689999999999998 999999 5666653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=311.05 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=197.3
Q ss_pred eEEeecCceEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-cCCeEEEEEec
Q 013064 44 TLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSDFLYLIMEY 119 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~---t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-~~~~lylVmEy 119 (450)
+.||+|+||.||+|.... .+..+|+|.+... ......+.+..|..+++.++||||+++++++. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998654 3457999987542 22345677888999999999999999999765 56678999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 120 LPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 120 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
+++|+|.+++.+. ...++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999999764 4567888889999999999999999999999999999999999999999999986533210000
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFC 277 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~ 277 (450)
.......+++.|+|||.+.+..++.++|+|||||++|||++ |.+||.
T Consensus 157 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 157 --------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred --------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 00112356789999999988899999999999999999999 577887
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
..+..+....+..+. ....+ ..+++.+.+++.+||. +|++|| ++.+++.
T Consensus 205 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~il~ 254 (262)
T cd05058 205 DVDSFDITVYLLQGR-RLLQP--EYCPDPLYEVMLSCWHPKPEMRP---TFSELVS 254 (262)
T ss_pred CCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 777666666555432 22222 3578999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=312.24 Aligned_cols=250 Identities=28% Similarity=0.503 Sum_probs=207.3
Q ss_pred CeEEEeEEeecCceEEEEEEEcC-CCCEEEEEEeechhh-------cchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEc
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEM-------LKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQD 109 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~-t~~~~AiK~i~k~~~-------~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~ 109 (450)
+|++.+.||+|+||.||++.++. +++.+|+|.+..... ........+..|..++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999987 788999998864321 223345667788888865 799999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
++..|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3569999999999999999999996 7899999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
+....... ......|+..|+|||++.+..++.++|+|||||
T Consensus 161 ~~~~~~~~---------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ 201 (269)
T cd08528 161 AKQKQPES---------------------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGC 201 (269)
T ss_pred eeeccccc---------------------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHH
Confidence 98654321 012357899999999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|+|++|.+||...+.......+...... ..+ ...+++.+.+||.+||. ||.+|| ++.|+..
T Consensus 202 ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~li~~cl~~~p~~Rp---~~~e~~~ 265 (269)
T cd08528 202 ILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLP-EGMYSEDVTDVITSCLTPDAEARP---DIIQVSA 265 (269)
T ss_pred HHHHHHhCCCcccccCHHHHHHHHhhccCC-cCC-cccCCHHHHHHHHHHCCCCCccCC---CHHHHHH
Confidence 999999999999877766666555542211 111 23678999999999998 999999 5666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=311.64 Aligned_cols=237 Identities=19% Similarity=0.252 Sum_probs=191.0
Q ss_pred eEEeecCceEEEEEEEcC------------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 44 TLIGKGAFGEVRLCRAKT------------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~------------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+.||+|+||.||++.... ....+|+|++.... ......+..|..++..++||||+++++++.++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 22358888876542 234456778889999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc-------eEEeecc
Q 013064 112 FLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-------LKLSDFG 183 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~-------ikL~DFG 183 (450)
..++||||+++|.|..++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+|. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999988875 457999999999999999999999999999999999999987764 8999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-cCCCCccccccch
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSL 262 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-~~~y~~~~DiWSl 262 (450)
++...... ....|++.|+|||++. +..++.++|+|||
T Consensus 158 ~~~~~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (262)
T cd05077 158 IPITVLSR------------------------------------------QECVERIPWIAPECVEDSKNLSIAADKWSF 195 (262)
T ss_pred CCccccCc------------------------------------------ccccccccccChhhhcCCCCCCchhHHHHH
Confidence 98754321 1246889999999987 4678999999999
Q ss_pred hHHHHHHh-hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 263 GAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 263 Gvilyeml-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
||++|||+ .|..||.+....+.. ++... .... ....++++++||.+||. ||.+|| ++.+|+.+
T Consensus 196 G~~l~el~~~~~~p~~~~~~~~~~-~~~~~--~~~~--~~~~~~~~~~li~~cl~~dp~~Rp---~~~~il~~ 260 (262)
T cd05077 196 GTTLWEICYNGEIPLKDKTLAEKE-RFYEG--QCML--VTPSCKELADLMTHCMNYDPNQRP---FFRAIMRD 260 (262)
T ss_pred HHHHHHHHhCCCCCCCCcchhHHH-HHHhc--CccC--CCCChHHHHHHHHHHcCCChhhCc---CHHHHHHh
Confidence 99999998 589998776543332 22221 1111 12356889999999998 999999 67888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.52 Aligned_cols=259 Identities=31% Similarity=0.502 Sum_probs=224.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE----
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ---- 108 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~---- 108 (450)
+..-+-|+++.+||.|.+|+||+++++.+++..|+|++.... ..-+.+..|.+||+.. +|||++.+|++|.
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 444578999999999999999999999999999999987543 3345677899999887 7999999999986
Q ss_pred -cCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 109 -DSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 109 -~~~~lylVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
.++.+|||||||.||+..+++++ ..++.|+.+..++.+++.||.|||++.++|||||-.|||++.+|.|||+|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 35679999999999999999865 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCcccccc
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWW 260 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~DiW 260 (450)
..+... +.+..+.+|||.|||||++.. ..|+..+|+|
T Consensus 171 aQldsT--------------------------------------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~W 212 (953)
T KOG0587|consen 171 AQLDST--------------------------------------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLW 212 (953)
T ss_pred eeeecc--------------------------------------cccccCcCCCcccccceeeecccCCCCCcccccchh
Confidence 876543 122357899999999999975 3478999999
Q ss_pred chhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|||++..||.-|.||+.+.-+...+-+|... ++..+-.+..+|.++.|||..||. |-++|| ...+++.|||...
T Consensus 213 sLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP---~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 213 SLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRP---STEELLKHPFITE 287 (953)
T ss_pred hccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCc---chhhhccCCcccc
Confidence 9999999999999999999888877777653 233333345889999999999998 999999 6789999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=330.75 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=216.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCC---E-EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---I-FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~-~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
.+..++-.+.++||+|+||.||+++.+..+. . ||+|..+-+....+.++..+.+|.++|+.++|||||++||+..+
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3555677778999999999999999876533 3 89999886555677889999999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+.-+|+|||+|+||+|.++|++.+ .++..+...|+.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++..
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999999999987 5999999999999999999999999999999999999999999999999998864
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
..-... ....--...|+|||.+...-|+.++||||+||++||
T Consensus 313 ~~~~~~--------------------------------------~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~E 354 (474)
T KOG0194|consen 313 SQYVMK--------------------------------------KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWE 354 (474)
T ss_pred cceeec--------------------------------------cccccCcceecChhhhccCccccccchhheeeeEEe
Confidence 311000 000123467999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
+++ |..||.+....+...+|.........| ...+.++..++.+|+. ||+.|++.
T Consensus 355 if~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm 410 (474)
T KOG0194|consen 355 IFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRPTM 410 (474)
T ss_pred eeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCChhhccCH
Confidence 998 899999999999999996644555555 3788899999999998 99999953
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.72 Aligned_cols=268 Identities=28% Similarity=0.468 Sum_probs=221.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
..+|.-++.+|.|+- .|..+-+.-+++.+|+|.+... ........+..+|..++..++|+||++++.+|.-.+
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457888999999999 7888889999999999998766 344556678899999999999999999999997544
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+||||| .++|...+. -.++.+.+++++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+.-..
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 589999999 457777665 4578899999999999999999999999999999999999999999999999986433
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
. .+.+..+.|..|.|||++.+.+|...+||||+|||+.||+
T Consensus 171 ~---------------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 171 D---------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI 211 (369)
T ss_pred c---------------------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHh
Confidence 2 1233579999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccc-----------------------------cccCCC---------CCCCCHHHHHHHH
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKT-----------------------------CLKFPE---------EPKISDEARDLIC 312 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~-----------------------------~~~~p~---------~~~~s~~~~dli~ 312 (450)
.|...|.|.+..+.+.+|+.--. .-.+|+ .+.-+..|+||+.
T Consensus 212 ~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~ 291 (369)
T KOG0665|consen 212 LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLS 291 (369)
T ss_pred hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHH
Confidence 99999999987777766652100 001121 0133567999999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCCccc
Q 013064 313 HLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKP 353 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p 353 (450)
+||. ||++|+ +++++|.||||+ -|-...+.++|..|
T Consensus 292 ~MLvi~pe~Ri---sv~daL~HPY~~--vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 292 KMLVIDPEKRI---SVDDALRHPYIK--VWYDPDEVEAPPPE 328 (369)
T ss_pred HhhccChhhcc---cHHHHhcCCeee--eecccccccCCCCc
Confidence 9998 999999 799999999998 68555566666655
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=312.11 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=204.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEc----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--C
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--S 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~ 110 (450)
..+|++++.||+|+||.||+|+.. .+++.||+|++++.... ...+.+.+|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 467899999999999999999864 35889999999765422 356788999999999999999999999887 6
Q ss_pred CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997754 69999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
...... .......++..|+|||.+.+..++.++|+|||||++|||
T Consensus 161 ~~~~~~-----------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 161 EDKDYY-----------------------------------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred cCCcce-----------------------------------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 321100 000112456679999999888899999999999999999
Q ss_pred hhCCCCCCCCChhh--------------hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LIGYPPFCSDDPRI--------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~G~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|..||....... ....++.. ....+.....+.++.+|+.+||. +|.+|| ++.+|+.
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRP---SFADLIL 278 (284)
T ss_pred eccCCCcccccchhccccccccccccHHHHHHHHHc--CCcCCCCccCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99999986543221 11112221 12233334678899999999998 999999 5666653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.14 Aligned_cols=269 Identities=30% Similarity=0.461 Sum_probs=203.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-------- 108 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-------- 108 (450)
++||+.+..||+||||.||+|+++-+|..||||.|.-.. .......+.+|+.+|++|+|||||++|.++.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 479999999999999999999999999999999997653 4556678999999999999999999993220
Q ss_pred ----------------------------------------------------------------------c---------
Q 013064 109 ----------------------------------------------------------------------D--------- 109 (450)
Q Consensus 109 ----------------------------------------------------------------------~--------- 109 (450)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ------------------------C--------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHhhh
Q 013064 110 ------------------------S--------DFLYLIMEYLPGGDIMTLLMREDIL-SEDVARFYIAESVLAIHSIHQ 156 (450)
Q Consensus 110 ------------------------~--------~~lylVmEy~~gg~L~~~l~~~~~~-~e~~~~~~~~qil~aL~~LH~ 156 (450)
+ ..+|+-||||+...|.+++.++... .-..++.+++||++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 2479999999887777777665544 478899999999999999999
Q ss_pred CCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhcccccccc
Q 013064 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 236 (450)
Q Consensus 157 ~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 236 (450)
+|||||||||.||+||++++|||+|||+|+......... +... .+.+...++ .....++.
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~-----d~~~-~~~~~~~g~--------------~~~~~Ts~ 775 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESI-----DQDL-SFSTNRAGS--------------NDGDLTSQ 775 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhH-----hhcc-CccccccCC--------------CCcccccc
Confidence 999999999999999999999999999999743210000 0000 000000000 01123468
Q ss_pred ccCCCccchhhhccCC---CCccccccchhHHHHHHhhCCCCCCCCC-hhhhhhhhhcccccccCCCC----CCCCHHHH
Q 013064 237 VGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEMLIGYPPFCSDD-PRITCRKIVNWKTCLKFPEE----PKISDEAR 308 (450)
Q Consensus 237 ~Gt~~Y~APEvl~~~~---y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~----~~~s~~~~ 308 (450)
+||.-|+|||++.+.. |+.++|+||||||+|||+. ||...- ...++.++- ...+|.+ ..--+...
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR----~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR----KGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc----cCCCCCCcccccccchHHH
Confidence 9999999999998755 9999999999999999984 575332 222333332 3344432 12345678
Q ss_pred HHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 309 DLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 309 dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
.+|++||. ||.+|| +|.|+|++.||-
T Consensus 849 slI~~Ll~hdP~kRP---tA~eLL~s~llp 875 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRP---TATELLNSELLP 875 (1351)
T ss_pred HHHHHHhcCCCccCC---CHHHHhhccCCC
Confidence 89999998 999999 689999999997
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=310.59 Aligned_cols=250 Identities=22% Similarity=0.400 Sum_probs=204.0
Q ss_pred eEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 40 FEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
|.+.++||+|+||.||+|..+ .+++.+|||++.... ......+.+.+|..+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677899999999999999865 367899999996543 33445677889999999999999999999886532
Q ss_pred -eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 112 -FLYLIMEYLPGGDIMTLLMRE------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
..++++||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 357899999999998887432 2578999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
++........ .......+++.|++||.+.+..++.++|+|||||
T Consensus 160 ~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~ 203 (273)
T cd05074 160 SKKIYSGDYY------------------------------------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGV 203 (273)
T ss_pred cccccCCcce------------------------------------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHH
Confidence 8865332100 0011234678899999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 265 IMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 265 ilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|+|++ |.+||.+.+..+.+..+..+.. +..+ ...+..+.+++.+||. +|.+|| ++.+++.
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---s~~~~~~ 267 (273)
T cd05074 204 TMWEIMTRGQTPYAGVENSEIYNYLIKGNR-LKQP--PDCLEDVYELMCQCWSPEPKCRP---SFQHLRD 267 (273)
T ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-CCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999999 9999988877777766665322 2222 3678999999999998 999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=307.99 Aligned_cols=234 Identities=19% Similarity=0.276 Sum_probs=192.2
Q ss_pred eEEeecCceEEEEEEEcCCC----------CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 44 TLIGKGAFGEVRLCRAKTTG----------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~----------~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
+.||+|+||.||++.++.++ ..+++|++..... ....+.+|..+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998877 3477777654431 15678889999999999999999999988 778
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-------ceEEeecccc
Q 013064 114 YLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-------HLKLSDFGLC 185 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-------~ikL~DFGla 185 (450)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999888 8999999998
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC--CCCccccccchh
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLG 263 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~--~y~~~~DiWSlG 263 (450)
...... ....+++.|+|||++.+. .++.++|+||||
T Consensus 156 ~~~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 193 (259)
T cd05037 156 ITVLSR------------------------------------------EERVERIPWIAPECIRNGQASLTIAADKWSFG 193 (259)
T ss_pred cccccc------------------------------------------cccccCCCccChhhhcCCCCCcchhhHHHHHH
Confidence 864321 124677889999999876 789999999999
Q ss_pred HHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 264 AIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 264 vilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|++|+|++ |..||...+......... ... ..|. ..+..+.+||.+||. +|.+|| ++.++++
T Consensus 194 ~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~--~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~il~ 256 (259)
T cd05037 194 TTLLEICSNGEEPLSTLSSSEKERFYQ-DQH--RLPM--PDCAELANLINQCWTYDPTKRP---SFRAILR 256 (259)
T ss_pred HHHHHHHhCCCCCcccCCchhHHHHHh-cCC--CCCC--CCchHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99999999 688887765433332222 111 1221 234899999999998 999999 5777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=313.54 Aligned_cols=258 Identities=17% Similarity=0.149 Sum_probs=191.8
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhh--------HHHHHHHHHHHHhcCCCCeeeE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQ--------VEHVRSERNLLAEVDSRCIVQL 103 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~--------~~~~~~E~~il~~l~hp~Iv~l 103 (450)
+.-++|.+.+.||+|+||.||+|++..+ +..+|+|+........... ......+...+..+.|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4447899999999999999999999887 6778888643221100000 0111223344556789999999
Q ss_pred EEEEEcCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEE
Q 013064 104 FYSFQDSD----FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 104 ~~~f~~~~----~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL 179 (450)
++...... ..|++||++. .++...+.....+++..++.++.|++.||+|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98766543 4578899884 467777766666889999999999999999999999999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccc
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~Di 259 (450)
+|||+|+.+........ .........+||+.|+|||++.+..|+.++|+
T Consensus 168 ~DFGla~~~~~~~~~~~-------------------------------~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Di 216 (294)
T PHA02882 168 IDYGIASHFIIHGKHIE-------------------------------YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDL 216 (294)
T ss_pred EEcCCceeeccCCcccc-------------------------------cccccccccCCCccccCHHHhCCCCCCcHHHH
Confidence 99999987643211000 00001123579999999999999999999999
Q ss_pred cchhHHHHHHhhCCCCCCCCChhhh---------hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDPRIT---------CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~~~~---------~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
|||||++|||++|.+||.+.+.... ..++.. ..... ...++++.++++.|+. +|.+|| +.++
T Consensus 217 wSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~rp---~~~~ 288 (294)
T PHA02882 217 ESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--GKIKI---KNANKFIYDFIECVTKLSYEEKP---DYDA 288 (294)
T ss_pred HHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh--hhhcc---CCCCHHHHHHHHHHHhCCCCCCC---CHHH
Confidence 9999999999999999987643221 122222 11222 3568999999999998 999999 5677
Q ss_pred HHc
Q 013064 330 LKE 332 (450)
Q Consensus 330 il~ 332 (450)
|++
T Consensus 289 l~~ 291 (294)
T PHA02882 289 LIK 291 (294)
T ss_pred HHH
Confidence 653
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=312.18 Aligned_cols=236 Identities=19% Similarity=0.253 Sum_probs=191.0
Q ss_pred EEeecCceEEEEEEEcCC------------------------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe
Q 013064 45 LIGKGAFGEVRLCRAKTT------------------------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~~t------------------------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I 100 (450)
.||+|+||.||++....+ ...+|+|++.... ......+.+|..+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999875322 1358899886543 2334567788999999999999
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC----
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---- 175 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---- 175 (450)
+++++++.++...|+||||++||+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 56789999999999999999999999999999999999998654
Q ss_pred ---ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-C
Q 013064 176 ---HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-K 251 (450)
Q Consensus 176 ---~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~ 251 (450)
.+||+|||++...... ....|++.|+|||.+.+ .
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------------------------------------------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------------------------------------------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred ccceeeecCCccccccccc------------------------------------------cccccCCcccCchhhcCCC
Confidence 4899999987643211 12357888999999875 5
Q ss_pred CCCccccccchhHHHHHHh-hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 252 GYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 252 ~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
.++.++|+|||||++|||+ +|..||.+....+... ... .....|. ..++.+.+||.+||. +|.+|| ++.+
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp---s~~~ 268 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE--KKHRLPE--PSCKELATLISQCLTYEPTQRP---SFRT 268 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH--hccCCCC--CCChHHHHHHHHHcccChhhCc---CHHH
Confidence 6899999999999999995 7999998776544332 222 1223332 457889999999998 999999 6888
Q ss_pred HHcC
Q 013064 330 LKEH 333 (450)
Q Consensus 330 il~H 333 (450)
|+++
T Consensus 269 il~~ 272 (274)
T cd05076 269 ILRD 272 (274)
T ss_pred HHHh
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.76 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=192.7
Q ss_pred eEEeecCceEEEEEEEcCCC--CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKGAFGEVRLCRAKTTG--EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~--~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
+.||+|+||.||+++....+ ..+++|.+.... .....+.+.+|..+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36999999999999764333 346666665432 22345678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 122 GGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 122 gg~L~~~l~~~----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
+|+|.+++.+. ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++++||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~--- 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI--- 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh---
Confidence 99999999764 34667788899999999999999999999999999999999999999999998643211000
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-------CCCCccccccchhHHHHHHh
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-------KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-------~~y~~~~DiWSlGvilyeml 270 (450)
......+|++.|+|||++.. ..++.++|+|||||++|||+
T Consensus 156 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (268)
T cd05086 156 ---------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202 (268)
T ss_pred ---------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence 00123578999999999853 24578999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccc-cccCCC-CCCCCHHHHHHHHHhhcCccccCCCCCHHHHH
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKT-CLKFPE-EPKISDEARDLICHLLCDVETRLGTRGVEELK 331 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~-~~~~p~-~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil 331 (450)
+ |.+||...+..+.+..+..... .+..|. ...+++.+.+++..|+.+|.+|| ++++|+
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---~~~~i~ 263 (268)
T cd05086 203 ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRA---TAEEVH 263 (268)
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCC---CHHHHH
Confidence 6 6789987777666666554321 111111 13578899999999998999999 567765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=338.53 Aligned_cols=265 Identities=20% Similarity=0.308 Sum_probs=185.6
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCC----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 106 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t----~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 106 (450)
.+.....++|++.+.||+|+||.||+|++..+ +..||+|.+.... ..+....|+ +....+.+++.+...
T Consensus 125 ~~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 125 FRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYG 197 (566)
T ss_pred cCCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHh
Confidence 34567889999999999999999999999988 9999999876432 111111111 111222222222222
Q ss_pred ------EEcCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHhhhCCeE
Q 013064 107 ------FQDSDFLYLIMEYLPGGDIMTLLMREDI--------------------LSEDVARFYIAESVLAIHSIHQHNYV 160 (450)
Q Consensus 107 ------f~~~~~lylVmEy~~gg~L~~~l~~~~~--------------------~~e~~~~~~~~qil~aL~~LH~~giv 160 (450)
..++..+|+||||+++|+|.+++..... ..+..++.++.||+.||+|||++||+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 2456689999999999999999865421 12345678999999999999999999
Q ss_pred EeecCCCcEEEcc-CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccC
Q 013064 161 HRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 239 (450)
Q Consensus 161 HrDLKpeNILld~-~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt 239 (450)
||||||+|||++. ++.+||+|||+|+.+...... ...+.+||
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-------------------------------------~~~~~~~t 320 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-------------------------------------IPKEFLLD 320 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-------------------------------------CCcccccC
Confidence 9999999999986 689999999999865432110 11246899
Q ss_pred CCccchhhhccC----------------------CCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhc-------
Q 013064 240 LDYMAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN------- 290 (450)
Q Consensus 240 ~~Y~APEvl~~~----------------------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------- 290 (450)
+.|+|||++... .++.++|+|||||+||||+++..|+.. ....+.+++.
T Consensus 321 ~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~ 398 (566)
T PLN03225 321 PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLV 398 (566)
T ss_pred CCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHH
Confidence 999999976432 234567999999999999987666532 2222222211
Q ss_pred -cccccc--C--------CCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccc
Q 013064 291 -WKTCLK--F--------PEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 291 -~~~~~~--~--------p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 344 (450)
|..... . ......+..++|||.+||+ ||.+|+ ++.++++||||.+..+..+
T Consensus 399 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~---ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 399 AWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI---SAKAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC---CHHHHhCCcCcCCCCcccc
Confidence 100000 0 0001123456799999999 999999 6899999999999877543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=308.01 Aligned_cols=263 Identities=29% Similarity=0.450 Sum_probs=211.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------- 109 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------- 109 (450)
.+-|+-+..||+|.||.||+|+.+.+|+.||+|++-... .+.+......+|+++|..++|+|++.+++.+.+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 356777889999999999999999999999998653321 244556778899999999999999998876543
Q ss_pred -CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
...+||||++|+. ||..+|... -+|+..+++.++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 2359999999965 899998765 5899999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvil 266 (450)
+....... +..-+..+-|.+|.+||.+.+ ..|+.+.|+|..|||+
T Consensus 174 fs~~~n~~----------------------------------kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 174 FSTSKNVV----------------------------------KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM 219 (376)
T ss_pred eecccccC----------------------------------CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence 65432110 011224678999999999987 6799999999999999
Q ss_pred HHHhhCCCCCCCCChhhhhhhhhc---------cccccc-----------CCCC-----------CCCCHHHHHHHHHhh
Q 013064 267 YEMLIGYPPFCSDDPRITCRKIVN---------WKTCLK-----------FPEE-----------PKISDEARDLICHLL 315 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~~~~~i~~---------~~~~~~-----------~p~~-----------~~~s~~~~dli~~lL 315 (450)
.||.+|.+-|.+.+...++..|.. |...-. .|.. ..-.+++.||+.+||
T Consensus 220 aeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 220 AEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 999999999999887766655531 111111 1110 112468999999999
Q ss_pred c-CccccCCCCCHHHHHcCCCcCC
Q 013064 316 C-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 316 ~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
. ||.+|+ .++++++|.||..
T Consensus 300 ~~DP~kR~---~ad~alnh~~F~k 320 (376)
T KOG0669|consen 300 KLDPTKRI---DADQALNHDFFWK 320 (376)
T ss_pred ccCcccCc---chHhhhchhhhhc
Confidence 9 999999 6899999999953
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=295.65 Aligned_cols=253 Identities=29% Similarity=0.458 Sum_probs=208.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCC--e
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD--F 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~--~ 112 (450)
..++|++++.+|+|.|+.||.+++..+++.++||+++.-. .+.+.+|+.||+.|. ||||++|++...|.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 5689999999999999999999999999999999987532 467899999999996 999999999998754 5
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-CceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~-g~ikL~DFGla~~~~~~ 191 (450)
..||+||+...|...+. ..++.-.+++|+.|++.||.|||++||+|||+||.|++||.. -.++|+|+|||.+....
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 78999999998876654 458899999999999999999999999999999999999964 57999999999987654
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
..-+ -.+.+..|--||.+.. +.|+.+.|+|||||+|..|+
T Consensus 187 ~eYn---------------------------------------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi 227 (338)
T KOG0668|consen 187 KEYN---------------------------------------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 227 (338)
T ss_pred ceee---------------------------------------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHH
Confidence 2211 2467888999999876 66899999999999999999
Q ss_pred hCCCCC-CCCChhhhhhhhhcc-----------cccccC---------------------CCC-CCCCHHHHHHHHHhhc
Q 013064 271 IGYPPF-CSDDPRITCRKIVNW-----------KTCLKF---------------------PEE-PKISDEARDLICHLLC 316 (450)
Q Consensus 271 ~G~~PF-~~~~~~~~~~~i~~~-----------~~~~~~---------------------p~~-~~~s~~~~dli~~lL~ 316 (450)
+.+-|| .|.+..+++.+|.+- +..+.+ ++. .-.++++.|||.+||.
T Consensus 228 FrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLr 307 (338)
T KOG0668|consen 228 FRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLR 307 (338)
T ss_pred hccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHh
Confidence 988887 466655555554310 000000 111 2347999999999999
Q ss_pred -CccccCCCCCHHHHHcCCCcCCC
Q 013064 317 -DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 317 -dp~~R~~~~~~~eil~Hpff~~i 339 (450)
|-.+|+ ++.|++.||||..+
T Consensus 308 YDHqeRl---TakEam~HpyF~~~ 328 (338)
T KOG0668|consen 308 YDHQERL---TAKEAMAHPYFAPV 328 (338)
T ss_pred hcccccc---chHHHhcCchHHHH
Confidence 999999 68999999999753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=325.40 Aligned_cols=256 Identities=20% Similarity=0.284 Sum_probs=209.7
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
....+..+++.+...||+|.||+||.+++-.+ ||||+++.... ..++.+.+++|..+|++-+|.||+-+.+++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 44567778889999999999999999998643 99999987764 455899999999999999999999999999988
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.. .+|+-+|+|-+|+.+|.-. ..|.....+.|+.||+.|+.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 87 9999999999999999654 468899999999999999999999999999999999999999999999999987422
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIM 266 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvil 266 (450)
--. ...-....-|...|||||+++. .+|+..+||||+||++
T Consensus 540 ~w~------------------------------------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 540 RWS------------------------------------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred eec------------------------------------cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence 110 0001123468889999999984 5799999999999999
Q ss_pred HHHhhCCCCCCCCChhhhhhhhhccc--ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 267 YEMLIGYPPFCSDDPRITCRKIVNWK--TCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|||++|..||...+.+.++-.+-.+. ..+..+ ....+.++++|+..|+. ++++||. +.+|+
T Consensus 584 YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~-~s~~pk~mk~Ll~~C~~~~~~eRP~---F~~il 647 (678)
T KOG0193|consen 584 YELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI-RSNCPKAMKRLLSDCWKFDREERPL---FPQLL 647 (678)
T ss_pred HHHHhCcCCcCCCChhheEEEecccccCccchhh-hccCHHHHHHHHHHHHhcCcccCcc---HHHHH
Confidence 99999999999666655444443321 111111 13556799999999998 9999994 55665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=346.34 Aligned_cols=269 Identities=39% Similarity=0.678 Sum_probs=223.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..-.-+||+.||.|..|+||.||+++|+.|.+.+|| .++|..++-+ +||....+|++|
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilR----------nilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILR----------NILTFAGNPFVV----------- 135 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhh----------ccccccCCccee-----------
Confidence 445568999999999999999999999999999999 5555544322 267777888887
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
||-.+.+..-+.++.+. +.|++|||+-||+|||+||+|+||..-||+|++|||+++......
T Consensus 136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 78888887777776554 889999999999999999999999999999999999998654332
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
..++.+ +.++. ..+-......||||.|+||||+..++|+..||||+||+|+||.|.|
T Consensus 198 atnl~e--g~I~k---------------------~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVg 254 (1205)
T KOG0606|consen 198 ATNLKE--GHIEK---------------------DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 254 (1205)
T ss_pred cchhhh--cchHH---------------------HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhee
Confidence 222111 00000 0011112246999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAA 350 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p 350 (450)
..||.++++++++...+. ..+.+|+ ...+.++++|+|..||. +|..|+|+.++-++++|+||..+||..|.+.++.
T Consensus 255 cvpffGdtpeelfg~vis--d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkae 332 (1205)
T KOG0606|consen 255 CVPFFGDTPEELFGQVIS--DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAE 332 (1205)
T ss_pred eeeccCCCHHHHHhhhhh--hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhcc
Confidence 999999999999998886 3445554 35688999999999998 9999999989999999999999999999999999
Q ss_pred ccccCCCcccCCCCCC
Q 013064 351 YKPTVNGELDTQNFEK 366 (450)
Q Consensus 351 ~~p~~~~~~d~~~f~~ 366 (450)
|+|.+..+.|+++|+.
T Consensus 333 fvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 333 FVPQLESEDDTSYFDT 348 (1205)
T ss_pred ccccccccccchhhcc
Confidence 9999999999999985
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.15 Aligned_cols=207 Identities=32% Similarity=0.522 Sum_probs=187.9
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHH-----HHHHHHHHHHhcC---CCCeeeE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE-----HVRSERNLLAEVD---SRCIVQL 103 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~-----~~~~E~~il~~l~---hp~Iv~l 103 (450)
...-.+.+|..++.||.|+||+|++|.++.+...|++|.|.|++++-...++ .+-.|+.||..++ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 3445678999999999999999999999999999999999999887554443 3678999999997 9999999
Q ss_pred EEEEEcCCeEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 104 FYSFQDSDFLYLIMEYL-PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 104 ~~~f~~~~~lylVmEy~-~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
+++|++++++||+||-- +|-||+++|..+..++|.+++.++.|++.|+++||+.||||||||-||+.++.+|-+||+||
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 99999999999999976 78899999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-Cccccccc
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWS 261 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWS 261 (450)
|.|....+.. .-.++||..|.|||++.+..| +..-|||+
T Consensus 715 gsaa~~ksgp----------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwa 754 (772)
T KOG1152|consen 715 GSAAYTKSGP----------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWA 754 (772)
T ss_pred cchhhhcCCC----------------------------------------cceeeeeccccchhhhCCCccCCCcchhhh
Confidence 9988654421 235899999999999999998 89999999
Q ss_pred hhHHHHHHhhCCCCCCC
Q 013064 262 LGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 262 lGvilyeml~G~~PF~~ 278 (450)
||++||.+.+...||+.
T Consensus 755 lgillytivykenpyyn 771 (772)
T KOG1152|consen 755 LGILLYTIVYKENPYYN 771 (772)
T ss_pred hhheeeEEEeccCCCcC
Confidence 99999999999999863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.00 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=191.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc----------------CCCCEEEEEEeechhhcc-----------hhhHHHH
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK----------------TTGEIFAMKKLKKSEMLK-----------RGQVEHV 85 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~----------------~t~~~~AiK~i~k~~~~~-----------~~~~~~~ 85 (450)
.+.+.++|++.++||+|+||.||++... ..++.||||.+....... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 4567899999999999999999998642 245679999986432110 1112233
Q ss_pred HHHHHHHHhcCCCCe-----eeEEEEEEc--------CCeEEEEEeccCCCChHHHHHhc--------------------
Q 013064 86 RSERNLLAEVDSRCI-----VQLFYSFQD--------SDFLYLIMEYLPGGDIMTLLMRE-------------------- 132 (450)
Q Consensus 86 ~~E~~il~~l~hp~I-----v~l~~~f~~--------~~~lylVmEy~~gg~L~~~l~~~-------------------- 132 (450)
..|..++.++.|.++ ++++++|.. ....||||||+++|+|.+++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 456777777766544 666666542 45689999999999999988642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccccccccc
Q 013064 133 ----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208 (450)
Q Consensus 133 ----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 208 (450)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-------------- 365 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-------------- 365 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--------------
Confidence 12456778999999999999999999999999999999999999999999999754322100
Q ss_pred ccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC--------------------CC--ccccccchhHHH
Q 013064 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--------------------YG--MECDWWSLGAIM 266 (450)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~--------------------y~--~~~DiWSlGvil 266 (450)
......+||.|+|||++.... |+ ..+|+||+||++
T Consensus 366 -----------------------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil 422 (507)
T PLN03224 366 -----------------------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL 422 (507)
T ss_pred -----------------------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence 001134589999999986422 22 347999999999
Q ss_pred HHHhhCCC-CCCCCChh----hhhhhhh-----cccccccCCCCCCCCHHHHHHHHHhhc-Cc---cccCCCCCHHHHHc
Q 013064 267 YEMLIGYP-PFCSDDPR----ITCRKIV-----NWKTCLKFPEEPKISDEARDLICHLLC-DV---ETRLGTRGVEELKE 332 (450)
Q Consensus 267 yeml~G~~-PF~~~~~~----~~~~~i~-----~~~~~~~~p~~~~~s~~~~dli~~lL~-dp---~~R~~~~~~~eil~ 332 (450)
|+|++|.. ||.+.... ..+.... .......++.....++.++|||++||+ +| .+|+ +++|+|+
T Consensus 423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl---Sa~eaL~ 499 (507)
T PLN03224 423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRL---SVGQALS 499 (507)
T ss_pred HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCC---CHHHHhC
Confidence 99999985 77542111 1111111 011234455556789999999999997 66 5688 7999999
Q ss_pred CCCcCC
Q 013064 333 HPWFRG 338 (450)
Q Consensus 333 Hpff~~ 338 (450)
||||..
T Consensus 500 Hp~f~~ 505 (507)
T PLN03224 500 HRFFLP 505 (507)
T ss_pred CCCcCC
Confidence 999953
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.93 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=219.6
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 106 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 106 (450)
...+...+-...+.||+|+||+||+++... ....||||.++... .......+++|.++|..++|||||+|+++
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345777889999999999999999998643 34579999998654 23356789999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRE--------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 172 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~--------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld 172 (450)
+..++-+|||+|||..|||..+|+.. ..++..+...++.||+.|++||-++.+|||||-..|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 99999999999999999999999643 1278889999999999999999999999999999999999
Q ss_pred cCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC
Q 013064 173 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252 (450)
Q Consensus 173 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~ 252 (450)
++-.|||+||||++..=+..+ ||-.. ...-...|||||.|....
T Consensus 638 e~l~VKIsDfGLsRdiYssDY-------------------------------Yk~~~-----~t~lPIRWMppEsIly~k 681 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDY-------------------------------YKVRG-----NTLLPIRWMPPESILYGK 681 (774)
T ss_pred cceEEEecccccchhhhhhhh-------------------------------hcccC-----CceeeeecCCHHHhhcCc
Confidence 999999999999986433211 11100 123456799999999999
Q ss_pred CCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHH
Q 013064 253 YGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330 (450)
Q Consensus 253 y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei 330 (450)
|+.++||||+||+|||+++ |..|+.+.+..+....|.+++. +.-|+ ..+.++.+|+..|+. +|.+||+..++.-+
T Consensus 682 FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe--~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~ 758 (774)
T KOG1026|consen 682 FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPE--NCPTEVYSLMLECWNENPKRRPSFKEIHSR 758 (774)
T ss_pred ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCC--CCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 9999999999999999996 9999999999999999988654 66675 899999999999998 99999964444434
Q ss_pred H
Q 013064 331 K 331 (450)
Q Consensus 331 l 331 (450)
|
T Consensus 759 L 759 (774)
T KOG1026|consen 759 L 759 (774)
T ss_pred H
Confidence 4
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=316.57 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=218.1
Q ss_pred HHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC------CCe
Q 013064 27 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS------RCI 100 (450)
Q Consensus 27 ~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h------p~I 100 (450)
|++.+-..+.-+.|++....|+|-|++|..|++...|..||||+|...++.- +.=..|+.||++|+. -++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHH
Confidence 6667777777789999999999999999999999999999999998766433 334679999999953 589
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-c
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-H 176 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~---~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ 176 (450)
++|+-.|...+++|||+|-+ ..+|...|.+.+ .+....++.|+.|++.||..|-++||+|.||||+|||+++.. .
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 99999999999999999988 668999998865 588899999999999999999999999999999999998765 5
Q ss_pred eEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcc
Q 013064 177 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256 (450)
Q Consensus 177 ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~ 256 (450)
+||||||.|....... .+.+.-+..|.|||++.+.+|++.
T Consensus 576 LKLCDfGSA~~~~ene----------------------------------------itPYLVSRFYRaPEIiLG~~yd~~ 615 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE----------------------------------------ITPYLVSRFYRAPEIILGLPYDYP 615 (752)
T ss_pred eeeccCcccccccccc----------------------------------------ccHHHHHHhccCcceeecCcccCC
Confidence 7999999998765431 113455667999999999999999
Q ss_pred ccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccc-----------------------------------------
Q 013064 257 CDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL----------------------------------------- 295 (450)
Q Consensus 257 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------------------------------------- 295 (450)
.|+||+||.||||.||+..|.|.+...++...+..+..+
T Consensus 616 iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~v 695 (752)
T KOG0670|consen 616 IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNV 695 (752)
T ss_pred ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEeccc
Confidence 999999999999999999999987766654443211100
Q ss_pred --------------cCCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 296 --------------KFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 296 --------------~~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+|. .+.+-..++||+.+||. ||++|+ ++.++|+||||.+
T Consensus 696 kPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi---t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 696 KPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI---TVNQALKHPFITE 751 (752)
T ss_pred CcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC---CHHHHhcCCcccC
Confidence 0010 01223468999999999 999999 6899999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=297.26 Aligned_cols=260 Identities=27% Similarity=0.463 Sum_probs=209.5
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+.++.+-+..||.|+||.|++..++.+|+..|+|.|+.... .....++..|.+. ++.-++||||++|++.-.++.
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 4555677778899999999999999999999999999986543 3344566667765 455689999999999999999
Q ss_pred EEEEEeccCCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 113 LYLIMEYLPGGDIMTLL-----MREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l-----~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
.|+.||+|. -+|-.+- .++..++|...-.+.-..+.||+||-. ..|||||+||.|||+|..|.|||||||+|.
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 999999994 3443222 245689999999999999999999986 699999999999999999999999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc--cCCCCccccccchhH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMECDWWSLGA 264 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~--~~~y~~~~DiWSlGv 264 (450)
.+..+... +.-.|-..|||||.+. +.+|+-++|+||||+
T Consensus 217 qLv~SiAk---------------------------------------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 217 QLVDSIAK---------------------------------------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGI 257 (361)
T ss_pred hHHHHHHh---------------------------------------hhccCCccccChhccCCccCCcchhhhhhhhcc
Confidence 77553211 1246889999999996 467999999999999
Q ss_pred HHHHHhhCCCCCCCCCh-hhhhhhhhcccccc-cCCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 265 IMYEMLIGYPPFCSDDP-RITCRKIVNWKTCL-KFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~-~~~~~~i~~~~~~~-~~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+|||..||..|+.+-+. -+....++.+..+. .++. ....|..++.||..||. |-..|| ...+++++||++.
T Consensus 258 TL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp---ky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP---KYDDLKKFPFYRM 332 (361)
T ss_pred eEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc---chhhhhcCchhhh
Confidence 99999999999987543 34445555543322 2222 24589999999999998 999999 5789999999975
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=306.52 Aligned_cols=199 Identities=26% Similarity=0.406 Sum_probs=173.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-eEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD-FLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~-~lylV 116 (450)
++|..-..||+|+||.||++..... ..+|||.+....... ...+.+|+.+|..++|||+|+|++++.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 7888889999999999999987644 889999876543211 445999999999999999999999999988 59999
Q ss_pred EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCC---eEEeecCCCcEEEccCCceEEeeccccccCcc-
Q 013064 117 MEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHN---YVHRDIKPDNLILDKNGHLKLSDFGLCKPLED- 190 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~g---ivHrDLKpeNILld~~g~ikL~DFGla~~~~~- 190 (450)
+||++.|+|.++|.... .+++.....|+.+++.||+|||... ||||||||.|||||++...||+|||+|+....
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 99999999999998765 8999999999999999999999853 99999999999999999999999999976543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhcccccccc-ccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... ..+. .||..|+|||.+.....+.++||||+||+|.||
T Consensus 231 ~~~---------------------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 231 DTS---------------------------------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLEL 271 (361)
T ss_pred ccc---------------------------------------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHH
Confidence 210 0122 799999999999888889999999999999999
Q ss_pred hhCCCCCCCC
Q 013064 270 LIGYPPFCSD 279 (450)
Q Consensus 270 l~G~~PF~~~ 279 (450)
++|+.|....
T Consensus 272 itgr~~~d~~ 281 (361)
T KOG1187|consen 272 ITGRKAVDQS 281 (361)
T ss_pred HhCCcccCCC
Confidence 9999888643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=331.87 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=215.8
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCC-CC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTT-GE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t-~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+....-++.+.||+|+||.||.+..... |. .||+|.+++. .+......+.+|..+|+.++|||||+|+++.-+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3356788999999999999999997643 32 3899988764 456678899999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE-------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~-------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
....++|+|||.||||..+|++. ..++......++.+|+.|++||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999875 35888999999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|+|+.+-...+ |+...+ ..-...|||||.+....++.++|||||
T Consensus 847 GlArDiy~~~y-------------------------------yr~~~~-----a~lPvkWm~PEsl~d~iFtskSDvWsF 890 (1025)
T KOG1095|consen 847 GLARDIYDKDY-------------------------------YRKHGE-----AMLPVKWMPPESLKDGIFTSKSDVWSF 890 (1025)
T ss_pred chhHhhhhchh-------------------------------eeccCc-----cccceecCCHHHHhhcccccccchhhh
Confidence 99994432211 111100 122457999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 263 GAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 263 Gvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
||+|||+++ |.+||.+.+..+++.-.+.+. .+..| ...+..+.+++..|+. +|++|| ++..|++
T Consensus 891 GVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP---~F~~i~~ 956 (1025)
T KOG1095|consen 891 GVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRP---SFRTIVE 956 (1025)
T ss_pred HHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC--CCCChHHHHHHHHHccCChhhCc---cHHHHHh
Confidence 999999997 999999999988888777654 45555 5899999999999998 999999 5667765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=284.95 Aligned_cols=241 Identities=47% Similarity=0.773 Sum_probs=205.5
Q ss_pred CceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHH
Q 013064 50 AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL 129 (450)
Q Consensus 50 ~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l 129 (450)
+||.||+|....+|+.+|+|++........ .+.+.+|..+++.++|++|+++++.+.+....++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999976543221 578889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccc
Q 013064 130 MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209 (450)
Q Consensus 130 ~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 209 (450)
.....+++..+..++.+++.+|.+||+.||+|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 877779999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC-CChhhhhhhh
Q 013064 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS-DDPRITCRKI 288 (450)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i 288 (450)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.......+
T Consensus 142 ----------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~ 199 (244)
T smart00220 142 ----------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI 199 (244)
T ss_pred ----------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 01235789999999999988899999999999999999999999987 4444444444
Q ss_pred hcccccccCCCC-CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 289 VNWKTCLKFPEE-PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 289 ~~~~~~~~~p~~-~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
.... ...... ..++.++.+++.+||. +|.+|| ++.++++||||
T Consensus 200 ~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~~~~~~~ 244 (244)
T smart00220 200 GKPK--PPFPPPEWKISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 244 (244)
T ss_pred hccC--CCCccccccCCHHHHHHHHHHccCCchhcc---CHHHHhhCCCC
Confidence 3321 111111 1288999999999998 999999 68999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.44 Aligned_cols=262 Identities=27% Similarity=0.450 Sum_probs=214.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
..|.+--+-||-|+||.||.|.+..+|+.+|+|++..- ..+-...+.+.+|..+|...+|.|++.+++..|...
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 34666678999999999999999999999999988542 223334578999999999999999999999888654
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+|+|.| ..||..++.....++.+.++.++.||+.||.|||+.||.||||||.|+|++++..+||||||+|+..+..
T Consensus 131 EiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 131 ELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 488999999 4589888888889999999999999999999999999999999999999999999999999999975432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
.. +. .+.-+-|.+|.|||++++ ..|+.++||||+|||+.|||
T Consensus 210 ~~------------------------------------~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELL 252 (449)
T KOG0664|consen 210 DR------------------------------------LN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELL 252 (449)
T ss_pred hh------------------------------------hh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHH
Confidence 11 01 123477899999999997 67899999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcc---------------------cccccCCCC---------CCCCHHHHHHHHHhhc-Ccc
Q 013064 271 IGYPPFCSDDPRITCRKIVNW---------------------KTCLKFPEE---------PKISDEARDLICHLLC-DVE 319 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~---------------------~~~~~~p~~---------~~~s~~~~dli~~lL~-dp~ 319 (450)
-.+..|...++.+.+..|... +...+-|.. ..-..++.+++..||. ||.
T Consensus 253 gRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 253 QRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred hhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 999999999888777666521 111222211 1234578889999998 999
Q ss_pred ccCCCCCHHHHHcCCCcCCCC
Q 013064 320 TRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 320 ~R~~~~~~~eil~Hpff~~i~ 340 (450)
+|+ +.++.+.|++.....
T Consensus 333 kri---s~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 333 KRI---SVEEALQHRYLEEGR 350 (449)
T ss_pred ccc---cHhhhcccccccccc
Confidence 999 688999999987643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=328.11 Aligned_cols=238 Identities=21% Similarity=0.266 Sum_probs=184.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|....+||+|+||.||+|+.+.+|..||+|.+..... ....|+.++++++|||||++++++.+++..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45667789999999999999999999999999865321 11245788999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh---hCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH---QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH---~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|++||+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999853 889999999999999999999 6799999999999999998888775 665443211
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
..+..||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus 835 -------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 835 -------------------------------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred -------------------------------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 0124689999999999999999999999999999999999999
Q ss_pred CCCCChh--hhh---hhhhc------cc-ccc--cCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 276 FCSDDPR--ITC---RKIVN------WK-TCL--KFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 276 F~~~~~~--~~~---~~i~~------~~-~~~--~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|...... ... ..... +. ..+ ..+.......++.+++.+|+. ||.+|| ++.++++
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~evl~ 946 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP---CANDVLK 946 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc---CHHHHHH
Confidence 9543211 000 00000 00 000 000001112356789999998 999999 5677764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=282.15 Aligned_cols=130 Identities=23% Similarity=0.425 Sum_probs=116.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----C---CCeeeEEEEEEc
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----S---RCIVQLFYSFQD 109 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-----h---p~Iv~l~~~f~~ 109 (450)
.+|-++++||.|-|++||||.+..+.+.||||+.+... ...+....|+.+|+++. | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 79999999999999999999999999999999998654 35567888999999882 3 479999999975
Q ss_pred ----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEc
Q 013064 110 ----SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILD 172 (450)
Q Consensus 110 ----~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld 172 (450)
..++|||+|++ |..|..+|.+. +.++...++.|+.||+.||.|||. +||||-||||||||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 56899999999 88999999764 579999999999999999999997 6999999999999994
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=260.67 Aligned_cols=216 Identities=27% Similarity=0.485 Sum_probs=180.2
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEcCC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~~~ 111 (450)
-.+.-++..-+..||+|+||.|-+.++..+|...|+|.+.... .....++..+|.++... ..+|++|.+|+.+.++.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3455567777889999999999999999999999999986542 33345667778887654 58999999999999999
Q ss_pred eEEEEEeccCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 112 FLYLIMEYLPGGDIMTL----LMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~----l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
.+++.||.|. .+|..+ +.+.+.++|..+-.++..++.||+|||+ ..+||||+||.||||+.+|+||+||||.+.
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999994 344433 4557789999999999999999999997 599999999999999999999999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccc-cccCCCccchhhhcc----CCCCccccccc
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYS-TVGTLDYMAPEVLLK----KGYGMECDWWS 261 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~Gt~~Y~APEvl~~----~~y~~~~DiWS 261 (450)
.+.++.. .+ -.|-..|||||.+.. .+|+-++|+||
T Consensus 198 ~L~dSiA----------------------------------------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWS 237 (282)
T KOG0984|consen 198 YLVDSIA----------------------------------------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWS 237 (282)
T ss_pred eehhhhH----------------------------------------HHHhcCCCccCChhhcCcccCcccceeehhhhh
Confidence 7765321 12 468889999999863 58999999999
Q ss_pred hhHHHHHHhhCCCCCCC-CChhhhhhhhhcc
Q 013064 262 LGAIMYEMLIGYPPFCS-DDPRITCRKIVNW 291 (450)
Q Consensus 262 lGvilyeml~G~~PF~~-~~~~~~~~~i~~~ 291 (450)
||+.+.||.+++.||.. .++-+++.+++..
T Consensus 238 LGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 238 LGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 99999999999999964 5666777777763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=304.44 Aligned_cols=244 Identities=29% Similarity=0.421 Sum_probs=194.5
Q ss_pred EeEEeecCceE-EEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEEEecc
Q 013064 43 LTLIGKGAFGE-VRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 43 ~~~LG~G~fg~-V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
-+++|.|+-|+ ||++.. .|+.||+|.+-. +..+.+.+|+..|+.. +|||||+.|+.=++..++|+..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35789999986 677765 577999997743 3456788999999988 6999999999999999999999999
Q ss_pred CCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CC--ceEEeeccccccCccc
Q 013064 121 PGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NG--HLKLSDFGLCKPLEDK 191 (450)
Q Consensus 121 ~gg~L~~~l~~~~----~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g--~ikL~DFGla~~~~~~ 191 (450)
-.+|.+++...+ .......+..+.|++.||+|||+.+||||||||.||||+. +| .++|+|||+|+.+...
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 558999987631 1111345788999999999999999999999999999976 34 6799999999998765
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
..+ ++ +..+..||-.|+|||++....-..++|++||||++|..++
T Consensus 665 ~sS------------------------------~~-----r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvlt 709 (903)
T KOG1027|consen 665 KSS------------------------------FS-----RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLT 709 (903)
T ss_pred cch------------------------------hh-----cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEec
Confidence 322 11 1335689999999999998888889999999999999998
Q ss_pred C-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 272 G-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 272 G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
| ..||.+.- +...+|++....+..-. +.-..+|+|||.+||. +|..|| ++.+++.||||
T Consensus 710 gG~HpFGd~~--~R~~NIl~~~~~L~~L~-~~~d~eA~dLI~~ml~~dP~~RP---sa~~VL~HPlF 770 (903)
T KOG1027|consen 710 GGSHPFGDSL--ERQANILTGNYTLVHLE-PLPDCEAKDLISRMLNPDPQLRP---SATDVLNHPLF 770 (903)
T ss_pred CCccCCCchH--HhhhhhhcCccceeeec-cCchHHHHHHHHHhcCCCcccCC---CHHHHhCCCcc
Confidence 6 89996543 33456666544332211 1111299999999999 999999 68999999999
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.83 Aligned_cols=240 Identities=25% Similarity=0.384 Sum_probs=204.5
Q ss_pred EEeEEeecCceEEEEEEEcCC--C--CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTT--G--EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t--~--~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.+.||.|-||.||.+..... | --||||..++.. ..+..+.+..|.-+|++++|||||+|++++.+. -.|+||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 346799999999999986433 3 358999988754 344578899999999999999999999999864 589999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|+++-|+|..+|+.+ ..++......|+.||+.||.|||+.++|||||-..|||+.+...|||+||||++.+....+.
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY-- 547 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY-- 547 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh--
Confidence 999999999999875 57899999999999999999999999999999999999999999999999999988654221
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~P 275 (450)
+.+ ...-..-|||||.+.-..++.++|+|.|||.+||+|. |..|
T Consensus 548 -----------------------------kaS------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkP 592 (974)
T KOG4257|consen 548 -----------------------------KAS------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKP 592 (974)
T ss_pred -----------------------------hcc------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCc
Confidence 111 1223567999999999999999999999999999885 9999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
|.+-...+....|.++. .+ |.++..++.+..|..+|+. +|.+||..
T Consensus 593 fqgvkNsDVI~~iEnGe-Rl--P~P~nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 593 FQGVKNSDVIGHIENGE-RL--PCPPNCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred cccccccceEEEecCCC-CC--CCCCCCChHHHHHHHHHhccCcccCCcH
Confidence 99988888888887753 33 4446899999999999999 99999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=301.83 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=222.8
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
-.+||+++.++|.|+||.||+++++.+++..|+|+++-.. .....-+..|+-+++..+|||||-+++.|-..+.+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3489999999999999999999999999999999997543 3456678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
.||||.||+|.+.-.-.+.++|.++.+..++.+.+|+|||+.|-+|||||-.|||+++.|++||+|||.+..+.....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-- 167 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-- 167 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh--
Confidence 999999999999887788999999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhhC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~G 272 (450)
+..++.|||+|||||+-. ..+|+..||+|++|+...|+---
T Consensus 168 ------------------------------------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eL 211 (829)
T KOG0576|consen 168 ------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGEL 211 (829)
T ss_pred ------------------------------------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhc
Confidence 123689999999999874 57899999999999999999988
Q ss_pred CCCCCCCChhhhhhhhhc-ccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 273 YPPFCSDDPRITCRKIVN-WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
++|-...-+......+.+ ...+....+....++.+-+|++..|. +|++|+ +++-++.|||...-
T Consensus 212 qpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp---taeklL~h~fvs~~ 277 (829)
T KOG0576|consen 212 QPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP---TAEKLLQHPFVSQT 277 (829)
T ss_pred CCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC---Chhhheeceeeccc
Confidence 999766655544433322 22223333345789999999999998 999999 57888999998753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=287.68 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=206.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+-.+...+.+.||+|-||.|.+|... .+..||+|+++... .......+..|+.+|.+++|||||+|++++..++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34456778899999999999999865 36889999997653 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||++.|||..+|.++. ....+....++.||+.|++||.+.++|||||.+.|+|+|.++++||+|||+++.+-+..
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999998873 33445566799999999999999999999999999999999999999999998654332
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh--
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-- 270 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml-- 270 (450)
+..+ -...+-...|||||.+....++.++|+|++||++||++
T Consensus 692 yy~v------------------------------------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~ 735 (807)
T KOG1094|consen 692 YYRV------------------------------------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFML 735 (807)
T ss_pred ceee------------------------------------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHH
Confidence 2211 01246678899999999999999999999999999986
Q ss_pred hCCCCCCCCChhhhhhhhh---ccccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 271 IGYPPFCSDDPRITCRKIV---NWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~---~~~~~-~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+...||.....+...++.. ..+.. ...+.++-.+..+..|+.+|+. +-.+|| +++++-
T Consensus 736 C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP---sFe~lh 798 (807)
T KOG1094|consen 736 CREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP---SFEQLH 798 (807)
T ss_pred HhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC---CHHHHH
Confidence 4788998776665554432 11111 1122235678899999999998 999999 577763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.83 Aligned_cols=246 Identities=21% Similarity=0.340 Sum_probs=210.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCC-CC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTT-GE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t-~~--~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
++..+.+.||+|.||.|+.+.++.. |+ .||+|+++...... ....+.+|..+|-+|+||++++||++.-+ ..+-
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 4566778999999999999998753 44 48999997665432 67889999999999999999999999988 6789
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
||||++++|+|.+.|.+ +..|.......|+.||+.|+.||.++++|||||-..|+|+.....|||+||||.+.+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999987 4578899999999999999999999999999999999999999999999999999887642
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
....+ +...--...|.|||.++...++.++|+|++||++|||++
T Consensus 267 d~Yvm-----------------------------------~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFty 311 (1039)
T KOG0199|consen 267 DMYVM-----------------------------------APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTY 311 (1039)
T ss_pred cceEe-----------------------------------cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhcc
Confidence 22111 001123456999999999999999999999999999996
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
|.-||.|.....++++|- .+..+..|. ..|+++.++++.|+. +|.+|++.
T Consensus 312 GEePW~G~~g~qIL~~iD-~~erLpRPk--~csedIY~imk~cWah~paDRptF 362 (1039)
T KOG0199|consen 312 GEEPWVGCRGIQILKNID-AGERLPRPK--YCSEDIYQIMKNCWAHNPADRPTF 362 (1039)
T ss_pred CCCCCCCCCHHHHHHhcc-ccccCCCCC--CChHHHHHHHHHhccCCccccccH
Confidence 899999999999999887 445566664 799999999999999 99999954
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=291.56 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=223.2
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+.+..+.-.+-++||.|-||.|+.++.+..|+ .||||.++-.. ...+...+..|..||-+++||||++|-++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 46777888899999999999999999998775 69999997653 45567789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
.+-+.+|+|||++|.|..+|+++ +.|+..+..-+++.|+.|+.||-++|+|||||-..|||++.+-.+|++||||++.+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999875 57999999999999999999999999999999999999999999999999999987
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccc-c--CCCccchhhhccCCCCccccccchhHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV-G--TLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~-G--t~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
.+.... +++.. | ...|.|||.|....++.++|+||+|++
T Consensus 782 edd~~~--------------------------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIV 823 (996)
T KOG0196|consen 782 EDDPEA--------------------------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 823 (996)
T ss_pred ccCCCc--------------------------------------cccccCCccceeecChhHhhhcccCchhhccccceE
Confidence 654211 12222 2 357999999999999999999999999
Q ss_pred HHHHh-hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 266 MYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 266 lyeml-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|||.+ +|..||...+..+.+..|.++ +.+|.+...+..+..|+..|++ |-..|| .+.+|..+
T Consensus 824 mWEVmSyGERPYWdmSNQdVIkaIe~g---yRLPpPmDCP~aL~qLMldCWqkdR~~RP---~F~qiV~~ 887 (996)
T KOG0196|consen 824 MWEVMSYGERPYWDMSNQDVIKAIEQG---YRLPPPMDCPAALYQLMLDCWQKDRNRRP---KFAQIVST 887 (996)
T ss_pred EEEecccCCCcccccchHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHHHHHHhhcCC---CHHHHHHH
Confidence 99966 699999999999999888863 5666667899999999999998 999999 46777653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=277.64 Aligned_cols=293 Identities=22% Similarity=0.343 Sum_probs=209.5
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ 108 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~---t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~ 108 (450)
.+-..+.|..+..||.|+|+.||++.+.. .++.+|+|.+.... ...++.+|.++|..+ .+.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34455889999999999999999999887 78899999986543 456799999999998 6899999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-cCCceEEeecccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKP 187 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-~~g~ikL~DFGla~~ 187 (450)
.++.+.+||||++..+..++... ++-.+++.|+.+++.||.++|.+|||||||||.|+|.+ ..+.-.|+|||||..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999999988888754 67899999999999999999999999999999999997 467889999999984
Q ss_pred Cccccccccccc----cccc-cccccccccc-cCCChHHHHHHH-H---hhccccccccccCCCccchhhhccC-CCCcc
Q 013064 188 LEDKYSSILLED----EDII-NQETVSEAEG-QWMMPKERLQQW-K---RNRRALAYSTVGTLDYMAPEVLLKK-GYGME 256 (450)
Q Consensus 188 ~~~~~~~~~~~~----~~~~-~~~~~~~~~~-~~~~~~~~~~~~-~---~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~ 256 (450)
............ .... .......... ....| ..+ + ..++..-....|||.|.|||++.+- .-+.+
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p----~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKP----AGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCC----CCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 221100000000 0000 0000000000 00000 000 0 1122233456899999999999864 45899
Q ss_pred ccccchhHHHHHHhhCCCCCCCCC-hhhhhhhh-------------------hccc-c-------------cc-------
Q 013064 257 CDWWSLGAIMYEMLIGYPPFCSDD-PRITCRKI-------------------VNWK-T-------------CL------- 295 (450)
Q Consensus 257 ~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i-------------------~~~~-~-------------~~------- 295 (450)
+|+||.|||+.-++++..||.... .......| .-|. . .+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999985332 11111111 0010 0 00
Q ss_pred -cC------CCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 296 -KF------PEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 296 -~~------p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
.. ......+..+.||+.+||. ||.+|+ +++++|+||||...+
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRi---tAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRI---TAEDALKHPFFDEAD 388 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcc---cHHHHhcCcCCcchh
Confidence 00 0012345689999999998 999999 689999999998543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=281.82 Aligned_cols=246 Identities=21% Similarity=0.332 Sum_probs=210.7
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
...|.....+||-|.||.||.+.++.-.-.+|+|.++...+ .++.+..|..+|+.++|||+|+|++++..+--+|+
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33566677899999999999999998888899999976543 57889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 116 IMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+|||..|+|.+||++.. -++.-...+++.||..|++||..+++|||||-..|+|+.++..||++||||++.+....+
T Consensus 341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 999999999999998754 356666677788999999999999999999999999999999999999999998876533
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
.... ..--..-|.|||-+....++.++|+|+|||+|||+.| |
T Consensus 421 TAHA-------------------------------------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYG 463 (1157)
T KOG4278|consen 421 TAHA-------------------------------------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYG 463 (1157)
T ss_pred eccc-------------------------------------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcC
Confidence 2110 0112456999999999999999999999999999986 9
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 325 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~ 325 (450)
-.||.|-+....|..+.++ ..+.-|+ .+++.+..|++.|+. .|.+||...
T Consensus 464 MsPYPGidlSqVY~LLEkg-yRM~~Pe--GCPpkVYeLMraCW~WsPsDRPsFa 514 (1157)
T KOG4278|consen 464 MSPYPGIDLSQVYGLLEKG-YRMDGPE--GCPPKVYELMRACWNWSPSDRPSFA 514 (1157)
T ss_pred CCCCCCccHHHHHHHHhcc-ccccCCC--CCCHHHHHHHHHHhcCCcccCccHH
Confidence 9999999888777666543 4455564 899999999999999 999999643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=251.13 Aligned_cols=212 Identities=41% Similarity=0.660 Sum_probs=183.9
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
|.+.+.||.|++|.||++.+..+++.+|+|.+.+.... ...+.+.+|...++.++|++++++++++......|+|+||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999998999999999865422 2567888999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 120 LPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 120 ~~gg~L~~~l~~~~~-~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
+++++|.+++..... +++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence 999999999988776 899999999999999999999999999999999999999999999999998876432100
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh-ccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-LKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
......++..|++||++ ....++.++|+||||+++|+|++|++||.
T Consensus 155 ---------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 ---------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ---------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 01135788999999999 66778889999999999999999999998
Q ss_pred C-CChh-hhhhhhhc
Q 013064 278 S-DDPR-ITCRKIVN 290 (450)
Q Consensus 278 ~-~~~~-~~~~~i~~ 290 (450)
+ .+.. .....|..
T Consensus 202 ~~~~~~~~~~~~~~~ 216 (225)
T smart00221 202 GEGEFTSLLSDVWSF 216 (225)
T ss_pred ccchhHHHHHHHHhc
Confidence 7 4444 55555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-31 Score=241.03 Aligned_cols=211 Identities=42% Similarity=0.683 Sum_probs=186.6
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCCh
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L 125 (450)
||.|++|.||++....+|+.+++|++....... ..+.+.+|..+++.+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654211 356789999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeeccccccCccccccccccccccc
Q 013064 126 MTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDII 203 (450)
Q Consensus 126 ~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DFGla~~~~~~~~~~~~~~~~~~ 203 (450)
..++... ..++++.+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999776 57899999999999999999999999999999999999999 89999999999986543210
Q ss_pred cccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCCCCCCCCChh
Q 013064 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282 (450)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 282 (450)
......+...|++||.+... .++.+.|+|+||+++|+|
T Consensus 149 ----------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------- 187 (215)
T cd00180 149 ----------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------- 187 (215)
T ss_pred ----------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------
Confidence 01135688999999999876 889999999999999999
Q ss_pred hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCC
Q 013064 283 ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334 (450)
Q Consensus 283 ~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hp 334 (450)
..+.+++.+|+. +|.+|+ +++++++|+
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~---~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCc---CHHHHhhCC
Confidence 678999999998 999999 688998875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=282.95 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=204.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcC---C----CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKT---T----GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ 108 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~---t----~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~ 108 (450)
.++..+.+.||.|+||+|+++..+. . ...+|+|.++.... ..+.+.+..|+++|+.+ .||||+.|.+++.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 3445566799999999999988531 1 34699999876543 36678899999999998 6999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 172 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld 172 (450)
..+.+++|+||+..|+|..+|+..+ .++......++.||+.|++||++..+|||||-..|||+.
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 9999999999999999999998766 488889999999999999999999999999999999999
Q ss_pred cCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhcccccccccc--CCCccchhhhcc
Q 013064 173 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVG--TLDYMAPEVLLK 250 (450)
Q Consensus 173 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G--t~~Y~APEvl~~ 250 (450)
.+..+|++|||+|+.......... ....| ...|||||.+..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~-------------------------------------~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT-------------------------------------KSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe-------------------------------------cCCCCccceeecCHHHhcc
Confidence 999999999999996543211100 01122 234999999999
Q ss_pred CCCCccccccchhHHHHHHhh-CCCCCCCCC-hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 251 KGYGMECDWWSLGAIMYEMLI-GYPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 251 ~~y~~~~DiWSlGvilyeml~-G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
..|+.++|+||+||+|||+++ |..||.+-. ..+.+..+.. ...+..|. ..+++..++++.|+. +|++||+ +
T Consensus 496 ~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r~~~P~--~c~~eiY~iM~~CW~~~p~~RP~---F 569 (609)
T KOG0200|consen 496 RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNRMEQPE--HCSDEIYDLMKSCWNADPEDRPT---F 569 (609)
T ss_pred CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHhCCCcccCCC---H
Confidence 999999999999999999997 999998854 4455554444 34566665 679999999999998 9999995 4
Q ss_pred HHHH
Q 013064 328 EELK 331 (450)
Q Consensus 328 ~eil 331 (450)
.++.
T Consensus 570 ~~~~ 573 (609)
T KOG0200|consen 570 SECV 573 (609)
T ss_pred HHHH
Confidence 4444
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=253.28 Aligned_cols=239 Identities=22% Similarity=0.334 Sum_probs=188.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEE-EEEcCCeEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY-SFQDSDFLYL 115 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~-~f~~~~~lyl 115 (450)
+.|.+.+.||.|-||++.+|+|+.++..+++|.+.+... ....+.+|...--.| .|.||+.-|+ +||+.+.+.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 689999999999999999999999999999999987653 345677777765555 5899999887 5899999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc--cCCceEEeeccccccCccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld--~~g~ikL~DFGla~~~~~~~~ 193 (450)
+|||+|-|||.+-+.. ..+-|...+.+++|+++||+|+|+.++||||||.|||||- +...|||||||+.+..+....
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 9999999999988765 4488999999999999999999999999999999999994 334899999999876543210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CC--CCccccccchhHHHHH
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KG--YGMECDWWSLGAIMYE 268 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~--y~~~~DiWSlGvilye 268 (450)
-.--+..|.|||++.. +. ..+.+|+|.||+++|.
T Consensus 179 -----------------------------------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~ 217 (378)
T KOG1345|consen 179 -----------------------------------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFY 217 (378)
T ss_pred -----------------------------------------hhhhhcccCCcHHHhhccccceEecccccchheeeeeee
Confidence 0123567899998753 33 3788999999999999
Q ss_pred HhhCCCCCCCCChhh-hhhhhhcccc--cccCCC-CCCCCHHHHHHHHHhhc-CccccC
Q 013064 269 MLIGYPPFCSDDPRI-TCRKIVNWKT--CLKFPE-EPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 269 ml~G~~PF~~~~~~~-~~~~i~~~~~--~~~~p~-~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+|+|.+||.....+. -+.+-++|.. ....|. ...+|+.+..+.++.|. ++++|-
T Consensus 218 cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 218 CLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred eecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 999999997543221 2222222221 223342 24689999999999998 888884
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=263.74 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=195.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEcCC-
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQDSD- 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~f~~~~- 111 (450)
+.+...+++.+||+|.||.||+++. +++.||||++... +.+.+.+|++|.+. ++|+||++++++-....
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 3456778889999999999999976 5699999999744 45678899999876 48999999998876544
Q ss_pred ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC---------CeEEeecCCCcEEEccCCceEE
Q 013064 112 ---FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH---------NYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 112 ---~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~---------givHrDLKpeNILld~~g~ikL 179 (450)
.++||++|-+.|+|.++|.. ..++......++..|+.||+|||+- .|+|||||..|||+..|+...|
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 79999999999999999965 5689999999999999999999963 4999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCC----
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYG---- 254 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~---- 254 (450)
+|||||..+...... ..+...+||..|||||++.+. .+.
T Consensus 358 aDFGLAl~~~p~~~~------------------------------------~d~~~qVGT~RYMAPEvLEgainl~d~~A 401 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQ------------------------------------GDTHGQVGTRRYMAPEVLEGAINLQDRDA 401 (534)
T ss_pred eccceeEEecCCCCC------------------------------------cchhhhhhhhhhcCHHHHhhhcccccHHH
Confidence 999999987643211 112246999999999999752 222
Q ss_pred -ccccccchhHHHHHHhhCCC------------CCC-----CCChhhhhhhhhcccccccCCCCC---CCCHHHHHHHHH
Q 013064 255 -MECDWWSLGAIMYEMLIGYP------------PFC-----SDDPRITCRKIVNWKTCLKFPEEP---KISDEARDLICH 313 (450)
Q Consensus 255 -~~~DiWSlGvilyeml~G~~------------PF~-----~~~~~~~~~~i~~~~~~~~~p~~~---~~s~~~~dli~~ 313 (450)
...|+||+|.+||||++... ||. ..+..++...++..+....+|+.. .--..+++.|..
T Consensus 402 fkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~Ee 481 (534)
T KOG3653|consen 402 FKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEE 481 (534)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHH
Confidence 56899999999999998643 332 123345555566656666666521 223467888999
Q ss_pred hhc-CccccCCCC
Q 013064 314 LLC-DVETRLGTR 325 (450)
Q Consensus 314 lL~-dp~~R~~~~ 325 (450)
|+. |++.|+++.
T Consensus 482 CWDhDaeARLTA~ 494 (534)
T KOG3653|consen 482 CWDHDAEARLTAG 494 (534)
T ss_pred HcCCchhhhhhhH
Confidence 998 999999763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=255.09 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=187.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEcCC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~f~~~~ 111 (450)
+.-..+-.+++.||+|.||+||.+++ .|+.||+|++...+ .....+|.+|.+. |+|+||+.++++=..++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 33447889999999999999999988 58889999997432 3556778888765 59999999998755433
Q ss_pred ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC--------CeEEeecCCCcEEEccCCceEE
Q 013064 112 ----FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--------NYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 112 ----~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~--------givHrDLKpeNILld~~g~ikL 179 (450)
.+|||++|-+.|+|+++|.+ ..++.+....++..+++||+|||.. .|.|||||..|||+.++|.+.|
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 59999999999999999987 6799999999999999999999953 3999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC----C--
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----Y-- 253 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~----y-- 253 (450)
+|+|||....+.....- ......|||..|||||++...- +
T Consensus 358 ADLGLAv~h~~~t~~id----------------------------------i~~N~rVGTKRYMAPEvLdetin~~~Fes 403 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTID----------------------------------IPPNPRVGTKRYMAPEVLDETINMKHFES 403 (513)
T ss_pred eeceeeEEecccCCccc----------------------------------CCCCCccceeeccChHHhhhhcChhhhhh
Confidence 99999987655321100 0123579999999999996421 1
Q ss_pred CccccccchhHHHHHHhhC----------CCCCCCC----Chhhhhhhhh-cccccccCCCCCCCCHHH---HHHHHHhh
Q 013064 254 GMECDWWSLGAIMYEMLIG----------YPPFCSD----DPRITCRKIV-NWKTCLKFPEEPKISDEA---RDLICHLL 315 (450)
Q Consensus 254 ~~~~DiWSlGvilyeml~G----------~~PF~~~----~~~~~~~~i~-~~~~~~~~p~~~~~s~~~---~dli~~lL 315 (450)
-..+||||||.++||++-. .+||.+- ...+.+++++ -.+....+|....-.+.+ ..|++.|+
T Consensus 404 yk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 404 YKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECW 483 (513)
T ss_pred hhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhh
Confidence 2558999999999998853 4788652 2223333333 223334444432333443 45677888
Q ss_pred c-CccccCCC
Q 013064 316 C-DVETRLGT 324 (450)
Q Consensus 316 ~-dp~~R~~~ 324 (450)
. +|..|+++
T Consensus 484 ~~Np~aRltA 493 (513)
T KOG2052|consen 484 YANPAARLTA 493 (513)
T ss_pred cCCchhhhHH
Confidence 7 99999953
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=269.53 Aligned_cols=243 Identities=21% Similarity=0.297 Sum_probs=201.7
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
....++||+|+||+||++.+-..|+ +||+|++.... .......+..|.-+|..++|||+++|+++.+... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456799999999999999865555 68999887654 3344567889999999999999999999999877 889
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|++|+|+|.|.++++.+ +.+-......|..||+.|+.|||.+++|||||-..|||+.+-.|+|++|||+|+.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999764 57888899999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~ 273 (450)
.. +...--.+.|||-|.+....|+.++||||+||.+||++| |.
T Consensus 855 y~------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 855 YS------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred cc------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 00 011123567999999999999999999999999999996 99
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
.|+.+....++-..+..+ ..+.-| +..+.++.-++.+||. |+..||+.
T Consensus 899 ~Py~gi~~~eI~dlle~g-eRLsqP--piCtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 899 KPYDGIPAEEIPDLLEKG-ERLSQP--PICTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred CccCCCCHHHhhHHHhcc-ccCCCC--CCccHHHHHHHHHHhccCcccCccH
Confidence 999988776655444433 334444 5789999999999997 99999964
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=294.66 Aligned_cols=229 Identities=13% Similarity=0.141 Sum_probs=155.3
Q ss_pred cCC-CCeeeEEEEE-------EcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecC
Q 013064 95 VDS-RCIVQLFYSF-------QDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165 (450)
Q Consensus 95 l~h-p~Iv~l~~~f-------~~~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLK 165 (450)
+.| +||++++++| .....++++|||+ +++|..+|.. ...+++.+++.|+.||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 5788888887 3345688899988 6699999975 3569999999999999999999999999999999
Q ss_pred CCcEEEccCCceEEeeccccccCcccccccc-ccccccccccccccccccCCChHHHHHHHHhh-ccccccccccCCCcc
Q 013064 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSIL-LEDEDIINQETVSEAEGQWMMPKERLQQWKRN-RRALAYSTVGTLDYM 243 (450)
Q Consensus 166 peNILld~~g~ikL~DFGla~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~Gt~~Y~ 243 (450)
|+||||+..|.+|++|||+|..........+ ..+.+....... ... ............ ........+||+.||
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI----LSE-RRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCccccccccccccccc----ccc-cchhhhhccccCCCcccccccCCCcceE
Confidence 9999999888888888888875432211000 000000000000 000 000000000000 000011357999999
Q ss_pred chhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCC-CCCCCHHHHHHHHHhhc-Ccccc
Q 013064 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 244 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-dp~~R 321 (450)
|||++.+..|+.++|||||||+||||++|.+||..... ....+... .+|. ...-.+.+.+++.+||. +|.+|
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~~~P~~R 256 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR----VLPPQILLNWPKEASFCLWLLHPEPSCR 256 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh----hcChhhhhcCHHHHHHHHHhCCCChhhC
Confidence 99999999999999999999999999999999864321 22222111 1111 11235667899999998 99999
Q ss_pred CCCCCHHHHHcCCCcCC
Q 013064 322 LGTRGVEELKEHPWFRG 338 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~ 338 (450)
| ++.+|+.||||..
T Consensus 257 p---s~~eil~h~~~~~ 270 (793)
T PLN00181 257 P---SMSELLQSEFINE 270 (793)
T ss_pred c---ChHHHhhchhhhh
Confidence 9 6899999999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=276.15 Aligned_cols=322 Identities=32% Similarity=0.497 Sum_probs=266.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
.++++|.+++-+-+|++|.++.+....+|...+.|+..+...+...+.+....+.+++....+|.++.....|.....++
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 57889999999999999999999999999999999999888888888888999999998889999999999988888999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|||+|+.||+|...|+.-++.+++.++.++..++.++++||...++|||++|.|+|+..+||.+++|||.......-...
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999965543221100
Q ss_pred ccccccccccccccccccccCCC-hHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMM-PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
. +.. .......+.+. ...+..+............+||+.|.|||++.+...+..+|||++|++++|.++|.
T Consensus 961 ~-----~~s---g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 961 T-----DLS---GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred C-----Ccc---cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 0 000 00000000000 00000111110011234578999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCCc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAY 351 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~ 351 (450)
+||....+...+.+|.+.. ...|. ....++++++++..+|. +|.+|+++.++.+++.||||++++|+.|.....+|
T Consensus 1033 pp~na~tpq~~f~ni~~~~--~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~ 1110 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRD--IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEF 1110 (1205)
T ss_pred CCCCCcchhhhhhccccCC--CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCcc
Confidence 9999999999999998743 33332 24689999999999998 99999999888999999999999999999989999
Q ss_pred cccCCCcccCCCCCC
Q 013064 352 KPTVNGELDTQNFEK 366 (450)
Q Consensus 352 ~p~~~~~~d~~~f~~ 366 (450)
+|...+..|+++|..
T Consensus 1111 ~p~~~s~~dtS~~~~ 1125 (1205)
T KOG0606|consen 1111 VPQPESTQDTSYFES 1125 (1205)
T ss_pred CCCCCCCCccchhhc
Confidence 999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-28 Score=232.54 Aligned_cols=261 Identities=40% Similarity=0.602 Sum_probs=207.2
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC-CeeeEEEEEEcCCeEEEEEe
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~f~~~~~lylVmE 118 (450)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999987 78999999877654434577889999999999988 79999999988888999999
Q ss_pred ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccCcccccc
Q 013064 119 YLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 119 y~~gg~L~~~l~~~~---~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~~~~~ 194 (450)
|+.|+++..++.... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++..+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997777664 799999999999999999999999999999999999999988 7999999999855433111
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHHHHHhh
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvilyeml~ 271 (450)
... .......+||+.|+|||.+.+ ..+....|+||+|++++++++
T Consensus 159 ~~~--------------------------------~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 159 SSI--------------------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred ccc--------------------------------cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence 000 001235789999999999987 578999999999999999999
Q ss_pred CCCCCCCCCh----hhhhhhhhccccc-ccCCCCCCC----CHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 272 GYPPFCSDDP----RITCRKIVNWKTC-LKFPEEPKI----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 272 G~~PF~~~~~----~~~~~~i~~~~~~-~~~p~~~~~----s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|..||..... ......+...... ...+..... ...+.+++.+++. +|..|.. ..+...++|...
T Consensus 207 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~~ 280 (384)
T COG0515 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLAH 280 (384)
T ss_pred CCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhhC
Confidence 9999877663 3344444332211 111111111 2578999999998 9999994 455555655443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=273.58 Aligned_cols=266 Identities=24% Similarity=0.385 Sum_probs=208.0
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeech---hhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~---~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
....++|.|++|.|+.+......+.++.|..... ....+.....+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999999998888877777777765421 1112222233566666777789999988888777777777779
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||++ ||+.++...+.++..++..++.|++.||.|||+.||.||||||+|+|+..+|.+||+|||.+..+........
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~- 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI- 478 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh-
Confidence 99999 9999999988999999999999999999999999999999999999999999999999999987655432210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF 276 (450)
......+|+..|+|||++.+..| ...+|+||.|++++.|.+|+.||
T Consensus 479 ---------------------------------~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~W 525 (601)
T KOG0590|consen 479 ---------------------------------HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPW 525 (601)
T ss_pred ---------------------------------hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcc
Confidence 12335799999999999999999 57799999999999999999999
Q ss_pred CCCChhhhh-hhh--hccccc--ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccc
Q 013064 277 CSDDPRITC-RKI--VNWKTC--LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 277 ~~~~~~~~~-~~i--~~~~~~--~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 344 (450)
.-....+.. ..+ ..+... ...+....++...+.+|.+||. ||.+|. ++++|++.+||+.|+-..+
T Consensus 526 k~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~---ti~~i~~d~W~~~i~~c~v 596 (601)
T KOG0590|consen 526 KVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI---TIEQILNDEWIRSIECCHV 596 (601)
T ss_pred ccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee---cHHHHhhChHhhhcceEEe
Confidence 765443332 111 111100 1111124678899999999999 999999 7999999999999875544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=225.24 Aligned_cols=161 Identities=20% Similarity=0.194 Sum_probs=129.2
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 123 GDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 123 g~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
|+|.+++.. ...+++++++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 789999987 456999999999999999999999999 999999999999999 9998764321
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCCh
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 281 (450)
..+||+.|||||++.+..|+.++|||||||++|||++|..||.....
T Consensus 63 ---------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 63 ---------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred ---------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 23689999999999999999999999999999999999999976543
Q ss_pred h-hhhhhhhcccccccC---CCCCCCCH--HHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 282 R-ITCRKIVNWKTCLKF---PEEPKISD--EARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 282 ~-~~~~~i~~~~~~~~~---p~~~~~s~--~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
. .....+......... +....++. .+++||.+||. ||.+|+ ++.+++.|+|+.
T Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~ll~~~~~~ 169 (176)
T smart00750 110 LSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE---AANHYLAHCRAL 169 (176)
T ss_pred hcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc---CHHHHHHHHHHH
Confidence 2 233333321111100 11123344 69999999998 999999 689999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=239.51 Aligned_cols=147 Identities=16% Similarity=0.168 Sum_probs=118.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcC-CCCEEEEEEeechhh--cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~-t~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+.-.++|.+.+.||+|+||+||+|+++. +++.+|||++..... ......+.+.+|..+|+.++|++|+..+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456889999999999999999999876 788889998753311 1223456789999999999999998533322
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeec-CCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI-KPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDL-KpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+..|+|||||+|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.+|.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45899999999999963 211 11 1467899999999999999999999 9999999999999999999999765
Q ss_pred c
Q 013064 190 D 190 (450)
Q Consensus 190 ~ 190 (450)
.
T Consensus 164 ~ 164 (365)
T PRK09188 164 R 164 (365)
T ss_pred c
Confidence 3
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=224.82 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=186.4
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCC-CEEEEEEeechhhcchhhHHHHHHHHHHHHhcC----CCCeeeEEEEE-EcCCe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD----SRCIVQLFYSF-QDSDF 112 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~-~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~----hp~Iv~l~~~f-~~~~~ 112 (450)
.|.+.+.||+|+||.||+|.+..++ +.+|+|+......... ..+..|..+|..+. .+++..+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998775 6799998876432211 15777899988886 36999999999 58889
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-----CceEEeecccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-----GHLKLSDFGLC 185 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~-----g~ikL~DFGla 185 (450)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.||++||+.|++||||||+|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999988554 589999999999999999999999999999999999999865 35999999999
Q ss_pred ccCc--cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchh
Q 013064 186 KPLE--DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263 (450)
Q Consensus 186 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlG 263 (450)
+... ....... +..+.....+.||..|.++.+..+...+...|+||++
T Consensus 175 r~~~~~~~~~~~~------------------------------~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~ 224 (322)
T KOG1164|consen 175 RRFKYVGDSGGNL------------------------------RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLF 224 (322)
T ss_pred ccccccCCCCccc------------------------------ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHH
Confidence 9432 2111000 0000101236799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhhhhhhhcccccccCC-CCCCCCHHHHHHHHHhhc-CccccC
Q 013064 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
.++.+|+.|..||.+........++.........+ .....+.+...+...+-. +...+|
T Consensus 225 Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 285 (322)
T KOG1164|consen 225 YMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKP 285 (322)
T ss_pred HHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence 99999999999997765433333332221222221 111233455555444444 555665
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=220.02 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=205.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCE-----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI-----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ- 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~-----~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~- 108 (450)
+...++++...+-+|.||.||.+.+++...+ +-+|.++.. ..+-++..+..|--+|..+.|||+....++..
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 4445688888999999999999977654332 334444322 24456778888999999999999999998765
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEe
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE--------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~--------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~ 180 (450)
+....+.++.++.-|+|..+|... ..++..+...++.|+..|++|||+.||||.||-..|.+||+.-.|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 456788889999999999999732 347777888899999999999999999999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcccccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiW 260 (450)
|=.+++.+-...+..+.+. ---...|||||.+.+..|+.++|+|
T Consensus 439 DsaLSRDLFP~DYhcLGDn------------------------------------EnRPvkWMslEal~n~~yssasDvW 482 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDN------------------------------------ENRPVKWMSLEALQNSHYSSASDVW 482 (563)
T ss_pred cchhccccCcccccccCCC------------------------------------CCCcccccCHHHHhhhhhcchhhhH
Confidence 9999998766544443211 1124569999999999999999999
Q ss_pred chhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 261 SLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 261 SlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
||||+||||++ |+.|+..-++.++...+..+ ..+..|. +.++++-.++..|+. +|++||+ .+++.
T Consensus 483 sfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-yRlaQP~--NCPDeLf~vMacCWallpeeRPs---f~Qlv 549 (563)
T KOG1024|consen 483 SFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-YRLAQPF--NCPDELFTVMACCWALLPEERPS---FSQLV 549 (563)
T ss_pred HHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-ceecCCC--CCcHHHHHHHHHHHhcCcccCCC---HHHHH
Confidence 99999999997 99999999999998888775 3455564 799999999999998 9999994 55543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=206.48 Aligned_cols=145 Identities=20% Similarity=0.197 Sum_probs=115.6
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhh-----------------------HHHHHHHHHHHHhcCCCC
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-----------------------VEHVRSERNLLAEVDSRC 99 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~-----------------------~~~~~~E~~il~~l~hp~ 99 (450)
...||+|+||.||+|.+. +|+.||+|++++........ ......|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999998653211110 123456999999998777
Q ss_pred eeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhCCeEEeecCCCcEEEccCCceE
Q 013064 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI-HQHNYVHRDIKPDNLILDKNGHLK 178 (450)
Q Consensus 100 Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~L-H~~givHrDLKpeNILld~~g~ik 178 (450)
+.......... .||||||++|+++...+.+...++++.+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 64433332222 389999999988876655567899999999999999999999 799999999999999998 58999
Q ss_pred EeeccccccCccc
Q 013064 179 LSDFGLCKPLEDK 191 (450)
Q Consensus 179 L~DFGla~~~~~~ 191 (450)
|+|||+|.....+
T Consensus 158 LiDFG~a~~~~~~ 170 (190)
T cd05147 158 IIDVSQSVEHDHP 170 (190)
T ss_pred EEEccccccCCCc
Confidence 9999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=209.99 Aligned_cols=216 Identities=23% Similarity=0.367 Sum_probs=181.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylV 116 (450)
-.|.+.++||.|+||..+++.+.-++++||||.-... ...-+++.|....+.| ..+.|...|++-+...+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 3799999999999999999999999999999975432 2345677788888877 569999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-----ceEEeeccccccCcc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-----HLKLSDFGLCKPLED 190 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-----~ikL~DFGla~~~~~ 190 (450)
||++ |-+|.+++.= .++|+...+..++.|++.-++|+|++.+|+|||||+|+||...| .|.++|||+|+.+..
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999 8888888754 46899999999999999999999999999999999999997554 488999999998876
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.......+ |+. ..+..||..||+---..+..-+..-|.=|||-+++..|
T Consensus 182 p~TkqHIP--------------------------YrE-----~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 182 PKTKQHIP--------------------------YRE-----HKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred ccccccCc--------------------------ccc-----ccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 53322110 111 23678999999998888999999999999999999999
Q ss_pred hCCCCCCC---CChhhhhhhhhc
Q 013064 271 IGYPPFCS---DDPRITCRKIVN 290 (450)
Q Consensus 271 ~G~~PF~~---~~~~~~~~~i~~ 290 (450)
-|..||.| ++.++-+++|-.
T Consensus 231 RGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 231 RGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cCCCccccccCcchHHHHHHhcc
Confidence 99999976 455666666643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=204.99 Aligned_cols=141 Identities=19% Similarity=0.206 Sum_probs=117.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHH------HHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH------VRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~------~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
-++|.++++||.|+||.||++.. ++..+|+|++.......+..... +.+|...+.++.||+|+.+..++.+.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 48999999999999999999755 46679999997655433333334 57898999999999999999887754
Q ss_pred --------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 111 --------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 111 --------~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
...||||||++|.+|.++. .++++ ...+++.+|..||+.|++|||+||.||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3589999999999997763 24443 456999999999999999999999999999999 999999
Q ss_pred cccccC
Q 013064 183 GLCKPL 188 (450)
Q Consensus 183 Gla~~~ 188 (450)
|.++..
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 988755
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=197.12 Aligned_cols=204 Identities=17% Similarity=0.204 Sum_probs=146.5
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch-hhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-GQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~-~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.+...|++|+||+|+++.. .+..++.+.+.-...... -....+.+|.++|+++. |++|++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678999999999997765 667788777764432211 12235789999999995 5889999886 4479999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeec-CCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI-KPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDL-KpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|+++|+|||+|........-.
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~- 149 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM- 149 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH-
Confidence 99999998654321 1 1347889999999999999999999 7999999999999999999998644321000
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCC-ccccccchhHHHHHHhhCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYG-MECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~-~~~DiWSlGvilyeml~G~~ 274 (450)
.+. ..+.+.+..+. -...+|+|++|+.-.-. ..+ ...+|.+.|+-+|.|+||..
T Consensus 150 ----r~L--------------~~rDl~~llk~------~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~ 205 (218)
T PRK12274 150 ----RLL--------------AREDLRHLLKH------KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRV 205 (218)
T ss_pred ----HHH--------------HHHHHHHHHHH------HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccC
Confidence 000 00111111111 12378999999875432 223 67899999999999999999
Q ss_pred CCCCCCh
Q 013064 275 PFCSDDP 281 (450)
Q Consensus 275 PF~~~~~ 281 (450)
|+.+++.
T Consensus 206 ~~~~~~~ 212 (218)
T PRK12274 206 LHWEDNE 212 (218)
T ss_pred CccccCC
Confidence 9877653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=197.88 Aligned_cols=145 Identities=19% Similarity=0.177 Sum_probs=116.8
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchh-----------------------hHHHHHHHHHHHHhcCCCC
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-----------------------QVEHVRSERNLLAEVDSRC 99 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~-----------------------~~~~~~~E~~il~~l~hp~ 99 (450)
.+.||+|+||.||+|.+. +|+.||||++++....... .......|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999999875311000 0223467899999999998
Q ss_pred eeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceE
Q 013064 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLK 178 (450)
Q Consensus 100 Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ik 178 (450)
|.....+.... .||||||++|+++.........++++.+..++.|++.+|.+||+ .||+||||||+|||++ +|.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75544443332 48999999998665543455678899999999999999999999 9999999999999999 89999
Q ss_pred EeeccccccCccc
Q 013064 179 LSDFGLCKPLEDK 191 (450)
Q Consensus 179 L~DFGla~~~~~~ 191 (450)
|+|||+|+.+...
T Consensus 158 liDFG~a~~~~~~ 170 (190)
T cd05145 158 IIDVSQAVELDHP 170 (190)
T ss_pred EEEcccceecCCC
Confidence 9999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=196.74 Aligned_cols=221 Identities=23% Similarity=0.310 Sum_probs=179.5
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~ 112 (450)
-+....|.+++.||+|+||.+|++....+|+.||||+-+... .-.++..|..+...+.+ ..|+.+..++....+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 355689999999999999999999999999999999875442 12356778889888865 788899999999999
Q ss_pred EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC---CceEEeeccccccC
Q 013064 113 LYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLKLSDFGLCKPL 188 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~---g~ikL~DFGla~~~ 188 (450)
-.||||.+ |-+|.+++.- .+.|+-..+.-.+-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 8899888753 4679999999999999999999999999999999999998644 45889999999987
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
-+....... + |++. ....||..|.+--...+..-+..-|+=|+|.+|..
T Consensus 165 ~d~~t~~HI----------------p----------yre~-----r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmY 213 (341)
T KOG1163|consen 165 RDIRTRQHI----------------P----------YRED-----RNLTGTARYASINAHLGIEQSRRDDMESVGYVLMY 213 (341)
T ss_pred ccccccccC----------------c----------cccC-----Cccceeeeehhhhhhhhhhhhhhhhhhhhcceeee
Confidence 543211110 0 1111 24689999999887777777889999999999999
Q ss_pred HhhCCCCCCCCC---hhhhhhhhhcc
Q 013064 269 MLIGYPPFCSDD---PRITCRKIVNW 291 (450)
Q Consensus 269 ml~G~~PF~~~~---~~~~~~~i~~~ 291 (450)
+.-|..||.+-. ...-+++|...
T Consensus 214 fnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 214 FNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred eecCCCcccccchhhHHHHHHHHHHh
Confidence 999999998753 34456667653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=200.83 Aligned_cols=232 Identities=24% Similarity=0.351 Sum_probs=152.6
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC----------CCeeeEEEE---
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS----------RCIVQLFYS--- 106 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h----------p~Iv~l~~~--- 106 (450)
+.....||.|+++.||.|.+..||+.+|+|++.-........++.+++|.-....+.+ -.++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4566789999999999999999999999999876554445567777766644433221 112222221
Q ss_pred ------EEcC---C-----eEEEEEeccCCCChHHHHH---hcCCC---CHHHHHHH-HHHHHHHHHHhhhCCeEEeecC
Q 013064 107 ------FQDS---D-----FLYLIMEYLPGGDIMTLLM---REDIL---SEDVARFY-IAESVLAIHSIHQHNYVHRDIK 165 (450)
Q Consensus 107 ------f~~~---~-----~lylVmEy~~gg~L~~~l~---~~~~~---~e~~~~~~-~~qil~aL~~LH~~givHrDLK 165 (450)
++.. . +.+++|+-+ .+||..++. ..... ....|+.+ ..|++..+++||..|+||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1111 1 347788877 568877753 22222 22334444 4899999999999999999999
Q ss_pred CCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccch
Q 013064 166 PDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAP 245 (450)
Q Consensus 166 peNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~AP 245 (450)
|+|++++.+|.+.|+||+.......... ....+..|.+|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----------------------------------------~~~~~~~~~PP 211 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR-----------------------------------------CSEFPVAFTPP 211 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE-----------------------------------------GGGS-TTTS-H
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee-----------------------------------------ccCCCcccCCh
Confidence 9999999999999999998776543210 12345779999
Q ss_pred hhhccC--------CCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-
Q 013064 246 EVLLKK--------GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC- 316 (450)
Q Consensus 246 Evl~~~--------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~- 316 (450)
|+.... .++.+.|.|+||+++|.|.+|..||........... .|.....+++..++||.+||.
T Consensus 212 e~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~ 283 (288)
T PF14531_consen 212 ELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQR 283 (288)
T ss_dssp HHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-S
T ss_pred hhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccC
Confidence 987542 478999999999999999999999987654433321 222223688999999999998
Q ss_pred Ccccc
Q 013064 317 DVETR 321 (450)
Q Consensus 317 dp~~R 321 (450)
||.+|
T Consensus 284 ~~~~R 288 (288)
T PF14531_consen 284 NPEDR 288 (288)
T ss_dssp SGGGS
T ss_pred CcccC
Confidence 99987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=204.34 Aligned_cols=275 Identities=25% Similarity=0.332 Sum_probs=187.0
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCC-----------------------------------EEEEEEeechh
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----------------------------------IFAMKKLKKSE 75 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~-----------------------------------~~AiK~i~k~~ 75 (450)
...+..++||++...||+|.-+.||.++.+..|. +.|||.+-.-.
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 4467889999999999999999999988653111 23555432111
Q ss_pred hcch--hhHHHHHHHH------------H-----HHH-----hcCCCCeeeEEEEEEc----------------------
Q 013064 76 MLKR--GQVEHVRSER------------N-----LLA-----EVDSRCIVQLFYSFQD---------------------- 109 (450)
Q Consensus 76 ~~~~--~~~~~~~~E~------------~-----il~-----~l~hp~Iv~l~~~f~~---------------------- 109 (450)
.... ...+..-+|. . .+. .-.|||||++..+|.+
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 1100 0011111111 0 011 1269999999988854
Q ss_pred -----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE--ccCC--ceEEe
Q 013064 110 -----SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL--DKNG--HLKLS 180 (450)
Q Consensus 110 -----~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl--d~~g--~ikL~ 180 (450)
...+|+||.-++. +|..++..+ ..+....+.+++|+++|+.|||++||.|||||.+|||| |+|+ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 2468999998854 788888654 46788889999999999999999999999999999998 4555 57899
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC------CC
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YG 254 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~------y~ 254 (450)
|||+|---....-....+ ....+.-|.-..||||+....+ --
T Consensus 388 DFGCcLAd~~hGlqlpy~--------------------------------S~~Vd~GGNa~lmAPEi~ta~PGp~avvny 435 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQLPYE--------------------------------SDEVDLGGNAKLMAPEIATAVPGPNAVVNY 435 (598)
T ss_pred ccceeeeccccccccccc--------------------------------cccccCCCcceecchhhhhcCCCCceeecc
Confidence 999986432210000000 0011345788899999997432 12
Q ss_pred ccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 255 MECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 255 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
.++|.|+.|.+.||++....||++.....+-.+-.+.......| ..+++.+++||..+|+ ||++|.+.+-+..+++-
T Consensus 436 ~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp--~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 436 EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP--SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred chhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc--ccCChHHHHHHHHHhcCCccccCCccHHHhHHHH
Confidence 57899999999999999999999854332222222211222333 4789999999999998 99999987657777766
Q ss_pred CCcCCCCc
Q 013064 334 PWFRGIQW 341 (450)
Q Consensus 334 pff~~i~w 341 (450)
..|..-+|
T Consensus 514 sLw~~~~~ 521 (598)
T KOG4158|consen 514 SLWRMGED 521 (598)
T ss_pred HHhcCchH
Confidence 65555555
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=188.36 Aligned_cols=137 Identities=14% Similarity=0.196 Sum_probs=110.8
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-----CCCCeeeEEEEEEcCC---eE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-----DSRCIVQLFYSFQDSD---FL 113 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~f~~~~---~l 113 (450)
-.+.||+|+||.||. ++.++.. +||++.... ....+.+.+|+.+++.+ +||||+++|++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999994 7777765 699887643 22456789999999999 6799999999999974 54
Q ss_pred E-EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHhhhCCeEEeecCCCcEEEccC----CceEEeecccc
Q 013064 114 Y-LIMEY--LPGGDIMTLLMREDILSEDVARFYIAESVLAI-HSIHQHNYVHRDIKPDNLILDKN----GHLKLSDFGLC 185 (450)
Q Consensus 114 y-lVmEy--~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL-~~LH~~givHrDLKpeNILld~~----g~ikL~DFGla 185 (450)
| +|||| +++|+|.+++.+. .++++ ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+-+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 5 78999 6689999999664 57766 35688888888 99999999999999999999743 37999995544
Q ss_pred cc
Q 013064 186 KP 187 (450)
Q Consensus 186 ~~ 187 (450)
..
T Consensus 157 ~~ 158 (210)
T PRK10345 157 ST 158 (210)
T ss_pred cc
Confidence 43
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-24 Score=224.10 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=214.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcC-CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~-t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~ly 114 (450)
...|.+.+.||+|+|+.|-++.... +...+|+|.+.... ......+++..|..+-+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5789999999999999999888744 44567888776543 33455677778888888886 999999999999999999
Q ss_pred EEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHhh-hCCeEEeecCCCcEEEccCC-ceEEeeccccccCcc
Q 013064 115 LIMEYLPGGDIMTLL-MRED-ILSEDVARFYIAESVLAIHSIH-QHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLED 190 (450)
Q Consensus 115 lVmEy~~gg~L~~~l-~~~~-~~~e~~~~~~~~qil~aL~~LH-~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~ 190 (450)
++++|..||+++..+ .... ..+...+.+|+.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5554 6889999999999999999999 99999999999999999999 999999999987654
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhcccccccccc-CCCccchhhhccCCC-CccccccchhHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVG-TLDYMAPEVLLKKGY-GMECDWWSLGAIMYE 268 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~G-t~~Y~APEvl~~~~y-~~~~DiWSlGvilye 268 (450)
.... .......|| ++.|+|||...+..| +...|+||+|+++.-
T Consensus 178 ~~g~-----------------------------------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~ 222 (601)
T KOG0590|consen 178 KNGA-----------------------------------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA 222 (601)
T ss_pred cCCc-----------------------------------ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence 1100 111234688 999999999998655 889999999999999
Q ss_pred HhhCCCCCCCCChhhhh-hhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 269 MLIGYPPFCSDDPRITC-RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~-~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|++|..|+......... ..-...........+..++..+.+++.++|. +|..|. +.+++..+||+..
T Consensus 223 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~---s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 223 MLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL---SIEELKLDNWLSS 291 (601)
T ss_pred cccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcc---ccccccccccccc
Confidence 99999999765543322 2222211222334456899999999999997 999999 6789999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-23 Score=218.15 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=180.3
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechh-hcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE-MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+|...+.||++.|=+|.+|++. .|. +++|++-|.. ...-....+-..|+. ...+++||.+.+.-+-.+++..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 7899999999999999988775 444 8999987654 222223333344444 66679999999988888899999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
+|+. -+|++.|..+..+.+-+.+.|+.||+.||.-+|..||+|+|||.|||||..=.-+.|+||..-|..= +.
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY------LP 173 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY------LP 173 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc------CC
Confidence 9994 4899999888888899999999999999999999999999999999999999999999998766421 11
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC-----------CCccccccchhHHH
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-----------YGMECDWWSLGAIM 266 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~-----------y~~~~DiWSlGvil 266 (450)
++.. .+...+.+ .++| -..|+|||.+.... ..++.||+|+||++
T Consensus 174 eDNP-adf~fFFD----------------TSrR--------RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 174 EDNP-ADFTFFFD----------------TSRR--------RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred CCCc-ccceEEEe----------------cCCc--------eeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 1110 00001100 1111 12599999875422 46889999999999
Q ss_pred HHHhh-CCCCCCC-----------CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 267 YEMLI-GYPPFCS-----------DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 267 yeml~-G~~PF~~-----------~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
.||++ |.|||.- .++...+++|. +...+.||..|+. ||.+|+ ++++.|+-
T Consensus 229 aELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~Rl---SAedyL~~ 291 (1431)
T KOG1240|consen 229 AELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRL---SAEDYLQK 291 (1431)
T ss_pred HHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCc--------------CccHHHHHHHHHccCchhcc---CHHHHHHh
Confidence 99986 8999941 11111222221 2367999999998 999999 68888865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=185.68 Aligned_cols=148 Identities=14% Similarity=0.101 Sum_probs=118.3
Q ss_pred CeEEEeEEeecCceEEEEEE-EcCCCCEEEEEEeechhhcch---------------------hhHHHHHHHHHHHHhcC
Q 013064 39 DFEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKSEMLKR---------------------GQVEHVRSERNLLAEVD 96 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~-~~~t~~~~AiK~i~k~~~~~~---------------------~~~~~~~~E~~il~~l~ 96 (450)
.|.+.+.||+|+||.||+|. +..+|+.||+|+++....... .....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 777999999999875431100 01124568999999997
Q ss_pred CC--CeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCC-eEEeecCCCcEEEcc
Q 013064 97 SR--CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN-YVHRDIKPDNLILDK 173 (450)
Q Consensus 97 hp--~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~g-ivHrDLKpeNILld~ 173 (450)
+. .++++++. ...|+||||++|++|...+.....+.+..+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455542 235899999999988776555566777788899999999999999999 99999999999999
Q ss_pred CCceEEeeccccccCccc
Q 013064 174 NGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 174 ~g~ikL~DFGla~~~~~~ 191 (450)
++.++|+|||+|......
T Consensus 184 ~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 184 DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred CCCEEEEEChhhhccCCc
Confidence 899999999999876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=186.68 Aligned_cols=262 Identities=17% Similarity=0.230 Sum_probs=211.1
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH
Q 013064 13 QEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92 (450)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il 92 (450)
|+..|+.++.|.++....+..-+.+.+..++.+|.....|..|.+++.. .-++.|+++-.+...+ ....+..|.-.|
T Consensus 165 kdt~wkgtktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~r-isrdfneefp~l 241 (448)
T KOG0195|consen 165 KDTTWKGTKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTAR-ISRDFNEEFPAL 241 (448)
T ss_pred cccccccccccccccccccccCcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchh-hcchhhhhCcce
Confidence 4566777777777777777788999999999999999999999998854 4466788876554332 335577888889
Q ss_pred HhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCC-eEE-eecCCCc
Q 013064 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHN-YVH-RDIKPDN 168 (450)
Q Consensus 93 ~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~g-ivH-rDLKpeN 168 (450)
+...||||+.++++++...++.+|..|||.|+|+..|..+. .++..++..++-.|+.++.|||+.. ++- --|....
T Consensus 242 rifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~h 321 (448)
T KOG0195|consen 242 RIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKH 321 (448)
T ss_pred eeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccce
Confidence 99999999999999999999999999999999999998764 3678889999999999999999974 443 3577888
Q ss_pred EEEccCCceEEe--eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchh
Q 013064 169 LILDKNGHLKLS--DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 246 (450)
Q Consensus 169 ILld~~g~ikL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APE 246 (450)
++||++-..+|. |--++.. .....-.|.||+||
T Consensus 322 vmidedltarismad~kfsfq---------------------------------------------e~gr~y~pawmspe 356 (448)
T KOG0195|consen 322 VMIDEDLTARISMADTKFSFQ---------------------------------------------EVGRAYSPAWMSPE 356 (448)
T ss_pred EEecchhhhheecccceeeee---------------------------------------------ccccccCcccCCHH
Confidence 999887665543 3222111 01234579999999
Q ss_pred hhccCCC---CccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccC
Q 013064 247 VLLKKGY---GMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 247 vl~~~~y---~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
.+..++- -.++|+|||.+++|||.|...||..-++.+.-.+|.-......+| +.+|..+..|+.-|+. ||.+||
T Consensus 357 alqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip--pgis~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 357 ALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP--PGISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred HHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC--CCccHHHHHHHHHHhcCCCCcCC
Confidence 9987664 367999999999999999999999999999988887655555666 5999999999999998 999999
Q ss_pred CC
Q 013064 323 GT 324 (450)
Q Consensus 323 ~~ 324 (450)
..
T Consensus 435 kf 436 (448)
T KOG0195|consen 435 KF 436 (448)
T ss_pred Cc
Confidence 53
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-21 Score=211.59 Aligned_cols=198 Identities=22% Similarity=0.322 Sum_probs=158.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~ 110 (450)
.+....|.|-+.||+|+||+||.|.... |+.+|+|+=+.... .+ +..=.+++.+|+ -+-|..+..++.-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WE----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--ee----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4667899999999999999999999887 99999998765432 11 122233344444 24455555555555
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-------CCceEEeecc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-------NGHLKLSDFG 183 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-------~g~ikL~DFG 183 (450)
+.-+||+||.+.|+|.+++...+.++|..+.+++.||+.-|++||..+|||+||||+|+||.. .--++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 667899999999999999998899999999999999999999999999999999999999942 2358999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchh
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlG 263 (450)
.+..+.--. ++ ......++|-.+-.+|+..+.+|++.+|+|.|.
T Consensus 847 ~siDm~lfp------~~------------------------------~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlA 890 (974)
T KOG1166|consen 847 RSIDMKLFP------DG------------------------------TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLA 890 (974)
T ss_pred cceeeeEcC------CC------------------------------cEEeeeeccccchhHHHhcCCCCchhhhhHHHH
Confidence 987653210 00 112346889999999999999999999999999
Q ss_pred HHHHHHhhCCC
Q 013064 264 AIMYEMLIGYP 274 (450)
Q Consensus 264 vilyeml~G~~ 274 (450)
.++|-||+|..
T Consensus 891 a~~h~mLFG~y 901 (974)
T KOG1166|consen 891 ATVHVMLFGKY 901 (974)
T ss_pred HHHHHHHHHHH
Confidence 99999999963
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=176.22 Aligned_cols=139 Identities=23% Similarity=0.312 Sum_probs=116.1
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++.||+|++|.||+++. .|..+++|+....... .......+.+|..++..+.|++|+....++.+....++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 6777999976533211 1112346788999999999999888777777888899999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
||++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++...
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999999865432 7788999999999999999999999999999999 889999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=169.80 Aligned_cols=134 Identities=25% Similarity=0.290 Sum_probs=108.4
Q ss_pred EEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
.||+|+||.||++.. +|..+++|+....... ......++.+|..++..+.|+++.....++.+....++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 6778999986532211 112246678899999999888765555555566778999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 120 ~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
++|++|.+++..... .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988755321 7889999999999999999999999999999 899999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-20 Score=170.81 Aligned_cols=140 Identities=16% Similarity=0.159 Sum_probs=110.8
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch-------------------hhHHHHHHHHHHHHhcCCC--
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-------------------GQVEHVRSERNLLAEVDSR-- 98 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~-------------------~~~~~~~~E~~il~~l~hp-- 98 (450)
|.+.+.||+|+||.||.+... +|+.+|+|++........ ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999875 799999999765321000 0112367788899988776
Q ss_pred CeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceE
Q 013064 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 178 (450)
Q Consensus 99 ~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ik 178 (450)
.++..+. ....++||||++|++|..+.. ...+..++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4555544 244689999999999876532 144567889999999999999999999999999999999999
Q ss_pred EeeccccccCcc
Q 013064 179 LSDFGLCKPLED 190 (450)
Q Consensus 179 L~DFGla~~~~~ 190 (450)
|+|||+|.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=163.60 Aligned_cols=141 Identities=17% Similarity=0.205 Sum_probs=102.9
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHH---------------------HHHHHHHHHHhcCCC--C
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE---------------------HVRSERNLLAEVDSR--C 99 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~---------------------~~~~E~~il~~l~hp--~ 99 (450)
.+.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999886 8999999998764321111111 113566666666443 3
Q ss_pred eeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceE
Q 013064 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLK 178 (450)
Q Consensus 100 Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ik 178 (450)
+.+++++ ...++||||++||.+........... +.++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4555544 23599999999965432211111111 6788999999999999999 9999999999999999 99999
Q ss_pred EeeccccccCcc
Q 013064 179 LSDFGLCKPLED 190 (450)
Q Consensus 179 L~DFGla~~~~~ 190 (450)
|+|||.|.....
T Consensus 155 liDfg~a~~~~~ 166 (187)
T cd05119 155 IIDVPQAVEIDH 166 (187)
T ss_pred EEECcccccccC
Confidence 999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-19 Score=186.59 Aligned_cols=140 Identities=24% Similarity=0.294 Sum_probs=113.1
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechh-----hcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE-----MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.|...+.||+|+||.||++...... +++|+..+.. .......+.+.+|..++..++|++|+..+.++.+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3455789999999999998875443 4444322211 11112345688999999999999999888888777788
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
++||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+|+...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999999885 356789999999999999999999999999999 68899999999998754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=157.87 Aligned_cols=139 Identities=19% Similarity=0.292 Sum_probs=107.7
Q ss_pred eEEe-ecCceEEEEEEEcCCCCEEEEEEeechhhc----c------hhhHHHHHHHHHHHHhcCCCCe--eeEEEEEEcC
Q 013064 44 TLIG-KGAFGEVRLCRAKTTGEIFAMKKLKKSEML----K------RGQVEHVRSERNLLAEVDSRCI--VQLFYSFQDS 110 (450)
Q Consensus 44 ~~LG-~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~----~------~~~~~~~~~E~~il~~l~hp~I--v~l~~~f~~~ 110 (450)
..|| .||.|.||.+... +..+++|.+.+..+. . ......+.+|..++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 7888999988764 778999988653321 1 1233567889999999988774 6777664432
Q ss_pred -Ce---EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 111 -DF---LYLIMEYLPG-GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 111 -~~---lylVmEy~~g-g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
.. .++||||++| .+|..++.. ..++++. +.+|+.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 688888754 4566654 568999999999999999999999999999999999999998
Q ss_pred ccCc
Q 013064 186 KPLE 189 (450)
Q Consensus 186 ~~~~ 189 (450)
....
T Consensus 190 ~~~~ 193 (239)
T PRK01723 190 ELRT 193 (239)
T ss_pred ccCC
Confidence 8643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.4e-19 Score=176.70 Aligned_cols=181 Identities=27% Similarity=0.351 Sum_probs=135.1
Q ss_pred CeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~---~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
.++|+.|++|.-+.|.++|.+.. .-+......++.|+..|++| +|.+|||+||.||.+..++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36999999999999999997544 35567788999999999999 9999999999999999999999999999886
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
....... ..+. ......+||+.||+||.|.+..|+.++||||||+|||
T Consensus 406 ~~~~~~~---------------------~~~~-----------a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~ 453 (516)
T KOG1033|consen 406 QDKDETV---------------------APAA-----------ASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILA 453 (516)
T ss_pred cccCCcc---------------------cchh-----------hhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHH
Confidence 6543100 0000 0112458999999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhhhhhhcccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 268 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 268 eml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|++. =..+|.. ..++..|-. ..+|. ...=-++..+|+.+||. .|.+|| .+.+.--|+|.
T Consensus 454 EL~~~f~T~~er---~~t~~d~r~----g~ip~~~~~d~p~e~~ll~~lls~~p~~RP---~~~~~~~~~~~ 515 (516)
T KOG1033|consen 454 ELLIQFSTQFER---IATLTDIRD----GIIPPEFLQDYPEEYTLLQQLLSPSPEERP---SAIEVALHEFL 515 (516)
T ss_pred HHHHHhccHHHH---HHhhhhhhc----CCCChHHhhcCcHHHHHHHHhcCCCcccCc---hHHHHhhhhhc
Confidence 9997 3333321 122222322 33331 11123456799999998 999999 56666666664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=142.65 Aligned_cols=134 Identities=20% Similarity=0.268 Sum_probs=114.6
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCCeEEEEEec
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~~lylVmEy 119 (450)
+++.||+|.++.||.+.... ..+++|...+... ...+..|..++..+.+ +++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999754 6799999865432 4568889999999976 5999999999888899999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC---CeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH---NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 120 ~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~---givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+||+++..+.++++|||++....
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 999877654 5566677889999999999985 79999999999999999999999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.5e-16 Score=157.18 Aligned_cols=197 Identities=23% Similarity=0.246 Sum_probs=149.3
Q ss_pred HHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCe-EEeecCCCcE
Q 013064 92 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNY-VHRDIKPDNL 169 (450)
Q Consensus 92 l~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~gi-vHrDLKpeNI 169 (450)
|+.+.|.|+.++++..-+...++.|.+||.-|+|.+.+... -.++.--...+++.|+.||+|||+.-| .|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999773 457777778889999999999998755 9999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
++|..-.+||+|||+........... ......-..-|.|||++.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~------------------------------------~~~~~~~~~lw~aPellr 124 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPE------------------------------------AHHPIRKALLWTAPELLR 124 (484)
T ss_pred eeeeeEEEEechhhhccccccccccc------------------------------------ccchhHHHHhccCHHHhc
Confidence 99999999999999987653210000 000011234589999998
Q ss_pred cCC-------CCccccccchhHHHHHHhhCCCCCCCCCh----hhhhhhhhcccccccCCCC---CCCCHHHHHHHHHhh
Q 013064 250 KKG-------YGMECDWWSLGAIMYEMLIGYPPFCSDDP----RITCRKIVNWKTCLKFPEE---PKISDEARDLICHLL 315 (450)
Q Consensus 250 ~~~-------y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~~~p~~---~~~s~~~~dli~~lL 315 (450)
... -+.+.|+||+|+++||+++..-||..... .+...++.+.....-.|.- ..+.+++..++..|+
T Consensus 125 ~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw 204 (484)
T KOG1023|consen 125 GALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCW 204 (484)
T ss_pred ccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhc
Confidence 632 35679999999999999999999976322 2344444441222222321 144567899999999
Q ss_pred c-CccccCCC
Q 013064 316 C-DVETRLGT 324 (450)
Q Consensus 316 ~-dp~~R~~~ 324 (450)
. +|.+||..
T Consensus 205 ~e~P~~rPs~ 214 (484)
T KOG1023|consen 205 EEIPEKRPSI 214 (484)
T ss_pred ccChhhCccH
Confidence 8 99999964
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-16 Score=164.52 Aligned_cols=145 Identities=21% Similarity=0.367 Sum_probs=103.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-------------------------------chhhHHHH
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-------------------------------KRGQVEHV 85 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-------------------------------~~~~~~~~ 85 (450)
+.+|+. +.||+|++|+||.|+.+.+|+.||||++++.... -.+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 457887 8999999999999999988999999999754200 00122344
Q ss_pred HHHHHHHHhcCCCCeeeEEEEEEc-------------CCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHH
Q 013064 86 RSERNLLAEVDSRCIVQLFYSFQD-------------SDFLYLIMEYLPGGDIMTL--LMRED----ILSEDVARFYIAE 146 (450)
Q Consensus 86 ~~E~~il~~l~hp~Iv~l~~~f~~-------------~~~lylVmEy~~gg~L~~~--l~~~~----~~~e~~~~~~~~q 146 (450)
.+|.+++... .|+.++...|.+ ...-+|||||+.|+.+.++ +...+ .+.+..+..|+.|
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 4555544433 233333333332 2345699999999999764 33433 3566667777777
Q ss_pred HHHHHHHhhhCCeEEeecCCCcEEEccCC----ceEEeeccccccCccc
Q 013064 147 SVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLEDK 191 (450)
Q Consensus 147 il~aL~~LH~~givHrDLKpeNILld~~g----~ikL~DFGla~~~~~~ 191 (450)
++ ..|++|+|+||.||+++.+| .++++|||++..+...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 65 48999999999999999988 9999999999887543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.8e-15 Score=151.45 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=195.3
Q ss_pred CCeEEEeEEee--cCceEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 013064 38 DDFEQLTLIGK--GAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 38 ~~f~~~~~LG~--G~fg~V~l~~~--~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 112 (450)
..|.+.+.+|. |.+|.||.++. ..++..+|+|.-+... .......+-.+|..-...+ .|++.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence 45677889999 99999999998 8899999999743221 1111222334555555555 48999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHhhhCCeEEeecCCCcEEEccC-CceEEeeccccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVL----AIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCK 186 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~-~~e~~~~~~~~qil~----aL~~LH~~givHrDLKpeNILld~~-g~ikL~DFGla~ 186 (450)
+|+-+|+| |.+|..+...... +++..++.++.+... ||.++|+.+++|-|+||+||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 5788888766554 888999999999999 9999999999999999999999988 889999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvil 266 (450)
.+......... .. ....-|..-|++||++. .-++...|++|||.+.
T Consensus 272 ~i~~~~~~~~~--------------------------------~~-~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~ 317 (524)
T KOG0601|consen 272 KISDGNFSSVF--------------------------------KV-SKRPEGDCIYAAKELLN-GLATFASDIFSLGEVI 317 (524)
T ss_pred EccCCccccce--------------------------------ee-eecCCCCceEeChhhhc-cccchHhhhcchhhhh
Confidence 87654211110 00 01235788899999985 5589999999999999
Q ss_pred HHHhhCCCCCCCC--ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 267 YEMLIGYPPFCSD--DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 267 yeml~G~~PF~~~--~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
.+-.+|..++... +.....+++. ...++- ...+..+...+..|+. +|..|+ .++.+++|++......-
T Consensus 318 l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~---~~q~~~~l~~i~s~~~~ 388 (524)
T KOG0601|consen 318 LEAILGSHLPSVGKNSSWSQLRQGY---IPLEFC--EGGSSSLRSVTSQMLDEDPRLRL---TAQILTALNVIHSKLFV 388 (524)
T ss_pred HhhHhhcccccCCCCCCcccccccc---Cchhhh--cCcchhhhhHHHHhcCcchhhhh---HHHHHhccccccchhhh
Confidence 9988887766543 3332232222 112222 2566677778888887 888888 57899999999865443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.1e-14 Score=145.74 Aligned_cols=141 Identities=17% Similarity=0.301 Sum_probs=95.9
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc-------------------------------hhhHH------HHH
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-------------------------------RGQVE------HVR 86 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~-------------------------------~~~~~------~~~ 86 (450)
+.||.|++|+||+|+.+ +|+.||||+.+...... ..... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 78999999986531000 00001 133
Q ss_pred HHHHHHHhc-----CCCCe--eeEEEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHhhhC
Q 013064 87 SERNLLAEV-----DSRCI--VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVL-AIHSIHQH 157 (450)
Q Consensus 87 ~E~~il~~l-----~hp~I--v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~-aL~~LH~~ 157 (450)
+|...+..+ ++++| ++.+..+ ...-+|||||++|++|.++.... ..++ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 344444443 23433 3333322 33468999999999998876432 1222 2234444444 47788999
Q ss_pred CeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 158 givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
|++|+|+||.||+++.+|.++|+|||++..+..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999988754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.4e-13 Score=125.94 Aligned_cols=144 Identities=14% Similarity=0.147 Sum_probs=106.9
Q ss_pred EeEEeecCceEEEEEEEcC------CCCEEEEEEeechhhc-------------------chhhHHHHH----HHHHHHH
Q 013064 43 LTLIGKGAFGEVRLCRAKT------TGEIFAMKKLKKSEML-------------------KRGQVEHVR----SERNLLA 93 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~------t~~~~AiK~i~k~~~~-------------------~~~~~~~~~----~E~~il~ 93 (450)
..+||.|--+.||.|.... .+..+|+|+.+..... +.+....+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 3578999987532110 111223333 7999998
Q ss_pred hcCC--CCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHh-hhCCeEEeecCCCcEE
Q 013064 94 EVDS--RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI-HQHNYVHRDIKPDNLI 170 (450)
Q Consensus 94 ~l~h--p~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~L-H~~givHrDLKpeNIL 170 (450)
++.. -.+++++++ ..-+|||||+.|+.+..-..+...++++.+..+..+++.+|..| |+.||||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8843 466677765 44689999997765543333444567777788889999999999 8999999999999999
Q ss_pred EccCCceEEeeccccccCccc
Q 013064 171 LDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 171 ld~~g~ikL~DFGla~~~~~~ 191 (450)
++ +|.+.|+|||.|.....+
T Consensus 158 ~~-~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred EE-CCcEEEEECCCceeCCCC
Confidence 96 578999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.7e-14 Score=125.63 Aligned_cols=129 Identities=16% Similarity=0.208 Sum_probs=97.5
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEEEeccC
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
++.|+.|.++.||+++.. ++.|++|+...... .......|..+++.+.+.. ++++++... ..-++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 567899999999998864 77899998765421 1223567888888885443 455655543 23479999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCe-----EEeecCCCcEEEccCCceEEeeccccccC
Q 013064 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 122 gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~gi-----vHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.|...
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 9887543 11123456899999999999985 9999999999999 778999999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.6e-14 Score=143.68 Aligned_cols=252 Identities=23% Similarity=0.217 Sum_probs=185.7
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
......+|.++..||.|.|+.|+.+... .++..|++|.+.+.......++ .-..|..+...+ .|.++++.+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence 4456689999999999999999988866 6788999998866543333332 234466666555 589999999999888
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-CceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~-g~ikL~DFGla~~~~ 189 (450)
...|+=.|||.|+++...+.-...+++...+...+|++.|+.++|+..++|+|+||+||++..+ +..++.|||.++.+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 8899999999999988777555678999999999999999999999999999999999999876 788999999987533
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCcc--chhhhccCCCCccccccchhHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM--APEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~--APEvl~~~~y~~~~DiWSlGvily 267 (450)
-.. ....++-.++ +++......+..++|++|||.-++
T Consensus 419 ~~~-----------------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~ 457 (524)
T KOG0601|consen 419 FSS-----------------------------------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVD 457 (524)
T ss_pred eec-----------------------------------------ccccccccccccchhhcccccccccccccccccccc
Confidence 210 0122233334 455555678899999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
+.++|.+.-...+. ...|.. ...|..+..+.++..+.+.++. ++..|+ .+.++..|+=|
T Consensus 458 e~~~~~~ls~~~~~---~~~i~~----~~~p~~~~~~~~~q~~~kv~~~~~~~~~~---l~~~l~~~~~~ 517 (524)
T KOG0601|consen 458 EAITGSPLSESGVQ---SLTIRS----GDTPNLPGLKLQLQVLLKVMINPDRKRRP---SAVELSLHSEF 517 (524)
T ss_pred ccccCcccCccccc---ceeeec----ccccCCCchHHhhhhhhhhhcCCccccch---hhhhhcccchh
Confidence 99988754332222 222222 1223223455778888888887 777776 45666666544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.7e-12 Score=131.76 Aligned_cols=169 Identities=19% Similarity=0.246 Sum_probs=130.6
Q ss_pred EEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCC
Q 013064 56 LCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL 135 (450)
Q Consensus 56 l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~ 135 (450)
-+..+.++.++.+.+.+.+.- ...+.+.+-..-|+.++||+|++++..+..++.+|+|+|-+. -|..++.+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 355677888899998875532 445667788888999999999999999999999999999884 355566554
Q ss_pred CHHHHHHHHHHHHHHHHHhh-hCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccccccccccccccccc
Q 013064 136 SEDVARFYIAESVLAIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214 (450)
Q Consensus 136 ~e~~~~~~~~qil~aL~~LH-~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (450)
++..+..-+.||+.||.||| +.+++|++|.-..|+++..|+.||++|.++........
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------------------- 160 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------------------- 160 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------------------
Confidence 37788888999999999998 57999999999999999999999999999865432110
Q ss_pred CCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
......---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 161 -----------------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 -----------------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -----------------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000112222366676654322 567999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-11 Score=109.11 Aligned_cols=137 Identities=24% Similarity=0.289 Sum_probs=101.4
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEE-eech----hhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKK-LKKS----EMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~-i~k~----~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
..+++|+-+.++.+... |..+++|. ++|. .+..+-..++..+|..++..+.--.|.-.+-++.+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999988653 33466664 2222 22222234567889999998865555555556667777889999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
|++|-.|.+.+... . -.++..+-.-+.-||..||||+||.+.||++..++ +.++||||+.....
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~~ 143 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSDE 143 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccccc
Confidence 99999888888765 1 34566777778889999999999999999997555 99999999986443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.3e-12 Score=115.96 Aligned_cols=142 Identities=17% Similarity=0.229 Sum_probs=108.2
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCC---eEEEEE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSD---FLYLIM 117 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~---~lylVm 117 (450)
++.||.|..+.||++.... |+.|++|+....... .....+..|..+++.+.+ ..+++++.+..... ..|+||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 4678999999999998743 678999998654321 134567889999999865 45677777766543 678999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ----------------------------------------- 156 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~----------------------------------------- 156 (450)
||++|+++...+.. ..++++....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888665432 356677777777777777777773
Q ss_pred ---------------CCeEEeecCCCcEEEcc--CCceEEeeccccccC
Q 013064 157 ---------------HNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPL 188 (450)
Q Consensus 157 ---------------~givHrDLKpeNILld~--~g~ikL~DFGla~~~ 188 (450)
..++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 34799999999999998 677899999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.6e-12 Score=120.71 Aligned_cols=214 Identities=18% Similarity=0.192 Sum_probs=151.3
Q ss_pred HHHHHHhcCCCCeeeEEEEEEcCC-----eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhC-
Q 013064 88 ERNLLAEVDSRCIVQLFYSFQDSD-----FLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQH- 157 (450)
Q Consensus 88 E~~il~~l~hp~Iv~l~~~f~~~~-----~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~- 157 (450)
-.+-|-.+.|.|||+++.++.+.+ ...++.||+..|+|..+|++ +..+.....+.|+.||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 334455667999999999887655 48899999999999999975 34688899999999999999999997
Q ss_pred -CeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhcccccccc
Q 013064 158 -NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 236 (450)
Q Consensus 158 -givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 236 (450)
-|+|+++..+-|++..+|-||+.---.......- ++ . +... ..--
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~------------------------~~----~---~~~E---k~~~ 242 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSV------------------------NS----T---REAE---KSVN 242 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhh------------------------hh----h---hHhh---hhcc
Confidence 4999999999999999998887532111110000 00 0 0000 0012
Q ss_pred ccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC-CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhh
Q 013064 237 VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP-FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315 (450)
Q Consensus 237 ~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P-F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL 315 (450)
.|-+.|.|||.=.-...+.++|||++|....||..|..- -.+.+..+.-..|.+....+. .+.-+++|.+||
T Consensus 243 ~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl 315 (458)
T KOG1266|consen 243 TSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCL 315 (458)
T ss_pred ccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccc
Confidence 467889999986666678899999999999999988764 333333333333332111111 112367899999
Q ss_pred c-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 316 C-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 316 ~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
. .|..|+ ++.+++.||-.=+|.-.++.
T Consensus 316 ~~eP~~rp---~ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 316 EGEPNGRP---DARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred cCCCCCCc---chhhhhcCceeeecchHHHH
Confidence 9 999999 67899999988776655544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=102.22 Aligned_cols=144 Identities=24% Similarity=0.289 Sum_probs=107.5
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEE-----eechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKK-----LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~-----i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.+..|-+|+-+.|+.+.. .|+.+.||. ++...+..+-...+..+|..+|.++.--.|.-..-+|.|...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 677888999999997765 688888874 2333333333456788899999888654555555567777777899
Q ss_pred EeccCC-CChHHHHHhcC-CCCHH-HHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEEeecccccc
Q 013064 117 MEYLPG-GDIMTLLMRED-ILSED-VARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKP 187 (450)
Q Consensus 117 mEy~~g-g~L~~~l~~~~-~~~e~-~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL~DFGla~~ 187 (450)
|||++| -.+.+++.... .-+++ ....++..|-..|.-||.++|||+||..+||++..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 46777776532 22333 3367888999999999999999999999999997666 358999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.4e-09 Score=107.01 Aligned_cols=250 Identities=16% Similarity=0.212 Sum_probs=167.8
Q ss_pred HHHHHHHHHHHHHHH----HHHHHhcCCCCCCCeEEEeEEee--c-CceEEEEEEEcCCCCEEEEEEeechhhcchhhHH
Q 013064 11 EEQEEMLRNLERRET----EYMRLQRRKIGIDDFEQLTLIGK--G-AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 83 (450)
Q Consensus 11 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~f~~~~~LG~--G-~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~ 83 (450)
+.+++++..-....+ .+.....-+....+|.-+..+-- | .-.+.|+|..+.+|..|++|.+.-...... .
T Consensus 242 ~iR~~l~~k~la~~~~~~s~~~vi~~~p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---n 318 (655)
T KOG3741|consen 242 EIRERLIVKNLASLQYADSAYKVIDGIPSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQST---N 318 (655)
T ss_pred hHHHHHHHHhhHHHhhcchhhhhhccCCcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccccccCc---c
Confidence 556655554433222 12222223444556655554332 2 335789999999999999999843322222 1
Q ss_pred HHHHHHHHHHhcCCCCeeeEEEEEEc----CCeEEEEEeccCC-CChHHHHH---------------hcCCCCHHHHHHH
Q 013064 84 HVRSERNLLAEVDSRCIVQLFYSFQD----SDFLYLIMEYLPG-GDIMTLLM---------------REDILSEDVARFY 143 (450)
Q Consensus 84 ~~~~E~~il~~l~hp~Iv~l~~~f~~----~~~lylVmEy~~g-g~L~~~l~---------------~~~~~~e~~~~~~ 143 (450)
....-.++++++.|+|||.+.++|.+ +..++||++|.|+ ++|.++.- .+...+|+..+.|
T Consensus 319 k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y 398 (655)
T KOG3741|consen 319 KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSY 398 (655)
T ss_pred cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHH
Confidence 23345678999999999999999984 4569999999986 56766542 2235789999999
Q ss_pred HHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHH
Q 013064 144 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223 (450)
Q Consensus 144 ~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (450)
+.||..||.++|+.|+.-+-|.|.+||++.+-.|+|...|....+....
T Consensus 399 ~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------------------------- 447 (655)
T KOG3741|consen 399 ISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------------------------- 447 (655)
T ss_pred HHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------------------------------
Confidence 9999999999999999999999999999888888888777765543321
Q ss_pred HHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC-CChhhh-hhhhhcccccccCCCCC
Q 013064 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS-DDPRIT-CRKIVNWKTCLKFPEEP 301 (450)
Q Consensus 224 ~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~-~~~i~~~~~~~~~p~~~ 301 (450)
+ |-+.. -..-|.=.||.++..|.+|..--.. +...+. ...|. .
T Consensus 448 --------------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~ 492 (655)
T KOG3741|consen 448 --------------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------T 492 (655)
T ss_pred --------------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------h
Confidence 0 01111 1346888899999999999643221 222222 22222 2
Q ss_pred CCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 302 KISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 302 ~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
..|.+++++|.-+.. ++.++ ++.+++.|
T Consensus 493 ~yS~D~rn~v~yl~s~~~~~k----sI~~llp~ 521 (655)
T KOG3741|consen 493 TYSTDLRNVVEYLESLNFREK----SIQDLLPM 521 (655)
T ss_pred hhhHHHHHHHHHHHhcCcccc----cHHHHHHH
Confidence 678999999988876 66643 36676654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.5e-09 Score=102.06 Aligned_cols=133 Identities=13% Similarity=0.100 Sum_probs=93.7
Q ss_pred EEEEEEEcCCCCEEEEEEeechhh---cch-----hhHHHHHHHHHHHHhcCCC--CeeeEEEEEEc-----CCeEEEEE
Q 013064 53 EVRLCRAKTTGEIFAMKKLKKSEM---LKR-----GQVEHVRSERNLLAEVDSR--CIVQLFYSFQD-----SDFLYLIM 117 (450)
Q Consensus 53 ~V~l~~~~~t~~~~AiK~i~k~~~---~~~-----~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~~-----~~~lylVm 117 (450)
.|..+.. .|+.|.+|....... .+. .-...+.+|...+..+..- .++.+..++.. ...-||||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3554433 567888886632210 010 1112477888888777332 23344444432 23578999
Q ss_pred eccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-------CCceEEeecccccc
Q 013064 118 EYLPGG-DIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-------NGHLKLSDFGLCKP 187 (450)
Q Consensus 118 Ey~~gg-~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-------~g~ikL~DFGla~~ 187 (450)
|+++|- +|.+++.. ....++.....++.+++..+.-||..||+|+||++.|||++. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999886 78888754 345677788899999999999999999999999999999985 46899999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-09 Score=97.28 Aligned_cols=130 Identities=20% Similarity=0.220 Sum_probs=84.4
Q ss_pred EEEEEEEcCCCCEEEEEEeechhhc-----------------------chhhHHHHHHHHHHHHhcCCC--CeeeEEEEE
Q 013064 53 EVRLCRAKTTGEIFAMKKLKKSEML-----------------------KRGQVEHVRSERNLLAEVDSR--CIVQLFYSF 107 (450)
Q Consensus 53 ~V~l~~~~~t~~~~AiK~i~k~~~~-----------------------~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f 107 (450)
.||.|... .|..+|+|+.+..... ..-......+|...|..+..- ++++++++-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48888764 6778999987542100 011134577899999999654 567776553
Q ss_pred EcCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-hhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 108 QDSDFLYLIMEYLP--GGDIMTLLMREDILSEDVARFYIAESVLAIHS-IHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 108 ~~~~~lylVmEy~~--gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~-LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
.-+|||||++ |..+..+. .. .++.+....++.+++..+.. +|+.||+|+||.+.|||++.+ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-DV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-HC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHH-hc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 65554433 22 12245566777888886555 579999999999999999876 999999999
Q ss_pred cccCcc
Q 013064 185 CKPLED 190 (450)
Q Consensus 185 a~~~~~ 190 (450)
|.....
T Consensus 153 av~~~~ 158 (188)
T PF01163_consen 153 AVDSSH 158 (188)
T ss_dssp EEETTS
T ss_pred ceecCC
Confidence 987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.5e-10 Score=118.79 Aligned_cols=168 Identities=21% Similarity=0.352 Sum_probs=121.6
Q ss_pred HHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeeccccccCccccc-cccccccccccccccccccccCCChHHHH
Q 013064 145 AESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS-SILLEDEDIINQETVSEAEGQWMMPKERL 222 (450)
Q Consensus 145 ~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (450)
.+++.|+.|+|.. ++||+.|.|++|.++..|..||+.|++|........ ...
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~-------------------------- 159 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFS-------------------------- 159 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccc--------------------------
Confidence 3455899999975 999999999999999999999999999886544210 000
Q ss_pred HHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh-hCCCCCCCCChhhhhhhhhcccccccCCCCC
Q 013064 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 301 (450)
Q Consensus 223 ~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~ 301 (450)
.|. ..+..-..-...|.|||++....-+.++|++||||++|-+. .|..-|.+.+....+..-........+-...
T Consensus 160 -~yd---~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~ 235 (700)
T KOG2137|consen 160 -EYD---PPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSN 235 (700)
T ss_pred -cCC---CCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccc
Confidence 000 00011123567899999999988899999999999999998 6776676655444443332211111222224
Q ss_pred CCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 302 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 302 ~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
.+++++++=+.++|. ++..|+ ++.+++.-|||.+..-..|+
T Consensus 236 ~~p~el~~~l~k~l~~~~~~rp---~~~~l~~~~ff~D~~~~aLr 277 (700)
T KOG2137|consen 236 NLPSELRESLKKLLNGDSAVRP---TLDLLLSIPFFSDPGLKALR 277 (700)
T ss_pred cCcHHHHHHHHHHhcCCcccCc---chhhhhcccccCCchhhhhh
Confidence 789999999999998 999999 58899999999987655554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.7e-08 Score=93.74 Aligned_cols=128 Identities=20% Similarity=0.226 Sum_probs=93.9
Q ss_pred CCCEEEEEEeechh----hcchhhHHHHHHHHHHHHhcCCC--CeeeEEEEEEcC----CeEEEEEeccCCC-ChHHHHH
Q 013064 62 TGEIFAMKKLKKSE----MLKRGQVEHVRSERNLLAEVDSR--CIVQLFYSFQDS----DFLYLIMEYLPGG-DIMTLLM 130 (450)
Q Consensus 62 t~~~~AiK~i~k~~----~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~~~----~~lylVmEy~~gg-~L~~~l~ 130 (450)
.++.|-+|.+.... +...-......+|...+..+..- .+++.+++.... ...|||||+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221 11112334577788877776332 244555554432 2458999999985 7999988
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEEeeccccccCc
Q 013064 131 REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLE 189 (450)
Q Consensus 131 ~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL~DFGla~~~~ 189 (450)
.....+......++.++...+.-||..||+|+|++|.|||++.++ .+.|+||+-++...
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 755678888899999999999999999999999999999999887 89999999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.3e-10 Score=115.92 Aligned_cols=242 Identities=21% Similarity=0.203 Sum_probs=161.8
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lylVm 117 (450)
-++....+++|+++++++.+...+.... .+.+... ....-++++|.+++||| .+..++.++-+.+++++|
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 4555667899999999988876655444 5555322 34566899999999999 777777888888999999
Q ss_pred eccCCC-Ch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 118 EYLPGG-DI-MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 118 Ey~~gg-~L-~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
+++.+| +- .......-.|.+-+.......-+.+|++||+.-=+||| ||+..+ +..++.||+....+....
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---
Confidence 999887 21 11111112234444555666777889999998778998 777654 788999999887665431
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
..++..+|+.++|||++....+....|.||+|+-..+|.-|-+|
T Consensus 386 ------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 386 ------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 12367899999999999999999999999999988888888877
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHH-HHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEA-RDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~-~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
-.. +......+-+.............++.. +++...|+. .|..|. ....++.|.+|++
T Consensus 430 r~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pk---v~mgacfsKvfng 489 (829)
T KOG0576|consen 430 RSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPK---VHMGACFSKVFNG 489 (829)
T ss_pred CCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCc---chhhHHHHHHhcc
Confidence 654 211222222111011110000111111 246666776 676666 3456777888776
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=87.38 Aligned_cols=142 Identities=18% Similarity=0.303 Sum_probs=94.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHH------HHHHHHHHHhc---CCCCeeeEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH------VRSERNLLAEV---DSRCIVQLFY 105 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~------~~~E~~il~~l---~hp~Iv~l~~ 105 (450)
+.-.+|.+++++-......|.+..- .|+.|++|..+......+..... ..++...+..+ ..-.++.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4458999999999988888877654 67889999886543222211111 23333333333 2222223222
Q ss_pred E-----EEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEe
Q 013064 106 S-----FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 106 ~-----f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~ 180 (450)
+ +.-....+|||||++|..|.+... ++++ +...++.++.-||+.|++|+|..|.|++++.++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 2 222334678999999988866532 3332 445677889999999999999999999998555 9999
Q ss_pred ecccccc
Q 013064 181 DFGLCKP 187 (450)
Q Consensus 181 DFGla~~ 187 (450)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.6e-08 Score=94.89 Aligned_cols=232 Identities=14% Similarity=0.179 Sum_probs=147.7
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE------EcC-CeEE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF------QDS-DFLY 114 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f------~~~-~~ly 114 (450)
.+-||+|+-+.+|-+-.- +. .+-|++.+.... .....+..|... .||-+-.-+.+= -+. ..+-
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa------~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA------AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCch------HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 467999999999965432 22 345877655321 111123334333 455433211111 122 2378
Q ss_pred EEEeccCCCChHHHHH----h---cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 115 LIMEYLPGGDIMTLLM----R---EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~----~---~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
++|..++|-.=-..+. + ...+..+-+....++|+.|...||..|.+-+|+.++|+|+++++.|.|+|=..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 8999998753222221 1 23466788888999999999999999999999999999999999999987432111
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccch
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSL 262 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSl 262 (450)
.... ....-.+|.++|.+||.-. +.+-+...|-|.|
T Consensus 167 ~~ng---------------------------------------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGL 207 (637)
T COG4248 167 NANG---------------------------------------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGL 207 (637)
T ss_pred ccCC---------------------------------------ceEecccCccccCCHHHhccccccccCCCccccchhH
Confidence 1110 1112368999999999865 3345688999999
Q ss_pred hHHHHHHhhC-CCCCCCC-------Chhhhhhhhhcc-------c------ccccCCCCCCCCHHHHHHHHHhhc---Cc
Q 013064 263 GAIMYEMLIG-YPPFCSD-------DPRITCRKIVNW-------K------TCLKFPEEPKISDEARDLICHLLC---DV 318 (450)
Q Consensus 263 Gvilyeml~G-~~PF~~~-------~~~~~~~~i~~~-------~------~~~~~p~~~~~s~~~~dli~~lL~---dp 318 (450)
||++|++|.| +.||.|- ++.++ .|..+ . .+...| +.-+++++..|..++.. ++
T Consensus 208 avLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P-~~~Lpp~vqAlF~qaF~~~~~~ 284 (637)
T COG4248 208 AVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIP-LSMLPPDVQALFQQAFTESGVA 284 (637)
T ss_pred HHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCC-hhhcCHHHHHHHHHHhcccCCC
Confidence 9999999987 9999763 22221 22110 0 111111 24578899999988886 35
Q ss_pred cccCCCC
Q 013064 319 ETRLGTR 325 (450)
Q Consensus 319 ~~R~~~~ 325 (450)
.-||++.
T Consensus 285 ~~RP~a~ 291 (637)
T COG4248 285 TPRPTAK 291 (637)
T ss_pred CCCCCHH
Confidence 5788753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.2e-08 Score=91.39 Aligned_cols=140 Identities=16% Similarity=0.187 Sum_probs=104.3
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh-----------------cch--hhHHHHHHHHHHHHhcCCC--Ce
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-----------------LKR--GQVEHVRSERNLLAEVDSR--CI 100 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~-----------------~~~--~~~~~~~~E~~il~~l~hp--~I 100 (450)
+...||-|--|.||.|... .|..+|||.=+-... ..+ -......+|..+|..|... .|
T Consensus 95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4578999999999999876 788899996421100 010 1123467888999998654 67
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEe
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~ 180 (450)
++.++. +.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+=||+++++|.+.++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEE
Confidence 776654 4567999999997775442 2455566666677777776668999999999999999999999999
Q ss_pred eccccccCccc
Q 013064 181 DFGLCKPLEDK 191 (450)
Q Consensus 181 DFGla~~~~~~ 191 (450)
||--|.....+
T Consensus 245 DwPQ~v~~~hp 255 (304)
T COG0478 245 DWPQAVPISHP 255 (304)
T ss_pred eCcccccCCCC
Confidence 99988876544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.4e-07 Score=83.00 Aligned_cols=140 Identities=13% Similarity=0.168 Sum_probs=101.4
Q ss_pred eecCceEEEEEEEcCCCCEEEEEEeech---hhcchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEc----CCeEEEEE
Q 013064 47 GKGAFGEVRLCRAKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQD----SDFLYLIM 117 (450)
Q Consensus 47 G~G~fg~V~l~~~~~t~~~~AiK~i~k~---~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~----~~~lylVm 117 (450)
|+||-+.|+.... .|+.|-+|..... .+.-+.....+.+|...|..+.. -.++++...-.. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6789999997765 3446778865411 11112345678899999988843 225555522211 12478999
Q ss_pred eccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc--eEEeeccccccC
Q 013064 118 EYLPG-GDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--LKLSDFGLCKPL 188 (450)
Q Consensus 118 Ey~~g-g~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~--ikL~DFGla~~~ 188 (450)
|-++| -+|.+++... ...++..-..++.++..+|.-||+.|+.|+|+-+.|||++.+|. ++++||.-++..
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 98854 5888887653 34577778899999999999999999999999999999987777 999999987653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.2e-06 Score=80.17 Aligned_cols=141 Identities=17% Similarity=0.179 Sum_probs=99.3
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchh-------------------hH--HHHHHHHHHHHhcC--CCCe
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG-------------------QV--EHVRSERNLLAEVD--SRCI 100 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~-------------------~~--~~~~~E~~il~~l~--hp~I 100 (450)
..|+.|--++||+|.. ..+..+|+|+++.....-+. ++ .-+..|..-|.++. +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 4788899999999875 46788999998654322111 11 11345666666662 3455
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceE
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDI-MTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLK 178 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L-~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ik 178 (450)
++.+.++. -.|||||+....+ .-.|.. -.+..+++..+..+++..+.-|-. .|+||+||..=|||+. +|.+.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 66666654 4699999954311 111222 224444788889999999998887 8999999999999998 99999
Q ss_pred EeeccccccCccc
Q 013064 179 LSDFGLCKPLEDK 191 (450)
Q Consensus 179 L~DFGla~~~~~~ 191 (450)
++|||-|.....+
T Consensus 207 iID~~QaV~~~hp 219 (268)
T COG1718 207 IIDVSQAVTIDHP 219 (268)
T ss_pred EEECccccccCCC
Confidence 9999999887654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.6e-06 Score=79.57 Aligned_cols=139 Identities=19% Similarity=0.303 Sum_probs=84.4
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEEEEEE---cCCeEEEEE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYSFQ---DSDFLYLIM 117 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~---~~~~lylVm 117 (450)
++.|+.|..+.||++.... ..|++|..... .....+..|..+++.+... -+++++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 6789999999999998765 47999987544 2456677888888887422 3566666443 334589999
Q ss_pred eccCCCChHH----------------HHH---hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 013064 118 EYLPGGDIMT----------------LLM---RE----DILSEDV------ARFY---------------IAESVL-AIH 152 (450)
Q Consensus 118 Ey~~gg~L~~----------------~l~---~~----~~~~e~~------~~~~---------------~~qil~-aL~ 152 (450)
++++|..+.. .+. .. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 0111000 0000 111222 233
Q ss_pred Hhh-------hCCeEEeecCCCcEEEc-cCCceEEeeccccccC
Q 013064 153 SIH-------QHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPL 188 (450)
Q Consensus 153 ~LH-------~~givHrDLKpeNILld-~~g~ikL~DFGla~~~ 188 (450)
.++ ...++|+|+.|.|||++ .+|.|-|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 333 24699999999999999 6677789999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-06 Score=81.50 Aligned_cols=135 Identities=20% Similarity=0.133 Sum_probs=85.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
..||+|..+.||++ .|..+++|...... ....+.+|.++++.+..- -+++.+.+..+.+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 24567889876422 234568899999988532 25777888888888899999999
Q ss_pred CCC-hH--------------HHH-------Hhc--CCCCHH-HHHHHHH----------HHHHH-HHHhh----hCCeEE
Q 013064 122 GGD-IM--------------TLL-------MRE--DILSED-VARFYIA----------ESVLA-IHSIH----QHNYVH 161 (450)
Q Consensus 122 gg~-L~--------------~~l-------~~~--~~~~e~-~~~~~~~----------qil~a-L~~LH----~~givH 161 (450)
|.+ +. ..+ ... ...... ....+.. .+... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 964 11 111 110 011100 0001100 01111 12222 125789
Q ss_pred eecCCCcEEEccCCceEEeeccccccC
Q 013064 162 RDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 162 rDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+|+.|.||+++.+| +.++||+.|...
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 99999999999888 999999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=7.1e-07 Score=93.19 Aligned_cols=144 Identities=19% Similarity=0.264 Sum_probs=92.1
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhh--------------------cc-----------hhhHHHH------H
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--------------------LK-----------RGQVEHV------R 86 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~--------------------~~-----------~~~~~~~------~ 86 (450)
.-|+.++-|+||.|+.+. |+.||||+....-. .. .+..+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999999875 99999999864210 00 0111222 2
Q ss_pred HHHHHHHhc-----CCCCeeeEEEEEEcCCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHhhhCCe
Q 013064 87 SERNLLAEV-----DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL--LMREDILSEDVARFYIAESVLAIHSIHQHNY 159 (450)
Q Consensus 87 ~E~~il~~l-----~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~--l~~~~~~~e~~~~~~~~qil~aL~~LH~~gi 159 (450)
+|..-+.++ +.|+|.=..=+.+-.+.-.|+|||+.|-.+.+. +.. ..++...+...+.++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 333333333 234432222222223445799999999988877 333 4455333332222221 223334899
Q ss_pred EEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 160 vHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|.|..|.||+++.+|++.+.|||+...+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999999887653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.7e-06 Score=75.70 Aligned_cols=128 Identities=22% Similarity=0.321 Sum_probs=91.3
Q ss_pred CCeEEEeEEeecCc-eEEEEEEEcCCCCEEEEEEeechhhcch------------------hhHHHHHHHHHHHHhc---
Q 013064 38 DDFEQLTLIGKGAF-GEVRLCRAKTTGEIFAMKKLKKSEMLKR------------------GQVEHVRSERNLLAEV--- 95 (450)
Q Consensus 38 ~~f~~~~~LG~G~f-g~V~l~~~~~t~~~~AiK~i~k~~~~~~------------------~~~~~~~~E~~il~~l--- 95 (450)
.+++.++.||.|+- |.||+++. .|+.||+|+++.-..... ...+-+..|-+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 79999999999999 99999987 677999999432111110 1223456677765555
Q ss_pred CCCCe--eeEEEEEEcC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh
Q 013064 96 DSRCI--VQLFYSFQDS------------------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 155 (450)
Q Consensus 96 ~hp~I--v~l~~~f~~~------------------~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH 155 (450)
.+..+ |++++++--. ....+|.||++... .++.. -+.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 44455 9999987321 12467889887654 22333 3457788889999
Q ss_pred hCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 156 ~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+.||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3489999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.6e-06 Score=93.88 Aligned_cols=201 Identities=21% Similarity=0.247 Sum_probs=144.5
Q ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 013064 82 VEHVRSERNLLAEVDSRCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157 (450)
Q Consensus 82 ~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~----lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~ 157 (450)
+.....|...+.++.|+|++.++.+--.... +.+..++|++-++...+..-+..+.+.++.|.++++++|.++|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3445556677888899999999877543332 345568999999999999999999999999999999999999999
Q ss_pred CeEEeecCCC---cEEEccCCceEEe--eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhcccc
Q 013064 158 NYVHRDIKPD---NLILDKNGHLKLS--DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRAL 232 (450)
Q Consensus 158 givHrDLKpe---NILld~~g~ikL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (450)
...|.-|... +-..+..+.+..+ ||+..+.+......
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-------------------------------------- 347 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-------------------------------------- 347 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--------------------------------------
Confidence 6666655444 4444566677766 88888776543211
Q ss_pred ccccccCCCccchhhhccCCCCcc--ccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCH-HHHH
Q 013064 233 AYSTVGTLDYMAPEVLLKKGYGME--CDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISD-EARD 309 (450)
Q Consensus 233 ~~s~~Gt~~Y~APEvl~~~~y~~~--~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~-~~~d 309 (450)
.+..-+..+.|||......+..+ .|+|.+|.++..+..|..+-.-. .+...++ + ..+. ...+
T Consensus 348 -~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l--------~---~~~~~~~~d 412 (1351)
T KOG1035|consen 348 -FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL--------D---VLSTSELLD 412 (1351)
T ss_pred -hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh--------c---cccchhhhh
Confidence 13355667888998887666544 69999999999998776442111 1111111 0 1221 6778
Q ss_pred HHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 310 LICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 310 li~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++.+|+. ++++|+ ++.+++.|||.+.
T Consensus 413 ~~~~~~~~~~~~Rl---~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 413 ALPKCLDEDSEERL---SALELLTHPFLRF 439 (1351)
T ss_pred hhhhhcchhhhhcc---chhhhhhchhccc
Confidence 8888887 999999 5789999999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.1e-06 Score=77.98 Aligned_cols=136 Identities=16% Similarity=0.103 Sum_probs=85.6
Q ss_pred EEeecCc-eEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 45 LIGKGAF-GEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 45 ~LG~G~f-g~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
.|-.|.. +.||.+... +..+.+|+..... ...+.+|..++..+. +--+++++++..+.+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 788988653 3578888875432 234667888888773 34577888888877778999999999
Q ss_pred CChHHHH----------------HhcC-------CCCHH------HHHHH-------------------HHHHHHHHHHh
Q 013064 123 GDIMTLL----------------MRED-------ILSED------VARFY-------------------IAESVLAIHSI 154 (450)
Q Consensus 123 g~L~~~l----------------~~~~-------~~~e~------~~~~~-------------------~~qil~aL~~L 154 (450)
..|.... .+-. .+... ..... ..++...|...
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765331 0000 11100 00000 11112222111
Q ss_pred ----hhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 155 ----HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 155 ----H~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
....++|+|+.|.|||++.++.+.|+||+.|...
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 2235999999999999999888899999988754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-05 Score=90.08 Aligned_cols=146 Identities=18% Similarity=0.323 Sum_probs=92.7
Q ss_pred EEeEEeecCceEEEEEEEcCCC--CEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCe--eeEEEEEEcC---CeE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTG--EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCI--VQLFYSFQDS---DFL 113 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~--~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~I--v~l~~~f~~~---~~l 113 (450)
.++.|+.|.++.+|++.....+ ..|++|+........ ....+.+|..+|+.+. |++| ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 4788899999999998765433 467888765432211 2346788999999985 6654 7888877765 468
Q ss_pred EEEEeccCCCChHH--------------------HH---HhcC----------C---CCHHHHHHHHHH-----------
Q 013064 114 YLIMEYLPGGDIMT--------------------LL---MRED----------I---LSEDVARFYIAE----------- 146 (450)
Q Consensus 114 ylVmEy~~gg~L~~--------------------~l---~~~~----------~---~~e~~~~~~~~q----------- 146 (450)
|+||||++|..+.+ .| +.-. . +.+.++..+..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 99999999864321 11 1100 0 111223222111
Q ss_pred ----HHHHHHHhhh-----------CCeEEeecCCCcEEEccC-Cc-eEEeeccccccCc
Q 013064 147 ----SVLAIHSIHQ-----------HNYVHRDIKPDNLILDKN-GH-LKLSDFGLCKPLE 189 (450)
Q Consensus 147 ----il~aL~~LH~-----------~givHrDLKpeNILld~~-g~-ikL~DFGla~~~~ 189 (450)
+...+.+|.. ..+||+|++|.|||++.+ +. +-|+||++|....
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2223455522 359999999999999853 34 5799999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=6.3e-06 Score=85.98 Aligned_cols=142 Identities=20% Similarity=0.301 Sum_probs=89.8
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhc----------------------------chhhHHHHHHHHH-----
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML----------------------------KRGQVEHVRSERN----- 90 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~----------------------------~~~~~~~~~~E~~----- 90 (450)
+.||.-+.|+|+.|+.+. |+.||+|+-+..--. -.+..+.+..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568999999999999886 999999997542100 0011111222222
Q ss_pred -----HHHhcCCCC------eeeEEEEEEcCCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 013064 91 -----LLAEVDSRC------IVQLFYSFQDSDFLYLIMEYLPGGDIMTL--LMREDILSEDVARFYIAESVLAIHSIHQH 157 (450)
Q Consensus 91 -----il~~l~hp~------Iv~l~~~f~~~~~lylVmEy~~gg~L~~~--l~~~~~~~e~~~~~~~~qil~aL~~LH~~ 157 (450)
+.+.+.|-. |+++|..+.+ .-.|+||||+|..+.+. |.+.+ ++...+...+.+... +-|=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHhc
Confidence 223333433 5555554443 35899999999866554 44443 555443333333222 223346
Q ss_pred CeEEeecCCCcEEEcc----CCceEEeeccccccCccc
Q 013064 158 NYVHRDIKPDNLILDK----NGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 158 givHrDLKpeNILld~----~g~ikL~DFGla~~~~~~ 191 (450)
|++|.|-.|.||+++. ++.+.+.|||+...+...
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999984 668999999999877543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.5e-07 Score=103.46 Aligned_cols=258 Identities=17% Similarity=0.061 Sum_probs=170.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-- 109 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-- 109 (450)
.-.+.++++.--+|-|.+++-...+.+..+ +.+|+.+..... .+-..+....|++-++...|+++...+.-..+
T Consensus 1225 ~s~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~ 1302 (2724)
T KOG1826|consen 1225 FSAMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSE 1302 (2724)
T ss_pred HHHhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCC
Confidence 345577887777777777654333323222 455555433221 12234556677777778899998877766554
Q ss_pred CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhC-C----eEEeecCCCcEEEccCCceEEe
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQH-N----YVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~----~~~~e~~~~~~~~qil~aL~~LH~~-g----ivHrDLKpeNILld~~g~ikL~ 180 (450)
+...|.+++|+.+|++++.|.+. ..+++..+-....+.+++..-+|++ | .+|++||+-|.+|..+-.+|+.
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~g 1382 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLG 1382 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccc
Confidence 34579999999999999999764 2344555544445558888888865 2 7999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcccccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiW 260 (450)
++|+.+..... .......+++|.|++|++...-.++.++|+|
T Consensus 1383 k~gLdKIknp~--------------------------------------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1383 KGGLDKIKNPV--------------------------------------LSFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred ccccccccCch--------------------------------------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence 99999832211 0112256899999999999988899889999
Q ss_pred chhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
.+|+.+|+.-.|.++|........ ..++........+. -.|.++-.+...+|- .-..||+ ...++.-+.|.
T Consensus 1425 r~s~~ly~rs~~n~~fi~flq~~L-kgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a 1496 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYFIFFLQPAL-KGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPG---QYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHHhcccHHHHHHHHHHH-cCcccccccccccc--cCCCcccHHHHHHHHHHhhhcch---hhhhccccccc
Confidence 999999999999999853332222 22222222233332 224444444444444 6667773 45555555554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.9e-05 Score=70.57 Aligned_cols=137 Identities=20% Similarity=0.252 Sum_probs=96.5
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhh-------------cchhhHHHHHHHHHHHHhcC------CCCeeeE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-------------LKRGQVEHVRSERNLLAEVD------SRCIVQL 103 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~-------------~~~~~~~~~~~E~~il~~l~------hp~Iv~l 103 (450)
...||+|+.=.|| .|..+. ..+||++.+... ..........+|......+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy--~HP~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEE--ECCCCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3568999998888 455443 368899877650 11123455666776665554 7899999
Q ss_pred EEEEEcCCeEEEEEeccCC--C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC--C
Q 013064 104 FYSFQDSDFLYLIMEYLPG--G----DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--G 175 (450)
Q Consensus 104 ~~~f~~~~~lylVmEy~~g--g----~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~--g 175 (450)
|++.+++.-+-+|+|.+.. | +|.+++. .+.+++ ..+ ..+-.-..+|-+.+|+.+||+|.||++... |
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998743 2 5777774 445666 333 333445667889999999999999999643 2
Q ss_pred --ceEEee-cccccc
Q 013064 176 --HLKLSD-FGLCKP 187 (450)
Q Consensus 176 --~ikL~D-FGla~~ 187 (450)
.+.|+| ||....
T Consensus 158 ~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 158 EFRLVLIDGLGEKEL 172 (199)
T ss_pred ceEEEEEeCCCCccc
Confidence 588888 676544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2e-05 Score=70.18 Aligned_cols=129 Identities=16% Similarity=0.224 Sum_probs=91.6
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCee-eEEEEEEcCCeEEEEEecc
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV-QLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv-~l~~~f~~~~~lylVmEy~ 120 (450)
..+.||+|.+|.||++.. .|..+|+|+-.... ....+..|.++|..+...++. ++|.+-. -++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 457799999999999987 46688999875432 345678899999999876664 4444422 23559999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeec-CCCcEEEccCCceEEeeccccccC
Q 013064 121 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI-KPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 121 ~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDL-KpeNILld~~g~ikL~DFGla~~~ 188 (450)
.|-.|...-... + +.-+..++.+---|-..||-|..| .|..++|-.++.+.|+||..|+.-
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 998887765321 2 222334555544566789999999 466666667779999999999843
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.1e-05 Score=74.46 Aligned_cols=74 Identities=11% Similarity=0.179 Sum_probs=47.2
Q ss_pred EeEEeecCceE-EEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC---CeeeEEEEEEcC---CeEEE
Q 013064 43 LTLIGKGAFGE-VRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR---CIVQLFYSFQDS---DFLYL 115 (450)
Q Consensus 43 ~~~LG~G~fg~-V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~f~~~---~~lyl 115 (450)
+..|+.|+... ||.+. ..+++|+.... .....+.+|..+|..+... -+.+.++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 35678777764 89762 34778875432 1234688899999887532 345555544332 24589
Q ss_pred EEeccCCCChH
Q 013064 116 IMEYLPGGDIM 126 (450)
Q Consensus 116 VmEy~~gg~L~ 126 (450)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00025 Score=72.07 Aligned_cols=97 Identities=16% Similarity=0.171 Sum_probs=62.9
Q ss_pred HHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc--c--hhhHHHHHHHHHHHHhcC---CC
Q 013064 26 EYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--K--RGQVEHVRSERNLLAEVD---SR 98 (450)
Q Consensus 26 ~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~--~--~~~~~~~~~E~~il~~l~---hp 98 (450)
+|......-.....=.-.+.||.|.++.||.+.....++.+++|.-...... . .-..++...|...|..+. ..
T Consensus 14 ~yl~~~~~~~~~~~~~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~ 93 (401)
T PRK09550 14 EYAALKLGLFDPKALLTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPD 93 (401)
T ss_pred HHHHHhcCCCCCcccceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCC
Confidence 3443333333334434567899999999999998644457999975321110 0 123567778888888762 35
Q ss_pred CeeeEEEEEEcCCeEEEEEeccCCCC
Q 013064 99 CIVQLFYSFQDSDFLYLIMEYLPGGD 124 (450)
Q Consensus 99 ~Iv~l~~~f~~~~~lylVmEy~~gg~ 124 (450)
++++++.+ +.+..++||||+++..
T Consensus 94 ~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 94 LVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred CCCeEEEE--CCCCCEEEEecCCCcc
Confidence 67777777 4566789999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=68.72 Aligned_cols=138 Identities=14% Similarity=0.194 Sum_probs=83.6
Q ss_pred EeEEeecCceEEEEEEEcC-CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEecc
Q 013064 43 LTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~-t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
++.|..|-...||++.... .++.|++|+...... ..-...+|..++..+. +..++++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 5678888889999987543 356799998754321 1112346888888874 3445666655432 3799999
Q ss_pred CCCChHHH--------------HHh---cC-CC----------C-HHHHHHHHHHH------------------------
Q 013064 121 PGGDIMTL--------------LMR---ED-IL----------S-EDVARFYIAES------------------------ 147 (450)
Q Consensus 121 ~gg~L~~~--------------l~~---~~-~~----------~-e~~~~~~~~qi------------------------ 147 (450)
+|..+... +.+ .. .. . .+.+..|...+
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 99765211 111 00 11 1 12222222111
Q ss_pred -HHHHH-Hh----hhCCeEEeecCCCcEEEcc-CCceEEeeccccccC
Q 013064 148 -VLAIH-SI----HQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPL 188 (450)
Q Consensus 148 -l~aL~-~L----H~~givHrDLKpeNILld~-~g~ikL~DFGla~~~ 188 (450)
+..|. .+ ...+++|+|+.|.|||++. ++.+.|+||..|...
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 11111 11 1246999999999999997 588999999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00015 Score=71.14 Aligned_cols=138 Identities=15% Similarity=0.169 Sum_probs=85.3
Q ss_pred EeEEeecCceEEEEEEEcC------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEE
Q 013064 43 LTLIGKGAFGEVRLCRAKT------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~lyl 115 (450)
++.|..|--..||++.... +++.|++|+..... .......+|..++..+.. -..+++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4567777778999987643 36789999976532 122345778888888743 334566776653 35
Q ss_pred EEeccCCCChHHH--------------HH---hcC-CC--------C--HHHHHH-------------------------
Q 013064 116 IMEYLPGGDIMTL--------------LM---RED-IL--------S--EDVARF------------------------- 142 (450)
Q Consensus 116 VmEy~~gg~L~~~--------------l~---~~~-~~--------~--e~~~~~------------------------- 142 (450)
|+||++|..+... |. +.. .. + ......
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 8999998765431 11 100 00 0 001111
Q ss_pred -HHHHHHHHHHHhh---------hCCeEEeecCCCcEEEccC----CceEEeeccccccC
Q 013064 143 -YIAESVLAIHSIH---------QHNYVHRDIKPDNLILDKN----GHLKLSDFGLCKPL 188 (450)
Q Consensus 143 -~~~qil~aL~~LH---------~~givHrDLKpeNILld~~----g~ikL~DFGla~~~ 188 (450)
...++...+..|- ..+++|+|+.|.|||++.+ +.+.|+||..|...
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 1122222333443 2368999999999999975 88999999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00043 Score=67.99 Aligned_cols=78 Identities=10% Similarity=0.052 Sum_probs=55.7
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC---CCeeeEEEEEEcC---CeEE
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS---RCIVQLFYSFQDS---DFLY 114 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~f~~~---~~ly 114 (450)
.-++.||.|..+.||.+... .+ .+.+|..+. . .....+.+|...|+.+.. -.++++++++.+. +.-|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS-F----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecc-c----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34678999999999988542 23 467777432 1 122467889999988843 4678888877643 6689
Q ss_pred EEEeccCCCCh
Q 013064 115 LIMEYLPGGDI 125 (450)
Q Consensus 115 lVmEy~~gg~L 125 (450)
+|||+++|+.+
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00013 Score=66.57 Aligned_cols=99 Identities=18% Similarity=0.221 Sum_probs=79.7
Q ss_pred HHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHhhh---CC
Q 013064 86 RSERNLLAEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL---LMREDILSEDVARFYIAESVLAIHSIHQ---HN 158 (450)
Q Consensus 86 ~~E~~il~~l~h-p~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~---l~~~~~~~e~~~~~~~~qil~aL~~LH~---~g 158 (450)
..|.-+|+.+.+ +++++++|++-+ ++|.||++.+++... +.....-++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888865 699999999843 578999988766421 2222346788999999999999999997 35
Q ss_pred eEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 159 ivHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+...|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00036 Score=68.80 Aligned_cols=146 Identities=15% Similarity=0.158 Sum_probs=87.9
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEEEE------E
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYS------F 107 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~------f 107 (450)
.++....++.++.|.-..||++.. .+| .|++|+..+.. ..+.+..|..++..|.. -.+++++.. .
T Consensus 20 ~~~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 20 DLGELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred CCCCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 455666788889888899998864 344 58889875421 13345567777777632 124444432 1
Q ss_pred EcCCeEEEEEeccCCCChH----H-------H---HHh-cCCCC--------HHH-----HH----------HHHHHHHH
Q 013064 108 QDSDFLYLIMEYLPGGDIM----T-------L---LMR-EDILS--------EDV-----AR----------FYIAESVL 149 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~----~-------~---l~~-~~~~~--------e~~-----~~----------~~~~qil~ 149 (450)
...+..++||+|++|..+. . . +.. ...++ ... .. .....+..
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~ 172 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK 172 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence 2345679999999985431 1 1 111 00110 000 00 00112233
Q ss_pred HHHHhh-------hCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 150 AIHSIH-------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 150 aL~~LH-------~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+++++. ..+++|+|+.+.||+++.++.+.|+||+.|...
T Consensus 173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 455553 268999999999999998887789999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00038 Score=66.64 Aligned_cols=134 Identities=19% Similarity=0.213 Sum_probs=79.6
Q ss_pred EeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC-CeeeEEEEEEcCCeEEEEEeccCCCC
Q 013064 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDSDFLYLIMEYLPGGD 124 (450)
Q Consensus 46 LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~f~~~~~lylVmEy~~gg~ 124 (450)
+..|-.+.+|++. .+++.|++|........ -.+ ...+|..+++.+..- -.+++++... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4567788899886 45677889976543210 001 246788888888532 3355555443 268999999865
Q ss_pred hHH--------------HHHh---c----CCCC-HHHHHHHHHHH---------HHHHHHhhh--------CCeEEeecC
Q 013064 125 IMT--------------LLMR---E----DILS-EDVARFYIAES---------VLAIHSIHQ--------HNYVHRDIK 165 (450)
Q Consensus 125 L~~--------------~l~~---~----~~~~-e~~~~~~~~qi---------l~aL~~LH~--------~givHrDLK 165 (450)
+.. .+.+ . ..++ .+.+..|..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 431 1111 1 1122 12223332222 111222211 258999999
Q ss_pred CCcEEEccCCceEEeeccccccCc
Q 013064 166 PDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 166 peNILld~~g~ikL~DFGla~~~~ 189 (450)
|.|||++.+| +.|+||..|....
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcCC
Confidence 9999999877 8999999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00078 Score=65.81 Aligned_cols=142 Identities=13% Similarity=0.110 Sum_probs=86.2
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEEEE------EEcC
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYS------FQDS 110 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~------f~~~ 110 (450)
+..-++.|..|....+|++.. .+..|++|+.... ..+.+..|..++..+.+- .+++++.. ...+
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~ 86 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA 86 (296)
T ss_pred chhheecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence 344477888888899998864 3446899987541 234566677777777321 24454432 2334
Q ss_pred CeEEEEEeccCCCChHH----H-------H---Hhc-CCCCH--------HHH----H--------HHHHHHHHHHHHhh
Q 013064 111 DFLYLIMEYLPGGDIMT----L-------L---MRE-DILSE--------DVA----R--------FYIAESVLAIHSIH 155 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~----~-------l---~~~-~~~~e--------~~~----~--------~~~~qil~aL~~LH 155 (450)
+..++|++|++|..+.. . | +.. ..+.. ... . .....+..++.++.
T Consensus 87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~ 166 (296)
T cd05153 87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD 166 (296)
T ss_pred CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence 56789999999976421 1 1 110 00100 000 0 01111223344444
Q ss_pred h-------CCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 156 Q-------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 156 ~-------~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+ .+++|+|+.|.|||++.++.+.|+||+.|...
T Consensus 167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 3 47999999999999998877799999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0013 Score=65.06 Aligned_cols=140 Identities=13% Similarity=0.096 Sum_probs=77.3
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEEE------EEEcCCe
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFY------SFQDSDF 112 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~------~f~~~~~ 112 (450)
.-++.|+.|....+|.+... +| .|++|++.. .. .+.+..|..++..|.. -.+++.+. +....+.
T Consensus 25 ~~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~---~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~ 96 (319)
T PRK05231 25 LSLKGIAEGIENSNFFLTTT-QG-EYVLTLFER---LT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK 96 (319)
T ss_pred hccchhccccccceEEEEeC-CC-cEEEEEecc---CC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence 33566778888899988743 34 589998751 11 2233345555555421 11333332 1233566
Q ss_pred EEEEEeccCCCChH-----------HHH---Hh-cCCC--------C--H--HHH-----------HHHHHH-HHHHHHH
Q 013064 113 LYLIMEYLPGGDIM-----------TLL---MR-EDIL--------S--E--DVA-----------RFYIAE-SVLAIHS 153 (450)
Q Consensus 113 lylVmEy~~gg~L~-----------~~l---~~-~~~~--------~--e--~~~-----------~~~~~q-il~aL~~ 153 (450)
.++||||++|..+. ..| .. ...+ . . +.. ...+.+ +-..++.
T Consensus 97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (319)
T PRK05231 97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF 176 (319)
T ss_pred EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence 89999999997431 111 11 0001 0 0 000 111111 1112233
Q ss_pred hh-------hCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 154 IH-------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 154 LH-------~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+. ..|+||+|+.|.|||++.+...-|+||+.|...
T Consensus 177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred hhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 32 238999999999999986655589999998753
|
|
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=97.54 E-value=7.8e-05 Score=55.21 Aligned_cols=59 Identities=32% Similarity=0.634 Sum_probs=39.8
Q ss_pred CCCCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCC-CcCCCcCCceee
Q 013064 337 RGIQWDKLY--EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLT-SKDTNFIGYTFK 400 (450)
Q Consensus 337 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~~~~~~ 400 (450)
++|+|+.|. ++.|||+|.+.+..|+++|+. ++......+... + .+.. ..+..|.||+|.
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~---~--~~~~~~~~~~F~gfsy~ 63 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVD---S--PASGGSQQEPFRGFSYV 63 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCC---c--cccccccccccCCCccc
Confidence 479999996 588999999999999999997 554432211111 0 0111 114689999986
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00069 Score=66.99 Aligned_cols=141 Identities=21% Similarity=0.237 Sum_probs=96.6
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---------------------hhHHHHHH--HHHHHHhcCC-
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---------------------GQVEHVRS--ERNLLAEVDS- 97 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---------------------~~~~~~~~--E~~il~~l~h- 97 (450)
+-.+|..|--+.||.|.. .+|..+|||+++.+-+.-+ ...-.+.. |.+-|.+++.
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 446888999999999875 4788899999875433211 11112233 4444666643
Q ss_pred ----CCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEc
Q 013064 98 ----RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILD 172 (450)
Q Consensus 98 ----p~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld 172 (450)
|--+-| ..-.|||+|+.+...-.=..+.-.++...++.+-.|++.-+.-|-+ +++||.||.-=|+|+
T Consensus 227 GIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-
Confidence 322222 2347999999532222222244568888899888899888888764 799999999999998
Q ss_pred cCCceEEeeccccccCccc
Q 013064 173 KNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 173 ~~g~ikL~DFGla~~~~~~ 191 (450)
.+|++.++|-+-+.....+
T Consensus 299 hdG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred ECCEEEEEEccccccCCCh
Confidence 6899999999988876543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0016 Score=65.34 Aligned_cols=143 Identities=13% Similarity=0.150 Sum_probs=86.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcC----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCC
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~ 111 (450)
.+... ++.|-.|-...+|++.... +++.|++|+..... ...+++ .+|..+++.+. +.--+++++.|.+.
T Consensus 36 ~~~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g- 109 (344)
T PLN02236 36 DEALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG- 109 (344)
T ss_pred cCcEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc-
Confidence 34444 4455558888999987532 34689999886532 222333 67888888884 33445667777543
Q ss_pred eEEEEEeccCCCChHHH--------------HH---hcC----C-CC-HHHHHHHHHHHH--------------------
Q 013064 112 FLYLIMEYLPGGDIMTL--------------LM---RED----I-LS-EDVARFYIAESV-------------------- 148 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~--------------l~---~~~----~-~~-e~~~~~~~~qil-------------------- 148 (450)
.|++|++|..|... +. ... . ++ .+.+..++.++.
T Consensus 110 ---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~ 186 (344)
T PLN02236 110 ---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEI 186 (344)
T ss_pred ---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHH
Confidence 58999987665321 11 101 0 11 223333332221
Q ss_pred HHHHH-----hhhCCeEEeecCCCcEEEcc-CCceEEeeccccccC
Q 013064 149 LAIHS-----IHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPL 188 (450)
Q Consensus 149 ~aL~~-----LH~~givHrDLKpeNILld~-~g~ikL~DFGla~~~ 188 (450)
..|+. .+...++|+|+++.|||++. ++.+.|+||..|...
T Consensus 187 ~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 187 NLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 11111 12336999999999999986 478999999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0053 Score=60.32 Aligned_cols=30 Identities=23% Similarity=0.558 Sum_probs=26.9
Q ss_pred CCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 157 ~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
.+++|+|+.+.||+++. +.+.|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 58999999999999987 7789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0042 Score=62.11 Aligned_cols=85 Identities=15% Similarity=0.117 Sum_probs=53.8
Q ss_pred EEeecCceEEEEEEEcCCCCEEEEEEeechhhc-c---hhhHHHHHHHHHHHHhcC--CC-CeeeEEEEEEcCCeEEEEE
Q 013064 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-K---RGQVEHVRSERNLLAEVD--SR-CIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-~---~~~~~~~~~E~~il~~l~--hp-~Iv~l~~~f~~~~~lylVm 117 (450)
.||.|...-||.|.....++-++||.-...... . .-..++...|...|+... .| .++++|.+ |.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997644467899964322111 1 223566778888887763 24 45555443 445566999
Q ss_pred eccCCC-ChHHHHHh
Q 013064 118 EYLPGG-DIMTLLMR 131 (450)
Q Consensus 118 Ey~~gg-~L~~~l~~ 131 (450)
|+++.. .|...|.+
T Consensus 80 EdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 80 EDLSHHKIARKGLIE 94 (370)
T ss_pred hhCccchHHHHHHHc
Confidence 999553 34444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0032 Score=62.81 Aligned_cols=144 Identities=15% Similarity=0.198 Sum_probs=83.7
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCC
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSD 111 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~ 111 (450)
..++..+....| |--..+|++..... +..|++|+..... ...+ .-.+|..+++.+.. ..-+++++++.. +
T Consensus 13 ~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~-G 86 (330)
T PLN02421 13 DDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGN-G 86 (330)
T ss_pred CcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCC-c
Confidence 345555544444 77788998875432 3379999876432 1112 23568888888854 333567777643 2
Q ss_pred eEEEEEeccCCCChHH--------------HHHh---cC-----CCC-HHHHHHHHHHH---------------------
Q 013064 112 FLYLIMEYLPGGDIMT--------------LLMR---ED-----ILS-EDVARFYIAES--------------------- 147 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~--------------~l~~---~~-----~~~-e~~~~~~~~qi--------------------- 147 (450)
+|.+|++|..|.. .+.+ .. .++ ...+..|+.++
T Consensus 87 ---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (330)
T PLN02421 87 ---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEE 163 (330)
T ss_pred ---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHH
Confidence 5899998765421 1111 11 011 22233333222
Q ss_pred ----HHHHHHh-hhC----CeEEeecCCCcEEEcc-CCceEEeeccccccC
Q 013064 148 ----VLAIHSI-HQH----NYVHRDIKPDNLILDK-NGHLKLSDFGLCKPL 188 (450)
Q Consensus 148 ----l~aL~~L-H~~----givHrDLKpeNILld~-~g~ikL~DFGla~~~ 188 (450)
+..+..+ ... -++|.||-+.|||+++ ++.++|+||..|...
T Consensus 164 l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 164 LRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 1111212 122 2899999999999975 578999999998753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0058 Score=59.33 Aligned_cols=32 Identities=25% Similarity=0.504 Sum_probs=27.1
Q ss_pred CeEEeecCCCcEEEccCCce-EEeeccccccCc
Q 013064 158 NYVHRDIKPDNLILDKNGHL-KLSDFGLCKPLE 189 (450)
Q Consensus 158 givHrDLKpeNILld~~g~i-kL~DFGla~~~~ 189 (450)
.++|+|+.|.|||++.+|.+ -|+||+.+....
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 58999999999999975654 699999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0087 Score=60.92 Aligned_cols=77 Identities=16% Similarity=0.146 Sum_probs=52.7
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch----hhHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR----GQVEHVRSERNLLAEVD---SRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~----~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~ly 114 (450)
..+.||.|....||++... +..++||.-........ -...+...|...|+.+. ...+++++.+..+ .-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4788999999999999863 44588997542221111 13455666777776663 2478888888774 357
Q ss_pred EEEeccCC
Q 013064 115 LIMEYLPG 122 (450)
Q Consensus 115 lVmEy~~g 122 (450)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00076 Score=65.69 Aligned_cols=139 Identities=12% Similarity=0.127 Sum_probs=92.5
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----------------chhhH--HHHHHHHHHHHhcC-CCC
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----------------KRGQV--EHVRSERNLLAEVD-SRC 99 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----------------~~~~~--~~~~~E~~il~~l~-hp~ 99 (450)
+.+...||-|--+.||.|-+. .|.++++|.-+-.... .+-.+ -...+|...|+.+. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999998764 6888999963211100 00011 12455777777763 322
Q ss_pred -eeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceE
Q 013064 100 -IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLK 178 (450)
Q Consensus 100 -Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ik 178 (450)
|++.++ .+.-++|||++.|-.|...-. + +.+..+...++.-+--|-..|+||+|..-=||+++++++++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~----v--~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH----V--EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee----c--CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 333333 345689999999877654321 1 11223344555666778899999999999999999999999
Q ss_pred EeeccccccCc
Q 013064 179 LSDFGLCKPLE 189 (450)
Q Consensus 179 L~DFGla~~~~ 189 (450)
++||--+....
T Consensus 243 vIDFPQmvS~s 253 (465)
T KOG2268|consen 243 VIDFPQMVSTS 253 (465)
T ss_pred EeechHhhccC
Confidence 99998776543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.018 Score=58.44 Aligned_cols=88 Identities=18% Similarity=0.205 Sum_probs=57.9
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc---hhhHHHHHHHHHHHHhcC--CC-CeeeEEEEEEcCCeEEE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK---RGQVEHVRSERNLLAEVD--SR-CIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~---~~~~~~~~~E~~il~~l~--hp-~Iv~l~~~f~~~~~lyl 115 (450)
.++.||.|.-.-||+|.....++-++||.-....-.. .-..++...|..+|+... .| .++++|.+ |.+...+
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~ 110 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC 110 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence 3889999999999999985445678888643211111 224677888999988763 24 56666554 4556679
Q ss_pred EEeccCCC-ChHHHHHh
Q 013064 116 IMEYLPGG-DIMTLLMR 131 (450)
Q Consensus 116 VmEy~~gg-~L~~~l~~ 131 (450)
|||+++.. .|...|.+
T Consensus 111 vMEdL~~~~ilR~~Li~ 127 (409)
T PRK12396 111 VMEDLSDHTILRTALIN 127 (409)
T ss_pred HHHhCcccHHHHHHHHc
Confidence 99999653 34444443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.014 Score=57.65 Aligned_cols=149 Identities=15% Similarity=0.160 Sum_probs=88.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCC--eE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSD--FL 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~--~l 113 (450)
....++..+-.|.--.+|.... +++.++++ ... ............+|..+++.+.- --+...+..+.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 5566666664454455665544 38889888 321 12223345667788888887743 23444555555555 67
Q ss_pred EEEEeccCCCChHH------------------HHHh--------------cCCCCHHHHHHHHHHH--------------
Q 013064 114 YLIMEYLPGGDIMT------------------LLMR--------------EDILSEDVARFYIAES-------------- 147 (450)
Q Consensus 114 ylVmEy~~gg~L~~------------------~l~~--------------~~~~~e~~~~~~~~qi-------------- 147 (450)
|.||+|+.|..+.+ .|.. .+.+...+...+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99999999932211 1110 0001112222222222
Q ss_pred HHHHHHhhhC--------CeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 148 VLAIHSIHQH--------NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 148 l~aL~~LH~~--------givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..-..+|+.+ .++|+|+.+.||+|+.++-+=++||+++...+.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 1223344332 489999999999999999999999999987554
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.018 Score=58.53 Aligned_cols=82 Identities=15% Similarity=0.143 Sum_probs=49.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCC-CCE-----EEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTT-GEI-----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQ 108 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t-~~~-----~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~ 108 (450)
..++.++ +.|..|--+.+|+|..... +.. |.+++.... ....-.-.+|..+++.+. +..-.++++.|.
T Consensus 49 ~~~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~ 123 (383)
T PTZ00384 49 NPEFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG 123 (383)
T ss_pred CcccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecC
Confidence 3344554 4555588899999975433 223 333332111 111112356888998885 456677888886
Q ss_pred cCCeEEEEEeccCCCChH
Q 013064 109 DSDFLYLIMEYLPGGDIM 126 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~ 126 (450)
. ++|.||++|-.|.
T Consensus 124 ~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 D----FTIQEWVEGNTMG 137 (383)
T ss_pred C----EEEEEEeccccCC
Confidence 3 6999999997653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.052 Score=53.52 Aligned_cols=30 Identities=13% Similarity=0.164 Sum_probs=28.3
Q ss_pred CeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 158 givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+++|+|+.+.|+|++.+|.+.++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.06 Score=52.53 Aligned_cols=136 Identities=17% Similarity=0.219 Sum_probs=73.6
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEcCCeEEEEE
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+-++.||-|....+|.+. .+++.|.+|+-... ....+..|..-|+.| ..-.+++.+.+.+.++.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345678889999999876 67788999987632 224566777777777 3456888898888777779999
Q ss_pred eccCCCC--------hHH---HHHh-c--C-----------------CCCHHHHHHHHHH--------------------
Q 013064 118 EYLPGGD--------IMT---LLMR-E--D-----------------ILSEDVARFYIAE-------------------- 146 (450)
Q Consensus 118 Ey~~gg~--------L~~---~l~~-~--~-----------------~~~e~~~~~~~~q-------------------- 146 (450)
||++.+. |-. .|.+ . + .....-..||+.+
T Consensus 92 e~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~ 171 (288)
T PF03881_consen 92 EFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELE 171 (288)
T ss_dssp E--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHH
T ss_pred EeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHH
Confidence 9997761 111 1122 1 1 1223334444432
Q ss_pred -HHHHHH-HhhhC----CeEEeecCCCcEEEccCCceEEeeccc
Q 013064 147 -SVLAIH-SIHQH----NYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 147 -il~aL~-~LH~~----givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
++..+. .|+.. -.+|+||-+.|++++.+|...|.|-..
T Consensus 172 ~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa~ 215 (288)
T PF03881_consen 172 RLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPAC 215 (288)
T ss_dssp HHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S---
T ss_pred HHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeecccc
Confidence 111111 12222 389999999999999999999988663
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.016 Score=53.77 Aligned_cols=31 Identities=32% Similarity=0.694 Sum_probs=22.6
Q ss_pred CCeEEeecCCCcEEE-ccCCceEEeecccccc
Q 013064 157 HNYVHRDIKPDNLIL-DKNGHLKLSDFGLCKP 187 (450)
Q Consensus 157 ~givHrDLKpeNILl-d~~g~ikL~DFGla~~ 187 (450)
..++|.||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 469999999999999 8899999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.014 Score=57.89 Aligned_cols=72 Identities=21% Similarity=0.420 Sum_probs=53.9
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
..++|++|++- |+.|... ..-..+++..++.+.+..+.-+... ..-|||+..+||||+ +|+|.|+||-+|+.
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 44678888876 6555322 1224556666777777777766654 789999999999999 99999999999983
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.21 Score=57.34 Aligned_cols=139 Identities=19% Similarity=0.229 Sum_probs=79.1
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-------CCCCeeeEE-----EEEEc-
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-------DSRCIVQLF-----YSFQD- 109 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-------~hp~Iv~l~-----~~f~~- 109 (450)
++.|+ |..-.+|++.. .+|..|++|+.+... ....+..|..+|..| ..|.++... ....+
T Consensus 30 ~~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~ 102 (1013)
T PRK06148 30 ATPLD-GERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDP 102 (1013)
T ss_pred EeecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecC
Confidence 46775 45688898864 467789999997542 122333455555544 223333321 12222
Q ss_pred CC--eEEEEEeccCCCChHHH-------H----------Hh----c------CCCC-----------------HHHHHHH
Q 013064 110 SD--FLYLIMEYLPGGDIMTL-------L----------MR----E------DILS-----------------EDVARFY 143 (450)
Q Consensus 110 ~~--~lylVmEy~~gg~L~~~-------l----------~~----~------~~~~-----------------e~~~~~~ 143 (450)
++ ..+-+++|++|..+... + .. . ..+. ....+..
T Consensus 103 ~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~ 182 (1013)
T PRK06148 103 DGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRAL 182 (1013)
T ss_pred CCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHH
Confidence 22 56789999999766541 1 00 0 0000 1112223
Q ss_pred HHHHHHHHH-----Hhh--hCCeEEeecCCCcEEEccCC--ceE-EeeccccccC
Q 013064 144 IAESVLAIH-----SIH--QHNYVHRDIKPDNLILDKNG--HLK-LSDFGLCKPL 188 (450)
Q Consensus 144 ~~qil~aL~-----~LH--~~givHrDLKpeNILld~~g--~ik-L~DFGla~~~ 188 (450)
+.+++...+ .|. ..++||.|+.+.|||++.++ .+. |+|||.+...
T Consensus 183 l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 183 VERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 333333322 122 24799999999999999876 666 9999998753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.15 Score=52.95 Aligned_cols=82 Identities=20% Similarity=0.135 Sum_probs=51.8
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC--------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCe-eeEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT--------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI-VQLFY 105 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~--------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~ 105 (450)
+..++. -++.|..|---.+|++.... .++.|.+|+..... ...+ .-..|..+++.+..-.| .++++
T Consensus 103 ~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~ 177 (442)
T PTZ00296 103 FTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLN 177 (442)
T ss_pred CCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEE
Confidence 444566 67777778888999997652 25679999875432 1112 23557777777743333 45666
Q ss_pred EEEcCCeEEEEEeccCCCCh
Q 013064 106 SFQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L 125 (450)
.|. -+.|.||++|-.|
T Consensus 178 ~f~----gg~I~efi~g~~l 193 (442)
T PTZ00296 178 TFS----GGRIEEWLYGDPL 193 (442)
T ss_pred EeC----CCEEEEeeCCccC
Confidence 664 2467899998643
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.0037 Score=43.47 Aligned_cols=45 Identities=29% Similarity=0.409 Sum_probs=24.1
Q ss_pred CCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCC
Q 013064 355 VNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 402 (450)
Q Consensus 355 ~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 402 (450)
|+++.|++|||. |+......... .....+..+.+.+|.||||+++
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t~~---~~~~~~~~~~~~~F~GFTy~~~ 47 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDTPP---SDPSPLSSSMQENFQGFTYVNP 47 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS--S-----HHHHCTSSGGGGTT-CEETC
T ss_pred CCchhhhhhcCcccccCCCCCCCc---ccCCcccccccCcCCCCeecCC
Confidence 678999999997 55443211110 1112233445567999999986
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.37 Score=47.93 Aligned_cols=74 Identities=11% Similarity=0.076 Sum_probs=43.6
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEE---E--EEEcCCeEEE
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLF---Y--SFQDSDFLYL 115 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~---~--~f~~~~~lyl 115 (450)
..|+ +.-..||.+.. .+|..|++|+..... .....+..|...+..+. -| ++... + ....++..+.
T Consensus 32 ~~l~-s~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~ 104 (325)
T PRK11768 32 LALN-SYENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFA 104 (325)
T ss_pred Eeec-cccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEE
Confidence 3444 44467998864 356679999876432 12345666777776662 22 22211 1 1233567889
Q ss_pred EEeccCCCC
Q 013064 116 IMEYLPGGD 124 (450)
Q Consensus 116 VmEy~~gg~ 124 (450)
|+++++|..
T Consensus 105 l~~~~~G~~ 113 (325)
T PRK11768 105 LFPRRGGRA 113 (325)
T ss_pred EEeeeCCCC
Confidence 999998864
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.092 Score=54.50 Aligned_cols=79 Identities=19% Similarity=0.183 Sum_probs=54.7
Q ss_pred ccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCC-----------CCCCHHHHHHHHHhhc-CccccC
Q 013064 255 MECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE-----------PKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 255 ~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-----------~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+++||||+|.++.++..|...+......+....|.+. ...+.. ..+.....++..+|+. .|..|+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~---~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY---YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh---ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 3999999999999999998877665555555544431 111110 1234556677788887 899998
Q ss_pred CCCCHHHHHcCCCcCCC
Q 013064 323 GTRGVEELKEHPWFRGI 339 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~i 339 (450)
-..++.+|+-|.++
T Consensus 187 ---l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 ---LPMELSKRCSFTEV 200 (725)
T ss_pred ---chhHHhcCccHHHH
Confidence 46788888888776
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.14 Score=47.61 Aligned_cols=86 Identities=24% Similarity=0.292 Sum_probs=59.6
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--CCeE
Q 013064 83 EHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ--HNYV 160 (450)
Q Consensus 83 ~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~--~giv 160 (450)
..+..+.++++++. .|++|..= +.-.+-+|.|+|---.. ...-++.+ =+.+|.-.|+ .+.+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~N~i~a-gi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFSNFITA-GIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chhHHHHH-hHHHHHHhhccCCCee
Confidence 44577888888875 47777722 33346699999833111 11112222 2456788894 4799
Q ss_pred EeecCCCcEEEccCCceEEeecccc
Q 013064 161 HRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 161 HrDLKpeNILld~~g~ikL~DFGla 185 (450)
|+|-.|+||+-|..|.+||.|-+.-
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCCCEEecChhhh
Confidence 9999999999999999999998753
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 450 | ||||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-76 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-76 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-76 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-76 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-74 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-73 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-73 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-68 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-59 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-59 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-59 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-58 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-58 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-58 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-58 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-58 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-58 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-58 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-58 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-58 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-58 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-57 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-57 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-57 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-57 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-57 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-57 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-57 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-57 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-57 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-56 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-56 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-56 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-56 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-56 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-56 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-56 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-56 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-56 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-56 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-56 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-56 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-56 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-56 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-56 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-56 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-56 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-56 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-56 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-56 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-56 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-56 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-56 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-56 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-55 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-55 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-55 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-55 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-55 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-55 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-55 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-55 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-55 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-52 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-50 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-50 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-50 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-50 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-50 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-50 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-50 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-50 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-50 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-49 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-49 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-49 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-49 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-49 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-49 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-49 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-49 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-48 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-46 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-45 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-43 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-43 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-43 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-43 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-43 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-42 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-42 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-41 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-41 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-41 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-41 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-41 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-40 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-40 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-40 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-40 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-40 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-40 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-40 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-40 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-40 | ||
| 3nyn_B | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-40 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-40 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-40 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-40 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-40 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-40 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-40 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-40 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-36 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-36 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-36 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-36 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-36 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-36 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-36 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-33 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-33 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-33 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-33 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-32 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-32 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-32 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-32 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-32 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-32 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-32 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-32 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-32 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-32 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-32 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-32 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-32 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-32 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-32 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-32 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-32 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-32 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-32 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-32 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-32 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-32 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-32 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-32 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-31 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-31 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-31 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-30 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-30 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-30 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-29 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-29 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-29 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-28 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-28 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-28 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-26 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-26 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-26 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-26 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-26 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-26 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-26 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-26 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-25 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-25 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-25 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-25 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-25 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-25 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-25 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-25 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-25 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-25 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-25 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-25 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-25 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-24 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-24 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-24 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-24 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-24 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-24 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-24 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-23 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-23 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-23 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-23 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-23 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-23 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-23 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-22 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-21 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-21 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-20 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-20 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-18 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-18 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-18 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-18 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-18 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-18 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-18 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-18 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-04 |
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 479 bits (1235), Expect = e-169
Identities = 147/409 (35%), Positives = 213/409 (52%), Gaps = 49/409 (11%)
Query: 11 EEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK 70
+ + + L+ E +RL+ ++ DDFE L +IG+GAF EV + + K TG+++AMK
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI 93
Query: 71 LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM 130
+ K +MLKRG+V R ER++L D R I QL ++FQD ++LYL+MEY GGD++TLL
Sbjct: 94 MNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS 153
Query: 131 R-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189
+ + + ++ARFY+AE V+AI S+H+ YVHRDIKPDN++LD+ GH++L+DFG C
Sbjct: 154 KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL--- 210
Query: 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249
+ + S VGT DY++PE+L
Sbjct: 211 ----------KLRADGTVRS------------------------LVAVGTPDYLSPEILQ 236
Query: 250 KKG-------YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPK 302
G YG ECDWW+LG YEM G PF +D T KIV++K L P +
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296
Query: 303 -ISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDT 361
+ +EARD I LLC ETRLG G + + HP+F G+ WD L + + P G DT
Sbjct: 297 GVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDT 356
Query: 362 QNFEKFPE---VDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407
NF+ + F+GY++ + S
Sbjct: 357 CNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 471 bits (1213), Expect = e-165
Identities = 158/420 (37%), Positives = 228/420 (54%), Gaps = 46/420 (10%)
Query: 11 EEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK 70
++ +L LE + ++++ ++ +DFE L +IG+GAFGEV + + K ++FAMK
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 71 LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM 130
L K EMLKR + R ER++L DS+ I L Y+FQD + LYL+M+Y GGD++TLL
Sbjct: 107 LNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS 166
Query: 131 R-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189
+ ED L E++ARFY+AE V+AI S+HQ +YVHRDIKPDN+++D NGH++L+DFG C
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL--- 223
Query: 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249
+ + + S VGT DY++PE+L
Sbjct: 224 ----------KLMEDGTVQS------------------------SVAVGTPDYISPEILQ 249
Query: 250 -----KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKI 303
K YG ECDWWSLG MYEML G PF ++ T KI+N K +FP + +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 304 SDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQN 363
S+ A+DLI L+C E RLG G+E+ K+HP+F GI WD + EA Y P V+ DT N
Sbjct: 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSN 369
Query: 364 FEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRSNGSSKV 423
F+ + +P P + F+G+T+ S VL + +
Sbjct: 370 FDVDDDCLKNSETMPP--PTHTAFSGHHLPFVGFTYTSSCVLSDRSCLRVTAGPTSAENL 427
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 468 bits (1206), Expect = e-164
Identities = 152/412 (36%), Positives = 223/412 (54%), Gaps = 49/412 (11%)
Query: 11 EEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK 70
+ + + L R + +++ ++ +D+E + +IG+GAFGEV+L R K+T +++AMK
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 71 LKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM 130
L K EM+KR ER+++A +S +VQLFY+FQD +LY++MEY+PGGD++ L+
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 161
Query: 131 REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190
D+ E ARFY AE VLA+ +IH ++HRD+KPDN++LDK+GHLKL+DFG C +
Sbjct: 162 NYDV-PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220
Query: 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250
+ VGT DY++PEVL
Sbjct: 221 -------------------------------------EGMVRCDTAVGTPDYISPEVLKS 243
Query: 251 KG----YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDE 306
+G YG ECDWWS+G +YEML+G PF +D T KI+N K L FP++ IS E
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 307 ARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNF 364
A++LIC L D E RLG GVEE+K H +F+ QW + A P ++ ++DT NF
Sbjct: 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363
Query: 365 EKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMR 416
+ E G P K F+G+T+ + S + D R
Sbjct: 364 DDLEEDKGEEETFPI----PKAFVGNQLPFVGFTYYSNRRYLS-SANPNDNR 410
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-135
Identities = 123/348 (35%), Positives = 191/348 (54%), Gaps = 51/348 (14%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
K + DF+ L +G G+FG V L R++ G +AMK LKK +++ QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 94 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
V I++++ +FQD+ +++IM+Y+ GG++ +LL + VA+FY AE LA+
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H + ++RD+KP+N++LDKNGH+K++DFG K + D
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---------------------- 159
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
Y+ GT DY+APEV+ K Y DWWS G ++YEML GY
Sbjct: 160 -------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEEL 330
PF + T KI+N + L+FP P +++ +DL+ L+ D+ RLG G E++
Sbjct: 201 TPFYDSNTMKTYEKILNAE--LRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256
Query: 331 KEHPWFRGIQWDKLY--EMEAAYKPTV-NGELDTQNFEKFPEVDGPPS 375
K HPWF+ + W+KL +E Y+P + G+ DT F+K+PE D
Sbjct: 257 KNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYG 304
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 389 bits (1001), Expect = e-134
Identities = 117/378 (30%), Positives = 199/378 (52%), Gaps = 50/378 (13%)
Query: 3 AQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT 62
A++ + +E + + E ++ + +D F+++ +G G+FG V L + K +
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65
Query: 63 GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 122
G +AMK L K +++K Q+EH +E+ +L V+ +V+L +SF+D+ LY++MEY+ G
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182
G++ + L R SE ARFY A+ VL +H + ++RD+KP+NL++D+ G+++++DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 242
G K ++ + ++ GT +
Sbjct: 186 GFAKRVKGR-----------------------------------------TWTLCGTPEA 204
Query: 243 MAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPK 302
+APE++L KGY DWW+LG ++YEM GYPPF +D P KIV+ K ++FP
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFP--SH 260
Query: 303 ISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNG 357
S + +DL+ +LL D+ R G GV ++K H WF W +Y ++EA + P G
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320
Query: 358 ELDTQNFEKFPEVDGPPS 375
DT NF+ + E + S
Sbjct: 321 PGDTSNFDDYEEEEIRVS 338
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-126
Identities = 97/330 (29%), Positives = 167/330 (50%), Gaps = 44/330 (13%)
Query: 24 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE 83
+ Q RK +DF+ ++G+G+F V L R T +A+K L+K ++K +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 84 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY 143
+V ER++++ +D V+L+++FQD + LY + Y G+++ + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 144 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
AE V A+ +H +HRD+KP+N++L+++ H++++DFG K L +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------------ 183
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263
+++A A S VGT Y++PE+L +K D W+LG
Sbjct: 184 ------------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG 219
Query: 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 322
I+Y+++ G PPF + + + +KI+ + FP K +ARDL+ LL D RL
Sbjct: 220 CIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFP--EKFFPKARDLVEKLLVLDATKRL 275
Query: 323 G---TRGVEELKEHPWFRGIQWDKLYEMEA 349
G G LK HP+F + W+ L++
Sbjct: 276 GCEEMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-126
Identities = 130/344 (37%), Positives = 190/344 (55%), Gaps = 51/344 (14%)
Query: 32 RRKIGIDDFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRG-QVEHVRS 87
KI + FE L ++GKG +G+V R TG+IFAMK LKK+ +++ H ++
Sbjct: 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 88 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
ERN+L EV IV L Y+FQ LYLI+EYL GG++ L RE I ED A FY+AE
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+A+ +HQ ++RD+KP+N++L+ GH+KL+DFGLCK E I +
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-------------ESIHDGTV 177
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
++ GT++YMAPE+L++ G+ DWWSLGA+MY
Sbjct: 178 -------------------------THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212
Query: 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-- 324
+ML G PPF ++ + T KI+ K L P P ++ EARDL+ LL + +RLG
Sbjct: 213 DMLTGAPPFTGENRKKTIDKILKCK--LNLP--PYLTQEARDLLKKLLKRNAASRLGAGP 268
Query: 325 RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 366
E++ HP+FR I W++L ++E +KP + E D F+
Sbjct: 269 GDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDS 312
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-126
Identities = 125/375 (33%), Positives = 186/375 (49%), Gaps = 51/375 (13%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
K+ ++DF+ L L+GKG FG+V L R K TG +AMK L+K ++ + +V H +E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 94 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
+ L Y+FQ D L +MEY GG++ L RE + +E+ ARFY AE V A+
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H + V+RDIK +NL+LDK+GH+K++DFGLCK E I + T
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------EGISDGAT------ 161
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
+ GT +Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 162 -------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRGVEEL 330
PF + D I+ + ++FP +S EA+ L+ LL D + RLG +E+
Sbjct: 203 LPFYNQDHERLFELILMEE--IRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 331 KEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWR 384
EH +F I W + ++ +KP V E+DT+ F+ PP S+G
Sbjct: 259 MEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLE 318
Query: 385 KMLTSKDTNFIGYTF 399
+ F + +
Sbjct: 319 LDQREEQEMFEDFDY 333
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-125
Identities = 128/407 (31%), Positives = 195/407 (47%), Gaps = 56/407 (13%)
Query: 7 AVSNEEQEEMLR------NLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK 60
+S ++ E++ ++ DF L +IGKG+FG+V L R K
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 61 TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLYLIMEY 119
+A+K L+K +LK+ + +H+ SERN+L + V +V L +SFQ +D LY +++Y
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 120
Query: 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179
+ GG++ L RE E ARFY AE A+ +H N V+RD+KP+N++LD GH+ L
Sbjct: 121 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180
Query: 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 239
+DFGLCK E+I + T + GT
Sbjct: 181 TDFGLCK-------------ENIEHNST-------------------------TSTFCGT 202
Query: 240 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE 299
+Y+APEVL K+ Y DWW LGA++YEML G PPF S + I+N L+
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--LQLK- 259
Query: 300 EPKISDEARDLICHLLC-DVETRLG-TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTV 355
P I++ AR L+ LL D RLG E+K H +F I WD L ++ + P V
Sbjct: 260 -PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNV 318
Query: 356 NGELDTQNFEKF---PEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 399
+G D ++F+ V + P + F+G+++
Sbjct: 319 SGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSY 365
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-124
Identities = 123/350 (35%), Positives = 188/350 (53%), Gaps = 51/350 (14%)
Query: 25 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRGQ 81
T +++ K FE L ++G+G+FG+V L + +++AMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 82 VEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR 141
V + ER++L EV+ IV+L Y+FQ LYLI+++L GGD+ T L +E + +E+ +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 142 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
FY+AE LA+ +H ++RD+KP+N++LD+ GH+KL+DFGL K E
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-------------ES 176
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
I +++ AYS GT++YMAPEV+ ++G+ DWWS
Sbjct: 177 IDHEKK-------------------------AYSFCGTVEYMAPEVVNRRGHTQSADWWS 211
Query: 262 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 320
G +M+EML G PF D + T I+ K L P +S EA+ L+ L +
Sbjct: 212 FGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMP--QFLSPEAQSLLRMLFKRNPAN 267
Query: 321 RLG--TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 366
RLG GVEE+K H +F I W+KLY E+ +KP DT F+
Sbjct: 268 RLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP 317
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-122
Identities = 121/391 (30%), Positives = 188/391 (48%), Gaps = 60/391 (15%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
R ++ + DF L ++GKG+FG+V L K T E++A+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 91 LLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 149
+LA + QL FQ D LY +MEY+ GGD+M + + E A FY AE +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ + ++RD+K DN++LD GH+K++DFG+CK E+I + T
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------------ENIWDGVT-- 177
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+ GT DY+APE++ + YG DWW+ G ++YEM
Sbjct: 178 -----------------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RG 326
L G PF +D + I+ + +P +S EA + L+ RLG G
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHN--VAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEG 270
Query: 327 VEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSV 380
++KEH +FR I W+KL E++ YKP G + +NF++F P V PP +
Sbjct: 271 ERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEV-- 327
Query: 381 GPWRKMLTSKDTNFIGYTFKKSDVLKSLENS 411
+ + F G++F S+ LK S
Sbjct: 328 -----IRNIDQSEFEGFSFVNSEFLKPEVKS 353
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-122
Identities = 122/372 (32%), Positives = 194/372 (52%), Gaps = 57/372 (15%)
Query: 9 SNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCR---AKTTGEI 65
+ E++L T + K+GI++FE L ++G GA+G+V L R TG++
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 66 FAMKKLKKSEMLKRG-QVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGG 123
+AMK LKK+ ++++ EH R+ER +L + +V L Y+FQ L+LI++Y+ GG
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 124 DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183
++ T L + + +E + Y+ E VLA+ +H+ ++RDIK +N++LD NGH+ L+DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243
L K E + ++ AY GT++YM
Sbjct: 205 LSK-------------EFVADETER------------------------AYDFCGTIEYM 227
Query: 244 APEVLL--KKGYGMECDWWSLGAIMYEMLIGYPPFCSDD----PRITCRKIVNWKTCLKF 297
AP+++ G+ DWWSLG +MYE+L G PF D R+I+ + +
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPY 285
Query: 298 PEEPKISDEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGIQWDKLY--EMEAAYK 352
P ++S A+DLI LL D + RLG R +E+KEH +F+ I WD L ++ A +K
Sbjct: 286 P--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFK 343
Query: 353 PTVNGELDTQNF 364
P + ELD NF
Sbjct: 344 PVIRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-121
Identities = 112/390 (28%), Positives = 186/390 (47%), Gaps = 60/390 (15%)
Query: 21 ERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG 80
+ ++GID+FE + ++GKG+FG+V L R K TG+++A+K LKK +L+
Sbjct: 6 SKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD 65
Query: 81 QVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
VE +E+ +L+ + + QLF FQ D L+ +ME++ GGD+M + + E
Sbjct: 66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR 125
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
ARFY AE + A+ +H ++RD+K DN++LD GH KL+DFG+CK
Sbjct: 126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK------------- 172
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
E I N T + GT DY+APE+L + YG DW
Sbjct: 173 EGICNGVT-------------------------TATFCGTPDYIAPEILQEMLYGPAVDW 207
Query: 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 318
W++G ++YEML G+ PF +++ I+N + + +P + ++A ++ + +
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--VVYP--TWLHEDATGILKSFMTKNP 263
Query: 319 ETRLG---TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PE 369
RLG G + HP+F+ I W +L ++E ++P + D NF+
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEP 323
Query: 370 VDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 399
V P E + F + +
Sbjct: 324 VLTPIDE-------GHLPMINQDEFRNFEY 346
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-121
Identities = 112/378 (29%), Positives = 174/378 (46%), Gaps = 61/378 (16%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
+ K+ I+DF ++GKG+FG+V L K T + FA+K LKK +L VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 91 LLAEVDSRC--IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
+L+ + +F +FQ + L+ +MEYL GGD+M + A FY AE +
Sbjct: 70 VLSLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
L + +H V+RD+K DN++LDK+GH+K++DFG+CK E+++
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-------------ENMLGDAK- 174
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+ GT DY+APE+LL + Y DWWS G ++YE
Sbjct: 175 ------------------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210
Query: 269 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327
MLIG PF D I +P + EA+DL+ L + E RLG
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRMDN--PFYP--RWLEKEAKDLLVKLFVREPEKRLG--VR 264
Query: 328 EELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVG 381
++++HP FR I W++L E++ ++P V D NF+K
Sbjct: 265 GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADR----- 319
Query: 382 PWRKMLTSKDTNFIGYTF 399
+ + F ++F
Sbjct: 320 --ALINSMDQNMFRNFSF 335
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 350 bits (899), Expect = e-118
Identities = 92/390 (23%), Positives = 170/390 (43%), Gaps = 58/390 (14%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
+ + D FE L IGKG+FG+V + + T +++AMK + K + ++R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
++ ++ +V L+YSFQD + ++++++ L GGD+ L + E+ + +I E V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ + +HRD+KPDN++LD++GH+ ++DF + L
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-------------------- 167
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK---GYGMECDWWSLGAIMY 267
+ GT YMAPE+ + GY DWWSLG Y
Sbjct: 168 -------------------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 268 EMLIGYPPF---CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 323
E+L G P+ S + + +P S E L+ LL + + R
Sbjct: 209 ELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYP--SAWSQEMVSLLKKLLEPNPDQRFS 264
Query: 324 TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVG 381
+ +++ P+ I WD ++ + + P N + E++ E +
Sbjct: 265 --QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNCDPTFELEEMILESKPLH 318
Query: 382 PWRKMLTSKDTNFIGYTFKKSDVLKSLENS 411
+K L K+ + ++ +L+ +S
Sbjct: 319 KKKKRLAKKEKDMRKCDSSQTCLLQEHLDS 348
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-117
Identities = 107/388 (27%), Positives = 188/388 (48%), Gaps = 69/388 (17%)
Query: 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL 91
+G+ DF+ L +IG+G++ +V L R K T I+AMK +KK + ++ V++E+++
Sbjct: 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 92 LAEVDSR-CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
+ + +V L FQ L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
++ +H+ ++RD+K DN++LD GH+KL+D+G+CK E + +T
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------------EGLRPGDT--- 166
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ GT +Y+APE+L + YG DWW+LG +M+EM+
Sbjct: 167 ----------------------TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204
Query: 271 IGYPPFC---------SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 320
G PF + + I+ + ++ P +S +A ++ L D +
Sbjct: 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP--RSLSVKAASVLKSFLNKDPKE 260
Query: 321 RLG---TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNF-EKF---PEVD 371
RLG G +++ HP+FR + WD + ++ +KP ++GE NF +F P
Sbjct: 261 RLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQL 320
Query: 372 GPPSEIPSVGPWRKMLTSKDTNFIGYTF 399
P + + + F G+ +
Sbjct: 321 TPDDD-------DIVRKIDQSEFEGFEY 341
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-116
Identities = 107/417 (25%), Positives = 191/417 (45%), Gaps = 69/417 (16%)
Query: 3 AQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTT 62
+ + E T +G+ DF+ L +IG+G++ +V L R K T
Sbjct: 17 TENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT 76
Query: 63 GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDSDFLYLIMEYLP 121
I+AM+ +KK + ++ V++E+++ + + +V L FQ L+ ++EY+
Sbjct: 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GGD+M + R+ L E+ ARFY AE LA++ +H+ ++RD+K DN++LD GH+KL+D
Sbjct: 137 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 196
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 241
+G+CK E + +T + GT +
Sbjct: 197 YGMCK-------------EGLRPGDT-------------------------TSTFCGTPN 218
Query: 242 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC---------SDDPRITCRKIVNWK 292
Y+APE+L + YG DWW+LG +M+EM+ G PF + + I+ +
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278
Query: 293 TCLKFPEEPKISDEARDLICHLLC-DVETRLG---TRGVEELKEHPWFRGIQWDKLY--E 346
++ P +S +A ++ L D + RLG G +++ HP+FR + WD + +
Sbjct: 279 --IRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQ 334
Query: 347 MEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTF 399
+ +KP ++GE NF+ P P + + + F G+ +
Sbjct: 335 VVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDD-------DIVRKIDQSEFEGFEY 384
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 346 bits (889), Expect = e-116
Identities = 122/342 (35%), Positives = 181/342 (52%), Gaps = 48/342 (14%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
+ ++ +++FE L L+GKG FG+V L + K TG +AMK LKK ++ + +V H +E
Sbjct: 141 PKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 200
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
+L + L YSFQ D L +MEY GG++ L RE + SED ARFY AE V A
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 151 IHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ +H + N V+RD+K +NL+LDK+GH+K++DFGLCK E I + T
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-------------EGIKDGAT-- 305
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+ GT +Y+APEVL YG DWW LG +MYEM
Sbjct: 306 -----------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG--TRG 326
+ G PF + D I+ + ++FP + EA+ L+ LL D + RLG +
Sbjct: 343 MCGRLPFYNQDHEKLFELILMEE--IRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSED 398
Query: 327 VEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEK 366
+E+ +H +F GI W +Y ++ +KP V E DT+ F++
Sbjct: 399 AKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-115
Identities = 122/421 (28%), Positives = 196/421 (46%), Gaps = 60/421 (14%)
Query: 1 MRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK 60
+ ++A + + + R ++ + DF L ++GKG+FG+V L K
Sbjct: 304 QKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK 363
Query: 61 TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLFYSFQDSDFLYLIMEY 119
T E++A+K LKK +++ VE E+ +LA + QL FQ D LY +MEY
Sbjct: 364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 423
Query: 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179
+ GGD+M + + E A FY AE + + + ++RD+K DN++LD GH+K+
Sbjct: 424 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 483
Query: 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 239
+DFG+CK E+I + T + GT
Sbjct: 484 ADFGMCK-------------ENIWDGVT-------------------------TKTFCGT 505
Query: 240 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE 299
DY+APE++ + YG DWW+ G ++YEML G PF +D + I+ + +P
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYP- 562
Query: 300 EPKISDEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPT 354
+S EA + L+ RLG G ++KEH +FR I W+KL E++ YKP
Sbjct: 563 -KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621
Query: 355 VNGELDTQNFEKF----PEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLEN 410
+G + +NF++F P V PP + + + F G++F S+ LK
Sbjct: 622 ASGR-NAENFDRFFTRHPPVLTPPDQEV-------IRNIDQSEFEGFSFVNSEFLKPEVK 673
Query: 411 S 411
S
Sbjct: 674 S 674
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-114
Identities = 107/389 (27%), Positives = 167/389 (42%), Gaps = 69/389 (17%)
Query: 21 ERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRG 80
R ++ L+ + +G D F ++G+G FGEV C+ K TG+++A KKL K + KR
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 81 QVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIM----TLLMREDILS 136
+ E+ +LA+V SR IV L Y+F+ L L+M + GGDI +
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 137 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196
E A FY A+ V + +HQ N ++RD+KP+N++LD +G++++SD GL
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV---------- 337
Query: 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256
E Q GT +MAPE+LL + Y
Sbjct: 338 ---ELKAGQTKTK-------------------------GYAGTPGFMAPELLLGEEYDFS 369
Query: 257 CDWWSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEPKISDEARDLIC 312
D+++LG +YEM+ PF + ++ ++++ + +P K S ++D
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYP--DKFSPASKDFCE 425
Query: 313 HLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNF--E 365
LL D E RLG R + L+ HP FR I W +L + + P
Sbjct: 426 ALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVG 485
Query: 366 KFPEVDGPPSEIPSVGPWRKMLTSKDTNF 394
F V G DT F
Sbjct: 486 AFSTVKGVA------------FEKADTEF 502
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-113
Identities = 108/366 (29%), Positives = 174/366 (47%), Gaps = 56/366 (15%)
Query: 22 RRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ 81
R ++ L+R+ + + F Q ++GKG FGEV C+ + TG+++A KKL+K + KR
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 82 VEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDV 139
+E+ +L +V+SR +V L Y+++ D L L++ + GGD+ + M + E
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR 287
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
A FY AE + +H+ V+RD+KP+N++LD +GH+++SD GL + +
Sbjct: 288 AVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-------- 339
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
VGT+ YMAPEV+ + Y DW
Sbjct: 340 -------------------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 260 WSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEPKISDEARDLICHLL 315
W+LG ++YEM+ G PF +I R + ++ + S +AR L LL
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYS--ERFSPQARSLCSQLL 424
Query: 316 C-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGE--LDTQNFEKFP 368
C D RLG R E+KEHP F+ + + +L +E +KP D + E+F
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFS 484
Query: 369 EVDGPP 374
V G
Sbjct: 485 TVKGVE 490
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-109
Identities = 111/413 (26%), Positives = 182/413 (44%), Gaps = 74/413 (17%)
Query: 13 QEEMLRNLERRETEYMRLQR-RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL 71
Q+ + + R ++ ++ + ++DF +IG+G FGEV CR TG+++AMK L
Sbjct: 163 QKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
Query: 72 KKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTL 128
K + + +ER +L+ V D IV + Y+F D L I++ + GGD+
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH 282
Query: 129 LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188
L + + SE RFY AE +L + +H V+RD+KP N++LD++GH+++SD GL
Sbjct: 283 LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248
K +++VGT YMAPEVL
Sbjct: 343 SKK----------------------------------------KPHASVGTHGYMAPEVL 362
Query: 249 LKK-GYGMECDWWSLGAIMYEMLIGYPPF---CSDDPRITCRKIVNWKTCLKFPEEPKIS 304
K Y DW+SLG +++++L G+ PF + D R + ++ P S
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELP--DSFS 418
Query: 305 DEARDLICHLLC-DVETRLG--TRGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNG-- 357
E R L+ LL DV RLG RG +E+KE P+FR + W ++ + P
Sbjct: 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN 478
Query: 358 ---ELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407
D +F++ + G +L S + + S+ +
Sbjct: 479 AADAFDIGSFDEE-DTKGIK-----------LLDSDQELYRNFPLTISERWQQ 519
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 4e-96
Identities = 93/308 (30%), Positives = 143/308 (46%), Gaps = 48/308 (15%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
++R+ ++DFE +GKG FG V L R K + I A+K L K+++ K G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
+ + + I++L+ F D+ +YLI+EY P G + L + E YI E A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ H +HRDIKP+NL+L G LK++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------------------- 161
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+RR GTLDY+ PE++ + + + D WSLG + YE L
Sbjct: 162 -----------------SRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329
+G PPF ++ + T ++I + FP +++ ARDLI LL + R + E
Sbjct: 202 VGKPPFEANTYQETYKRISRVE--FTFP--DFVTEGARDLISRLLKHNPSQRP---MLRE 254
Query: 330 LKEHPWFR 337
+ EHPW
Sbjct: 255 VLEHPWIT 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 7e-96
Identities = 98/314 (31%), Positives = 148/314 (47%), Gaps = 48/314 (15%)
Query: 25 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH 84
T + +RK IDDF+ +GKG FG V L R K I A+K L KS++ K G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 85 VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 144
+R E + + + I++++ F D +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
E A+H H+ +HRDIKP+NL++ G LK++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264
P R + + GTLDY+ PE++ K + + D W G
Sbjct: 163 -----------HAPSLRRR-----------TMCGTLDYLPPEMIEGKTHDEKVDLWCAGV 200
Query: 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 323
+ YE L+G PPF S T R+IVN LKFP P +SD ++DLI LL RL
Sbjct: 201 LCYEFLVGMPPFDSPSHTETHRRIVNVD--LKFP--PFLSDGSKDLISKLLRYHPPQRL- 255
Query: 324 TRGVEELKEHPWFR 337
++ + EHPW +
Sbjct: 256 --PLKGVMEHPWVK 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 8e-81
Identities = 73/323 (22%), Positives = 136/323 (42%), Gaps = 49/323 (15%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DFE++ ++G+GAFG+V R +A+KK++ +E ++ + SE LLA ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61
Query: 98 RCIVQLFYSFQDSD-------------FLYLIMEYLPGGDIMTLLMREDI-LSEDVARFY 143
+ +V+ + ++ + L++ MEY G + L+ E++ D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 144 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+ + A+ IH +HRD+KP N+ +D++ ++K+ DFGL K + + L+ +++
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSL 262
S +GT Y+A EVL G Y + D +SL
Sbjct: 182 GSSD------------------------NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217
Query: 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 321
G I +EM+ YP + +K+ + + + +I L+ D R
Sbjct: 218 GIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 322 LGTRGVEELKEHPWFRGIQWDKL 344
G L W D++
Sbjct: 276 P---GARTLLNSGWLPVKHQDEV 295
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 4e-79
Identities = 69/380 (18%), Positives = 137/380 (36%), Gaps = 91/380 (23%)
Query: 11 EEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKK 70
+++L N ++ + I+D+ + + +G F ++ L + + +A+KK
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIIL--CEKDNKFYALKK 61
Query: 71 LKKSEMLK--------------RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116
+KS + K + + + ++E ++ ++ + + + D +Y+I
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 117 MEYLPGGDIMTLLMREDIL--------SEDVARFYIAESVLAIHSIHQHNYV-HRDIKPD 167
EY+ I+ +L V + I + + IH + HRD+KP
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 168 NLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKR 227
N+++DKNG +KLSDFG + M ++++
Sbjct: 182 NILMDKNGRVKLSDFGESE-----------------------------YMVDKKIK---- 208
Query: 228 NRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMYEMLIGYPPFCSD-DPRIT 284
+ GT ++M PE + G + D WSLG +Y M PF
Sbjct: 209 -------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 285 CRKIVNWKTCLKFPEEPK-----------------ISDEARDLICHLLC-DVETRLGTRG 326
I +++P + +S+E D + L + R+
Sbjct: 262 FNNIRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---T 316
Query: 327 VEELKEHPWFRGIQWDKLYE 346
E+ +H W + L E
Sbjct: 317 SEDALKHEWLADTNIEDLRE 336
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 5e-79
Identities = 88/304 (28%), Positives = 151/304 (49%), Gaps = 49/304 (16%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
I+DF+ L+GKG+F V + TG A+K + K M K G V+ V++E + ++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIH 155
I++L+ F+DS+++YL++E G++ L R SE+ AR ++ + + + +H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
H +HRD+ NL+L +N ++K++DFGL + L+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGL---------ATQLKMPH-------------- 166
Query: 216 MMPKERLQQWKRNRRALAYSTV-GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
E+ T+ GT +Y++PE+ + +G+E D WSLG + Y +LIG P
Sbjct: 167 ----EKHY------------TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333
PF +D + T K+V + P +S EA+DLI LL + RL + + +H
Sbjct: 211 PFDTDTVKNTLNKVVLAD--YEMP--SFLSIEAKDLIHQLLRRNPADRL---SLSSVLDH 263
Query: 334 PWFR 337
P+
Sbjct: 264 PFMS 267
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 6e-79
Identities = 67/313 (21%), Positives = 112/313 (35%), Gaps = 51/313 (16%)
Query: 27 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 86
Y + F++L+ +G G++GEV R+K G ++A+K+ + + +
Sbjct: 46 YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA 105
Query: 87 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIA 145
+ C V+L ++++ LYL E G + L E Y+
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLR 164
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+++LA+ +H VH D+KP N+ L G KL DFGL L
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----------------- 207
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
G YMAPE+ L+ YG D +SLG
Sbjct: 208 ----------------------GTAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLT 244
Query: 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324
+ E+ + +++ +F +S E R ++ +L D + R
Sbjct: 245 ILEVACNMELPHGGEGW---QQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRA-- 297
Query: 325 RGVEELKEHPWFR 337
E L P R
Sbjct: 298 -TAEALLALPVLR 309
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-78
Identities = 83/311 (26%), Positives = 137/311 (44%), Gaps = 48/311 (15%)
Query: 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE 88
+ + + +GKG F + T E+FA K + KS +LK Q E + E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
++ + + +V F+D+DF+++++E ++ L R L+E AR+Y+ + V
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
L +H++ +HRD+K NL L+++ +K+ DFGL +
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------------------- 165
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTV-GTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
ER + + GT +Y+APEVL KKG+ E D WS+G IMY
Sbjct: 166 -------EYDGERKK------------VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 206
Query: 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326
+L+G PPF + + T +I + P I+ A LI +L D R
Sbjct: 207 TLLVGKPPFETSCLKETYLRIKKNE--YSIP--KHINPVAASLIQKMLQTDPTARP---T 259
Query: 327 VEELKEHPWFR 337
+ EL +F
Sbjct: 260 INELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 4e-78
Identities = 83/311 (26%), Positives = 137/311 (44%), Gaps = 48/311 (15%)
Query: 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE 88
+ + + +GKG F + T E+FA K + KS +LK Q E + E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
++ + + +V F+D+DF+++++E ++ L R L+E AR+Y+ + V
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
L +H++ +HRD+K NL L+++ +K+ DFGL +
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-------------------- 191
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTV-GTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
ER + + GT +Y+APEVL KKG+ E D WS+G IMY
Sbjct: 192 -------EYDGERKK------------VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMY 232
Query: 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326
+L+G PPF + + T +I + P I+ A LI +L D R
Sbjct: 233 TLLVGKPPFETSCLKETYLRIKKNE--YSIP--KHINPVAASLIQKMLQTDPTARP---T 285
Query: 327 VEELKEHPWFR 337
+ EL +F
Sbjct: 286 INELLNDEFFT 296
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 3e-76
Identities = 76/331 (22%), Positives = 138/331 (41%), Gaps = 60/331 (18%)
Query: 22 RRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ 81
TE + Q + + L IG G +V + +I+A+K + E +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ-T 69
Query: 82 VEHVRSERNLLAEVD--SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
++ R+E L ++ S I++L+ ++Y++ME D+ + L ++ +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE 128
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
+ Y + A+H+IHQH VH D+KP N ++ +G LKL DFG+ ++ +S++ +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD- 186
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---------- 249
S VGT++YM PE +
Sbjct: 187 -----------------------------------SQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 250 -KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEA 307
K + D WSLG I+Y M G PF +I I++ ++FP+ +
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDL 269
Query: 308 RDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
+D++ L D + R+ + EL HP+ +
Sbjct: 270 QDVLKCCLKRDPKQRI---SIPELLAHPYVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-73
Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 60/319 (18%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
+ + L IG G +V + +I+A+K + E + ++ R+E L
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 62
Query: 94 EVD--SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 151
++ S I++L+ ++Y++ME D+ + L ++ + + Y + A+
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
H+IHQH VH D+KP N ++ +G LKL DFG+ ++ +S++ +
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD------------- 167
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----------KKGYGMECDWW 260
S VGT++YM PE + K + D W
Sbjct: 168 -----------------------SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 261 SLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 318
SLG I+Y M G PF +I I++ ++FP + +D++ L D
Sbjct: 205 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDP 262
Query: 319 ETRLGTRGVEELKEHPWFR 337
+ R+ + EL HP+ +
Sbjct: 263 KQRI---SIPELLAHPYVQ 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-72
Identities = 80/358 (22%), Positives = 143/358 (39%), Gaps = 50/358 (13%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++ + +L IG+G+FG+ L ++ G + +K++ S M + + E R E +LA +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMK 81
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSI 154
IVQ SF+++ LY++M+Y GGD+ + + + ED + + LA+ +
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H +HRDIK N+ L K+G ++L DFG+ + L
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--------------------- 180
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
LA + +GT Y++PE+ K Y + D W+LG ++YE+
Sbjct: 181 -----------------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGTRGVEELKE 332
F + + KI++ FP S + R L+ L + R V + E
Sbjct: 224 AFEAGSMKNLVLKIIS----GSFPPVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILE 276
Query: 333 HPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSK 390
+ L A + + + + SV P +K+
Sbjct: 277 KGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPA 334
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-71
Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 60/319 (18%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
+ + L IG G +V + +I+A+K + E + ++ R+E L
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 109
Query: 94 EVD--SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 151
++ S I++L+ ++Y++ME D+ + L ++ + + Y + A+
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
H+IHQH VH D+KP N ++ +G LKL DFG+ ++ +S++ +
Sbjct: 169 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD------------- 214
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----------KKGYGMECDWW 260
S VG ++YM PE + K + D W
Sbjct: 215 -----------------------SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 261 SLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 318
SLG I+Y M G PF +I I++ ++FP+ + +D++ L D
Sbjct: 252 SLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDP 309
Query: 319 ETRLGTRGVEELKEHPWFR 337
+ R+ + EL HP+ +
Sbjct: 310 KQRI---SIPELLAHPYVQ 325
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-69
Identities = 87/307 (28%), Positives = 142/307 (46%), Gaps = 54/307 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
F + ++G GAF EV L + + TG++FA+K +KKS + + +E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV L ++ + YL+M+ + GG++ ++ + +E A I + + A+ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 158 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
VHRD+KP+NL+ ++N + ++DFGL S + ++ +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGL---------SKMEQNGIM------------ 164
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+ GT Y+APEVL +K Y D WS+G I Y +L GYP
Sbjct: 165 -------------------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP 205
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 331
PF + KI +F IS+ A+D ICHLL D R T E+
Sbjct: 206 PFYEETESKLFEKIKEGY--YEFESPFWDDISESAKDFICHLLEKDPNERY-T--CEKAL 260
Query: 332 EHPWFRG 338
HPW G
Sbjct: 261 SHPWIDG 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-69
Identities = 80/305 (26%), Positives = 129/305 (42%), Gaps = 56/305 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--VEHVRSERNLLAEVDSRCIVQL 103
IGKG F VR C + TG+ FA+K + ++ E ++ E ++ + IV+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 104 FYSFQDSDFLYLIMEYLPGGD----IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
++ LY++ E++ G D I+ + SE VA Y+ + + A+ H +N
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 160 VHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+KP ++L + + +KL FG+ L + G
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE---------------------SGLVA 190
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
VGT +MAPEV+ ++ YG D W G I++ +L G PF
Sbjct: 191 -----------------GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
Query: 277 CSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEH 333
R+ I+ K K IS+ A+DL+ +L D R+ T V E H
Sbjct: 234 YGTKERLF-EGIIKGK--YKMNPRQWSHISESAKDLVRRMLMLDPAERI-T--VYEALNH 287
Query: 334 PWFRG 338
PW +
Sbjct: 288 PWLKE 292
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 2e-69
Identities = 79/299 (26%), Positives = 131/299 (43%), Gaps = 51/299 (17%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+GKGAF VR C KTTG FA K + ++ R + + E + ++ IV+L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHD 72
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
S Q+ F YL+ + + GG++ ++ + SE A I + + +I H + VHR++K
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 166 PDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
P+NL+L K +KL+DFGL + + +
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVN----------------------DSEAW------ 164
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282
+ GT Y++PEVL K Y D W+ G I+Y +L+GYPPF +D
Sbjct: 165 -----------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213
Query: 283 ITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
+I +P ++ EA+ LI +L + + R+ ++ + PW
Sbjct: 214 RLYAQIKAGA--YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 2e-69
Identities = 74/301 (24%), Positives = 130/301 (43%), Gaps = 56/301 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+G GAFG+V L +++G +K + K + +E + +E +L +D I+++F
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 106 SFQDSDFLYLIMEYLPGGD----IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVH 161
F+D +Y++ME GG+ I++ R LSE + + + A+ H + VH
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 162 RDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
+D+KP+N++ + +K+ DFGL + L + ++
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGL---------AELFKSDEHSTN------------- 185
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
GT YMAPEV K+ +CD WS G +MY +L G PF
Sbjct: 186 -----------------AAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 279 DDPRITCRKIVNWKTCLKFPEEPK-ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+K + + E + ++ +A DL+ +L D E R ++ H WF
Sbjct: 228 TSLEEVQQKATYKE--PNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWF 282
Query: 337 R 337
+
Sbjct: 283 K 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-69
Identities = 84/299 (28%), Positives = 136/299 (45%), Gaps = 52/299 (17%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
+GKG+FGEV C+ + T + +A+K + K+ + + E LL ++D I++LF
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFE 88
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
+DS Y++ E GG++ +++ SE A I + I +H+HN VHRD+K
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 166 PDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
P+N++L +K+ +K+ DFGL + + M
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQ----------------------QNTKM------ 180
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282
+GT Y+APEV L+ Y +CD WS G I+Y +L G PPF +
Sbjct: 181 -----------KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 283 ITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
+++ K F ISD+A+DLI +L R+ + EHPW +
Sbjct: 229 DILKRVETGK--YAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-69
Identities = 87/322 (27%), Positives = 144/322 (44%), Gaps = 52/322 (16%)
Query: 23 RETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQV 82
R +E+M K D+++ +GKGAF VR C KTTG FA K + ++ R
Sbjct: 15 RGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DF 72
Query: 83 EHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF 142
+ + E + ++ IV+L S Q+ F YL+ + + GG++ ++ + SE A
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLED 199
I + + +I H + VHR++KP+NL+L K +KL+DFGL +I + D
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL---------AIEVND 183
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
+ + GT Y++PEVL K Y D
Sbjct: 184 SEAW------------------------------HGFAGTPGYLSPEVLKKDPYSKPVDI 213
Query: 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC- 316
W+ G I+Y +L+GYPPF +D +I +P ++ EA+ LI +L
Sbjct: 214 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--YDYPSPEWDTVTPEAKSLIDSMLTV 271
Query: 317 DVETRLGTRGVEELKEHPWFRG 338
+ + R+ T ++ + PW
Sbjct: 272 NPKKRI-T--ADQALKVPWICN 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 7e-69
Identities = 86/318 (27%), Positives = 147/318 (46%), Gaps = 48/318 (15%)
Query: 27 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 86
+++ D ++ ++GKG+FGEV LC+ K TG+ A+K + K ++ ++ E +
Sbjct: 16 FVQHSTAIFS-DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 87 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAE 146
E LL ++D I++L+ F+D + YL+ E GG++ ++ SE A I +
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 134
Query: 147 SVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+ I +H++ VHRD+KP+NL+L K+ ++++ DFGL E
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-------------- 180
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263
+ M +GT Y+APEV L Y +CD WS G
Sbjct: 181 --------ASKKMK-----------------DKIGTAYYIAPEV-LHGTYDEKCDVWSTG 214
Query: 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 322
I+Y +L G PPF + +K+ K + P+ K+S+ A+DLI +L R+
Sbjct: 215 VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
Query: 323 GTRGVEELKEHPWFRGIQ 340
+ +H W +
Sbjct: 275 ---SARDALDHEWIQTYT 289
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-68
Identities = 93/342 (27%), Positives = 157/342 (45%), Gaps = 49/342 (14%)
Query: 1 MRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK 60
M S E +L+ ++ ++ + + ++++ +G GA+GEV LCR K
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDK 59
Query: 61 TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYL 120
T A+K ++K+ + + E +L +D I++L+ F+D YL+ME
Sbjct: 60 VTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118
Query: 121 PGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHL 177
GG++ ++ +E A I + + + +H+HN VHRD+KP+NL+L +K+ +
Sbjct: 119 KGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178
Query: 178 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV 237
K+ DFGL E + M +
Sbjct: 179 KIVDFGLSAVFE----------------------NQKKM-----------------KERL 199
Query: 238 GTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKF 297
GT Y+APEV L+K Y +CD WS+G I++ +L GYPPF + RK+ K
Sbjct: 200 GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
Query: 298 PEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
PE +S+ A+DLI +L D + R+ ++ EHPW +
Sbjct: 259 PEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKE 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-68
Identities = 82/367 (22%), Positives = 143/367 (38%), Gaps = 84/367 (22%)
Query: 18 RNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM- 76
+ RE Y + + IG+G++G VR+ T I A+K + K+++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 77 -LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDI---------- 125
+ VE +++E L+ ++ I +L+ ++D ++ L+ME GG +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 126 ------------------------------MTLLMREDILSEDVARFYIAESVLAIHSIH 155
+ + E + + + A+H +H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 156 QHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
HRDIKP+N + +K+ +KL DFGL K + E
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKL-----------------NNGEY 228
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKGYGMECDWWSLGAIMYEMLI 271
M + GT ++APEVL + YG +CD WS G +++ +L+
Sbjct: 229 YGMT-----------------TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330
G PF + T +++N K C + P +S ARDL+ +LL +V+ R
Sbjct: 272 GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMRA 328
Query: 331 KEHPWFR 337
+HPW
Sbjct: 329 LQHPWIS 335
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-68
Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 48/307 (15%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ + + ++GKG+FGEV C+ + T + +A+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
I++LF +DS Y++ E GG++ +++ SE A I + I +H+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 158 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
N VHRD+KP+N++L +K+ +K+ DFGL + +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----------------------QNT 178
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
M +GT Y+APEV L+ Y +CD WS G I+Y +L G P
Sbjct: 179 KM-----------------KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTP 220
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333
PF + +++ K P+ ISD+A+DLI +L R+ + EH
Sbjct: 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEH 277
Query: 334 PWFRGIQ 340
PW +
Sbjct: 278 PWIQKYS 284
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-68
Identities = 80/315 (25%), Positives = 131/315 (41%), Gaps = 60/315 (19%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-------SR 98
+G+G VR C K T + +A+K + + E L EVD
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 158
I+QL +++ + F +L+ + + G++ L + LSE R + + I ++H+ N
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
VHRD+KP+N++LD + ++KL+DFG L+ G+ +
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLD----------------------PGEKLR- 181
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECDWWSLGAIMYEMLIG 272
GT Y+APE++ GYG E D WS G IMY +L G
Sbjct: 182 ----------------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEE 329
PPF + R I++ +F SD +DL+ L + R EE
Sbjct: 226 SPPFWHRKQMLMLRMIMSGN--YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEE 280
Query: 330 LKEHPWFRGIQWDKL 344
HP+F+ +++
Sbjct: 281 ALAHPFFQQYVVEEV 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 9e-68
Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 54/303 (17%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAEVDSRCIVQ 102
+G G F VR CR K TG+ +A K +KK + + E + E N+L E+ I+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
L F++ + LI+E + GG++ L ++ L+ED A ++ + + +H +H H
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 163 DIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
D+KP+N++L N +KL DFG+ +E
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----------------------------A 164
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278
+ GT +++APE++ + G+E D WS+G I Y +L G PF
Sbjct: 165 GNEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213
Query: 279 DDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335
+ + T I F EE S+ A+D I LL D + R+ + + EH W
Sbjct: 214 ETKQETLTNISAVN--YDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSW 268
Query: 336 FRG 338
+
Sbjct: 269 IKA 271
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-67
Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 54/311 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 94
D ++ +G G F V+ CR K+TG +A K +KK + + E + E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
V ++ L +++ + LI+E + GG++ L +++ LSE+ A +I + + ++ +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 155 HQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
H H D+KP+N++L H+KL DFGL +E
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------------------- 170
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 171 -------DGVEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGV 327
G PF D + T I + F EE S+ A+D I LL + RL +
Sbjct: 213 SGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRL---TI 267
Query: 328 EELKEHPWFRG 338
+E HPW
Sbjct: 268 QEALRHPWITP 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-67
Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IG+G++GEV++ K T A KK+ K + V+ + E ++ +D I++L+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIK 165
+F+D+ +YL+ME GG++ ++ + + E A + + + A+ H+ N HRD+K
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 166 PDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERL 222
P+N + + LKL DFGL + + ++
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGL---------AARFKPGKMMRT----------------- 167
Query: 223 QQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR 282
VGT Y++P+V L+ YG ECD WS G +MY +L GYPPF +
Sbjct: 168 -------------KVGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213
Query: 283 ITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
KI FPE+ +S +A LI LL + R+ + EH WF
Sbjct: 214 EVMLKIREGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 6e-67
Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 50/307 (16%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
++++ +GKGAF VR C G+ +A + L + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV+L S + YLI + + GG++ ++ + SE A I + + A+ HQ
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 158 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
VHR++KP+NL+L K +KL+DFGL +I +E E Q
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGL---------AIEVEG------------EQQ 168
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+ GT Y++PEVL K YG D W+ G I+Y +L+GYP
Sbjct: 169 AW-----------------FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 331
PF +D ++I FP ++ EA+DLI +L + R+ T E
Sbjct: 212 PFWDEDQHRLYQQIKAGA--YDFPSPEWDTVTPEAKDLINKMLTINPSKRI-T--AAEAL 266
Query: 332 EHPWFRG 338
+HPW
Sbjct: 267 KHPWISH 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 86/314 (27%), Positives = 138/314 (43%), Gaps = 59/314 (18%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+D+E L IG G++G + R K+ G+I K+L M + + + + SE NLL E+
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELK 63
Query: 97 SRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLA 150
IV+ + D + LY++MEY GGD+ +++ + L E+ + + LA
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 151 IHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ H+ + +HRD+KP N+ LD ++KL DFGL + L
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---------------- 167
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
+ + A + VGT YM+PE + + Y + D WSLG +
Sbjct: 168 ----------------------HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 205
Query: 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI-SDEARDLICHLLC-DVETRLG 323
+YE+ PPF + + KI KF P SDE ++I +L R
Sbjct: 206 LYELCALMPPFTAFSQKELAGKIRE----GKFRRIPYRYSDELNEIITRMLNLKDYHRP- 260
Query: 324 TRGVEELKEHPWFR 337
VEE+ E+P
Sbjct: 261 --SVEEILENPLIL 272
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-66
Identities = 96/349 (27%), Positives = 153/349 (43%), Gaps = 58/349 (16%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
S+ + + + Y+R + KIG + + ++ +G GA+GEV LC+ K
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 64 EIFAMKKLKKSEM----------LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113
A+K +KKS+ E + +E +LL +D I++LF F+D +
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL-- 171
YL+ E+ GG++ ++ E A + + + I +H+HN VHRDIKP+N++L
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181
Query: 172 -DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRR 230
+ ++K+ DFGL + +
Sbjct: 182 KNSLLNIKIVDFGLSSFFS----------------------KDYKL-------------- 205
Query: 231 ALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN 290
+GT Y+APEV LKK Y +CD WS G IMY +L GYPPF + + +K+
Sbjct: 206 ---RDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261
Query: 291 WKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
K F + ISDEA++LI +L D R EE W +
Sbjct: 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKK 307
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-66
Identities = 86/307 (28%), Positives = 131/307 (42%), Gaps = 63/307 (20%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLF 104
+G+G+F R C K + + FA+K + K + + E L + IV+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLH 72
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
F D +L+ME L GG++ + ++ SE A + + + V A+ +H VHRD+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 165 KPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
KP+NL+ + N +K+ DFG + + + Q +
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFAR---------------------LKPPDNQPLK---- 167
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281
+ TL Y APE+L + GY CD WSLG I+Y ML G PF S D
Sbjct: 168 -------------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214
Query: 282 RITC-------RKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 331
+TC +KI F E +S EA+DLI LL D RL + L+
Sbjct: 215 SLTCTSAVEIMKKIKKGD--FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL-K--MSGLR 269
Query: 332 EHPWFRG 338
+ W +
Sbjct: 270 YNEWLQD 276
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-66
Identities = 81/311 (26%), Positives = 136/311 (43%), Gaps = 54/311 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 94
D ++ +G G F V+ CR K+TG +A K +KK + + E + E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
V I+ L +++ + LI+E + GG++ L +++ LSE+ A +I + + ++ +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 155 HQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
H H D+KP+N++L H+KL DFGL +E
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------------------- 170
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 171 -------DGVEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRGV 327
G PF D + T I F EE + S+ A+D I LL + RL +
Sbjct: 213 SGASPFLGDTKQETLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TI 267
Query: 328 EELKEHPWFRG 338
+E HPW
Sbjct: 268 QEALRHPWITP 278
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 4e-66
Identities = 72/311 (23%), Positives = 135/311 (43%), Gaps = 54/311 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 94
D ++ +G G F V+ CR K+TG +A K +KK + E + E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
+ ++ L +++ + LI+E + GG++ L ++ L+E+ A ++ + + ++ +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 155 HQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
H H D+KP+N++L +K+ DFGL ++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------------------- 169
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 170 -------FGNEFKN-----------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGV 327
G PF D + T + +F +E S A+D I LL D + R+ +
Sbjct: 212 SGASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TI 266
Query: 328 EELKEHPWFRG 338
++ +HPW +
Sbjct: 267 QDSLQHPWIKP 277
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 5e-66
Identities = 77/301 (25%), Positives = 129/301 (42%), Gaps = 54/301 (17%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR-CIVQLF 104
+G+G F VR C +K+TG+ +A K LKK + + E +L S ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHR 162
++++ + LI+EY GG+I +L + E +SE+ I + + ++ +HQ+N VH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 163 DIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
D+KP N++L G +K+ DFG+ + +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG----------------------------HA 187
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
L++ +GT +Y+APE+L D W++G I Y +L PF +
Sbjct: 188 CELRE-----------IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236
Query: 280 DPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
D + T I + + EE +S A D I LL + E R E H W
Sbjct: 237 DNQETYLNISQVN--VDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWL 291
Query: 337 R 337
+
Sbjct: 292 Q 292
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-65
Identities = 81/301 (26%), Positives = 140/301 (46%), Gaps = 56/301 (18%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
+G+GA V C+ K T + +A+K LKK+ + VR+E +L + I++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164
F+ + L++E + GG++ ++ + SE A + + + A+ +H++ VHRD+
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDL 174
Query: 165 KPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKER 221
KP+NL+ + LK++DFGL S ++E + ++
Sbjct: 175 KPENLLYATPAPDAPLKIADFGL---------SKIVEHQVLM------------------ 207
Query: 222 LQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD-D 280
+ GT Y APE+L YG E D WS+G I Y +L G+ PF +
Sbjct: 208 ------------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255
Query: 281 PRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
+ R+I+N + F ++S A+DL+ L+ D + RL T + +HPW
Sbjct: 256 DQFMFRRILNCE--YYFISPWWDEVSLNAKDLVRKLIVLDPKKRL-T--TFQALQHPWVT 310
Query: 338 G 338
G
Sbjct: 311 G 311
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 4e-65
Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 56/306 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMK-----KLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
+G GA GEV+L + T + A++ K + +V +E +L +++ CI
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 160
+++ F D Y+++E + GG++ ++ L E + Y + +LA+ +H++ +
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 161 HRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
HRD+KP+N++L +++ +K++DFG K L E M
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG----------------------ETSLM- 298
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWSLGAIMYEMLIGYP 274
+ GT Y+APEVL GY D WSLG I++ L GYP
Sbjct: 299 ----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 275 PFCSDDPRITC-RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332
PF +++ +I + K ++S++A DL+ LL D + R EE
Sbjct: 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALR 399
Query: 333 HPWFRG 338
HPW +
Sbjct: 400 HPWLQD 405
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-65
Identities = 73/307 (23%), Positives = 126/307 (41%), Gaps = 54/307 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ + +G+G FG V C ++ + + K +K K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIM-TLLMREDILSEDVARFYIAESVLAIHSIHQ 156
R I+ L SF+ + L +I E++ G DI + L+E Y+ + A+ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 157 HNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
HN H DI+P+N+I ++ +K+ +FG + L+
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------------------------- 155
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
P + + +Y APEV D WSLG ++Y +L G
Sbjct: 156 ---PGDNFRL-----------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEELK 331
PF ++ + I+N + F EE +IS EA D + LL + ++R+ E
Sbjct: 202 PFLAETNQQIIENIMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEAL 256
Query: 332 EHPWFRG 338
+HPW +
Sbjct: 257 QHPWLKQ 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-65
Identities = 75/306 (24%), Positives = 136/306 (44%), Gaps = 53/306 (17%)
Query: 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR 98
+ ++G G FG+V C TG A K +K E V++E +++ ++D
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHA 146
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQH 157
++QL+ +F+ + + L+MEY+ GG++ ++ E L+E ++ + I +HQ
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 158 NYVHRDIKPDNLIL-DKNGH-LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
+H D+KP+N++ +++ +K+ DFGL + +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------------------------- 240
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
P+E+L+ GT +++APEV+ D WS+G I Y +L G P
Sbjct: 241 --PREKLKV-----------NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
Query: 276 FCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETRLGTRGVEELKE 332
F D+ T I+ + +E IS+EA++ I LL + R+ E +
Sbjct: 288 FLGDNDAETLNNILACR--WDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALK 342
Query: 333 HPWFRG 338
HPW
Sbjct: 343 HPWLSD 348
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 7e-65
Identities = 82/343 (23%), Positives = 150/343 (43%), Gaps = 53/343 (15%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
R + + ++ ++ ++ ++ D ++ L +G GAFG V C K
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TG +F K + V++E +++ ++ ++ L +F+D + LI+E+L
Sbjct: 75 TGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 122 GGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL--DKNGHLK 178
GG++ + ED +SE Y+ ++ + +H+H+ VH DIKP+N++ K +K
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK 191
Query: 179 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVG 238
+ DFGL L P E ++ T
Sbjct: 192 IIDFGLATKLN----------------------------PDEIVKV-----------TTA 212
Query: 239 TLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP 298
T ++ APE++ ++ G D W++G + Y +L G PF +D T + + +F
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD--WEFD 270
Query: 299 EE--PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
E+ +S EA+D I +LL + RL V + EHPW +G
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-64
Identities = 88/306 (28%), Positives = 133/306 (43%), Gaps = 59/306 (19%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMK-----KLKKSEMLKRGQVEHVRSERNLLAEV-DSRC 99
IG+G VR C + TG FA+K + S E R E ++L +V
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
I+ L S++ S F++L+ + + G++ L + LSE R + + A+ +H +N
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
VHRD+KP+N++LD N ++LSDFG LE G+ +
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLE----------------------PGEKL--- 256
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECDWWSLGAIMYEMLIGY 273
GT Y+APE+L GYG E D W+ G I++ +L G
Sbjct: 257 --------------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEEL 330
PPF + R I+ + +F S +DLI LL D E RL T E+
Sbjct: 303 PPFWHRRQILMLRMIMEGQ--YQFSSPEWDDRSSTVKDLISRLLQVDPEARL-T--AEQA 357
Query: 331 KEHPWF 336
+HP+F
Sbjct: 358 LQHPFF 363
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-64
Identities = 82/313 (26%), Positives = 138/313 (44%), Gaps = 60/313 (19%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMK-----KLKKSEMLKRGQVEHVRSERNLLAEVDSRCI 100
+G GA GEV+L + T + A+K K + +V +E +L +++ CI
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 160
+++ F D+ Y+++E + GG++ ++ L E + Y + +LA+ +H++ +
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 161 HRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
HRD+KP+N++L +++ +K++DFG K L E M
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG----------------------ETSLM- 173
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWSLGAIMYEMLIGYP 274
+ GT Y+APEVL GY D WSLG I++ L GYP
Sbjct: 174 ----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 275 PFCSD-DPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGVEEL 330
PF +I + K F E ++S++A DL+ LL D + R EE
Sbjct: 218 PFSEHRTQVSLKDQITSGK--YNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEA 272
Query: 331 KEHPWFRGIQWDK 343
HPW + +
Sbjct: 273 LRHPWLQDEDMKR 285
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-64
Identities = 84/341 (24%), Positives = 146/341 (42%), Gaps = 54/341 (15%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG 63
+ VS+ + ++ + + ++ + D ++ +G GAFG V + TG
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATG 182
Query: 64 EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
FA K + E VR E ++ + +V L +F+D + + +I E++ GG
Sbjct: 183 NNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 124 DIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL--DKNGHLKLS 180
++ + E +SED A Y+ + + +H++NYVH D+KP+N++ ++ LKL
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLI 299
Query: 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 240
DFGL L+ PK+ ++ T GT
Sbjct: 300 DFGLTAHLD----------------------------PKQSVKV-----------TTGTA 320
Query: 241 DYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE 300
++ APEV K G D WS+G + Y +L G PF ++ T R + + +
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD--WNMDDS 378
Query: 301 --PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
IS++ +D I LL D TR+ + + EHPW
Sbjct: 379 AFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTP 416
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-64
Identities = 82/311 (26%), Positives = 132/311 (42%), Gaps = 59/311 (18%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D +E IG G++ + C K T FA+K + KS+ ++E LL
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------LLRYGQH 75
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
I+ L + D ++Y++ E + GG+++ ++R+ SE A + + +H
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 158 NYVHRDIKPDNLIL-DKNGH---LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
VHRD+KP N++ D++G+ +++ DFG K L AE
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---------------------RAEN 174
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
+M + T +++APEVL ++GY CD WSLG ++Y ML GY
Sbjct: 175 GLLM-----------------TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217
Query: 274 PPF---CSDDPRITCRKIVNWKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRGV 327
PF D P +I + K +SD A+DL+ +L D RL
Sbjct: 218 TPFANGPDDTPEEILARIGSGK--FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TA 272
Query: 328 EELKEHPWFRG 338
+ HPW
Sbjct: 273 ALVLRHPWIVH 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-64
Identities = 73/308 (23%), Positives = 126/308 (40%), Gaps = 54/308 (17%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ +F IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL----MREDILSEDVARFYIAESVLAIH 152
+++ + SF + + L +++E GD+ ++ ++ ++ E Y + A+
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+H +HRDIKP N+ + G +KL D GL + K +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT------------------- 191
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
A+S VGT YM+PE + + GY + D WSLG ++YEM
Sbjct: 192 -------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 273 YPPFCSDDPRIT--CRKIVNWKTCLKFPEEPK--ISDEARDLICHLLC-DVETRLGTRGV 327
PF D + C+KI +P P S+E R L+ + D E R V
Sbjct: 233 QSPFYGDKMNLYSLCKKIEQ----CDYPPLPSDHYSEELRQLVNMCINPDPEKR---PDV 285
Query: 328 EELKEHPW 335
+ +
Sbjct: 286 TYVYDVAK 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-64
Identities = 65/320 (20%), Positives = 112/320 (35%), Gaps = 78/320 (24%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DF+++ LIG G FG+V + + G+ + +K++K + E E LA++D
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63
Query: 98 RCIVQLFYSFQDSD----------------FLYLIMEYLPGGDIMTLL--MREDILSEDV 139
IV + D L++ ME+ G + + R + L + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
A + + IH ++RD+KP N+ L +K+ DFGL L++
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-------- 175
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
+ GTL YM+PE + + YG E D
Sbjct: 176 -------------------------------GKRTRSKGTLRYMSPEQISSQDYGKEVDL 204
Query: 260 WSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-D 317
++LG I+ E+L + F + R + + L+ LL
Sbjct: 205 YALGLILAELLHVCDTAFETSKFFTDLRDG-------IIS--DIFDKKEKTLLQKLLSKK 255
Query: 318 VETRLGTRGVEELKEHPWFR 337
E R E+
Sbjct: 256 PEDRP---NTSEILRTLTVW 272
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-64
Identities = 42/341 (12%), Positives = 94/341 (27%), Gaps = 98/341 (28%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER--------------- 89
++G+ + TGE F + +E ++ ++ E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 90 ----------NLLAEVDSRCIVQLFYSFQDSDFL--YLIME------YLPGGDIMTLLMR 131
+L+ + + ++++ +D L + + G +++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 132 EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191
L + + + S+H + VH ++P +++LD+ G + L+ F +
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259
Query: 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-- 249
+ + + PE+
Sbjct: 260 ------------------------------------------VVSSVSRGFEPPELEARR 277
Query: 250 ---------KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE 300
+ D W+LG ++Y + P D I F
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------FRSC 329
Query: 301 PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340
I R L+ L E RL + E P + ++
Sbjct: 330 KNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR 367
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-63
Identities = 69/350 (19%), Positives = 121/350 (34%), Gaps = 87/350 (24%)
Query: 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER 89
+ + + ++G+GA V R K TG++FA+K L+ V+ E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 90 NLLAEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYI 144
+L +++ + IV+LF ++ + LIME+ P G + T+L L E +
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDE 200
+ V ++ + ++ VHR+IKP N++ D KL+DFG + LED
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------- 169
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--------LKKG 252
S GT +Y+ P++ +K
Sbjct: 170 ------------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 253 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN---------------------W 291
YG D WS+G Y G PF + ++++
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 292 KTCLKFPEEPKISDEARDLICHLL-----CDVETRLGTRGVEELKEHPWF 336
P +S + L+ +L D E G ++
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETSD 306
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 4e-63
Identities = 78/319 (24%), Positives = 133/319 (41%), Gaps = 62/319 (19%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQL 103
++G+GA V+ C T + +A+K ++K R V E +L + R +++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRD 163
F++ D YL+ E + GG I++ + + +E A + + A+ +H HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 164 IKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 220
+KP+N++ ++ +K+ DF L ++ S ++
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKL--------------NGDCSPISTPELL--- 179
Query: 221 RLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIMYEMLIGYPP 275
+ G+ +YMAPEV+ Y CD WSLG I+Y +L GYPP
Sbjct: 180 --------------TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
Query: 276 FCSD-DPRITCRKIVNWKTC------------LKFPEEP--KISDEARDLICHLLC-DVE 319
F + C +FP++ IS A+DLI LL D +
Sbjct: 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 320 TRLGTRGVEELKEHPWFRG 338
RL ++ +HPW +G
Sbjct: 286 QRL---SAAQVLQHPWVQG 301
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 5e-63
Identities = 90/339 (26%), Positives = 139/339 (41%), Gaps = 76/339 (22%)
Query: 21 ERRETEYMRLQRRKIGIDDFEQLT--LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 78
E + + +K + D QL+ ++G G G+V C + TG+ A+K L S +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR 69
Query: 79 RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----FLYLIMEYLPGGDIMTLLMR--- 131
+ +V+H IV + +++ L +IME + GG+ L R
Sbjct: 70 Q-EVDH------HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQE 119
Query: 132 --EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCK 186
+ +E A + + AI +H HN HRD+KP+NL+ +K+ LKL+DFG K
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 246
+ P T Y+APE
Sbjct: 180 ETT----------------------QNALQTP------------------CYTPYYVAPE 199
Query: 247 VLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEP- 301
VL + Y CD WSLG IMY +L G+PPF S+ + R+I + FP
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ--YGFPNPEW 257
Query: 302 -KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
++S++A+ LI LL D RL + + HPW
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-62
Identities = 90/324 (27%), Positives = 142/324 (43%), Gaps = 77/324 (23%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC----- 99
IGKG++G V+L + +AMK L K +++++ R
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 100 ------------------IVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
+V+L + D LY++ E + G +M + LSED
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQ 138
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
ARFY + + I +H +HRDIKP NL++ ++GH+K++DFG+ S +
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV---------SNEFKG 189
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKGY-GME 256
D AL +TVGT +MAPE L +K + G
Sbjct: 190 SD-----------------------------ALLSNTVGTPAFMAPESLSETRKIFSGKA 220
Query: 257 CDWWSLGAIMYEMLIGYPPFCSDDPRITC--RKIVNWKTCLKFPEEPKISDEARDLICHL 314
D W++G +Y + G PF D RI C KI + L+FP++P I+++ +DLI +
Sbjct: 221 LDVWAMGVTLYCFVFGQCPF--MDERIMCLHSKIKSQA--LEFPDQPDIAEDLKDLITRM 276
Query: 315 LC-DVETRLGTRGVEELKEHPWFR 337
L + E+R+ V E+K HPW
Sbjct: 277 LDKNPESRI---VVPEIKLHPWVT 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-62
Identities = 69/306 (22%), Positives = 130/306 (42%), Gaps = 50/306 (16%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++D++ + +G+GA+GEV+L + T E A+K + + E+++ E + ++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
+V+ + ++ + YL +EY GG++ + + + E A+ + + + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
HRDIKP+NL+LD+ +LK+SDFGL LL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------------ 165
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275
GTL Y+APE+L ++ + D WS G ++ ML G P
Sbjct: 166 ------------------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 276 FCSDDPRITC---RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331
+ D P +C + KI L+ +L + R+ + ++K
Sbjct: 208 W--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIK 260
Query: 332 EHPWFR 337
+ W+
Sbjct: 261 KDRWYN 266
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-62
Identities = 67/321 (20%), Positives = 121/321 (37%), Gaps = 54/321 (16%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ DFE + +G+G FG V + K +A+K+++ E V E LA+++
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLE 61
Query: 97 SRCIVQLFYSFQDSD------------FLYLIMEYLPGGDIMTLLMR---EDILSEDVAR 141
IV+ F ++ + + +LY+ M+ ++ + + V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 142 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
+ A+ +H +HRD+KP N+ + +K+ DFGL + D+D
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM----------DQD 171
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
Q ++ A VGT YM+PE + Y + D +S
Sbjct: 172 EEEQTVLTPMPAY----------------ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215
Query: 262 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVE 319
LG I++E+L YP + T + N LKFP + ++ +L
Sbjct: 216 LGLILFELL--YPFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 320 TRLGTRGVEELKEHPWFRGIQ 340
R + E+ F +
Sbjct: 270 ERP---EAINIIENAVFEDLD 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 77/309 (24%), Positives = 128/309 (41%), Gaps = 60/309 (19%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE-----HVRSERNL 91
+ ++ +G GAFG V K + +K +KK ++L+ +E V E +
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 92 LAEVDSRCIVQLFYSFQDSDFLYLIME-YLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
L+ V+ I+++ F++ F L+ME + G D+ + R L E +A + + V A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ + + +HRDIK +N+++ ++ +KL DFG LE
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-------------------- 182
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 269
L Y+ GT++Y APEVL+ Y G E + WSLG +Y +
Sbjct: 183 -------------------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTL 223
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328
+ PFC + V + P +S E L+ LL E R +E
Sbjct: 224 VFEENPFCEL------EETVEAA--IHPP--YLVSKELMSLVSGLLQPVPERRT---TLE 270
Query: 329 ELKEHPWFR 337
+L PW
Sbjct: 271 KLVTDPWVT 279
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 8e-61
Identities = 71/352 (20%), Positives = 143/352 (40%), Gaps = 51/352 (14%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++D++ + +G+GA+GEV+L + T E A+K + + E+++ E + ++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
+V+ + ++ + YL +EY GG++ + + + E A+ + + + + +H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
HRDIKP+NL+LD+ +LK+SDFGL LL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------------ 165
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275
GTL Y+APE+L ++ + D WS G ++ ML G P
Sbjct: 166 ------------------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
Query: 276 FCSDDPRITC---RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331
+ D P +C + KI L+ +L + R+ + ++K
Sbjct: 208 W--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIK 260
Query: 332 EHPWFR-GIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGP 382
+ W+ ++ + + + +++ + + S + G
Sbjct: 261 KDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGS 312
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 8e-61
Identities = 78/319 (24%), Positives = 127/319 (39%), Gaps = 66/319 (20%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE---HVRS 87
+ R+ ++ L+GKG FG V T A+K + ++ +L +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 88 ERNLLAEVDSRC----IVQLFYSFQDSDFLYLIMEY-LPGGDIMTLLMREDILSEDVARF 142
E LL +V + +++L F+ + L++E LP D+ + + L E +R
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDED 201
+ + V AI H VHRDIK +N+++D + G KL DFG LL DE
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS---------GALLHDE- 193
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLLKKGY-GMECDW 259
Y+ GT Y PE + + Y +
Sbjct: 194 -------------------------------PYTDFDGTRVYSPPEWISRHQYHALPATV 222
Query: 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 318
WSLG ++Y+M+ G PF D ++I+ + L FP +S + LI L
Sbjct: 223 WSLGILLYDMVCGDIPFERD------QEILEAE--LHFP--AHVSPDCCALIRRCLAPKP 272
Query: 319 ETRLGTRGVEELKEHPWFR 337
+R +EE+ PW +
Sbjct: 273 SSRP---SLEEILLDPWMQ 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-61
Identities = 84/312 (26%), Positives = 122/312 (39%), Gaps = 73/312 (23%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQL 103
+G G G+V K T E FA+K L+ +R E L S+C IV++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA-SQCPHIVRI 120
Query: 104 FYSFQDS----DFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSI 154
+++ L ++ME L GG+ L R + +E A + AI +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 155 HQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
H N HRD+KP+NL+ N LKL+DFG K
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------- 215
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271
+ + T Y+APEVL + Y CD WSLG IMY +L
Sbjct: 216 SHNSLT-----------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258
Query: 272 GYPPFCSDDPRITCRKIVN--WKTCLKFPEEP--KISDEARDLICHLLC-DVETRLGTRG 326
GYPPF S+ + +FP ++S+E + LI +LL + R+
Sbjct: 259 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---T 315
Query: 327 VEELKEHPWFRG 338
+ E HPW
Sbjct: 316 ITEFMNHPWIMQ 327
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-60
Identities = 75/309 (24%), Positives = 132/309 (42%), Gaps = 48/309 (15%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
++ I + +G G FG+V++ + TG A+K L + ++ V ++ E
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
L I++L+ +++MEY+ GG++ + + + E AR + + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ H+H VHRD+KP+N++LD + + K++DFGL
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------- 158
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 269
M E L+ G+ +Y APEV+ + Y G E D WS G I+Y +
Sbjct: 159 ---NMMSDGEFLRTS-----------CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328
L G PF + +KI F ++ L+ H+L D R ++
Sbjct: 205 LCGTLPFDDEHVPTLFKKIRG----GVFYIPEYLNRSVATLLMHMLQVDPLKRA---TIK 257
Query: 329 ELKEHPWFR 337
+++EH WF+
Sbjct: 258 DIREHEWFK 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-60
Identities = 69/349 (19%), Positives = 121/349 (34%), Gaps = 87/349 (24%)
Query: 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER 89
+ + + ++G+GA V R K TG++FA+K L+ V+ E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 90 NLLAEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYI 144
+L +++ + IV+LF ++ + LIME+ P G + T+L L E +
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLCKPLEDKYSSILLEDE 200
+ V ++ + ++ VHR+IKP N++ D KL+DFG + LED
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------- 169
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--------LKKG 252
S GT +Y+ P++ +K
Sbjct: 170 ------------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKK 199
Query: 253 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN---------------------W 291
YG D WS+G Y G PF + ++++
Sbjct: 200 YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPI 259
Query: 292 KTCLKFPEEPKISDEARDLICHLL-----CDVETRLGTRGVEELKEHPW 335
P +S + L+ +L D E G ++
Sbjct: 260 DWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETS 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-59
Identities = 62/328 (18%), Positives = 109/328 (33%), Gaps = 52/328 (15%)
Query: 23 RETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQV 82
RE Y + I + + +G+G F V L G +A+K++ E R
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR--- 70
Query: 83 EHVRSERNLLAEVDSRCIVQLFYSFQDSDF----LYLIMEYLPGGD----IMTLLMREDI 134
E + E ++ + I++L +L++ + G I L + +
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 135 LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194
L+ED + + + +IH Y HRD+KP N++L G L D G
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY- 253
+ + T+ Y APE+ + +
Sbjct: 191 -----------------------------SRQALTLQDWAAQRCTISYRAPELFSVQSHC 221
Query: 254 --GMECDWWSLGAIMYEMLIGYPPFCSDDPRI--TCRKIVNWKTCLKFPEEPKISDEARD 309
D WSLG ++Y M+ G P+ + + N L P+ P+ S
Sbjct: 222 VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---QLSIPQSPRHSSALWQ 278
Query: 310 LICHLLC-DVETRLGTRGVEELKEHPWF 336
L+ ++ D R + L
Sbjct: 279 LLNSMMTVDPHQRP---HIPLLLSQLEA 303
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-59
Identities = 80/346 (23%), Positives = 134/346 (38%), Gaps = 62/346 (17%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
++ M + T+ + ++ ++ L+G G FG V +
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVS 66
Query: 62 TGEIFAMKKLKKSEMLKRGQVEH---VRSERNLLAEVDSRC--IVQLFYSFQDSDFLYLI 116
A+K ++K + G++ + V E LL +V S +++L F+ D LI
Sbjct: 67 DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126
Query: 117 MEY-LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN- 174
+E P D+ + L E++AR + + + A+ H +HRDIK +N+++D N
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186
Query: 175 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAY 234
G LKL DFG L+D + D
Sbjct: 187 GELKLIDFGSGALLKDT----VYTD----------------------------------- 207
Query: 235 STVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT 293
GT Y PE + Y G WSLG ++Y+M+ G PF D +I+ +
Sbjct: 208 -FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQ- 259
Query: 294 CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
+ F ++S E + LI L R EE++ HPW +
Sbjct: 260 -VFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQD 299
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 7e-59
Identities = 96/360 (26%), Positives = 145/360 (40%), Gaps = 63/360 (17%)
Query: 16 MLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE 75
M R M + D ++ + IG G FG RL R K T E+ A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD---SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA 57
Query: 76 MLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL 135
+ E+V+ E + IV+ L +IMEY GG++ +
Sbjct: 58 AID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113
Query: 136 SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--GHLKLSDFGLCKPLEDKYS 193
SED ARF+ + + + H HRD+K +N +LD + LK+ DFG K
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------- 166
Query: 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253
+ + + STVGT Y+APEVLL++ Y
Sbjct: 167 ---------------------SSVLHSQPK-----------STVGTPAYIAPEVLLRQEY 194
Query: 254 -GMECDWWSLGAIMYEMLIGYPPFCSDDP------RITCRKIVNWKTCLKFPEEPKISDE 306
G D WS G +Y ML+G PF +DP R T ++I++ K P++ +IS E
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPF--EDPEEPRDYRKTIQRILSVK--YSIPDDIRISPE 250
Query: 307 ARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFE 365
LI + D TR+ + E+K H WF L E Q+ +
Sbjct: 251 CCHLISRIFVADPATRI---SIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLD 307
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-59
Identities = 78/303 (25%), Positives = 130/303 (42%), Gaps = 49/303 (16%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
I ++ L IGKG F +V+L R TG A+K + K++ L ++ + E ++ ++
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN 72
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
IV+LF + LYLIMEY GG++ L+ + E AR + V A+ HQ
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
VHRD+K +NL+LD + ++K++DFG
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFS----------------------------NEF 164
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275
+L + G Y APE+ K Y G E D WSLG I+Y ++ G P
Sbjct: 165 TVGGKLDAF-----------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
Query: 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334
F + + +++ K+ +S + +L+ L + R +E++ +
Sbjct: 214 FDGQNLKELRERVLR----GKYRIPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDR 266
Query: 335 WFR 337
W
Sbjct: 267 WIN 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-58
Identities = 72/349 (20%), Positives = 124/349 (35%), Gaps = 55/349 (15%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
+ Q+ E+ E +L + + +Y + + +G+G+FGEV + K
Sbjct: 26 KLQRLGPETEDNEGVLLTEKLKPVDY----EYREEVHWMTHQPRVGRGSFGEVHRMKDKQ 81
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
TG A+KK++ E A + S IV L+ + ++ ++ + ME L
Sbjct: 82 TGFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLS 180
GG + L+ + L ED A +Y+ +++ + +H +H D+K DN++L +G L
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALC 193
Query: 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 240
DFG L+ GT
Sbjct: 194 DFGHALCLQPDGLG---------------------------------KSLLTGDYIPGTE 220
Query: 241 DYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE 300
+MAPEV++ K + D WS +M ML G P+ C KI + +
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPIREIP 279
Query: 301 PKISDEARDLICHLLC---DVETRLGTRGVEELKEHPWFRGIQWDKLYE 346
P + I + R EL+ + L
Sbjct: 280 PSCAPLTAQAI--QEGLRKEPVHRA---SAMELRRKVGKALQEVGGLKS 323
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-57
Identities = 79/312 (25%), Positives = 140/312 (44%), Gaps = 51/312 (16%)
Query: 28 MRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS 87
M + +R IG + +G+G+FG+V+L T + A+K + + + K V
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 88 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
E + L + I++L+ + +++EY GG++ ++ + ++ED R + +
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ AI H+H VHRD+KP+NL+LD N ++K++DFGL
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSN--------------------- 156
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIM 266
M L+ G+ +Y APEV+ K Y G E D WS G ++
Sbjct: 157 -------IMTDGNFLKTS-----------CGSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
Query: 267 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 325
Y ML+G PF + +K+ + + +S A+ LI ++ D R+
Sbjct: 199 YVMLVGRLPFDDEFIPNLFKKVNSC----VYVMPDFLSPGAQSLIRRMIVADPMQRI--- 251
Query: 326 GVEELKEHPWFR 337
++E++ PWF
Sbjct: 252 TIQEIRRDPWFN 263
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 8e-57
Identities = 54/380 (14%), Positives = 89/380 (23%), Gaps = 84/380 (22%)
Query: 1 MRAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK 60
R + E + + + E G + + + G V L R
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV 84
Query: 61 TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF---------------- 104
E FA+K R ++E + A + +
Sbjct: 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144
Query: 105 ----------YSFQDSDFLYLIMEYLPG--GDIMTLLMREDI----LSEDVARFYIAESV 148
L+M + + L + A+ +
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
++ VH PDNL + +G L L D + + +
Sbjct: 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS------------- 251
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIM 266
+ Y E L + + W LG +
Sbjct: 252 ----------------------------SVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 267 YEMLIGYPPFCSDDPRITCRKIVNWKTC-----LKFPEEPKISDEARDLICHLLC-DVET 320
Y + + PF P I L F + D + LI L D
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343
Query: 321 RLGTRGVEELKEHPWFRGIQ 340
RL E E P F +Q
Sbjct: 344 RL---LPLEAMETPEFLQLQ 360
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 192 bits (488), Expect = 9e-57
Identities = 48/371 (12%), Positives = 100/371 (26%), Gaps = 92/371 (24%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER--------------- 89
++G+ + TGE F + +E ++ ++ E
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 90 ----------NLLAEVDSRCIVQLFYSFQDSDFL--YLIMEYLPG-----GDIMTLLMRE 132
+L+ + + ++++ +D L + + + G+++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 133 DILSEDVARFYIAESVL-AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191
AR + V+ + S+H + VH ++P +++LD+ G + L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-- 249
+ + A +L
Sbjct: 265 -------------------------------------AVSPIGRGFAPPETTAERMLPFG 287
Query: 250 ---KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDE 306
D W+LG +Y + P D I F I
Sbjct: 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--------FRSCKNIPQP 339
Query: 307 ARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFE 365
R L+ L E RL + E P + +L +A P + +
Sbjct: 340 VRALLEGFLRYPKEDRLLP---LQAMETPEYE-----QLRTELSAALPLYQTDGEPTREG 391
Query: 366 KFPEVDGPPSE 376
P +
Sbjct: 392 GAPPSGTSQPD 402
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-56
Identities = 76/309 (24%), Positives = 134/309 (43%), Gaps = 48/309 (15%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
++ I + +G G FG+V++ + + TG A+K L + ++ V +R E
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
L I++L+ ++++MEY+ GG++ + + L E +R + +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ H+H VHRD+KP+N++LD + + K++DFGL
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------- 163
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 269
M E L+ G+ +Y APEV+ + Y G E D WS G I+Y +
Sbjct: 164 ---NMMSDGEFLRTS-----------CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328
L G PF D +KI + F ++ L+ H+L D R ++
Sbjct: 210 LCGTLPFDDDHVPTLFKKICDG----IFYTPQYLNPSVISLLKHMLQVDPMKRA---TIK 262
Query: 329 ELKEHPWFR 337
+++EH WF+
Sbjct: 263 DIREHEWFK 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 189 bits (480), Expect = 5e-56
Identities = 53/345 (15%), Positives = 106/345 (30%), Gaps = 75/345 (21%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSE 88
++G L+G+GAF +V + F +K K + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFY 143
L ++ + + + L+ E G ++ + E ++ + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 144 IAESVLAIHSIHQHNYVHRDIKPDNLIL-----------DKNGHLKLSDFGLCKPLEDKY 192
+ I +H +H DIKPDN IL D + L L D G ++
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK--- 234
Query: 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252
+ PK + + T + E+L K
Sbjct: 235 -----------------------LFPKGT----------IFTAKCETSGFQCVEMLSNKP 261
Query: 253 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIV--------NWK----TCLKFPEE 300
+ + D++ + A +Y ML G ++ + + W L P+
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDC 321
Query: 301 PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQWDKLY 345
+ + DL+ L V + T + L+ + + K
Sbjct: 322 HHLP--SLDLLRQKLKKVFQQHYTNKIRALR-NRLIVLLLECKRS 363
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 5e-55
Identities = 64/322 (19%), Positives = 113/322 (35%), Gaps = 63/322 (19%)
Query: 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92
+G F ++G GA G + + R A+K++ E LL
Sbjct: 19 VIVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLL 71
Query: 93 AEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGG--DIMTLLMREDILSEDVARFYIAESVL 149
E D +++ F + +D F Y+ +E + + ++ + ++
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV--EQKDFAHLGLEPITLLQQTTS 129
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ +H N VHRD+KP N+++ +SDFGLCK L S
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF--------- 180
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMECDWWS 261
+ GT ++APE+L K+ D +S
Sbjct: 181 --------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS 214
Query: 262 LGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DV 318
G + Y ++ G PF R I+ L E AR+LI ++ D
Sbjct: 215 AGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAMDP 272
Query: 319 ETRLGTRGVEELKEHPWFRGIQ 340
+ R + + +HP+F ++
Sbjct: 273 QKRP---SAKHVLKHPFFWSLE 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-53
Identities = 68/337 (20%), Positives = 113/337 (33%), Gaps = 77/337 (22%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+E +G G FG V + TGE A+K+ ++ L E E ++ +++
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLN 70
Query: 97 SRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYIAES 147
+V +D L MEY GGD+ L L E R +++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYSSILLEDEDIIN 204
A+ +H++ +HRD+KP+N++L K+ D G K L+
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG------------- 177
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264
L VGTL Y+APE+L +K Y + D+WS G
Sbjct: 178 --------------------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 265 IMYEMLIGYPPFCSDDPRITCRKIV----------------NWKTCLKFPEEPKISDEAR 308
+ +E + G+ PF + + V K P +S
Sbjct: 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILA 271
Query: 309 DLICHLL-----CDVETRLGTRGVEELKEHPWFRGIQ 340
+ L R + F+ +
Sbjct: 272 GKLERWLQCMLMWHQRQRG---TDPQNPNVGCFQALD 305
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-53
Identities = 67/327 (20%), Positives = 115/327 (35%), Gaps = 80/327 (24%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQL 103
++G G+ G V G A+K++ + E LL E D +++
Sbjct: 22 ILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRY 74
Query: 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES-------VLAIHSIHQ 156
+ S FLY+ +E ++ L+ +++ E++ + +H
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 157 HNYVHRDIKPDNLILD-------------KNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+HRD+KP N+++ +N + +SDFGLCK L+ SS
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF-------- 185
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-------KKGYGME 256
R + GT + APE+L K+
Sbjct: 186 --------------------------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 257 CDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCL---KFPEEPKISDEARDLIC 312
D +S+G + Y +L G PF R + I+ L K + + EA DLI
Sbjct: 220 IDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 313 HLLC-DVETRLGTRGVEELKEHPWFRG 338
++ D R ++ HP F
Sbjct: 278 QMIDHDPLKRP---TAMKVLRHPLFWP 301
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-53
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 50/300 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVE-HVRSERNLLAEVDSRCIVQL 103
L+G+G++G+V+ T A+K LKK ++ + E +V+ E LL + + ++QL
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 104 F--YSFQDSDFLYLIMEYLPGGDI-MTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 160
++ +Y++MEY G M + E A Y + + + +H V
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 161 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 220
H+DIKP NL+L G LK+S G+ + L +
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR---------------------- 169
Query: 221 RLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGY-GMECDWWSLGAIMYEMLIGYPPFCS 278
++ G+ + PE+ + G + D WS G +Y + G PF
Sbjct: 170 --------------TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
Query: 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
D+ I P + DL+ +L + R + ++++H WFR
Sbjct: 216 DNIYKLFENIGKGS--YAIPGD--CGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 87/346 (25%), Positives = 139/346 (40%), Gaps = 72/346 (20%)
Query: 7 AVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF 66
++ + E+ + +L + EY R ++GKG +G V R +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRV----------VLGKGTYGIVYAGRDLSNQVRI 50
Query: 67 AMK--KLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD 124
A+K + S + + E L + + IVQ SF ++ F+ + ME +PGG
Sbjct: 51 AIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105
Query: 125 IMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLS 180
+ LL + +E FY + + + +H + VHRDIK DN++++ +G LK+S
Sbjct: 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165
Query: 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 240
DFG K L + GTL
Sbjct: 166 DFGTSKRLAGINPC--------------------------------------TETFTGTL 187
Query: 241 DYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCS-DDPRITCRKIVNWKTCLKF 297
YMAPE++ K +GYG D WSLG + EM G PPF +P+ K+ +K +
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEI 247
Query: 298 PEEPKISDEARDLICHLLC---DVETRLGTRGVEELKEHPWFRGIQ 340
PE +S EA+ I L C D + R +L + +
Sbjct: 248 PES--MSAEAKAFI--LKCFEPDPDKRA---CANDLLVDEFLKVSS 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-53
Identities = 54/308 (17%), Positives = 102/308 (33%), Gaps = 42/308 (13%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+F +L IG G FG V C + G I+A+K+ KK + +R
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL----MREDILSEDVARFYIAESVLAIHS 153
+V+ F ++ + D + + EY GG + + E + + + +
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL-LEDEDIINQETVSEAE 212
IH + VH DIKP N+ + + + + + + D + + +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS----- 185
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLI 271
G ++A EVL + + D ++L +
Sbjct: 186 -------------------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG 226
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGTRGVEE 329
P + D +I + P P +S E +L+ ++ D E R
Sbjct: 227 AEPLPRNGDQW---HEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMA 276
Query: 330 LKEHPWFR 337
L +H
Sbjct: 277 LVKHSVLL 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 64/319 (20%), Positives = 111/319 (34%), Gaps = 55/319 (17%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
++G ++ +G F V + +G +A+K+L +E K + E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMK 80
Query: 94 EV-DSRCIVQLFYSF-------QDSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARF 142
++ IVQ + +L++ L G ++ L + LS D
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 143 YIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200
++ A+ +H+ +HRD+K +NL+L G +KL DFG +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY--------- 191
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMEC 257
P +R + T Y PE++ G +
Sbjct: 192 -----------------PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 258 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC- 316
D W+LG I+Y + PF +D +IVN K P LI +L
Sbjct: 235 DIWALGCILYLLCFRQHPF--EDGAK--LRIVNGK--YSIPPHDTQYTVFHSLIRAMLQV 288
Query: 317 DVETRLGTRGVEELKEHPW 335
+ E RL + E+
Sbjct: 289 NPEERL---SIAEVVHQLQ 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-46
Identities = 84/340 (24%), Positives = 148/340 (43%), Gaps = 53/340 (15%)
Query: 4 QQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDD----FEQLTLIGKGAFGEVRLCRA 59
+ V + ++ ++ R + D + IG+G+ G V L R
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66
Query: 60 KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119
K +G A+K + + +R E + +E ++ + +V+++ S+ + L+++ME+
Sbjct: 67 KHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 120 LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179
L GG + T ++ + L+E+ + A+ +H +HRDIK D+++L +G +KL
Sbjct: 124 LQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 239
SDFG C + KR S VGT
Sbjct: 183 SDFGFCAQISKDVP--------------------------------KRK------SLVGT 204
Query: 240 LDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT-CLKFP 298
+MAPEV+ + Y E D WSLG ++ EM+ G PP+ SD P +++ + LK
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS 264
Query: 299 EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
K+S RD + +L D + R +EL +HP+
Sbjct: 265 H--KVSPVLRDFLERMLVRDPQERATA---QELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-46
Identities = 89/306 (29%), Positives = 143/306 (46%), Gaps = 57/306 (18%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ + IG+GA G V TG+ A++++ + K+ E + +E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA----ESVLAIHS 153
IV S+ D L+++MEYL GG + T ++ E + E IA E + A+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEG----QIAAVCRECLQALEF 131
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H + +HRDIK DN++L +G +KL+DFG C + + S
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-------------------- 171
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
KR+ + VGT +MAPEV+ +K YG + D WSLG + EM+ G
Sbjct: 172 ------------KRS------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
Query: 274 PPFCSDDPRITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331
PP+ +++P I T L+ PE K+S RD + L DVE R +EL
Sbjct: 214 PPYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSA---KELL 268
Query: 332 EHPWFR 337
+H + +
Sbjct: 269 QHQFLK 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 2e-45
Identities = 58/363 (15%), Positives = 111/363 (30%), Gaps = 97/363 (26%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTG----------------------EIFAMKKLK--- 72
DFE + +G+G FG V + K E+ A+ KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 73 ------------------------------KSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
+ ++ + + ++ V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARFYIAESVLAIHSIHQHNY 159
+LY+ M+ ++ + R + V + A+ +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+HRD+KP N+ + +K+ DFGL ++ + +
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ--------- 236
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
VGT YM+PE + Y + D +SLG I++E+L F +
Sbjct: 237 -----------------VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQ 276
Query: 280 DPRI-TCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
R+ + N LKFP + + ++ +L R ++ E+ F
Sbjct: 277 MERVRIITDVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA---TDIIENAIF 329
Query: 337 RGI 339
+
Sbjct: 330 ENL 332
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 79/304 (25%), Positives = 127/304 (41%), Gaps = 54/304 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--VEHVRSERNLLAEV 95
+ F +L IGKG+FGEV T ++ A+K + L+ + +E ++ E +L++
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 155
DS + + + S+ L++IMEYL GG + L + L E + E + + +H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLH 136
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
+HRDIK N++L ++G +KL+DFG+ L D
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---------------------- 174
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
KRN + VGT +MAPEV+ + Y + D WSLG E+ G PP
Sbjct: 175 ----------KRN------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
Query: 276 FCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333
P I P E S ++ + L + R +EL +H
Sbjct: 219 HSELHPMKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTA---KELLKH 271
Query: 334 PWFR 337
+
Sbjct: 272 KFIL 275
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-45
Identities = 55/301 (18%), Positives = 112/301 (37%), Gaps = 54/301 (17%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
IG+G+F V T A +L+ ++ K + + + E +L + IV+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 105 YSFQDS----DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY- 159
S++ + + L+ E + G + T L R ++ V R + + + + +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 160 -VHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRD+K DN+ + G +K+ D GL +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF------------------------- 186
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277
A + +GT ++MAPE+ ++ Y D ++ G M EM P+
Sbjct: 187 ---------------AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYS 230
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+ V ++ E +++I + + + R + +L H +F
Sbjct: 231 ECQNAAQIYRRVTSGVKPASFDK-VAIPEVKEIIEGCIRQNKDERYSIK---DLLNHAFF 286
Query: 337 R 337
+
Sbjct: 287 Q 287
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 72/321 (22%), Positives = 129/321 (40%), Gaps = 65/321 (20%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERN 90
+D + L IG+GA+G V K +G+I A+K+++ + K+ ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL----DV 73
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG--DIMTLLM--REDILSEDVARFYIAE 146
++ D IVQ + + ++ ME + + +D++ E++ I
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-KITL 132
Query: 147 SVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + A++ + +HRDIKP N++LD++G++KL DFG+ L D +
Sbjct: 133 ATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA----------- 181
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYGMECDWW 260
K G YMAPE + ++GY + D W
Sbjct: 182 ---------------------KTR-------DAGCRPYMAPERIDPSASRQGYDVRSDVW 213
Query: 261 SLGAIMYEMLIGYPPFCSDDPRITC-RKIVNWKT-CLKFPEEPKISDEARDLI--CHLLC 316
SLG +YE+ G P+ + ++V L EE + S + + C L
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLC-LTK 272
Query: 317 DVETRLGTRGVEELKEHPWFR 337
D R + EL +HP+
Sbjct: 273 DESKRPKYK---ELLKHPFIL 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-44
Identities = 71/318 (22%), Positives = 125/318 (39%), Gaps = 58/318 (18%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--VEHVRSERNLLAEV 95
DD+E +IG GA V+ E A+K++ L++ Q ++ + E +++
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAMSQC 70
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMRED-----ILSEDVARFYIAES 147
IV + SF D L+L+M+ L GG DI+ ++ + +L E + E
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ + +H++ +HRD+K N++L ++G ++++DFG+
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS---------------------- 168
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266
+ + R + VGT +MAPEV+ + +GY + D WS G
Sbjct: 169 -----AFLATGGDITRNKVRK------TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217
Query: 267 YEMLIGYPPFCSDDPRITCRKIVNWKT------CLKFPEEPKISDEARDLICHLLC-DVE 319
E+ G P+ P + K R +I L D E
Sbjct: 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE 277
Query: 320 TRLGTRGVEELKEHPWFR 337
R EL H +F+
Sbjct: 278 KRPTA---AELLRHKFFQ 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-44
Identities = 73/333 (21%), Positives = 131/333 (39%), Gaps = 62/333 (18%)
Query: 18 RNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KS 74
+ ++ + QR + I+D E L +G G G+V R + TG + A+K+++
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 75 EMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI 134
E KR ++ +L D IVQ F +F + +++ ME + +
Sbjct: 65 EENKRILMDL----DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 135 LSEDVARFYIAESVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192
+ E + + +++ A++ + +H +HRD+KP N++LD+ G +KL DFG+ L D
Sbjct: 121 IPERILG-KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179
Query: 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---- 248
+ K + G YMAPE +
Sbjct: 180 A--------------------------------KDR-------SAGCAAYMAPERIDPPD 200
Query: 249 -LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDE 306
K Y + D WSLG + E+ G P+ + K++ + P S +
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHMGFSGD 259
Query: 307 ARDLI--CHLLCDVETRLGTRGVEELKEHPWFR 337
+ + C L D R +L EH + +
Sbjct: 260 FQSFVKDC-LTKDHRKRPKYN---KLLEHSFIK 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-44
Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 55/305 (18%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ F+ L +G+G++G V K TG+I A+K++ ++ + E +++ + DS
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 154
+V+ + S+ + L+++MEY G DI+ L R L+ED + ++ + +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H +HRDIK N++L+ GH KL+DFG+ L D +
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--------------------- 180
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
KRN + +GT +MAPEV+ + GY D WSLG EM G P
Sbjct: 181 -----------KRN------TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223
Query: 275 PFCSDDPRITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332
P+ P I + PE SD D + L E R +L +
Sbjct: 224 PYADIHPMRAIFMIPTNPPPTFRKPE--LWSDNFTDFVKQCLVKSPEQRATA---TQLLQ 278
Query: 333 HPWFR 337
HP+ R
Sbjct: 279 HPFVR 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-42
Identities = 71/309 (22%), Positives = 124/309 (40%), Gaps = 59/309 (19%)
Query: 15 EMLRNLERRETEYMRL--------QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF 66
+ L LE E + RL + ++ DDFE+++ +G G G V K +G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 67 AMKKLK---KSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG 123
A K + K + + + E +L E +S IV + +F + + ME++ GG
Sbjct: 62 ARKLIHLEIKPAIRNQ-----IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116
Query: 124 DIMTLLMREDILSEDVARFYIAESVL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSD 181
+ +L + + E + ++ +V+ + + +H +HRD+KP N++++ G +KL D
Sbjct: 117 SLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 241
FG+ L D ++A S VGT
Sbjct: 176 FGVSGQLID----------------------------------------SMANSFVGTRS 195
Query: 242 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 301
YM+PE L Y ++ D WS+G + EM +G P D + P
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 302 KISDEARDL 310
+ R L
Sbjct: 256 RPRTPGRPL 264
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-42
Identities = 76/320 (23%), Positives = 135/320 (42%), Gaps = 67/320 (20%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERN 90
++ DD E + +G+GA+G V R +G+I A+K+++ S+ KR ++
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----DI 58
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAES 147
+ VD V + + +++ ME + ++ + + ED+ IA S
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-KIAVS 117
Query: 148 VL-AIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
++ A+ +H + + +HRD+KP N++++ G +K+ DFG+ L D
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-------------- 163
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL----KKGYGMECDWW 260
+A G YMAPE + +KGY ++ D W
Sbjct: 164 --------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIW 197
Query: 261 SLGAIMYEMLIGYPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLI--CHLLCD 317
SLG M E+ I P+ S P +++V + + P + K S E D C L +
Sbjct: 198 SLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPAD-KFSAEFVDFTSQC-LKKN 254
Query: 318 VETRLGTRGVEELKEHPWFR 337
+ R EL +HP+F
Sbjct: 255 SKERPTYP---ELMQHPFFT 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 75/340 (22%), Positives = 124/340 (36%), Gaps = 57/340 (16%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
F L IG G+FG V R E+ A+KK+ S + + + E L ++
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+Q + +L+MEY G L + + L E ++ + +H H
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
N +HRD+K N++L + G +KL DFG
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSAS------------------------------- 202
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYP 274
N S VGT +MAPEV+L + Y + D WSLG E+ P
Sbjct: 203 -----IMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251
Query: 275 PFCSDDPRITCRKIVNWKTCLKFP--EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331
P + + I ++ P + S+ R+ + L + R + E L
Sbjct: 252 PLFNMNAMSALYHIAQNES----PALQSGHWSEYFRNFVDSCLQKIPQDRPTS---EVLL 304
Query: 332 EHPWFRGIQWDK-LYEMEAAYKPTVNGELDTQNFEKFPEV 370
+H + + + ++ K V ELD + K ++
Sbjct: 305 KHRFVLRERPPTVIMDLIQRTKDAVR-ELDNLQYRKMKKI 343
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 81/310 (26%), Positives = 129/310 (41%), Gaps = 58/310 (18%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ +E + +G GAFG+V + K TG + A K ++ + +E E +LA D
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDH 75
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIHSI 154
IV+L ++ L++++E+ PGG IM L R L+E + + + A++ +
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFL 133
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H +HRD+K N+++ G ++L+DFG+
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--------------------- 172
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEM 269
KR+ S +GT +MAPEV++ Y + D WSLG + EM
Sbjct: 173 -----------KRD------SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
Query: 270 LIGYPPFCSDDPRITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327
PP +P KI L P K S E RD + L + ETR
Sbjct: 216 AQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--KWSVEFRDFLKIALDKNPETRPSA--- 270
Query: 328 EELKEHPWFR 337
+L EHP+
Sbjct: 271 AQLLEHPFVS 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 3e-41
Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 40/251 (15%)
Query: 38 DDFEQLTLIGKGA--FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+E LT+IGKG V L R K TGE ++++ E V ++ E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESVLAIH 152
+ IV +F + L+++ ++ G D++ D ++E + + + A+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALD 142
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
IH YVHR +K ++++ +G + LS +
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH--------------------- 181
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL--LKKGYGMECDWWSLGAIMYEML 270
Q +R +V L +++PEVL +GY + D +S+G E+
Sbjct: 182 ----------GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 271 IGYPPFCSDDP 281
G+ PF
Sbjct: 232 NGHVPFKDMPA 242
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 84/339 (24%), Positives = 136/339 (40%), Gaps = 66/339 (19%)
Query: 16 MLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSE 75
M + R + + L + FE + L+G G +G+V R TG++ A+K +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--- 58
Query: 76 MLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF------QDSDFLYLIMEYLPGGDIMTL 128
+ + E ++ E N+L + R I + +F D L+L+ME+ G + L
Sbjct: 59 -VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 129 LM--REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186
+ + + L E+ + E + + +HQH +HRDIK N++L +N +KL DFG+
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE 246
L+ +RN + +GT +MAPE
Sbjct: 178 QLDRTVG--------------------------------RRN------TFIGTPYWMAPE 199
Query: 247 VLLKK-----GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFP--E 299
V+ Y + D WSLG EM G PP C P I P +
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----PRLK 255
Query: 300 EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
K S + + I L + R T E+L +HP+ R
Sbjct: 256 SKKWSKKFQSFIESCLVKNHSQRPAT---EQLMKHPFIR 291
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 81/340 (23%), Positives = 138/340 (40%), Gaps = 87/340 (25%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLLA 93
+ +E++ IG+G++G V CR + TG+I A+KK +SE ++ E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLK 57
Query: 94 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIH 152
++ +V L F+ L+L+ EY ++ L + + E + + +++ A++
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL---EDKYSSILLEDEDIINQETVS 209
H+HN +HRD+KP+N+++ K+ +KL DFG + L D Y DE
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD-----DE--------- 162
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 268
V T Y +PE+L+ YG D W++G + E
Sbjct: 163 ---------------------------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAE 195
Query: 269 MLIGYP--------------------------PFCSDDPRITCRKIVNWKTCLKFPEE-P 301
+L G P S + + KI + + + P
Sbjct: 196 LLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP 255
Query: 302 KISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFRGIQ 340
IS A L+ L D RL E+L HP+F I+
Sbjct: 256 NISYPALGLLKGCLHMDPTERL---TCEQLLHHPYFENIR 292
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-38
Identities = 88/357 (24%), Positives = 142/357 (39%), Gaps = 92/357 (25%)
Query: 22 RRETEYMRLQRRKIG---IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK 78
+ + L + ++ +E L L+G+G++G V CR K TG I A+KK +S+
Sbjct: 6 HHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--- 62
Query: 79 RGQVEHVRS----ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MRED 133
+ V+ E LL ++ +V L + YL+ E++ I+ L + +
Sbjct: 63 --DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN 119
Query: 134 ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL---ED 190
L V + Y+ + + I H HN +HRDIKP+N+++ ++G +KL DFG + L +
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179
Query: 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL- 249
Y DE V T Y APE+L+
Sbjct: 180 VYD-----DE------------------------------------VATRWYRAPELLVG 198
Query: 250 KKGYGMECDWWSLGAIMYEMLIGYPPFCSD----------------DPRI--TCRKIVNW 291
YG D W++G ++ EM +G P F D PR K +
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258
Query: 292 KTCLKFPEE----------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
++ PE PK+S+ DL L D + R EL H +F+
Sbjct: 259 AG-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP---FCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 71/341 (20%), Positives = 121/341 (35%), Gaps = 87/341 (25%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH----VRSERNLL 92
+E + IG GA+G V R +G A+K ++ G VR E LL
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVALL 65
Query: 93 AEVDSRC---IVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARF 142
+++ +V+L + L+ E++ D+ T L L + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP--LEDKYSSILLEDE 200
+ + + + +H + VHRD+KP+N+++ G +KL+DFGL + + + +
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV----- 179
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260
V TL Y APEVLL+ Y D W
Sbjct: 180 ------------------------------------VVTLWYRAPEVLLQSTYATPVDMW 203
Query: 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIV---------NWKTCLKFPEE----------- 300
S+G I EM P FC + KI +W + P
Sbjct: 204 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQ 263
Query: 301 ---PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
P++ + L+ +L + R+ L+ H +
Sbjct: 264 SVVPEMEESGAQLLLEMLTFNPHKRISAF--RALQ-HSYLH 301
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 81/348 (23%), Positives = 138/348 (39%), Gaps = 92/348 (26%)
Query: 28 MRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--- 84
+ ++ R +E+L +G+G F V R K T +I A+KK+K + R + +
Sbjct: 3 LDVKSR---AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGIN 56
Query: 85 ---VRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVA 140
+R E LL E+ I+ L +F + L+ +++ D+ ++ + L+
Sbjct: 57 RTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHI 114
Query: 141 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED---KYSSILL 197
+ Y+ ++ + +HQH +HRD+KP+NL+LD+NG LKL+DFGL K Y+
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT---- 170
Query: 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGME 256
V T Y APE+L + YG+
Sbjct: 171 -------------------------------------HQVVTRWYRAPELLFGARMYGVG 193
Query: 257 CDWWSLGAIMYEMLIGYPPFCSDD--------------------PRITCRKIVNWKTCLK 296
D W++G I+ E+L+ P D P + + ++ T
Sbjct: 194 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC--SLPDYVTFKS 251
Query: 297 FPEE------PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 337
FP D+ DLI L + R+ + LK +F
Sbjct: 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT--QALK-MKYFS 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 71/256 (27%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
I + E ++G+GAFG V C+AK + A+K+++ K E L+
Sbjct: 5 IDYKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESERK-----AFIVELRQLSR 57
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSE-----------DVAR-- 141
V+ IV+L+ + + + L+MEY GG + +L + L ++
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 142 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSSILLEDE 200
Y+ HS+ +HRD+KP NL+L G LK+ DFG ++
Sbjct: 116 AYL-------HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--------- 159
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260
M + G+ +MAPEV Y +CD +
Sbjct: 160 ---------------MT-----------------NNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 261 SLGAIMYEMLIGYPPF 276
S G I++E++ PF
Sbjct: 188 SWGIILWEVITRRKPF 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 77/342 (22%), Positives = 133/342 (38%), Gaps = 97/342 (28%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--------VRSE 88
++ + +L +G+G + V ++K T + A+K+++ +EH +R E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-E 50
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAES 147
+LL ++ IV L L L+ EYL D+ L +I++ + ++ +
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ + H+ +HRD+KP NL++++ G LKL+DFGL + S
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA----KSI------------- 152
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYST-VGTLDYMAPEVLL-KKGYGMECDWWSLGAI 265
P + Y V TL Y P++LL Y + D W +G I
Sbjct: 153 ----------PTKT------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 190
Query: 266 MYEMLIGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE----- 300
YEM G P F P I +KT +P+
Sbjct: 191 FYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL--SNEEFKT-YNYPKYRAEAL 247
Query: 301 ----PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 337
P++ + DL+ LL + R+ E+ +HP+F
Sbjct: 248 LSHAPRLDSDGADLLTKLLQFEGRNRISA---EDAMKHPFFL 286
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 77/351 (21%), Positives = 130/351 (37%), Gaps = 106/351 (30%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH--------VRSE 88
F+QL +G G + V KTTG A+K++K ++ +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR-E 53
Query: 89 RNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL------MREDILSEDVARF 142
+L+ E+ IV+L+ + L L+ E++ D+ + L ++ ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLE 198
+ + + + H++ +HRD+KP NL+++K G LKL DFGL P+ +S
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFS----- 166
Query: 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMEC 257
E V TL Y AP+VL+ + Y
Sbjct: 167 ------SEVV------------------------------TLWYRAPDVLMGSRTYSTSI 190
Query: 258 DWWSLGAIMYEMLIGYPPFCSDD------------------------------PRITCRK 287
D WS G I+ EM+ G P F + P I R
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 288 IVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
+ + L+ + + D + LL + + RL ++ HPWF
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL---SAKQALHHPWFA 298
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 83/334 (24%), Positives = 133/334 (39%), Gaps = 82/334 (24%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEV 95
++ + L IG+G +G V + GE FA+KK++ E G +R E ++L E+
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LEKEDEGIPSTTIR-EISILKEL 57
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSI 154
IV+L+ L L+ E+L D+ LL + E L A+ ++ + + I
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLEDEDIINQETVSE 210
H +HRD+KP NL++++ G LK++DFGL P+ KY+ E V
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT-----------HEIV-- 162
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 269
TL Y AP+VL+ K Y D WS+G I EM
Sbjct: 163 ----------------------------TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194
Query: 270 LIGYPPFCSDDPRITCRKI---------VNWKTCLKFPE----------------EPKIS 304
+ G P F +I NW + P+ +
Sbjct: 195 VNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD 254
Query: 305 DEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 337
+ DL+ +L D R+ ++ EH +F+
Sbjct: 255 ESGIDLLSKMLKLDPNQRITA---KQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 82/339 (24%), Positives = 136/339 (40%), Gaps = 91/339 (26%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 94
++ +++L +G+G +G V +AK + G I A+K+++ + G +R E +LL E
Sbjct: 20 MEKYQKLEKVGEGTYGVV--YKAKDSQGRIVALKRIR-LDAEDEGIPSTAIR-EISLLKE 75
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHS 153
+ IV L L L+ E++ D+ +L + L + + Y+ + + +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLEDEDIINQETVS 209
HQH +HRD+KP NL+++ +G LKL+DFGL P+ Y+ E V
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYT-----------HEVV- 181
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYE 268
TL Y AP+VL+ K Y D WS+G I E
Sbjct: 182 -----------------------------TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212
Query: 269 MLIGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE-------- 300
M+ G P F P++ ++ WK F
Sbjct: 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ--ELPLWKQ-RTFQVFEKKPWSSI 269
Query: 301 -PKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 337
P E DL+ ++L D R+ + HP+F+
Sbjct: 270 IPGFCQEGIDLLSNMLCFDPNKRISA---RDAMNHPYFK 305
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 85/337 (25%), Positives = 137/337 (40%), Gaps = 86/337 (25%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEV 95
+ +E+L IG+G +G V + + T EI A+K+++ + G +R E LL E+
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALR-EICLLKEL 58
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSI 154
+ IV+L L L+ E+ D+ L ++ + ++ + + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGL----CKPLEDKYSSILLEDEDIINQETVSE 210
H N +HRD+KP NL++++NG LKL++FGL P+ YS E V
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS-----------AEVV-- 163
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEM 269
TL Y P+VL K Y D WS G I E+
Sbjct: 164 ----------------------------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195
Query: 270 L-IGYPPFCSDD--------------------PRITCRKIVNWKTCLKFPEE-------P 301
G P F +D P +T K+ ++K +P P
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--KLPDYKPYPMYPATTSLVNVVP 253
Query: 302 KISDEARDLICHLL-CDVETRLGTRGVEELKEHPWFR 337
K++ RDL+ +LL C+ R+ E L+ HP+F
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAE--EALQ-HPYFS 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 79/363 (21%), Positives = 138/363 (38%), Gaps = 85/363 (23%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 94
+E + IG+GA+G+V R K G A+K+++ + + G + +R E +L
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIR-EVAVLRH 67
Query: 95 VDSRC---IVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYI 144
+++ +V+LF L L+ E++ D+ T L + E + + + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP--LEDKYSSILLEDEDI 202
+ + + +H H VHRD+KP N+++ +G +KL+DFGL + + +S+
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV------- 179
Query: 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262
V TL Y APEVLL+ Y D WS+
Sbjct: 180 ----------------------------------VVTLWYRAPEVLLQSSYATPVDLWSV 205
Query: 263 GAIMYEMLIGYPPFCSDDPRITCRKIV---------NWKTCLKFPEE------------- 300
G I EM P F KI+ +W + P +
Sbjct: 206 GCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKF 265
Query: 301 -PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGE 358
I + +DL+ L + R+ HP+F+ ++ K E
Sbjct: 266 VTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCKENLDSHLPPSQNTSE 322
Query: 359 LDT 361
L+T
Sbjct: 323 LNT 325
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 60/247 (24%), Positives = 97/247 (39%), Gaps = 51/247 (20%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+ L + IG G+FG V RA+ G A+K L + + +V E ++ +
Sbjct: 35 PWCDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRL 91
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESV-LAI 151
IV + L ++ EYL G + LL + L E R +A V +
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR-RLSMAYDVAKGM 150
Query: 152 HSIHQHNY--VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ +H N VHR++K NL++DK +K+ DFGL + + S
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--------------- 195
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
S GT ++MAPEVL + + D +S G I++E+
Sbjct: 196 ------SK-----------------SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232
Query: 270 LIGYPPF 276
P+
Sbjct: 233 ATLQQPW 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 80/339 (23%), Positives = 130/339 (38%), Gaps = 86/339 (25%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAEV 95
ID + ++T +G+G +GEV T E A+K++ + E + G +R E +LL E+
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIR-EVSLLKEL 90
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 155
R I++L + L+LI EY D+ + + +S V + ++ + + ++ H
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 156 QHNYVHRDIKPDNLILDKN-----GHLKLSDFGL----CKPLEDKYSSILLEDEDIINQE 206
+HRD+KP NL+L + LK+ DFGL P+ +++ E
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFT-----------HE 197
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAI 265
+ TL Y PE+LL + Y D WS+ I
Sbjct: 198 II------------------------------TLWYRPPEILLGSRHYSTSVDIWSIACI 227
Query: 266 MYEMLIGYPPFCSDDPRITCRKI---------VNWKTCLKFPE----------------- 299
EML+ P F D KI W P+
Sbjct: 228 WAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL 287
Query: 300 EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
+ DE DL+ +L D R+ + EHP+F
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISA---KNALEHPYFS 323
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 81/338 (23%), Positives = 126/338 (37%), Gaps = 94/338 (27%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
+ +IG G+FG V + +GE+ A+KK+ + + K R E ++ ++D
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK------NR-ELQIMRKLDHCN 108
Query: 100 IVQLFYSF------QDSDFLYLIMEYLPGGDIMTL--LMRE-----DILSEDVARFYIAE 146
IV+L Y F +D +L L+++Y+P T+ + R L + Y+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 147 SVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
++ IH HRDIKP NL+LD + LKL DFG K L +
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-------------GE 211
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 264
VS + + Y APE++ Y D WS G
Sbjct: 212 PNVSY--------------------------ICSRYYRAPELIFGATDYTSSIDVWSAGC 245
Query: 265 IMYEMLIGYPPFCSDDPRITCRKIVN---------WKTCL------KFPE---------- 299
++ E+L+G P F D +I+ + KFP+
Sbjct: 246 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 305
Query: 300 EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
P+ EA L LL RL E H +F
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFF 340
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 54/257 (21%), Positives = 103/257 (40%), Gaps = 49/257 (19%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKK-SEMLKRGQVEHVRSERNLLAE 94
L +GKG FG+ + TGE+ MK+L + E +R E ++
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR----TFLKEVKVMRC 63
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI---------LSEDVARFYIA 145
++ +++ L I EY+ GG + ++ D ++D+A
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS---- 119
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ +H N +HRD+ N ++ +N ++ ++DFGL + + D+ +
Sbjct: 120 ----GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ----------- 164
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
E L+ K+ R Y+ VG +MAPE++ + Y + D +S G +
Sbjct: 165 -------------PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211
Query: 266 MYEMLIGYPPFCSDDPR 282
+ E++ PR
Sbjct: 212 LCEIIGRVNADPDYLPR 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 81/339 (23%), Positives = 124/339 (36%), Gaps = 97/339 (28%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSR 98
+ +IG G+FG V + + E+ A+KK+ + + K R E ++ V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR--------ELQIMRIVKHP 92
Query: 99 CIVQLFYSF------QDSDFLYLIMEYLPGGDIMTL--LMR-----EDILSEDVARFYIA 145
+V L F +D FL L++EY+P T+ R + + + + Y+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + ++ IH HRDIKP NL+LD G LKL DFG K L
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-------------G 195
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 263
+ VS + + Y APE++ Y D WS G
Sbjct: 196 EPNVSY--------------------------ICSRYYRAPELIFGATNYTTNIDIWSTG 229
Query: 264 AIMYEMLIGYPPFCSDDP-----RIT----------CRKIVNWKTCLKFPE--------- 299
+M E++ G P F + I + + KFP+
Sbjct: 230 CVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKV 289
Query: 300 -EPKISDEARDLICHLL-CDVETRLGTRGVEELKEHPWF 336
P+ +A DLI LL RL E HP+F
Sbjct: 290 FRPRTPPDAIDLISRLLEYTPSARL---TAIEALCHPFF 325
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 65/260 (25%), Positives = 100/260 (38%), Gaps = 72/260 (27%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ-VEHVRSERNLLAE 94
DF +LTL IG G FG+V RA G+ A+K + Q +E+VR E L A
Sbjct: 5 DFAELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-------LSEDVARFYIAES 147
+ I+ L L L+ME+ GG + +L + I + +AR
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIAR------ 116
Query: 148 VLAIHSIHQHNY---VHRDIKPDNLILDK--------NGHLKLSDFGLCKPLEDKYSSIL 196
++ +H +HRD+K N+++ + N LK++DFGL +
Sbjct: 117 --GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---- 170
Query: 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256
M S G +MAPEV+ +
Sbjct: 171 -------------------KM-----------------SAAGAYAWMAPEVIRASMFSKG 194
Query: 257 CDWWSLGAIMYEMLIGYPPF 276
D WS G +++E+L G PF
Sbjct: 195 SDVWSYGVLLWELLTGEVPF 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 77/346 (22%), Positives = 126/346 (36%), Gaps = 90/346 (26%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRS----ERNLL 92
+ +E+L IG+G FGEV R + TG+ A+KK+ E K G E +L
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEG----FPITALREIKIL 70
Query: 93 AEVDSRCIVQLF--------YSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFY 143
+ +V L + +YL+ ++ D+ LL + + +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 144 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+ + ++ IH++ +HRD+K N+++ ++G LKL+DFGL
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL------------------- 170
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAY-STVGTLDYMAPEVLL-KKGYGMECDWWS 261
A R +N + Y + V TL Y PE+LL ++ YG D W
Sbjct: 171 -------A---------RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214
Query: 262 LGAIMYEMLIGYPPFCSDD-----PRI-------------TCRKIVNWKTCLKFPEEPK- 302
G IM EM P + I ++ L+ + K
Sbjct: 215 AGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK-LELVKGQKR 273
Query: 303 ----------ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
A DLI LL D R+ ++ H +F
Sbjct: 274 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFW 316
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 51/251 (20%), Positives = 93/251 (37%), Gaps = 51/251 (20%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
FEQL + IGKG FG+V + GE+ A++ + + Q++ + E +
Sbjct: 31 PFEQLEIGELIGKGRFGQV--YHGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYRQT 86
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV-LAIHSI 154
+V + L +I G + +++ I+ + IA+ + + +
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H +H+D+K N+ D NG + ++DFGL I E +
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFS---------------ISGVLQAGRREDK 190
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---------LKKGYGMECDWWSLGAI 265
+ G L ++APE++ K + D ++LG I
Sbjct: 191 LRIQ------------------NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 266 MYEMLIGYPPF 276
YE+ PF
Sbjct: 233 WYELHAREWPF 243
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 80/364 (21%), Positives = 133/364 (36%), Gaps = 98/364 (26%)
Query: 21 ERRETEYMRLQRRKIG---IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML 77
R EY + + DD++ + +G+G + EV T E +K LK
Sbjct: 16 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---- 71
Query: 78 KRGQVEHVRSER--NLLAEV-DSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMRE 132
V+ + +R +L + I+ L +D S L+ E++ D L
Sbjct: 72 ----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 124
Query: 133 DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDK 191
L++ RFY+ E + A+ H +HRD+KP N+++D ++ L+L D+GL
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL------- 177
Query: 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK- 250
AE P + N R V + + PE+L+
Sbjct: 178 -------------------AEFY--HPGQEY-----NVR------VASRYFKGPELLVDY 205
Query: 251 KGYGMECDWWSLGAIMYEMLIGYPPFC-----------------SDDPRITCRKI----- 288
+ Y D WSLG ++ M+ PF ++D K
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 289 ------------VNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335
W+ + + +S EA D + LL D ++RL T E EHP+
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-T--AREAMEHPY 322
Query: 336 FRGI 339
F +
Sbjct: 323 FYTV 326
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 52/256 (20%), Positives = 94/256 (36%), Gaps = 62/256 (24%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKK----SEMLKRGQVEHVRSERNL 91
++ IGKG FG V R + A+K L E + + + E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 92 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESV-L 149
++ ++ IV+L+ + ++ME++P GD+ L+ + + V + + + L
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRLMLDIAL 133
Query: 150 AIHSIHQHNY--VHRDIKPDNLILDKNG-----HLKLSDFGLCKPLEDKYSSILLEDEDI 202
I + N VHRD++ N+ L K++DFGL
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------------------ 175
Query: 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWW 260
S+ + +G +MAPE + + Y + D +
Sbjct: 176 ------SQQSVHSVS-----------------GLLGNFQWMAPETIGAEEESYTEKADTY 212
Query: 261 SLGAIMYEMLIGYPPF 276
S I+Y +L G PF
Sbjct: 213 SFAMILYTILTGEGPF 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 81/346 (23%), Positives = 131/346 (37%), Gaps = 97/346 (28%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
D F+ + G+G FG V K +TG A+KK+ + + +++ ++ LA +
Sbjct: 23 DRFQVERMAGQGTFGTV--QLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVL 76
Query: 96 DSRCIVQL---FYSFQDSDF----LYLIMEYLPGGD----IMTLLMREDILSEDVARFY- 143
IVQL FY+ + D L ++MEY+P R+ + + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 144 --IAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDE 200
+ S+ +H N HRDIKP N+++++ +G LKL DFG K L
Sbjct: 136 FQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---------- 184
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDW 259
++ V+ + + Y APE++ + Y D
Sbjct: 185 ---SEPNVAY--------------------------ICSRYYRAPELIFGNQHYTTAVDI 215
Query: 260 WSLGAIMYEMLIGYPPFCSDDP-----RIT----------CRKIVNWKTCLKFP------ 298
WS+G I EM++G P F D+ I RK+ T +
Sbjct: 216 WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIP 275
Query: 299 -------EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
K + EA DL+ LL E R+ E HP+F
Sbjct: 276 WSNVFSDHSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYF 318
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-29
Identities = 49/245 (20%), Positives = 101/245 (41%), Gaps = 48/245 (19%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
Q+T+ IG G+FG V + K G++ A+K L + + Q++ ++E +L +
Sbjct: 22 PDGQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 77
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV-LAIHSI 154
I+ F + + L ++ ++ G + L + E IA + +
Sbjct: 78 RHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
H + +HRD+K +N+ L ++ +K+ DFGL + + + +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT----------EKSRWSGSHQFEQLS--- 183
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSLGAIMYEMLI 271
G++ +MAPEV+ + Y + D ++ G ++YE++
Sbjct: 184 -----------------------GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 272 GYPPF 276
G P+
Sbjct: 221 GQLPY 225
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 26/172 (15%)
Query: 37 IDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
IDD++ ++G G G+V K T E FA+K L+ +R E L
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 67
Query: 96 -DSRCIVQLFYSFQDS----DFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIA 145
IV++ +++ L ++ME L GG+ L R + +E A +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 124
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKP-LEDKYS 193
AI +H N HRD+KP+NL+ N LKL+DFG K +KY
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYD 176
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVN--WKTCLKFPEEP 301
A E + Y CD WSLG IMY +L GYPPF S+ + +FP
Sbjct: 167 AKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225
Query: 302 --KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
++S+E + LI +LL + R+ T + E HPW
Sbjct: 226 WSEVSEEVKMLIRNLLKTEPTQRM-T--ITEFMNHPWIMQ 262
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-28
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 39/240 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
L+G+G G+V I A+K + ++ ++ E + +V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVHRD 163
+ LY+ M + G D+ +L R+ L+ A I + A+ + H HRD
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA-VAIVRQIGSALDAAHAAGATHRD 159
Query: 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQ 223
+KP+N+++ + L DFG+ D E +++
Sbjct: 160 VKPENILVSADDFAYLVDFGIASATTD---------------EKLTQLG----------- 193
Query: 224 QWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI 283
+TVGTL YMAPE + D ++L ++YE L G PP+ D +
Sbjct: 194 -----------NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 35/251 (13%), Positives = 74/251 (29%), Gaps = 60/251 (23%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
DF+QL + + GE+ + + G +K LK + R + E L
Sbjct: 8 DFKQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIF 64
Query: 96 DSRCIVQLFY---SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVA-RFYIAESV-LA 150
++ + LI ++P G + +L D + A +
Sbjct: 65 SHPNVLP-VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 151 IHSIHQHNY--VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ +H + ++++D++ ++S + +
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----------------- 166
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME---CDWWSLGAI 265
+ ++APE L KK D WS +
Sbjct: 167 --------------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 266 MYEMLIGYPPF 276
++E++ PF
Sbjct: 201 LWELVTREVPF 211
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 69/362 (19%), Positives = 122/362 (33%), Gaps = 110/362 (30%)
Query: 40 FEQLTLIGKGAFGEVRLCRAK--TTGEIFAMKKL-------------------------- 71
+ +G G+FG V C +G+ FA+KK+
Sbjct: 9 YSLGKTLGTGSFGIV--CEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 72 -----KKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGD-- 124
E K Q ++ + + + + +L +IMEY+P
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 125 --IMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSD 181
+ + + + ++ YI + A+ IH HRDIKP NL+++ K+ LKL D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 241
FG K L ++ +V+ + +
Sbjct: 186 FGSAKKLIP-------------SEPSVAY--------------------------ICSRF 206
Query: 242 YMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFCSDD---------------PRITC 285
Y APE++L Y D WS+G + E+++G P F + +
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266
Query: 286 RKIVNWKTCLKFPEEPKIS----------DEARDLICHLLC-DVETRLGTRGVEELKEHP 334
++ T ++FP A DL+ +L + + R+ E HP
Sbjct: 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHP 323
Query: 335 WF 336
+F
Sbjct: 324 FF 325
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 37/242 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC 99
++ + +G G V L A+K + K ++ E + +++ +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 100 IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY 159
IV + ++ D YL+MEY+ G + + LS D A + + + I H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
VHRDIKP N+++D N LK+ DFG+ K +++ ++++
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAK---------------ALSETSLTQTN------- 170
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279
+GT+ Y +PE + D +S+G ++YEML+G PPF +
Sbjct: 171 ---------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215
Query: 280 DP 281
Sbjct: 216 TA 217
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 60/280 (21%), Positives = 114/280 (40%), Gaps = 28/280 (10%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDD-FEQLTLIGKGAFGEVRLCRAK 60
+ S +E ++ ++ + T M I D +E LIG G++G V K
Sbjct: 16 TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 61 TTGEIFAMKKLKK---SEML-KRGQVEHVRSERNLLAEVDSRCIVQL---FYSFQDSDF- 112
+ A+KK+ + + KR +R E +L ++ +V++ F
Sbjct: 76 LEKRVVAIKKILRVFEDLIDCKRI----LR-EIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 113 -LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL 171
LY+++E D L L+E + + ++ + +H +HRD+KP N ++
Sbjct: 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189
Query: 172 DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRA 231
+++ +K+ DFGL + ++ + + K +L
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG------- 242
Query: 232 LAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEML 270
+ V T Y APE++L ++ Y D WS+G I E+L
Sbjct: 243 --H--VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 39/241 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104
++G G EV L R A+K L+ R E A ++ IV ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 105 ----YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 160
Y++MEY+ G + ++ E ++ A IA++ A++ HQ+ +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII 138
Query: 161 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKE 220
HRD+KP N+++ +K+ DFG+ + + D +S+ T +
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-----------TQTA---------- 177
Query: 221 RLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD 280
+ +GT Y++PE D +SLG ++YE+L G PPF D
Sbjct: 178 --------------AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
Query: 281 P 281
P
Sbjct: 224 P 224
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 38/258 (14%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 93
D++ LIG+G++G V L K T + A+KK+ + KR +R E +L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI----LR-EITILN 80
Query: 94 EVDSRCIVQL--------FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA 145
+ S I++L F + LY+++E D+ L L+E+ + +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDE---LYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILY 136
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+L + IH+ +HRD+KP N +L+++ +K+ DFGL + + + + ++ D + +
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGA 264
+ + + +W Y APE++L + Y D WS G
Sbjct: 197 PGPHNKNLKKQLTSHVVTRW----------------YRAPELILLQENYTKSIDIWSTGC 240
Query: 265 IMYEMLIGYPPFCSDDPR 282
I E+L +D
Sbjct: 241 IFAELLNMLQSHINDPTN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 77/359 (21%), Positives = 131/359 (36%), Gaps = 91/359 (25%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKL----KKSEMLKRGQVE-----HVR 86
+E + +GKGA+G V ++ + TGE+ A+KK+ + S +R E +
Sbjct: 9 RKYELVKKLGKGAYGIV--WKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 87 SERNLLAEVDSRCIVQLFYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYI 144
N IV L + + +YL+ +Y+ D + ++R +IL ++ +
Sbjct: 67 GHEN---------IVNLLNVLRADNDRDVYLVFDYM-ETD-LHAVIRANILEPVHKQYVV 115
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + I +H +HRD+KP N++L+ H+K++DFGL + + I
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 263
+ + + Y V T Y APE+LL Y D WSLG
Sbjct: 176 NTENFDDDQPILTD---------------Y--VATRWYRAPEILLGSTKYTKGIDMWSLG 218
Query: 264 AIMYEMLIGYPPF---------------------------CSDD-----------PRITC 285
I+ E+L G P F S I
Sbjct: 219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQ 278
Query: 286 RKIVNWKTCLKFPEE-----PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
+ T K ++EA DL+ LL + R+ + +HP+
Sbjct: 279 SNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 84/339 (24%), Positives = 140/339 (41%), Gaps = 80/339 (23%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLL 92
DF+ +L+G+GA+G V C A K TGEI A+KK++ K R +R E +L
Sbjct: 11 SDFQLKSLLGEGAYGVV--CSATHKPTGEIVAIKKIEPFDKPLFALRT----LR-EIKIL 63
Query: 93 AEVDSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
I+ + +F +Y+I E + D + ++ +LS+D +++I ++
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTD-LHRVISTQMLSDDHIQYFIYQT 121
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ A+ +H N +HRD+KP NL+++ N LK+ DFGL + +++ +
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA-----------ADNS 170
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266
+ M+ + V T Y APEV+L Y D WS G I+
Sbjct: 171 EPTGQQSGMVE---------------F--VATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213
Query: 267 YEMLIGYPPFCSDDP-----RIT-----------CRKIVNWKT---CLKFPEEPKI---- 303
E+ + P F D I R I + + P P
Sbjct: 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK 273
Query: 304 -----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+ + DL+ +L D R+ T +E EHP+
Sbjct: 274 MFPRVNPKGIDLLQRMLVFDPAKRI-T--AKEALEHPYL 309
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/346 (18%), Positives = 114/346 (32%), Gaps = 90/346 (26%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQV--EHVRS------E 88
+ I G++G V C + G A+K++ + R E
Sbjct: 22 SPYTVQRFISSGSYGAV--CAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 89 RNLLAEVDSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLL-MREDILSEDVARF 142
LL I+ L F F++ LYL+ E + D+ ++ + ++S ++
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY 138
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202
++ +L +H +H+ VHRD+ P N++L N + + DF L +
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR---------------- 182
Query: 203 INQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWS 261
+ Y V Y APE++++ KG+ D WS
Sbjct: 183 ------EDTADANKTH---------------Y--VTHRWYRAPELVMQFKGFTKLVDMWS 219
Query: 262 LGAIMYEMLIGYPPFCSDDP--------------------RITCRKIVNW-KTCLKFPEE 300
G +M EM F + ++ + L
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279
Query: 301 -------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
P A DLI +L + + R+ E+ HP+F
Sbjct: 280 RAWTAVVPTADPVALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 52/252 (20%), Positives = 90/252 (35%), Gaps = 60/252 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKS---EMLKRGQVEHVRSERNLLAEV 95
+E I G G + L G +K L S E +ER LAEV
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-----AMAERQFLAEV 136
Query: 96 DSRCIVQLFYSFQDSD-----FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
IVQ+F + +D Y++MEY+ G + ++ L A Y+ E + A
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPA 194
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H V+ D+KP+N++L + LKL D G + + + +
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI-NSFGYL--------------- 237
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
GT + APE+ ++ G + D +++G + +
Sbjct: 238 --------------------------YGTPGFQAPEI-VRTGPTVATDIYTVGRTLAALT 270
Query: 271 IGYPPFCSDDPR 282
+ P
Sbjct: 271 LDLPTRNGRYVD 282
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 55/260 (21%), Positives = 96/260 (36%), Gaps = 64/260 (24%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN--LL 92
+ +D+ + L LIG+G +G V + A+K + ++ +E+N +
Sbjct: 10 LDLDNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANR------QNFINEKNIYRV 61
Query: 93 AEVDSRCIVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
++ I + + L+MEY P G + L R +A S
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR--LAHS 119
Query: 148 V---LA-IHS------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197
V LA +H+ ++ HRD+ N+++ +G +SDFGL L
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-------LK 250
E+++ E VGT+ YMAPEVL
Sbjct: 180 EEDNAAISE------------------------------VGTIRYMAPEVLEGAVNLRDX 209
Query: 251 KGYGMECDWWSLGAIMYEML 270
+ + D ++LG I +E+
Sbjct: 210 ESALKQVDMYALGLIYWEIF 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 77/339 (22%), Positives = 128/339 (37%), Gaps = 90/339 (26%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 93
+ ++ L+ +G GA+G V TG A+KKL + KR R E LL
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT----YR-ELRLLK 83
Query: 94 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
+ ++ L S ++ + +YL+ + G D + +++ L++D +F I +
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GAD-LNNIVKCQKLTDDHVQFLIYQI 141
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ + IH + +HRD+KP NL ++++ LK+ DFGL + D
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----------------- 184
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266
M V T Y APE++L Y D WS+G IM
Sbjct: 185 --------EMTGY----------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220
Query: 267 YEMLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI----- 303
E+L G F D I +KI + + PK+
Sbjct: 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280
Query: 304 ----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
+ A DL+ +L D + R+ + H +F
Sbjct: 281 FIGANPLAVDLLEKMLVLDSDKRI---TAAQALAHAYFA 316
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 78/336 (23%), Positives = 127/336 (37%), Gaps = 82/336 (24%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK---KSEMLKRGQVEHVRSERNLLAE 94
+ L+ IG+GA+G V A+KK+ +R +R E +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT----LR-EIKILLR 81
Query: 95 VDSRCIVQL---FYSFQDSDF--LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 149
I+ + + +Y++ + + D + L++ LS D +++ + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETD-LYKLLKTQHLSNDHICYFLYQILR 139
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ IH N +HRD+KP NL+L+ LK+ DFGL + D D + ++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA----------DPDHDHTGFLT 189
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 268
E Y V T Y APE++L KGY D WS+G I+ E
Sbjct: 190 E-----------------------Y--VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224
Query: 269 MLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI------- 303
ML P F I I+N K L P + K+
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 284
Query: 304 --SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+A DL+ +L + R+ VE+ HP+
Sbjct: 285 NADSKALDLLDKMLTFNPHKRI---EVEQALAHPYL 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 82/338 (24%), Positives = 126/338 (37%), Gaps = 90/338 (26%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 93
+ L +G GA+G V TG A+KKL + KR R E LL
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA----YR-ELRLLK 79
Query: 94 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
+ ++ L + D YL+M ++ G D + LM+ + L ED +F + +
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD-LGKLMKHEKLGEDRIQFLVYQM 137
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ + IH +HRD+KP NL ++++ LK+ DFGL + + + +
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG------------- 184
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266
Y V T Y APEV+L Y D WS+G IM
Sbjct: 185 --------------------------Y--VVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 267 YEMLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI----- 303
EM+ G F D I +++ + + PE K
Sbjct: 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276
Query: 304 ----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
S A +L+ +L D E R+ E HP+F
Sbjct: 277 LTNASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYF 311
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 52/263 (19%), Positives = 85/263 (32%), Gaps = 60/263 (22%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+ L IGKG FGEV R K GE A+K E + +E +
Sbjct: 40 IARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVML 93
Query: 96 DSRCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVL 149
I+ + + L+L+ +Y G + L R + E + + A +
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153
Query: 150 AIHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+H HRD+K N+++ KNG ++D GL + +I +
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP----- 208
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YGMECD 258
VGT YMAPEVL D
Sbjct: 209 -----------------------------NHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239
Query: 259 WWSLGAIMYEMLIGYPPFCSDDP 281
+++G + +E+ +
Sbjct: 240 IYAMGLVFWEIARRCSIGGIHED 262
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 50/265 (18%), Positives = 88/265 (33%), Gaps = 60/265 (22%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+ L + +G FG V +A+ E A+K + Q E L
Sbjct: 21 FQSMPLQLLEVKARGRFGCV--WKAQLLNEYVAVKIFPIQD----KQSWQNEYEVYSLPG 74
Query: 95 VDSRCIVQLF----YSFQDSDFLYLIMEYLPGGDIMTLLMREDI-------LSEDVAR-- 141
+ I+Q L+LI + G + L + ++E +AR
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGL 134
Query: 142 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
Y+ E + + H+ HRDIK N++L N ++DFGL + +
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL--------ALKFEAGKS 186
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-----LKKGYGME 256
+ + VGT YMAPEVL ++ +
Sbjct: 187 AGD-----------THGQ-----------------VGTRRYMAPEVLEGAINFQRDAFLR 218
Query: 257 CDWWSLGAIMYEMLIGYPPFCSDDP 281
D +++G +++E+
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVD 243
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 72/344 (20%), Positives = 121/344 (35%), Gaps = 94/344 (27%)
Query: 40 FEQLTLIGKGAFGEVRLCRA--KTTGEIFAMKKL--KKSEMLKRGQVEHVRSERNLLAEV 95
+ L +G G G V A + A+KK+ + +K +R E ++ +
Sbjct: 13 YMDLKPLGCGGNGLV--FSAVDNDCDKRVAIKKIVLTDPQSVKHA----LR-EIKIIRRL 65
Query: 96 DSRCIVQLF--------------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR 141
D IV++F S + + +Y++ EY+ D + ++ + L E+ AR
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETD-LANVLEQGPLLEEHAR 123
Query: 142 FYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDE 200
++ + + + IH N +HRD+KP NL ++ ++ LK+ DFGL + ++ YS
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS------- 176
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDW 259
+ + T Y +P +LL Y D
Sbjct: 177 -----------HKGHLSE---------------G--LVTKWYRSPRLLLSPNNYTKAIDM 208
Query: 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNW-----------------KTCLKFPEEPK 302
W+ G I EML G F + I+ EP
Sbjct: 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPH 268
Query: 303 I---------SDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
S EA D + +L RL EE HP+
Sbjct: 269 KPLTQLLPGISREAVDFLEQILTFSPMDRL---TAEEALSHPYM 309
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 83/343 (24%), Positives = 130/343 (37%), Gaps = 97/343 (28%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 93
+ T +G GA+G V K +GE A+KKL + KR R E LL
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA----YR-ELLLLK 78
Query: 94 EVDSRCIVQL---------FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYI 144
+ ++ L +F D YL+M ++ D+ ++ + SE+ ++ +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYD---FYLVMPFM-QTDLQKIMGLK--FSEEKIQYLV 132
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + + IH VHRD+KP NL ++++ LK+ DFGL + + +
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------------- 179
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 263
M Y V T Y APEV+L Y D WS+G
Sbjct: 180 -----------MTG---------------Y--VVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 264 AIMYEMLIGYPPFCSDDP-----RIT----------CRKIVNWKT---CLKFPEEPKI-- 303
IM EML G F D +I +K+ + P+ P+
Sbjct: 212 CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 271
Query: 304 -------SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338
S +A DL+ +L DV+ RL + HP+F
Sbjct: 272 TQLFPRASPQAADLLEKMLELDVDKRL---TAAQALTHPFFEP 311
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 54/263 (20%), Positives = 85/263 (32%), Gaps = 64/263 (24%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+TL +GKG +GEV R GE A+K + + +E +
Sbjct: 8 RDITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDE----KSWFRETELYNTVMLRH 61
Query: 98 RCIVQLF----YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV---LA 150
I+ S S L+LI Y G + L + + R I S+ LA
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLA 119
Query: 151 -IHSIHQHNY-----VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+H HRD+K N+++ KNG ++D GL + + + +
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN----- 174
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECD 258
VGT YMAPEVL D
Sbjct: 175 -----------------------------NPRVGTKRYMAPEVLDETIQVDCFDSYKRVD 205
Query: 259 WWSLGAIMYEMLIGYPPFCSDDP 281
W+ G +++E+ +
Sbjct: 206 IWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 49/263 (18%), Positives = 84/263 (31%), Gaps = 60/263 (22%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+Q+ + IGKG +GEV K GE A+K +E +E +
Sbjct: 35 IAKQIQMVKQIGKGRYGEV--WMGKWRGEKVAVKVFFTTEE----ASWFRETEIYQTVLM 88
Query: 96 DSRCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARF--YIAESVL 149
I+ + LYLI +Y G + L + ++ + + +
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLC 148
Query: 150 AIHS-----IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+H+ + HRD+K N+++ KNG ++D GL
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------ 190
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL------LKKGYGMECD 258
+ + VGT YM PEVL + D
Sbjct: 191 ----------------KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMAD 234
Query: 259 WWSLGAIMYEMLIGYPPFCSDDP 281
+S G I++E+ +
Sbjct: 235 MYSFGLILWEVARRCVSGGIVEE 257
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 76/348 (21%), Positives = 122/348 (35%), Gaps = 99/348 (28%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 93
++ L IG GA G V A+KKL + KR R E L+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA----YR-ELVLMK 79
Query: 94 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
V+ + I+ L S ++ +Y++ME + ++ ++ E L + + + +
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQM 136
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG------------------ 178
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
M P Y V T Y APEV+L GY D WS+G IM
Sbjct: 179 ----TSFMMTP---------------Y--VVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 268 EMLIGYPPFCSDDP-----RIT-----------------CRKIV---------------- 289
EM+ G F D ++ R V
Sbjct: 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFP 277
Query: 290 NWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+ + +ARDL+ +L D R+ V+E +HP+
Sbjct: 278 DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI---SVDEALQHPYI 322
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 70/378 (18%), Positives = 129/378 (34%), Gaps = 118/378 (31%)
Query: 28 MRLQRRKIGIDDFEQLTL-IGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEH 84
+ +R ++ D FE +G+G +G V + K + +A+K+++ + + E
Sbjct: 11 LSSERERV-EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI 69
Query: 85 VRSERNLLAEVDSRCIVQL---FYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVAR 141
LL E+ ++ L F S D ++L+ +Y D+ ++ +
Sbjct: 70 -----ALLRELKHPNVISLQKVFLSHADRK-VWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 142 FYIAESVL---------AIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGL---- 184
+ ++ IH +H + +HRD+KP N+++ + G +K++D G
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 244
PL+ + + V T Y A
Sbjct: 183 NSPLK-PLADLDPV--------------------------------------VVTFWYRA 203
Query: 245 PEVLL-KKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR---------KIV----- 289
PE+LL + Y D W++G I E+L P F I +I
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
Query: 290 ----NWKTCLKFPE-------------------------EPKISDEARDLICHLLC-DVE 319
+W+ K PE + K +A L+ LL D
Sbjct: 264 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323
Query: 320 TRLGTRGVEELKEHPWFR 337
R+ E+ + P+F
Sbjct: 324 KRI---TSEQAMQDPYFL 338
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 74/348 (21%), Positives = 122/348 (35%), Gaps = 99/348 (28%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL----KKSEMLKRGQVEHVRSERNLLA 93
++ L IG GA G V A+KKL + KR R E L+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA----YR-ELVLMK 116
Query: 94 EVDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
V+ + I+ L + ++ +YL+ME + ++ ++ E L + + + +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 173
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ I +H +HRD+KP N+++ + LK+ DFGL +
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG------------------ 215
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
M P Y V T Y APEV+L GY D WS+G IM
Sbjct: 216 ----TSFMMTP---------------Y--VVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 268 EMLIGYPPFCSDDPRITCRKIVN-----------------WKTCLKFPEEPKIS------ 304
EM+ F D K++ P+ ++
Sbjct: 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 314
Query: 305 ---------------DEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+ARDL+ +L D R+ V++ +HP+
Sbjct: 315 DSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYI 359
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 53/243 (21%), Positives = 103/243 (42%), Gaps = 48/243 (19%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVE-HVRSERNLLAEVDS 97
+E L +IGKG+FG+V + A+K ++ + ++ E + + ++
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIH 155
++ + +F + + + E L ++ L+ + S + R + + + ++H
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 156 QHNYVHRDIKPDNLILDKNGH--LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
++ +H D+KP+N++L + G +K+ DFG S E + +
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG----------SSCYEHQRV----------- 256
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
Y+ + + Y APEV+L YGM D WSLG I+ E+L GY
Sbjct: 257 --------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
Query: 274 PPF 276
P
Sbjct: 297 PLL 299
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 18/155 (11%), Positives = 44/155 (28%), Gaps = 7/155 (4%)
Query: 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
L G + A+ + +L ++ S L+ +D + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 103 LFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHSIHQHNYVH 161
+ ++ E++ GG + + R +S+ A + H+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-DTSPSPVGAIR--AMQSLAAAADAAHRAGVAL 152
Query: 162 RDIKPDNLILDKNGHLKLSDFGLCKPLE---DKYS 193
P + + +G + L+ D
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRG 187
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 52/246 (21%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVE-HVRSERNLLAEVDS 97
+E +LIGKG+FG+V + E A+K +K K L + Q+E + N
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFY---IAESVLAIH 152
IV L F + L L+ E L ++ LL + +S ++ R + + ++L +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 153 SIHQHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ + + +H D+KP+N++L K +K+ DFG S + I
Sbjct: 175 T-PELSIIHCDLKPENILLCNPKRSAIKIVDFG----------SSCQLGQRI-------- 215
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
Y + + Y +PEVLL Y + D WSLG I+ EM
Sbjct: 216 -----------------------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 271 IGYPPF 276
G P F
Sbjct: 253 TGEPLF 258
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 50/250 (20%), Positives = 95/250 (38%), Gaps = 40/250 (16%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNL-LAEVDS 97
F + +G G FG V LC+ + +A+K ++ + + ++E + + ++++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINN 95
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIH 155
IV+ F D + LI E L G + ++ R + + + Y E + A++ +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI---------INQE 206
+ + H D+KP+N++LD K K + I +
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
S + T Y APEV+L G+ + D WS G ++
Sbjct: 215 YH-------------------------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 267 YEMLIGYPPF 276
E+ G F
Sbjct: 250 AELYTGSLLF 259
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 46/262 (17%), Positives = 98/262 (37%), Gaps = 62/262 (23%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK-KSEMLKRGQVE-----HVRSERNLLA 93
+ + +G G F V L + AMK ++ + + E V N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 94 E-VDSRCIVQLFYSFQ----DSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAE 146
+ + + I++L F + + ++ E L G +++ L+ + + + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 147 SVLAIHSIH-QHNYVHRDIKPDNLILD------KNGHLKLSDFGLCKPLEDKYSSILLED 199
+L + +H + +H DIKP+N++++ +K++D G + D
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG----------NACWYD 189
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
E +++ T +Y +PEVLL +G D
Sbjct: 190 EHY-------------------------------TNSIQTREYRSPEVLLGAPWGCGADI 218
Query: 260 WSLGAIMYEMLIGYPPFCSDDP 281
WS +++E++ G F D+
Sbjct: 219 WSTACLIFELITGDFLFEPDEG 240
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 53/242 (21%)
Query: 41 EQLTL---IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
L +G+G FG+V L TGE+ A+K LK + + E ++L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 94 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFY--IAESVL 149
+ I++ + L L+MEY+P G + L R I + F I E
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICE--- 145
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+ +H +Y+HRD+ N++LD + +K+ DFGL K + + +
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE--------GHE----YYRV 193
Query: 210 EAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+G P W APE L + + D WS G +YE
Sbjct: 194 REDGDS--PVF-----W-----------------YAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 269 ML 270
+L
Sbjct: 230 LL 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 61/247 (24%), Positives = 91/247 (36%), Gaps = 62/247 (25%)
Query: 41 EQLTL---IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
L +GKG FG V +CR TGE+ A+KKL+ S + E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 97
Query: 94 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 151
+ IV+ L LIMEYLP G L D L + R + +
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS---LR---DYLQKHKERIDHIKLLQYT 151
Query: 152 HSI-------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
I Y+HRD+ N++++ +K+ DFGL K L D++
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--------DKE--- 200
Query: 205 QETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263
+ G+ P W APE L + + + D WS G
Sbjct: 201 -YYKVKEPGES--PIF-----W-----------------YAPESLTESKFSVASDVWSFG 235
Query: 264 AIMYEML 270
++YE+
Sbjct: 236 VVLYELF 242
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 61/247 (24%), Positives = 91/247 (36%), Gaps = 62/247 (25%)
Query: 41 EQLTL---IGKGAFGEVRLCRAK----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
L +GKG FG V +CR TGE+ A+KKL+ S + E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 66
Query: 94 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 151
+ IV+ L LIMEYLP G L D L + R + +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS---LR---DYLQKHKERIDHIKLLQYT 120
Query: 152 HSI-------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
I Y+HRD+ N++++ +K+ DFGL K L D++
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ--------DKE--- 169
Query: 205 QETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263
+ G+ P W APE L + + + D WS G
Sbjct: 170 -FFKVKEPGES--PIF-----W-----------------YAPESLTESKFSVASDVWSFG 204
Query: 264 AIMYEML 270
++YE+
Sbjct: 205 VVLYELF 211
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 63/364 (17%), Positives = 105/364 (28%), Gaps = 78/364 (21%)
Query: 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL---AEVDS-- 97
+ +G G F V L + AMK +K +E E E LL D
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPND 97
Query: 98 ---RCIVQLFYSFQ----DSDFLYLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESV 148
+VQL F+ + + ++ E L G ++ +++ L + I + +
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 149 LAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ +H +H DIKP+N++L N + + +
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP-SGSAVSTAPA 215
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVG---------TLDYMAPEVLLKKGYGMECD 258
+ + + ++ K L + T Y + EVL+ GY D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 259 WWSLGAIMYEMLIGYPPFCSDDPRITCRK------------------IVNWKTCLKF--- 297
WS + +E+ G F R IV K +F
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335
Query: 298 -------------------PEEPKISDEARDLICHLLC-----DVETRLGTRGVEELKEH 333
E+ + S E L E R E H
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA---ECLRH 392
Query: 334 PWFR 337
PW
Sbjct: 393 PWLN 396
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 69/251 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
L +G+G FG+V LCR TGE A+K LK + ++ E +L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILR 78
Query: 94 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR- 141
+ IV+ + + + LIME+LP G + L + + + +
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 142 -FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200
Y+ YVHRD+ N++++ +K+ DFGL K +E D+
Sbjct: 139 MDYLGS----------RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET--------DK 180
Query: 201 DIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
+ + P W APE L++ + + D
Sbjct: 181 EYY------TVKDDRDSPVF-----W-----------------YAPECLMQSKFYIASDV 212
Query: 260 WSLGAIMYEML 270
WS G ++E+L
Sbjct: 213 WSFGVTLHELL 223
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 49/261 (18%), Positives = 93/261 (35%), Gaps = 66/261 (25%)
Query: 40 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLK-KSEMLKRGQVE-HVRSERNLLAEVD 96
+E + +G+G FG+V C A+K ++ + + ++E +V + + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSI 154
V + F + + E L G + L + R + A+ +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 155 HQHNYVHRDIKPDNLIL-------------------DKNGHLKLSDFGLCKPLEDKYSSI 195
H++ H D+KP+N++ KN ++++DFG S+
Sbjct: 140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---------SAT 190
Query: 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255
+ E + V T Y PEV+L+ G+
Sbjct: 191 F-DHEHH-------------------------------TTIVATRHYRPPEVILELGWAQ 218
Query: 256 ECDWWSLGAIMYEMLIGYPPF 276
CD WS+G I++E G+ F
Sbjct: 219 PCDVWSIGCILFEYYRGFTLF 239
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 64/251 (25%), Positives = 94/251 (37%), Gaps = 70/251 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKT----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
L +GKG FG V LCR TG + A+K+L+ S Q + E +L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILK 79
Query: 94 EVDSRCIVQLF--YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR- 141
+ S IV+ L L+MEYLP G + L R + S + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 142 -FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200
Y+ VHRD+ N++++ H+K++DFGL K +L D+
Sbjct: 140 MEYLGS----------RRCVHRDLAARNILVESEAHVKIADFGLAK--------LLPLDK 181
Query: 201 DIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
D V GQ P W APE L + + D
Sbjct: 182 D----YYVVREPGQS--PIF-----W-----------------YAPESLSDNIFSRQSDV 213
Query: 260 WSLGAIMYEML 270
WS G ++YE+
Sbjct: 214 WSFGVVLYELF 224
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 49/256 (19%), Positives = 94/256 (36%), Gaps = 56/256 (21%)
Query: 40 FEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLK-KSEMLKRGQVEHVRSERNLLAEV-- 95
+E + +G+GAFG+V C K G A+K +K + + E +L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70
Query: 96 ----DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVL 149
+ VQ+ F+ + ++ E L G + D R +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL---------LEDE 200
+++ +H + H D+KP+N++ ++ + + + + + + + +DE
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260
+ V T Y APEV+L G+ CD W
Sbjct: 190 HH-------------------------------STLVSTRHYRAPEVILALGWSQPCDVW 218
Query: 261 SLGAIMYEMLIGYPPF 276
S+G I+ E +G+ F
Sbjct: 219 SIGCILIEYYLGFTVF 234
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 54/264 (20%), Positives = 102/264 (38%), Gaps = 69/264 (26%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVR 86
R + +F+++ ++G GAFG V GE A+K+L+++ K + +
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEIL 65
Query: 87 SERNLLAEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILS 136
E ++A VD+ + +L + + LI + +P G ++ +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 137 EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194
+A+ Y+ + VHRD+ N+++ H+K++DFGL K L
Sbjct: 124 VQIAKGMNYLED----------RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---- 169
Query: 195 ILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253
++ G+ P K W MA E +L + Y
Sbjct: 170 ---------EEKEYHAEGGKV--PIK-----W-----------------MALESILHRIY 196
Query: 254 GMECDWWSLGAIMYEML-IGYPPF 276
+ D WS G ++E++ G P+
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-16
Identities = 61/256 (23%), Positives = 102/256 (39%), Gaps = 66/256 (25%)
Query: 39 DFEQLTL----IGKGAFGEVR--LCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92
D + LTL +G G FG V+ + K + A+K LK + E + E N++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVM 72
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSE--------DVAR--F 142
++D+ IV++ +++ L+ME G + L + + + V+
Sbjct: 73 QQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202
Y+ E N+VHRD+ N++L + K+SDFGL S L DE+
Sbjct: 132 YLEE----------SNFVHRDLAARNVLLVTQHYAKISDFGL--------SKALRADEN- 172
Query: 203 INQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
++ G+W P K W APE + + + D WS
Sbjct: 173 ---YYKAQTHGKW--PVK-----W-----------------YAPECINYYKFSSKSDVWS 205
Query: 262 LGAIMYEML-IGYPPF 276
G +M+E G P+
Sbjct: 206 FGVLMWEAFSYGQKPY 221
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 53/242 (21%), Positives = 90/242 (37%), Gaps = 42/242 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+D IG+G FGEV R + + A+K +++ E +L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQ 156
IV+L +Y++ME + GGD +T L L + ++ + +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+HRD+ N ++ + LK+SDFG+ + D + + G
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD---------------GVYAASGGLRQ 276
Query: 217 MP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYP 274
+P K W APE L Y E D WS G +++E +G
Sbjct: 277 VPVK-----W-----------------TAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
Query: 275 PF 276
P+
Sbjct: 315 PY 316
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 65/265 (24%), Positives = 106/265 (40%), Gaps = 66/265 (24%)
Query: 26 EYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVE 83
+ + L+R + I D E +G G FG VR + + A+K LK+ E
Sbjct: 328 KKLFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTE 381
Query: 84 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVAR 141
+ E ++ ++D+ IV+L ++ L L+ME GG + L+ RE+I +VA
Sbjct: 382 EMMREAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 440
Query: 142 F---------YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192
Y+ E N+VHR++ N++L + K+SDFGL
Sbjct: 441 LLHQVSMGMKYLEE----------KNFVHRNLAARNVLLVNRHYAKISDFGL-------- 482
Query: 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252
S L D+ + + G+W + W APE + +
Sbjct: 483 SKALGADDS----YYTARSAGKWPLK------W-----------------YAPECINFRK 515
Query: 253 YGMECDWWSLGAIMYEML-IGYPPF 276
+ D WS G M+E L G P+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 63/255 (24%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLL 92
D +++ +G G FGEV R K + A+K LK K Q E +++
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIM 100
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
+ D I++L S + ++ EY+ G + + L + D A+F + + V +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQLVGMLR 154
Query: 153 SI-------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
I YVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA----------- 203
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMECDWWSL 262
AY+T G + + +PE + + + D WS
Sbjct: 204 ---------------------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY 236
Query: 263 GAIMYEML-IGYPPF 276
G +++E++ G P+
Sbjct: 237 GIVLWEVMSYGERPY 251
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 41/166 (24%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--------VDS 97
IG+G+FG + + A+K E RS+ L +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-------- 149
I ++Y Q+ L+++ L G + ED+L +F + ++V
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSL------EDLLDLCGRKFSV-KTVAMAAKQMLA 117
Query: 150 AIHSIHQHNYVHRDIKPDNLIL----DKNGH-LKLSDFGLCKPLED 190
+ SIH+ + V+RDIKPDN ++ KN + + + DFG+ K D
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 60/257 (23%), Positives = 90/257 (35%), Gaps = 74/257 (28%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 94
E + L +G+G FGEV A+K KK L E SE ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FY 143
+D IV+L + + ++IME P G++ L R + S + + Y
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 144 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+ N VHRDI N+++ +KL DFGL S +EDED
Sbjct: 129 LES----------INCVHRDIAVRNILVASPECVKLGDFGL---------SRYIEDED-- 167
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWW 260
Y T +M+PE + + + D W
Sbjct: 168 -----------------------------YYKASVTRLPIKWMSPESINFRRFTTASDVW 198
Query: 261 SLGAIMYEML-IGYPPF 276
M+E+L G PF
Sbjct: 199 MFAVCMWEILSFGKQPF 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 59/260 (22%), Positives = 94/260 (36%), Gaps = 72/260 (27%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVRSERNL 91
+T IG G FGEV KT+ A+K LK K Q E +
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGI 99
Query: 92 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR- 141
+ + I++L + +I EY+ G + L +D + +A
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 142 -FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200
Y+A NYVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 160 MKYLAN----------MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA------ 203
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT---LDYMAPEVLLKKGYGMEC 257
Y+T G + + APE + + +
Sbjct: 204 --------------------------------TYTTSGGKIPIRWTAPEAISYRKFTSAS 231
Query: 258 DWWSLGAIMYEML-IGYPPF 276
D WS G +M+E++ G P+
Sbjct: 232 DVWSFGIVMWEVMTYGERPY 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 56/252 (22%), Positives = 99/252 (39%), Gaps = 69/252 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
E L L +G+G FGEV + T + A+K LK M E E ++ ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 145
+VQL+ + Y++ EY+ G ++ L E ++ +A Y+
Sbjct: 322 EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
NYVHRD++ N+++ +N K++DFGL + +ED
Sbjct: 381 R----------MNYVHRDLRAANILVGENLVCKVADFGLARLIED--------------N 416
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
E + ++ + +W APE L + ++ D WS G +
Sbjct: 417 EYTARQGAKFPI------KW-----------------TAPEAALYGRFTIKSDVWSFGIL 453
Query: 266 MYEML-IGYPPF 276
+ E+ G P+
Sbjct: 454 LTELTTKGRVPY 465
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 53/255 (20%), Positives = 91/255 (35%), Gaps = 62/255 (24%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVR--LCRAKTTGEIF-AMKKLKKSEMLKRGQVEHVRS 87
IG D L +G G+FG VR A + + A+K LK + + ++
Sbjct: 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 88 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSED 138
E N + +D R +++L Y + + ++ E P G ++ L + +
Sbjct: 71 EVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 139 VAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196
VA Y+ ++HRD+ NL+L +K+ DFGL L
Sbjct: 130 VAEGMGYLES----------KRFIHRDLAARNLLLATRDLVKIGDFGL--------MRAL 171
Query: 197 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255
+++D V + + P W APE L + +
Sbjct: 172 PQNDD----HYVMQEHRKV--PFA-----W-----------------CAPESLKTRTFSH 203
Query: 256 ECDWWSLGAIMYEML 270
D W G ++EM
Sbjct: 204 ASDTWMFGVTLWEMF 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 55/254 (21%), Positives = 94/254 (37%), Gaps = 69/254 (27%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
D +LT IG G FG V L ++ A+K +++ M E E ++ ++
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKL 60
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FYI 144
+VQL+ + + L+ E++ G + L + + DV Y+
Sbjct: 61 SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
E +HRD+ N ++ +N +K+SDFG+ + + D +
Sbjct: 121 EE----------ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------------D 157
Query: 205 QETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263
Q T S P K W +PEV Y + D WS G
Sbjct: 158 QYTSSTGT---KFPVK-----W-----------------ASPEVFSFSRYSSKSDVWSFG 192
Query: 264 AIMYEML-IGYPPF 276
+M+E+ G P+
Sbjct: 193 VLMWEVFSEGKIPY 206
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 37/163 (22%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSER-NLLAEV-------DS 97
IG G+FG++ L GE A+K E V+++ L E
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF------YIAESVLA- 150
I + + + D+ ++ME L G + ED+ + +F +A+ +++
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSL------EDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLED 190
I IH N++HRD+KPDN ++ + + DFGL K D
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 54/264 (20%), Positives = 102/264 (38%), Gaps = 69/264 (26%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVR 86
R + +F+++ ++G GAFG V GE A+K+L+++ K + +
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEIL 65
Query: 87 SERNLLAEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILS 136
E ++A VD+ + +L + + LI + +P G ++ +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 137 EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194
+A+ Y+ + VHRD+ N+++ H+K++DFGL K L
Sbjct: 124 VQIAKGMNYLED----------RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---- 169
Query: 195 ILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253
++ G+ P K W MA E +L + Y
Sbjct: 170 ---------EEKEYHAEGGKV--PIK-----W-----------------MALESILHRIY 196
Query: 254 GMECDWWSLGAIMYEML-IGYPPF 276
+ D WS G ++E++ G P+
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPY 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 53/257 (20%), Positives = 86/257 (33%), Gaps = 74/257 (28%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 94
E++ L IG+G FG+V + A+K K E E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQ 447
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FY 143
D IV+L + +++IME G++ + L + + ++ Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 144 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+ +VHRDI N+++ N +KL DFGL S +ED
Sbjct: 507 LES----------KRFVHRDIAARNVLVSSNDCVKLGDFGL---------SRYMEDST-- 545
Query: 204 NQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWW 260
Y +MAPE + + + D W
Sbjct: 546 -----------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVW 576
Query: 261 SLGAIMYEML-IGYPPF 276
G M+E+L G PF
Sbjct: 577 MFGVCMWEILMHGVKPF 593
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 37/160 (23%), Positives = 64/160 (40%), Gaps = 20/160 (12%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLK---------KSEM--LKRGQVEHVRSERNLLA 93
IG G FG + L E A +K SE+ +R + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 94 EVDSRCIVQLFYS----FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 149
++D I + S F+ + +++ME L G D+ + + + + +L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV-LQLGIRML 161
Query: 150 -AIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCK 186
+ IH++ YVH DIK NL+L + L+D+GL
Sbjct: 162 DVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-15
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 59/253 (23%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ ++ + IG G GEV R + G+ A+K LK + Q SE +++
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIM 104
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
+ D I++L ++ EY+ G + T L D +F I + V +
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------GQFTIMQLVGMLR 158
Query: 153 SI-------HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ YVHRD+ N+++D N K+SDFGL + LED +
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-------------DP 205
Query: 206 ETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264
+ G +P + W APE + + + D WS G
Sbjct: 206 DAAYTTTGG-KIPIR-----W-----------------TAPEAIAFRTFSSASDVWSFGV 242
Query: 265 IMYEML-IGYPPF 276
+M+E+L G P+
Sbjct: 243 VMWEVLAYGERPY 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 41/162 (25%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--------VDS 97
IG G FGE+RL + T E A+K +E ++S L
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-------- 149
I Q++Y + +++E L G + ED+ F + ++VL
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSL------EDLFDLCDRTFSL-KTVLMIAIQLIS 116
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLK-----LSDFGLCK 186
+ +H N ++RD+KP+N ++ + G+ + DF L K
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/252 (22%), Positives = 101/252 (40%), Gaps = 69/252 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
E L L +G+G FGEV + T + A+K LK M E E ++ ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 145
+VQL Y+ + +Y++ EY+ G ++ L E ++ +A Y+
Sbjct: 239 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
NYVHRD++ N+++ +N K++DFGL + +ED
Sbjct: 298 R----------MNYVHRDLRAANILVGENLVCKVADFGLARLIED--------------N 333
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
E + ++ + +W APE L + ++ D WS G +
Sbjct: 334 EYTARQGAKFPI------KW-----------------TAPEAALYGRFTIKSDVWSFGIL 370
Query: 266 MYEML-IGYPPF 276
+ E+ G P+
Sbjct: 371 LTELTTKGRVPY 382
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 48/252 (19%), Positives = 94/252 (37%), Gaps = 64/252 (25%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSE--------DVAR--FYIA 145
+VQL Y+I E++ G+++ L +S ++ Y+
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ N++HR++ N ++ +N +K++DFGL + +
Sbjct: 336 K----------KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--------------D 371
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
+ A ++ + +W APE L + ++ D W+ G +
Sbjct: 372 TYTAHAGAKFPI------KW-----------------TAPESLAYNKFSIKSDVWAFGVL 408
Query: 266 MYEML-IGYPPF 276
++E+ G P+
Sbjct: 409 LWEIATYGMSPY 420
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 65/262 (24%), Positives = 102/262 (38%), Gaps = 68/262 (25%)
Query: 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRS 87
L+R + I D E +G G FG VR + + A+K LK+ E +
Sbjct: 6 LKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 59
Query: 88 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSED 138
E ++ ++D+ IV+L ++ L L+ME GG + L+ + L
Sbjct: 60 EAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 139 VAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196
V+ Y+ E N+VHRD+ N++L + K+SDFGL S L
Sbjct: 119 VSMGMKYLEE----------KNFVHRDLAARNVLLVNRHYAKISDFGL--------SKAL 160
Query: 197 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255
D+ + + G+W P K W APE + + +
Sbjct: 161 GADDS----YYTARSAGKW--PLK-----W-----------------YAPECINFRKFSS 192
Query: 256 ECDWWSLGAIMYEML-IGYPPF 276
D WS G M+E L G P+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPY 214
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 51/256 (19%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
E++TL +G G FG V+L + K ++ A+K +K+ M + E + ++
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKL 60
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FYI 144
+V+ + +Y++ EY+ G ++ L + DV ++
Sbjct: 61 SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
H ++HRD+ N ++D++ +K+SDFG+ + + D+
Sbjct: 121 ES----------HQFIHRDLAARNCLVDRDLCVKVSDFGM---------TRYVLDDQ--- 158
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWWS 261
S+VGT + APEV Y + D W+
Sbjct: 159 ----------------------------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 262 LGAIMYEML-IGYPPF 276
G +M+E+ +G P+
Sbjct: 191 FGILMWEVFSLGKMPY 206
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 39/164 (23%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE-RNLLAEV-------DS 97
IG G+FGE+ L T E A+K E+V+++ LL E
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIYRILQGG 62
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-------- 149
I + + + D+ L+M+ L G + ED+ + + + ++VL
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSL------EDLFNFCSRKLSL-KTVLMLADQMIN 114
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLED 190
+ +H +++HRDIKPDN ++ + + DFGL K D
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 53/268 (19%), Positives = 94/268 (35%), Gaps = 82/268 (30%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+Q TL +GKG FG VR + K F A+K LK + +E E + E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS-DIEEFLREAACMKE 81
Query: 95 VDSRCIVQLF------YSFQDSDFLYLIMEYLPGGDIMTLLMR------------EDILS 136
D + +L + +I+ ++ GD+ L+ + ++
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 137 --EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK- 191
D+A Y++ N++HRD+ N +L ++ + ++DFGL + +
Sbjct: 142 FMVDIACGMEYLSS----------RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 192 -YSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249
Y +P K W +A E L
Sbjct: 192 YY-----------------RQGCASKLPVK-----W-----------------LALESLA 212
Query: 250 KKGYGMECDWWSLGAIMYEML-IGYPPF 276
Y + D W+ G M+E++ G P+
Sbjct: 213 DNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 64/248 (25%)
Query: 46 IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
IGKG FG V + A+K L + ++ QVE E L+ ++ ++
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREGLLMRGLNHPNVLA 86
Query: 103 LF-YSFQDSDFLYLIMEYLPGGDIMTLLMRE-------DILS--EDVAR--FYIAESVLA 150
L ++++ Y+ GD++ + D++S VAR Y+AE
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---- 142
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+VHRD+ N +LD++ +K++DFGL + + D + + +
Sbjct: 143 ------QKFVHRDLAARNCMLDESFTVKVADFGL---------ARDILDREYYSVQQHRH 187
Query: 211 AEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
A +P K W A E L + + D WS G +++E+
Sbjct: 188 A----RLPVK-----W-----------------TALESLQTYRFTTKSDVWSFGVLLWEL 221
Query: 270 L-IGYPPF 276
L G PP+
Sbjct: 222 LTRGAPPY 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 7e-14
Identities = 53/259 (20%), Positives = 86/259 (33%), Gaps = 74/259 (28%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLL 92
E++ L IG+G FG+V + A+K K E E +
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTM 70
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR-- 141
+ D IV+L + +++IME G++ + L + + ++
Sbjct: 71 RQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 142 FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201
Y+ +VHRDI N+++ N +KL DFGL S +ED
Sbjct: 130 AYLES----------KRFVHRDIAARNVLVSSNDCVKLGDFGL---------SRYMEDST 170
Query: 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECD 258
Y +MAPE + + + D
Sbjct: 171 Y-------------------------------YKASKGKLPIKWMAPESINFRRFTSASD 199
Query: 259 WWSLGAIMYEML-IGYPPF 276
W G M+E+L G PF
Sbjct: 200 VWMFGVCMWEILMHGVKPF 218
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 33/168 (19%), Positives = 62/168 (36%), Gaps = 33/168 (19%)
Query: 45 LIGKGAFGEVRLCRAKT-----TGEIFAMKKLKK--------SEMLKRGQVEHVRSERNL 91
IG+G FG + L + + +K + +R +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 92 LAEVDSRCIVQLFYS----FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARF----- 142
++ + + + S + ++IM+ G D+ + I + RF
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAKRFSRKTV 154
Query: 143 -YIAESVL-AIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCK 186
++ +L + IH+H YVH DIK NL+L+ + L D+GL
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 50/248 (20%), Positives = 95/248 (38%), Gaps = 64/248 (25%)
Query: 46 IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
IG+G FG V A+K L + + +V +E ++ + ++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLS 90
Query: 103 LF-YSFQDSDFLYLIMEYLPGGDIMTLLMRE-------DILS--EDVAR--FYIAESVLA 150
L + +++ Y+ GD+ + E D++ VA+ Y+A
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---- 146
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+VHRD+ N +LD+ +K++DFGL + + D++ + +
Sbjct: 147 ------KKFVHRDLAARNCMLDEKFTVKVADFGL---------ARDMYDKEYYSVHNKTG 191
Query: 211 AEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
A +P K W MA E L + + + D WS G +++E+
Sbjct: 192 A----KLPVK-----W-----------------MALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 270 L-IGYPPF 276
+ G PP+
Sbjct: 226 MTRGAPPY 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 53/253 (20%), Positives = 103/253 (40%), Gaps = 72/253 (28%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
E L L +G G FGEV + ++ A+K +K M VE +E N++ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 145
+V+L ++ + +Y+I E++ G ++ L ++ S +A +I
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
+ NY+HRD++ N+++ + K++DFGL + +ED
Sbjct: 302 Q----------RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-------------- 337
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
E + ++ + +W APE + + ++ D WS G +
Sbjct: 338 EYTAREGAKFPI------KW-----------------TAPEAINFGSFTIKSDVWSFGIL 374
Query: 266 MYEML----IGYP 274
+ E++ I YP
Sbjct: 375 LMEIVTYGRIPYP 387
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 49/248 (19%), Positives = 95/248 (38%), Gaps = 64/248 (25%)
Query: 46 IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ 102
IG+G FG V A+K L + + +V +E ++ + ++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLS 154
Query: 103 LF-YSFQDSDFLYLIMEYLPGGDIMTLLMRE-------DILS--EDVAR--FYIAESVLA 150
L + +++ Y+ GD+ + E D++ VA+ ++A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---- 210
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+VHRD+ N +LD+ +K++DFGL + + D++ + +
Sbjct: 211 ------KKFVHRDLAARNCMLDEKFTVKVADFGL---------ARDMYDKEFDSVHNKTG 255
Query: 211 AEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
A +P K W MA E L + + + D WS G +++E+
Sbjct: 256 A----KLPVK-----W-----------------MALESLQTQKFTTKSDVWSFGVLLWEL 289
Query: 270 L-IGYPPF 276
+ G PP+
Sbjct: 290 MTRGAPPY 297
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 51/256 (19%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
D + LT +G G FG V+ + + ++ A+K +K+ M + E ++ +
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNL 76
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSEDVAR--FYI 144
+VQL+ +++I EY+ G ++ L + +DV Y+
Sbjct: 77 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
++HRD+ N +++ G +K+SDFGL S + D++
Sbjct: 137 ES----------KQFLHRDLAARNCLVNDQGVVKVSDFGL---------SRYVLDDE--- 174
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL---DYMAPEVLLKKGYGMECDWWS 261
S+VG+ + PEVL+ + + D W+
Sbjct: 175 ----------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 262 LGAIMYEML-IGYPPF 276
G +M+E+ +G P+
Sbjct: 207 FGVLMWEIYSLGKMPY 222
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 43/271 (15%), Positives = 92/271 (33%), Gaps = 83/271 (30%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEMLKRGQVEHVR 86
KI +D +G+G F ++ + G+ +K L K+ E
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFF 60
Query: 87 SERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------ILSE 137
++++++ + +V + D L+ E++ G + T L + +++
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 138 DVAR--FYIAESVLAIHSIHQHNYVHRDI--------KPDNLILDKNGHLKLSDFGLCKP 187
+A ++ E + +H ++ + ++ +KLSD G+
Sbjct: 121 QLAAAMHFLEE----------NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--- 167
Query: 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEV 247
SI + +DI+ +ER+ W + PE
Sbjct: 168 ------SITVLPKDIL---------------QERI-PW-----------------VPPEC 188
Query: 248 LL-KKGYGMECDWWSLGAIMYEML-IGYPPF 276
+ K + D WS G ++E+ G P
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 49/256 (19%), Positives = 89/256 (34%), Gaps = 70/256 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVRSERNLLA 93
+L +G G FG V GE +K ++ + + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIG 70
Query: 94 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMT-LLMREDILSE--------DVAR--F 142
+D IV+L L L+ +YLP G ++ + L +A+ +
Sbjct: 71 SLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202
Y+ E H VHR++ N++L ++++DFG+ L
Sbjct: 130 YLEE----------HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP------------ 167
Query: 203 INQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
+ + + +E + P K W MA E + Y + D WS
Sbjct: 168 -DDKQLLYSEAKT--PIK-----W-----------------MALESIHFGKYTHQSDVWS 202
Query: 262 LGAIMYEML-IGYPPF 276
G ++E++ G P+
Sbjct: 203 YGVTVWELMTFGAEPY 218
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 26/167 (15%), Positives = 53/167 (31%), Gaps = 33/167 (19%)
Query: 46 IGKGAFGEVRL--------CRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL------ 91
+ G + C + + F++K K L Q R+ + L
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 92 -LAEVDSRCIVQLFYS-FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 149
L I + +L++ L G + + L SVL
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL------QSALDVSPKHVLSERSVL 162
Query: 150 --------AIHSIHQHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCK 186
A+ +H++ YVH ++ +N+ + + + L+ +G
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 48/248 (19%), Positives = 91/248 (36%), Gaps = 68/248 (27%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+ +T+ +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI 66
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDIL----------SEDVAR--FY 143
+VQL Y+I E++ G+++ L + + ++ Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 144 IAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDII 203
+ + N++HRD+ N ++ +N +K++DFGL + +
Sbjct: 127 LEK----------KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----------- 165
Query: 204 NQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262
A P K W APE L + ++ D W+
Sbjct: 166 -----YTAHAGAKFPIK-----W-----------------TAPESLAYNKFSIKSDVWAF 198
Query: 263 GAIMYEML 270
G +++E+
Sbjct: 199 GVLLWEIA 206
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 54/267 (20%), Positives = 93/267 (34%), Gaps = 81/267 (30%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAE 94
L L +G+G FG V K A+K +K +R ++E SE + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSEAACMKD 92
Query: 95 VDSRCIVQLF-----YSFQDSDFLYLIMEYLPGGDIMTLLMR------------EDILS- 136
+++L S Q +I+ ++ GD+ T L+ + +L
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 137 -EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK-- 191
D+A Y++ N++HRD+ N +L + + ++DFGL K +
Sbjct: 153 MVDIALGMEYLSN----------RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 192 YSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250
Y MP K W +A E L
Sbjct: 203 Y-----------------RQGRIAKMPVK-----W-----------------IAIESLAD 223
Query: 251 KGYGMECDWWSLGAIMYEML-IGYPPF 276
+ Y + D W+ G M+E+ G P+
Sbjct: 224 RVYTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 52/245 (21%), Positives = 100/245 (40%), Gaps = 68/245 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
E L L +G G FGEV + ++ A+K LK+ M + +E NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDVAR--FYIA 145
+ +V+L Y+ + +Y+I EY+ G ++ L ++ +A +I
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 146 ESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQ 205
E NY+HRD++ N+++ K++DFGL + +ED
Sbjct: 127 E----------RNYIHRDLRAANILVSDTLSCKIADFGLARLIED--------------N 162
Query: 206 ETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265
E + ++ + +W APE + + ++ D WS G +
Sbjct: 163 EYTAREGAKFPI------KW-----------------TAPEAINYGTFTIKSDVWSFGIL 199
Query: 266 MYEML 270
+ E++
Sbjct: 200 LTEIV 204
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 54/255 (21%), Positives = 95/255 (37%), Gaps = 65/255 (25%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ L +G+GAFG+V L A+K LK + R + + E LL
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELL 71
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLA 150
+ IV+ + D D L ++ EY+ GD+ L D + + A+ L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 151 IHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196
+ + ++VHRD+ N ++ N +K+ DFG+ +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---------- 181
Query: 197 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255
D+ + + G M+P + W M PE ++ + +
Sbjct: 182 ----DVYSTDYY-RVGGHTMLPIR-----W-----------------MPPESIMYRKFTT 214
Query: 256 ECDWWSLGAIMYEML 270
E D WS G I++E+
Sbjct: 215 ESDVWSFGVILWEIF 229
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 47/268 (17%), Positives = 101/268 (37%), Gaps = 83/268 (30%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 92
E++T+ +G+G+FG V AK + A+K + ++ ++ + +E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----------------EDILS 136
E + +V+L +IME + GD+ + L ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 137 --EDVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL--ED 190
++A Y+ + +VHRD+ N ++ ++ +K+ DFG+ + + D
Sbjct: 143 MAGEIADGMAYLNA----------NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 191 KYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249
Y G+ ++P + W M+PE L
Sbjct: 193 YY-----------------RKGGKGLLPVR-----W-----------------MSPESLK 213
Query: 250 KKGYGMECDWWSLGAIMYEML-IGYPPF 276
+ D WS G +++E+ + P+
Sbjct: 214 DGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 55/256 (21%), Positives = 97/256 (37%), Gaps = 66/256 (25%)
Query: 41 EQLTL---IGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92
++L L +G+GAFG+V A T A+K LK+ + + SE +L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 93 AEVDS-RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESV 148
+ +V L + L +I+E+ G++ T L R + + VA + +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 149 LAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194
L + + +HRD+ N++L + +K+ DFGL +
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-------- 196
Query: 195 ILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253
DI +G +P K W MAPE + + Y
Sbjct: 197 ------DIYKDP-DYVRKGDARLPLK-----W-----------------MAPETIFDRVY 227
Query: 254 GMECDWWSLGAIMYEM 269
++ D WS G +++E+
Sbjct: 228 TIQSDVWSFGVLLWEI 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 64/254 (25%)
Query: 41 EQLTL---IGKGAFGEVRLCRAK----TTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ L +G+GAFG+V L ++ A+K LK++ R + + E LL
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELL 97
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAI 151
+ + IV+ F + L ++ EY+ GD+ L +A L +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 152 HSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197
+ ++VHRD+ N ++ + +K+ DFG+ +
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----------- 206
Query: 198 EDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256
DI + + G+ M+P + W M PE +L + + E
Sbjct: 207 ---DIYSTDYY-RVGGRTMLPIR-----W-----------------MPPESILYRKFTTE 240
Query: 257 CDWWSLGAIMYEML 270
D WS G +++E+
Sbjct: 241 SDVWSFGVVLWEIF 254
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 60/270 (22%), Positives = 107/270 (39%), Gaps = 81/270 (30%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV 95
+ ++L L IGKG FG+V G A+K +K + +E +++ ++
Sbjct: 19 NMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQL 71
Query: 96 DSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMT--------LLMREDIL--SEDVAR--F 142
+VQL ++ LY++ EY+ G ++ +L + +L S DV
Sbjct: 72 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 143 YIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDI 202
Y+ +N+VHRD+ N+++ ++ K+SDFGL K +
Sbjct: 132 YLEG----------NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EAS---------- 168
Query: 203 INQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261
+ +P K W APE L +K + + D WS
Sbjct: 169 -------STQDTGKLPVK-----W-----------------TAPEALREKKFSTKSDVWS 199
Query: 262 LGAIMYEML-IGYPPFCSDDPRITCRKIVN 290
G +++E+ G P+ PRI + +V
Sbjct: 200 FGILLWEIYSFGRVPY----PRIPLKDVVP 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 46/255 (18%), Positives = 79/255 (30%), Gaps = 64/255 (25%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ +G+ FG+V A+K LK E R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLR 66
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 150
A + +V L L +I Y GD+ L +S L
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 151 IHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196
H+ VH+D+ N+++ ++K+SD GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL---------FRE 177
Query: 197 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255
+ D + G ++P + W MAPE ++ + +
Sbjct: 178 VYAADYY------KLLGNSLLPIR-----W-----------------MAPEAIMYGKFSI 209
Query: 256 ECDWWSLGAIMYEML 270
+ D WS G +++E+
Sbjct: 210 DSDIWSYGVVLWEVF 224
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 59/264 (22%), Positives = 101/264 (38%), Gaps = 72/264 (27%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH-VRSERNLLAEVDSRCIVQL 103
+G+G FG V + A+KKL + +++ E ++A+ +V+L
Sbjct: 38 KMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 104 F-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV--------ARFYIAESV---LAI 151
+S D L+ Y+P G +L D LS R IA+ +
Sbjct: 96 LGFSSDGDDLC-LVYVYMPNG---SL---LDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+H+++++HRDIK N++LD+ K+SDFGL + E Q ++
Sbjct: 149 --LHENHHIHRDIKSANILLDEAFTAKISDFGLAR---------ASEKFA---QTVMTSR 194
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPE----VLLKKGYGMECDWWSLGAIMY 267
VGT YMAPE + K D +S G ++
Sbjct: 195 ------------------------IVGTTAYMAPEALRGEITPK-----SDIYSFGVVLL 225
Query: 268 EMLIGYPPFCSDDPRITCRKIVNW 291
E++ G P D + +++
Sbjct: 226 EIITGLPAV---DEHREPQLLLDI 246
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 57/266 (21%), Positives = 99/266 (37%), Gaps = 79/266 (29%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ +TL +G GAFGEV + A+K L + + E ++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-------------EDILS--E 137
++ + + IV+ S +++ME + GGD+ + L D+L
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 138 DVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKY 192
D+A Y+ E ++++HRDI N +L G K+ DFG+ +
Sbjct: 148 DIACGCQYLEE----------NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------ 191
Query: 193 SSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 251
DI G M+P K W M PE ++
Sbjct: 192 --------DIYRASY-YRKGGCAMLPVK-----W-----------------MPPEAFMEG 220
Query: 252 GYGMECDWWSLGAIMYEML-IGYPPF 276
+ + D WS G +++E+ +GY P+
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMPY 246
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 61/261 (23%), Positives = 111/261 (42%), Gaps = 67/261 (25%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
++L L IGKG FG+V G A+K +K + +E +++ ++
Sbjct: 193 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 98 RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLL---MREDILSEDVARFY--IAESVLAI 151
+VQL ++ LY++ EY+ G ++ L R + + + +F + E A+
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE---AM 302
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ +N+VHRD+ N+++ ++ K+SDFGL K + S ++
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASS---------------TQD 344
Query: 212 EGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
G+ P K W APE L +K + + D WS G +++E+
Sbjct: 345 TGKL--PVK-----W-----------------TAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 271 -IGYPPFCSDDPRITCRKIVN 290
G P+ PRI + +V
Sbjct: 381 SFGRVPY----PRIPLKDVVP 397
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 58/257 (22%), Positives = 96/257 (37%), Gaps = 67/257 (26%)
Query: 41 EQLTL---IGKGAFGEVRLCRA----KTTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 92
+L+ +G GAFG+V A K+ + A+K LK S L + E + SE +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 93 AEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVL 149
+ + + IV L + +I EY GD++ L R+ + + + + L
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 150 AIHS----------------IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193
A+ + N +HRD+ N++L K+ DFGL +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR------- 193
Query: 194 SILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252
I ++ +G +P K W MAPE +
Sbjct: 194 --------DIKNDSNYVVKGNARLPVK-----W-----------------MAPESIFNCV 223
Query: 253 YGMECDWWSLGAIMYEM 269
Y E D WS G ++E+
Sbjct: 224 YTFESDVWSYGIFLWEL 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 56/266 (21%), Positives = 99/266 (37%), Gaps = 79/266 (29%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-----AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ +TL +G GAFGEV + A+K L + + E ++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-------------EDILS--E 137
++ + + IV+ S ++++E + GGD+ + L D+L
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 138 DVAR--FYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKY 192
D+A Y+ E ++++HRDI N +L G K+ DFG+ +
Sbjct: 189 DIACGCQYLEE----------NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------ 232
Query: 193 SSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 251
DI G M+P K W M PE ++
Sbjct: 233 --------DIYRAGYY-RKGGCAMLPVK-----W-----------------MPPEAFMEG 261
Query: 252 GYGMECDWWSLGAIMYEML-IGYPPF 276
+ + D WS G +++E+ +GY P+
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 59/253 (23%), Positives = 95/253 (37%), Gaps = 63/253 (24%)
Query: 41 EQLTL---IGKGAFGEVRLCRA----KTTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 92
L +G GAFG+V A K + A+K LK + + E + SE ++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIM 103
Query: 93 AEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 151
+ + IV L + + +I EY GD++ L R+ + E F IA S +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 152 HSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197
+ N +HRD+ N++L K+ DFGL +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----------- 212
Query: 198 EDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256
DI+N +G +P K W MAPE + Y ++
Sbjct: 213 ---DIMNDS-NYIVKGNARLPVK-----W-----------------MAPESIFDCVYTVQ 246
Query: 257 CDWWSLGAIMYEM 269
D WS G +++E+
Sbjct: 247 SDVWSYGILLWEI 259
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 61/275 (22%), Positives = 103/275 (37%), Gaps = 68/275 (24%)
Query: 38 DDFEQLTLIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
++F+ LIG G FG+V L G A+K+ +G E +E L+
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVL----RDGAKVALKRRTPES--SQGIEE-FETEIETLSF 91
Query: 95 VDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSED---VARFYIA-ESVL 149
+V L + + ++ + LI +Y+ G++ L D+ + R I +
Sbjct: 92 CRHPHLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
+H +H +HRD+K N++LD+N K++DFG+ K D+ +
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK-------KGTELDQTHL------ 197
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTV--GTLDYMAPE-----VLLKKGYGMECDWWSL 262
STV GTL Y+ PE L +K D +S
Sbjct: 198 -------------------------STVVKGTLGYIDPEYFIKGRLTEK-----SDVYSF 227
Query: 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNW-KTCLK 296
G +++E+L PR + W
Sbjct: 228 GVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHN 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 52/254 (20%), Positives = 92/254 (36%), Gaps = 65/254 (25%)
Query: 39 DFEQLTL---IGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLA 93
D+ + IG+G FG+V R K G A+K++K+ E +L
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLC 80
Query: 94 EVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAESVLA 150
++ I+ L + + +LYL +EY P G+++ L R A S L+
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 151 IHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196
+ ++HRD+ N+++ +N K++DFGL + ++ Y
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVY---- 195
Query: 197 LEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255
+ +P + W MA E L Y
Sbjct: 196 -------------VKKTMGRLPVR-----W-----------------MAIESLNYSVYTT 220
Query: 256 ECDWWSLGAIMYEM 269
D WS G +++E+
Sbjct: 221 NSDVWSYGVLLWEI 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 67/257 (26%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEMLKRGQVEHVRSERN 90
++LTL +G+GAFG+V + A + A+K LK K + + SE
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 91 LLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLL--MREDILSEDVARFYIAES 147
++ + I+ L + LY+I+EY G++ L R + + E
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 148 VLAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193
+ + +HRD+ N+++ +N +K++DFGL +
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR------- 205
Query: 194 SILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252
DI N + + +P K W MAPE L +
Sbjct: 206 -------DINNID-YYKKTTNGRLPVK-----W-----------------MAPEALFDRV 235
Query: 253 YGMECDWWSLGAIMYEM 269
Y + D WS G +M+E+
Sbjct: 236 YTHQSDVWSFGVLMWEI 252
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 72/262 (27%)
Query: 41 EQLTL---IGKGAFGEVRLCRA----KTTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ L L +G+G FG+V A G A+K LK++ ++ + SE N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAES 147
+V+ +++L+ + L LI+EY G + L L +R +
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 148 VLAIHSIH-------------------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188
++ + VHRD+ N+++ + +K+SDFGL +
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 189 EDKYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEV 247
D+ ++ Q +P K W MA E
Sbjct: 199 ------------DVYEED-SYVKRSQGRIPVK-----W-----------------MAIES 223
Query: 248 LLKKGYGMECDWWSLGAIMYEM 269
L Y + D WS G +++E+
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEI 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 55/257 (21%), Positives = 97/257 (37%), Gaps = 67/257 (26%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEMLKRGQVEHVRSERN 90
++L L +G+GAFG+V L A + A+K LK K + + SE
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 91 LLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAES 147
++ + I+ L + LY+I+EY G++ L R L + E
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 148 VLAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193
L+ + +HRD+ N+++ ++ +K++DFGL +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------- 239
Query: 194 SILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252
DI + + + +P K W MAPE L +
Sbjct: 240 -------DIHHIDYY-KKTTNGRLPVK-----W-----------------MAPEALFDRI 269
Query: 253 YGMECDWWSLGAIMYEM 269
Y + D WS G +++E+
Sbjct: 270 YTHQSDVWSFGVLLWEI 286
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 3e-10
Identities = 35/203 (17%), Positives = 63/203 (31%), Gaps = 48/203 (23%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKL-----KKSEMLKRGQVEHVRSERNLL 92
+ ++ IG+G FGEV + A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 93 AEVD-----------------SRCIVQLFY----------------------SFQDSDFL 113
E+ S VQ Y F D L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILD 172
++++E+ GG + MR + S A+ + + ++ + HRD+ N++L
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 173 KNGHLKLSDFGLCKPLEDKYSSI 195
K KL K +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGL 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 65/297 (21%), Positives = 108/297 (36%), Gaps = 77/297 (25%)
Query: 11 EEQEEMLRNLERRETEYMRLQRRKIGIDDF-----EQLTL---IGKGAFGEVRLCRAKTT 62
E Q +M++ + EY + R+ D E L +G GAFG+V A
Sbjct: 10 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 69
Query: 63 GEIF-----AMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLI 116
+ A+K LK+ + E + SE ++ ++ S IV L + S +YLI
Sbjct: 70 SKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127
Query: 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS----------------------- 153
EY GD++ L + + Y + L
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+ + VHRD+ N+++ +K+ DFGL + DI++ G
Sbjct: 188 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR--------------DIMSDS-NYVVRG 232
Query: 214 QWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+P K W MAPE L + Y ++ D WS G +++E+
Sbjct: 233 NARLPVK-----W-----------------MAPESLFEGIYTIKSDVWSYGILLWEI 267
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 55/257 (21%), Positives = 96/257 (37%), Gaps = 67/257 (26%)
Query: 41 EQLTL---IGKGAFGEVRLCRAKTTGEIF-------AMKKLKKSEMLKRGQVEHVRSERN 90
++LTL +G+G FG+V + A + A+K LK K + + SE
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 91 LLAEVDSRC-IVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAES 147
++ + I+ L + LY+I+EY G++ L R + + E
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 148 VLAIHSIHQ--------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193
+ + +HRD+ N+++ +N +K++DFGL +
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR------- 251
Query: 194 SILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252
DI N + + +P K W MAPE L +
Sbjct: 252 -------DINNID-YYKKTTNGRLPVK-----W-----------------MAPEALFDRV 281
Query: 253 YGMECDWWSLGAIMYEM 269
Y + D WS G +M+E+
Sbjct: 282 YTHQSDVWSFGVLMWEI 298
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 54/265 (20%), Positives = 90/265 (33%), Gaps = 76/265 (28%)
Query: 41 EQLTL---IGKGAFGEVRLCRAK----TTGEIF-AMKKLKKSEMLKRGQVEHVRSERNLL 92
+ IG+GAFG V RA A+K LK+ + E L+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 104
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
AE D+ IV+L + L+ EY+ GD+ L + + +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 153 SIH------------------------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188
S + +VHRD+ N ++ +N +K++DFGL + +
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 189 --EDKYSSILLEDEDIINQETVSEAEGQWMMP-KERLQQWKRNRRALAYSTVGTLDYMAP 245
D Y +A+G +P + W M P
Sbjct: 225 YSADYY-----------------KADGNDAIPIR-----W-----------------MPP 245
Query: 246 EVLLKKGYGMECDWWSLGAIMYEML 270
E + Y E D W+ G +++E+
Sbjct: 246 ESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 85/265 (32%)
Query: 38 DDFEQLTLIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
D+F ++G+G FG+V RL G + A+K+LK+ +R Q E E
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRL----ADGTLVAVKRLKE----ERTQ----GGELQFQTE 77
Query: 95 VDS------RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV----ARFY 143
V+ R +++L + ++ L L+ Y+ G + + L RE S+ R
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCL-RERPESQPPLDWPKRQR 135
Query: 144 IAESV---LA-IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
IA LA +H +HRD+K N++LD+ + DFGL K ++ K + +
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV---- 191
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST--VGTLDYMAPEVLLKKGYGME- 256
+T GT+ ++APE Y
Sbjct: 192 -----------------------------------TTAVRGTIGHIAPE------YLSTG 210
Query: 257 -----CDWWSLGAIMYEMLIGYPPF 276
D + G ++ E++ G F
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAF 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 52/335 (15%), Positives = 98/335 (29%), Gaps = 79/335 (23%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFE-----------QLTLIGKGAFGEV 54
A ++ + L E + L + + + +L++I
Sbjct: 284 ATTTHISLDHHSMTLTPDEVK--SLLLKYLDCRPQDLPREVLTTNPRRLSIIA--ESIRD 339
Query: 55 RLCRAKTTGEIFAMKKLKKSEM-LKRGQVEHVRSERNLLAEVDSRCIVQLFYS---FQDS 110
L + K E L N+L + R ++F F S
Sbjct: 340 GLATWDNWKHVNCDKLTTIIESSL------------NVLEPAEYR---KMFDRLSVFPPS 384
Query: 111 --------DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHR 162
++ + ++ L + ++ + I+ I SI+ V
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS-----IPSIYLELKVKL 439
Query: 163 DIKPD--NLILDK-NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
+ + I+D N L P D+Y + G +
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI---------------GHHLKNI 484
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM--LIGYPPF- 276
E ++ R LD+ L +K W + G+I+ + L Y P+
Sbjct: 485 EHPERMTLFRMVF-------LDF---RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI 534
Query: 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 311
C +DP+ R + L EE I + DL+
Sbjct: 535 CDNDPKYE-RLVNAILDFLPKIEENLICSKYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 6e-06
Identities = 75/488 (15%), Positives = 140/488 (28%), Gaps = 123/488 (25%)
Query: 10 NEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRL----CRAKTT--- 62
N+ Q N+ R + Y++L++ + + + + + G G+ + C +
Sbjct: 121 NDNQVFAKYNVSRLQ-PYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 63 --GEIF--AMKKLKKSE-MLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLI 116
+IF +K E +L+ Q + + N + D I +S Q L
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK 239
Query: 117 MEYLPGGDIMTLLMREDILSEDVAR-FYIAESVLAIHSIHQHNYVHRDIK-PDNLILDKN 174
+ LL+ ++ + F ++ +L R + D L
Sbjct: 240 SKPYENC----LLVLLNVQNAKAWNAFNLSCKILLT---------TRFKQVTDFLSAATT 286
Query: 175 GHLKLSDFGLCKPLEDKYS-SILLEDEDIINQETVSEAEGQWMMP-------------KE 220
H+ L L S+LL+ D Q+ E P
Sbjct: 287 THISLDHHS--MTLTPDEVKSLLLKYLDCRPQDLPREVLT--TNPRRLSIIAESIRDGLA 342
Query: 221 RLQQWKR-NRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC-- 277
WK N L +L+ + P +K + L I
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPA-EYRKMF------DRLSVFPPSAHIPTILLSLI 395
Query: 278 -SDDPRITCRKIVN--WKTCL--KFPEEPKIS--DEARDLICHLLCDVETRLGTRGVEEL 330
D + +VN K L K P+E IS +L + E L V+
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK--LENEYALHRSIVDHY 453
Query: 331 KEHPWFRGIQWDKL--------------YEMEAAYKPTVNGELDTQNFEKFPEVDGPPSE 376
+ D L + ++ + F V
Sbjct: 454 NIP---KTFDSDDLIPPYLDQYFYSHIGHHLKNIEH--------PERMTLFRMV------ 496
Query: 377 IPSVGPWRKMLTSKDTNFIGYTFKKSDVLKSLENSGTDMRSNGSSKVPSLISLLGRIDVQ 436
L D F+ +K + + T ++G S+++ L ++
Sbjct: 497 ---------FL---DFRFLE---QK------IRHDSTAWNASG-----SILNTLQQLKFY 530
Query: 437 ETAISECD 444
+ I + D
Sbjct: 531 KPYICDND 538
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 42/299 (14%), Positives = 81/299 (27%), Gaps = 71/299 (23%)
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE--DIINQETVSEA 211
+H Y ++DI D + +F CK ++D SIL ++E II +
Sbjct: 11 TGEHQYQYKDILSVFE--DA----FVDNFD-CKDVQDMPKSILSKEEIDHIIMSKDAVS- 62
Query: 212 EGQWMMPKERLQQW--KRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
W + + V + L+ Y + + I E
Sbjct: 63 -------GTLRLFWTLLSKQEEMVQKFVEEV--------LRINYK-----FLMSPIKTEQ 102
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEE 329
P I R + + F K + L + + E
Sbjct: 103 RQ---PSMMTRMYIEQRDRL-YNDNQVFA---KYNVSRLQPYLKL---------RQALLE 146
Query: 330 LKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTS 389
L+ + + + K T + + +I W L
Sbjct: 147 LRPAKNV------LIDGVLGSGK-TW---VALDVCLSYKVQCKMDFKIF----W---LN- 188
Query: 390 KDTNFIGYTFKKSDVLKSLENSGTDMRSNGSSKVPSLISLLGRIDVQETAISECDQQKQ 448
+ VL+ L+ + N +S+ ++ RI + + + K
Sbjct: 189 -----LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 55/280 (19%), Positives = 96/280 (34%), Gaps = 51/280 (18%)
Query: 41 EQLTL---IGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92
++L L +G+GAFG+V A T A+K LK+ + + SE +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 93 AEVDS-RCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
+ +V L + L +I+E+ G++ T L + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----RNEFVPYKTKGARF 135
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE--DKYSSILLEDEDIINQETV 208
+ D+K + + S F K L ++ + +D + E +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTV--------------------GTLDY------ 242
Q E L K R LA + DY
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 243 ------MAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPP 275
MAPE + + Y ++ D WS G +++E+ +G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 33/154 (21%), Positives = 57/154 (37%), Gaps = 18/154 (11%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIF---AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCI- 100
LIGKGA +++ I K + + + + E LA V I
Sbjct: 343 LIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIP 402
Query: 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYV 160
+ D D ++M Y+ G ++ ++ + + +H+++ +
Sbjct: 403 APYIFDV-DLDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE--------IVGKLHKNDVI 453
Query: 161 HRDIKPDNLILDKNGHLKLSDFGLCK---PLEDK 191
H D+ N I D L + DFGL K EDK
Sbjct: 454 HNDLTTSNFIFD--KDLYIIDFGLGKISNLDEDK 485
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.24 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.77 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.6 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.95 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.66 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.4 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.86 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.92 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 86.54 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 85.56 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-75 Score=571.24 Aligned_cols=279 Identities=35% Similarity=0.662 Sum_probs=255.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
.+...+||+++++||+|+||+||+|+++.+|+.||||++.+..+......+.+.+|+++|+.++|||||+++++|+++++
T Consensus 27 ~~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 27 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp CCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 45677899999999999999999999999999999999999887777788899999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|||||||+||+|.++|.+.+.++|.++++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999765321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
. ...+.+.||||.|||||++.+.+|+.++|||||||+||||++|
T Consensus 187 ~------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 230 (311)
T 4aw0_A 187 K------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230 (311)
T ss_dssp T------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHS
T ss_pred C------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 1 1224578999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC---CHHHHHcCCCcCCCCcccccccc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGIQWDKLYEME 348 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~---~~~eil~Hpff~~i~w~~l~~~~ 348 (450)
.+||.+.+..+++.+|.+. .+.+|. .+|++++|||++||+ ||.+|+++. +..+|++||||+++||+.|.+..
T Consensus 231 ~~PF~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~ 306 (311)
T 4aw0_A 231 LPPFRAGNEGLIFAKIIKL--EYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 306 (311)
T ss_dssp SCSSCCSSHHHHHHHHHHT--CCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSC
T ss_pred CCCCCCCCHHHHHHHHHcC--CCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCC
Confidence 9999999999999999874 356664 799999999999998 999999752 34568999999999999999877
Q ss_pred CCc
Q 013064 349 AAY 351 (450)
Q Consensus 349 ~p~ 351 (450)
||.
T Consensus 307 pP~ 309 (311)
T 4aw0_A 307 PPK 309 (311)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-72 Score=594.55 Aligned_cols=317 Identities=34% Similarity=0.613 Sum_probs=267.4
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH---hcCCCCeeeEEEEEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA---EVDSRCIVQLFYSFQ 108 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~---~l~hp~Iv~l~~~f~ 108 (450)
..+++++||+++++||+|+||+||+|+++.||+.||||+++|..+........+.+|+.++. .++|||||+++++|+
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 35899999999999999999999999999999999999999988776667777777766554 568999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+++++|||||||+||+|.++|.+.+.|+|..+++|++||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-cCCCCccccccchhHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-~~~y~~~~DiWSlGvily 267 (450)
... .+.+.||||.|||||++. +.+|+.++|||||||+||
T Consensus 343 ~~~----------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilY 382 (689)
T 3v5w_A 343 SKK----------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382 (689)
T ss_dssp SSC----------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred CCC----------------------------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence 432 134689999999999996 468999999999999999
Q ss_pred HHhhCCCCCCCCChh---hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCc
Q 013064 268 EMLIGYPPFCSDDPR---ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQW 341 (450)
Q Consensus 268 eml~G~~PF~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w 341 (450)
||++|.+||.+.+.. ++...+.. ..+.+| ..+|+++++||.+||+ ||.+|+|. .+++||++||||++|||
T Consensus 383 EmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 383 KLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp HHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred HHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 999999999875433 34445554 334555 4799999999999998 99999985 57999999999999999
Q ss_pred cccc--cccCCccccCCCcccCCCCCC--CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeC
Q 013064 342 DKLY--EMEAAYKPTVNGELDTQNFEK--FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKK 401 (450)
Q Consensus 342 ~~l~--~~~~p~~p~~~~~~d~~~f~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 401 (450)
+.|. ++.|||+|.+.+..++++||. |.+..... . .....++..|.||+|..
T Consensus 459 ~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~~~~--~-------~~~~~d~~~f~~Fs~~~ 513 (689)
T 3v5w_A 459 QMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKG--I-------KLLDSDQELYRNFPLTI 513 (689)
T ss_dssp HHHHTTCSCCSCCCCTTCSSTTBCCC---------CC--C-------CCCHHHHTTTTTCCEEC
T ss_pred HHHHcCCCCcCccCCCCCCCcCCCCCCccCCccccCC--C-------CCCchHHHHHhCCCccC
Confidence 9997 478999999888777777763 22211110 0 11123455788998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-73 Score=556.24 Aligned_cols=280 Identities=41% Similarity=0.746 Sum_probs=244.7
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
-+.++..++|++++.||+|+||+||+|++. .+++.||||++++..... .....+.+|+.+|+.++|||||+++++|
T Consensus 17 ~~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 17 GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp TCCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEE
T ss_pred ccccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 345677899999999999999999999984 478899999998765433 2334678899999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
++++.+|||||||+||+|.++|.+.+.++|.+++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
..... ....+.||||.|||||++.+.+|+.++|||||||++|
T Consensus 176 ~~~~~--------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvily 217 (304)
T 3ubd_A 176 SIDHE--------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMF 217 (304)
T ss_dssp -------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred ccCCC--------------------------------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHH
Confidence 53321 1234689999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCcccc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l 344 (450)
||++|.+||.+.+..+++.+|.+. .+.+|. .+|+++++||++||+ ||.+|+++. +++|+++||||+++||+.+
T Consensus 218 emltG~~PF~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l 293 (304)
T 3ubd_A 218 EMLTGTLPFQGKDRKETMTMILKA--KLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293 (304)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHhCCCCCCCcCHHHHHHHHHcC--CCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence 999999999999999999999874 355564 799999999999998 999999863 5899999999999999999
Q ss_pred c--cccCCccc
Q 013064 345 Y--EMEAAYKP 353 (450)
Q Consensus 345 ~--~~~~p~~p 353 (450)
. ++.|||+|
T Consensus 294 ~~~~~~pP~~P 304 (304)
T 3ubd_A 294 YRREIHPPFKP 304 (304)
T ss_dssp HTTCSCCSSCC
T ss_pred HhCCCCcCcCC
Confidence 6 47899988
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-68 Score=542.20 Aligned_cols=339 Identities=43% Similarity=0.803 Sum_probs=291.4
Q ss_pred HHHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEE
Q 013064 25 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF 104 (450)
Q Consensus 25 ~~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 104 (450)
......+..++..++|+++++||+|+||+||+|+++.+++.||||++++.........+.+.+|+.+|+.++|||||+++
T Consensus 56 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp HHHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred HHHHHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34455667788999999999999999999999999999999999999987766666667789999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 105 ~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
++|++++.+|+|||||+||+|.+++.+ ..+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+
T Consensus 136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 136 YAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999999999999865 4699999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC----CCcccccc
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG----YGMECDWW 260 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~----y~~~~DiW 260 (450)
|+....... ..+.+.+||+.|+|||++.+.+ |+.++|||
T Consensus 215 a~~~~~~~~-------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~Diw 257 (410)
T 3v8s_A 215 CMKMNKEGM-------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257 (410)
T ss_dssp CEECCTTSE-------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHH
T ss_pred eEeeccCCc-------------------------------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEe
Confidence 987543210 1123679999999999998766 88999999
Q ss_pred chhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCC
Q 013064 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
||||++|||++|.+||.+.+...++.+|+++...+.+|....+|+++++||++||+++.+|+|+.+++||++||||++++
T Consensus 258 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 258 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred cchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999999877777888777899999999999999666666666899999999999999
Q ss_pred ccccc--cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCccc
Q 013064 341 WDKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 405 (450)
Q Consensus 341 w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 405 (450)
|+.+. ++.|||+|.+.++.|++||+.+++........+. .......+..|.||||.+....
T Consensus 338 w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~~----~~~~~~~~~~f~~f~~~~~~~~ 400 (410)
T 3v8s_A 338 WAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPI----PKAFVGNQLPFVGFTYYSNRRY 400 (410)
T ss_dssp CCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCCC----CSSCCCTTGGGTTCCEECC---
T ss_pred HHHHhhcccCCCCCCcCCCccchhhcCCccccccccccCCC----chhhcccccccccceEeCcccc
Confidence 87654 6889999999999999999987755433222111 1122345678999999987544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-68 Score=541.72 Aligned_cols=345 Identities=42% Similarity=0.774 Sum_probs=285.5
Q ss_pred HHHHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeE
Q 013064 24 ETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQL 103 (450)
Q Consensus 24 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l 103 (450)
+....++++.++..++|+++++||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|..++||||+++
T Consensus 47 ~~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l 126 (412)
T 2vd5_A 47 EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126 (412)
T ss_dssp HHHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred hhhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 34456677788999999999999999999999999999999999999998776666677789999999999999999999
Q ss_pred EEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 104 ~~~f~~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
+++|++.+++|+||||++||+|.+++.+. ..++++.+++|++||+.||+|||++||+||||||+|||++.+|++||+||
T Consensus 127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999999999875 48999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-------cCCCCc
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-------KKGYGM 255 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-------~~~y~~ 255 (450)
|+|+....... ....+.+||+.|+|||++. ...|+.
T Consensus 207 Gla~~~~~~~~-------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~ 249 (412)
T 2vd5_A 207 GSCLKLRADGT-------------------------------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGP 249 (412)
T ss_dssp TTCEECCTTSC-------------------------------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECT
T ss_pred hhheeccCCCc-------------------------------------cccceeccccCcCCHHHHhhcccCcCCCCCCh
Confidence 99987643210 0123469999999999997 356899
Q ss_pred cccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCC-CCCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCC
Q 013064 256 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLCDVETRLGTRGVEELKEHP 334 (450)
Q Consensus 256 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hp 334 (450)
++|||||||++|||++|.+||.+.+..+++.+|+++...+.+|. ...+|+++++||++||++|.+|+|+.+++||++||
T Consensus 250 ~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 250 ECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSG
T ss_pred HHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCC
Confidence 99999999999999999999999999999999988665566663 24799999999999999999999888899999999
Q ss_pred CcCCCCccccccccCCccccCCCcccCCCCCCCCCCCCCCCC--CCCCCccc-ccCCCcCCCcCCceeeCCccc
Q 013064 335 WFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSE--IPSVGPWR-KMLTSKDTNFIGYTFKKSDVL 405 (450)
Q Consensus 335 ff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~f~~~~~~~~~~~ 405 (450)
||++++|+.+.+..|||+|.+.++.|++||+.+.+....... ........ ......+..|.||||.+....
T Consensus 330 ff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~ 403 (412)
T 2vd5_A 330 FFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALR 403 (412)
T ss_dssp GGTTCCSTTSTTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCCCCC
T ss_pred CcCCCCHHHHhhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccCcccc
Confidence 999999999999999999999999999999975432211100 00000000 111234568999999986543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-67 Score=539.75 Aligned_cols=340 Identities=46% Similarity=0.836 Sum_probs=286.1
Q ss_pred HHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 29 ~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
.....++..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|..++||||++++++|+
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45556788899999999999999999999999999999999999877666666667899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+.+.+|+|||||+||+|.+++.+ .+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 57899999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccch
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSL 262 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSl 262 (450)
...... ....+.+||+.|+|||++. ...|+.++|||||
T Consensus 225 ~~~~~~-------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl 267 (437)
T 4aw2_A 225 LMEDGT-------------------------------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267 (437)
T ss_dssp CCTTSC-------------------------------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred cccCCC-------------------------------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence 543211 0123469999999999997 4568999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCC-CCCCHHHHHHHHHhhcCccccCCCCCHHHHHcCCCcCCCCc
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE-PKISDEARDLICHLLCDVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dli~~lL~dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
||++|||++|.+||.+.+..+++.+|+++...+.+|.. ..+|+++++||++||+.+.+|+++.+++||++||||++++|
T Consensus 268 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 268 GVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp HHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred HHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 99999999999999999999999999887666777753 46899999999999995556666668999999999999999
Q ss_pred cccccccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCccccc
Q 013064 342 DKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLKS 407 (450)
Q Consensus 342 ~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 407 (450)
+.+.+..|||+|.+.++.|++||+...+........+. +......+.+..|.||||.++....+
T Consensus 348 ~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~~~--~~~~~~~~~~~~f~~~~~~~~~~~~~ 411 (437)
T 4aw2_A 348 DNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPP--PTHTAFSGHHLPFVGFTYTSSCVLSD 411 (437)
T ss_dssp TTGGGSCCSCCCCCSSTTCCTTSCCC--------------------CCTTGGGTTCCEESSCTTST
T ss_pred HHHhhCCCCCCCcCCCccchhhcCCcccccccccCCCC--CccccccccCccccCCCcCCchhhcc
Confidence 99999999999999999999999875432221111111 11112234567899999998865543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-68 Score=511.35 Aligned_cols=255 Identities=31% Similarity=0.566 Sum_probs=217.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||+++++|++++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 58999999999999999999999999999999999987766666778899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||| +|+|.+++.+++.+++.+++.|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----- 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG----- 165 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-----
Confidence 9999 7899999999999999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G~~P 275 (450)
....+.||||.|||||++.+.+| +.++|||||||++|+|++|++|
T Consensus 166 ----------------------------------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~P 211 (275)
T 3hyh_A 166 ----------------------------------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 211 (275)
T ss_dssp -------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------------------------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCC
Confidence 11235799999999999998887 6899999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|.+.+..+++.+|.+. ...+| ..+|+++++||.+||. ||.+|+ +++|+++||||+.
T Consensus 212 F~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hpw~k~ 268 (275)
T 3hyh_A 212 FDDESIPVLFKNISNG--VYTLP--KFLSPGAAGLIKRMLIVNPLNRI---SIHEIMQDDWFKV 268 (275)
T ss_dssp SCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHCHHHHT
T ss_pred CCCCCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHccCChhHCc---CHHHHHcCccccc
Confidence 9999998888888874 34555 4799999999999998 999999 6999999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-67 Score=523.53 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=230.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||+|+||+||+|+++.||+.||||++++... ...+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999987643 23456789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+++.+ +.++|++++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----- 224 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 224 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-----
Confidence 99999999998865 569999999999999999999999999999999999999999999999999998765321
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
....+.||||.|||||++.+.+|+.++|||||||++|||++|.+||.
T Consensus 225 ---------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 225 ---------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp ---------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 11346899999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+.+..+.+..|... ....++.+..+|++++|||.+||+ ||.+|+ +++|+++||||+..
T Consensus 272 ~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 272 NEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 330 (346)
T ss_dssp TSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhcCC
Confidence 99998888888653 223344445799999999999998 999999 69999999999763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-67 Score=525.66 Aligned_cols=258 Identities=28% Similarity=0.509 Sum_probs=227.4
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
++++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 56899999999999999999999999999999999988754 34457889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 116 IMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|||||+||+|.++|... ..++|.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999999754 457999999999999999999999999999999999999999999999999999764320
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
..+.+.||||.|||||++.+.+|+.++|||||||+||||++|.
T Consensus 180 -------------------------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~ 222 (350)
T 4b9d_A 180 -------------------------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222 (350)
T ss_dssp -------------------------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 1123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+||.+.+..+++.+|.+.... |.+..+|+++++||.+||. ||.+|+ +++|+++||||+.
T Consensus 223 ~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 223 HAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGFIAK 282 (350)
T ss_dssp CSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHT
T ss_pred CCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHHhhc
Confidence 999999999999999874321 2235799999999999998 999999 7999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-67 Score=524.66 Aligned_cols=328 Identities=33% Similarity=0.655 Sum_probs=275.0
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD 109 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~ 109 (450)
...++.+++|+++++||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|..+ +||||++++++|++
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 95 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT 95 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence 34568899999999999999999999999999999999999988776777888999999999988 79999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+.+|+|||||+||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998643
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... ....+.|||+.|+|||++.+..|+.++|||||||++|||
T Consensus 176 ~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 217 (353)
T 3txo_A 176 CNG--------------------------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217 (353)
T ss_dssp C-----------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHH
T ss_pred cCC--------------------------------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHH
Confidence 221 112357999999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CCHHHHHcCCCcCCCCccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l~ 345 (450)
++|.+||.+.+..+++.+|.+. ...+|. .+++++++||++||+ ||.+|+++ .++++|++||||++++|+.+.
T Consensus 218 l~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~ 293 (353)
T 3txo_A 218 LCGHAPFEAENEDDLFEAILND--EVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLN 293 (353)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHh
Confidence 9999999999999999999874 355564 799999999999998 99999986 456999999999999999986
Q ss_pred --cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCcc
Q 013064 346 --EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDV 404 (450)
Q Consensus 346 --~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~ 404 (450)
++.|||+|.+++..|++||+. |........+. ... .+....+..|.||+|.++..
T Consensus 294 ~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~-~~~---~~~~~~~~~f~~f~~~~~~~ 351 (353)
T 3txo_A 294 HRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPI-DEG---HLPMINQDEFRNFEYVSPEL 351 (353)
T ss_dssp TTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCC-CTT---SGGGSCGGGGTTCCEECC--
T ss_pred cCcCCCCccCCCCCcccccccCcccccCCCcCCCc-ccc---ccCcccccccCCceeeCccc
Confidence 478999999999999999985 33222111111 111 11122346899999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=518.58 Aligned_cols=327 Identities=37% Similarity=0.648 Sum_probs=278.4
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
++++++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|+.++||||++++++|++.+.+
T Consensus 1 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence 46789999999999999999999999999999999999988766667788999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999998643221
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....+.+||+.|+|||++.+.+|+.++|||||||++|||++|.
T Consensus 160 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 202 (337)
T 1o6l_A 160 -------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp -------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCC
Confidence 1123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--ccc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EME 348 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~ 348 (450)
+||.+.+....+..|... ...+|. .+|+++++||.+||. ||.+|+|. .++++|++||||++++|+.+. .+.
T Consensus 203 ~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~ 278 (337)
T 1o6l_A 203 LPFYNQDHERLFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp CSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCC
Confidence 999999988888888763 455664 799999999999998 99999975 379999999999999999986 478
Q ss_pred CCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccC---CCcCCCcCCceeeCC
Q 013064 349 AAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKML---TSKDTNFIGYTFKKS 402 (450)
Q Consensus 349 ~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~f~~~~~~~~ 402 (450)
|||+|.+.++.|+++|+. |+.......+.........+. ...+..|.||+|.+.
T Consensus 279 pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 279 PPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp CSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred CCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 999999999999999985 433221111100001111111 124568999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-67 Score=531.20 Aligned_cols=328 Identities=31% Similarity=0.645 Sum_probs=271.9
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 111 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 111 (450)
..+++++|+++++||+|+||+||+|+++.+++.||||++++.........+.+.+|+.+|..+ +|||||+++++|++.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 468889999999999999999999999999999999999988766666777899999999887 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999863321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
. ....+.|||+.|+|||++.+.+|+.++|||||||++|||++
T Consensus 207 ~--------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~ 248 (396)
T 4dc2_A 207 G--------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248 (396)
T ss_dssp T--------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 0 11346799999999999999999999999999999999999
Q ss_pred CCCCCCCCC---------hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CCHHHHHcCCCcCC
Q 013064 272 GYPPFCSDD---------PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFRG 338 (450)
Q Consensus 272 G~~PF~~~~---------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~---~~~~eil~Hpff~~ 338 (450)
|.+||.+.. ....+..|.. ..+.+|. .+|+++++||++||+ ||.+|+++ .++++|++||||++
T Consensus 249 G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 249 GRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCCCCcccccccccchhhHHHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999996432 2234455554 3455664 799999999999998 99999986 35899999999999
Q ss_pred CCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCcccc
Q 013064 339 IQWDKLY--EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 406 (450)
Q Consensus 339 i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~ 406 (450)
++|+.+. ++.|||+|.+.++.|++||+. |+.... ...+.... .+....+..|.||+|.++..+.
T Consensus 325 i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~--~~~~~~~~--~~~~~~~~~f~~f~~~~~~~~~ 391 (396)
T 4dc2_A 325 VDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPV--QLTPDDDD--IVRKIDQSEFEGFEYINPLLMS 391 (396)
T ss_dssp CCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCC--CCCCCCHH--HHTTSCGGGGTTCCEECC----
T ss_pred CCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCC--ccCCCcch--hhccccccccCCcEeECccccc
Confidence 9999987 478999999999999999996 433221 11111111 1112245689999999986654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-66 Score=522.62 Aligned_cols=329 Identities=35% Similarity=0.647 Sum_probs=278.0
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD 109 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~ 109 (450)
...++.+++|+++++||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|..+ +||||++++++|++
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 92 (353)
T 2i0e_A 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 92 (353)
T ss_dssp ------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred CcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence 34568899999999999999999999999999999999999988766667788899999999987 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+.+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... ....+.+||+.|+|||++.+.+|+.++|||||||++|||
T Consensus 173 ~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (353)
T 2i0e_A 173 WDG--------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214 (353)
T ss_dssp CTT--------------------------------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHH
T ss_pred cCC--------------------------------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHH
Confidence 211 112357999999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc-
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY- 345 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~- 345 (450)
++|.+||.+.+..+++.+|... .+.+|. .+|+++++||++||+ ||.+|++. .++++|++||||++++|+.+.
T Consensus 215 l~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~ 290 (353)
T 2i0e_A 215 LAGQAPFEGEDEDELFQSIMEH--NVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 290 (353)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHT
T ss_pred HcCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHh
Confidence 9999999999999999998874 355664 799999999999998 99999985 368999999999999999996
Q ss_pred -cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCccc
Q 013064 346 -EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 405 (450)
Q Consensus 346 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 405 (450)
++.|||+|.+.+. |++||+.+.+...+... +. .. ..+....+..|.||+|.+++..
T Consensus 291 ~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~-~~-~~-~~~~~~~~~~f~~f~~~~~~~~ 347 (353)
T 2i0e_A 291 KEIQPPYKPKACGR-NAENFDRFFTRHPPVLT-PP-DQ-EVIRNIDQSEFEGFSFVNSEFL 347 (353)
T ss_dssp TCSCCSCCCCCCCC---CHHHHHHHHSCCCCC-CC-CH-HHHHHSCTTTTCSCCEECTTCC
T ss_pred CCCCCCcCCCCCCc-chhhccchhccCCcccC-Cc-cc-cccccccccccCCCeeeCcccc
Confidence 5789999999988 99999864322211111 11 00 0011124568999999988654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-66 Score=524.17 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=230.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||+|+||.||+|+++.||+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999986543 23456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|.+++.. +.++|++++.|+.||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----- 301 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 301 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-----
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-----
Confidence 99999999998865 569999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
....+.||||.|||||++.+.+|+.++|||||||++|||++|.+||.
T Consensus 302 ---------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 302 ---------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp ---------------------------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 11346899999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+.+..+.+..|... ....++....+|+++++||.+||+ ||.+|+ +++|+++||||+..
T Consensus 349 ~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 349 NEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 407 (423)
T ss_dssp TSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHHhcCC
Confidence 99998888888653 223344446899999999999998 999999 69999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=513.04 Aligned_cols=326 Identities=35% Similarity=0.646 Sum_probs=252.8
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
..++.+++|+++++||+|+||.||+|+++.+|+.||||++++.........+.+..|+.+|..+ +||||++++++|++.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 4568899999999999999999999999999999999999988766666788899999999877 999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+.+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ....+.+||+.|+|||++.+.+|+.++|||||||++|||+
T Consensus 171 ~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 212 (345)
T 1xjd_A 171 GD--------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212 (345)
T ss_dssp TT--------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CC--------------------------------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHh
Confidence 11 1123579999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc--cc
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EM 347 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~ 347 (450)
+|.+||.+.+..+++.+|... ...+|. .+|+++++||.+||+ ||.+|++.. ++|++||||++++|+.+. ++
T Consensus 213 ~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dp~~R~~~~--~~i~~hp~f~~~~w~~l~~~~~ 286 (345)
T 1xjd_A 213 IGQSPFHGQDEEELFHSIRMD--NPFYPR--WLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEI 286 (345)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCS
T ss_pred cCCCCCCCCCHHHHHHHHHhC--CCCCCc--ccCHHHHHHHHHHhcCCHhHcCCCh--HHHHcCccccCCCHHHHhhCCC
Confidence 999999999998888888764 344553 799999999999998 999999642 389999999999999996 47
Q ss_pred cCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCccc
Q 013064 348 EAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVL 405 (450)
Q Consensus 348 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 405 (450)
.|||+|.+.++.|++||+. |........ ..... ......+..|.||+|.++...
T Consensus 287 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~-~~~~~---~~~~~~~~~f~~f~~~~~~~~ 341 (345)
T 1xjd_A 287 DPPFRPKVKSPFDCSNFDKEFLNEKPRLS-FADRA---LINSMDQNMFRNFSFMNPGME 341 (345)
T ss_dssp CC------------------------------------------CCTTTTCCC------
T ss_pred CCCcCCCCCCcchhhhcchhhcccCccCC-ccccc---ccccccccccCCCeeeChhhh
Confidence 8999999999999999996 543321111 10000 011224568999999886543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-65 Score=518.17 Aligned_cols=329 Identities=38% Similarity=0.674 Sum_probs=247.2
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEcCC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-LAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~f~~~~ 111 (450)
.++..++|+++++||+|+||+||+|+++.+++.||||++++..........++.+|+.+ ++.++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45788999999999999999999999999999999999999877766777788889887 57789999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999863321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
. ....+.+||+.|+|||++.+.+|+.++|||||||++|||++
T Consensus 193 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 234 (373)
T 2r5t_A 193 N--------------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234 (373)
T ss_dssp C--------------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc
Confidence 1 11336799999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC-CCHHHHHcCCCcCCCCccccc--cc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT-RGVEELKEHPWFRGIQWDKLY--EM 347 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~--~~ 347 (450)
|.+||.+.+..+++.+|+.. .+.+| ..+++++++||.+||+ ||.+|+++ .++++|++||||++++|+.+. ++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~ 310 (373)
T 2r5t_A 235 GLPPFYSRNTAEMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI 310 (373)
T ss_dssp SSCTTCCSBHHHHHHHHHHS--CCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CCCCCCCCCHHHHHHHHHhc--ccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCC
Confidence 99999999999999999874 34555 4799999999999998 99999987 358999999999999999996 47
Q ss_pred cCCccccCCCcccCCCCCC-CCCCCCCCCCC--CCCCcccccCCCcCCCcCCceeeCCc
Q 013064 348 EAAYKPTVNGELDTQNFEK-FPEVDGPPSEI--PSVGPWRKMLTSKDTNFIGYTFKKSD 403 (450)
Q Consensus 348 ~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~f~~~~~~~~~ 403 (450)
.|||+|.+.++.|++||+. |+....+.... +............+..|.||||.++.
T Consensus 311 ~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 369 (373)
T 2r5t_A 311 TPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPT 369 (373)
T ss_dssp CCSCCCSCCC-------------------------------------------------
T ss_pred CCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCch
Confidence 8999999999999999995 54432211110 00000011112235679999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-64 Score=497.70 Aligned_cols=293 Identities=42% Similarity=0.855 Sum_probs=255.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
++++++|++++.||+|+||.||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||++++++|++...+
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 46789999999999999999999999999999999999987766666788899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||++||+|.+++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999865331
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
..+.+||+.|+|||++.+.+|+.++|||||||++|||++|.
T Consensus 160 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 200 (318)
T 1fot_A 160 ---------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200 (318)
T ss_dssp ---------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCC
Confidence 23579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--ccc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EME 348 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~ 348 (450)
+||.+.+....+.+|.+. .+.+| ..+++++++||++||. ||.+|++. .++++|++||||++++|+.+. .+.
T Consensus 201 ~pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~ 276 (318)
T 1fot_A 201 TPFYDSNTMKTYEKILNA--ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE 276 (318)
T ss_dssp CTTCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSC
T ss_pred CCCCCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCC
Confidence 999999998899888874 35556 3789999999999998 99999975 379999999999999999986 478
Q ss_pred CCccccCC-CcccCCCCCCCCCCC
Q 013064 349 AAYKPTVN-GELDTQNFEKFPEVD 371 (450)
Q Consensus 349 ~p~~p~~~-~~~d~~~f~~~~~~~ 371 (450)
|||.|.+. +..|+++|+.+++..
T Consensus 277 ~p~~p~~~~~~~d~~~f~~~~~~~ 300 (318)
T 1fot_A 277 TPYEPPIQQGQGDTSQFDKYPEED 300 (318)
T ss_dssp CSCCCCC----------------C
T ss_pred CCCCCCcCCCccchhhcCCCCccc
Confidence 99999998 589999999887653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-63 Score=500.24 Aligned_cols=297 Identities=38% Similarity=0.772 Sum_probs=272.1
Q ss_pred HHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 29 ~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
........+++|++++.||+|+||.||+|+++.+|+.||||++.+.........+++.+|+.+|+.++||||++++++|+
T Consensus 32 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp SCCCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 33455688899999999999999999999999999999999999887666677889999999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+.+.+|+||||++||+|.+++.+.+.+++..++.|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence 99999999999999999999999889999999999999999999999999999999999999999999999999999865
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
... ..+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 192 ~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 230 (350)
T 1rdq_E 192 KGR-----------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230 (350)
T ss_dssp SSC-----------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred cCC-----------------------------------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhH
Confidence 432 225789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~ 345 (450)
|++|.+||.+.+..+.+.+|... .+.+|. .+++++++||.+||+ ||.+|++. .++++|++||||++++|+.+.
T Consensus 231 ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~ 306 (350)
T 1rdq_E 231 MAAGYPPFFADQPIQIYEKIVSG--KVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306 (350)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHh
Confidence 99999999999998999888874 345554 799999999999998 99999973 358999999999999999987
Q ss_pred --cccCCccccCCCcccCCCCCCCCCC
Q 013064 346 --EMEAAYKPTVNGELDTQNFEKFPEV 370 (450)
Q Consensus 346 --~~~~p~~p~~~~~~d~~~f~~~~~~ 370 (450)
.+.|||+|.+.++.|+++|+.|++.
T Consensus 307 ~~~~~~p~~p~~~~~~~~~~f~~~~~~ 333 (350)
T 1rdq_E 307 QRKVEAPFIPKFKGPGDTSNFDDYEEE 333 (350)
T ss_dssp TTCSCCSCCCCCCSTTCCTTSCCCCCC
T ss_pred hccCCCCCCCCCCCccccccccccccc
Confidence 4789999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-65 Score=502.25 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=223.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
...++|++.++||+|+||+||+|+++.+|+.||||++++.... .+|+.+|+.++|||||+++++|++++.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3457899999999999999999999999999999999875432 36999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~~~~ 193 (450)
||||||+||+|.++|.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999999999999999999999999999999999999999999999999998 699999999997654211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.. ......+.||||.|||||++.+.+|+.++|||||||+||||++|.
T Consensus 207 ~~---------------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 253 (336)
T 4g3f_A 207 GK---------------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253 (336)
T ss_dssp ----------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cc---------------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence 00 001123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccc-cCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHH-------------HcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCL-KFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL-------------KEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei-------------l~Hpff~~ 338 (450)
+||.+.+..+++.+|......+ .+| +.+|+++++||.+||. ||.+|+ ++.|| ++|||+..
T Consensus 254 ~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~---sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 254 HPWTQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRA---SAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp CSSTTTCCSCCHHHHHHSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred CCCCCCCHHHHHHHHHcCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 9999999888888888754332 234 4799999999999998 999999 67887 46777754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-64 Score=504.69 Aligned_cols=325 Identities=32% Similarity=0.651 Sum_probs=275.1
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
..++++++|++++.||+|+||.||+|+++.+|+.||||++++.........+.+.+|+.+|..+ +||||++++++|++.
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 3567889999999999999999999999999999999999988776677788899999999987 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+.+|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ....+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 163 ~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 204 (345)
T 3a8x_A 163 PG--------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204 (345)
T ss_dssp TT--------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CC--------------------------------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHH
Confidence 10 1123579999999999999999999999999999999999
Q ss_pred hCCCCCCCC---------ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC---CCHHHHHcCCCcC
Q 013064 271 IGYPPFCSD---------DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT---RGVEELKEHPWFR 337 (450)
Q Consensus 271 ~G~~PF~~~---------~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~---~~~~eil~Hpff~ 337 (450)
+|.+||... +....+..|.. ....+|. .+|+++++||.+||. ||.+|+++ .++++|++||||+
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp HSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred hCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 999999752 23334555554 2345553 799999999999998 99999986 2579999999999
Q ss_pred CCCccccc--cccCCccccCCCcccCCCCCC-CCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCC
Q 013064 338 GIQWDKLY--EMEAAYKPTVNGELDTQNFEK-FPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKS 402 (450)
Q Consensus 338 ~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~ 402 (450)
+++|+.+. +..|||+|.+.++.|+++|+. |....... .+. .. .......+..|.||+|.++
T Consensus 281 ~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-~~-~~~~~~~~~~f~~f~~~~~ 344 (345)
T 3a8x_A 281 NVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQL--TPD-DD-DIVRKIDQSEFEGFEYINP 344 (345)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSC--CCC-CH-HHHTTSCGGGGTTCCEECC
T ss_pred CCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccC--CCc-cc-cccccccccccCCCEeeCC
Confidence 99999986 478999999999999999985 43322111 111 10 0011224568999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-64 Score=489.07 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=219.7
Q ss_pred CCe-EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCe
Q 013064 38 DDF-EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----SDF 112 (450)
Q Consensus 38 ~~f-~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~~~ 112 (450)
.+| .+.+.||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+.+|+.++|||||+++++|++ +..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 345 677889999999999999999999999999987654 34456789999999999999999999999976 457
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEc-cCCceEEeeccccccCc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILD-KNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld-~~g~ikL~DFGla~~~~ 189 (450)
+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|++||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999999999999999999999999999999998 99999999999998 48999999999998543
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
.. .+.+.||||.|||||++.+ +|+.++|||||||+||||
T Consensus 184 ~~----------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyel 222 (290)
T 3fpq_A 184 AS----------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222 (290)
T ss_dssp TT----------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred CC----------------------------------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHH
Confidence 21 1346799999999999865 699999999999999999
Q ss_pred hhCCCCCCCCCh-hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 270 LIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 270 l~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|.+||.+.+. ..++..+........++ ..+++++++||.+||. ||.+|+ +++|+++||||++
T Consensus 223 ltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~---s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 223 ATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQE 288 (290)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC-
T ss_pred HHCCCCCCCCCcHHHHHHHHHcCCCCCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccC
Confidence 999999987554 44555555533333333 4689999999999998 999999 7999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-64 Score=546.57 Aligned_cols=329 Identities=35% Similarity=0.646 Sum_probs=283.5
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
+..+.+++|+++++||+|+||+||+|+++.+++.||||++++.........+.+..|+.+|..+ +||+|++++++|++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3467889999999999999999999999999999999999988766677788899999999987 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+.+||||||++||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ....+.+||+.|+|||++.+.+|+.++|||||||+||||+
T Consensus 495 ~~--------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyell 536 (674)
T 3pfq_A 495 DG--------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536 (674)
T ss_dssp TT--------------------------------------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHH
T ss_pred CC--------------------------------------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHH
Confidence 21 1133679999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY-- 345 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~-- 345 (450)
+|.+||.+.+..+++.+|+.. .+.+|. .+|+++++||++||. ||.+|++. .++++|++||||+++||+.+.
T Consensus 537 tG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~ 612 (674)
T 3pfq_A 537 AGQAPFEGEDEDELFQSIMEH--NVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 612 (674)
T ss_dssp HSSCSSCCSSHHHHHHHHHSS--CCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTT
T ss_pred cCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhC
Confidence 999999999999999999874 456664 799999999999998 99999986 457999999999999999997
Q ss_pred cccCCccccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCCcCCCcCCceeeCCcccc
Q 013064 346 EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTSKDTNFIGYTFKKSDVLK 406 (450)
Q Consensus 346 ~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~ 406 (450)
++.|||+|.+.+ .|++|||.+.+...+....+.. ..+....+..|.||+|.++.++.
T Consensus 613 ~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~---~~~~~~~~~~f~~f~~~~~~~~~ 669 (674)
T 3pfq_A 613 EIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQ---EVIRNIDQSEFEGFSFVNSEFLK 669 (674)
T ss_dssp CSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCH---HHHTTCCGGGGTTCCEECSSCCC
T ss_pred CCCCCCCCcCCC-CchhhcCchhccCCCccCCCch---hhhhcccccccCCCcccChhhhc
Confidence 478999999988 8999999865543322211111 11122345689999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=499.70 Aligned_cols=265 Identities=23% Similarity=0.396 Sum_probs=226.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc------CC
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------SD 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~~ 111 (450)
++|++++.||+|+||+||+|+++.||+.||||++++.. ......+.+.+|+.+|+.++|||||++++++.+ .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999999999999999997654 334456788999999999999999999999764 46
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|||||||. |+|.+++.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 8999999995 689999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml 270 (450)
... ......+.|||+.|||||++.+. .|+.++|||||||++|||+
T Consensus 212 ~~~----------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 212 PAE----------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp --------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred ccc----------------------------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 100 01223468999999999999875 5699999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhccccccc------------------CCC---------CCCCCHHHHHHHHHhhc-CccccC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLK------------------FPE---------EPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~------------------~p~---------~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+|++||.+.+..+++.+|........ +|. .+.+|++++|||++||+ ||.+|+
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 99999999999888888764321110 111 13579999999999999 999999
Q ss_pred CCCCHHHHHcCCCcCCCCc
Q 013064 323 GTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~i~w 341 (450)
+++|+|+||||+....
T Consensus 338 ---ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 338 ---SAAAALRHPFLAKYHD 353 (398)
T ss_dssp ---CHHHHTTSGGGTTTCC
T ss_pred ---CHHHHhcCHhhCcCCC
Confidence 7999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-62 Score=480.95 Aligned_cols=267 Identities=24% Similarity=0.418 Sum_probs=205.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC------
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD------ 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~------ 111 (450)
+||++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 58999999999999999999999999999999997653 3344577899999999999999999999997644
Q ss_pred ------eEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 112 ------FLYLIMEYLPGGDIMTLLMREDIL---SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 112 ------~lylVmEy~~gg~L~~~l~~~~~~---~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
++|+|||||+||+|.+++...+.+ ++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 489999999999999999877654 45678999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|+|+.+......... ... ........+.||||.|||||++.+.+|+.++|||||
T Consensus 163 Gla~~~~~~~~~~~~----------~~~----------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl 216 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV----------LTP----------------MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSL 216 (299)
T ss_dssp CCC----------------------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHH
T ss_pred ccceecCCCcccccc----------ccc----------------cccccccCCcccCccccCHHHHcCCCCCCHHHHHHH
Confidence 999987543111000 000 000112346799999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChh-hhhhhhhcccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 263 GAIMYEMLIGYPPFCSDDPR-ITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~-~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||++|||++ ||.+.... .....+.+ ..+|. ....++.+++||++||. ||.+|| +++|+++||||+++
T Consensus 217 Gvilyell~---Pf~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eil~h~~~~~~ 286 (299)
T 4g31_A 217 GLILFELLY---PFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHHHS---CCSSHHHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGCCC
T ss_pred HHHHHHHcc---CCCCccHHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCCC
Confidence 999999996 88654321 22333332 23332 13467889999999998 999999 68999999999999
Q ss_pred Ccc
Q 013064 340 QWD 342 (450)
Q Consensus 340 ~w~ 342 (450)
+|.
T Consensus 287 ~~p 289 (299)
T 4g31_A 287 DFP 289 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-62 Score=515.27 Aligned_cols=264 Identities=30% Similarity=0.512 Sum_probs=237.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|+++..+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 579999999999999999999999999999999997653 23456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC--CceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--GHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~--g~ikL~DFGla~~~~~~~~ 193 (450)
||||+||+|+++|.+ .+.++|.+++.|++||+.||+|||++||+||||||+|||++.+ |++||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999999864 4689999999999999999999999999999999999999854 899999999999765431
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
...+.|||+.|||||++.+.+|+.++|||||||++|||++|.
T Consensus 312 --------------------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~ 353 (573)
T 3uto_A 312 --------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353 (573)
T ss_dssp --------------------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred --------------------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
+||.+.+..+++.+|......+..+.+..+|++++|||++||+ ||.+|+ +++|+++||||+..+|....
T Consensus 354 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~---t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 354 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp CSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTSCCCCTTTT
T ss_pred CCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcCcCCCCCCCch
Confidence 9999999999999998755444444446799999999999998 999999 68999999999999987644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-61 Score=483.42 Aligned_cols=282 Identities=28% Similarity=0.431 Sum_probs=212.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~l 113 (450)
++|++++.||+|+||+||+|+++ .+++.||+|++.+.. ....+.+|+++|+.+ +|||||+++++|++++++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 67999999999999999999985 467899999986542 345688999999988 699999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-CceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~-g~ikL~DFGla~~~~~~~ 192 (450)
|+|||||+||+|.+++ +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999998 359999999999999999999999999999999999999876 899999999998765432
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~ 271 (450)
.... .+............ ........++....+.||||.|||||++.+. .|+.++||||+||++|||++
T Consensus 173 ~~~~----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 173 IELL----KFVQSEAQQERCSQ------NKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp CGGG----GGC--------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred cccc----cccccccccccccc------ccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 1110 00000000000000 0000000112234567999999999999875 58999999999999999999
Q ss_pred CCCCCCCC-Chhhhhhhhhcccc--------------------------------------------------cccCCCC
Q 013064 272 GYPPFCSD-DPRITCRKIVNWKT--------------------------------------------------CLKFPEE 300 (450)
Q Consensus 272 G~~PF~~~-~~~~~~~~i~~~~~--------------------------------------------------~~~~p~~ 300 (450)
|++||.+. +..+.+.+|..... ....+.+
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99999654 44344433321000 0011123
Q ss_pred CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 301 PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 301 ~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
..+|++++|||++||+ ||.+|+ +++|+++||||++++
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~---ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRI---TAEEALLHPFFKDMS 360 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGTTC-
T ss_pred ccCCHHHHHHHHHHCcCChhHCc---CHHHHhcCcccCCCC
Confidence 4689999999999999 999999 699999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=496.18 Aligned_cols=287 Identities=35% Similarity=0.667 Sum_probs=253.6
Q ss_pred HHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 013064 27 YMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 106 (450)
Q Consensus 27 ~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 106 (450)
+..+.+.++..++|+++++||+|+||.||+|+++.+|+.||||++.+..+........+.+|+.+|+.++|||||+++++
T Consensus 173 ~~~l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp HHHHHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 34456778999999999999999999999999999999999999998877666677889999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
|++.+.+|+||||++||+|..++...+ .+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccc
Confidence 999999999999999999999998754 499999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
|+.+.... ...+.+||+.|+|||++.+.+|+.++|||||||
T Consensus 333 a~~~~~~~---------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGv 373 (576)
T 2acx_A 333 AVHVPEGQ---------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373 (576)
T ss_dssp CEECCTTC---------------------------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHH
T ss_pred ceecccCc---------------------------------------cccccCCCccccCHHHHcCCCCCccchHHHHHH
Confidence 98754321 112468999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCh----hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcC
Q 013064 265 IMYEMLIGYPPFCSDDP----RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFR 337 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~ 337 (450)
++|||++|.+||.+.+. ..+...+.. ....+| ..+|+++++||++||+ ||.+|+|.. +++||++||||+
T Consensus 374 ilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 374 LLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp HHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred HHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 99999999999987643 334444443 233444 4799999999999999 999999864 689999999999
Q ss_pred CCCccccc--cccCCccccCC
Q 013064 338 GIQWDKLY--EMEAAYKPTVN 356 (450)
Q Consensus 338 ~i~w~~l~--~~~~p~~p~~~ 356 (450)
+++|+.+. .+.|||+|...
T Consensus 450 ~i~w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 450 KLNFKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp TCCHHHHHTTCSCCSCCCCCC
T ss_pred cCCHHHHhcCCCCCCCCCCcc
Confidence 99999997 47899999865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=474.23 Aligned_cols=281 Identities=30% Similarity=0.645 Sum_probs=248.9
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
...+.+++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45788999999999999999999999999999999999999887767777889999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++||+|..++.+.+.+++..++.|++||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvilye 268 (450)
....+.+||+.|+|||++.+ .+|+.++|||||||++||
T Consensus 169 ---------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~e 209 (384)
T 4fr4_A 169 ---------------------------------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209 (384)
T ss_dssp ---------------------------------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHH
T ss_pred ---------------------------------------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHH
Confidence 11235799999999999974 568999999999999999
Q ss_pred HhhCCCCCCCCCh---hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccc
Q 013064 269 MLIGYPPFCSDDP---RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 269 ml~G~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 344 (450)
|++|.+||.+.+. .+....+.. ....+| ..+|+++.+||.+||. ||.+|++ ++++|++||||++++|+.+
T Consensus 210 lltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p--~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 210 LLRGRRPYHIRSSTSSKEIVHTFET--TVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp HHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCHHHH
T ss_pred HHhCCCCCCCCCCccHHHHHHHHhh--cccCCC--CcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCHHHH
Confidence 9999999976443 233333333 234445 4789999999999998 9999996 3899999999999999998
Q ss_pred cc--ccCCccccCCC
Q 013064 345 YE--MEAAYKPTVNG 357 (450)
Q Consensus 345 ~~--~~~p~~p~~~~ 357 (450)
.. +.|||+|....
T Consensus 284 ~~~~~~p~~~p~~~~ 298 (384)
T 4fr4_A 284 FQKRLIPGFIPNKGR 298 (384)
T ss_dssp HTTCSCCCCCCSCCS
T ss_pred HhCCCCCCCCCCCCC
Confidence 74 78999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=491.87 Aligned_cols=285 Identities=35% Similarity=0.628 Sum_probs=253.3
Q ss_pred HhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 30 ~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
+...++..++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|++
T Consensus 177 ~~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp HHTSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 35578999999999999999999999999999999999999998877666677889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
...+|+||||++||+|..++... ..+++..+++|++||+.||+|||++||+||||||+||||+.+|++||+|||+|
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence 99999999999999999999764 36999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
+.+.... ....+.+||+.|+|||++.+.+|+.++|||||||+
T Consensus 337 ~~~~~~~--------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvi 378 (543)
T 3c4z_A 337 VELKAGQ--------------------------------------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVT 378 (543)
T ss_dssp EECCTTC--------------------------------------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHH
T ss_pred eeccCCC--------------------------------------cccccccCCccccChhhhcCCCCChHHhcCcchHH
Confidence 8754321 01234699999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCC----hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCC
Q 013064 266 MYEMLIGYPPFCSDD----PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRG 338 (450)
Q Consensus 266 lyeml~G~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~ 338 (450)
+|||++|.+||.+.+ ..+....|.. ....+| ..+|+++++||++||. ||.+|++.. ++++|++||||++
T Consensus 379 lyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 379 LYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 999999999998764 3445555654 234455 4799999999999998 999999863 5799999999999
Q ss_pred CCcccccc--ccCCccccCC
Q 013064 339 IQWDKLYE--MEAAYKPTVN 356 (450)
Q Consensus 339 i~w~~l~~--~~~p~~p~~~ 356 (450)
++|+.+.. ..|||+|...
T Consensus 455 i~w~~l~~~~~~pp~~P~~~ 474 (543)
T 3c4z_A 455 ISWRQLEAGMLTPPFVPDSR 474 (543)
T ss_dssp CCHHHHHTTCSCCSCCCCSS
T ss_pred CCHHHHHcCCCCCCCCCCcc
Confidence 99999874 7899999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=484.52 Aligned_cols=292 Identities=41% Similarity=0.738 Sum_probs=251.6
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+..++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+|..+|+.++||||++++++|.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 45677899999999999999999999999999999999998766666667788899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+||||+.+|++||+|||+|+.....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999999999998999999999999999999999998 99999999999999999999999999999864322
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
. ....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 303 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 344 (446)
T 4ejn_A 303 G--------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344 (446)
T ss_dssp ------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh
Confidence 1 01235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE-- 346 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~-- 346 (450)
|.+||.+.+.......|... ...+|. .+++++++||.+||. ||.+|++. .+++++++||||++++|+.+.+
T Consensus 345 g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~ 420 (446)
T 4ejn_A 345 GRLPFYNQDHEKLFELILME--EIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK 420 (446)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCc
Confidence 99999999988888888763 345553 799999999999999 99999964 3699999999999999999874
Q ss_pred ccCCccccCCCcccCCCCCC
Q 013064 347 MEAAYKPTVNGELDTQNFEK 366 (450)
Q Consensus 347 ~~~p~~p~~~~~~d~~~f~~ 366 (450)
+.|||+|.+.++.|+++|++
T Consensus 421 ~~pp~~p~~~~~~~~~~~~~ 440 (446)
T 4ejn_A 421 LSPPFKPQVTSETDTRYFDE 440 (446)
T ss_dssp SCCSCCCSCSSTTCCTTC--
T ss_pred CCCCccCCCCCccchhhcch
Confidence 78999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=462.02 Aligned_cols=293 Identities=43% Similarity=0.810 Sum_probs=239.7
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
..++..++|++++.||+|+||.||+|++. .+|+.||+|++++..... ......+.+|+.+|+.++||||++++++|
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 35678899999999999999999999985 689999999998765432 23456788999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
.+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999985
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
..... ....+.+||+.|+|||++.+..++.++|||||||++|
T Consensus 171 ~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 212 (327)
T 3a62_A 171 SIHDG--------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMY 212 (327)
T ss_dssp ----------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHH
T ss_pred cccCC--------------------------------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHH
Confidence 43210 0123568999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCCCCcccc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l 344 (450)
+|++|.+||.+.+......+|... ...+| ..+++++++||.+||. ||.+|++.. +++++++||||++++|+.+
T Consensus 213 el~~g~~pf~~~~~~~~~~~i~~~--~~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~ 288 (327)
T 3a62_A 213 DMLTGAPPFTGENRKKTIDKILKC--KLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288 (327)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence 999999999999988888888763 34455 4789999999999998 999999865 7999999999999999988
Q ss_pred c--cccCCccccCCCcccCCCCCC
Q 013064 345 Y--EMEAAYKPTVNGELDTQNFEK 366 (450)
Q Consensus 345 ~--~~~~p~~p~~~~~~d~~~f~~ 366 (450)
. ...|||+|.+.+..|.++|+.
T Consensus 289 ~~~~~~~p~~p~~~~~~~~~~~~~ 312 (327)
T 3a62_A 289 LARKVEPPFKPLLQSEEDVSQFDS 312 (327)
T ss_dssp HTTCSCCSCCCC------------
T ss_pred hhccCCCCCCCCcCChhhhhhcch
Confidence 6 478999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=453.15 Aligned_cols=257 Identities=21% Similarity=0.379 Sum_probs=221.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
.+..++|.+.+.||+|+||+||+|++. .++..||||++++. .....+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 466789999999999999999999875 46789999999754 3345678999999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE-------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG 175 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~-------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g 175 (450)
+++.+|||||||+||+|.++|.+. ..+++.++..++.||+.||+|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCc
Q 013064 176 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255 (450)
Q Consensus 176 ~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~ 255 (450)
++||+|||+|+........ ......+||+.|||||++.+..|+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~~~~~~~~~ 209 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYY------------------------------------RVGGHTMLPIRWMPPESIMYRKFTT 209 (299)
T ss_dssp CEEECCCSCHHHHTGGGCE------------------------------------EETTTEEECGGGCCHHHHHHCCCCH
T ss_pred cEEECCcccceecCCCCce------------------------------------eecCceecChhhcCHHHHcCCCCCc
Confidence 9999999999865432110 1122467999999999999999999
Q ss_pred cccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 256 ECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 256 ~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++|||||||+||||+| |.+||.+.+..+....|..+. .+..| ..+|+++.+||.+||. ||.+|| ++.+| |
T Consensus 210 k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~~i--~ 281 (299)
T 4asz_A 210 ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPQEVYELMLGCWQREPHMRK---NIKGI--H 281 (299)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHH--H
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcCCChhHCc---CHHHH--H
Confidence 9999999999999998 999999999988888887643 23444 4799999999999998 999999 67887 4
Q ss_pred CCcC
Q 013064 334 PWFR 337 (450)
Q Consensus 334 pff~ 337 (450)
+|++
T Consensus 282 ~~L~ 285 (299)
T 4asz_A 282 TLLQ 285 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-58 Score=452.42 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=216.1
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
..+..+||.+.+.||+|+||+||+|+.+ .+++.||||++++. .....+.+.+|+.+|+.++|||||++++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4567789999999999999999999875 46889999999754 344567899999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRE---------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 172 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~---------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld 172 (450)
.+++.+|||||||+||+|.++|.+. +.+++.++..|+.||+.||+|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999764 3599999999999999999999999999999999999999
Q ss_pred cCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC
Q 013064 173 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252 (450)
Q Consensus 173 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~ 252 (450)
.++++||+|||+|+.+...... ....+.+||+.|||||++.+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~~~~~~ 236 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY------------------------------------RVGGRTMLPIRWMPPESILYRK 236 (329)
T ss_dssp TTTEEEECCCC----------------------------------------------------CCCCGGGCCHHHHTTCC
T ss_pred CCCcEEEcccccceeccCCCcc------------------------------------eecCcccccccccChhhhcCCC
Confidence 9999999999999865432110 1123468999999999999999
Q ss_pred CCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHH
Q 013064 253 YGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330 (450)
Q Consensus 253 y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei 330 (450)
|+.++|||||||+||||+| |++||.+.+..+.+..|.... .+..| ..+++++.+||.+||. ||.+|| ++.||
T Consensus 237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~ei 310 (329)
T 4aoj_A 237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-ELERP--RACPPEVYAIMRGCWQREPQQRH---SIKDV 310 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHCCSSTTTSC---CHHHH
T ss_pred CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCc--ccccHHHHHHHHHHcCcChhHCc---CHHHH
Confidence 9999999999999999998 999999999888888887643 34455 4799999999999998 999999 67888
Q ss_pred HcC
Q 013064 331 KEH 333 (450)
Q Consensus 331 l~H 333 (450)
+.+
T Consensus 311 ~~~ 313 (329)
T 4aoj_A 311 HAR 313 (329)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=445.24 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=208.0
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+..+++++.+.||+|+||+||+|+.+. .+|||+++... ......+.+.+|+.+|+.++|||||++++++. ++.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence 35788999999999999999999998643 48999997543 33456788999999999999999999999875 456
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|||||||+||+|.++|... ..+++.++..|+.||+.||+|||++|||||||||+||||++++++||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 89999999999999999764 57999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvilye 268 (450)
... ....+.+||+.|||||++.+ .+|+.++|||||||+|||
T Consensus 186 ~~~------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~E 229 (307)
T 3omv_A 186 SGS------------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYE 229 (307)
T ss_dssp --------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHH
T ss_pred Ccc------------------------------------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHH
Confidence 110 11235799999999999974 358999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhccc-ccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWK-TCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~-~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|++|.+||.+.+.......++... .....+ .+..+++++++||.+||. ||.+|| ++.+|+
T Consensus 230 lltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ei~ 292 (307)
T 3omv_A 230 LMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP---LFPQIL 292 (307)
T ss_dssp HHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC---CHHHHH
T ss_pred HHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc---CHHHHH
Confidence 999999999877665555444321 111111 124689999999999998 999999 456554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=445.11 Aligned_cols=257 Identities=21% Similarity=0.339 Sum_probs=221.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
..+..+++++++.||+|+||+||+++.. .+++.||||+++... .....+.+.+|+.+|+.++|||||++++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 4578899999999999999999999863 467899999997542 334457899999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL 171 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl 171 (450)
.+++.+|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999653 358999999999999999999999999999999999999
Q ss_pred ccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC
Q 013064 172 DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 251 (450)
Q Consensus 172 d~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~ 251 (450)
++++++||+|||+|+.+...... ....+.+||+.|||||++.+.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~l~~~ 222 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY------------------------------------KLLGNSLLPIRWMAPEAIMYG 222 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB------------------------------------CSSSSSCBCGGGCCHHHHHHC
T ss_pred CCCCCEEECCcccceeccCCCce------------------------------------eEecccccCCcccCHHHHhCC
Confidence 99999999999999865432110 112356899999999999999
Q ss_pred CCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 252 GYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 252 ~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
.|+.++|||||||+||||++ |.+||.+.+..+....|.+.. .+..| ..+++++.+|+.+||. ||.+|| ++.|
T Consensus 223 ~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~~~~li~~C~~~dP~~RP---s~~e 296 (308)
T 4gt4_A 223 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ-VLPCP--DDCPAWVYALMIECWNEFPSRRP---RFKD 296 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHH
T ss_pred CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCc--ccchHHHHHHHHHHcCCChhHCc---CHHH
Confidence 99999999999999999998 899999999888888887642 23344 4799999999999998 999999 5778
Q ss_pred HHcC
Q 013064 330 LKEH 333 (450)
Q Consensus 330 il~H 333 (450)
|+++
T Consensus 297 i~~~ 300 (308)
T 4gt4_A 297 IHSR 300 (308)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=448.37 Aligned_cols=267 Identities=30% Similarity=0.489 Sum_probs=237.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3679999999999999999999999999999999987653321 2357789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC----ceEEeeccccccCc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLE 189 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g----~ikL~DFGla~~~~ 189 (450)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888999999999999999999999999999999999999998877 89999999998754
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... ...+.+||+.|+|||++.+.+|+.++|||||||++|+|
T Consensus 171 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~l 211 (361)
T 2yab_A 171 DGV---------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (361)
T ss_dssp TTC---------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CCC---------------------------------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHH
Confidence 321 12356899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
++|.+||.+.+..+.+.+|......+..+.+..+|+++++||.+||. ||.+|+ +++++++||||++++|....
T Consensus 212 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~~~~~~~~ 285 (361)
T 2yab_A 212 LSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDTQQAM 285 (361)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTSCSSHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCcCcCCCchhhhh
Confidence 99999999999988888887643322211234789999999999998 999999 68999999999999997654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=448.46 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=219.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCC-----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f 107 (450)
.+..++|++.+.||+|+||+||+|++..++ +.||+|++++.. .....+.+.+|+.+|..++| ||||+++++|
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 466789999999999999999999987543 679999997643 33456778999999999966 8999999998
Q ss_pred Ec-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEE
Q 013064 108 QD-SDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 170 (450)
Q Consensus 108 ~~-~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNIL 170 (450)
.+ ++.+|+|||||+||+|.++|.+. ..++++.+..|+.||+.||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 46799999999999999999763 34899999999999999999999999999999999999
Q ss_pred EccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc
Q 013064 171 LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250 (450)
Q Consensus 171 ld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~ 250 (450)
++.++++||+|||+|+.+...... ....+.+||+.|||||++.+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~------------------------------------~~~~~~~gt~~ymAPE~l~~ 261 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY------------------------------------VRKGDARLPLKWMAPETIFD 261 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS------------------------------------EEETTEEECGGGCCHHHHHH
T ss_pred eCCCCCEEECcchhhhhcccCCCc------------------------------------eeeccccccccccCHHHHhc
Confidence 999999999999999876432111 11235789999999999999
Q ss_pred CCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 251 KGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 251 ~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
..|+.++|||||||+||||++ |.+||.+.+..+.+.+++.....+..| ..+++++.+||.+||. ||.+|| ++.
T Consensus 262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p--~~~~~~~~~li~~c~~~dP~~RP---t~~ 336 (353)
T 4ase_A 262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFS 336 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCC--ccCCHHHHHHHHHHcCcChhHCc---CHH
Confidence 999999999999999999998 999999877666555555444445555 4789999999999998 999999 688
Q ss_pred HHHcC
Q 013064 329 ELKEH 333 (450)
Q Consensus 329 eil~H 333 (450)
+|++|
T Consensus 337 eil~~ 341 (353)
T 4ase_A 337 ELVEH 341 (353)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99887
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=435.23 Aligned_cols=262 Identities=29% Similarity=0.500 Sum_probs=234.5
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
.....+++|++++.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345567899999999999999999999999999999999987653 4455678899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml 270 (450)
. ...+.+||+.|+|||++.+..| +.++|+|||||++|+|+
T Consensus 168 ~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 208 (328)
T 3fe3_A 168 G---------------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV 208 (328)
T ss_dssp C---------------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH
T ss_pred C---------------------------------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH
Confidence 1 1235789999999999998887 48999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
+|.+||.+.+..+...++... ...+| ..+|+++.+||++||. ||.+|+ +++++++||||+...
T Consensus 209 ~g~~pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 209 SGSLPFDGQNLKELRERVLRG--KYRIP--FYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWINAGH 272 (328)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHCCSSTTTSC---CHHHHTTCTTTTTTC
T ss_pred hCCCCCCCCCHHHHHHHHHhC--CCCCC--CCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCHhhcCCC
Confidence 999999999998888888764 34455 3689999999999999 999999 799999999998644
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=442.78 Aligned_cols=291 Identities=41% Similarity=0.764 Sum_probs=242.8
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.++.+++|++++.||+|+||.||+|++. .+|+.||||++++..... ....+.+.+|+.+|..+ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 4567789999999999999999999984 589999999998654322 22345677899999999 799999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
.+...+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999986
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAI 265 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvi 265 (450)
+..... ......+||+.|+|||++.+ ..++.++|+|||||+
T Consensus 209 ~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~i 251 (355)
T 1vzo_A 209 FVADET-------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251 (355)
T ss_dssp CCGGGG-------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHH
T ss_pred cccCCC-------------------------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHH
Confidence 543211 11234689999999999985 457899999999999
Q ss_pred HHHHhhCCCCCCCCChhhh----hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC--CHHHHHcCCCcCC
Q 013064 266 MYEMLIGYPPFCSDDPRIT----CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRG 338 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~--~~~eil~Hpff~~ 338 (450)
+|||++|..||...+.... ...+.. ....+| ..+++.+++||.+||. ||.+|++.. +++++++||||..
T Consensus 252 l~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 252 MYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 9999999999976543332 233332 122333 4789999999999998 999999753 7999999999999
Q ss_pred CCcccccc--ccCCccccCCCcccCCCC
Q 013064 339 IQWDKLYE--MEAAYKPTVNGELDTQNF 364 (450)
Q Consensus 339 i~w~~l~~--~~~p~~p~~~~~~d~~~f 364 (450)
++|+.+.. ..+||.|.+.+..|.+||
T Consensus 328 ~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 328 INWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp CCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred CChhHhhhccCCCCCCCccccccccccC
Confidence 99998874 678999999999998887
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=441.80 Aligned_cols=259 Identities=31% Similarity=0.554 Sum_probs=232.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|..+|+.++|||||+++++|.+++.+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999987653 3345677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc---cCCceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld---~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~- 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ- 168 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence 9999999999999999999999999999999999999999999999999999998 468899999999987643211
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
...+.+||+.|+|||++.+..|+.++|+|||||++|+|++|.+
T Consensus 169 -------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 169 -------------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp -------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 1234689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||.+.+..+.+..+......+..+.+..+|+++++||.+||. ||.+|+ +++++++||||+.
T Consensus 212 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~L~hp~~~~ 273 (444)
T 3soa_A 212 PFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273 (444)
T ss_dssp SCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSCTTHH
T ss_pred CCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCC---CHHHHhcCccccC
Confidence 999999999998888765555555566899999999999998 999999 7899999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=428.93 Aligned_cols=258 Identities=30% Similarity=0.534 Sum_probs=230.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
+..+++|.+++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999999876654444556789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 9999999 78999999988999999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G 272 (450)
...+.+||+.|+|||++.+..| +.++|+|||||++|+|++|
T Consensus 163 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (336)
T 3h4j_B 163 --------------------------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204 (336)
T ss_dssp --------------------------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhC
Confidence 1235689999999999998877 7899999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
..||.+........++... ...+| ..+|+++++||++||. ||.+|+ +++|+++||||+.
T Consensus 205 ~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 264 (336)
T 3h4j_B 205 RLPFDDEFIPNLFKKVNSC--VYVMP--DFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFNV 264 (336)
T ss_dssp SCSSBCSSSTTCBCCCCSS--CCCCC--TTSCHHHHHHHHTTSCSSGGGSC---CHHHHTTCHHHHT
T ss_pred CCCCCCccHHHHHHHHHcC--CCCCc--ccCCHHHHHHHHHHcCCChhHCc---CHHHHHhChhhcc
Confidence 9999988777777666542 23444 4789999999999998 999999 7999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-54 Score=430.43 Aligned_cols=259 Identities=31% Similarity=0.542 Sum_probs=231.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|..+|+.++|||||+++++|.+++.+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999987653 344567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL~DFGla~~~~~~~~ 193 (450)
|||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 99999999999998888999999999999999999999999999999999999998654 59999999998764321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus 186 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 186 --------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227 (362)
T ss_dssp --------------------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence 112468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+||.+.+....+..|.........+.+..+++++++||.+||. ||.+|+ +++++++||||..
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 228 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 290 (362)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSHHHHT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCcccCC
Confidence 9999999888888887754444344445789999999999998 999999 6899999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=431.10 Aligned_cols=269 Identities=30% Similarity=0.572 Sum_probs=228.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lyl 115 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+... ...+|+.+|..+ +||||++++++|++.+.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3689999999999999999999999999999999987542 134678888877 79999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-C---CceEEeeccccccCccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-N---GHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~---g~ikL~DFGla~~~~~~ 191 (450)
|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.. + +.+||+|||+|+.....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999999999999999999999999999999999999999999999999999843 3 35999999999875432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
. ....+.+||+.|+|||++.+.+|+.++|||||||++|+|++
T Consensus 174 ~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 174 N--------------------------------------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215 (342)
T ss_dssp T--------------------------------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred C--------------------------------------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence 1 11235789999999999998889999999999999999999
Q ss_pred CCCCCCC---CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccccc-
Q 013064 272 GYPPFCS---DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE- 346 (450)
Q Consensus 272 G~~PF~~---~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~- 346 (450)
|.+||.+ .+..+....|......+..+.+..+|+++++||++||. ||.+|+ +++++++||||. +|+.+..
T Consensus 216 g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~~--~~~~~~~~ 290 (342)
T 2qr7_A 216 GYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TAALVLRHPWIV--HWDQLPQY 290 (342)
T ss_dssp SSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHH--TGGGSCCS
T ss_pred CCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCCeec--Cccccccc
Confidence 9999986 34455666666544333333345799999999999998 999999 689999999994 5877653
Q ss_pred -ccCCccccC
Q 013064 347 -MEAAYKPTV 355 (450)
Q Consensus 347 -~~~p~~p~~ 355 (450)
+.+|+.|..
T Consensus 291 ~~~~~~~p~~ 300 (342)
T 2qr7_A 291 QLNRQDAPHL 300 (342)
T ss_dssp CCCCCCCHHH
T ss_pred cCCCccchhh
Confidence 456666643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=422.89 Aligned_cols=266 Identities=26% Similarity=0.471 Sum_probs=233.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999999987543221 13577899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC----ceEEeeccccccCcc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLED 190 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g----~ikL~DFGla~~~~~ 190 (450)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999998888999999999999999999999999999999999999999888 899999999987643
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. .....+||+.|+|||++.+..|+.++|+|||||++|+|+
T Consensus 171 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 211 (326)
T 2y0a_A 171 GN---------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 211 (326)
T ss_dssp TS---------------------------------------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CC---------------------------------------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 21 012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
+|.+||.+.+..+....+.........+....+|+.+++||.+||. ||.+|| +++++++||||+..+|....
T Consensus 212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~~~~~ 284 (326)
T 2y0a_A 212 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQAL 284 (326)
T ss_dssp HSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTSCCSHHHHH
T ss_pred HCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCC---CHHHHhcCCCccCCcchhhh
Confidence 9999999988888777776533222111124789999999999998 999999 69999999999998886543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=421.40 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=227.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++... ......+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 57999999999999999999999999999999998743 23456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc--CCceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~--~g~ikL~DFGla~~~~~~~~ 193 (450)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999999765 47999999999999999999999999999999999999987 78999999999987643210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 160 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 160 ---------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp ---------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 12468999999999999888999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+||.+.+..+....+......+..+.+..+|+++++||.+||. ||.+|| +++|+++||||+.
T Consensus 201 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~ 263 (321)
T 1tki_A 201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp CTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred CCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc---CHHHHhcChhhcc
Confidence 9999999888888887643322222234789999999999998 999999 7899999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=410.85 Aligned_cols=258 Identities=30% Similarity=0.497 Sum_probs=226.1
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
..++|++++.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|..+++.++||||++++++|.+.+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 34789999999999999999999999999999999976542 335678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
||||++||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 99999999999998765 699999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
...+.+||+.|+|||++.+..|+.++|||||||++|+|++|..|
T Consensus 172 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 215 (297)
T 3fxz_A 172 ------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (297)
T ss_dssp ------------------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ------------------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 12246899999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
|.+.+.......+.... ....+....+++.+++||.+||. ||.+|+ +++++++||||+..
T Consensus 216 f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 216 YLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHQFLKIA 276 (297)
T ss_dssp TTTSCHHHHHHHHHHHC-SCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CCCCCHHHHHHHHHhCC-CCCCCCccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhccc
Confidence 99888776666554321 12222335789999999999999 999999 79999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=407.03 Aligned_cols=260 Identities=28% Similarity=0.487 Sum_probs=217.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|..+++.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 478999999999999999999999999999999998654 3344567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l-~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||++| +|...+ ...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--
Confidence 999976 555554 4467899999999999999999999999999999999999999999999999999986543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC-CCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~-y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+||+.|+|||++.+.. |+.++|+|||||++|+|++|..
T Consensus 157 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~ 200 (292)
T 3o0g_A 157 ------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp ------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred ------------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCC
Confidence 112468999999999998755 8999999999999999998777
Q ss_pred C-CCCCChhhhhhhhhcccccc---------------cCC----------CCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 275 P-FCSDDPRITCRKIVNWKTCL---------------KFP----------EEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 275 P-F~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
| |.+.+.......+....... .++ ..+.+++++++||++||. ||.+|+ ++
T Consensus 201 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~ 277 (292)
T 3o0g_A 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SA 277 (292)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CH
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC---CH
Confidence 7 55666555555554211000 000 113578999999999999 999999 79
Q ss_pred HHHHcCCCcCCC
Q 013064 328 EELKEHPWFRGI 339 (450)
Q Consensus 328 ~eil~Hpff~~i 339 (450)
+|+++||||+++
T Consensus 278 ~e~l~hp~f~~~ 289 (292)
T 3o0g_A 278 EEALQHPYFSDF 289 (292)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHhcCcccccC
Confidence 999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=412.96 Aligned_cols=264 Identities=28% Similarity=0.487 Sum_probs=219.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
.-.++|++++.||+|+||.||+|++. +|+.||+|++.... ........+.+|+.+|+.++||||+++++++.++..+|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 45689999999999999999999985 58999999997653 23345577889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99999975 788887664 4699999999999999999999999999999999999999999999999999987543211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G 272 (450)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus 175 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 216 (311)
T 3niz_A 175 --------------------------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216 (311)
T ss_dssp -----------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhC
Confidence 0124589999999999976 5689999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccC--------------------C------CCCCCCHHHHHHHHHhhc-CccccCCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKF--------------------P------EEPKISDEARDLICHLLC-DVETRLGTR 325 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~--------------------p------~~~~~s~~~~dli~~lL~-dp~~R~~~~ 325 (450)
.+||.+.+..+...++......... . ..+.+++++++||.+||+ ||.+|+
T Consensus 217 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp--- 293 (311)
T 3niz_A 217 KPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI--- 293 (311)
T ss_dssp SCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC---
T ss_pred CCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC---
Confidence 9999988777766665431110000 0 013578999999999999 999999
Q ss_pred CHHHHHcCCCcCCCCcc
Q 013064 326 GVEELKEHPWFRGIQWD 342 (450)
Q Consensus 326 ~~~eil~Hpff~~i~w~ 342 (450)
+++|+++||||+++++.
T Consensus 294 t~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 294 SARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CHHHHHTSGGGTTSCTT
T ss_pred CHHHHhcCcccccCCcc
Confidence 79999999999998863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-53 Score=438.20 Aligned_cols=262 Identities=28% Similarity=0.532 Sum_probs=236.8
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
....+.+++|.+.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34567889999999999999999999999999999999999887655555677899999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyem 269 (450)
.. ...+.+||+.|+|||++.+..| +.++|||||||++|+|
T Consensus 169 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 209 (476)
T 2y94_A 169 GE---------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209 (476)
T ss_dssp TC---------------------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHH
T ss_pred cc---------------------------------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHH
Confidence 21 1235689999999999998776 7899999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|.+||.+.+....+.+|... ....| ..+++++++||++||. ||.+|+ ++++|++||||+.
T Consensus 210 ltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~Rp---t~~eil~hp~~~~ 272 (476)
T 2y94_A 210 LCGTLPFDDDHVPTLFKKICDG--IFYTP--QYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFKQ 272 (476)
T ss_dssp HHSSCSSCCSSSHHHHHHHHTT--CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHT
T ss_pred hhCCCCCCCCCHHHHHHHHhcC--CcCCC--ccCCHHHHHHHHHHcCCCchhCc---CHHHHHhCHHhhh
Confidence 9999999998888888888763 23444 4789999999999998 999999 7999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=424.75 Aligned_cols=262 Identities=30% Similarity=0.534 Sum_probs=223.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||++++++|.+++.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 579999999999999999999999999999999987653322 246778999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc---eEEeeccccccC
Q 013064 116 IMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPL 188 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~---ikL~DFGla~~~ 188 (450)
|||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999999887643 35899999999999999999999999999999999999987655 999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
..... ...+.+||+.|+|||++.+..|+.++|+|||||++|+
T Consensus 184 ~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 225 (351)
T 3c0i_A 184 GESGL--------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225 (351)
T ss_dssp CTTSC--------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred cCCCe--------------------------------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHH
Confidence 43210 1224689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
|++|.+||.+.. ...+..+.........+.+..+|+++++||.+||. ||.+|+ ++.++++||||++.++
T Consensus 226 ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 226 LLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI---TVYEALNHPWLKERDR 295 (351)
T ss_dssp HHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHTHHH
T ss_pred HHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcChhhcCCcc
Confidence 999999998754 45556665533222211224789999999999998 999999 6899999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=423.72 Aligned_cols=276 Identities=21% Similarity=0.313 Sum_probs=226.8
Q ss_pred CCCCCeEEEeEEeec--CceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 35 IGIDDFEQLTLIGKG--AFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G--~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
...++|++++.||+| +||.||+|+++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456799999999999 999999999999999999999987643 44567788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilye 268 (450)
...... .........+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 181 ~~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 229 (389)
T 3gni_B 181 HGQRQR-------------------------------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229 (389)
T ss_dssp TTEECS-------------------------------CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHH
T ss_pred cccccc-------------------------------ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHH
Confidence 211000 00011123589999999999987 689999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhccccc------------------------------------------ccCCCCCCCCHH
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWKTC------------------------------------------LKFPEEPKISDE 306 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~~~------------------------------------------~~~p~~~~~s~~ 306 (450)
|++|.+||.+.+.......+...... ...+....++++
T Consensus 230 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 309 (389)
T 3gni_B 230 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309 (389)
T ss_dssp HHHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHH
T ss_pred HHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHH
Confidence 99999999887766665554432110 001122468999
Q ss_pred HHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 307 ARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 307 ~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
+++||.+||. ||.+|+ +++|+++||||+.+.|....
T Consensus 310 ~~~li~~~L~~dP~~Rp---ta~ell~hp~f~~~~~~~~~ 346 (389)
T 3gni_B 310 FHHFVEQCLQRNPDARP---SASTLLNHSFFKQIKRRASE 346 (389)
T ss_dssp HHHHHHHHTCSCTTTSC---CHHHHTTSGGGGGC---CCS
T ss_pred HHHHHHHHhhcCcccCC---CHHHHhcCHHHHHHhhcchh
Confidence 9999999999 999999 68999999999998875543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=422.83 Aligned_cols=260 Identities=29% Similarity=0.528 Sum_probs=228.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999997643 22345788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc--CCceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~--~g~ikL~DFGla~~~~~~~~ 193 (450)
|||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 99999999999987654 7999999999999999999999999999999999999974 5789999999998764321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 206 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 247 (387)
T 1kob_A 206 --------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247 (387)
T ss_dssp --------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred --------------------------------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCC
Confidence 012458999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
+||.+.+..+...++......+..+....+|+++++||.+||. ||.+|+ +++++++||||++..+
T Consensus 248 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 248 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGDHS 313 (387)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSCCT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCccccCCcc
Confidence 9999998888888877644333333345789999999999998 999999 7999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=424.73 Aligned_cols=278 Identities=27% Similarity=0.481 Sum_probs=213.5
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCC--eE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSD--FL 113 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~--~l 113 (450)
+++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|..+. ||||++++++|..++ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 479999999999999999999999999999999997543 34455677889999999997 999999999998654 79
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+|||||+ |+|..++.. +.+++..++.++.||+.||+|||+.||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999997 589888865 5799999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G 272 (450)
... .. ....... ...+. .......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 165 ~~~----~~----~~~~~~~--------~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 165 VTN----NI----PLSINEN--------TENFD-DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp CCC----CG----GGCCC------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccc----cc----ccccccc--------ccccc-cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 000 00 0000000 00000 00112345799999999999986 6799999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCC----------------------------------------------CCCCCCHH
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFP----------------------------------------------EEPKISDE 306 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p----------------------------------------------~~~~~s~~ 306 (450)
.+||.+.+....+.+|+.. +..| ....++++
T Consensus 228 ~~pf~~~~~~~~~~~i~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (388)
T 3oz6_A 228 KPIFPGSSTMNQLERIIGV---IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304 (388)
T ss_dssp SCSCCCSSHHHHHHHHHHH---HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHH
T ss_pred CCCCCCCCHHHHHHHHHHh---cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHH
Confidence 9999999888777776531 1111 11267999
Q ss_pred HHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 307 ARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 307 ~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
+.+||.+||. ||.+|+ +++|+++||||+.+.
T Consensus 305 ~~dll~~~L~~dP~~R~---t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 305 ALDLLDKLLQFNPNKRI---SANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHHCCSSGGGSC---CHHHHTTSTTTTTTC
T ss_pred HHHHHHHhhccCcccCC---CHHHHhCCHHHHHhc
Confidence 9999999999 999999 699999999998653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=440.37 Aligned_cols=265 Identities=32% Similarity=0.582 Sum_probs=238.4
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
.-.++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 33468999999999999999999999999999999998876655666788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE---ccCCceEEeeccccccCccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl---d~~g~ikL~DFGla~~~~~~ 191 (450)
+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999999999999999999999999999999999999999999999 56789999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
. ...+.+||+.|+|||++.+ .|+.++|+|||||++|+|++
T Consensus 183 ~---------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 222 (484)
T 3nyv_A 183 K---------------------------------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS 222 (484)
T ss_dssp C---------------------------------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH
Confidence 1 0124689999999999976 69999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
|.+||.+.+..+...++.........|.+..+|+++++||++||. ||.+|| +++++++||||+...+.
T Consensus 223 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 223 GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYTKE 291 (484)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHHHTC-
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhhChhhcccccc
Confidence 999999999999998888766556666666899999999999999 999999 79999999999876554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=416.09 Aligned_cols=267 Identities=29% Similarity=0.448 Sum_probs=217.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
....+++|++++.||+|+||.||+|++..+|+.||+|+++... ........+.+|+.+|+.++||||+++++++.+++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 4567789999999999999999999999999999999997653 233345667889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-----cCCceEEeecccccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-----KNGHLKLSDFGLCKP 187 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-----~~g~ikL~DFGla~~ 187 (450)
+|+||||++| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+|+.
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999974 9999999998999999999999999999999999999999999999994 455699999999986
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIM 266 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvil 266 (450)
...... .....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 187 ~~~~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 187 FGIPIR--------------------------------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228 (329)
T ss_dssp HC-------------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred cCCccc--------------------------------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 532210 0124589999999999987 4589999999999999
Q ss_pred HHHhhCCCCCCCCChhhhhhhhhccccccc----------------CCCC----------CCCCHHHHHHHHHhhc-Ccc
Q 013064 267 YEMLIGYPPFCSDDPRITCRKIVNWKTCLK----------------FPEE----------PKISDEARDLICHLLC-DVE 319 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------------~p~~----------~~~s~~~~dli~~lL~-dp~ 319 (450)
|+|++|.+||.+.+..+...++........ ++.. ..+++++++||.+||. ||.
T Consensus 229 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 308 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308 (329)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChh
Confidence 999999999999888777766653211000 0000 1278999999999999 999
Q ss_pred ccCCCCCHHHHHcCCCcCCCCcc
Q 013064 320 TRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 320 ~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
+|+ +++|+++||||++++|+
T Consensus 309 ~R~---t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 309 KRI---SAKNALEHPYFSHNDFD 328 (329)
T ss_dssp GSC---CHHHHHTSGGGSSSCSC
T ss_pred hCC---CHHHHhCCcccCCCCCC
Confidence 999 69999999999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=401.76 Aligned_cols=260 Identities=35% Similarity=0.593 Sum_probs=232.0
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+....+++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++.++||||++++++|.+..
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 35678899999999999999999999999999999999998776555555678899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998654322
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
. ....+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 163 ~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (279)
T 3fdn_A 163 R----------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202 (279)
T ss_dssp ---------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred c----------------------------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH
Confidence 0 124689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|..||.+.+..+....+... ...+| ..+++.+++||.+||. ||.+|| +++++++||||++
T Consensus 203 g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~h~~~~~ 263 (279)
T 3fdn_A 203 GKPPFEANTYQETYKRISRV--EFTFP--DFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 263 (279)
T ss_dssp SSCTTCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHCCSSGGGSC---CHHHHHHCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHhC--CCCCC--CcCCHHHHHHHHHHhccChhhCC---CHHHHhhCccccC
Confidence 99999998888887777652 33444 4689999999999998 999999 6999999999976
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=397.67 Aligned_cols=264 Identities=30% Similarity=0.527 Sum_probs=235.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|..+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4899999999999999999999999999999999987653 444567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc---eEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~---ikL~DFGla~~~~~~~~ 193 (450)
|||++||+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 999999999999998899999999999999999999999999999999999999987665 9999999997654321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 163 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 163 --------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp --------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence 012468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
.||.+.+.......+.........+....+++++.+||.+||. ||.+|| +++++++||||++..+..
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICNRERVA 272 (284)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSHHHHSCCCGG
T ss_pred CCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC---CHHHHhcCccccCChhHH
Confidence 9999998888888877654444445556789999999999999 999999 789999999998866543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=433.18 Aligned_cols=294 Identities=23% Similarity=0.349 Sum_probs=208.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-----CC
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-----SD 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-----~~ 111 (450)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999997642 344556788999999999999999999999943 46
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||+ +|+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 6799999998889999999999999999999999999999999999999999999999999999976533
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh-ccCCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-LKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl-~~~~y~~~~DiWSlGvilyeml 270 (450)
.......... ....... ... ... ...........+||+.|+|||++ .+..|+.++|||||||++|||+
T Consensus 210 ~~~~~~~~~~-~~~~~~~--~~~-------~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 210 ENGNSQLPIS-PREDDMN--LVT-------FPH-TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp TTCCCCCC--------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccccccC-ccccccc--ccc-------ccc-cccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 1110000000 0000000 000 000 00011123457999999999987 4577999999999999999999
Q ss_pred h-----------CCCCCCCCCh--------------------hhhhhhhhcccc------------------cccCC---
Q 013064 271 I-----------GYPPFCSDDP--------------------RITCRKIVNWKT------------------CLKFP--- 298 (450)
Q Consensus 271 ~-----------G~~PF~~~~~--------------------~~~~~~i~~~~~------------------~~~~p--- 298 (450)
+ |.++|.+.+. ...+..|.+.-. ...+|
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 358 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE 358 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence 8 7888876542 111111111000 00000
Q ss_pred ------CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccccc
Q 013064 299 ------EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 346 (450)
Q Consensus 299 ------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 346 (450)
..+.+++++.+||++||. ||.+|+ +++|+++||||+++.|..+..
T Consensus 359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---t~~e~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 359 GTDLAERFPASSADAIHLLKRMLVFNPNKRI---TINECLAHPFFKEVRIAEVET 410 (458)
T ss_dssp CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGTTTCCGGGCC
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhccCccccC---CHHHHhcCHhhhhcCCCccCC
Confidence 123579999999999999 999999 689999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=400.91 Aligned_cols=263 Identities=36% Similarity=0.630 Sum_probs=234.2
Q ss_pred HhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 30 ~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
.....+.+++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..+++.++||||+++++++.+
T Consensus 6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp ----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 34567888999999999999999999999999999999999987665444556788999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+.+|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999987543
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... ....+||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 166 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 205 (284)
T 2vgo_A 166 SLR----------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205 (284)
T ss_dssp SSC----------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHH
T ss_pred ccc----------------------------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHH
Confidence 210 1246899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
++|..||.+.+.......+... ...+| ..+++++++||.+||. ||.+|+ +++++++||||+..
T Consensus 206 ~~g~~pf~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 206 LVGMPPFDSPSHTETHRRIVNV--DLKFP--PFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPWVKAN 269 (284)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTT--CCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHHTCHHHHHH
T ss_pred HHCCCCCCCCCHhHHHHHHhcc--ccCCC--CcCCHHHHHHHHHHhhcCHhhCC---CHHHHhhCHHHHhh
Confidence 9999999998888777777763 34444 4789999999999998 999999 79999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=418.55 Aligned_cols=258 Identities=33% Similarity=0.522 Sum_probs=212.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
...++|++++.||+|+||.||+|+++.+|+.||+|++.+.... .+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4568999999999999999999999999999999999765422 256789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc--eEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--LKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~--ikL~DFGla~~~~~~~ 192 (450)
+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999998889999999999999999999999999999999999999987765 9999999987432210
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcc-ccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME-CDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~-~DiWSlGvilyeml~ 271 (450)
...+.+||+.|+|||++.+..+..+ +|||||||++|+|++
T Consensus 173 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 213 (361)
T 3uc3_A 173 ---------------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213 (361)
T ss_dssp -----------------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh
Confidence 0124689999999999998887655 899999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcc--cccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 272 GYPPFCSDDPRITCRKIVNW--KTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|.+||.+.+....+.+++.. .....+|....+|+++++||.+||. ||.+|+ +++++++||||..
T Consensus 214 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~ 280 (361)
T 3uc3_A 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI---SIPEIKTHSWFLK 280 (361)
T ss_dssp SSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSC---CHHHHHTSHHHHT
T ss_pred CCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCc---CHHHHHhCcchhc
Confidence 99999886654443333221 1234556556799999999999998 999999 7999999999954
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=412.80 Aligned_cols=260 Identities=25% Similarity=0.456 Sum_probs=220.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|+++.+++.||+|++..... ....+.+.+|..+++.++||||+++++++.+++.+|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5899999999999999999999999999999999975432 22345688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||||+||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc--
Confidence 999999999999988888999999999999999999999999999999999999999999999999999865432110
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G~~P 275 (450)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 162 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 207 (323)
T 3tki_A 162 ----------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (323)
T ss_dssp ----------------------------------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------------------------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 11235789999999999988776 7889999999999999999999
Q ss_pred CCCCChhhh-hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 276 FCSDDPRIT-CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 276 F~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
|.+.+.... +..+... ....+....+++.+.+||.+||. ||.+|+ +++|+++||||+..
T Consensus 208 f~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~ 268 (323)
T 3tki_A 208 WDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (323)
T ss_dssp CSSSCTTSHHHHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred CCCCchHHHHHHHHhcc--cccCCccccCCHHHHHHHHHHccCChhhCc---CHHHHhhChhhccc
Confidence 987665432 2222221 12223335789999999999998 999999 69999999999763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=408.05 Aligned_cols=260 Identities=34% Similarity=0.644 Sum_probs=220.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch-----------------------hhHHHHHHHHH
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----------------------GQVEHVRSERN 90 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~-----------------------~~~~~~~~E~~ 90 (450)
.+.+++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 3567899999999999999999999999999999999987643221 22456889999
Q ss_pred HHHhcCCCCeeeEEEEEEc--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCc
Q 013064 91 LLAEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 168 (450)
Q Consensus 91 il~~l~hp~Iv~l~~~f~~--~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeN 168 (450)
+|+.++||||+++++++.+ ...+|+||||++||+|..++ ..+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999987 67899999999999998765 44679999999999999999999999999999999999
Q ss_pred EEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 169 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 169 ILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
||++.+|++||+|||+++....... .....+||+.|+|||++
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~ 209 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA--------------------------------------LLSNTVGTPAFMAPESL 209 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC--------------------------------------EECCCCSCGGGCCGGGC
T ss_pred EEECCCCCEEEecCCCccccccccc--------------------------------------cccCCcCCccccChhhh
Confidence 9999999999999999987543210 01246899999999999
Q ss_pred ccCC---CCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 249 LKKG---YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 249 ~~~~---y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
.+.. ++.++|+|||||++|+|++|..||.+.+.......+.. ....+|....+++++++||.+||. ||.+|+
T Consensus 210 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~-- 285 (298)
T 2zv2_A 210 SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QALEFPDQPDIAEDLKDLITRMLDKNPESRI-- 285 (298)
T ss_dssp CTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC--
T ss_pred ccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc--ccCCCCCccccCHHHHHHHHHHhhcChhhCC--
Confidence 8755 47889999999999999999999998887777666665 334556556899999999999998 999999
Q ss_pred CCHHHHHcCCCcC
Q 013064 325 RGVEELKEHPWFR 337 (450)
Q Consensus 325 ~~~~eil~Hpff~ 337 (450)
++.++++||||+
T Consensus 286 -s~~e~l~hp~~~ 297 (298)
T 2zv2_A 286 -VVPEIKLHPWVT 297 (298)
T ss_dssp -CHHHHTTCHHHH
T ss_pred -CHHHHhcCcccc
Confidence 689999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=410.21 Aligned_cols=265 Identities=30% Similarity=0.521 Sum_probs=233.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|..+|+.++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3679999999999999999999999999999999987543221 1357789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC----ceEEeeccccccCc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLE 189 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g----~ikL~DFGla~~~~ 189 (450)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999888999999999999999999999999999999999999999888 89999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
... .....+||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 171 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 211 (321)
T 2a2a_A 171 DGV---------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211 (321)
T ss_dssp TTC---------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred ccc---------------------------------------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHH
Confidence 321 01246799999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
++|..||.+.+..+....+..... .++. ...+++.+++||.+||. ||.+|| +++++++||||.+++|....
T Consensus 212 ~~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~hp~~~~~~~~~~~ 285 (321)
T 2a2a_A 212 LSGASPFLGDTKQETLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDNQQAM 285 (321)
T ss_dssp HHSCCSSCCSSHHHHHHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSC---CHHHHHHSTTTSCSSHHHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhcCccccCCCccccc
Confidence 999999999888888877765322 2221 14689999999999998 999999 68999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=435.89 Aligned_cols=261 Identities=32% Similarity=0.595 Sum_probs=233.5
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+|+.++|||||++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3689999999999999999999999999999999987653 334567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc---cCCceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld---~~g~ikL~DFGla~~~~~~~~ 193 (450)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 99999999999999889999999999999999999999999999999999999995 45689999999998654321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.
T Consensus 179 --------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~ 219 (486)
T 3mwu_A 179 --------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT 219 (486)
T ss_dssp -----------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCC
Confidence 0124689999999999976 5999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
+||.+.+..+...++.........|.+..+|+++++||.+||. ||.+|| ++.++++||||+....
T Consensus 220 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 220 PPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSS 285 (486)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHHHCHHHHHTCC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCHhhccCcc
Confidence 9999999988888888766666666667899999999999999 999999 6899999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=409.72 Aligned_cols=263 Identities=28% Similarity=0.481 Sum_probs=208.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
+.++|++++.||+|+||.||+|+++.+|+.||+|+++... .....+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 4579999999999999999999999999999999997653 23344678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 116 IMEYLPGGDIMTLLMRE------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999998 5999988654 359999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilye 268 (450)
.... .....+||+.|+|||++.+ ..|+.++|+|||||++|+
T Consensus 160 ~~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 160 IPVN--------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp SCCC--------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred CCcc--------------------------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHH
Confidence 3210 0124689999999999986 468999999999999999
Q ss_pred HhhCCCCCCCCChhhhhhhhhcccccc---------cCC---------------------CCCCCCHHHHHHHHHhhc-C
Q 013064 269 MLIGYPPFCSDDPRITCRKIVNWKTCL---------KFP---------------------EEPKISDEARDLICHLLC-D 317 (450)
Q Consensus 269 ml~G~~PF~~~~~~~~~~~i~~~~~~~---------~~p---------------------~~~~~s~~~~dli~~lL~-d 317 (450)
|++|.+||.+.+..+....|....... ..+ ....+++++++||.+||. |
T Consensus 202 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 281 (317)
T 2pmi_A 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281 (317)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCC
Confidence 999999999988877766664311000 000 012578999999999999 9
Q ss_pred ccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 318 VETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 318 p~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
|.+|+ +++++++||||++..|.
T Consensus 282 P~~Rp---t~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 282 PDMRL---SAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGSC---CHHHHTTSGGGGGGCC-
T ss_pred cccCC---CHHHHhCChhhhcccch
Confidence 99999 68999999999987664
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=402.98 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=215.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|++ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 6899999999976532 233346788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 999976 899988764 6799999999999999999999999999999999999999999999999999876432100
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+
T Consensus 156 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (288)
T 1ob3_A 156 ------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199 (288)
T ss_dssp ------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0123589999999999976 458999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccc----------------cCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 275 PFCSDDPRITCRKIVNWKTCL----------------KFP---------EEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~----------------~~p---------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
||.+.+..+...++....... .++ ....+++++++||.+||. ||.+|+ +++
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ 276 (288)
T 1ob3_A 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAK 276 (288)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred CCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC---CHH
Confidence 999888776666554310000 000 013589999999999999 999999 689
Q ss_pred HHHcCCCcCCCC
Q 013064 329 ELKEHPWFRGIQ 340 (450)
Q Consensus 329 eil~Hpff~~i~ 340 (450)
++++||||++.+
T Consensus 277 e~l~hp~f~~~n 288 (288)
T 1ob3_A 277 QALEHAYFKENN 288 (288)
T ss_dssp HHHTSGGGGC--
T ss_pred HHhcCcchhhcC
Confidence 999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=410.13 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=191.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----eE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----FL 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----~l 113 (450)
.+|.+.+.||+|+||+||+|++ +|+.||||++++... ......+|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4789999999999999999987 689999999975431 1122234555567789999999999998654 68
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC--------CeEEeecCCCcEEEccCCceEEeecccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--------NYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~--------givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
|||||||+||+|.++|.+. .++++.+..++.|++.||+|||++ +||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999999764 689999999999999999999987 9999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC------CCCccccc
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK------GYGMECDW 259 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~------~y~~~~Di 259 (450)
+......... .....+.+||+.|||||++.+. .|+.++||
T Consensus 156 ~~~~~~~~~~----------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DV 201 (303)
T 3hmm_A 156 VRHDSATDTI----------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201 (303)
T ss_dssp EEEETTTTEE----------------------------------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred ccccCCCCce----------------------------------eeecccccccccccCHHHhcccccccCCccChhHhh
Confidence 8754321110 0112246899999999999764 36789999
Q ss_pred cchhHHHHHHhhCCCCCCCCCh---------------hhhhhhhhcccccccCCCC---CCCCHHHHHHHHHhhc-Cccc
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDP---------------RITCRKIVNWKTCLKFPEE---PKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~---------------~~~~~~i~~~~~~~~~p~~---~~~s~~~~dli~~lL~-dp~~ 320 (450)
|||||+||||++|.+||..... ......+........+|.. ...++.+.+|+.+||. ||.+
T Consensus 202 wS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~ 281 (303)
T 3hmm_A 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGG
T ss_pred hhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhH
Confidence 9999999999999887743321 1122222322222233321 1133568899999998 9999
Q ss_pred cCCCCCHHHHHc
Q 013064 321 RLGTRGVEELKE 332 (450)
Q Consensus 321 R~~~~~~~eil~ 332 (450)
|| ++.||++
T Consensus 282 RP---t~~ei~~ 290 (303)
T 3hmm_A 282 RL---TALRIKK 290 (303)
T ss_dssp SC---CHHHHHH
T ss_pred Cc---CHHHHHH
Confidence 99 5777764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=413.37 Aligned_cols=258 Identities=33% Similarity=0.525 Sum_probs=212.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++.+.||+|+||.||+|+++.+++.||+|++++.. ..+.+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467999999999999999999999999999999997643 235678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFGla~~~~~~~~ 193 (450)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999999999999988889999999999999999999999999999999999999975 8999999999998653320
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
...+.+||+.|+|||++.+..|+.++|+|||||++|||++|.
T Consensus 206 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 247 (349)
T 2w4o_A 206 --------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF 247 (349)
T ss_dssp ---------------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 112468999999999999999999999999999999999999
Q ss_pred CCCCCCChhh-hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 274 PPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 274 ~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
.||.+..... .+..+.+.......+....++.++++||.+||. ||.+|+ ++.++++||||.+..+
T Consensus 248 ~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 248 EPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGKAA 314 (349)
T ss_dssp CTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTTSTTC
T ss_pred CCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCcc
Confidence 9998766544 566666644333334445789999999999998 999999 6899999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=421.11 Aligned_cols=254 Identities=33% Similarity=0.511 Sum_probs=211.3
Q ss_pred CCCCCeEEE-eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH-hcCCCCeeeEEEEEEc---
Q 013064 35 IGIDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQLFYSFQD--- 109 (450)
Q Consensus 35 ~~~~~f~~~-~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~f~~--- 109 (450)
..+++|.++ ++||+|+||+||+|+++.+|+.||||++.+. ..+.+|+.++. ..+||||++++++|.+
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 345789988 7899999999999999999999999999643 24567888874 4589999999999876
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeecc
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFG 183 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFG 183 (450)
..++|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 678999999999999999998754 5999999999999999999999999999999999999997 7899999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchh
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlG 263 (450)
+++...... ...+.+||+.|+|||++.+..|+.++||||||
T Consensus 210 ~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 250 (400)
T 1nxk_A 210 FAKETTSHN---------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250 (400)
T ss_dssp TCEECC--------------------------------------------------CTTCCGGGSCCCCSSSHHHHHHHH
T ss_pred cccccCCCC---------------------------------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHH
Confidence 998654320 01257899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhh----hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 264 AIMYEMLIGYPPFCSDDPRI----TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|++|+|++|.+||.+.+... ...++......+..+.+..+|+++++||++||. ||.+|+ +++++++||||..
T Consensus 251 ~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 327 (400)
T 1nxk_A 251 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCccccC
Confidence 99999999999998765433 334455433333444446799999999999998 999999 6999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=433.59 Aligned_cols=262 Identities=35% Similarity=0.602 Sum_probs=228.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch----------hhHHHHHHHHHHHHhcCCCCeeeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR----------GQVEHVRSERNLLAEVDSRCIVQLFY 105 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv~l~~ 105 (450)
..++|++++.||+|+||.||+|+++.+++.||+|++.+...... ...+.+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34789999999999999999999999999999999987654321 34577899999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEEeec
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDF 182 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL~DF 182 (450)
+|.+...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999999889999999999999999999999999999999999999998876 6999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|+|+...... .....+||+.|+|||++. ..|+.++|+|||
T Consensus 194 g~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Diwsl 233 (504)
T 3q5i_A 194 GLSSFFSKDY---------------------------------------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSC 233 (504)
T ss_dssp TTCEECCTTS---------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHH
T ss_pred CCCEEcCCCC---------------------------------------ccccccCCcCCCCHHHhc-cCCCchHHHHHH
Confidence 9998764321 122468999999999987 569999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
||++|+|++|.+||.+.+..+....+......+..+.+..+|+++++||++||. ||.+|| +++++++||||+...
T Consensus 234 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 234 GVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHHTC
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC---CHHHHhcCHhhhhch
Confidence 999999999999999999988888888754444434445799999999999999 999999 799999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=430.92 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=211.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 110 (450)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 478999999999999999999999999999999998653 3445667889999999999999999999999765
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..+|+||||+.++ |...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 4689999999765 666653 3599999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ...+.+||+.|+|||++.+.+|+.++|||||||++|||+
T Consensus 217 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 257 (464)
T 3ttj_A 217 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257 (464)
T ss_dssp CC---------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred Cc---------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence 21 123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccc-----------------cCCCCC---------------------CCCHHHHHHHH
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCL-----------------KFPEEP---------------------KISDEARDLIC 312 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~-----------------~~p~~~---------------------~~s~~~~dli~ 312 (450)
+|++||.+.+..+.+.+|+...... ..|... ..+++++|||.
T Consensus 258 ~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 337 (464)
T 3ttj_A 258 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337 (464)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHH
Confidence 9999999998877777665421100 000000 01678999999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 313 HLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+||. ||.+|+ +++|+++||||+.
T Consensus 338 ~mL~~dP~~R~---ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 338 KMLVIDPAKRI---SVDDALQHPYINV 361 (464)
T ss_dssp HHSCSSTTTSC---CHHHHHTSTTTGG
T ss_pred HHcCCChhhCC---CHHHHhcChhhhh
Confidence 9999 999999 6999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=406.62 Aligned_cols=265 Identities=28% Similarity=0.471 Sum_probs=229.5
Q ss_pred CCeEEE-eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 013064 38 DDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 38 ~~f~~~-~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lyl 115 (450)
+.|.+. +.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|..++..+ .||||++++++|.+.+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457777 899999999999999999999999999987543 233467788999999998 56999999999999999999
Q ss_pred EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeeccccccCcc
Q 013064 116 IMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLED 190 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFGla~~~~~ 190 (450)
||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998553 67999999999999999999999999999999999999987 78999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. .....+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 187 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 187 AC---------------------------------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227 (327)
T ss_dssp ----------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cc---------------------------------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH
Confidence 21 012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
+|..||.+.+..+....+.........+....+++.+++||.+||. ||.+|| +++++++||||++++|+.+.
T Consensus 228 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 228 THTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTCGGGCCCCTTCC-
T ss_pred hCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhCCHhhccccccccc
Confidence 9999999998888887777654444444445789999999999998 999999 69999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=430.22 Aligned_cols=260 Identities=33% Similarity=0.603 Sum_probs=226.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.++..||+|++.+.... ......+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999999876532 233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFGla~~~~~~~~~ 194 (450)
|||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|.......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 99999999999998899999999999999999999999999999999999999976 4559999999998764321
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
...+.+||+.|+|||++. ..|+.++|||||||++|+|++|.+
T Consensus 194 -------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~ 235 (494)
T 3lij_A 194 -------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235 (494)
T ss_dssp -------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCC
Confidence 122468999999999986 569999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
||.+.+..+...++......+..|.+..+|+.+++||++||. ||.+|+ +++++++||||+...+
T Consensus 236 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 236 PFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKEMCS 300 (494)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc---cHHHHhcCcccccCcc
Confidence 999999998888888765555555556899999999999998 999999 7999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=410.57 Aligned_cols=254 Identities=31% Similarity=0.528 Sum_probs=199.1
Q ss_pred CCeEEE---eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeE
Q 013064 38 DDFEQL---TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 38 ~~f~~~---~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~l 113 (450)
++|++. +.||+|+||.||+|+++.+|+.||+|++.+. ......+|+.+++.+. ||||++++++|.++..+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 456765 7899999999999999999999999999754 2456778999999996 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEEeeccccccCcc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPLED 190 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL~DFGla~~~~~ 190 (450)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999999999999999999999999999999999999999999999999999999998766 899999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
... ...+.+||+.|+|||++.+..|+.++|+|||||++|+|+
T Consensus 162 ~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 203 (325)
T 3kn6_A 162 DNQ--------------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203 (325)
T ss_dssp ------------------------------------------------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred CCC--------------------------------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 210 112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-------hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 271 IGYPPFCSDDP-------RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~~~~-------~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+|.+||.+.+. .+...++......+..+.+..+|+++++||.+||. ||.+|+ +++++++||||++
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~h~w~~~ 276 (325)
T 3kn6_A 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276 (325)
T ss_dssp HSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC---CTTTSTTCGGGCT
T ss_pred hCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCC---CHHHHhcChhhcc
Confidence 99999987543 34455555432222222224689999999999998 999999 6789999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=398.97 Aligned_cols=265 Identities=29% Similarity=0.450 Sum_probs=220.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|++..+|+.||+|++.+.. ......+.+.+|..+++.++||||+++++++.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 578999999999999999999999999999999987653 2334456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--- 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+|
T Consensus 158 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 202 (311)
T 4agu_A 158 -----------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202 (311)
T ss_dssp -------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -----------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 0124589999999999986 6789999999999999999999999
Q ss_pred CCCCChhhhhhhhhccc-----------------ccccCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 276 FCSDDPRITCRKIVNWK-----------------TCLKFPE----------EPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~-----------------~~~~~p~----------~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
|.+.+..+....+.... .....|. .+.+++++.+||.+||. ||.+|| ++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~ 279 (311)
T 4agu_A 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL---TC 279 (311)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC---CH
T ss_pred CCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC---CH
Confidence 99887766555443210 0011111 13689999999999999 999999 69
Q ss_pred HHHHcCCCcCCCCccc
Q 013064 328 EELKEHPWFRGIQWDK 343 (450)
Q Consensus 328 ~eil~Hpff~~i~w~~ 343 (450)
+++++||||+++.|..
T Consensus 280 ~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 280 EQLLHHPYFENIREIE 295 (311)
T ss_dssp HHHHTSGGGTTCC---
T ss_pred HHHhcChHHHhccCHH
Confidence 9999999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=419.54 Aligned_cols=289 Identities=27% Similarity=0.433 Sum_probs=218.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----C
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----D 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~ 111 (450)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++.+. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 479999999999999999999999999999999997643 3444567889999999999999999999999876 5
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||+. |+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 7999999986 599999998888999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh-ccCCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL-LKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl-~~~~y~~~~DiWSlGvilyeml 270 (450)
........ ........ ......+....+.+||+.|+|||++ .+..|+.++|||||||++|||+
T Consensus 183 ~~~~~~~~--------~~~~~~~~--------~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell 246 (432)
T 3n9x_A 183 KDTNIVND--------LEENEEPG--------PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246 (432)
T ss_dssp --------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred cccccccc--------cccccccc--------ccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence 21100000 00000000 0000011123467999999999986 4577999999999999999999
Q ss_pred h-----------CCCCCCCCCh-----------------hhhhhhhhccc----------------------ccccCC--
Q 013064 271 I-----------GYPPFCSDDP-----------------RITCRKIVNWK----------------------TCLKFP-- 298 (450)
Q Consensus 271 ~-----------G~~PF~~~~~-----------------~~~~~~i~~~~----------------------~~~~~p-- 298 (450)
+ |.++|.+.+. ...+..|.+.- .....+
T Consensus 247 ~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (432)
T 3n9x_A 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326 (432)
T ss_dssp TTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred hcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCC
Confidence 8 4555555431 11111111100 000001
Q ss_pred ---CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccccc
Q 013064 299 ---EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 346 (450)
Q Consensus 299 ---~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 346 (450)
..+.+++++.+||.+||. ||.+|+ +++|+++||||+++.|.....
T Consensus 327 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 327 LKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTCGGGTTTCCTTTC-
T ss_pred HHHHCCCCCHHHHHHHHHHhcCCcccCC---CHHHHhcChhhhhccCcccCc
Confidence 014689999999999999 999999 699999999999999977653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=395.79 Aligned_cols=270 Identities=30% Similarity=0.504 Sum_probs=231.6
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc------chhhHHHHHHHHHHHHhcC-CCCeeeEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML------KRGQVEHVRSERNLLAEVD-SRCIVQLFYS 106 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~------~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~ 106 (450)
.-..++|++++.||+|+||.||+|+++.+|+.||+|++...... .....+.+.+|..+|+.+. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 34568999999999999999999999999999999999764311 1233567889999999995 9999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
+.++..+|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc------cCCCCcccccc
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWW 260 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~------~~~y~~~~DiW 260 (450)
...... .....+||+.|+|||++. ...++.++|+|
T Consensus 173 ~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~ 213 (298)
T 1phk_A 173 QLDPGE---------------------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213 (298)
T ss_dssp ECCTTC---------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred hcCCCc---------------------------------------ccccccCCccccCHHHhccccccccccCCcccccH
Confidence 654321 012468999999999986 45689999999
Q ss_pred chhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||||++|+|++|..||.+.+.......+.........+....+++.+++||.+||. ||.+|| +++++++||||++.
T Consensus 214 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~ 290 (298)
T 1phk_A 214 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQY 290 (298)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCTT
T ss_pred hHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCC---CHHHHHhChHhhhc
Confidence 99999999999999999988888777777654444444445789999999999998 999999 78999999999998
Q ss_pred Cccccc
Q 013064 340 QWDKLY 345 (450)
Q Consensus 340 ~w~~l~ 345 (450)
.|+.+.
T Consensus 291 ~~~~~~ 296 (298)
T 1phk_A 291 VVEEVR 296 (298)
T ss_dssp C-----
T ss_pred cchhhc
Confidence 887664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=393.97 Aligned_cols=259 Identities=33% Similarity=0.596 Sum_probs=204.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45799999999999999999999999999999999987665555556789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 116 IMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 99999999999999875 6799999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 168 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (278)
T 3cok_A 168 -------------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210 (278)
T ss_dssp -------------------------------------------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0124679999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||...+......++... ....| ..++.++++||.+||. ||.+|| +++++++||||...
T Consensus 211 p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 211 PFDTDTVKNTLNKVVLA--DYEMP--SFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMSRN 269 (278)
T ss_dssp SSCCCSCC-----CCSS--CCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSTTTC--
T ss_pred CCCChhHHHHHHHHhhc--ccCCc--cccCHHHHHHHHHHcccCHhhCC---CHHHHhcCccccCC
Confidence 99887766666655542 23334 4689999999999998 999999 79999999999763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=399.62 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=215.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc--hhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEc
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK--RGQVEHVRSERNLLAEV---DSRCIVQLFYSFQD 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~ 109 (450)
+..++|++++.||+|+||.||+|+++.+|+.||+|++....... ......+.+|..+++.+ +||||+++++++.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44589999999999999999999999999999999997543211 11234566788777766 59999999999987
Q ss_pred CC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 110 SD-----FLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 110 ~~-----~lylVmEy~~gg~L~~~l~~~~~--~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
.. .+|+||||+. |+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 5899999996 599999987654 999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|+|+...... .....+||+.|+|||++.+..|+.++|+|||
T Consensus 165 g~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (308)
T 3g33_A 165 GLARIYSYQM---------------------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 205 (308)
T ss_dssp SCTTTSTTCC---------------------------------------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred ccccccCCCc---------------------------------------ccCCccccccccCchHHcCCCCCchHHHHHH
Confidence 9998654321 1124689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhcccccc---------c-----CCC---------CCCCCHHHHHHHHHhhc-Cc
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL---------K-----FPE---------EPKISDEARDLICHLLC-DV 318 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~---------~-----~p~---------~~~~s~~~~dli~~lL~-dp 318 (450)
||++|+|++|.+||.+.+......++....... . ++. .+.+++++.+||.+||. ||
T Consensus 206 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (308)
T 3g33_A 206 GCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNP 285 (308)
T ss_dssp HHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCC
Confidence 999999999999999998887777765421110 0 000 13588999999999999 99
Q ss_pred cccCCCCCHHHHHcCCCcCCC
Q 013064 319 ETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 319 ~~R~~~~~~~eil~Hpff~~i 339 (450)
.+|+ ++.|+++||||+..
T Consensus 286 ~~R~---t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 286 HKRI---SAFRALQHSYLHKD 303 (308)
T ss_dssp TTSC---CHHHHHTSTTC---
T ss_pred ccCC---CHHHHhcCccccCC
Confidence 9999 68999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=411.49 Aligned_cols=267 Identities=29% Similarity=0.515 Sum_probs=227.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML--KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
++|++++.||+|+||.||+|+++.+++.||+|++.+.... .....+.+.+|+.+|+.++||||++++++|.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5899999999999999999999999999999999876542 34566789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHhh
Q 013064 116 IMEYLPGGDIMTLLMR----------------------------------------EDILSEDVARFYIAESVLAIHSIH 155 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~----------------------------------------~~~~~e~~~~~~~~qil~aL~~LH 155 (450)
|||||+||+|.+++.. ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112468889999999999999999
Q ss_pred hCCeEEeecCCCcEEEccCC--ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccc
Q 013064 156 QHNYVHRDIKPDNLILDKNG--HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALA 233 (450)
Q Consensus 156 ~~givHrDLKpeNILld~~g--~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (450)
++||+||||||+|||++.++ .+||+|||+++.+....... ....
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----------------------------------~~~~ 231 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----------------------------------YYGM 231 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc----------------------------------cccc
Confidence 99999999999999998777 89999999998654321000 0011
Q ss_pred cccccCCCccchhhhcc--CCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHH
Q 013064 234 YSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 311 (450)
Q Consensus 234 ~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli 311 (450)
...+||+.|+|||++.+ ..|+.++|+|||||++|||++|..||.+.+..+...++......+..|....+++++++||
T Consensus 232 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311 (345)
T ss_dssp ---CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHH
T ss_pred cccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHH
Confidence 24689999999999975 6789999999999999999999999999998888888887655555554456899999999
Q ss_pred HHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 312 CHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 312 ~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
.+||. ||.+|| ++.++++||||+++.|
T Consensus 312 ~~~l~~~p~~Rp---s~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 312 SNLLNRNVDERF---DAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHSCSCTTTSC---CHHHHHHSHHHHTTSS
T ss_pred HHHcCCChhHCC---CHHHHhcChhhccChH
Confidence 99998 999999 6899999999998765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=416.15 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=220.2
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
.+.||+|+||.||+|++..+|+.||+|+++.... ...+.+.+|+.+|+.++||||++++++|.+.+.+|+||||++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 6789999999999999999999999999986532 3456788999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE--ccCCceEEeeccccccCccccccccccc
Q 013064 123 GDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLED 199 (450)
Q Consensus 123 g~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl--d~~g~ikL~DFGla~~~~~~~~~~~~~~ 199 (450)
|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------- 243 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------- 243 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-------
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-------
Confidence 9999988664 479999999999999999999999999999999999999 567899999999998764321
Q ss_pred cccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCC
Q 013064 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSD 279 (450)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 279 (450)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.
T Consensus 244 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 244 --------------------------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp --------------------------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------------------------------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 112458999999999999889999999999999999999999999999
Q ss_pred ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 280 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 280 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
+..+.+.+|......+..+....+++++++||.+||. ||.+|+ +++++++||||.+..|..
T Consensus 292 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 292 NDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKLHS 353 (373)
T ss_dssp SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHCHHHHH
T ss_pred CHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCC---CHHHHhcCcCcCCCchhh
Confidence 9888888887654333333335789999999999999 999999 689999999999876643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=409.49 Aligned_cols=291 Identities=25% Similarity=0.398 Sum_probs=239.6
Q ss_pred hhhhcCCCHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhh
Q 013064 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ 81 (450)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~ 81 (450)
+++...+.++.......-+. .......+..++|++++.||+|+||.||+|++..+|+.||+|++.... ....
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~ 74 (360)
T 3eqc_A 3 KLEELELDEQQRKRLEAFLT------QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAI 74 (360)
T ss_dssp ---CCCCCHHHHHHHHHHHH------HHHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHH
T ss_pred chhhhhhhhhhhhhHHHHhh------hhhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHH
Confidence 45556666666555544443 233445778899999999999999999999999999999999997652 3445
Q ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC-CeE
Q 013064 82 VEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH-NYV 160 (450)
Q Consensus 82 ~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~-giv 160 (450)
.+.+.+|..+|+.++||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||+. ||+
T Consensus 75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~ 154 (360)
T 3eqc_A 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154 (360)
T ss_dssp HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 6788999999999999999999999999999999999999999999999988999999999999999999999996 999
Q ss_pred EeecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCC
Q 013064 161 HRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTL 240 (450)
Q Consensus 161 HrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~ 240 (450)
||||||+|||++.+|++||+|||++...... .....+||+
T Consensus 155 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----------------------------------------~~~~~~gt~ 194 (360)
T 3eqc_A 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----------------------------------------MANSFVGTR 194 (360)
T ss_dssp CSCCSGGGEEECTTCCEEECCCCCCHHHHHH----------------------------------------C----CCCC
T ss_pred cCCccHHHEEECCCCCEEEEECCCCcccccc----------------------------------------cccCCCCCC
Confidence 9999999999999999999999998754221 112468999
Q ss_pred CccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhh---------------------------------
Q 013064 241 DYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRK--------------------------------- 287 (450)
Q Consensus 241 ~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------------------------------- 287 (450)
.|+|||++.+..|+.++|+|||||++|+|++|..||...+.......
T Consensus 195 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
T 3eqc_A 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274 (360)
T ss_dssp TTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------C
T ss_pred CeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCc
Confidence 99999999999999999999999999999999999987665433221
Q ss_pred ---------hhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 288 ---------IVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 288 ---------i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
+... .....+ ...+++++++||.+||. ||.+|+ +++++++||||++.+|+.+.
T Consensus 275 ~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~~ 337 (360)
T 3eqc_A 275 MAIFELLDYIVNE-PPPKLP-SGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVD 337 (360)
T ss_dssp CCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHHHHHSCCC
T ss_pred ccchhhhhHHhcc-CCCCCC-cccccHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhcchHhhhh
Confidence 1111 111112 13579999999999998 999999 79999999999988776654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=405.81 Aligned_cols=261 Identities=26% Similarity=0.478 Sum_probs=213.7
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|+++.+++.||+|++..... ......+.+|..+|+.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 4789999999999999999999999999999999975431 11122345799999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||++ |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--
Confidence 99997 5898888765 4699999999999999999999999999999999999999999999999999986543210
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+
T Consensus 156 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (324)
T 3mtl_A 156 ------------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199 (324)
T ss_dssp -------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 0124589999999999986 678999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccc-----------------cCC---------CCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 275 PFCSDDPRITCRKIVNWKTCL-----------------KFP---------EEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~-----------------~~p---------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
||.+.+..+....+....... .++ ..+.+++++++||.+||. ||.+|+ ++
T Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~ 276 (324)
T 3mtl_A 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI---SA 276 (324)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC---CH
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC---CH
Confidence 999988777666654311100 011 013578999999999999 999999 79
Q ss_pred HHHHcCCCcCCCCc
Q 013064 328 EELKEHPWFRGIQW 341 (450)
Q Consensus 328 ~eil~Hpff~~i~w 341 (450)
+|+++||||.++..
T Consensus 277 ~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 277 EDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHTTSGGGGGGCS
T ss_pred HHHhcChhhhhccc
Confidence 99999999988654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=391.97 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=234.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
...++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45679999999999999999999999999999999998876666667788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 171 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 213 (294)
T 2rku_A 171 -------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213 (294)
T ss_dssp -------------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0124679999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
||.+.+..+....+... ...+| ..+++.+.+||.+||. ||.+|+ +++++++||||....
T Consensus 214 p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 214 PFETSCLKETYLRIKKN--EYSIP--KHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSGY 273 (294)
T ss_dssp TTCCSSHHHHHHHHHTT--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTSC
T ss_pred CCCCCCHHHHHHHHhhc--cCCCc--cccCHHHHHHHHHHcccChhhCc---CHHHHhhChheecCC
Confidence 99998887777777653 23444 4789999999999998 999999 689999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=410.14 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=216.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999997643 33445678899999999999999999999998763
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8899999876 5799999999999999999999999999999999999999999999999999986532
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 269 (450)
. ....+||+.|+|||++.+ ..|+.++|+|||||++|||
T Consensus 181 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 219 (367)
T 1cm8_A 181 E-----------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219 (367)
T ss_dssp S-----------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 2 124689999999999987 7899999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccc------------------cCC---------CCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCL------------------KFP---------EEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~------------------~~p---------~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
++|.+||.+.+....+..|....... .+| ....+++++.+||.+||. ||.+|
T Consensus 220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R 299 (367)
T 1cm8_A 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299 (367)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence 99999999988777766665311100 000 013679999999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCCCcc
Q 013064 322 LGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i~w~ 342 (450)
+ +++++++||||+.+.+.
T Consensus 300 ~---t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 300 V---TAGEALAHPYFESLHDT 317 (367)
T ss_dssp C---CHHHHHHSGGGTTTC--
T ss_pred C---CHHHHhcChHHHhhcCC
Confidence 9 68999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=391.97 Aligned_cols=253 Identities=32% Similarity=0.567 Sum_probs=225.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++.+.||+|+||.||+|+++.++..+|+|++.+... ...+.+.+|..+++.++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999987542 34567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE---ccCCceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl---d~~g~ikL~DFGla~~~~~~~~~ 194 (450)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 999999999999988999999999999999999999999999999999999999 788999999999998654321
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
...+.+||+.|+|||++.+. ++.++|+|||||++|+|++|..
T Consensus 164 -------------------------------------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~ 205 (277)
T 3f3z_A 164 -------------------------------------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYP 205 (277)
T ss_dssp -------------------------------------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCC
Confidence 11246899999999998754 9999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||.+.+..+...++.... ..+|. ...+++.+.+||.+||. ||.+|+ ++.++++||||++
T Consensus 206 p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 206 PFSAPTDSEVMLKIREGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267 (277)
T ss_dssp SSCCSSHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHHH
T ss_pred CCCCCCHHHHHHHHHhCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhc
Confidence 999988888887777643 23332 23689999999999998 999999 6899999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=402.78 Aligned_cols=268 Identities=29% Similarity=0.519 Sum_probs=214.3
Q ss_pred CCCeEEE-eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEE
Q 013064 37 IDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 37 ~~~f~~~-~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ly 114 (450)
.+.|+++ +.||+|+||.||+|+++.+|+.||+|++.+.. ......+.+|+.+|..+ +||||++++++|.+++.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3678986 78999999999999999999999999997653 33456788999999885 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc---eEEeeccccccCccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLEDK 191 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~---ikL~DFGla~~~~~~ 191 (450)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999998889999999999999999999999999999999999999998776 999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCccccccchhHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGMECDWWSLGAIM 266 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~~~DiWSlGvil 266 (450)
..... .......+.+||+.|+|||++.+ ..|+.++|+|||||++
T Consensus 168 ~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 216 (316)
T 2ac3_A 168 GDCSP-------------------------------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216 (316)
T ss_dssp ---------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHH
T ss_pred Ccccc-------------------------------ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHH
Confidence 10000 00001224689999999999975 5589999999999999
Q ss_pred HHHhhCCCCCCCCChh---------------hhhhhhhcccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 267 YEMLIGYPPFCSDDPR---------------ITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 267 yeml~G~~PF~~~~~~---------------~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
|+|++|.+||.+.+.. .....+... ...+|. ...+++++++||.+||. ||.+|+ +++
T Consensus 217 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ 291 (316)
T 2ac3_A 217 YILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRL---SAA 291 (316)
T ss_dssp HHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHH
T ss_pred HHHHHCCCCCcccccccccccccccchhHHHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCC---CHH
Confidence 9999999999876532 234444442 233332 24689999999999998 999999 789
Q ss_pred HHHcCCCcCCCCccc
Q 013064 329 ELKEHPWFRGIQWDK 343 (450)
Q Consensus 329 eil~Hpff~~i~w~~ 343 (450)
++++||||++..|..
T Consensus 292 e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 292 QVLQHPWVQGCAPEN 306 (316)
T ss_dssp HHHHSTTCC------
T ss_pred HHhcChhhcCCCCcc
Confidence 999999999876643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=407.38 Aligned_cols=258 Identities=30% Similarity=0.553 Sum_probs=220.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...... .....+.+|..+|+.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 689999999999999999999999999999999987654322 134457789999999999999999999999999
Q ss_pred EEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGG-DIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg-~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|+||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999766 99999999889999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml 270 (450)
. ...+.+||+.|+|||++.+..+ +.++|||||||++|+|+
T Consensus 184 ~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 224 (335)
T 3dls_A 184 K---------------------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224 (335)
T ss_dssp C---------------------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHH
T ss_pred C---------------------------------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHH
Confidence 1 1234689999999999998887 88999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC------CCccc
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG------IQWDK 343 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~------i~w~~ 343 (450)
+|..||..... +.. .....| ..+++++++||.+||. ||.+|| +++++++||||+. ++|+.
T Consensus 225 ~g~~pf~~~~~------~~~--~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~~~~~~~~~~~ 291 (335)
T 3dls_A 225 FEENPFCELEE------TVE--AAIHPP--YLVSKELMSLVSGLLQPVPERRT---TLEKLVTDPWVTQPVNLADYTWEE 291 (335)
T ss_dssp HSSCSCSSGGG------GTT--TCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHHCTTTTCCCCGGGCCHHH
T ss_pred hCCCchhhHHH------HHh--hccCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHhcCccccCCccccccCHHH
Confidence 99999975221 121 112223 3689999999999998 999999 6999999999965 45555
Q ss_pred cccc
Q 013064 344 LYEM 347 (450)
Q Consensus 344 l~~~ 347 (450)
+...
T Consensus 292 ~~~~ 295 (335)
T 3dls_A 292 VFRV 295 (335)
T ss_dssp HC--
T ss_pred Hhhh
Confidence 5443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=398.81 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=234.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
...++|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44578999999999999999999999999999999998876666667788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 197 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 239 (335)
T 2owb_A 197 -------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239 (335)
T ss_dssp -------------------------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcC
Confidence 0124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
||.+.+..+.+..+... ...+| ..+++.+.+||.+||. ||.+|+ +++++++||||....
T Consensus 240 pf~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~~~~~~~~~ 299 (335)
T 2owb_A 240 PFETSCLKETYLRIKKN--EYSIP--KHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSGY 299 (335)
T ss_dssp TTCCSSHHHHHHHHHHT--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTSC
T ss_pred CCCCCCHHHHHHHHhcC--CCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccCCC
Confidence 99988877777777653 23444 3789999999999998 999999 689999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=397.06 Aligned_cols=257 Identities=33% Similarity=0.600 Sum_probs=226.5
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|.+++.||+|+||.||+|+++.+|+.||+|++++... ...+.+.+|..+++.++||||+++++++.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3689999999999999999999999999999999986532 2335678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE---ccCCceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl---d~~g~ikL~DFGla~~~~~~~~ 193 (450)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 9999999999999888899999999999999999999999999999999999999 788999999999987543210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....+||+.|+|||++.+..|+.++|+|||||++|+|++|.
T Consensus 164 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 204 (304)
T 2jam_A 164 ---------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY 204 (304)
T ss_dssp ---------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 12357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
.||.+.+.......+.........+....+++++++||.+||. ||.+|+ +++++++||||.+.
T Consensus 205 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 205 PPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCEKALSHPWIDGN 268 (304)
T ss_dssp CTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHSS
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCccccCC
Confidence 9999988888888877654444334445789999999999998 999999 68999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=407.73 Aligned_cols=258 Identities=33% Similarity=0.569 Sum_probs=225.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCC
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSD 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~ 111 (450)
++|++.+.||+|+||.||+|+++.+|+.||||++...... .....+.+.+|..++..+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999999999999999764311 112346678999999999 8999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc------CCCCccccccchhHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK------KGYGMECDWWSLGAI 265 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~------~~y~~~~DiWSlGvi 265 (450)
. .....+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 254 ~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 294 (365)
T 2y7j_A 254 E---------------------------------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294 (365)
T ss_dssp C---------------------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHH
T ss_pred c---------------------------------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHH
Confidence 1 1124689999999999963 368999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
+|+|++|..||.+.+.......+.........|.+..+++.+.+||.+||. ||.+|+ +++++++||||+
T Consensus 295 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~ 364 (365)
T 2y7j_A 295 LFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGC
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCcccC
Confidence 999999999999988877777777644333333335789999999999998 999999 799999999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=410.09 Aligned_cols=271 Identities=27% Similarity=0.428 Sum_probs=214.7
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
.++|++++.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|.+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 579999999999999999999999999999999997643 33445677889999999999999999999998765
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+||||++| +|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 79999999975 7888875 4599999999999999999999999999999999999999999999999999986533
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ...+.+||+.|+|||++.+..|+.++|+|||||++|+|+
T Consensus 180 ~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 220 (371)
T 2xrw_A 180 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220 (371)
T ss_dssp -------------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cc---------------------------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence 20 012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhccccc----------------------------------ccCCCC----CCCCHHHHHHHH
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTC----------------------------------LKFPEE----PKISDEARDLIC 312 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~~----~~~s~~~~dli~ 312 (450)
+|.+||.+.+....+.+++..... ..+|.. ...++++++||+
T Consensus 221 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 300 (371)
T 2xrw_A 221 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 300 (371)
T ss_dssp HSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHH
Confidence 999999998887776666542110 000100 012578999999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCCccc
Q 013064 313 HLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKP 353 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p 353 (450)
+||. ||.+|+ +++++++||||+...........+|..|
T Consensus 301 ~mL~~dP~~R~---t~~e~l~hp~~~~~~~~~~~~~~~~~~~ 339 (371)
T 2xrw_A 301 KMLVIDASKRI---SVDEALQHPYINVWYDPSEAEAPPPKIP 339 (371)
T ss_dssp HHSCSSGGGSC---CHHHHHHSHHHHTTCCHHHHTCCCCCCC
T ss_pred HHCcCChhhCC---CHHHHhCCcchhhhcCccccCCCCCCCC
Confidence 9999 999999 7999999999985332222233444444
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=394.25 Aligned_cols=264 Identities=30% Similarity=0.520 Sum_probs=228.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
++|++++.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|..+++.++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999987643322 13677899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC----ceEEeeccccccCcc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLED 190 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g----~ikL~DFGla~~~~~ 190 (450)
+||||++|++|.+++.+...+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999998877 899999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
... ....+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 165 ~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 205 (283)
T 3bhy_A 165 GNE---------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205 (283)
T ss_dssp ----------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CCc---------------------------------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHH
Confidence 210 12357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
+|..||.+.+..+....+.........+....+++.+++||.+||. ||.+|| ++.++++||||+.+.|..
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 206 SGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC---CHHHHHHCHHHHHHHHCC
T ss_pred HCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc---CHHHHHhCHHHHHHHHHh
Confidence 9999999988877777766533222111124689999999999998 999999 689999999999876544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=390.77 Aligned_cols=255 Identities=28% Similarity=0.521 Sum_probs=217.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|.+.+.||+|+||.||+|+++.+++.+|+|++.+.. .....+.+.+|..+|+.++||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 68999999999999999999999999999999998764 2334678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE---ccCCceEEeeccccccCcc
Q 013064 118 EYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 118 Ey~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl---d~~g~ikL~DFGla~~~~~ 190 (450)
||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999998854 3689999999999999999999999999999999999999 4568899999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
... ....+||+.|+|||++. ..++.++|+|||||++|+|+
T Consensus 180 ~~~---------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll 219 (285)
T 3is5_A 180 DEH---------------------------------------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL 219 (285)
T ss_dssp ----------------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH
T ss_pred ccc---------------------------------------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHH
Confidence 210 12468999999999985 57899999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+|..||.+.+..+....+......... ....+++++.+||.+||. ||.+|| +++|+++||||+.
T Consensus 220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~ 284 (285)
T 3is5_A 220 TGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFKQ 284 (285)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGGC
T ss_pred hCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHhhc
Confidence 999999998877776666543222222 123589999999999998 999999 7999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=388.72 Aligned_cols=261 Identities=28% Similarity=0.525 Sum_probs=224.0
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
...+..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+.+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45677899999999999999999999999999999999998766545556778999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml 270 (450)
. .....+||+.|+|||++.+..+ +.++|+|||||++|+|+
T Consensus 165 ~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 205 (276)
T 2h6d_A 165 E---------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205 (276)
T ss_dssp ---------------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 1 0123579999999999988766 68999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+|..||.+.+.......+... ...+| ..+++.+.+||.+||. ||.+|| +++++++||||+.
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 206 CGTLPFDDEHVPTLFKKIRGG--VFYIP--EYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFKQ 267 (276)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHT
T ss_pred hCCCCCCCCcHHHHHHHhhcC--cccCc--hhcCHHHHHHHHHHccCChhhCC---CHHHHHhChhhcc
Confidence 999999988877777776653 23344 3689999999999998 999999 7899999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=395.64 Aligned_cols=256 Identities=30% Similarity=0.513 Sum_probs=224.0
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|+..+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888999999999999999999999999999997543 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
|++||+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-----
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-----
Confidence 9999999998754 5799999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCS 278 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 278 (450)
.....+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+
T Consensus 197 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 197 ---------------------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp ---------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---------------------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01246899999999999999999999999999999999999999998
Q ss_pred CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 279 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
.+.......+..... ...+....+++.+++||.+||. ||.+|| +++++++||||....
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~ 302 (321)
T 2c30_A 244 DSPVQAMKRLRDSPP-PKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLLQTG 302 (321)
T ss_dssp SCHHHHHHHHHHSSC-CCCTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGGGCC
T ss_pred CCHHHHHHHHhcCCC-CCcCccccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhccCC
Confidence 888777776654321 2223334689999999999998 999999 799999999997644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=404.20 Aligned_cols=267 Identities=27% Similarity=0.385 Sum_probs=220.2
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc------
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------ 109 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------ 109 (450)
.+++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|..+|+.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45899999999999999999999999999999999876542 33344567889999999999999999999987
Q ss_pred --CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 110 --SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 110 --~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
.+.+|+||||++| +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999975 777777654 679999999999999999999999999999999999999999999999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAI 265 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvi 265 (450)
.+....... .......+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 173 ~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 218 (351)
T 3mi9_A 173 AFSLAKNSQ----------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218 (351)
T ss_dssp ECCCCSSSS----------------------------------CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred ccccccccc----------------------------------ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence 764321110 011234689999999999976 568999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCC----------------------------CCHHHHHHHHHhhc-
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPK----------------------------ISDEARDLICHLLC- 316 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~----------------------------~s~~~~dli~~lL~- 316 (450)
+|+|++|.+||.+.+.......+...........++. .++.+++||.+||.
T Consensus 219 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 298 (351)
T 3mi9_A 219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298 (351)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence 9999999999999888777666654222111111111 27889999999999
Q ss_pred CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 317 DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 317 dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
||.+|+ +++|+++||||.+..+
T Consensus 299 dP~~R~---t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 299 DPAQRI---DSDDALNHDFFWSDPM 320 (351)
T ss_dssp SGGGSC---CHHHHHTSGGGGSSSC
T ss_pred ChhhCC---CHHHHhCCCCcCCCCC
Confidence 999999 6899999999987554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=387.58 Aligned_cols=257 Identities=21% Similarity=0.369 Sum_probs=219.4
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc----C
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----S 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~ 110 (450)
..-..|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|..+|+.++||||++++++|.+ .
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 334569999999999999999999999999999999986653 44567788999999999999999999999875 4
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEc-cCCceEEeecccccc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILD-KNGHLKLSDFGLCKP 187 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld-~~g~ikL~DFGla~~ 187 (450)
..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 679999999999999999998889999999999999999999999999 99999999999997 789999999999975
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
..... ....+||+.|+|||++. ..++.++|+|||||++|
T Consensus 182 ~~~~~----------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~ 220 (290)
T 1t4h_A 182 KRASF----------------------------------------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCML 220 (290)
T ss_dssp CCTTS----------------------------------------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHH
T ss_pred ccccc----------------------------------------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHH
Confidence 43221 12467999999999886 45999999999999999
Q ss_pred HHhhCCCCCCCCChh-hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 268 EMLIGYPPFCSDDPR-ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 268 eml~G~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+|++|..||.+.... .....+........++ ...++++.+||.+||. ||.+|| +++++++||||++
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~f~~ 288 (290)
T 1t4h_A 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC-
T ss_pred HHHhCCCCCCCcCcHHHHHHHHhccCCccccC--CCCCHHHHHHHHHHccCChhhCC---CHHHHhhCccccc
Confidence 999999999875443 3444444332222333 3678999999999999 999999 7999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=403.38 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=220.1
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD---- 111 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~---- 111 (450)
-.++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..+++.++||||+++++++.+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999999999999999998765555556778899999999999999999999988654
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 45999999999999999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 170 ~~~-----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 214 (311)
T 3ork_A 170 GNS-----------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214 (311)
T ss_dssp -----------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccc-----------------------------------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 110 001224689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|..||.+.+.......+..............+++++.+||.+||. ||.+|+ +..+++.|+|++.
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~~ 279 (311)
T 3ork_A 215 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY---QTAAEMRADLVRV 279 (311)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh---hhHHHHHHHHHHH
Confidence 999999988877766665432211111124689999999999998 999999 4678889999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=419.18 Aligned_cols=265 Identities=29% Similarity=0.567 Sum_probs=214.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR-----GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
.++|.+.+.||+|+||.||+|.++.+++.||+|++.+...... .....+.+|+.+|+.++|||||+++++|.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 3789999999999999999999999999999999987653221 122357889999999999999999999865 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceEEeeccccccC
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLKLSDFGLCKPL 188 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ikL~DFGla~~~ 188 (450)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999998888999999999999999999999999999999999999997554 5999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAI 265 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvi 265 (450)
.... ...+.+||+.|+|||++.+ ..|+.++|+|||||+
T Consensus 293 ~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i 333 (419)
T 3i6u_A 293 GETS---------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333 (419)
T ss_dssp C--------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHH
T ss_pred CCCc---------------------------------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHH
Confidence 4321 1225689999999999864 678899999999999
Q ss_pred HHHHhhCCCCCCCCChhhhh-hhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 266 MYEMLIGYPPFCSDDPRITC-RKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~-~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
+|+|++|.+||.+....... ..+.........+.+..+++.+++||.+||. ||.+|+ +++++++||||++.+|..
T Consensus 334 l~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~~~~~ 410 (419)
T 3i6u_A 334 LFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDEDMKR 410 (419)
T ss_dssp HHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGCCHHHHH
T ss_pred HHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCc---CHHHHhCCcccCChhHHH
Confidence 99999999999876554333 3333321111111124689999999999998 999999 689999999999887754
Q ss_pred c
Q 013064 344 L 344 (450)
Q Consensus 344 l 344 (450)
.
T Consensus 411 ~ 411 (419)
T 3i6u_A 411 K 411 (419)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=400.30 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=219.9
Q ss_pred HHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----CCCeeeE
Q 013064 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----SRCIVQL 103 (450)
Q Consensus 29 ~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-----hp~Iv~l 103 (450)
..+...+..++|++++.||+|+||.||+|++..+++.||+|++++. .........|..+++.+. ||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3444456668999999999999999999999999999999999743 234556778999999986 9999999
Q ss_pred EEEEEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc--------
Q 013064 104 FYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-------- 173 (450)
Q Consensus 104 ~~~f~~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-------- 173 (450)
+++|.+.+.+|+||||+ ||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 999999998764 5999999999999999999999999999999999999975
Q ss_pred -----------------CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhcccccccc
Q 013064 174 -----------------NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYST 236 (450)
Q Consensus 174 -----------------~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 236 (450)
++.+||+|||+|+..... ..+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------------------------------------~~~~ 219 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------------------------------------HGSI 219 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------------------------------------CCSC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC-----------------------------------------CcCc
Confidence 889999999999864322 1246
Q ss_pred ccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhccccc----------------------
Q 013064 237 VGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTC---------------------- 294 (450)
Q Consensus 237 ~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---------------------- 294 (450)
+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 220 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 299 (360)
T 3llt_A 220 INTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE 299 (360)
T ss_dssp CSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTT
T ss_pred cCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCccc
Confidence 8999999999999999999999999999999999999999988776665554431110
Q ss_pred --ccCCCC------------------CCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 295 --LKFPEE------------------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 295 --~~~p~~------------------~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
..+|.. ...++.+.+||.+||. ||.+|| +++|+++||||+
T Consensus 300 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~ 360 (360)
T 3llt_A 300 LKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360 (360)
T ss_dssp TEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGC
T ss_pred ceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC---CHHHHhcCcccC
Confidence 011110 0124778899999999 999999 789999999995
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=401.17 Aligned_cols=266 Identities=28% Similarity=0.446 Sum_probs=216.8
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK--RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
..++|++++.||+|+||.||+|+++.+|+.||+|++....... ......+.+|+.+++.++||||++++++|.+.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4589999999999999999999999999999999997643221 11234678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|+||||++| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999986 888888664 469999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~ 271 (450)
. .....+||+.|+|||++.+ ..|+.++|+|||||++|+|++
T Consensus 167 ~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 208 (346)
T 1ua2_A 167 R--------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208 (346)
T ss_dssp C--------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred c--------------------------------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH
Confidence 0 1124689999999999975 458999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccc---------cCCC---------------CCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCL---------KFPE---------------EPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~---------~~p~---------------~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
|.+||.+.+..+.+.+|....... ..+. ...+++++++||.+||. ||.+|+ +
T Consensus 209 g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t 285 (346)
T 1ua2_A 209 RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---T 285 (346)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---C
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC---C
Confidence 999999988887777765421110 0000 13567999999999998 999999 6
Q ss_pred HHHHHcCCCcCCCCccc
Q 013064 327 VEELKEHPWFRGIQWDK 343 (450)
Q Consensus 327 ~~eil~Hpff~~i~w~~ 343 (450)
++|+++||||++..|..
T Consensus 286 ~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 286 ATQALKMKYFSNRPGPT 302 (346)
T ss_dssp HHHHHTSGGGTSSSCCC
T ss_pred HHHHhcChhhhcCCCCC
Confidence 89999999999876544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=388.35 Aligned_cols=261 Identities=25% Similarity=0.378 Sum_probs=218.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..+++.++||||+++++++.+++.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 44578999999999999999999999999999999997765555566788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL- 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999987543210
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 167 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 210 (294)
T 4eqm_A 167 ------------------------------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210 (294)
T ss_dssp --------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 01124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhccccc-ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 275 PFCSDDPRITCRKIVNWKTC-LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
||.+.+......+.+..... ........+++.+.++|.+||. ||.+|++ ++++++ +.|
T Consensus 211 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~--~~~~l~-~~l 270 (294)
T 4eqm_A 211 PFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK--TIQEMK-DDL 270 (294)
T ss_dssp SSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS--SHHHHH-HHH
T ss_pred CCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc--cHHHHH-HHH
Confidence 99998877665555442211 1111124789999999999998 9999995 344444 444
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=398.60 Aligned_cols=255 Identities=27% Similarity=0.368 Sum_probs=222.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998654444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~-~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||+. |+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9997 57877775 4568999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHHHHHhhCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.+.+||+.|+|||++. ...|+.++|||||||++|||++|.
T Consensus 208 -------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~ 250 (348)
T 1u5q_A 208 -------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250 (348)
T ss_dssp -------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 2468999999999995 467899999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
+||.+.+.......+........ ....+++.+++||.+||. ||.+|| +++++++||||....
T Consensus 251 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 251 PPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRER 313 (348)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHSCC
T ss_pred CCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCc---CHHHHhhChhhhccC
Confidence 99998887777666665332221 224789999999999998 999999 689999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=404.04 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=203.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------C
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------D 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------~ 111 (450)
++|++++.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.+|+.++||||++++++|... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 79999999999999999999999999999999997643 2344567788999999999999999999999764 5
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||+ |++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 689999999 7899998865 67999999999999999999999999999999999999999999999999999864321
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
....+||+.|+|||++.+ ..|+.++|||||||++|||+
T Consensus 186 -----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 224 (367)
T 2fst_X 186 -----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224 (367)
T ss_dssp ----------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH
T ss_pred -----------------------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH
Confidence 124689999999999987 67899999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhccccc---------------------ccCCC------CCCCCHHHHHHHHHhhc-CccccC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTC---------------------LKFPE------EPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+|.+||.+.+....+..|...... ...+. ...+++++++||.+||. ||.+|+
T Consensus 225 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~ 304 (367)
T 2fst_X 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304 (367)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc
Confidence 999999998877766665431100 00010 13578999999999999 999999
Q ss_pred CCCCHHHHHcCCCcCCCCc
Q 013064 323 GTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~i~w 341 (450)
+++++++||||+.+..
T Consensus 305 ---t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 305 ---TAAQALAHAYFAQYHD 320 (367)
T ss_dssp ---CHHHHHTSGGGTTTCC
T ss_pred ---CHHHHhcChhhhhccC
Confidence 6899999999997654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=392.64 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=206.0
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~~~~lylV 116 (450)
++|++++.||+|+||+||+|+++.+|+.||||++.+...... .......|...+.. ..||||++++++|.+.+.+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 569999999999999999999999999999999866432222 33344445555544 4999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||+ +|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--- 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--- 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---
Confidence 9999 77898888764 469999999999999999999999999999999999999999999999999988654321
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|..|
T Consensus 212 ------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 212 ------------------------------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp ---------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred ------------------------------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 0124579999999999876 799999999999999999999877
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|.+... ...+........++ ..+++++.+||.+||. ||.+|+ +++++++||||+.
T Consensus 255 ~~~~~~---~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 310 (311)
T 3p1a_A 255 PHGGEG---WQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRA---TAEALLALPVLRQ 310 (311)
T ss_dssp CSSHHH---HHHHTTTCCCHHHH--TTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGSC
T ss_pred CCCccH---HHHHhccCCCcccc--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHhCccccC
Confidence 765433 22333221122222 3689999999999999 999999 7999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=392.47 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=212.7
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEc--CCe
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQD--SDF 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~--~~~ 112 (450)
..++|++++.||+|+||.||+|++..+++.||+|++++. ..+.+.+|..+|+.+. ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 357999999999999999999999999999999998743 2466889999999997 9999999999998 678
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~~ 191 (450)
.|+||||+++++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999998874 489999999999999999999999999999999999999777 8999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
.. ....+||+.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 185 ~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 225 (330)
T 3nsz_A 185 QE---------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225 (330)
T ss_dssp CC---------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred Cc---------------------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence 10 124689999999999987 67899999999999999999
Q ss_pred hCCCCCCCC-Chhhhhhhhhcc---------------------------------cccccCCCCCCCCHHHHHHHHHhhc
Q 013064 271 IGYPPFCSD-DPRITCRKIVNW---------------------------------KTCLKFPEEPKISDEARDLICHLLC 316 (450)
Q Consensus 271 ~G~~PF~~~-~~~~~~~~i~~~---------------------------------~~~~~~p~~~~~s~~~~dli~~lL~ 316 (450)
+|..||... +..+....+... ...........+++++++||.+||.
T Consensus 226 ~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 305 (330)
T 3nsz_A 226 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305 (330)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSC
T ss_pred hCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhc
Confidence 999999543 322222222110 0000111112379999999999999
Q ss_pred -CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 317 -DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 317 -dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
||.+|+ +++|+++||||+++.|+
T Consensus 306 ~dP~~Rp---ta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 306 YDHQSRL---TAREAMEHPYFYTVVKD 329 (330)
T ss_dssp SSGGGSC---CHHHHHTSGGGTTCC--
T ss_pred CCcccCC---CHHHHhcCccHhhhccC
Confidence 999999 79999999999999876
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=406.70 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=211.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS------ 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~------ 110 (450)
..+|++++.||+|+||.||+|++..+++ +|+|++.+.... ..+|+.+|+.++||||++++++|...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3579999999999999999999988777 777776543321 23699999999999999999999543
Q ss_pred CeEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-cCCceEEeeccccc
Q 013064 111 DFLYLIMEYLPGGDIMTLL---MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCK 186 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l---~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-~~g~ikL~DFGla~ 186 (450)
.++|+||||++++.+.... .....+++..++.|+.||+.||.|||++||+||||||+|||++ .+|++||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 3489999999876443332 2356899999999999999999999999999999999999999 79999999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAI 265 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvi 265 (450)
...... ...+.+||+.|+|||++.+. .|+.++|||||||+
T Consensus 191 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 231 (394)
T 4e7w_A 191 ILIAGE---------------------------------------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCV 231 (394)
T ss_dssp ECCTTC---------------------------------------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred cccCCC---------------------------------------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHH
Confidence 754321 01246899999999999764 58999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccc---------------cccCCC----------CCCCCHHHHHHHHHhhc-Ccc
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKT---------------CLKFPE----------EPKISDEARDLICHLLC-DVE 319 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~~lL~-dp~ 319 (450)
+|||++|.+||.+.+..+.+..|+.... ...+|. ...+++++++||.+||. ||.
T Consensus 232 l~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (394)
T 4e7w_A 232 MAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS 311 (394)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChh
Confidence 9999999999999887777666653110 011111 13589999999999999 999
Q ss_pred ccCCCCCHHHHHcCCCcCCCCcccc
Q 013064 320 TRLGTRGVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 320 ~R~~~~~~~eil~Hpff~~i~w~~l 344 (450)
+|+ ++.|+++||||+++.|...
T Consensus 312 ~R~---t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 312 ARL---TAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp GSC---CHHHHHTSGGGSTTTSSCC
T ss_pred hCC---CHHHHhcChhhhhhccccc
Confidence 999 6899999999999887654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=397.20 Aligned_cols=266 Identities=23% Similarity=0.406 Sum_probs=211.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
+++|++++.||+|+||.||+|+++.+|+.||+|+++... .....+.+.+|..+|+.++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 368999999999999999999999999999999997653 3345678999999999999999999999986543
Q ss_pred ----------------------------------------------------eEEEEEeccCCCChHHHHHhcCC---CC
Q 013064 112 ----------------------------------------------------FLYLIMEYLPGGDIMTLLMREDI---LS 136 (450)
Q Consensus 112 ----------------------------------------------------~lylVmEy~~gg~L~~~l~~~~~---~~ 136 (450)
++|+|||||+||+|.+++.+... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 48999999999999999987643 55
Q ss_pred HHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCC
Q 013064 137 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216 (450)
Q Consensus 137 e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (450)
+..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++........... ..
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~----------~~------- 225 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV----------LT------- 225 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc----------cc-------
Confidence 6678999999999999999999999999999999999999999999999876543111000 00
Q ss_pred ChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhccccccc
Q 013064 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLK 296 (450)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~ 296 (450)
...........+||+.|+|||++.+..|+.++|+|||||++|+|++|..|+... ......+.. ..
T Consensus 226 ---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~----~~ 290 (332)
T 3qd2_B 226 ---------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN----LK 290 (332)
T ss_dssp ---------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT----TC
T ss_pred ---------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc----cC
Confidence 000001123468999999999999999999999999999999999998876321 122222222 22
Q ss_pred CCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 297 FPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 297 ~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+|. ....++++++||.+||. ||.+|| +++++++||||+++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFENL 332 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSC---CHHHHHHSTTCCCC
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCC---CHHHHhhchhhhcC
Confidence 221 12467889999999998 999999 68999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=411.71 Aligned_cols=261 Identities=21% Similarity=0.227 Sum_probs=204.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc--CCCCeeeEE-------EEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV--DSRCIVQLF-------YSFQ 108 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~-------~~f~ 108 (450)
.+|.+++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4699999999999999999999999999999999987654556677888886555555 699988866 4554
Q ss_pred cC-----------------CeEEEEEeccCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHhhhCCeEEeec
Q 013064 109 DS-----------------DFLYLIMEYLPGGDIMTLLMRED-ILSEDVA------RFYIAESVLAIHSIHQHNYVHRDI 164 (450)
Q Consensus 109 ~~-----------------~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~------~~~~~qil~aL~~LH~~givHrDL 164 (450)
.. ..+|+|||||+ |+|.+++...+ .+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 34899999998 89999998743 3444444 456699999999999999999999
Q ss_pred CCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccc
Q 013064 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 244 (450)
Q Consensus 165 KpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~A 244 (450)
||+||||+.+|++||+|||+|+..... .....||+.|+|
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~-----------------------------------------~~~~~~t~~y~a 259 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR-----------------------------------------GPASSVPVTYAP 259 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE-----------------------------------------EEGGGSCGGGCC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC-----------------------------------------ccCccCCcCCcC
Confidence 999999999999999999999865432 113467799999
Q ss_pred hhhhcc--CCCCccccccchhHHHHHHhhCCCCCCCCChhh--hhhh---hhcccccccCCCCCCCCHHHHHHHHHhhc-
Q 013064 245 PEVLLK--KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI--TCRK---IVNWKTCLKFPEEPKISDEARDLICHLLC- 316 (450)
Q Consensus 245 PEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~---i~~~~~~~~~p~~~~~s~~~~dli~~lL~- 316 (450)
||++.+ ..|+.++|||||||++|||++|.+||.+..... .+.. +......+.++....+++.+++||.+||.
T Consensus 260 PE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 339 (371)
T 3q60_A 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339 (371)
T ss_dssp HHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCS
T ss_pred hhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCC
Confidence 999987 789999999999999999999999998774432 1111 12222344555556899999999999998
Q ss_pred CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 317 DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 317 dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
||.+|+ +++++++||||+++.|..
T Consensus 340 dP~~Rp---t~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 340 DRRRRL---LPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp STTTCC---CHHHHTTSHHHHHHHHHH
T ss_pred ChhhCC---CHHHHhcCHHHHHHHHHH
Confidence 999999 689999999999988753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=414.66 Aligned_cols=249 Identities=18% Similarity=0.206 Sum_probs=210.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH---HHHhcCCCCeeeEE-------EE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN---LLAEVDSRCIVQLF-------YS 106 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~---il~~l~hp~Iv~l~-------~~ 106 (450)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999998766556667788999995 45556899999998 77
Q ss_pred EEcCCe-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHhhhCCeEEe
Q 013064 107 FQDSDF-----------------LYLIMEYLPGGDIMTLLMREDILSE-------DVARFYIAESVLAIHSIHQHNYVHR 162 (450)
Q Consensus 107 f~~~~~-----------------lylVmEy~~gg~L~~~l~~~~~~~e-------~~~~~~~~qil~aL~~LH~~givHr 162 (450)
+.+.+. .|+||||+ +|+|.+++.+.+.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 6899999987666666 7778899999999999999999999
Q ss_pred ecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCc
Q 013064 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 242 (450)
Q Consensus 163 DLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y 242 (450)
||||+|||++.+|.+||+|||+|+..... ..+.+| +.|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~-----------------------------------------~~~~~g-~~y 268 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----------------------------------------VVSSVS-RGF 268 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCE-----------------------------------------EECCCC-TTC
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCc-----------------------------------------ccCCCC-cCc
Confidence 99999999999999999999999854321 124678 999
Q ss_pred cchhhhccC-----------CCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHH
Q 013064 243 MAPEVLLKK-----------GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLI 311 (450)
Q Consensus 243 ~APEvl~~~-----------~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli 311 (450)
+|||++.+. .|+.++|||||||++|||++|..||.+.+.......+... ...+++++++||
T Consensus 269 ~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~li 340 (377)
T 3byv_A 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS--------CKNIPQPVRALL 340 (377)
T ss_dssp CCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS--------CCCCCHHHHHHH
T ss_pred cChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh--------ccCCCHHHHHHH
Confidence 999999987 8999999999999999999999999887776666555431 137899999999
Q ss_pred HHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 312 CHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 312 ~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
.+||. ||.+|| ++.++++||||+++
T Consensus 341 ~~~L~~dp~~Rp---t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 341 EGFLRYPKEDRL---LPLQAMETPEYEQL 366 (377)
T ss_dssp HHHTCSSGGGCC---CHHHHHTSHHHHHH
T ss_pred HHHcCCCchhCC---CHHHHhhChHHHHH
Confidence 99998 999999 78999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=388.42 Aligned_cols=261 Identities=32% Similarity=0.593 Sum_probs=229.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||.||+|+++.+++.||+|++.+... .....+.+.+|..+++.++||||+++++++.+...+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 689999999999999999999999999999999987543 3345678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC---CceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~---g~ikL~DFGla~~~~~~~~~ 194 (450)
||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-- 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--
Confidence 999999999999888899999999999999999999999999999999999999764 479999999998654321
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
.....+||+.|+|||++.+ .++.++|+|||||++|+|++|..
T Consensus 179 -------------------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~ 220 (287)
T 2wei_A 179 -------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220 (287)
T ss_dssp -------------------------------------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCC
Confidence 0123578999999999875 48999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
||.+.+.......+.........|....+++++.+||.+||. ||.+|| +++++++||||++.+|+
T Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 221 PFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHHHCCC
T ss_pred CCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc---CHHHHhcCHHHhccccC
Confidence 999988888777777654444445445789999999999998 999999 68999999999876654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=397.37 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=215.4
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEcCCe
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYSFQDSDF 112 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~f~~~~~ 112 (450)
+.-++|++++.||+|+||.||+|.+. +++.||+|++.... ......+.+.+|+.+|..+.| |||+++++++.++..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 45578999999999999999999874 68999999997654 334456788999999999976 999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+.+....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999999 56889999999999999999999999999999999999999999999999996 7899999999998764321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----------CCCCccccccc
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----------KGYGMECDWWS 261 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----------~~y~~~~DiWS 261 (450)
.. ....+.+||+.|+|||++.+ ..|+.++||||
T Consensus 162 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diws 205 (343)
T 3dbq_A 162 TS------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 205 (343)
T ss_dssp --------------------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHH
T ss_pred cc------------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHH
Confidence 10 01224689999999999975 67899999999
Q ss_pred hhHHHHHHhhCCCCCCCCCh-hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 262 LGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 262 lGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|||++|+|++|..||.+... ......++.......+|. ..++++.+||.+||. ||.+|| ++.++++||||+.
T Consensus 206 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~ 279 (343)
T 3dbq_A 206 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQI 279 (343)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHS
T ss_pred HHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCC---CHHHHHhCccccc
Confidence 99999999999999976433 334445554334444553 678899999999998 999999 7999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=404.47 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=212.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE------
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ------ 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~------ 108 (450)
...++|++++.||+|+||.||+|++..+|+.||+|++..... ...+|..+|+.++|||||+++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345799999999999999999999999999999999875432 1236999999999999999999994
Q ss_pred --------------------------------cCCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 013064 109 --------------------------------DSDFLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIH 152 (450)
Q Consensus 109 --------------------------------~~~~lylVmEy~~gg~L~~~l~----~~~~~~e~~~~~~~~qil~aL~ 152 (450)
+..++|+||||++| +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34569999999985 7666554 4578999999999999999999
Q ss_pred HhhhCCeEEeecCCCcEEEc-cCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccc
Q 013064 153 SIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRA 231 (450)
Q Consensus 153 ~LH~~givHrDLKpeNILld-~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (450)
|||++||+||||||+|||++ .+|.+||+|||+|+.+....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------- 196 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------------------------------------- 196 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------------------------------------
Confidence 99999999999999999998 68999999999998654321
Q ss_pred cccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccc---------------cc
Q 013064 232 LAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT---------------CL 295 (450)
Q Consensus 232 ~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~~ 295 (450)
...+.+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+...+|+.... ..
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~ 276 (383)
T 3eb0_A 197 PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV 276 (383)
T ss_dssp CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C
T ss_pred CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc
Confidence 11246899999999999874 589999999999999999999999999888777776653110 11
Q ss_pred cCCC----------CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 296 KFPE----------EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 296 ~~p~----------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
.+|. ...+++++++||.+||. ||.+|+ ++.|+++||||+++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 277 RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLR 329 (383)
T ss_dssp CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGHHHH
T ss_pred cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcCHHHHHHH
Confidence 1111 13589999999999999 999999 789999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=382.94 Aligned_cols=260 Identities=25% Similarity=0.464 Sum_probs=222.5
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||.||+|+++.+|+.||+|++..... ....+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3689999999999999999999999999999999976542 34567789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 161 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-- 161 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch--
Confidence 999999999999987788999999999999999999999999999999999999999999999999999865432100
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G~~P 275 (450)
......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..|
T Consensus 162 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 207 (276)
T 2yex_A 162 ----------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (276)
T ss_dssp ----------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred ----------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 11234689999999999988776 7899999999999999999999
Q ss_pred CCCCChhh-hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 276 FCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 276 F~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
|.+.+... .+..+.... ...+....+++.+++||.+||. ||.+|| +++++++||||++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 268 (276)
T 2yex_A 208 WDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (276)
T ss_dssp CSCSCTTSHHHHHHHTTC--TTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred CCCCchHHHHHHHhhhcc--cccCchhhcCHHHHHHHHHHCCCCchhCC---CHHHHhcCccccCh
Confidence 98765542 233333211 2223335789999999999998 999999 69999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=406.75 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=211.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc------CC
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------SD 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~~ 111 (450)
.+|++++.||+|+||.||+|+++.+|+.||||++.+... ...+|+.+|+.++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 379999999999999999999999999999999875431 13469999999999999999999853 23
Q ss_pred eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-CceEEeeccccc
Q 013064 112 FLYLIMEYLPGGDIMTLLM----REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCK 186 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~----~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~-g~ikL~DFGla~ 186 (450)
++++||||+++ +|...+. ....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 57899999976 5655553 35689999999999999999999999999999999999999965 578999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAI 265 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvi 265 (450)
.+.... ...+.+||+.|+|||++.+. .|+.++|||||||+
T Consensus 206 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 246 (420)
T 1j1b_A 206 QLVRGE---------------------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246 (420)
T ss_dssp ECCTTC---------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred hcccCC---------------------------------------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHH
Confidence 654321 01246899999999999764 79999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhccc---------------ccccCCC----------CCCCCHHHHHHHHHhhc-Ccc
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWK---------------TCLKFPE----------EPKISDEARDLICHLLC-DVE 319 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dli~~lL~-dp~ 319 (450)
+|||++|.+||.+.+..+.+.+|++.. ..+.+|. ...+++++++||.+||. ||.
T Consensus 247 l~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 326 (420)
T 1j1b_A 247 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326 (420)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGG
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChh
Confidence 999999999999988777666665310 1112221 13578999999999999 999
Q ss_pred ccCCCCCHHHHHcCCCcCCCCccc
Q 013064 320 TRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 320 ~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
+|+ +++|+++||||+++.+..
T Consensus 327 ~R~---t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 327 ARL---TPLEACAHSFFDELRDPN 347 (420)
T ss_dssp GSC---CHHHHHTSGGGGGGGCTT
T ss_pred HCC---CHHHHhCCHhhccccccc
Confidence 999 689999999998766543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=397.46 Aligned_cols=268 Identities=30% Similarity=0.469 Sum_probs=224.6
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
-..+++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+.+|..+++.++||||+++++++.+.+.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 356789999999999999999999999999999999987653 2334456678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999999999888888899999999999999999999999999999999999999999999999999986543210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~G 272 (450)
.....+||+.|+|||++.+. .++.++|+|||||++|+|++|
T Consensus 180 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 221 (331)
T 4aaa_A 180 --------------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221 (331)
T ss_dssp ------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhC
Confidence 01246899999999999875 789999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccc-----------------cccCCC----------CCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKT-----------------CLKFPE----------EPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
.+||.+.+..+....+..... ....|. .+.+++.+.+||.+||. ||.+||
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-- 299 (331)
T 4aaa_A 222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP-- 299 (331)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC--
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC--
Confidence 999998887666655542110 011111 13679999999999999 999999
Q ss_pred CCHHHHHcCCCcCCCCccc
Q 013064 325 RGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 325 ~~~~eil~Hpff~~i~w~~ 343 (450)
+++|+++||||+...|..
T Consensus 300 -t~~ell~hp~f~~~~~~~ 317 (331)
T 4aaa_A 300 -FCAELLHHDFFQMDGFAE 317 (331)
T ss_dssp -CGGGGGGSHHHHGGGHHH
T ss_pred -CHHHHhcCchhccCChhh
Confidence 689999999999876654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=404.30 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=216.9
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEcCCeE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~f~~~~~l 113 (450)
.-.+|++++.||+|+||.||+|.+.. ++.||||++.+... .....+.+.+|+.+|..+. ||||+++++++.+++.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 89999999987643 3456678999999999996 59999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+||| +.+|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+.+.....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 67899999999989999999999999999999999999999999999999995 68999999999987643211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----------CCCCccccccch
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----------KGYGMECDWWSL 262 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----------~~y~~~~DiWSl 262 (450)
. ....+.+||+.|+|||++.+ ..|+.++|||||
T Consensus 210 ~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl 253 (390)
T 2zmd_A 210 S------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253 (390)
T ss_dssp ----------------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred c------------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence 0 01235689999999999975 368999999999
Q ss_pred hHHHHHHhhCCCCCCCCCh-hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 263 GAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||++|||++|.+||.+... ...+..++.......+|. ..++++++||.+||. ||.+|| ++.++++||||..
T Consensus 254 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~~~~ 326 (390)
T 2zmd_A 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQI 326 (390)
T ss_dssp HHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHS
T ss_pred HHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCC---CHHHHhhCcCccc
Confidence 9999999999999987543 344555665444445553 568999999999998 999999 7899999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=395.85 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=219.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----Ce
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~~ 112 (450)
++|++++.||+|+||.||+|++..+++.||+|++.+.. .......+.+|+.+|..++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999997532 334557788999999999999999999999765 47
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999999997 589998865 469999999999999999999999999999999999999999999999999998764321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~ 271 (450)
.. .......+||+.|+|||++.+ ..|+.++|+|||||++|+|++
T Consensus 183 ~~-----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 227 (364)
T 3qyz_A 183 DH-----------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227 (364)
T ss_dssp CB-----------------------------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred Cc-----------------------------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence 10 011234689999999998764 558999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhccccc------------------ccCCC---------CCCCCHHHHHHHHHhhc-CccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTC------------------LKFPE---------EPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~------------------~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
|.+||.+.+..+....|...... ...|. .+.+++++.+||.+||. ||.+|+
T Consensus 228 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~- 306 (364)
T 3qyz_A 228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI- 306 (364)
T ss_dssp SSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC-
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC-
Confidence 99999998877777666531100 00110 13678999999999999 999999
Q ss_pred CCCHHHHHcCCCcCCC
Q 013064 324 TRGVEELKEHPWFRGI 339 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i 339 (450)
+++++++||||+..
T Consensus 307 --t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 307 --EVEQALAHPYLEQY 320 (364)
T ss_dssp --CHHHHHTSGGGTTT
T ss_pred --CHHHHhcCcchhhc
Confidence 79999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=389.07 Aligned_cols=274 Identities=28% Similarity=0.444 Sum_probs=226.7
Q ss_pred HHHHHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEE
Q 013064 26 EYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105 (450)
Q Consensus 26 ~~~~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 105 (450)
+|...++.--..++|++++.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|..+++.++||||+++++
T Consensus 7 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~ 83 (302)
T 2j7t_A 7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLG 83 (302)
T ss_dssp ---CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeee
Confidence 44444444455679999999999999999999999999999999987543 345677889999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
++.+++.+|+||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGV 163 (302)
T ss_dssp EEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred eeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999999999998876 56799999999999999999999999999999999999999999999999998
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccc
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDW 259 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~Di 259 (450)
+....... ......+||+.|+|||++. +..++.++|+
T Consensus 164 ~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 205 (302)
T 2j7t_A 164 SAKNLKTL--------------------------------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205 (302)
T ss_dssp HHHHHHHH--------------------------------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHH
T ss_pred Cccccccc--------------------------------------cccccccCChhhcCCeeeccccCCCCCCchhhhH
Confidence 76422110 0012468999999999984 5778999999
Q ss_pred cchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|||||++|+|++|..||.+.+.......+..... ...+....++..+.+||.+||. ||.+|| +++++++||||++
T Consensus 206 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~ 281 (302)
T 2j7t_A 206 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSS 281 (302)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSC---CHHHHTTSTTTTT
T ss_pred HHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-cccCCccccCHHHHHHHHHHcccChhhCC---CHHHHhcChHHhh
Confidence 9999999999999999998887777666654322 1222234789999999999998 999999 6899999999999
Q ss_pred CCcccc
Q 013064 339 IQWDKL 344 (450)
Q Consensus 339 i~w~~l 344 (450)
+.|...
T Consensus 282 ~~~~~~ 287 (302)
T 2j7t_A 282 ITSNKA 287 (302)
T ss_dssp CCCCHH
T ss_pred hccchh
Confidence 988653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=380.70 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=211.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylV 116 (450)
++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|..++..+ +||||+++++++.+++.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 689999999999999999999999999999999986532 233456778899999998 999999999999999999999
Q ss_pred EeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-----------------
Q 013064 117 MEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----------------- 175 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~----~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g----------------- 175 (450)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999765 6799999999999999999999999999999999999998544
Q ss_pred --ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-C
Q 013064 176 --HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-G 252 (450)
Q Consensus 176 --~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~ 252 (450)
.+||+|||++...... ...+||+.|+|||++.+. .
T Consensus 170 ~~~~kl~Dfg~~~~~~~~------------------------------------------~~~~gt~~y~aPE~~~~~~~ 207 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP------------------------------------------QVEEGDSRFLANEVLQENYT 207 (289)
T ss_dssp CCCEEECCCTTCEETTCS------------------------------------------CCCCCCGGGCCHHHHTTCCT
T ss_pred ceEEEEcccccccccCCc------------------------------------------cccCCCccccChhHhcCCCC
Confidence 7999999998865432 134699999999999865 5
Q ss_pred CCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 253 YGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 253 y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
++.++|||||||++|+|++|.+|+..... ...+.... ...+| ..+++++.+||.+||. ||.+|| ++.+++
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll 278 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGR-LPRIP--QVLSQEFTELLKVMIHPDPERRP---SAMALV 278 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTC-CCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCC-CCCCC--cccCHHHHHHHHHHhCCCcccCC---CHHHHh
Confidence 67899999999999999999988765433 33333321 12333 4789999999999998 999999 799999
Q ss_pred cCCCcCCC
Q 013064 332 EHPWFRGI 339 (450)
Q Consensus 332 ~Hpff~~i 339 (450)
+||||.+.
T Consensus 279 ~h~~~~~~ 286 (289)
T 1x8b_A 279 KHSVLLSA 286 (289)
T ss_dssp TCTTC---
T ss_pred hChHhhhh
Confidence 99999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=399.23 Aligned_cols=267 Identities=26% Similarity=0.493 Sum_probs=231.2
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhh--------------HHHHHHHHHHHHhcCCC
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ--------------VEHVRSERNLLAEVDSR 98 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~--------------~~~~~~E~~il~~l~hp 98 (450)
..+..++|++++.||+|+||.||+|++ +|+.||+|++.+........ .+.+.+|..+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 445678999999999999999999998 89999999998765433222 27889999999999999
Q ss_pred CeeeEEEEEEcCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcE
Q 013064 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTL------LMR--EDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNL 169 (450)
Q Consensus 99 ~Iv~l~~~f~~~~~lylVmEy~~gg~L~~~------l~~--~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNI 169 (450)
||+++++++.+.+.+|+||||++||+|.++ +.+ ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 665 5789999999999999999999999 9999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.+|++||+|||++....... ....+||+.|+|||++.
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~ 223 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK----------------------------------------IKGSRGTYEFMPPEFFS 223 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE----------------------------------------ECSSCSCGGGCCGGGGS
T ss_pred EEcCCCcEEEecccccccccccc----------------------------------------ccCCCCCcCccCchhhc
Confidence 99999999999999998654320 12468999999999998
Q ss_pred cC-CCCc-cccccchhHHHHHHhhCCCCCCCCCh-hhhhhhhhcccccccCCCC-----------------CCCCHHHHH
Q 013064 250 KK-GYGM-ECDWWSLGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEE-----------------PKISDEARD 309 (450)
Q Consensus 250 ~~-~y~~-~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~-----------------~~~s~~~~d 309 (450)
+. .++. ++|+|||||++|+|++|..||.+.+. .+....+.... ..+|.. ..+++++.+
T Consensus 224 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 301 (348)
T 2pml_X 224 NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID 301 (348)
T ss_dssp SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCC--CCCCCSSSSSTTTTCC--------CCCHHHHH
T ss_pred CCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC--cCCccchhhhhccccccccccchhhcCHHHHH
Confidence 77 6766 99999999999999999999988776 56666665532 333321 468999999
Q ss_pred HHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccccc
Q 013064 310 LICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 346 (450)
Q Consensus 310 li~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 346 (450)
||.+||. ||.+|| +++++++||||++++|..+.+
T Consensus 302 li~~~L~~dP~~Rp---s~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 302 FLKLFLRKNPAERI---TSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp HHHHHCCSSGGGSC---CHHHHHTSGGGTTCCHHHHHH
T ss_pred HHHHHccCChhhCC---CHHHHhcCccccCCCHHHHHH
Confidence 9999999 999999 789999999999999988754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=395.37 Aligned_cols=261 Identities=31% Similarity=0.615 Sum_probs=215.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
++|++++.||+|+||.||+|+++.+++.||||++.+.... .......+.+|+.+|+.++||||+++++++.++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999999999999999999765432 1123345789999999999999999999998765
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc---eEEeeccccccCc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDFGLCKPLE 189 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~---ikL~DFGla~~~~ 189 (450)
+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987665 9999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIM 266 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvil 266 (450)
... .....+||+.|+|||++. ...|+.++|+|||||++
T Consensus 169 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 209 (322)
T 2ycf_A 169 ETS---------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209 (322)
T ss_dssp CCH---------------------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHH
T ss_pred ccc---------------------------------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHH
Confidence 320 011357999999999984 46789999999999999
Q ss_pred HHHhhCCCCCCCCChhhhh-hhhhcccccccCC--CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 267 YEMLIGYPPFCSDDPRITC-RKIVNWKTCLKFP--EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~~~-~~i~~~~~~~~~p--~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
|+|++|..||.+....... ..+.... ..++ ....+++.+.+||.+||. ||.+|+ +++++++||||++.+|.
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 210 FICLSGYPPFSEHRTQVSLKDQITSGK--YNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHHHSSCSSCSTTCSSCHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGCCHHHH
T ss_pred HHHHhCCCCCcccchHHHHHHHHHhCc--cccCchhhhhcCHHHHHHHHHHcccCHhhCC---CHHHHhhCcCcCCHHHH
Confidence 9999999999876554333 3333321 1111 113689999999999998 999999 68999999999987775
Q ss_pred c
Q 013064 343 K 343 (450)
Q Consensus 343 ~ 343 (450)
.
T Consensus 285 ~ 285 (322)
T 2ycf_A 285 R 285 (322)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=383.66 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=204.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+..+..+++.++||||+++++++.+++.+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 467789999999999999999999999999999999997653 2223334455555667888999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 114 YLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
|+||||++| +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 77776643 56899999999999999999999998 9999999999999999999999999999865
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh----ccCCCCccccccchhH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYGMECDWWSLGA 264 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl----~~~~y~~~~DiWSlGv 264 (450)
..... ....+||+.|+|||++ .+..++.++|+|||||
T Consensus 161 ~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 201 (290)
T 3fme_A 161 VDDVA---------------------------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201 (290)
T ss_dssp ------------------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHH
T ss_pred ccccc---------------------------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHH
Confidence 43210 1135799999999997 4567899999999999
Q ss_pred HHHHHhhCCCCCCCC-ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 265 IMYEMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 265 ilyeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|+|++|..||.+. ........+.... ....+ ...+++++.+||.+||. ||.+|| +++++++||||+.
T Consensus 202 il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~e~l~hp~f~~ 272 (290)
T 3fme_A 202 TMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQLP-ADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHHH
T ss_pred HHHHHHHCCCCccccCchHHHHHHHhccC-CCCcc-cccCCHHHHHHHHHHhhcChhhCc---CHHHHHhCccccc
Confidence 999999999999863 3334444444322 22222 24689999999999999 999999 6999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=397.87 Aligned_cols=257 Identities=30% Similarity=0.453 Sum_probs=216.7
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE----
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL---- 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l---- 113 (450)
++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|..+++.++||||++++++|.+.+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 69999999999999999999999999999999997653 3344567888999999999999999999999987765
Q ss_pred --EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 --YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 --ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||+. |+|..++ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 99999997 6888776 345999999999999999999999999999999999999999999999999999865332
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
....+||+.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 198 -----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 236 (371)
T 4exu_A 198 -----------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236 (371)
T ss_dssp -------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH
Confidence 124689999999999987 78999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccc---------------------cCC------CCCCCCHHHHHHHHHhhc-CccccC
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCL---------------------KFP------EEPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p------~~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
+|..||.+.+..+.+..+....... ..+ ..+.+++++++||.+||. ||.+|+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 316 (371)
T 4exu_A 237 TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 316 (371)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC
Confidence 9999999988777666664311000 000 013579999999999999 999999
Q ss_pred CCCCHHHHHcCCCcCCCCcc
Q 013064 323 GTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 323 ~~~~~~eil~Hpff~~i~w~ 342 (450)
+++++++||||+.+...
T Consensus 317 ---t~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 317 ---TAAQALTHPFFEPFRDP 333 (371)
T ss_dssp ---CHHHHHTSGGGTTTCCG
T ss_pred ---CHHHHhcCcccccCCCc
Confidence 68999999999976543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=390.07 Aligned_cols=275 Identities=28% Similarity=0.449 Sum_probs=220.6
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS----- 110 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~----- 110 (450)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+.. .......+.+|+.+|+.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 3479999999999999999999999999999999996532 334456788999999999999999999988764
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..+|+||||+. |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67999999997 589988866 5799999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 269 (450)
....... ...........+||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 165 ~~~~~~~----------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 216 (353)
T 2b9h_A 165 SAADNSE----------------------------PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216 (353)
T ss_dssp -------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccC----------------------------ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHH
Confidence 3111000 0000011234689999999999865 7789999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhccccc----------------------ccCCC------CCCCCHHHHHHHHHhhc-Cccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTC----------------------LKFPE------EPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~----------------------~~~p~------~~~~s~~~~dli~~lL~-dp~~ 320 (450)
++|.+||.+.+.......+...... ...+. .+.+++++++||.+||. ||.+
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 296 (353)
T 2b9h_A 217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296 (353)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGG
T ss_pred HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCccc
Confidence 9999999988766554443321000 00010 13689999999999998 9999
Q ss_pred cCCCCCHHHHHcCCCcCCCCccccc
Q 013064 321 RLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 321 R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
|+ +++++++||||+.+.|....
T Consensus 297 Rp---t~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 297 RI---TAKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp SC---CHHHHHTSGGGTTTCCTTSS
T ss_pred CC---CHHHHhcCccccccCCcccc
Confidence 99 68999999999988775543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=403.87 Aligned_cols=252 Identities=25% Similarity=0.459 Sum_probs=214.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc------CCCCeeeEEEEEEcCC
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV------DSRCIVQLFYSFQDSD 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~f~~~~ 111 (450)
.+|++++.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.+ +|+||++++++|....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 57999999999999999999999999999999997542 3345677888888877 5789999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc--eEEeecccccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--LKLSDFGLCKP 187 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~--ikL~DFGla~~ 187 (450)
.+|+||||+. |+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.+|. +||+|||+|..
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999999995 69999987754 4999999999999999999999999999999999999999987 99999999975
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
.... ..+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus 252 ~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 290 (429)
T 3kvw_A 252 EHQR-----------------------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILA 290 (429)
T ss_dssp TTCC-----------------------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHH
T ss_pred cCCc-----------------------------------------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHH
Confidence 4321 23568999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccc------------------cC-----------------------------CC-
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCL------------------KF-----------------------------PE- 299 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~------------------~~-----------------------------p~- 299 (450)
||++|.+||.+.+..+.+..++...... .+ |.
T Consensus 291 elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (429)
T 3kvw_A 291 ELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370 (429)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccc
Confidence 9999999999988776665554210000 00 00
Q ss_pred -------CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 300 -------EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 300 -------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
....++++.+||++||+ ||.+|+ +++|+++||||+.
T Consensus 371 ~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp---ta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRM---TPGQALRHPWLRR 414 (429)
T ss_dssp SCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSTTTC-
T ss_pred hhhHhhccccchHHHHHHHHHHCCCChhhCC---CHHHHhCChhhcc
Confidence 01247889999999999 999999 7999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=385.63 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=214.0
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
....+..++|++.+.||+|+||.||+|++ +|+.||+|++.+... .....+.+.+|..+|+.++||||+++++++.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 33457788999999999999999999976 688899999976542 344567889999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEccCCceEEeecccc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~---~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld~~g~ikL~DFGla 185 (450)
..+|+||||++||+|.+++.+.+. +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999987654 999999999999999999999999 999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
+....... ...+.+||+.|+|||++.+..++.++|||||||+
T Consensus 187 ~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 228 (309)
T 3p86_A 187 RLKASTFL--------------------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228 (309)
T ss_dssp -----------------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccccc--------------------------------------ccccCCCCccccChhhhcCCCCCchhhHHHHHHH
Confidence 75432210 0124689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|+|++|..||.+.+..+....+........+| ..+++++.+||.+||. ||.+|| +++++++
T Consensus 229 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~ 291 (309)
T 3p86_A 229 LWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP--RNLNPQVAAIIEGCWTNEPWKRP---SFATIMD 291 (309)
T ss_dssp HHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999999999988877777665433444555 4799999999999998 999999 5777775
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=383.97 Aligned_cols=261 Identities=25% Similarity=0.430 Sum_probs=221.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDFL 113 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~~~l 113 (450)
+++|++++.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|..+++.++||||+++++++. +...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998765432 345678899999999999999999999984 45689
Q ss_pred EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||+++| |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999887 7777765 457999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC--CCccccccchhHHHHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG--YGMECDWWSLGAIMYEM 269 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~--y~~~~DiWSlGvilyem 269 (450)
... .......||+.|+|||++.+.. ++.++|+|||||++|+|
T Consensus 163 ~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 206 (305)
T 2wtk_C 163 AAD------------------------------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206 (305)
T ss_dssp CSS------------------------------------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHH
T ss_pred ccc------------------------------------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHH
Confidence 110 0112467999999999998644 37899999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
++|..||.+.+..+....+... ...+| ..+++.+.+||.+||. ||.+|+ +++++++||||+....
T Consensus 207 ~~g~~p~~~~~~~~~~~~i~~~--~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 207 TTGLYPFEGDNIYKLFENIGKG--SYAIP--GDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHC--CCCCC--SSSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSHHHHSCCC
T ss_pred HhCCCCCCCchHHHHHHHHhcC--CCCCC--CccCHHHHHHHHHHccCChhhCC---CHHHHhcCcccccCCC
Confidence 9999999998888777777653 23344 4789999999999998 999999 7999999999987553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=388.49 Aligned_cols=277 Identities=22% Similarity=0.345 Sum_probs=206.3
Q ss_pred HHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEE
Q 013064 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105 (450)
Q Consensus 29 ~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 105 (450)
.+....+..++|++++.||+|+||.||+|+++.++. .||+|+++.... .....+.+.+|..+++.++||||+++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 344556777899999999999999999999887775 899999976542 3445778999999999999999999999
Q ss_pred EEEcCCeE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc
Q 013064 106 SFQDSDFL------YLIMEYLPGGDIMTLLMRED------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK 173 (450)
Q Consensus 106 ~f~~~~~l------ylVmEy~~gg~L~~~l~~~~------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~ 173 (450)
++.+.... |+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC
Confidence 99887765 99999999999999986543 6999999999999999999999999999999999999999
Q ss_pred CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC
Q 013064 174 NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY 253 (450)
Q Consensus 174 ~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y 253 (450)
+|.+||+|||+|+........ .......||+.|+|||++.+..|
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 216 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYY------------------------------------RQGCASKLPVKWLALESLADNLY 216 (323)
T ss_dssp TSCEEECCCCC-----------------------------------------------------CCGGGCCHHHHHHCCC
T ss_pred CCCEEEeeccccccccccccc------------------------------------cccccccCcccccCchhhcCCCC
Confidence 999999999999865432110 00113467889999999999999
Q ss_pred CccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC----CH
Q 013064 254 GMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR----GV 327 (450)
Q Consensus 254 ~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~----~~ 327 (450)
+.++|+|||||++|+|++ |.+||.+.+..+....+.... .... ...+++++.+||.+||. ||.+||+.. .+
T Consensus 217 ~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 293 (323)
T 3qup_A 217 TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQ--PPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293 (323)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCC--CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCC--CCccCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999 999999988888887776532 2223 34789999999999998 999999421 27
Q ss_pred HHHHcCCCcCCCCccccc
Q 013064 328 EELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 328 ~eil~Hpff~~i~w~~l~ 345 (450)
++++.|||+....++.+.
T Consensus 294 ~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 294 ENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp HHHHHC------------
T ss_pred HHHHHHhhhcCCCCCCCC
Confidence 889999999887766554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=383.61 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=222.1
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
...++|++++.||+|+||.||+|+++.+|+.||+|++.... ..+.+.+|..+++.++||||+++++++.+.+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 44578999999999999999999999999999999997643 3456888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~-~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|.+++. ....+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999987 456899999999999999999999999999999999999999999999999999976543210
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 181 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 222 (314)
T 3com_A 181 --------------------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222 (314)
T ss_dssp --------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCC
Confidence 012467999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
.||.+.+.......+... ....+.....+++.+.+||.+||. ||.+|| +++++++||||++..+....
T Consensus 223 ~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 223 PPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp CTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHTCCCGGGG
T ss_pred CCCCCCChHHHHHHHhcC-CCcccCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhcCCcchHH
Confidence 999887766555444332 112222234679999999999998 999999 79999999999998776554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=385.28 Aligned_cols=266 Identities=29% Similarity=0.481 Sum_probs=220.5
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEc
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD 109 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~ 109 (450)
.......++|++++.||+|+||.||+|++..+|+.||+|++.... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 334456689999999999999999999999999999999997542 2346788999999998 89999999999987
Q ss_pred ------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEee
Q 013064 110 ------SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181 (450)
Q Consensus 110 ------~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~D 181 (450)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 56899999999999999999864 5799999999999999999999999999999999999999999999999
Q ss_pred ccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCcc
Q 013064 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGME 256 (450)
Q Consensus 182 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~ 256 (450)
||++........ .....+||+.|+|||++. +..++.+
T Consensus 173 fg~~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 214 (326)
T 2x7f_A 173 FGVSAQLDRTVG--------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFK 214 (326)
T ss_dssp CTTTC---------------------------------------------------CCGGGCCHHHHC--------CCTT
T ss_pred CcCceecCcCcc--------------------------------------ccccccCCccccChhhhccccccCcCCCcc
Confidence 999886543210 012468999999999997 5668999
Q ss_pred ccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 257 CDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 257 ~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
+|+|||||++|+|++|..||.+.+.......+..... .......+++.+++||.+||. ||.+|| +++++++|||
T Consensus 215 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~hp~ 289 (326)
T 2x7f_A 215 SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKHPF 289 (326)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSC---CHHHHHTSHH
T ss_pred chHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--ccCCccccCHHHHHHHHHHhccChhhCC---CHHHHhhChH
Confidence 9999999999999999999988877766665554221 111234789999999999998 999999 6899999999
Q ss_pred cCCCCccc
Q 013064 336 FRGIQWDK 343 (450)
Q Consensus 336 f~~i~w~~ 343 (450)
|++..+..
T Consensus 290 ~~~~~~~~ 297 (326)
T 2x7f_A 290 IRDQPNER 297 (326)
T ss_dssp HHCCTTHH
T ss_pred HhhCcccc
Confidence 99877654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=384.57 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=219.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEc-CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEE----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAK-TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQ---- 108 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~-~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~---- 108 (450)
.++|++++.||+|+||.||+|++. .+|+.||+|++..... .......+.+|..+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 378999999999999999999995 6789999999976532 122223456777777766 8999999999997
Q ss_pred -cCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 109 -DSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 109 -~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+...+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678999999997 69999998754 4999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
....... .....+||+.|+|||++.+..++.++|+|||||+
T Consensus 168 ~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 208 (326)
T 1blx_A 168 RIYSFQM---------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208 (326)
T ss_dssp CCCCGGG---------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred ccccCCC---------------------------------------CccccccccceeCHHHHhcCCCCcchhHHHHHHH
Confidence 8654321 0124689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccc---------cccCC--------------CCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKT---------CLKFP--------------EEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~---------~~~~p--------------~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
+|+|++|.+||.+.+......+++.... ....+ ....+++.+++||.+||. ||.+|
T Consensus 209 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 288 (326)
T 1blx_A 209 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288 (326)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccC
Confidence 9999999999999887777666653110 00000 113689999999999998 99999
Q ss_pred CCCCCHHHHHcCCCcCCCCccc
Q 013064 322 LGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i~w~~ 343 (450)
+ ++.++++||||+++++..
T Consensus 289 p---t~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 289 I---SAYSALSHPYFQDLERCK 307 (326)
T ss_dssp C---CHHHHHTSGGGTTCCCCC
T ss_pred C---CHHHHhcCccccccchhh
Confidence 9 689999999999987643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=402.58 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=196.1
Q ss_pred CCeEEE-eEEeecCceEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCe
Q 013064 38 DDFEQL-TLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDF 112 (450)
Q Consensus 38 ~~f~~~-~~LG~G~fg~V~l~~~~--~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~~~ 112 (450)
+.|++. ++||+|+||.||+|+++ .+++.||+|++.+... ...+.+|+.+|+.++|||||+++++|. ++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 557764 57999999999999976 5788999999975432 245788999999999999999999995 4779
Q ss_pred EEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE----ccCCceEE
Q 013064 113 LYLIMEYLPGGDIMTLLMRE---------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKL 179 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~---------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl----d~~g~ikL 179 (450)
+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.+|.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999996 5888877532 249999999999999999999999999999999999999 77899999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCcccc
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECD 258 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~D 258 (450)
+|||+|+.+...... .....+.+||+.|+|||++.+ ..|+.++|
T Consensus 174 ~Dfg~a~~~~~~~~~-----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 218 (405)
T 3rgf_A 174 ADMGFARLFNSPLKP-----------------------------------LADLDPVVVTFWYRAPELLLGARHYTKAID 218 (405)
T ss_dssp CCTTCCC---------------------------------------------------CCCTTCCHHHHTTCCSCCHHHH
T ss_pred EECCCceecCCCCcc-----------------------------------cccCCCceecCcccCchhhcCCCcccchhh
Confidence 999999876432110 011234689999999999987 45899999
Q ss_pred ccchhHHHHHHhhCCCCCCCCChh---------hhhhhhhccccccc---------CC----------------------
Q 013064 259 WWSLGAIMYEMLIGYPPFCSDDPR---------ITCRKIVNWKTCLK---------FP---------------------- 298 (450)
Q Consensus 259 iWSlGvilyeml~G~~PF~~~~~~---------~~~~~i~~~~~~~~---------~p---------------------- 298 (450)
||||||++|+|++|.+||.+.+.. +.+..|...-.... .|
T Consensus 219 iwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (405)
T 3rgf_A 219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKY 298 (405)
T ss_dssp HHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHH
T ss_pred hHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhh
Confidence 999999999999999999876542 22333322100000 00
Q ss_pred ---CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 299 ---EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 299 ---~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
.....++.+.+||.+||+ ||.+|+ +++|+++||||.+..|..
T Consensus 299 ~~~~~~~~~~~~~~Ll~~~L~~dP~~R~---ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 299 MEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHTTTCCTTSHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGTSSSCCC
T ss_pred HhhcCCCCCHHHHHHHHHHccCCcccCC---CHHHHhcChhhccCCCCc
Confidence 001237899999999999 999999 689999999999866543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=398.99 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=209.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--------CCCeeeEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--------SRCIVQLFY 105 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--------hp~Iv~l~~ 105 (450)
.+-.++|++++.||+|+||.||+|++..+++.||+|++.+. ....+.+.+|+.+|+.+. ||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34457899999999999999999999999999999999754 234567889999999885 788999999
Q ss_pred EEE----cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCC---
Q 013064 106 SFQ----DSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNG--- 175 (450)
Q Consensus 106 ~f~----~~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g--- 175 (450)
+|. +...+|+||||+ +|+|..++.+. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.+|
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 998 667899999999 67777777654 5699999999999999999999998 999999999999999776
Q ss_pred ----------------------------------------------ceEEeeccccccCccccccccccccccccccccc
Q 013064 176 ----------------------------------------------HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209 (450)
Q Consensus 176 ----------------------------------------------~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 209 (450)
.+||+|||+|......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------------------ 249 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------------------ 249 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------------------
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------------------
Confidence 7999999999865432
Q ss_pred cccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhh------
Q 013064 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRI------ 283 (450)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------ 283 (450)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+...
T Consensus 250 -----------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 306 (397)
T 1wak_A 250 -----------------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306 (397)
T ss_dssp -----------------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHH
T ss_pred -----------------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHH
Confidence 124689999999999999999999999999999999999999998765322
Q ss_pred hhhhhhcccccc--------------------------------------cCCCCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 284 TCRKIVNWKTCL--------------------------------------KFPEEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 284 ~~~~i~~~~~~~--------------------------------------~~p~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
....+....... .++.....++.+++||.+||. ||.+|+
T Consensus 307 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-- 384 (397)
T 1wak_A 307 HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA-- 384 (397)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC--
T ss_pred HHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC--
Confidence 111121100000 000012345678999999999 999999
Q ss_pred CCHHHHHcCCCcCC
Q 013064 325 RGVEELKEHPWFRG 338 (450)
Q Consensus 325 ~~~~eil~Hpff~~ 338 (450)
+++|+++||||++
T Consensus 385 -t~~e~l~hp~~~~ 397 (397)
T 1wak_A 385 -TAAECLRHPWLNS 397 (397)
T ss_dssp -CHHHHHTSGGGGC
T ss_pred -CHHHHhhCccccC
Confidence 7899999999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=377.65 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=222.3
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--cCCeE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ--DSDFL 113 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~--~~~~l 113 (450)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|..+++.++||||+++++++. +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 46899999999999999999999999999999999986543 3445678899999999999999999999884 46789
Q ss_pred EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHhhhCC-----eEEeecCCCcEEEccCCceEEeeccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE----DILSEDVARFYIAESVLAIHSIHQHN-----YVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~----~~~~e~~~~~~~~qil~aL~~LH~~g-----ivHrDLKpeNILld~~g~ikL~DFGl 184 (450)
|+||||++||+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.+|.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999753 34999999999999999999999999 99999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
+........ .....+||+.|+|||++.+..++.++|+|||||
T Consensus 163 ~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 204 (279)
T 2w5a_A 163 ARILNHDTS--------------------------------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204 (279)
T ss_dssp HHHC---CH--------------------------------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHH
T ss_pred heeeccccc--------------------------------------cccccCCCccccChHHhccCCCCchhhHHHHHH
Confidence 886543210 011357999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|+|++|..||.+.+.......+..... ..+| ..+++++.+||.+||. ||.+|| ++++|++|||+.+
T Consensus 205 il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~ 273 (279)
T 2w5a_A 205 LLYELCALMPPFTAFSQKELAGKIREGKF-RRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILENPLILE 273 (279)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTCCG
T ss_pred HHHHHHHCCCCCcccCHHHHHHHHhhccc-ccCC--cccCHHHHHHHHHHcCCCcccCC---CHHHHHhChhhhh
Confidence 99999999999999887777777765322 2333 3789999999999998 999999 7999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.26 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=216.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF---- 112 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~---- 112 (450)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|..+|+.++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 378999999999999999999999999999999997643 334456778899999999999999999999988764
Q ss_pred --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 113 --LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 113 --lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+|+||||+. |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999997 58887763 3599999999999999999999999999999999999999999999999999986432
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 269 (450)
. ....+||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 179 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el 217 (353)
T 3coi_A 179 E-----------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217 (353)
T ss_dssp ----------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHH
Confidence 1 123589999999999987 7789999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccc--------------------------cccCC-CCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKT--------------------------CLKFP-EEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~--------------------------~~~~p-~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
++|..||.+.+..+.+..+..... ...++ ..+.+++++++||.+||. ||.+|
T Consensus 218 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 297 (353)
T 3coi_A 218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297 (353)
T ss_dssp HHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccC
Confidence 999999998887666555543100 00111 123679999999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCCCcc
Q 013064 322 LGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i~w~ 342 (450)
+ +++++++||||+.+...
T Consensus 298 p---t~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 298 L---TAAQALTHPFFEPFRDP 315 (353)
T ss_dssp C---CHHHHHTSGGGTTTCCG
T ss_pred C---CHHHHhcCcchhhccCc
Confidence 9 68999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=383.76 Aligned_cols=274 Identities=26% Similarity=0.426 Sum_probs=200.5
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+..++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|..+++.++||||+++++++.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45777999999999999999999999999999999999876532 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 113 LYLIMEYLPGGDIMTLLMR--------EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~--------~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999874 45699999999999999999999999999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchh
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLG 263 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlG 263 (450)
+.......... ........+||+.|+|||++.+ ..++.++|+||||
T Consensus 168 ~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 214 (303)
T 2vwi_A 168 SAFLATGGDIT---------------------------------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214 (303)
T ss_dssp HHHCC------------------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred hheeccCCCcc---------------------------------chhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence 97654321000 0001124689999999999976 6789999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhhhhhhhccccc-cc-----CCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTC-LK-----FPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~-----~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|++|+|++|..||.+.+.............. .. ......+++++++||.+||. ||.+|| +++++++||||
T Consensus 215 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~ 291 (303)
T 2vwi_A 215 ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---TAAELLRHKFF 291 (303)
T ss_dssp HHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSTTC
T ss_pred HHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc---CHHHHhhChhh
Confidence 9999999999999887766555444332111 00 01124678999999999998 999999 78999999999
Q ss_pred CCCCcccc
Q 013064 337 RGIQWDKL 344 (450)
Q Consensus 337 ~~i~w~~l 344 (450)
+...+..+
T Consensus 292 ~~~~~~~~ 299 (303)
T 2vwi_A 292 QKAKNKEF 299 (303)
T ss_dssp --------
T ss_pred hcCCCCcc
Confidence 98776544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=377.77 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=223.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|..+++.++||||+++++++.++..+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 569999999999999999999999999999999976542 345678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---- 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC----
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc----
Confidence 99999999998854 6799999999999999999999999999999999999999999999999999986543210
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.
T Consensus 175 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 220 (303)
T 3a7i_A 175 ----------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220 (303)
T ss_dssp ----------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----------------------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence 0124689999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
..+.......+.... ...++ ..++..+.+||.+||. ||.+|| +++++++||||..
T Consensus 221 ~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 221 ELHPMKVLFLIPKNN-PPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFILR 276 (303)
T ss_dssp TSCHHHHHHHHHHSC-CCCCC--SSCCHHHHHHHHHHCCSSGGGSC---CHHHHTTCHHHHH
T ss_pred CcCHHHHHHHhhcCC-CCCCc--cccCHHHHHHHHHHcCCChhhCc---CHHHHhhChhhhc
Confidence 887776665554422 12222 4789999999999998 999999 6999999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=391.04 Aligned_cols=256 Identities=20% Similarity=0.333 Sum_probs=218.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEc-------CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAK-------TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 105 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~-------~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 105 (450)
.+..++|++.+.||+|+||.||+|++. .++..||+|++++.. .....+.+.+|..+|+.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 355689999999999999999999975 345679999997652 345567899999999999 8999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
+|.+.+.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998753 489999999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.+|++||+|||+|+........ .......||+.|+|||++.
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~ 278 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYY------------------------------------KKTTNGRLPVKWMAPEALF 278 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTT------------------------------------CTTTTTTSCGGGCCHHHHH
T ss_pred EECCCCCEEEccccCCcccCcccce------------------------------------ecccCCCcccceECHhHhc
Confidence 9999999999999999865432110 0112356889999999999
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+..|+.++|||||||++|||++ |..||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|| ++
T Consensus 279 ~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---t~ 352 (370)
T 2psq_A 279 DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAVPSQRP---TF 352 (370)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CH
Confidence 9999999999999999999999 999999988877776665532 23333 4789999999999998 999999 67
Q ss_pred HHHHcC
Q 013064 328 EELKEH 333 (450)
Q Consensus 328 ~eil~H 333 (450)
.+++++
T Consensus 353 ~ell~~ 358 (370)
T 2psq_A 353 KQLVED 358 (370)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 787753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=384.78 Aligned_cols=260 Identities=26% Similarity=0.442 Sum_probs=216.7
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEE-cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC------CeeeEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRA-KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR------CIVQLF 104 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~-~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp------~Iv~l~ 104 (450)
...+-.++|++++.||+|+||.||+|.+ +.+|+.||+|+++... ...+.+.+|..+++.++|+ +|++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3445568999999999999999999998 5688999999997532 3456788899999888654 599999
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---------
Q 013064 105 YSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK--------- 173 (450)
Q Consensus 105 ~~f~~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~--------- 173 (450)
++|.+.+.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 999999998765 6899999999999999999999999999999999999987
Q ss_pred ----------CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCcc
Q 013064 174 ----------NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243 (450)
Q Consensus 174 ----------~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~ 243 (450)
++.+||+|||+++..... ..+.+||+.|+
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------~~~~~gt~~y~ 201 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH-----------------------------------------HSTLVSTRHYR 201 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC-----------------------------------------CCSSCSCGGGC
T ss_pred ccccccccccCCCceEeeCcccccCccc-----------------------------------------cccccCCcccc
Confidence 678999999999764322 12468999999
Q ss_pred chhhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhccccc-------------------ccC-------
Q 013064 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTC-------------------LKF------- 297 (450)
Q Consensus 244 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-------------------~~~------- 297 (450)
|||++.+..|+.++|+|||||++|||++|.+||.+.+..+....+...... ..+
T Consensus 202 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (339)
T 1z57_A 202 APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAG 281 (339)
T ss_dssp CHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHH
T ss_pred ChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccccccccc
Confidence 999999999999999999999999999999999988766554433221000 000
Q ss_pred --------------CCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 298 --------------PEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 298 --------------p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
......++++.+||.+||. ||.+|| +++|+++||||+.+.
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~ 336 (339)
T 1z57_A 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGGG
T ss_pred chhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc---CHHHHhcCHHHHHHh
Confidence 0011235778999999999 999999 799999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=385.02 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=212.3
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--e
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--F 112 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--~ 112 (450)
+.-++|++.+.||+|+||.||+|+++.+|+.||+|++.+... ....+.+.+|..+|+.++||||+++++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 445789999999999999999999999999999999986543 234567789999999999999999999998765 8
Q ss_pred EEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE----ccCCceEEeecccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDI---LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC 185 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~---~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl----d~~g~ikL~DFGla 185 (450)
+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999999986543 9999999999999999999999999999999999999 78888999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc--------cCCCCccc
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--------KKGYGMEC 257 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~--------~~~y~~~~ 257 (450)
+...... ...+.+||+.|+|||++. +..|+.++
T Consensus 164 ~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (319)
T 4euu_A 164 RELEDDE---------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (319)
T ss_dssp EECCTTC---------------------------------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTH
T ss_pred eecCCCC---------------------------------------ceeecccCCCccCHHHhhhccccccccCCCCcHH
Confidence 8764321 112468999999999997 57789999
Q ss_pred cccchhHHHHHHhhCCCCCCCCCh----hhhhhhhhccccc-----------------ccCCCC----CCCCHHHHHHHH
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDDP----RITCRKIVNWKTC-----------------LKFPEE----PKISDEARDLIC 312 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~-----------------~~~p~~----~~~s~~~~dli~ 312 (450)
|||||||++|||++|..||..... .+...++...... ..+|.. ..+++.+.+||+
T Consensus 205 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 284 (319)
T 4euu_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (319)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHH
Confidence 999999999999999999975433 2333333322110 011211 234568899999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCC
Q 013064 313 HLLC-DVETRLGTRGVEELKEHP 334 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hp 334 (450)
+||. ||.+|+ +++|+++||
T Consensus 285 ~~L~~dP~~R~---s~~ell~h~ 304 (319)
T 4euu_A 285 NILEADQEKCW---GFDQFFAET 304 (319)
T ss_dssp HHSCCCTTTSC---CHHHHHHHH
T ss_pred HhccCChhhhc---cHHHhhhcc
Confidence 9999 999999 689999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=393.36 Aligned_cols=258 Identities=29% Similarity=0.419 Sum_probs=213.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CC-----CeeeEEEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SR-----CIVQLFYSFQ 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp-----~Iv~l~~~f~ 108 (450)
.-.++|++++.||+|+||.||+|+++.+++.||||++++.. .....+.+|..+++.+. |+ +|++++++|.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34589999999999999999999999999999999997542 34566778889988874 44 5999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhh--hCCeEEeecCCCcEEEc--cCCceEEeec
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIH--QHNYVHRDIKPDNLILD--KNGHLKLSDF 182 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH--~~givHrDLKpeNILld--~~g~ikL~DF 182 (450)
..+.+|+||||++ |+|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999995 5999999875 46999999999999999999999 57999999999999994 5788999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|+|+..... ..+.+||+.|+|||++.+..|+.++|||||
T Consensus 206 G~a~~~~~~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 206 GSSCQLGQR-----------------------------------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp TTCEETTCC-----------------------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred cCceecccc-----------------------------------------cccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 999865432 124689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhcccccc----------------cCCC-------------------CCC-----
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL----------------KFPE-------------------EPK----- 302 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------------~~p~-------------------~~~----- 302 (450)
||++|||++|.+||.+.+..+.+.+|....... ..|. ...
T Consensus 245 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 324 (382)
T 2vx3_A 245 GCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNIL 324 (382)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHh
Confidence 999999999999999988877766665311000 0000 000
Q ss_pred --------------------CCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 303 --------------------ISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 303 --------------------~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
.++++++||.+||. ||.+|+ +++|+++||||++..|
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp---ta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 325 GVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI---QPYYALQHSFFKKTAD 381 (382)
T ss_dssp TTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGCC---
T ss_pred hccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC---CHHHHhcCcccccCCC
Confidence 01478999999999 999999 7999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=390.18 Aligned_cols=260 Identities=30% Similarity=0.454 Sum_probs=202.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC---
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--- 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--- 111 (450)
..+++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......|...+..++||||++++++|.+..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345899999999999999999999999999999999865432 2234566778888899999999999997643
Q ss_pred ----eEEEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHhh--hCCeEEeecCCCcEEEcc-CCceEEe
Q 013064 112 ----FLYLIMEYLPGGDIMTLL----MREDILSEDVARFYIAESVLAIHSIH--QHNYVHRDIKPDNLILDK-NGHLKLS 180 (450)
Q Consensus 112 ----~lylVmEy~~gg~L~~~l----~~~~~~~e~~~~~~~~qil~aL~~LH--~~givHrDLKpeNILld~-~g~ikL~ 180 (450)
++|+||||++|+ |...+ .....+++..++.++.||+.||.||| ++||+||||||+|||++. +|.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 389999999875 44333 35678999999999999999999999 999999999999999997 8999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDW 259 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~Di 259 (450)
|||+++....... ....+||+.|+|||++.+. .++.++||
T Consensus 175 Dfg~a~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (360)
T 3e3p_A 175 DFGSAKKLSPSEP---------------------------------------NVAYICSRYYRAPELIFGNQHYTTAVDI 215 (360)
T ss_dssp CCTTCBCCCTTSC---------------------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred eCCCceecCCCCC---------------------------------------cccccCCcceeCHHHHcCCCCCCcHHHH
Confidence 9999987643211 1246899999999999764 48999999
Q ss_pred cchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccc---------------c------------CC-CCCCCCHHHHHHH
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL---------------K------------FP-EEPKISDEARDLI 311 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~---------------~------------~p-~~~~~s~~~~dli 311 (450)
|||||++|+|++|.+||.+.+....+..+....... . ++ .....++++++||
T Consensus 216 ~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (360)
T 3e3p_A 216 WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295 (360)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHH
Confidence 999999999999999999988877776665311000 0 00 0123678999999
Q ss_pred HHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 312 CHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 312 ~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
.+||+ ||.+|+ ++.|+++||||+++.+
T Consensus 296 ~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 296 SALLQYLPEERM---KPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHTCSSGGGSC---CHHHHTTSGGGGGGGC
T ss_pred HHHhccCccccC---CHHHHhcCccccccCC
Confidence 99999 999999 6899999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=385.61 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=218.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCC-CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC------eeeEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC------IVQLFYS 106 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~-~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~------Iv~l~~~ 106 (450)
....++|++++.||+|+||.||+|++..++ +.||+|++++.. ...+.+.+|+.+++.+.|++ ++.++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 344589999999999999999999998887 689999997532 34567788999999887655 9999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE-------------
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL------------- 171 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl------------- 171 (450)
+...+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 777888776653 79999999999999999999999999999999999999
Q ss_pred ------ccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccch
Q 013064 172 ------DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAP 245 (450)
Q Consensus 172 ------d~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~AP 245 (450)
+.++.+||+|||+++..... ..+.+||+.|+||
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------------------------------------~~~~~gt~~y~aP 208 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----------------------------------------HTTIVATRHYRPP 208 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----------------------------------------CCSSCSCGGGCCH
T ss_pred cccccccCCCcEEEeecCcccccccc-----------------------------------------ccCCcCCCcccCC
Confidence 67889999999999764322 1246899999999
Q ss_pred hhhccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccc-------------------c----------
Q 013064 246 EVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCL-------------------K---------- 296 (450)
Q Consensus 246 Evl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-------------------~---------- 296 (450)
|++.+..|+.++|+|||||++|||++|.+||.+.+..+....+....... .
T Consensus 209 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T 2eu9_A 209 EVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRY 288 (355)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHH
T ss_pred eeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcc
Confidence 99999999999999999999999999999999877665544433210000 0
Q ss_pred -----------CCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 297 -----------FPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 297 -----------~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
.......++++.+||.+||. ||.+|| +++++++||||++++|+...
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp HHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGCCHHHHC
T ss_pred ccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcCCChhhcc
Confidence 00111235688999999998 999999 68999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=387.41 Aligned_cols=256 Identities=20% Similarity=0.312 Sum_probs=212.2
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCE----EEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~----~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
..+..++|++++.||+|+||.||+|++..+++. +|+|++.... .......+.+|..++..++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 456778999999999999999999999988887 5566554332 1223345678999999999999999999987
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+..+|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45689999999999999999875 5799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
....... .......||+.|+|||++.+..|+.++|||||||++|
T Consensus 165 ~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (325)
T 3kex_A 165 LPPDDKQ------------------------------------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208 (325)
T ss_dssp SCCCTTC------------------------------------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cCccccc------------------------------------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHH
Confidence 6543111 0112457889999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 268 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 268 eml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+|++ |..||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|| ++.++++|
T Consensus 209 el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~el~~~ 270 (325)
T 3kex_A 209 ELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQP--QICTIDVYMVMVKCWMIDENIRP---TFKELANE 270 (325)
T ss_dssp HHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCC--TTBCTTTTHHHHHHTCSCTTTSC---CHHHHHHH
T ss_pred HHHhCCCCCccccCHHHHHHHHHcC-CCCCCC--CcCcHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999 99999988877776666543 223333 3688899999999998 999999 57777765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=383.98 Aligned_cols=265 Identities=21% Similarity=0.254 Sum_probs=213.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lyl 115 (450)
-++|++++.||+|+||.||+|++..+|+.||||++..... .+.+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 4789999999999999999999999999999999875532 23477899999999 99999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc-----eEEeeccccccCc
Q 013064 116 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCKPLE 189 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~-----ikL~DFGla~~~~ 189 (450)
||||+ ||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|+ +||+|||+|+.+.
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 9999999987 468999999999999999999999999999999999999999887 9999999998764
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
....... .......+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 162 DPETKKH-------------------------------IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CTTTCCB-------------------------------CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCcc-------------------------------ccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHH
Confidence 4311100 000112357899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChh---hhhhhhhcccccccCCC-CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc----------CC
Q 013064 270 LIGYPPFCSDDPR---ITCRKIVNWKTCLKFPE-EPKISDEARDLICHLLC-DVETRLGTRGVEELKE----------HP 334 (450)
Q Consensus 270 l~G~~PF~~~~~~---~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~----------Hp 334 (450)
++|..||.+.+.. +.+.++.........+. ...++ ++.+||..||. ||.+||+ +++|++ .+
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~---~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPD---YDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCC---HHHHHHHHHHHHHHTTCC
T ss_pred hcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCC---HHHHHHHHHHHHHHcCCC
Confidence 9999999885433 33444443221111110 11244 99999999998 9999995 444443 34
Q ss_pred CcCCCCcc
Q 013064 335 WFRGIQWD 342 (450)
Q Consensus 335 ff~~i~w~ 342 (450)
+...++|+
T Consensus 287 ~~~~~dw~ 294 (330)
T 2izr_A 287 FDYEYDWI 294 (330)
T ss_dssp CSCCCTTT
T ss_pred CCCCccCC
Confidence 44567776
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=396.10 Aligned_cols=261 Identities=18% Similarity=0.276 Sum_probs=221.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEE-----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCR-----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~-----~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
.+..++|++++.||+|+||.||+|+ +..+++.||+|++++. ........+.+|..+++.++|||||++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4667899999999999999999999 4567889999999653 23445567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---ceE
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRED-------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG---HLK 178 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~-------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g---~ik 178 (450)
+....|+|||||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997653 599999999999999999999999999999999999999666 499
Q ss_pred EeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcccc
Q 013064 179 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 258 (450)
Q Consensus 179 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~D 258 (450)
|+|||+|+.+...... ......+||+.|+|||++.+..|+.++|
T Consensus 225 L~DFG~a~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~D 268 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYY------------------------------------RKGGCAMLPVKWMPPEAFMEGIFTSKTD 268 (367)
T ss_dssp ECCCHHHHHHHHHSSC------------------------------------TTCCGGGSCGGGCCHHHHHHCCCCHHHH
T ss_pred ECCCcccccccccccc------------------------------------ccCCCcCCcccEECHHHhcCCCCCcHHH
Confidence 9999999754321100 1122467899999999999999999999
Q ss_pred ccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 259 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 259 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
||||||++|||++ |.+||.+.+..+....+.... ....| ..+++.+.+||.+||. ||.+|| ++.+|++|.++
T Consensus 269 vwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~eil~~l~~ 342 (367)
T 3l9p_A 269 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRP---NFAIILERIEY 342 (367)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCCHhHCc---CHHHHHHHHHH
Confidence 9999999999998 999999998888887776542 22233 4789999999999998 999999 68999999876
Q ss_pred CC
Q 013064 337 RG 338 (450)
Q Consensus 337 ~~ 338 (450)
-.
T Consensus 343 ~~ 344 (367)
T 3l9p_A 343 CT 344 (367)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=381.78 Aligned_cols=264 Identities=27% Similarity=0.433 Sum_probs=213.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-------- 108 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-------- 108 (450)
.++|++++.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|..+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 37899999999999999999999999999999998754 2445678899999999999999999999884
Q ss_pred ------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-cCCceEEee
Q 013064 109 ------DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSD 181 (450)
Q Consensus 109 ------~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-~~g~ikL~D 181 (450)
+...+|+||||++ |+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4478999999997 59999885 46799999999999999999999999999999999999997 567999999
Q ss_pred ccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCcccccc
Q 013064 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWW 260 (450)
Q Consensus 182 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiW 260 (450)
||+++........ ........||+.|+|||++.+ ..++.++|+|
T Consensus 165 fg~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 209 (320)
T 2i6l_A 165 FGLARIMDPHYSH-----------------------------------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 209 (320)
T ss_dssp CTTCBCC-------------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHH
T ss_pred CccccccCCCccc-----------------------------------ccccccccccccccCcHHhcCcccCCchhhhH
Confidence 9999876432110 011224578999999999876 7789999999
Q ss_pred chhHHHHHHhhCCCCCCCCChhhhhhhhhccccc--------------------ccCCC------CCCCCHHHHHHHHHh
Q 013064 261 SLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTC--------------------LKFPE------EPKISDEARDLICHL 314 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------------------~~~p~------~~~~s~~~~dli~~l 314 (450)
||||++|+|++|..||.+.+..+....+...... ...+. .+.+++++++||.+|
T Consensus 210 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (320)
T 2i6l_A 210 AAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI 289 (320)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTT
T ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHH
Confidence 9999999999999999998877766665532110 00010 136899999999999
Q ss_pred hc-CccccCCCCCHHHHHcCCCcCCCCccc
Q 013064 315 LC-DVETRLGTRGVEELKEHPWFRGIQWDK 343 (450)
Q Consensus 315 L~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 343 (450)
|. ||.+|+ +++++++||||+.++|..
T Consensus 290 L~~dP~~Rp---t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 290 LTFSPMDRL---TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp SCSSGGGSC---CHHHHHTSHHHHTTCC--
T ss_pred cCCCccccC---CHHHHhCCcccccccCcc
Confidence 98 999999 799999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=388.82 Aligned_cols=257 Identities=22% Similarity=0.339 Sum_probs=218.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEE-----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCR-----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~-----~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|++++.||+|+||.||+|+ +..+++.||+|++++.. .....+.+.+|+.+|..+ +|||||++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4667899999999999999999999 55677899999997643 344567789999999999 789999999999
Q ss_pred EcCC-eEEEEEeccCCCChHHHHHhcCC----------------------------------------------------
Q 013064 108 QDSD-FLYLIMEYLPGGDIMTLLMREDI---------------------------------------------------- 134 (450)
Q Consensus 108 ~~~~-~lylVmEy~~gg~L~~~l~~~~~---------------------------------------------------- 134 (450)
.+.+ .+|+|||||+||+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8765 49999999999999999976543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccccc
Q 013064 135 --------------LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDE 200 (450)
Q Consensus 135 --------------~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~ 200 (450)
+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~------ 249 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------ 249 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc------
Confidence 899999999999999999999999999999999999999999999999999866432110
Q ss_pred ccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCC
Q 013064 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSD 279 (450)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~ 279 (450)
.......||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.
T Consensus 250 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 250 ------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp ------------------------------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ------------------------------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 01124679999999999999999999999999999999998 99999987
Q ss_pred ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 280 DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 280 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+........+........| ..+++++.+||.+||. ||.+|| +++++++|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 349 (359)
T 3vhe_A 300 KIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 349 (359)
T ss_dssp CCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred chhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHHHH
Confidence 7666555555433344444 4789999999999998 999999 68888876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=386.78 Aligned_cols=254 Identities=32% Similarity=0.528 Sum_probs=187.1
Q ss_pred CCCCCeEEEe-EEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc----
Q 013064 35 IGIDDFEQLT-LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD---- 109 (450)
Q Consensus 35 ~~~~~f~~~~-~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~---- 109 (450)
.-.++|.+++ +||+|+||.||+|+++.+|+.||+|++.+.. .........++.+.||||++++++|.+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 3457999976 6999999999999999999999999996532 112223344667799999999999986
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeeccc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGL 184 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFGl 184 (450)
...+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 556999999999999999998764 6999999999999999999999999999999999999976 45699999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
++...... ....+||+.|+|||++.+..|+.++|+|||||
T Consensus 178 ~~~~~~~~----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 217 (336)
T 3fhr_A 178 AKETTQNA----------------------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217 (336)
T ss_dssp CEEC--------------------------------------------------------------CHHHHHHHHHHHHH
T ss_pred ceeccccc----------------------------------------cccCCCCcCccChhhhCCCCCCchhhHHHHHH
Confidence 98654321 12468999999999998888999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhh----hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 265 IMYEMLIGYPPFCSDDPRIT----CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|+|++|..||.+...... ...+.........+....+++++++||.+||. ||.+|| +++++++||||++
T Consensus 218 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 293 (336)
T 3fhr_A 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL---TITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCccccc
Confidence 99999999999987665443 22232222233334445789999999999998 999999 6999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=377.05 Aligned_cols=266 Identities=21% Similarity=0.315 Sum_probs=214.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|.+.+.||+|+||.||+|.+..+++.||+|++.+. .....+.+.+|..+|+.++||||+++++++.+++.+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 5678999999999999999999999999999999998543 3455678899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 56799999999999999999999999999999999999999999999999999987654311
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
... ..............+.+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 164 ~~~------------------------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 219 (310)
T 3s95_A 164 QPE------------------------GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219 (310)
T ss_dssp ----------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTC
T ss_pred ccc------------------------ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCC
Confidence 100 00000001111223578999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhh-hcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 274 PPFCSDDPRITCRKI-VNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i-~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.||............ .........| ..+++.+.+||.+||. ||.+|| +++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~l~~ 275 (310)
T 3s95_A 220 NADPDYLPRTMDFGLNVRGFLDRYCP--PNCPPSFFPITVRCCDLDPEKRP---SFVKLEH 275 (310)
T ss_dssp CSSTTTSCBCTTSSBCHHHHHHHTCC--TTCCTTHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCcchhhhHHHHhhhhhccccccCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999764433221111 1100111223 4789999999999998 999999 5777775
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=381.14 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=219.2
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
...+..++|++.+.||+|+||.||+|+++.+++ .||+|+++... .....+.+.+|..+|+.++||||+++++++.
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345777899999999999999999999987665 49999997542 3445677899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+.+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999999765 5899999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
........ .......||+.|+|||++.+..|+.++|||||||++|
T Consensus 201 ~~~~~~~~-----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 245 (325)
T 3kul_A 201 LEDDPDAA-----------------------------------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245 (325)
T ss_dssp CC----CC-----------------------------------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred cccCccce-----------------------------------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHH
Confidence 65431110 0012346788999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 268 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 268 eml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|++ |..||.+.+..+....+... ...+....+++.+.+||.+||. ||.+|| ++.+|++
T Consensus 246 ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~ 306 (325)
T 3kul_A 246 EVLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRP---RFSQIVS 306 (325)
T ss_dssp HHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 9999 99999998888877777653 2333345799999999999998 999999 5677664
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=388.05 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=209.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh--------cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--------LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
.++|++++.||+|+||.||+|.+.. |+.||+|++.+... ......+.+.+|..+|+.++||||++++++|.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4899999999999999999998865 89999999865432 12223578899999999999999999999994
Q ss_pred c-----CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeec
Q 013064 109 D-----SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDF 182 (450)
Q Consensus 109 ~-----~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DF 182 (450)
+ ...+|+||||+. |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 447999999997 5888887654 47999999999999999999999999999999999999999999999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccc
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWS 261 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWS 261 (450)
|+++...... .....+||+.|+|||++.+ ..++.++|+||
T Consensus 179 g~~~~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 219 (362)
T 3pg1_A 179 NLAREDTADA---------------------------------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219 (362)
T ss_dssp TC------------------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHH
T ss_pred Cccccccccc---------------------------------------ccceecccceecCcHHhcCCCCCCcHhHHHh
Confidence 9997543221 0124689999999999987 77899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhhhhhhhccccc----------------------ccCCC------CCCCCHHHHHHHHH
Q 013064 262 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTC----------------------LKFPE------EPKISDEARDLICH 313 (450)
Q Consensus 262 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------------------~~~p~------~~~~s~~~~dli~~ 313 (450)
|||++|+|++|..||.+.+..+...++...... ...+. .+.+++.+.+||.+
T Consensus 220 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 299 (362)
T 3pg1_A 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299 (362)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHH
Confidence 999999999999999998877766665431110 00110 13578999999999
Q ss_pred hhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 314 LLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 314 lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||. ||.+|+ +++++++||||+.+
T Consensus 300 ~L~~dP~~Rp---t~~ell~hp~f~~~ 323 (362)
T 3pg1_A 300 MLEFNPQRRI---STEQALRHPYFESL 323 (362)
T ss_dssp HTCSSGGGSC---CHHHHHTSGGGTTT
T ss_pred HhcCChhhCC---CHHHHHcCchhhhc
Confidence 999 999999 68999999999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=366.51 Aligned_cols=252 Identities=20% Similarity=0.312 Sum_probs=218.4
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++++.||+|+||.||+|++. +++.||+|++.+... ..+.+.+|..+++.++||||+++++++.++..+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 467789999999999999999999987 567799999986542 235688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999999999764 469999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
. .......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 161 ~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~ 203 (269)
T 4hcu_A 161 Y-------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 203 (269)
T ss_dssp H-------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred c-------------------------------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcC
Confidence 0 01123568889999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|.+||.+.+..+....+.... ..+....+++.+.+||.+||. ||.+|| ++.++++|
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~ 260 (269)
T 4hcu_A 204 GKIPYENRSNSEVVEDISTGF---RLYKPRLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 260 (269)
T ss_dssp SCCTTTTCCHHHHHHHHHTTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCc---cCCCCCcCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 999999988888877776532 222234689999999999998 999999 67888765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=371.62 Aligned_cols=271 Identities=27% Similarity=0.486 Sum_probs=210.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--------
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-------- 109 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-------- 109 (450)
++|++++.||+|+||.||+|++..+|+.||+|++.+. ....+.+.+|..+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999999653 3456778899999999999999999999865
Q ss_pred -----CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecc
Q 013064 110 -----SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFG 183 (450)
Q Consensus 110 -----~~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFG 183 (450)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 457899999999999999998654 68899999999999999999999999999999999999999999999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccch
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSL 262 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSl 262 (450)
++............. ... . ..........+||+.|+|||++.+. .++.++|+|||
T Consensus 162 ~~~~~~~~~~~~~~~-----------~~~------------~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 217 (303)
T 1zy4_A 162 LAKNVHRSLDILKLD-----------SQN------------L-PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSL 217 (303)
T ss_dssp CCSCTTC-------------------------------------------------CTTSCHHHHTSCSCCCTHHHHHHH
T ss_pred chhhcccccchhccc-----------ccc------------c-cccccccccCCCcccccCcccccCCCCCcchhhHHHH
Confidence 998765321100000 000 0 0000112346899999999999865 68999999999
Q ss_pred hHHHHHHhhCCCCCCC-CChhhhhhhhhcccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 263 GAIMYEMLIGYPPFCS-DDPRITCRKIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 263 Gvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||++|+|++ ||.. .+.......+.... ..+|. ....++.+++||.+||. ||.+|| +++++++||||..
T Consensus 218 G~il~~l~~---p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~ 289 (303)
T 1zy4_A 218 GIIFFEMIY---PFSTGMERVNILKKLRSVS--IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHHHS---CCSSHHHHHHHHHHHHSTT--CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC---CHHHHHHSSCSCC
T ss_pred HHHHHHHHh---ccCCchhHHHHHHhccccc--cccCccccccchHHHHHHHHHHHhcCcccCc---CHHHHhCCCCcCC
Confidence 999999998 5543 23333444444322 22222 24677889999999998 999999 7999999999998
Q ss_pred CCcccc
Q 013064 339 IQWDKL 344 (450)
Q Consensus 339 i~w~~l 344 (450)
..++..
T Consensus 290 ~~~~~~ 295 (303)
T 1zy4_A 290 KHQDEV 295 (303)
T ss_dssp CCHHHH
T ss_pred CChHHH
Confidence 776644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=380.30 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=217.0
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 106 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 106 (450)
..+..++|++.+.||+|+||.||+|++. .++..||+|++.+.. .....+.+.+|..+|..+ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3466789999999999999999999973 456789999997543 233457789999999999 99999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEee
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRED-----------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRD 163 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~-----------------------~~~e~~~~~~~~qil~aL~~LH~~givHrD 163 (450)
+.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999999999999997653 379999999999999999999999999999
Q ss_pred cCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCcc
Q 013064 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243 (450)
Q Consensus 164 LKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~ 243 (450)
|||+|||++.+|.+||+|||++......... .......||+.|+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~t~~y~ 241 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY------------------------------------VVRGNARLPVKWM 241 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS------------------------------------EEETTEEECGGGC
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc------------------------------------eeccCccCccCcc
Confidence 9999999999999999999999865432110 0112457899999
Q ss_pred chhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 244 APEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 244 APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
|||++.+..++.++|||||||++|+|++ |..||.+.........++........| ..+++++.+||.+||. ||.+|
T Consensus 242 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~R 319 (344)
T 1rjb_A 242 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKR 319 (344)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCCchhC
Confidence 9999999999999999999999999998 999999887666666665533333333 4789999999999998 99999
Q ss_pred CCCCCHHHHHcC
Q 013064 322 LGTRGVEELKEH 333 (450)
Q Consensus 322 ~~~~~~~eil~H 333 (450)
| ++.++++|
T Consensus 320 p---s~~~l~~~ 328 (344)
T 1rjb_A 320 P---SFPNLTSF 328 (344)
T ss_dssp C---CHHHHHHH
T ss_pred c---CHHHHHHH
Confidence 9 67888876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=365.67 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=206.3
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
.+..++|++.+.||+|+||.||+|++. |+.||+|++.+..... ....+.+.+|..+++.++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 356789999999999999999999974 8899999987654322 2345778999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCC---eEEeecCCCcEEEcc--------CCceEEee
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN---YVHRDIKPDNLILDK--------NGHLKLSD 181 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~g---ivHrDLKpeNILld~--------~g~ikL~D 181 (450)
+|+||||++||+|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999998884 567999999999999999999999999 999999999999986 78899999
Q ss_pred ccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccc
Q 013064 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWS 261 (450)
Q Consensus 182 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWS 261 (450)
||++....... .....||+.|+|||++.+..++.++|+||
T Consensus 160 fg~~~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 199 (271)
T 3dtc_A 160 FGLAREWHRTT----------------------------------------KMSAAGAYAWMAPEVIRASMFSKGSDVWS 199 (271)
T ss_dssp CCC-----------------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHH
T ss_pred CCccccccccc----------------------------------------ccCCCCccceeCHHHhccCCCCchhhHHH
Confidence 99998654321 11357999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 262 LGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 262 lGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|||++|+|++|..||.+.+.......+.........| ..+++.+.+||.+||. ||.+|| ++.++++|
T Consensus 200 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 267 (271)
T 3dtc_A 200 YGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--STCPEPFAKLMEDCWNPDPHSRP---SFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--cccCHHHHHHHHHHhcCCcccCc---CHHHHHHH
Confidence 9999999999999999988777766666543333334 5789999999999998 999999 67888764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=374.77 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=221.0
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 106 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 106 (450)
...+..++|.+.+.||+|+||.||+|.+. .+++.||+|++.+.. .....+.+.+|..+|+.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 34567789999999999999999999983 456899999997542 34556788999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHhhhCCeEEe
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMREDI------------------------LSEDVARFYIAESVLAIHSIHQHNYVHR 162 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~~------------------------~~e~~~~~~~~qil~aL~~LH~~givHr 162 (450)
+.+.+.+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987543 8999999999999999999999999999
Q ss_pred ecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCc
Q 013064 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 242 (450)
Q Consensus 163 DLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y 242 (450)
||||+|||++.+|.+||+|||++......... .......||+.|
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y 218 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSY------------------------------------VKRSQGRIPVKW 218 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCE------------------------------------ECSSCCCSCGGG
T ss_pred ccchheEEEcCCCCEEEccccccccccccccc------------------------------------eeccCCCCcccc
Confidence 99999999999999999999999865432110 001235688999
Q ss_pred cchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 013064 243 MAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 243 ~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~ 320 (450)
+|||++.+..++.++|+|||||++|+|++ |..||.+.+.......+.... ....| ..+++++.+||.+||. ||.+
T Consensus 219 ~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~dp~~ 295 (314)
T 2ivs_A 219 MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-RMERP--DNCSEEMYRLMLQCWKQEPDK 295 (314)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGG
T ss_pred cChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-cCCCC--ccCCHHHHHHHHHHccCChhh
Confidence 99999999999999999999999999999 999999988877776665432 23333 4789999999999998 9999
Q ss_pred cCCCCCHHHHHcC
Q 013064 321 RLGTRGVEELKEH 333 (450)
Q Consensus 321 R~~~~~~~eil~H 333 (450)
|| ++.++++|
T Consensus 296 Rp---s~~~l~~~ 305 (314)
T 2ivs_A 296 RP---VFADISKD 305 (314)
T ss_dssp SC---CHHHHHHH
T ss_pred Cc---CHHHHHHH
Confidence 99 67888764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=380.70 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=219.9
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcC--CCCeeeEEE
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVD--SRCIVQLFY 105 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---~~~~~~~~E~~il~~l~--hp~Iv~l~~ 105 (450)
.......++|++++.||+|+||.||+|++..+|+.||+|++.+...... .....+.+|..+++.+. ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3445567899999999999999999999999999999999987654321 12245667999999996 599999999
Q ss_pred EEEcCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-cCCceEEeecc
Q 013064 106 SFQDSDFLYLIMEYLPG-GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFG 183 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~g-g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-~~g~ikL~DFG 183 (450)
++.+.+.+|+||||+.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999999976 89999999889999999999999999999999999999999999999999 78999999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-Cccccccch
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSL 262 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSl 262 (450)
+++...... ....+||+.|+|||++.+..+ +.++|+|||
T Consensus 196 ~~~~~~~~~----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 235 (320)
T 3a99_A 196 SGALLKDTV----------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL 235 (320)
T ss_dssp TCEECCSSC----------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred ccccccccc----------------------------------------ccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence 998654321 124679999999999987776 788999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
||++|||++|..||...+ .+.. ....++ ..+++++.+||.+||. ||.+|| ++++|++||||+++.+
T Consensus 236 G~il~el~~g~~pf~~~~------~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 236 GILLYDMVCGDIPFEHDE------EIIR--GQVFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHHHHSSCSCCSHH------HHHH--CCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCCC
T ss_pred HHHHHHHHHCCCCCCChh------hhhc--cccccc--ccCCHHHHHHHHHHccCChhhCc---CHHHHhcCHhhcCccC
Confidence 999999999999996542 1222 112233 4789999999999998 999999 7999999999998765
Q ss_pred cc
Q 013064 342 DK 343 (450)
Q Consensus 342 ~~ 343 (450)
..
T Consensus 303 ~~ 304 (320)
T 3a99_A 303 PQ 304 (320)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=385.31 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=209.0
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----------CCCee
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----------SRCIV 101 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv 101 (450)
..+..++|++++.||+|+||.||+|++..+|+.||+|++.+.. ...+.+.+|..+++.+. ||||+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 3456689999999999999999999999999999999997543 23466788999998876 89999
Q ss_pred eEEEEEEcCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEcc-
Q 013064 102 QLFYSFQDSD----FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDK- 173 (450)
Q Consensus 102 ~l~~~f~~~~----~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~- 173 (450)
+++++|...+ .+++||||+ ||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999998654 899999999 99999999873 4599999999999999999999998 9999999999999954
Q ss_pred -----CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 174 -----NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 174 -----~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
.+.+||+|||+++..... ....+||+.|+|||++
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----------------------------------------~~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----------------------------------------YTNSIQTREYRSPEVL 207 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----------------------------------------CCSCCSCGGGCCHHHH
T ss_pred CCCcCcceEEEcccccccccCCC-----------------------------------------CCCCCCCccccCcHHH
Confidence 348999999999865432 1235899999999999
Q ss_pred ccCCCCccccccchhHHHHHHhhCCCCCCCCChh------hhhhhhhccc------------------------------
Q 013064 249 LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPR------ITCRKIVNWK------------------------------ 292 (450)
Q Consensus 249 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~------------------------------ 292 (450)
.+..|+.++|+|||||++|||++|..||.+.+.. .....+....
T Consensus 208 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
T 1q8y_A 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287 (373)
T ss_dssp HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc
Confidence 9999999999999999999999999999865421 1222221100
Q ss_pred ----------ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 293 ----------TCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 293 ----------~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
....++ ..+++++.+||.+||. ||.+|| +++++++||||++.
T Consensus 288 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 288 KFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 340 (373)
T ss_dssp CBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTC
T ss_pred cccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccC---CHHHHhhChhhhcc
Confidence 001111 2456789999999999 999999 78999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=363.67 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=217.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++++.||+|+||.||+|+++ ++..||+|+++.... ..+.+.+|..++..++||||+++++++.++..+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 466789999999999999999999876 566799999976542 235688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997754 59999999999999999999999999999999999999999999999999998654331
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 159 ~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (268)
T 3sxs_A 159 YV-------------------------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL 201 (268)
T ss_dssp EE-------------------------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTT
T ss_pred hh-------------------------------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcC
Confidence 10 0123467889999999999899999999999999999998
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|..||.+.+.......+.... ....| ...++.+.+||.+||. ||.+|| ++.++++|
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (268)
T 3sxs_A 202 GKMPYDLYTNSEVVLKVSQGH-RLYRP--HLASDTIYQIMYSCWHELPEKRP---TFQQLLSS 258 (268)
T ss_dssp TCCTTTTSCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred CCCCccccChHHHHHHHHcCC-CCCCC--CcChHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999888887777776532 22223 4689999999999998 999999 68888865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=372.40 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=208.4
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
....+++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..+++.++||||+++++++.+++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 44567999999999999999999999999999999999987655455556789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
.. .....+||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 189 ~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (309)
T 2h34_A 189 LT-------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231 (309)
T ss_dssp ---------------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred cc-------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence 00 01245799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
..||.+.+.......+..... ........+++++.+||.+||. ||.+|++ ++++++
T Consensus 232 ~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~--s~~~l~ 288 (309)
T 2h34_A 232 SPPYQGDQLSVMGAHINQAIP-RPSTVRPGIPVAFDAVIARGMAKNPEDRYV--TCGDLS 288 (309)
T ss_dssp SCSSCSCHHHHHHHHHHSCCC-CGGGTSTTCCTHHHHHHHHHTCSSGGGSCS--SHHHHH
T ss_pred CCCCCCchHHHHHHHhccCCC-CccccCCCCCHHHHHHHHHhccCCHHHHHH--hHHHHH
Confidence 999988776544433332111 1111224789999999999998 9999995 366665
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=370.00 Aligned_cols=261 Identities=30% Similarity=0.482 Sum_probs=214.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
....++|.....||+|+||.||+|++..+++.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+.+
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 345566666779999999999999999999999999997643 33456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeeccccccCc
Q 013064 114 YLIMEYLPGGDIMTLLMRE---DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLE 189 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~---~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DFGla~~~~ 189 (450)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 9999999999999999765 25679999999999999999999999999999999999987 8999999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC--CCCccccccchhHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLGAIMY 267 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~--~y~~~~DiWSlGvily 267 (450)
.... .....+||+.|+|||++.+. .++.++|+|||||++|
T Consensus 175 ~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 216 (295)
T 2clq_A 175 GINP--------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII 216 (295)
T ss_dssp C-------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHH
T ss_pred CCCC--------------------------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHH
Confidence 3210 01246899999999999764 3899999999999999
Q ss_pred HHhhCCCCCCCCChhh-hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 268 EMLIGYPPFCSDDPRI-TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 268 eml~G~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
+|++|..||....... .............+| ..+++++.+||.+||. ||.+|| ++++++.||||+...
T Consensus 217 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 217 EMATGKPPFYELGEPQAAMFKVGMFKVHPEIP--ESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC--TTSCHHHHHHHHHTTCSSTTTSC---CHHHHHTSGGGCC--
T ss_pred HHHHCCCCccCCCchhHHHHhhcccccccccc--ccCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhhcc
Confidence 9999999997643322 222221111222333 4789999999999998 999999 689999999998643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=377.98 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=221.0
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 106 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 106 (450)
...+..++|++++.||+|+||.||+|++. .+++.||+|++++.. .....+.+.+|..+++.++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34677799999999999999999999997 456899999997653 34456788999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEe
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRE------------------------DILSEDVARFYIAESVLAIHSIHQHNYVHR 162 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~------------------------~~~~e~~~~~~~~qil~aL~~LH~~givHr 162 (450)
+.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999774 579999999999999999999999999999
Q ss_pred ecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCc
Q 013064 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 242 (450)
Q Consensus 163 DLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y 242 (450)
||||+|||++.+|.+||+|||+++........ .......||+.|
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~t~~y 242 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY------------------------------------KADGNDAIPIRW 242 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB------------------------------------C----CCBCGGG
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc------------------------------------cccCCCccccee
Confidence 99999999999999999999999765332100 001235789999
Q ss_pred cchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-Cccc
Q 013064 243 MAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 243 ~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~ 320 (450)
+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~ 319 (343)
T 1luf_A 243 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSKLPAD 319 (343)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGG
T ss_pred cChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-cCCCC--CCCCHHHHHHHHHHcccCccc
Confidence 99999999999999999999999999998 999999988887777776532 22333 4789999999999998 9999
Q ss_pred cCCCCCHHHHHcC
Q 013064 321 RLGTRGVEELKEH 333 (450)
Q Consensus 321 R~~~~~~~eil~H 333 (450)
|| ++.+++++
T Consensus 320 Rp---s~~~~~~~ 329 (343)
T 1luf_A 320 RP---SFCSIHRI 329 (343)
T ss_dssp SC---CHHHHHHH
T ss_pred CC---CHHHHHHH
Confidence 99 57777653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=363.38 Aligned_cols=250 Identities=17% Similarity=0.231 Sum_probs=217.1
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS- 110 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~- 110 (450)
...+.+++|++++.||+|+||.||+|++. |+.||+|++.... ......+.+.+|..+++.++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 35678899999999999999999999984 8889999998654 2334567789999999999999999999999987
Q ss_pred -CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEccCCceEEeecccc
Q 013064 111 -DFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 111 -~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld~~g~ikL~DFGla 185 (450)
..+|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 78999999999999999998765 4899999999999999999999999 999999999999999999999999987
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCc---cccccch
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM---ECDWWSL 262 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~---~~DiWSl 262 (450)
..... ...+||+.|+|||++.+..++. ++|+|||
T Consensus 161 ~~~~~-------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl 197 (271)
T 3kmu_A 161 FSFQS-------------------------------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197 (271)
T ss_dssp CTTSC-------------------------------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred eeecc-------------------------------------------cCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence 64322 1357999999999998766554 7999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
||++|+|++|..||.+.+.......+........+| ..+++++.+||.+||. ||.+|| +++++++
T Consensus 198 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (271)
T 3kmu_A 198 AVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP--PGISPHVSKLMKICMNEDPAKRP---KFDMIVP 263 (271)
T ss_dssp HHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999999999999999988877777766544444444 4799999999999998 999999 5777764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=366.85 Aligned_cols=255 Identities=20% Similarity=0.336 Sum_probs=217.5
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
....+..++|++++.||+|+||.||++.+. ++..||+|++.+... ..+.+.+|..++..++||||+++++++.+.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 344677889999999999999999999876 677899999986532 235688999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+.+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999977 5679999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... ......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 172 ~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l 214 (283)
T 3gen_A 172 DDEYT-------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214 (283)
T ss_dssp CHHHH-------------------------------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred ccccc-------------------------------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 32100 01234678999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++ |..||.+.+.......+.... ..+.....++.+.+||.+||. ||.+|| ++.++++|
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 274 (283)
T 3gen_A 215 YSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 274 (283)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HhCCCCCccccChhHHHHHHhccc---CCCCCCcCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 98 999999988888887776532 222234689999999999998 999999 67888865
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=372.83 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=202.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
...+++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+..+..+++.++||||+++++++.+++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 4567899999999999999999999999999999999976542 222334445555678888999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||+ ++.+..++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.+|++||+|||++......
T Consensus 100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999999 5566555543 57899999999999999999999995 9999999999999999999999999999765432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHH
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIM 266 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvil 266 (450)
.. ....+||+.|+|||++. ...++.++|+|||||++
T Consensus 179 ~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il 219 (318)
T 2dyl_A 179 KA---------------------------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219 (318)
T ss_dssp -----------------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHH
T ss_pred cc---------------------------------------ccccCCCccccChhhcccccccccCCccccchhhHHHHH
Confidence 10 11357999999999994 46689999999999999
Q ss_pred HHHhhCCCCCCCC-ChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 267 YEMLIGYPPFCSD-DPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 267 yeml~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
|+|++|..||... +..+....+... ....+|....+++++.+||.+||. ||.+|| +++++++||||++..
T Consensus 220 ~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 220 VELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP---KYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHHHH
T ss_pred HHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCc---CHHHHhhCHHHHhcc
Confidence 9999999999873 444555555543 223344445789999999999998 999999 689999999998643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=377.72 Aligned_cols=267 Identities=26% Similarity=0.452 Sum_probs=198.7
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEcC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN-LLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~f~~~ 110 (450)
...+..++|++++.||+|+||.||+|.++.+|+.||+|++.... .......+..|.. +++.++||||+++++++.++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~ 93 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE 93 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence 34678899999999999999999999999999999999997642 2233344555555 67778999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhC-CeEEeecCCCcEEEccCCceEEeeccc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSIHQH-NYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~-----~~~~~e~~~~~~~~qil~aL~~LH~~-givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
+.+|+||||++| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999999985 78777753 57899999999999999999999998 999999999999999999999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh----ccCCCCcccccc
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL----LKKGYGMECDWW 260 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl----~~~~y~~~~DiW 260 (450)
++....... ....+||+.|+|||++ .+..++.++|+|
T Consensus 173 ~~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~ 213 (327)
T 3aln_A 173 SGQLVDSIA---------------------------------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213 (327)
T ss_dssp SCC---------------------------------------------------------------------CCSHHHHH
T ss_pred ceecccccc---------------------------------------cccCCCCccccCceeeccccCcCCCCchhhHH
Confidence 986543210 1134799999999999 456789999999
Q ss_pred chhHHHHHHhhCCCCCCCCCh-hhhhhhhhcccc-cccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 261 SLGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKT-CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 261 SlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~-~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
||||++|+|++|..||.+.+. .+....+..... .+.......+++.+.+||.+||. ||.+|| ++.+|++||||.
T Consensus 214 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~ 290 (327)
T 3aln_A 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP---KYKELLKHPFIL 290 (327)
T ss_dssp HHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCc---CHHHHHhChHHH
Confidence 999999999999999987543 233333333211 11111224689999999999998 999999 689999999998
Q ss_pred CCCccc
Q 013064 338 GIQWDK 343 (450)
Q Consensus 338 ~i~w~~ 343 (450)
...+..
T Consensus 291 ~~~~~~ 296 (327)
T 3aln_A 291 MYEERA 296 (327)
T ss_dssp HHHHSC
T ss_pred HhHhhH
Confidence 766544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=375.17 Aligned_cols=266 Identities=19% Similarity=0.271 Sum_probs=224.8
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
..+..++|++.+.||+|+||.||+|+++ .+++.||+|++.+.. .......+.+|..+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 3466689999999999999999999887 467889999997543 233456788999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCce
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRE----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 177 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~----------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~i 177 (450)
.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999998753 457999999999999999999999999999999999999999999
Q ss_pred EEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccc
Q 013064 178 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 257 (450)
Q Consensus 178 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~ 257 (450)
||+|||+++........ ......+||+.|+|||++.+..++.++
T Consensus 178 kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~ 221 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY------------------------------------RKGGKGLLPVRWMSPESLKDGVFTTYS 221 (322)
T ss_dssp EECCTTCCCGGGGGGCE------------------------------------EGGGSSEECGGGCCHHHHHHCCCCHHH
T ss_pred EECcCcccccccccccc------------------------------------ccccCCCCCCCccChhhhccCCCCchh
Confidence 99999999865432110 011235789999999999999999999
Q ss_pred cccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC--
Q 013064 258 DWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH-- 333 (450)
Q Consensus 258 DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H-- 333 (450)
|+|||||++|+|++ |..||.+.+.......+.... ....+ ..+++.+.+||.+||. ||.+|| ++.++++|
T Consensus 222 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~e~l~~L~ 295 (322)
T 1p4o_A 222 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEIISSIK 295 (322)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHG
T ss_pred hHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHHHH
Confidence 99999999999999 899999988877777776532 12223 4789999999999998 999999 67788765
Q ss_pred ----CCcCCCCcc
Q 013064 334 ----PWFRGIQWD 342 (450)
Q Consensus 334 ----pff~~i~w~ 342 (450)
|+|+.++|.
T Consensus 296 ~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 296 EEMEPGFREVSFY 308 (322)
T ss_dssp GGSCTTHHHHCST
T ss_pred HhhccCCcccccc
Confidence 666665553
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=371.53 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=218.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~-----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|++.+.||+|+||.||+|++ ..+++.||+|++.+.. .....+.+.+|..+|+.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 46668999999999999999999985 4577899999997653 233467789999999999 999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRED------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~------------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
.+.+..|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999998754 489999999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.++.+||+|||++......... .......||+.|+|||++.
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~ 220 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNY------------------------------------VVKGNARLPVKWMAPESIF 220 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTS------------------------------------EECSSSEECGGGCCHHHHH
T ss_pred EEcCCCCEEEccccccccccccccc------------------------------------eeccCCCCcceeeChHHhc
Confidence 9999999999999999876543111 0112356899999999999
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+..++.++|+|||||++|+|++ |..||.+.........++..... .+....+++.+.+||.+||. ||.+|| ++
T Consensus 221 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~ 295 (313)
T 1t46_A 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR--MLSPEHAPAEMYDIMKTCWDADPLKRP---TF 295 (313)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC--CCCcccCCHHHHHHHHHHcCCCchhCc---CH
Confidence 9999999999999999999998 99999887766655555543222 22234789999999999998 999999 57
Q ss_pred HHHHcC
Q 013064 328 EELKEH 333 (450)
Q Consensus 328 ~eil~H 333 (450)
.+++++
T Consensus 296 ~ell~~ 301 (313)
T 1t46_A 296 KQIVQL 301 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 787754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=365.37 Aligned_cols=258 Identities=19% Similarity=0.224 Sum_probs=210.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 112 (450)
.+..++|++++.||+|+||.||+|++..+|+.||+|++.+.. ..+.+.+|..+++.+ +|++|+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 455689999999999999999999999999999999987543 223477899999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc-----eEEeeccccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH-----LKLSDFGLCK 186 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~-----ikL~DFGla~ 186 (450)
.|+||||+ ||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+|||+|+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999998754 6999999999999999999999999999999999999988776 9999999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvil 266 (450)
........... ........+||+.|+|||++.+..++.++|+|||||++
T Consensus 160 ~~~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (298)
T 1csn_A 160 FYRDPVTKQHI-------------------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 208 (298)
T ss_dssp ESBCTTTCCBC-------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ccccccccccc-------------------------------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHH
Confidence 76543111000 00112356899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCC---hhhhhhhhhcccccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 267 YEMLIGYPPFCSDD---PRITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 267 yeml~G~~PF~~~~---~~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|+|++|..||.+.+ ....+..+.........+ ....+++++.+||.+||. ||.+||+ +++|+
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~---~~~l~ 275 (298)
T 1csn_A 209 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD---YDYLQ 275 (298)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC---HHHHH
T ss_pred HHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCC---HHHHH
Confidence 99999999998754 333344443321111111 113689999999999998 9999995 55554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=380.45 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=220.6
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCC-------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTT-------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 105 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t-------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 105 (450)
.+..++|.+.+.||+|+||.||+|++..+ +..||+|++++.. .......+.+|+.+++.+ +|||||++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 46668999999999999999999997643 3579999997652 344567889999999999 9999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
++.+++.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998754 499999999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.+|.+||+|||+|+........ .......||+.|+|||++.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~ 266 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYY------------------------------------KKTTNGRLPVKWMAPEALF 266 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTT------------------------------------CCCTTCCCGGGGSCHHHHH
T ss_pred EEcCCCcEEEcccCccccccccccc------------------------------------ccccCCCCCcceeCHHHhc
Confidence 9999999999999999876432110 0112357899999999999
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+..++.++|||||||++|+|++ |..||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|| ++
T Consensus 267 ~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~ 340 (382)
T 3tt0_A 267 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMDKP--SNCTNELYMMMRDCWHAVPSQRP---TF 340 (382)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--SSCCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCChhhCc---CH
Confidence 9999999999999999999999 999999988877777666532 23333 4789999999999998 999999 68
Q ss_pred HHHHcC
Q 013064 328 EELKEH 333 (450)
Q Consensus 328 ~eil~H 333 (450)
.+|++|
T Consensus 341 ~ell~~ 346 (382)
T 3tt0_A 341 KQLVED 346 (382)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=384.98 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=217.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++.+.||+|+||.||+|+++.+++.||+|+++.. ......+.+.+|..+|+.++|||||++++++.+++.+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 5567999999999999999999999999999999999754 23344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999999997654 699999999999999999999999999999999999999999999999999986433211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
. .......+|+.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 269 ~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g 312 (377)
T 3cbl_A 269 A------------------------------------ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLG 312 (377)
T ss_dssp E------------------------------------CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTS
T ss_pred e------------------------------------ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 0 00012346788999999998899999999999999999998 9
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
..||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+|| ++++|+.
T Consensus 313 ~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~ 367 (377)
T 3cbl_A 313 ASPYPNLSNQQTREFVEKG-GRLPCP--ELCPDAVFRLMEQCWAYEPGQRP---SFSTIYQ 367 (377)
T ss_dssp CCSSTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 9999988877766666543 223334 4789999999999998 999999 5677653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=371.81 Aligned_cols=263 Identities=27% Similarity=0.442 Sum_probs=215.5
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--CCCeeeEEEEEE
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFYSFQ 108 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~f~ 108 (450)
+...+.-++|++++.||+|+||.||+|++. +++.||+|++.... ......+.+.+|+.++..+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 334456678999999999999999999885 58899999997654 23445678899999999997 599999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+++.+|+||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++..
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 9999999999 66899999999989999999999999999999999999999999999999996 599999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----------CCCCccc
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----------KGYGMEC 257 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----------~~y~~~~ 257 (450)
...... ......+||+.|+|||++.+ ..++.++
T Consensus 177 ~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 220 (313)
T 3cek_A 177 QPDTTS------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220 (313)
T ss_dssp -------------------------------------------------CCGGGCCHHHHTTCC----------CCCHHH
T ss_pred cCcccc------------------------------------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchH
Confidence 432110 01124589999999999975 4688999
Q ss_pred cccchhHHHHHHhhCCCCCCCCCh-hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCC
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDDP-RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpf 335 (450)
|+|||||++|+|++|..||..... ......+........+| ...++++.+||.+||. ||.+|| +++++++|||
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~ 295 (313)
T 3cek_A 221 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPY 295 (313)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHH
T ss_pred HHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc--ccchHHHHHHHHHHccCCcccCc---CHHHHhcCcc
Confidence 999999999999999999976543 33344444433334444 3568999999999998 999999 7999999999
Q ss_pred cCC
Q 013064 336 FRG 338 (450)
Q Consensus 336 f~~ 338 (450)
|+.
T Consensus 296 ~~~ 298 (313)
T 3cek_A 296 VQI 298 (313)
T ss_dssp HHC
T ss_pred ccC
Confidence 975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=364.52 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=212.2
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhh----HHHHHHHHHHHHhcCCCCeeeEEEE
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ----VEHVRSERNLLAEVDSRCIVQLFYS 106 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~----~~~~~~E~~il~~l~hp~Iv~l~~~ 106 (450)
....+..++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|..+++.++||||++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 344577899999999999999999999999999999999997654322222 2678899999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEccCCc-----eE
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGH-----LK 178 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld~~g~-----ik 178 (450)
+.+.. ++||||++||+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++. +|
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 98776 6999999999999988665 47999999999999999999999999 999999999999998887 99
Q ss_pred EeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc--cCCCCcc
Q 013064 179 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGME 256 (450)
Q Consensus 179 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~--~~~y~~~ 256 (450)
|+|||+++..... ....+||+.|+|||++. ...++.+
T Consensus 170 l~Dfg~~~~~~~~-----------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~ 208 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----------------------------------------VSGLLGNFQWMAPETIGAEEESYTEK 208 (287)
T ss_dssp ECCCTTCBCCSSC-----------------------------------------EECCCCCCTTSCGGGSSCSSCEECHH
T ss_pred eCCCCcccccccc-----------------------------------------ccccCCCccccCchhhccCCCCcCch
Confidence 9999999854322 12468999999999994 4567899
Q ss_pred ccccchhHHHHHHhhCCCCCCCCChhhh--hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 257 CDWWSLGAIMYEMLIGYPPFCSDDPRIT--CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 257 ~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|+|||||++|+|++|..||.+.+.... ...+........+| ..+++++.+||.+||. ||.+|| +++++++
T Consensus 209 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 282 (287)
T 4f0f_A 209 ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRP---HFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 9999999999999999999987654443 33333322233333 4789999999999998 999999 5777764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=367.62 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=209.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCC-------EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-------IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYS 106 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~-------~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 106 (450)
++..++|++.+.||+|+||.||+|+++.+++ .||+|++.+.. ....+.+.+|..+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4667899999999999999999999998874 69999997643 3456778999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc--------e
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH--------L 177 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~~~-~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~--------i 177 (450)
+.+++..|+||||++||+|.+++.+.+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999999887 9
Q ss_pred EEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCcc
Q 013064 178 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGME 256 (450)
Q Consensus 178 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~ 256 (450)
||+|||++...... ....||+.|+|||++.+ ..++.+
T Consensus 161 kl~Dfg~~~~~~~~------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~ 198 (289)
T 4fvq_A 161 KLSDPGISITVLPK------------------------------------------DILQERIPWVPPECIENPKNLNLA 198 (289)
T ss_dssp EECCCCSCTTTSCH------------------------------------------HHHHHTTTTSCHHHHHCGGGCCHH
T ss_pred eeccCcccccccCc------------------------------------------cccCCcCcccCHHHhCCCCCCCch
Confidence 99999998765321 12468999999999987 779999
Q ss_pred ccccchhHHHHHHhhC-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 257 CDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 257 ~DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+|+|||||++|+|++| .+||...+..... .+.. ....+| ...++++.+||.+||. ||.+|| ++.++++|
T Consensus 199 ~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~--~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 269 (289)
T 4fvq_A 199 TDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE--DRHQLP--APKAAELANLINNCMDYEPDHRP---SFRAIIRD 269 (289)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH--TTCCCC--CCSSCTTHHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred hHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh--ccCCCC--CCCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 9999999999999995 5555554443333 3332 123333 3568899999999998 999999 68888865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=364.67 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=207.1
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
-.+..++|++.+.||+|+||.||+|++..+ +..+|+|++.... .....+.+.+|..+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 456778999999999999999999998754 4579999987542 3345677899999999999999999999985
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
++.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 567899999999999999998654 7999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
...... ......||+.|+|||++.+..++.++|+|||||++||
T Consensus 167 ~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 209 (281)
T 1mp8_A 167 EDSTYY-------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209 (281)
T ss_dssp -------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred Cccccc-------------------------------------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHH
Confidence 432100 0113467899999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|++ |.+||.+.+..+....+.... .... ...+++.+.+||.+||. ||.+|| ++.+++++
T Consensus 210 ll~~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 270 (281)
T 1mp8_A 210 ILMHGVKPFQGVKNNDVIGRIENGE-RLPM--PPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 270 (281)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhcCCCCCCcCCHHHHHHHHHcCC-CCCC--CCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 996 999999988877777776532 2223 35799999999999998 999999 57777653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=374.03 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=207.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEE----EEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF----AMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~----AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+..++|++++.||+|+||.||+|++..+|+.+ |+|.+.... .....+.+.+|..+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 56689999999999999999999998888765 666664332 234557789999999999999999999999976
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
. .++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999987 4679999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... .......||+.|+|||++.+..|+.++|||||||++|||
T Consensus 169 ~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 212 (327)
T 3poz_A 169 AEEKE------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 212 (327)
T ss_dssp TTCC-------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCccc------------------------------------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHH
Confidence 32110 001234678999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++ |..||.+.+.......+... . ..+.....+.++.+||.+||. ||.+|| ++.+++.|
T Consensus 213 lt~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~ 272 (327)
T 3poz_A 213 MTFGSKPYDGIPASEISSILEKG-E--RLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 272 (327)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTBCHHHHHHHHHHTCSCGGGSC---CHHHHHHH
T ss_pred HhcCCCCccCCCHHHHHHHHHcC-C--CCCCCccCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 99 99999988777666555442 2 233335789999999999998 999999 67888765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=373.74 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=215.4
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEE--EEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIF--AMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~--AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
.+..++|++.+.||+|+||.||+|+++.+|..+ |+|.++... .....+.+.+|..+|..+ +||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 367789999999999999999999999999865 999887532 334456788999999999 999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 174 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~ 174 (450)
+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 99999999999999999997754 79999999999999999999999999999999999999999
Q ss_pred CceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCC
Q 013064 175 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 254 (450)
Q Consensus 175 g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~ 254 (450)
|.+||+|||+++....... .....+|+.|+|||++.+..++
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~ 219 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYT 219 (327)
T ss_dssp GCEEECCTTCEESSCEECC---------------------------------------C----CCTTTCCHHHHHHCEEC
T ss_pred CeEEEcccCcCcccccccc---------------------------------------ccCCCCCccccChhhhccccCC
Confidence 9999999999875432100 1134678999999999998999
Q ss_pred ccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 255 MECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 255 ~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.++|+|||||++|+|++ |..||.+.+..+....+.... ....| ..+++.+++||.+||. ||.+|| ++++++.
T Consensus 220 ~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 293 (327)
T 1fvr_A 220 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 293 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-CCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 99999999999999998 999999988887777776531 22233 4789999999999998 999999 6888886
Q ss_pred C
Q 013064 333 H 333 (450)
Q Consensus 333 H 333 (450)
|
T Consensus 294 ~ 294 (327)
T 1fvr_A 294 S 294 (327)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=372.05 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=218.6
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCC-----EEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 106 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~-----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 106 (450)
..+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|..+|+.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34667899999999999999999999987765 79999997643 334567789999999999 89999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMRE--------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD 172 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~~--------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld 172 (450)
+.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999998753 4689999999999999999999999999999999999999
Q ss_pred cCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC
Q 013064 173 KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG 252 (450)
Q Consensus 173 ~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~ 252 (450)
.++.+||+|||++......... .......||+.|+|||++.+..
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 242 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY------------------------------------IVKGNARLPVKWMAPESIFDCV 242 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS------------------------------------EECSSCEECGGGSCHHHHHHCC
T ss_pred CCCeEEECccccccccccccce------------------------------------eecCCCCCCccccCHHHhccCC
Confidence 9999999999999865432110 0112356899999999999999
Q ss_pred CCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHH
Q 013064 253 YGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330 (450)
Q Consensus 253 y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei 330 (450)
++.++|+|||||++|+|++ |.+||.+.........+.........| ...++.+.+||.+||. ||.+|| ++.++
T Consensus 243 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l 317 (333)
T 2i1m_A 243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRP---TFQQI 317 (333)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCc---CHHHH
Confidence 9999999999999999998 999999877666666665533333333 4689999999999998 999999 67787
Q ss_pred Hc
Q 013064 331 KE 332 (450)
Q Consensus 331 l~ 332 (450)
++
T Consensus 318 ~~ 319 (333)
T 2i1m_A 318 CS 319 (333)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=370.87 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=216.5
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEE-----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~-----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|++.+.||+|+||.||+|++ ..+++.||+|++.+.. .......+.+|..++..+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45678999999999999999999985 4577899999997653 334556788999999999 789999999998
Q ss_pred EcCC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEE
Q 013064 108 QDSD-FLYLIMEYLPGGDIMTLLMREDI----------------LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 170 (450)
Q Consensus 108 ~~~~-~lylVmEy~~gg~L~~~l~~~~~----------------~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNIL 170 (450)
.+.+ .+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 8755 59999999999999999987654 899999999999999999999999999999999999
Q ss_pred EccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc
Q 013064 171 LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250 (450)
Q Consensus 171 ld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~ 250 (450)
++.+|++||+|||+++........ .......||+.|+|||++.+
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~~ 224 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDY------------------------------------VRKGDARLPLKWMAPETIFD 224 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS------------------------------------EEETTEEECGGGCCHHHHHH
T ss_pred ECCCCCEEECCCccccccccCccc------------------------------------eeccCCCcceeecCchhhcc
Confidence 999999999999999876432110 01124578999999999999
Q ss_pred CCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 251 KGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 251 ~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
..++.++|||||||++|+|++ |..||.+..........+........| ..+++.+.+||.+||. ||.+|| ++.
T Consensus 225 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ 299 (316)
T 2xir_A 225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFS 299 (316)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHH
Confidence 999999999999999999998 999998877555544444322333334 4689999999999998 999999 688
Q ss_pred HHHcC
Q 013064 329 ELKEH 333 (450)
Q Consensus 329 eil~H 333 (450)
++++|
T Consensus 300 ell~~ 304 (316)
T 2xir_A 300 ELVEH 304 (316)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=364.80 Aligned_cols=254 Identities=20% Similarity=0.331 Sum_probs=220.5
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
...+..++|++.+.||+|+||.||+|.++.+++.||+|++... ....+.+.+|..+++.++||||+++++++.++.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3456778999999999999999999999999999999999754 235677889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999874 459999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... ......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 163 ~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 205 (288)
T 3kfa_A 163 GDTYT-------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205 (288)
T ss_dssp SSSSE-------------------------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCccc-------------------------------------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHH
Confidence 43111 01235688999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++ |.+||.+.+.......+... ..... ...+++.+.+||.+||. ||.+|| +++++++
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~~~ 264 (288)
T 3kfa_A 206 ATYGMSPYPGIDLSQVYELLEKD-YRMER--PEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 264 (288)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHhcc-CCCCC--CCCCCHHHHHHHHHHhCCChhhCc---CHHHHHH
Confidence 99 99999988877766666542 22233 35789999999999999 999999 5677754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=371.33 Aligned_cols=253 Identities=29% Similarity=0.472 Sum_probs=207.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhc----CCCCeeeEEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEV----DSRCIVQLFYSF 107 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---~~~~~~~~E~~il~~l----~hp~Iv~l~~~f 107 (450)
.-.++|++++.||+|+||.||+|+++.+|+.||+|++.+...... .....+.+|..++..+ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 445789999999999999999999999999999999976643322 1223456789999888 899999999999
Q ss_pred EcCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc-cCCceEEeecccc
Q 013064 108 QDSDFLYLIMEY-LPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHLKLSDFGLC 185 (450)
Q Consensus 108 ~~~~~lylVmEy-~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld-~~g~ikL~DFGla 185 (450)
.+.+..|+|||| +.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 79999999999888999999999999999999999999999999999999999 8999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGA 264 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGv 264 (450)
....... ....+||+.|+|||++.+..+ +.++|+|||||
T Consensus 188 ~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 227 (312)
T 2iwi_A 188 ALLHDEP----------------------------------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227 (312)
T ss_dssp EECCSSC----------------------------------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred hhcccCc----------------------------------------ccccCCcccccCceeeecCCCCCccchHHHHHH
Confidence 8654321 124679999999999987776 45899999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
++|+|++|..||.+.. .+.. ....++ ..+++.+++||.+||. ||.+|+ +++++++||||+...
T Consensus 228 il~~l~~g~~pf~~~~------~~~~--~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 228 LLYDMVCGDIPFERDQ------EILE--AELHFP--AHVSPDCCALIRRCLAPKPSSRP---SLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHSSCSCCSHH------HHHH--TCCCCC--TTSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSTTTCC--
T ss_pred HHHHHHHCCCCCCChH------HHhh--hccCCc--ccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhcCch
Confidence 9999999999996532 2222 123344 3789999999999998 999999 799999999998643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.02 Aligned_cols=254 Identities=21% Similarity=0.349 Sum_probs=208.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEE----EEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAM----KKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~Ai----K~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
.+..++|++++.||+|+||.||+|++..+++.+|+ |.+... ........+.+|..+++.++||||+++++++.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 36678999999999999999999999999887644 444322 233456788999999999999999999999997
Q ss_pred CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+. .++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 65 8899999999999999977 457999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
...... .......||+.|+|||++.+..|+.++|||||||++|+
T Consensus 168 ~~~~~~------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 211 (327)
T 3lzb_A 168 GAEEKE------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211 (327)
T ss_dssp ------------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cCcccc------------------------------------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHH
Confidence 432110 00123467899999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|++ |.+||.+.+..+....+... . ..+....+++++.+||.+||. ||.+|| ++.+++.
T Consensus 212 ll~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 271 (327)
T 3lzb_A 212 LMTFGSKPYDGIPASEISSILEKG-E--RLPQPPICTIDVYMIMRKCWMIDADSRP---KFRELII 271 (327)
T ss_dssp HHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHcC-C--CCCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999 99999988877766665542 2 233335789999999999998 999999 6788875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=364.06 Aligned_cols=256 Identities=28% Similarity=0.476 Sum_probs=205.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
...+++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|..+++.++||||+++++++.+++.+
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 45678999999999999999999999999999999999876555556677889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 114 YLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999864 4679999999999999999999999999999999999999999999999999988654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
.... ......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 188 ~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l 229 (310)
T 2wqm_A 188 SKTT--------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229 (310)
T ss_dssp -------------------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCc--------------------------------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHH
Confidence 3210 11245799999999999999999999999999999999
Q ss_pred hhCCCCCCCCCh--hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LIGYPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~G~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++|..||.+... ......+..... ...+ ...+++++.+||.+||. ||.+|| ++.+++.
T Consensus 230 ~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---s~~~il~ 290 (310)
T 2wqm_A 230 AALQSPFYGDKMNLYSLCKKIEQCDY-PPLP-SDHYSEELRQLVNMCINPDPEKRP---DVTYVYD 290 (310)
T ss_dssp HHSSCTTC---CCHHHHHHHHHTTCS-CCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCcccchhHHHHHHHhhcccC-CCCc-ccccCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 999999976532 233344433211 1111 24689999999999998 999999 6778775
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=357.41 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=217.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++++.||+|+||.||+|.+. +++.||+|++.+... ..+.+.+|..+++.++||||+++++++.+++.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 466789999999999999999999987 677899999986542 235788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999999999775 569999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
. .......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 159 ~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (267)
T 3t9t_A 159 Y-------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201 (267)
T ss_dssp H-------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred c-------------------------------------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhcc
Confidence 0 00123568899999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|.+||.+.+..+....+.... ....| ...++.+.+||.+||. ||.+|| ++.+++++
T Consensus 202 g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (267)
T 3t9t_A 202 GKIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 258 (267)
T ss_dssp SCCTTTTCCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCC-cCCCC--ccCcHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 999999988887777776532 12223 4689999999999998 999999 67787754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=365.21 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=207.1
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~----~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
..+..++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|..+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35677899999999999999999999 5678999999999754 2445677899999999999999999999986
Q ss_pred c--CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 109 D--SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 109 ~--~~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+ ...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 456999999999999999998754 5999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
.......... .......||+.|+|||++.+..++.++|+|||||+
T Consensus 162 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 206 (295)
T 3ugc_A 162 KVLPQDKEFF-----------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 206 (295)
T ss_dssp C------------------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ccccCCccee-----------------------------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHH
Confidence 8764321100 00123468889999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChh----------------hhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 266 MYEMLIGYPPFCSDDPR----------------ITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
+|+|++|..||...... .....+.. ....+....+++++.+||.+||. ||.+|| ++.
T Consensus 207 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ 280 (295)
T 3ugc_A 207 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRP---SFR 280 (295)
T ss_dssp HHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHSCSSGGGSC---CHH
T ss_pred HHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc---cCcCCCCcCcCHHHHHHHHHHcCCChhhCC---CHH
Confidence 99999999998653211 11111111 12333345789999999999998 999999 567
Q ss_pred HHHc
Q 013064 329 ELKE 332 (450)
Q Consensus 329 eil~ 332 (450)
++++
T Consensus 281 el~~ 284 (295)
T 3ugc_A 281 DLAL 284 (295)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=369.19 Aligned_cols=257 Identities=20% Similarity=0.332 Sum_probs=218.1
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-------CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-------TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLF 104 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-------~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 104 (450)
..+..++|++.+.||+|+||.||+|++. .++..||+|+++... .......+.+|..+++.+ +||||++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 4466789999999999999999999986 467789999997643 344567889999999999 899999999
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCc
Q 013064 105 YSFQDSDFLYLIMEYLPGGDIMTLLMRED----------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDN 168 (450)
Q Consensus 105 ~~f~~~~~lylVmEy~~gg~L~~~l~~~~----------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeN 168 (450)
+++.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 99999999999999999999999998654 38999999999999999999999999999999999
Q ss_pred EEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 169 LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 169 ILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
||++.+|.+||+|||+++........ .......||+.|+|||++
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~ 231 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYY------------------------------------KKTTNGRLPVKWMAPEAL 231 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSE------------------------------------ECCSCCCCCGGGCCHHHH
T ss_pred EEEcCCCCEEEccccccccccccccc------------------------------------cccCCCCcccceeChHHh
Confidence 99999999999999999865432110 001234688999999999
Q ss_pred ccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 249 LKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 249 ~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|| +
T Consensus 232 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s 305 (334)
T 2pvf_A 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAVPSQRP---T 305 (334)
T ss_dssp HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---C
T ss_pred cCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHccCChhhCc---C
Confidence 99899999999999999999999 999999988877776665432 22333 4789999999999998 999999 6
Q ss_pred HHHHHcC
Q 013064 327 VEELKEH 333 (450)
Q Consensus 327 ~~eil~H 333 (450)
+.+++++
T Consensus 306 ~~ell~~ 312 (334)
T 2pvf_A 306 FKQLVED 312 (334)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7888764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=390.86 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=203.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~ 112 (450)
.+.-.+|.+.++||+|+||+|+. +...+|+.||||++.+... ..+.+|+.+|+.+ +|||||++++++.+...
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred EEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 34556799999999999999874 4566899999999976432 2256799999999 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CC--ceEEeeccccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NG--HLKLSDFGLCK 186 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g--~ikL~DFGla~ 186 (450)
+|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. +| .+||+|||+|+
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999999996 59999997654 4667778899999999999999999999999999999953 33 57799999998
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchh
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLG 263 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlG 263 (450)
......... ......+||+.|+|||++. ...++.++||||||
T Consensus 172 ~~~~~~~~~-----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG 216 (432)
T 3p23_A 172 KLAVGRHSF-----------------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216 (432)
T ss_dssp CC-----------------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHH
T ss_pred eccCCCcce-----------------------------------eeccccCCCcCccChhhhhcccccCCCcHHHHHHHH
Confidence 765321100 0122468999999999998 45678899999999
Q ss_pred HHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 264 AIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 264 vilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
|++|||++ |.+||...........+...... ..+.....+..+++||.+||. ||.+|| +++++++||||.+++|
T Consensus 217 ~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 217 CVFYYVISEGSHPFGKSLQRQANILLGACSLD-CLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHPFFWSLEK 292 (432)
T ss_dssp HHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSC---CHHHHHTSTTTCCHHH
T ss_pred HHHHHHHcCCCCCcchhhHHHHHHHhccCCcc-ccCccccccHHHHHHHHHHHhCCHhhCC---CHHHHHhCccccChHH
Confidence 99999999 99999765544333222221111 111123456779999999999 999999 6899999999999888
Q ss_pred c
Q 013064 342 D 342 (450)
Q Consensus 342 ~ 342 (450)
.
T Consensus 293 ~ 293 (432)
T 3p23_A 293 Q 293 (432)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=361.61 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=215.3
Q ss_pred HHhcCCCCCCCeEEEe-EEeecCceEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEE
Q 013064 29 RLQRRKIGIDDFEQLT-LIGKGAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105 (450)
Q Consensus 29 ~~~~~~~~~~~f~~~~-~LG~G~fg~V~l~~~--~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 105 (450)
+.....+..++|++.+ .||+|+||.||+|.. +.+++.||+|++++.. ......+.+.+|..+++.++||||+++++
T Consensus 7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3445567778999998 999999999999954 5678899999997653 23344678999999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
++ ..+.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 99 56778999999999999999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
.......... .......||+.|+|||++.+..++.++|+|||||+
T Consensus 165 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 209 (291)
T 1xbb_A 165 KALRADENYY-----------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209 (291)
T ss_dssp EECCTTCSEE-----------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred eeeccCCCcc-----------------------------------cccccCCCCceeeChHHhccCCCChhhhHHHHHHH
Confidence 8764331100 00112457899999999998889999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 266 MYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 266 lyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|+|++ |..||.+.+..+....+.... ....| ..+++.+.+||.+||. ||.+|| ++.++++
T Consensus 210 l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 272 (291)
T 1xbb_A 210 MWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 272 (291)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999999 999999988877766665532 23333 4789999999999998 999999 5666653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=377.42 Aligned_cols=274 Identities=16% Similarity=0.167 Sum_probs=206.0
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCC-----CCEEEEEEeechhhcc--------hhhHHHHHHHHHHHHhcCCCCeee
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTT-----GEIFAMKKLKKSEMLK--------RGQVEHVRSERNLLAEVDSRCIVQ 102 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t-----~~~~AiK~i~k~~~~~--------~~~~~~~~~E~~il~~l~hp~Iv~ 102 (450)
..++|++++.||+|+||.||+|.++.+ ++.||+|++.+..... .........|...+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999999765 5789999987643111 111122344556677788999999
Q ss_pred EEEEEEcC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc--cCC
Q 013064 103 LFYSFQDS----DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNG 175 (450)
Q Consensus 103 l~~~f~~~----~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld--~~g 175 (450)
+++++.+. .++|+||||+ ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99999875 5699999999 99999999876 6899999999999999999999999999999999999999 889
Q ss_pred ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCc
Q 013064 176 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255 (450)
Q Consensus 176 ~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~ 255 (450)
++||+|||+|+.+........ .........+||+.|+|||++.+..|+.
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 240 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKA-------------------------------YAADPKRCHDGTIEFTSIDAHNGVAPSR 240 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCC-------------------------------SSCCSSCCCCCCTTTCCHHHHTTCCCCH
T ss_pred eEEEEECCcceecccCCcccc-------------------------------cccCcccccCCCCCccCHHHhCCCCCCc
Confidence 999999999987654311100 0001123467999999999999999999
Q ss_pred cccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccc--c------ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCC
Q 013064 256 ECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKT--C------LKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326 (450)
Q Consensus 256 ~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~--~------~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~ 326 (450)
++|||||||++|||++|..||.+............... . ..++ ...+++++.+||..||. ||.+||+
T Consensus 241 ~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~--- 316 (364)
T 3op5_A 241 RGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPL--- 316 (364)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCC---
T ss_pred hhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCC---
Confidence 99999999999999999999986443332222111000 0 0111 13689999999999998 9999995
Q ss_pred HHHHHc----------CCCcCCCCccccc
Q 013064 327 VEELKE----------HPWFRGIQWDKLY 345 (450)
Q Consensus 327 ~~eil~----------Hpff~~i~w~~l~ 345 (450)
+.+|++ .++...++|..+.
T Consensus 317 ~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 317 YENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 455442 3444556665443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=378.09 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=207.4
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc---CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK---TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~---~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
..+..++|++.+.||+|+||.||+|+++ .++..||+|+++... .....+.+.+|..+|+.++||||+++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3566789999999999999999999987 467789999997542 34456778999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
...+|+||||++||+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999998754 7999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
....... .......+|+.|+|||++.+..|+.++|||||||++||
T Consensus 198 ~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 242 (373)
T 2qol_A 198 EDDPEAA-----------------------------------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242 (373)
T ss_dssp ---------------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ccCCccc-----------------------------------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHH
Confidence 4321100 00112356889999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|++ |..||.+.+..+....+... ...|....++..+.+||.+||. ||.+|| ++++|++
T Consensus 243 llt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~i~~ 302 (373)
T 2qol_A 243 VMSYGERPYWEMSNQDVIKAVDEG---YRLPPPMDCPAALYQLMLDCWQKDRNNRP---KFEQIVS 302 (373)
T ss_dssp HHTTC-CTTTTCCHHHHHHHHHTT---EECCCCTTCBHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccccHHHHHHHHHHhCcChhhCc---CHHHHHH
Confidence 997 99999988887777766543 2333345789999999999998 999999 5666664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=381.64 Aligned_cols=246 Identities=23% Similarity=0.400 Sum_probs=212.1
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
...+..++|++++.||+|+||.||++..+ |+.||||+++... ..+.+.+|..+|+.++|||||++++++.+..
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 34578899999999999999999999875 7799999997643 3467889999999999999999999987655
Q ss_pred -eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 112 -FLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~~~--~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
.+|+||||++||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999987653 799999999999999999999999999999999999999999999999999854
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
... .....+|+.|+|||++.+..|+.++|||||||++||
T Consensus 340 ~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~e 378 (450)
T 1k9a_A 340 SST-----------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 378 (450)
T ss_dssp C-----------------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHH
T ss_pred ccc-----------------------------------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHH
Confidence 321 012467899999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|++ |..||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+|| ++.+|+
T Consensus 379 l~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dp~~Rp---t~~~l~ 437 (450)
T 1k9a_A 379 IYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYDVMKNCWHLDAATRP---TFLQLR 437 (450)
T ss_dssp HHTTTCCSSTTSCTTTHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 998 99999988877777776653 223344 4789999999999998 999999 566665
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=361.36 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=207.4
Q ss_pred CCCCCeEEEeEEeecCceEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~----~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+....|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|..+|+.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445679999999999999999999 56789999999997653 334567889999999999999999999999887
Q ss_pred --CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 111 --DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 111 --~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
..+|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 679999999999999999954 46799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
........ .......||+.|+|||++.+..++.++|+|||||++|
T Consensus 176 ~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 220 (302)
T 4e5w_A 176 IETDKEYY-----------------------------------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220 (302)
T ss_dssp CCTTCCEE-----------------------------------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred ccCCCcce-----------------------------------eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHH
Confidence 65431110 0122457899999999999999999999999999999
Q ss_pred HHhhCCCCCCCCC--------------hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 268 EMLIGYPPFCSDD--------------PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 268 eml~G~~PF~~~~--------------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|++|..|+.... ........+... ...+....+++++.+||.+||. ||.+|| ++.++++
T Consensus 221 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 295 (302)
T 4e5w_A 221 ELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG--KRLPCPPNCPDEVYQLMRKCWEFQPSNRT---SFQNLIE 295 (302)
T ss_dssp HHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHH
T ss_pred HHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc--CCCCCCCCCCHHHHHHHHHHcCCCCCCCC---CHHHHHH
Confidence 9999999864321 111111222211 2233335799999999999998 999999 5677664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=370.14 Aligned_cols=252 Identities=22% Similarity=0.239 Sum_probs=199.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC---
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--- 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--- 111 (450)
+..++|++++.||+|+||.||+|++. ++.||+|++.... .......+|+.+|+.++|||||++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 66789999999999999999999875 7899999997543 23345566888899999999999999998754
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC----------CeEEeecCCCcEEEccCCceEEe
Q 013064 112 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH----------NYVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~----------givHrDLKpeNILld~~g~ikL~ 180 (450)
.+|+||||++||+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 489999999999999999764 599999999999999999999999 99999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----CCCCc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-----KGYGM 255 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-----~~y~~ 255 (450)
|||+|+........ ......+||+.|+|||++.+ ..++.
T Consensus 174 DFg~a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 217 (322)
T 3soc_A 174 DFGLALKFEAGKSA------------------------------------GDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217 (322)
T ss_dssp CCTTCEEECTTSCC------------------------------------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHH
T ss_pred cCCcccccccccCc------------------------------------cccccCccCccccCHhhcccccccCcCCCc
Confidence 99999865432110 01224689999999999986 35677
Q ss_pred cccccchhHHHHHHhhCCCCCCCCChhh----------------hhhhhhcccccccCCC---CCCCCHHHHHHHHHhhc
Q 013064 256 ECDWWSLGAIMYEMLIGYPPFCSDDPRI----------------TCRKIVNWKTCLKFPE---EPKISDEARDLICHLLC 316 (450)
Q Consensus 256 ~~DiWSlGvilyeml~G~~PF~~~~~~~----------------~~~~i~~~~~~~~~p~---~~~~s~~~~dli~~lL~ 316 (450)
++|||||||++|||++|..||.+..... ....+.........+. ....++++.+||.+||.
T Consensus 218 ~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (322)
T 3soc_A 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297 (322)
T ss_dssp HHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTC
T ss_pred cchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHcc
Confidence 8999999999999999999998654321 1111111111111111 01123559999999998
Q ss_pred -CccccCCCCCHHHHHc
Q 013064 317 -DVETRLGTRGVEELKE 332 (450)
Q Consensus 317 -dp~~R~~~~~~~eil~ 332 (450)
||.+|| ++.++++
T Consensus 298 ~dP~~Rp---s~~ell~ 311 (322)
T 3soc_A 298 HDAEARL---SAGCVGE 311 (322)
T ss_dssp SSGGGSC---CHHHHHH
T ss_pred CChhhCc---CHHHHHH
Confidence 999999 5777764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=357.17 Aligned_cols=255 Identities=25% Similarity=0.301 Sum_probs=213.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~---t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
..+..++|++.+.||+|+||.||+|++.. ++..||+|++.+.. .....+.+.+|..+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 35677899999999999999999998754 34569999997653 33456788999999999999999999999876
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+ ..|+||||++||+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 5 568999999999999999765 46999999999999999999999999999999999999999999999999999875
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
...... ......||+.|+|||++.+..++.++|+|||||++|+
T Consensus 164 ~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 206 (281)
T 3cc6_A 164 EDEDYY-------------------------------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 206 (281)
T ss_dssp ----------------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cccccc-------------------------------------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHH
Confidence 432100 0123468899999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|++ |..||...+.......+... ... +....+++.+.+||.+||. ||.+|| ++.+++++
T Consensus 207 llt~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 267 (281)
T 3cc6_A 207 ILSFGKQPFFWLENKDVIGVLEKG-DRL--PKPDLCPPVLYTLMTRCWDYDPSDRP---RFTELVCS 267 (281)
T ss_dssp HHTTTCCTTTTSCGGGHHHHHHHT-CCC--CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhCCCCCcccCChHHHHHHHhcC-CCC--CCCCCCCHHHHHHHHHHccCCchhCc---CHHHHHHH
Confidence 998 99999887777766665542 222 3334789999999999998 999999 67888754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=358.18 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=216.9
Q ss_pred CCCCCCeEEEe-EEeecCceEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLT-LIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~-~LG~G~fg~V~l~~~~--~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
.+..++|.++. .||+|+||.||+|.+. .++..||+|+++... .....+.+.+|..+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence 35668899998 9999999999999864 467889999997642 3456678899999999999999999999995 5
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 5699999999999999998654 569999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
...... .......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 162 ~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 162 ADDSYY-----------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp TCSCEE-----------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred cCccee-----------------------------------eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 321100 001234689999999999988999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++ |..||.+.+..+....+.... ...+| ..+++++.+||.+||. ||.+|| ++.++++|
T Consensus 207 lt~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 266 (287)
T 1u59_A 207 LSYGQKPYKKMKGPEVMAFIEQGK-RMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVEQR 266 (287)
T ss_dssp HTTSCCTTTTCCTHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HcCCCCCcccCCHHHHHHHHhcCC-cCCCC--CCcCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 98 999999888777776666532 23334 4789999999999998 999999 68888876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=361.77 Aligned_cols=258 Identities=21% Similarity=0.367 Sum_probs=209.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcC-CCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-TGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~-t~~--~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
.+..++|++++.||+|+||.||+|++.. +++ .||+|++++.........+.+.+|..+++.++||||+++++++.++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3566899999999999999999998653 333 6899999876554556678899999999999999999999999876
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
. .++||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 89999999999999999764 579999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
...... .......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 173 ~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 217 (291)
T 1u46_A 173 QNDDHY-----------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217 (291)
T ss_dssp C-CCEE-----------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred ccccch-----------------------------------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHH
Confidence 331110 011235688999999999998899999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++ |..||.+.+..+....+....... +....+++++++||.+||. ||.+|| ++.++++
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 277 (291)
T 1u46_A 218 FTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 277 (291)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCcccCCHHHHHHHHHccCCCC--CCCcCcCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99 999999998888887776643333 3345799999999999998 999999 6778875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=369.43 Aligned_cols=260 Identities=18% Similarity=0.271 Sum_probs=216.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEE-----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCR-----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~-----~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
.+..++|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|..+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4677899999999999999999999 56788899999996432 3345567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC---CceE
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRED-------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN---GHLK 178 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~-------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~---g~ik 178 (450)
+...+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 48999999999999999999999999999999999999854 4699
Q ss_pred EeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcccc
Q 013064 179 LSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECD 258 (450)
Q Consensus 179 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~D 258 (450)
|+|||++......... .......||+.|+|||++.+..++.++|
T Consensus 184 l~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 227 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY------------------------------------RKGGCAMLPVKWMPPEAFMEGIFTSKTD 227 (327)
T ss_dssp ECCCHHHHHHHC------------------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHH
T ss_pred ECcccccccccccccc------------------------------------ccCCCcCCCcceeCHhHhcCCCCCchhh
Confidence 9999998754322100 0112357899999999999999999999
Q ss_pred ccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 259 WWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 259 iWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
+|||||++|+|++ |..||.+.+..+....+.... ....+ ..+++.+.+||.+||. ||.+|| ++.++++|.|+
T Consensus 228 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~l~~ 301 (327)
T 2yfx_A 228 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRP---NFAIILERIEY 301 (327)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHHHHHH
Confidence 9999999999998 999999888777777666532 22223 4789999999999998 999999 68999999876
Q ss_pred C
Q 013064 337 R 337 (450)
Q Consensus 337 ~ 337 (450)
-
T Consensus 302 ~ 302 (327)
T 2yfx_A 302 C 302 (327)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.32 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=213.0
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCC----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
..+..++|++.+.||+|+||.||+|+++.++ ..||+|+++... .......+.+|..+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4577899999999999999999999987654 359999997542 3345567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+.+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999765 6799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
........ .......||+.|+|||++.+..++.++|+|||||++|
T Consensus 197 ~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 241 (333)
T 1mqb_A 197 LEDDPEAT-----------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241 (333)
T ss_dssp -------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred hccccccc-----------------------------------cccCCCCccccccCchhcccCCCCchhhhHHHHHHHH
Confidence 64321100 0011245788999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 268 EMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 268 eml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
||++ |..||.+.+..+....+... ...+....+++.+.+||.+||. ||.+|| ++.+++++
T Consensus 242 ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 303 (333)
T 1mqb_A 242 EVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVSI 303 (333)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred HHHcCCCCCcccCCHHHHHHHHHCC---CcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9998 99999988887777777653 2233345789999999999998 999999 57777653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=381.55 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=197.6
Q ss_pred hcCCCCCCCe-EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 013064 31 QRRKIGIDDF-EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQ 108 (450)
Q Consensus 31 ~~~~~~~~~f-~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~ 108 (450)
......++++ .+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.
T Consensus 7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp -CCSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cchhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 3334444555 45688999999999875 45689999999986532 34578899999876 8999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC-------
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILS-------EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN------- 174 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~-------e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~------- 174 (450)
+++.+|+|||||. |+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999995 69999998765433 33456799999999999999999999999999999764
Q ss_pred ------CceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 175 ------GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 175 ------g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
+++||+|||+|+......... .......+||+.|+|||++
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~ 204 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSF----------------------------------RTNLNNPSGTSGWRAPELL 204 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC------------------------------------------------CCTTSCHHHH
T ss_pred ccCCCceEEEEcccccceecCCCCccc----------------------------------eeeecCCCCCCCccCHHHh
Confidence 489999999998765431100 0011246899999999999
Q ss_pred cc-------CCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccC---CCCCCCCHHHHHHHHHhhc-
Q 013064 249 LK-------KGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKF---PEEPKISDEARDLICHLLC- 316 (450)
Q Consensus 249 ~~-------~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~---p~~~~~s~~~~dli~~lL~- 316 (450)
.+ ..++.++|||||||++|||++ |..||.+..... ..++........ .....+++++++||.+||.
T Consensus 205 ~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 282 (434)
T 2rio_A 205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282 (434)
T ss_dssp SCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCS
T ss_pred ccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhC
Confidence 76 678999999999999999999 999997654433 233332211111 1112456899999999998
Q ss_pred CccccCCCCCHHHHHcCCCcCCC
Q 013064 317 DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 317 dp~~R~~~~~~~eil~Hpff~~i 339 (450)
||.+|| ++.++++||||...
T Consensus 283 dP~~Rp---s~~eil~hp~f~~~ 302 (434)
T 2rio_A 283 DPLKRP---TAMKVLRHPLFWPK 302 (434)
T ss_dssp SGGGSC---CHHHHHTSGGGSCH
T ss_pred ChhhCC---CHHHHHhCCccCCc
Confidence 999999 68999999999653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=387.57 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=218.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++.+.||+|+||.||+++++.++..||+|+++... ...+.+.+|..+|+.++|||||++++++.+...+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 345678999999999999999999999999999999997643 2356789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999999864 45999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... ......+|+.|+|||++.+..|+.++|||||||++|||++
T Consensus 372 ~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t 414 (495)
T 1opk_A 372 TYT-------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414 (495)
T ss_dssp CEE-------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred cee-------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHh
Confidence 110 0113467889999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||.+.+..+....+... ..+..| ..+++.+.+||.+||. ||.+|| ++.+|++
T Consensus 415 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RP---s~~el~~ 471 (495)
T 1opk_A 415 YGMSPYPGIDLSQVYELLEKD-YRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 471 (495)
T ss_dssp TSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCcChhHCc---CHHHHHH
Confidence 99999998877776665542 223333 4789999999999998 999999 5677664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=366.55 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=212.5
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~----~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
.-+..++|++++.||+|+||.||+|+ +..+++.||+|++.+.. ....+.+.+|..+++.++||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 34667899999999999999999999 46789999999997642 345567899999999999999999999987
Q ss_pred --cCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 109 --DSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 109 --~~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+...+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 56679999999999999999977 456999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
.......... .......||+.|+|||++.+..++.++|+|||||+
T Consensus 175 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 219 (327)
T 3lxl_A 175 KLLPLDKDYY-----------------------------------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVV 219 (327)
T ss_dssp EECCTTCSEE-----------------------------------ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHH
T ss_pred eecccCCccc-----------------------------------eeeccCCccccccCHHHhccCCCChHHhHHHHHHH
Confidence 8764331110 01123578999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhh--------------hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHH
Q 013064 266 MYEMLIGYPPFCSDDPRI--------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ei 330 (450)
+|+|++|..||....... .....+... ...+....+++++.+||.+||. ||.+|| ++.++
T Consensus 220 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~el 294 (327)
T 3lxl_A 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG--QRLPAPPACPAEVHELMKLCWAPSPQDRP---SFSAL 294 (327)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred HHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc--cCCCCCCcccHHHHHHHHHHcCCChhhCc---CHHHH
Confidence 999999999996543321 111111111 2223335799999999999998 999999 56777
Q ss_pred HcC
Q 013064 331 KEH 333 (450)
Q Consensus 331 l~H 333 (450)
++|
T Consensus 295 l~~ 297 (327)
T 3lxl_A 295 GPQ 297 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=371.23 Aligned_cols=245 Identities=18% Similarity=0.245 Sum_probs=199.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEE-----EEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLC-----RAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYS 106 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~-----~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~ 106 (450)
+.-++|.+.+.||+|+||.||+| .+..+++.||+|++++. ....+..|..+++.+. |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 45578999999999999999999 46778999999999754 2346778888888886 8999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc--------
Q 013064 107 FQDSDFLYLIMEYLPGGDIMTLLMR-----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-------- 173 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~~l~~-----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-------- 173 (450)
+.+.+..|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974 467999999999999999999999999999999999999998
Q ss_pred ---CCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc
Q 013064 174 ---NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250 (450)
Q Consensus 174 ---~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~ 250 (450)
++++||+|||+|+.+...... ....+.+||+.|+|||++.+
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKG------------------------------------TIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTT------------------------------------EEECCSSCTTSCCCHHHHTT
T ss_pred ccccCCEEEeeCchhhhhhccCCC------------------------------------ceeeeecCCCCCCChHHhcC
Confidence 899999999999764321100 11235689999999999999
Q ss_pred CCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 251 KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 251 ~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
..|+.++|||||||++|||++|..||......... +. ..++. ...++.+.+++..||. +|.+|+. ++.+
T Consensus 260 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~-----~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~--~~~~ 329 (365)
T 3e7e_A 260 KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--PE-----GLFRR-LPHLDMWNEFFHVMLNIPDCHHLP--SLDL 329 (365)
T ss_dssp CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--EC-----SCCTT-CSSHHHHHHHHHHHHCCCCTTCCC--CHHH
T ss_pred CCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--ec-----hhccc-cCcHHHHHHHHHHHcCCCCCCcch--HHHH
Confidence 99999999999999999999999999654332111 11 11111 1357889999999998 9999975 3444
Q ss_pred HH
Q 013064 330 LK 331 (450)
Q Consensus 330 il 331 (450)
+.
T Consensus 330 l~ 331 (365)
T 3e7e_A 330 LR 331 (365)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.15 Aligned_cols=260 Identities=20% Similarity=0.290 Sum_probs=209.6
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcC---CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~---t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
....+..++|.+.+.||+|+||.||+|.... ++..||+|+++... ......+.+.+|..+++.++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445677899999999999999999998765 55689999997653 2344567889999999999999999999999
Q ss_pred EcCC-----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc
Q 013064 108 QDSD-----FLYLIMEYLPGGDIMTLLMR------EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH 176 (450)
Q Consensus 108 ~~~~-----~lylVmEy~~gg~L~~~l~~------~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ 176 (450)
.+.. ..|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8765 45999999999999999853 356999999999999999999999999999999999999999999
Q ss_pred eEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcc
Q 013064 177 LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256 (450)
Q Consensus 177 ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~ 256 (450)
+||+|||+++........ .......||+.|+|||++.+..++.+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 229 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYY------------------------------------RQGRIAKMPVKWIAIESLADRVYTSK 229 (313)
T ss_dssp EEECSCSCC----------------------------------------------------CCGGGSCHHHHHSSCCCHH
T ss_pred EEEeecCcceeccccccc------------------------------------CcccccCCCccccCchhhcCCCccch
Confidence 999999999865432100 00113468899999999999999999
Q ss_pred ccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 257 CDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 257 ~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+|+|||||++|+|++ |.+||.+.+.......+.... ....| ..+++.+.+||.+||. ||.+|| ++.+++.|
T Consensus 230 ~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~~ 302 (313)
T 3brb_A 230 SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQP--EDCLDELYEIMYSCWRTDPLDRP---TFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCB--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999999 999999988887777776532 22333 4789999999999998 999999 67888754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=354.62 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=209.5
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE-E
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL-Y 114 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l-y 114 (450)
.|.+.+.||+|+||.||+|++..+++ .+|+|++.+. ......+.+.+|..+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 56677999999999999999866655 7999998753 2345567889999999999999999999999877665 9
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999977 45789999999999999999999999999999999999999999999999999986643211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
.. ........||+.|+|||++.+..++.++|+|||||++|+|++ |
T Consensus 180 ~~----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 225 (298)
T 3pls_A 180 YS----------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRG 225 (298)
T ss_dssp GC----------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred cc----------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCC
Confidence 00 011224578999999999999999999999999999999999 5
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.+||.+.+.......+.... ..+....+++.+.+||.+||. ||.+|| ++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~ 280 (298)
T 3pls_A 226 APPYRHIDPFDLTHFLAQGR---RLPQPEYCPDSLYQVMQQCWEADPAVRP---TFRVLVG 280 (298)
T ss_dssp CCTTTTSCGGGHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCccCCHHHHHHHhhcCC---CCCCCccchHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 66666666666666555432 223335789999999999998 999999 5677764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=355.59 Aligned_cols=265 Identities=20% Similarity=0.285 Sum_probs=208.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEE-EEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLF-YSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~-~~f~~~~~lylV 116 (450)
++|++++.||+|+||.||+|++..+++.||+|++...... ..+.+|..+++.+.|++++..+ .++.+....|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 7899999999999999999999999999999987654322 3477899999999887655554 455788899999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE---ccCCceEEeeccccccCcccc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl---d~~g~ikL~DFGla~~~~~~~ 192 (450)
|||+ ||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999 9999999975 4679999999999999999999999999999999999999 889999999999998765431
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
..... ........+||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 163 ~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 211 (296)
T 4hgt_A 163 THQHI-------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211 (296)
T ss_dssp TCCBC-------------------------------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCccC-------------------------------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcC
Confidence 11000 00012246899999999999999999999999999999999999
Q ss_pred CCCCCCCChh---hhhhhhhcccccccCCC---CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc----------CCC
Q 013064 273 YPPFCSDDPR---ITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLC-DVETRLGTRGVEELKE----------HPW 335 (450)
Q Consensus 273 ~~PF~~~~~~---~~~~~i~~~~~~~~~p~---~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~----------Hpf 335 (450)
..||.+.+.. ..+..+.... ...|. ...+++++.+||.+||. ||.+||+ ++++++ .+|
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 212 SLPWQGLKAATKRQKYERISEKK--MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD---YSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp SCTTSSCCCSSSSSHHHHHHHHH--HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC---HHHHHHHHHHHHHHHTCCT
T ss_pred CCCCcccchhhhhhhhhhhhccc--ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCC---HHHHHHHHHHHHHHhCCCc
Confidence 9999875443 2333333211 12221 13679999999999998 9999994 555553 456
Q ss_pred cCCCCcccc
Q 013064 336 FRGIQWDKL 344 (450)
Q Consensus 336 f~~i~w~~l 344 (450)
-..+||+.+
T Consensus 287 ~~~~dw~~~ 295 (296)
T 4hgt_A 287 DYVFDWNML 295 (296)
T ss_dssp TCCCGGGGC
T ss_pred cCccchhhc
Confidence 666777765
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=380.15 Aligned_cols=254 Identities=27% Similarity=0.423 Sum_probs=207.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC--e
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD--F 112 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~--~ 112 (450)
..-++|.+.+.||+|+||.||+|+++.+|+.||+|++.+... ....+.+.+|..+|+.++||||+++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 445789999999999999999999999999999999986543 234567789999999999999999999998765 7
Q ss_pred EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE----ccCCceEEeecccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL----DKNGHLKLSDFGLC 185 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~---~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl----d~~g~ikL~DFGla 185 (450)
+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 77888999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--------CCCCccc
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--------KGYGMEC 257 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--------~~y~~~~ 257 (450)
+...... ...+.+||+.|+|||++.+ ..|+.++
T Consensus 164 ~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 204 (396)
T 4eut_A 164 RELEDDE---------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204 (396)
T ss_dssp EECCCGG---------------------------------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHH
T ss_pred eEccCCC---------------------------------------ccccccCCccccCHHHhhccccccccccCCCcHH
Confidence 8754321 1224689999999999975 5678999
Q ss_pred cccchhHHHHHHhhCCCCCCCCC----hhhhhhhhhccccc-----------------ccCCCC----CCCCHHHHHHHH
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDD----PRITCRKIVNWKTC-----------------LKFPEE----PKISDEARDLIC 312 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~~~~~~-----------------~~~p~~----~~~s~~~~dli~ 312 (450)
|+|||||++|||++|..||.... ..+...+++..... ..+|.. ..+++.+.+||+
T Consensus 205 DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~ 284 (396)
T 4eut_A 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (396)
T ss_dssp HHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHH
Confidence 99999999999999999996532 23334444432111 011211 234567889999
Q ss_pred Hhhc-CccccCCCCCHHHHHc
Q 013064 313 HLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~ 332 (450)
+||. ||.+|+ +++++++
T Consensus 285 ~~L~~dP~~R~---s~~e~l~ 302 (396)
T 4eut_A 285 NILEADQEKCW---GFDQFFA 302 (396)
T ss_dssp HHSCCCTTTSC---CHHHHHH
T ss_pred HhhccChhhhc---cHHHHHH
Confidence 9998 999999 5666643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=372.57 Aligned_cols=263 Identities=17% Similarity=0.178 Sum_probs=202.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC---CCCEEEEEEeechhhc--------chhhHHHHHHHHHHHHhcCCCCeeeE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT---TGEIFAMKKLKKSEML--------KRGQVEHVRSERNLLAEVDSRCIVQL 103 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~---t~~~~AiK~i~k~~~~--------~~~~~~~~~~E~~il~~l~hp~Iv~l 103 (450)
+..++|++++.||+|+||.||+|++.. ++..+|+|++.+.... .......+.+|..++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 8889999998764311 11112346678889999999999999
Q ss_pred EEEEEc----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC--ce
Q 013064 104 FYSFQD----SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG--HL 177 (450)
Q Consensus 104 ~~~f~~----~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g--~i 177 (450)
++++.+ ...+|+||||+ ||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999988 78999999999 999999998878999999999999999999999999999999999999999887 99
Q ss_pred EEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccc
Q 013064 178 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 257 (450)
Q Consensus 178 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~ 257 (450)
||+|||+|+.+........ .........+||+.|+|||++.+..++.++
T Consensus 193 kL~Dfg~a~~~~~~~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 241 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQ-------------------------------YQENPRKGHNGTIEFTSLDAHKGVALSRRS 241 (345)
T ss_dssp EECCCTTCEESSGGGCCCC-------------------------------CCCCGGGCSCSCTTTCCHHHHHTCCCCHHH
T ss_pred EEEeCCCceeccccccccc-------------------------------chhccccccCCCccccCHHHhcCCCCCchh
Confidence 9999999987654311100 000112356899999999999999999999
Q ss_pred cccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCC-------CCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPE-------EPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
|+|||||++|||++|..||.+..................+|. ...+++++++||.+||. ||.+|| ++++
T Consensus 242 Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ 318 (345)
T 2v62_A 242 DVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP---NYQA 318 (345)
T ss_dssp HHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC---CHHH
T ss_pred hHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC---CHHH
Confidence 999999999999999999965322221111111111111221 12689999999999998 999999 5667
Q ss_pred HHc
Q 013064 330 LKE 332 (450)
Q Consensus 330 il~ 332 (450)
|++
T Consensus 319 l~~ 321 (345)
T 2v62_A 319 LKK 321 (345)
T ss_dssp HHH
T ss_pred HHH
Confidence 664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=363.43 Aligned_cols=261 Identities=22% Similarity=0.371 Sum_probs=209.0
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE----cC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ----DS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~----~~ 110 (450)
+..++|++++.||+|+||.||+|+++.+|+.||+|++... .....+.+.+|..+++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 5567899999999999999999999999999999998653 2345677889999999999999999999987 34
Q ss_pred CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
..+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 589999999999999999876 4679999999999999999999999999999999999999999999999999988
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC---CCccccccchh
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG---YGMECDWWSLG 263 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~---y~~~~DiWSlG 263 (450)
.......... ....... .....||+.|+|||++.+.. ++.++|+||||
T Consensus 183 ~~~~~~~~~~---------------------~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 233 (317)
T 2buj_A 183 QACIHVEGSR---------------------QALTLQD--------WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233 (317)
T ss_dssp ESCEEEESHH---------------------HHHHHHH--------HHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHH
T ss_pred hccccccccc---------------------ccccccc--------cccccCCcccCCHhHhccCCCcCCCchhhHHHHH
Confidence 6543210000 0000000 12357899999999997654 68999999999
Q ss_pred HHHHHHhhCCCCCCCCCh--hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 264 AIMYEMLIGYPPFCSDDP--RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|++|+|++|..||..... ......+.. ...+|....+++++.+||.+||. ||.+|| +++++++|
T Consensus 234 ~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 300 (317)
T 2buj_A 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRP---HIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHSSCTTHHHHHTTSCHHHHHHC---C--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHhCCCChhhhhcccchhhHHhhc---cCCCCccccCCHHHHHHHHHHhhcChhhCC---CHHHHHHH
Confidence 999999999999954211 111222221 23445556789999999999998 999999 68888875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=355.72 Aligned_cols=256 Identities=19% Similarity=0.277 Sum_probs=210.4
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE-EcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF-QDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f-~~~ 110 (450)
....+|++.+.||+|+||.||+|++..++ ..+|+|.+.+. ......+.+.+|..+++.++||||+++++++ .++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 34467999999999999999999975443 36899998753 2345567889999999999999999999985 566
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+..|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 789999999999999999976 4568999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
....... .......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 180 ~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 225 (298)
T 3f66_A 180 DKEYYSV----------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225 (298)
T ss_dssp CGGGCBC---------------------------------------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccchhcc----------------------------------ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHH
Confidence 4311100 011245789999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++ |.+||.+.+..+....+..... ...| ..+++.+.+||.+||. ||.+|| ++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 284 (298)
T 3f66_A 226 MTRGAPPYPDVNTFDITVYLLQGRR-LLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVS 284 (298)
T ss_dssp HTTSCCSSTTSCTTTHHHHHHTTCC-CCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCCccCCHHHHHHHHhcCCC-CCCC--ccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99 7788888777777766665432 2223 4689999999999998 999999 5677764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.16 Aligned_cols=242 Identities=25% Similarity=0.427 Sum_probs=207.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--------
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-------- 109 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-------- 109 (450)
++|++++.||+|+||.||+|++..+|+.||+|++.... +.+.+|..+++.++||||+++++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 57999999999999999999999999999999997542 245689999999999999999999865
Q ss_pred --------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEE
Q 013064 110 --------SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 110 --------~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL 179 (450)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999764 67999999999999999999999999999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccc
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~Di 259 (450)
+|||++........ ....+||+.|+|||++.+..++.++|+
T Consensus 164 ~Dfg~~~~~~~~~~---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (284)
T 2a19_B 164 GDFGLVTSLKNDGK---------------------------------------RTRSKGTLRYMSPEQISSQDYGKEVDL 204 (284)
T ss_dssp CCCTTCEESSCCSC---------------------------------------CCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred Ccchhheecccccc---------------------------------------ccccCCcccccChhhhccCCCcchhhh
Confidence 99999987643210 123579999999999999999999999
Q ss_pred cchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 260 WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|||||++|+|++|..||.... .....+.. ..++ ..+++.+++||.+||. ||.+|| ++.++++|++.
T Consensus 205 ~slG~il~~l~~~~~~~~~~~--~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~~l~~ 271 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFETS--KFFTDLRD----GIIS--DIFDKKEKTLLQKLLSKKPEDRP---NTSEILRTLTV 271 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHHH--HHHHHHHT----TCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCcchhHH--HHHHHhhc----cccc--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHHHHH
Confidence 999999999999999985321 22222222 1223 3689999999999998 999999 68999998765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=380.61 Aligned_cols=250 Identities=21% Similarity=0.363 Sum_probs=213.7
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++.+.||+|+||.||+|..+ ++..||||++++.. ...+.+.+|..+|+.++|||||++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 355678999999999999999999986 46779999997643 24678899999999999999999999987 5679
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999999754 37899999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... ......+|+.|+|||++....|+.++|||||||++|||++
T Consensus 338 ~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 380 (454)
T 1qcf_A 338 EYT-------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380 (454)
T ss_dssp HHH-------------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cee-------------------------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHh
Confidence 100 0113457889999999998999999999999999999999
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||.+.+..+....+... ...|....+++++.+||.+||. ||.+|| ++++|+.
T Consensus 381 ~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~i~~ 437 (454)
T 1qcf_A 381 YGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 437 (454)
T ss_dssp TSCCSSTTCCHHHHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 99999998888777776643 2333345789999999999998 999999 5666653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=354.64 Aligned_cols=246 Identities=23% Similarity=0.396 Sum_probs=205.3
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-C
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-D 111 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-~ 111 (450)
..+..++|++++.||+|+||.||++.+ +|+.||+|+++... ..+.+.+|..+++.++||||+++++++.+. +
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 457789999999999999999999987 48899999997542 456788999999999999999999997654 5
Q ss_pred eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDI--LSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~--~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
.+|+||||++||+|.+++.+.+. +++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 79999999999999999977543 8999999999999999999999999999999999999999999999999987543
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
.. .....||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 169 ~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 207 (278)
T 1byg_A 169 ST-----------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207 (278)
T ss_dssp ------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cc-----------------------------------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHH
Confidence 21 0124689999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++ |.+||.+.+..+....+... .....+ ..+++.+.+||.+||. ||.+|| ++.++++
T Consensus 208 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 266 (278)
T 1byg_A 208 YSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRP---SFLQLRE 266 (278)
T ss_dssp HTTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHhcC-CCCCCc--ccCCHHHHHHHHHHhcCChhhCC---CHHHHHH
Confidence 98 99999988877777666543 122333 4789999999999998 999999 5666653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=368.40 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=210.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
....++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|..+|+.++||||+++++++.+.+.+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 345689999999999999999999964 78999999887542 34567789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 114 YLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~----~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999986543 59999999999999999999999999999999999999999999999999998644
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... ......+||+.|+|||++.+..++.++|+|||||++|||
T Consensus 191 ~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 234 (321)
T 2qkw_B 191 ELDQT------------------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234 (321)
T ss_dssp SSSCC------------------------------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHH
T ss_pred ccccc------------------------------------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHH
Confidence 32110 011245799999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhh-------ccc------ccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 270 LIGYPPFCSDDPRITCRKIV-------NWK------TCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~-------~~~------~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++|..||.+..+.+....+. ... ..+.....+..+..+.+||.+||. ||.+|| ++.++++|
T Consensus 235 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 309 (321)
T 2qkw_B 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP---SMGDVLWK 309 (321)
T ss_dssp HHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 99999998765543321110 000 000001112346778999999998 999999 68888865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=384.54 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=196.9
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----chhhHHHHHHHHHHHHhcC---------CCCe
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----KRGQVEHVRSERNLLAEVD---------SRCI 100 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----~~~~~~~~~~E~~il~~l~---------hp~I 100 (450)
+..++|++++.||+|+||.||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 7899999999876431 2334577889999998886 7777
Q ss_pred eeEEEEE-----------------Ec-------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 013064 101 VQLFYSF-----------------QD-------------SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150 (450)
Q Consensus 101 v~l~~~f-----------------~~-------------~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~a 150 (450)
|++.+++ .+ ...+|+|||||+||++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 7766654 32 7899999999999987777744 678999999999999999
Q ss_pred HHHhh-hCCeEEeecCCCcEEEccCC--------------------ceEEeeccccccCccccccccccccccccccccc
Q 013064 151 IHSIH-QHNYVHRDIKPDNLILDKNG--------------------HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209 (450)
Q Consensus 151 L~~LH-~~givHrDLKpeNILld~~g--------------------~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 209 (450)
|+||| ++||+||||||+||||+.+| .+||+|||+|+.....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------ 235 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------ 235 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------------
Confidence 99999 99999999999999999987 9999999999865321
Q ss_pred cccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH-HHHHhhCCCCCCCCCh-hhhhhh
Q 013064 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI-MYEMLIGYPPFCSDDP-RITCRK 287 (450)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi-lyeml~G~~PF~~~~~-~~~~~~ 287 (450)
+.+||+.|+|||++.+.. +.++||||||++ .++++.|..||.+... ......
T Consensus 236 -------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~ 289 (336)
T 2vuw_A 236 -------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK 289 (336)
T ss_dssp -------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHH
T ss_pred -------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHh
Confidence 358999999999998776 899999998777 8889999999954211 112222
Q ss_pred hhcc---cccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH-cCCCcC
Q 013064 288 IVNW---KTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK-EHPWFR 337 (450)
Q Consensus 288 i~~~---~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil-~Hpff~ 337 (450)
+... ......+....+|+++++||++||+ | +++|++ +||||+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--------sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 290 MLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--------SATDLLCQHSLFK 336 (336)
T ss_dssp HHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--------SHHHHHHHCGGGC
T ss_pred hhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--------CHHHHHhcCCCcC
Confidence 2211 1111111113578999999999998 5 689999 999995
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=351.36 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=212.8
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+..++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|..+|+.++||||+++++++.+ +.
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 3466689999999999999999999975 56789999997643 234678899999999999999999999874 46
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 113 LYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 899999999999999986543 799999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.... ......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 204 (279)
T 1qpc_A 162 NEYT-------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204 (279)
T ss_dssp SCEE-------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred cccc-------------------------------------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence 2110 012346789999999999888999999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+ |..||.+.+..+....+.... .... ...+++++.+||.+||. ||.+|| ++++++.
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 262 (279)
T 1qpc_A 205 THGRIPYPGMTNPEVIQNLERGY-RMVR--PDNCPEELYQLMRLCWKERPEDRP---TFDYLRS 262 (279)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTC-CCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCCcccCHHHHHHHHhccc-CCCC--cccccHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 9 999999888877777665431 2222 34789999999999998 999999 5666664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=355.87 Aligned_cols=232 Identities=33% Similarity=0.557 Sum_probs=192.1
Q ss_pred CCCCeEEE-eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH-HhcCCCCeeeEEEEEEc----
Q 013064 36 GIDDFEQL-TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL-AEVDSRCIVQLFYSFQD---- 109 (450)
Q Consensus 36 ~~~~f~~~-~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~f~~---- 109 (450)
.+++|.++ +.||+|+||.||+|+++.+|+.||+|+++.. ....+|..++ +.++||||++++++|.+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 45789998 7899999999999999999999999999643 3456788887 56699999999999987
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeeccc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGL 184 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFGl 184 (450)
...+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 778999999999999999998764 6999999999999999999999999999999999999998 78999999999
Q ss_pred cccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhH
Q 013064 185 CKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264 (450)
Q Consensus 185 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGv 264 (450)
+.... +..|+.++|+|||||
T Consensus 167 a~~~~------------------------------------------------------------~~~~~~~~DiwslG~ 186 (299)
T 3m2w_A 167 AKETT------------------------------------------------------------GEKYDKSCDMWSLGV 186 (299)
T ss_dssp CEECT------------------------------------------------------------TCGGGGHHHHHHHHH
T ss_pred ccccc------------------------------------------------------------cccCCchhhHHHHHH
Confidence 86432 134677899999999
Q ss_pred HHHHHhhCCCCCCCCChhhhhhhhhcccc--cccCC--CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKT--CLKFP--EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 265 ilyeml~G~~PF~~~~~~~~~~~i~~~~~--~~~~p--~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
++|+|++|.+||.+.+.......+..... ...+| ....+++++++||.+||. ||.+|| +++++++||||.+
T Consensus 187 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~e~l~hp~~~~ 262 (299)
T 3m2w_A 187 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 262 (299)
T ss_dssp HHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHT
T ss_pred HHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC---CHHHHhcChhhcc
Confidence 99999999999987665443322222111 11222 114689999999999998 999999 6999999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=355.51 Aligned_cols=243 Identities=26% Similarity=0.423 Sum_probs=198.2
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++.+.||+|+||.||++++. ++.||+|++... ...+.+.+|..+|+.++||||+++++++.+. .
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP--V 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--T
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--c
Confidence 356789999999999999999999874 788999998643 3456788999999999999999999998744 7
Q ss_pred EEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhh---CCeEEeecCCCcEEEccCCc-eEEeeccccc
Q 013064 114 YLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQ---HNYVHRDIKPDNLILDKNGH-LKLSDFGLCK 186 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~---~~~e~~~~~~~~qil~aL~~LH~---~givHrDLKpeNILld~~g~-ikL~DFGla~ 186 (450)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.+|. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 99999999999999998765 47899999999999999999999 89999999999999999887 7999999987
Q ss_pred cCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHH
Q 013064 187 PLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266 (450)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvil 266 (450)
..... .....||+.|+|||++.+..++.++|+|||||++
T Consensus 155 ~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 193 (307)
T 2eva_A 155 DIQTH-----------------------------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193 (307)
T ss_dssp ---------------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHH
T ss_pred ccccc-----------------------------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHH
Confidence 54321 1134799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhh--hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 267 YEMLIGYPPFCSDDPRI--TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~--~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|+|++|..||....... ....+... ... +....+++.+.+||.+||. ||.+|| +++++++
T Consensus 194 ~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 256 (307)
T 2eva_A 194 WEVITRRKPFDEIGGPAFRIMWAVHNG-TRP--PLIKNLPKPIESLMTRCWSKDPSQRP---SMEEIVK 256 (307)
T ss_dssp HHHHHTCCTTTTTCSSHHHHHHHHHTT-CCC--CCBTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHCCCCchhhCccHHHHHHHHhcC-CCC--CcccccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999999997643322 22222221 112 2224789999999999998 999999 5777775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=356.95 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=199.0
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEc--
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQD-- 109 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~f~~-- 109 (450)
.+..++|++++.||+|+||.||++++ +|+.||+|++.+.. ......|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 45568999999999999999999987 68999999986542 3456677888777 799999999998654
Q ss_pred --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh--------hCCeEEeecCCCcEEEccCCceEE
Q 013064 110 --SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH--------QHNYVHRDIKPDNLILDKNGHLKL 179 (450)
Q Consensus 110 --~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH--------~~givHrDLKpeNILld~~g~ikL 179 (450)
...+|+||||++||+|.+++. ...+++..+..++.||+.||.||| +.||+||||||+|||++.++++||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356999999999999999994 457999999999999999999999 999999999999999999999999
Q ss_pred eeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC------CC
Q 013064 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK------GY 253 (450)
Q Consensus 180 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~------~y 253 (450)
+|||+|+......... .....+.+||+.|+|||++.+. .+
T Consensus 155 ~Dfg~a~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 200 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQL----------------------------------DVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200 (301)
T ss_dssp CCCTTCEEEETTTTEE----------------------------------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHH
T ss_pred eeCCCeeecccccccc----------------------------------cccccccccccceeChhhhcCcCCCCcccC
Confidence 9999997654321100 0011245899999999999876 45
Q ss_pred CccccccchhHHHHHHhhC----------CCCCCCCChh----hhhhhhhc-ccccccCCC---CCCCCHHHHHHHHHhh
Q 013064 254 GMECDWWSLGAIMYEMLIG----------YPPFCSDDPR----ITCRKIVN-WKTCLKFPE---EPKISDEARDLICHLL 315 (450)
Q Consensus 254 ~~~~DiWSlGvilyeml~G----------~~PF~~~~~~----~~~~~i~~-~~~~~~~p~---~~~~s~~~~dli~~lL 315 (450)
+.++|||||||++|||++| .+||.+.... .....+.. .......|. ....++.+.+||.+||
T Consensus 201 ~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 280 (301)
T 3q4u_A 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW 280 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHC
T ss_pred CchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHh
Confidence 6799999999999999999 8999654322 12222221 111122221 0124578999999999
Q ss_pred c-CccccCCCCCHHHHHc
Q 013064 316 C-DVETRLGTRGVEELKE 332 (450)
Q Consensus 316 ~-dp~~R~~~~~~~eil~ 332 (450)
. ||.+|| ++++|++
T Consensus 281 ~~dP~~Rp---s~~~i~~ 295 (301)
T 3q4u_A 281 YQNPSARL---TALRIKK 295 (301)
T ss_dssp CSSGGGSC---CHHHHHH
T ss_pred hcChhhCC---CHHHHHH
Confidence 8 999999 5777764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=354.89 Aligned_cols=258 Identities=19% Similarity=0.300 Sum_probs=200.1
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
....+.-++|++.+.||+|+||.||++++.. .+|+|+++... ......+.+.+|+.+|+.++||||++++++ ...
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccC
Confidence 3346778899999999999999999997643 49999997653 344566789999999999999999999995 456
Q ss_pred CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
..+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 678999999999999999954 4579999999999999999999999999999999999999999999999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc---cCCCCccccccchhHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIM 266 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~---~~~y~~~~DiWSlGvil 266 (450)
..... ......+||+.|+|||++. +..++.++|+|||||++
T Consensus 172 ~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 172 RWSGS------------------------------------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp ------------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred ccccc------------------------------------ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 32100 0112457999999999997 56788999999999999
Q ss_pred HHHhhCCCCCCCCChhhhhhhhhcccc-cccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 267 YEMLIGYPPFCSDDPRITCRKIVNWKT-CLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 267 yeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|+|++|..||.+.+.......++.... ....+ ....+++.+++||.+||. ||.+|| ++.++++
T Consensus 216 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 281 (289)
T 3og7_A 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP---SFPRILA 281 (289)
T ss_dssp HHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 999999999988666555444433211 11111 123688999999999998 999999 5777764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.31 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=204.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeee-EEEEEEcCCeEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ-LFYSFQDSDFLYL 115 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~-l~~~f~~~~~lyl 115 (450)
.++|++++.||+|+||.||+|++..+|+.||+|++..... ...+.+|..+++.+.|++++. +..++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 3789999999999999999999999999999999875432 235788999999998877554 4445577889999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE---ccCCceEEeeccccccCccc
Q 013064 116 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl---d~~g~ikL~DFGla~~~~~~ 191 (450)
||||+ ||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 4679999999999999999999999999999999999999 58899999999999876543
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
...... ........+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 162 ~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 162 RTHQHI-------------------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp TTCCBC-------------------------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccc-------------------------------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh
Confidence 111000 0001234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCh---hhhhhhhhcccccccCC---CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 272 GYPPFCSDDP---RITCRKIVNWKTCLKFP---EEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 272 G~~PF~~~~~---~~~~~~i~~~~~~~~~p---~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
|..||.+.+. ...+..+.... ...| ....+++++.+||.+||. ||.+||+ +++++
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~l~ 272 (296)
T 3uzp_A 211 GSLPWQGLKAATKRQKYERISEKK--MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD---YSYLR 272 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHH--HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC---HHHHH
T ss_pred CCCCCCCcCchhhhhhhhhhcccc--cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCC---HHHHH
Confidence 9999987433 33444444321 2222 113689999999999998 9999994 55554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=365.95 Aligned_cols=260 Identities=21% Similarity=0.289 Sum_probs=206.4
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+..++|++.+.||+|+||.||+|++. +|+.||+|++.+.... .....+.+|..+++.++||||+++++++.+.+.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 3456689999999999999999999854 6899999999765422 122357899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHhhhC---CeEEeecCCCcEEEccCCceEEeecccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRED----ILSEDVARFYIAESVLAIHSIHQH---NYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~----~~~e~~~~~~~~qil~aL~~LH~~---givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
.|+||||++||+|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 999999999999999997653 499999999999999999999999 9999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
+........ .....+||+.|+|||++.+..++.++|+|||||+
T Consensus 182 ~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 224 (326)
T 3uim_A 182 KLMDYKDTH-------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 224 (326)
T ss_dssp EECCSSSSC-------------------------------------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHH
T ss_pred cccCccccc-------------------------------------ccccccCCcCccCHHHhccCCCCccccchhHHHH
Confidence 876432111 1124579999999999998899999999999999
Q ss_pred HHHHhhCCCCCCCC----Chhhhhhhh----hcccc-------cccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 266 MYEMLIGYPPFCSD----DPRITCRKI----VNWKT-------CLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 266 lyeml~G~~PF~~~----~~~~~~~~i----~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
+|+|++|..||... ......... ..... .+........++.+.+||.+||. ||.+|| ++.+
T Consensus 225 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~e 301 (326)
T 3uim_A 225 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP---KMSE 301 (326)
T ss_dssp HHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC---CHHH
T ss_pred HHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC---CHHH
Confidence 99999999999521 111111111 00000 00000112334789999999998 999999 6888
Q ss_pred HHcCCC
Q 013064 330 LKEHPW 335 (450)
Q Consensus 330 il~Hpf 335 (450)
+++|-.
T Consensus 302 ll~~L~ 307 (326)
T 3uim_A 302 VVRMLE 307 (326)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 888743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=378.76 Aligned_cols=274 Identities=20% Similarity=0.221 Sum_probs=218.7
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~ly 114 (450)
..++|++++.||+|+||.||+|++..+++.||||++...... ..+..|..+++.+.| ++|+.+..++.+.+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 347999999999999999999999999999999998755322 246789999999976 67777777888899999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEE---ccCCceEEeeccccccCcc
Q 013064 115 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILl---d~~g~ikL~DFGla~~~~~ 190 (450)
|||||+ ||+|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++++||+|||+|+.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 5689999999999999999999999999999999999999 6899999999999987654
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
....... .-......+||+.|+|||++.+..|+.++|||||||+||||+
T Consensus 159 ~~~~~~~-------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell 207 (483)
T 3sv0_A 159 TSTHQHI-------------------------------PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL 207 (483)
T ss_dssp TTTCCBC-------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred Ccccccc-------------------------------ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 3111000 000122578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChh---hhhhhhhcccccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCCHH-------HHHcCCCcCC
Q 013064 271 IGYPPFCSDDPR---ITCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVE-------ELKEHPWFRG 338 (450)
Q Consensus 271 ~G~~PF~~~~~~---~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~-------eil~Hpff~~ 338 (450)
+|..||.+.... ..+.++.........+ ....+++++.+||..||. ||.+||+...+. .-+.|+|+..
T Consensus 208 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~ 287 (483)
T 3sv0_A 208 RGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYV 287 (483)
T ss_dssp HSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSC
T ss_pred hCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCC
Confidence 999999875442 3333333211110000 013679999999999998 999999542211 1235899999
Q ss_pred CCcccccc
Q 013064 339 IQWDKLYE 346 (450)
Q Consensus 339 i~w~~l~~ 346 (450)
+||+.+..
T Consensus 288 ~dW~~~~~ 295 (483)
T 3sv0_A 288 FDWTILKY 295 (483)
T ss_dssp CHHHHHTC
T ss_pred cCchhhcc
Confidence 99998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=389.16 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=208.4
Q ss_pred CeEEE-eEEeecCceEEEEEEE--cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 39 DFEQL-TLIGKGAFGEVRLCRA--KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 39 ~f~~~-~~LG~G~fg~V~l~~~--~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+.+. +.||+|+||.||+|.. +.+++.||||+++... ......+.+.+|+.+|+.++|||||++++++.+ +.+|+
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999954 5677899999997653 334456789999999999999999999999975 45899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||||+||+|.+++...+.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999999999999998999999999999999999999999999999999999999999999999999998764321100
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~ 274 (450)
.......||+.|+|||++.+..|+.++|||||||++|||++ |..
T Consensus 527 -----------------------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 571 (635)
T 4fl3_A 527 -----------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571 (635)
T ss_dssp -------------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----------------------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 00113467899999999999999999999999999999998 999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|| ++++|+
T Consensus 572 Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~~l~ 623 (635)
T 4fl3_A 572 PYRGMKGSEVTAMLEKGE-RMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVE 623 (635)
T ss_dssp SSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHH
T ss_pred CCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHH
Confidence 999998888777776532 33344 4789999999999998 999999 466665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=358.17 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=190.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE-----
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQ----- 108 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~----- 108 (450)
+.-.+|++.+.||+|+||.||+|++..+|+.||+|++.+.. ......+.+|..++..+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 44458999999999999999999999999999999986542 344567889999999995 999999999994
Q ss_pred ---cCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEccCCceEEe
Q 013064 109 ---DSDFLYLIMEYLPGGDIMTLLMR---EDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 109 ---~~~~lylVmEy~~gg~L~~~l~~---~~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld~~g~ikL~ 180 (450)
....+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+|++||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 4456899999995 789888865 567999999999999999999999999 9999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh---ccCCCCccc
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL---LKKGYGMEC 257 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl---~~~~y~~~~ 257 (450)
|||+++............ .+........+.+||+.|+|||++ .+..++.++
T Consensus 181 Dfg~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~ 234 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSA--------------------------QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234 (337)
T ss_dssp CCTTCBCCSSCC---------------------------------------------------------CCTTSCSSHHH
T ss_pred cCccceeccccCcccccc--------------------------cccccchhhccccCCCCcCChhhhhccccCCCChHH
Confidence 999998765431110000 000000011246799999999999 567789999
Q ss_pred cccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
|||||||++|+|++|..||.+.......... ...+.....++.+.+||.+||. ||.+|+ +++++++|
T Consensus 235 Dv~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 302 (337)
T 3ll6_A 235 DIWALGCILYLLCFRQHPFEDGAKLRIVNGK------YSIPPHDTQYTVFHSLIRAMLQVNPEERL---SIAEVVHQ 302 (337)
T ss_dssp HHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCcchhHHHhhcCc------ccCCcccccchHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999999999999999999765544332222 2333345778899999999999 999999 68899877
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=363.95 Aligned_cols=253 Identities=15% Similarity=0.206 Sum_probs=202.3
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCC--------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeee------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTT--------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQ------ 102 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t--------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~------ 102 (450)
.++|++.+.||+|+||.||+|+++.+ ++.||+|++.+. +.+.+|..+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999884 889999999754 24778999999999999887
Q ss_pred ---------EEEEEEc-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEE
Q 013064 103 ---------LFYSFQD-SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 170 (450)
Q Consensus 103 ---------l~~~f~~-~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNIL 170 (450)
+++++.. +..+|+||||+ ||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 78999999999 99999999886 78999999999999999999999999999999999999
Q ss_pred EccCC--ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhh
Q 013064 171 LDKNG--HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVL 248 (450)
Q Consensus 171 ld~~g--~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl 248 (450)
++.++ .+||+|||+++.+........ .........+||+.|+|||++
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~ 240 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA-------------------------------YVEGSRSPHEGDLEFISMDLH 240 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCC-------------------------------CCTTSSCTTCSCTTTCCHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCcccc-------------------------------ccccccccccCCccccCHHHH
Confidence 99998 999999999987654311100 000112245899999999999
Q ss_pred ccCCCCccccccchhHHHHHHhhCCCCCCCCC--hhhhhhhhhccc-ccccCC----CCCCCCHHHHHHHHHhhc-Cccc
Q 013064 249 LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDD--PRITCRKIVNWK-TCLKFP----EEPKISDEARDLICHLLC-DVET 320 (450)
Q Consensus 249 ~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~-~~~~~p----~~~~~s~~~~dli~~lL~-dp~~ 320 (450)
.+..++.++|+|||||++|+|++|..||.+.. .......+.... ....++ .+..+++++.+||.+||. ||.+
T Consensus 241 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 320 (352)
T 2jii_A 241 KGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEE 320 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhh
Confidence 99999999999999999999999999998754 222222221110 111111 112579999999999998 9999
Q ss_pred cCCCCCHHHHHc
Q 013064 321 RLGTRGVEELKE 332 (450)
Q Consensus 321 R~~~~~~~eil~ 332 (450)
|| ++++|++
T Consensus 321 Rp---s~~~l~~ 329 (352)
T 2jii_A 321 KP---PYAMLRN 329 (352)
T ss_dssp CC---CHHHHHH
T ss_pred CC---CHHHHHH
Confidence 99 4666653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=367.63 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=202.0
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-cCCeEE
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSDFLY 114 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-~~~~ly 114 (450)
.|++.+.||+|+||.||+|+...++ ..+|+|.+++. ......+.+.+|..+|+.++||||+++++++. .++..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 5788999999999999999976443 46899998753 23456778999999999999999999999864 556889
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999999765 4689999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
... .......||+.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 248 ~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~ 293 (373)
T 3c1x_A 248 DSV----------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293 (373)
T ss_dssp --------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccc----------------------------------cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCc
Confidence 000 00123568899999999999999999999999999999999 7
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
.+||.+.+..+....+.... ....| ..+++.+.+||.+||. ||.+|| ++.+++++
T Consensus 294 ~~p~~~~~~~~~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RP---s~~ell~~ 349 (373)
T 3c1x_A 294 APPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 349 (373)
T ss_dssp CCSCTTSCSSCHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 88998887777766666543 22233 4789999999999998 999999 57777754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=385.48 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=211.6
Q ss_pred CCCCeEEEe-EEeecCceEEEEEEEcC--CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 36 GIDDFEQLT-LIGKGAFGEVRLCRAKT--TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 36 ~~~~f~~~~-~LG~G~fg~V~l~~~~~--t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+++.+.+ .||+|+||.||+|..+. ++..||||++++.. .....+.+.+|+.+|+.++|||||++++++.+ +.
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 445667777 89999999999998763 55679999997652 34456789999999999999999999999987 56
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
+|+|||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999999999754 46999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
.... .......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 490 ~~~~-----------------------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 534 (613)
T 2ozo_A 490 DSYY-----------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534 (613)
T ss_dssp -----------------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred Ccee-----------------------------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 1100 00112356799999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|..||.+.+..+....|.... .+..| ..+++++.+||.+||. ||.+||+...+.+.+++.|+
T Consensus 535 ~G~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 535 YGQKPYKKMKGPEVMAFIEQGK-RMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TSCCTTTTCCSHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCC-CCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 999999988888877776542 33444 4799999999999998 99999953333334445443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=373.51 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=208.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++.+.||+|+||.||++.++.+ ..||+|+++.... ..+.+.+|..+|+.++||||+++++++.+ +.+|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 5567899999999999999999998754 5699999976532 24678899999999999999999999876 6789
Q ss_pred EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 115 LIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999999964 3569999999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~- 271 (450)
.. ......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 335 ~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 377 (452)
T 1fmk_A 335 YT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377 (452)
T ss_dssp ---------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ee-------------------------------------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence 00 0113457889999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||.+.+..+....+... ...|....+++.+.+||.+||. ||.+|| ++++|+.
T Consensus 378 g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~~l~~ 433 (452)
T 1fmk_A 378 GRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 433 (452)
T ss_dssp TCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 99999998888777777653 2233335789999999999998 999999 5777764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=359.69 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=192.8
Q ss_pred cCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHH--HhcCCCCeeeEEEEEEc
Q 013064 32 RRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL--AEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 32 ~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il--~~l~hp~Iv~l~~~f~~ 109 (450)
...+.+++|++++.||+|+||.||+|+. +++.||+|++.... ......|..++ ..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccc
Confidence 3468889999999999999999999976 78999999997543 23344455554 45899999999986542
Q ss_pred -----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC---------CeEEeecCCCcEEEccCC
Q 013064 110 -----SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH---------NYVHRDIKPDNLILDKNG 175 (450)
Q Consensus 110 -----~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~---------givHrDLKpeNILld~~g 175 (450)
...+|+|||||+||+|.+++.... +++..+..++.||+.||.|||+. ||+||||||+|||++.+|
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 346899999999999999996654 59999999999999999999999 999999999999999999
Q ss_pred ceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-----
Q 013064 176 HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK----- 250 (450)
Q Consensus 176 ~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~----- 250 (450)
.+||+|||+|+.+........ ........+.+||+.|+|||++.+
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRP------------------------------GEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------------------------------------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred cEEEeeccceeecccccccCc------------------------------cccccccccCCCccceeCchhhcCCcccc
Confidence 999999999987654311000 000011234689999999999986
Q ss_pred --CCCCccccccchhHHHHHHhhCCCCCCCCChhhhhh------------------hhhcccccccCCC----CCCCCHH
Q 013064 251 --KGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCR------------------KIVNWKTCLKFPE----EPKISDE 306 (450)
Q Consensus 251 --~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------------------~i~~~~~~~~~p~----~~~~s~~ 306 (450)
..++.++|||||||++|||++|..||........+. .+........+|. ....++.
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHH
Confidence 456789999999999999999977664332211110 0111111222222 1224568
Q ss_pred HHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 307 ARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 307 ~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+.+||.+||. ||.+|| ++.+++
T Consensus 288 l~~li~~cl~~dP~~Rp---s~~e~l 310 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARL---TAQXAE 310 (336)
T ss_dssp HHHHHHHHSCSSGGGSC---CHHHHH
T ss_pred HHHHHHHHhcCChhhCc---chHHHH
Confidence 9999999998 999999 567774
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=356.22 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=204.9
Q ss_pred CCeEEEeEEeecCceEEEEEEE----cCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CC
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRA----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SD 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~----~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~ 111 (450)
..|++++.||+|+||.||++.. ..+|+.||+|++++.. .....+.+.+|..+|+.++||||+++++++.+ ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3459999999999999988764 4578899999998652 34456778999999999999999999999987 46
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+||||+++|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 899999999999999998665 4999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
.... .......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 188 ~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 232 (318)
T 3lxp_A 188 HEYY-----------------------------------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232 (318)
T ss_dssp CSEE-----------------------------------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred cccc-----------------------------------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 1100 01123578999999999999999999999999999999999
Q ss_pred CCCCCCCCChhh--------------hhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 GYPPFCSDDPRI--------------TCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 G~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||....... .....+... ...+....+++++.+||++||. ||.+|| +++++++
T Consensus 233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~ 303 (318)
T 3lxp_A 233 HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG--ERLPRPDKCPAEVYHLMKNCWETEASFRP---TFENLIP 303 (318)
T ss_dssp TTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCcccccchhhhhhhcccccchhHHHHHHHHhcc--cCCCCCccccHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 999997543210 111122211 2233335789999999999998 999999 5777763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=353.00 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=197.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc--CCCCeeeEEEEEEcC--
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV--DSRCIVQLFYSFQDS-- 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~f~~~-- 110 (450)
...++|++++.||+|+||.||+|++. |+.||+|++.... ......|..++..+ +||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34479999999999999999999875 8999999986542 23445566666554 999999999999887
Q ss_pred --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC--------CeEEeecCCCcEEEccCCceEEe
Q 013064 111 --DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--------NYVHRDIKPDNLILDKNGHLKLS 180 (450)
Q Consensus 111 --~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~--------givHrDLKpeNILld~~g~ikL~ 180 (450)
..+|+||||++||+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.+|.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999654 699999999999999999999998 99999999999999999999999
Q ss_pred eccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCcc----
Q 013064 181 DFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME---- 256 (450)
Q Consensus 181 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~---- 256 (450)
|||+|+.+....... .....+.+||+.|+|||++.+..++..
T Consensus 185 Dfg~a~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 230 (337)
T 3mdy_A 185 DLGLAVKFISDTNEV----------------------------------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230 (337)
T ss_dssp CCTTCEECC-------------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHH
T ss_pred eCCCceeeccccccc----------------------------------cCCCCCCccCcceeChhhcccccCCccccCc
Confidence 999998654321100 001124689999999999988777665
Q ss_pred --ccccchhHHHHHHhhC----------CCCCCCCChhh----hhhhhh-cccccccCCC---CCCCCHHHHHHHHHhhc
Q 013064 257 --CDWWSLGAIMYEMLIG----------YPPFCSDDPRI----TCRKIV-NWKTCLKFPE---EPKISDEARDLICHLLC 316 (450)
Q Consensus 257 --~DiWSlGvilyeml~G----------~~PF~~~~~~~----~~~~i~-~~~~~~~~p~---~~~~s~~~~dli~~lL~ 316 (450)
+|||||||++|||++| ..||....... ....+. .......+|. ...+++++.+||.+||.
T Consensus 231 ~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 310 (337)
T 3mdy_A 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSC
T ss_pred cccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhh
Confidence 9999999999999999 77775532211 112211 1111122221 12456779999999998
Q ss_pred -CccccCCCCCHHHHHcC
Q 013064 317 -DVETRLGTRGVEELKEH 333 (450)
Q Consensus 317 -dp~~R~~~~~~~eil~H 333 (450)
||.+|| ++.++++|
T Consensus 311 ~dP~~Rp---s~~ell~~ 325 (337)
T 3mdy_A 311 HNPASRL---TALRVKKT 325 (337)
T ss_dssp SSGGGSC---CHHHHHHH
T ss_pred hChhhCC---CHHHHHHH
Confidence 999999 67888765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=372.26 Aligned_cols=250 Identities=18% Similarity=0.198 Sum_probs=199.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CC----------e-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RC----------I----- 100 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~----------I----- 100 (450)
...|...+.||+|+||.||+|++..+|+.||||++...........+.+.+|..++..+.| ++ +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3468889999999999999999999999999999885443344446778899999999876 21 1
Q ss_pred ------eeEEEEEEc-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEe
Q 013064 101 ------VQLFYSFQD-----SDFLYLIMEYLPGGDIMTLLMR-------EDILSEDVARFYIAESVLAIHSIHQHNYVHR 162 (450)
Q Consensus 101 ------v~l~~~f~~-----~~~lylVmEy~~gg~L~~~l~~-------~~~~~e~~~~~~~~qil~aL~~LH~~givHr 162 (450)
..+..++.. ...++++|+++ +|+|.+++.. ...+++..+..++.||+.||+|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 111122222 22467888876 7899998842 3357788889999999999999999999999
Q ss_pred ecCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCc
Q 013064 163 DIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDY 242 (450)
Q Consensus 163 DLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y 242 (450)
||||+||||+.+|.+||+|||+|+..... ..+.+| +.|
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------------------------------------~~~~~g-~~y 273 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------------------------------------AVSPIG-RGF 273 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----------------------------------------ECCCCC-TTT
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----------------------------------------cccCCC-Cce
Confidence 99999999999999999999998865432 124688 999
Q ss_pred cchhhh----------ccCCCCccccccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHH
Q 013064 243 MAPEVL----------LKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLIC 312 (450)
Q Consensus 243 ~APEvl----------~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~ 312 (450)
+|||++ .+..|+.++|||||||++|||++|..||.+.+.......+.. ....+++++++||.
T Consensus 274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~ 345 (413)
T 3dzo_A 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLE 345 (413)
T ss_dssp CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHH
T ss_pred eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHH
Confidence 999999 555688999999999999999999999998877666655543 12368899999999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 313 HLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
+||. ||.+|+ ++.++++||||+.+.
T Consensus 346 ~~l~~dP~~Rp---t~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 346 GFLRYPKEDRL---LPLQAMETPEYEQLR 371 (413)
T ss_dssp HHTCSSGGGSC---CHHHHTTSHHHHHHH
T ss_pred HHccCChhhCc---CHHHHHhCHHHHHHH
Confidence 9998 999999 689999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.49 Aligned_cols=261 Identities=25% Similarity=0.419 Sum_probs=209.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-----
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----- 109 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----- 109 (450)
..+++|++++.||+|+||.||+|+++.+|+.||+|++.+. ......+.+.+|..+|+.++||||+++++++.+
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 4458999999999999999999999999999999998764 234456778999999999999999999999866
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCc---eEEeec
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGH---LKLSDF 182 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~~~---~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~---ikL~DF 182 (450)
.+..|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 778899999999999999998754 6999999999999999999999999999999999999998775 999999
Q ss_pred cccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccch
Q 013064 183 GLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSL 262 (450)
Q Consensus 183 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSl 262 (450)
|++....... .....+||+.|+|||++.+..|+.++|+|||
T Consensus 169 G~a~~~~~~~---------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSL 209 (676)
T 3qa8_A 169 GYAKELDQGE---------------------------------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209 (676)
T ss_dssp CCCCBTTSCC---------------------------------------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHH
T ss_pred cccccccccc---------------------------------------ccccccCCcccCChHHhccCCCCchhHHHHH
Confidence 9998764321 1224689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhhhhh--------------hhc----ccccccCCC--CCCCCHHHHHHHHHhhc-Ccccc
Q 013064 263 GAIMYEMLIGYPPFCSDDPRITCRK--------------IVN----WKTCLKFPE--EPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 263 Gvilyeml~G~~PF~~~~~~~~~~~--------------i~~----~~~~~~~p~--~~~~s~~~~dli~~lL~-dp~~R 321 (450)
||++|+|++|..||.+......... ... +...+..|. ...+++.+.+||.+||. ||.+|
T Consensus 210 GviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kR 289 (676)
T 3qa8_A 210 GTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289 (676)
T ss_dssp HHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC--
T ss_pred HHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhC
Confidence 9999999999999976532221110 011 001111111 12467899999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCC
Q 013064 322 LGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i 339 (450)
| ++++++.||||+.+
T Consensus 290 P---Ta~elL~hp~F~~l 304 (676)
T 3qa8_A 290 G---TDPQNPNVGCFQAL 304 (676)
T ss_dssp ----CCTTCCCCTTHHHH
T ss_pred c---CHHHHhcCHHHHHH
Confidence 9 57899999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=349.48 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=202.5
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh-cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEec
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEY 119 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy 119 (450)
...+.||+|+||.||+|.. +++.+|+|++.+... ......+.+.+|..+++.++||||+++++++.+.+.+|+||||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 3348999999999999975 688999999876432 2334567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 120 LPGGDIMTLLMR---EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 120 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 189 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT-- 189 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC--
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc--
Confidence 999999999874 346999999999999999999999999999999999999999999999999999865432110
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
......+||+.|+|||++.+ .++.++|+|||||++|+|++|.+||
T Consensus 190 ----------------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 190 ----------------------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp ----------------------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred ----------------------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence 01124589999999999875 4899999999999999999999999
Q ss_pred CCCChhhhhhhhhccccc----------ccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 277 CSDDPRITCRKIVNWKTC----------LKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 277 ~~~~~~~~~~~i~~~~~~----------~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
.+.........+...... ...+ .....++.+.+||.+||. ||.+|| ++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~l~~~ 300 (307)
T 2nru_A 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP---DIKKVQQL 300 (307)
T ss_dssp CTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred ccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 876654443333211000 0011 112345778999999998 999999 57777753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=352.32 Aligned_cols=257 Identities=24% Similarity=0.408 Sum_probs=208.7
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEE----EcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCR----AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~----~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
..+..++|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|..+|+.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 45667889999999999999999998 4668999999999763 3445678899999999999999999999987
Q ss_pred cCC--eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 109 DSD--FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 109 ~~~--~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+.+ .+|+||||++||+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999876 46999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
.......... .......||+.|+|||++.+..++.++|+|||||+
T Consensus 193 ~~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 237 (326)
T 2w1i_A 193 KVLPQDKEYY-----------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 237 (326)
T ss_dssp EECCSSCSEE-----------------------------------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred hhcccccccc-----------------------------------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHH
Confidence 8765431100 00123468889999999999889999999999999
Q ss_pred HHHHhhCCCCCCCCChh------------hh---hhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 266 MYEMLIGYPPFCSDDPR------------IT---CRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~------------~~---~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
+|+|++|..||...... .. ....+... ...+....+++++.+||.+||. ||.+|| ++.+
T Consensus 238 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~e 312 (326)
T 2w1i_A 238 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN--GRLPRPDGCPDEIYMIMTECWNNNVNQRP---SFRD 312 (326)
T ss_dssp HHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHSCSSGGGSC---CHHH
T ss_pred HHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC--CCCCCCCcccHHHHHHHHHHcCCChhhCc---CHHH
Confidence 99999999998643110 00 11111111 1223335789999999999998 999999 5777
Q ss_pred HHc
Q 013064 330 LKE 332 (450)
Q Consensus 330 il~ 332 (450)
+++
T Consensus 313 l~~ 315 (326)
T 2w1i_A 313 LAL 315 (326)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=376.67 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=213.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++.+.||+|+||.||++.++.+ ..||||+++.... ..+.+.+|..+|+.++|||||++++++.+ +.+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 35567899999999999999999998754 5699999976542 24678899999999999999999999876 679
Q ss_pred EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+||||++||+|.++|.. ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999999964 356999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... ......+|+.|+|||++.+..|+.++|||||||+||||++
T Consensus 417 ~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t 459 (535)
T 2h8h_A 417 EYT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459 (535)
T ss_dssp HHH-------------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred cee-------------------------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 100 0113467889999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|..||.+.+..+....+... ...+....+++.+.+||.+||. ||.+|| ++++|+.
T Consensus 460 ~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~ 516 (535)
T 2h8h_A 460 KGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 516 (535)
T ss_dssp TTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 99999998888777777643 2223335789999999999998 999999 5677764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=356.17 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=211.6
Q ss_pred HHhcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 29 ~~~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
..+...+..++|++.+.||+|+||.||+|++.. .+|+|+++.... .....+.+.+|..+++.++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 345667889999999999999999999998864 399999976532 2333455778999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||++..
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999999997754 799999999999999999999999999999999999998 78999999999876
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---------CCCCcccc
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---------KGYGMECD 258 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---------~~y~~~~D 258 (450)
....... ..........||+.|+|||++.+ ..|+.++|
T Consensus 179 ~~~~~~~---------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~D 225 (319)
T 2y4i_B 179 SGVLQAG---------------------------------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225 (319)
T ss_dssp ------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHH
T ss_pred ccccccc---------------------------------ccccccccCCCcccccChHHhhhccccccccccCCCchhh
Confidence 5321100 00011224579999999999974 45789999
Q ss_pred ccchhHHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 259 WWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 259 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|||||++|+|++|..||.+.+.......+....... .....+++++.+||.+||. ||.+|| ++.++++
T Consensus 226 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~ 295 (319)
T 2y4i_B 226 VFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--LSQIGMGKEISDILLFCWAFEQEERP---TFTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--CCCSSCCTTHHHHHHHHHCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--CCcCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 9999999999999999999888877777666532211 1123688999999999998 999999 5777775
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=379.56 Aligned_cols=253 Identities=26% Similarity=0.365 Sum_probs=212.4
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCC---CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t---~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
.+..++|++.+.||+|+||.||+|++..+ +..+|+|+++... .....+.+.+|..+|+.++||||+++++++. +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34557899999999999999999998654 4579999986532 3345577899999999999999999999985 4
Q ss_pred CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 56899999999999999998654 69999999999999999999999999999999999999999999999999998764
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... ......||+.|+|||++.+..|+.++|||||||++|||
T Consensus 543 ~~~~~-------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 585 (656)
T 2j0j_A 543 DSTYY-------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585 (656)
T ss_dssp C-----------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCcce-------------------------------------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 32110 01134678999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
++ |.+||.+.+..+....+.... ....| ..+++.+.+||.+||. ||.+|| ++.+|++
T Consensus 586 lt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~RP---s~~el~~ 644 (656)
T 2j0j_A 586 LMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKA 644 (656)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHcCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 97 999999988888877776532 23333 4789999999999998 999999 5777764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.34 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=200.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEcCC----
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE--VDSRCIVQLFYSFQDSD---- 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~f~~~~---- 111 (450)
++|++.+.||+|+||.||++++ +|+.||+|++.+.. ...+.+|..++.. ++||||+++++++.+..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 6899999999999999999987 58999999996542 3567789999987 79999999999999876
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh--------hCCeEEeecCCCcEEEccCCceEEeecc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH--------QHNYVHRDIKPDNLILDKNGHLKLSDFG 183 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH--------~~givHrDLKpeNILld~~g~ikL~DFG 183 (450)
.+|+||||+++|+|.+++.+ ..+++..+..++.||+.||.||| +.||+||||||+|||++.+|.+||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 89999999999999999976 46999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC------CCCccc
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK------GYGMEC 257 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~------~y~~~~ 257 (450)
++.......... .......+||+.|+|||++.+. .++.++
T Consensus 193 ~~~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 238 (342)
T 1b6c_B 193 LAVRHDSATDTI----------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238 (342)
T ss_dssp TCEEEETTTTEE----------------------------------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHH
T ss_pred Cceecccccccc----------------------------------ccccccCCcCcccCCHhhhcccccccccccCCcc
Confidence 997654321100 0011246899999999999865 234789
Q ss_pred cccchhHHHHHHhhC----------CCCCCCCCh-----hhhhhhhhcccccccCCC---CCCCCHHHHHHHHHhhc-Cc
Q 013064 258 DWWSLGAIMYEMLIG----------YPPFCSDDP-----RITCRKIVNWKTCLKFPE---EPKISDEARDLICHLLC-DV 318 (450)
Q Consensus 258 DiWSlGvilyeml~G----------~~PF~~~~~-----~~~~~~i~~~~~~~~~p~---~~~~s~~~~dli~~lL~-dp 318 (450)
|+|||||++|||++| ..||..... ......+........+|. ....++.+.+||.+||. ||
T Consensus 239 Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (342)
T 1b6c_B 239 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318 (342)
T ss_dssp HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSG
T ss_pred cHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccCh
Confidence 999999999999999 789876532 222333333222222232 11334678999999998 99
Q ss_pred cccCCCCCHHHHHcC
Q 013064 319 ETRLGTRGVEELKEH 333 (450)
Q Consensus 319 ~~R~~~~~~~eil~H 333 (450)
.+|| ++++|++|
T Consensus 319 ~~Rp---s~~~i~~~ 330 (342)
T 1b6c_B 319 AARL---TALRIKKT 330 (342)
T ss_dssp GGSC---CHHHHHHH
T ss_pred hhCC---CHHHHHHH
Confidence 9999 67888765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=336.68 Aligned_cols=227 Identities=13% Similarity=0.094 Sum_probs=189.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..++||||+++++++.+++.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 34478999999999999999999999999999999998765544556688999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~ 194 (450)
+||||++||+|.+++.+ + ..+.++..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999854 3 4666788899999999999999999999999999999999999988554
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
|++ +++.++|+|||||++|||++|..
T Consensus 175 -----------------------------------------------~~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 175 -----------------------------------------------TMP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp -----------------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred -----------------------------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 222 37889999999999999999999
Q ss_pred CCCCCChhhhhh---hhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 275 PFCSDDPRITCR---KIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 275 PF~~~~~~~~~~---~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
||.+.+...... ++..............+++++++||.+||. ||.+| + +.++++
T Consensus 201 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s---~~el~~ 258 (286)
T 3uqc_A 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-S---ASTLLN 258 (286)
T ss_dssp CSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-C---HHHHHH
T ss_pred CCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-C---HHHHHH
Confidence 999877654332 222211110000124789999999999998 99999 4 667664
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.94 Aligned_cols=241 Identities=24% Similarity=0.294 Sum_probs=198.9
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcC-CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe--
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKT-TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF-- 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~-t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~-- 112 (450)
..++|++++.||+|+||.||+|.+.. +|+.||||++.+.. .......+.+|+.+|..++|||||+++++|.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 34799999999999999999999976 78999999987532 23455678899999999999999999999987665
Q ss_pred ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 113 ---LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 113 ---lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
+|+||||++||+|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++...
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999988754 79999999999999999999999999999999999999875 99999999998654
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
.. ...+||+.|+|||++.+. ++.++|||||||++|+|
T Consensus 233 ~~------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 233 SF------------------------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269 (681)
T ss_dssp CC------------------------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred cC------------------------------------------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence 31 146899999999999764 58999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
++|.+||.+....... . ..+ ....++.+.+||.+||. ||.+|++ ..+.+.|+|+.
T Consensus 270 ~~g~~~~~~~~~~~~~----~-----~~~-~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 270 TLDLPTRNGRYVDGLP----E-----DDP-VLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp HSCCCEETTEECSSCC----T-----TCH-HHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HhCCCCCccccccccc----c-----ccc-ccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 9999999753221110 0 000 01356889999999998 9999994 46777788774
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.36 Aligned_cols=190 Identities=15% Similarity=0.193 Sum_probs=140.5
Q ss_pred EEeecCceEEEEEEEcCCCCEEEEEEeechhhc-------chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcCCeEEEE
Q 013064 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-------KRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 45 ~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-------~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++.|+.|.+..++...+|+.||+|++.+.... .....+.+.+|+++|+++ .|+||++++++|++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356788888888888889999999999765321 123346789999999999 799999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||||+||+|.++|.+.+.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---- 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---- 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-------
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC----
Confidence 9999999999999999999875 478999999999999999999999999999999999999999998764321
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF 276 (450)
....+.||||.|||||++.+. +..++|+||+|+++|+|.+|..||
T Consensus 394 ----------------------------------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 ----------------------------------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----------------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ----------------------------------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 112367999999999999764 677899999999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-31 Score=277.52 Aligned_cols=193 Identities=19% Similarity=0.187 Sum_probs=148.6
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK-----RGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
..+.||+|+||.||++ ...++.+|+|......... ....+.+.+|..+|+.++||||+++..++.+.+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999999 4467889999865433221 12245689999999999999999665555577778999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||||+||+|.+++.+ +..++.||+.||+|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~- 486 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA- 486 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH-
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc-
Confidence 999999999999865 6689999999999999999999999999999998 99999999999765421100
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc--CCCCccccccchhHHHHHHhhCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK--KGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~--~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
. .......+.+||+.|||||++.. .+|+..+|+||.++-..+...++.
T Consensus 487 --------------------------~----~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~ 536 (540)
T 3en9_A 487 --------------------------V----DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA 536 (540)
T ss_dssp --------------------------H----HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred --------------------------c----chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence 0 00001235799999999999987 789999999999999888887777
Q ss_pred CCC
Q 013064 275 PFC 277 (450)
Q Consensus 275 PF~ 277 (450)
+|.
T Consensus 537 rY~ 539 (540)
T 3en9_A 537 RYV 539 (540)
T ss_dssp CCC
T ss_pred ccC
Confidence 663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=235.26 Aligned_cols=130 Identities=14% Similarity=0.154 Sum_probs=107.2
Q ss_pred eEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---------------hhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 44 TLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---------------GQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---------------~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
+.||+|+||.||+|++ .+|+.||+|+++....... .....+.+|..+|+.++| ++++.++.
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence 9999999999999999 8899999999975432111 135678899999999984 55555554
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~ 186 (450)
. +..|+||||++||+|.. + ....+..++.||+.||.|||++||+||||||+|||++ +|++||+|||+|+
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred c-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 4 45699999999999987 3 1234567999999999999999999999999999999 9999999999976
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-23 Score=196.97 Aligned_cols=143 Identities=16% Similarity=0.112 Sum_probs=111.5
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCE--EEEEEeechhhcch---------------------hhHHHHHHHHHHHHhc
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEI--FAMKKLKKSEMLKR---------------------GQVEHVRSERNLLAEV 95 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~--~AiK~i~k~~~~~~---------------------~~~~~~~~E~~il~~l 95 (450)
-|++.+.||+|+||.||+|.+..+|+. ||||+++....... .....+.+|..+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999788999 99999765421100 1123678899999999
Q ss_pred CCCCe--eeEEEEEEcCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh-hCCeEEeecCCC
Q 013064 96 DSRCI--VQLFYSFQDSDFLYLIMEYLPG-G----DIMTLLMREDILSEDVARFYIAESVLAIHSIH-QHNYVHRDIKPD 167 (450)
Q Consensus 96 ~hp~I--v~l~~~f~~~~~lylVmEy~~g-g----~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH-~~givHrDLKpe 167 (450)
.|++| +.++.. ...||||||+.+ | .|.++... .++..+..++.||+.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87753 444442 356899999942 4 66655322 346678899999999999999 999999999999
Q ss_pred cEEEccCCceEEeeccccccCcc
Q 013064 168 NLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 168 NILld~~g~ikL~DFGla~~~~~ 190 (450)
|||++. .++|+|||+|.....
T Consensus 201 NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SEEESS--SEEECCCTTCEETTS
T ss_pred HEEEcC--cEEEEECcccccCCC
Confidence 999988 999999999987643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-20 Score=186.36 Aligned_cols=140 Identities=11% Similarity=0.143 Sum_probs=103.3
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-----------ch----hhH----HHHHHHHHHHHhcCCCCe
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-----------KR----GQV----EHVRSERNLLAEVDSRCI 100 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-----------~~----~~~----~~~~~E~~il~~l~hp~I 100 (450)
|.+.+.||.|+||.||+|.+. +|+.||||+++..... .. ... .....|...|.++.+..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999875 6999999998643211 00 001 112356677777754443
Q ss_pred --eeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC---
Q 013064 101 --VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG--- 175 (450)
Q Consensus 101 --v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g--- 175 (450)
...++. . . .+|||||++|+.|..+. ..+.++.++.||+.+|.+||+.|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~--~-~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ--S-R-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE--E-T-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec--c-C-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 233322 1 2 27999999999885442 2334567889999999999999999999999999998887
Q ss_pred -------ceEEeeccccccCcc
Q 013064 176 -------HLKLSDFGLCKPLED 190 (450)
Q Consensus 176 -------~ikL~DFGla~~~~~ 190 (450)
.+.|+||+-+.....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETTS
T ss_pred cccccccceEEEEeCCcccCCC
Confidence 389999998876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.9e-13 Score=129.71 Aligned_cols=141 Identities=13% Similarity=0.108 Sum_probs=113.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lyl 115 (450)
+..|++...+|.|+.+.||.+.. .+..|++|+...... .....+.+|..+|+.+. +..++++++++.+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 35799999999999999999864 367899999875321 11235788999999884 6778899999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ--------------------------------------- 156 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~--------------------------------------- 156 (450)
||||++|.+|...+ .+......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999999987652 1223345678899999999998
Q ss_pred --------------------CCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 157 --------------------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 157 --------------------~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
..++|+|++|.|||++.++.+.|+||+.|..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999998755567999998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-12 Score=122.82 Aligned_cols=137 Identities=12% Similarity=0.119 Sum_probs=101.7
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEcCCeEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC--IVQLFYSFQDSDFLY 114 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~f~~~~~ly 114 (450)
+.+|.+....+.|..+.||++.. .+|..|++|+.... ....+.+|..+|+.+.+.. ++++++++.+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 45677655555666799999854 46778999997543 1234678999998885433 677999998888899
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCC------------------------------------
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN------------------------------------ 158 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~g------------------------------------ 158 (450)
+||||++|.+|. . ...+. ..++.++..+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998883 1 11222 245667777777777643
Q ss_pred ----------------------eEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 159 ----------------------YVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 159 ----------------------ivHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
++|+|++|.|||++.++.+.|+|||.|...
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987666679999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=123.00 Aligned_cols=145 Identities=17% Similarity=0.221 Sum_probs=109.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEee--chhhcchhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEcC---
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLK--KSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFYSFQDS--- 110 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~--k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~f~~~--- 110 (450)
.....++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|+.+. +..+++++.++.+.
T Consensus 38 ~~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~ 113 (359)
T 3dxp_A 38 AGPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI 113 (359)
T ss_dssp CCCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred CCCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence 34445788999999999998753 4678899876 33211 12346778999999986 45688999988876
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ---------------------------------- 156 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~---------------------------------- 156 (450)
+..|+||||++|..+.+. ....++++....++.+++.+|..||+
T Consensus 114 g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 458999999999877432 12347788888999999999999997
Q ss_pred ------------------------CCeEEeecCCCcEEEccCCc--eEEeeccccccC
Q 013064 157 ------------------------HNYVHRDIKPDNLILDKNGH--LKLSDFGLCKPL 188 (450)
Q Consensus 157 ------------------------~givHrDLKpeNILld~~g~--ikL~DFGla~~~ 188 (450)
.+++|+|++|.|||++.++. +.|+||+.|...
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 46999999999999997763 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.24 E-value=7.3e-12 Score=121.62 Aligned_cols=134 Identities=18% Similarity=0.237 Sum_probs=100.5
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCC--eeeEEEEEEcCC---eEEEE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRC--IVQLFYSFQDSD---FLYLI 116 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~--Iv~l~~~f~~~~---~lylV 116 (450)
++.++.|....||++. ..+++|+.... .....+.+|..+|+.+ .+.. +++++....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999874 45889986533 2356788999999887 3322 455555544443 35899
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ---------------------------------------- 156 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~---------------------------------------- 156 (450)
|++++|..|..... ..++.++...++.++...|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998875433 346788888888888888888886
Q ss_pred ------------------CCeEEeecCCCcEEEcc--CCceEEeeccccccC
Q 013064 157 ------------------HNYVHRDIKPDNLILDK--NGHLKLSDFGLCKPL 188 (450)
Q Consensus 157 ------------------~givHrDLKpeNILld~--~g~ikL~DFGla~~~ 188 (450)
..++|+|++|.|||++. .+.+.|+||+.+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 24799999999999998 456789999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=9.9e-08 Score=92.59 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=94.4
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC---CeeeEEEEEE-cCCeEEEEEe
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR---CIVQLFYSFQ-DSDFLYLIME 118 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~f~-~~~~lylVmE 118 (450)
++.++.|....||++ |..+++|+.... .....+.+|..+|+.+.+. .|++.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456799999999988 566889985322 2356788999999998642 3667776664 4567889999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh------------------------------------------
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ------------------------------------------ 156 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~------------------------------------------ 156 (450)
|++|..|..... ..++++....++.++...|..||+
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988865321 123444444444444444444443
Q ss_pred ------------------CCeEEeecCCCcEEEcc---CCce-EEeeccccccC
Q 013064 157 ------------------HNYVHRDIKPDNLILDK---NGHL-KLSDFGLCKPL 188 (450)
Q Consensus 157 ------------------~givHrDLKpeNILld~---~g~i-kL~DFGla~~~ 188 (450)
..++|+|++|.|||++. +|.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999987 4665 89999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=3.1e-07 Score=86.84 Aligned_cols=134 Identities=19% Similarity=0.164 Sum_probs=94.6
Q ss_pred EEeecCce-EEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEeccCC
Q 013064 45 LIGKGAFG-EVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYLPG 122 (450)
Q Consensus 45 ~LG~G~fg-~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~~g 122 (450)
.+..|..| .||.+.....+..+++|+-... ....+.+|..+|+.+. +--+.+++.+..+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 6998887777778999986533 3456788999998874 32378889999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhC---------------------------------------------
Q 013064 123 GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH--------------------------------------------- 157 (450)
Q Consensus 123 g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~--------------------------------------------- 157 (450)
..+....... ......+..++...|.-||..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8876654321 111222334444444444421
Q ss_pred -------------CeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 158 -------------NYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 158 -------------givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
.++|+|+.|.|||++.++.+-|+||+.+...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 2799999999999998777779999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=2e-07 Score=93.67 Aligned_cols=82 Identities=18% Similarity=0.215 Sum_probs=52.4
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh-cch---hhHHHHHHHHHHHHhcCC--C-CeeeEEEEEEcCCeE
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LKR---GQVEHVRSERNLLAEVDS--R-CIVQLFYSFQDSDFL 113 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~-~~~---~~~~~~~~E~~il~~l~h--p-~Iv~l~~~f~~~~~l 113 (450)
..++.||.|..+.||++....+++.+++|....... ... ...+.+..|..+|+.+.. | .+++++.+ +.+..
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 347789999999999997666678899998653211 000 123456779999987732 3 44566644 34456
Q ss_pred EEEEeccCCCC
Q 013064 114 YLIMEYLPGGD 124 (450)
Q Consensus 114 ylVmEy~~gg~ 124 (450)
++||||++|..
T Consensus 111 ~lvmE~l~g~~ 121 (397)
T 2olc_A 111 VTVMEDLSHLK 121 (397)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEEeCCCcc
Confidence 89999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.41 E-value=2.3e-06 Score=83.38 Aligned_cols=138 Identities=12% Similarity=0.163 Sum_probs=80.6
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--CCCeeeEEE------EEEcCCeE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFY------SFQDSDFL 113 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~------~f~~~~~l 113 (450)
-++.|+.|..+.||++... +| .|++|+..... ..+..|..+++.+. .-.+++++. +..+.+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET-TE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC-CC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 4556777788999998753 33 49999987521 23334555555442 112333332 22356788
Q ss_pred EEEEeccCCCChH--------------HHHHh-cCCC--C-----------HH--------H------------------
Q 013064 114 YLIMEYLPGGDIM--------------TLLMR-EDIL--S-----------ED--------V------------------ 139 (450)
Q Consensus 114 ylVmEy~~gg~L~--------------~~l~~-~~~~--~-----------e~--------~------------------ 139 (450)
|+||+|++|..+. ..++. ...+ + .. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 11111 1111 1 00 0
Q ss_pred -----HHHHHHHHHHHHHHhh-------------hCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 140 -----ARFYIAESVLAIHSIH-------------QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 140 -----~~~~~~qil~aL~~LH-------------~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
...+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.|...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 1112223344566665 358999999999999988889999999998643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=5.6e-06 Score=81.53 Aligned_cols=86 Identities=9% Similarity=0.077 Sum_probs=57.2
Q ss_pred eEEEeEE-eecCceEEEEEEEc--C----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEc
Q 013064 40 FEQLTLI-GKGAFGEVRLCRAK--T----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYSFQD 109 (450)
Q Consensus 40 f~~~~~L-G~G~fg~V~l~~~~--~----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~ 109 (450)
...++.| +.|..+.+|++... . ++..+++|+..............+.+|..+|+.+. .-.+++++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88889999988753 1 15678999875433000000134677888888773 2357788888776
Q ss_pred C---CeEEEEEeccCCCCh
Q 013064 110 S---DFLYLIMEYLPGGDI 125 (450)
Q Consensus 110 ~---~~lylVmEy~~gg~L 125 (450)
. +..|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 357899999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.3e-05 Score=79.26 Aligned_cols=77 Identities=14% Similarity=0.173 Sum_probs=46.9
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhh-cchh---hHHHHHHHHHHHHhc---CCCCeeeEEEEEEcCCeEE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM-LKRG---QVEHVRSERNLLAEV---DSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~-~~~~---~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~~~~ly 114 (450)
-++.||.|..+.||++.. +++.+++|....... .... .......|.+++..+ ....+++++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467899999999999853 567899994322110 0110 011223344443332 335677777775 46679
Q ss_pred EEEecc-CC
Q 013064 115 LIMEYL-PG 122 (450)
Q Consensus 115 lVmEy~-~g 122 (450)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 87
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.95 E-value=7.2e-05 Score=72.60 Aligned_cols=134 Identities=15% Similarity=0.154 Sum_probs=91.6
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEcCCeEEEEE
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD---SRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~f~~~~~lylVm 117 (450)
.-++.|+.|....||++.. ++..|++|+.... ....+..|...|+.+. ...+++++.+..+.+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3467789999999999874 4677889987643 2456788988888873 367889999888888999999
Q ss_pred eccCCCChH--------H---HHHhcC---CC-----------------CHHHHHHHHH---------------------
Q 013064 118 EYLPGGDIM--------T---LLMRED---IL-----------------SEDVARFYIA--------------------- 145 (450)
Q Consensus 118 Ey~~gg~L~--------~---~l~~~~---~~-----------------~e~~~~~~~~--------------------- 145 (450)
||++|..+. . .|.... .| ......++..
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 999997642 1 122211 11 1112222211
Q ss_pred HHHHHH-HHhh----hCCeEEeecCCCcEEEccCCceEEeecc
Q 013064 146 ESVLAI-HSIH----QHNYVHRDIKPDNLILDKNGHLKLSDFG 183 (450)
Q Consensus 146 qil~aL-~~LH----~~givHrDLKpeNILld~~g~ikL~DFG 183 (450)
+++..+ ..|. ...+||+|+.+.|++++.+| +.|+||.
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 122222 2342 24699999999999999888 9999984
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=5.6e-05 Score=75.42 Aligned_cols=144 Identities=15% Similarity=0.187 Sum_probs=88.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYS 106 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~ 106 (450)
+..++.+ ++.|..|-...+|++.... +++.|++|+.... ........+|..+++.+. +...+++++.
T Consensus 48 ~~~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 48 VQPEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp CCGGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred CCcCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 3445555 4567778888999998642 3578999986432 123455668999998873 4445778877
Q ss_pred EEcCCeEEEEEeccCCCChH--------------HHH---Hhc-----CCCC--HHHHHHHHHHHHH-------------
Q 013064 107 FQDSDFLYLIMEYLPGGDIM--------------TLL---MRE-----DILS--EDVARFYIAESVL------------- 149 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~--------------~~l---~~~-----~~~~--e~~~~~~~~qil~------------- 149 (450)
+.+. +||||++|..|. ..| ... +... ...+..|+.++-.
T Consensus 123 ~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 7642 999999985442 111 111 1111 3556666654422
Q ss_pred ------HHHHh----hh----CCeEEeecCCCcEEEccC----CceEEeecccccc
Q 013064 150 ------AIHSI----HQ----HNYVHRDIKPDNLILDKN----GHLKLSDFGLCKP 187 (450)
Q Consensus 150 ------aL~~L----H~----~givHrDLKpeNILld~~----g~ikL~DFGla~~ 187 (450)
.++.| .. ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 12222 22 359999999999999876 7899999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=4.6e-05 Score=73.22 Aligned_cols=133 Identities=10% Similarity=0.002 Sum_probs=76.2
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEEEecc-
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLIMEYL- 120 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylVmEy~- 120 (450)
++.|+.|....+|++ ..|++|+....... .....+|..+++.+. +....++++.+ .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 788999999999998 45889987643110 111245777777663 22225666554 33347899999
Q ss_pred CCCChHHH---------------H---HhcC-CC----C-HHHHHHHHHH--------------HHHHHHHhh-------
Q 013064 121 PGGDIMTL---------------L---MRED-IL----S-EDVARFYIAE--------------SVLAIHSIH------- 155 (450)
Q Consensus 121 ~gg~L~~~---------------l---~~~~-~~----~-e~~~~~~~~q--------------il~aL~~LH------- 155 (450)
+|..|... | +... .+ + ...+..|... +...+..|.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66444210 1 1111 01 1 1122222111 111111111
Q ss_pred -hCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 156 -QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 156 -~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
...++|+|+.|.||| ..+|.+.|+||..|...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 124899999999999 66788999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00015 Score=73.54 Aligned_cols=73 Identities=18% Similarity=0.265 Sum_probs=51.3
Q ss_pred EEeEEeecCceEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeE
Q 013064 42 QLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~-------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~l 113 (450)
-++.|+.|....||++.... ++..|++|+..... ..+.+.+|..+++.+. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 46778889999999998753 35789999884311 1134557888888873 3345778877653
Q ss_pred EEEEeccCCC
Q 013064 114 YLIMEYLPGG 123 (450)
Q Consensus 114 ylVmEy~~gg 123 (450)
.+||||++|.
T Consensus 148 g~v~e~l~G~ 157 (429)
T 1nw1_A 148 GRLEEYIPSR 157 (429)
T ss_dssp EEEECCCCEE
T ss_pred CEEEEEeCCc
Confidence 2899999873
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0002 Score=69.14 Aligned_cols=146 Identities=13% Similarity=0.071 Sum_probs=82.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCC--CeeeEEEE------
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR--CIVQLFYS------ 106 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~------ 106 (450)
..+.+..-++.|+.|....||++... .| .|++|+..... ..+.+..|..++..+... .+++++..
T Consensus 19 ~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~ 91 (322)
T 2ppq_A 19 YDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL 91 (322)
T ss_dssp BCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred CCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEE
Confidence 34455566788888999999998753 34 58899887531 112345677777666311 13333321
Q ss_pred EEcCCeEEEEEeccCCCChHH--------------HHHhc-CCC--------CHHHHHH---------------HHHHHH
Q 013064 107 FQDSDFLYLIMEYLPGGDIMT--------------LLMRE-DIL--------SEDVARF---------------YIAESV 148 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~--------------~l~~~-~~~--------~e~~~~~---------------~~~qil 148 (450)
....+..++||+|++|..+.. .+... ..+ ....-.. +...+.
T Consensus 92 ~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~ 171 (322)
T 2ppq_A 92 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR 171 (322)
T ss_dssp EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred EEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHH
Confidence 123466899999999865310 11110 111 1000000 001133
Q ss_pred HHHHHhhh-------CCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 149 LAIHSIHQ-------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 149 ~aL~~LH~-------~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
..++.++. .+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 172 ~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 172 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 34444542 4799999999999998766568999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00022 Score=69.03 Aligned_cols=137 Identities=11% Similarity=0.142 Sum_probs=79.8
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC--CCeeeEEEE-----EEcCCeEEE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS--RCIVQLFYS-----FQDSDFLYL 115 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~-----f~~~~~lyl 115 (450)
+..|+ |....||++.. .+|+.|++|+...... ....+..|..++..+.. -.+++++.. ...++..++
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 34566 88889998754 3466799999864321 23456678888777631 124444432 223556789
Q ss_pred EEeccCCCChH----H-------H---HHh---c------CCCCHHHH----H------------------HHHHHHHHH
Q 013064 116 IMEYLPGGDIM----T-------L---LMR---E------DILSEDVA----R------------------FYIAESVLA 150 (450)
Q Consensus 116 VmEy~~gg~L~----~-------~---l~~---~------~~~~e~~~----~------------------~~~~qil~a 150 (450)
||+|++|..+. . . ++. . ..++.... + ..+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999885431 0 1 111 0 01111110 0 111222222
Q ss_pred HHHh----hhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 151 IHSI----HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 151 L~~L----H~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
++-+ ....++|+|++|.|||++ + .+.|+||+.|..
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 2222 234689999999999998 4 899999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00022 Score=69.30 Aligned_cols=138 Identities=16% Similarity=0.140 Sum_probs=73.5
Q ss_pred EEeEEeecCceE-EEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-C-CCeeeEEEEEEcCCeEEEEEe
Q 013064 42 QLTLIGKGAFGE-VRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-S-RCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 42 ~~~~LG~G~fg~-V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-h-p~Iv~l~~~f~~~~~lylVmE 118 (450)
-++.|+.|+... +|.+.. .+|..|++|...... ...+..|..++..+. + -.+++++.+-.+.+ ++|||
T Consensus 22 ~~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e 92 (333)
T 3csv_A 22 NRTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIE 92 (333)
T ss_dssp EECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEEC
T ss_pred eeeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEe
Confidence 355676665555 666643 236677777654321 023445677776663 2 23566666533333 78999
Q ss_pred ccCCCChHHHHHhc--------------------------CCCCHHHHH--------HHH------------HHHHHHHH
Q 013064 119 YLPGGDIMTLLMRE--------------------------DILSEDVAR--------FYI------------AESVLAIH 152 (450)
Q Consensus 119 y~~gg~L~~~l~~~--------------------------~~~~e~~~~--------~~~------------~qil~aL~ 152 (450)
++.|..+.+.+... ..++..... .+. ..+..+++
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 99776665433211 112222110 011 01111222
Q ss_pred Hh------hhCCeEEeecCCCcEEEccC----CceEEeeccccccC
Q 013064 153 SI------HQHNYVHRDIKPDNLILDKN----GHLKLSDFGLCKPL 188 (450)
Q Consensus 153 ~L------H~~givHrDLKpeNILld~~----g~ikL~DFGla~~~ 188 (450)
.| +...++|+|+.+.|||++.+ +.+.|+||+.|...
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 22 23579999999999999874 68999999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00019 Score=70.95 Aligned_cols=75 Identities=17% Similarity=0.127 Sum_probs=46.0
Q ss_pred EEeEEeecCceEEEEEEEcC--------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCe
Q 013064 42 QLTLIGKGAFGEVRLCRAKT--------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDF 112 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~--------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~ 112 (450)
.++.|+.|....||++.... .+..|++|+.....- .......|..+++.+. +..++++++.+. +
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN--G- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET--T-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC--C-
Confidence 36678888889999998653 136789998754311 1112356888888773 333557776652 2
Q ss_pred EEEEEeccCCCC
Q 013064 113 LYLIMEYLPGGD 124 (450)
Q Consensus 113 lylVmEy~~gg~ 124 (450)
++||||++|..
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999999853
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00075 Score=66.03 Aligned_cols=32 Identities=16% Similarity=0.225 Sum_probs=28.6
Q ss_pred CCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 157 ~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
..++|+|+.|.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998889999999988753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0052 Score=58.27 Aligned_cols=80 Identities=15% Similarity=0.037 Sum_probs=55.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC---CCeeeEEEEEEcCCeEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS---RCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~f~~~~~ly 114 (450)
....-++.+|.|..+.||.+.. .+|+.|.+|+...... .....+..|...|+.+.. -.+++++.+ +. -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence 3566789999999999999975 4788899998654321 122346789999988732 235555554 22 37
Q ss_pred EEEeccCCCCh
Q 013064 115 LIMEYLPGGDI 125 (450)
Q Consensus 115 lVmEy~~gg~L 125 (450)
+||||+.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.002 Score=65.71 Aligned_cols=75 Identities=9% Similarity=0.172 Sum_probs=49.8
Q ss_pred EEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEEEecc
Q 013064 42 QLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLIMEYL 120 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~lylVmEy~ 120 (450)
-++.|+.|-...+|++.....+..|++|+..... ...++ ..+|..+|..+.. ...+++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 4678888999999999876545789999875421 11111 2578889988854 34477888773 2 2599999
Q ss_pred CCCC
Q 013064 121 PGGD 124 (450)
Q Consensus 121 ~gg~ 124 (450)
+|..
T Consensus 184 ~G~~ 187 (458)
T 2qg7_A 184 DGYA 187 (458)
T ss_dssp CSEE
T ss_pred CCcc
Confidence 9843
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0045 Score=56.28 Aligned_cols=120 Identities=18% Similarity=0.107 Sum_probs=78.0
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhh-hCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 124 DIMTLLMR-EDILSEDVARFYIAESVLAIHSIH-QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 124 ~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH-~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
+|.++|.. ..+++|++|+.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 68888865 568999999999999999987762 11112334467899999999988764 2110
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCCCCCh
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDP 281 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 281 (450)
.....+.|||... .+-+.+.=|+|||+++|.-|-=..|
T Consensus 98 -----------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------ 135 (229)
T 2yle_A 98 -----------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------ 135 (229)
T ss_dssp --------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------
T ss_pred -----------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------
Confidence 1122355777762 3445667799999999987731111
Q ss_pred hhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc
Q 013064 282 RITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC 316 (450)
Q Consensus 282 ~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~ 316 (450)
-.....+|+.+..||..|..
T Consensus 136 ---------------e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 136 ---------------ENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ---------------TTEEECCCHHHHHHHHHHTT
T ss_pred ---------------cccchhhCHHHHHHHHHHHh
Confidence 01124799999999999975
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.013 Score=59.12 Aligned_cols=75 Identities=12% Similarity=0.152 Sum_probs=50.0
Q ss_pred EEeEEeecCceEEEEEEEcCC-------CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeE
Q 013064 42 QLTLIGKGAFGEVRLCRAKTT-------GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 42 ~~~~LG~G~fg~V~l~~~~~t-------~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~l 113 (450)
-++.|..|-...+|++..... ++.|++|+..... ...-...+|..+++.+. +...+++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 456777788899999987531 5789999875421 11112356888887773 444667776553 2
Q ss_pred EEEEeccCCCC
Q 013064 114 YLIMEYLPGGD 124 (450)
Q Consensus 114 ylVmEy~~gg~ 124 (450)
++||||++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 78999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.052 Score=54.10 Aligned_cols=30 Identities=27% Similarity=0.470 Sum_probs=25.9
Q ss_pred CeEEeecCCCcEEE------ccCCceEEeecccccc
Q 013064 158 NYVHRDIKPDNLIL------DKNGHLKLSDFGLCKP 187 (450)
Q Consensus 158 givHrDLKpeNILl------d~~g~ikL~DFGla~~ 187 (450)
.++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 37899999999999 4567899999999875
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=86.54 E-value=8.5 Score=40.14 Aligned_cols=81 Identities=25% Similarity=0.309 Sum_probs=50.6
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCC-----------------CCHHHHHHHHHHHHH--HHHHhhhCCeEE
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-----------------LSEDVARFYIAESVL--AIHSIHQHNYVH 161 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~-----------------~~e~~~~~~~~qil~--aL~~LH~~givH 161 (450)
+..|.+.......-+ +|++++.++.+.+.+.+. ...+....|+..++. .+.|+= ||
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YIL--Gi-- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYIL--GV-- 476 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHH--TC--
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheee--ec--
Confidence 566677776666554 477776555554432211 112344445544432 344553 43
Q ss_pred eecCCCcEEEccCCceEEeeccccc
Q 013064 162 RDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 162 rDLKpeNILld~~g~ikL~DFGla~ 186 (450)
+|=.++||||+.+|++.-+|||.+-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 3778999999999999999999985
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=85.56 E-value=8.4 Score=40.84 Aligned_cols=81 Identities=26% Similarity=0.334 Sum_probs=48.4
Q ss_pred eeEEEEEEcCCeEEEEEeccCCCChHHHHHhcCC---------------C--CHHHHHHHHHHHH--HHHHHhhhCCeEE
Q 013064 101 VQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI---------------L--SEDVARFYIAESV--LAIHSIHQHNYVH 161 (450)
Q Consensus 101 v~l~~~f~~~~~lylVmEy~~gg~L~~~l~~~~~---------------~--~e~~~~~~~~qil--~aL~~LH~~givH 161 (450)
+..|.+.......-| +|++++-+|.+++.+.+. + ..+....|+..++ +.+.|+=..
T Consensus 476 i~~Y~Vipls~~~GL-IE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YILGl---- 550 (696)
T 2x6h_A 476 LTPYKVLATSSKHGF-LQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLLGV---- 550 (696)
T ss_dssp CCCCCEEESSTTCEE-EECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHHTC----
T ss_pred EeccEEEeccCCCCe-eeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHccC----
Confidence 445555555544443 366666555555543321 1 1233344444443 234454333
Q ss_pred eecCCCcEEEccCCceEEeeccccc
Q 013064 162 RDIKPDNLILDKNGHLKLSDFGLCK 186 (450)
Q Consensus 162 rDLKpeNILld~~g~ikL~DFGla~ 186 (450)
+|-.++||||+.+|++.-+|||.+-
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred CCCCCcceEEeCCCCEEEEeehhhh
Confidence 4889999999999999999999975
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 450 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-88 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-87 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-86 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-84 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-79 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-77 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-75 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-73 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-72 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-71 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-67 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-53 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-48 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-45 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-44 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-14 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (688), Expect = 2e-88
Identities = 97/327 (29%), Positives = 165/327 (50%), Gaps = 44/327 (13%)
Query: 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN 90
Q RK +DF+ ++G+G+F V L R T +A+K L+K ++K +V +V ER+
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
+++ +D V+L+++FQD + LY + Y G+++ + + E RFY AE V A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ +H +HRD+KP+N++L+++ H++++DFG K
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK------------------------ 156
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+++A A S VGT Y++PE+L +K D W+LG I+Y+++
Sbjct: 157 ------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG---TRG 326
G PPF + + + +KI+ + FPE K +ARDL+ LL D RLG G
Sbjct: 205 AGLPPFRAGNEYLIFQKIIKLE--YDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEG 260
Query: 327 VEELKEHPWFRGIQWDKLYEMEAAYKP 353
LK HP+F + W+ L++
Sbjct: 261 YGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (687), Expect = 1e-87
Identities = 122/375 (32%), Positives = 184/375 (49%), Gaps = 51/375 (13%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
K+ ++DF+ L L+GKG FG+V L R K TG +AMK L+K ++ + +V H +E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 94 EVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
+ L Y+FQ D L +MEY GG++ L RE + +E+ ARFY AE V A+
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H + V+RDIK +NL+LDK+GH+K++DFGLCK ++
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT------------------- 161
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
+ GT +Y+APEVL YG DWW LG +MYEM+ G
Sbjct: 162 -------------------MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEEL 330
PF + D I+ + ++FP +S EA+ L+ LL D + RLG +E+
Sbjct: 203 LPFYNQDHERLFELILMEE--IRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 331 KEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKF----PEVDGPPSEIPSVGPWR 384
EH +F I W + ++ +KP V E+DT+ F+ PP S+G
Sbjct: 259 MEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLE 318
Query: 385 KMLTSKDTNFIGYTF 399
+ F + +
Sbjct: 319 LDQREEQEMFEDFDY 333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 265 bits (677), Expect = 2e-86
Identities = 123/356 (34%), Positives = 194/356 (54%), Gaps = 52/356 (14%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ DF+ L +G G+FG V L R++ G +AMK LKK +++ QVEH ER +L+ V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
I++++ +FQD+ +++IM+Y+ GG++ +LL + VA+FY AE LA+ +H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+ ++RD+KP+N++LDKNGH+K++DFG K + D
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------------------------ 158
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
Y+ GT DY+APEV+ K Y DWWS G ++YEML GY PF
Sbjct: 159 -----------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 277 CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR--GVEELKEH 333
+ T KI+N + L+FP P +++ +DL+ L+ D+ RLG G E++K H
Sbjct: 202 YDSNTMKTYEKILNAE--LRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257
Query: 334 PWFRGIQWDKLY--EMEAAYKPTV-NGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 386
PWF+ + W+KL +E Y+P + G+ DT F+K+PE D + P+ +
Sbjct: 258 PWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED-INYGVQGEDPYADL 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (661), Expect = 6e-84
Identities = 118/369 (31%), Positives = 179/369 (48%), Gaps = 55/369 (14%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV- 95
I+DF ++GKG+FG+V L K T + FA+K LKK +L VE E+ +L+
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 96 DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH 155
+ + +F +FQ + L+ +MEYL GGD+M + A FY AE +L + +H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
V+RD+K DN++LDK+GH+K++DFG+CK +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-------------------- 160
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275
+ GT DY+APE+LL + Y DWWS G ++YEMLIG P
Sbjct: 161 ------------------NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
Query: 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334
F D I +P + EA+DL+ L + E RLG RG ++++HP
Sbjct: 203 FHGQDEEELFHSIRMDN--PFYPR--WLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHP 256
Query: 335 WFRGIQWDKLY--EMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGP-WRKMLTSKD 391
FR I W++L E++ ++P V D NF+K +E P + R ++ S D
Sbjct: 257 LFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL-----NEKPRLSFADRALINSMD 311
Query: 392 TN-FIGYTF 399
N F ++F
Sbjct: 312 QNMFRNFSF 320
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 4e-79
Identities = 90/307 (29%), Positives = 139/307 (45%), Gaps = 48/307 (15%)
Query: 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92
R+ ++DFE +GKG FG V L R K + I A+K L K+++ K G +R E +
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 93 AEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
+ + I++L+ F D+ +YLI+EY P G + L + E YI E A+
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
H +HRDIKP+NL+L G LK++DFG
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------------------- 159
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
+ GTLDY+ PE++ + + + D WSLG + YE L+G
Sbjct: 160 -------------------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331
PPF ++ + T ++I ++F +++ ARDLI LL + R + E+
Sbjct: 201 KPPFEANTYQETYKRISR----VEFTFPDFVTEGARDLISRLLKHNPSQRP---MLREVL 253
Query: 332 EHPWFRG 338
EHPW
Sbjct: 254 EHPWITA 260
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 247 bits (630), Expect = 6e-79
Identities = 117/375 (31%), Positives = 197/375 (52%), Gaps = 54/375 (14%)
Query: 6 AAVSNEEQEEMLRNLERRETEYMR----LQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
AA EQE + L + + ++++ + +D F+++ +G G+FG V L + K
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121
+G +AMK L K +++K Q+EH +E+ +L V+ +V+L +SF+D+ LY++MEY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSD 181
GG++ + L R SE ARFY A+ VL +H + ++RD+KP+NL++D+ G+++++D
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 182 FGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLD 241
FG K ++ + ++ GT +
Sbjct: 185 FGFAKRVKGRTWTL-----------------------------------------CGTPE 203
Query: 242 YMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP 301
+APE++L KGY DWW+LG ++YEM GYPPF +D P KI ++FP
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFP--S 259
Query: 302 KISDEARDLICHLLC-DVETRLGTR--GVEELKEHPWFRGIQWDKLY--EMEAAYKPTVN 356
S + +DL+ +LL D+ R G GV ++K H WF W +Y ++EA + P
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319
Query: 357 GELDTQNFEKFPEVD 371
G DT NF+ + E +
Sbjct: 320 GPGDTSNFDDYEEEE 334
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 242 bits (618), Expect = 4e-77
Identities = 90/366 (24%), Positives = 150/366 (40%), Gaps = 53/366 (14%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+D ++ +G GAFG V + TG FA K + E VR E ++ +
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR 81
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIH 155
+V L +F+D + + +I E++ GG++ + E +SED A Y+ + + +H
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 156 QHNYVHRDIKPDNLIL--DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
++NYVH D+KP+N++ ++ LKL DFGL L+ K S
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-------------------- 181
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
T GT ++ APEV K G D WS+G + Y +L G
Sbjct: 182 -------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332
PF ++ T R + + + IS++ +D I LL D TR+ + + E
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALE 279
Query: 333 HPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRK----MLT 388
HPW + + T + ++ +PE P I + RK +
Sbjct: 280 HPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYS 339
Query: 389 SKDTNF 394
+D +
Sbjct: 340 IRDAFW 345
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 238 bits (607), Expect = 2e-75
Identities = 108/384 (28%), Positives = 167/384 (43%), Gaps = 61/384 (15%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERN---L 91
+ ++DF +IG+G FGEV CR TG+++AMK L K + + +ER L
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 92 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 151
++ D IV + Y+F D L I++ + GGD+ L + + SE RFY AE +L +
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+H V+RD+KP N++LD++GH+++SD GL K
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP------------------ 162
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270
+++VGT YMAPEVL K Y DW+SLG +++++L
Sbjct: 163 ----------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGV 327
G+ PF + +I + S E R L+ LL DV RLG RG
Sbjct: 201 RGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 328 EELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELDTQNF--EKFPEVDGPPSEIPSVGPW 383
+E+KE P+FR + W ++ + P F F E D I
Sbjct: 260 QEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEED--TKGIK----- 312
Query: 384 RKMLTSKDTNFIGYTFKKSDVLKS 407
+L S + + S+ +
Sbjct: 313 --LLDSDQELYRNFPLTISERWQQ 334
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 233 bits (594), Expect = 2e-73
Identities = 82/354 (23%), Positives = 150/354 (42%), Gaps = 50/354 (14%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
D ++ L +G GAFG V C K TG +F K + L + V++E +++ ++
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 84
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIH 155
++ L +F+D + LI+E+L GG++ + ED +SE Y+ ++ + +H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 156 QHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H+ VH DIKP+N++ + K +K+ DFGL L
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---------------------- 182
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
+ T T ++ APE++ ++ G D W++G + Y +L G
Sbjct: 183 -----------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332
PF +D T + + +S EA+D I +LL + RL V + E
Sbjct: 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALE 282
Query: 333 HPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKM 386
HPW +G + + ++ + ++ + + +P I + RK
Sbjct: 283 HPWLKGDHSNLTSRIPSSRYNKIRQKIK-EKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 4e-73
Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
++D++ + +G+GA+GEV+L + T E A+K + + E+++ E + ++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 61
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ 156
+V+ + ++ + YL +EY GG++ + + + E A+ + + + + +H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
HRDIKP+NL+LD+ +LK+SDFGL
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN------------------------- 156
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275
NR L GTL Y+APE+L ++ + D WS G ++ ML G P
Sbjct: 157 -----------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
Query: 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHP 334
+ K KI L+ +L + R+ + ++K+
Sbjct: 206 WDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDR 261
Query: 335 WFR 337
W+
Sbjct: 262 WYN 264
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 4e-72
Identities = 117/348 (33%), Positives = 185/348 (53%), Gaps = 49/348 (14%)
Query: 25 TEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCR---AKTTGEIFAMKKLKKSEMLKRGQ 81
T + K+GI++FE L ++G GA+G+V L R TG+++AMK LKK+ ++++ +
Sbjct: 11 TANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK 70
Query: 82 -VEHVRSERNLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
EH R+ER +L + S +V L Y+FQ L+LI++Y+ GG++ T L + + +E
Sbjct: 71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE 130
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
+ Y+ E VLA+ +H+ ++RDIK +N++LD NGH+ L+DFGL K +
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---- 186
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL--KKGYGMEC 257
AY GT++YMAP+++ G+
Sbjct: 187 ---------------------------------AYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 258 DWWSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC- 316
DWWSLG +MYE+L G PF D + + +I + P ++S A+DLI LL
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 317 DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAAYKPTVNGELD 360
D + RLG R +E+KEH +F+ I WD L ++ A +KP + ELD
Sbjct: 274 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 225 bits (575), Expect = 1e-71
Identities = 80/314 (25%), Positives = 133/314 (42%), Gaps = 56/314 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK------RGQVEHVRSERNL 91
+++E ++G+G VR C K T + +A+K + + + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 92 LAEVDS-RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
L +V I+QL +++ + F +L+ + + G++ L + LSE R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
I ++H+ N VHRD+KP+N++LD + ++KL+DFG L+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---------------- 166
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGA 264
GT Y+APE++ GYG E D WS G
Sbjct: 167 -----------------------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 265 IMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLG 323
IMY +L G PPF + R I++ PE SD +DL+ L + R
Sbjct: 204 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY- 262
Query: 324 TRGVEELKEHPWFR 337
EE HP+F+
Sbjct: 263 --TAEEALAHPFFQ 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 1e-71
Identities = 73/322 (22%), Positives = 133/322 (41%), Gaps = 52/322 (16%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D +E + +G GAFG+V + K T + A K + ++E E ++LA D
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQ 156
IV+L +F + L++++E+ GG + +++ E L+E + +++ A++ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
+ +HRD+K N++ +G +KL+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---------------------- 166
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 271
S +GT +MAPEV++ + Y + D WSLG + EM
Sbjct: 167 ----------------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330
PP +P KI + + + S +D + L +V+ R +L
Sbjct: 211 IEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQL 266
Query: 331 KEHPWFRGIQWDKLYEMEAAYK 352
+HP+ + E+ A K
Sbjct: 267 LQHPFVTVDSNKPIRELIAEAK 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (573), Expect = 5e-71
Identities = 88/334 (26%), Positives = 146/334 (43%), Gaps = 51/334 (15%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D ++ ++G GAF EV L K T ++ A+K + K + G+ + +E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV L ++ LYLIM+ + GG++ ++ + +E A I + + A+ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 158 NYVHRDIKPDNLIL---DKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
VHRD+KP+NL+ D++ + +SDFGL K +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---------------------- 164
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+ + GT Y+APEVL +K Y D WS+G I Y +L GYP
Sbjct: 165 -----------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333
PF ++ +I+ + P ISD A+D I HL+ D E R E+ +H
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQH 264
Query: 334 PWFRG-IQWDKLYEMEAAYKPTVNGELDTQNFEK 366
PW G DK + + + +++
Sbjct: 265 PWIAGDTALDK--NIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-70
Identities = 70/348 (20%), Positives = 128/348 (36%), Gaps = 87/348 (25%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
DDFE+++ +G G G V K +G + A K + +K + E +L E +S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ- 156
IV + +F + + ME++ GG + +L + + E + + + + +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 157 HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWM 216
H +HRD+KP N++++ G +KL DFG+ L D +
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----------------------- 160
Query: 217 MPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPF 276
S VGT YM+PE L Y ++ D WS+G + EM +G P
Sbjct: 161 -----------------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
Query: 277 CSDD--------------------------------------PRITCRKIVNWKTCLKFP 298
D P + +++++ P
Sbjct: 204 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263
Query: 299 EEP--KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343
+ P S E +D + L + R +++L H + + ++
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEE 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-69
Identities = 83/319 (26%), Positives = 140/319 (43%), Gaps = 51/319 (15%)
Query: 24 ETEYMRLQRRKIGIDD----FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR 79
+ E + R + + D + + IG+GA G V TG+ A++++ + K+
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 80 GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDV 139
E + +E ++ E + IV S+ D L+++MEYL GG + ++ + E
Sbjct: 62 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQ 117
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
E + A+ +H + +HRDIK DN++L +G +KL+DFG C + + S
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK----- 172
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
+ VGT +MAPEV+ +K YG + D
Sbjct: 173 ---------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 260 WSLGAIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DV 318
WSLG + EM+ G PP+ +++P I T + K+S RD + L DV
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 319 ETRLGTRGVEELKEHPWFR 337
E R +EL +H + +
Sbjct: 259 EKRG---SAKELLQHQFLK 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 4e-68
Identities = 88/311 (28%), Positives = 137/311 (44%), Gaps = 59/311 (18%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+D+E L IG G++G + R K+ G+I K+L M + + + SE NLL E+
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKH 62
Query: 98 RCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAI 151
IV+ + D + LY++MEY GGD+ +++ + L E+ + + LA+
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 152 HSIHQ-----HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQE 206
H+ H +HRD+KP N+ LD ++KL DFGL + L S
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS------------- 169
Query: 207 TVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIM 266
A + VGT YM+PE + + Y + D WSLG ++
Sbjct: 170 -------------------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 204
Query: 267 YEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEP-KISDEARDLICHLLC-DVETRLGT 324
YE+ PPF + + KI KF P + SDE ++I +L R
Sbjct: 205 YELCALMPPFTAFSQKELAGKIREG----KFRRIPYRYSDELNEIITRMLNLKDYHRP-- 258
Query: 325 RGVEELKEHPW 335
VEE+ E+P
Sbjct: 259 -SVEEILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 216 bits (551), Expect = 1e-67
Identities = 72/337 (21%), Positives = 118/337 (35%), Gaps = 51/337 (15%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
F L IG G+FG V R E+ A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+Q + +L+MEY G L + + L E ++ + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
N +HRD+K N++L + G +KL DFG +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------------------------- 167
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEMLIGYP 274
A S VGT +MAPEV+L + Y + D WSLG E+ P
Sbjct: 168 ---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333
P + + I + + S+ R+ + L + R E L +H
Sbjct: 213 PLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKH 267
Query: 334 PWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEV 370
+ + + ELD + K ++
Sbjct: 268 RFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-66
Identities = 71/324 (21%), Positives = 137/324 (42%), Gaps = 52/324 (16%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAE 94
D ++ +G G F V+ CR K+TG +A K +KK + E + E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSI 154
+ ++ L +++ + LI+E + GG++ L ++ L+E+ A ++ + + ++ +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 155 HQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
H H D+KP+N++L +K+ DFGL ++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---------------- 173
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ GT +++APE++ + G+E D WS+G I Y +L
Sbjct: 174 -----------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEE 329
G PF D + T + + S A+D I LL D + R+ +++
Sbjct: 211 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQD 267
Query: 330 LKEHPWFRGIQWDKLYEMEAAYKP 353
+HPW + + + +A+
Sbjct: 268 SLQHPWIKPKDTQQA--LSSAWSH 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 5e-65
Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 50/304 (16%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ + +G+G FG V C ++ + + K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIHQ 156
R I+ L SF+ + L +I E++ G DI + L+E Y+ + A+ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 157 HNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
HN H DI+P+N+I ++ +K+ +FG + L+ +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--------------------- 159
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274
+Y APEV D WSLG ++Y +L G
Sbjct: 160 ------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
Query: 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333
PF ++ + I+N + +IS EA D + LL + ++R+ E +H
Sbjct: 202 PFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQH 258
Query: 334 PWFR 337
PW +
Sbjct: 259 PWLK 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 8e-63
Identities = 56/301 (18%), Positives = 115/301 (38%), Gaps = 56/301 (18%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IG+G+F V T A +L+ ++ K + + + E +L + IV+ +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 106 SFQDS----DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNY-- 159
S++ + + L+ E + G + T L R ++ V R + + + + +H
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135
Query: 160 VHRDIKPDN-LILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
+HRD+K DN I G +K+ D GL ++
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK------------------------ 171
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC- 277
+ +GT ++MAPE+ ++ Y D ++ G M EM P+
Sbjct: 172 ----------------AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336
+ R++ + F + E +++I + + + R +++L H +F
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 269
Query: 337 R 337
+
Sbjct: 270 Q 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 197 bits (501), Expect = 1e-60
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 43/305 (14%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
D +E ++G G EV L R A+K L+ R E A ++
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 98 RCIVQLFYSFQDSD----FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
IV ++ + + Y++MEY+ G + ++ E ++ A IA++ A++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
HQ+ +HRD+KP N+++ +K+ DFG+ + + D
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--------------------- 165
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
N + +GT Y++PE D +SLG ++YE+L G
Sbjct: 166 --------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332
PPF D P + V +S + ++ L + E R T E++
Sbjct: 212 PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMR- 268
Query: 333 HPWFR 337
R
Sbjct: 269 ADLVR 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-59
Identities = 87/359 (24%), Positives = 142/359 (39%), Gaps = 72/359 (20%)
Query: 28 MRLQRRKIGIDDFEQLT-LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVR 86
+++++ I IDD++ + ++G G G+V K T E FA+K L+ + R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-------R 53
Query: 87 SERNLLAEVDSRCIVQLFYSFQDS----DFLYLIMEYLPGGDIMTLLMR--EDILSEDVA 140
IV++ +++ L ++ME L GG++ + + + +E A
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 141 RFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFGLCKPLEDKYSSILL 197
+ AI +H N HRD+KP+NL+ N LKL+DFG K S
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--- 170
Query: 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 257
+ T Y+APEVL + Y C
Sbjct: 171 ------------------------------------TTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 258 DWWSLGAIMYEMLIGYPPFCSDDPRITC----RKIVNWKTCLKFPEEPKISDEARDLICH 313
D WSLG IMY +L GYPPF S+ +I + PE ++S+E + LI +
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254
Query: 314 LLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVD 371
LL + R+ + E HPW + P + ++ E++ +V
Sbjct: 255 LLKTEPTQRM---TITEFMNHPWIMQ-------STKVPQTPLHTSRVLKEDKERWEDVK 303
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-58
Identities = 77/311 (24%), Positives = 124/311 (39%), Gaps = 62/311 (19%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEH---VRSERNLLAE 94
++ L+G G FG V + A+K ++K + G++ + V E LL +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 95 VDSRC--IVQLFYSFQDSDFLYLIMEYL-PGGDIMTLLMREDILSEDVARFYIAESVLAI 151
V S +++L F+ D LI+E P D+ + L E++AR + + + A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 152 HSIHQHNYVHRDIKPDNLILDKN-GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
H +HRDIK +N+++D N G LKL DFG L+D +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---------------- 167
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 269
GT Y PE + Y G WSLG ++Y+M
Sbjct: 168 ------------------------DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328
+ G PF D+ I + + F ++S E + LI L R E
Sbjct: 204 VCGDIPFEHDEEIIRGQ--------VFFR--QRVSSECQHLIRWCLALRPSDRP---TFE 250
Query: 329 ELKEHPWFRGI 339
E++ HPW + +
Sbjct: 251 EIQNHPWMQDV 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-57
Identities = 75/325 (23%), Positives = 122/325 (37%), Gaps = 69/325 (21%)
Query: 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEM--LKRGQVEHVRSERNLLAEVDSR 98
E+L +G+G F V R K T +I A+KK+K K G E LL E+
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 158
I+ L +F + L+ +++ + + +L+ + Y+ ++ + +HQH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 159 YVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMP 218
+HRD+KP+NL+LD+NG LKL+DFGL K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----------------------- 157
Query: 219 KERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFC 277
V T Y APE+L + YG+ D W++G I+ E+L+ P
Sbjct: 158 ---------------THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202
Query: 278 SDDPRITCRKIVN---------WKTCLKFPEE---------------PKISDEARDLICH 313
D +I W P+ D+ DLI
Sbjct: 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG 262
Query: 314 LLC-DVETRLGTRGVEELKEHPWFR 337
L + R+ + + +F
Sbjct: 263 LFLFNPCARI---TATQALKMKYFS 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 5e-57
Identities = 62/317 (19%), Positives = 117/317 (36%), Gaps = 48/317 (15%)
Query: 30 LQRRKIGIDDFEQLTLIGKGAFGEVRLC--RAKTTGEIFAMKKLKKSEMLKRGQVEHVRS 87
L R+ + ++D E +G G FG V+ + K + A+K LK E + + +
Sbjct: 3 LDRKLLTLEDKE----LGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 57
Query: 88 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAES 147
E N++ ++D+ IV++ +++ L+ME G + L + + + + +
Sbjct: 58 EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ + + + N+VHRD+ N++L + K+SDFGL K L
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------------- 161
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
N + + APE + + + D WS G +M+
Sbjct: 162 --------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 201
Query: 268 EML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR 325
E G P+ + + + E DL+ DVE R G
Sbjct: 202 EAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYDLMNLCWTYDVENRPGFA 258
Query: 326 GVEELKEHPWFRGIQWD 342
VE + ++ +
Sbjct: 259 AVELRLRNYYYDVVNEG 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-55
Identities = 67/314 (21%), Positives = 115/314 (36%), Gaps = 50/314 (15%)
Query: 28 MRLQRRKIGIDDFEQLTLIGKGAFGEVRLC--RAKTTGEIFAMKKLKKSEMLKRGQVEHV 85
+ L+R + I D E +G G FG VR R + A+K LK+ ++ E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 86 RSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM-REDILSEDVARFYI 144
E ++ ++D+ IV+L Q L L+ME GG + L+ + + + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 145 AESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIIN 204
+ + + + + N+VHRD+ N++L + K+SDFGL K L
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA-------------- 161
Query: 205 QETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGA 264
+ + L + APE + + + D WS G
Sbjct: 162 ---------------------DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGV 200
Query: 265 IMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 322
M+E L G P+ I K + P+ E L+ E R
Sbjct: 201 TMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMSDCWIYKWEDRP 257
Query: 323 GTRGVEELKEHPWF 336
VE+ ++
Sbjct: 258 DFLTVEQRMRACYY 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-54
Identities = 76/331 (22%), Positives = 127/331 (38%), Gaps = 70/331 (21%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+++F+++ IG+G +G V R K TGE+ A+KK++ + G E +LL E++
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 97 SRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHSIH 155
IV+L + LYL+ E+L + + + + Y+ + + + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 156 QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQW 215
H +HRD+KP NL+++ G +KL+DFGL + +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-------------------- 159
Query: 216 MMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYP 274
V TL Y APE+LL Y D WSLG I EM+
Sbjct: 160 ------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
Query: 275 PFCSDDPRITCRKIVN---------WKTCLKFPEE----------------PKISDEARD 309
F D +I W P+ P + ++ R
Sbjct: 202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRS 261
Query: 310 LICHLLC-DVETRLGTRGVEELKEHPWFRGI 339
L+ +L D R+ + HP+F+ +
Sbjct: 262 LLSQMLHYDPNKRI---SAKAALAHPFFQDV 289
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-53
Identities = 52/294 (17%), Positives = 104/294 (35%), Gaps = 48/294 (16%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
I IG G+FG V + A+K L + + Q++ ++E +L +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRK 60
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHS 153
I+ LF + + L ++ ++ G + L + ++ +
Sbjct: 61 TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+H + +HRD+K +N+ L ++ +K+ DFGL S E
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE--------------- 164
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL---KKGYGMECDWWSLGAIMYEML 270
G++ +MAPEV+ K Y + D ++ G ++YE++
Sbjct: 165 ---------------------QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEE--PKISDEARDLICHLLC-DVETR 321
G P+ + + R +V + + L+ L + R
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-53
Identities = 79/362 (21%), Positives = 125/362 (34%), Gaps = 75/362 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ L+ IG+GA+G V A+KK+ E + + E +L
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 98 RCIVQLFYSFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHS 153
I+ + + ++ +L G D+ LL + LS D +++ + + +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
IH N +HRD+KP NL+L+ LK+ DFGL + +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP----------------------- 161
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLIG 272
+ V T Y APE++L GY D WS+G I+ EML
Sbjct: 162 ------------DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 273 YPPFCSDDPRITCRKIVN------------------WKTCLKFPEE---------PKISD 305
P F I+ L P + P
Sbjct: 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 269
Query: 306 EARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNF 364
+A DL+ +L + R+ VE+ HP+ +D E A + ELD
Sbjct: 270 KALDLLDKMLTFNPHKRI---EVEQALAHPYLEQY-YDPSDEPIAEAPFKFDMELDDLPK 325
Query: 365 EK 366
EK
Sbjct: 326 EK 327
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-53
Identities = 70/339 (20%), Positives = 117/339 (34%), Gaps = 76/339 (22%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ +E+L IG+G FGEV R + TG+ A+KK+ K G E +L +
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 97 SRCIVQLFYSFQDSDF--------LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESV 148
+V L + +YL+ ++ L + + + +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
++ IH++ +HRD+K N+++ ++G LKL+DFGL +
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA----------------- 170
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMY 267
K ++ + V TL Y PE+LL ++ YG D W G IM
Sbjct: 171 -----------------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213
Query: 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKI------------------------ 303
EM P + + I + P +
Sbjct: 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273
Query: 304 ----SDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
A DLI LL D R+ ++ H +F
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-52
Identities = 78/344 (22%), Positives = 123/344 (35%), Gaps = 86/344 (25%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ +IG G+FG V + +GE+ A+KK+ + + K E ++ ++D
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDH 72
Query: 98 RCIVQLFYSFQDSD------FLYLIMEYLPGG---DIMTLLMREDILSEDVARFYIAESV 148
IV+L Y F S +L L+++Y+P + L + Y+ +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
++ IH HRDIKP NL+LD + LKL DFG K L +
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN------------- 179
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIM 266
S + + Y APE++ Y D WS G ++
Sbjct: 180 --------------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 267 YEMLIGYPPFCSDDPRITCRKIVN---------------WKTCLKFPE----------EP 301
E+L+G P F D +I+ T KFP+ P
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 302 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 344
+ EA L LL RL E H +F ++ +
Sbjct: 274 RTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV 314
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-52
Identities = 52/293 (17%), Positives = 97/293 (33%), Gaps = 44/293 (15%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNL 91
IG D L +G G+FG VR A+K LK + + ++ E N
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 92 LAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLA 150
+ +D R +++L+ + ++ E P G ++ L + Y +
Sbjct: 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
+ + ++HRD+ NL+L +K+ DFGL + L ++++
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE----------- 172
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ APE L + + D W G ++EM
Sbjct: 173 ------------------------HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 271 -IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 321
G P+ + KI + P + +++ E R
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 4e-52
Identities = 56/308 (18%), Positives = 112/308 (36%), Gaps = 60/308 (19%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+ + + + L IGKG FG+V G A+K +K + +E +++ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQ 56
Query: 95 VDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAI 151
+ +VQL ++ LY++ EY+ G ++ L +L D + + A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
+ +N+VHRD+ N+++ ++ K+SDFGL K
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------------------ 158
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML- 270
+ + + APE L +K + + D WS G +++E+
Sbjct: 159 -----------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV-- 327
G P+ + ++ K +++ + D R +
Sbjct: 196 FGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
Query: 328 --EELKEH 333
E +K H
Sbjct: 253 QLEHIKTH 260
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 174 bits (442), Expect = 5e-52
Identities = 74/327 (22%), Positives = 121/327 (37%), Gaps = 70/327 (21%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ + L IG+G +G V + GE FA+KK++ E G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
IV+L+ L L+ E+L L + E L A+ ++ + + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
+HRD+KP NL++++ G LK++DFGL +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----------------------- 156
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPPF 276
+ TL Y AP+VL+ Y D WS+G I EM+ G P F
Sbjct: 157 ---------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
Query: 277 CSDDPRITCRKIV---------NWKTCLKFPEE----------------PKISDEARDLI 311
+I NW + P+ + + DL+
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 312 CHLLC-DVETRLGTRGVEELKEHPWFR 337
+L D R+ ++ EH +F+
Sbjct: 262 SKMLKLDPNQRI---TAKQALEHAYFK 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 1e-51
Identities = 64/313 (20%), Positives = 113/313 (36%), Gaps = 48/313 (15%)
Query: 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSER 89
++I I + +IG G FGEV K G+ A+K LK Q SE
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEA 78
Query: 90 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESV 148
+++ + D ++ L S + +I E++ G + + L + D + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ + NYVHRD+ N++++ N K+SDFGL + LED S T
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS-----------DPTY 187
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+ A G + + APE + + + D WS G +M+E
Sbjct: 188 TSALGGK----------------------IPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 269 ML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRG 326
++ G P+ + I + P L+ D R
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 327 V----EELKEHPW 335
+ +++ +P
Sbjct: 283 IVNTLDKMIRNPN 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-51
Identities = 74/340 (21%), Positives = 125/340 (36%), Gaps = 75/340 (22%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCR-AKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL--LA 93
+E + IG+GA+G+V R K G A+K+++ + + +R L L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 94 EVDSRCIVQLFYSFQDSDF-----LYLIMEYLPGGDIMTLLM-REDILSEDVARFYIAES 147
+ +V+LF S L L+ E++ L E + + + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 148 VLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQET 207
+ + +H H VHRD+KP N+++ +G +KL+DFGL + + +
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL------------- 172
Query: 208 VSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267
S V TL Y APEVLL+ Y D WS+G I
Sbjct: 173 --------------------------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206
Query: 268 EMLIGYPPFCSDDPRITCRKIVN---------WKTCLKFPEE--------------PKIS 304
EM P F KI++ W + P + I
Sbjct: 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266
Query: 305 DEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343
+ +DL+ L + R+ HP+F+ ++ K
Sbjct: 267 ELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCK 303
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 7e-50
Identities = 49/283 (17%), Positives = 102/283 (36%), Gaps = 45/283 (15%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+ D +G G +GEV K A+K LK+ M +VE E ++ E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM--REDILSEDVARFYIAESVLAIH 152
+ +VQL Y+I E++ G+++ L +S V + + A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+ + N++HRD+ N ++ +N +K++DFGL + +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---------------------- 167
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272
+ + + APE L + ++ D W+ G +++E+
Sbjct: 168 ---------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
+++ ++ PE ++ +L+
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYELMRACW 253
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 170 bits (430), Expect = 1e-49
Identities = 77/381 (20%), Positives = 134/381 (35%), Gaps = 98/381 (25%)
Query: 2 RAQQAAVSNEEQEEMLRNLERRETEYMRLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAKT 61
RA+ N + + E E+ DD++ + +G+G + EV T
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEW-------GNQDDYQLVRKLGRGKYSEVFEAINIT 58
Query: 62 TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQD--SDFLYLIME 118
E +K LK + + ++ E +L + I+ L +D S L+ E
Sbjct: 59 NNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112
Query: 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD-KNGHL 177
++ D L L++ RFY+ E + A+ H +HRD+KP N+++D ++ L
Sbjct: 113 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 169
Query: 178 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTV 237
+L D+GL + + P + V
Sbjct: 170 RLIDWGLAE----------------------------FYHPGQEYNVR-----------V 190
Query: 238 GTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFC-SDDPRITCRKIVN----- 290
+ + PE+L+ + Y D WSLG ++ M+ PF D +I
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 291 ----------------------------WKTCLKFPEEPKISDEARDLICHLLC-DVETR 321
W+ + + +S EA D + LL D ++R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 322 LGTRGVEELKEHPWFRGIQWD 342
L E EHP+F + D
Sbjct: 311 L---TAREAMEHPYFYTVVKD 328
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 2e-49
Identities = 54/326 (16%), Positives = 101/326 (30%), Gaps = 47/326 (14%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
++G + + IG G+FG++ L GE A+K + + E +
Sbjct: 4 RVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYK 57
Query: 94 EVDSR-CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
+ I + + + D+ ++ME L S + + I
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 153 SIHQHNYVHRDIKPDNLI---LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVS 209
IH N++HRD+KPDN + K + + DFGL K D +
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--------------- 162
Query: 210 EAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269
+ + GT Y + L D SLG ++
Sbjct: 163 ----------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 270 LIGYPPFCSDDPRITCRKIVNWKTC-LKFPEE---PKISDEARDLICHLLC-DVETRLGT 324
+G P+ +K + P E E + + +
Sbjct: 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
Query: 325 RGVEELKEHPWFR-GIQWDKLYEMEA 349
+ +L + + R G +D +++
Sbjct: 267 SYLRQLFRNLFHRQGFSYDYVFDWNM 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-49
Identities = 49/283 (17%), Positives = 101/283 (35%), Gaps = 47/283 (16%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
I D L +G G FG V+ + + A+K +K+ M + + E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMN 55
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLM-REDILSEDVARFYIAESVLAIHS 153
+ +VQL+ +++I EY+ G ++ L + A+
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+ ++HRD+ N +++ G +K+SDFGL + + D
Sbjct: 116 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----------------------- 152
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IG 272
+ + + + + PEVL+ + + D W+ G +M+E+ +G
Sbjct: 153 --------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
P+ T I L+ S++ ++
Sbjct: 199 KMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVYTIMYSCW 238
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-49
Identities = 48/282 (17%), Positives = 98/282 (34%), Gaps = 45/282 (15%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
I + + IG G FG V L + A+K +++ M + E E ++ +
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMK 56
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL-AIHS 153
+ +VQL+ + + L+ E++ G + L + L + V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+ + +HRD+ N ++ +N +K+SDFG+ + + D +
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS------------------ 158
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
+ T + + +PEV Y + D WS G +M+E+
Sbjct: 159 -------------------STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
+ + ++ L P S ++ H
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYKPRL--ASTHVYQIMNHCW 239
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-49
Identities = 62/310 (20%), Positives = 116/310 (37%), Gaps = 51/310 (16%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
I + +G+G FGEV + T + A+K LK M E E ++ +
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKK 68
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIH 152
+ +VQL Y+ + +Y++ EY+ G ++ L E L A+ +
Sbjct: 69 LRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
+ + NYVHRD++ N+++ +N K++DFGL + +ED +
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR---------------- 171
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI- 271
+ + APE L + ++ D WS G ++ E+
Sbjct: 172 ---------------------QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330
G P+ R ++ + P P+ + DL+C + E R ++
Sbjct: 211 GRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 267
Query: 331 KEHPWFRGIQ 340
+F +
Sbjct: 268 L-EDYFTSTE 276
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-48
Identities = 63/350 (18%), Positives = 127/350 (36%), Gaps = 79/350 (22%)
Query: 11 EEQEEMLRNLERRETEYMRLQRRK--------IGIDDFEQLTLIGKGAFGEVRLCRAKTT 62
E Q +M++ + EY + R+ ++ E ++G GAFG+V A
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 63 GEI-----FAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLI 116
+ A+K LK+ + E + SE ++ ++ S IV L + S +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 117 MEYLPGGDIMTLLMRE-----------------------DILSEDVARFYIAESVLAIHS 153
EY GD++ L + ++L+ + + + +
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+ + VHRD+ N+++ +K+ DFGL + + + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV------------------ 221
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IG 272
+ + + +MAPE L + Y ++ D WS G +++E+ +G
Sbjct: 222 ------------------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 321
P+ K++ K + ++E ++ D R
Sbjct: 264 VNPYPGIPVDANFYKLIQNG--FKMDQPFYATEEIYIIMQSCWAFDSRKR 311
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-48
Identities = 78/343 (22%), Positives = 123/343 (35%), Gaps = 86/343 (25%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ L +G GA+G V TG A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 98 RCIVQLFYSFQDSDFL------YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAI 151
++ L F + L YL+M ++ G + LM+ + L ED +F + + + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 152 HSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEA 211
IH +HRD+KP NL ++++ LK+ DFGL + + + +
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY---------------- 178
Query: 212 EGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270
V T Y APEV+L Y D WS+G IM EM+
Sbjct: 179 -------------------------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213
Query: 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEE-----------------------------P 301
G F D ++I+ K P E
Sbjct: 214 TGKTLFKGSDHLDQLKEIM--KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271
Query: 302 KISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDK 343
S A +L+ +L D E R+ E HP+F + +
Sbjct: 272 NASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYFESLHDTE 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 75/328 (22%), Positives = 124/328 (37%), Gaps = 70/328 (21%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+E+L IG+G +G V + + T EI A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 98 RCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQH 157
+ IV+L L L+ E+ L ++ + ++ + + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 158 NYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMM 217
N +HRD+KP NL++++NG LKL++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC----------------------- 157
Query: 218 PKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIG-YPP 275
+ V TL Y P+VL Y D WS G I E+ P
Sbjct: 158 ---------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
Query: 276 FCSDDPRITCRKIVN---------WKTCLKFPEE----------------PKISDEARDL 310
F +D ++I W + K P+ PK++ RDL
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 311 ICHLLC-DVETRLGTRGVEELKEHPWFR 337
+ +LL + R+ EE +HP+F
Sbjct: 263 LQNLLKCNPVQRI---SAEEALQHPYFS 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-46
Identities = 55/304 (18%), Positives = 113/304 (37%), Gaps = 50/304 (16%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+ + + + +G G FGEV + ++ A+K LK+ M + +E NL+ +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIH 152
+ + +V+L Y+ + +Y+I EY+ G ++ L L+ + A+ +
Sbjct: 65 LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
I + NY+HRD++ N+++ K++DFGL + +ED
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---------------------- 161
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML-I 271
N + + APE + + ++ D WS G ++ E++
Sbjct: 162 ---------------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEEL 330
G P+ + + + +E L+ E R + +
Sbjct: 207 GRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 331 KEHP 334
E
Sbjct: 264 LEDF 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-46
Identities = 56/300 (18%), Positives = 104/300 (34%), Gaps = 60/300 (20%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA 93
+ +D + +IG+G FG+V R K G + E + E +L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 94 EV-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI----------------LS 136
++ I+ L + + +LYL +EY P G+++ L + + LS
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 137 EDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196
+ A+ + + Q ++HRD+ N+++ +N K++DFGL + E
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183
Query: 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGME 256
+ +MA E L Y
Sbjct: 184 -------------------------------------TMGRLPVRWMAIESLNYSVYTTN 206
Query: 257 CDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLL 315
D WS G +++E++ +G P+C K+ + + DE DL+
Sbjct: 207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCW 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-45
Identities = 63/302 (20%), Positives = 102/302 (33%), Gaps = 52/302 (17%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTT---GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE 94
+ E IG+G FG+V + A+K K E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 95 VDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDI-LSEDVARFYIAESVLAIHS 153
D IV+L + + +++IME G++ + L L Y + A+
Sbjct: 65 FDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 154 IHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
+ +VHRDI N+++ N +KL DFGL + +ED
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----------------------- 160
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272
+ A + +MAPE + + + D W G M+E+L+ G
Sbjct: 161 --------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331
PF +I N + + P P L+ D R ELK
Sbjct: 207 VKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELK 260
Query: 332 EH 333
Sbjct: 261 AQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-45
Identities = 53/351 (15%), Positives = 117/351 (33%), Gaps = 46/351 (13%)
Query: 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKK--SEMLKRGQVEHVRSERN 90
R + +F+++ ++G GAFG V GE + K E + + E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 91 LLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
++A VD+ + +L S + G + + +D + + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
++ + VHRD+ N+++ H+K++DFGL K L
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-------------------- 163
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ A + +MA E +L + Y + D WS G ++E++
Sbjct: 164 ----------------EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207
Query: 271 -IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328
G P+ + + + P+ P + + ++ D ++R
Sbjct: 208 TFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDVYMIMVKCWMIDADSRP---KFR 261
Query: 329 ELKEHPWFRGIQWDKLYEMEAAYKPTVNGELDTQNFEKFPEVDGPPSEIPS 379
EL + ++ + + D+ + + + + +
Sbjct: 262 ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDA 312
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 8e-45
Identities = 58/317 (18%), Positives = 104/317 (32%), Gaps = 71/317 (22%)
Query: 29 RLQRRKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVE 83
+L + ++ E + IG+GAFG V RA + A+K LK+
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQA 61
Query: 84 HVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED---------- 133
+ E L+AE D+ IV+L + L+ EY+ GD+ L
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 134 --------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKL 179
LS + + + + +VHRD+ N ++ +N +K+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181
Query: 180 SDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGT 239
+DFGL + + + +
Sbjct: 182 ADFGLSRNIYSA------------------------------------DYYKADGNDAIP 205
Query: 240 LDYMAPEVLLKKGYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFP 298
+ +M PE + Y E D W+ G +++E+ G P+ + + L P
Sbjct: 206 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-LACP 264
Query: 299 EEPKISDEARDLICHLL 315
E E +L+
Sbjct: 265 EN--CPLELYNLMRLCW 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-45
Identities = 76/375 (20%), Positives = 128/375 (34%), Gaps = 93/375 (24%)
Query: 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD 96
+ ++ L IG GA G V A+KKL + + + E L+ V+
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 97 SRCIVQLFYSF------QDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLA 150
+ I+ L F ++ +YL+ME + + M D + + + + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCG 131
Query: 151 IHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSE 210
I +H +HRD+KP N+++ + LK+ DFGL + +
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF------------------ 173
Query: 211 AEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270
+ V T Y APEV+L GY D WS+G IM EM+
Sbjct: 174 ---------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 271 IGYPPFCSDDPRITCRKIVN-------------WKTCLKFPEE----------------- 300
F D K++ T + E
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 301 --------PKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAY 351
+ +ARDL+ +L D R+ V++ +HP+ W E+EA
Sbjct: 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN--VWYDPAEVEAPP 327
Query: 352 KPTVNGELDTQNFEK 366
+ +LD +
Sbjct: 328 PQIYDKQLDEREHTI 342
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-44
Identities = 58/311 (18%), Positives = 101/311 (32%), Gaps = 49/311 (15%)
Query: 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSER 89
+I + +IG G FGEV KT+ A+K LK Q E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 90 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED-ILSEDVARFYIAESV 148
++ + I++L + +I EY+ G + L +D S +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 149 LAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETV 208
+ + NYVHRD+ N++++ N K+SDFGL + LED +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--------- 171
Query: 209 SEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268
+ + APE + + + D WS G +M+E
Sbjct: 172 --------------------------GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205
Query: 269 MLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327
++ + K +N + P L+ + R +
Sbjct: 206 VMTYGERPYWELSNHEVMKAINDG--FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263
Query: 328 ----EELKEHP 334
++L P
Sbjct: 264 VSILDKLIRAP 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 2e-44
Identities = 50/319 (15%), Positives = 101/319 (31%), Gaps = 48/319 (15%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSR- 98
++ IG+G+FG + + A+K + R +R E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 99 CIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN 158
I ++Y Q+ L+++ L L + S + + + SIH+ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 159 YVHRDIKPDNLILDK-----NGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEG 213
V+RDIKPDN ++ + + + DFG+ K D +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 214 QWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273
K+ + ++ + GT YM+ L + D +LG + L G
Sbjct: 162 -----KQHIPYREKK------NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
Query: 274 PPFCSDDPRITCRKIVNWKTCLKFPE----EPKISDEARDLICHLLC-DVETRLGTRGVE 328
P+ +K + +E + + + ++
Sbjct: 211 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270
Query: 329 ELKEHPWFR-GIQWDKLYE 346
L R D+ ++
Sbjct: 271 GLFSKVLERLNTTEDENFD 289
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 70/334 (20%), Positives = 124/334 (37%), Gaps = 80/334 (23%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS 97
+ ++ L+ +G GA+G V TG A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 98 RCIVQLFYSFQDSDFL-----YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIH 152
++ L F + L ++ +L G D+ + ++ L++D +F I + + +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 153 SIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAE 212
IH + +HRD+KP NL ++++ LK+ DFGL + +D+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 213 GQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLI 271
V T Y APE++L Y D WS+G IM E+L
Sbjct: 176 ---------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 272 GYPPFCSDDPRITCRKIVN---------------------WKTCLKFPEE------PKIS 304
G F D + I+ ++ + P+ +
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274
Query: 305 DEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337
A DL+ +L D + R+ + H +F
Sbjct: 275 PLAVDLLEKMLVLDSDKRI---TAAQALAHAYFA 305
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 49/325 (15%), Positives = 109/325 (33%), Gaps = 61/325 (18%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSER 89
+ + +G+G+FG V AK A+K + ++ ++ + +E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEA 74
Query: 90 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMRED----------ILSEDV 139
+++ E + +V+L +IME + GD+ + L S
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 140 ARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLED 199
E + ++ + +VHRD+ N ++ ++ +K+ DFG+ + + +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-------- 186
Query: 200 EDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDW 259
+ + + +M+PE L + D
Sbjct: 187 ----------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 218
Query: 260 WSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-D 317
WS G +++E+ P+ R ++ + D +L+ +
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYN 275
Query: 318 VETRLGTRGV-EELKE--HPWFRGI 339
+ R + +KE P FR +
Sbjct: 276 PKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-42
Identities = 47/284 (16%), Positives = 99/284 (34%), Gaps = 46/284 (16%)
Query: 45 LIGKGAFGEV---RLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIV 101
+IG+G FG V L A+K L + G+V +E ++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 102 QLF-YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIA-ESVLAIHSIHQHNY 159
L + +++ Y+ GD+ + E + + + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 160 VHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPK 219
VHRD+ N +LD+ +K++DFGL + + DK
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDK---------------------------- 183
Query: 220 ERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCS 278
+ + + +MA E L + + + D WS G +++E++ G PP+
Sbjct: 184 ------EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237
Query: 279 DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 321
+ ++ + + + D +++ E R
Sbjct: 238 VNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 60/313 (19%), Positives = 104/313 (33%), Gaps = 66/313 (21%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSER 89
+ +G GAFG+V A A+K LK S L + E + SE
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSEL 77
Query: 90 NLLAEV-DSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR----------------- 131
+L+ + + IV L + +I EY GD++ L R
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 132 -EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190
E L + + + + + N +HRD+ N++L K+ DFGL + +++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250
+ + + + +MAPE +
Sbjct: 198 D------------------------------------SNYVVKGNARLPVKWMAPESIFN 221
Query: 251 KGYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARD 309
Y E D WS G ++E+ +G P+ K++ + PE E D
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH--APAEMYD 279
Query: 310 LICHLLC-DVETR 321
++ D R
Sbjct: 280 IMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 49/305 (16%), Positives = 104/305 (34%), Gaps = 64/305 (20%)
Query: 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-------IFAMKKLKKSEMLKRGQVEHVRS 87
+ D +G+GAFG+V L A + A+K LK + ++ + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISE 68
Query: 88 ERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMR---------------- 131
+ + I+ L + LY+I+EY G++ L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 132 EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191
E+ LS + + + +HRD+ N+++ ++ +K++DFGL + +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK 251
+ + + +MAPE L +
Sbjct: 189 ------------------------------------DYYKKTTNGRLPVKWMAPEALFDR 212
Query: 252 GYGMECDWWSLGAIMYEML-IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDL 310
Y + D WS G +++E+ +G P+ + + K + + ++E +
Sbjct: 213 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL---KEGHRMDKPSNCTNELYMM 269
Query: 311 ICHLL 315
+
Sbjct: 270 MRDCW 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-38
Identities = 57/320 (17%), Positives = 110/320 (34%), Gaps = 66/320 (20%)
Query: 38 DDFEQLTLIGKGAFGEVRLCRA-----KTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLL 92
D + +G+GAFG+V A T A+K LK+ + + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILI 71
Query: 93 AEVDSRCIVQLF-YSFQDSDFLYLIMEYLPGGDIMTLL----------------MREDIL 135
+V L + L +I+E+ G++ T L + +D L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 136 SEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195
+ + Y + + + +HRD+ N++L + +K+ DFGL +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--------D 183
Query: 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGM 255
+ +D D + + L +MAPE + + Y +
Sbjct: 184 IYKDPDYVRKGDA----------------------------RLPLKWMAPETIFDRVYTI 215
Query: 256 ECDWWSLGAIMYEMLIGY-PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHL 314
+ D WS G +++E+ P+ + + T ++ P+ + E +
Sbjct: 216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDC 273
Query: 315 LC-DVETRLGTRGVEELKEH 333
+ R EL EH
Sbjct: 274 WHGEPSQRP---TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 4e-36
Identities = 51/263 (19%), Positives = 84/263 (31%), Gaps = 57/263 (21%)
Query: 46 IGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFY 105
IGKG FGEV R K GE A+K E + +E + I+
Sbjct: 11 IGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIA 64
Query: 106 SFQDSDF----LYLIMEYLPGGDIMTLLMREDILSEDVARFY--IAESVLAIHS-----I 154
+ + L+L+ +Y G + L R + E + + A + +H
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 155 HQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQ 214
+ HRD+K N+++ KNG ++D GL + +I
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------------------- 165
Query: 215 WMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL------KKGYGMECDWWSLGAIMYE 268
VGT YMAPEVL D +++G + +E
Sbjct: 166 ---------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210
Query: 269 MLIGYPPFCSDDPRITCRKIVNW 291
+ + +
Sbjct: 211 IARRCSIGGIHEDYQLPYYDLVP 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (301), Expect = 5e-31
Identities = 54/362 (14%), Positives = 119/362 (32%), Gaps = 108/362 (29%)
Query: 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL-------L 92
+ + +G G F V L + AMK ++ ++ + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 93 AEVDSRCIVQLFYSFQD--SDFLYLIMEYLPGGDIMTLLMRED---ILSEDVARFYIAES 147
+ + I++L F + ++++M + G+ + L+++ + + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 148 VLAIHSIH-QHNYVHRDIKPDNLILDKNG------HLKLSDFGLCKPLEDKYSSILLEDE 200
+L + +H + +H DIKP+N++++ +K++D G ++ Y
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-------- 186
Query: 201 DIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWW 260
+++ T +Y +PEVLL +G D W
Sbjct: 187 ---------------------------------TNSIQTREYRSPEVLLGAPWGCGADIW 213
Query: 261 SLGAIMYEMLIGYPPFCSDD---------------------------------------- 280
S +++E++ G F D+
Sbjct: 214 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 273
Query: 281 --PRITCRKIVNWKTCL--KFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPW 335
I+ K + L K+ + E D + +L D R L HPW
Sbjct: 274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPW 330
Query: 336 FR 337
+
Sbjct: 331 LK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.9 bits (165), Expect = 6e-14
Identities = 21/169 (12%), Positives = 55/169 (32%), Gaps = 28/169 (16%)
Query: 45 LIGKGAFGEVRLCRAKTTGEIFAMKKLKKS---------------EMLKRGQVEHVRSER 89
L+G+G V C +K K + R+E
Sbjct: 7 LMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 90 NLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVL 149
L ++ + +++ + ++ME + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDEVLDMILE 114
Query: 150 AIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198
+ + VH D+ N+++ + G + + DF + ++ +LE
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE 162
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.98 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-74 Score=567.98 Aligned_cols=291 Identities=41% Similarity=0.723 Sum_probs=269.4
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
+++++||++++.||+|+||+||+|+++.+|+.||||++++..+......+++.+|+.+|+.++|||||+++++|++++++
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 57899999999999999999999999999999999999998777777889999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+|||||+||+|..++.+.+.++|+.+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
....+.||||.|+|||++.+.+|+.++|||||||++|||++|+
T Consensus 160 -------------------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~ 202 (337)
T d1o6la_ 160 -------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp -------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCC
Confidence 1134679999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc--cc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE--ME 348 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~ 348 (450)
+||.+.+..+++.++... .+.+|. .+|++++|||++||+ ||.+|++. .++++|++||||++++|+.+.. +.
T Consensus 203 ~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~ 278 (337)
T d1o6la_ 203 LPFYNQDHERLFELILME--EIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278 (337)
T ss_dssp CSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCcCHHHHHHHHhcC--CCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCC
Confidence 999999999999888873 456664 799999999999999 99999974 2589999999999999999864 78
Q ss_pred CCccccCCCcccCCCCCC
Q 013064 349 AAYKPTVNGELDTQNFEK 366 (450)
Q Consensus 349 ~p~~p~~~~~~d~~~f~~ 366 (450)
|||+|.+.++.|+++|+.
T Consensus 279 ~p~~P~~~~~~~~~~f~~ 296 (337)
T d1o6la_ 279 PPFKPQVTSEVDTRYFDD 296 (337)
T ss_dssp CSCCCCCSSTTCCTTSCH
T ss_pred CCCCCCCCChhhhhhcCc
Confidence 999999999999999985
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-70 Score=541.87 Aligned_cols=296 Identities=38% Similarity=0.781 Sum_probs=270.9
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
.+....+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 34 ~~~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp CCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 33457789999999999999999999999999999999999987766667788899999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
..+|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
. ..+.+||+.|||||++.+.+|+.++|||||||++|||+
T Consensus 194 ~-----------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 194 R-----------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp C-----------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH
Confidence 2 22578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccccc-
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLYE- 346 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~- 346 (450)
+|.+||.+.+....+.+|... ...+| ..+|+++++||++||. ||.+|++. .++++|++||||++++|+.+.+
T Consensus 233 tG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~ 308 (350)
T d1rdqe_ 233 AGYPPFFADQPIQIYEKIVSG--KVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC--CCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred hCCCCCCCcCHHHHHHHHhcC--CCCCC--ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhc
Confidence 999999999998889888874 34445 4799999999999998 99999853 3799999999999999999874
Q ss_pred -ccCCccccCCCcccCCCCCCCCCCC
Q 013064 347 -MEAAYKPTVNGELDTQNFEKFPEVD 371 (450)
Q Consensus 347 -~~~p~~p~~~~~~d~~~f~~~~~~~ 371 (450)
+.|||+|.+.++.|++||+.+++..
T Consensus 309 ~~~~p~~p~~~~~~d~s~~~~~~~~~ 334 (350)
T d1rdqe_ 309 KVEAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp CSCCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred CCCcCccCCCCCcchhhhcCCCCccc
Confidence 7899999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-70 Score=536.03 Aligned_cols=291 Identities=42% Similarity=0.858 Sum_probs=255.1
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
+++||++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|++++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 67899999999999999999999999999999999998876666778899999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||||+||+|..++.....++++.++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
..+.+||+.|||||++.+.+|+.++|||||||++|||++|..|
T Consensus 158 -------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 158 -------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp -------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred -------------------------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCC
Confidence 2357999999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCccccc--cccCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKLY--EMEAA 350 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~~p 350 (450)
|.+.+..+.+.+|.+. ...+| +.+|+++++||.+||. ||.+|++. .++++|++||||++++|+.+. .+++|
T Consensus 201 f~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p 276 (316)
T d1fota_ 201 FYDSNTMKTYEKILNA--ELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP 276 (316)
T ss_dssp TCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred CCCcCHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcC
Confidence 9999999999998874 34555 4799999999999998 99999864 379999999999999999986 47899
Q ss_pred ccccCC-CcccCCCCCCCCCCC
Q 013064 351 YKPTVN-GELDTQNFEKFPEVD 371 (450)
Q Consensus 351 ~~p~~~-~~~d~~~f~~~~~~~ 371 (450)
|+|.+. ...|+++|+.+++..
T Consensus 277 ~~p~~~~~~~d~~~f~~~~~~~ 298 (316)
T d1fota_ 277 YEPPIQQGQGDTSQFDKYPEED 298 (316)
T ss_dssp CCCCC----------------C
T ss_pred CCCCcCCCcchhhhcCCCcccc
Confidence 998864 456899999877643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-69 Score=534.47 Aligned_cols=315 Identities=36% Similarity=0.652 Sum_probs=250.4
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHH-hcCCCCeeeEEEEEEcCCeEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLA-EVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
++||+++++||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++|||||+++++|++++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 589999999999999999999999999999999999877666677788888888875 6899999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||||+||+|..++...+.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-- 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.....+||+.|+|||++.+.+|+.++|||||||++|||++|++|
T Consensus 159 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 159 ------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp ------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------------------------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC
Confidence 12246899999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccc--cccCCcc
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY--EMEAAYK 352 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~ 352 (450)
|.+.+..+++.+|... ...+| ..+|+++++||++||+ ||.+|+++ ..++++||||++++|+.+. ++.||++
T Consensus 203 F~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~dli~~~L~~dP~~R~s~--~~~l~~hpff~~~~~~~l~~~~~~pp~~ 276 (320)
T d1xjda_ 203 FHGQDEEELFHSIRMD--NPFYP--RWLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWEELERKEIDPPFR 276 (320)
T ss_dssp SCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHSCSSGGGSBTT--BSCGGGSGGGTTCCHHHHHTTCSCC---
T ss_pred CCCCCHHHHHHHHHcC--CCCCC--ccCCHHHHHHHHHhcccCCCCCcCH--HHHHHhCchhccCCHHHHHhcCCCCCCC
Confidence 9999999999888764 34555 3789999999999999 99999953 1489999999999999886 4789999
Q ss_pred ccCCCcccCCCCCCCCCCCCCCCCCCCCCcccccCCC-cCCCcCCcee
Q 013064 353 PTVNGELDTQNFEKFPEVDGPPSEIPSVGPWRKMLTS-KDTNFIGYTF 399 (450)
Q Consensus 353 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~~~~~ 399 (450)
|.++++.|++||+.......+.. .. ..+.+..+ ++..|.||+|
T Consensus 277 p~~~~~~d~~~f~~~~~~~~~~~-~~---~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 277 PKVKSPFDCSNFDKEFLNEKPRL-SF---ADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp ---------------------------------------CCTTTTCCC
T ss_pred CCCCCccchhhcChHhhhCCccC-CC---CcccccCchhhcccCcCcC
Confidence 99999999999986332211111 10 11122233 4567999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-70 Score=527.02 Aligned_cols=281 Identities=35% Similarity=0.655 Sum_probs=251.0
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
.+...+||++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||+++++|++++.
T Consensus 3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 35567899999999999999999999999999999999998877667778899999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+....
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
.. ....+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 163 ~~------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g 206 (288)
T d1uu3a_ 163 KQ------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206 (288)
T ss_dssp -------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cc------------------------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhC
Confidence 10 112357899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCC---CHHHHHcCCCcCCCCcccccccc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTR---GVEELKEHPWFRGIQWDKLYEME 348 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~---~~~eil~Hpff~~i~w~~l~~~~ 348 (450)
.+||.+.+..+++.+|.+. .+.+|. .+|+++++||++||+ ||.+|+++. +...|++||||++++|++|.+..
T Consensus 207 ~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~ 282 (288)
T d1uu3a_ 207 LPPFRAGNEYLIFQKIIKL--EYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282 (288)
T ss_dssp SCSSCCSSHHHHHHHHHTT--CCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSC
T ss_pred CCCCCCcCHHHHHHHHHcC--CCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCC
Confidence 9999999999999999874 355664 799999999999998 999999652 23458999999999999999888
Q ss_pred CCccc
Q 013064 349 AAYKP 353 (450)
Q Consensus 349 ~p~~p 353 (450)
||..|
T Consensus 283 pP~l~ 287 (288)
T d1uu3a_ 283 PPKLT 287 (288)
T ss_dssp CCCCC
T ss_pred CCCCC
Confidence 77554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-66 Score=519.73 Aligned_cols=287 Identities=34% Similarity=0.636 Sum_probs=240.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHH---HHHHHhcCCCCeeeEEEEEEcCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSE---RNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E---~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+++++|+++++||+|+||.||+|+++.||+.||||++.+..+........+.+| ..+++.++|||||+++++|++++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 578999999999999999999999999999999999988766554444555555 45566668999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
.+|+|||||+||+|.++|.+...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999866432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-cCCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-~~~y~~~~DiWSlGvilyeml 270 (450)
...+.+||+.|+|||++. +..|+.++|||||||+||||+
T Consensus 161 ----------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (364)
T d1omwa3 161 ----------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200 (364)
T ss_dssp ----------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHH
Confidence 123568999999999997 467999999999999999999
Q ss_pred hCCCCCCCCChhhhhh---hhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCCcccc
Q 013064 271 IGYPPFCSDDPRITCR---KIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~---~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l 344 (450)
+|.+||.+.+...... .+.. ....+| ..+|+++++||.+||. ||.+|++. .+++||++||||++++|..+
T Consensus 201 tG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 201 RGHSPFRQHKTKDKHEIDRMTLT--MAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp HSSCSSCSSCSSCHHHHHHHSSS--CCCCCC--SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHhccc--CCCCCC--CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence 9999998766543322 2222 223333 4799999999999998 99999974 34899999999999999988
Q ss_pred c--cccCCccccCCCcccCCCCC
Q 013064 345 Y--EMEAAYKPTVNGELDTQNFE 365 (450)
Q Consensus 345 ~--~~~~p~~p~~~~~~d~~~f~ 365 (450)
. +..||++|..........|+
T Consensus 277 ~~~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 277 FLQKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp HTTCSCCSCCCCCC---------
T ss_pred hcCCCCcCcCCCCCCCCcCCccc
Confidence 6 46799999766554444443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-66 Score=498.48 Aligned_cols=258 Identities=35% Similarity=0.594 Sum_probs=238.1
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
+.++++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 45789999999999999999999999999999999999987766666778899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
..+.+||+.|||||++.+.+|+.++|||||||++|||++|.
T Consensus 161 ---------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~ 201 (263)
T d2j4za1 161 ---------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 201 (263)
T ss_dssp ---------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCC
Confidence 22468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+||.+.+..+++.+|.+. .+.+|. .+|+++++||.+||. ||.+|+ +++|+++||||.+
T Consensus 202 ~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dp~~R~---t~~eil~hp~~~~ 260 (263)
T d2j4za1 202 PPFEANTYQETYKRISRV--EFTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260 (263)
T ss_dssp CTTCCSSHHHHHHHHHTT--CCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHTCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcC--CCCCCc--cCCHHHHHHHHHHccCCHhHCc---CHHHHHcCcCcCC
Confidence 999999998888888763 345554 799999999999999 999999 7999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-65 Score=490.46 Aligned_cols=260 Identities=25% Similarity=0.457 Sum_probs=221.8
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++++... ....+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5899999999999999999999999999999999987542 22345688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G~~P 275 (450)
.....+.+||+.|||||++.+.+| +.++|||||||++|||++|.+|
T Consensus 159 ---------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p 205 (271)
T d1nvra_ 159 ---------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205 (271)
T ss_dssp ---------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ---------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence 112345799999999999998876 6789999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|.+.+.......+..... ...+....+|+++++||.+||+ ||.+|+ +++|+++||||+.
T Consensus 206 f~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~ 265 (271)
T d1nvra_ 206 WDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265 (271)
T ss_dssp CSSSSTTSHHHHHHHTTC-TTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTC
T ss_pred CCCCChHHHHHHHHhcCC-CCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCc
Confidence 987655443333322211 2222335789999999999998 999999 6999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-64 Score=493.10 Aligned_cols=257 Identities=33% Similarity=0.573 Sum_probs=218.1
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||+++++|++++.+|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999876542 23456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc---cCCceEEeeccccccCcccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKYSS 194 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld---~~g~ikL~DFGla~~~~~~~~~ 194 (450)
|||+||+|.++|.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||+. .+|++||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--- 163 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--- 163 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC---
Confidence 9999999999999999999999999999999999999999999999999999994 5789999999999865432
Q ss_pred ccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCC
Q 013064 195 ILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~ 274 (450)
....+.+||+.|||||++.+.+|+.++|||||||++|||++|.+
T Consensus 164 ------------------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 207 (307)
T d1a06a_ 164 ------------------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207 (307)
T ss_dssp ---------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCC
Confidence 11235789999999999999999999999999999999999999
Q ss_pred CCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 275 PFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
||.+.+..++..+|.+....+..|....+|+++++||.+||. ||.+|+ +++|+++||||++
T Consensus 208 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 269 (307)
T d1a06a_ 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAG 269 (307)
T ss_dssp SCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTTS
T ss_pred CCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCC
Confidence 999999999999998876666666667899999999999999 999999 7999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-64 Score=487.33 Aligned_cols=267 Identities=26% Similarity=0.469 Sum_probs=232.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR---GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+.|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|+.++|||||+++++|++++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999987654322 24678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC----ceEEeeccccccCcc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG----HLKLSDFGLCKPLED 190 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g----~ikL~DFGla~~~~~ 190 (450)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+| ++||+|||+|+....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999999989999999999999999999999999999999999999998777 599999999987643
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 170 ~~---------------------------------------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell 210 (293)
T d1jksa_ 170 GN---------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 210 (293)
T ss_dssp SC---------------------------------------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred Cc---------------------------------------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH
Confidence 21 123568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccccc
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYE 346 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 346 (450)
+|..||.+.+..+++.+|......+..+....+|+++++||++||. ||.+|+ +++|+++||||++.+|.....
T Consensus 211 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~~~~~~l~ 284 (293)
T d1jksa_ 211 SGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQALS 284 (293)
T ss_dssp HSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTCC--------
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCChhHhhc
Confidence 9999999999999998888754333222235789999999999999 999999 799999999999999987653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-63 Score=485.09 Aligned_cols=255 Identities=31% Similarity=0.508 Sum_probs=226.6
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
++|++++.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 479999999999999999999999999999999987643 23567899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 118 EYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 118 Ey~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
|||+||+|..++.+ +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----
Confidence 99999999988765 5699999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
...+.+||+.|+|||++.+.+|+.++|||||||++|+|++|.+||.
T Consensus 172 ----------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 172 ----------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp ----------------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ----------------------------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence 1235689999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 278 SDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
+.+.......+.... ...++.+..+|+++++||.+||. ||.+|+ +++|+++||||+.
T Consensus 218 ~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 218 NENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (293)
T ss_dssp TSCHHHHHHHHHHHC-SCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHTTCGGGGG
T ss_pred CCCHHHHHHHHHhCC-CCCCCCcccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCC
Confidence 988877777666432 22333335799999999999998 999999 7999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-63 Score=494.74 Aligned_cols=264 Identities=30% Similarity=0.514 Sum_probs=235.0
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
.+++|++++.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|++++.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3579999999999999999999999999999999997653 2345778999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc--cCCceEEeeccccccCcccc
Q 013064 116 IMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld--~~g~ikL~DFGla~~~~~~~ 192 (450)
|||||+||+|.+++.+ .+.+++.+++.|+.||+.||+|||++|||||||||+|||++ .+|.+||+|||+|+.+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999999854 56799999999999999999999999999999999999995 46899999999998765431
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
...+.+||+.|||||++.+.+|+.++|||||||++|||++|
T Consensus 181 ---------------------------------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 181 ---------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp ---------------------------------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 12357899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCcccc
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKL 344 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 344 (450)
.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+|+ +++|+++||||+..+|...
T Consensus 222 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC---CHHHHHHSTTTSCTTCCSC
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCCCCc
Confidence 99999999999999988754443333335799999999999999 999999 6999999999998877543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-64 Score=492.61 Aligned_cols=265 Identities=26% Similarity=0.413 Sum_probs=225.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+.-++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+++++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 55689999999999999999999999999999999997652 3445678899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999999999999999999999999999997 59999999999999999999999999999864321
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+
T Consensus 159 --------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~ 200 (322)
T d1s9ja_ 159 --------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200 (322)
T ss_dssp --------------------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhh---c--------------------------------------ccccccCCCCCCCCHHHHHHHH
Q 013064 274 PPFCSDDPRITCRKIV---N--------------------------------------WKTCLKFPEEPKISDEARDLIC 312 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~---~--------------------------------------~~~~~~~p~~~~~s~~~~dli~ 312 (450)
.||.+.+......... . .......|. ..+|++++|||.
T Consensus 201 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~ 279 (322)
T d1s9ja_ 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS-GVFSLEFQDFVN 279 (322)
T ss_dssp CCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCB-TTBCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCcc-ccCCHHHHHHHH
Confidence 9998765433211100 0 000011111 246899999999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCCCcCCCCccccc
Q 013064 313 HLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLY 345 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 345 (450)
+||+ ||.+|+ +++|+++||||+..+|+.+.
T Consensus 280 ~~L~~dP~~R~---ta~e~L~Hpf~~~~~~~~~d 310 (322)
T d1s9ja_ 280 KCLIKNPAERA---DLKQLMVHAFIKRSDAEEVD 310 (322)
T ss_dssp HHTCSSTTTSC---CHHHHHTSHHHHHHHHSCCC
T ss_pred HHcCCChhHCc---CHHHHhhCHhhCcCCccccc
Confidence 9999 999999 79999999999988776543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-63 Score=479.00 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=226.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIM 117 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVm 117 (450)
+.|++++.||+|+||+||+|+++.+|+.||+|++++.. ....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46899999999999999999999999999999997653 344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 118 EYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 118 Ey~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||+||+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999765 4679999999999999999999999999999999999999999999999999998653320
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-----cCCCCccccccchhHHHHHHhh
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-----KKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-----~~~y~~~~DiWSlGvilyeml~ 271 (450)
....+.+||+.|||||++. +.+|+.++|||||||++|||++
T Consensus 165 ----------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt 210 (288)
T d2jfla1 165 ----------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210 (288)
T ss_dssp ----------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh
Confidence 0123578999999999984 4668999999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|.+||.+.+..+.+.+|.+... ..++.+..+|+++++||++||. ||.+|+ +++|+++||||+.
T Consensus 211 g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~ell~hp~~~~ 274 (288)
T d2jfla1 211 IEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274 (288)
T ss_dssp SSCTTTTSCGGGHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSGGGCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCC
Confidence 9999999999888888876432 2233335799999999999998 999999 6999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-62 Score=471.90 Aligned_cols=255 Identities=33% Similarity=0.568 Sum_probs=216.7
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc--CCeEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD--SDFLY 114 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~--~~~ly 114 (450)
.+||++++.||+|+||+||+|+++.||+.||+|++.+... .....+.+.+|+.+|+.++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 5899999999999999999999999999999999987654 44556788999999999999999999999965 56799
Q ss_pred EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHhhhCC-----eEEeecCCCcEEEccCCceEEeecccc
Q 013064 115 LIMEYLPGGDIMTLLMR----EDILSEDVARFYIAESVLAIHSIHQHN-----YVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~----~~~~~e~~~~~~~~qil~aL~~LH~~g-----ivHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+|||||+||+|.+++.+ ...+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 467999999999999999999999976 999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHH
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAI 265 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvi 265 (450)
+.+.... ....+.+|||.|||||++.+.+|+.++|||||||+
T Consensus 162 ~~~~~~~--------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvi 203 (269)
T d2java1 162 RILNHDT--------------------------------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 203 (269)
T ss_dssp HHC-------------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred eecccCC--------------------------------------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHH
Confidence 8764321 11235789999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 266 MYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 266 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
+|||++|.+||.+.+..++..+|.+... ..+| ..+|+++++||.+||. ||.+|| +++||++|||.
T Consensus 204 lyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l~~li~~~L~~dp~~Rp---s~~ell~hp~i 269 (269)
T d2java1 204 LYELCALMPPFTAFSQKELAGKIREGKF-RRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILENPLI 269 (269)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTC
T ss_pred HHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCC--cccCHHHHHHHHHHcCCChhHCc---CHHHHHhCCcC
Confidence 9999999999999998888888876432 2333 4799999999999998 999999 69999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-62 Score=487.18 Aligned_cols=258 Identities=30% Similarity=0.537 Sum_probs=230.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
.++|++++.||+|+||.||+|+++.+|+.||||++++... .....+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999987542 2345788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc--cCCceEEeeccccccCccccc
Q 013064 117 MEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD--KNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld--~~g~ikL~DFGla~~~~~~~~ 193 (450)
||||+||+|.+++.+.+ .+++.+++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 99999999999876654 699999999999999999999999999999999999998 67899999999998765431
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
...+.+||+.|+|||++.+.+|+.++|||||||++|||++|.
T Consensus 184 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 184 --------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp --------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred --------------------------------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCC
Confidence 123578999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
+||.+.+..+.+.+|......+..+....+|+++++||.+||+ ||.+|+ +++|+++||||++.
T Consensus 226 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGD 289 (352)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCCC
Confidence 9999999999988888754433333345799999999999999 999999 69999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-62 Score=479.31 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=228.6
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 39999999999999999999999999999999988765556667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
||+||+|..++...+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------
Confidence 9999999888888889999999999999999999999999999999999999999999999999999865431
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHHHHHhhCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+|
T Consensus 169 -----------------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~P 213 (309)
T d1u5ra_ 169 -----------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213 (309)
T ss_dssp -----------------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -----------------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCC
Confidence 24689999999999964 4589999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 276 FCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|.+.+..+.+.++....... +....+|+++++||.+||. ||.+|| +++|+++||||..
T Consensus 214 f~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 214 LFNMNAMSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (309)
T ss_dssp TTTSCHHHHHHHHHHSCCCC--CSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHS
T ss_pred CCCCCHHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHCcCChhHCc---CHHHHHhCHHhcC
Confidence 99988888888877643222 2234789999999999999 999999 7999999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-61 Score=467.18 Aligned_cols=260 Identities=31% Similarity=0.534 Sum_probs=232.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcc------hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEc
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLK------RGQVEHVRSERNLLAEVD-SRCIVQLFYSFQD 109 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~------~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~ 109 (450)
.++|++++.||+|+||+||+|+++.+|+.||||++++..... ....+.+.+|+.+|+.++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 379999999999999999999999999999999998765332 223456889999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
++++|||||||+||+|.++|..++.++++.++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc------CCCCccccccchh
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK------KGYGMECDWWSLG 263 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~------~~y~~~~DiWSlG 263 (450)
... .....+||+.|+|||++.+ ..|+.++||||+|
T Consensus 162 ~~~---------------------------------------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslG 202 (277)
T d1phka_ 162 PGE---------------------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202 (277)
T ss_dssp TTC---------------------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred CCC---------------------------------------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccc
Confidence 421 1124689999999999963 4578999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
|++|||++|..||.+.+......+|.+.......+....+|+++++||.+||. ||.+|+ +++||++||||+.
T Consensus 203 vilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---s~~eil~h~~~~~ 275 (277)
T d1phka_ 203 VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCT
T ss_pred hhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHHHH
Confidence 99999999999999999988888888765555555556899999999999999 999999 6999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-62 Score=481.33 Aligned_cols=294 Identities=39% Similarity=0.717 Sum_probs=252.1
Q ss_pred hcCCCCCCCeEEEeEEeecCceEEEEEEE---cCCCCEEEEEEeechhhcc-hhhHHHHHHHHHHHHhcCC-CCeeeEEE
Q 013064 31 QRRKIGIDDFEQLTLIGKGAFGEVRLCRA---KTTGEIFAMKKLKKSEMLK-RGQVEHVRSERNLLAEVDS-RCIVQLFY 105 (450)
Q Consensus 31 ~~~~~~~~~f~~~~~LG~G~fg~V~l~~~---~~t~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~h-p~Iv~l~~ 105 (450)
...++++++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++
T Consensus 17 ~~~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 17 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp CCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred CCcccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 34568899999999999999999999997 4579999999998765433 2345678899999999977 89999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccc
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLC 185 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla 185 (450)
+|.+...+|+||||+.||+|..++...+.+++..++.+++||+.||+|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC--CCCccccccchh
Q 013064 186 KPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK--GYGMECDWWSLG 263 (450)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~--~y~~~~DiWSlG 263 (450)
+.+..... ....+.+||+.|+|||++.+. .++.++||||||
T Consensus 177 ~~~~~~~~-------------------------------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 177 KEFVADET-------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219 (322)
T ss_dssp EECCGGGG-------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred hhhccccc-------------------------------------ccccccccccccchhHHhhcCCcCCCchhhhHHHH
Confidence 87654311 112357899999999999764 468899999999
Q ss_pred HHHHHHhhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCC--CCHHHHHcCCCcCCCC
Q 013064 264 AIMYEMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGT--RGVEELKEHPWFRGIQ 340 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~ 340 (450)
|+||+|++|..||.+.+.......+.+.......+.+..+|+++++||.+||. ||.+|++. .+++|+++||||++++
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 99999999999999888777766665533333333335799999999999999 99999975 3699999999999999
Q ss_pred cccccc--ccCCccccCCCcccC
Q 013064 341 WDKLYE--MEAAYKPTVNGELDT 361 (450)
Q Consensus 341 w~~l~~--~~~p~~p~~~~~~d~ 361 (450)
|+.+.. +++|++|.++++.|.
T Consensus 300 ~~~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 300 WDDLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp HHHHHTTCSCCSCCCCCCC-CCC
T ss_pred HHHHHhCCCCcCCCCCCCCCCCC
Confidence 999874 789999999988763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-61 Score=462.02 Aligned_cols=251 Identities=22% Similarity=0.393 Sum_probs=218.4
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc----CCeEEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD----SDFLYL 115 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~----~~~lyl 115 (450)
|++.+.||+|+||+||+|+++.+++.||+|++.+... .....+.+.+|+++|+.++|||||+++++|.+ +..+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4677899999999999999999999999999987653 34456789999999999999999999999975 457999
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCC--eEEeecCCCcEEEc-cCCceEEeeccccccCcccc
Q 013064 116 IMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHN--YVHRDIKPDNLILD-KNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~g--ivHrDLKpeNILld-~~g~ikL~DFGla~~~~~~~ 192 (450)
|||||+||+|.+++.+.+.++++.++.++.||+.||+|||++| |+||||||+||||+ .+|++||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999999999999999999999999999999998 99999999999996 5899999999999854322
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
...+.+|||.|||||++.+ +|+.++|||||||++|||++|
T Consensus 169 ---------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g 208 (270)
T d1t4ha_ 169 ---------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATS 208 (270)
T ss_dssp ---------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHC
Confidence 1235789999999999865 699999999999999999999
Q ss_pred CCCCCCCC-hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 273 YPPFCSDD-PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 273 ~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
..||.+.. ...++.++........++ ...++++++||.+||. ||++|+ +++|+++||||+
T Consensus 209 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~---s~~ell~Hp~fk 270 (270)
T d1t4ha_ 209 EYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270 (270)
T ss_dssp SCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC
T ss_pred CCCCCCcccHHHHHHHHHcCCCCcccC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHhCCcccC
Confidence 99997654 445556666543333333 3689999999999998 999999 799999999995
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-61 Score=474.04 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=228.5
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEE
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lyl 115 (450)
-.++|++++.||+|+||+||+|+++.+|+.||+|++++.. .....+.+|+.+|+.++|||||+++++|++++++|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3588999999999999999999999999999999998653 234567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC--CceEEeeccccccCcccc
Q 013064 116 IMEYLPGGDIMTLLMRED-ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN--GHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 116 VmEy~~gg~L~~~l~~~~-~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~--g~ikL~DFGla~~~~~~~ 192 (450)
|||||+||+|.+++.+.+ .++|++++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999997765 79999999999999999999999999999999999999854 489999999998754321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
...+.+||+.|+|||++.+..|+.++|||||||++|+|++|
T Consensus 159 ---------------------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 159 ---------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp ---------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 12356899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~ 338 (450)
.+||.+.+..+.+.+|.+....+..+.++.+|+++++||.+||. ||.+|+ +++|+++||||+.
T Consensus 200 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~ 263 (321)
T d1tkia_ 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhcc
Confidence 99999999999999998754333222234799999999999998 999999 7999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-60 Score=461.07 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=217.3
Q ss_pred EEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcch--hhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEe
Q 013064 41 EQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKR--GQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIME 118 (450)
Q Consensus 41 ~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmE 118 (450)
+.+++||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|+.++|||||+++++|.+++++|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 468899999999999999999999999999976543222 123568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccccc
Q 013064 119 YLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLE 198 (450)
Q Consensus 119 y~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~ 198 (450)
||.||++..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~----- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-----
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-----
Confidence 999998887777778899999999999999999999999999999999999999999999999999987654311
Q ss_pred ccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCCCC
Q 013064 199 DEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 156 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 156 ---------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp ---------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 1235689999999999975 568999999999999999999999999
Q ss_pred CCChhhhhhhhhcccccc------------------cCCC------CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 278 SDDPRITCRKIVNWKTCL------------------KFPE------EPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 278 ~~~~~~~~~~i~~~~~~~------------------~~p~------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+.+..+++.+|.+..... .++. ...+|++++|||++||+ ||++|+ +++|+++
T Consensus 203 ~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~---sa~e~L~ 279 (299)
T d1ua2a_ 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALK 279 (299)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---CHHHHHT
T ss_pred CCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc---CHHHHhC
Confidence 998888777765321000 0000 13578999999999999 999999 7999999
Q ss_pred CCCcCCCC
Q 013064 333 HPWFRGIQ 340 (450)
Q Consensus 333 Hpff~~i~ 340 (450)
||||++..
T Consensus 280 Hp~f~~~p 287 (299)
T d1ua2a_ 280 MKYFSNRP 287 (299)
T ss_dssp SGGGTSSS
T ss_pred CHhhCCCC
Confidence 99998744
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-60 Score=469.14 Aligned_cols=252 Identities=33% Similarity=0.532 Sum_probs=213.8
Q ss_pred CCCCCeEEEe-EEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEc---
Q 013064 35 IGIDDFEQLT-LIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAE-VDSRCIVQLFYSFQD--- 109 (450)
Q Consensus 35 ~~~~~f~~~~-~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~f~~--- 109 (450)
..+++|+++. +||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++.+ ++|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3468999985 699999999999999999999999999754 346679988755 589999999999986
Q ss_pred -CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc---CCceEEeecc
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK---NGHLKLSDFG 183 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~---~g~ikL~DFG 183 (450)
+.++|+|||||+||+|.++|.+. ..|+|.+++.|+.||+.||+|||++||+||||||+|||++. .+++||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46799999999999999999875 46999999999999999999999999999999999999975 5689999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchh
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLG 263 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlG 263 (450)
+|+...... ...+.+|||.|||||++.+..|+.++||||||
T Consensus 160 ~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlG 200 (335)
T d2ozaa1 160 FAKETTSHN---------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 200 (335)
T ss_dssp TCEECCCCC---------------------------------------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHH
T ss_pred eeeeccCCC---------------------------------------ccccccCCcccCCcHHHcCCCCCHHHHHHhhc
Confidence 998764421 12357899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhhhh----hhhcccccccCCC--CCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 264 AIMYEMLIGYPPFCSDDPRITCR----KIVNWKTCLKFPE--EPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 264 vilyeml~G~~PF~~~~~~~~~~----~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
|+||+|++|.+||.+.+...... ++... ...+|. ...+|+++++||++||. ||.+|+ +++|+++||||
T Consensus 201 vily~lltg~~Pf~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~ 275 (335)
T d2ozaa1 201 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWI 275 (335)
T ss_dssp HHHHHHTTSSCSCEETTCC--------CCCSC--SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSHHH
T ss_pred hhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC--CCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHh
Confidence 99999999999998876555443 33332 233332 34689999999999998 999999 69999999999
Q ss_pred CC
Q 013064 337 RG 338 (450)
Q Consensus 337 ~~ 338 (450)
..
T Consensus 276 ~~ 277 (335)
T d2ozaa1 276 MQ 277 (335)
T ss_dssp HT
T ss_pred hC
Confidence 64
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=449.87 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=216.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhh---HHHHHHHHHHHHhcC--CCCeeeEEEEEEcCCe
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQ---VEHVRSERNLLAEVD--SRCIVQLFYSFQDSDF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~---~~~~~~E~~il~~l~--hp~Iv~l~~~f~~~~~ 112 (450)
++|++.+.||+|+||.||+|+++.+|+.||||++++........ ...+.+|+.+|+.++ |||||+++++|++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 68999999999999999999999999999999998765443222 234668999999986 8999999999999999
Q ss_pred EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-CCceEEeeccccccCcc
Q 013064 113 LYLIMEYLPG-GDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-NGHLKLSDFGLCKPLED 190 (450)
Q Consensus 113 lylVmEy~~g-g~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-~g~ikL~DFGla~~~~~ 190 (450)
+|+||||+.| +++..++.+.+.+++++++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 688899988899999999999999999999999999999999999999985 47999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyem 269 (450)
. ...+.+||+.|+|||++.+..| +.++|||||||++|||
T Consensus 164 ~----------------------------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyel 203 (273)
T d1xwsa_ 164 T----------------------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203 (273)
T ss_dssp S----------------------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred c----------------------------------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhH
Confidence 2 1235789999999999987765 6789999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCC
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQ 340 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 340 (450)
++|.+||.+.+ .+... ...++ ..+|+++++||++||. ||.+|| +++|+++||||+++.
T Consensus 204 l~g~~Pf~~~~------~i~~~--~~~~~--~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 204 VCGDIPFEHDE------EIIRG--QVFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHSSCSCCSHH------HHHHC--CCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCC
T ss_pred hhCCCCCCCch------HHhhc--ccCCC--CCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCCCC
Confidence 99999997642 23332 23444 4799999999999998 999999 799999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-59 Score=452.22 Aligned_cols=262 Identities=29% Similarity=0.481 Sum_probs=217.2
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+++|+.++|||||+++++|+++.++|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 589999999999999999999999999999999997654 2334467889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccc
Q 013064 117 MEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSI 195 (450)
Q Consensus 117 mEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~ 195 (450)
|||+.|+.+...... ...+++..++.|+.||+.||+|||++|||||||||+|||++.++++||+|||+|+......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--- 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--- 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc---
Confidence 999976544443333 4579999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCC-CccccccchhHHHHHHhhCCC
Q 013064 196 LLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGY-GMECDWWSLGAIMYEMLIGYP 274 (450)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y-~~~~DiWSlGvilyeml~G~~ 274 (450)
......+||+.|+|||++....+ +.++|+|||||++|+|++|+.
T Consensus 157 -----------------------------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~ 201 (298)
T d1gz8a_ 157 -----------------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201 (298)
T ss_dssp -----------------------------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------------------------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCC
Confidence 11234689999999999887665 899999999999999999999
Q ss_pred CCCCCChhhhhhhhhccccc----------------ccCCC---------CCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 275 PFCSDDPRITCRKIVNWKTC----------------LKFPE---------EPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 275 PF~~~~~~~~~~~i~~~~~~----------------~~~p~---------~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
||.+.+..+...++.+.... ..++. ...+|++++|||++||+ ||.+|+ +++
T Consensus 202 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---t~~ 278 (298)
T d1gz8a_ 202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI---SAK 278 (298)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc---CHH
Confidence 99988877666555421100 00110 13678999999999999 999999 799
Q ss_pred HHHcCCCcCCCC
Q 013064 329 ELKEHPWFRGIQ 340 (450)
Q Consensus 329 eil~Hpff~~i~ 340 (450)
|+++||||++++
T Consensus 279 ell~H~ff~~~~ 290 (298)
T d1gz8a_ 279 AALAHPFFQDVT 290 (298)
T ss_dssp HHHTSGGGTTCC
T ss_pred HHhCCHhhccCC
Confidence 999999998865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-58 Score=444.92 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=220.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC----eE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----FL 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----~l 113 (450)
++|++++.||+|+||.||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++.+++ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 67999999999999999999999999999999998876656666788999999999999999999999998754 48
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
|+|||||+||+|..++...+.+++++++.++.||+.||+|||++|||||||||+|||++.++.++|+|||+++.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGY 273 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~ 273 (450)
. .....+.+||+.|||||++.+..|+.++|||||||++|||++|.
T Consensus 167 ~-----------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 211 (277)
T d1o6ya_ 167 S-----------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211 (277)
T ss_dssp -----------------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred c-----------------------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCC
Confidence 0 01123579999999999999999999999999999999999999
Q ss_pred CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCc
Q 013064 274 PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWF 336 (450)
Q Consensus 274 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff 336 (450)
+||.+.+..+...+++.............+|+++++||.+||. ||.+|++ ++++++ |+|.
T Consensus 212 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~l~-~~l~ 272 (277)
T d1o6ya_ 212 PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMR-ADLV 272 (277)
T ss_dssp CSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHHHH-HHHH
T ss_pred CCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh--HHHHHH-HHHH
Confidence 9999999888888877654333323345799999999999998 9999995 366654 5544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-58 Score=449.06 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=217.3
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCC-CCEEEEEEeechhhcchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEc----
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTT-GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV---DSRCIVQLFYSFQD---- 109 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t-~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~f~~---- 109 (450)
++|++++.||+|+||+||+|++..+ ++.||||++++... .......+.+|+.+|+.+ +|||||+++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 7899999999999999999999765 67899999976542 222333456788877665 79999999999863
Q ss_pred -CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
...+|++||||.||.+...... ...++++.++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 3579999999998877655443 45799999999999999999999999999999999999999999999999999886
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
..... ...+.+||+.|+|||++.+.+|+.++|||||||++|
T Consensus 166 ~~~~~---------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ 206 (305)
T d1blxa_ 166 YSFQM---------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206 (305)
T ss_dssp CCGGG---------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred hcccc---------------------------------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence 54321 123578999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhccccc---ccC--------------------CCCCCCCHHHHHHHHHhhc-CccccCC
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTC---LKF--------------------PEEPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~---~~~--------------------p~~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
||++|.+||.+.+..+.+.+|++.... ..+ .....+|+.++|||.+||. ||.+|+
T Consensus 207 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~- 285 (305)
T d1blxa_ 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI- 285 (305)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC-
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc-
Confidence 999999999999888777766531000 000 0123689999999999999 999999
Q ss_pred CCCHHHHHcCCCcCCCCcc
Q 013064 324 TRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i~w~ 342 (450)
+++|+++||||+++++.
T Consensus 286 --sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 286 --SAYSALSHPYFQDLERC 302 (305)
T ss_dssp --CHHHHHTSGGGTTCCCC
T ss_pred --CHHHHhcChhhcCchhh
Confidence 68999999999998864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-57 Score=441.54 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=218.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||+||+|+++ +|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 579999999999999999999986 889999999976542 344567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
|||+.|+.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--- 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc---
Confidence 99999888888877788999999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml~G~~P 275 (450)
.....+||+.|+|||++.+ ..++.++|+|||||++|||++|++|
T Consensus 156 -----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p 200 (286)
T d1ob3a_ 156 -----------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200 (286)
T ss_dssp -----------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred -----------------------------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence 1124579999999999976 4569999999999999999999999
Q ss_pred CCCCChhhhhhhhhcccccc---------cC-------C---------CCCCCCHHHHHHHHHhhc-CccccCCCCCHHH
Q 013064 276 FCSDDPRITCRKIVNWKTCL---------KF-------P---------EEPKISDEARDLICHLLC-DVETRLGTRGVEE 329 (450)
Q Consensus 276 F~~~~~~~~~~~i~~~~~~~---------~~-------p---------~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~e 329 (450)
|.+.+..+.+.++....... .. . ....+|++++|||++||. ||++|+ +++|
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---s~~e 277 (286)
T d1ob3a_ 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQ 277 (286)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CHHH
T ss_pred CCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc---CHHH
Confidence 99888777666654211000 00 0 013678999999999999 999999 7899
Q ss_pred HHcCCCcCC
Q 013064 330 LKEHPWFRG 338 (450)
Q Consensus 330 il~Hpff~~ 338 (450)
+++||||++
T Consensus 278 ll~Hp~f~~ 286 (286)
T d1ob3a_ 278 ALEHAYFKE 286 (286)
T ss_dssp HHTSGGGGC
T ss_pred HhcCcccCc
Confidence 999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-57 Score=444.43 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=218.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCC-----EEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE-----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~-----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|+++++||+|+||+||+|++..+++ .||+|++.+.. .......+.+|..+|..+ +|||||+++++|
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 3566899999999999999999999876654 68999986543 233456788999999988 899999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeec
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRE-----------------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDI 164 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~-----------------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDL 164 (450)
.+.+.+|+|||||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999999999999999999764 24899999999999999999999999999999
Q ss_pred CCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccc
Q 013064 165 KPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMA 244 (450)
Q Consensus 165 KpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~A 244 (450)
||+|||++.+|++||+|||+|+........ ....+.+||+.|||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~y~a 234 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY------------------------------------VVRGNARLPVKWMA 234 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTS------------------------------------EEETTEEECGGGCC
T ss_pred chhccccccCCeEEEeeccccccccCCCce------------------------------------eeeccccCCCccCC
Confidence 999999999999999999999875443111 11224679999999
Q ss_pred hhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccC
Q 013064 245 PEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRL 322 (450)
Q Consensus 245 PEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~ 322 (450)
||++.+..|+.++|||||||++|||++ |.+||.+.+....+.+++.....+..| ..+|+++++||.+||. ||++||
T Consensus 235 PE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RP 312 (325)
T d1rjba_ 235 PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSRKRP 312 (325)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCChhHCc
Confidence 999999999999999999999999997 999999988777777777654444444 4799999999999998 999999
Q ss_pred CCCCHHHHHcC
Q 013064 323 GTRGVEELKEH 333 (450)
Q Consensus 323 ~~~~~~eil~H 333 (450)
+++||++|
T Consensus 313 ---t~~ei~~~ 320 (325)
T d1rjba_ 313 ---SFPNLTSF 320 (325)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 68898875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-56 Score=439.30 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=213.1
Q ss_pred CCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEc--CCe
Q 013064 36 GIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQD--SDF 112 (450)
Q Consensus 36 ~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~--~~~ 112 (450)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. .+.+.+|+.+|+.+. ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999997542 456889999999995 9999999999984 457
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccCccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPLEDK 191 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~~~~ 191 (450)
+|+|||||.+|+|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999997663 5699999999999999999999999999999999999999765 6999999999876432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHHh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyeml 270 (450)
. .....+||+.|+|||++.+ ..|+.++|+|||||++|||+
T Consensus 184 ~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~ 224 (328)
T d3bqca1 184 Q---------------------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224 (328)
T ss_dssp C---------------------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred C---------------------------------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc
Confidence 1 1235689999999999886 45899999999999999999
Q ss_pred hCCCCCCCCChh-hhhhhhhc---------------------------------ccccccCCCCCCCCHHHHHHHHHhhc
Q 013064 271 IGYPPFCSDDPR-ITCRKIVN---------------------------------WKTCLKFPEEPKISDEARDLICHLLC 316 (450)
Q Consensus 271 ~G~~PF~~~~~~-~~~~~i~~---------------------------------~~~~~~~p~~~~~s~~~~dli~~lL~ 316 (450)
+|..||...... .....+.. +......+....+|++++|||++||+
T Consensus 225 ~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~ 304 (328)
T d3bqca1 225 FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304 (328)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSC
T ss_pred cCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHcc
Confidence 999999765432 11111110 00001111224589999999999999
Q ss_pred -CccccCCCCCHHHHHcCCCcCCCCcc
Q 013064 317 -DVETRLGTRGVEELKEHPWFRGIQWD 342 (450)
Q Consensus 317 -dp~~R~~~~~~~eil~Hpff~~i~w~ 342 (450)
||.+|+ +++|+|+||||++|.|+
T Consensus 305 ~dP~~R~---ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 305 YDHQSRL---TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp SSGGGSC---CHHHHHTSGGGTTSCCC
T ss_pred CChhHCc---CHHHHhcCcccCCCCCC
Confidence 999999 79999999999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=438.63 Aligned_cols=264 Identities=26% Similarity=0.346 Sum_probs=217.0
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-------
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------- 109 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------- 109 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5899999999999999999999999999999999977643 34456778899999999999999999999865
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 -SDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 -~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
+.++|+|||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999998877777666788999999999999999999999999999999999999999999999999999866
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMY 267 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvily 267 (450)
....... .....+.+||+.|+|||++.+. +|+.++|||||||++|
T Consensus 168 ~~~~~~~----------------------------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~ 213 (318)
T d3blha1 168 SLAKNSQ----------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213 (318)
T ss_dssp CC---------------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred ccccccc----------------------------------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceee
Confidence 4321110 0112357899999999999864 7899999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhcccccccCCCC----------------------------CCCCHHHHHHHHHhhc-Cc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWKTCLKFPEE----------------------------PKISDEARDLICHLLC-DV 318 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~----------------------------~~~s~~~~dli~~lL~-dp 318 (450)
||++|++||.+.+.......+............ ...+++++|||.+||. ||
T Consensus 214 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 214 EMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred eHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 999999999988877776665432111110000 0137889999999999 99
Q ss_pred cccCCCCCHHHHHcCCCcCC
Q 013064 319 ETRLGTRGVEELKEHPWFRG 338 (450)
Q Consensus 319 ~~R~~~~~~~eil~Hpff~~ 338 (450)
++|+ +++|+++||||+.
T Consensus 294 ~~R~---sa~elL~Hpff~~ 310 (318)
T d3blha1 294 AQRI---DSDDALNHDFFWS 310 (318)
T ss_dssp TTSC---CHHHHHHSGGGSS
T ss_pred hHCc---CHHHHHcChhhcc
Confidence 9999 7999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=442.57 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=210.8
Q ss_pred CeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc------CCe
Q 013064 39 DFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------SDF 112 (450)
Q Consensus 39 ~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~~~ 112 (450)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|+.++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 799999999999999999999999999999999765421 2469999999999999999999853 446
Q ss_pred EEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCC-ceEEeeccccccC
Q 013064 113 LYLIMEYLPGGDIMTL---LMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNG-HLKLSDFGLCKPL 188 (450)
Q Consensus 113 lylVmEy~~gg~L~~~---l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g-~ikL~DFGla~~~ 188 (450)
+|||||||++|.+..+ ......+++..++.++.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+.+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999987744333 23456899999999999999999999999999999999999999876 8999999999865
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMY 267 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvily 267 (450)
.... ...+.+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 174 ~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~ 214 (350)
T d1q5ka_ 174 VRGE---------------------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214 (350)
T ss_dssp CTTS---------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred cCCc---------------------------------------ccccccccccccChHHhhcccCCCcceeecccceEEE
Confidence 4321 1235789999999999875 57899999999999999
Q ss_pred HHhhCCCCCCCCChhhhhhhhhccc---------------ccccCC----------CCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 268 EMLIGYPPFCSDDPRITCRKIVNWK---------------TCLKFP----------EEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 268 eml~G~~PF~~~~~~~~~~~i~~~~---------------~~~~~p----------~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
||++|.+||.+.+..+.+.+|.+.. ....++ ....+|++++|||.+||. ||.+|
T Consensus 215 el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 294 (350)
T d1q5ka_ 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294 (350)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred ehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHC
Confidence 9999999999888777766664310 011111 123689999999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCC
Q 013064 322 LGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i 339 (450)
+ ++.|+++||||+++
T Consensus 295 ~---ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 295 L---TPLEACAHSFFDEL 309 (350)
T ss_dssp C---CHHHHHTSGGGGGG
T ss_pred c---CHHHHhcCHhhccc
Confidence 9 69999999999764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=443.85 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=213.6
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC-----
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD----- 111 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~----- 111 (450)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 479999999999999999999999999999999998654 34556788999999999999999999999998765
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 -FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 -~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
++|+||||| |++|..++ +.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66776665 556799999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc-CCCCccccccchhHHHHHH
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK-KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~-~~y~~~~DiWSlGvilyem 269 (450)
. ..+.+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 174 ~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (346)
T d1cm8a_ 174 E-----------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212 (346)
T ss_dssp S-----------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHH
Confidence 2 124689999999999986 4569999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhccccc---------------------ccCC------CCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWKTC---------------------LKFP------EEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p------~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
++|.+||.+.+....+..+...... .... ....+|++++|||++||+ ||.+|
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (346)
T d1cm8a_ 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHC
Confidence 9999999988766655444321100 0000 113679999999999999 99999
Q ss_pred CCCCCHHHHHcCCCcCCCCc
Q 013064 322 LGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 322 ~~~~~~~eil~Hpff~~i~w 341 (450)
+ +++||++||||+++.+
T Consensus 293 ~---ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 293 V---TAGEALAHPYFESLHD 309 (346)
T ss_dssp C---CHHHHHHSGGGTTTC-
T ss_pred c---CHHHHhcChhhCcCCC
Confidence 9 7999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-56 Score=433.14 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=216.7
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF 112 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ 112 (450)
..+..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3467789999999999999999999999999999999997643 245678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 113 LYLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+|+|||||++|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999764 5789999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.... ......||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 168 ~~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell 210 (287)
T d1opja_ 168 DTYT-------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210 (287)
T ss_dssp SSSE-------------------------------------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred CCce-------------------------------------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHH
Confidence 3111 012356899999999999999999999999999999999
Q ss_pred hCCCCC-CCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 271 IGYPPF-CSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 271 ~G~~PF-~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
+|..|| .+.+.......+.. ...+.+| ..+|+++++||.+||. ||.+|| ++++|++
T Consensus 211 ~~~~p~~~~~~~~~~~~~i~~-~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~ei~~ 268 (287)
T d1opja_ 211 TYGMSPYPGIDLSQVYELLEK-DYRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 268 (287)
T ss_dssp TTSCCSSTTCCHHHHHHHHHT-TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCCCcchHHHHHHHHhc-CCCCCCC--ccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 965554 55555554444433 3334444 4799999999999998 999999 6788864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=432.41 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=212.4
Q ss_pred eEEeecCceEEEEEEEc--CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 44 TLIGKGAFGEVRLCRAK--TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 44 ~~LG~G~fg~V~l~~~~--~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
+.||+|+||+||+|.++ .+++.||||+++... ......+.+.+|+.+|++++|||||++++++.++ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999865 456789999997654 3444567899999999999999999999999765 5789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccccccc
Q 013064 122 GGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDED 201 (450)
Q Consensus 122 gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~ 201 (450)
||+|.+++.+...+++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 164 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence 99999999999999999999999999999999999999999999999999999999999999998765431110
Q ss_pred cccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-CCCCCCCCC
Q 013064 202 IINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-GYPPFCSDD 280 (450)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~ 280 (450)
.......||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 -----------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 165 -----------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp -----------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -----------------------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 01124579999999999999999999999999999999997 999999988
Q ss_pred hhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCC
Q 013064 281 PRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGI 339 (450)
Q Consensus 281 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i 339 (450)
..+....|.++ ..+..| ..+|+++++||.+||. ||.+||+...+.+.++|+|+.-+
T Consensus 216 ~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 216 GSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp HHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 88877777653 234444 4799999999999998 99999953333334678776543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=423.99 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=222.9
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEEEE
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~lylV 116 (450)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+...+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 479999999999999999999999999999999997654 3455678899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccccccc
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSIL 196 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~ 196 (450)
||++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||.|+........
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-- 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-- 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc--
Confidence 999999999999998999999999999999999999999999999999999999999999999999999876543111
Q ss_pred ccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC-CCccccccchhHHHHHHhhCCCC
Q 013064 197 LEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG-YGMECDWWSLGAIMYEMLIGYPP 275 (450)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~-y~~~~DiWSlGvilyeml~G~~P 275 (450)
.....+++.|+|||++.+.. ++.++|+|||||++|||++|..|
T Consensus 158 ------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p 201 (292)
T d1unla_ 158 ------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_dssp ------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred ------------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCC
Confidence 12357889999999998655 69999999999999999999988
Q ss_pred C-CCCChhhhhhhhhcccccc---------cC----------------CCCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 276 F-CSDDPRITCRKIVNWKTCL---------KF----------------PEEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 276 F-~~~~~~~~~~~i~~~~~~~---------~~----------------p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
| .+.+..+.+.++....... .. .....+|+.++|||++||+ ||.+|+ +++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---sa~ 278 (292)
T d1unla_ 202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAE 278 (292)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHH
T ss_pred CCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc---CHH
Confidence 5 4555555555443211000 00 0114678999999999999 999999 799
Q ss_pred HHHcCCCcCCC
Q 013064 329 ELKEHPWFRGI 339 (450)
Q Consensus 329 eil~Hpff~~i 339 (450)
|+++||||+++
T Consensus 279 e~L~Hp~f~~~ 289 (292)
T d1unla_ 279 EALQHPYFSDF 289 (292)
T ss_dssp HHTTSGGGSSC
T ss_pred HHhcChhhcCC
Confidence 99999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=428.97 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=220.9
Q ss_pred CCCCCeEEEeE-EeecCceEEEEEEEcCC--CCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 35 IGIDDFEQLTL-IGKGAFGEVRLCRAKTT--GEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 35 ~~~~~f~~~~~-LG~G~fg~V~l~~~~~t--~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+..++|.+... ||+|+||.||+|.++.+ +..||||++++.. .....+.+.+|..+|+.++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 44578888885 99999999999987644 4579999997642 345567899999999999999999999999764
Q ss_pred eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+|||||+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 58999999999999999865 46799999999999999999999999999999999999999999999999999987654
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
..... ......+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 162 ~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~l 206 (285)
T d1u59a_ 162 DDSYY-----------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206 (285)
T ss_dssp CSCEE-----------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred ccccc-----------------------------------ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHH
Confidence 31110 1122467999999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
+ |.+||.+.+..+....|.++. .+..| ..+|+++.+||.+||. ||++||+..++.+.++|+|++
T Consensus 207 t~G~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 207 SYGQKPYKKMKGPEVMAFIEQGK-RMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTSCCTTTTCCTHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 8 999999988888877776643 34444 4799999999999998 999999654555667888874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-55 Score=428.36 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=209.0
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCCC---EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTGE---IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD 109 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~---~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~ 109 (450)
..+..++|++.+.||+|+||+||+|+++.+|+ .+|+|.+.+.. .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 35778899999999999999999999987765 58888876542 34456778999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccC
Q 013064 110 SDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPL 188 (450)
Q Consensus 110 ~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~ 188 (450)
++.+|+|||||+||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999999988774 57999999999999999999999999999999999999999999999999999876
Q ss_pred ccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHH
Q 013064 189 EDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYE 268 (450)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilye 268 (450)
........ ........||+.|||||++.+..|+.++|||||||++||
T Consensus 179 ~~~~~~~~---------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~e 225 (299)
T d1jpaa_ 179 EDDTSDPT---------------------------------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225 (299)
T ss_dssp --------------------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCcce---------------------------------eeecccccCCccccCHHHHhcCCCCcccccccchHHHHH
Confidence 54311000 001123568999999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 269 MLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 269 ml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
|++ |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|| ++.+|++
T Consensus 226 l~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ei~~ 285 (299)
T d1jpaa_ 226 VMSYGERPYWDMTNQDVINAIEQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRP---KFGQIVN 285 (299)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 998 89999999888888777653 2233345799999999999998 999999 5666654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=418.86 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=208.8
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|++++.||+|+||.||+|+++ +++.||||++++... ..+.+.+|..+++.++|||||++++++.+++.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 45689999999999999999999986 567899999976432 2356889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+|||||++|+|.+++... ..++++.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998765 5689999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
. .....+||+.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 157 ~-------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~ 199 (263)
T d1sm2a_ 157 T-------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199 (263)
T ss_dssp ---------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred e-------------------------------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCC
Confidence 0 1123579999999999999999999999999999999998 6
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
.+||.+.+..+....+..+ .....| ...++++.+||.+||. ||.+|| ++++|++|
T Consensus 200 ~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 255 (263)
T d1sm2a_ 200 KIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255 (263)
T ss_dssp CCTTCSCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhc-CCCCCc--cccCHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 7888887877777777653 223334 4689999999999998 999999 68898876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=425.05 Aligned_cols=256 Identities=19% Similarity=0.260 Sum_probs=208.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++.+.||+|+||.||+|+.+ ..||||++++... .....+.+.+|..+|+.++|||||++++++. +..+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 467789999999999999999999754 3599999976543 3456788999999999999999999999764 5678
Q ss_pred EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
|+|||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999765 569999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc---CCCCccccccchhHHHHHH
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK---KGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~---~~y~~~~DiWSlGvilyem 269 (450)
.. ....+.+||+.|||||++.+ ..|+.++|||||||++|||
T Consensus 159 ~~------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 159 GS------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp -------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHH
T ss_pred Cc------------------------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHH
Confidence 10 11235689999999999974 3589999999999999999
Q ss_pred hhCCCCCCCCChhhhhhhhhccc-ccccCC-CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 270 LIGYPPFCSDDPRITCRKIVNWK-TCLKFP-EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 270 l~G~~PF~~~~~~~~~~~i~~~~-~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++|..||.+.+.......++... .....+ ....+++++++||.+||. ||.+|| ++.+|++|
T Consensus 203 ~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~il~~ 266 (276)
T d1uwha_ 203 MTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266 (276)
T ss_dssp HHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 99999999877665554444321 111111 124689999999999998 999999 68888875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-55 Score=432.02 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=212.2
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCe----E
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDF----L 113 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~----l 113 (450)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++..+.. .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999998653 34456788999999999999999999999976542 3
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 114 YLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+++|+|+.||+|.+++..+ .+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 4445566799999998654 699999999999999999999999999999999999999999999999999987654311
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc-cCCCCccccccchhHHHHHHhhC
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL-KKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~-~~~y~~~~DiWSlGvilyeml~G 272 (450)
. .......+||+.|+|||++. +..|+.++|+||+||++|+|++|
T Consensus 165 ~-----------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g 209 (345)
T d1pmea_ 165 H-----------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209 (345)
T ss_dssp B-----------------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred c-----------------------------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence 1 01123578999999999985 45679999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhccccc------------------ccCC---------CCCCCCHHHHHHHHHhhc-CccccCCC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTC------------------LKFP---------EEPKISDEARDLICHLLC-DVETRLGT 324 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~------------------~~~p---------~~~~~s~~~~dli~~lL~-dp~~R~~~ 324 (450)
.+||.+.+.......+...... ...+ ..+.+|+++++||.+||+ ||.+|+
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-- 287 (345)
T d1pmea_ 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-- 287 (345)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC--
T ss_pred CCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc--
Confidence 9999988765555443210000 0011 023688999999999999 999999
Q ss_pred CCHHHHHcCCCcCCC
Q 013064 325 RGVEELKEHPWFRGI 339 (450)
Q Consensus 325 ~~~~eil~Hpff~~i 339 (450)
+++|+++||||+..
T Consensus 288 -ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 288 -EVEQALAHPYLEQY 301 (345)
T ss_dssp -CHHHHHTSGGGTTT
T ss_pred -CHHHHhcCHhhccC
Confidence 69999999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-55 Score=420.14 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=216.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++++.||+|+||.||+|+++ +++.||||++++... ..+.+.+|+.+|+.++|||||++++++.+ +.+
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 356689999999999999999999986 577899999976432 34678999999999999999999998754 567
Q ss_pred EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMRE--DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~~--~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999999977543 36999999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... ......||+.|||||++.+..|+.++|||||||++|||++
T Consensus 163 ~~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt 205 (272)
T d1qpca_ 163 EYT-------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (272)
T ss_dssp CEE-------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred ccc-------------------------------------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHh
Confidence 111 1124679999999999998999999999999999999999
Q ss_pred -CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc--CCCcC
Q 013064 272 -GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE--HPWFR 337 (450)
Q Consensus 272 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~--Hpff~ 337 (450)
|.+||...+..+....+..+ .....| ..+++++++||.+||. ||++|| ++++|++ |+||.
T Consensus 206 ~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~P~~Rp---t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 206 HGRIPYPGMTNPEVIQNLERG-YRMVRP--DNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhc-CCCCCc--ccChHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhhhhh
Confidence 56677777777777777653 223334 4799999999999998 999999 6888887 78875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=434.39 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=214.9
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC-----Ce
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS-----DF 112 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~-----~~ 112 (450)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+++|+.++|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 68999999999999999999999999999999998754 3444567789999999999999999999999743 34
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcccc
Q 013064 113 LYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~ 192 (450)
.++||+|+.||+|.+++. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++|++|||+|......
T Consensus 97 ~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~- 174 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 174 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-
T ss_pred eEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc-
Confidence 566777888999999885 457999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccC-CCCccccccchhHHHHHHhh
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKK-GYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~-~y~~~~DiWSlGvilyeml~ 271 (450)
..+.+||+.|+|||++.+. .++.++|+|||||++|+|++
T Consensus 175 ----------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~ 214 (348)
T d2gfsa1 175 ----------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214 (348)
T ss_dssp ----------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh
Confidence 1256899999999998775 46899999999999999999
Q ss_pred CCCCCCCCChhhhhhhhhcccccc---------------------cCCC------CCCCCHHHHHHHHHhhc-CccccCC
Q 013064 272 GYPPFCSDDPRITCRKIVNWKTCL---------------------KFPE------EPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 272 G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
|.+||.+.+.......|....... ..+. ...+|++++|||++||+ ||.+|+
T Consensus 215 g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~- 293 (348)
T d2gfsa1 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI- 293 (348)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC-
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc-
Confidence 999999988777766665321110 0110 13689999999999999 999999
Q ss_pred CCCHHHHHcCCCcCCC
Q 013064 324 TRGVEELKEHPWFRGI 339 (450)
Q Consensus 324 ~~~~~eil~Hpff~~i 339 (450)
+++|+++||||+.+
T Consensus 294 --ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 294 --TAAQALAHAYFAQY 307 (348)
T ss_dssp --CHHHHHTSGGGTTT
T ss_pred --CHHHHhcCHhhCCC
Confidence 79999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-55 Score=415.11 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=221.7
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFLY 114 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~ly 114 (450)
+..++|+++++||+|+||+||+|+++ +++.||||++++... ..+.+.+|..+++.++|||||++++++.+++.+|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence 35789999999999999999999985 778899999987543 2357889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccc
Q 013064 115 LIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYS 193 (450)
Q Consensus 115 lVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~ 193 (450)
+||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+.....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999999999765 46799999999999999999999999999999999999999999999999999987654311
Q ss_pred cccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh-C
Q 013064 194 SILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI-G 272 (450)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~-G 272 (450)
. .....+||+.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 156 ~-------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g 198 (258)
T d1k2pa_ 156 T-------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198 (258)
T ss_dssp C-------------------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred e-------------------------------------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcC
Confidence 1 1123679999999999999999999999999999999998 8
Q ss_pred CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 273 YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+.||.+.+..++..+|.+.. .+..| ...++++++||.+||. ||++|| ++++|++|
T Consensus 199 ~~Pf~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~ 254 (258)
T d1k2pa_ 199 KMPYERFTNSETAEHIAQGL-RLYRP--HLASEKVYTIMYSCWHEKADERP---TFKILLSN 254 (258)
T ss_dssp CCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhCC-CCCCc--ccccHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 99999999988888887642 33444 4789999999999998 999999 68999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=436.36 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=208.1
Q ss_pred CCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc------C
Q 013064 37 IDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD------S 110 (450)
Q Consensus 37 ~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~------~ 110 (450)
+++|++++.||+|+||+||+|+++.||+.||||++++.. ........+.+|+.+|+.++|||||+++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 378999999999999999999999999999999998764 345566789999999999999999999999964 4
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.++|+|||||.|+. ...+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 95 ~~~~iv~Ey~~~~l-~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDANL-CQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEEH-HHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchHH-HHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 78999999997654 4444 45799999999999999999999999999999999999999999999999999886543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
.. .....+||+.|+|||++.+..|+.++|+||+||++|+|+
T Consensus 172 ~~---------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell 212 (355)
T d2b1pa1 172 SF---------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212 (355)
T ss_dssp ------------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cc---------------------------------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHh
Confidence 21 122468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhhhhhhhccccc--------------------cc--------------CCC----CCCCCHHHHHHHH
Q 013064 271 IGYPPFCSDDPRITCRKIVNWKTC--------------------LK--------------FPE----EPKISDEARDLIC 312 (450)
Q Consensus 271 ~G~~PF~~~~~~~~~~~i~~~~~~--------------------~~--------------~p~----~~~~s~~~~dli~ 312 (450)
+|++||.+.+......+++..... .. .+. ....|++++|||+
T Consensus 213 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~ 292 (355)
T d2b1pa1 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292 (355)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHH
Confidence 999999988876665555321000 00 000 0124778999999
Q ss_pred Hhhc-CccccCCCCCHHHHHcCCCcCCCCc
Q 013064 313 HLLC-DVETRLGTRGVEELKEHPWFRGIQW 341 (450)
Q Consensus 313 ~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 341 (450)
+||. ||++|+ +++|+|+||||+..-+
T Consensus 293 ~mL~~dP~~R~---ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 293 KMLVIDPAKRI---SVDDALQHPYINVWYD 319 (355)
T ss_dssp HHSCSSTTTSC---CHHHHHTSTTTGGGCC
T ss_pred HHCcCChhHCc---CHHHHhcCcccCCCCC
Confidence 9999 999999 7999999999987433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=414.10 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=208.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+..++|++.+.||+|+||.||+|++..++ ..+|+|.+++.. .....+.+.+|..+|+.++|||||++++++. ++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 55689999999999999999999987654 468888886432 3445678999999999999999999999996 46
Q ss_pred eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMR-EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~-~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+|||||++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999999999998765 45799999999999999999999999999999999999999999999999999987543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
... ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 161 ~~~-------------------------------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l 203 (273)
T d1mp8a_ 161 STY-------------------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203 (273)
T ss_dssp -----------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred Ccc-------------------------------------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence 211 0122457999999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+ |.+||.+.+..+.+.++.+.. ...+| +.+|+++++||.+||. ||.+|| +++||++|
T Consensus 204 t~g~~P~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~dp~~Rp---s~~ei~~~ 262 (273)
T d1mp8a_ 204 MHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262 (273)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 8 999999999988888887643 23333 5899999999999998 999999 68888875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=414.28 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=212.6
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCCeE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSDFL 113 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~~l 113 (450)
.+..++|++.+.||+|+||+||+|+++.+ +.||||++++... ..+.+.+|..+|+.++|||||++++++.+ +.+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 46779999999999999999999998766 4699999976532 23578899999999999999999999965 457
Q ss_pred EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccc
Q 013064 114 YLIMEYLPGGDIMTLLMR--EDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDK 191 (450)
Q Consensus 114 ylVmEy~~gg~L~~~l~~--~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~ 191 (450)
|+|||||++|+|..++.. ...+++.++..++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999999988754 457999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhh
Q 013064 192 YSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLI 271 (450)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~ 271 (450)
... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 167 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t 209 (285)
T d1fmka3 167 EYT-------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209 (285)
T ss_dssp ----------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred Cce-------------------------------------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHh
Confidence 110 1124679999999999999999999999999999999999
Q ss_pred C-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc--CCCcCC
Q 013064 272 G-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE--HPWFRG 338 (450)
Q Consensus 272 G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~--Hpff~~ 338 (450)
| .+||.+.+..+.+..+... . ..|....+|+++++||.+||. ||++|| ++++|++ |+||..
T Consensus 210 ~~~p~~~~~~~~~~~~~i~~~-~--~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 210 KGRVPYPGMVNREVLDQVERG-Y--RMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTCCSSTTCCHHHHHHHHHTT-C--CCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCCHHHHHHHHHhc-C--CCCCCcccCHHHHHHHHHHcccCHhHCc---CHHHHHHHHhhhhcC
Confidence 5 6666777777777766643 2 233345899999999999998 999999 6889887 888876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=417.00 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=210.3
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCC----EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGE----IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDS 110 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~ 110 (450)
+.-+||+++++||+|+||+||+|++..+|+ .||+|.+++.. .....+.+.+|..+|+.++|||||++++++.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345789999999999999999999998887 46777775432 334567899999999999999999999999875
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCc
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLE 189 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~ 189 (450)
..++||||+.+|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 578889999999999988764 679999999999999999999999999999999999999999999999999998765
Q ss_pred cccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHH
Q 013064 190 DKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEM 269 (450)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyem 269 (450)
..... ..+...+||+.|||||++.+..|+.++|||||||++|||
T Consensus 163 ~~~~~------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el 206 (317)
T d1xkka_ 163 AEEKE------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206 (317)
T ss_dssp TTCC--------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccccc------------------------------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHH
Confidence 43111 112235799999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 270 LI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 270 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
++ |.+||.+.+..+....+.++ ..+..| ..+++++++||.+||. ||.+|| ++.+|+.|
T Consensus 207 ~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~ 266 (317)
T d1xkka_ 207 MTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRP---KFRELIIE 266 (317)
T ss_dssp HTTSCCTTTTSCGGGHHHHHHHT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHhCCCChhhCc---CHHHHHHH
Confidence 98 89999988877776666543 233334 5799999999999998 999999 68899988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=416.05 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=206.4
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|++++.||+|+||.||+|++.. +++.||+|++++.. .....+.+.+|..++.++ +|||||.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3566899999999999999999999764 45689999997543 234456677777777766 689999999997
Q ss_pred EcC-CeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEE
Q 013064 108 QDS-DFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLI 170 (450)
Q Consensus 108 ~~~-~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNIL 170 (450)
..+ ..+|+|||||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 654 5699999999999999999753 34899999999999999999999999999999999999
Q ss_pred EccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhcc
Q 013064 171 LDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLK 250 (450)
Q Consensus 171 ld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~ 250 (450)
|+.+|++||+|||+|+........ ....+.+||+.|||||++.+
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~------------------------------------~~~~~~~gt~~y~APE~l~~ 210 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDY------------------------------------VRKGDARLPLKWMAPETIFD 210 (299)
T ss_dssp ECGGGCEEECC------CCSCTTS------------------------------------CCTTSCCCGGGGCCHHHHHH
T ss_pred ECCCCcEEEccCcchhhccccccc------------------------------------cccCceeeCccccchhHhhc
Confidence 999999999999999865433111 11235689999999999999
Q ss_pred CCCCccccccchhHHHHHHhhC-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHH
Q 013064 251 KGYGMECDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVE 328 (450)
Q Consensus 251 ~~y~~~~DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~ 328 (450)
..|+.++|||||||++|||++| .+||.+.+..+.+.+++.....+..| ..+++++++||.+||. ||.+|| +++
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---t~~ 285 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFS 285 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHcCCChhHCc---CHH
Confidence 9999999999999999999986 57898877666666665544444555 4789999999999998 999999 688
Q ss_pred HHHcC
Q 013064 329 ELKEH 333 (450)
Q Consensus 329 eil~H 333 (450)
||++|
T Consensus 286 eil~~ 290 (299)
T d1ywna1 286 ELVEH 290 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=409.56 Aligned_cols=257 Identities=22% Similarity=0.289 Sum_probs=208.9
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcCCC----CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKTTG----EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ 108 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~ 108 (450)
+++..+.|++.++||+|+||.||+|..+.++ ..||||+++... .......+.+|..+|+.++|||||++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 3567789999999999999999999987665 369999997543 3344567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 109 DSDFLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 109 ~~~~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+.+.+|+|||||.+|++..++... ..+++..+..++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999988765 6799999999999999999999999999999999999999999999999999987
Q ss_pred CccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHH
Q 013064 188 LEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMY 267 (450)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvily 267 (450)
+....... .......||+.|||||++.+..|+.++|||||||++|
T Consensus 160 ~~~~~~~~-----------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~ 204 (283)
T d1mqba_ 160 LEDDPEAT-----------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 204 (283)
T ss_dssp -------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred ccCCCccc-----------------------------------eEeccCCCCccccCHHHHccCCCCCcccccccHHHHH
Confidence 64321100 0112357999999999999999999999999999999
Q ss_pred HHhhC-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 268 EMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 268 eml~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
||++| .+||.+.+..+.+..+... ..+..| ..+++++++||.+||. ||.+|| ++.+|++
T Consensus 205 el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~RP---t~~eil~ 265 (283)
T d1mqba_ 205 EVMTYGERPYWELSNHEVMKAINDG-FRLPTP--MDCPSAIYQLMMQCWQQERARRP---KFADIVS 265 (283)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCBHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHhCCCCccccCCHHHHHHHHhcc-CCCCCc--hhhHHHHHHHHHHHCcCCHhHCc---CHHHHHH
Confidence 99985 5566666666666666543 233333 4799999999999998 999999 5777765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-54 Score=411.66 Aligned_cols=256 Identities=21% Similarity=0.360 Sum_probs=208.6
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-CCC--EEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEcCC
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-TGE--IFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQDSD 111 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-t~~--~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~~~ 111 (450)
+..+||++++.||+|+||.||+|+... +++ .||||++++.........+.+.+|+.+|+.++|||||++++++.++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 456899999999999999999998653 333 6899999887766666678899999999999999999999999764
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 112 FLYLIMEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
.+|+|||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 678999999999999887654 5799999999999999999999999999999999999999999999999999997654
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
..... ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 164 ~~~~~-----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 164 NDDHY-----------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208 (273)
T ss_dssp -CCEE-----------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CCCcc-----------------------------------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence 31110 1122457889999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHH
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELK 331 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil 331 (450)
+ |.+||.+.+..+...+|......+..| ..+|+++++||.+||. ||++|| ++++|+
T Consensus 209 t~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---t~~ei~ 266 (273)
T d1u46a_ 209 TYGQEPWIGLNGSQILHKIDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRP---TFVALR 266 (273)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred hCCCCCCCCcCHHHHHHHHHhCCCCCCCc--ccccHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 8 899999999999988888754444433 5899999999999998 999999 577775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=414.32 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=215.9
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCE--EEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEcC
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEI--FAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSFQDS 110 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~--~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f~~~ 110 (450)
.+..++|++.++||+|+||.||+|+++.+|.. ||||.+++. ......+.+.+|+.+|..+ +|||||++++++.++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 36789999999999999999999999998875 566766533 2334566789999999998 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccC
Q 013064 111 DFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKN 174 (450)
Q Consensus 111 ~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~ 174 (450)
+.+|+||||++||+|.++|.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 9999999999999999999754 579999999999999999999999999999999999999999
Q ss_pred CceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCC
Q 013064 175 GHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 254 (450)
Q Consensus 175 g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~ 254 (450)
+.+||+|||+|+....... ....+||+.|+|||++.+..|+
T Consensus 164 ~~~kl~DfG~a~~~~~~~~---------------------------------------~~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK---------------------------------------KTMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp GCEEECCTTCEESSCEECC---------------------------------------C----CCTTTCCHHHHHHCEEC
T ss_pred CceEEcccccccccccccc---------------------------------------ccceecCCcccchHHhccCCCC
Confidence 9999999999986543211 1245799999999999999999
Q ss_pred ccccccchhHHHHHHhhC-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc
Q 013064 255 MECDWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE 332 (450)
Q Consensus 255 ~~~DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~ 332 (450)
.++|||||||++|||++| .+||.+.+..+.+..|.++. .+..| ..+++++++||.+||. ||++|| ++++|++
T Consensus 205 ~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~dP~~RP---s~~eil~ 278 (309)
T d1fvra_ 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 278 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-CCCCC--ccCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999999999996 56898888888888887642 23333 4799999999999998 999999 6899998
Q ss_pred C
Q 013064 333 H 333 (450)
Q Consensus 333 H 333 (450)
|
T Consensus 279 ~ 279 (309)
T d1fvra_ 279 S 279 (309)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-52 Score=409.70 Aligned_cols=256 Identities=22% Similarity=0.300 Sum_probs=218.6
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
-.+..++|++++.||+|+||+||+|+.+ .+++.||||++++.. .....+.+.+|+.+|+.++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3445689999999999999999999976 356789999997543 344567899999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEee
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRED------------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRD 163 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~------------------------~~~e~~~~~~~~qil~aL~~LH~~givHrD 163 (450)
.+.+.+++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999996532 389999999999999999999999999999
Q ss_pred cCCCcEEEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCcc
Q 013064 164 IKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYM 243 (450)
Q Consensus 164 LKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~ 243 (450)
|||+|||||.++++||+|||+|+.+..... .....+.+||+.|+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~------------------------------------~~~~~~~~~~~~y~ 209 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY------------------------------------YKADGNDAIPIRWM 209 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC------------------------------------BC----CCBCGGGC
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc------------------------------------ccccCCCCcCcCcC
Confidence 999999999999999999999986543211 11123568999999
Q ss_pred chhhhccCCCCccccccchhHHHHHHhhCC-CCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-Ccccc
Q 013064 244 APEVLLKKGYGMECDWWSLGAIMYEMLIGY-PPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETR 321 (450)
Q Consensus 244 APEvl~~~~y~~~~DiWSlGvilyeml~G~-~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R 321 (450)
|||++.+..|+.++|||||||++|||++|. +||.+.+..+....+..+. ....| ..+++++.+||.+||. ||.+|
T Consensus 210 aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p--~~~~~~~~~li~~cl~~~P~~R 286 (301)
T d1lufa_ 210 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSKLPADR 286 (301)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcCCChhHC
Confidence 999999999999999999999999999985 7899999888888887643 23334 4799999999999999 99999
Q ss_pred CCCCCHHHHHc
Q 013064 322 LGTRGVEELKE 332 (450)
Q Consensus 322 ~~~~~~~eil~ 332 (450)
| ++.||++
T Consensus 287 P---t~~ev~~ 294 (301)
T d1lufa_ 287 P---SFCSIHR 294 (301)
T ss_dssp C---CHHHHHH
T ss_pred c---CHHHHHH
Confidence 9 5777753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=403.93 Aligned_cols=246 Identities=23% Similarity=0.408 Sum_probs=207.3
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-cCCe
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQ-DSDF 112 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~-~~~~ 112 (450)
.++.++|++++.||+|+||.||+|+. +|+.||||++++.. ..+.+.+|+.+|++++|||||++++++. +++.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 46789999999999999999999998 47789999997643 3467889999999999999999999885 4567
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCcc
Q 013064 113 LYLIMEYLPGGDIMTLLMRED--ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLED 190 (450)
Q Consensus 113 lylVmEy~~gg~L~~~l~~~~--~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~ 190 (450)
+|+||||+++|+|.++|.+.+ .++++.++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 899999999999999997643 599999999999999999999999999999999999999999999999999986543
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
. ..+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 156 ~-----------------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~ 194 (262)
T d1byga_ 156 T-----------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194 (262)
T ss_dssp -----------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C-----------------------------------------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHH
Confidence 2 12357899999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 271 I-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 271 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
+ |.+||.+.+..+....|.+. ....+| ..+++++++||.+||. ||.+|| ++.+|+++
T Consensus 195 t~~~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~~ 253 (262)
T d1byga_ 195 SFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253 (262)
T ss_dssp TTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcccCHhHCc---CHHHHHHH
Confidence 8 89999998888888887653 234444 4789999999999998 999999 57777653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=406.73 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=220.8
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEc-----CCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAK-----TTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYSF 107 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~-----~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~f 107 (450)
.+..++|++.++||+|+||.||+|+.. .+++.||||++++.. .......+.+|..+++.+ +|||||++++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 466789999999999999999999864 467789999997653 344566789999999998 799999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRED------------------ILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~~------------------~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
.+...+|+|||||+||+|.+++.+.. .+++..+..|+.||+.||+|||++|||||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 99999999999999999999997643 589999999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.++++||+|||+++........ ......+||+.|+|||++.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~ 220 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNY------------------------------------VVKGNARLPVKWMAPESIF 220 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTS------------------------------------EECSSSEECGGGCCHHHHH
T ss_pred cccccCcccccccchheeccCCCcc------------------------------------eEeeecccChHHcCHHHhc
Confidence 9999999999999999876543111 1122468999999999999
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+..|+.++|||||||++|||++ |.+||.+.+..+.+.+++........| ..+|+++++||.+||. ||.+|| ++
T Consensus 221 ~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RP---s~ 295 (311)
T d1t46a_ 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRP---TF 295 (311)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCc---CH
Confidence 9999999999999999999998 777888877777777777654444444 4789999999999998 999999 57
Q ss_pred HHHHc
Q 013064 328 EELKE 332 (450)
Q Consensus 328 ~eil~ 332 (450)
++|++
T Consensus 296 ~~il~ 300 (311)
T d1t46a_ 296 KQIVQ 300 (311)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 78764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=404.92 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=214.6
Q ss_pred CCCCCCeEEEeEEeecCceEEEEEEEcCCC-------CEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 013064 34 KIGIDDFEQLTLIGKGAFGEVRLCRAKTTG-------EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFY 105 (450)
Q Consensus 34 ~~~~~~f~~~~~LG~G~fg~V~l~~~~~t~-------~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 105 (450)
.+..++|++++.||+|+||.||+|+...++ ..||+|++++.. .......+.+|..++..+ +|||||++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 366799999999999999999999987655 379999997653 344567788898888887 8999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcE
Q 013064 106 SFQDSDFLYLIMEYLPGGDIMTLLMRE----------------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNL 169 (450)
Q Consensus 106 ~f~~~~~lylVmEy~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNI 169 (450)
+|.++..+|+|||||++|+|.++|... ..+++.++..++.||+.||+|||++|||||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 999999999999999999999999754 3589999999999999999999999999999999999
Q ss_pred EEccCCceEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhc
Q 013064 170 ILDKNGHLKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLL 249 (450)
Q Consensus 170 Lld~~g~ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~ 249 (450)
|++.+|.+||+|||+++........ ......+||+.|+|||++.
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~y~aPE~l~ 210 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYY------------------------------------KKTTNGRLPVKWMAPEALF 210 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTT------------------------------------CCCTTSCCGGGGSCHHHHH
T ss_pred eecCCCCeEeccchhhccccccccc------------------------------------cccccCCCChhhhhhhHhc
Confidence 9999999999999999876543111 1123468999999999999
Q ss_pred cCCCCccccccchhHHHHHHhh-CCCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCH
Q 013064 250 KKGYGMECDWWSLGAIMYEMLI-GYPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGV 327 (450)
Q Consensus 250 ~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~ 327 (450)
+..|+.++|||||||++|||++ |.+||.+.+....+..+.+. ..+..| ..+|+++++||.+||. ||.+|| ++
T Consensus 211 ~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~Rp---s~ 284 (299)
T d1fgka_ 211 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCWHAVPSQRP---TF 284 (299)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--SSCCHHHHHHHHHHTCSSGGGSC---CH
T ss_pred CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccchHHHHHHHHHHccCCHhHCc---CH
Confidence 9999999999999999999997 79999988888777776653 334444 5799999999999998 999999 67
Q ss_pred HHHHc
Q 013064 328 EELKE 332 (450)
Q Consensus 328 ~eil~ 332 (450)
.||++
T Consensus 285 ~eil~ 289 (299)
T d1fgka_ 285 KQLVE 289 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-52 Score=404.09 Aligned_cols=264 Identities=19% Similarity=0.265 Sum_probs=225.4
Q ss_pred CCCCCCCeEEEeEEeecCceEEEEEEEcC-----CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 013064 33 RKIGIDDFEQLTLIGKGAFGEVRLCRAKT-----TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSF 107 (450)
Q Consensus 33 ~~~~~~~f~~~~~LG~G~fg~V~l~~~~~-----t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f 107 (450)
..+..++|++.+.||+|+||.||+|.++. ++..||||++++.. .......+.+|+.++++++|||||++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 45677999999999999999999999863 35689999997643 334556789999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCce
Q 013064 108 QDSDFLYLIMEYLPGGDIMTLLMRE----------DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHL 177 (450)
Q Consensus 108 ~~~~~lylVmEy~~gg~L~~~l~~~----------~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~i 177 (450)
..+..+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||||+.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999998643 347899999999999999999999999999999999999999999
Q ss_pred EEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccc
Q 013064 178 KLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMEC 257 (450)
Q Consensus 178 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~ 257 (450)
||+|||+|+.+...... ......+||+.|+|||.+.+..|+.++
T Consensus 173 Kl~DFGla~~~~~~~~~------------------------------------~~~~~~~~t~~y~aPe~l~~~~~~~~~ 216 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYY------------------------------------RKGGKGLLPVRWMSPESLKDGVFTTYS 216 (308)
T ss_dssp EECCTTCCCGGGGGGCE------------------------------------EGGGSSEECGGGCCHHHHHHCCCCHHH
T ss_pred EEeecccceeccCCcce------------------------------------eeccceecccccCCHHHHccCCCCccc
Confidence 99999999876443111 112245799999999999999999999
Q ss_pred cccchhHHHHHHhhC-CCCCCCCChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHc---
Q 013064 258 DWWSLGAIMYEMLIG-YPPFCSDDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKE--- 332 (450)
Q Consensus 258 DiWSlGvilyeml~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~--- 332 (450)
|+|||||++|||++| .+||.+.+..+.+..+.++. .+..| ..+++.+++||.+||. ||.+|| ++++|++
T Consensus 217 Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RP---s~~~il~~L~ 290 (308)
T d1p4oa_ 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEIISSIK 290 (308)
T ss_dssp HHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHG
T ss_pred ccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccchHHHHHHHHHHcCCChhHCc---CHHHHHHHHH
Confidence 999999999999998 58899999888888887643 23333 4789999999999998 999999 6778876
Q ss_pred ---CCCcCCCC
Q 013064 333 ---HPWFRGIQ 340 (450)
Q Consensus 333 ---Hpff~~i~ 340 (450)
+|+|+.++
T Consensus 291 ~~~~~~~~~~~ 301 (308)
T d1p4oa_ 291 EEMEPGFREVS 301 (308)
T ss_dssp GGSCTTHHHHC
T ss_pred HhcCCCCcCCC
Confidence 66665443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-51 Score=397.36 Aligned_cols=263 Identities=20% Similarity=0.260 Sum_probs=204.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRC-IVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~f~~~~~lylV 116 (450)
++|++++.||+|+||.||+|+++.+|+.||||++..... ...+..|..+++.++|++ |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 469999999999999999999999999999999876432 134678999999997665 66667777889999999
Q ss_pred EeccCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEc---cCCceEEeeccccccCcccc
Q 013064 117 MEYLPGGDIMTLL-MREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILD---KNGHLKLSDFGLCKPLEDKY 192 (450)
Q Consensus 117 mEy~~gg~L~~~l-~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld---~~g~ikL~DFGla~~~~~~~ 192 (450)
|||+ ||+|...+ ...+.+++..+..++.|++.||+|||++|||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 45555555 4466899999999999999999999999999999999999985 45579999999999775432
Q ss_pred ccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhC
Q 013064 193 SSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIG 272 (450)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G 272 (450)
.... .......+.+||+.|||||++.+.+|+.++|||||||++|||++|
T Consensus 161 ~~~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg 209 (299)
T d1ckia_ 161 THQH-------------------------------IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 209 (299)
T ss_dssp TCCB-------------------------------CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccc-------------------------------eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhC
Confidence 1100 000112357899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhhhhhhcccc-cccCC---CCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcC
Q 013064 273 YPPFCSDDPRITCRKIVNWKT-CLKFP---EEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFR 337 (450)
Q Consensus 273 ~~PF~~~~~~~~~~~i~~~~~-~~~~p---~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~ 337 (450)
.+||.+.........+..... ....| ....+|+++.+||..||. ||.+||+...+.++++|+|.+
T Consensus 210 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 210 SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp SCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 999987665544433322111 11111 123689999999999998 999999654456778888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-49 Score=383.68 Aligned_cols=249 Identities=19% Similarity=0.224 Sum_probs=203.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-RCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~f~~~~~lylV 116 (450)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+|.++++.+.| ++|+.+++++.++...|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 689999999999999999999999999999999865432 2346778999999965 8999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEcc-----CCceEEeeccccccCcc
Q 013064 117 MEYLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDK-----NGHLKLSDFGLCKPLED 190 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~-----~g~ikL~DFGla~~~~~ 190 (450)
|||+ ||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999 78999988765 47999999999999999999999999999999999999974 67899999999997654
Q ss_pred ccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHh
Q 013064 191 KYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEML 270 (450)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml 270 (450)
....... ......+.+|||.|||||++.+..|+.++|+|||||++|||+
T Consensus 159 ~~~~~~~-------------------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell 207 (293)
T d1csna_ 159 PVTKQHI-------------------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207 (293)
T ss_dssp TTTCCBC-------------------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred Cccccce-------------------------------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHH
Confidence 3111000 001123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhh---hhhhhhcccccccCC-CCCCCCHHHHHHHHHhhc-CccccCC
Q 013064 271 IGYPPFCSDDPRI---TCRKIVNWKTCLKFP-EEPKISDEARDLICHLLC-DVETRLG 323 (450)
Q Consensus 271 ~G~~PF~~~~~~~---~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-dp~~R~~ 323 (450)
+|..||.+..... ...++.........+ ....+++++.+|+..|+. +|.+||.
T Consensus 208 tg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~ 265 (293)
T d1csna_ 208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265 (293)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred hCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 9999998655433 333343322111111 013689999999999998 9999995
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=385.01 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=203.6
Q ss_pred EeEEeecCceEEEEEEEcCCC---CEEEEEEeechhhcchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEc-CCeEEEEEe
Q 013064 43 LTLIGKGAFGEVRLCRAKTTG---EIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDSRCIVQLFYSFQD-SDFLYLIME 118 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~f~~-~~~lylVmE 118 (450)
-++||+|+||+||+|++..++ ..||||++++. ......+.+.+|+++|++++|||||++++++.+ +..+|+|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 578999999999999987654 36899999753 345567889999999999999999999998764 568999999
Q ss_pred ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccccccCccccccccc
Q 013064 119 YLPGGDIMTLLMRE-DILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGLCKPLEDKYSSILL 197 (450)
Q Consensus 119 y~~gg~L~~~l~~~-~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGla~~~~~~~~~~~~ 197 (450)
||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||++++.+||+|||+++..........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~- 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV- 188 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT-
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc-
Confidence 99999999998754 4677889999999999999999999999999999999999999999999999997654311100
Q ss_pred cccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCCccccccchhHHHHHHhhCCCCCC
Q 013064 198 EDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAIMYEMLIGYPPFC 277 (450)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 277 (450)
.......||+.|+|||++....|+.++|||||||++|||++|..||.
T Consensus 189 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 189 ---------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp ---------------------------------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred ---------------------------------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 01123579999999999999999999999999999999999766665
Q ss_pred C-CChhhhhhhhhcccccccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcC
Q 013064 278 S-DDPRITCRKIVNWKTCLKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEH 333 (450)
Q Consensus 278 ~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~H 333 (450)
. .+..+....+.++. .+..| ..+++++.+||.+||. ||++|| ++.||++|
T Consensus 236 ~~~~~~~~~~~i~~g~-~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 287 (311)
T d1r0pa_ 236 PDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 287 (311)
T ss_dssp C------CHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-CCCCc--ccCcHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 4 44445556665543 33344 4789999999999998 999999 68898876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-48 Score=385.42 Aligned_cols=273 Identities=21% Similarity=0.354 Sum_probs=207.5
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-----------CCCeeeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-----------SRCIVQLFYS 106 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~l~~~ 106 (450)
.+|+++++||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|+.++ |||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 359999999999999999999999999999999986542 3456778888888774 5789999988
Q ss_pred EE--cCCeEEEEEeccCCCChHHHHH---hcCCCCHHHHHHHHHHHHHHHHHhhh-CCeEEeecCCCcEEEccCCc----
Q 013064 107 FQ--DSDFLYLIMEYLPGGDIMTLLM---REDILSEDVARFYIAESVLAIHSIHQ-HNYVHRDIKPDNLILDKNGH---- 176 (450)
Q Consensus 107 f~--~~~~lylVmEy~~gg~L~~~l~---~~~~~~e~~~~~~~~qil~aL~~LH~-~givHrDLKpeNILld~~g~---- 176 (450)
+. .....+++|+++.++....... ....+++..++.++.||+.||+|||+ .||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 75 4567888888876665444332 24579999999999999999999998 89999999999999987664
Q ss_pred --eEEeeccccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCCCC
Q 013064 177 --LKLSDFGLCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKGYG 254 (450)
Q Consensus 177 --ikL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~y~ 254 (450)
++|+|||.|...... ..+.+||+.|+|||++.+.+|+
T Consensus 169 ~~~kl~dfg~s~~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----------------------------------------YTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp EEEEECCCTTCEETTBC-----------------------------------------CCSCCSCGGGCCHHHHHTCCCC
T ss_pred ceeeEeecccccccccc-----------------------------------------cccccccccccChhhccccCCC
Confidence 999999998865432 1246899999999999999999
Q ss_pred ccccccchhHHHHHHhhCCCCCCCCChhh------hhhhhhc---------------------------cccc-------
Q 013064 255 MECDWWSLGAIMYEMLIGYPPFCSDDPRI------TCRKIVN---------------------------WKTC------- 294 (450)
Q Consensus 255 ~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~---------------------------~~~~------- 294 (450)
.++|+|||||++++|++|+.||...+... ....++. ....
T Consensus 208 ~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (362)
T d1q8ya_ 208 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 287 (362)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh
Confidence 99999999999999999999997543211 1111000 0000
Q ss_pred ----ccCCCCCCCCHHHHHHHHHhhc-CccccCCCCCHHHHHcCCCcCCCCccccccccCCccccCCCccc
Q 013064 295 ----LKFPEEPKISDEARDLICHLLC-DVETRLGTRGVEELKEHPWFRGIQWDKLYEMEAAYKPTVNGELD 360 (450)
Q Consensus 295 ----~~~p~~~~~s~~~~dli~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d 360 (450)
.........+++++|||.+||+ ||.+|| +++|+|+||||+++.+. .+...|..|...+..|
T Consensus 288 ~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp---ta~e~L~Hp~f~~~~~~--~~~~~p~~~~~~~~~~ 353 (362)
T d1q8ya_ 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDTLGM--EEIRVPDRELYGSGSD 353 (362)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTCTTC--TTCCCTTSCTTCBSTT
T ss_pred hhcccccccCcccCHHHHHHHHHHCCCChhHCc---CHHHHhcCcccCCCCCc--ccCCCCCcccCCCCCC
Confidence 0001112357889999999999 999999 79999999999976532 2344555555544433
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=375.23 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=189.8
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHH--HHhcCCCCeeeEEEEEEcCC----
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNL--LAEVDSRCIVQLFYSFQDSD---- 111 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~i--l~~l~hp~Iv~l~~~f~~~~---- 111 (450)
.+|.+.+.||+|+||.||+|+. +|+.||||+++... .....+|.++ +..++|||||++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 5789999999999999999986 68899999986543 2233444444 45789999999999998654
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhh--------CCeEEeecCCCcEEEccCCceEEeecc
Q 013064 112 FLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQ--------HNYVHRDIKPDNLILDKNGHLKLSDFG 183 (450)
Q Consensus 112 ~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~--------~givHrDLKpeNILld~~g~ikL~DFG 183 (450)
.+|+|||||++|+|.++|.+. .++++....++.|++.||.|||+ +|||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 689999999999999999765 68999999999999999999996 599999999999999999999999999
Q ss_pred ccccCccccccccccccccccccccccccccCCChHHHHHHHHhhccccccccccCCCccchhhhccCC------CCccc
Q 013064 184 LCKPLEDKYSSILLEDEDIINQETVSEAEGQWMMPKERLQQWKRNRRALAYSTVGTLDYMAPEVLLKKG------YGMEC 257 (450)
Q Consensus 184 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~Gt~~Y~APEvl~~~~------y~~~~ 257 (450)
+|+......... .......+||+.|||||++.+.. ++.++
T Consensus 154 l~~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~ 199 (303)
T d1vjya_ 154 LAVRHDSATDTI----------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199 (303)
T ss_dssp TCEEEETTTTEE----------------------------------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHH
T ss_pred ccccccCCCcce----------------------------------eccccceecccCcCChhhccccccccCCCcCcch
Confidence 998764331110 00122468999999999997643 67789
Q ss_pred cccchhHHHHHHhhCCCCCCCCChhh---------------hhhhhhcccccccCCCC---CCCCHHHHHHHHHhhc-Cc
Q 013064 258 DWWSLGAIMYEMLIGYPPFCSDDPRI---------------TCRKIVNWKTCLKFPEE---PKISDEARDLICHLLC-DV 318 (450)
Q Consensus 258 DiWSlGvilyeml~G~~PF~~~~~~~---------------~~~~i~~~~~~~~~p~~---~~~s~~~~dli~~lL~-dp 318 (450)
|||||||+||||++|.+||....... ....+........+|.. ......+.+|+.+||. ||
T Consensus 200 Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred hhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 99999999999999998885432111 11111111111122221 1123458899999998 99
Q ss_pred cccCCCCCHHHHHc
Q 013064 319 ETRLGTRGVEELKE 332 (450)
Q Consensus 319 ~~R~~~~~~~eil~ 332 (450)
.+|| ++.||++
T Consensus 280 ~~Rp---s~~ei~~ 290 (303)
T d1vjya_ 280 AARL---TALRIKK 290 (303)
T ss_dssp GGSC---CHHHHHH
T ss_pred hHCc---CHHHHHH
Confidence 9999 5778765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5.3e-27 Score=211.80 Aligned_cols=137 Identities=13% Similarity=0.130 Sum_probs=109.3
Q ss_pred eEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc---------------chhhHHHHHHHHHHHHhcCCCCeeeEE
Q 013064 40 FEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML---------------KRGQVEHVRSERNLLAEVDSRCIVQLF 104 (450)
Q Consensus 40 f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~---------------~~~~~~~~~~E~~il~~l~hp~Iv~l~ 104 (450)
+.+.+.||+|+||.||+|++. +|+.||||+++..... ..........|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999885 7899999987542211 011123455688899999999999988
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhhhCCeEEeecCCCcEEEccCCceEEeeccc
Q 013064 105 YSFQDSDFLYLIMEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIHQHNYVHRDIKPDNLILDKNGHLKLSDFGL 184 (450)
Q Consensus 105 ~~f~~~~~lylVmEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH~~givHrDLKpeNILld~~g~ikL~DFGl 184 (450)
++.. .++||||++++.+. .+++..+..++.|++.||.|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7643 27999999887553 35667778899999999999999999999999999999865 489999999
Q ss_pred cccCc
Q 013064 185 CKPLE 189 (450)
Q Consensus 185 a~~~~ 189 (450)
|+...
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 98654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=7.1e-08 Score=88.58 Aligned_cols=140 Identities=14% Similarity=0.102 Sum_probs=92.4
Q ss_pred CCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEcCCeEEEE
Q 013064 38 DDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD-SRCIVQLFYSFQDSDFLYLI 116 (450)
Q Consensus 38 ~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~f~~~~~lylV 116 (450)
+.|+.++..+-|+.+.||.+. ..++.+.+|....... .....+.+|..+|..+. +--+.+++++..+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 567777776656667999774 4566788888765432 22335677888888774 33467888888899999999
Q ss_pred EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhh-----------------------------------------
Q 013064 117 MEYLPGGDIMTLLMREDILSEDVARFYIAESVLAIHSIH----------------------------------------- 155 (450)
Q Consensus 117 mEy~~gg~L~~~l~~~~~~~e~~~~~~~~qil~aL~~LH----------------------------------------- 155 (450)
|++++|..+........ . ...++.++...|..||
T Consensus 89 ~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99999987754321100 0 1111112222222222
Q ss_pred ------------h------CCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 156 ------------Q------HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 156 ------------~------~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
+ ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 1389999999999998766667999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.28 E-value=1.3e-06 Score=85.29 Aligned_cols=81 Identities=20% Similarity=0.245 Sum_probs=51.5
Q ss_pred EeEEeecCceEEEEEEEcCCCCEEEEEEeechhhc-c---hhhHHHHHHHHHHHHhcC-C--CCeeeEEEEEEcCCeEEE
Q 013064 43 LTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEML-K---RGQVEHVRSERNLLAEVD-S--RCIVQLFYSFQDSDFLYL 115 (450)
Q Consensus 43 ~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~-~---~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~f~~~~~lyl 115 (450)
++.||.|....||++....+++.+++|.-...... . ....++...|..+|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 66799999999999988878888999965332111 1 112345667888887662 2 356666654 4445578
Q ss_pred EEeccCCCCh
Q 013064 116 IMEYLPGGDI 125 (450)
Q Consensus 116 VmEy~~gg~L 125 (450)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1.2e-05 Score=72.67 Aligned_cols=136 Identities=12% Similarity=0.102 Sum_probs=82.3
Q ss_pred EEeecCc-eEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEcCCeEEEEEeccC
Q 013064 45 LIGKGAF-GEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVD--SRCIVQLFYSFQDSDFLYLIMEYLP 121 (450)
Q Consensus 45 ~LG~G~f-g~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~f~~~~~lylVmEy~~ 121 (450)
.+..|.. +.||++.. ..+..+++|.-.... ...+..|...|+.+. .-.+++++.+..+++..|+||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 3344543 67898864 456678889765432 223667888877663 2337888888888889999999999
Q ss_pred CCChHH--------------HHHhcC-------CCC--HH-----HHHHHH---------------HHHHHHHHHhhh--
Q 013064 122 GGDIMT--------------LLMRED-------ILS--ED-----VARFYI---------------AESVLAIHSIHQ-- 156 (450)
Q Consensus 122 gg~L~~--------------~l~~~~-------~~~--e~-----~~~~~~---------------~qil~aL~~LH~-- 156 (450)
|.++.. .+.+-. .+. .. ....+. ......+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 865422 111100 000 00 000000 001112222222
Q ss_pred -----CCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 157 -----HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 157 -----~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2389999999999998776678999999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.69 E-value=8.1e-05 Score=72.17 Aligned_cols=81 Identities=16% Similarity=0.267 Sum_probs=56.5
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcC-------CCCEEEEEEeechhhcchhhHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKT-------TGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEV-DSRCIVQLFYS 106 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~-------t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 106 (450)
+..+++++ +.|+.|---.+|+|.... .++.|.+++..... . .....+|..+++.+ .+...++++++
T Consensus 40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~ 113 (395)
T d1nw1a_ 40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGI 113 (395)
T ss_dssp CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEE
Confidence 45566664 678889999999998753 34568888875321 1 23456788888877 35556788888
Q ss_pred EEcCCeEEEEEeccCCCCh
Q 013064 107 FQDSDFLYLIMEYLPGGDI 125 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L 125 (450)
|.+ .+||||++|..|
T Consensus 114 ~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 114 FSG----GRLEEYIPSRPL 128 (395)
T ss_dssp ETT----EEEECCCCEEEC
T ss_pred cCC----ceEEEEeccccC
Confidence 764 689999988533
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.14 E-value=0.0006 Score=63.93 Aligned_cols=130 Identities=11% Similarity=0.180 Sum_probs=75.7
Q ss_pred ceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC---C--CeeeE--EEEEEcCCeEEEEEeccCCC
Q 013064 51 FGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS---R--CIVQL--FYSFQDSDFLYLIMEYLPGG 123 (450)
Q Consensus 51 fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h---p--~Iv~l--~~~f~~~~~lylVmEy~~gg 123 (450)
--.||++.. .+|..|++|+..... ...+.+..|...|..|.. | ..+.. -..+..+...+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999876 478889999986542 224556778888877631 2 11111 12334567889999999874
Q ss_pred ChH----H----------HHHh----------------------------cCCCCHHHHHHH---HHHHHHHHHHhh---
Q 013064 124 DIM----T----------LLMR----------------------------EDILSEDVARFY---IAESVLAIHSIH--- 155 (450)
Q Consensus 124 ~L~----~----------~l~~----------------------------~~~~~e~~~~~~---~~qil~aL~~LH--- 155 (450)
.+. . .+.. ...++.+....+ +.+++..+.-+-
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 221 0 1110 011222212222 333333333221
Q ss_pred -hCCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 156 -QHNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 156 -~~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
..++||+|+.|.|||++. | ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 136999999999999964 4 45899999885
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.98 E-value=0.00086 Score=62.23 Aligned_cols=146 Identities=12% Similarity=0.037 Sum_probs=82.2
Q ss_pred CCCCCeEEEeEEeecCceEEEEEEEcCCCCEEEEEEeechhhcchhhHHHHHHHHHHHHhcCC-----CCeeeEE---EE
Q 013064 35 IGIDDFEQLTLIGKGAFGEVRLCRAKTTGEIFAMKKLKKSEMLKRGQVEHVRSERNLLAEVDS-----RCIVQLF---YS 106 (450)
Q Consensus 35 ~~~~~f~~~~~LG~G~fg~V~l~~~~~t~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-----p~Iv~l~---~~ 106 (450)
..+....-++.|..|---+.|++... +|+ |++|++.+.. . .+.+..|..+|..+.. |..+... ..
T Consensus 15 Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g~-yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~ 87 (316)
T d2ppqa1 15 YDVGSLTSYKGIAEGVENSNFLLHTT-KDP-LILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELL 87 (316)
T ss_dssp BCCCCEEEEEEECC---EEEEEEEES-SCC-EEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSC
T ss_pred CCCCCceEeecCCCCcccCeEEEEEC-CCc-EEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCcc
Confidence 46677777788888888999998754 444 8999986532 1 2334556666666532 2222211 11
Q ss_pred EEcCCeEEEEEeccCCCChHH--------------HHHhc---------------------------CCCCHHHHHHHHH
Q 013064 107 FQDSDFLYLIMEYLPGGDIMT--------------LLMRE---------------------------DILSEDVARFYIA 145 (450)
Q Consensus 107 f~~~~~lylVmEy~~gg~L~~--------------~l~~~---------------------------~~~~e~~~~~~~~ 145 (450)
..-....+.++.++.|..... .+... ...........+.
T Consensus 88 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 167 (316)
T d2ppqa1 88 GELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIR 167 (316)
T ss_dssp EEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHH
T ss_pred eeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHH
Confidence 222455677777777643311 00000 0001111222333
Q ss_pred HHHHHHHHhhh----CCeEEeecCCCcEEEccCCceEEeecccccc
Q 013064 146 ESVLAIHSIHQ----HNYVHRDIKPDNLILDKNGHLKLSDFGLCKP 187 (450)
Q Consensus 146 qil~aL~~LH~----~givHrDLKpeNILld~~g~ikL~DFGla~~ 187 (450)
.+...+.-.+. .|+||+|+.++||+++.++..-|+||+.|..
T Consensus 168 ~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 168 PEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 34444444432 4799999999999999887778999999874
|